PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mardis, ER; Ding, L; Dooling, DJ; Larson, DE; McLellan, MD; Chen, K; Koboldt, DC; Fulton, RS; Delehaunty, KD; McGrath, SD; Fulton, LA; Locke, DP; Magrini, VJ; Abbott, RM; Vickery, TL; Reed, JS; Robinson, JS; Wylie, T; Smith, SM; Carmichael, L; Eldred, JM; Harris, CC; Walker, J; Peck, JB; Du, FY; Dukes, AF; Sanderson, GE; Brummett, AM; Clark, E; McMichael, JF; Meyer, RJ; Schindler, JK; Pohl, CS; Wallis, JW; Shi, XQ; Lin, L; Schmidt, H; Tang, YZ; Haipek, C; Wiechert, ME; Ivy, JV; Kalicki, J; Elliott, G; Ries, RE; Payton, JE; Westervelt, P; Tomasson, MH; Watson, MA; Baty, J; Heath, S; Shannon, WD; Nagarajan, R; Link, DC; Walter, MJ; Graubert, TA; DiPersio, JF; Wilson, RK; Ley, TJ				Mardis, Elaine R.; Ding, Li; Dooling, David J.; Larson, David E.; McLellan, Michael D.; Chen, Ken; Koboldt, Daniel C.; Fulton, Robert S.; Delehaunty, Kim D.; McGrath, Sean D.; Fulton, Lucinda A.; Locke, Devin P.; Magrini, Vincent J.; Abbott, Rachel M.; Vickery, Tammi L.; Reed, Jerry S.; Robinson, Jody S.; Wylie, Todd; Smith, Scott M.; Carmichael, Lynn; Eldred, James M.; Harris, Christopher C.; Walker, Jason; Peck, Joshua B.; Du, Feiyu; Dukes, Adam F.; Sanderson, Gabriel E.; Brummett, Anthony M.; Clark, Eric; McMichael, Joshua F.; Meyer, Rick J.; Schindler, Jonathan K.; Pohl, Craig S.; Wallis, John W.; Shi, Xiaoqi; Lin, Ling; Schmidt, Heather; Tang, Yuzhu; Haipek, Carrie; Wiechert, Madeline E.; Ivy, Jolynda V.; Kalicki, Joelle; Elliott, Glendoria; Ries, Rhonda E.; Payton, Jacqueline E.; Westervelt, Peter; Tomasson, Michael H.; Watson, Mark A.; Baty, Jack; Heath, Sharon; Shannon, William D.; Nagarajan, Rakesh; Link, Daniel C.; Walter, Matthew J.; Graubert, Timothy A.; DiPersio, John F.; Wilson, Richard K.; Ley, Timothy J.			Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPY NUMBER ALTERATIONS; EXPRESSION; CANCER; GENE; IDH1; CLASSIFICATION; ABNORMALITIES; PATTERNS; AML	BACKGROUND The full complement of DNA mutations that are responsible for the pathogenesis of acute myeloid leukemia (AML) is not yet known. METHODS We used massively parallel DNA sequencing to obtain a very high level of coverage (approximately 98%) of a primary, cytogenetically normal, de novo genome for AML with minimal maturation (AML-M1) and a matched normal skin genome. RESULTS We identified 12 acquired (somatic) mutations within the coding sequences of genes and 52 somatic point mutations in conserved or regulatory portions of the genome. All mutations appeared to be heterozygous and present in nearly all cells in the tumor sample. Four of the 64 mutations occurred in at least 1 additional AML sample in 188 samples that were tested. Mutations in NRAS and NPM1 had been identified previously in patients with AML, but two other mutations had not been identified. One of these mutations, in the IDH1 gene, was present in 15 of 187 additional AML genomes tested and was strongly associated with normal cytogenetic status; it was present in 13 of 80 cytogenetically normal samples (16%). The other was a nongenic mutation in a genomic region with regulatory potential and conservation in higher mammals; we detected it in one additional AML tumor. The AML genome that we sequenced contains approximately 750 point mutations, of which only a small fraction are likely to be relevant to pathogenesis. CONCLUSIONS By comparing the sequences of tumor and skin genomes of a patient with AML-M1, we have identified recurring mutations that may be relevant for pathogenesis.	[Mardis, Elaine R.; Ding, Li; Magrini, Vincent J.; Wilson, Richard K.; Ley, Timothy J.] Washington Univ, Dept Genet, 660 S Euclid Ave,Campus Box 8007, St Louis, MO 63110 USA; [Ries, Rhonda E.; Westervelt, Peter; Tomasson, Michael H.; Heath, Sharon; Shannon, William D.; Link, Daniel C.; Walter, Matthew J.; Graubert, Timothy A.; DiPersio, John F.; Ley, Timothy J.] Washington Univ, Dept Med, St Louis, MO 63110 USA; [Payton, Jacqueline E.; Watson, Mark A.; Nagarajan, Rakesh] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Mardis, Elaine R.; Ding, Li; Dooling, David J.; Larson, David E.; McLellan, Michael D.; Chen, Ken; Koboldt, Daniel C.; Fulton, Robert S.; Delehaunty, Kim D.; McGrath, Sean D.; Fulton, Lucinda A.; Locke, Devin P.; Magrini, Vincent J.; Abbott, Rachel M.; Vickery, Tammi L.; Reed, Jerry S.; Robinson, Jody S.; Wylie, Todd; Smith, Scott M.; Carmichael, Lynn; Eldred, James M.; Harris, Christopher C.; Walker, Jason; Peck, Joshua B.; Du, Feiyu; Dukes, Adam F.; Sanderson, Gabriel E.; Brummett, Anthony M.; Clark, Eric; McMichael, Joshua F.; Meyer, Rick J.; Schindler, Jonathan K.; Pohl, Craig S.; Wallis, John W.; Shi, Xiaoqi; Lin, Ling; Schmidt, Heather; Tang, Yuzhu; Haipek, Carrie; Wiechert, Madeline E.; Ivy, Jolynda V.; Kalicki, Joelle; Elliott, Glendoria; Watson, Mark A.; Wilson, Richard K.; Ley, Timothy J.] Washington Univ, Genome Ctr, St Louis, MO 63110 USA; [Westervelt, Peter; Tomasson, Michael H.; Watson, Mark A.; Heath, Sharon; Shannon, William D.; Nagarajan, Rakesh; Link, Daniel C.; Walter, Matthew J.; Graubert, Timothy A.; DiPersio, John F.; Wilson, Richard K.; Ley, Timothy J.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Baty, Jack] Washington Univ, Div Biostat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Dept Genet, 660 S Euclid Ave,Campus Box 8007, St Louis, MO 63110 USA.	timley@wustl.edu	Chen, Ken/AAU-1432-2021; Chen, Ken/A-1074-2009; Mardis, Elaine/W-2202-2019; Magrini, Vincent/AAT-5830-2020; Walter, Matthew J/S-7758-2018; Wilson, Richard K./AAF-4139-2019; Walker, Jason/A-9702-2013; McGrath, Sean David/AAT-3540-2020	Chen, Ken/0000-0003-4013-5279; Magrini, Vincent/0000-0002-2019-4872; Wilson, Richard K./0000-0002-1992-1358; Walker, Jason/0000-0001-7547-5789; McGrath, Sean David/0000-0001-9064-8449; Locke, Devin/0000-0002-2527-0475; Tomasson, Michael/0000-0003-4518-7123; Ries, Rhonda/0000-0002-3702-7923; MCLELLAN, MICHAEL/0000-0002-2703-8784; Graubert, Timothy/0000-0002-7710-1171; Larson, David/0000-0001-7934-5906	National Institutes of Health [PO1-CA101937, U54-HG003079]; Barnes-Jewish Hospital Foundation [00335-0505-01]; NATIONAL CANCER INSTITUTE [P01CA101937] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the National Institutes of Health (PO1-CA101937, to Dr. Ley; and U54-HG003079, to Dr. Wilson) and the Barnes-Jewish Hospital Foundation (00335-0505-01, to Dr. Ley).	Baldus CD, 2007, BRIT J HAEMATOL, V137, P387, DOI 10.1111/j.1365-2141.2007.06566.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; DULBECCO R, 1986, SCIENCE, V231, P1055, DOI 10.1126/science.3945817; Falini B, 2005, NEW ENGL J MED, V352, P740; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Langer C, 2008, BLOOD, V111, P5371, DOI 10.1182/blood-2007-11-124958; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Marcucci G, 2007, J CLIN ONCOL, V25, P3337, DOI 10.1200/JCO.2007.10.8720; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Owen C, 2008, BRIT J HAEMATOL, V140, P123, DOI 10.1111/j.1365-2141.2007.06909.x; Pratz K, 2008, LEUKEMIA LYMPHOMA, V49, P852, DOI 10.1080/10428190801895352; Rucker FG, 2006, J CLIN ONCOL, V24, P3887, DOI 10.1200/JCO.2005.04.5450; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Suela J, 2007, LEUKEMIA, V21, P1224, DOI 10.1038/sj.leu.2404653; Tyybakinoja A, 2007, LEUKEMIA, V21, P571, DOI 10.1038/sj.leu.2404543; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	30	1680	1780	4	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1058	1066		10.1056/NEJMoa0903840	http://dx.doi.org/10.1056/NEJMoa0903840			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492LP	19657110	Green Accepted			2022-12-28	WOS:000269659400008
J	den Exter, A				den Exter, Andre			European Commission takes on Big Pharma	LANCET			English	Editorial Material									Erasmus Univ, Inst Hlth Policy & Management, Erasmus Observ Hlth Law, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam	den Exter, A (corresponding author), Erasmus Univ, Inst Hlth Policy & Management, Erasmus Observ Hlth Law, NL-3000 DR Rotterdam, Netherlands.	a.denexter@erasmusmc.nl						*EUR COMM, 2008, DG COMP PHARM SECT I; European Commission, 2009, PHARM SECT INQ; *UN GEN SECR, 2008, PROM PROT HUM RIGHTS	3	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 22	2009	374	9690					599	600		10.1016/S0140-6736(09)61370-2	http://dx.doi.org/10.1016/S0140-6736(09)61370-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19699998				2022-12-28	WOS:000269222600010
J	Patrinos, AAN; Bradley, RA				Patrinos, Aristides A. N.; Bradley, Richard A.			Energy and Technology Policies for Managing Carbon Risk	SCIENCE			English	Editorial Material									[Patrinos, Aristides A. N.] Synthet Genom Inc, Washington, DC 20024 USA; [Bradley, Richard A.] Int Energy Agcy, F-75739 Paris, France		Patrinos, AAN (corresponding author), Synthet Genom Inc, Washington, DC 20024 USA.	apatrinos@syntheticgenomics.com						Committee on America's Energy Future National Academy of Sciences National Academy of Engineering and National Research Council, 2009, AM EN FUT TECHN TRAN; Fisher B. S., 2007, CLIMATE CHANGE 2007, P170; *IEA, 2009, G8 EN MIN M ROM 24 2; IEA, 2007, MIND GAP QUANT PRINC; IEA, 2008, ENERGY TECHNOLOGY PE, DOI [10.1787/9789264041431-EN, DOI 10.1787/9789264041431-EN]; *IEA EN TECHN R D, 2008, FUND DAT; International Energy Agency (IEA), 2008, WORLD EN OUTL	7	11	12	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					949	950		10.1126/science.1177603	http://dx.doi.org/10.1126/science.1177603			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AN	19696336				2022-12-28	WOS:000269242800028
J	Markel, H				Markel, Howard			Experiments and Observations How William Beaumont and Alexis St. Martin Seized the Moment of Scientific Progress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Michigan, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Ctr Hist Med, 100 Simpson Inst,Box 0724,100 Observ, Ann Arbor, MI 48109 USA.	howard@umich.edu						Beaumont W., 1833, EXPT OBSERVATIONS GA; BEAUMONT W, SUNDRY CASES PRACTIC; Bensley E H, 1970, Bull Hist Med, V44, P101; BYLEBYL J J, 1970, Journal of the History of Medicine and Allied Sciences, V25, P3; Dunbar W. F., 1995, MICHIGAN HIST WOLVER; Horsman Reginald, 1996, FRONTIER DOCTOR W BE; LEBLOND S, 1963, CAN MED ASSOC J, V88, P1205; Madsen A., 2001, JOHN JACOB ASTOR AME; MYER JS, 1912, LIFE LETT W BEAUMONT, P289; NUMBERS RL, 1981, ISIS, V72, P590, DOI 10.1086/352844; Numbers Ronald L, 1979, J Hist Biol, V12, P113, DOI 10.1007/BF00128137; Osler W, 1902, J AMER MED ASSOC, V39, P1223; ROSEN G, 1942, RECEPTION W BEAUMONT; Rutkow IM, 1998, ARCH SURG-CHICAGO, V133, P1259, DOI 10.1001/archsurg.133.11.1259	14	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					804	806		10.1001/jama.2009.1212	http://dx.doi.org/10.1001/jama.2009.1212			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690317				2022-12-28	WOS:000269073800033
J	Renear, AH; Palmer, CL				Renear, Allen H.; Palmer, Carole L.			Strategic Reading, Ontologies, and the Future of Scientific Publishing	SCIENCE			English	Review							INFORMATION-SEEKING BEHAVIOR; BIO-ONTOLOGIES; DIGITAL ENVIRONMENT; DATA INTEGRATION; DISCOVERY; BIOLOGY; TEXT; RETRIEVAL; SERVICES; SYSTEMS	The revolution in scientific publishing that has been promised since the 1980s is about to take place. Scientists have always read strategically, working with many articles simultaneously to search, filter, scan, link, annotate, and analyze fragments of content. An observed recent increase in strategic reading in the online environment will soon be further intensified by two current trends: (i) the widespread use of digital indexing, retrieval, and navigation resources and (ii) the emergence within many scientific disciplines of interoperable ontologies. Accelerated and enhanced by reading tools that take advantage of ontologies, reading practices will become even more rapid and indirect, transforming the ways in which scientists engage the literature and shaping the evolution of scientific publishing.	[Renear, Allen H.; Palmer, Carole L.] Univ Illinois, Ctr Informat Res Sci & Scholarship, Grad Sch Lib & Informat Sci, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign	Renear, AH (corresponding author), Univ Illinois, Ctr Informat Res Sci & Scholarship, Grad Sch Lib & Informat Sci, Champaign, IL 61820 USA.	renear@illinois.edu	Renear, Allen/AAC-3844-2020; DE OLIVEIRA, EUZEBIO/AAT-4425-2021; DE OLIVEIRA, EUZEBIO/AAC-3942-2020	DE OLIVEIRA, EUZEBIO/0000-0001-8059-5902; Nabeel, Abdalrahman/0000-0002-8889-2036	NSF [0222848]	NSF(National Science Foundation (NSF))	This research was supported in part by NSF grant 0222848	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bishop AP, 1999, INFORM PROCESS MANAG, V35, P255, DOI 10.1016/S0306-4573(98)00061-2; Blake J, 2004, NAT BIOTECHNOL, V22, P773, DOI 10.1038/nbt0604-773; Blake JA, 2006, J BIOMED INFORM, V39, P314, DOI 10.1016/j.jbi.2006.01.003; Bodenreider O, 2006, BRIEF BIOINFORM, V7, P256, DOI 10.1093/bib/bbl027; Bourne P, 2005, PLOS COMPUT BIOL, V1, P179, DOI 10.1371/journal.pcbi.0010034; COOMBS JH, 1987, COMMUN ACM, V30, P933, DOI 10.1145/32206.32209; Foster I, 2005, SCIENCE, V308, P814, DOI 10.1126/science.1110411; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Huitfeldt, 2002, P 2002 ACM S DOC ENG, P119, DOI DOI 10.1145/585058.585081; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Kim JJ, 2008, BRIEF BIOINFORM, V9, P452, DOI 10.1093/bib/bbn032; KING DW, 2003, D LIB MAG, V9; Krallinger M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-224; Mons B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-142; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; MURRAYRUST P, 2004, J DIGIT INFORM, V5; Nicholas D, 2004, J DOC, V60, P24, DOI 10.1108/00220410410516635; Nicholas D, 2007, INFORM PROCESS MANAG, V43, P1085, DOI 10.1016/j.ipm.2006.08.007; Palmer C.L., 2001, WORK BOUNDARIES SCI; Palmer CL, 2007, INFORM PROCESS MANAG, V43, P808, DOI 10.1016/j.ipm.2006.06.003; Schatz B, 1999, COMPUTER, V32, P51, DOI 10.1109/2.745720; Seringhaus MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-17; SHOLTON D, 2009, LEARN PUBL, V22, P85; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Spasic I, 2005, BRIEF BIOINFORM, V6, P239, DOI 10.1093/bib/6.3.239; Stromback L, 2007, PROTEOMICS, V7, P857, DOI 10.1002/pmic.200600438; Swanson DR, 1997, ARTIF INTELL, V91, P183, DOI 10.1016/S0004-3702(97)00008-8; TENOPIR C, 2008, D LIB MAG, V14; Tenopir C., 2004, SERIALS LIBR, V46, P20, DOI DOI 10.1300/J123v46n01_14	30	98	101	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					828	832		10.1126/science.1157784	http://dx.doi.org/10.1126/science.1157784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679805				2022-12-28	WOS:000269242400034
J	Kasen, D; Ropke, FK; Woosley, SE				Kasen, D.; Roepke, F. K.; Woosley, S. E.			The diversity of type Ia supernovae from broken symmetries	NATURE			English	Article							DELAYED-DETONATION MODEL; LIGHT CURVES; LUMINOSITY	Type Ia supernovae result when carbon-oxygen white dwarfs in binary systems accrete mass from companion stars, reach a critical mass and explode. The near uniformity of their light curves makes these supernovae good `standard candles' for measuring cosmic expansion(1-4), but a correction must be applied to account for the fact that the brighter ones have broader light curves(5). One-dimensional modelling, with a certain choice of parameters, can reproduce this general trend in the width-luminosity relation(6-8); but the processes of ignition and detonation have recently been shown to be intrinsically asymmetric(9-13), so parameterization must have its limits. Here we report multi-dimensional modelling of the explosion physics and radiative transfer, which reveals that the breaking of spherical symmetry is a critical factor in determining both the width luminosity relation and the observed scatter about it. The deviation from spherical symmetry can also explain the finite polarization detected in the light from some supernovae(14). The slope and normalization of the width-luminosity relation has a weak dependence on certain properties of the white dwarf progenitor, in particular the trace abundances of elements other than carbon and oxygen. Failing to correct for this effect could lead to systematic overestimates of up to 2 per cent in the distance to remote supernovae.	[Kasen, D.; Woosley, S. E.] UCSC, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Roepke, F. K.] Max Planck Inst Astrophys, D-85741 Garching, Germany	University of California System; University of California Santa Cruz; Max Planck Society	Kasen, D (corresponding author), UCSC, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA.	kasen@ucolick.org	Kasen, Daniel/I-3443-2015	Kasen, Daniel/0000-0002-5981-1022; Ropke, Friedrich/0000-0002-4460-0097	DOE SciDAC Program; NASA; German Research Foundation	DOE SciDAC Program(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); German Research Foundation(German Research Foundation (DFG))	D. K. and S. E. W. thank the Max Planck Institute for Astrophysics for hospitality during a visit when much of this research was carried out. Support for this work was provided by the DOE SciDAC Program. Support for D. K. was provided by NASA through a Hubble fellowship grant awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA. The research of F. K. R. is supported through the Emmy Noether Program of the German Research Foundation. We are grateful for computer time provided by NERSC and ORNL through an INCITE award.	Aspden AJ, 2008, ASTROPHYS J, V689, P1173, DOI 10.1086/592726; Astier P, 2006, ASTRON ASTROPHYS, V447, P31, DOI 10.1051/0004-6361:20054185; BRANCH D, 1993, ASTRON J, V106, P2383, DOI 10.1086/116810; Gamezo VN, 2005, ASTROPHYS J, V623, P337, DOI 10.1086/428767; Hillebrandt W, 2000, ANNU REV ASTRON ASTR, V38, P191, DOI 10.1146/annurev.astro.38.1.191; Hoflich P, 2004, ASTROPHYS J, V617, P1258, DOI 10.1086/425571; HOFLICH P, 1995, ASTROPHYS J, V444, P831, DOI 10.1086/175656; Hoflich P, 1996, ASTROPHYS J, V457, P500, DOI 10.1086/176748; HOFLICH P, 1996, APJ, V472, P81; Howell DA, 2009, ASTROPHYS J, V691, P661, DOI 10.1088/0004-637X/691/1/661; Kasen D, 2007, ASTROPHYS J, V656, P661, DOI 10.1086/510375; Kasen D, 2006, ASTROPHYS J, V651, P366, DOI 10.1086/506190; KHOKHLOV AM, 1991, ASTRON ASTROPHYS, V245, P114; Krisciunas K, 2004, ASTROPHYS J, V602, pL81, DOI 10.1086/382731; Kuhlen M, 2006, ASTROPHYS J, V640, P407, DOI 10.1086/500105; Livne E, 2005, ASTROPHYS J, V632, P443, DOI 10.1086/432975; Livne E, 1999, ASTROPHYS J, V527, pL97, DOI 10.1086/312405; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Pinto PA, 2001, NEW ASTRON, V6, P307, DOI 10.1016/S1384-1076(01)00057-4; Reinecke M, 2002, ASTRON ASTROPHYS, V391, P1167, DOI 10.1051/0004-6361:20020885; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Stanishev V, 2007, ASTRON ASTROPHYS, V469, P645, DOI 10.1051/0004-6361:20066020; Timmes FX, 2003, ASTROPHYS J, V590, pL83, DOI 10.1086/376721; Wang LF, 2008, ANNU REV ASTRON ASTR, V46, P433, DOI 10.1146/annurev.astro.46.060407.145139; Wood-Vasey WM, 2007, ASTROPHYS J, V666, P694, DOI 10.1086/518642; Woosley SE, 2007, ASTROPHYS J, V668, P1109, DOI 10.1086/520835; Woosley SE, 2007, J PHYS CONF SER, V78, DOI 10.1088/1742-6596/78/l/012081; WOOSLEY SE, 2008, ASTROPHYS J UNPUB	30	233	234	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					869	872		10.1038/nature08256	http://dx.doi.org/10.1038/nature08256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675647	Green Submitted			2022-12-28	WOS:000268938300032
J	Chan, AT; Ogino, S; Fuchs, CS				Chan, Andrew T.; Ogino, Shuji; Fuchs, Charles S.			Aspirin Use and Survival After Diagnosis of Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Digestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association	MAY 30-JUN 04, 2009	Chicago, IL	Amer Gastroenterol Assoc			CYCLOOXYGENASE-2 GENE-EXPRESSION; FOOD FREQUENCY QUESTIONNAIRE; MALE HEALTH-PROFESSIONALS; NATIONAL DEATH INDEX; COLON-CANCER; LIVER METASTASIS; RANDOMIZED-TRIAL; UP-REGULATION; HEMATOGENOUS METASTASIS; SELECTIVE-INHIBITION	Context Aspirin reduces risk of colorectal neoplasia in randomized trials and inhibits tumor growth and metastases in animal models. However, the influence of aspirin on survival after diagnosis of colorectal cancer is unknown. Objective To examine the association between aspirin use after colorectal cancer diagnosis on colorectal cancer-specific and overall survival. Design, Setting, and Participants Prospective cohort study of 1279 men and women diagnosed with stage I, II, or III colorectal cancer. Participants were enrolled in 2 nationwide health professional cohorts in 1980 and 1986 prior to diagnosis and followed up through June 1, 2008. Main Outcome Measure Colorectal cancer-specific and overall mortality. Results After a median follow-up of 11.8 years, there were 193 total deaths (35%) and 81 colorectal cancer-specific deaths (15%) among 549 participants who regularly used aspirin after colorectal cancer diagnosis, compared with 287 total deaths (39%) and 141 colorectal cancer-specific deaths (19%) among 730 participants who did not use aspirin. Compared with nonusers, participants who regularly used aspirin after diagnosis experienced a multivariate hazard ratio (HR) for colorectal cancer-specific mortality of 0.71 (95% confidence interval [CI], 0.53-0.95) and for overall mortality of 0.79 ( 95% CI, 0.65-0.97). Among 719 participants who did not use aspirin before diagnosis, aspirin use initiated after diagnosis was associated with a multivariate HR for colorectal cancer-specific mortality of 0.53 ( 95% CI, 0.33-0.86). Among 459 participants with colorectal cancers that were accessible for immunohistochemical assessment, the effect of aspirin differed significantly according to cyclooxygenase 2 (COX-2) expression (P for interaction = .04). Regular aspirin use after diagnosis was associated with a lower risk of colorectal cancer-specific mortality among participants in whom primary tumors overexpressed COX-2 ( multivariate HR, 0.39; 95% CI, 0.20-0.76), whereas aspirin use was not associated with lower risk among those with primary tumors with weak or absent expression ( multivariate HR, 1.22; 95% CI, 0.36-4.18). Conclusion Regular aspirin use after the diagnosis of colorectal cancer is associated with lower risk of colorectal cancer-specific and overall mortality, especially among individuals with tumors that overexpress COX-2. JAMA. 2009; 302(6):649-659 www.jama.com	[Chan, Andrew T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Ogino, Shuji] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ogino, Shuji; Fuchs, Charles S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chan, Andrew T.; Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Chan, AT (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, 55 Fruit St,GRJ 722, Boston, MA 02114 USA.	achan@partners.org	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; Ogino, Shuji/0000-0002-3909-2323	NATIONAL CANCER INSTITUTE [P01CA055075, P50CA127003, R01CA118553, K07CA122826, P01CA087969, R01CA137178, K07CA107412] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA118553, CA137178, P01 CA087969, P01 CA055075-18, P50 CA127003, K07 CA107412-05, P01 CA055075, R01 CA137178, P01 CA055075-110002, CA87969, K07 CA107412, K07 CA122826, CA122826, CA107412, CA55075, P50 CA127003-03, R01 CA137178-01A1, R01 CA118553-03, CA127003, CA118553] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arber N, 2008, CANCER EPIDEM BIOMAR, V17, P1852, DOI 10.1158/1055-9965.EPI-08-0167; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Buchanan FG, 2004, GASTROENTEROLOGY, V127, P1391, DOI 10.1053/j.gastro.2004.07.025; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chen WS, 2001, INT J CANCER, V91, P894, DOI 10.1002/1097-0215(200102)9999:9999<894::AID-IJC1146>3.3.CO;2-R; Cianchi F, 2001, GASTROENTEROLOGY, V121, P1339, DOI 10.1053/gast.2001.29691; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Fuchs C, 2005, J CLIN ONCOL, V23, p253S; Fux R, 2005, CLIN CANCER RES, V11, P4754, DOI 10.1158/1078-0432.CCR-04-2586; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Goel A, 2003, CLIN CANCER RES, V9, P383; Greene FL, 2002, AJCC CANC STAGING HD; Gum PA, 2001, JAMA-J AM MED ASSOC, V286, P1187, DOI 10.1001/jama.286.10.1187; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Joo YE, 2002, J GASTROINTEST CANC, V31, P147, DOI 10.1385/IJGC:31:1-3:147; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Lin J, 2005, BIOCHEM PHARMACOL, V70, P658, DOI 10.1016/j.bcp.2005.05.028; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; LUNDHOLM K, 1994, CANCER RES, V54, P5602; MANSON JE, 1991, JAMA-J AM MED ASSOC, V266, P521, DOI 10.1001/jama.266.4.521; Markowitz SD, 2007, NEW ENGL J MED, V356, P2195, DOI 10.1056/NEJMe078044; Martinez ME, 2003, P NATL ACAD SCI USA, V100, P7859, DOI 10.1073/pnas.1332465100; Masunaga R, 2000, CLIN CANCER RES, V6, P4064; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Ogino S, 2008, CLIN CANCER RES, V14, P8221, DOI 10.1158/1078-0432.CCR-08-1841; Petersen S, 2002, ANTICANCER RES, V22, P1225; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1992, AM J EPIDEMIOL, V135, P1127, DOI [DOI 10.1093/OXFORDJOURNALS.AJE.A116211, DOI 10.1093/OXFORDJOUMALS.AJE.A116211]; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Tomozawa S, 1999, BRIT J CANCER, V81, P1274, DOI 10.1038/sj.bjc.6694262; Tomozawa S, 2000, BRIT J CANCER, V83, P324, DOI 10.1054/bjoc.2000.1270; Trifan OC, 2002, CANCER RES, V62, P5778; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Uchida K, 2005, CLIN CANCER RES, V11, P3363, DOI 10.1158/1078-0432.CCR-04-1650; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Williams CS, 2000, CANCER RES, V60, P6045; Williams CS, 2000, J CLIN INVEST, V105, P1589, DOI 10.1172/JCI9621; Williams CS, 2001, NEOPLASIA, V3, P428, DOI 10.1038/sj.neo.7900177; Yamac D, 2005, PATHOL RES PRACT, V201, P497, DOI 10.1016/j.prp.2005.04.006; Yamauchi T, 2003, ANTICANCER RES, V23, P245; Yao M, 2005, CLIN CANCER RES, V11, P1618, DOI 10.1158/1078-0432.CCR-04-1696; Yao M, 2003, CANCER RES, V63, P586; Yao M, 2004, BRIT J CANCER, V90, P712, DOI 10.1038/sj.bjc.6601489; Zhang H, 2002, AM J GASTROENTEROL, V97, P1037	66	423	443	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					649	659		10.1001/jama.2009.1112	http://dx.doi.org/10.1001/jama.2009.1112			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	481ZI	19671906	Green Accepted, Bronze			2022-12-28	WOS:000268852300023
J	Arunakumari, PS; Walker, S				Arunakumari, P. S.; Walker, S.			Practice 10-Minute Consultation Reduced sexual desire in women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Arunakumari, P. S.] Royal United Hosp Bath NHS Trust, Bath BA1 3NG, Avon, England; [Walker, S.] Psychosexual Med, Box Surg SN13 8NA, Wilts, England		Arunakumari, PS (corresponding author), Royal United Hosp Bath NHS Trust, Bath BA1 3NG, Avon, England.	aruna2805@yahoo.co.uk						LITVINOFF S, 2005, RELATE GUIDE SEX LOV; Stoppard M., 2003, HLTH SEX; Tomlinson J., 2004, ABC SEXUAL HLTH	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2009	339								b2371	10.1136/bmj.b2371	http://dx.doi.org/10.1136/bmj.b2371			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	485YG	19666985				2022-12-28	WOS:000269161700001
J	Kerouedan, D				Kerouedan, Dominique			Health and development financing in Africa	LANCET			English	Editorial Material												d.kerouedan@skynet.be						*ACT GLOB HLTH, 2008, 2 ACT GLOB HLTH; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; *DEP HLTH, 2008, EV LINKS N S HEALTHC; *EUR COURT AUD, 2007, 62007 EUR COURT AUD; *EUR COURT AUD, 2009, EUR COMM DEV ASS HLT; *IND EV GROUP, 2009, EV HNP EX SUMM; *MACR INT INC, 2009, EX SUMM GLOB FUND 5; MORANGE P, 2005, EVALUATION FRANCES C; *NAT AUD OFF DEP I, 2008, PROV BUDG SUPP DEV C; Over M., 2008, PREVENTION FAILURE B; Piot P, 2009, LANCET, V374, P260, DOI 10.1016/S0140-6736(09)60321-4; 2009, ALQUILLA G8 HLTH EXP	13	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 8	2009	374	9688					435	437		10.1016/S0140-6736(09)61434-3	http://dx.doi.org/10.1016/S0140-6736(09)61434-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482OK	19665632				2022-12-28	WOS:000268898400008
J	Nori, F				Nori, Franco			Quantum Football	SCIENCE			English	Editorial Material							SUPERCONDUCTING QUBIT; SYSTEMS; CIRCUIT; STATE		[Nori, Franco] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Nori, Franco] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	RIKEN; University of Michigan System; University of Michigan	Nori, F (corresponding author), RIKEN, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	fnori@riken.jp	Nori, Franco/B-1222-2009	Nori, Franco/0000-0003-3682-7432				Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Deppe F, 2008, NAT PHYS, V4, P686, DOI 10.1038/nphys1016; Grajcar M, 2008, NAT PHYS, V4, P612, DOI 10.1038/nphys1019; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Neeley M, 2008, NAT PHYS, V4, P523, DOI 10.1038/nphys972; Neeley M, 2009, SCIENCE, V325, P722, DOI 10.1126/science.1173440; Nori F, 2008, NAT PHYS, V4, P589, DOI 10.1038/nphys1044; Schoelkopf RJ, 2008, NATURE, V451, P664, DOI 10.1038/451664a; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Valenzuela SO, 2006, SCIENCE, V314, P1589, DOI 10.1126/science.1134008; Wilson CM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.257003; Yamamoto T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.064505; You JQ, 2005, PHYS TODAY, V58, P42, DOI 10.1063/1.2155757; Zagoskin AM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.077001	14	15	15	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					689	690		10.1126/science.1178828	http://dx.doi.org/10.1126/science.1178828			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661411				2022-12-28	WOS:000268723700029
J	Schilling, G				Schilling, Govert			Spain unveils its eye on the sky	NATURE			English	News Item																		Hand E, 2008, NATURE, V452, P142, DOI 10.1038/452142a; Peplow M, 2005, NATURE, V435, P140, DOI 10.1038/435140a; 2009, NATURE, V460, P563	3	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					674	674		10.1038/460674a	http://dx.doi.org/10.1038/460674a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661879	Bronze			2022-12-28	WOS:000268670300007
J	Slack, E; Hapfelmeier, S; Stecher, B; Velykoredko, Y; Stoel, M; Lawson, MAE; Geuking, MB; Beutler, B; Tedder, TF; Hardt, WD; Bercik, P; Verdu, EF; McCoy, KD; Macpherson, AJ				Slack, Emma; Hapfelmeier, Siegfried; Stecher, Baerbel; Velykoredko, Yuliya; Stoel, Maaike; Lawson, Melissa A. E.; Geuking, Markus B.; Beutler, Bruce; Tedder, Thomas F.; Hardt, Wolf-Dietrich; Bercik, Premysl; Verdu, Elena F.; McCoy, Kathy D.; Macpherson, Andrew J.			Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism	SCIENCE			English	Article							TOLL-LIKE RECEPTORS; CROHNS-DISEASE; INTESTINAL HOMEOSTASIS; CITROBACTER-RODENTIUM; COMMENSAL BACTERIA; RESPONSES; MYD88; MICE; SUSCEPTIBILITY; PATHOGENESIS	Commensal bacteria in the lower intestine of mammals are 10 times as numerous as the body's cells. We investigated the relative importance of different immune mechanisms in limiting the spread of the intestinal microbiota. Here, we reveal a flexible continuum between innate and adaptive immune function in containing commensal microbes. Mice deficient in critical innate immune functions such as Toll-like receptor signaling or oxidative burst production spontaneously produce high-titer serum antibodies against their commensal microbiota. These antibody responses are functionally essential to maintain host-commensal mutualism in vivo in the face of innate immune deficiency. Spontaneous hyper-activation of adaptive immunity against the intestinal microbiota, secondary to innate immune deficiency, may clarify the underlying mechanisms of inflammatory diseases where immune dysfunction is implicated.	[Slack, Emma; Hapfelmeier, Siegfried; Velykoredko, Yuliya; Stoel, Maaike; Lawson, Melissa A. E.; Geuking, Markus B.; Bercik, Premysl; Verdu, Elena F.; McCoy, Kathy D.; Macpherson, Andrew J.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON L8S 4L8, Canada; [Stecher, Baerbel; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8032 Zurich, Switzerland; [Beutler, Bruce] Scripps Res Inst, Dept Genet, La Jolla, CA 92121 USA; [Tedder, Thomas F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Slack, Emma; Hapfelmeier, Siegfried; Macpherson, Andrew J.] Univ Bern, UVCM, DKF Dept Clin Res, Maurice Muller Labs, CH-3008 Bern, Switzerland	McMaster University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Scripps Research Institute; Duke University; University of Bern	Slack, E (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON L8S 4L8, Canada.	emma.slack@dkf.unibe.ch; andrew.macpherson@insel.ch	Eckhardt, Erik/G-1567-2010; Lawson, Melissa/K-5848-2014; McCoy, Kathy/ABD-5814-2021; Stecher, Barbel/B-9940-2019; Slack, Emma/B-1612-2016; Hapfelmeier, Siegfried/B-6005-2011; Bercik, Premysl/ABF-3983-2020; Slack, Emma/AAD-5837-2019; Stecher, Bärbel/A-2911-2015	Slack, Emma/0000-0002-2473-1145; Hapfelmeier, Siegfried/0000-0002-6913-7932; Slack, Emma/0000-0002-2473-1145; Stecher, Bärbel/0000-0002-7445-5193; Hardt, Wolf-Dietrich/0000-0002-9892-6420; Lawson, Melissa/0000-0001-9882-8663	Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada; Genome Canada; Canada Research Chairs; Canadian Association of Gastroenterology; NIH [CA105001, AI56363]; NATIONAL CANCER INSTITUTE [R01CA105001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056363] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Foundation of Canada; Genome Canada(Genome Canada); Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Association of Gastroenterology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant support: Canadian Institutes of Health Research, Crohn's and Colitis Foundation of Canada, Genome Canada, Canada Research Chairs, Canadian Association of Gastroenterology, NIH grant numbers CA105001 and AI56363.	Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Fux CA, 2005, TRENDS MICROBIOL, V13, P58, DOI 10.1016/j.tim.2004.11.001; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Mueller C, 2006, GUT, V55, P276, DOI 10.1136/gut.2004.054098; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Sigthorsson G, 2002, GASTROENTEROLOGY, V122, P1913, DOI 10.1053/gast.2002.33647; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	22	366	377	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					617	620		10.1126/science.1172747	http://dx.doi.org/10.1126/science.1172747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644121	Green Accepted			2022-12-28	WOS:000268493000052
J	Drysdale, RN; Hellstrom, JC; Zanchetta, G; Fallick, AE; Goni, MFS; Couchoud, I; McDonald, J; Maas, R; Lohmann, G; Isola, I				Drysdale, R. N.; Hellstrom, J. C.; Zanchetta, G.; Fallick, A. E.; Goni, M. F. Sanchez; Couchoud, I.; McDonald, J.; Maas, R.; Lohmann, G.; Isola, I.			Evidence for Obliquity Forcing of Glacial Termination II	SCIENCE			English	Article							PAST 800,000 YEARS; SEA-LEVEL; IBERIAN MARGIN; PENULTIMATE DEGLACIATION; MEDITERRANEAN REGION; ICE AGES; STALAGMITE; CYCLES; LAND; PRECIPITATION	Variations in the intensity of high-latitude Northern Hemisphere summer insolation, driven largely by precession of the equinoxes, are widely thought to control the timing of Late Pleistocene glacial terminations. However, recently it has been suggested that changes in Earth's obliquity may be a more important mechanism. We present a new speleothem-based North Atlantic marine chronology that shows that the penultimate glacial termination (Termination II) commenced 141,000 +/- 2500 years before the present, too early to be explained by Northern Hemisphere summer insolation but consistent with changes in Earth's obliquity. Our record reveals that Terminations I and II are separated by three obliquity cycles and that they started at near-identical obliquity phases.	[Drysdale, R. N.; Couchoud, I.; McDonald, J.] Univ Newcastle, Environm & Climate Change Grp, Callaghan, NSW 2308, Australia; [Hellstrom, J. C.; Maas, R.] Univ Melbourne, Sch Earth Sci, Parkville, Vic 2010, Australia; [Zanchetta, G.] Univ Pisa, Dept Earth Sci, I-56100 Pisa, Italy; [Zanchetta, G.; Isola, I.] Ist Nazl Geofis & Vulcanol, I-56126 Pisa, Italy; [Zanchetta, G.] IGG CNR, I-56100 Pisa, Italy; [Fallick, A. E.] Scottish Univ Environm Res Ctr, E Kilbride G75 0GF, Lanark, Scotland; [Goni, M. F. Sanchez] Univ Bordeaux 1, EPHE, CNRS, UMR EPOC 5805, F-33405 Talence, France; [Lohmann, G.] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany	University of Newcastle; University of Melbourne; University of Pisa; Istituto Nazionale Geofisica e Vulcanologia (INGV); Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); Scottish Universities Research & Reactor Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Bordeaux; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Drysdale, RN (corresponding author), Univ Newcastle, Environm & Climate Change Grp, Callaghan, NSW 2308, Australia.	russell.drysdale@newcastle.edu.au	Hellstrom, John C/B-1770-2008; Couchoud, Isabelle/C-3309-2012; Isola, Ilaria/AAU-1895-2021; Goñi, Maria Fernanda Sanchez/R-3699-2019; Drysdale, Russell/AAH-9376-2019; Lohmann, Gerrit/M-7453-2016	Hellstrom, John C/0000-0001-9427-3525; Couchoud, Isabelle/0000-0002-7166-9575; Goñi, Maria Fernanda Sanchez/0000-0001-8238-7488; Lohmann, Gerrit/0000-0003-2089-733X; Isola, Ilaria/0000-0002-3911-4676; Zanchetta, Giovanni/0000-0002-7080-9599; Fallick, Anthony/0000-0002-7649-6167; Drysdale, Russell/0000-0001-7867-031X	Federazione Speleologica Toscana; University of Newcastle; Australian Research Council [DP0773700]; Scottish Alliance for Geoscience, Environment, and Society (SAGES)	Federazione Speleologica Toscana; University of Newcastle; Australian Research Council(Australian Research Council); Scottish Alliance for Geoscience, Environment, and Society (SAGES)	We acknowledge the comments of P. Huybers, S. Frisia, R. Lever, P. Hoare, and three anonymous reviewers and thank A. Berger, B. Martrat, and L. Skinner for providing data. Laboratory and drafting assistance was provided by T. Smith, S. Komar, A. Tait, J. Dougans, and O. Rey-Lescure. This research was funded by the Federazione Speleologica Toscana, the University of Newcastle, and the Australian Research Council (DP0773700) and falls within the framework of the Scottish Alliance for Geoscience, Environment, and Society (SAGES).	Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Bard E, 2002, EARTH PLANET SC LETT, V196, P135, DOI 10.1016/S0012-821X(01)00600-8; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Celle-Jeanton H, 2001, GEOPHYS RES LETT, V28, P1215, DOI 10.1029/2000GL012407; DANSGAARD W, 1964, TELLUS, V16, P436; Drysdale RN, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024658; Drysdale RN, 2004, EARTH PLANET SC LETT, V227, P215, DOI 10.1016/j.epsl.2004.09.010; Drysdale RN, 2007, GEOLOGY, V35, P77, DOI 10.1130/G23161A.1; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; Gallup CD, 2002, SCIENCE, V295, P310, DOI 10.1126/science.1065494; Goni MFS, 2005, EARTH PLANET SC LETT, V231, P111, DOI 10.1016/j.epsl.2004.12.010; Goni MFS, 1999, EARTH PLANET SC LETT, V171, P123; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Henderson GM, 2006, QUATERNARY SCI REV, V25, P3346, DOI 10.1016/j.quascirev.2006.03.003; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; Huybers P, 2007, QUATERNARY SCI REV, V26, P37, DOI 10.1016/j.quascirev.2006.07.013; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; Martrat B, 2004, SCIENCE, V306, P1762, DOI 10.1126/science.1101706; Martrat B, 2007, SCIENCE, V317, P502, DOI 10.1126/science.1139994; Milankovitch M., 1941, KANON ERDBESTRAHLUNG; Pailler D, 2002, PALAEOGEOGR PALAEOCL, V181, P431, DOI 10.1016/S0031-0182(01)00444-8; Raymo ME, 2008, NATURE, V451, P284, DOI 10.1038/nature06589; Raymo ME, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000791; Schulz KG, 2006, EARTH PLANET SC LETT, V249, P326, DOI 10.1016/j.epsl.2006.07.004; Shackleton N. J., 1973, Quaternary Research, V3, P39, DOI 10.1016/0033-5894(73)90052-5; Shackleton NJ, 2002, QUATERNARY RES, V58, P14, DOI 10.1006/qres.2001.2312; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Siddall M, 2006, GEOLOGY, V34, P817, DOI 10.1130/G22705.1; Skinner LC, 2006, QUATERNARY SCI REV, V25, P3312, DOI 10.1016/j.quascirev.2006.07.005; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; Thomas AL, 2009, SCIENCE, V324, P1186, DOI 10.1126/science.1168754; Thompson WG, 2005, SCIENCE, V308, P401, DOI 10.1126/science.1104035; Waelbroeck C, 2008, EARTH PLANET SC LETT, V265, P183, DOI 10.1016/j.epsl.2007.10.006; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255	40	173	176	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1527	1531		10.1126/science.1170371	http://dx.doi.org/10.1126/science.1170371			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19679773				2022-12-28	WOS:000269887900035
J	Boland, MJ; Hazen, JL; Nazor, KL; Rodriguez, AR; Gifford, W; Martin, G; Kupriyanov, S; Baldwin, KK				Boland, Michael J.; Hazen, Jennifer L.; Nazor, Kristopher L.; Rodriguez, Alberto R.; Gifford, Wesley; Martin, Greg; Kupriyanov, Sergey; Baldwin, Kristin K.			Adult mice generated from induced pluripotent stem cells	NATURE			English	Article							TETRAPLOID CELLS; FIBROBLASTS; EXPRESSION; INDUCTION; NEURONS	Recent landmark experiments have shown that transient overexpression of a small number of transcription factors can reprogram differentiated cells into induced pluripotent stem (iPS) cells that resemble embryonic stem (ES) cells(1-7). These iPS cells hold great promise for medicine because they have the potential to generate patient-specific cell types for cell replacement therapy and produce in vitro models of disease, without requiring embryonic tissues or oocytes(8-10). Although current iPS cell lines resemble ES cells, they have not passed the most stringent test of pluripotency by generating full-term or adult mice in tetraploid complementation assays(3,11), raising questions as to whether they are sufficiently potent to generate all of the cell types in an organism. Whether this difference between iPS and ES cells reflects intrinsic limitations of direct reprogramming is not known. Here we report fertile adult mice derived entirely from iPS cells that we generated by inducible genetic reprogramming of mouse embryonic fibroblasts. Producing adult mice derived entirely from a reprogrammed fibroblast shows that all features of a differentiated cell can be restored to an embryonic level of pluripotency without exposure to unknown ooplasmic factors. Comparing these fully pluripotent iPS cell lines to less developmentally potent lines may reveal molecular markers of different pluripotent states. Furthermore, mice derived entirely from iPS cells will provide a new resource to assess the functional and genomic stability of cells and tissues derived from iPS cells, which is important to validate their utility in cell replacement therapy and research applications.	[Boland, Michael J.; Hazen, Jennifer L.; Nazor, Kristopher L.; Baldwin, Kristin K.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Rodriguez, Alberto R.; Martin, Greg; Kupriyanov, Sergey] Scripps Res Inst, Mouse Genet Core Facil, La Jolla, CA 92037 USA; [Gifford, Wesley] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego	Baldwin, KK (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kitnazor@scripps.edu; kbaldwin@scripps.edu		Baldwin, Kristin/0000-0002-6137-030X; Boland, Michael/0000-0001-5649-9603	Pew Scholars Award; California Institute of Regenerative Medicine; Whitehall Foundation; O'Keefe Foundation; Shapiro Family Foundation	Pew Scholars Award; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Whitehall Foundation; O'Keefe Foundation; Shapiro Family Foundation	We wish to thank S. Carlson for help with animal husbandry, K. Spencer for help with imaging, and D. Trajkovic for help with histology. We thank G. Joyce, U. Mueller, L. Stowers, A. Patapoutian and A. Maximov for critical reading of the manuscript. We thank M. Mayford for the gift of rtTAM2.2, A. Maximov for the lentiviral vector backbones, and members of A. Kralli's laboratory for assistance with qPCR. We thank R. Axel for supporting the generation of the Pcdh21/Cre mouse strain, which was a gift. This work was supported by a Pew Scholars Award (K. K. B.) and grants from the California Institute of Regenerative Medicine, the Whitehall Foundation, the O'Keefe Foundation, and the Shapiro Family Foundation.	Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2003, METHOD ENZYMOL, V365, P25; Eggan K, 2006, PRIN PRACT, P41; Go WY, 2002, J GENE MED, V4, P258, DOI 10.1002/jgm.271; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MacKay GE, 2005, MECH DEVELOP, V122, P1266, DOI 10.1016/j.mod.2005.09.001; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nagai Y, 2005, GENESIS, V43, P12, DOI 10.1002/gene.20146; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A, 2003, MANIPULATING MOUSE E, P453; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	32	335	360	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					91	U94		10.1038/nature08310	http://dx.doi.org/10.1038/nature08310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19672243				2022-12-28	WOS:000269478800036
J	Araya, R; Alvarado, R; Minoletti, A				Araya, Ricardo; Alvarado, Ruben; Minoletti, Alberto			Chile: an ongoing mental health revolution	LANCET			English	Editorial Material							CARE		[Araya, Ricardo] Univ Bristol, Acad Unit Psychiat, Bristol BS6 6JL, Avon, England; [Alvarado, Ruben] Univ Chile, Fac Med, Dept Publ Hlth, Santiago 7, Chile; [Minoletti, Alberto] Minist Hlth Santiago, Santiago, Chile	University of Bristol; Universidad de Chile	Araya, R (corresponding author), Univ Bristol, Acad Unit Psychiat, Bristol BS6 6JL, Avon, England.	R.Araya@bris.ac.uk	Araya, Ricardo/S-3144-2019	Araya, Ricardo/0000-0002-0420-5148				Araya R, 2006, AM J PUBLIC HEALTH, V96, P109, DOI 10.2105/AJPH.2004.055715; Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; *MIN SAL, 2009, AV PROGR DEPR GES; *MIN SAL, 2009, EST CAS GES JUL 2005; *MIN SAL, 2001, GUIA CLIN AT PRIM DE; MINOLETTI A, SALUD MENTA IN PRESS; Patel V, 2008, LANCET, V372, P1354, DOI 10.1016/S0140-6736(08)61556-1; *SUP SAL, 2009, INF FISC SUP SAL, V2; Unger JP, 2008, PLOS MED, V5, P542, DOI 10.1371/journal.pmed.0050079; World Bank, 2008, REAL RIGHTS SOC GUAR	10	38	41	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 22	2009	374	9690					597	598		10.1016/S0140-6736(09)61490-2	http://dx.doi.org/10.1016/S0140-6736(09)61490-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19699997				2022-12-28	WOS:000269222600009
J	Jones, L; Asare, JB; El Masri, M; Mohanraj, A; Sherief, H; van Ommeren, M				Jones, Lynne; Asare, Joseph B.; El Masri, Mustafa; Mohanraj, Andrew; Sherief, Hassen; van Ommeren, Mark			Severe mental disorders in complex emergencies	LANCET			English	Article							HEALTH-SERVICES; LOW-INCOME; CARE; KNOWLEDGE; VALIDITY; ILLNESS; TSUNAMI; ETHICS	People with severe mental disorders are a neglected and vulnerable group in complex emergencies. Here, we describe field experiences in establishing mental health services in five humanitarian settings. We show data to quantify the issue, and suggest reasons for this neglect. We then outline the actions needed to establish services in these settings, including the provision of practical training, medication, psychosocial supports, and, when appropriate, work with traditional healers. We have identified some persisting problems locally, nationally, and internationally, and suggest some solutions. Protection and care of people with severe mental disorders in complex emergencies is a humanitarian responsibility.	[Jones, Lynne] Int Med Corps, Santa Monica, CA USA; [El Masri, Mustafa] Int Med Corps, Gaza, Israel; [Mohanraj, Andrew] CBM Aceh Psychosocial Rehabil Programme Prov Hlth, Banda Aceh, Indonesia; [Sherief, Hassen] Karamara Reg Hosp, Jijiga, Somali Region, Ethiopia; [van Ommeren, Mark] WHO, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland	World Health Organization	Jones, L (corresponding author), Univ Cambridge Dev Psychiat, Douglas House,18B Trumpington Rd, Cambridge CB2 8AH, England.	ljones@imcworldwide.org			Bureau for Population, Refugees and Migration, US Department of State, USA; Office for Disaster Assistance, US Department of State, USA; Department of International Development, UK	Bureau for Population, Refugees and Migration, US Department of State, USA; Office for Disaster Assistance, US Department of State, USA; Department of International Development, UK	This report is based partly on a presentation at the Academy of Medical Sciences global mental health symposium in London on Sept 4, 2008. We thank all the International Medical Corps staff members in Aceh, Pakistan, Sierra Leone, Chad, and Ethiopia who have contributed to running mental health services in those locations and assisted in collecting data; and Prof Allen Dyer and unknown reviewers for their comments on earlier drafts of this report. The views expressed in this article are solely those of the authors and do not necessarily represent the views, policies, and decisions of the authors' employers. Funding for the programmes described in the report was provided by Bureau for Population, Refugees and Migration, US Department of State, USA; Office for Disaster Assistance, US Department of State, USA; and Department of International Development, UK. The figure was kindly provided by Dr Lynne Jones. This report is dedicated to the memory of Hassen Sherief (1960-2009).	Allden K, 2009, PREHOSP DISASTER MED, V24, pE217, DOI 10.1017/S1049023X00021622; Asare Joe, 2005, BMJ, V331, P720, DOI 10.1136/bmj.331.7519.720-b; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; Boyden Jo, 2004, CHILDREN YOUTH FRONT, P237; BUDOSAN B, 2007, J HUMAN ASSIST; Carballo M, 2006, INT REV PSYCHIATR, V18, P217, DOI 10.1080/09540260600655870; de Jong K, 1999, LANCET, V353, P1616, DOI 10.1016/S0140-6736(99)00084-7; Hodges B, 2001, AM J PSYCHIAT, V158, P1579, DOI 10.1176/appi.ajp.158.10.1579; Inter-Agency Standing Committee (IASC), 2007, AM PSYCHOL ASS, DOI [DOI 10.1037/E518422011-002, 10.1037/e518422011-002]; Jones L, 2003, BRIT J PSYCHIAT, V183, P540, DOI 10.1192/bjp.183.6.540; JONES L, 1995, BRIT MED J, V310, P1052, DOI 10.1136/bmj.310.6986.1052; Jones L M, 2007, Asia Pac J Public Health, V19 Spec No, P60; Jones L, 2007, BMJ-BRIT MED J, V335, P679, DOI 10.1136/bmj.39329.580891.BE; Karam EG, 2006, LANCET, V367, P1000, DOI 10.1016/S0140-6736(06)68427-4; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; Kessler RC, 2006, B WORLD HEALTH ORGAN, V84, P930, DOI 10.2471/BLT.06.033019; Kleinman A., 1988, RETHINKING PSYCHIAT; Leaning J, 2001, LANCET, V357, P1432, DOI 10.1016/S0140-6736(00)04572-4; Mahoney J, 2006, INT REV PSYCHIATR, V18, P593, DOI 10.1080/09540260601129206; Minas Harry, 2008, Int J Ment Health Syst, V2, P8, DOI 10.1186/1752-4458-2-8; *OFF COORD HUM AFF, 1999, OCHA OR HDB COMPL EM; Patel V, 2001, BRIT MED J, V322, P482, DOI 10.1136/bmj.322.7284.482; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Prasetiyawan, 2006, INT REV PSYCHIATR, V18, P559, DOI 10.1080/09540260601039959; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; SARTORIUS N, 1993, ARCH GEN PSYCHIAT, V50, P115; Scholte W. F., 2004, INTERVENTION INT J M, V2, P181; Silove D, 2000, LANCET, V355, P1548, DOI 10.1016/S0140-6736(00)02177-2; Silove D, 2008, ARCH GEN PSYCHIAT, V65, P1205, DOI 10.1001/archpsyc.65.10.1205; *SPHER PROJ, 2004, SPHER HDB; Sumathipala A, 2005, LANCET, V366, P1418, DOI 10.1016/S0140-6736(05)67581-2; Summerfield D, 1999, SOC SCI MED, V48, P1449, DOI 10.1016/S0277-9536(98)00450-X; Summerfield D, 2008, BMJ-BRIT MED J, V336, P992, DOI 10.1136/bmj.39513.441030.AD; TENANT C, 2005, B BOARD INT AFFAIRS, V8, P17; Toole M, 2002, LANCET, V360, P869, DOI 10.1016/S0140-6736(02)09959-2; Van De Put WACM, 2002, PL S STRESS, P93; van Ommeren M, 2005, B WORLD HEALTH ORGAN, V83, P71; van Ommeren M, 2004, J NERV MENT DIS, V192, P313, DOI 10.1097/01.nmd.0000122381.09491.7f; van Ommeren M, 2003, LANCET, V362, P574, DOI 10.1016/S0140-6736(03)14123-2; Ventevogel Peter, 2002, J Ayub Med Coll Abbottabad, V14, P1; Weiss MG, 2003, J NERV MENT DIS, V191, P611, DOI 10.1097/01.nmd.0000087188.96516.a3; *WHO, 2008, INT MENT HLTH PRIM H; *WHO, MENT HLTH S IN PRESS; World Health Organization, 2006, EC ASP MENT HLTH SYS; Yule W, 2006, INT REV PSYCHIATR, V18, P259, DOI 10.1080/09540260600656134; [No title captured]	46	54	55	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2009	374	9690					654	661		10.1016/S0140-6736(09)61253-8	http://dx.doi.org/10.1016/S0140-6736(09)61253-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19700007				2022-12-28	WOS:000269222600026
J	Awasthi, A; Kuchroo, VK				Awasthi, Amit; Kuchroo, Vijay K.			The Yin and Yang of Follicular Helper T Cells	SCIENCE			English	Editorial Material							C-MAF; IL-21; GENERATION; ICOS; INTERLEUKIN-21		[Awasthi, Amit; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Awasthi, A (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu						Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303	15	21	22	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					953	955		10.1126/science.1178752	http://dx.doi.org/10.1126/science.1178752			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AN	19696339				2022-12-28	WOS:000269242800031
J	Marder, S				Marder, Steven			Both typical and atypical antipsychotic agents were associated with increased risk for sudden cardiac death Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									US Dept Vet Affairs, Los Angeles, CA USA	US Department of Veterans Affairs	Marder, S (corresponding author), US Dept Vet Affairs, Los Angeles, CA USA.							Marder SR, 2004, AM J PSYCHIAT, V161, P1334, DOI 10.1176/appi.ajp.161.8.1334; Schneeweiss S, 2009, NEW ENGL J MED, V360, P294, DOI 10.1056/NEJMe0809417	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2009	151	4								10.7326/0003-4819-151-4-200908180-02012	http://dx.doi.org/10.7326/0003-4819-151-4-200908180-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484IW	19687486				2022-12-28	WOS:000269038900041
J	Torquato, S; Jiao, Y				Torquato, S.; Jiao, Y.			Dense packings of the Platonic and Archimedean solids	NATURE			English	Article							MOLECULAR-DYNAMICS SIMULATION; NONSPHERICAL HARD PARTICLES	Dense particle packings have served as useful models of the structures of liquid, glassy and crystalline states of matter(1-4), granular media(3,5), heterogeneous materials(3) and biological systems(6-8). Probing the symmetries and other mathematical properties of the densest packings is a problem of interest in discrete geometry and number theory(9-11). Previous work has focused mainly on spherical particles-very little is known about dense polyhedral packings. Here we formulate the generation of dense packings of polyhedra as an optimization problem, using an adaptive fundamental cell subject to periodic boundary conditions (we term this the 'adaptive shrinking cell' scheme). Using a variety of multi-particle initial configurations, we find the densest known packings of the four non-tiling Platonic solids (the tetrahedron, octahedron, dodecahedron and icosahedron) in three-dimensional Euclidean space. The densities are 0.782..., 0.947..., 0.904... and 0.836..., respectively. Unlike the densest tetrahedral packing, which must not be a Bravais lattice packing, the densest packings of the other non-tiling Platonic solids that we obtain are their previously known optimal (Bravais) lattice packings. Combining our simulation results with derived rigorous upper bounds and theoretical arguments leads us to the conjecture that the densest packings of the Platonic and Archimedean solids with central symmetry are given by their corresponding densest lattice packings. This is the analogue of Kepler's sphere conjecture for these solids.	[Torquato, S.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Torquato, S.] Princeton Univ, Princeton Ctr Theoret Sci, Princeton, NJ 08544 USA; [Torquato, S.] Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA; [Torquato, S.; Jiao, Y.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Torquato, S.] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	Princeton University; Princeton University; Princeton University; Princeton University; Institute for Advanced Study - USA	Torquato, S (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	torquato@princeton.edu	Jiao, Yang/H-3823-2011		National Science Foundation [DMS-0804431, DMR-0820341]	National Science Foundation(National Science Foundation (NSF))	We are grateful to H. Cohn and J. Conway for comments on our manuscript. S. T. thanks the Institute for Advanced Study for its hospitality during his stay there. This work was supported by the National Science Foundation under award numbers DMS-0804431 and DMR-0820341. The figures showing the polyhedra were generated using the AntiPrism package developed by A. Rossiter.	Bernal J. D, 1965, LIQUIDS STRUCTURE PR, P25; Betke U, 2000, COMP GEOM-THEOR APPL, V16, P157, DOI 10.1016/S0925-7721(00)00007-9; Chaikin P. M., 2000, PRINCIPLES CONDENSED; Chen ER, 2008, DISCRETE COMPUT GEOM, V40, P214, DOI 10.1007/s00454-008-9101-y; Conway JH, 2006, P NATL ACAD SCI USA, V103, P10612, DOI 10.1073/pnas.0601389103; Conway J. H., 1998, SPHERE PACKINGS LATT; Cromwell P. R., 1997, POLYHEDRA; Donev A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.255506; Donev A, 2005, J COMPUT PHYS, V202, P765, DOI 10.1016/j.jcp.2004.08.025; Donev A, 2005, J COMPUT PHYS, V202, P737, DOI 10.1016/j.jcp.2004.08.014; Donev A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051304; Edwards S. F., 1994, GRANULAR MATTER INTE, P121; Gardner M, 2001, COLOSSAL BOOK MATH C, P135; Gevertz JL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000152; GOLSHTEIN E, 1996, MODIFIED LAGRANGIANS; Hales TC, 2005, ANN MATH, V162, P1065, DOI 10.4007/annals.2005.162.1065; HOYLMAN DJ, 1970, B AM MATH SOC, V76, P135, DOI 10.1090/S0002-9904-1970-12400-4; Jiao Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041309; JODREY WS, 1985, PHYS REV A, V32, P2347, DOI 10.1103/PhysRevA.32.2347; Liang J, 2001, BIOPHYS J, V81, P751, DOI 10.1016/S0006-3495(01)75739-6; Minkowski H., 1904, NACHRICHTEN GES WISS, P311; Purohit PK, 2003, P NATL ACAD SCI USA, V100, P3173, DOI 10.1073/pnas.0737893100; Rintoul MD, 1998, PHYS REV E, V58, P532, DOI 10.1103/PhysRevE.58.532; Torquato S, 2001, J PHYS CHEM B, V105, P11849, DOI 10.1021/jp011960q; Torquato S., 2002, APPL MECH REV, V55, pB62, DOI [10.1115/1.1483342, DOI 10.1115/1.1483342]; Uche OU, 2004, PHYSICA A, V342, P428, DOI 10.1016/j.physa.2004.05.082; Zallen R., 1983, PHYS AMORPHOUS SOLID	28	308	315	3	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					876	U109		10.1038/nature08239	http://dx.doi.org/10.1038/nature08239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675649	Green Submitted			2022-12-28	WOS:000268938300034
J	Davies, IW; Welch, CJ				Davies, Ian W.; Welch, Christopher J.			Looking Forward in Pharmaceutical Process Chemistry	SCIENCE			English	Editorial Material								Core activities of process chemistry involve the synthesis of drug candidates at a scale that supports clinical evaluations and the creation of a manufacturing process that is safe, robust, and cost effective. Innovative problem solving has always been a key element in process chemistry and will be increasingly important for addressing emerging challenges in science, globalization, and commoditization. The acquisition and creation of platform chemical technologies that enable rapid problem solving through the use of high-throughput experimentation will continue to be an important focus going forward. Linking and deploying platforms throughout the discovery-development continuum is expected to enable drug discovery. Increasing collaboration with academia will also become more important for accessing technical solutions and providing the next generation of innovative problem solvers.	[Davies, Ian W.; Welch, Christopher J.] Merck, Rahway, NJ 07065 USA	Merck & Company	Davies, IW (corresponding author), Merck, 126 E Lincoln Ave, Rahway, NJ 07065 USA.		Welch, Christopher J/P-4171-2016	Welch, Christopher J/0000-0002-8899-4470				Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Desrosiers P. J., 2004, MOD DRUG DISCOV, P40; Federsel HJ, 2009, ACCOUNTS CHEM RES, V42, P671, DOI 10.1021/ar800257v; Fox RJ, 2008, TRENDS BIOTECHNOL, V26, P132, DOI 10.1016/j.tibtech.2007.12.001; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; RAINSFORD KD, 1999, IBUPROFEN CRITICAL B; Shultz CS, 2007, ACCOUNTS CHEM RES, V40, P1320, DOI 10.1021/ar700141v; Welch CJ, 2008, ORG PROCESS RES DEV, V12, P674, DOI 10.1021/op800107u; Welch CJ, 2008, ORG PROCESS RES DEV, V12, P81, DOI 10.1021/op700191z	9	47	47	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					701	704		10.1126/science.1174501	http://dx.doi.org/10.1126/science.1174501			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661417				2022-12-28	WOS:000268723700035
J	Falk, G; Fahey, T				Falk, Gavin; Fahey, Tom			Diagnosis in General Practice Clinical prediction rules	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; LIKELIHOOD RATIOS; SEVERITY; ACCURACY		[Fahey, Tom] Royal Coll Surgeons Ireland, Sch Med, Dept Gen Practice, Dublin 2, Ireland	Royal College of Surgeons - Ireland	Fahey, T (corresponding author), Royal Coll Surgeons Ireland, Sch Med, Dept Gen Practice, Dublin 2, Ireland.	tomfahey@rcsi.ie	Falk, Gavin A/D-7658-2013; Fahey, Tom/C-9367-2012	Falk, Gavin A/0000-0003-1765-0838; Fahey, Tom/0000-0002-5896-5783				Bachmann LM, 2006, BRIT MED J, V332, P1127, DOI 10.1136/bmj.38793.637789.2F; Bont J, 2008, ARCH INTERN MED, V168, P1465, DOI 10.1001/archinte.168.13.1465; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; BUCHSBAUM DG, 1991, ANN INTERN MED, V115, P774, DOI 10.7326/0003-4819-115-10-774; Fahey T, 2008, EVIDENCE BASE CLIN D, P213; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; McGinn T, 2002, USERS GUIDES MED LIT, P471; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009	12	14	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2009	339								b2899	10.1136/bmj.b2899	http://dx.doi.org/10.1136/bmj.b2899			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KF	19666679				2022-12-28	WOS:000268808200003
J	Han, D; Lerner, AG; Vande Walle, L; Upton, JP; Xu, WH; Hagen, A; Backes, BJ; Oakes, SA; Papa, FR				Han, Dan; Lerner, Alana G.; Vande Walle, Lieselotte; Upton, John-Paul; Xu, Weihong; Hagen, Andrew; Backes, Bradley J.; Oakes, Scott A.; Papa, Feroz R.			IRE1 alpha Kinase Activation Modes Control Alternate Endoribonuclease Outputs to Determine Divergent Cell Fates	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; TYROSINE KINASE; IRE1 REVEALS; ER STRESS; GENES; LOAD	During endoplasmic reticulum ( ER) stress, homeostatic signaling through the unfolded protein response (UPR) augments ER protein-folding capacity. If homeostasis is not restored, the UPR triggers apoptosis. We found that the ER transmembrane kinase/endoribonuclease (RNase) IRE1 alpha is a key component of this apoptotic switch. ER stress induces IRE1 alpha kinase autophosphorylation, activating the RNase to splice XBP1 mRNA and produce the homeostatic transcription factor XBP1s. Under ER stress-or forced autophosphorylation-IRE1 alpha's RNase also causes endonucleolytic decay of many ER-localized mRNAs, including those encoding chaperones, as early events culminating in apoptosis. Using chemical genetics, we show that kinase inhibitors bypass autophosphorylation to activate the RNase by an alternate mode that enforces XBP1 splicing and averts mRNA decay and apoptosis. Alternate RNase activation by kinase-inhibited IRE1 alpha can be reconstituted in vitro. We propose that divergent cell fates during ER stress hinge on a balance between IRE1 alpha RNase outputs that can be tilted with kinase inhibitors to favor survival.	[Han, Dan; Lerner, Alana G.; Vande Walle, Lieselotte; Hagen, Andrew; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Upton, John-Paul; Oakes, Scott A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Han, Dan; Lerner, Alana G.; Vande Walle, Lieselotte; Hagen, Andrew; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Han, Dan; Lerner, Alana G.; Vande Walle, Lieselotte; Hagen, Andrew; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Xu, Weihong] Stanford Univ, Stanford Genome Technol Ctr, Stanford, CA 94304 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	frpapa@medicine.ucsf.edu	Longo, Kenneth A/A-5631-2010; Xu, Weihong/C-4175-2012	Xu, Weihong/0000-0002-3988-3571; Hagen, Andrew/0000-0002-2691-157X; Papa, Feroz/0000-0002-3684-9108	National Institutes of Health [DP2 OD001925, K08 DK065671, RO1 DK080955, K08 A1054650, RO1 CA136577]; NIGMS-IMSD [R25 GM56847]; Howard Hughes Medical Institute Physician-Scientist Early Career Award; Steward Trust Foundation; Sandler Program in Basic Sciences; Burroughs Wellcome Foundation; Hillblom Foundation; Partnership for Cures; NATIONAL CANCER INSTITUTE [R01CA136577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI054650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080955, K08DK065671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS-IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); Steward Trust Foundation; Sandler Program in Basic Sciences; Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Hillblom Foundation; Partnership for Cures; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Ryffel for INS-1/FRT/TO cells, L. Glimcher for Xbp1<SUP>-/-</SUP> MEFs, D. Ron for Ire1 alpha<SUP>-/-</SUP> MEFs, F. Urano for anti-IRE1 alpha antibodies, P. Merksamer for ER and cytosolic GFP vectors, and C. Zhang and K. Shokat for 1NM-PP1. We thank J. Bluestone, D. Ganem, M. Hebrok, D. Sheppard, and members of the Oakes and Papa labs for comments. This work was supported by National Institutes of Health: Director's New Innovator Award DP2 OD001925 ( F. R. P), K08 DK065671 ( F. R. P.), RO1 DK080955 ( F. R. P), K08 A1054650 ( S. A. O.), RO1 CA136577 ( S. A. O.), and NIGMS-IMSD R25 GM56847 ( A. G. L.); a Howard Hughes Medical Institute Physician-Scientist Early Career Award ( S. A. O.); the Steward Trust Foundation ( S. A. O.); the Sandler Program in Basic Sciences ( S. A. O. and F. R. P.); the Burroughs Wellcome Foundation ( F. R. P.); the Hillblom Foundation ( F. R. P.); and the Partnership for Cures ( F. R. P.).	Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Harding HP, 2001, COLD SPRING HARB SYM, V66, P499, DOI 10.1101/sqb.2001.66.499; Higashio H, 2002, BIOCHEM BIOPH RES CO, V296, P568, DOI 10.1016/S0006-291X(02)00923-3; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	31	586	611	4	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					562	575		10.1016/j.cell.2009.07.017	http://dx.doi.org/10.1016/j.cell.2009.07.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665977	Green Accepted, Bronze			2022-12-28	WOS:000268771900020
J	Leong, T; Bourke, W				Leong, Tora; Bourke, William			The many faces of tension pneumothoraces	LANCET			English	Editorial Material									[Leong, Tora; Bourke, William] Our Ladys Hosp, Dept Med, Navan, Meath, Ireland		Leong, T (corresponding author), Our Ladys Hosp, Dept Med, Navan, Meath, Ireland.	toraleong@gmail.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 1	2009	374	9687					404	404		10.1016/S0140-6736(09)60311-1	http://dx.doi.org/10.1016/S0140-6736(09)60311-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481MJ	19647608				2022-12-28	WOS:000268815200024
J	Becker, NB; Everaers, R				Becker, Nils B.; Everaers, Ralf			Comment on "Remeasuring the Double Helix"	SCIENCE			English	Editorial Material							DNA	Mathew-Fenn et al. (Reports, 17 October 2008, p. 446) reported unexpected distance fluctuations in short end-labeled DNA constructs and interpreted them as evidence for cooperative DNA stretching modes. We show that when accounting for a subtle linker leverage effect, their data can be understood within standard noncooperative DNA elasticity.	[Everaers, Ralf] Univ Lyon, Ctr Blaise Pascal, F-69007 Lyon, France; Univ Lyon, Ecole Normale Super, Phys Lab, CNRS UMR 5672, F-69007 Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON)	Everaers, R (corresponding author), Univ Lyon, Ctr Blaise Pascal, 46 Allee Italie, F-69007 Lyon, France.	ralf.everaers@ens-lyons.fr	M & C, Matter & Complexity/B-9044-2011; Everaers, Ralf/K-2228-2013	Everaers, Ralf/0000-0002-6843-2753; Becker, Nils/0000-0002-7490-6425				Becker NB, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021923; Becker NB, 2006, NUCLEIC ACIDS RES, V34, P5638, DOI 10.1093/nar/gkl683; CALLADINE CR, 1984, J MOL BIOL, V178, P773, DOI 10.1016/0022-2836(84)90251-1; Gore J, 2006, NATURE, V442, P836, DOI 10.1038/nature04974; Kroy K, 1996, PHYS REV LETT, V77, P306, DOI 10.1103/PhysRevLett.77.306; Lankas F, 2003, BIOPHYS J, V85, P2872, DOI 10.1016/S0006-3495(03)74710-9; Lionnet T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.178102; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mathew-Fenn RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003229; Mathew-Fenn RS, 2008, SCIENCE, V322, P446, DOI 10.1126/science.1158881; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163	11	24	24	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940								10.1126/science.1168786	http://dx.doi.org/10.1126/science.1168786			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644093				2022-12-28	WOS:000268493000017
J	Pevzner, P; Shamir, R				Pevzner, Pavel; Shamir, Ron			Computing Has Changed Biology-Biology Education Must Catch Up	SCIENCE			English	Editorial Material							21ST-CENTURY		[Pevzner, Pavel] Univ Calif San Diego, Dept Comp Sci, La Jolla, CA 92093 USA; [Shamir, Ron] Tel Aviv Univ, Blavatn Sch Comp Sci, IL-69978 Tel Aviv, Israel	University of California System; University of California San Diego; Tel Aviv University	Pevzner, P (corresponding author), Univ Calif San Diego, Dept Comp Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ppevzner@cs.ucsd.edu	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bialek W, 2004, SCIENCE, V303, P788, DOI 10.1126/science.1095480; Brent Roger, 2004, Cell Biol Educ, V3, P88, DOI 10.1187/cbe.04-03-0041; Grindrod P, 2008, MATH TODAY, V44, P80; Gross Louis J, 2004, Cell Biol Educ, V3, P85, DOI 10.1187/cbe.04-03-0040; Iyer LM, 2001, GENOME BIOL, V2; National Research Council, 2003, BIO2010 TRANSF UND E; Pevzner PA, 2004, BIOINFORMATICS, V20, P2159, DOI 10.1093/bioinformatics/bth217; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wingreen N, 2006, NAT REV MOL CELL BIO, V7, P829, DOI 10.1038/nrm2023	9	54	56	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					541	542		10.1126/science.1173876	http://dx.doi.org/10.1126/science.1173876			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19644094				2022-12-28	WOS:000268493000022
J	Gansel, JK; Thiel, M; Rill, MS; Decker, M; Bade, K; Saile, V; von Freymann, G; Linden, S; Wegener, M				Gansel, Justyna K.; Thiel, Michael; Rill, Michael S.; Decker, Manuel; Bade, Klaus; Saile, Volker; von Freymann, Georg; Linden, Stefan; Wegener, Martin			Gold Helix Photonic Metamaterial as Broadband Circular Polarizer	SCIENCE			English	Article							NEGATIVE REFRACTIVE-INDEX	We investigated propagation of light through a uniaxial photonic metamaterial composed of three-dimensional gold helices arranged on a two-dimensional square lattice. These nanostructures are fabricated via an approach based on direct laser writing into a positive-tone photoresist followed by electrochemical deposition of gold. For propagation of light along the helix axis, the structure blocks the circular polarization with the same handedness as the helices, whereas it transmits the other, for a frequency range exceeding one octave. The structure is scalable to other frequency ranges and can be used as a compact broadband circular polarizer.	[Gansel, Justyna K.; Thiel, Michael; Rill, Michael S.; Decker, Manuel; von Freymann, Georg; Linden, Stefan; Wegener, Martin] Univ Karlsruhe TH, Inst Angew Phys, D-76131 Karlsruhe, Germany; [Gansel, Justyna K.; Thiel, Michael; Rill, Michael S.; Decker, Manuel; von Freymann, Georg; Linden, Stefan; Wegener, Martin] Univ Karlsruhe TH, DFG CFN, D-76131 Karlsruhe, Germany; [Bade, Klaus; Saile, Volker] Forschungszentrum Karlsruhe Helmholtz Gemeinschaf, Inst Mikrostrukturtech, D-76021 Karlsruhe, Germany; [von Freymann, Georg; Linden, Stefan; Wegener, Martin] Forschungszentrum Karlsruhe Helmholtz Gemeinschaf, Inst Nanotechnol, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Gansel, JK (corresponding author), Univ Karlsruhe TH, Inst Angew Phys, Wolfgang Gaede Str 1, D-76131 Karlsruhe, Germany.	Justyna.Gansel@physik.uni-karlsruhe.de	Wegener, Martin/ABD-5353-2021; Decker, Manuel/A-4961-2009; Wegener, Martin/S-5456-2016; Bade, Klaus/H-1842-2015; von Freymann, Georg/B-8577-2011	Wegener, Martin/0000-0002-9770-2441; Wegener, Martin/0000-0002-9770-2441; Bade, Klaus/0000-0001-9806-443X; von Freymann, Georg/0000-0003-2389-5532; Decker, Manuel/0000-0002-9125-0851	European Commission [213390]; Bundesministerium fur Bildung und Forschung (BMBF); Helmholtz-Hochschul-Nachwuchsgruppe [VH-NG-232]; DFG Emmy-Noether [DFG-Fr 1671/4-3]	European Commission(European CommissionEuropean Commission Joint Research Centre); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz-Hochschul-Nachwuchsgruppe(Helmholtz Association); DFG Emmy-Noether(German Research Foundation (DFG))	We thank I. Staude for help regarding the optical measurements and C. E. Kriegler for discussions. We acknowledge support by the Deutsche Forschungsgemeinschaft (DFG) and the State of Baden-Wurttemberg through the DFG Center for Functional Nanostructures (CFN) within subprojects A1.4 and A1.5. The project PHOME acknowledges the financial support of the Future and Emerging Technologies (FET) program within the Seventh Framework Programme for Research of the European Commission, under FET Open grant 213390. The project METAMAT is supported by the Bundesministerium fur Bildung und Forschung (BMBF). The research of S. L. is further supported through a Helmholtz-Hochschul-Nachwuchsgruppe (VH-NG-232) and that of G. v. F. through a DFG Emmy-Noether fellowship (DFG-Fr 1671/4-3). The Ph. D. education of J. K. G., M. T., M. S. R., and M. D. is embedded in the Karlsruhe School of Optics and Photonics (KSOP).	Abdeddaim R, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3086873; Busch K, 2007, PHYS REP, V444, P101, DOI 10.1016/j.physrep.2007.02.011; CHATTERJEE JS, 1953, J APPL PHYS, V24, P550, DOI 10.1063/1.1721328; Decker M, 2007, OPT LETT, V32, P856, DOI 10.1364/OL.32.000856; Dyson J., 1959, IRE T ANTENNAS PROPA, V7, P181, DOI DOI 10.1109/TAP.1959.1144653; Enkrich C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.203901; Hecht E, 2002, OPTICS; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; Liu N, 2009, NAT PHOTONICS, V3, P157, DOI 10.1038/NPHOTON.2009.4; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2004, SCIENCE, V306, P1353, DOI 10.1126/science.1104467; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Plum E, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3021082; Plum E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.113902; Plum E, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.035407; Rill MS, 2008, NAT MATER, V7, P543, DOI 10.1038/nmat2197; Rogacheva AV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.177401; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Shamonina E, 2006, J MAGN MAGN MATER, V300, P38, DOI 10.1016/j.jmmm.2005.10.028; Silveirinha MG, 2008, IEEE T ANTENN PROPAG, V56, P390, DOI 10.1109/TAP.2007.915428; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Soukoulis CM, 2007, SCIENCE, V315, P47, DOI 10.1126/science.1136481; Wegener M., 2009, PHYSICS, V2, P3; Zhang S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.023901; Zhou WH, 2002, SCIENCE, V296, P1106, DOI 10.1126/science.296.5570.1106	28	1914	1964	47	1052	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1513	1515		10.1126/science.1177031	http://dx.doi.org/10.1126/science.1177031			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19696310				2022-12-28	WOS:000269887900030
J	Boffetta, P; Straif, K				Boffetta, Paolo; Straif, Kurt			Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SWEDISH MOIST SNUFF; NORTHERN SWEDEN; MEN; SMOKING; DISEASE; MORTALITY	Objective To assess whether people who use smokeless tobacco products are at increased risk of myocardial infarction and stroke. Design Meta-analysis of observational studies from Sweden and the United States. Data sources Electronic databases and reference lists. Data extraction Quantitative estimates of the association between use of smokeless tobacco products and risk of myocardial infarction and stroke among never smokers. Review methods Both authors independently abstracted risk estimates and study characteristics. Summary relative risks were estimated on the basis of random effects models. Results 11 studies, mainly in men, were included. Eight risk estimates were available for fatal myocardial infarction: the relative risk for ever use of smokeless tobacco products was 1.13 (95% confidence 1.06 to 1.21) and the excess risk was restricted to current users. The relative risk of fatal stroke, on the basis of five risk estimates, was 1.40 (1.28 to 1.54). The studies from both the United States and Sweden showed an increased risk of death from myocardial infarction and stroke. The inclusion of non-fatal myocardial infarction and non-fatal stroke lowered the summary risk estimates. Data on dose-response were limited but did not suggest a strong relation between risk of dying from either disease and frequency or duration of use of smokeless tobacco products. Conclusion An association was detected between use of smokeless tobacco products and risk of fatal myocardial infarction and stroke, which does not seem to be explained by chance.	[Boffetta, Paolo; Straif, Kurt] Int Agcy Res Canc, F-69008 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Boffetta, P (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69008 Lyon, France.	boffetta@iarc.fr	Boffetta, Paolo/AAI-7767-2021	Boffetta, Paolo/0000-0002-3811-2791				Accortt NA, 2002, AM J EPIDEMIOL, V156, P730, DOI 10.1093/aje/kwf106; Asplund K, 2003, STROKE, V34, P1754, DOI 10.1161/01.STR.0000076011.02935.A1; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BROADSTOCK M, 2007, NZ HLTH TECHNOLOGY A, V10, P1; Critchley JA, 2004, EUR J CARDIOV PREV R, V11, P101, DOI 10.1097/01.hjr.0000114971.39211.d7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Giovino Gary A., 1994, Morbidity and Mortality Weekly Report, V43, P1; Greenland S, 2008, MODERN EPIDEMIOLOGY, P652; Haglund B, 2007, SCAND J PUBLIC HEALT, V35, P618, DOI 10.1080/14034940701436949; Henley SJ, 2005, CANCER CAUSE CONTROL, V16, P347, DOI 10.1007/s10552-004-5519-6; Hergens MP, 2007, J INTERN MED, V262, P351, DOI 10.1111/j.1365-2796.2007.01816.x; Hergens MP, 2008, EPIDEMIOLOGY, V19, P794, DOI 10.1097/EDE.0b013e3181878b33; Hergens MP, 2005, EPIDEMIOLOGY, V16, P12, DOI 10.1097/01.ede.0000147108.92895.ba; HUHTASAARI F, 1992, BRIT MED J, V305, P1252, DOI 10.1136/bmj.305.6864.1252; Huhtasaari F, 1999, J AM COLL CARDIOL, V34, P1784, DOI 10.1016/S0735-1097(99)00409-X; *INT AG RES CANC, 2008, IARC MON EV CARC RIS, V89; Lee PN, 2007, INT J EPIDEMIOL, V36, P789, DOI 10.1093/ije/dym039; Rodu B, 2002, J INTERN MED, V252, P398, DOI 10.1046/j.1365-2796.2002.01057.x; Rodu Brad, 2006, Harm Reduct J, V3, P37, DOI 10.1186/1477-7517-3-37; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P115; Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), 2008, SCI OP HLTH EFF SMOK; *SOC, 2006, 2005 SOC, P24; StataCorp LP, 2005, INT STAT 9 1 WIND; Stegmayr B, 2005, SCAND J PUBLIC HEALT, V33, P321, DOI 10.1080/14034940510032301; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tomar SL, 2003, NICOTINE TOB RES, V5, P561, DOI 10.1080/1462220031000118667; Wermberg P, 2007, J INTERN MED, V262, P360, DOI 10.1111/j.1365-2796.2007.01813.x; World Health Organization, 2008, MORT DAT	28	141	143	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2009	339								b3060	10.1136/bmj.b3060	http://dx.doi.org/10.1136/bmj.b3060			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486RZ	19690343	Green Published, hybrid			2022-12-28	WOS:000269216700005
J	Carlberg, B				Carlberg, Bo			Time to lower treatment BP targets for hypertension?	LANCET			English	Editorial Material							BLOOD-PRESSURE		Univ Hosp, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden	Umea University	Carlberg, B (corresponding author), Univ Hosp, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden.	bo.carlberg@medicin.umu.se						ARGUEDAS JA, 2009, COCHRANE DB SYST REV, V3; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1; Yusuf S, 2000, NEW ENGL J MED, V342, P145	9	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					503	504		10.1016/S0140-6736(09)61467-7	http://dx.doi.org/10.1016/S0140-6736(09)61467-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484BX	19683626				2022-12-28	WOS:000269019400004
J	Karberg, S				Karberg, Sascha			Biotech's Perfect Storm	CELL			English	Editorial Material								The global financial crisis has hit biotech companies hard both in the US and Europe as venture capital dries up. Finding new sources of long-term financing for translating research into new therapeutics will be essential for maintaining innovation and new drug development by biotech companies.											0	4	4	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 7	2009	138	3					413	415		10.1016/j.cell.2009.07.026	http://dx.doi.org/10.1016/j.cell.2009.07.026			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665960	Bronze			2022-12-28	WOS:000268771900002
J	Sansonetti, PJ; Medzhitov, R				Sansonetti, Philippe J.; Medzhitov, Ruslan			Learning Tolerance while Fighting Ignorance	CELL			English	Article							INTESTINAL IMMUNE HOMEOSTASIS; NF-KAPPA-B; EPITHELIAL-CELLS; INNATE IMMUNITY; GENE-EXPRESSION; INFLAMMATION; GUT; DISEASE; MICROBIOTA; BACTERIA	Research on microbe-host interactions focuses principally on pathogens, yet our immune system must deal with the huge number of beneficial commensal bacteria in our gut. It is becoming clear that the host immune system must reach a delicate balance between destroying dangerous bacterial pathogens while preserving the beneficial gut microbiota.	[Sansonetti, Philippe J.] Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France; [Sansonetti, Philippe J.] Coll France, F-75231 Paris 05, France; [Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Medzhitov, Ruslan] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06510 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; Howard Hughes Medical Institute; Yale University; Yale University	Sansonetti, PJ (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France.	psanson@pasteur.fr			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	P.J.S. is a foreign scholar of the Howard Hughes Medical Institute. The authors thank members of their respective groups for invaluable discussions.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Arseneau Kristen O, 2007, Curr Gastroenterol Rep, V9, P508, DOI 10.1007/s11894-007-0067-3; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; Collier-Hyams LS, 2005, J IMMUNOL, V175, P4194, DOI 10.4049/jimmunol.175.7.4194; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Hoffmann JC, 2002, PATHOBIOLOGY, V70, P121, DOI 10.1159/000068143; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nuding S, 2007, GUT, V56, P1240, DOI 10.1136/gut.2006.118646; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Swidsinski A, 2005, WORLD J GASTROENTERO, V11, P1131, DOI 10.3748/wjg.v11.i8.1131; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	33	108	116	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					416	420		10.1016/j.cell.2009.07.024	http://dx.doi.org/10.1016/j.cell.2009.07.024			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665961	Bronze			2022-12-28	WOS:000268771900003
J	Goldston, D				Goldston, David			Sending out an SOS	NATURE			English	Editorial Material									Nat Resources Def Council, Govt Affairs, Washington, DC USA		Goldston, D (corresponding author), Nat Resources Def Council, Govt Affairs, Washington, DC USA.	partyofonecolumn@gmail.com							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					679	679		10.1038/460679a	http://dx.doi.org/10.1038/460679a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479OO	19661888	Bronze			2022-12-28	WOS:000268670300012
J	Groblacher, S; Hammerer, K; Vanner, MR; Aspelmeyer, M				Groeblacher, Simon; Hammerer, Klemens; Vanner, Michael R.; Aspelmeyer, Markus			Observation of strong coupling between a micromechanical resonator and an optical cavity field	NATURE			English	Article							SINGLE QUANTUM-DOT; RADIATION-PRESSURE; ATOM; ELECTRODYNAMICS; MICROMIRROR; MICROCAVITY; FORCES; PHOTON	Achieving coherent quantum control over massive mechanical resonators is a current research goal. Nano-and micromechanical devices can be coupled to a variety of systems, for example to single electrons by electrostatic(1,2) or magnetic coupling(3,4), and to photons by radiation pressure(5-9) or optical dipole forces(10,11). So far, all such experiments have operated in a regime of weak coupling, in which reversible energy exchange between the mechanical device and its coupled partner is suppressed by fast decoherence of the individual systems to their local environments. Controlled quantum experiments are in principle not possible in such a regime, but instead require strong coupling. So far, this has been demonstrated only between microscopic quantum systems, such as atoms and photons (in the context of cavity quantum electrodynamics(12)) or solid state qubits and photons(13,14). Strong coupling is an essential requirement for the preparation of mechanical quantum states, such as squeezed or entangled states(15-18), and also for using mechanical resonators in the context of quantum information processing, for example, as quantum transducers. Here we report the observation of optomechanical normal mode splitting(19,20), which provides unambiguous evidence for strong coupling of cavity photons to a mechanical resonator. This paves the way towards full quantum optical control of nano-and micromechanical devices.	[Groeblacher, Simon; Vanner, Michael R.; Aspelmeyer, Markus] Austrian Acad Sci, IQOQI, A-1090 Vienna, Austria; [Groeblacher, Simon; Vanner, Michael R.] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Hammerer, Klemens] Austrian Acad Sci, IQOQI, A-6020 Innsbruck, Austria; [Hammerer, Klemens] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria	Austrian Academy of Sciences; University of Vienna; Austrian Academy of Sciences; University of Innsbruck	Aspelmeyer, M (corresponding author), Austrian Acad Sci, IQOQI, Boltzmanngasse 3, A-1090 Vienna, Austria.	markus.aspelmeyer@quantum.at	Groeblacher, Simon/O-2455-2014; Aspelmeyer, Markus/C-4098-2017; Hammerer, Klemens/C-3538-2008; Vanner, Michael R/B-8025-2013	Groeblacher, Simon/0000-0003-3932-7820; Aspelmeyer, Markus/0000-0003-4499-7335; Hammerer, Klemens/0000-0002-7179-0666; Vanner, Michael/0000-0001-9816-5994	Austrian Science Fund FWF; European Commission; Foundational Questions Institute; Austrian Academy of Sciences; Austrian Science Fund (FWF) [Y 414] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Foundational Questions Institute; Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to T. Corbitt, C. Genes, S. Goaler, P. K. Lam, G. Milburn, P. Rabl and P. Zoller for discussions. We also thank M. Metzler, R. Ilic and M. Skvarla (CNF), and K. C. Schwab and J. Hertzberg, for microfabrication support, and R. Blach for technical support. We acknowledge financial support from the Austrian Science Fund FWF, the European Commission and the Foundational Questions Institute. S. G. is a recipient of a DOC fellowship of the Austrian Academy of Sciences; S. G. and M. R. V. are members of the FWF doctoral programme Complex Quantum Systems (CoQuS).	Aoki T, 2006, NATURE, V443, P671, DOI 10.1038/nature05147; Arcizet O, 2006, NATURE, V444, P71, DOI 10.1038/nature05244; Bose S, 1997, PHYS REV A, V56, P4175, DOI 10.1103/PhysRevA.56.4175; Cleland AN, 2002, APPL PHYS LETT, V81, P1699, DOI 10.1063/1.1497436; Clerk AA, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/095010; Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331; Dobrindt JM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.263602; Eichenfield M, 2007, NAT PHOTONICS, V1, P416, DOI 10.1038/nphoton.2007.96; Gigan S, 2006, NATURE, V444, P67, DOI 10.1038/nature05273; Hammerer K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.020501; Khitrova G, 2006, NAT PHYS, V2, P81, DOI 10.1038/nphys227; Kippenberg TJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033901; Li M, 2008, NATURE, V456, P480, DOI 10.1038/nature07545; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Marshall W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130401; Naik A, 2006, NATURE, V443, P193, DOI 10.1038/nature05027; Rabl P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.041302; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715; THOMPSON RJ, 1992, PHYS REV LETT, V68, P1132, DOI 10.1103/PhysRevLett.68.1132; Vitali D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.030405; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Walther H, 2006, REP PROG PHYS, V69, P1325, DOI 10.1088/0034-4885/69/5/R02; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314; Wilson-Rae I, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/095007; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; Zhang J, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.013808; ZHU YF, 1990, PHYS REV LETT, V64, P2499, DOI 10.1103/PhysRevLett.64.2499	30	743	752	2	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					724	727		10.1038/nature08171	http://dx.doi.org/10.1038/nature08171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661913	Green Submitted			2022-12-28	WOS:000268670300035
J	Lagomarsino, G; de Ferranti, D; Pablos-Mendez, A; Nachuk, S; Nishtar, S; Wibulpolprasert, S				Lagomarsino, Gina; de Ferranti, David; Pablos-Mendez, Ariel; Nachuk, Stefan; Nishtar, Sania; Wibulpolprasert, Suwit			Public stewardship of mixed health systems	LANCET			English	Editorial Material									[Lagomarsino, Gina; de Ferranti, David] Results Dev Inst, Washington, DC 20009 USA; [Pablos-Mendez, Ariel; Nachuk, Stefan] Rockefeller Fdn, New York, NY USA; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Wibulpolprasert, Suwit] Minist Publ Hlth, Nonthaburi, Thailand	Ministry of Public Health - Thailand	Lagomarsino, G (corresponding author), Results Dev Inst, Washington, DC 20009 USA.	glagomarsino@resultsfordevelopment.org						de Costa A, 2007, HEALTH POLICY, V84, P269, DOI 10.1016/j.healthpol.2007.04.004; Nishtar S, 2007, LANCET, V370, P935, DOI 10.1016/S0140-6736(07)61442-1; TANGCHAROENSATH.V, 2008, REGULATION HLTH SERV; *WHO, 2006, NAT HLTH ACC DAT	4	28	28	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 7	2009	374	9701					1577	1578		10.1016/S0140-6736(09)61241-1	http://dx.doi.org/10.1016/S0140-6736(09)61241-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518EZ	19679344				2022-12-28	WOS:000271674600009
J	Lartigue, C; Vashee, S; Algire, MA; Chuang, RY; Benders, GA; Ma, L; Noskov, VN; Denisova, EA; Gibson, DG; Assad-Garcia, N; Alperovich, N; Thomas, DW; Merryman, C; Hutchison, CA; Smith, HO; Venter, JC; Glass, JI				Lartigue, Carole; Vashee, Sanjay; Algire, Mikkel A.; Chuang, Ray-Yuan; Benders, Gwynedd A.; Ma, Li; Noskov, Vladimir N.; Denisova, Evgeniya A.; Gibson, Daniel G.; Assad-Garcia, Nacyra; Alperovich, Nina; Thomas, David W.; Merryman, Chuck; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig; Glass, John I.			Creating Bacterial Strains from Genomes That Have Been Cloned and Engineered in Yeast	SCIENCE			English	Article							TRANSFORMATION-ASSOCIATED RECOMBINATION; MYCOPLASMA-GENITALIUM GENOME; MYCOIDES; CLONING	We recently reported the chemical synthesis, assembly, and cloning of a bacterial genome in yeast. To produce a synthetic cell, the genome must be transferred from yeast to a receptive cytoplasm. Here we describe methods to accomplish this. We cloned a Mycoplasma mycoides genome as a yeast centromeric plasmid and then transplanted it into Mycoplasma capricolum to produce a viable M. mycoides cell. While in yeast, the genome was altered by using yeast genetic systems and then transplanted to produce a new strain of M. mycoides. These methods allow the construction of strains that could not be produced with genetic tools available for this bacterium.	[Lartigue, Carole; Vashee, Sanjay; Algire, Mikkel A.; Chuang, Ray-Yuan; Ma, Li; Noskov, Vladimir N.; Denisova, Evgeniya A.; Gibson, Daniel G.; Assad-Garcia, Nacyra; Alperovich, Nina; Thomas, David W.; Merryman, Chuck; Venter, J. Craig; Glass, John I.] J Craig Venter Inst, Rockville, MD 20850 USA; [Benders, Gwynedd A.; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig] J Craig Venter Inst, San Diego, CA 92121 USA	J. Craig Venter Institute; J. Craig Venter Institute	Vashee, S (corresponding author), J Craig Venter Inst, 9704 Med Ctr Dr, Rockville, MD 20850 USA.	svashee@jcvi.org	lartigue, carole/I-1576-2013; Lartigue, Carole/GQP-4896-2022; Glass, John/A-6572-2015	Lartigue, Carole/0000-0001-5550-7579; Glass, John/0000-0002-3784-5301	Synthetic Genomics, Inc. (SGI)	Synthetic Genomics, Inc. (SGI)	We thank R. Roberts for helpful information and the Synthetic Biology team at the J. Craig Venter Institute (JCVI) for critical discussions about the manuscript. This work was supported by Synthetic Genomics, Inc. (SGI). J. C. V. is Chief Executive Officer and Co-Chief Scientific Officer of SGI. H. O. S. is Co-Chief Scientific Officer and on the Board of Directors of SGI. C. A. H. is Chairman of the SGI Scientific Advisory Board. All three of these authors and JCVI hold SGI stock. JCVI has filed patent applications on some of the techniques described in this paper.	BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; DAMASSA AJ, 1983, AM J VET RES, V44, P322; Dedieu-Engelmann L, 2008, COMP IMMUNOL MICROB, V31, P227, DOI 10.1016/j.cimid.2007.07.009; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Janis C, 2005, APPL ENVIRON MICROB, V71, P2888, DOI 10.1128/AEM.71.6.2888-2893.2005; KING KW, 1991, PLASMID, V26, P108, DOI 10.1016/0147-619X(91)90050-7; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Larionov V, 1997, P NATL ACAD SCI USA, V94, P7384, DOI 10.1073/pnas.94.14.7384; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Manso-Silvan L, 2009, INT J SYST EVOL MICR, V59, P1353, DOI 10.1099/ijs.0.005546-0; Thiaucourt F., 2003, VVolume 114, P147	13	181	207	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1693	1696		10.1126/science.1173759	http://dx.doi.org/10.1126/science.1173759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19696314				2022-12-28	WOS:000270131800047
J	Zofall, M; Fischer, T; Zhang, K; Zhou, M; Cui, BW; Veenstra, TD; Grewal, SIS				Zofall, Martin; Fischer, Tamas; Zhang, Ke; Zhou, Ming; Cui, Bowen; Veenstra, Timothy D.; Grewal, Shiv I. S.			Histone H2A.Z cooperates with RNAi and heterochromatin factors to suppress antisense RNAs	NATURE			English	Article							FISSION YEAST; QUALITY CONTROL; NONCODING RNAS; VARIANT; TRANSCRIPTION; CHROMATIN; GENOME; DROSOPHILA; COMPLEX; EXOSOME	Eukaryotic transcriptomes are characterized by widespread transcription of noncoding and antisense RNAs(1-3), which is linked to key chromosomal processes, such as chromatin remodelling, gene regulation and heterochromatin assembly(4-7). However, these transcripts can be deleterious, and their accumulation is suppressed by several mechanisms including degradation by the nuclear exosome(8,9). The mechanisms by which cells differentiate coding RNAs from transcripts targeted for degradation are not clear. Here we show that the variant histone H2A.Z, which is loaded preferentially at the 5' ends of genes by the Swr1 complex containing a JmjC domain protein, mediates suppression of antisense transcripts in the fission yeast Schizosaccharomyces pombe genome. H2A.Z is partially redundant in this regard with the Clr4 (known as SUV39H in mammals)-containing heterochromatin silencing complex that is also distributed at euchromatic loci, and with RNA interference component Argonaute (Ago1). Loss of Clr4 or Ago1 alone has little effect on antisense transcript levels, but cells lacking either of these factors and H2A.Z show markedly increased levels of antisense RNAs that are normally degraded by the exosome. These analyses suggest that as well as performing other functions, H2A.Z is a component of a genome indexing mechanism that cooperates with heterochromatin and RNAi factors to suppress read-through antisense transcripts.	[Zofall, Martin; Fischer, Tamas; Zhang, Ke; Cui, Bowen; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhou, Ming; Veenstra, Timothy D.] NCI Frederick, SAIC Frederick Inc, Lab Prote & Analyt Technol, Adv Technol Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Fischer, Tamas/A-7729-2016; Cui, Bowen/F-1038-2011	Fischer, Tamas/0000-0002-7996-4042; 	National Institutes of Health [N01-CO-12400]; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Acknowledgements We thank K. Noma for strain constructions, D. McPheeters for the run-on protocol, M. Lichten, F. Reyes-Turcu, E. Bartlett and H. Cam for comments on the manuscript, P. Fitzgerald for designing microarrays, and D. Venzon for advice with data analyses. This research was supported by the Intramural Research Program, and under Contract N01-CO-12400 of the National Institutes of Health, National Cancer Institute.	Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; CARR AM, 1994, MOL GEN GENET, V245, P628, DOI 10.1007/BF00282226; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; Wagner EJ, 2007, MOL CELL, V28, P692, DOI 10.1016/j.molcel.2007.10.009; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	30	114	115	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 17	2009	461	7262					419	U120		10.1038/nature08321	http://dx.doi.org/10.1038/nature08321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19693008	Green Accepted			2022-12-28	WOS:000269828100045
J	Rothman, SM; Rothman, DJ				Rothman, Sheila M.; Rothman, David J.			Marketing HPV Vaccine Implications for Adolescent Health and Medical Professionalism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; TYPE-16	The new vaccine against 4 types of human papillomavirus (HPV), Gardasil, like other immunizations appears to be a cost-effective intervention with the potential to enhance both adolescent health and the quality of their adult lives. However, the messages and the methods by which the vaccine was marketed present important challenges to physician practice and medical professionalism. By making the vaccine's target disease cervical cancer, the sexual transmission of HPV was minimized, the threat of cervical cancer to adolescents was maximized, and the subpopulations most at risk practically ignored. The vaccine manufacturer also provided educational grants to professional medical associations (PMAs) concerned with adolescent and women's health and oncology. The funding encouraged many PMAs to create educational programs and product-specific speakers' bureaus to promote vaccine use. However, much of the material did not address the full complexity of the issues surrounding the vaccine and did not provide balanced recommendations on risks and benefits. As important and appropriate as it is for PMAs to advocate for vaccination as a public good, their recommendations must be consistent with appropriate and cost-effective use. JAMA. 2009; 302(7):781-786 www.jama.com	[Rothman, Sheila M.] Mailman Sch Publ Hlth, New York, NY USA		Rothman, SM (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Soc & Med, 630 W 168th St,PH 15-25, New York, NY 10023 USA.	smr4@columbia.edu			Pew Charitable Trusts	Pew Charitable Trusts	This work was funded by the Pew Charitable Trusts.	Allen A, 2007, VACCINE CONTROVERSIA; *AM COLL HLTH ASS, HPV VACC TOOLK; *AM COLL HLTH ASS, VACC PREV DIS ADV CO; *AM COLL HLTH ASS, AM COLL HLTH ASS VOI; *AM COLL HLTH ASS, ACHA YEAR REV; *AM COLL HLTH ASS, FREE WEBC HPV VACC U; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; AULT KA, EXPANDING BENEFITS H; Baden LR, 2007, NEW ENGL J MED, V356, P1990, DOI 10.1056/NEJMe078088; BOCK P, 2007, SEATTLE TIMES   1005; CARREYROU J, 2007, WALL STREET J   0416, pA1; *CDC, 1988, MMWR-MORBID MORTAL W, V37, P341; *CDCP, 1982, MMWR-MORBID MORTAL W, V31, P317; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P549; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P563; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P1100; Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P351; CRUM CP, 1984, NEW ENGL J MED, V310, P880, DOI 10.1056/NEJM198404053101403; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; FREED GL, 1994, PEDIATRICS, V93, P747; Freeman H, 2005, EXCESS CERVICAL CANC; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P1921, DOI 10.1001/jama.297.17.1921; Haug CJ, 2008, NEW ENGL J MED, V359, P861, DOI 10.1056/NEJMe0804638; HERSKOVITS B, 2007, PHARM EXEC, V27, P58; *I MED PROF, HPV VACC SOURC; Karlan BY, 2006, GYNECOL ONCOL, V102, P1, DOI 10.1016/j.ygyno.2006.05.004; KAUFMAN M, 2006, WASHINGTON POST 0609; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Lawrence RS, 2009, ADOLESCENT HEALTH SERVICES: MISSING OPPORTUNITIES, P194; *MERCK, 2007 ANN REV DRIV GR; *NAT BOARD PROF TE, 1997, STAT LOC ACT SUPP NA, P1; Orenstein WA, 2005, HEALTH AFFAIR, V24, P599, DOI 10.1377/hlthaff.24.3.599; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Runowicz CD, 2002, GYNECOL ONCOL, V84, P357, DOI 10.1006/gyno.2001.6421; Sawaya GF, 2007, NEW ENGL J MED, V356, P1991, DOI 10.1056/NEJMe078060; SHARFSTEIN J, 2000, AM PROSPECT, V11, P15; *SOC GYN ONC, CORP SPONS OPP; *SOC GYN ONC, HIST SGO OR SOC; *SOC GYN ONC, FAQ CERV CANC VACC; *SOC GYN ONC, RAIS AW GYN CANC PHY; *SOC GYN ONC, HPV CERV CANC VACC S; *SOC GYN ONC, ED RES PAN; SPITZER M, 2006, COMMUNICATION   0317; Spitzer Mark, 2007, J Low Genit Tract Dis, V11, P133, DOI 10.1097/LGT.0b013e31805d8cea; *US FDA, 2006, FDA LIC NEW VACC PRE; Vetter KM, 2007, J WOMENS HEALTH, V16, P1258, DOI 10.1089/jwh.2007.0493; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	50	75	76	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					781	786		10.1001/jama.2009.1179	http://dx.doi.org/10.1001/jama.2009.1179			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690311				2022-12-28	WOS:000269073800027
J	May, C; Montori, VM; Mair, FS				May, Carl; Montori, Victor M.; Mair, Frances S.			We need minimally disruptive medicine	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIABETES-MELLITUS; HELPING PATIENTS; PRIMARY-CARE; ADHERENCE; HEALTH; MEDICATION; MORTALITY		[May, Carl] Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; [Montori, Victor M.] Mayo Clin, UK Knowledge & Encounter Res Unit, Rochester, MN USA; [Mair, Frances S.] Univ Glasgow, Sect Gen Practice & Primary Care, Glasgow, Lanark, Scotland	Newcastle University - UK; Mayo Clinic; University of Glasgow	May, C (corresponding author), Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.	c.r.may@ncl.ac.uk	May, Carl/A-8502-2011	Montori, Victor/0000-0003-0595-2898; May, Carl/0000-0002-0451-2690; Mair, Frances/0000-0001-9780-1135				ARMSTRONG D, 1982, PROBLEM MED KNOWLEDG; Baker RM, 2006, SOC SCI MED, V63, P2341, DOI 10.1016/j.socscimed.2006.06.007; Barber N, 2004, QUAL SAF HEALTH CARE, V13, P172, DOI 10.1136/qshc.2003.005926; Charmaz K, 2006, GOOD DAYS BAD DAYS S; DeJesus E, 2009, JAIDS-J ACQ IMM DEF, V51, P163, DOI 10.1097/QAI.0b013e3181a572cf; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Gately C, 2007, SOC SCI MED, V65, P934, DOI 10.1016/j.socscimed.2007.04.018; Golin CE, 1996, DIABETES CARE, V19, P1153, DOI 10.2337/diacare.19.10.1153; Greene JA, 2004, SOC HIST MED, V17, P327, DOI 10.1093/shm/17.3.327; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; May C, 2006, SOC SCI MED, V62, P1022, DOI 10.1016/j.socscimed.2005.07.003; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Wens J, 2008, DIABETES RES CLIN PR, V79, P377, DOI 10.1016/j.diabres.2007.06.006; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076; *WHO, 2003, INF SHEET FACTS REL; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	19	380	383	2	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2009	339								b2803	10.1136/bmj.b2803	http://dx.doi.org/10.1136/bmj.b2803			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YH	19671932				2022-12-28	WOS:000269161800001
J	Buchen, L				Buchen, Lizzie			SNAPSHOT The guts of a dying star	NATURE			English	News Item																		Blondin JM, 2007, NATURE, V445, P58, DOI 10.1038/nature05428	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					671	671		10.1038/460671b	http://dx.doi.org/10.1038/460671b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661877	Bronze			2022-12-28	WOS:000268670300005
J	Lassen, MR; Raskob, GE; Gallus, A; Pineo, G; Chen, D; Portman, RJ				Lassen, Michael Rud; Raskob, Gary E.; Gallus, Alexander; Pineo, Graham; Chen, Dalei; Portman, Ronald J.		ADVANCE-1 Investigators	Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR-XA INHIBITOR; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; TOTAL HIP; DABIGATRAN ETEXILATE; DOUBLE-BLIND; PREVENTION; ARTHROPLASTY; TRIAL; XIMELAGATRAN	BACKGROUND The optimal strategy for thromboprophylaxis after major joint replacement has not been established. Low-molecular-weight heparins such as enoxaparin predominantly target factor Xa but to some extent also inhibit thrombin. Apixaban, a specific factor Xa inhibitor, may provide effective thromboprophylaxis with a low risk of bleeding and improved ease of use. METHODS In a double-blind, double-dummy study, we randomly assigned patients undergoing total knee replacement to receive 2.5 mg of apixaban orally twice daily or 30 mg of enoxaparin subcutaneously every 12 hours. Both medications were started 12 to 24 hours after surgery and continued for 10 to 14 days. Bilateral venography was then performed. The primary efficacy outcome was a composite of asymptomatic and symptomatic deep-vein thrombosis, nonfatal pulmonary embolism, and death from any cause during treatment. Patients were followed for 60 days after anticoagulation therapy was stopped. RESULTS A total of 3195 patients underwent randomization, with 1599 assigned to the apixaban group and 1596 to the enoxaparin group; 908 subjects were not eligible for the efficacy analysis. The overall rate of primary events was much lower than anticipated. The rate of the primary efficacy outcome was 9.0% with apixaban as compared with 8.8% with enoxaparin (relative risk, 1.02; 95% confidence interval, 0.78 to 1.32). The composite incidence of major bleeding and clinically relevant nonmajor bleeding was 2.9% with apixaban and 4.3% with enoxaparin (P = 0.03). CONCLUSIONS As compared with enoxaparin for efficacy of thromboprophylaxis after knee replacement, apixaban did not meet the prespecified statistical criteria for noninferiority, but its use was associated with lower rates of clinically relevant bleeding and it had a similar adverse-event profile. (ClinicalTrials.gov number, NCT00371683.)	[Lassen, Michael Rud] Univ Copenhagen, Horsholm Hosp, Dept Orthoped, Spine Clin,Clin Trial Unit, DK-2970 Horsholm, Denmark; [Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA; [Gallus, Alexander] Flinders Med Ctr, SA Pathol, Adelaide, SA, Australia; [Gallus, Alexander] Flinders Univ S Australia, Adelaide, SA, Australia; [Pineo, Graham] Univ Calgary, Dept Med & Oncol, Calgary, AB, Canada; [Chen, Dalei; Portman, Ronald J.] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ USA	University of Copenhagen; University of Oklahoma System; University of Oklahoma Health Sciences Center; Flinders Medical Centre; SA Pathology; Flinders University South Australia; University of Calgary; Bristol-Myers Squibb	Lassen, MR (corresponding author), Univ Copenhagen, Horsholm Hosp, Dept Orthoped, Spine Clin,Clin Trial Unit, Usserod Kongevej 102, DK-2970 Horsholm, Denmark.	mirula@noh.regionh.dk		Gallus, Alexander/0000-0001-7347-9989	Bristol-Myers Squibb; Pfizer	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer)	Supported by Bristol-Myers Squibb and Pfizer.	Andersen KV, 2007, ACTA ORTHOP, V78, P180, DOI 10.1080/17453670710013654; Colwell CW, 2005, J BONE JOINT SURG AM, V87A, P2169, DOI 10.2106/JBJS.D.02184; Eriksson BI, 2007, LANCET, V370, P2004; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Francis CW, 2003, NEW ENGL J MED, V349, P1703, DOI 10.1056/NEJMoa035162; Friedman RJ, 2008, CURR MED RES OPIN, V24, P87, DOI 10.1185/030079907X242746; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; KEHLET H, 1993, ANESTH ANALG, V77, P1048; Lassen MR, 2007, J THROMB HAEMOST, V5, P2368, DOI 10.1111/j.1538-7836.2007.02764.x; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lassen MR, 2003, BLOOD, V102, p15A; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schunemann H, 2004, CHEST, V126, p688S, DOI 10.1378/chest.126.3_suppl.688S; TURPIE AG, 2007, J THROMB HAEMOST S2, V5, pPT652; TURPIE AGG, 2008, BLOOD, V112, P35; White RH, 2003, THROMB HAEMOSTASIS, V90, P446, DOI 10.1160/TH03-03-0152; White RH, 1998, ARCH INTERN MED, V158, P1525, DOI 10.1001/archinte.158.14.1525; Wong PC, 2008, J THROMB HAEMOST, V6, P820, DOI 10.1111/j.1538-7836.2008.02939.x; YANAGAWA T, 1994, BIOMETRICS, V50, P859, DOI 10.2307/2532800; YANAGAWA T, 1995, BIOMETRICS, V51, P392	24	533	560	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					594	604		10.1056/NEJMoa0810773	http://dx.doi.org/10.1056/NEJMoa0810773			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479NR	19657123				2022-12-28	WOS:000268667300009
J	Epstein, D; Bojke, L; Sculpher, MJ				Epstein, David; Bojke, Laura; Sculpher, Mark J.		REFLUX Trial Grp	Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MINIMAL ACCESS SURGERY; THERAPY; ESOPHAGITIS; TRIALS	Objective To describe the long term costs, health benefits, and cost effectiveness of laparoscopic surgery compared with those of continued medical management for patients with gastro-oesophageal reflux disease (GORD). Design We estimated resource use and costs for the first year on the basis of data from the REFLUX trial. A Markov model was used to extrapolate cost and health benefit over a lifetime using data collected in the REFLUX trial and other sources. Participants The model compared laparoscopic surgery and continued proton pump inhibitors in male patients aged 45 and stable on GORD medication. Intervention Laparoscopic surgery versus continued medical management. Main outcome measures We estimated quality adjusted life years and GORD related costs to the health service over a lifetime. Sensitivity analyses considered other plausible scenarios, in particular size and duration of treatment effect and the GORD symptoms of patients in whom surgery is unsuccessful. Main results The base case model indicated that surgery is likely to be considered cost effective on average with an incremental cost effectiveness ratio of 2648 pound ((sic)3110; US $4385) per quality adjusted life year and that the probability that surgery is cost effective is 0.94 at a threshold incremental cost effectiveness ratio of 20 pound 000. The results were sensitive to some assumptions within the extrapolation modelling. Conclusion Surgery seems to be more cost effective on average than medical management in many of the scenarios examined in this study. Surgery might not be cost effective if the treatment effect does not persist over the long term, if patients who return to medical management have poor health related quality of life, or if proton pump inhibitors were cheaper. Further follow-up of patients from the REFLUX trial may be valuable.	[Epstein, David; Sculpher, Mark J.] Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England; [Epstein, David] Fac Econ & Business Sci, Granada 18071, Spain	University of York - UK		lg116@york.ac.uk	Epstein, David/I-2839-2019; Toh, Simon Khay Chuan/X-7081-2019; Jankowski, Janusz/H-2706-2012	Epstein, David/0000-0002-2275-0916; Toh, Simon Khay Chuan/0000-0001-5110-2371; Jankowski, Janusz/0000-0003-2130-9181; Campbell, Marion/0000-0001-5386-4097; El-Omar, Emad/0000-0002-0011-3924; Macintyre, Iain/0000-0003-2716-8500; Thursz, Mark/0000-0002-8218-192X; Sculpher, Mark/0000-0003-3746-9913	National Coordinating Centre for Health Technology Assessment (NCCHTA); Chief Scientist Office [HSRU1] Funding Source: researchfish	National Coordinating Centre for Health Technology Assessment (NCCHTA); Chief Scientist Office	This study was commissioned and funded by the National Coordinating Centre for Health Technology Assessment (NCCHTA). The funder of this study, other than the initial peer review process prior to funding and six-monthly progress reviews, did not have any involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. The views expressed in this report are those of the authors and not necessarily those of the NCCHTA or the funders that provide institutional support for the authors of this report.	Arguedas MR, 2004, AM J GASTROENTEROL, V99, P1023, DOI 10.1111/j.1572-0241.2004.30891.x; Blazeby JM, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2747; Bojke L, 2007, PHARMACOECONOMICS, V25, P829, DOI 10.2165/00019053-200725100-00003; Briggs A, 2006, DECISION MODELLING H; *BRIT MED ASS ROY, 2009, BRIT NAT FORM 57; Cookson R, 2005, BRIT J SURG, V92, P700, DOI 10.1002/bjs.4933; Curtis L., 2008, UNIT COSTS HLTH SOCI; *DEP HLTH, 2008, NAT SCH REF COSTS 20; Dolan P., 1995, SOCIAL TARIFF EUROQO; Efron B., 1994, MONOGRAPHS STAT APPL; Grant A, 2008, HEALTH TECHNOL ASSES, V12, P1; Grant AM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2664; IMBENS GW, 1994, ECONOMETRICA, V62, P467, DOI 10.2307/2951620; Kennedy T, 2000, ALIMENT PHARM THER, V14, P1589, DOI 10.1046/j.1365-2036.2000.00884.x; Kind P, 1999, 172 CTR HLTH EC; Kind P, 1996, QUALITY LIFE PHARMAC; LIESKE B, 2008, BRIT MED J, V337, pA2664; Lundell L, 2008, GUT, V57, P1207, DOI 10.1136/gut.2008.148833; McDougall NI, 1996, GUT, V38, P481, DOI 10.1136/gut.38.4.481; Myrvold HE, 2001, GUT, V49, P488, DOI 10.1136/gut.49.4.488; Nagelkerke N, 2000, STAT MED, V19, P1849, DOI 10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1; *NAT STAT, 2005, KS02 AG STRUCT CENS; National Institute for Clinical Excellence, 2008, GUID METH TECHN APPR; NORRIS L, 2008, UPDATE GROWTH PRESCR, P1; Romagnuolo J, 2002, ANN SURG, V236, P191, DOI 10.1097/00000658-200208000-00007; van Pinxteren B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002095.pub3	26	38	39	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2009	339								b2576	10.1136/bmj.b2576	http://dx.doi.org/10.1136/bmj.b2576			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472BU	19654097	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000268104900004
J	Garrett, L; Chowdhury, AMR; Pablos-Mendez, A				Garrett, Laurie; Chowdhury, A. Mushtaque R.; Pablos-Mendez, Ariel			All for universal health coverage	LANCET			English	Editorial Material							CARE		[Garrett, Laurie] Council Foreign Relat, New York, NY 10065 USA; [Chowdhury, A. Mushtaque R.] Rockefeller Fdn, Asia Off, Bangkok, Thailand; [Pablos-Mendez, Ariel] Rockefeller Fdn, New York, NY USA; [Pablos-Mendez, Ariel] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Chowdhury, A. Mushtaque R.; Pablos-Mendez, Ariel] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Columbia University; Columbia University	Garrett, L (corresponding author), Council Foreign Relat, 58 E 68th St, New York, NY 10065 USA.	lgarrett@cfr.org						*ACC PROJ, 2005, HOM SICK MED DEBT UN; [Anonymous], 1978, INT C PRIM HLTH CAR; [Anonymous], 1976, INT COVENANT EC SOCI; [Anonymous], 1948, UNIVERSAL DECLARATIO; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Ban J., 2003, SETON HALL J DIPLOMA, V4, P19; Banthin JS, 2006, JAMA-J AM MED ASSOC, V296, P2712, DOI 10.1001/jama.296.22.2712; Carrin G, 2008, B WORLD HEALTH ORGAN, V86, P857, DOI 10.2471/BLT.07.049387; CHAN M, 2009, HIGH LEV DIAL MAX PO; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; DeNavas-Walt C, 2008, INCOME POVERTY HLTH; Families USA, 2009, AM RISK ON 3 UN; Frenk J, 2009, LANCET, V373, P2181, DOI 10.1016/S0140-6736(09)60002-7; Frenk J, 2009, B WORLD HEALTH ORGAN, V87, P542, DOI 10.2471/BLT.08.053199; Garrett L, 2005, HIV NATL SECURITY AR; GETZEN TE, 2000, J HLTH EC, V19, P266; Gilmer TP, 2009, HEALTH AFFAIR, V28, pW573, DOI 10.1377/hlthaff.28.4.w573; Himmelstein D.U., 2005, HLTH AFF, V24, pW5, DOI 10.1377/hlthaff.W5.63; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; *I HLTH METR EV, 2009, FIN GLOB HLTH 2009 T; International Labour Organization, 2008, SOC HLTH PROT ILO ST; Keehan S, 2008, HEALTH AFFAIR, V27, pW145, DOI 10.1377/hlthaff.27.2.w145; Kutzin J, 2009, B WORLD HEALTH ORGAN, V87, P549, DOI 10.2471/BLT.07.049544; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Narayan PK, 2007, HEALTH ECON, V16, P993, DOI 10.1002/hec.1196; OBAID TA, 2009, GLOBAL EC CRISIS HLT; PATTERSON A, 2004, AFRICAN STATE AIDS C; PIFERBIXLER J, 2009, STUD 86 7 MILL AM UN; Poisal JA, 2007, HEALTH AFFAIR, V26, pW242, DOI 10.1377/hlthaff.26.2.w242; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1; Robertson Christopher Tarver, 2008, Health Matrix Clevel, V18, P65; SCHOEN C, 2008, MANY ARE UNDERINSURE; UN General Assembly, 1979, CONV EL ALL FORMS DI, P40; UN General Assembly, 1948, UNIVERSAL DECLARATIO, V302; UN General Assembly, 1989, CONV RIGHTS CHILD; UN General Assembly, 1966, INT COVENANT EC SOCI; *US C, 2007, LONG TERM OUTL HLTH; Wagstaff A, 2009, HLTH NUTR POPULATION; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; *WORLD BANK, WORLD DEV IND 2002; World Bank, 2009, WORLD DEV IND DAT; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organisation, 2007, NAT HLTH ACC; *WORLD SUMM SOC DE, 1995, COP DECL SOC DEV; Yates R, 2009, LANCET, V373, P2078, DOI 10.1016/S0140-6736(09)60258-0; 2008, B WHO, V86, P823; GLOBAL CAMPAIGN HLTH, P33; 2007, STUDY FINDS 24 AM UN	49	76	79	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2009	374	9697					1294	1299		10.1016/S0140-6736(09)61503-8	http://dx.doi.org/10.1016/S0140-6736(09)61503-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	507KQ	19698983				2022-12-28	WOS:000270852500035
J	Johnson, DD				Johnson, Donna D.			Induced labour for pre-eclampsia and gestational hypertension	LANCET			English	Editorial Material							MANAGEMENT		Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Johnson, DD (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.	johnsodo@musc.edu						Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gilbert WM, 2003, OBSTET GYNECOL, V102, P488, DOI 10.1016/S0029-7844(03)00617-3; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Sibai BM, 2007, AM J OBSTET GYNECOL, V196, P514, DOI 10.1016/j.ajog.2007.02.021; Sibai BM, 1996, NEW ENGL J MED, V335, P257, DOI 10.1056/NEJM199607253350407; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; SIBAI BM, 1990, AM J OBSTET GYNECOL, V163, P1049, DOI 10.1016/0002-9378(90)91123-T; SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I	8	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					951	952		10.1016/S0140-6736(09)61380-5	http://dx.doi.org/10.1016/S0140-6736(09)61380-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PK	19656557				2022-12-28	WOS:000270154100004
J	Roushan, P; Seo, J; Parker, CV; Hor, YS; Hsieh, D; Qian, D; Richardella, A; Hasan, MZ; Cava, RJ; Yazdani, A				Roushan, Pedram; Seo, Jungpil; Parker, Colin V.; Hor, Y. S.; Hsieh, D.; Qian, Dong; Richardella, Anthony; Hasan, M. Z.; Cava, R. J.; Yazdani, Ali			Topological surface states protected from backscattering by chiral spin texture	NATURE			English	Article							INTERFERENCE; INSULATOR; PHASE	Topological insulators are a new class of insulators in which a bulk gap for electronic excitations is generated because of the strong spin-orbit coupling(1-5) inherent to these systems. These materials are distinguished from ordinary insulators by the presence of gapless metallic surface states, resembling chiral edge modes in quantum Hall systems, but with unconventional spin textures. A key predicted feature of such spin-textured boundary states is their insensitivity to spin-independent scattering, which is thought to protect them from backscattering and localization. Recently, experimental and theoretical efforts have provided strong evidence for the existence of both two-and three-dimensional classes of such topological insulator materials in semiconductor quantum well structures(6-8) and several bismuth-based compounds(9-13), but so far experiments have not probed the sensitivity of these chiral states to scattering. Here we use scanning tunnelling spectroscopy and angle-resolved photoemission spectroscopy to visualize the gapless surface states in the three-dimensional topological insulator Bi1-xSbx, and examine in detail the influence of scattering from disorder caused by random alloying in this compound. We show that, despite strong atomic scale disorder, backscattering between states of opposite momentum and opposite spin is absent. Our observations demonstrate that the chiral nature of these states protects the spin of the carriers. These chiral states are therefore potentially useful for spin-based electronics, in which long spin coherence is critical(14), and also for quantum computing applications, where topological protection can enable fault-tolerant information processing(15,16).	[Roushan, Pedram; Seo, Jungpil; Parker, Colin V.; Hsieh, D.; Qian, Dong; Richardella, Anthony; Hasan, M. Z.; Cava, R. J.; Yazdani, Ali] Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; [Roushan, Pedram; Seo, Jungpil; Parker, Colin V.; Hsieh, D.; Qian, Dong; Richardella, Anthony; Hasan, M. Z.; Cava, R. J.; Yazdani, Ali] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Hor, Y. S.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Yazdani, A (corresponding author), Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA.	yazdani@princeton.edu	San Hor, Yew/S-1429-2017; Parker, Colin/AAK-6766-2021; HASAN, M. Zahid/D-8237-2012; Qian, Dong/O-1028-2015	San Hor, Yew/0000-0002-1417-4357; Parker, Colin/0000-0001-6902-4471; Yazdani, Ali/0000-0003-4996-8904; Seo, Jungpil/0000-0002-0442-288X	ONR; ARO; DOE; NSF-DMR; NSF-MRSEC; NSF graduate fellowship	ONR(Office of Naval Research); ARO; DOE(United States Department of Energy (DOE)); NSF-DMR(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NSF graduate fellowship(National Science Foundation (NSF))	We acknowledge K. K. Gomes and A. N. Pasupathy for suggestions about experimental procedure and initial analysis. This work was supported by grants from ONR, ARO, DOE, NSF-DMR and the NSF-MRSEC programme through the Princeton Center for Complex Materials. P. R. acknowledges an NSF graduate fellowship.	Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; Brihuega I, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.206802; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Fu L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045302; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Hsieh D, 2009, SCIENCE, V323, P919, DOI 10.1126/science.1167733; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Kim TK, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.085440; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; LaShell S, 1996, PHYS REV LETT, V77, P3419, DOI 10.1103/PhysRevLett.77.3419; Leek PJ, 2007, SCIENCE, V318, P1889, DOI 10.1126/science.1149858; Markiewicz RS, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.214517; McElroy K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067005; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Pascual JI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.196802; Petersen L, 1998, PHYS REV B, V57, pR6858, DOI 10.1103/PhysRevB.57.R6858; Petersen L, 2000, SURF SCI, V459, P49, DOI 10.1016/S0039-6028(00)00441-6; ROY R, 2006, Z2 CLASSIFICATION QU; Rutter GM, 2007, SCIENCE, V317, P219, DOI 10.1126/science.1142882; Teo JCY, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045426; Wang QH, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020511; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; ZHANG HJ, 2009, ELECT STRUCTURES SUR	28	813	822	16	359	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1106	U64		10.1038/nature08308	http://dx.doi.org/10.1038/nature08308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19668187				2022-12-28	WOS:000269314000033
J	Nolen, BJ; Tomasevic, N; Russell, A; Pierce, DW; Jia, Z; McCormick, CD; Hartman, J; Sakowicz, R; Pollard, TD				Nolen, B. J.; Tomasevic, N.; Russell, A.; Pierce, D. W.; Jia, Z.; McCormick, C. D.; Hartman, J.; Sakowicz, R.; Pollard, T. D.			Characterization of two classes of small molecule inhibitors of Arp2/3 complex	NATURE			English	Article							ACTIN-FILAMENT; PROTEIN; CRYSTALLOGRAPHY; POLYMERIZATION; ASSOCIATION; NUCLEATION; WASP; ADP; ATP	Polymerization of actin filaments directed by the actin-related protein (Arp)2/3 complex supports many types of cellular movements(1). However, questions remain regarding the relative contributions of Arp2/3 complex versus other mechanisms of actin filament nucleation to processes such as path finding by neuronal growth cones; this is because of the lack of simple methods to inhibit Arp2/3 complex reversibly in living cells. Here we describe two classes of small molecules that bind to different sites on the Arp2/3 complex and inhibit its ability to nucleate actin filaments. CK-0944636 binds between Arp2 and Arp3, where it appears to block movement of Arp2 and Arp3 into their active conformation. CK-0993548 inserts into the hydrophobic core of Arp3 and alters its conformation. Both classes of compounds inhibit formation of actin filament comet tails by Listeria and podosomes by monocytes. Two inhibitors with different mechanisms of action provide a powerful approach for studying the Arp2/3 complex in living cells.	[Nolen, B. J.; Pollard, T. D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Nolen, B. J.; Pollard, T. D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Nolen, B. J.; McCormick, C. D.; Pollard, T. D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Tomasevic, N.; Russell, A.; Pierce, D. W.; Jia, Z.; Hartman, J.; Sakowicz, R.] Cytokinetics Inc, San Francisco, CA 94080 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu		Nolen, Brad/0000-0002-0224-9980; Russell, Alan/0000-0001-7545-5008	Cytokinetics, Inc.; NIH [GM-066311]; NSF; Ruth Kirschstein postdoctoral fellowship [GM074374-02]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074374, P01GM066311] Funding Source: NIH RePORTER	Cytokinetics, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Ruth Kirschstein postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Cytokinetics, Inc., NIH research grant GM-066311 ( to T. D. P.), an NSF graduate research fellowship ( C. D. M.) and a Ruth Kirschstein postdoctoral fellowship (GM074374-02 to B. J. N.). We thank L. Belmont, Z. Khurshid, O. Ezizika, J. Lee, S. Leuenroth, Z. Cournia and H. Chen for help with the project.	Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Nolen BJ, 2004, P NATL ACAD SCI USA, V101, P15627, DOI 10.1073/pnas.0407149101; Nolen BJ, 2008, J BIOL CHEM, V283, P26490, DOI 10.1074/jbc.M802607200; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105	24	346	353	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1031	U121		10.1038/nature08231	http://dx.doi.org/10.1038/nature08231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19648907	Green Accepted			2022-12-28	WOS:000269085500038
J	Surnmerskill, B				Surnmerskill, Benjamin			Online social networks and wellbeing	LANCET			English	Editorial Material									Crypt Sch, Gloucester GL2 5AE, England		Surnmerskill, B (corresponding author), Crypt Sch, Gloucester GL2 5AE, England.	Ben_SNS@hotmail.co.uk						Ellison N, 2006, J COMPUT-MEDIAT COMM, V11; ROBERTS B, 2009, DAILY MIRROR    0806; van der Aa N, 2009, J YOUTH ADOLESCENCE, V38, P765, DOI 10.1007/s10964-008-9298-3	3	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					514	514		10.1016/S0140-6736(09)61472-0	http://dx.doi.org/10.1016/S0140-6736(09)61472-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484BX	19683631				2022-12-28	WOS:000269019400011
J	Lam, FC; Law, A; Wykes, W				Lam, Fook Chang; Law, Allison; Wykes, William			Practice 10-Minute Consultation Herpes zoster ophthalmicus	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lam, Fook Chang; Wykes, William] So Gen Hosp, Dept Ophthalmol, Glasgow G51 4TF, Lanark, Scotland; [Law, Allison] Southbank Surg, Kirkintilloch G66 1NH, Scotland	University of Glasgow	Lam, FC (corresponding author), So Gen Hosp, Dept Ophthalmol, Glasgow G51 4TF, Lanark, Scotland.	fook_chang@hotmail.com							0	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 13	2009	339								b2624	10.1136/bmj.b2624	http://dx.doi.org/10.1136/bmj.b2624			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YK	19679612				2022-12-28	WOS:000269162100001
J	Katz, MH				Katz, Mitchell H.			Structural Interventions for Addressing Chronic Health Problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICAL-ACTIVITY; PUBLIC-HEALTH		San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA	San Francisco Department of Public Health	Katz, MH (corresponding author), San Francisco Dept Publ Hlth, 101 Grove St,Room 308, San Francisco, CA 94102 USA.	Mitch.Katz@sfdph.org						Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; Eckel RH, 2005, JAMA-J AM MED ASSOC, V293, P96, DOI 10.1001/jama.293.1.96; Frieden TR, 2008, INT J EPIDEMIOL, V37, P966, DOI 10.1093/ije/dyn108; King AC, 1998, AM J PREV MED, V15, P316, DOI 10.1016/S0749-3797(98)00085-3; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moulton AD, 2009, AM J PUBLIC HEALTH, V99, P17, DOI 10.2105/AJPH.2007.130278; National Center for Health Marketing Centers for Disease Control and Prevention, GUID COMM PREV SERV; Rigotti NA, 2002, NEW ENGL J MED, V346, P506, DOI 10.1056/NEJMcp012279; Sallis JF, 1998, AM J PREV MED, V15, P379, DOI 10.1016/S0749-3797(98)00076-2; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350	10	19	20	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					683	685		10.1001/jama.2009.1147	http://dx.doi.org/10.1001/jama.2009.1147			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481ZI	19671911				2022-12-28	WOS:000268852300029
J	Collombat, P; Xu, XB; Ravassard, P; Sosa-Pineda, B; Dussaud, S; Billestrup, N; Madsen, OD; Serup, P; Heimberg, H; Mansouri, A				Collombat, Patrick; Xu, Xiaobo; Ravassard, Philippe; Sosa-Pineda, Beatriz; Dussaud, Sebastien; Billestrup, Nils; Madsen, Ole D.; Serup, Palle; Heimberg, Harry; Mansouri, Ahmed			The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into alpha and Subsequently beta Cells	CELL			English	Article							ENDOCRINE PANCREAS; ADULT PANCREAS; KNOCKOUT MICE; DIFFERENTIATION; GLUCAGON; LINEAGES; GENE; ARX; INACTIVATION; REPLACEMENT	We have previously reported that the loss of Arx and/or Pax4 gene activity leads to a shift in the fate of the different endocrine cell subtypes in the mouse pancreas, without affecting the total endocrine cell numbers. Here, we conditionally and ectopically express Pax4 using different cell-specific promoters and demonstrate that Pax4 forces endocrine precursor cells, as well as mature alpha cells, to adopt a beta cell destiny. This results in a glucagon deficiency that provokes a compensatory and continuous glucagon(+) cell neogenesis requiring the re-expression of the pro-endocrine gene Ngn3. However, the newly formed alpha cells fail to correct the hypoglucagonemia since they subsequently acquire a beta cell phenotype upon Pax4 ectopic expression. Notably, this cycle of neogenesis and redifferentiation caused by ectopic expression of Pax4 in alpha cells is capable of restoring a functional beta cellmass and curing diabetes in animals that have been chemically depleted of beta cells.	[Collombat, Patrick; Mansouri, Ahmed] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; [Collombat, Patrick; Madsen, Ole D.; Serup, Palle; Heimberg, Harry; Mansouri, Ahmed] Beta Cell Biol Consortium, Nashville, TN 37323 USA; [Collombat, Patrick; Ravassard, Philippe; Madsen, Ole D.; Serup, Palle; Heimberg, Harry] JDRF Ctr Beta Cell Therapy Diabet, B-1090 Brussels, Belgium; [Xu, Xiaobo; Heimberg, Harry] Vrije Univ Brussels, Diabet Res Ctr, B-1090 Brussels, Belgium; [Ravassard, Philippe; Dussaud, Sebastien] Univ Paris 06, CNRS, INSERM,Ctr Rech,Inst Cerveau & Moelle, UMR 7225,UMRS 975,Biotechnol & Biotherapy Lab, FR-75013 Paris, France; [Sosa-Pineda, Beatriz] St Jude Childrens Hosp, Dept Genet Tumor Cell Biol, Memphis, TN 38105 USA; [Dussaud, Sebastien] Univ Paris 06, Fac Med Pitie Salpetriere, Ctr Experimentat Fonct, FR-75013 Paris, France; [Billestrup, Nils] Res Inst, Dept Translat Diabetol, DK-2820 Gentofte, Denmark; [Madsen, Ole D.; Serup, Palle] Res Inst, Dept Dev Biol, DK-2820 Gentofte, Denmark; [Mansouri, Ahmed] Univ Gottingen, Dept Clin Neurophysiol, D-37075 Gottingen, Germany	Max Planck Society; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; St Jude Children's Research Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Gottingen	Collombat, P (corresponding author), Fac Sci, INSERM, U636, Diabet Genet Team, FR-06108 Nice, France.	collombat@unice.fr; amansou@gwdg.de	Serup, Palle/A-7407-2011; collombat, patrick/P-3741-2019; Madsen, Ole D./A-7415-2011; collombat, patrick/F-4495-2015	Serup, Palle/0000-0002-0858-590X; collombat, patrick/0000-0001-8232-1438; Madsen, Ole D./0000-0002-2753-5203; collombat, patrick/0000-0001-8232-1438; ravassard, philippe/0000-0002-0393-9262; Billestrup, Nils/0000-0002-4968-8067; Dussaud, Sebastien/0000-0002-5365-8338; Heimberg, Harry/0000-0003-1954-7375	Max-Planck Society; Dr. H. Storz and Alte Leipziger Foundation; INSERM; INSERM-Avenir Program; National Fund for Scientific Research-FlanderS [G000609N10]; Juvenile Diabetes Research foundation [26-2008-639]; National Institutes of Health Beta Cell Biology Consortium [U19 DK 072495-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK072495, R01DK060542] Funding Source: NIH RePORTER	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Dr. H. Storz and Alte Leipziger Foundation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INSERM-Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); National Fund for Scientific Research-FlanderS(FWO); Juvenile Diabetes Research foundation(Juvenile Diabetes Research Foundation); National Institutes of Health Beta Cell Biology Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are most grateful to J. Hecksher-Sorensen, G. Gradwohl, G. Mellitzer, A. Stoykova, G. Collombat, D. Pipeleers, and P. Gruss for discussion. We are indebted to D. A. Melton, C. V. Wright, P. Herrera, M. Sander, B. Ahren, and L. Kvist for providing us with mice and/or antibodies. We also thank M. Van de Casteele, J. Hald, T. Rabe, S. Niemann-Seyde, T. Mundinger, R. Faubel, O. Jackle, T. Schulz, U. Franke, and S. Schrotter for excellent technical assistance, as well as the biotechnical laboratory crew for their support with the mice. The authors are supported by the Max-Planck Society, the Dr. H. Storz and Alte Leipziger Foundation, the INSERM, the INSERM-Avenir Program, the National Fund for Scientific Research-Flanders (G000609N10), the Juvenile Diabetes Research foundation (26-2008-639), and the National Institutes of Health Beta Cell Biology Consortium (U19 DK 072495-01).	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; BLUME N, 1995, J CLIN INVEST, V96, P2227, DOI 10.1172/JCI118278; Brun T, 2004, J CELL BIOL, V167, P1123, DOI 10.1083/jcb.200405148; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dor Y, 2008, CELL, V132, P183, DOI 10.1016/j.cell.2008.01.004; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Offield MF, 1996, DEVELOPMENT, V122, P983; PETERSSON B, 1963, ACTA ENDOCRINOL-COP, V44, P139; Rosenberg L, 1998, MICROSC RES TECHNIQ, V43, P337, DOI 10.1002/(SICI)1097-0029(19981115)43:4<337::AID-JEMT8>3.0.CO;2-U; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Theis M, 2004, EXP CELL RES, V294, P18, DOI 10.1016/j.yexcr.2003.09.031; Wang Q, 2008, DEV DYNAM, V237, P51, DOI 10.1002/dvdy.21379; Webb GC, 2002, DIABETES, V51, P398, DOI 10.2337/diabetes.51.2.398; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	30	399	427	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					449	462		10.1016/j.cell.2009.05.035	http://dx.doi.org/10.1016/j.cell.2009.05.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665969	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000268771900011
J	Liu, Y; Yan, H				Liu, Yan; Yan, Hao			Designer Curvature	SCIENCE			English	Editorial Material							DNA; SHAPES		[Liu, Yan; Yan, Hao] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Liu, Yan; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Liu, Y (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	hao.yan@asu.edu	Liu, Yan/K-1999-2014	Liu, Yan/0000-0003-0906-2606				Aldaye FA, 2007, J AM CHEM SOC, V129, P13376, DOI 10.1021/ja075966q; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307	12	11	12	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					685	686		10.1126/science.1178328	http://dx.doi.org/10.1126/science.1178328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661408				2022-12-28	WOS:000268723700026
J	Buchanan, M				Buchanan, Mark			Economics: Meltdown modelling	NATURE			English	Editorial Material														Waldrop, M Mitchell/0000-0002-8063-1472					0	64	68	7	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					680	682		10.1038/460680a	http://dx.doi.org/10.1038/460680a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661889	Bronze			2022-12-28	WOS:000268670300013
J	Cacchio, A; De Blasis, E; Necozione, S; di Orio, F; Santilli, V				Cacchio, Angelo; De Blasis, Elisabetta; Necozione, Stefano; di Orio, Ferdinando; Santilli, Valter			Mirror Therapy for Chronic Complex Regional Pain Syndrome Type 1 and Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Cacchio, Angelo; Santilli, Valter] Univ Roma La Sapienza, Rome, Italy; [De Blasis, Elisabetta] Santissimi Filippo & Nicola Hosp Avezzano, Avezzano, Italy; [Necozione, Stefano; di Orio, Ferdinando] Univ Aquila, I-67100 Laquila, Italy	Sapienza University Rome; University of L'Aquila	Cacchio, A (corresponding author), Univ Roma La Sapienza, Rome, Italy.	angelo.cacchio@tin.it	Longo, Umile Giuseppe/K-9147-2016; Cacchio, Angelo/AAT-4844-2021	Longo, Umile Giuseppe/0000-0003-4063-9821; Cacchio, Angelo/0000-0001-8850-7938; Santilli, Valter/0000-0002-2547-6801; NECOZIONE, Stefano/0000-0003-2501-1665				Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; Moseley GL, 2004, NEUROLOGY, V62, P1644, DOI 10.1212/01.WNL.0000123019.13575.5E; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058	5	89	100	3	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					634	636		10.1056/NEJMc0902799	http://dx.doi.org/10.1056/NEJMc0902799			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479NR	19657134				2022-12-28	WOS:000268667300027
J	Raballo, A; Laroi, F				Raballo, Andrea; Laroi, Frank			Clinical staging: a new scenario for the treatment of psychosis	LANCET			English	Editorial Material							SCHIZOPHRENIA; FUTURE; RISK		[Raballo, Andrea] Univ Copenhagen, Danish Natl Res Fdn, Ctr Subject Res, DK-2300 Copenhagen, Denmark; [Raballo, Andrea] Univ Copenhagen, Hvidovre Hosp, Dept Psychiat, DK-2650 Hvidovre, Denmark; [Raballo, Andrea] AUSL Reggio Emilia, Dept Mental Hlth, Reggio Emilia, Italy; [Laroi, Frank] Univ Liege, Cognit Psychopathol Unit, Liege, Belgium; [Laroi, Frank] Intercommunal Soins Specialisees Liege Mental Hlt, Liege, Belgium	Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen; University of Liege	Raballo, A (corresponding author), Univ Copenhagen, Danish Natl Res Fdn, Ctr Subject Res, DK-2300 Copenhagen, Denmark.	anr@hum.ku.dk	Raballo, Andrea/J-6040-2015; Laroi, Frank/C-5237-2011	Raballo, Andrea/0000-0003-3709-4111; Laroi, Frank/0000-0002-4210-0099				Boonstra Nynke, 2008, Clin Pract Epidemiol Ment Health, V4, P29, DOI 10.1186/1745-0179-4-29; Crumlish N, 2009, BRIT J PSYCHIAT, V194, P18, DOI 10.1192/bjp.bp.107.048942; McGorry PD, 2008, WORLD PSYCHIATRY, V7, P148; McGorry PD, 2008, ARCH GEN PSYCHIAT, V65, P25, DOI 10.1001/archgenpsychiatry.2007.9; McGorry PD, 2007, AM J PSYCHIAT, V164, P859, DOI 10.1176/appi.ajp.164.6.859; Meyer SE, 2005, J CHILD ADOL PSYCHOP, V15, P434, DOI 10.1089/cap.2005.15.434; Parnas J, 2003, COMPR PSYCHIAT, V44, P121, DOI 10.1053/comp.2003.50017; Schultze-Lutter F, 2009, EUR PSYCHIAT, V24, P1, DOI 10.1016/j.eurpsy.2008.08.004; Schultze-Lutter F, 2009, SCHIZOPHRENIA BULL, V35, P5, DOI 10.1093/schbul/sbn139; Svirskis T, 2007, COMPR PSYCHIAT, V48, P155, DOI 10.1016/j.comppsych.2006.10.008; Yung AR, 2008, SCHIZOPHR RES, V105, P10, DOI 10.1016/j.schres.2008.07.012	11	25	25	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2009	374	9687					365	367		10.1016/S0140-6736(09)61398-2	http://dx.doi.org/10.1016/S0140-6736(09)61398-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481MJ	19647596				2022-12-28	WOS:000268815200007
J	Hodges, C; Bintu, L; Lubkowska, L; Kashlev, M; Bustamante, C				Hodges, Courtney; Bintu, Lacramioara; Lubkowska, Lucyna; Kashlev, Mikhail; Bustamante, Carlos			Nucleosomal Fluctuations Govern the Transcription Dynamics of RNA Polymerase II	SCIENCE			English	Article							C-MYC; IN-VIVO; ELONGATION; GENE; DNA; TEMPLATES; MECHANISM; BARRIER; BLOCK; END	RNA polymerase II (Pol II) must overcome the barriers imposed by nucleosomes during transcription elongation. We have developed an optical tweezers assay to follow individual Pol II complexes as they transcribe nucleosomal DNA. Our results indicate that the nucleosome behaves as a fluctuating barrier that locally increases pause density, slows pause recovery, and reduces the apparent pause-free velocity of Pol II. The polymerase, rather than actively separating DNA from histones, functions instead as a ratchet that rectifies nucleosomal fluctuations. We also obtained direct evidence that transcription through a nucleosome involves transfer of the core histones behind the transcribing polymerase via a transient DNA loop. The interplay between polymerase dynamics and nucleosome fluctuations provides a physical basis for the regulation of eukaryotic transcription.	[Hodges, Courtney; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Hodges, Courtney; Bustamante, Carlos] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Bintu, Lacramioara; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Lubkowska, Lucyna; Kashlev, Mikhail] NCI, Frederick Canc Res & Dev Ctr, NCI Ctr Canc Res, Frederick, MD 21702 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem & Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Hodges, C (corresponding author), Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Hodges, H. Courtney/0000-0003-4441-497X; Bustamante, Carlos/0000-0002-2970-0073	NIH [GM32543]; NATIONAL CANCER INSTITUTE [ZIABC010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032543, R37GM032543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant GM32543 (C.B.).	Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Depken M, 2009, BIOPHYS J, V96, P2189, DOI 10.1016/j.bpj.2008.12.3918; FELLER W, 1971, INTRO PROBABILITY TH, V2, P59; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; PLET A, 1995, ONCOGENE, V10, P319; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; STUDITSKY VM, 1994, CELL, V76, P371, DOI 10.1016/0092-8674(94)90343-3; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Walter W, 2003, J BIOL CHEM, V278, P36148, DOI 10.1074/jbc.M305647200; WIDMER RM, 1984, EMBO J, V3, P1635, DOI 10.1002/j.1460-2075.1984.tb02022.x; Yan J, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061905	25	269	275	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					626	628		10.1126/science.1172926	http://dx.doi.org/10.1126/science.1172926			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644123	Green Accepted			2022-12-28	WOS:000268493000054
J	Koopmans, CM; Bijlenga, D; Groen, H; Vijgen, SMC; Aarnoudse, JG; Bekedam, DJ; van den Berg, PP; de Boer, K; Burggraaff, JM; Bloemenkamp, KWM; Drogtrop, AP; Franx, A; de Groot, CJM; Huisjes, AJM; Kwee, A; van Loon, AJ; Lub, A; Papatsonis, DNM; van der Post, JAM; Roumen, FJME; Scheepers, HCJ; Willekes, C; Mol, BWJ; van Pampus, MG				Koopmans, Corine M.; Bijlenga, Denise; Groen, Henk; Vijgen, Sylvia M. C.; Aarnoudse, Jan G.; Bekedam, Dick J.; van den Berg, Paul P.; de Boer, Karin; Burggraaff, Jan M.; Bloemenkamp, Kitty W. M.; Drogtrop, Addy P.; Franx, Arie; de Groot, Christianne J. M.; Huisjes, Anjoke J. M.; Kwee, Anneke; van Loon, Aren J.; Lub, Annemiek; Papatsonis, Dimitri N. M.; van der Post, Joris A. M.; Roumen, Frans J. M. E.; Scheepers, Hubertina C. J.; Willekes, Christine; Mol, Ben W. J.; van Pampus, Maria G.		HYPITAT Study Grp	Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial	LANCET			English	Article							POSTPARTUM HEMORRHAGE; ELECTIVE INDUCTION; RISK-FACTORS; PREGNANCY; DIAGNOSIS; MANAGEMENT; WOMEN	Background Robust evidence to direct management of pregnant women with mild hypertensive disease at term is scarce. We investigated whether induction of labour in women with a singleton pregnancy complicated by gestational hypertension or mild pre-eclampsia reduces severe maternal morbidity. Methods We undertook a multicentre, parallel, open-label randomised controlled trial in six academic and 32 non-academic hospitals in the Netherlands between October, 2005, and March, 2008. We enrolled patients with a singleton pregnancy at 36-41 weeks gestation, and who had gestational hypertension or mild pre-eclampsia. Participants were randomly allocated in a 1:1 ratio by block randomisation. with a web-based application system to receive either induction of labour or expectant monitoring. Masking of intervention allocation was not possible. The primary outcome was a composite measure of poor maternal outcome-maternal mortality, maternal morbidity (eclampsia, HELLP syndrome, pulmonary oedema, thromboembolic disease, and placental abruption), progression to severe hypertension or proteinuria, and major post-partum haemorrhage (>1000 ml, blood loss). Analysis was by intention to treat and treatment effect is presented as relative risk. This study is registered, number ISRCTN08132825. Findings 756 patients were allocated to receive induction of labour (n=377 patients) or expectant monitoring (n=379). 397 patients refused randomisation but authorised use of their medical records. Of women who were randomised, 117 (31%) allocated to induction of labour developed poor maternal outcome compared with 166 (44%) allocated to expectant monitoring (relative risk 0.71, 95% CI 0.59-0.86, p<0.0001). No cases of maternal or neonatal death or eclampsia were recorded. Interpretation Induction of labour is associated with improved maternal outcome and should be advised for women with mild hypertensive disease beyond 37 weeks' gestation. Funding ZonMw.	[Koopmans, Corine M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, NL-9700 RB Groningen, Netherlands; [Bijlenga, Denise; Vijgen, Sylvia M. C.; van der Post, Joris A. M.; Mol, Ben W. J.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Mol, Ben W. J.] Maxima Med Ctr, Veldhoven, Netherlands; [Bekedam, Dick J.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [de Boer, Karin] Hosp Rijnstate, Arnhem, Netherlands; [Burggraaff, Jan M.] Scheper Hosp, Emmen, Netherlands; [Bloemenkamp, Kitty W. M.] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands; [Drogtrop, Addy P.] Twee Steden Hosp, Tilburg, Netherlands; [Franx, Arie] Sint Elisabeth Hosp, Tilburg, Netherlands; [de Groot, Christianne J. M.] Med Ctr Haaglanden, The Hague, Netherlands; [Huisjes, Anjoke J. M.] Gelre Hosp, Apeldoorn, Netherlands; [Kwee, Anneke] Univ Med Ctr, Utrecht, Netherlands; [van Loon, Aren J.] Martini Hosp, Groningen, Netherlands; [Lub, Annemiek] Spaarne Hosp, Hoofddorp, Netherlands; [Papatsonis, Dimitri N. M.] Amphia Hosp, Breda, Netherlands; [Roumen, Frans J. M. E.] Atrium Med Ctr, Heerlen, Netherlands; [Scheepers, Hubertina C. J.] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Willekes, Christine] Univ Hosp Maastricht, Maastricht, Netherlands	University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Maxima Medical Center; Onze Lieve Vrouwe Gasthuis Hospital; Rijnstate Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Elisabeth-TweeSteden Ziekenhuis (ETZ); Haaglanden Medical Center; Gelre Hospitals; Utrecht University; Utrecht University Medical Center; Martini Hospital; Spaarne Hospital; Amphia Hospital; Atrium Medical Center; Radboud University Nijmegen; Maastricht University; Maastricht University Medical Centre (MUMC)	Koopmans, CM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands.	c.m.koopmans@og.umcg.nl	Willekes, Christine/GWZ-1205-2022; van der Post, Joris A M/A-8991-2008; Mol, Ben/I-4526-2012; Franx, Arie/AAA-1739-2021; Groen, Henk/B-2163-2013	Groen, Henk/0000-0002-6629-318X; van der Post, Joris/0000-0003-3311-2116; van Pampus, Maria/0000-0002-3020-8908; Roumen, Frans JME/0000-0003-2319-4808	ZonMw; Netherlands organisation for health research and development [945-06-553]	ZonMw(Netherlands Organization for Health Research and Development); Netherlands organisation for health research and development(Netherlands Organization for Health Research and Development)	We thank research nurses and midwives of our consortium, and residents, midwives, nurses, and gynaecologists of the participating centres for their help with patient recruitment and data collection. This trial was funded by ZonMw, the Netherlands organisation for health research and development, programme Doelmatigheidsonderzoek (grant number 945-06-553).	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Barbour L A, 2001, Int J Gynaecol Obstet, V75, P203; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Cammu H, 2002, AM J OBSTET GYNECOL, V186, P240, DOI 10.1067/mob.2002.119643; COMBS CA, 1991, OBSTET GYNECOL, V77, P77; COMBS CA, 1991, OBSTET GYNECOL, V77, P69; Cunningham FG, 2005, OBSTET GYNECOL, V105, P237, DOI 10.1097/01.AOG.0000153144.05885.fa; FUENTES A, 1995, CLIN OBSTET GYNECOL, V38, P224, DOI 10.1097/00003081-199506000-00005; Gant NF, 1996, INT J GYNECOL OBSTET, V53, P175; Garovic VD, 2000, MAYO CLIN PROC, V75, P1071, DOI 10.4065/75.10.1071; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; HANNAH ME, 1992, NEW ENGL J MED, V326, P1587, DOI 10.1056/NEJM199206113262402; Hannah ME, 1996, NEW ENGL J MED, V334, P1005, DOI 10.1056/NEJM199604183341601; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Klebanoff MA, 2007, AM J OBSTET GYNECOL, V197, p10A, DOI 10.1016/j.ajog.2007.02.030; KLOOSTERMAN GJ, 1970, INT J GYNECOL OBSTET, V8, P895, DOI DOI 10.1002/J.1879-3479.1970.TB00313.X; Koopmans Corine M, 2007, BMC Pregnancy Childbirth, V7, P14, DOI 10.1186/1471-2393-7-14; Martin JN, 2005, OBSTET GYNECOL, V105, P246, DOI 10.1097/01.AOG.0000151116.84113.56; Maslow AS, 2000, OBSTET GYNECOL, V95, P917, DOI 10.1016/S0029-7844(00)00794-8; Mousa HA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003249.pub2; Paruk F, 2000, Semin Neonatol, V5, P197, DOI 10.1053/siny.2000.0023; Roberts JM, 2003, HYPERTENS PREGNANCY, V22, P109, DOI 10.1081/PRG-120016792; Schuitemaker N, 1998, EUR J OBSTET GYN R B, V79, P57, DOI 10.1016/S0301-2115(98)00053-0; Schutte JM, 2008, BJOG-INT J OBSTET GY, V115, P732, DOI 10.1111/j.1471-0528.2008.01702.x; Sheiner E, 2005, J MATERN-FETAL NEO M, V18, P149, DOI 10.1080/14767050500170088; Sibai BM, 2005, OBSTET GYNECOL, V105, P402, DOI 10.1097/01.AOG.0000152351.13671.99; Sibai BM, 1996, NEW ENGL J MED, V335, P257, DOI 10.1056/NEJM199607253350407; Sibai BM, 2003, SEMIN PERINATOL, V27, P239, DOI 10.1016/S0146-0005(03)00022-3; STONES RW, 1993, EUR J OBSTET GYN R B, V48, P15, DOI 10.1016/0028-2243(93)90047-G; van Gemund N, 2003, GYNECOL OBSTET INVES, V56, P133, DOI 10.1159/000073771	31	485	502	0	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					979	988		10.1016/S0140-6736(09)60736-4	http://dx.doi.org/10.1016/S0140-6736(09)60736-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PK	19656558				2022-12-28	WOS:000270154100028
J	Wu, YI; Frey, D; Lungu, OI; Jaehrig, A; Schlichting, I; Kuhlman, B; Hahn, KM				Wu, Yi I.; Frey, Daniel; Lungu, Oana I.; Jaehrig, Angelika; Schlichting, Ilme; Kuhlman, Brian; Hahn, Klaus M.			A genetically encoded photoactivatable Rac controls the motility of living cells	NATURE			English	Article							LIGHT; BINDING; RHO; DYNAMICS; ACTIVATION; MIGRATION; DOMAINS; SITES	The precise spatio-temporal dynamics of protein activity are often critical in determining cell behaviour, yet for most proteins they remain poorly understood; it remains difficult to manipulate protein activity at precise times and places within living cells. Protein activity has been controlled by light, through protein derivatization with photocleavable moieties(1) or using photoreactive small-molecule ligands(2). However, this requires use of toxic ultraviolet wavelengths, activation is irreversible, and/or cell loading is accomplished via disruption of the cell membrane (for example, through microinjection). Here we have developed a new approach to produce genetically encoded photoactivatable derivatives of Rac1, a key GTPase regulating actin cytoskeletal dynamics in metazoan cells(3,4.) Rac1 mutants were fused to the photoreactive LOV (light oxygen voltage) domain from phototropin(5,6), sterically blocking Rac1 interactions until irradiation unwound a helix linking LOV to Rac1. Photoactivatable Rac1 (PA-Rac1) could be reversibly and repeatedly activated using 458-or 473-nm light to generate precisely localized cell protrusions and ruffling. Localized Rac activation or inactivation was sufficient to produce cell motility and control the direction of cell movement. Myosin was involved in Rac control of directionality but not in Rac-induced protrusion, whereas PAK was required for Rac-induced protrusion. PA-Rac1 was used to elucidate Rac regulation of RhoA in cell motility. Rac and Rho coordinate cytoskeletal behaviours with seconds and submicrometre precision(7,8). Their mutual regulation remains controversial(9), with data indicating that Rac inhibits and/or activates Rho(10,11). Rac was shown to inhibit RhoA in mouse embryonic fibroblasts, with inhibition modulated at protrusions and ruffles. A PA-Rac crystal structure and modelling revealed LOV-Rac interactions that will facilitate extension of this photoactivation approach to other proteins.	[Wu, Yi I.; Lungu, Oana I.; Jaehrig, Angelika; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Lungu, Oana I.; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Wu, Yi I.; Lungu, Oana I.; Jaehrig, Angelika; Kuhlman, Brian; Hahn, Klaus M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Frey, Daniel; Schlichting, Ilme] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Max Planck Society	Hahn, KM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	yiwu@med.unc.edu; khahn@med.unc.edu	Schlichting, Ilme/I-1339-2013	Hahn, Klaus/0000-0002-1970-7562	American Heart Association; National Institutes of Health [GM057464, GM64346]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM057464, U54GM064346, R01GM057464] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for help and constructs from W. Briggs, K. Moffat, A. Tripathy, G. Bokoch and K. Jacobson. Diffraction data were collected at the Swiss Light Source, beamline X10SA, Paul Scherrer Institute, Villigen, Switzerland. We thank the Dortmund-Heidelberg team for data collection, and A. Pauluhn and M. Fuchs for their support in setting up the beamline. This research was supported by the American Heart Association (Y. I. W.) and the National Institutes of Health (K. M. H. grants GM057464 and GM64346).	Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Goeldner M, 2005, DYNAMIC STUDIES IN BIOLOGY: PHOTOTRIGGERS, PHOTOSWITCHES AND CAGED BIOMOLECULES, P1, DOI 10.1002/3527605592; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; HODGSON L, CURR PROTOC IN PRESS; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Leung DW, 2008, P NATL ACAD SCI USA, V105, P12797, DOI 10.1073/pnas.0801232105; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Yao XL, 2008, NAT CHEM BIOL, V4, P491, DOI 10.1038/nchembio.99	29	769	793	3	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					104	U111		10.1038/nature08241	http://dx.doi.org/10.1038/nature08241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19693014	Green Submitted, Green Accepted			2022-12-28	WOS:000269478800039
J	Kajimura, S; Seale, P; Kubota, K; Lunsford, E; Frangioni, JV; Gygi, SP; Spiegelman, BM				Kajimura, Shingo; Seale, Patrick; Kubota, Kazuishi; Lunsford, Elaine; Frangioni, John V.; Gygi, Steven P.; Spiegelman, Bruce M.			Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex	NATURE			English	Article							ADIPOSE-TISSUE; C/EBP-BETA; ADIPOCYTE DIFFERENTIATION; OLIGONUCLEOTIDE ARRAYS; ADULT HUMANS; MICE LACKING; PPAR-GAMMA; PROTEIN; GENE; EXPRESSION	Brown adipose cells are specialized to dissipate chemical energy in the form of heat, as a physiological defence against cold and obesity(1). PRDM16 (PR domain containing 16) is a 140 kDa zinc finger protein that robustly induces brown fat determination and differentiation(2). Recent data suggests that brown fat cells arise in vivo from a Myf5-positive, myoblastic lineage by the action of PRDM16 (ref. 3); however, the molecular mechanisms responsible for this developmental switch is unclear. Here we show that PRDM16 forms a transcriptional complex with the active form of C/EBP-beta ( also known as LAP), acting as a critical molecular unit that controls the cell fate switch from myoblastic precursors to brown fat cells. Forced expression of PRDM16 and C/EBP-beta is sufficient to induce a fully functional brown fat program in naive fibroblastic cells, including skin fibroblasts from mouse and man. Transplantation of fibroblasts expressing these two factors into mice gives rise to an ectopic fat pad with the morphological and biochemical characteristics of brown fat. Like endogenous brown fat, this synthetic brown fat tissue acts as a sink for glucose uptake, as determined by positron emission tomography with fluorodeoxyglucose. These data indicate that the PRDM16-C/EBP-beta complex initiates brown fat formation from myoblastic precursors, and may provide opportunities for the development of new therapeutics for obesity and type-2 diabetes.	[Kajimura, Shingo; Seale, Patrick; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Kajimura, Shingo; Seale, Patrick; Kubota, Kazuishi; Gygi, Steven P.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lunsford, Elaine; Frangioni, John V.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Kajimura, Shingo/AAC-5090-2019	Kajimura, Shingo/0000-0003-0672-5910	AHA [0930125N]; National Institutes of Health ( NIH) [DK081605, HG3456, GM67945]; Picower Foundation [DK31405]; NIH/NCRR [S10-RR-023010]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK081605, R37DK031405, K99DK087853, R00DK081605, R01DK031405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	AHA(American Heart Association); National Institutes of Health ( NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Picower Foundation; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. R. Farmer, J. Rheinwald and P. F. Johnson for providing cells and other reagents, R. Gupta for his critical comments on the manuscript, and J. Y. Choi and E. Naseri for their assistance. S. K. is supported by AHA scientist development grant (0930125N). P. S. is supported by a National Institutes of Health ( NIH) grant (DK081605). This work was supported by grants from the Picower Foundation and the NIH (DK31405) to B. M. S., NIH HG3456 and GM67945 to S. P. G., and NIH/NCRR shared instrumentation grant S10-RR-023010.	Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang H, 2008, MOL ENDOCRINOL, V22, P1596, DOI 10.1210/me.2007-0388; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350	36	526	564	3	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1154	U125		10.1038/nature08262	http://dx.doi.org/10.1038/nature08262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19641492	Green Accepted			2022-12-28	WOS:000269314000044
J	Zhang, FJ; Dou, ZH; Ma, Y; Zhao, Y; Liu, ZF; Bulterys, M; Chen, RY				Zhang, Fujie; Dou, Zhihui; Ma, Ye; Zhao, Yan; Liu, Zhongfu; Bulterys, Marc; Chen, Ray Y.			Five-Year Outcomes of the China National Free Antiretroviral Treatment Program	ANNALS OF INTERNAL MEDICINE			English	Article							HIV-INFECTED PATIENTS; CD4 CELL COUNT; RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; VIRAL LOAD; SCALE-UP; TREATMENT FAILURE; EARLY MORTALITY; 1ST YEAR; THERAPY	Background: China's National Free Antiretroviral Treatment Program began in 2002 and, by August 2008, included more than 52 000 patients. Objective: To report 5-year outcomes on adult mortality and immunologic treatment failure rates and risk factors. Design: Open cohort analysis of a prospectively collected, observational database. Setting: China. Patients: All patients in the national treatment database from June 2002 to August 2008. Patients were excluded if they had not started triple therapy or had missing treatment regimen information. Intervention: Antiretroviral therapy according to Chinese national treatment guidelines. Measurements: Mortality rate and immunologic treatment failure rate, according to World Health Organization criteria. Results: Of 52 191 patients, 48 785 were included. Median age was 38 years, 58% were men, 53% were infected through plasma or blood, and the median baseline CD4 cell count was 0.118 x 10(9) cells/L. Mortality was greatest during the first 3 months of treatment (22.6 deaths per 100 person-years) but decreased to a steady rate of 4 to 5 deaths per 100 person-years after 6 months and maintained this rate over the subsequent 4.5 years. The strongest mortality risk factors were a baseline CD4 cell count less than 0.050 x 10(9) cells/L (adjusted hazard ratio [HR] compared with a count >= 0.200 x 10(9) cells/L, 3.3 [95% CI, 2.9 to 3.8]) and having 4 to 5 baseline symptom categories (adjusted HR compared with no baseline symptom categories, 3.4 [CI, 2.9 to 4.0]). Treatment failure was determined among 31 070 patients with 1 or more follow-up CD4 cell counts. Overall, treatment failed for 25% of patients (12.0 treatment failures per 100 person-years), with the cumulative treatment failure rate increasing to 50% at 5 years. Limitation: Immunologic treatment failure does not necessarily correlate well with virologic treatment failure. Conclusion: The National Free Antiretroviral Treatment Program reduced mortality among adult patients in China with AIDS to rates similar to those of other low-or middle-income countries. A cumulative immunologic treatment failure rate of 50% after 5 years, due to the limited availability of second-line regimens, is of great concern.	[Zhang, Fujie] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, FJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, 27 Nanwei Rd, Beijing 100050, Peoples R China.	treatment@chinaaids.cn	Chen, Ray/T-5102-2019; Chen, Ray/GRJ-6736-2022	Chen, Ray/0000-0001-6344-1442	AIDS preventionand treatment of the China Ministry of Health [WA-2006-03]; U. S. National Institutes of Health [U2R TW006918, R03 TW008203]; U. S. Centers for Disease Control and Prevention Global AIDS Program to the Chinese Center for Disease Control and Prevention [1U2GPS001188-01]; FOGARTY INTERNATIONAL CENTER [R03TW008203, U2RTW006918] Funding Source: NIH RePORTER	AIDS preventionand treatment of the China Ministry of Health; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Centers for Disease Control and Prevention Global AIDS Program to the Chinese Center for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	By the applied research program on AIDS preventionand treatment of the China Ministry of Health ( grant WA-2006-03), the U. S. National Institutes of Health ( grants U2R TW006918 and R03 TW008203), and a cooperative agreement from the U. S. Centers for Disease Control and Prevention Global AIDS Program to the Chinese Center for Disease Control and Prevention ( grant 1U2GPS001188-01).	Barth RE, 2008, EUR J CLIN MICROBIOL, V27, P977, DOI 10.1007/s10096-008-0534-2; Bartlett JG, 2008, J INFECT DIS, V197, pS250, DOI 10.1086/533417; BASENERO A, 2007, 4 INT AIDS SOC C HIV; Bisson GP, 2006, AIDS, V20, P1613, DOI 10.1097/01.aids.0000238407.00874.dc; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; *CHIN CTR DIS CONT, 2005, CHIN FREE ART MAN; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Corey DM, 2007, JAIDS-J ACQ IMM DEF, V44, P451, DOI 10.1097/QAI.0b013e31802f8512; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Grinszten B, 2007, JAIDS-J ACQ IMM DEF, V45, P515, DOI 10.1097/QAI.0b013e3180decb6a; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; HOSSEINIPOUR M, 2007, 4 INT AIDS SOC C HIV; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; MA Y, 2009, INT J EPIDEMIOL 0625; Madec Y, 2007, AIDS, V21, P351, DOI 10.1097/QAD.0b013e328012c54f; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Moore DM, 2008, LANCET, V371, P1396, DOI 10.1016/S0140-6736(08)60607-8; Moore DM, 2006, JAIDS-J ACQ IMM DEF, V43, P436, DOI 10.1097/01.qai.0000243105.80393.42; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sherer R, 2008, HEALTH AFFAIR, V27, P1140, DOI 10.1377/hlthaff.27.4.1140; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Sterne JAC, 2007, JAIDS-J ACQ IMM DEF, V46, P607, DOI 10.1097/QAI.0b013e31815b7dba; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Van der Borght SF, 2009, ANTIVIR THER, V14, P63; Wang L, 2009, JAIDS-J ACQ IMM DEF, V50, P414, DOI 10.1097/QAI.0b013e3181958530; World Health Organization, 2006, ANT THER HIV INF AD; Zhang F., 2005, CHINA FREE ART MANUA; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhou J, 2007, HIV MED, V8, P8, DOI 10.1111/j.1468-1293.2007.00417.x	48	205	293	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2009	151	4					241	W52		10.7326/0003-4819-151-4-200908180-00006	http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484IW	19687491				2022-12-28	WOS:000269038900003
J	Gurwitz, D; Fortier, I; Lunshof, JE; Knoppers, BM				Gurwitz, David; Fortier, Isabel; Lunshof, Jeantine E.; Knoppers, Bartha Maria			Children and Population Biobanks	SCIENCE			English	Editorial Material							GENETIC PRIVACY; RESOURCE; SCIENCE		[Gurwitz, David] Tel Aviv Univ, Natl Lab Genet Israeli Populat, Dept Human Mol Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Fortier, Isabel] P3G, Montreal, PQ H3V 1A2, Canada; [Lunshof, Jeantine E.] Maastricht Univ, European Ctr Publ Hlth Genom, NL-6200 MD Maastricht, Netherlands; [Lunshof, Jeantine E.] Maastricht Univ, Fac Hlth Med & Life Sci, NL-6200 MD Maastricht, Netherlands; [Lunshof, Jeantine E.] Vrije Univ Amsterdam, Dept Mol Cell Physiol, NL-1081 HV Amsterdam, Netherlands; [Knoppers, Bartha Maria] McGill Univ, Dept Human Genet, Fac Med, Ctr Genom & Policy, Montreal, PQ H3A 1A4, Canada	Tel Aviv University; Sackler Faculty of Medicine; Maastricht University; Maastricht University; Vrije Universiteit Amsterdam; McGill University	Gurwitz, D (corresponding author), Tel Aviv Univ, Natl Lab Genet Israeli Populat, Dept Human Mol Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	gurwitz@post.tau.ac.il	Gurwitz, David/E-7642-2013	Gurwitz, David/0000-0002-9363-1869; Lunshof, Jeantine E/0000-0002-5630-7947				Asslaber Martin, 2007, Briefings in Functional Genomics & Proteomics, V6, P193, DOI 10.1093/bfgp/elm023; Borry P, 2009, NAT REV GENET, V10, P8, DOI 10.1038/nrg2501; Couzin J, 2008, SCIENCE, V321, P1278, DOI 10.1126/science.321.5894.1278; Couzin-Frankel J, 2009, SCIENCE, V324, P166, DOI 10.1126/science.324.5924.166; Glantz LH, 1998, AM J LAW MED, V24, P213; Goldenberg AJ, 2009, J PEDIATR-US, V155, P578, DOI 10.1016/j.jpeds.2009.04.034; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Kaiser J, 2006, SCIENCE, V312, P1584; Knoppers BM, 2008, EUR J HUM GENET, V16, P664, DOI 10.1038/ejhg.2008.55; Kohane IS, 2005, NEW ENGL J MED, V353, P2074, DOI 10.1056/NEJMsb051220; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Samuel J, 2008, GENEDIT, V6, P1; Yuille M, 2008, BRIEF BIOINFORM, V9, P14, DOI 10.1093/bib/bbm050	16	70	70	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					818	819		10.1126/science.1173284	http://dx.doi.org/10.1126/science.1173284			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679798	Green Published			2022-12-28	WOS:000269242400027
J	Shannon, K; Kerr, T; Strathdee, SA; Shoveller, J; Montaner, JS; Tyndall, MW				Shannon, Kate; Kerr, T.; Strathdee, S. A.; Shoveller, J.; Montaner, J. S.; Tyndall, M. W.			Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POLICE VIOLENCE; HIV-INFECTION; DRUG-USERS; RISK; WOMEN; POWER; PROSTITUTES; CLIENTS; LAW	Objective To examine the prevalence and structural correlates of gender based violence against female sex workers in an environment of criminalised prostitution. Design Prospective observational study. Setting Vancouver, Canada during 2006-8. Participants Female sex workers 14 years of age or older (inclusive of transgender women) who used illicit drugs (excluding marijuana) and engaged in street level sex work. Main outcome measure Self reported gender based violence. Results Of 267 female sex workers invited to participate, 251 women returned to the study office and consented to participate (response rate of 94%). Analyses were based on 237 female sex workers who completed a baseline visit and at least one follow-up visit. Of these 237 female sex workers, 57% experienced gender based violence over an 18 month follow-up period. In multivariate models adjusted for individual and interpersonal risk practices, the following structural factors were independently correlated with violence against female sex workers: homelessness (adjusted odds ratio for physical violence (aOR(physicalviolence)) 2.14, 95% confidence interval 1.34 to 3.43; adjusted odds ratio for rape (aOR(rape)) 1.73, 1.09 to 3.12); inability to access drug treatment (adjusted odds ratio for client violence (aOR(clientviolence)) 2.13, 1.26 to 3.62; aOR(physicalviolence) 1.96, 1.03 to 3.43); servicing clients in cars or public spaces (aOR(clientviolence) 1.50, 1.08 to 2.57); prior assault by police (aOR(clientviolence) 3.45, 1.98 to 6.02; aOR(rape) 2.61, 1.32 to 5.16); confiscation of drug use paraphernalia by police without arrest (aOR(physicalviolence) 1.50, 1.02 to 2.41); and moving working areas away from main streets owing to policing (aOR(clientviolence) 2.13, 1.26 to 3.62). Conclusions Our results demonstrate an alarming prevalence of gender based violence against female sex workers. The structural factors of criminalisation, homelessness, and poor availability of drug treatment independently correlated with gender based violence against street based female sex workers. Socio-legal policy reforms, improved access to housing and drug treatment, and scale up of violence prevention efforts, including police-sex worker partnerships, will be crucial to stemming violence against female sex workers.	[Shannon, Kate; Kerr, T.; Montaner, J. S.; Tyndall, M. W.] HIV AIDS St Pauls Hosp, British Columbia Ctr Excellence, Vancouver, BC V6Z 1Y6, Canada; [Shannon, Kate; Kerr, T.; Shoveller, J.; Montaner, J. S.; Tyndall, M. W.] Univ British Columbia, Fac Med, Vancouver, BC V6T 1Z3, Canada; [Strathdee, S. A.] Univ Calif San Diego, Sch Med, Div Global Publ Hlth, La Jolla, CA 92093 USA	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of British Columbia; University of California System; University of California San Diego	Shannon, K (corresponding author), HIV AIDS St Pauls Hosp, British Columbia Ctr Excellence, Vancouver, BC V6Z 1Y6, Canada.	kshannon@cfenet.ubc.ca	Montaner, Julio/K-7621-2012; Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; National Institute on Drug Abuse of the National Institutes of Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This research was primarily funded through an operating grant from the HIV/AIDS Community-Based Research Program of the Canadian Institutes of Health Research. KS, TK, and JS are supported by the Canadian Institutes of Health Research. TK and MWT are supported by the Michael Smith Foundation for Health Research. JSM is supported through an Avant-Garde Award from the National Institute on Drug Abuse of the National Institutes of Health. The funders had no role in study design, data collection, or in analysis and interpretation of the results, and this paper does not necessarily reflect views or opinions of the funders.	[Anonymous], 2002, INT J DRUG POLICY, DOI [DOI 10.1016/S0955-3959(02)00075-0, DOI 10.1016/S0955-3959]; Blankenship KM, 2002, J LAW MED ETHICS, V30, P548, DOI 10.1111/j.1748-720X.2002.tb00425.x; Brooks-Gordon B, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a908; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; *CAN HIV AIDS LEG, 2007, HUM RIGHTS BAS COMM; Church S, 2001, BMJ-BRIT MED J, V322, P524, DOI 10.1136/bmj.322.7285.524; Cooper H, 2004, AM J PUBLIC HEALTH, V94, P1109, DOI 10.2105/AJPH.94.7.1109; Davis CS, 2005, AM J PUBLIC HEALTH, V95, P233, DOI 10.2105/AJPH.2003.031310; DeBeck K, 2006, HIV AIDS POLICY LAW, V11, P5; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2007, SEX TRANSM INFECT, V83, P173, DOI 10.1136/sti.2007.024950; El-Bassel N, 2005, SOC SCI MED, V61, P171, DOI 10.1016/j.socscimed.2004.11.035; GILBERT L, 1998, VIOLENCE VICTIMS, V13, P1; Goodyear M, 2005, LANCET, V366, P1264, DOI 10.1016/S0140-6736(05)67523-X; Goodyear MDE, 2007, BMJ-BRIT MED J, V334, P52, DOI 10.1136/bmj.39087.642801.BE; Gupta GR, 2002, BRIT MED J, V324, P183, DOI 10.1136/bmj.324.7331.183; Human Rights Watch, 2003, AB US POL MISC HARM; Lowman J, 2004, CAN MED ASSOC J, V171, P147, DOI 10.1503/cmaj.1040781; Lowman J., 2000, VIOLENCE AGAINST WOM, V6, P987, DOI DOI 10.1177/10778010022182245; Maher Lisa, 1997, SEXED WORK GENDER RA; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Miller CL, 2008, INT J DRUG POLICY, V19, P324, DOI 10.1016/j.drugpo.2007.06.002; Ntumbanzondo M, 2006, AIDS CARE, V18, P777, DOI 10.1080/09540120500412824; PAPERNY AM, 2008, GLOBE MAIL; Pyett PM, 1997, AIDS CARE, V9, P539, DOI 10.1080/713613193; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Rhodes T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a811; Shannon K, 2008, AIDS CARE, V20, P235, DOI 10.1080/09540120701561270; Shannon Kate, 2007, Harm Reduct J, V4, P20, DOI 10.1186/1477-7517-4-20; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Spittal PM, 2006, AIDS CARE, V18, P101, DOI 10.1080/09540120500159292; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Surratt HL, 2004, CRIME DELINQUENCY, V50, P43, DOI 10.1177/0011128703258875; UNAIDS, 2002, SEX WORK HIV AIDS; United Nations General Assembly, 1993, DECL EL VIOL WOM; Ward H, 2000, SEX TRANSM INFECT, V76, P292, DOI 10.1136/sti.76.4.292; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Wenzel SL, 2001, J INTERPERS VIOLENCE, V16, P739, DOI 10.1177/088626001016008001; Werb D, 2008, INT J DRUG POLICY, V19, P332, DOI 10.1016/j.drugpo.2007.08.004; Wood E, 2004, JAIDS-J ACQ IMM DEF, V36, P750, DOI 10.1097/00126334-200406010-00013; Wood E, 2004, CAN MED ASSOC J, V170, P1551, DOI 10.1503/cmaj.1031928; World Health Organization, 2007, 3 MIL GLOB CAMP VIOL; World Health Organization, 2002, WORLD REPORT VIOLENC; OTTAWA CITIZEN  1205	46	176	176	1	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2009	339								b2939	10.1136/bmj.b2939	http://dx.doi.org/10.1136/bmj.b2939			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	485YH	19671935	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000269161800003
J	Moreno, SG; Sutton, AJ; Turner, EH; Abrams, KR; Cooper, NJ; Palmer, TM; Ades, AE				Moreno, Santiago G.; Sutton, Alex J.; Turner, Erick H.; Abrams, Keith R.; Cooper, Nicola J.; Palmer, Tom M.; Ades, A. E.			Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENTION-TO-TREAT; EMPIRICAL-EVIDENCE; FUNNEL-PLOT; RANDOMIZED-TRIALS; EFFECT SIZE; FILL METHOD; METAANALYSIS; OUTCOMES; TESTS; HETEROGENEITY	Objective To assess the performance of novel contour enhanced funnel plots and a regression based adjustment method to detect and adjust for publication biases. Design Secondary analysis of a published systematic literature review. Data sources Placebo controlled trials of antidepressants previously submitted to the US Food and Drug Administration (FDA) and matching journal publications. Methods Publication biases were identified using novel contour enhanced funnel plots, a regression based adjustment method, Egger's test, and the trim and fill method. Results were compared with a meta-analysis of the gold standard data submitted to the FDA. Results Severe asymmetry was observed in the contour enhanced funnel plot that appeared to be heavily influenced by the statistical significance of results, suggesting publication biases as the cause of the asymmetry. Applying the regression based adjustment method to the journal data produced a similar pooled effect to that observed by a meta-analysis of the FDA data. Contrasting journal and FDA results suggested that, in addition to other deviations from study protocol, switching from an intention to treat analysis to a per protocol one would contribute to the observed discrepancies between the journal and FDA results. Conclusion Novel contour enhanced funnel plots and a regression based adjustment method worked convincingly and might have an important part to play in combating publication biases.	[Moreno, Santiago G.; Sutton, Alex J.; Abrams, Keith R.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Turner, Erick H.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland Vet Affairs Med Ctr, Portland, OR 97201 USA; [Palmer, Tom M.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Dept Social Med, Bristol BS8 1TH, Avon, England; [Ades, A. E.] Univ Bristol, Dept Community Based Med, Bristol BS8 1TH, Avon, England	University of Leicester; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System; University of Bristol; University of Bristol	Moreno, SG (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England.	sgm8@le.ac.uk	Turner, Erick/A-4848-2008; Abrams, Keith/AAA-2557-2020	Turner, Erick/0000-0002-3522-3357; Palmer, Tom/0000-0003-4655-4511; Sutton, Alexander/0000-0002-8934-9940; Ades, Tony/0000-0001-7822-3552; Abrams, Keith/0000-0002-7557-1567	Medical Research Council Health Services Research Collaboration; MRC [MC_U145079307, G106/1170, G0800800, G0600705] Funding Source: UKRI; Medical Research Council [G0800800, G106/1170, MC_U145079307, G0600705] Funding Source: researchfish	Medical Research Council Health Services Research Collaboration(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SGM was supported by a Medical Research Council Health Services Research Collaboration studentship in the UK. AEA was funded by the Medical Research Council Health Services Research Collaboration. The funding agreement ensured the authors' independence in designing the study, interpreting the data, and writing and publishing the report. The corresponding author as well as the other authors had access to all the data and take responsibility for the integrity of the data and the accuracy of the data analysis.	[Anonymous], 2008, COCHRANE HDB SYSTEMA; Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340; Bollini P, 1999, BRIT J PSYCHIAT, V174, P297, DOI 10.1192/bjp.174.4.297; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Copas JB, 2008, STAT MED, V27, P4267, DOI 10.1002/sim.3284; DUMOUCHEL W, 2000, METAANALYSIS MED HLT, P157; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2002, INT J EPIDEMIOL, V31, P1, DOI 10.1093/ije/31.1.1; EGGER M, 1995, BMJ-BRIT MED J, V310, P752, DOI 10.1136/bmj.310.6982.752; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Furukawa TA, 2007, JAMA-J AM MED ASSOC, V297, P468, DOI 10.1001/jama.297.5.468-b; Gartlehner G, 2006, J CLIN EPIDEMIOL, V59, P1040, DOI 10.1016/j.jclinepi.2006.01.011; Gerber AS, 2008, SOCIOL METHOD RES, V37, P3, DOI 10.1177/0049124108318973; Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223; Hahn S, 2000, STAT MED, V19, P3325, DOI 10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490; Heritier SR, 2003, MED J AUSTRALIA, V179, P438, DOI 10.5694/j.1326-5377.2003.tb05627.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hotopf M, 2005, EPIDEMIOL PSICHIAT S, V14, P55, DOI 10.1017/S1121189X00006242; Hotopf M, 1997, J EPIDEMIOL COMMUN H, V51, P354, DOI 10.1136/jech.51.4.354; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; Ioannidis JPA, 2008, J EVAL CLIN PRACT, V14, P951, DOI 10.1111/j.1365-2753.2008.00986.x; Ioannidis John P A, 2008, Philos Ethics Humanit Med, V3, P14, DOI 10.1186/1747-5341-3-14; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; JUNI P, 2008, GERMAN J QUAL HLTH C, V102, P7; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lewis JA, 1999, STAT MED, V18, P1903, DOI 10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.3.CO;2-6; McMahon B, 2008, EUR CHILD ADOLES PSY, V17, P432, DOI 10.1007/s00787-008-0685-9; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Palmer TM, 2008, STATA J, V8, P242, DOI 10.1177/1536867X0800800206; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Porta N, 2007, J CLIN EPIDEMIOL, V60, P663, DOI 10.1016/j.jclinepi.2006.09.013; Revicki DA, 1999, PHARMACOECONOMICS, V15, P423, DOI 10.2165/00019053-199915050-00001; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Rucker G, 2008, STAT MED, V27, P746, DOI 10.1002/sim.2971; Schulz KF, 2002, LANCET, V359, P781, DOI 10.1016/S0140-6736(02)07882-0; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Steichen T, 1998, STATA TECHNICAL B RE, V41, P9; Steichen T.J., 2001, STATA TECHNICAL B, V10, P8; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Tang JL, 2000, J CLIN EPIDEMIOL, V53, P477, DOI 10.1016/S0895-4356(99)00204-8; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; Turner E, 2009, LANCET, V373, P1760, DOI 10.1016/S0140-6736(09)60975-2; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Williamson PR, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-9; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	70	109	109	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2009	339								b2981	10.1136/bmj.b2981	http://dx.doi.org/10.1136/bmj.b2981			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KF	19666685	hybrid, Green Published			2022-12-28	WOS:000268808200002
J	Bogdanovic, J; Djozic, J				Bogdanovic, Jovo; Djozic, Jasenko			Stent-Associated Urinary Calculi	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bogdanovic, Jovo; Djozic, Jasenko] Clin Ctr Vojvodina, Novi Sad 21000, Serbia		Bogdanovic, J (corresponding author), Clin Ctr Vojvodina, Novi Sad 21000, Serbia.	boggyjor@hotmail.com	Bogdanovic, Jovo/R-8305-2019; Bogdanovic, Jovo/S-6944-2019	Bogdanovic, Jovo/0000-0003-0784-9157; 					0	2	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					612	612		10.1056/NEJMicm0805768	http://dx.doi.org/10.1056/NEJMicm0805768			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479NR	19657125				2022-12-28	WOS:000268667300011
J	Bohmer, RMJ; Lee, TH				Bohmer, Richard M. J.; Lee, Thomas H.			The Shifting Mission of Health Care Delivery Organizations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MODELS		[Bohmer, Richard M. J.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Lee, Thomas H.] Partners HealthCare Syst, Boston, MA USA	Harvard University; Partners Healthcare System	Bohmer, RMJ (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							Baron RJ, 2008, JAMA-J AM MED ASSOC, V299, P1595, DOI 10.1001/jama.299.13.1595; Bohmer R.M.J., 2009, DESIGNING CARE ALIGN, DOI 10.1001/jama.2010.245; Burns LR, 2008, MILBANK Q, V86, P375, DOI 10.1111/j.1468-0009.2008.00527.x; Hackbarth G, 2008, NEW ENGL J MED, V359, P3, DOI 10.1056/NEJMp0803749; Rosenthal MB, 2008, NEW ENGL J MED, V359, P1197, DOI 10.1056/NEJMp0804658	5	26	26	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					551	553		10.1056/NEJMp0903406	http://dx.doi.org/10.1056/NEJMp0903406			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479NR	19657119				2022-12-28	WOS:000268667300002
J	van Dokkum, PG; Kriek, M; Franx, M				van Dokkum, Pieter G.; Kriek, Mariska; Franx, Marijn			A high stellar velocity dispersion for a compact massive galaxy at redshift z=2.186	NATURE			English	Article							STAR-FORMATION; QUIESCENT GALAXIES; FUNDAMENTAL PLANE; ELLIPTIC GALAXIES; SIZE EVOLUTION; Z-SIMILAR-TO-2.3; RED; CO; FORM	Recent studies have found that the oldest and most luminous galaxies in the early Universe are surprisingly compact(1-7), having stellar masses similar to present-day elliptical galaxies but much smaller sizes. This finding has attracted considerable attention(8-13), as it suggests that massive galaxies have grown in size by a factor of about five over the past ten billion years (10 Gyr). A key test of these results is a determination of the stellar kinematics of one of the compact galaxies: if the sizes of these objects are as extreme as has been claimed, their stars are expected to have much higher velocities than those in present-day galaxies of the same mass. Here we report a measurement of the stellar velocity dispersion of a massive compact galaxy at redshift z = 2.186, corresponding to a look-back time of 10.7 Gyr. The velocity dispersion is very high at 510(-95)(+165) km s(-1), consistent with the mass and compactness of the galaxy inferred from photometric data. This would indicate significant recent structural and dynamical evolution of massive galaxies over the past 10 Gyr. The uncertainty in the dispersion was determined from simulations that include the effects of noise and template mismatch. However, we cannot exclude the possibility that some subtle systematic effect may have influenced the analysis, given the low signal-to-noise ratio of our spectrum.	[van Dokkum, Pieter G.] Yale Univ, Dept Astron, New Haven, CT 06511 USA; [Kriek, Mariska] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Franx, Marijn] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands	Yale University; Princeton University; Leiden University; Leiden University - Excl LUMC	van Dokkum, PG (corresponding author), Yale Univ, Dept Astron, 260 Whitney Ave, New Haven, CT 06511 USA.	pieter.vandokkum@yale.edu			NASA; NSF	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	This Letter is based on observations obtained at the Gemini Observatory and with the HST. This work was supported by NASA and the NSF. We thank I. Labbe, G. Illingworth, D. Marchesini and R. Quadri for their contributions in the initial stages of this project.	Bernardi M, 2008, MON NOT R ASTRON SOC, V391, P1191, DOI 10.1111/j.1365-2966.2008.13876.x; BERNARDI M, 2006, ASTRON J, V391, P1191; Bertoldi F, 2003, ASTRON ASTROPHYS, V409, pL47, DOI 10.1051/0004-6361:20031345; BEZANSON R, 2009, ASTROPHYS J IN PRESS; Boylan-Kolchin M, 2006, MON NOT R ASTRON SOC, V369, P1081, DOI 10.1111/j.1365-2966.2006.10379.x; Cimatti A, 2008, ASTRON ASTROPHYS, V482, P21, DOI 10.1051/0004-6361:20078739; DAMJANOV I, 2008, ASTROPHYS J IN PRESS; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Fan L, 2008, ASTROPHYS J LETT, V689, pL101, DOI 10.1086/595784; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; FRANX M, 1989, ASTROPHYS J, V344, P613, DOI 10.1086/167830; Franx M, 2008, ASTROPHYS J, V688, P770, DOI 10.1086/592431; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Greve TR, 2005, MON NOT R ASTRON SOC, V359, P1165, DOI 10.1111/j.1365-2966.2005.08979.x; HOPKINS PF, 2009, ASTROPHYS J UNPUB; Cenarro AJ, 2009, ASTROPHYS J LETT, V696, pL43, DOI 10.1088/0004-637X/696/1/L43; KRIEK M, 2009, ASTROPHYS J IN PRESS; Kriek M, 2008, ASTROPHYS J, V677, P219, DOI 10.1086/528945; Kriek M, 2006, ASTROPHYS J, V649, pL71, DOI 10.1086/508371; NAAB T, 2009, ASTROPHYS J UNPUB; Naab T, 2007, ASTROPHYS J, V658, P710, DOI 10.1086/510841; Narayanan D, 2008, ASTROPHYS J SUPPL S, V174, P13, DOI 10.1086/521776; Toft S, 2007, ASTROPHYS J, V671, P285, DOI 10.1086/521810; Trujillo I, 2006, ASTROPHYS J, V650, P18, DOI 10.1086/506464; Van Der Wel A, 2008, ASTROPHYS J, V688, P48, DOI 10.1086/592267; van Dokkum PG, 2003, ASTROPHYS J, V585, P78, DOI 10.1086/345989; van Dokkum PG, 2008, ASTROPHYS J LETT, V677, pL5, DOI 10.1086/587874; VANDERWEL A, 2009, ASTROPHYS J UNPUB	28	149	149	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					717	719		10.1038/nature08220	http://dx.doi.org/10.1038/nature08220			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661911	Green Submitted			2022-12-28	WOS:000268670300033
J	Hirschmann, MM				Hirschmann, Marc M.			Ironing Out the Oxidation of Earth's Mantle	SCIENCE			English	Editorial Material									Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hirschmann, MM (corresponding author), Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA.	marc.m.hirschmann-1@umn.edu	Hirschmann, marc m/B-9455-2016	Hirschmann, marc m/0000-0003-1213-6645				Delano JW, 2001, ORIGINS LIFE EVOL B, V31, P311, DOI 10.1023/A:1011895600380; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Kelley KA, 2009, SCIENCE, V325, P605, DOI 10.1126/science.1174156; Lee CTA, 2005, J PETROL, V46, P2313, DOI 10.1093/petrology/egi056	4	13	14	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					545	546		10.1126/science.1176882	http://dx.doi.org/10.1126/science.1176882			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644097				2022-12-28	WOS:000268493000025
J	Norton, DA				Norton, David A.			Species Invasions and the Limits to Restoration: Learning from the New Zealand Experience	SCIENCE			English	Editorial Material							CONSERVATION; ISLANDS; ECOLOGY; FORESTS; BIRDS	Species invasions impose key biotic thresholds limiting the success of ecological restoration projects. These thresholds may be difficult to reverse and will have long-term consequences for restoration because of invasion legacies such as extinctions; because most invasive species cannot be eliminated given current technology and resources; and because even when controlled to low levels, invasive species continue to exert substantial pressure on native biodiversity. Restoration outcomes in the face of biological invasions are likely to be novel and will require long-term resource commitment, as any letup in invasive species management will result in the loss of the conservation gains achieved.	Univ Canterbury, Sch Forestry, Rural Ecol Res Grp, Christchurch 8140, New Zealand	University of Canterbury	Norton, DA (corresponding author), Univ Canterbury, Sch Forestry, Rural Ecol Res Grp, Private Bag 4800, Christchurch 8140, New Zealand.	david.norton@canterbury.ac.nz	Norton, David/D-6978-2011					Allen RB, 2006, BIOL INVASIONS NZ; CLOUT MN, 1989, NEW ZEAL J ECOL, V12, P27; Coomes DA, 2003, CONSERV BIOL, V17, P450, DOI 10.1046/j.1523-1739.2003.15099.x; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Didham RK, 2005, SCIENCE, V307, P1412, DOI 10.1126/science.1107333; Heenan PB, 2004, NEW ZEAL J BOT, V42, P21, DOI 10.1080/0028825X.2004.9512888; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hoare JM, 2007, J WILDLIFE MANAGE, V71, P1576, DOI 10.2193/2006-488; MOLLOY BPJ, 1994, NEW ZEAL J BOT, V32, P37, DOI 10.1080/0028825X.1994.10410405; Saunders A, 2001, BIOL CONSERV, V99, P109, DOI 10.1016/S0006-3207(00)00192-0; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Sullivan JJ, 2007, NEW ZEAL J ECOL, V31, P22; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006	15	88	92	4	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					569	571		10.1126/science.1172978	http://dx.doi.org/10.1126/science.1172978			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19644109				2022-12-28	WOS:000268493000037
J	Dondorp, AM; Nosten, F; Yi, P; Das, D; Phyo, AP; Tarning, J; Lwin, KM; Ariey, F; Hanpithakpong, W; Lee, SJ; Ringwald, P; Silamut, K; Imwong, M; Chotivanich, K; Lim, P; Herdman, T; An, SS; Yeung, S; Singhasivanon, P; Day, NPJ; Lindegardh, N; Socheat, D; White, NJ				Dondorp, Arjen M.; Nosten, Francois; Yi, Poravuth; Das, Debashish; Phyo, Aung Phae; Tarning, Joel; Lwin, Khin Maung; Ariey, Frederic; Hanpithakpong, Warunee; Lee, Sue J.; Ringwald, Pascal; Silamut, Kamolrat; Imwong, Mallika; Chotivanich, Kesinee; Lim, Pharath; Herdman, Trent; An, Sen Sam; Yeung, Shunmay; Singhasivanon, Pratap; Day, Nicholas P. J.; Lindegardh, Niklas; Socheat, Duong; White, Nicholas J.			Artemisinin Resistance in Plasmodium falciparum Malaria.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTESUNATE-MEFLOQUINE; ARTEMETHER-LUMEFANTRINE; COMBINATION THERAPY; IN-VITRO; THAILAND; CAMBODIA; BORDER; EFFICACY; EPIDEMIOLOGY; DEPLOYMENT	Background: Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease. There are recent concerns that the efficacy of such therapies has declined on the Thai-Cambodian border, historically a site of emerging antimalarial-drug resistance. Methods: In two open-label, randomized trials, we compared the efficacies of two treatments for uncomplicated falciparum malaria in Pailin, western Cambodia, and Wang Pha, northwestern Thailand: oral artesunate given at a dose of 2 mg per kilogram of body weight per day, for 7 days, and artesunate given at a dose of 4 mg per kilogram per day, for 3 days, followed by mefloquine at two doses totaling 25 mg per kilogram. We assessed in vitro and in vivo Plasmodium falciparum susceptibility, artesunate pharmacokinetics, and molecular markers of resistance. Results: We studied 40 patients in each of the two locations. The overall median parasite clearance times were 84 hours (interquartile range, 60 to 96) in Pailin and 48 hours (interquartile range, 36 to 66) in Wang Pha (P<0.001). Recrudescence confirmed by means of polymerase-chain-reaction assay occurred in 6 of 20 patients (30%) receiving artesunate monotherapy and 1 of 20 (5%) receiving artesunate-mefloquine therapy in Pailin, as compared with 2 of 20 (10%) and 1 of 20 (5%), respectively, in Wang Pha (P=0.31). These markedly different parasitologic responses were not explained by differences in age, artesunate or dihydroartemisinin pharmacokinetics, results of isotopic in vitro sensitivity tests, or putative molecular correlates of P. falciparum drug resistance (mutations or amplifications of the gene encoding a multidrug resistance protein [PfMDR1] or mutations in the gene encoding sarco-endoplasmic reticulum calcium ATPase6 [PfSERCA]). Adverse events were mild and did not differ significantly between the two treatment groups. Conclusions: P. falciparum has reduced in vivo susceptibility to artesunate in western Cambodia as compared with northwestern Thailand. Resistance is characterized by slow parasite clearance in vivo without corresponding reductions on conventional in vitro susceptibility testing. Containment measures are urgently needed. (ClinicalTrials.gov number, NCT00493363, and Current Controlled Trials number, ISRCTN64835265.) N Engl J Med 2009;361:455-67.	[Dondorp, Arjen M.; Nosten, Francois; Das, Debashish; Tarning, Joel; Hanpithakpong, Warunee; Lee, Sue J.; Silamut, Kamolrat; Imwong, Mallika; Chotivanich, Kesinee; Herdman, Trent; Yeung, Shunmay; Singhasivanon, Pratap; Day, Nicholas P. J.; Lindegardh, Niklas; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok 10400, Thailand; [Nosten, Francois; Phyo, Aung Phae; Lwin, Khin Maung] Shoklo Malaria Res Unit, Mae Sot, Thailand; [An, Sen Sam] Family Hlth Int, Bangkok, Thailand; [Dondorp, Arjen M.; Nosten, Francois; Tarning, Joel; Lee, Sue J.; Day, Nicholas P. J.; Lindegardh, Niklas; White, Nicholas J.] Churchill Hosp, Ctr Trop Med, Oxford OX3 7LJ, England; [Yi, Poravuth; Socheat, Duong] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Ariey, Frederic; Lim, Pharath] Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Ringwald, Pascal] WHO, Global Malaria Program, Geneva, NY USA	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; University of Oxford; National Center Parasitology, Entomology & Malaria Control; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; World Health Organization	Dondorp, AM (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.	arjen@tropmedres.ac	ariey, frederic/P-1185-2017; Nosten, Francois/AAC-5509-2019; Phyo, Aung Pyae/GYU-6181-2022; White, Nick/AAC-6527-2019; Phyo, Aung Pyae/K-2413-2019; White, Nicholas J/I-4629-2012; Lim, Pharath/AAF-6699-2020; Imwong, Mallika/ABE-6493-2020	ariey, frederic/0000-0002-0680-1090; Nosten, Francois/0000-0002-7951-0745; Phyo, Aung Pyae/0000-0002-0383-9624; White, Nick/0000-0002-1897-1978; Phyo, Aung Pyae/0000-0002-0383-9624; Yeung, Shunmay/0000-0002-0997-0850; Tarning, Joel/0000-0003-4566-4030; Singhasivanon, Pratap/0000-0002-9759-1702; Lim, Pharath/0000-0002-1012-2461	Wellcome Trust of Great Britain; Li Ka Shing Foundation [B9RMXT0-2]; Global Malaria Program; WHO; Bill and Melinda Gates Foundation [48821]; Western Pacific Regional Office [WP/07/66224]	Wellcome Trust of Great Britain(Wellcome Trust); Li Ka Shing Foundation; Global Malaria Program; WHO(World Health Organization); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Western Pacific Regional Office	Supported by grants from the Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant), the Li Ka Shing Foundation (B9RMXT0-2), the Global Malaria Program, and the WHO (Bill and Melinda Gates Foundation grant 48821 and Western Pacific Regional Office grant WP/07/66224 CAM).	Alker AP, 2007, AM J TROP MED HYG, V76, P641, DOI 10.4269/ajtmh.2007.76.641; Angus BJ, 2002, ANTIMICROB AGENTS CH, V46, P778, DOI 10.1128/AAC.46.3.778-782.2002; Ashley EA, 2007, TROP MED INT HEALTH, V12, P195, DOI [10.1111/j.1365-3165.2006.01784.x, 10.1111/j.1365-3156.2006.01784.x]; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Carrara VI, 2006, PLOS MED, V3, P856, DOI 10.1371/journal.pmed.0030183; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Denis MB, 2006, TROP MED INT HEALTH, V11, P1800, DOI 10.1111/j.1365-3156.2006.01739.x; Denis MB, 2006, TROP MED INT HEALTH, V11, P1360, DOI 10.1111/j.1365-3156.2006.01690.x; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Faiz MA, 2005, LANCET, V366, P717; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Keoluangkhot V, 2008, AM J TROP MED HYG, V78, P552, DOI 10.4269/ajtmh.2008.78.552; Lindegardh N, 2007, J PHARMACEUT BIOMED, V45, P149, DOI 10.1016/j.jpba.2007.04.030; Lindegardh N, 2008, J CHROMATOGR B, V876, P54, DOI 10.1016/j.jchromb.2008.10.021; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; NOSTEN F, 1995, J INFECT DIS, V171, P519; NOSTEN F, 1994, J INFECT DIS, V170, P971, DOI 10.1093/infdis/170.4.971; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Snounou G, 2000, T ROY SOC TROP MED H, V94, P65; TERKUILE F, 1993, EXP PARASITOL, V76, P85, DOI 10.1006/expr.1993.1010; Udomsangpetch R, 1996, J INFECT DIS, V173, P691, DOI 10.1093/infdis/173.3.691; VERDRAGER J, 1986, J TROP MED HYG, V89, P277; WEBSTER HK, 1985, AM J TROP MED HYG, V34, P228, DOI 10.4269/ajtmh.1985.34.228; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; WHO, 2006, WHO GUID TREATM MAL; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; World Health Organization (WHO), 2008, GEN ID PAR POP; Yeung S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-96	33	2346	2400	52	1010	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					455	467		10.1056/NEJMoa0808859	http://dx.doi.org/10.1056/NEJMoa0808859			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LW	19641202	Green Accepted			2022-12-28	WOS:000268443900006
J	Stone, JH; Caruso, PA; Deshpande, V				Stone, John H.; Caruso, Paul A.; Deshpande, Vikram			Chronic sclerosing sialadenitis (IgG4-associated chronic sclerosing sialadenitis, Kuttner's tumor).A Woman with Painful Swelling of the Neck	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOIMMUNE PANCREATITIS; SJOGRENS-SYNDROME; SUBMANDIBULAR-GLAND; DISEASE; CHOLANGITIS; PROGNOSIS; LYMPHOMA; FIBROSIS; COMPLEX		[Stone, John H.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Med, Boston, MA 02114 USA; [Caruso, Paul A.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Radiol, Boston, MA 02114 USA; [Deshpande, Vikram] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Pathol, Boston, MA 02114 USA; [Stone, John H.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Caruso, Paul A.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Deshpande, Vikram] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Stone, JH (corresponding author), Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Med, Boston, MA 02114 USA.							BLOCH KJ, 1965, MEDICINE, V44, P187, DOI 10.1097/00005792-196505000-00001; DANIELS E, 1991, SURG PATHOLOGY SALIV, P83; Deshpande V, 2007, AM J SURG PATHOL, V31, P328; Deshpande V, 2006, AM J SURG PATHOL, V30, P1537, DOI 10.1097/01.pas.0000213331.09864.2c; Ellis GL, 1996, TUMORS SALIVARY GLAN, P412; Ferry JA, 2008, ARCH PATHOL LAB MED, V132, P565, DOI 10.1043/1543-2165(2008)132[565:EL]2.0.CO;2; Finkelberg DL, 2006, NEW ENGL J MED, V355, P2670, DOI 10.1056/NEJMra061200; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Fukui T, 2005, PANCREATOLOGY, V5, P86, DOI 10.1159/000084494; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Harrison JD, 1997, HISTOPATHOLOGY, V31, P237, DOI 10.1046/j.1365-2559.1997.2530856.x; ISACSSON G, 1981, ARCH OTO-RHINO-LARYN, V232, P91, DOI 10.1007/BF00661007; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Kamisawa T, 2007, J GASTROENTEROL, V42, P59, DOI 10.1007/s00535-007-2052-x; Kamisawa T, 2006, J GASTROENTEROL, V41, P613, DOI 10.1007/s00535-006-1862-6; Khosroshahi A, 2009, LANCET, V373, P1494, DOI 10.1016/S0140-6736(09)60615-2; Kitagawa S, 2005, AM J SURG PATHOL, V29, P783, DOI 10.1097/01.pas.0000164031.59940.fc; Kuttner H., 1896, BEITR KLIN CHIR, V15, P815; MIKULICZ J, 1937, BERLINER KLIN WOCHEN, V759, P165; MONTEFUSCO PP, 1984, AM J SURG, V147, P822, DOI 10.1016/0002-9610(84)90212-5; MORGAN WS, 1953, AM J PATHOL, V29, P471; Rapidis AD, 2004, J ORAL MAXIL SURG, V62, P1203, DOI 10.1016/j.joms.2003.12.033; Sepehr A, 2008, AM J SURG PATHOL, V32, P1770, DOI 10.1097/PAS.0b013e318185490a; SJOGREN I, 1979, ACTA MED SCAND, V205, P139; SOOD S, 1995, PANCREAS, V10, P419, DOI 10.1097/00006676-199505000-00018; Stone J. H., ARTHRITIS R IN PRESS; Theander E, 2006, ANN RHEUM DIS, V65, P796, DOI 10.1136/ard.2005.041186; Turbiner J, 2009, MODERN PATHOL, V22, p252A; Wakabayashi T, 2005, PANCREAS, V30, P31; WEBER RS, 1990, ARCH OTOLARYNGOL, V116, P1055; Yamamoto M, 2005, AUTOIMMUN REV, V4, P195, DOI 10.1016/j.autrev.2004.10.005	31	25	27	2	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					511	518		10.1056/NEJMcpc0902221	http://dx.doi.org/10.1056/NEJMcpc0902221			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LW	19641208				2022-12-28	WOS:000268443900013
J	Gong, X; Tong, MH; Xia, YJ; Cai, WZ; Moon, JS; Cao, Y; Yu, G; Shieh, CL; Nilsson, B; Heeger, AJ				Gong, Xiong; Tong, Minghong; Xia, Yangjun; Cai, Wanzhu; Moon, Ji Sun; Cao, Yong; Yu, Gang; Shieh, Chan-Long; Nilsson, Boo; Heeger, Alan J.			High-Detectivity Polymer Photodetectors with Spectral Response from 300 nm to 1450 nm	SCIENCE			English	Article							QUANTUM; COPOLYMERS; TRANSPORT; ENERGIES; DONOR; CELLS	Sensing from the ultraviolet-visible to the infrared is critical for a variety of industrial and scientific applications. Today, gallium nitride-, silicon-, and indium gallium arsenide-based detectors are used for different sub-bands within the ultraviolet to near-infrared wavelength range. We demonstrate polymer photodetectors with broad spectral response (300 to 1450 nanometers) fabricated by using a small-band-gap semiconducting polymer blended with a fullerene derivative. Operating at room temperature, the polymer photodetectors exhibit detectivities greater than 10(12) cm Hz(1/2)/W and a linear dynamic range over 100 decibels. The self-assembled nanomorphology and device architecture result in high photodetectivity over this wide spectral range and reduce the dark current (and noise) to values well below dark currents obtained in narrow-band photodetectors made with inorganic semiconductors.	[Gong, Xiong; Tong, Minghong; Moon, Ji Sun; Heeger, Alan J.] Univ Calif Santa Barbara, Ctr Polymers & Organ Solids, Santa Barbara, CA 93106 USA; [Gong, Xiong; Yu, Gang; Shieh, Chan-Long; Nilsson, Boo; Heeger, Alan J.] CBrite Inc, Goleta, CA 93117 USA; [Xia, Yangjun; Cai, Wanzhu; Cao, Yong] S China Univ Technol, Inst Polymer Optoelect Mat & Devices, Guangzhou 510640, Guangdong, Peoples R China	University of California System; University of California Santa Barbara; South China University of Technology	Gong, X (corresponding author), Univ Calif Santa Barbara, Ctr Polymers & Organ Solids, Santa Barbara, CA 93106 USA.	xgong@physics.ucsb.edu; poycao@scut.edu.cn; ajhe@physics.ucsb.edu	Gong, Xiong/G-8191-2018		National Science Foundation of China [50433030, 50828301]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was partially supported by the Defense Advanced Research Projects Agency Hemispheric Array Detectors for Imaging Program (D. Shenoy, Program Officer). The authors are grateful to A. Jen at the University of Washington for providing PS-TPD-PFCB. X. Gong thanks S. H. Park and N. Coates for assistance in optical measurements. The South China University of Technology thanks the National Science Foundation of China (50433030 and 50828301).	Bhattacharya P., 1997, SEMICONDUCTOR OPTOEL, P345; CHEN TA, 1995, J AM CHEM SOC, V117, P233, DOI 10.1021/ja00106a027; de Melo JS, 1999, J CHEM PHYS, V111, P5427, DOI 10.1063/1.479825; Ettenberg M. A., 2005, ADV IMAGING, V20, P29; Gong X, 2003, APPL PHYS LETT, V83, P183, DOI 10.1063/1.1589185; Hou Q, 2004, MACROMOLECULES, V37, P6299, DOI 10.1021/ma049204g; Hutchison GR, 2005, J AM CHEM SOC, V127, P2339, DOI 10.1021/ja0461421; Hutchison GR, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.035204; Jha A. R., 2000, WILEY MICRO, P245; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Konstantatos G, 2006, NATURE, V442, P180, DOI 10.1038/nature04855; LEE CH, 1993, PHYS REV B, V48, P15425, DOI 10.1103/PhysRevB.48.15425; McDonald SA, 2005, NAT MATER, V4, P138, DOI 10.1038/nmat1299; O'Brien GA, 2006, ADV MATER, V18, P2379, DOI 10.1002/adma.200601012; Peumans P, 2000, APPL PHYS LETT, V76, P3855, DOI 10.1063/1.126800; Rogalski A, 2009, J APPL PHYS, V105, DOI 10.1063/1.3099572; Saadeh H, 1997, MACROMOLECULES, V30, P4608, DOI 10.1021/ma970577+; Sargent EH, 2005, ADV MATER, V17, P515, DOI 10.1002/adma.200401552; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Schilinsky P, 2002, APPL PHYS LETT, V81, P3885, DOI 10.1063/1.1521244; Shao Y, 2009, ADV MATER, V21, P1972, DOI 10.1002/adma.200803698; TANAKA S, 1995, SYNTHETIC MET, V69, P599, DOI 10.1016/0379-6779(94)02587-O; Xia YJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2338017; Yu G, 1998, ADV MATER, V10, P1431, DOI 10.1002/(SICI)1521-4095(199812)10:17<1431::AID-ADMA1431>3.0.CO;2-4; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789	25	1385	1423	41	929	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1665	1667		10.1126/science.1176706	http://dx.doi.org/10.1126/science.1176706			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19679770				2022-12-28	WOS:000270131800038
J	Dimas, AS; Deutsch, S; Stranger, BE; Montgomery, SB; Borel, C; Attar-Cohen, H; Ingle, C; Beazley, C; Arcelus, MG; Sekowska, M; Gagnebin, M; Nisbett, J; Deloukas, P; Dermitzakis, ET; Antonarakis, SE				Dimas, Antigone S.; Deutsch, Samuel; Stranger, Barbara E.; Montgomery, Stephen B.; Borel, Christelle; Attar-Cohen, Homa; Ingle, Catherine; Beazley, Claude; Arcelus, Maria Gutierrez; Sekowska, Magdalena; Gagnebin, Marilyne; Nisbett, James; Deloukas, Panos; Dermitzakis, Emmanouil T.; Antonarakis, Stylianos E.			Common Regulatory Variation Impacts Gene Expression in a Cell Type-Dependent Manner	SCIENCE			English	Article							HUMAN GENOME; MOUSE; ASSOCIATION; DISEASE	Studies correlating genetic variation to gene expression facilitate the interpretation of common human phenotypes and disease. As functional variants may be operating in a tissue-dependent manner, we performed gene expression profiling and association with genetic variants (single-nucleotide polymorphisms) on three cell types of 75 individuals. We detected cell type-specific genetic effects, with 69 to 80% of regulatory variants operating in a cell type-specific manner, and identified multiple expressive quantitative trait loci (eQTLs) per gene, unique or shared among cell types and positively correlated with the number of transcripts per gene. Cell type-specific eQTLs were found at larger distances from genes and at lower effect size, similar to known enhancers. These data suggest that the complete regulatory variant repertoire can only be uncovered in the context of cell-type specificity.	[Deutsch, Samuel; Borel, Christelle; Attar-Cohen, Homa; Gagnebin, Marilyne; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Dimas, Antigone S.; Stranger, Barbara E.; Montgomery, Stephen B.; Ingle, Catherine; Beazley, Claude; Arcelus, Maria Gutierrez; Sekowska, Magdalena; Nisbett, James; Deloukas, Panos; Dermitzakis, Emmanouil T.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Stranger, Barbara E.] Harvard Univ, Sch Med, Dept Med, Div Genet, Boston, MA 02115 USA; [Stranger, Barbara E.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Geneva; Wellcome Trust Sanger Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Dermitzakis, ET (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	emmanouil.dermitzakis@unige.ch; stylianos.antonarakis@unige.ch	borel, christelle/AAC-9645-2019; Deloukas, Panos/B-2922-2013; Dermitzakis, Emmanouil/B-7687-2013; Antonarakis, Stylianos E/N-8866-2014	Deloukas, Panos/0000-0001-9251-070X; Antonarakis, Stylianos E/0000-0001-8907-5823; Montgomery, Stephen/0000-0002-5200-3903; Stranger, Barbara/0000-0001-9021-7331; Deutsch, Samuel/0000-0001-9456-7101	Wellcome Trust; NIH; Infectigen Foundation; Swiss National Science Foundation; AnEUploidy EU	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Infectigen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); AnEUploidy EU	We thank N. Hammond for technical help. We acknowledge financial support from the Wellcome Trust and NIH to E. T. D. and Infectigen Foundation, Swiss National Science Foundation and AnEUploidy EU to S. E. A. Gene expression data are deposited in NCBI's Gene Expression Omnibus under accession number GSE17080.	ADAMS MD, 1995, NATURE, V377, P3; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Cotsapas CJ, 2006, MAMM GENOME, V17, P490, DOI 10.1007/s00335-005-0186-9; Dimas AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000244; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070	27	576	585	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 4	2009	325	5945					1246	1250		10.1126/science.1174148	http://dx.doi.org/10.1126/science.1174148			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19644074	Green Accepted			2022-12-28	WOS:000269523200038
J	Rosell, R; Moran, T; Queralt, C; Porta, R; Cardenal, F; Camps, C; Majem, M; Lopez-Vivanco, G; Isla, D; Provencio, M; Insa, A; Massuti, B; Gonzalez-Larriba, JL; Paz-Ares, L; Bover, I; Garcia-Campelo, R; Moreno, MA; Catot, S; Rolfo, C; Reguart, N; Palmero, R; Sanchez, JM; Bastus, R; Mayo, C; Bertran-Alamillo, J; Molina, MA; Sanchez, JJ; Taron, M				Rosell, Rafael; Moran, Teresa; Queralt, Cristina; Porta, Rut; Cardenal, Felipe; Camps, Carlos; Majem, Margarita; Lopez-Vivanco, Guillermo; Isla, Dolores; Provencio, Mariano; Insa, Amelia; Massuti, Bartomeu; Luis Gonzalez-Larriba, Jose; Paz-Ares, Luis; Bover, Isabel; Garcia-Campelo, Rosario; Angel Moreno, Miguel; Catot, Silvia; Rolfo, Christian; Reguart, Noemi; Palmero, Ramon; Miguel Sanchez, Jose; Bastus, Roman; Mayo, Clara; Bertran-Alamillo, Jordi; Angel Molina, Miguel; Javier Sanchez, Jose; Taron, Miquel		Spanish Lung Canc Grp	Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE INHIBITOR; ACTIVATING MUTATIONS; EGFR MUTATIONS; GENE-MUTATIONS; PROLONGED SURVIVAL; SENSITIVE METHOD; GEFITINIB; TRANSFORMATION; MUTANTS; EXON-19	Background: Activating mutations in the epidermal growth factor receptor gene (EGFR) confer hypersensitivity to the tyrosine kinase inhibitors gefitinib and erlotinib in patients with advanced non-small-cell lung cancer. We evaluated the feasibility of large-scale screening for EGFR mutations in such patients and analyzed the association between the mutations and the outcome of erlotinib treatment. Methods: From April 2005 through November 2008, lung cancers from 2105 patients in 129 institutions in Spain were screened for EGFR mutations. The analysis was performed in a central laboratory. Patients with tumors carrying EGFR mutations were eligible for erlotinib treatment. Results: EGFR mutations were found in 350 of 2105 patients (16.6%). Mutations were more frequent in women (69.7%), in patients who had never smoked (66.6%), and in those with adenocarcinomas (80.9%) (P<0.001 for all comparisons). The mutations were deletions in exon 19 (62.2%) and L858R (37.8%). Median progression-free survival and overall survival for 217 patients who received erlotinib were 14 months and 27 months, respectively. The adjusted hazard ratios for the duration of progression-free survival were 2.94 for men (P<0.001); 1.92 for the presence of the L858R mutation, as compared with a deletion in exon 19 (P=0.02); and 1.68 for the presence of the L858R mutation in paired serum DNA, as compared with the absence of the mutation (P=0.02). The most common adverse events were mild rashes and diarrhea; grade 3 cutaneous toxic effects were recorded in 16 patients (7.4%) and grade 3 diarrhea in 8 patients (3.7%). Conclusions: Large-scale screening of patients with lung cancer for EGFR mutations is feasible and can have a role in decisions about treatment. N Engl J Med 2009;361:958-67.	[Cardenal, Felipe; Palmero, Ramon] Hosp Duran & Reynals, Catalan Inst Oncol, Barcelona, Spain; [Rosell, Rafael; Moran, Teresa; Queralt, Cristina; Taron, Miquel] Autonomous Univ Barcelona, Hosp Germans Trias & Pujol, Barcelona, Spain; [Rosell, Rafael; Mayo, Clara; Bertran-Alamillo, Jordi; Angel Molina, Miguel; Taron, Miquel] USP Inst Univ Dexeus, Barcelona, Spain; [Porta, Rut] Hosp Josep Trueta, Catalan Inst Oncol, Girona, Spain; [Camps, Carlos] Hosp Gen Univ Valencia, Valencia, Spain; [Majem, Margarita] Hosp Sant Pau, Barcelona, Spain; [Lopez-Vivanco, Guillermo] Hosp Cruces, Baracaldo, Vizcaya, Spain; [Isla, Dolores] Hosp Lozano Blesa, Zaragoza, Spain; [Provencio, Mariano] Clin Puerta Hierro, Madrid, Spain; [Insa, Amelia] Hosp Clin Univ Valencia, Valencia, Spain; [Massuti, Bartomeu] Hosp Gen Univ Alicante, Alicante, Spain; [Luis Gonzalez-Larriba, Jose] Hosp Clin San Carlos, Madrid, Spain; [Paz-Ares, Luis] Hosp Univ Virgen Rocio, Seville, Spain; [Bover, Isabel] Hosp Son Llatzer, Palma de Mallorca, Spain; [Garcia-Campelo, Rosario] Hosp Juan Canalejo, La Coruna, Spain; [Angel Moreno, Miguel] Complejo Hosp Jaen, Jaen, Spain; [Catot, Silvia] Hosp Althaia, Manresa, Spain; [Rolfo, Christian] Clin Rotger, Palma de Mallorca, Spain; [Reguart, Noemi] Hosp Clin Barcelona, Barcelona, Spain; [Miguel Sanchez, Jose] Hosp 12 Octubre, E-28041 Madrid, Spain; [Bastus, Roman] Hosp Mutua Terrassa, Barcelona, Spain; [Javier Sanchez, Jose] Autonomous Univ Madrid, E-28049 Madrid, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Hospital Clinic Universitari de Valencia; Hospital of Santa Creu i Sant Pau; Hospital Universitario Cruces; Lozano Blesa University Clinical Hospital; Clinica Veterinaria Puerta de Hierro; Hospital Puerta de Hierro-Majadahonda; Hospital Clinic Universitari de Valencia; General University Hospital of Alicante; Hospital Clinico San Carlos; Virgen del Rocio University Hospital; Hospital Universitari Son Llatzer; Complejo Hospitalario Universitario A Coruna; Complejo Hospitalario de Jaen; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario 12 de Octubre; Hospital Universitario Mutua Terrassa; Autonomous University of Madrid	Rosell, R (corresponding author), Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona 08916, Spain.	rrosell@ico.scs.es	Insa, Amelia/G-2709-2016; Rolfo, Christian/M-8935-2016; Lopez, Guillermo/F-3435-2012; Valdivia Bautista, Javier/ABD-4463-2021; Romero, Jose Luis Alonso/AAC-3782-2020; Paz-Ares, Luis/AAH-2750-2019; Larriba, Jose Luis Gonzalez/G-6177-2016; Molina, Miguel Angel/AAB-8582-2020; Remon, Jordi/H-4405-2014; Palmero, Ramon/C-4711-2008; Provencio, Mariano/ABE-8586-2020; Herrero, Carlos Camps/L-3073-2017; MORALES, SERAFIN/L-7216-2019; Portae, Rut/HHD-1727-2022; Rolfo, Christian/AAW-5173-2021	Rolfo, Christian/0000-0002-5109-0267; Valdivia Bautista, Javier/0000-0002-3738-0655; Romero, Jose Luis Alonso/0000-0001-8746-2096; Larriba, Jose Luis Gonzalez/0000-0003-2631-0309; Molina, Miguel Angel/0000-0001-8866-9881; Provencio, Mariano/0000-0001-9053-9197; Herrero, Carlos Camps/0000-0002-0648-5403; MORALES, SERAFIN/0000-0001-7445-4193; Provencio Pulla, Mariano/0000-0001-6315-7919; FELIP, ENRIQUETA/0000-0002-7620-0098; GUILLEN PONCE, CARMEN/0000-0002-3594-1084; Sanz Rubiales, Alvaro/0000-0003-0594-3844; Roig, Jordi/0000-0002-5593-7090; Isla, Dolores/0000-0002-2483-198X; Sanchez-Escribano, Ricardo/0000-0002-5953-2867; INSA, AMELIA/0000-0002-3438-6170; Queralt, Cristina/0000-0001-9875-0173; Massuti, Bartomeu/0000-0002-6247-4493; Juan, Oscar/0000-0002-7772-9030; Rolfo, Christian/0000-0002-7860-8417; Balmana, Judith/0000-0002-0762-6415; Trigo, Jose/0000-0002-4489-2683; Palmero, Ramon/0000-0002-0189-6692	Spanish Ministry of Science and Innovation [RD06/0020/0056]; Fundacion Badalona Contra el Cancer; Bonnie J. Addario Lung Cancer Foundation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Badalona Contra el Cancer; Bonnie J. Addario Lung Cancer Foundation	Supported by a grant from the Spanish Ministry of Science and Innovation (RD06/0020/0056), by the Fundacion Badalona Contra el Cancer, and by the Bonnie J. Addario Lung Cancer Foundation.	Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Cortes-Funes H, 2005, ANN ONCOL, V16, P1081, DOI 10.1093/annonc/mdi221; Costa DB, 2007, LUNG CANCER, V58, P95, DOI 10.1016/j.lungcan.2007.05.017; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Jiang JR, 2005, CANCER RES, V65, P8968, DOI 10.1158/0008-5472.CAN-05-1829; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; López-Abente G., 2004, Anales Sis San Navarra, V27, P165, DOI 10.4321/s1137-66272004000300001; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Molina-Vila MA, 2008, J THORAC ONCOL, V3, P1224, DOI 10.1097/JTO.0b013e318189f579; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist, 2008, J CLIN ONCOL, V26, P3472, DOI 10.1200/JCO.2008.18.4747; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Tamura K, 2008, BRIT J CANCER, V98, P907, DOI 10.1038/sj.bjc.6604249; Taron M, 2005, CLIN CANCER RES, V11, P5878, DOI 10.1158/1078-0432.CCR-04-2618; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017	28	1821	1943	4	246	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					958	U38		10.1056/NEJMoa0904554	http://dx.doi.org/10.1056/NEJMoa0904554			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490EI	19692684				2022-12-28	WOS:000269480400005
J	Xia, ZP; Sun, LJ; Chen, X; Pineda, G; Jiang, XM; Adhikari, A; Zeng, WW; Chen, ZJ				Xia, Zong-Ping; Sun, Lijun; Chen, Xiang; Pineda, Gabriel; Jiang, Xiaomo; Adhikari, Anirban; Zeng, Wenwen; Chen, Zhijian J.			Direct activation of protein kinases by unanchored polyubiquitin chains	NATURE			English	Article							NF-KAPPA-B; UBIQUITIN-CONJUGATING ENZYME; LYS63-LINKED POLYUBIQUITINATION; BINDING; NEMO; TRAF6; TAK1; IL-1; IKK; AUTOUBIQUITINATION	TRAF6 is a ubiquitin ligase that is essential for the activation of NF-kappa B and MAP kinases in several signalling pathways, including those emanating from the interleukin 1 and Toll-like receptors(1-3). TRAF6 functions together with a ubiquitin-conjugating enzyme complex consisting of UBC13 (also known as UBE2N) and UEV1A (UBE2V1) to catalyse Lys 63-linked polyubiquitination, which activates the TAK1 (also known as MAP3K7) kinase complex(4,5). TAK1 in turn phosphorylates and activates I kappa B kinase (IKK), leading to the activation of NF-kappa B. Although several proteins are known to be polyubiquitinated in the IL1R and Toll-like receptor pathways, it is not clear whether ubiquitination of any of these proteins is important for TAK1 or IKK activation. By reconstituting TAK1 activation in vitro using purified proteins, here we show that free Lys 63 polyubiquitin chains, which are not conjugated to any target protein, directly activate TAK1 by binding to the ubiquitin receptor TAB2 (also known as MAP3K7IP2). This binding leads to autophosphorylation and activation of TAK1. Furthermore, we found that unanchored polyubiquitin chains synthesized by TRAF6 and UBCH5C (also known as UBE2D3) activate the IKK complex. Disassembly of the polyubiquitin chains by deubiquitination enzymes prevented TAK1 and IKK activation. These results indicate that unanchored polyubiquitin chains directly activate TAK1 and IKK, suggesting a new mechanism of protein kinase regulation.	[Xia, Zong-Ping; Sun, Lijun; Chen, Xiang; Pineda, Gabriel; Jiang, Xiaomo; Adhikari, Anirban; Zeng, Wenwen; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Xiang; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Zhijian.Chen@UTSouthwestern.edu	Sun, Lijun/ABD-4470-2021; Zeng, Wenwen/D-7276-2017; Chen, Zhijian/C-6039-2012	Zeng, Wenwen/0000-0001-8544-3318; Chen, Zhijian/0000-0002-8475-8251	National Institute of Health [RO1-AI09919, RO1-GM63692]; Robert Welch Foundation [I-1389]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060919, F32AI009919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C.-K. Ea for generating the HEK293 cell line stably expressing the TAP-tagged TAK1, J. Ashwell for the bacterial GST-Ub2 and GST-Ub3 expression plasmids, A. Garcia-Sastre for the expression vector encoding the viral OTU enzyme, CCHFV-L(1-169), and X. Li for the IRAK1-deficient HEK293 cells line. Wealso thank B. Skaug for critically reading the manuscript. This work was supported by grants from the National Institute of Health (RO1-AI09919 and RO1-GM63692) and the Robert Welch Foundation (I-1389). Z. J. C. is an Investigator of the Howard Hughes Medical Institute.	Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Courtois G, 2008, CELL MOL LIFE SCI, V65, P1123, DOI 10.1007/s00018-007-7465-4; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; HAYSTEAD CMM, 1993, EUR J BIOCHEM, V214, P459, DOI 10.1111/j.1432-1033.1993.tb17942.x; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li XX, 1999, MOL CELL BIOL, V19, P4643; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; You JX, 1999, BIOTECHNIQUES, V27, P950, DOI 10.2144/99275st01; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200	30	408	433	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					114	U125		10.1038/nature08247	http://dx.doi.org/10.1038/nature08247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19675569	Green Accepted			2022-12-28	WOS:000269478800041
J	Calverley, PMA				Calverley, P. M. A.			Leaving invasive ventilation behind	LANCET			English	Editorial Material							POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; NONINVASIVE VENTILATION; RESPIRATORY-FAILURE; EXACERBATIONS; METAANALYSIS; EXTUBATION; EDEMA		Aintree Univ Hosp NHS Fdn Trust, Sch Clin Sci, Liverpool L9 7AL, Merseyside, England	Aintree University Hospitals NHS Foundation Trust; University of Liverpool	Calverley, PMA (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Sch Clin Sci, Liverpool L9 7AL, Merseyside, England.	pmacal@liverpool.ac.uk						Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Elliott MW, 2005, BRIT MED BULL, V72, P83, DOI 10.1093/bmb/ldh042; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; Ferrer M, 2006, AM J RESP CRIT CARE, V173, P164, DOI 10.1164/rccm.200505-718OC; Ferrer M, 2009, LANCET, V374, P1082, DOI 10.1016/S0140-6736(09)61038-2; Gray A, 2008, NEW ENGL J MED, V359, P142, DOI 10.1056/NEJMoa0707992; Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238; Lightowler JV, 2003, BMJ-BRIT MED J, V326, P185, DOI 10.1136/bmj.326.7382.185; Peter JV, 2006, LANCET, V367, P1155, DOI 10.1016/S0140-6736(06)68506-1; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Vital FM, 2008, COCHRANE DB SYST REV, V3; Wildman MJ, 2007, BRIT MED J, V335, P1132, DOI 10.1136/bmj.39371.524271.55	13	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1044	1045		10.1016/S0140-6736(09)61462-8	http://dx.doi.org/10.1016/S0140-6736(09)61462-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19682736				2022-12-28	WOS:000270370900007
J	Blaha, G; Stanley, RE; Steitz, TA				Blaha, Gregor; Stanley, Robin E.; Steitz, Thomas A.			Formation of the First Peptide Bond: The Structure of EF-P Bound to the 70S Ribosome	SCIENCE			English	Article							TRANSLATION INITIATION COMPLEX; ELONGATION-FACTOR-P; ESCHERICHIA-COLI; TRANSFER-RNA; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; HYPUSINE MODIFICATION; GENE-PRODUCT; FACTOR 5A; L1 STALK	Elongation factor P (EF-P) is an essential protein that stimulates the formation of the first peptide bond in protein synthesis. Here we report the crystal structure of EF-P bound to the Thermus thermophilus 70S ribosome along with the initiator transfer RNA N-formyl-methionyl-tRNA(i) (fMet-tRNA(i)(fMet)) and a short piece of messenger RNA (mRNA) at a resolution of 3.5 angstroms. EF-P binds to a site located between the binding site for the peptidyl tRNA (P site) and the exiting tRNA (E site). It spans both ribosomal subunits with its amino terminal domain positioned adjacent to the aminoacyl acceptor stem and its carboxyl terminal domain positioned next to the anticodon stem-loop of the P site-bound initiator tRNA. Domain II of EF-P interacts with the ribosomal protein L1, which results in the largest movement of the L1 stalk that has been observed in the absence of ratcheting of the ribosomal subunits. EF-P facilitates the proper positioning of the fMet-tRNA(i)(fMet) for the formation of the first peptide bond during translation initiation.	[Blaha, Gregor; Stanley, Robin E.; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu	Stanley, Robin E/C-7128-2019; Steitz, Thomas A./C-6559-2009; Stanley, Robin/M-3008-2019	Stanley, Robin E/0000-0002-2106-3102; Stanley, Robin/0000-0002-2106-3102	NIH [GM22778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM22778 (to T.A.S.). The coordinates for both copies of the 70S in the asymmetric unit have been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data Bank with accession numbers 3HUW, 3HUX, 3HUY, and 3HUZ. T.A.S. owns stock in and is on the advisory board of Rib-X Pharmaceuticals, Inc., which does structure-based drug design targeted at the ribosome.	Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; AN G, 1980, CAN J BIOCHEM CELL B, V58, P1312, DOI 10.1139/o80-177; Aoki H, 1997, BIOCHIMIE, V79, P7, DOI 10.1016/S0300-9084(97)87619-5; Aoki H, 1997, J BIOL CHEM, V272, P32254, DOI 10.1074/jbc.272.51.32254; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; BENNE R, 1978, J BIOL CHEM, V253, P3070; Brochier C, 2004, GENE, V330, P169, DOI 10.1016/j.gene.2004.01.018; COLE JR, 1987, J MOL BIOL, V198, P383, DOI 10.1016/0022-2836(87)90288-9; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Ganoza MC, 2002, MICROBIOL MOL BIOL R, V66, P460, DOI 10.1128/MMBR.66.3.460-485.2002; Ganoza MC, 2000, BIOL CHEM, V381, P553, DOI 10.1515/BC.2000.071; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; HERSHEY JWB, 1990, BIOCHIM BIOPHYS ACTA, V1050, P160, DOI 10.1016/0167-4781(90)90159-Y; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; Korostelev A, 2007, TRENDS BIOCHEM SCI, V32, P434, DOI 10.1016/j.tibs.2007.08.002; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Maguire BA, 2005, MOL CELL, V20, P427, DOI 10.1016/j.molcel.2005.09.009; MOORE VG, 1975, P NATL ACAD SCI USA, V72, P844, DOI 10.1073/pnas.72.3.844; Newton DT, 1999, J BIOL CHEM, V274, P22143, DOI 10.1074/jbc.274.32.22143; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; SANDER G, 1983, J BIOL CHEM, V258, P98; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; SELMER M, 1935, SCIENCE, V313, P2006, DOI DOI 10.1126/SCIENCE.1131127; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Simonetti A, 2009, CELL MOL LIFE SCI, V66, P423, DOI 10.1007/s00018-008-8416-4; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; SUBRAMANIAN AR, 1980, EUR J BIOCHEM, V112, P425, DOI 10.1111/j.1432-1033.1980.tb07222.x; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Wower IK, 1998, J BIOL CHEM, V273, P19847, DOI 10.1074/jbc.273.31.19847; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0	40	155	159	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					966	970		10.1126/science.1175800	http://dx.doi.org/10.1126/science.1175800			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696344	Green Accepted			2022-12-28	WOS:000269242800038
J	Rick, TC; Erlandson, JM				Rick, Torben C.; Erlandson, Jon M.			Coastal Exploitation	SCIENCE			English	Editorial Material							SOUTH-AFRICA; ECOSYSTEMS; MIDDLE		[Rick, Torben C.] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Archaeobiol Program, Washington, DC 20013 USA; [Erlandson, Jon M.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Erlandson, Jon M.] Univ Oregon, Museum Nat & Cultural Hist, Eugene, OR 97403 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Oregon; University of Oregon	Rick, TC (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Archaeobiol Program, Washington, DC 20013 USA.	rickt@si.edu; jerland@uoregon.edu		Rick, Torben/0000-0002-8254-5885; Erlandson, Jon/0000-0002-4705-4319				Bourque BJ, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P165; Corbett DG, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P43; Erlandson J., 2005, P 6 CAL ISL C; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Hames R, 2007, ANNU REV ANTHROPOL, V36, P177, DOI 10.1146/annurev.anthro.35.081705.123321; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Lyman RL, 2006, EVOL ANTHROPOL, V15, P11, DOI 10.1002/evan.20083; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Martin Paul S., 2005, TWILIGHT MAMMOTHS IC; Steele TE, 2008, ARCHAEOFAUNA, V17, P63; Stiner MC, 2001, P NATL ACAD SCI USA, V98, P6993, DOI 10.1073/pnas.121176198; Voorhies B, 2004, COASTAL COLLECTORS H; Williams J., 2006, CLAM GARDENS ABORIGI	14	52	54	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					952	953		10.1126/science.1178539	http://dx.doi.org/10.1126/science.1178539			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AN	19696338				2022-12-28	WOS:000269242800030
J	Gemelke, N; Zhang, XB; Hung, CL; Chin, C				Gemelke, Nathan; Zhang, Xibo; Hung, Chen-Lung; Chin, Cheng			In situ observation of incompressible Mott-insulating domains in ultracold atomic gases	NATURE			English	Article							SUPERFLUID; TRANSITION	The observation of the superfluid to Mott insulator phase transition of ultracold atoms in optical lattices(1) was an enabling discovery in experimental many-body physics, providing the first tangible example of a quantum phase transition (one that occurs even at zero temperature) in an ultracold atomic gas. For a trapped gas, the spatially varying local chemical potential gives rise to multiple quantum phases within a single sample, complicating the interpretation of bulk measurements(1-5). Here we report spatially resolved, in-situ imaging of a two-dimensional ultracold atomic gas as it crosses the superfluid to Mott insulator transition, providing direct access to individual characteristics of the insulating, superfluid and normal phases. We present results for the local compressibility in all phases, observing a strong suppression in the insulator domain and suppressed density fluctuations for the Mott insulator, in accordance with the fluctuation-dissipation theorem. Furthermore, we obtain a direct measure of the finite temperature of the system. Taken together, these methods enable a complete characterization of multiple phases in a strongly correlated Bose gas, and of the interplay between quantum and thermal fluctuations in the quantum critical regime.	[Chin, Cheng] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Chin, C (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	cchin@uchicago.edu			NSF [PHY-0747907, NSF-MRSEC, DMR-0213745]; ARO [W911NF0710576]; DARPA OLE programme; Grainger Foundation	NSF(National Science Foundation (NSF)); ARO; DARPA OLE programme; Grainger Foundation	We thank T. L. Ho, R. Scalettar, E. Mueller and R. Hulet for discussions. This work was supported by NSF ( grant numbers PHY-0747907, NSF-MRSEC DMR-0213745) and ARO ( grant number W911NF0710576) with funds from the DARPA OLE programme. N. G. acknowledges support from the Grainger Foundation.	Batrouni GG, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.117203; Campbell GK, 2006, SCIENCE, V313, P649, DOI 10.1126/science.1130365; Capogrosso-Sansone B, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.134302; CHIN C, 2008, FESHBACH RESONANCES; Esteve J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.130403; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Folling S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.060403; Folling S, 2005, NATURE, V434, P481, DOI 10.1038/nature03500; Gerbier F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090401; Gerbier F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120405; Greiner M, 2002, NATURE, V419, P51, DOI 10.1038/nature00968; HO TL, 2008, OBTAINING PHASE DIAG; Huang K., 1963, STAT MECH, P152; Hung CL, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.011604; KAGANOV MI, 1987, USP FIZ NAUK+, V153, P537, DOI 10.1070/PU1987v030n12ABEH003065; Kohl M, 2005, J LOW TEMP PHYS, V138, P635, DOI 10.1007/s10909-005-2273-4; Spielman IB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120402; Spielman IB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080404; Tanatar B, 2002, PHYS LETT A, V302, P131, DOI 10.1016/S0375-9601(02)01142-8	21	290	292	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					995	U75		10.1038/nature08244	http://dx.doi.org/10.1038/nature08244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693080	Green Submitted			2022-12-28	WOS:000269085500030
J	Mouridsen, H; Giobbie-Hurder, A; Goldhirsch, A; Thurlimann, B; Paridaens, R; Smith, I; Mauriac, L; Forbes, JF; Price, KN; Regan, MM; Gelber, RD; Coates, AS				Mouridsen, Henning; Giobbie-Hurder, Anita; Goldhirsch, Aron; Thuerlimann, Beat; Paridaens, Robert; Smith, Ian; Mauriac, Louis; Forbes, John F.; Price, Karen N.; Regan, Meredith M.; Gelber, Richard D.; Coates, Alan S.		Big 1-98 Collaborative Grp	Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADJUVANT ENDOCRINE THERAPY; POSTMENOPAUSAL WOMEN; AROMATASE INHIBITORS; CONTINUED TAMOXIFEN; RANDOMIZED-TRIAL; ANASTROZOLE; SURVIVAL; EXEMESTANE	BACKGROUND The aromatase inhibitor letrozole, as compared with tamoxifen, improves disease-free survival among postmenopausal women with receptor-positive early breast cancer. It is unknown whether sequential treatment with tamoxifen and letrozole is superior to letrozole therapy alone. METHODS In this randomized, phase 3, double-blind trial of the treatment of hormone-receptor-positive breast cancer in postmenopausal women, we randomly assigned women to receive 5 years of tamoxifen monotherapy, 5 years of letrozole monotherapy, or 2 years of treatment with one agent followed by 3 years of treatment with the other. We compared the sequential treatments with letrozole monotherapy among 6182 women and also report a protocol-specified updated analysis of letrozole versus tamoxifen monotherapy in 4922 women. RESULTS At a median follow-up of 71 months after randomization, disease-free survival was not significantly improved with either sequential treatment as compared with letrozole alone (hazard ratio for tamoxifen followed by letrozole, 1.05; 99% confidence interval [CI], 0.84 to 1.32; hazard ratio for letrozole followed by tamoxifen, 0.96; 99% CI, 0.76 to 1.21). There were more early relapses among women who were assigned to tamoxifen followed by letrozole than among those who were assigned to letrozole alone. The updated analysis of monotherapy showed that there was a nonsignificant difference in overall survival between women assigned to treatment with letrozole and those assigned to treatment with tamoxifen (hazard ratio for letrozole, 0.87; 95% CI, 0.75 to 1.02; P = 0.08). The rate of adverse events was as expected on the basis of previous reports of letrozole and tamoxifen therapy. CONCLUSIONS Among postmenopausal women with endocrine-responsive breast cancer, sequential treatment with letrozole and tamoxifen, as compared with letrozole monotherapy, did not improve disease-free survival. The difference in overall survival with letrozole monotherapy and tamoxifen monotherapy was not statistically significant. (ClinicalTrials.gov number, NCT00004205.)	[Mouridsen, Henning] Vejle Hosp, Rigshosp, Danish Breast Canc Grp, Copenhagen, Denmark; [Giobbie-Hurder, Anita; Price, Karen N.; Regan, Meredith M.; Gelber, Richard D.] Dana Farber Canc Inst, IBCSG Stat Ctr, Boston, MA 02115 USA; [Regan, Meredith M.; Gelber, Richard D.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Regan, Meredith M.; Gelber, Richard D.] Harvard Univ, Sch Med, Boston, MA USA; [Price, Karen N.; Gelber, Richard D.] Frontier Sci & Technol Res Fdn Inc, Boston, MA USA; [Goldhirsch, Aron] European Inst Oncol, Milan, Italy; [Goldhirsch, Aron] Oncol Inst So Switzerland, Bellinzona, Switzerland; [Thuerlimann, Beat] Kantonsspital, Breast Ctr, St Gallen, Switzerland; [Thuerlimann, Beat] Swiss Grp Clin Canc Res, Bern, Switzerland; [Paridaens, Robert] Catholic Univ Louvain, Univ Hosp Gasthuisberg, Dept Med Oncol, B-3000 Leuven, Belgium; [Smith, Ian] Royal Marsden Hosp, London SW3 6JJ, England; [Smith, Ian] Royal Marsden Natl Hlth Serv Trust, Sutton, Surrey, England; [Mauriac, Louis] Inst Bergonie, Federat Natl Ctr Lutte Canc, Bordeaux, France; [Forbes, John F.] Univ Newcastle, Australian New Zealand Breast Canc Trials Grp, Newcastle, NSW 2308, Australia; [Coates, Alan S.] Univ Sydney, Sydney, NSW 2006, Australia	Danish Breast Cancer Cooperative Group (DBCG); Rigshospitalet; University of Copenhagen; University of Southern Denmark; Lillebaelt Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Frontier Science Foundation; IRCCS European Institute of Oncology (IEO); Institute of Oncology Research (IOR); Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Swiss Group for Clinical Cancer Research (SAKK); KU Leuven; University Hospital Leuven; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; UNICANCER; Institut Bergonie; University of Newcastle; University of Sydney	Mouridsen, H (corresponding author), Vejle Hosp, Rigshosp, Danish Breast Canc Grp, Copenhagen, Denmark.		Munzone, Elisabetta/G-8848-2011; Ales-Martinez, Jose E/D-6927-2016; Martín-Broto, Javier/AAI-2313-2019; Larriba, Jose Luis Gonzalez/G-6177-2016; Segelov, Eva/Q-7611-2019; IBIS, BIOMARCADORES/P-3515-2015; Giobbie-Hurder, Anita/AAU-6193-2021; GLADIEFF, Laurence/O-5129-2014; Basaran, Mert/AAT-7762-2020; friedlander, michael l/G-3490-2013; Rimassa, Lorenza/N-4884-2016; Rutten, Harm J/H-9595-2017; Wardley, Andrew/N-8135-2015; Cheuk, Robyn/H-1944-2013; Wyld, David/B-8893-2015; Perren, Timothy/D-5387-2013	Munzone, Elisabetta/0000-0003-3371-3878; Ales-Martinez, Jose E/0000-0002-4256-0060; Larriba, Jose Luis Gonzalez/0000-0003-2631-0309; Segelov, Eva/0000-0002-4410-6144; GLADIEFF, Laurence/0000-0002-6980-9719; friedlander, michael l/0000-0002-6488-0604; Rimassa, Lorenza/0000-0001-9957-3615; Wardley, Andrew/0000-0002-9639-0888; Cheuk, Robyn/0000-0001-9516-5526; Wyld, David/0000-0001-9523-4333; Perren, Timothy/0000-0001-8472-8856; Pienkowski, Tadeusz/0000-0002-0110-5950; Martin-Broto, Javier/0000-0001-7350-6916; Horvath, Zsolt/0000-0002-5376-7737; Villanova Biazus, Jorge/0000-0002-3821-5264; Hickish, Tamas/0000-0001-6770-7279; CARRECA, Ignazio/0000-0002-4426-2948	Novartis; Swedish Cancer Society; Cancer Council Australia; Australian New Zealand Breast Cancer Trials Group; Frontier Science and Technology Research Foundation; Swiss Group for Clinical Cancer Research; National Cancer Institute [CA-75362]; Cancer Research Switzerland and Oncosuisse; Foundation for Clinical Cancer Research of Eastern Switzerland; NATIONAL CANCER INSTITUTE [U24CA075362] Funding Source: NIH RePORTER	Novartis(Novartis); Swedish Cancer Society(Swedish Cancer Society); Cancer Council Australia(Cancer Council Australia); Australian New Zealand Breast Cancer Trials Group; Frontier Science and Technology Research Foundation; Swiss Group for Clinical Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Switzerland and Oncosuisse; Foundation for Clinical Cancer Research of Eastern Switzerland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Novartis. The International Breast Cancer Study Group (IBCSG), which coordinated the study, is also supported by the Swedish Cancer Society, the Cancer Council Australia, the Australian New Zealand Breast Cancer Trials Group, the Frontier Science and Technology Research Foundation, the Swiss Group for Clinical Cancer Research, the National Cancer Institute (CA-75362), Cancer Research Switzerland and Oncosuisse, and the Foundation for Clinical Cancer Research of Eastern Switzerland.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Baum M, 2002, LANCET, V359, P2131; Baum M, 2002, LANCET, V360, P1520; Boccardo F, 2008, NAT CLIN PRACT ONCOL, V5, P76, DOI 10.1038/ncponc1015; Boccardo F, 2005, J CLIN ONCOL, V23, P5138, DOI 10.1200/JCO.2005.04.120; Carlson Robert W, 2006, J Natl Compr Canc Netw, V4 Suppl 1, pS1; *CLIN TRIALS PDQ, PHAS 3 RAND STUD CON; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Coombes RC, 2007, LANCET, V369, P906; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Coombes RC, 2004, NEW ENGL J MED, V351, P2461; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; COX DR, 1972, J R STAT SOC B, V187, P220; Cuzick J, 2006, BRIT J CANCER, V94, P460, DOI 10.1038/sj.bjc.6602964; Giobbie-Hurder A, 2009, CLIN TRIALS, V6, P272, DOI 10.1177/1740774509105380; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2007, ANN ONCOL, V18, P1917; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; INGLE JN, 2009, CANC RES S, V69, P12; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; Jonat W, 2007, LANCET ONCOL, V8, P6; Jonat W, 2006, LANCET ONCOL, V7, P991, DOI 10.1016/S1470-2045(06)70948-2; Jordan VC, 2008, J CLIN ONCOL, V26, P3073, DOI 10.1200/JCO.2008.17.5190; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kaufmann M, 2007, J CLIN ONCOL, V25, P2664, DOI 10.1200/JCO.2006.08.8054; Macedo LF, 2008, CANCER RES, V68, P3516, DOI 10.1158/0008-5472.CAN-07-6807; Mamounas EP, 2008, J CLIN ONCOL, V26, P1965, DOI 10.1200/JCO.2007.14.0228; Mauriac L, 2007, ANN ONCOL, V18, P859, DOI 10.1093/annonc/mdm001; Punglia RS, 2005, J CLIN ONCOL, V23, P5178, DOI 10.1200/JCO.2005.02.964; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121	34	370	378	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					766	776		10.1056/nejmoa0810818	http://dx.doi.org/10.1056/nejmoa0810818			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484WX	19692688	Green Accepted, Green Published			2022-12-28	WOS:000269081200005
J	Slade, BA; Leidel, L; Vellozzi, C; Woo, EJ; Hua, W; Sutherland, A; Izurieta, HS; Ball, R; Miller, N; Braun, MM; Markowitz, LE; Iskander, J				Slade, Barbara A.; Leidel, Laura; Vellozzi, Claudia; Woo, Emily Jane; Hua, Wei; Sutherland, Andrea; Izurieta, Hector S.; Ball, Robert; Miller, Nancy; Braun, M. Miles; Markowitz, Lauri E.; Iskander, John			Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUILLAIN-BARRE-SYNDROME; SYNCOPE; SYSTEM	Context In June 2006, the Food and Drug Administration licensed the quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccine (qHPV) in the United States for use in females aged 9 to 26 years; the Advisory Committee on Immunization Practices then recommended qHPV for routine vaccination of girls aged 11 to 12 years. Objective To summarize reports to the Vaccine Adverse Event Reporting System (VAERS) following receipt of qHPV. Design, Setting, and Participants Review and describe adverse events following immunization (AEFIs) reported to VAERS, a national, voluntary, passive surveillance system, from June 1, 2006, through December 31, 2008. Additional analyses were performed for some AEFIs in prelicensure trials, those of unusual severity, or those that had received public attention. Statistical data mining, including proportional reporting ratios (PRRs) and empirical Bayesian geometric mean methods, were used to detect disproportionality in reporting. Main Outcome Measures Numbers of reported AEFIs, reporting rates (reports per 100 000 doses of distributed vaccine or per person-years at risk), and comparisons with expected background rates. Results VAERS received 12 424 reports of AEFIs following qHPV distribution, a rate of 53.9 reports per 100 000 doses distributed. A total of 772 reports (6.2% of all reports) described serious AEFIs, including 32 reports of death. The reporting rates per 100 000 qHPV doses distributed were 8.2 for syncope; 7.5 for local site reactions; 6.8 for dizziness; 5.0 for nausea; 4.1 for headache; 3.1 for hypersensitivity reactions; 2.6 for urticaria; 0.2 for venous thromboembolic events, autoimmune disorders, and Guillain-Barre syndrome; 0.1 for anaphylaxis and death; 0.04 for transverse myelitis and pancreatitis; and 0.009 for motor neuron disease. Disproportional reporting of syncope and venous thromboembolic events was noted with data mining methods. Conclusions Most of the AEFI rates were not greater than the background rates compared with other vaccines, but there was disproportional reporting of syncope and venous thromboembolic events. The significance of these findings must be tempered with the limitations (possible underreporting) of a passive reporting system. JAMA. 2009;302(7):750-757	[Slade, Barbara A.; Leidel, Laura; Vellozzi, Claudia; Markowitz, Lauri E.; Iskander, John] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Woo, Emily Jane; Hua, Wei; Sutherland, Andrea; Izurieta, Hector S.; Ball, Robert; Miller, Nancy; Braun, M. Miles] US FDA, Washington, DC 20204 USA	Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Slade, BA (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop D-26, Atlanta, GA 30333 USA.	bfs9@cdc.gov			CDC; FDA	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); FDA(United States Department of Health & Human Services)	The study was implemented by the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA). The only funds used were from CDC and FDA budgets. This study had no external sponsors.	Almenoff JS, 2007, CLIN PHARMACOL THER, V82, P157, DOI 10.1038/sj.clpt.6100258; [Anonymous], MED DICT REGULATORY; [Anonymous], 2005, GUID IND GOOD PHARM; Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Braun MM, 1997, ARCH PEDIAT ADOL MED, V151, P255, DOI 10.1001/archpedi.1997.02170400041007; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; Davis RL, 2005, EPIDEMIOLOGY, V16, P336, DOI 10.1097/01.ede.0000155506.05636.a4; DuMouchel W, 1999, AM STAT, V53, P177, DOI 10.2307/2686093; Ehresman K., 1999, Morbidity and Mortality Weekly Report, V48, P577; EVANS S, 2002, PHARMACOVIGILANCE, P273; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; *FOOD DRUG ADM, GRAD HUM PAP QUADR T; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Gomes MPV, 2004, ARCH INTERN MED, V164, P1965, DOI 10.1001/archinte.164.18.1965; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; LIN JTY, 1982, ANN NEUROL, V11, P525, DOI 10.1002/ana.410110513; PICKERING LK, 2006, RED BOOK 2006 REPORT; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; RODDY SM, 1983, PEDIATRICS, V72, P715; Ruggeberg JU, 2007, VACCINE, V25, P5675, DOI 10.1016/j.vaccine.2007.02.064; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; SCHONBERGER LB, 1981, ANN NEUROL, V9, P31, DOI 10.1002/ana.410090707; Sutherland A., 2008, Morbidity and Mortality Weekly Report, V57, P457; Szarfman A, 2002, DRUG SAFETY, V25, P381, DOI 10.2165/00002018-200225060-00001; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Weber J.C.P., 1984, ADV INFLAMMAT RES, V6, P1; Woo E. J., 2006, Morbidity and Mortality Weekly Report, V55, P1120; Woo EJ, 2005, ARCH PEDIAT ADOL MED, V159, P1083, DOI 10.1001/archpedi.159.11.1083; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1	33	314	335	7	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					750	757		10.1001/jama.2009.1201	http://dx.doi.org/10.1001/jama.2009.1201			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690307	Bronze			2022-12-28	WOS:000269073800023
J	Sweet, M				Sweet, Melissa			Pandemic flu Pandemic lessons from Australia	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	10	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2009	339								b3317	10.1136/bmj.b3317	http://dx.doi.org/10.1136/bmj.b3317			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486RZ	19690003				2022-12-28	WOS:000269216700016
J	Vos, M; Birkett, PJ; Birch, E; Griffiths, RI; Buckling, A				Vos, Michiel; Birkett, Philip J.; Birch, Elizabeth; Griffiths, Robert I.; Buckling, Angus			Local Adaptation of Bacteriophages to Their Bacterial Hosts in Soil	SCIENCE			English	Article							RESISTANCE		[Vos, Michiel; Birkett, Philip J.; Birch, Elizabeth; Buckling, Angus] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Griffiths, Robert I.] Ctr Ecol & Hydrol, Oxford OX1 35R, England	University of Oxford; UK Centre for Ecology & Hydrology (UKCEH)	Vos, M (corresponding author), Royal Netherlands Acad Arts & Sci NIOO KNAW, Netherlands Inst Ecol, Ctr Terr Ecol, NL-6666 GA Heteren, Netherlands.	michiel.vos@nioo.knaw.nl	Griffiths, Robert/D-5237-2011; Birch, Elizabeth/GXW-2925-2022	Griffiths, Robert/0000-0002-3341-4547; Buckling, Angus/0000-0003-1170-4604	European Research Council; the Royal Society; Netherlands Organisation for Scientific Research (NWO); NERC [NE/E012140/1] Funding Source: UKRI; Natural Environment Research Council [CEH010021, NE/E012140/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); the Royal Society(Royal Society of London); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by the European Research Council, the Royal Society, and a Netherlands Organisation for Scientific Research (NWO) Rubicon grant to M.V.	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913	7	126	134	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					833	833		10.1126/science.1174173	http://dx.doi.org/10.1126/science.1174173			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679806				2022-12-28	WOS:000269242400035
J	Okatan, E; Keijzer, R				Okatan, Eda; Keijzer, Richard			Testicular Torsion in a Hydrocele	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Okatan, Eda; Keijzer, Richard] Erasmus MC, NL-3000 CB Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Okatan, E (corresponding author), Erasmus MC, NL-3000 CB Rotterdam, Netherlands.	richardkeijzer@gmail.com	Keijzer, Richard/AAA-9598-2020	Keijzer, Richard/0000-0002-0108-3157					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					698	698		10.1056/NEJMicm0805348	http://dx.doi.org/10.1056/NEJMicm0805348			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19675332				2022-12-28	WOS:000268884100010
J	Schmitz, KH; Ahmed, RL; Troxel, A; Cheville, A; Smith, R; Lewis-Grant, L; Bryan, CJ; Williams-Smith, CT; Greene, QP				Schmitz, Kathryn H.; Ahmed, Rehana L.; Troxel, Andrea; Cheville, Andrea; Smith, Rebecca; Lewis-Grant, Lorita; Bryan, Cathy J.; Williams-Smith, Catherine T.; Greene, Quincy P.			Weight Lifting in Women with Breast-Cancer-Related Lymphedema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANCE EXERCISE; RISK-FACTORS; NODE BIOPSY; QUESTIONNAIRE; VALIDATION	Background Weight lifting has generally been proscribed for women with breast-cancer-related lymphedema, preventing them from obtaining the well-established health benefits of weight lifting, including increases in bone density. Methods We performed a randomized, controlled trial of twice-weekly progressive weight lifting involving 141 breast-cancer survivors with stable lymphedema of the arm. The primary outcome was the change in arm and hand swelling at 1 year, as measured through displaced water volume of the affected and unaffected limbs. Secondary outcomes included the incidence of exacerbations of lymphedema, number and severity of lymphedema symptoms, and muscle strength. Participants were required to wear a well-fitted compression garment while weight lifting. Results The proportion of women who had an increase of 5% or more in limb swelling was similar in the weight-lifting group (11%) and the control group (12%) (cumulative incidence ratio, 1.00; 95% confidence interval, 0.88 to 1.13). As compared with the control group, the weight-lifting group had greater improvements in self-reported severity of lymphedema symptoms (P=0.03) and upper- and lower-body strength (P<0.001 for both comparisons) and a lower incidence of lymphedema exacerbations as assessed by a certified lymphedema specialist (14% vs. 29%, P = 0.04). There were no serious adverse events related to the intervention. Conclusions In breast-cancer survivors with lymphedema, slowly progressive weight lifting had no significant effect on limb swelling and resulted in a decreased incidence of exacerbations of lymphedema, reduced symptoms, and increased strength. (ClinicalTrials.gov number, NCT00194363.)	[Schmitz, Kathryn H.] Univ Penn, Dept Biostat & Epidemiol, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Schmitz, Kathryn H.; Troxel, Andrea; Smith, Rebecca; Lewis-Grant, Lorita; Bryan, Cathy J.; Williams-Smith, Catherine T.; Greene, Quincy P.] Abramson Canc Ctr, Philadelphia, PA USA; [Ahmed, Rehana L.] Univ Minnesota, Sch Med, Dept Dermatol, Minneapolis, MN 55455 USA; [Cheville, Andrea] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Schmitz, KH (corresponding author), Univ Penn, Dept Biostat & Epidemiol, Sch Med, Ctr Clin Epidemiol & Biostat, 423 Guardian Dr,903 Blockley Hall, Philadelphia, PA 19104 USA.	schmitz@mail.med.upenn.edu	Schmitz, Kathryn/B-7154-2011; Schmitz, Kathryn H/F-3516-2012	Troxel, Andrea/0000-0002-1393-3075; Schmitz, Kathryn/0000-0003-2400-2935	National Cancer Institute [R01CA106851]; National Center for Research Resources [UL1RR024134]; NATIONAL CANCER INSTITUTE [R01CA106851] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from the National Cancer Institute (R01CA106851, to Dr. Schmitz) and the National Center for Research Resources (UL1RR024134, to the University of Pennsylvania). BSN Medical provided custom-fitted compression garments, and the fitness centers where the weight-lifting sessions took place ( YMCA of Philadelphia and Vicinity, Sisters in Shape, and the Family YMCA of Burlington County, NJ) provided discounted membership fees for study participants.	Ahmed RL, 2006, J CLIN ONCOL, V24, P2765, DOI 10.1200/JCO.2005.03.6749; *AM CANC SOC, 2009, LYMPH WHAT EV WOM BR; American Cancer Society, 2008, CANC FACTS FIG; Armer Jane M., 2005, Lymphatic Research and Biology, V3, P208, DOI 10.1089/lrb.2005.3.208; Barnard K L, 1999, J Cardiopulm Rehabil, V19, P52, DOI 10.1097/00008483-199901000-00007; Bjarnason NH, 2008, ACTA ONCOL, V47, P747, DOI 10.1080/02841860802001467; BOUGEOIS P, 1988, PROGR LYMPHOLOGY, P551; Brennan MJ, 1998, CANCER, V83, P2821, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2821::AID-CNCR33>3.0.CO;2-G; Cheville AL, 2003, SEMIN RADIAT ONCOL, V13, P214, DOI 10.1016/S1053-4296(03)00038-9; Courneya KS, 2007, J CLIN ONCOL, V25, P4396, DOI 10.1200/JCO.2006.08.2024; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Evans S. J. W., 1990, MINIM MINIMISATION P; Francis WP, 2006, AM J SURG, V192, P636, DOI 10.1016/j.amjsurg.2006.08.018; Golshan M, 2003, AM SURGEON, V69, P209; Harris SR, 2000, J SURG ONCOL, V74, P95, DOI 10.1002/1096-9098(200006)74:2<95::AID-JSO3>3.0.CO;2-Q; Hayes SC, 2008, J CLIN ONCOL, V26, P3536, DOI 10.1200/JCO.2007.14.4899; Johansson K, 2005, LYMPHOLOGY, V38, P167; King T I 2nd, 1993, J Hand Ther, V6, P202; Kraemer WJ., 1997, DESIGNING RESISTANCE; McKenzie DC, 2003, J CLIN ONCOL, V21, P463, DOI 10.1200/JCO.2003.04.069; MORTIMER P, 1990, INT CONGR SER, V887, P215; Mortimer PS, 1995, INT ANGIOL, V14, P32; *NAT CANC I, 2003, SEER CANC STAT REV C; *NAT LYMPH NETW, 2005, EX; *NAT LYMPH NETW, 2008, LYMPH RISK RED PRACT; *NAT LYMPH NETW, 2006, TREATM; *NAT LYMPH NETW NA, 2005, TRAIN LYMPH THER; NELSON ME, 1994, JAMA-J AM MED ASSOC, V272, P1909, DOI 10.1001/jama.272.24.1909; Norman SA, 2001, PHYS THER, V81, P1192, DOI 10.1093/ptj/81.6.1192; Phillips SM, 2007, APPL PHYSIOL NUTR ME, V32, P1198, DOI 10.1139/H07-129; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Ronka RH, 2004, ACTA ONCOL, V43, P551, DOI 10.1080/02841860410014867; Schmitz KH, 2007, AM J CLIN NUTR, V86, P566, DOI 10.1093/ajcn/86.3.566; Shaw C E, 1995, J Cardiopulm Rehabil, V15, P283, DOI 10.1097/00008483-199507000-00005; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Subar AF, 2000, AM J EPIDEMIOL, V152, P279, DOI 10.1093/aje/152.3.279; SUSAN G, 2009, UNDERSTANDING BREAST; Vignes S, 2007, ACTA ONCOL, V46, P1138, DOI 10.1080/02841860701403020; Warren AG, 2007, ANN PLAS SURG, V59, P464, DOI 10.1097/01.sap.0000257149.42922.7e; WAYLETTRENDALL J, 1991, J HAND THER, V4, P10; WERNER RS, 1991, RADIOLOGY, V180, P177, DOI 10.1148/radiology.180.1.2052688	41	369	387	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					664	673		10.1056/NEJMoa0810118	http://dx.doi.org/10.1056/NEJMoa0810118			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19675330				2022-12-28	WOS:000268884100006
J	Clark, PU; Dyke, AS; Shakun, JD; Carlson, AE; Clark, J; Wohlfarth, B; Mitrovica, JX; Hostetler, SW; McCabe, AM				Clark, Peter U.; Dyke, Arthur S.; Shakun, Jeremy D.; Carlson, Anders E.; Clark, Jorie; Wohlfarth, Barbara; Mitrovica, Jerry X.; Hostetler, Steven W.; McCabe, A. Marshall			The Last Glacial Maximum	SCIENCE			English	Article							MILLENNIAL TIME SCALES; SEA-LEVEL HISTORIES; ICE-SHEET; SOUTHERN-HEMISPHERE; CLIMATE-CHANGE; ATMOSPHERIC CO2; TEMPERATURE; ANTARCTICA; PERIOD; GREENLAND	We used 5704 C-14, Be-10, and He-3 ages that span the interval from 10,000 to 50,000 years ago (10 to 50 ka) to constrain the timing of the Last Glacial Maximum (LGM) in terms of global ice-sheet and mountain-glacier extent. Growth of the ice sheets to their maximum positions occurred between 33.0 and 26.5 ka in response to climate forcing from decreases in northern summer insolation, tropical Pacific sea surface temperatures, and atmospheric CO2. Nearly all ice sheets were at their LGM positions from 26.5 ka to 19 to 20 ka, corresponding to minima in these forcings. The onset of Northern Hemisphere deglaciation 19 to 20 ka was induced by an increase in northern summer insolation, providing the source for an abrupt rise in sea level. The onset of deglaciation of the West Antarctic Ice Sheet occurred between 14 and 15 ka, consistent with evidence that this was the primary source for an abrupt rise in sea level similar to 14.5 ka.	[Clark, Peter U.; Shakun, Jeremy D.; Clark, Jorie] Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA; [Dyke, Arthur S.] Geol Survey Canada, Ottawa, ON K1A 0E8, Canada; [Carlson, Anders E.] Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; [Wohlfarth, Barbara] Stockholm Univ, Dept Geol & Geochem, SE-10691 Stockholm, Sweden; [Mitrovica, Jerry X.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Hostetler, Steven W.] Oregon State Univ, Dept Geosci, US Geol Survey, Corvallis, OR 97331 USA; [McCabe, A. Marshall] Univ Ulster, Sch Environm Sci, Coleraine BT52 1SA, Londonderry, North Ireland	Oregon State University; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Wisconsin System; University of Wisconsin Madison; Stockholm University; Harvard University; Oregon State University; United States Department of the Interior; United States Geological Survey; Ulster University	Clark, PU (corresponding author), Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA.	clarkp@onid.orst.edu		Wong, Yuk Fai/0000-0002-3756-1237	NSF; Geological Survey of Canada Climate Change Program; University of Wisconsin; Swedish Nuclear Fuel and Waste Management Co.; Canadian Institute for Advanced Research	NSF(National Science Foundation (NSF)); Geological Survey of Canada Climate Change Program; University of Wisconsin; Swedish Nuclear Fuel and Waste Management Co.; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	This work was supported by NSF (P.U.C., J.D.S., A.E.C., and S.W.H.), the Geological Survey of Canada Climate Change Program (A.S.D.), the University of Wisconsin (A.E.C.), the Swedish Nuclear Fuel and Waste Management Co. (B.W.), and the Canadian Institute for Advanced Research (J.X.M.).	Ahn J, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004415; Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; Bassett SE, 2005, SCIENCE, V309, P925, DOI 10.1126/science.1111575; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Briner JP, 2005, CAN J EARTH SCI, V42, P67, DOI 10.1139/E04-102; Brook EJ, 2005, QUATERNARY SCI REV, V24, P1333, DOI 10.1016/j.quascirev.2005.02.002; Bush ABG, 1998, SCIENCE, V279, P1341, DOI 10.1126/science.279.5355.1341; Carlson A, 2008, GEOLOGY, V36, P359, DOI 10.1130/G24519A.1; Chappell J, 2002, QUATERNARY SCI REV, V21, P1229, DOI 10.1016/S0277-3791(01)00141-X; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Clark P.U., 2007, OCEAN CIRCULATION ME, V173, P209, DOI [10.1029/173GM15, DOI 10.1029/173GM15]; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; Clark PU, 2004, SCIENCE, V304, P1141, DOI 10.1126/science.1094449; Clement AC, 1999, PALEOCEANOGRAPHY, V14, P441, DOI 10.1029/1999PA900013; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; Dyke A.S., 1987, GEOGR PHYS QUATERNAI, V2, P237, DOI [10.7202/032681ar, DOI 10.7202/032681AR]; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; Feldberg MJ, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000740; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; Heroy DC, 2007, QUATERNARY SCI REV, V26, P3286, DOI 10.1016/j.quascirev.2007.07.012; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; IMBRIE J, 1993, PALEOCEANOGRAPHY, V8, P699, DOI 10.1029/93PA02751; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Levitus S, 1994, WORLD OCEAN ATLAS 19; Licciardi JM, 2004, GEOLOGY, V32, P81, DOI 10.1130/G19868.1; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Martinez I, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000877; Milne GA, 2008, QUATERNARY SCI REV, V27, P2292, DOI 10.1016/j.quascirev.2008.08.018; Mix AC, 1999, GEOPH MONOG SERIES, V112, P127; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Paterson W.S.B., 1994, PHYS GLACIERS, Vthird; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Price SF, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000725; Schaefer JM, 2006, SCIENCE, V312, P1510, DOI 10.1126/science.1122872; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Skinner LC, 2005, QUATERNARY SCI REV, V24, P571, DOI 10.1016/j.quascirev.2004.11.008; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Stott L, 2007, SCIENCE, V318, P435, DOI 10.1126/science.1143791; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	52	2102	2179	19	767	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					710	714		10.1126/science.1172873	http://dx.doi.org/10.1126/science.1172873			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661421				2022-12-28	WOS:000268723700039
J	Larkum, ME; Nevian, T; Sandler, M; Polsky, A; Schiller, J				Larkum, Matthew E.; Nevian, Thomas; Sandler, Maya; Polsky, Alon; Schiller, Jackie			Synaptic Integration in Tuft Dendrites of Layer 5 Pyramidal Neurons: A New Unifying Principle	SCIENCE			English	Article							DISTAL APICAL DENDRITES; ACTION-POTENTIALS; BASAL DENDRITES; VISUAL-CORTEX; IN-VIVO; CELLS; RAT; CONNECTIONS; MORPHOLOGY; INITIATION	Tuft dendrites are the main target for feedback inputs innervating neocortical layer 5 pyramidal neurons, but their properties remain obscure. We report the existence of N-methyl-D-aspartate (NMDA) spikes in the fine distal tuft dendrites that otherwise did not support the initiation of calcium spikes. Both direct measurements and computer simulations showed that NMDA spikes are the dominant mechanism by which distal synaptic input leads to firing of the neuron and provide the substrate for complex parallel processing of top-down input arriving at the tuft. These data lead to a new unifying view of integration in pyramidal neurons in which all fine dendrites, basal and tuft, integrate inputs locally through the recruitment of NMDA receptor channels relative to the fixed apical calcium and axosomatic sodium integration points.	[Larkum, Matthew E.; Nevian, Thomas] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland; [Sandler, Maya; Polsky, Alon; Schiller, Jackie] Technion Israel Inst Technol, Rappaport Fac Med, Dept Physiol, IL-31096 Haifa, Israel; [Sandler, Maya; Polsky, Alon; Schiller, Jackie] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel	University of Bern; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Larkum, ME (corresponding author), Univ Bern, Dept Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	matthew.larkum@gmail.com; jackie@tx.technion.ac.il		Sandler, Maya/0000-0002-6094-7517; Larkum, Matthew/0000-0001-9799-2656; Nevian, Thomas/0000-0001-9804-608X	NIH; Israel Science Foundation; Rappaport Foundation; Swiss National Science Foundation [PP0033-119159, 3100A0-118395]; SystemsX.ch	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Rappaport Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch	This study was supported by NIH, the Israel Science Foundation, and the Rappaport Foundation ( J.S.); by the Swiss National Science Foundation (M.L., grant PP0033-119159; T.N., grant 3100A0-118395); and by SystemsX.ch (M.L., Neurochoice). The authors declare that they have no competing financial interests.	Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Budd JML, 1998, P ROY SOC B-BIOL SCI, V265, P1037, DOI 10.1098/rspb.1998.0396; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Jones EG, 1999, CEREB CORTEX, V13, P139; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; Kuhn B, 2008, P NATL ACAD SCI USA, V105, P7588, DOI 10.1073/pnas.0802462105; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Milojkovic BA, 2005, J MEMBRANE BIOL, V208, P155, DOI 10.1007/s00232-005-0827-7; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Rhodes PA, 2001, J PHYSIOL-LONDON, V536, P167, DOI 10.1111/j.1469-7793.2001.00167.x; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Spruston N, 2004, NAT NEUROSCI, V7, P567, DOI 10.1038/nn0604-567; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	31	414	420	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					756	760		10.1126/science.1171958	http://dx.doi.org/10.1126/science.1171958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661433				2022-12-28	WOS:000268723700052
J	Yu, C; Feng, W; Wei, ZY; Miyanoiri, Y; Wen, WY; Zhao, YX; Zhang, MJ				Yu, Cong; Feng, Wei; Wei, Zhiyi; Miyanoiri, Yohei; Wen, Wenyu; Zhao, Yanxiang; Zhang, Mingjie			Myosin VI Undergoes Cargo-Mediated Dimerization	CELL			English	Article							UNCONVENTIONAL MYOSINS; CELLULAR FUNCTIONS; PROCESSIVE MOTOR; ORGANIZATION; DISABLED-2; BINDING; DOMAIN; KINESIN; MODEL; TRANSPORT	Myosin VI is the only known molecular motor that moves toward the minus ends of actin filaments; thus, it plays unique roles in diverse cellular processes. The processive walking of myosin VI on actin filaments requires dimerization of the motor, but the protein can also function as a nonprocessive monomer. The molecular mechanism governing the monomer-dimer conversion is not clear. We report the high-resolution NMR structure of the cargo-free myosin VI cargo-binding domain (CBD) and show that it is a stable monomer in solution. The myosin VI CBD binds to a fragment of the clathrin-coated vesicle adaptor Dab2 with a high affinity, and the X-ray structure of the myosin VI CBD in complex with Dab2 reveals that the motor undergoes a cargo-binding-mediated dimerization. The cargo-binding-induced dimerization may represent a general paradigm for the regulation of processivity for myosin VI as well as other myosins, including myosin VII and myosin X.	[Yu, Cong; Feng, Wei; Wei, Zhiyi; Miyanoiri, Yohei; Wen, Wenyu; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Dept Biochem, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China; [Zhao, Yanxiang] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong Polytechnic University	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/N-9995-2019; yu, cong/V-5140-2018; Wei, Zhiyi/B-5001-2010; , 余聪/AAK-9457-2020; Wei, Zhiyi/C-4315-2014; FENG, WEI/C-8966-2012	Wei, Zhiyi/0000-0002-4446-6502; yu, cong/0000-0003-2912-6347; Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Zhao, Yanxiang/0000-0002-9408-9979; Zhang, Mingjie/0000-0001-9404-0190; Miyanoiri, Yohei/0000-0001-6889-5160	Research Grants Council of Hong Kong [HKUST6419/05M, 6442/06M, 663407, 663808, CA07/08.SC01, AoE/B-15/01-II, 660708, PolyU5641/08M]; Hong Kong Jockey Club	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Jockey Club	We thank Anthony Zhang for critical reading of the manuscript and Joanne Chan for technical help. This work was supported by grants from the Research Grants Council of Hong Kong to M. Z. (HKUST6419/05M, 6442/06M, 663407, 663808, CA07/08.SC01, and AoE/B-15/01-II), W. F. (660708), and Y.Z. (PolyU5641/08M). The NMR spectrometers used in this work were purchased with funds donated to the Biotechnology Research Institute by the Hong Kong Jockey Club.	Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker JP, 1997, J MOL BIOL, V272, P523, DOI 10.1006/jmbi.1997.1232; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Feng W, 2004, NAT STRUCT MOL BIOL, V11, P475, DOI 10.1038/nsmb751; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Inoue A, 2002, BIOCHEM BIOPH RES CO, V292, P300, DOI 10.1006/bbrc.2002.6636; Kay LE, 1997, CURR OPIN STRUC BIOL, V7, P722, DOI 10.1016/S0959-440X(97)80084-X; KELLERMAN KA, 1992, J CELL BIOL, V119, P823, DOI 10.1083/jcb.119.4.823; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Menetrey J, 2008, EMBO J, V27, P244, DOI 10.1038/sj.emboj.7601937; Menetrey J, 2007, CELL, V131, P300, DOI 10.1016/j.cell.2007.08.027; MERMALL V, 1994, NATURE, V369, P560, DOI 10.1038/369560a0; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Nicholls A., 1992, GRASP GRAPHICAL REPR; O'Connell CB, 2007, BBA-MOL CELL RES, V1773, P615, DOI 10.1016/j.bbamcr.2006.06.012; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rodriguez OC, 2000, TRENDS CELL BIOL, V10, P307, DOI 10.1016/S0962-8924(00)01797-9; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Wu HJ, 2002, J BIOL CHEM, V277, P30928, DOI 10.1074/jbc.M203735200; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103	62	97	99	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					537	548		10.1016/j.cell.2009.05.030	http://dx.doi.org/10.1016/j.cell.2009.05.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665975	Bronze			2022-12-28	WOS:000268771900018
J	Chang, FR				Chang, Frederick R.			Is Your Computer Secure?	SCIENCE			English	Editorial Material									Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Chang, FR (corresponding author), Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA.	chang@cs.utexas.edu						Anderson R, 2006, SCIENCE, V314, P610, DOI 10.1126/science.1130992; [Anonymous], 2007, BBC NEWS 0620; BRYANT RE, 1986, IEEE T COMPUT, V35, P677, DOI 10.1109/TC.1986.1676819; Chess B., 2007, SECURE PROGRAMMING S, V1st; *DARKREADING, 2006, SOC ENG USB WAY; Geer DE, 2008, IEEE SECUR PRIV, V6, P87, DOI 10.1109/MSP.2008.27; GREENFELD N, 1996, UNIX REV, V14, P9; *IBM GLOB TECHN SE, 2009, IBM INT SEC SYST X F; Jones C, 2006, COMPUTER, V39, P93, DOI 10.1109/MC.2006.145; Kanich Chris, 2008, SPAMALYTICS EMPIRICA; McGraw G, 2004, IEEE SECUR PRIV, V2, P80, DOI 10.1109/MSECP.2004.1281254; *PAND SEC, 2007, MALW INF PROT SYST; PORRAS P., 2007, MULTIPERSPECTIVE ANA; Schneier B., 2008, PSYCHOL SECURITY; Stewart J., 2008, TOP SPAM BOTNETS EXP; *SYM CORP, 2008, SYM REP UND EC; Weber Tim, 2007, BBC NEWS        0125	17	9	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					550	551		10.1126/science.1168661	http://dx.doi.org/10.1126/science.1168661			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19644101				2022-12-28	WOS:000268493000029
J	Robeva, R; Laubenbacher, R				Robeva, Raina; Laubenbacher, Reinhard			Mathematical Biology Education: Beyond Calculus	SCIENCE			English	Editorial Material							NETWORK; COLI		[Robeva, Raina] Sweet Briar Coll, Dept Math Sci, Sweet Briar, VA 24595 USA; [Laubenbacher, Reinhard] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Robeva, R (corresponding author), Sweet Briar Coll, Dept Math Sci, Sweet Briar, VA 24595 USA.	Robeva@sbc.edu						Adler FR, 2005, MODELING DYNAMICS LI, V2nd; Apostolico A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1044; *APP STAT U, 2008, UND RES C QUANT BIOL; *APP STAT U, 2007, UND RES C QUANT BIOL; *DUK U, 2005, MATH 295 ALG STAT CO; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; LAUBENBACHER R, AM MATH MON IN PRESS; *MATH ASS AM PROF, 2006, COMP MATH BIOL; *MATH ASS AM PROF, 2007, COMP MATH BIOL; *MATH ASS AM PROF, 2004, COMP MATH BIOL; *MATH ASS AM PROF, 2005, COMP MATH BIOL; *MATH ASS AM PROF, 2003, COMP MATH BIOL; *NAT I HLTH PROGR, 2009, REC ACT LTD COMP NIH; *NAT SCI FDN PROGR, 2008, 08510 NSF PROGR SOL; National Research Council, 2003, BIO2010 TRANSF UND E; NEUHAUSER C, 2003, CALCULUS BIOL MED; *NIMBIOS, 2009, UND C INT MATH BIOL; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pachter L, 2004, P NATL ACAD SCI USA, V101, P16132, DOI 10.1073/pnas.0406010101; ROBEVA R, 2008, 0737467 DUE NAT SCI; Robeva R, 2009, METHOD ENZYMOL, V454, P305, DOI 10.1016/S0076-6879(08)03812-3; Samal A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-21; Sitharam M, 2006, J COMPUT BIOL, V13, P1232, DOI 10.1089/cmb.2006.13.1232; *U CA, 2007, MATH 127 MATH COMP B; Wingreen N, 2006, NAT REV MOL CELL BIO, V7, P829, DOI 10.1038/nrm2023; Zhang RR, 2008, P NATL ACAD SCI USA, V105, P16308, DOI 10.1073/pnas.0806447105; 2007, MATH BIOSC I WORKSH	27	21	23	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					542	543		10.1126/science.1176016	http://dx.doi.org/10.1126/science.1176016			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19644095				2022-12-28	WOS:000268493000023
J	Neal, DE; Donovan, JL; Martin, RM; Hamdy, FC				Neal, David E.; Donovan, Jenny L.; Martin, Richard M.; Hamdy, Freddie C.			Screening for prostate cancer remains controversial	LANCET			English	Editorial Material							RADICAL PROSTATECTOMY; MEN; MORTALITY; DESIGN		[Neal, David E.] Univ Cambridge, Dept Oncol, Cambridge CB2 0QQ, England; [Donovan, Jenny L.; Martin, Richard M.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Hamdy, Freddie C.] Univ Oxford, Dept Surg, Oxford, England	University of Cambridge; University of Bristol; University of Oxford	Neal, DE (corresponding author), Univ Cambridge, Dept Oncol, Cambridge CB2 0QQ, England.	den22@cam.ac.uk		Martin, Richard/0000-0002-7992-7719; Neal, David/0000-0002-6033-5086; Hamdy, Freddie/0000-0003-2627-2154	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Barry MJ, 2009, NEW ENGL J MED, V360, P1351, DOI 10.1056/NEJMe0901166; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; D'Amico AV, 2005, J CLIN ONCOL, V23, P4975, DOI 10.1200/JCO.2005.08.904; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Fall K, 2007, JNCI-J NATL CANCER I, V99, P526, DOI 10.1093/jnci/djk110; Gosselaar C, 2008, EUR UROL, V54, P581, DOI 10.1016/j.eururo.2008.03.104; Martin RM, 2006, J UROLOGY, V176, P439, DOI 10.1016/j.juro.2006.03.030; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Wilt TJ, 2008, J UROLOGY, V180, P820, DOI 10.1016/j.juro.2008.05.010; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Wilt TJ, 2009, CONTEMP CLIN TRIALS, V30, P81, DOI 10.1016/j.cct.2008.08.002; Witte JS, 2009, NAT REV GENET, V10, P77, DOI 10.1038/nrg2507	16	21	21	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2009	374	9700					1482	1483		10.1016/S0140-6736(09)61085-0	http://dx.doi.org/10.1016/S0140-6736(09)61085-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19664817				2022-12-28	WOS:000271591300008
J	Chen, C; Bobisch, CA; Ho, W				Chen, Chi; Bobisch, C. A.; Ho, W.			Visualization of Fermi's Golden Rule Through Imaging of Light Emission from Atomic Silver Chains	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; PHOTON-EMISSION; RESOLUTION; ELECTRON	Atomic-scale spatial imaging of one-dimensional chains of silver atoms allows Fermi's golden rule, a fundamental principle governing optical transitions, to be visualized. We used a scanning tunneling microscope (STM) to assemble a silver atom chain on a nickel-aluminum alloy surface. Photon emission was induced with electrons from the tip of the STM. The emission was spatially resolved with subnanometer resolution by changing the tip position along the chain. The number and positions of the emission maxima in the photon images match those of the nodes in the differential conductance images of particle-in-a-box states. This surprising correlation between the emission maxima and nodes in the density of states is a manifestation of Fermi's golden rule in real space for radiative transitions and provides an understanding of the mechanism of STM-induced light emission.	[Chen, Chi; Ho, W.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Bobisch, C. A.; Ho, W.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ho, W (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.	wilsonho@uci.edu	Chen, Chi/E-9667-2013; Bobisch, Christian A/B-7733-2008	Chen, Chi/0000-0002-2880-7215; 	Chemical Science, Geo- and Bioscience Division, Office of Science, US Department of Energy [DE-FG02-04ER1595]; Alexander von Humboldt Foundation	Chemical Science, Geo- and Bioscience Division, Office of Science, US Department of Energy(United States Department of Energy (DOE)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Supported by the Chemical Science, Geo- and Bioscience Division, Office of Science, US Department of Energy, under grant DE-FG02-04ER1595, and by the Alexander von Humboldt Foundation through a Feodor Lynen Fellowship to C.A.B. We thank R. Wu, D.L. Mills, P. Chu, Y. Jiang, and N. Ogawa for inspiring discussions.	BERNDT R, 1995, PHYS REV LETT, V74, P102, DOI 10.1103/PhysRevLett.74.102; BERNDT R, 1993, PHYS REV B, V48, P4746, DOI 10.1103/PhysRevB.48.4746; BERNDT R, 1991, PHYS REV LETT, V67, P3796, DOI 10.1103/PhysRevLett.67.3796; BERNDT R, 1993, SCIENCE, V262, P1425, DOI 10.1126/science.262.5138.1425; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; Hoffmann G, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.212107; JOHANSSON P, 1990, PHYS REV B, V42, P9210, DOI 10.1103/PhysRevB.42.9210; LUI SC, 1989, PHYS REV B, V39, P13149, DOI 10.1103/PhysRevB.39.13149; Maier SA, 2005, J APPL PHYS, V98, DOI 10.1063/1.1951057; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; Meguro K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165405; Nazin GV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.216110; Nilius N, 2005, J PHYS CHEM B, V109, P20657, DOI 10.1021/jp0534961; Nilius N, 2002, SCIENCE, V297, P1853, DOI 10.1126/science.1075242; Qiu XH, 2003, SCIENCE, V299, P542, DOI 10.1126/science.1078675; SCHATZ GC, 2002, QUANTUM MECH CHEM, pCH4; Schull G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.136801; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Wallis TM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.236802; Wu SW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.205430; Yan J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.216602	21	68	68	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					981	985		10.1126/science.1174592	http://dx.doi.org/10.1126/science.1174592			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696347				2022-12-28	WOS:000269242800042
J	Lake, JA				Lake, James A.			Evidence for an early prokaryotic endosymbiosis	NATURE			English	Article							HORIZONTAL GENE-TRANSFER; SYMBIOBACTERIUM-THERMOPHILUM; COMMUNITY STRUCTURE; GENOME SEQUENCE; EARLY EVOLUTION; LIFE; TREE; ROOT; BACTERIUM; DEPENDS	Endosymbioses have dramatically altered eukaryotic life, but are thought to have negligibly affected prokaryotic evolution. Here, by analysing the flows of protein families, I present evidence that the double-membrane, Gram-negative prokaryotes were formed as the result of a symbiosis between an ancient actinobacterium and an ancient clostridium. The resulting taxon has been extraordinarily successful, and has profoundly altered the evolution of life by providing endosymbionts necessary for the emergence of eukaryotes and by generating Earth's oxygen atmosphere. Their double-membrane architecture and the observed genome flows into them suggest a common evolutionary mechanism for their origin: an endosymbiosis between a clostridium and actinobacterium.	[Lake, James A.] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA; [Lake, James A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Lake, James A.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Lake, James A.] Univ Calif Los Angeles, UCLA Astrobiol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lake, JA (corresponding author), Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA.	lake@mbi.ucla.edu			NSF; UCLA NASA Astrobiology Institute	NSF(National Science Foundation (NSF)); UCLA NASA Astrobiology Institute	I thank C. Herbold, R. Skophammer, A. Norman and J. Servin for advice and help. This work was supported by grants from the NSF and the UCLA NASA Astrobiology Institute to J. A. L.	Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; BOONE DR, 1989, APPL ENVIRON MICROB, V55, P1735, DOI 10.1128/AEM.55.7.1735-1741.1989; BOONE DR, 2001, BERGEYS MANUAL SYSTE, V1; Bowler C, 2009, NATURE, V459, P180, DOI 10.1038/nature08056; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; DeLong EF, 2009, NATURE, V459, P200, DOI 10.1038/nature08059; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Fischer WW, 2008, NATURE, V455, P1051, DOI 10.1038/4551051a; Frostl JM, 2000, ARCH MICROBIOL, V174, P50, DOI 10.1007/s002030000172; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Garritya G. M., 2001, BERGEYS MANUAL SYSTE, P119, DOI DOI 10.1002/9781118960608.BM00031; GEST H, 1983, ARCH MICROBIOL, V136, P11, DOI 10.1007/BF00415602; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; HILARIO E, 1993, BIOSYSTEMS, V31, P111, DOI 10.1016/0303-2647(93)90038-E; Jain R, 2003, MOL BIOL EVOL, V20, P1598, DOI 10.1093/molbev/msg154; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jain R, 2002, THEOR POPUL BIOL, V61, P489, DOI 10.1006/tpbi.2002.1596; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; LAKE JA, 1995, P NATL ACAD SCI USA, V92, P9662, DOI 10.1073/pnas.92.21.9662; Lake JA, 2004, MOL BIOL EVOL, V21, P681, DOI 10.1093/molbev/msh061; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P2880, DOI 10.1073/pnas.91.8.2880; Lake JA, 2008, MOL BIOL EVOL, V25, P1677, DOI 10.1093/molbev/msn117; Lake JA, 2007, MOL BIOL EVOL, V24, P130, DOI 10.1093/molbev/msl140; Lake JA, 2008, SYST BIOL, V57, P835, DOI 10.1080/10635150802555933; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Margulis L., 1993, SYMBIOSIS CELL EVOLU; MARGULIS L, GENOMES FLU IN PRESS; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Martin W, 2004, NATURE, V431, P134, DOI 10.1038/431134a; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; McInerney JO, 2007, SCIENCE, V318, P1390, DOI 10.1126/science.1151657; Ohno M, 2000, INT J SYST EVOL MICR, V50, P1829, DOI 10.1099/00207713-50-5-1829; Overmann J, 2002, ARCH MICROBIOL, V177, P201, DOI 10.1007/s00203-001-0377-z; Poole A, 1999, BIOESSAYS, V21, P880, DOI 10.1002/(SICI)1521-1878(199910)21:10<880::AID-BIES11>3.0.CO;2-P; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Servin JA, 2008, MOL BIOL EVOL, V25, P1, DOI 10.1093/molbev/msm249; Skophammer RG, 2007, MOL BIOL EVOL, V24, P1761, DOI 10.1093/molbev/msm096; Skophammer RG, 2006, MOL BIOL EVOL, V23, P1648, DOI 10.1093/molbev/msl046; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Stanier R., 1976, MICROBIAL WORLD; Syvanen M, 1998, HORIZONTAL GENE TRAN; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Ueda K, 2004, NUCLEIC ACIDS RES, V32, P4937, DOI 10.1093/nar/gkh830; Ventura GT, 2007, P NATL ACAD SCI USA, V104, P14260, DOI 10.1073/pnas.0610903104; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Wanner G, 2008, J BACTERIOL, V190, P3721, DOI 10.1128/JB.00027-08; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065	51	43	46	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					967	971		10.1038/nature08183	http://dx.doi.org/10.1038/nature08183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693078				2022-12-28	WOS:000269085500025
J	Goldbach-Mansky, R; Wilson, M; Fleischmann, R; Olsen, N; Silverfield, J; Kempf, P; Kivitz, A; Sherrer, Y; Pucino, F; Csako, G; Costello, R; Pham, TH; Snyder, C; van der Heijde, D; Tao, XL; Wesley, R; Lipsky, PE				Goldbach-Mansky, Raphaela; Wilson, Mildred; Fleischmann, Roy; Olsen, Nancy; Silverfield, Joel; Kempf, Phillip; Kivitz, Alan; Sherrer, Yvonne; Pucino, Frank; Csako, Gyorgy; Costello, Rene; Pham, Tuyet Hang; Snyder, Christopher; van der Heijde, Desiree; Tao, Xuelian; Wesley, Robert; Lipsky, Peter E.			Comparison of Tripterygium wilfordii Hook F Versus Sulfasalazine in the Treatment of Rheumatoid Arthritis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; NF-KAPPA-B; DOUBLE-BLIND; TRIPTOLIDE; DISEASE; METHOTREXATE; LEFLUNOMIDE; INHIBITOR; EFFICACY; EXTRACT	Background: Extracts of the medicinal plant Tripterygium wilfordii Hook F (TwHF) have been used in China for centuries to treat a spectrum of inflammatory diseases. Objective: To compare the benefits and side effects of TwHF extract with those of sulfasalazine for the treatment of active rheumatoid arthritis. Design: Randomized, controlled trial. A computer-generated code with random, permuted blocks was used to assign treatment. Setting: 2 U. S. academic centers (National Institutes of Health, Bethesda, Maryland, and University of Texas, Dallas, Texas) and 9 rheumatology subspecialty clinics (in Dallas and Austin, Texas; Tampa and Fort Lauderdale, Florida; Arlington, Virginia; Duncanville, Pennsylvania; Wheaton and Greenbelt, Maryland; and Lansing, Michigan). Patients: 121 patients with active rheumatoid arthritis and 6 or more painful and swollen joints. Intervention: TwHF extract, 60 mg 3 times daily, or sulfasalazine, 1 g twice daily. Patients could continue stable doses of oral prednisone or nonsteroidal anti-inflammatory drugs but had to stop taking disease-modifying antirheumatic drugs at least 28 days before randomization. Measurements: The primary outcome was the rate of achievement of 20% improvement in the American College of Rheumatology criteria (ACR 20) at 24 weeks. Secondary end points were safety; radiographic scores of joint damage; and serum levels of interleukin-6, cholesterol, cortisol, and adrenocorticotropic hormone. Results: Outcome data were available for only 62 patients at 24 weeks. In a mixed-model analysis that imputed data for patients who dropped out, 65.0% (95% CI, 51.6% to 76.9%) of the TwHF group and 32.8% (CI, 21.3% to 46.0%) of the sulfasalazine group met the ACR 20 response criteria (P = 0.001). Patients receiving TwHF also had significantly higher response rates for ACR 50 and ACR 70 in mixed-model analyses. Analyses of only completers showed similar significant differences between the treatment groups. Significant improvement was demonstrated in all individual components of the ACR response, including the Health Assessment Questionnaire disability score. Interleukin-6 levels rapidly and significantly decreased in the TwHF group. Although not statistically significant, radiographic progression was lower in the TwHF group. The frequency of adverse events was similar in both groups. Limitations: Only 62% and 41% of patients continued receiving TwHF extract and sulfasalazine, respectively, during the 24 weeks of the study. Long-term outcome data were not collected on participants who discontinued treatment. Conclusion: In patients who continued treatment for 24 weeks and could also use stable oral prednisone and nonsteroidal anti-inflammatory drugs, attainment of the ACR 20 response criteria was significantly greater with TwHF extract than with sulfasalazine.	[Goldbach-Mansky, Raphaela] NIAMSD, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Metroplex Clin Res Ctr, Dallas, TX USA; Tampa Med Grp, Tampa, FL USA; Arthrit Ctr, Ft Lauderdale, FL USA; Arthrit Clin No Virginia, Arlington, VA USA; Altoona Ctr Clin Res, Duncanville, PA USA; Leiden Univ, Med Ctr, Leiden, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Texas System; University of Texas Southwestern Medical Center Dallas; Metroplex Clinical Research Center; Altoona Center for Clinical Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Goldbach-Mansky, R (corresponding author), NIAMSD, NIH, US Dept Hlth & Human Serv, Bldg 10,Room 6D-47B,10 Ctr Dr, Bethesda, MD 20892 USA.	goldbacr@mail.nih.gov	Wilson, Jennifer/Q-3623-2019; van der Heijde, Désirée/I-6774-2019	van der Heijde, Désirée/0000-0002-5781-158X	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and Phytomedics	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and Phytomedics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	By the Intramural Research Program of the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and Phytomedics.	*AR CTR ED RES THE, QT DRUG LISTS; Bai JP, 2002, CONTRACEPTION, V65, P441, DOI 10.1016/S0010-7824(02)00312-8; Brinker AM, 2007, PHYTOCHEMISTRY, V68, P732, DOI 10.1016/j.phytochem.2006.11.029; Chen L, 2005, AM J CHINESE MED, V33, P945, DOI 10.1142/S0192415X05003521; Cohen S, 2001, ARTHRITIS RHEUM-US, V44, P1984, DOI 10.1002/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Donahue KE, 2008, ANN INTERN MED, V148, P124, DOI 10.7326/0003-4819-148-2-200801150-00192; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; GU C-X, 1989, Zhonghua Xinxueguanbing Zazhi, V17, P236; Gu J, 2001, J Tradit Chin Med, V21, P50; Ji SM, 2006, TRANSPL P, V38, P1274, DOI 10.1016/j.transproceed.2006.03.017; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; Lee KY, 1999, J BIOL CHEM, V274, P13451, DOI 10.1074/jbc.274.19.13451; Leuenroth SJ, 2007, P NATL ACAD SCI USA, V104, P4389, DOI 10.1073/pnas.0700499104; Li K, 1998, Se Pu, V16, P356; Liu H, 2000, ACTA PHARMACOL SIN, V21, P782; Lu H, 1999, TRANSPLANT P, V31, P2056, DOI 10.1016/S0041-1345(99)00262-6; Maetzel A, 2000, RHEUMATOLOGY, V39, P975, DOI 10.1093/rheumatology/39.9.975; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; O'Dell JR, 2004, NEW ENGL J MED, V350, P2591, DOI 10.1056/NEJMra040226; Proudman SM, 2000, ARTHRITIS RHEUM, V43, P1809, DOI 10.1002/1529-0131(200008)43:8<1809::AID-ANR17>3.0.CO;2-D; QIU D, 2003, HOOK F DRUG R D BACK, V4, P1; Qiu DM, 1999, J BIOL CHEM, V274, P13443, DOI 10.1074/jbc.274.19.13443; REDELMEIER DA, 1993, ARCH INTERN MED, V153, P1337, DOI 10.1001/archinte.153.11.1337; Ren J, 2007, DIGEST DIS SCI, V52, P1790, DOI 10.1007/s10620-007-9747-y; SCOTT DL, 1987, LANCET, V1, P1108; Seriolo B, 2006, ANN NY ACAD SCI, V1069, P414, DOI 10.1196/annals.1351.039; Sharp JT, 2000, ARTHRITIS RHEUM-US, V43, P495, DOI 10.1002/1529-0131(200003)43:3<495::AID-ANR4>3.0.CO;2-U; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smolen JS, 1999, LANCET, V353, P259, DOI 10.1016/S0140-6736(98)09403-3; Suarez-Almazor ME, 2000, COCHRANE DB SYST REV; Tao XL, 2002, ARTHRITIS RHEUM, V46, P1735, DOI 10.1002/art.10411; Tao XL, 1998, ARTHRITIS RHEUM-US, V41, P130, DOI 10.1002/1529-0131(199801)41:1<130::AID-ART16>3.3.CO;2-W; Tao XL, 2000, RHEUM DIS CLIN N AM, V26, P29, DOI 10.1016/S0889-857X(05)70118-6; Tao XL, 2001, J RHEUMATOL, V28, P2160; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P1063, DOI 10.1002/art.21655; van der Heijde D, 2000, J RHEUMATOL, V27, P261; Wang B, 2004, ARTHRITIS RHEUM-US, V50, P2995, DOI 10.1002/art.20459; Yen JH, 2006, BIOMED PHARMACOTHER, V60, P688, DOI 10.1016/j.biopha.2006.09.008; Zheng J R, 1987, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V9, P317	43	171	193	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2009	151	4					229	W51		10.7326/0003-4819-151-4-200908180-00005	http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484IW	19687490	Green Accepted			2022-12-28	WOS:000269038900002
J	Rosove, MH; Grody, WW				Rosove, Michael H.; Grody, Wayne W.			Should We Be Applying Warfarin Pharmacogenetics to Clinical Practice? No, Not Now	ANNALS OF INTERNAL MEDICINE			English	Article							COAGULATION-FACTOR; CYP2C9 GENOTYPE; BLEEDING RISK; VKORC1 GENE; ANTICOAGULATION; POLYMORPHISMS; RESISTANCE; ASSOCIATION; SENSITIVITY; THERAPY	The U. S. Food and Drug Administration modified warfarin labeling in 2007 to suggest, but not mandate, pharmacogenetic testing. Genetic analysis is now commercially available. However, results predict only one third of all dosing variation, the value of testing in reducing bleeding and thrombosis rates remains unproved, and cost-effectiveness is not established. Careful consideration of clinical factors that influence dosing, conscientious prothrombin time monitoring, and sage dosage adjustment remain paramount in warfarin management. Further study is required before routine warfarin pharmacogenetic testing can be recommended.	[Rosove, Michael H.; Grody, Wayne W.] Univ Calif Los Angeles, Los Angeles, CA USA	University of California System; University of California Los Angeles	Rosove, MH (corresponding author), 100 UCLA Med Plaza,Suite 550, Los Angeles, CA 90095 USA.	mrosove@mednet.ucla.edu						Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; *AM COLL CHEST PHY, 2008, CHEST, V133, pS160; Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; *COUM GEN INV, 2007, CIRCULATION, V116, P2563; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Eckman MH, 2009, ANN INTERN MED, V150, P73, DOI 10.7326/0003-4819-150-2-200901200-00005; Gage BF, 2008, J THROMB THROMBOLYS, V25, P45, DOI 10.1007/s11239-007-0104-y; Harrington DJ, 2005, THROMB HAEMOSTASIS, V93, P23, DOI 10.1160/TH04-08-0540; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Hillman MA, 2005, CLIN MED RES, V3, P137, DOI 10.3121/cmr.3.3.137; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Kangelaris KN, 2009, J GEN INTERN MED, V24, P656, DOI 10.1007/s11606-009-0949-1; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Krynetskiy E, 2007, J PHARMACOL EXP THER, V322, P427, DOI 10.1124/jpet.106.117952; Limdi N, 2008, CLIN PHARMACOL THER, V83, P312, DOI 10.1038/sj.clpt.6100290; Linder MW, 2001, CLIN CHIM ACTA, V308, P9, DOI 10.1016/S0009-8981(01)00420-X; Loebstein R, 2007, BLOOD, V109, P2477, DOI 10.1182/blood-2006-08-038984; Margaglione M, 2000, THROMB HAEMOSTASIS, V84, P775; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609; POLLACK A, 2008, NY TIMES        1230; Reitsma PH, 2005, PLOS MED, V2, P996, DOI 10.1371/journal.pmed.0020312; Rettie AE, 2006, BRIT J CLIN PHARMACO, V62, P617, DOI 10.1111/j.1365-2125.2006.02688.x; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Taube J, 2000, BLOOD, V96, P1816, DOI 10.1182/blood.V96.5.1816.h8001816_1816_1819; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; Wen MS, 2008, CLIN PHARMACOL THER, V84, P83, DOI 10.1038/sj.clpt.6100453	31	32	32	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2009	151	4					270	W95		10.7326/0003-4819-151-4-200908180-00009	http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484IW	19687493				2022-12-28	WOS:000269038900007
J	Sun, JCJ; Davidson, MJ; Lamy, A; Eikelboom, JW				Sun, Jack C. J.; Davidson, Michael J.; Lamy, Andre; Eikelboom, John W.			Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends	LANCET			English	Review							PERCUTANEOUS TRANSCATHETER IMPLANTATION; ORAL ANTICOAGULANT-THERAPY; MOLECULAR-WEIGHT HEPARIN; CALCIFIC AORTIC-STENOSIS; SINGLE-CENTER EXPERIENCE; RATIO SELF-MANAGEMENT; HIGH-RISK PATIENTS; MECHANICAL VALVE; FOLLOW-UP; TRANSESOPHAGEAL ECHOCARDIOGRAPHY	Over 4 million people worldwide have received a prosthetic heart valve, and an estimated 300000 valves are being implanted every year. Prosthetic heart valves improve quality of life and survival of patients with severe valvular heart disease, but the need for antithrombotic therapy to prevent thrombotic complications in valve recipients poses challenges for clinicians and patients. Here, we review antithrombotic therapies for patients with prosthetic heart valves and management of thromboembolic complications. Advances in antithrombotic therapy and valve technologies are likely to improve the management of patients with prosthetic heart valves in developed countries, but the most important unmet need and potential for benefit from these new therapies is in developing countries where a massive and rapidly increasing burden of valvular heart disease exists.	[Sun, Jack C. J.; Lamy, Andre] McMaster Univ, Div Cardiac Surg, Hamilton, ON, Canada; [Davidson, Michael J.] Harvard Univ, Sch Med, Div Cardiac Surg, Boston, MA USA; [Eikelboom, John W.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; Harvard University; Harvard Medical School; McMaster University	Sun, JCJ (corresponding author), Hamilton Gen Hosp, Div Cardiac Surg, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	sunjc2@mcmaster.ca	Eikelboom, John/AAG-6117-2019; LAMY, ANDRE/AAS-3855-2021	Eikelboom, John/0000-0003-4126-1285; 	Bristol-Myers Squibb; GlaxoSmithKline; Astra-Zeneca; Bayer; Bristol-Myers-Squibb; Eisai; Eli Lilly; Johnson Johnson; McNeil; Sanofi-Aventis	Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Astra-Zeneca(AstraZeneca); Bayer(Bayer AG); Bristol-Myers-Squibb(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); Eli Lilly(Eli Lilly); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); McNeil; Sanofi-Aventis(Sanofi-Aventis)	JCJS has received research funding from Bristol-Myers Squibb and GlaxoSmithKline. JWE has received honoraria and/or research support from Astra-Zeneca, Bayer, Bristol-Myers-Squibb, Eisai, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, McNeil, and Sanofi-Aventis. MJ D is a consultant for Edwards Life Sciences arid Medtronic Inc. AL declares that lie has no conflicts of interest.	Acar J, 1996, CIRCULATION, V94, P2107, DOI 10.1161/01.CIR.94.9.2107; Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Altman L. K., NY TIMES; *AM HEAT ASS, 2008, HEART DIS STROK STAT; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; [Anonymous], 2006, J AM COLL CARDIOL, V48, P598, DOI 10.1016/j.jacc.2006.05.030; Ansell J, 2005, INT J CARDIOL, V99, P37, DOI 10.1016/j.ijcard.2003.11.008; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Antunes MJ, 2004, J HEART VALVE DIS, V13, pS7; ANTUNES MJ, 1988, J THORAC CARDIOV SUR, V95, P980; Aramendi JI, 2005, EUR J CARDIO-THORAC, V27, P854, DOI 10.1016/j.ejcts.2004.12.064; Aramendi JL, 1998, J HEART VALVE DIS, V7, P610; Asopa Sanjay, 2006, Interact Cardiovasc Thorac Surg, V5, P761, DOI 10.1510/icvts.2006.143099; BAUDET EM, 1995, J THORAC CARDIOV SUR, V109, P858, DOI 10.1016/S0022-5223(95)70309-8; Baykut D, 2006, ANN THORAC SURG, V82, P847, DOI 10.1016/j.athoracsur.2006.04.042; Berkowitz SD, 2001, AM HEART J, V142, P7, DOI 10.1067/mhj.2001.116331; Bernet FH, 2007, J HEART VALVE DIS, V16, P151; Bharat V, 2003, J HEART VALVE DIS, V12, P362; Bhuvaneshwar GS, 1996, J HEART VALVE DIS, V5, P448; BJORK V O, 1969, Scandinavian Journal of Thoracic and Cardiovascular Surgery, V3, P1, DOI 10.3109/14017436909131912; BLAIR KL, 1994, CIRCULATION, V90, P214; Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Brueck M, 2007, EUR J CARDIO-THORAC, V32, P108, DOI 10.1016/j.ejcts.2007.03.031; Buchanan-Lee B, 2002, J HEART VALVE DIS, V11, P583; Bussey HI, 2004, J HEART VALVE DIS, V13, P319; Butany J, 2003, CARDIOVASC PATHOL, V12, P322, DOI 10.1016/S1054-8807(03)00105-4; Butany J, 2003, CARDIOVASC PATHOL, V12, P119, DOI 10.1016/S1054-8807(03)00002-4; Butchart EG, 2001, J THORAC CARDIOV SUR, V121, P1090, DOI 10.1067/mtc.2001.113754; Caceres-Loriga FM, 2006, INT J CARDIOL, V110, P1, DOI 10.1016/j.ijcard.2005.06.051; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Colli A, 2008, EUR J CARDIO-THORAC, V33, P531, DOI 10.1016/j.ejcts.2007.12.019; Colli A, 2007, J HEART VALVE DIS, V16, P667; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Connock M., 2007, HEALTH TECHNOL ASSES, V11, pix; Cribier A, 2004, J AM COLL CARDIOL, V43, P698, DOI 10.1016/j.jacc.2003.11.026; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Cribier A, 2006, J AM COLL CARDIOL, V47, P1214, DOI 10.1016/j.jacc.2006.01.049; DAVID TE, 1985, ANN THORAC SURG, V40, P229, DOI 10.1016/S0003-4975(10)60033-1; Descoutures F, 2008, EUR HEART J, V29, P1410, DOI 10.1093/eurheartj/ehn081; di Marco F, 2007, J THORAC CARDIOV SUR, V133, P1597, DOI 10.1016/j.jtcvs.2006.12.060; Douketis JD, 2008, CHEST, V133, p299S, DOI 10.1378/chest.08-0675; Dunning J, 2008, EUR J CARDIO-THORAC, V34, P73, DOI 10.1016/j.ejcts.2008.02.024; Durrleman N, 2004, J THORAC CARDIOV SUR, V127, P1388, DOI 10.1016/j.jtcvs.2003.12.013; Eitz T, 2008, ANN THORAC SURG, V85, P949, DOI 10.1016/j.athoracsur.2007.08.071; EMERY RW, 1979, CIRCULATION, V60, pI48; Fanikos J, 2004, AM J CARDIOL, V93, P247, DOI 10.1016/j.amjcard.2003.09.054; Fritzsche D, 2007, J HEART VALVE DIS, V16, P558; Gage BF, 2008, J THROMB THROMBOLYS, V25, P45, DOI 10.1007/s11239-007-0104-y; Gao GQ, 2004, J AM COLL CARDIOL, V44, P384, DOI 10.1016/j.jacc.2004.01.053; Ghanbari H, 2008, TRENDS CARDIOVAS MED, V18, P117, DOI 10.1016/j.tcm.2008.02.002; Gherli T, 2004, CIRCULATION, V110, P496, DOI 10.1161/01.CIR.0000137122.95108.52; Goldsmith I, 1998, J HEART VALVE DIS, V7, P574; Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047; Grube E, 2006, CIRCULATION, V114, P1616, DOI 10.1161/CIRCULATIONAHA.106.639450; Grunkemeier GL, 2000, CURR PROB CARDIOLOGY, V25, P78, DOI 10.1053/cd.2000.v25.a103682; Gupta D, 2000, AM HEART J, V140, P906, DOI 10.1067/mhj.2000.111109; Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2; Heneghan C, 2006, LANCET, V367, P404, DOI 10.1016/S0140-6736(06)68139-7; HERAS M, 1995, J AM COLL CARDIOL, V25, P1111, DOI 10.1016/0735-1097(94)00563-6; Hering D, 2005, CHEST, V127, P53, DOI 10.1378/chest.127.1.53; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Hillman MA, 2005, CLIN MED RES, V3, P137, DOI 10.3121/cmr.3.3.137; Hirsh J, 2005, BLOOD, V105, P453, DOI 10.1182/blood-2003-12-4195; Horstkotte D, 1993, J Heart Valve Dis, V2, P291; Horstkotte D, 1995, J Heart Valve Dis, V4, P114; Jamieson WRE, 2007, ANN THORAC SURG, V83, P549, DOI 10.1016/j.athoracsur.2006.07.041; Jamieson WRE, 1998, ANN THORAC SURG, V66, pS49, DOI 10.1016/S0003-4975(98)01127-8; JAMIESON WRE, 2006, SURG TECHNOLOGY INT, V15; KINSLEY RH, 1986, J THORAC CARDIOV SUR, V92, P349; Koertke H, 2005, ANN THORAC SURG, V79, P1909, DOI 10.1016/j.athoracsur.2004.09.012; Koertke H, 2000, J THROMB THROMBOLYS, V9, pS41; Koertke H, 2007, EUR HEART J, V28, P2479, DOI 10.1093/eurheartj/ehm391; Kulik A, 2006, ANN THORAC SURG, V81, P770, DOI 10.1016/j.athoracsur.2005.07.023; Kunadian B, 2007, ANN THORAC SURG, V84, P73, DOI 10.1016/j.athoracsur.2007.02.057; Laffort P, 2000, J AM COLL CARDIOL, V35, P739, DOI 10.1016/S0735-1097(99)00598-7; Larson RJ, 2004, J GEN INTERN MED, V19, P879, DOI 10.1111/j.1525-1497.2004.30419.x; Lengyel M, 2005, J HEART VALVE DIS, V14, P567; Little S.H., 2003, COCHRANE DB SYST REV, V4; Lund O, 2006, J THORAC CARDIOV SUR, V132, P20, DOI 10.1016/j.jtcvs.2006.01.043; Marchand M, 1998, J HEART VALVE DIS, V7, P292; McClain MR, 2008, GENET MED, V10, P89, DOI 10.1097/GIM.0b013e31815bf924; McNicholas KW, 2006, J HEART VALVE DIS, V15, P73; MCWILLIAM A, HLTH CARE SAVINGS PE; Moinuddeen K, 1998, CIRCULATION, V98, pII95; MOK CK, 1985, CIRCULATION, V72, P1059, DOI 10.1161/01.CIR.72.5.1059; Montalescot G, 2000, CIRCULATION, V101, P1083, DOI 10.1161/01.CIR.101.10.1083; Montorsi P, 2000, AM J CARDIOL, V85, P58, DOI 10.1016/S0002-9149(99)00607-4; Ngow H, 2008, XENOBIOTICA, V38, P641, DOI [10.1080/00498250801999087, 10.1080/00498250801999087 ]; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Ogendo SWO, 2000, E AFR MED J, V77, P354; Ozkan M, 2000, J AM COLL CARDIOL, V35, P1881, DOI 10.1016/S0735-1097(00)00654-9; Palatianos GM, 2007, ANN THORAC SURG, V83, P40, DOI 10.1016/j.athoracsur.2006.08.010; PASUPATI S, 2007, CAN J CARDIOL SC, V23, pC78; Pezzella A Thomas, 2002, Semin Thorac Cardiovasc Surg, V14, P298, DOI 10.1053/stcs.2002.0140298; Poirier NC, 1998, ANN THORAC SURG, V66, pS57, DOI 10.1016/S0003-4975(98)01110-2; Puvimanasinghe JPA, 2004, HEART, V90, P1172, DOI 10.1136/hrt.2003.013102; Rao S, 1990, Indian Heart J, V42, P335; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rinaldi CA, 2002, J HEART VALVE DIS, V11, P839; Roudaut R, 2003, EUR J CARDIO-THORAC, V24, P868, DOI 10.1016/S1010-7940(03)00568-2; Roudaut R, 2003, J AM COLL CARDIOL, V41, P653, DOI 10.1016/S0735-1097(02)02872-3; Salem DN, 2008, CHEST, V133, p593S, DOI 10.1378/chest.08-0724; Sankarkumar R, 2001, J HEART VALVE DIS, V10, P619; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; SPENCER FC, 1986, ANN SURG, V203, P691, DOI 10.1097/00000658-198606000-00015; STARR A, 1961, ANN SURG, V154, P726, DOI 10.1097/00000658-196110000-00017; Sundt TM, 2005, J THORAC CARDIOV SUR, V129, P1024, DOI 10.1016/j.jtcvs.2004.11.028; Svennevig JL, 2007, CIRCULATION, V116, P1795, DOI 10.1161/CIRCULATIONAHA.106.677773; Svensson LG, 2008, ANN THORAC SURG, V86, P46, DOI 10.1016/j.athoracsur.2008.04.049; Talwar Sachin, 2004, Indian Heart J, V56, P225; THORBURN CW, 1983, AM J CARDIOL, V51, P1128, DOI 10.1016/0002-9149(83)90357-0; Tong AT, 2004, J AM COLL CARDIOL, V43, P77, DOI 10.1016/j.jacc.2003.08.028; Tossios P, 2007, J HEART VALVE DIS, V16, P551; TURPIE AGG, 1993, NEW ENGL J MED, V329, P524, DOI 10.1056/NEJM199308193290802; TURPIE AGG, 1988, LANCET, V1, P1242; Turpie AGG, 2008, EUR HEART J, V29, P155, DOI 10.1093/eurheartj/ehm575; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; Walther T, 2008, EUR J CARDIO-THORAC, V33, P983, DOI 10.1016/j.ejcts.2008.01.046; Walther T, 2008, CURR OPIN CARDIOL, V23, P111, DOI 10.1097/HCO.0b013e3282f47c1b; Walther T, 2007, CIRCULATION, V116, pI240, DOI 10.1161/CIRCULATIONAHA.106.677237; Webb JG, 2006, CIRCULATION, V113, P842, DOI 10.1161/CIRCULATIONAHA.105.582882; Webb JG, 2007, CIRCULATION, V116, P755, DOI 10.1161/CIRCULATIONAHA.107.698258; Williams MA, 2006, J HEART VALVE DIS, V15, P80; Williams MA, 2004, J CARDIAC SURG, V19, P410, DOI 10.1111/j.0886-0440.2004.04084.x; Yacoub N, 2005, NAT CLIN PRACT CARD, V2, P60, DOI 10.1038/ncpcardio0112; Yoganathan AP, 2004, ANNU REV BIOMED ENG, V6, P331, DOI 10.1146/annurev.bioeng.6.040803.140111; Zilla P, 2008, BIOMATERIALS, V29, P385, DOI 10.1016/j.biomaterials.2007.09.033; 2007, STJUDE MED      0709	132	156	166	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					565	576		10.1016/S0140-6736(09)60780-7	http://dx.doi.org/10.1016/S0140-6736(09)60780-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683642				2022-12-28	WOS:000269019400024
J	Veigel, C; Schmidt, CF				Veigel, Claudia; Schmidt, Christoph F.			Friction in Motor Proteins	SCIENCE			English	Editorial Material							MOTION; ORIGIN		[Veigel, Claudia] Natl Inst Med Res, London NW7 1AA, England; [Schmidt, Christoph F.] Univ Gottingen, Fak Phys, D-37077 Gottingen, Germany	MRC National Institute for Medical Research; University of Gottingen	Veigel, C (corresponding author), Natl Inst Med Res, The Ridgeway,Mill Hill, London NW7 1AA, England.	cfs@physik3.gwdg.de	Schmidt, Christoph F/G-3787-2011	Schmidt, Christoph F/0000-0003-2864-6973				Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Dudko OK, 2003, P NATL ACAD SCI USA, V100, P11378, DOI 10.1073/pnas.1534554100; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J., 2001, MECH MOTOR PROTEINS; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Landau L.D, 2013, STAT PHYS; Reif F., 1965, FUNDAMENTALS STAT TH; Suda H, 2001, LANGMUIR, V17, P6045, DOI 10.1021/la0106384; TAWADA K, 1991, J THEOR BIOL, V150, P193, DOI 10.1016/S0022-5193(05)80331-5; THOMPSON PA, 1990, SCIENCE, V250, P792, DOI 10.1126/science.250.4982.792; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750	13	10	10	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					826	827		10.1126/science.1178017	http://dx.doi.org/10.1126/science.1178017			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679804				2022-12-28	WOS:000269242400033
J	Mangtani, P; Mak, TK; Pfeifer, D				Mangtani, Punam; Mak, Tippi K.; Pfeifer, Dina			Pandemic H1N1 infection in pregnant women in the USA	LANCET			English	Editorial Material									[Mangtani, Punam] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England; [Mak, Tippi K.] Swiss Agcy Therapeut Prod, Vigilance Unit, Safety Med Div, Bern, Switzerland; [Pfeifer, Dina] WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Mangtani, P (corresponding author), London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England.	Punam.Mangtani@lshtm.ac.uk		Mangtani, Punam/0000-0001-7074-2999				Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; *ADV COMM IMM PRAC, 2009, NOV H1N1 VACC REC; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; *MIN HLTH, 1960, REP CONF ENQ MAT DEA; Tanaka T, 2009, CAN MED ASSOC J, V181, P55, DOI 10.1503/cmaj.090866; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P16; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P305; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P301; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	12	34	44	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 8	2009	374	9688					429	430		10.1016/S0140-6736(09)61431-8	http://dx.doi.org/10.1016/S0140-6736(09)61431-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482OK	19665629				2022-12-28	WOS:000268898400004
J	Liu, ZY; Habener, JF				Liu, Zhengyu; Habener, Joel F.			Alpha Cells Beget Beta Cells	CELL			English	Editorial Material							PANCREAS; DIFFERENTIATION; GENE; MICE	Understanding the origins of insulin-producing beta cells of the pancreas could lead to new treatments for diabetes. Collombat et al. ( 2009) now show that in response to injury, a population of pancreatic progenitor cells can give rise to glucagon-expressing alpha cells that then transdifferentiate into beta cells.	[Liu, Zhengyu; Habener, Joel F.] Massachusetts Gen Hosp, Mol Endocrinol Lab, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Liu, ZY (corresponding author), Massachusetts Gen Hosp, Mol Endocrinol Lab, Boston, MA 02114 USA.	zliu4@partners.org; jhabener@partners.org						Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dufrane D, 2009, XENOTRANSPLANTATION, V16, P152, DOI 10.1111/j.1399-3089.2009.00530.x; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Vuguin PM, 2006, ENDOCRINOLOGY, V147, P3995, DOI 10.1210/en.2005-1410; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	9	15	17	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 7	2009	138	3					424	426		10.1016/j.cell.2009.07.022	http://dx.doi.org/10.1016/j.cell.2009.07.022			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665963	Bronze			2022-12-28	WOS:000268771900005
J	Shimono, Y; Zabala, M; Cho, RW; Lobo, N; Dalerba, P; Qian, DL; Diehn, M; Liu, HP; Panula, SP; Chiao, E; Dirbas, FM; Somlo, G; Pera, RAR; Lao, KQ; Clarke, MF				Shimono, Yohei; Zabala, Maider; Cho, Robert W.; Lobo, Neethan; Dalerba, Piero; Qian, Dalong; Diehn, Maximilian; Liu, Huiping; Panula, Sarita P.; Chiao, Eric; Dirbas, Frederick M.; Somlo, George; Pera, Renee A. Reijo; Lao, Kaiqin; Clarke, Michael F.			Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells	CELL			English	Article							SELF-RENEWAL; MESENCHYMAL TRANSITION; MIR-200 FAMILY; HUMAN TUMORS; EXPRESSION; DICER; IDENTIFICATION; PROLIFERATION; SIGNATURE; MICRORNAS	Human breast tumors contain a breast cancer stem cell (BCSC) population with properties reminiscent of normal stem cells. We found 37 microRNAs that were differentially expressed between human BCSCs and nontumorigenic cancer cells. Three clusters, miR-200c-141, miR-200b-200a-429, and miR-18396-182 were downregulated in human BCSCs, normal human and murine mammary stem/progenitor cells, and embryonal carcinoma cells. Expression of BMI1, a known regulator of stem cell self-renewal, was modulated by miR-200c. miR-200c inhibited the clonal expansion of breast cancer cells and suppressed the growth of embryonal carcinoma cells in vitro. Most importantly, miR-200c strongly suppressed the ability of normal mammary stem cells to form mammary ducts and tumor formation driven by human BCSCs in vivo. The coordinated downregulation of three microRNA clusters and the similar functional regulation of clonal expansion by miR-200c provide a molecular link that connects BCSCs with normal stem cells.	[Shimono, Yohei; Zabala, Maider; Cho, Robert W.; Lobo, Neethan; Dalerba, Piero; Qian, Dalong; Diehn, Maximilian; Liu, Huiping; Panula, Sarita P.; Chiao, Eric; Pera, Renee A. Reijo; Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA; [Dirbas, Frederick M.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Somlo, George] City Hope Canc Ctr, Duarte, CA 91010 USA; [Lao, Kaiqin] Appl Biosyst Inc, Foster City, CA 94404 USA	Stanford University; Stanford University; City of Hope; Thermo Fisher Scientific; Applied Biosystems	Clarke, MF (corresponding author), Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	mfclarke@stanford.edu	Dalerba, Piero/E-2543-2018	Dalerba, Piero/0000-0002-8815-4981; Liu, Huiping/0000-0003-4822-7995; Diehn, Maximilian/0000-0003-2032-0581; Shimono, Yohei/0000-0002-6256-4704	California Breast Cancer Research Program of the University of California [12FB-0053]; Fundacion Alfonso Martin Escudero; Fulbright; NIH [CA100225, CA104987, CA126524, CA139490]; Breast Cancer Research Foundation; Morton Family Foundation; Ludwig Foundation; NATIONAL CANCER INSTITUTE [R01CA100225, R01CA104987, P01CA139490, U54CA126524] Funding Source: NIH RePORTER	California Breast Cancer Research Program of the University of California; Fundacion Alfonso Martin Escudero; Fulbright; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Morton Family Foundation; Ludwig Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Andy Fire for helpful discussions and advice. We thank Jessica S. Lam for technical assistance. This work was supported by the California Breast Cancer Research Program of the University of California #12FB-0053 to Y. S., by the Fundacion Alfonso Martin Escudero and the Fulbright to M. Z., and by the grants from the NIH (NIH CA100225, CA104987, CA126524, CA139490), the Breast Cancer Research Foundation, the Morton Family Foundation, and the Ludwig Foundation to M. F. C. Also, M. F. C. is a consultant for Oncomed Pharmaceuticals, which is developing therapeutics against cancer stem cells.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fialkow P J, 1976, Birth Defects Orig Artic Ser, V12, P123; FIALKOW PJ, 1990, VERH DEUT G, V74, P43; FIALKOW PJ, 1976, BIOCHIM BIOPHYS ACTA, V458, P283, DOI 10.1016/0304-419X(76)90003-2; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morrison SJ, 2002, J IMMUNOL, V168, P635, DOI 10.4049/jimmunol.168.2.635; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tang FC, 2006, NAT PROTOC, V1, P1154, DOI 10.1038/nprot.2006.161; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; WU AM, 1968, J EXP MED, V127, P455, DOI 10.1084/jem.127.3.455; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	52	951	1003	1	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					592	603		10.1016/j.cell.2009.07.011	http://dx.doi.org/10.1016/j.cell.2009.07.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665978	Green Accepted, Bronze			2022-12-28	WOS:000268771900022
J	Roberts, L; Stone, R; Sugden, A				Roberts, Leslie; Stone, Richard; Sugden, Andrew			The Rise of Restoration Ecology INTRODUCTION	SCIENCE			English	Editorial Material																			0	49	54	5	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					555	555		10.1126/science.325_555	http://dx.doi.org/10.1126/science.325_555			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644102				2022-12-28	WOS:000268493000030
J	Flum, DR; Belle, SH; King, WC; Wahed, AS; Berk, P; Chapman, W; Pories, W; Courcoulas, A; McCloskey, C; Mitchell, J; Patterson, E; Pomp, A; Staten, MA; Yanovski, SZ; Thirlby, R; Wolfe, B				Flum, David Reed; Belle, Steven H.; King, Wendy C.; Wahed, Abdus S.; Berk, Paul; Chapman, William; Pories, Walter; Courcoulas, Anita; McCloskey, Carol; Mitchell, James; Patterson, Emma; Pomp, Alfons; Staten, Myrlene A.; Yanovski, Susan Z.; Thirlby, Richard; Wolfe, Bruce		LABS Consortium	Perioperative Safety in the Longitudinal Assessment of Bariatric Surgery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY RISK SCORE; Y GASTRIC BYPASS; MULTIVARIATE-ANALYSIS; OBESITY	Background: To improve decision making in the treatment of extreme obesity, the risks of bariatric surgical procedures require further characterization. Methods: We performed a prospective, multicenter, observational study of 30-day outcomes in consecutive patients undergoing bariatric surgical procedures at 10 clinical sites in the United States from 2005 through 2007. A composite end point of 30-day major adverse outcomes (including death; venous thromboembolism; percutaneous, endoscopic, or operative reintervention; and failure to be discharged from the hospital) was evaluated among patients undergoing first-time bariatric surgery. Results: There were 4776 patients who had a first-time bariatric procedure (mean age, 44.5 years; 21.1% men; 10.9% nonwhite; median body-mass index [the weight in kilograms divided by the square of the height in meters], 46.5). More than half had at least two coexisting conditions. A Roux-en-Y gastric bypass was performed in 3412 patients (with 87.2% of the procedures performed laparoscopically), and laparoscopic adjustable gastric banding was performed in 1198 patients; 166 patients underwent other procedures and were not included in the analysis. The 30-day rate of death among patients who underwent a Roux-en-Y gastric bypass or laparoscopic adjustable gastric banding was 0.3%; a total of 4.3% of patients had at least one major adverse outcome. A history of deep-vein thrombosis or pulmonary embolus, a diagnosis of obstructive sleep apnea, and impaired functional status were each independently associated with an increased risk of the composite end point. Extreme values of body-mass index were significantly associated with an increased risk of the composite end point, whereas age, sex, race, ethnic group, and other coexisting conditions were not. Conclusions: The overall risk of death and other adverse outcomes after bariatric surgery was low and varied considerably according to patient characteristics. In helping patients make appropriate choices, short-term safety should be considered in conjunction with both the long-term effects of bariatric surgery and the risks associated with being extremely obese. (ClinicalTrials.gov number, NCT00433810.) N Engl J Med 2009;361:445-54.	[Flum, David Reed] Univ Washington, Surg Outcomes Res Ctr, Dept Surg, Seattle, WA 98195 USA; [Belle, Steven H.; King, Wendy C.; Wahed, Abdus S.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Berk, Paul] Columbia Univ, Med Ctr, New York, NY USA; [Chapman, William; Pories, Walter] E Carolina Univ, Brody Sch Med, Greenville, NC USA; [Courcoulas, Anita; McCloskey, Carol] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Mitchell, James] Neuropsychiat Res Inst, Fargo, ND USA; [Patterson, Emma] Legacy Good Samaritan Hosp, Portland, OR USA; [Pomp, Alfons] Cornell Univ, Med Ctr, New York, NY 10021 USA; [Staten, Myrlene A.; Yanovski, Susan Z.] NIDDK, Bethesda, MD USA; [Thirlby, Richard] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Wolfe, Bruce] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; University of North Carolina; East Carolina University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Neuropsychiatric Research Institute; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Virginia Mason Medical Center; Oregon Health & Science University	Flum, DR (corresponding author), Univ Washington, Surg Outcomes Res Ctr, Dept Surg, Box 356410, Seattle, WA 98195 USA.	sorce@u.washington.edu	Flum, David/GPX-7976-2022; King, Wendy C/AAC-5122-2022	King, Wendy C/0000-0002-0740-0029; Wahed, Abdus/0000-0001-6911-7221	National Institute of Diabetes and Digestive and Kidney Diseases [U01-DK066557, U01-DK66667, U01-DK66568, M01-RR-00037, U01-DK66471, U01-DK66526, U01-DK66585, U01-DK66555]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066667, U01DK066471, U01DK066585, U01DK066568, U01DK066555, U01DK066557, U01DK066526] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK066557, to the Data Coordinating Center; U01-DK66667, to Columbia University; U01-DK66568, to the University of Washington, in collaboration with General Clinical Research Center grant M01-RR-00037; U01-DK66471, to the Neuropsychiatric Research Institute; U01DK66526, to East Carolina University; U01-DK66585, to the University of Pittsburgh Medical Center; and U01-DK66555, to Oregon Health and Science University).	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Belle SH, 2007, SURG OBES RELAT DIS, V3, P116, DOI 10.1016/j.soard.2007.01.006; Buchwald H, 2005, JAMA-J AM MED ASSOC, V293, P1728; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buffington CK, 2006, OBES SURG, V16, P159, DOI 10.1381/096089206775565258; DeMaria EJ, 2007, SURG OBES RELAT DIS, V3, P134, DOI 10.1016/j.soard.2007.01.005; DeMaria EJ, 2007, ANN SURG, V246, P578, DOI 10.1097/SLA.0b013e318157206e; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Fernandez AZ, 2004, ANN SURG, V239, P698, DOI 10.1097/01.sla.0000124295.41578.ab; Flancbaum L, 2007, J GASTROINTEST SURG, V11, P500, DOI 10.1007/s11605-007-0117-z; Flum DR, 2007, JAMA-J AM MED ASSOC, V298, P1442, DOI 10.1001/jama.298.12.1442; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; King WC, 2008, SURG OBES RELAT DIS, V4, P721, DOI [10.1016/j.soard.2008.08.022, 10.1016/j.soard.2007.12.002]; Livingston EH, 2006, ARCH SURG-CHICAGO, V141, P1115, DOI 10.1001/archsurg.141.11.1115; Lutfi R, 2006, SURG ENDOSC, V20, P864, DOI 10.1007/s00464-005-0115-8; Parikh Manish, 2006, Surg Obes Relat Dis, V2, P607, DOI 10.1016/j.soard.2006.08.012; Perry CD, 2008, ANN SURG, V247, P21, DOI 10.1097/SLA.0b013e318142cb4b; Pope GD, 2002, J GASTROINTEST SURG, V6, P855, DOI 10.1016/S1091-255X(02)00085-9; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Zingmond DS, 2005, JAMA-J AM MED ASSOC, V294, P1918, DOI 10.1001/jama.294.15.1918	22	990	1011	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					445	454		10.1056/NEJMoa0901836	http://dx.doi.org/10.1056/NEJMoa0901836			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LW	19641201	Bronze, Green Accepted			2022-12-28	WOS:000268443900005
J	Khazeni, N; Bravata, DM; Holty, JEC; Uyeki, TM; Stave, CD; Gould, MK				Khazeni, Nayer; Bravata, Dena M.; Holty, Jon-Erik C.; Uyeki, Timothy M.; Stave, Christopher D.; Gould, Michael K.			Systematic Review: Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza	ANNALS OF INTERNAL MEDICINE			English	Review							LONG-TERM USE; IMMUNE-RESPONSE; PATIENT COMPLIANCE; INHALED ZANAMIVIR; VACCINE; OSELTAMIVIR; SURVEILLANCE; TRANSMISSION; VIRUSES; PROPHYLAXIS	Background: Neuraminidase inhibitors (NAIs) are stockpiled internationally for extended use in an influenza pandemic. Purpose: To evaluate the safety and efficacy of extended-duration (>4 weeks) NAI chemoprophylaxis against influenza. Data Sources: Studies published in any language through 11 June 2009 identified by searching 10 electronic databases and 3 trial registries. Study Selection: Randomized, placebo-controlled, double-blind human trials of extended-duration NAI chemoprophylaxis that reported outcomes of laboratory-confirmed influenza or adverse events. Data Extraction: 2 reviewers independently assessed study quality and abstracted information from eligible studies. Data Synthesis: Of 1876 potentially relevant citations, 7 trials involving 7021 unique participants met inclusion criteria. Data were pooled by using random-effects models. Chemoprophylaxis with NAIs decreased the frequency of symptomatic influenza (relative risk [RR], 0.26 [95% CI, 0.18 to 0.37]; risk difference [RD], -3.9 percentage points [CI, -5.8 to -1.9 percentage points]) but not asymptomatic influenza (RR, 1.03 [CI, 0.81 to 1.30]; RD, -0.4 percentage point [CI, -1.6 to 0.9 percentage point]). Adverse effects were not increased overall among NAI recipients (RR, 1.01 [CI, 0.94 to 1.08]; RD, 0.1 percentage point [CI, -0.2 to 0.4 percentage point]), but nausea and vomiting were more common among those who took oseltamivir (RR, 1.48 [CI, 1.86 to 2.33]; RD, 1.7 percentage points [CI, 0.6 to 2.9 percentage points]). Prevention of influenza did not statistically significantly differ between zanamivir and oseltamivir. Limitations: All trials were industry-sponsored. No study was powered to detect rare adverse events, and none included diverse racial groups, children, immunocompromised patients, or individuals who received live attenuated influenza virus vaccine. Conclusion: Extended-duration zanamivir and oseltamivir chemoprophylaxis seems to be highly efficacious for preventing symptomatic influenza among immunocompetent white and Japanese adults. Extended-duration oseltamivir is associated with increased nausea and vomiting. Safety and efficacy in several subpopulations that might receive extended-duration influenza chemoprophylaxis are unknown.	[Khazeni, Nayer] Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Ctr Hlth Policy, Stanford, CA 94305 USA; Stanford Sleep Disorders Ctr, Ctr Primary Care & Outcomes Res, Stanford, CA USA; Lane Med Lib, Stanford, CA USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khazeni, N (corresponding author), Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Ctr Hlth Policy, 300 Pasteur Dr,H3143, Stanford, CA 94305 USA.		Stave, Christopher/P-1919-2018	Stave, Christopher/0000-0001-8232-3994	Agency for Healthcare Research and Quality [1 F32 HS018003-01A1]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS018003] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (1 F32 HS018003-01A1, Dr. Khazeni) and resources and the use of facilities at the Veterans Affairs Palo Alto Health Care System (Dr. Gould).	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Bentley JP, 2004, J MED ETHICS, V30, P293, DOI 10.1136/jme.2002.001594; Bernstein E, 1999, VACCINE, V17, P82, DOI 10.1016/S0264-410X(98)00117-0; Brammer L., 2009, Morbidity and Mortality Weekly Report, V58, P115; *CDCP, 1996, FLU ACT SURV; *CDCP ACIP, 2003, AM FAM PHYSICIAN, V68, P2275; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Chik K. W., 2004, Hong Kong Medical Journal, V10, P103; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Counsell C, 1997, ANN INTERN MED, V127, P380, DOI 10.7326/0003-4819-127-5-199709010-00008; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Diggory P, 2001, BRIT MED J, V322, P577, DOI 10.1136/bmj.322.7286.577; Duchini A, 2001, LIVER TRANSPLANT, V7, P311, DOI 10.1053/jlts.2001.23010; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fleming DM, 2006, PEDIATR INFECT DIS J, V25, P860, DOI 10.1097/01.inf.0000237797.14283.cf; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; *GLAXOSMITHKLINE P, 2008, REL; Hatakeyama Shuji, 2006, Nihon Rinsho, V64, P1845; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; HAYNES RB, 1987, CONTROL CLIN TRIALS, V8, P12, DOI 10.1016/0197-2456(87)90021-3; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HURT AC, 2007, LANCET, V369, P1056; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kashiwagi S, 2000, Kansenshogaku Zasshi, V74, P1062; Kawado M, 2007, J EPIDEMIOL, V17, pS32, DOI 10.2188/jea.17.S32; Kimball P, 2000, TRANSPLANTATION, V69, P2449, DOI 10.1097/00007890-200006150-00042; Lackenby A, 2008, EURO SURVEILL, V13; LaForce C, 2007, CLIN THER, V29, P1579, DOI 10.1016/j.clinthera.2007.08.023; Lee C, 2000, INFECT CONT HOSP EP, V21, P700, DOI 10.1086/501727; LEWIS JA, 1981, TRENDS PHARMACOL SCI, V2, P93, DOI 10.1016/0165-6147(81)90275-3; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Mazzone PJ, 2001, EUR RESPIR J, V18, P971, DOI 10.1183/09031936.01.00215201; Meade MO, 1997, ANN INTERN MED, V127, P531, DOI 10.7326/0003-4819-127-7-199710010-00005; *MEDWATCH, 1996, CLIN IMP ADV DRUG RE; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; MONTO AS, 1995, ANTIMICROB AGENTS CH, V39, P2224, DOI 10.1128/AAC.39.10.2224; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; *NAT CTR HIV EP CL, 2009, PIPET B; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Parker R, 2001, Can Commun Dis Rep, V27, P37; Patrozou E, 2009, PUBLIC HEALTH REP, V124, P193, DOI 10.1177/003335490912400205; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; ROAN S, 2009, LOS ANGELES TIM 0429; *ROCH, 2009, STUD TAM OS SEAS PRO; *ROCH PHARM, 2008, TAM; Rungrotmongkol T, 2009, BIOCHEM BIOPH RES CO, V385, P390, DOI 10.1016/j.bbrc.2009.05.066; RUSSELL S, 2009, SAN FRANCISCO C 1115; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; STERNBERG S, 2009, US TODAY        0302; *US DEP HHS, 2009, PAND FLU PLAN; *US DEP HHS, COMM STRAT PAND INFL; VANDERSTICHELE R, 1991, EUR J CLIN PHARMACOL, V41, P27, DOI 10.1007/BF00280102; Webster A, 1999, CLIN PHARMACOKINET, V36, P51, DOI 10.2165/00003088-199936001-00006; WHO, 2009, 1 WHO; *WHO, 2009, INFLUENZA A H1N1 VIR; *WHO, 2009, GLOB AL RESP EPR PAN; *WHO, 2009, 211 WHO; *WHO, 2006, SCIENCE, V312, P382; *WHO RAP ADV GUID, 2007, LANCET INFECT DIS, V7, P21; Wright PF, 2008, NEW ENGL J MED, V358, P2540, DOI 10.1056/NEJMp0803650; 2009, WKLY EPIDEMIOL REC, V84, P65; 2009, CANADIAN PRESS  0420; 2009, MEDICAL NEWS TO 0130	72	37	38	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2009	151	7					464	W159		10.7326/0003-4819-151-7-200910060-00143	http://dx.doi.org/10.7326/0003-4819-151-7-200910060-00143			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502OT	19652173				2022-12-28	WOS:000270470500004
J	Dawes, A; Flisher, AJ				Dawes, Andrew; Flisher, Alan J.			Children's mental health in Afghanistan	LANCET			English	Editorial Material							RESILIENCE		[Flisher, Alan J.] Univ Cape Town, Div Child & Adolescent Psychiat, Red Cross War Mem Childrens Hosp, ZA-7925 Rondebosch, Western Cape, South Africa; [Flisher, Alan J.] Univ Cape Town, Adolescent Hlth Res Unit, Red Cross War Mem Childrens Hosp, ZA-7925 Rondebosch, Western Cape, South Africa; [Dawes, Andrew] Univ Oxford, Dept Social Policy & Social Work, Oxford, England; [Dawes, Andrew] Univ Cape Town, Dept Psychol, ZA-7700 Rondebosch, Western Cape, South Africa	University of Cape Town; University of Cape Town; University of Oxford; University of Cape Town	Flisher, AJ (corresponding author), Univ Cape Town, Div Child & Adolescent Psychiat, Red Cross War Mem Childrens Hosp, ZA-7925 Rondebosch, Western Cape, South Africa.	alan.flisher@uct.ac.za						Betancourt TS, 2008, INT REV PSYCHIATR, V20, P317, DOI 10.1080/09540260802090363; Cairns E., 1996, CHILDREN POLITICAL V; DAWES A, 1998, PEACE CONFLICT J PEA, V4, P335, DOI DOI 10.1207/S15327949PAC0404_3; de Berry Joanna., 2008, YEARS CONFLICT ADOLE, P209; Dybdahl R, 2001, CHILD DEV, V72, P1214, DOI 10.1111/1467-8624.00343; Freud A, 1943, WAR CHILDREN; Garbarino J, 1996, CHILD DEV, V67, P33, DOI 10.1111/j.1467-8624.1996.tb01717.x; GARBARINO J, 1991, NO PLACE BE CHILD GR; Kostelny K., 2006, WORLD TURNED UPSIDE, P19; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Panter-Brick C, 2009, LANCET, V374, P807, DOI 10.1016/S0140-6736(09)61080-1; Punamaki R. L, 2000, HLTH HAZARDS ORG VIO, V2, P29; Triplehorn C., 2006, WORLD TURNED UPSIDE, P223	13	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2009	374	9692					766	767		10.1016/S0140-6736(09)61501-4	http://dx.doi.org/10.1016/S0140-6736(09)61501-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492QU	19699515				2022-12-28	WOS:000269675000008
J	Hong, H; Takahashi, K; Ichisaka, T; Aoi, T; Kanagawa, O; Nakagawa, M; Okita, K; Yamanaka, S				Hong, Hyenjong; Takahashi, Kazutoshi; Ichisaka, Tomoko; Aoi, Takashi; Kanagawa, Osami; Nakagawa, Masato; Okita, Keisuke; Yamanaka, Shinya			Suppression of induced pluripotent stem cell generation by the p53-p21 pathway	NATURE			English	Article							SOMATIC-CELLS; MOUSE; P53; FIBROBLASTS; MYC	Induced pluripotent stem(iPS) cells can be generated from somatic cells by the introduction of Oct3/4 ( also known as Pou5f1), Sox2, Klf4 and c-Myc, in mouse(1-4) and in human(5-8). The efficiency of this process, however, is low(9). Pluripotency can be induced without c-Myc, but with even lower efficiency(10,11). A p53 (also known as TP53 in humans and Trp53 in mice) short-interfering RNA (siRNA) was recently shown to promote human iPS cell generation(12), but the specificity and mechanisms remain to be determined. Here we report that up to 10% of transduced mouse embryonic fibroblasts lacking p53 became iPS cells, even without the Myc retrovirus. The p53 deletion also promoted the induction of integration-free mouse iPS cells with plasmid transfection. Furthermore, in the p53-null background, iPS cells were generated from terminally differentiated T lymphocytes. The suppression of p53 also increased the efficiency of human iPS cell generation. DNA microarray analyses identified 34 p53-regulated genes that are common in mouse and human fibroblasts. Functional analyses of these genes demonstrate that the p53-p21 pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation.	[Hong, Hyenjong; Takahashi, Kazutoshi; Ichisaka, Tomoko; Aoi, Takashi; Nakagawa, Masato; Okita, Keisuke; Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Hong, Hyenjong; Nakagawa, Masato; Yamanaka, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama 3320012, Japan; [Kanagawa, Osami] RIKEN Yokohama Inst, RIKEN Ctr Allergy & Immunol, Lab Autoimmune Regulat, Tsurumi Ku, Kanagawa 2300045, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); RIKEN; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020; Jeong, Wonjun/AAM-5937-2020	Takahashi, Kazutoshi/0000-0002-5329-8395; Okita, Keisuke/0000-0001-5806-1090	Leading Project of MEXT; JSPS and MEXT; Program for Promotion of Fundamental Studies in Health Sciences of NIBIO; Japanese Government ( MEXT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100406] Funding Source: NIH RePORTER	Leading Project of MEXT; JSPS and MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of NIBIO(National Institute of Biomedical Innovation); Japanese Government ( MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Srivastava for critical reading of the manuscript; M. Narita, A. Okada, N. Takizawa, H. Miyachi and S. Kitano for technical assistance; and R. Kato, S. Takeshima, Y. Ohtsu and E. Nishikawa for administrative assistance. We also thank Y. Sasai and T. Tada for technical advices, T. Kitamura for Plat- E cells and pMXs retroviral vectors, R. Farese for RF8 ES cells, and B. Weinberg and W. Hahn for shRNA constructs. This study was supported in part by a grant from the Leading Project of MEXT, Grants-in-Aid for Scientific Research of JSPS and MEXT, and a grant from the Program for Promotion of Fundamental Studies in Health Sciences of NIBIO ( to S. Y.). H. H. is a research student under the Japanese Government ( MEXT).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bowman T, 1996, GENE DEV, V10, P826, DOI 10.1101/gad.10.7.826; Cecchinelli B, 2006, CELL DEATH DIFFER, V13, P1994, DOI 10.1038/sj.cdd.4401933; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	23	980	1056	5	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1132	U95		10.1038/nature08235	http://dx.doi.org/10.1038/nature08235			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19668191	Green Accepted, Green Submitted			2022-12-28	WOS:000269314000039
J	Califf, RM				Califf, Robert M.		Global Collaborative Cardiovasc Re	Key issues for global cardiovascular medicine	LANCET			English	Editorial Material									[Califf, Robert M.; Global Collaborative Cardiovasc Re] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27710 USA	Duke University	Califf, RM (corresponding author), Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27710 USA.	robert.califf@duke.edu						Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Mark DB, 2007, EUR HEART J, V28, P2678, DOI 10.1093/eurheartj/ehm411; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205	3	5	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 15	2009	374	9689					508	510		10.1016/S0140-6736(09)61470-7	http://dx.doi.org/10.1016/S0140-6736(09)61470-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484BX	19683629				2022-12-28	WOS:000269019400007
J	Degenhardt, T; Rybakova, KN; Tomaszewska, A; Mone, MJ; Westerhoff, HV; Bruggeman, FJ; Carlberg, C				Degenhardt, Tatjana; Rybakova, Katja N.; Tomaszewska, Aleksandra; Mone, Martijn J.; Westerhoff, Hans V.; Bruggeman, Frank J.; Carlberg, Carsten			RETRACTED: Population-Level Transcription Cycles Derive from Stochastic Timing of Single-Cell Transcription (Retracted article. See vol. 143, pg. 651, 2010)	CELL			English	Article; Retracted Publication							GENE-EXPRESSION; IN-VIVO; ORDERED RECRUITMENT; NUCLEAR RECEPTORS; CHROMATIN; COACTIVATOR; DYNAMICS; OSCILLATIONS; COMPLEX; ACTIVATION	Eukaryotic transcription is a dynamic process relying on a large number of proteins. By measuring the cycling expression of the pyruvate dehydrogenase kinase 4 gene in human cells, we constructed a detailed stochastic model for single-gene transcription at the molecular level using realistic kinetics for diffusion and protein complex dynamics. We observed that gene induction caused an approximate 60 min periodicity of several transcription related processes: first, the covalent histone modifications and presence of many regulatory proteins at the transcription start site; second, RNA polymerase II activity; third, chromatin loop formation; and fourth, mRNA accumulation. Our model can predict the precise timing of single-gene activity leading to transcriptional cycling on the cell population level when we take into account the sequential and irreversible multistep nature of transcriptional initiation. We propose that the cyclic nature of population gene expression is primarily based on the intrinsic periodicity of the transcription process itself.	[Degenhardt, Tatjana; Tomaszewska, Aleksandra; Carlberg, Carsten] Univ Kuopio, Dept Biosci, FIN-70211 Kuopio, Finland; [Rybakova, Katja N.; Mone, Martijn J.; Westerhoff, Hans V.; Bruggeman, Frank J.] Vrije Univ Amsterdam, Inst Mol Cell Biol, NL-1081 HV Amsterdam, Netherlands; [Tomaszewska, Aleksandra; Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, L-1511 Luxembourg, Luxembourg; [Westerhoff, Hans V.] Univ Manchester, Manchester Ctr Integrat Syst Biol, Manchester Interdisciplinary Bioctr, Manchester M1 7ND, Lancs, England; [Bruggeman, Frank J.] Ctr Math & Comp Sci, Netherlands Inst Syst Biol Multiscale Modelling &, NL-1098 SJ Amsterdam, Netherlands	University of Eastern Finland; Vrije Universiteit Amsterdam; University of Luxembourg; University of Manchester	Carlberg, C (corresponding author), Univ Kuopio, Dept Biosci, FIN-70211 Kuopio, Finland.	carsten.carlberg@uni.lu	Bruggeman, Frank/AAS-8371-2020; Westerhoff, Hans/I-5762-2012	Bruggeman, Frank/0000-0002-0255-4766; Westerhoff, Hans/0000-0002-0443-6114	European Union (Marie Curie RTN NucSys); University of Luxembourg; Academy of Finland; Juselius Foundation	European Union (Marie Curie RTN NucSys)(European Commission); University of Luxembourg; Academy of Finland(Academy of Finland); Juselius Foundation	We would like to thank M. Hiltunen, A. Hallama, and Dr. J. Bouwman for technical assistance and M. Dobrzynski for discussions. Grants from the European Union (Marie Curie RTN NucSys), the University of Luxembourg, the Academy of Finland, and the Juselius Foundation supported this research.	Antonson P, 2003, MOL CELL BIOL, V23, P1260, DOI 10.1128/MCB.23.4.1260-1268.2003; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Berk AJ, 1999, CURR OPIN CELL BIOL, V11, P330, DOI 10.1016/S0955-0674(99)80045-3; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; CARLBERG C, 1995, EUR J BIOCHEM, V231, P517, DOI 10.1111/j.1432-1033.1995.0517d.x; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Degenhardt T, 2007, J MOL BIOL, V372, P341, DOI 10.1016/j.jmb.2007.06.091; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; Feldman I, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.033; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Guenther MG, 2000, GENE DEV, V14, P1048; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; Lemaire V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198102; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mone MJ, 2004, P NATL ACAD SCI USA, V101, P15933, DOI 10.1073/pnas.0403664101; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Reid G, 2009, INT J BIOCHEM CELL B, V41, P155, DOI 10.1016/j.biocel.2008.08.028; Richard P, 1996, YEAST, V12, P731; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Sun L, 2008, BIOCHEM BIOPH RES CO, V371, P912, DOI 10.1016/j.bbrc.2008.03.112; Sun L, 2008, BIOCHEM BIOPH RES CO, V371, P900, DOI 10.1016/j.bbrc.2008.03.114; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; WOLFFE AP, 1994, CURR OPIN GENET DEV, V4, P245, DOI 10.1016/S0959-437X(05)80051-6; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116	44	38	38	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					489	501		10.1016/j.cell.2009.05.029	http://dx.doi.org/10.1016/j.cell.2009.05.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665971	Bronze			2022-12-28	WOS:000268771900014
J	Snyder, CF; Aaronson, NK				Snyder, Claire F.; Aaronson, Neil K.			Use of patient-reported outcomes in clinical practice	LANCET			English	Editorial Material							QUALITY-OF-LIFE; COMMUNICATION		[Snyder, Claire F.] Johns Hopkins Sch Med, Baltimore, MD 21205 USA; [Aaronson, Neil K.] Netherlands Canc Inst, Amsterdam, Netherlands	Johns Hopkins University; Johns Hopkins Medicine; Netherlands Cancer Institute	Snyder, CF (corresponding author), Johns Hopkins Sch Med, Baltimore, MD 21205 USA.	csnyder@jhsph.edu	Aaronson, Neil K/AAV-8194-2021					BRUNDAGE MD, 2006, 13 ANN C INT SOC QUA, pA2; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; Donaldson GW, 2009, QUAL LIFE RES, V18, P137, DOI 10.1007/s11136-008-9439-x; FAYERS PM, 2009, QUAL LIFE RES, V18, P1315; Feldman-Stewart D, 2009, QUAL LIFE RES, V18, P109, DOI 10.1007/s11136-008-9417-3; Fung CH, 2008, QUAL LIFE RES, V17, P1297, DOI 10.1007/s11136-008-9379-5; Greenhalgh J, 2009, QUAL LIFE RES, V18, P115, DOI 10.1007/s11136-008-9430-6; Lohr K, 2009, QUAL LIFE RES, V18, P99, DOI 10.1007/s11136-008-9413-7; Rose M, 2009, QUAL LIFE RES, V18, P125, DOI 10.1007/s11136-008-9436-0; Velikova G, 2004, J CLIN ONCOL, V22, P714, DOI 10.1200/JCO.2004.06.078	10	126	128	2	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2009	374	9687					369	370		10.1016/S0140-6736(09)61400-8	http://dx.doi.org/10.1016/S0140-6736(09)61400-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481MJ	19647598				2022-12-28	WOS:000268815200009
J	Choi, J; Jeong, HK; Snyder, MA; Stoeger, JA; Masel, RI; Tsapatsis, M				Choi, Jungkyu; Jeong, Hae-Kwon; Snyder, Mark A.; Stoeger, Jared A.; Masel, Richard I.; Tsapatsis, Michael			Grain Boundary Defect Elimination in a Zeolite Membrane by Rapid Thermal Processing	SCIENCE			English	Article							ORIENTED MFI MEMBRANES; SEEDED GROWTH; SEPARATION; XYLENE; PERMEATION; REACTORS; FILMS; GAS	Microporous molecular sieve catalysts and adsorbents discriminate molecules on the basis of size and shape. Interest in molecular sieve films stems from their potential for energy-efficient membrane separations. However, grain boundary defects, formed in response to stresses induced by heat treatment, compromise their selectivity by creating nonselective transport pathways for permeating molecules. We show that rapid thermal processing can improve the separation performance of thick columnar films of a certain zeolite (silicalite-1) by eliminating grain boundary defects, possibly by strengthening grain bonding at the grain boundaries. This methodology enables the preparation of silicalite-1 membranes with high separation performance for aromatic and linear versus branched hydrocarbon isomers and holds promise for realizing high-throughput and scalable production of these zeolite membranes with improved energy efficiency.	[Choi, Jungkyu; Stoeger, Jared A.; Tsapatsis, Michael] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Jeong, Hae-Kwon] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA; [Snyder, Mark A.] Lehigh Univ, Dept Chem Engn, Bethlehem, PA 18015 USA; [Masel, Richard I.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA	University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Lehigh University; University of Illinois System; University of Illinois Urbana-Champaign	Tsapatsis, M (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 151 Amundson Hall,421 Washington Ave SE, Minneapolis, MN 55455 USA.	tsapatsi@cems.umn.edu	Tsapatsis, Michael/AAA-2527-2019; Choi, Jungkyu/J-1854-2015; Masel, Richard I/E-1957-2011	Masel, Richard I/0000-0002-7392-6299	NSF [CBET-05 22518]; National Nanotechnology Infrastructure Network	NSF(National Science Foundation (NSF)); National Nanotechnology Infrastructure Network	Funding for this work was provided by NSF (CBET-05 22518). All the characterizations were performed at the Minnesota Characterization Facility, which receives support from the NSF through the National Nanotechnology Infrastructure Network (NNIN).	Baerlocher C., 2007, ATLAS ZEOLITE FRAMEW; Bonilla G, 2001, J MEMBRANE SCI, V182, P103, DOI 10.1016/S0376-7388(00)00549-4; Calzaferri G, 2008, CHEM-EUR J, V14, P7442, DOI 10.1002/chem.200800811; Caro J, 2008, MICROPOR MESOPOR MAT, V115, P215, DOI 10.1016/j.micromeso.2008.03.008; Carreon MA, 2008, J AM CHEM SOC, V130, P5412, DOI 10.1021/ja801294f; Choi J, 2006, ADSORPTION, V12, P339, DOI 10.1007/s10450-006-0564-y; Coronas J, 2004, TOP CATAL, V29, P29, DOI 10.1023/B:TOCA.0000024926.42080.a7; Dalmon JA, 2007, APPL CATAL A-GEN, V325, P198, DOI 10.1016/j.apcata.2007.03.024; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Dong JH, 2000, MICROPOR MESOPOR MAT, V34, P241, DOI 10.1016/S1387-1811(99)00175-4; Gouzinis A, 1998, CHEM MATER, V10, P2497, DOI 10.1021/cm9802402; Gu XH, 2006, J MEMBRANE SCI, V280, P624, DOI 10.1016/j.memsci.2006.02.020; Gualtieri ML, 2007, J MEMBRANE SCI, V290, P95, DOI 10.1016/j.memsci.2006.12.018; Hedlund J, 2002, MICROPOR MESOPOR MAT, V52, P179, DOI 10.1016/S1387-1811(02)00316-5; Jeong HK, 2005, MICROPOR MESOPOR MAT, V84, P332, DOI 10.1016/j.micromeso.2005.05.043; Kondo M, 1997, J MEMBRANE SCI, V133, P133, DOI 10.1016/S0376-7388(97)00087-2; Lai ZP, 2004, IND ENG CHEM RES, V43, P3000, DOI 10.1021/ie034096s; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; Lee JS, 2006, ANGEW CHEM INT EDIT, V45, P5288, DOI 10.1002/anie.200600075; Li ZJ, 2006, ANGEW CHEM INT EDIT, V45, P6329, DOI 10.1002/anie.200602036; Miachon S, 2007, J MEMBRANE SCI, V298, P71, DOI 10.1016/j.memsci.2007.04.008; Mintova S, 2001, MICROPOR MESOPOR MAT, V50, P159, DOI 10.1016/S1387-1811(01)00443-7; Nishiyama N, 2001, SEP PURIF TECHNOL, V22-3, P295, DOI 10.1016/S1383-5866(00)00152-0; Nomura M, 1997, IND ENG CHEM RES, V36, P4217, DOI 10.1021/ie970338a; Snyder MA, 2007, ANGEW CHEM INT EDIT, V46, P7560, DOI 10.1002/anie.200604910; Tarditi AM, 2008, CATAL LETT, V123, P7, DOI 10.1007/s10562-008-9442-4; Tarditi AM, 2008, SEP PURIF TECHNOL, V61, P136, DOI 10.1016/j.seppur.2007.10.008; Xomeritakis G, 2001, IND ENG CHEM RES, V40, P544, DOI 10.1021/ie000613k; Yan YS, 1997, J MEMBRANE SCI, V123, P95, DOI 10.1016/S0376-7388(96)00206-2	29	235	253	8	316	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					590	593		10.1126/science.1176095	http://dx.doi.org/10.1126/science.1176095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644115				2022-12-28	WOS:000268493000044
J	Nestle, FO; Kaplan, DH; Barker, J				Nestle, Frank O.; Kaplan, Daniel H.; Barker, Jonathan			Mechanisms of Disease: Psoriasis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; ENDOTHELIAL GROWTH-FACTOR; DENDRITIC CELLS; DOUBLE-BLIND; T-CELLS; SUSCEPTIBILITY LOCUS; SKIN INFLAMMATION; CYTOKINE NETWORK; PLAQUE PSORIASIS; PATHOGENIC ROLE		[Nestle, Frank O.; Barker, Jonathan] Kings Coll London, St Johns Inst Dermatol, Natl Inst Hlth Res Biomed Res Ctr, Cutaneous Med Theme & Federat Clin Immunol Soc Ct, London WC2R 2LS, England; [Nestle, Frank O.; Barker, Jonathan] St Thomas Fdn Trust, London, England; [Kaplan, Daniel H.] Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA	University of London; King's College London; University of Minnesota System; University of Minnesota Twin Cities	Nestle, FO (corresponding author), Guys Hosp, St Johns Inst Dermatol, Fl 9,Guys Tower Wing,Great Maze Pond, London SE1 9RT, England.	frank.nestle@kcl.ac.uk	Kaplan, Daniel H/N-2779-2013	Kaplan, Daniel H/0000-0002-7851-7320; Barker, Jonathan/0000-0002-9030-183X	Wellcome Trust Programme [GR078173MA]; National Institutes of Health [RO1AR040065]; National Institute for Health Research Comprehensive Biomedical Research Centre Guy's; St. Thomas' Hospital and King's College London; Medical Research Council United Kingdom Programme [G0601387]; Societe Italiana di Dermatologia Medica e Chirurgica e Malattie Sessualmente; Dunhill Medical Trust; MRC [G0601387] Funding Source: UKRI; Medical Research Council [G0601387] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040065, R01AR056632] Funding Source: NIH RePORTER	Wellcome Trust Programme(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research Comprehensive Biomedical Research Centre Guy's(National Institute for Health Research (NIHR)); St. Thomas' Hospital and King's College London; Medical Research Council United Kingdom Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Societe Italiana di Dermatologia Medica e Chirurgica e Malattie Sessualmente; Dunhill Medical Trust(Dunhill Medical Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by grants from the Wellcome Trust Programme (GR078173MA), the National Institutes of Health (RO1AR040065), the National Institute for Health Research Comprehensive Biomedical Research Centre Guy's and St. Thomas' Hospital and King's College London, and the Medical Research Council United Kingdom Programme (G0601387); a fellowship award from Societe Italiana di Dermatologia Medica e Chirurgica e Malattie Sessualmente; and the Dunhill Medical Trust.	Allen MH, 1999, LANCET, V353, P1589, DOI 10.1016/S0140-6736(99)01618-9; Allen MH, 2005, J INVEST DERMATOL, V124, P103, DOI 10.1111/j.0022-202X.2004.23511.x; ASADULLAH K, 2004, ALLERGY, V3, P185; Asumalahti K, 2003, J INVEST DERMATOL, V120, P627, DOI 10.1046/j.1523-1747.2003.12094.x; Asumalahti K, 2001, HUM MOL GENET, V10, P301; Asumalahti K, 2000, HUM MOL GENET, V9, P1533, DOI 10.1093/hmg/9.10.1533; Bateman T., 1836, PRACTICAL SYNOPSIS C; Boehncke WH, 2007, CLIN DERMATOL, V25, P596, DOI 10.1016/j.clindermatol.2007.08.014; BOS JD, 1983, ARCH DERMATOL RES, V275, P181, DOI 10.1007/BF00510050; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P826, DOI 10.1038/nri1734; Boyman O, 2007, TRENDS IMMUNOL, V28, P51, DOI 10.1016/j.it.2006.12.005; BRAUNFALCO O, 1970, ARCH KLIN EXP DERM, V238, P292, DOI 10.1007/BF00529328; Buchau AS, 2007, CLIN DERMATOL, V25, P616, DOI 10.1016/j.clindermatol.2007.08.016; Capon F, 2002, J INVEST DERMATOL, V118, P745, DOI 10.1046/j.1523-1747.2002.01749.x; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chang M, 2008, GENES IMMUN, V9, P176, DOI 10.1038/sj.gene.6364451; Christensen TE, 2006, J INVEST DERMATOL, V126, P2397, DOI 10.1038/sj.jid.5700489; Christophers E, 2001, CLIN EXP DERMATOL, V26, P314, DOI 10.1046/j.1365-2230.2001.00832.x; Collamer AN, 2008, ARTHRIT RHEUM-ARTHR, V59, P996, DOI 10.1002/art.23835; Conrad C, 2007, NAT MED, V13, P836, DOI 10.1038/nm1605; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; EEDY DJ, 1990, BRIT MED J, V300, P908, DOI 10.1136/bmj.300.6729.908; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; FARBER EM, 1974, DERMATOLOGICA, V148, P1, DOI 10.1159/000251595; FUNK J, 1991, BRIT J DERMATOL, V125, P463, DOI 10.1111/j.1365-2133.1991.tb14774.x; GARDEMBASPAIN M, 1990, ARCH DERMATOL, V126, P1523, DOI 10.1001/archderm.1990.01670350139033; Gelfand JM, 2004, J AM ACAD DERMATOL, V51, P704, DOI 10.1016/j.jaad.2004.04.014; Gelfand JM, 2006, J INVEST DERMATOL, V126, P2194, DOI 10.1038/sj.jid.5700410; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gisondi P, 2007, BRIT J DERMATOL, V157, P68, DOI 10.1111/j.1365-2133.2007.07986.x; Gladman DD, 2008, J RHEUMATOL, V35, P1458; Gottlieb A, 2009, LANCET, V373, P1340; Gottlieb A, 2009, LANCET, V373, P633, DOI 10.1016/S0140-6736(09)60140-9; Granstein RD, 2001, NEW ENGL J MED, V345, P284, DOI 10.1056/NEJM200107263450410; GRIFFITHS CEM, 1986, BRIT MED J, V293, P731, DOI 10.1136/bmj.293.6549.731; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Gudjonsson JE, 2007, J INVEST DERMATOL, V127, P1292, DOI 10.1038/sj.jid.5700807; Haider AS, 2008, J INVEST DERMATOL, V128, P606, DOI 10.1038/sj.jid.5701067; Haider AS, 2008, J IMMUNOL, V180, P1913, DOI 10.4049/jimmunol.180.3.1913; Halin C, 2008, AM J PATHOL, V173, P265, DOI 10.2353/ajpath.2008.071074; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Horn EJ, 2007, J AM ACAD DERMATOL, V57, P963, DOI 10.1016/j.jaad.2007.07.023; Huffmeier U, 2006, J MED GENET, V43, P517, DOI 10.1136/jmg.2005.037515; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Kupper TS, 2003, NEW ENGL J MED, V349, P1987, DOI 10.1056/NEJMp038164; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Leonardi CL, 2008, LANCET, V371, P1838; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Li YH, 2009, J INVEST DERMATOL, V129, P629, DOI 10.1038/jid.2008.297; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x; MENSSEN A, 1995, J IMMUNOL, V155, P4078; Mrowietz U, 2006, ARCH DERMATOL RES, V298, P309, DOI 10.1007/s00403-006-0707-8; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Nestle FO, 2005, E SCHERING RES FDN W, V50, P203; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; NESTLE FO, 1994, DERMATOL CLIN, V12, P271, DOI 10.1016/S0733-8635(18)30174-8; NESTLE FO, 1994, J CLIN INVEST, V94, P202, DOI 10.1172/JCI117308; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nickoloff BJ, 1999, J CLIN INVEST, V104, P1161, DOI 10.1172/JCI8633; NICKOLOFF BJ, 1991, ARCH DERMATOL, V127, P871, DOI 10.1001/archderm.127.6.871; Nijsten T, 2005, J AM ACAD DERMATOL, V52, P434, DOI 10.1016/j.jaad.2004.10.862; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; PRINZ J, 1991, LANCET, V338, P320, DOI 10.1016/0140-6736(91)90464-Z; Rahman P, 2008, ARTHRITIS RHEUM-US, V58, P1020, DOI 10.1002/art.23389; Rahman P, 2009, J RHEUMATOL, V36, P137, DOI 10.3899/jrheum.080458; Ravindran V, 2008, ANN RHEUM DIS, V67, P855, DOI 10.1136/ard.2007.072652; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Schon MP, 2008, EXP DERMATOL, V17, P703, DOI 10.1111/j.1600-0625.2008.00751.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Smith RL, 2008, BRIT J DERMATOL, V158, P962, DOI 10.1111/j.1365-2133.2008.08482.x; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Sterry W, 2004, BRIT J DERMATOL, V151, P3, DOI 10.1111/j.1365-2133.2004.06070.x; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Tsunemi Y, 2002, J DERMATOL SCI, V30, P161, DOI 10.1016/S0923-1811(02)00072-5; UYEMURA K, 1993, J INVEST DERMATOL, V101, P701, DOI 10.1111/1523-1747.ep12371679; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wang HL, 2008, J CLIN INVEST, V118, P2629, DOI 10.1172/JCI34916; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Wolf N, 2008, J MED GENET, V45, P114, DOI 10.1136/jmg.2007.053595; Yao Y., 2009, PLOS ONE, V4; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Young HS, 2006, J INVEST DERMATOL, V126, P453, DOI 10.1038/sj.jid.5700096; Zaba LC, 2008, J EXP MED, V205, P1941, DOI 10.1084/jem.20071094071408c; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	105	2027	2119	17	409	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					496	509		10.1056/NEJMra0804595	http://dx.doi.org/10.1056/NEJMra0804595			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LW	19641206				2022-12-28	WOS:000268443900010
J	Fukuoka, S; Saka, N; Koga, H; Ono, K; Shimizu, T; Ebana, K; Hayashi, N; Takahashi, A; Hirochika, H; Okuno, K; Yano, M				Fukuoka, Shuichi; Saka, Norikuni; Koga, Hironori; Ono, Kazuko; Shimizu, Takehiko; Ebana, Kaworu; Hayashi, Nagao; Takahashi, Akira; Hirochika, Hirohiko; Okuno, Kazutoshi; Yano, Masahiro			Loss of Function of a Proline-Containing Protein Confers Durable Disease Resistance in Rice	SCIENCE			English	Article							FIELD-RESISTANCE; GENE; TRANSPORTER; PATHOGENS; DOMAINS; BINDING; BLAST; WHEAT	Blast disease is a devastating fungal disease of rice, one of the world's staple foods. Race-specific resistance to blast disease has usually not been durable. Here, we report the cloning of a previously unknown type of gene that confers non-race-specific resistance and its successful use in breeding. Pi21 encodes a proline-rich protein that includes a putative heavy metal-binding domain and putative protein-protein interaction motifs. Wild-type Pi21 appears to slow the plant's defense responses, which may support optimization of defense mechanisms. Deletions in its proline-rich motif inhibit this slowing. Pi21 is separable from a closely linked gene conferring poor flavor. The resistant pi21 allele, which is found in some strains of japonica rice, could improve blast resistance of rice worldwide.	[Fukuoka, Shuichi; Ono, Kazuko; Ebana, Kaworu; Yano, Masahiro] Natl Inst Agrobiol Sci, QTL Genom Res Ctr, Tsukuba, Ibaraki 3058602, Japan; [Saka, Norikuni] Aichi Agr Res Ctr, Mountainous Region Agr Res Inst, Aichi 4412513, Japan; [Koga, Hironori] Ishikawa Prefectural Univ, Nonoichi, Ishikawa 9218836, Japan; [Shimizu, Takehiko] Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; [Hayashi, Nagao; Takahashi, Akira] Natl Inst Agrobiol Sci, Div Plant Sci, Tsukuba, Ibaraki 3058602, Japan; [Hirochika, Hirohiko] Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki 3058602, Japan; [Okuno, Kazutoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	National Institute of Agrobiological Sciences - Japan; Ishikawa Prefecture University; National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; University of Tsukuba	Fukuoka, S (corresponding author), Natl Inst Agrobiol Sci, QTL Genom Res Ctr, Kannondai 2-1-2, Tsukuba, Ibaraki 3058602, Japan.	fukusan@affrc.go.jp	Hayashi, Nagao/AAE-8295-2020; Yano, Masahiro/AAC-5441-2019; Okuno, Kazutoshi/AAQ-9507-2021	Yano, Masahiro/0000-0003-1510-4622	Ministry of Agriculture, Forestry and Fisheries of Japan [MP1103b, MP1132, QT4004, GB1004, QTL2002, RGB1101]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (MP1103b, MP1132, QT4004, GB1004, QTL2002, and RGB1101).	Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; EZUKA A, 1972, Review of Plant Protection Research, V5, P1; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fukuoka S, 2001, THEOR APPL GENET, V103, P185, DOI 10.1007/s001220100611; JOHNSON R, 1984, ANNU REV PHYTOPATHOL, V22, P309, DOI 10.1146/annurev.py.22.090184.001521; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Koga H, 2004, PHYSIOL MOL PLANT P, V64, P67, DOI 10.1016/j.pmpp.2004.07.002; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Liu GS, 2007, J CELL SCI, V120, P596, DOI 10.1242/jcs.001362; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; PARLEVLIET JE, 1979, ANNU REV PHYTOPATHOL, V17, P203, DOI 10.1146/annurev.py.17.090179.001223; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Saka N, 2006, PLANT PROD SCI, V9, P3, DOI 10.1626/pps.9.3; Shi JS, 1996, P NATL ACAD SCI USA, V93, P6014, DOI 10.1073/pnas.93.12.6014; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372	19	411	500	9	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					998	1001		10.1126/science.1175550	http://dx.doi.org/10.1126/science.1175550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696351				2022-12-28	WOS:000269242800047
J	Kamionkowski, M				Kamionkowski, Marc			ASTROPHYSICS Gravity ripples chased	NATURE			English	Editorial Material									CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Kamionkowski, M (corresponding author), CALTECH, Pasadena, CA 91125 USA.	kamion@tapir.caltech.edu		Kamionkowski, Marc/0000-0001-7018-2055				Abbott BP, 2009, NATURE, V460, P990, DOI 10.1038/nature08278; Allen B., 1996, HOUCHES SCH PHYS AST, P373; Smith TL, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.021301	3	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					964	965		10.1038/460964a	http://dx.doi.org/10.1038/460964a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693077				2022-12-28	WOS:000269085500024
J	Krumholz, HM; Wang, Y; Chen, J; Drye, EE; Spertus, JA; Ross, JS; Curtis, JP; Nallamothu, BK; Lichtman, JH; Havranek, EP; Masoudi, FA; Radford, MJ; Han, LF; Rapp, MT; Straube, BM; Normand, SLT				Krumholz, Harlan M.; Wang, Yun; Chen, Jersey; Drye, Elizabeth E.; Spertus, John A.; Ross, Joseph S.; Curtis, Jeptha P.; Nallamothu, Brahmajee K.; Lichtman, Judith H.; Havranek, Edward P.; Masoudi, Frederick A.; Radford, Martha J.; Han, Lein F.; Rapp, Michael T.; Straube, Barry M.; Normand, Sharon-Lise T.			Reduction in Acute Myocardial Infarction Mortality in the United States Risk-Standardized Mortality Rates From 1995-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; NATIONAL REGISTRY; HOSPITAL MORTALITY; TRENDS; MEDICARE; IMPROVEMENT; ELEVATION; COMMUNITY; OUTCOMES; PROGRAM	Context During the last 2 decades, health care professional, consumer, and payer organizations have sought to improve outcomes for patients hospitalized with acute myocardial infarction (AMI). However, little has been reported about improvements in hospital short-term mortality rates or reductions in between-hospital variation in short-term mortality rates. Objective To estimate hospital-level 30-day risk-standardized mortality rates (RSMRs) for patients discharged with AMI. Design, Setting, and Patients Observational study using administrative data and a validated risk model to evaluate 3 195 672 discharges in 2 755 370 patients discharged from nonfederal acute care hospitals in the United States between January 1, 1995, and December 31, 2006. Patients were 65 years or older (mean, 78 years) and had at least a 12-month history of fee-for-service enrollment prior to the index hospitalization. Patients discharged alive within 1 day of an admission not against medical advice were excluded, because it is unlikely that these patients had sustained an AMI. Main Outcome Measure Hospital-specific 30-day all-cause RSMR. Results At the patient level, the odds of dying within 30 days of admission if treated at a hospital 1 SD above the national average relative to that if treated at a hospital 1 SD below the national average were 1.63 (95% CI, 1.60-1.65) in 1995 and 1.56 (95% CI, 1.53-1.60) in 2006. In terms of hospital-specific RSMRs, a decrease from 18.8% in 1995 to 15.8% in 2006 was observed (odds ratio, 0.76; 95% CI, 0.75-0.77). A reduction in between-hospital heterogeneity in the RSMRs was also observed: the coefficient of variation decreased from 11.2% in 1995 to 10.8%, the interquartile range from 2.8% to 2.1%, and the between-hospital variance from 4.4% to 2.9%. Conclusion Between 1995 and 2006, the risk-standardized hospital mortality rate for Medicare patients discharged with AMI showed a significant decrease, as did between-hospital variation. JAMA. 2009;302(7):767-773	[Krumholz, Harlan M.; Wang, Yun; Chen, Jersey; Drye, Elizabeth E.; Curtis, Jeptha P.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Hlth Policy & Adm, Sch Publ Hlth, New Haven, CT 06510 USA; [Lichtman, Judith H.] Yale Univ, Sch Med, Sect Chron Dis Epidemiol, Sch Publ Hlth, New Haven, CT 06510 USA; [Krumholz, Harlan M.; Wang, Yun] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Spertus, John A.] Univ Missouri Kansas City, Sch Med, Kansas City, MO USA; [Spertus, John A.] Mid Amer Heart Inst, Kansas City, MO USA; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA; [Ross, Joseph S.] James J Peters VA Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA; [Ross, Joseph S.] Hlth Serv Res Enhancement Award Program, Bronx, NY USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor VA Med Ctr, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Div Cardiovasc Dis, Dept Internal Med, Ann Arbor, MI USA; [Havranek, Edward P.; Masoudi, Frederick A.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Havranek, Edward P.; Masoudi, Frederick A.] Denver Hlth Med Ctr, Denver, CO USA; [Radford, Martha J.] NYU, Sch Med, New York, NY USA; [Han, Lein F.; Rapp, Michael T.; Straube, Barry M.] Ctr Medicare, Baltimore, MD USA; [Han, Lein F.; Rapp, Michael T.; Straube, Barry M.] Ctr Medicaid Serv, Baltimore, MD USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Yale University; Yale University; Yale University; Yale University; Yale University; University of Missouri System; University of Missouri Kansas City; Saint Luke's Mid America Heart Institute; Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Denver Health Medical Center; New York University; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	Masoudi, Frederick/Q-7467-2019; Spertus, John/ABD-3075-2021; , Harlan/AAI-2875-2020	Normand, Sharon-Lise/0000-0001-7027-4769; Ross, Joseph/0000-0002-9218-3320; Radford, Martha/0000-0001-7503-9557	Centers for Medicare & Medicaid Services (CMS); US Department of Health and Human Services;  [HHSM-500-2005-CO001C]; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Centers for Medicare & Medicaid Services (CMS); US Department of Health and Human Services; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The analyses on which this article is based were performed under contract HHSM-500-2005-CO001C, "Utilization and Quality Control Quality Improvement Organization for the State (commonwealth) of Colorado," funded by the Centers for Medicare & Medicaid Services (CMS), an agency of the US Department of Health and Human Services.	Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Gunnar R M, 1990, Circulation, V82, P664; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; KRUMHOLZ HM, 1995, CIRCULATION, V92, P2841, DOI 10.1161/01.CIR.92.10.2841; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lewis WR, 2008, ARCH INTERN MED, V168, P1813, DOI 10.1001/archinte.168.16.1813; Masoudi FA, 2006, CIRCULATION, V114, P2806, DOI 10.1161/CIRCULATIONAHA.106.611707; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Myerson M, 2009, CIRCULATION, V119, P503, DOI 10.1161/CIRCULATIONAHA.107.693879; Peterson ED, 2008, AM HEART J, V156, P1045, DOI 10.1016/j.ahj.2008.07.028; Roger VL, 2006, CIRCULATION, V114, P790, DOI 10.1161/CIRCULATIONAHA.106.627505; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Shah Rahman, 2006, Crit Pathw Cardiol, V5, P160, DOI 10.1097/01.hpc.0000234779.87257.ad	21	205	211	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					767	773		10.1001/jama.2009.1178	http://dx.doi.org/10.1001/jama.2009.1178			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690309	Green Accepted, Bronze			2022-12-28	WOS:000269073800025
J	Sumner, SA; Layde, PM				Sumner, Steven A.; Layde, Peter M.			Expansion of Renewable Energy Industries and Implications for Occupational Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Layde, Peter M.] Med Coll Wisconsin, Injury Res Ctr, Dept Populat Hlth, Milwaukee, WI 53226 USA; [Sumner, Steven A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Medical College of Wisconsin; Duke University	Layde, PM (corresponding author), Med Coll Wisconsin, Injury Res Ctr, Dept Populat Hlth, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	playde@mcw.edu			NCIPC CDC HHS [R49/CE001175] Funding Source: Medline; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE001175] Funding Source: NIH RePORTER	NCIPC CDC HHS; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)		Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P429; *EUR COMM, EXTERNE EXT EN, V20; FTHENAKIS VM, REV RISKS SOLAR ELEC; Gardner R, 2003, ANN OCCUP HYG, V47, P201, DOI 10.1093/annhyg/meg028; Haines A, 2004, JAMA-J AM MED ASSOC, V291, P99, DOI 10.1001/jama.291.1.99; *I EN EC RAT US EN, 2004, NEW EL ASS EXT COSTS; KAMMEN DM, 2003, PUTTING RENEWABLES W; Madsen AM, 2006, ANN OCCUP HYG, V50, P821, DOI [10.1093/annhyg/mel052, 10.1093/annhyg/me1052]; Markandya A, 2007, LANCET, V370, P979, DOI 10.1016/S0140-6736(07)61253-7; REARDON J, 1993, MON LABOR REV, V116, P49; *US BUR CENS, 2009 STAT ABSTR; *US BUR LAB STAT, CAR GUID IND CGI 200; *US MIN SAF HLTH A, MIN SAF HLTH GLANC; Wilson N, 2006, INJURY PREV, V12, P135, DOI 10.1136/ip.2006.011650	14	16	16	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					787	789		10.1001/jama.2009.1214	http://dx.doi.org/10.1001/jama.2009.1214			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690312				2022-12-28	WOS:000269073800028
J	Wheeler, R				Wheeler, Robert			Personal View Priority patients in a pandemonium	BRITISH MEDICAL JOURNAL			English	Editorial Material									Southampton Univ Hosp Trust, Southampton, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust	Wheeler, R (corresponding author), Southampton Univ Hosp Trust, Southampton, Hants, England.	robert.wheeler@suht.swest.nhs.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 19	2009	339								b3321	10.1136/bmj.b3321	http://dx.doi.org/10.1136/bmj.b3321			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486SB	19692444				2022-12-28	WOS:000269216900007
J	Bhattacharyya, S; Schapira, AH; Mikhailidis, DP; Davar, J				Bhattacharyya, Sanjeev; Schapira, Anthony H.; Mikhailidis, Dimitri P.; Davar, Joseph			Drug-induced fibrotic valvular heart disease	LANCET			English	Review							VALVE DISEASE; DOPAMINE AGONISTS; PARKINSONS-DISEASE; ERGOTAMINE THERAPY; TRICUSPID REGURGITATION; CARDIAC VALVULOPATHY; AORTIC REGURGITATION; MIGRAINE HEADACHE; OBESE-PATIENTS; WEIGHT CONTROL	The initial association between the development of valvular heart disease and drugs stems from observations made during the use of methysergide and ergotamine for migraine prophylaxis in the 1960s. Since then, the appetite suppressants fenfluramine and dexfenfluramine, the dopamine agonists pergolide and cabergoline, and more recently, the recreational drug ecstasy (3,4 methylenedioxymethamphetamine; MDMA) have been implicated. Results from clinical trials show that drug dose and treatment duration affect both the risk of developing the disease and its severity. The natural history of the disease remains unclear, although regression of valvular lesions after the end of treatment has been reported. Interference with serotonin metabolism and its associated receptors and transporter gene seems a likely mechanism for development of the drug-induced valvular heart disease. Physicians need to balance the benefits of continued therapy with these drugs against possible risks. Further investigation is needed to assist with treatment decisions. Continued vigilance is necessary because several commonly prescribed treatments interact with serotonergic pathways.	[Bhattacharyya, Sanjeev; Davar, Joseph] Royal Free Hosp, Dept Cardiol, Valvular Heart Dis Clin, London NW3 2QG, England; [Schapira, Anthony H.] UCL, Dept Clin Neurosci, Inst Neurol, London, England; [Mikhailidis, Dimitri P.] Royal Free Hosp, Royal Free & Univ Coll Med Sch, Dept Clin Biochem, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Davar, J (corresponding author), Royal Free Hosp, Dept Cardiol, Valvular Heart Dis Clin, Pond St, London NW3 2QG, England.	joseph.davar@royalfree.nhs.uk	Schapira, Anthony H V/A-1245-2010; Mikhailidis, Dimitri P/A-1869-2013	Schapira, Anthony H V/0000-0002-3018-3966; Mikhailidis, Dimitri P/0000-0002-9566-2263				Antonini A, 2007, LANCET NEUROL, V6, P826, DOI 10.1016/S1474-4422(07)70218-1; BANA DS, 1974, AM HEART J, V88, P640, DOI 10.1016/0002-8703(74)90251-8; Baseman DG, 2004, NEUROLOGY, V63, P301, DOI 10.1212/01.WNL.0000129842.49926.07; Burger AJ, 1999, J AM COLL CARDIOL, V34, P1153, DOI 10.1016/S0735-1097(99)00321-6; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1061; Colao A, 2008, J CLIN ENDOCR METAB, V93, P3777, DOI 10.1210/jc.2007-1403; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Doblin R, 2002, J PSYCHOACTIVE DRUGS, V34, P185, DOI 10.1080/02791072.2002.10399952; Droogmans S, 2007, AM J CARDIOL, V100, P1442, DOI 10.1016/j.amjcard.2007.06.045; Droogmans S, 2007, EUR HEART J, V28, P2156, DOI 10.1093/eurheartj/ehm263; Elangbam CS, 2008, EXP TOXICOL PATHOL, V60, P253, DOI 10.1016/j.etp.2008.03.005; *EMEA, 2008, QUEST ANSW REV ERG D; Fishman AP, 1999, CIRCULATION, V99, P156, DOI 10.1161/01.CIR.99.1.156; Gardin JM, 2000, JAMA-J AM MED ASSOC, V283, P1703, DOI 10.1001/jama.283.13.1703; Gardin JM, 2001, JAMA-J AM MED ASSOC, V286, P2011, DOI 10.1001/jama.286.16.2011; Gillam MP, 2006, ENDOCR REV, V27, P485, DOI 10.1210/er.2005-9998; Goujon-Dubois J, 2003, Rev Med Liege, V58, P70; GRAHAM JR, 1967, AM J MED SCI, V254, P1; Gustafsson BI, 2005, CIRCULATION, V111, P1517, DOI 10.1161/01.CIR.0000159356.42064.48; Hattori N, 2003, CURR OPIN NEUROL, V16, pS21, DOI 10.1097/00019052-200312001-00005; HAUCK AJ, 1990, ARCH PATHOL LAB MED, V114, P62; Hendrikx M, 1996, J HEART VALVE DIS, V5, P235; Horvath J, 2004, MOVEMENT DISORD, V19, P656, DOI 10.1002/mds.20201; Horvath J., 2004, MOVEMENT DISORD, V19, P611; Jagroop IA, 2000, PLATELETS, V11, P161; Jian B, 2002, AM J PATHOL, V161, P2111, DOI 10.1016/S0002-9440(10)64489-6; Jick H, 1998, NEW ENGL J MED, V339, P719, DOI 10.1056/NEJM199809103391102; Jollis JG, 2000, CIRCULATION, V101, P2071, DOI 10.1161/01.CIR.101.17.2071; Junghanns S, 2007, MOVEMENT DISORD, V22, P234, DOI 10.1002/mds.21225; Kancherla MK, 1999, AM J CARDIOL, V84, P1335, DOI 10.1016/S0002-9149(99)00567-6; Kars M, 2008, J CLIN ENDOCR METAB, V93, P3348, DOI 10.1210/jc.2007-2658; Khan MA, 1998, NEW ENGL J MED, V339, P713, DOI 10.1056/NEJM199809103391101; KIM Y, 2006, MOVEMENT DISORD, V21, P1261; Klein A L, 1990, J Am Soc Echocardiogr, V3, P54; Lancellotti P, 2008, EUR J ENDOCRINOL, V159, P1, DOI 10.1530/EJE-08-0213; Lepor NE, 2000, AM J CARDIOL, V86, P107, DOI 10.1016/S0002-9149(00)00840-7; Levy RJ, 2006, CIRCULATION, V113, P2, DOI 10.1161/CIRCULATIONAHA.105.593459; Martins SS, 2005, EXP CLIN PSYCHOPHARM, V13, P244, DOI 10.1037/1064-1297.13.3.244; Mast ST, 2001, ANN INTERN MED, V134, P261, DOI 10.7326/0003-4819-134-4-200102200-00008; Mekontso-Dessap A, 2006, CIRCULATION, V113, P81, DOI 10.1161/CIRCULATIONAHA.105.554667; MISCH KA, 1974, BRIT MED J, V2, P365, DOI 10.1136/bmj.2.5915.365; MIZUNO Y, 1995, NEUROLOGY, V45, P13; NEMECEK GM, 1986, P NATL ACAD SCI USA, V83, P674, DOI 10.1073/pnas.83.3.674; Newman-Tancredi A, 2002, J PHARMACOL EXP THER, V303, P815, DOI 10.1124/jpet.102.039883; PAKALA R, 1994, CIRCULATION, V90, P1919, DOI 10.1161/01.CIR.90.4.1919; Peralta C, 2006, MOVEMENT DISORD, V21, P1109, DOI 10.1002/mds.20887; Pinero A, 2005, NEW ENGL J MED, V353, P1976, DOI 10.1056/NEJM200511033531822; Pritchett AM, 2002, MAYO CLIN PROC, V77, P1280, DOI 10.4065/77.12.1280; Quintana EM, 2005, REV ESP CARDIOL, V58, P97; Rasmussen VG, 2008, J INTERN MED, V263, P90, DOI 10.1111/j.1365-2796.2007.01874.x; REDFIELD MM, 1992, ANN INTERN MED, V117, P50, DOI 10.7326/0003-4819-117-1-50; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Rothman RB, 2000, AM J CARDIOL, V85, P913, DOI 10.1016/S0002-9149(99)00896-6; Rothman RB, 2000, CIRCULATION, V102, P2836; Schade R, 2007, NEW ENGL J MED, V356, P29, DOI 10.1056/NEJMoa062222; Schapira AHV, 2007, ARCH NEUROL-CHICAGO, V64, P1083, DOI 10.1001/archneur.64.8.1083; Seiler K, 1973, Vasa, V2, P366; Serratrice Jacques, 2002, Cardiol Rev, V10, P334, DOI 10.1097/00045415-200211000-00005; Setola V, 2003, MOL PHARMACOL, V63, P1223, DOI 10.1124/mol.63.6.1223; SEUWEN K, 1988, NATURE, V335, P254, DOI 10.1038/335254a0; Shively BK, 1999, CIRCULATION, V100, P2161, DOI 10.1161/01.CIR.100.21.2161; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silberstein SD, 1998, CEPHALALGIA, V18, P421, DOI 10.1046/j.1468-2982.1998.1807421.x; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Sutton TM, 2003, J AM COLL CARDIOL, V41, P2280, DOI 10.1016/S0735-1097(03)00486-8; Vallette S, 2009, PITUITARY, V12, P153, DOI 10.1007/s11102-008-0134-2; Van Camp G, 2003, NEUROLOGY, V61, P859, DOI 10.1212/01.WNL.0000083985.00343.F2; Van Camp G, 2004, LANCET, V363, P1179, DOI 10.1016/S0140-6736(04)15945-X; Verhelst J, 1999, J CLIN ENDOCR METAB, V84, P2518, DOI 10.1210/jc.84.7.2518; Wakil A, 2008, EUR J ENDOCRINOL, V159, pR11, DOI 10.1530/EJE-08-0365; Weber M, 2008, INT J CARDIOL, V127, P321, DOI 10.1016/j.ijcard.2007.07.174; WEBSTER J, 1994, NEW ENGL J MED, V331, P904, DOI 10.1056/NEJM199410063311403; WEINTRAUB M, 1984, ARCH INTERN MED, V144, P1143, DOI 10.1001/archinte.144.6.1143; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P595, DOI 10.1038/clpt.1992.70; Weissman NJ, 1998, NEW ENGL J MED, V339, P725, DOI 10.1056/NEJM199809103391103; Weissman NJ, 2001, AM J MED SCI, V321, P285, DOI 10.1097/00000441-200104000-00008; Wilke A, 1997, EUR HEART J, V18, P701; Yamamoto M, 2006, NEUROLOGY, V67, P1225, DOI 10.1212/01.wnl.0000238508.68593.1d; Yanovski SZ, 2002, NEW ENGL J MED, V346, P591, DOI 10.1056/NEJMra012586; Zanettini R, 2007, NEW ENGL J MED, V356, P39, DOI 10.1056/NEJMoa054830; Zolkowska D, 2008, J PHARMACOL EXP THER, V324, P791, DOI 10.1124/jpet.107.132654	82	94	95	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					577	585		10.1016/S0140-6736(09)60252-X	http://dx.doi.org/10.1016/S0140-6736(09)60252-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683643				2022-12-28	WOS:000269019400025
J	Bessen, T; Clark, R; Shakib, S; Hughes, G				Bessen, Taryn; Clark, Robyn; Shakib, Sepehr; Hughes, Geoffrey			Practice Quality Improvement Report A multifaceted strategy for implementation of the Ottawa ankle rules in two emergency departments	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DECISION RULES	Problem Despite widespread acceptance of the Ottawa ankle rules for assessment of acute ankle injuries, their application varies considerably. Design Before and after study. Background and setting Emergency departments of a tertiary teaching hospital and a community hospital in Australia. Key measures for improvement Documentation of the Ottawa ankle rules, proportion of patients referred for radiography, proportion of radiographs showing a fracture. Strategies for change Education, a problem specific radiography request form, reminders, audit and feedback, and using radiographers as "gatekeepers." Effects of change Documentation of the Ottawa ankle rules improved from 57.5% to 94.7% at the tertiary hospital, and 51.6% to 80.8% at the community hospital (P<0.001 for both). The proportion of patients undergoing radiography fell from 95.8% to 87.2% at the tertiary hospital, and from 91.4% to 78.9% at the community hospital (P<0.001 for both). The proportion of radiographs showing a fracture increased from 20.4% to 27.1% at the tertiary hospital (P=0.069), and 15.2% to 27.2% (P=0.002) at the community hospital. The missed fracture rate increased from 0% to 2.9% at the tertiary hospital and from 0% to 1.6% at the community hospital compared with baseline (P=0.783 and P=0.747). Lessons learnt Assessment of case note documentation has limitations. Clinician groups seem to differ in their capacity and willingness to change their practice. A multifaceted change strategy including a problem specific radiography request form can improve the selection of patients for radiography.	[Bessen, Taryn] Royal Adelaide Hosp, Dept Med Imaging, Adelaide, SA 5000, Australia; [Clark, Robyn] Univ S Australia, Fac Hlth Sci, Sansom Inst, Adelaide, SA 5000, Australia; [Shakib, Sepehr] Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia; [Hughes, Geoffrey] Royal Adelaide Hosp, Emergency Dept, Adelaide, SA 5000, Australia	Royal Adelaide Hospital; University of South Australia; Royal Adelaide Hospital; Royal Adelaide Hospital	Bessen, T (corresponding author), Royal Adelaide Hosp, Dept Med Imaging, Adelaide, SA 5000, Australia.	Taryn.Bessen@health.sa.gov.au	Clark, Robyn A/D-1604-2009	Clark, Robyn A/0000-0002-5063-2618				Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Brehaut JC, 2005, ACAD EMERG MED, V12, P948, DOI 10.1197/j.aem.2005.04.024; Davis D, 2003, BMJ-BRIT MED J, V327, P33, DOI 10.1136/bmj.327.7405.33; Dopson S, 2002, HEALTH CARE MANAGE R, V27, P35, DOI 10.1097/00004010-200207000-00005; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2001, MED CARE, V39, pII46; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Grol R, 2005, IMPROVING PATIENT CA; LOMAS J, 2000, HLTH SERVICES RES EV; National Institute Of Clinical Studies (NICS), 2006, IDENTIFYING BARRIERS; Sanson-Fisher RW, 2004, MED J AUSTRALIA, V180, pS55; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; Wilson RM, 1999, MED J AUSTRALIA, V170, P411, DOI 10.5694/j.1326-5377.1999.tb127814.x; WINKLER JD, 1985, ARCH INTERN MED, V145, P314, DOI 10.1001/archinte.145.2.314	15	25	25	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2009	339								b3056	10.1136/bmj.b3056	http://dx.doi.org/10.1136/bmj.b3056			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YI	19675080	hybrid, Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000269161900003
J	Chakravarthy, MV; Lodhi, IJ; Yin, L; Malapaka, RRV; Xu, HE; Turk, J; Semenkovich, CF				Chakravarthy, Manu V.; Lodhi, Irfan J.; Yin, Li; Malapaka, Raghu R. V.; Xu, H. Eric; Turk, John; Semenkovich, Clay F.			Identification of a Physiologically Relevant Endogenous Ligand for PPAR alpha in Liver	CELL			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; TANDEM MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; FATTY-ACID; BINDING DOMAIN; PHOSPHOLIPIDS; PHOSPHATIDYLCHOLINE; EICOSANOIDS; GAMMA; MICE	The nuclear receptor PPAR alpha is activated by drugs to treat human disorders of lipid metabolism. Its endogenous ligand is unknown. PPAR alpha-dependent gene expression is impaired with inactivation of fatty acid synthase (FAS), suggesting that FAS is involved in generation of a PPAR alpha ligand. Here we demonstrate the FAS-dependent presence of a phospholipid bound to PPAR alpha isolated from mouse liver. Binding was increased under conditions that induce FAS activity and displaced by systemic injection of a PPAR alpha agonist. Mass spectrometry identified the species as 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Knockdown of Cept1, required for phosphatidylcholine synthesis, suppressed PPAR alpha-dependent gene expression. Interaction of 16:0/18:1-GPC with the PPAR alpha ligand-binding domain and coactivator peptide motifs was comparable to PPAR alpha agonists, but interactions with PPAR delta were weak and none were detected with PPAR gamma. Portal vein infusion of 16:0/18:1-GPC induced PPAR alpha-dependent gene expression and decreased hepatic steatosis. These data suggest that 16:0/18:1-GPC is a physiologically relevant endogenous PPAR alpha ligand.	[Chakravarthy, Manu V.; Lodhi, Irfan J.; Yin, Li; Turk, John; Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Malapaka, Raghu R. V.; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	Washington University (WUSTL); Washington University (WUSTL); Van Andel Institute	Semenkovich, CF (corresponding author), Washington Univ, Sch Med, Dept Med, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	csemenko@wustl.edu	Chakravarthy, Manu/AAD-7553-2021; Malapaka, Raghu/B-6185-2012; Xu, H. Eric/ABD-7487-2021	Chakravarthy, Manu/0000-0002-3699-150X; Xu, H. Eric/0000-0002-6829-8144; Semenkovich, Clay/0000-0003-1163-1871; Lodhi, Irfan/0000-0002-6246-9862	NIH [DK076729, P50 HL083762, R37 DK34388, P41 RR00954, HL089301]; Clinical Nutrition Research Unit [DK56341]; Diabetes Research and Training Center [DK20579]; Betty Van Andel Foundation; American Diabetes Association [1-07-JF-12]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301, P50HL083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P60DK020579, P30DK020579, R37DK034388, R01DK076729] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition Research Unit; Diabetes Research and Training Center; Betty Van Andel Foundation; American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK076729, P50 HL083762, R37 DK34388, P41 RR00954, HL089301, the Clinical Nutrition Research Unit (DK56341), the Diabetes Research and Training Center (DK20579), the Jay and Betty Van Andel Foundation, and the American Diabetes Association ( Junior Faculty Award 1-07-JF-12 to M. V. C. and a Mentor-Based Postdoctoral Fellowship Award).	Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Barter PJ, 2008, ARTERIOSCL THROM VAS, V28, P39, DOI 10.1161/ATVBAHA.107.148817; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Clayton GM, 2001, P NATL ACAD SCI USA, V98, P1549, DOI 10.1073/pnas.041611298; Cuzzocrea S, 2004, LAB INVEST, V84, P1643, DOI 10.1038/labinvest.3700185; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Delerive P, 2000, FEBS LETT, V471, P34, DOI 10.1016/S0014-5793(00)01364-8; Forman BM, 2005, CELL METAB, V1, P153, DOI 10.1016/j.cmet.2005.02.006; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P437, DOI 10.1016/S1044-0305(99)00150-6; Hsu FF, 2003, J MASS SPECTROM, V38, P752, DOI 10.1002/jms.491; Hsu FF, 1998, J AM SOC MASS SPECTR, V9, P516, DOI 10.1016/S1044-0305(98)00012-9; Hsu FF, 2003, J AM SOC MASS SPECTR, V14, P352, DOI 10.1016/S1044-0305(03)00064-3; Kent C, 2005, BBA-MOL CELL BIOL L, V1733, P53, DOI 10.1016/j.bbalip.2004.12.008; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Lee H, 2000, CIRC RES, V87, P516; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Nichols JS, 1998, ANAL BIOCHEM, V257, P112, DOI 10.1006/abio.1997.2557; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Ramanadham S, 1998, BIOCHEMISTRY-US, V37, P4553, DOI 10.1021/bi9722507; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Ridgway ND, 2003, BIOCHEM J, V372, P811, DOI 10.1042/BJ20030252; Riserus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Stremmel W, 2007, ANN INTERN MED, V147, P603, DOI 10.7326/0003-4819-147-9-200711060-00004; Strubbe JH, 1999, PHYSIOL BEHAV, V65, P885; Treede I, 2007, J BIOL CHEM, V282, P27155, DOI 10.1074/jbc.M704408200; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	45	386	401	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					476	488		10.1016/j.cell.2009.05.036	http://dx.doi.org/10.1016/j.cell.2009.05.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19646743	Bronze, Green Accepted			2022-12-28	WOS:000268771900013
J	Cohen, BE; Marmar, C; Ren, L; Bertenthal, D; Seal, KH				Cohen, Beth E.; Marmar, Charles; Ren, Li; Bertenthal, Daniel; Seal, Karen H.			Association of Cardiovascular Risk Factors With Mental Health Diagnoses in Iraq and Afghanistan War Veterans Using VA Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							POSTTRAUMATIC-STRESS-DISORDER		[Cohen, Beth E.; Ren, Li; Seal, Karen H.] Vet Affairs Med Ctr, San Francisco Dept, Dept Med, San Francisco, CA 94121 USA; [Marmar, Charles] Vet Affairs Med Ctr, San Francisco Dept, Dept Psychiat, San Francisco, CA 94121 USA; [Bertenthal, Daniel] Vet Affairs Med Ctr, San Francisco Dept, Hlth Serv Res Enhancement Award Program, San Francisco, CA 94121 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cohen, BE (corresponding author), Vet Affairs Med Ctr, San Francisco Dept, Dept Med, San Francisco, CA 94121 USA.	beth.cohen@va.gov	Marmar, Charles R./O-1902-2017	Marmar, Charles R./0000-0001-8427-5607	NCRR NIH HHS [KL2 RR024130] Funding Source: Medline; NHLBI NIH HHS [K23 HL094765] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL094765] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Dobie DJ, 2006, J GEN INTERN MED, V21, pS58, DOI 10.1111/j.1525-1497.2006.00376.x; Elhai J. D., 2005, PSYCHOL SERV, V2, P3, DOI [10.1037/1541-1559.2.1.3, DOI 10.1037/1541-1559.2.1.3]; Kang HK, 2006, ANN EPIDEMIOL, V16, P381, DOI 10.1016/j.annepidem.2005.03.004; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Schnurr PP, 2000, J NERV MENT DIS, V188, P496, DOI 10.1097/00005053-200008000-00004	6	128	131	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					489	492		10.1001/jama.2009.1084	http://dx.doi.org/10.1001/jama.2009.1084			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479DS	19654382	Bronze			2022-12-28	WOS:000268640500012
J	Dixon, KW				Dixon, Kingsley W.			Pollination and Restoration	SCIENCE			English	Editorial Material							CROP POLLINATION; PLANT; BIODIVERSITY; CONSERVATION; DIVERSITY; NETWORKS; SERVICE; BEES	Pollination services underpin sustainability of restored ecosystems. Yet, outside of agri-environments, effective restoration of pollinator services in ecological restoration has received little attention. This deficiency in the knowledge needed to restore pollinator capability represents a major liability in restoration programs, particularly in regions where specialist invertebrate and vertebrate pollinators exist, such as global biodiversity hotspots. When compounded with the likely negative impacts of climate change on pollination services, the need to understand and manage pollinator services in restoration becomes paramount.	Univ Western Australia, Sch Plant Biol, Perth, WA 6005, Australia	University of Western Australia	Dixon, KW (corresponding author), Univ Western Australia, Sch Plant Biol, 6009 Kings Pk & Bot Garden, Perth, WA 6005, Australia.	kingsley.dixon@bgpa.wa.gov.au	Dixon, Kingsley W/B-1042-2011; Dixon, Kingsley W/A-8133-2016	Dixon, Kingsley W/0000-0001-5989-2929				Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Botes C, 2009, INT J PLANT SCI, V170, P151, DOI 10.1086/595291; BROWN AD, 2008, ILLUSTRATED GUIDE OR; BROWN EM, 1997, W AUSTR NATURALISTS, V15; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; COX PA, 1983, OIKOS, V41, P195, DOI 10.2307/3544263; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Fleming TH, 2008, J BIOGEOGR, V35, P764, DOI 10.1111/j.1365-2699.2007.01833.x; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Forup ML, 2008, J APPL ECOL, V45, P742, DOI 10.1111/j.1365-2664.2007.01390.x; Forup ML, 2005, RESTOR ECOL, V13, P265, DOI 10.1111/j.1526-100X.2005.00034.x; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; LAMONT BB, 1993, OECOLOGIA, V94, P446, DOI 10.1007/BF00317122; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Molina-Montenegro MA, 2008, OIKOS, V117, P1833, DOI 10.1111/j.0030-1299.2008.16896.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; N.R.C. Committee on the Status of Pollinators in North America, 2007, STATUS POLLINATORS N; Steltzer H, 2009, SCIENCE, V324, P886, DOI 10.1126/science.1171542; Townsend PA, 2005, ECOLOGY, V86, P466, DOI 10.1890/03-0607; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103	28	131	135	4	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					571	573		10.1126/science.1176295	http://dx.doi.org/10.1126/science.1176295			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19644110				2022-12-28	WOS:000268493000038
J	Katija, K; Dabiri, JO				Katija, Kakani; Dabiri, John O.			A viscosity-enhanced mechanism for biogenic ocean mixing	NATURE			English	Article							DRIFT; TURBULENCE; FLOW	Recent observations of biologically generated turbulence in the ocean have led to conflicting conclusions regarding the significance of the contribution of animal swimming to ocean mixing. Measurements indicate elevated turbulent dissipation-comparable with levels caused by winds and tides-in the vicinity of large populations of planktonic animals swimming together(1). However, it has also been noted that elevated turbulent dissipation is by itself insufficient proof of substantial biogenic mixing, because much of the turbulent kinetic energy of small animals is injected below the Ozmidov buoyancy length scale, where it is primarily dissipated as heat by the fluid viscosity before it can affect ocean mixing(2). Ongoing debate regarding biogenic mixing has focused on comparisons between animal wake turbulence and ocean turbulence(3,4). Here, we show that a second, previously neglected mechanism of fluid mixing-first described over 50 years ago by Charles Darwin(5)-is the dominant mechanism of mixing by swimming animals. The efficiency of mixing by Darwin's mechanism is dependent on animal shape rather than fluid length scale and, unlike turbulent wake mixing, is enhanced by fluid viscosity. Therefore, it provides a means of biogenic mixing that can be equally effective in small zooplankton and large mammals. A theoretical model for the relative contributions of Darwinian mixing and turbulent wake mixing is created and validated by in situ field measurements of swimming jellyfish using a newly developed scuba-based laser velocimetry device(6). Extrapolation of these results to other animals is straightforward given knowledge of the animal shape and orientation during vertical migration. On the basis of calculations of a broad range of aquatic animal species, we conclude that biogenic mixing via Darwin's mechanism can be a significant contributor to ocean mixing and nutrient transport.	[Dabiri, John O.] CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA	California Institute of Technology	Dabiri, JO (corresponding author), CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA.	kakani@caltech.edu; jodabiri@caltech.edu	Katija, Kakani/R-4935-2019		National Science Foundation Biological Oceanography Program; NSF; Office of Naval Research; NDSEG; Charles Lee Powell Foundation	National Science Foundation Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); NDSEG; Charles Lee Powell Foundation	We acknowledge W. M. Graham, J. H. Costello and H. Swift for assistance in field measurements and M. Schaadt for preparatory dive assistance. Additional logistical support was provided by the Coral Reef Research Foundation. Field work in Palau was supported by the National Science Foundation Biological Oceanography Program (to M. N. Dawson and J. O. D.). Additional support (to J. O. D.) from NSF Biological Oceanography, Ocean Technology, Fluid Dynamics, and Energy for Sustainability and from the Office of Naval Research (K.-H. Kim) is acknowledged, as are NSF and NDSEG fellowships (to K. K.) and the Charles Lee Powell Foundation.	Dabiri JO, 2006, J FLUID MECH, V547, P105, DOI 10.1017/S0022112005007585; DARWIN C, 1953, P CAMB PHILOS SOC, V49, P342, DOI 10.1017/S0305004100028449; Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720; Eames I, 2003, PHILOS T R SOC A, V361, P2951, DOI 10.1098/rsta.2003.1277; Eames I, 2003, J FLUID MECH, V485, P67, DOI 10.1017/S0022112003004361; Eames I, 1999, P ROY SOC A-MATH PHY, V455, P3665, DOI 10.1098/rspa.1999.0471; EAMES I, 1994, J FLUID MECH, V275, P201, DOI 10.1017/S0022112094002338; ECKART C, 1948, J MAR RES, V7, P265; Fish FE, 1998, J EXP BIOL, V201, P2867; HAMNER WM, 1982, LIMNOL OCEANOGR, V27, P896, DOI 10.4319/lo.1982.27.5.0896; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Katija K, 2008, LIMNOL OCEANOGR-METH, V6, P162, DOI 10.4319/lom.2008.6.162; Kunze E, 2006, SCIENCE, V313, P1768, DOI 10.1126/science.1129378; Lamb H, 1993, HYDRODYNAMICS, V6th; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Tennekes H., 1972, 1 COURSE TURBULENCE; Thorpe S. A, 2005, TURBULENT OCEAN; TURNER JS, 1964, J FLUID MECH, V18, P195, DOI 10.1017/S0022112064000155; WILLERT CE, 1991, EXP FLUIDS, V10, P181	20	124	125	7	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					624	U87		10.1038/nature08207	http://dx.doi.org/10.1038/nature08207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19641595				2022-12-28	WOS:000268454300049
J	Zhang, C; Wu, B; Beglopoulos, V; Wines-Samuelson, M; Zhang, DW; Dragatsis, I; Sudhof, TC; Shen, J				Zhang, Chen; Wu, Bei; Beglopoulos, Vassilios; Wines-Samuelson, Mary; Zhang, Dawei; Dragatsis, Ioannis; Suedhof, Thomas C.; Shen, Jie			Presenilins are essential for regulating neurotransmitter release	NATURE			English	Article							ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; AMYLOID-BETA; TRANSMITTER RELEASE; CORTICAL-NEURONS; TRANSGENIC MICE; RECEPTOR; MEMORY; INACTIVATION; PROBABILITY	Mutations in the presenilin genes are the main cause of familial Alzheimer's disease. Loss of presenilin activity and/or accumulation of amyloid-beta peptides have been proposed to mediate the pathogenesis of Alzheimer's disease by impairing synaptic function(1-5). However, the precise site and nature of the synaptic dysfunction remain unknown. Here we use a genetic approach to inactivate presenilins conditionally in either presynaptic (CA3) or postsynaptic (CA1) neurons of the hippocampal Schaeffer-collateral pathway. We show that long-term potentiation induced by theta-burst stimulation is decreased after presynaptic but not postsynaptic deletion of presenilins. Moreover, we found that presynaptic but not postsynaptic inactivation of presenilins alters short-term plasticity and synaptic facilitation. The probability of evoked glutamate release, measured with the open-channel NMDA (N-methyl-D-aspartate) receptor antagonist MK-801, is reduced by presynaptic inactivation of presenilins. Notably, depletion of endoplasmic reticulum Ca2+ stores by thapsigargin, or blockade of Ca2+ release from these stores by ryanodine receptor inhibitors, mimics and occludes the effects of presynaptic presenilin inactivation. Collectively, these results indicate a selective role for presenilins in the activity-dependent regulation of neurotransmitter release and long-term potentiation induction by modulation of intracellular Ca2+ release in presynaptic terminals, and further suggest that presynaptic dysfunction might be an early pathogenic event leading to dementia and neurodegeneration in Alzheimer's disease.	[Zhang, Chen; Wu, Bei; Beglopoulos, Vassilios; Wines-Samuelson, Mary; Zhang, Dawei; Shen, Jie] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA; [Zhang, Chen; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Dragatsis, Ioannis] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Stanford University; University of Tennessee System; University of Tennessee Health Science Center	Shen, J (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Program Neurosci, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Wu, Bei/F-6659-2012; Shen, Jie/GXH-9449-2022		National Institutes of Health [R01NS041783]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank K. Nakazawa and S. Tonegawa for Grik4-Cre transgenic mice, R. Kelleher for discussions and comments, and X. Zou for technical assistance. This work was supported by a grant from the National Institutes of Health (NIH; R01NS041783 to J. S.).	Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Handler M, 2000, DEVELOPMENT, V127, P2593; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Lazarov O, 2002, J NEUROSCI, V22, P9785; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200; Wines-Samuelson M, 2005, DEV BIOL, V277, P332, DOI 10.1016/j.ydbio.2004.09.024; Yao PJ, 1998, NEUROSCI LETT, V252, P33, DOI 10.1016/S0304-3940(98)00547-3; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zhang C, 2002, NAT NEUROSCI, V5, P425, DOI 10.1038/nn845	34	214	221	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					632	U100		10.1038/nature08177	http://dx.doi.org/10.1038/nature08177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19641596	Green Accepted, Green Submitted			2022-12-28	WOS:000268454300051
J	Garattini, S; Bertele, V				Garattini, Silvio; Bertele, Vittorio			Homoeopathy: not a matter for drug-regulatory authorities	LANCET			English	Editorial Material							PLACEBO		[Garattini, Silvio; Bertele, Vittorio] Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Bertele, V (corresponding author), Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy.	bertele@marionegri.it	Bertele, Vittorio/AAA-6461-2020; Garattini, Silvio/AAA-6390-2020	Bertele, Vittorio/0000-0002-0032-7033; Garattini, Silvio/0000-0003-0647-9297				Garattini S, 2003, LANCET, V361, P635, DOI 10.1016/S0140-6736(03)12615-3; *MHRA, ARN ARN 30C PILL; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; Taylor MA, 2000, BMJ-BRIT MED J, V321, P471, DOI 10.1136/bmj.321.7259.471; Vallance AK, 1998, J ALTERN COMPLEM MED, V4, P49, DOI 10.1089/acm.1998.4.1-49; 2005, LANCET, V366, P691	6	7	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2009	374	9701					1578	1580		10.1016/S0140-6736(09)61291-5	http://dx.doi.org/10.1016/S0140-6736(09)61291-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518EZ	19674776				2022-12-28	WOS:000271674600010
J	Watson, DA; Su, MJ; Teverovskiy, G; Zhang, Y; Garcia-Fortanet, J; Kinzel, T; Buchwald, SL				Watson, Donald A.; Su, Mingjuan; Teverovskiy, Georgiy; Zhang, Yong; Garcia-Fortanet, Jorge; Kinzel, Tom; Buchwald, Stephen L.			Formation of ArF from LPdAr(F): Catalytic Conversion of Aryl Triflates to Aryl Fluorides	SCIENCE			English	Article							F REDUCTIVE ELIMINATION; FLUORINATION; COMPLEXES; CARBON; PALLADIUM(II); ROUTE; SALTS; STEP; CL	Despite increasing pharmaceutical importance, fluorinated aromatic organic molecules remain difficult to synthesize. Present methods require either harsh reaction conditions or highly specialized reagents, making the preparation of complex fluoroarenes challenging. Thus, the development of general methods for their preparation that overcome the limitations of those techniques currently in use is of great interest. We have prepared [LPd(II)Ar(F)] complexes, where L is a biaryl monophosphine ligand and Ar is an aryl group, and identified conditions under which reductive elimination occurs to form an Ar-F bond. On the basis of these results, we have developed a catalytic process that converts aryl bromides and aryl triflates into the corresponding fluorinated arenes by using simple fluoride salts. We expect this method to allow the introduction of fluorine atoms into advanced, highly functionalized intermediates.	[Watson, Donald A.; Su, Mingjuan; Teverovskiy, Georgiy; Zhang, Yong; Garcia-Fortanet, Jorge; Kinzel, Tom; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Buchwald, SL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	sbuchwal@mit.edu			NIH [GM46059]; Merck; Nippon Chemical; Boehringer Ingelheim; BASF; Singapore-MIT Alliance; Spanish Ministerio de Educacion y Ciencia; Alexander von Humboldt Foundation; NSF [CHE 9808061, DBI 9729592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046059, R37GM046059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); Nippon Chemical; Boehringer Ingelheim(Boehringer Ingelheim); BASF(BASF); Singapore-MIT Alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NIH for financial support of this project (grant GM46059) and Merck, Nippon Chemical, Boehringer Ingelheim, and BASF for gifts of chemicals and additional funds. M. S. thanks the Singapore-MIT Alliance for a graduate fellowship. J. G.-F. thanks the Spanish Ministerio de Educacion y Ciencia for a postdoctoral fellowship. T. K. thanks the Alexander von Humboldt Foundation for a Feodor Lynen postdoctoral fellowship. The Varian NMR instrument used was supported by the NSF (grants CHE 9808061 and DBI 9729592). We also thank P. Muller for obtaining the crystal structure of 4. Cambridge Crystallographic Data Centre (CCDC) 741377 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from the CCDC via www.ccdc.cam.ac.uk/data_request/cif. A patent application has been filed by MIT covering portions of this work with S. L. B., D. A. W., M. S., and G. T. as co-inventors.	Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; ANGELINI G, 1985, J FLUORINE CHEM, V27, P177, DOI 10.1016/S0022-1139(00)84987-8; Ball ND, 2009, J AM CHEM SOC, V131, P3796, DOI 10.1021/ja8054595; Balz G, 1927, BER DTSCH CHEM GES, V60, P1186, DOI 10.1002/cber.19270600539; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; FINGER GC, 1956, J AM CHEM SOC, V78, P6034, DOI 10.1021/ja01604a022; Fors BP, 2008, J AM CHEM SOC, V130, P13552, DOI 10.1021/ja8055358; Furuya T, 2008, J AM CHEM SOC, V130, P10060, DOI 10.1021/ja803187x; Furuya T, 2008, ANGEW CHEM INT EDIT, V47, P5993, DOI 10.1002/anie.200802164; Furuya T, 2009, J AM CHEM SOC, V131, P1662, DOI 10.1021/ja8086664; Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017; Grushin VV, 2008, ORGANOMETALLICS, V27, P4825, DOI 10.1021/om800520e; Grushin VV, 2007, ORGANOMETALLICS, V26, P4997, DOI 10.1021/om700469k; Grushin VV, 2004, J AM CHEM SOC, V126, P3068, DOI 10.1021/ja049844z; Grushin VV, 2002, CHEM-EUR J, V8, P1006, DOI 10.1002/1521-3765(20020301)8:5<1006::AID-CHEM1006>3.0.CO;2-M; GRUSHIN VV, 2007, Patent No. 7202388; Hull KL, 2006, J AM CHEM SOC, V128, P7134, DOI 10.1021/ja061943k; Jeschke P, 2004, CHEMBIOCHEM, V5, P570, DOI 10.1002/cbic.200300833; Kaspi AW, 2008, INORG CHEM, V47, P5, DOI 10.1021/ic701722f; Macgregor SA, 2005, J AM CHEM SOC, V127, P15304, DOI 10.1021/ja054506z; Mann G, 1998, J AM CHEM SOC, V120, P9205, DOI 10.1021/ja981428p; Marshall WJ, 2004, ORGANOMETALLICS, V23, P2343, DOI 10.1021/om049813c; Marshall WJ, 2003, ORGANOMETALLICS, V22, P555, DOI 10.1021/om020838q; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Pan Y, 1999, J ORGANOMET CHEM, V577, P257, DOI 10.1016/S0022-328X(98)01071-7; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; PIKE VW, 1995, J CHEM SOC CHEM COMM, P2215, DOI 10.1039/C39950002215; Ross TL, 2007, J AM CHEM SOC, V129, P8018, DOI 10.1021/ja066850h; Roy AH, 2001, J AM CHEM SOC, V123, P1232, DOI 10.1021/ja0034592; Sun H, 2006, ANGEW CHEM INT EDIT, V45, P2720, DOI 10.1002/anie.200504555; Wang XS, 2009, J AM CHEM SOC, V131, P7520, DOI 10.1021/ja901352k; Withbroe GJ, 2008, ORG PROCESS RES DEV, V12, P480, DOI 10.1021/op7002858; Yandulov DV, 2007, J AM CHEM SOC, V129, P1342, DOI 10.1021/ja066930l	33	494	510	2	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1661	1664		10.1126/science.1178239	http://dx.doi.org/10.1126/science.1178239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	498II	19679769	Green Submitted, Green Accepted			2022-12-28	WOS:000270131800037
J	Ng, SB; Turner, EH; Robertson, PD; Flygare, SD; Bigham, AW; Lee, C; Shaffer, T; Wong, M; Bhattacharjee, A; Eichler, EE; Bamshad, M; Nickerson, DA; Shendure, J				Ng, Sarah B.; Turner, Emily H.; Robertson, Peggy D.; Flygare, Steven D.; Bigham, Abigail W.; Lee, Choli; Shaffer, Tristan; Wong, Michelle; Bhattacharjee, Arindam; Eichler, Evan E.; Bamshad, Michael; Nickerson, Deborah A.; Shendure, Jay			Targeted capture and massively parallel sequencing of 12 human exomes	NATURE			English	Article							HUMAN GENOME; EXON CAPTURE; ALLELES; GENE	Genome-wide association studies suggest that common genetic variants explain only a modest fraction of heritable risk for common diseases, raising the question of whether rare variants account for a significant fraction of unexplained heritability(1,2). Although DNA sequencing costs have fallen markedly(3), they remain far from what is necessary for rare and novel variants to be routinely identified at a genome-wide scale in large cohorts. We have therefore sought to develop second-generation methods for targeted sequencing of all protein-coding regions ('exomes'), to reduce costs while enriching for discovery of highly penetrant variants. Here we report on the targeted capture and massively parallel sequencing of the exomes of 12 humans. These include eight HapMap individuals representing three populations(4), and four unrelated individuals with a rare dominantly inherited disorder, Freeman-Sheldon syndrome (FSS)(5). We demonstrate the sensitive and specific identification of rare and common variants in over 300 megabases of coding sequence. Using FSS as a proof-of-concept, we show that candidate genes for Mendelian disorders can be identified by exome sequencing of a small number of unrelated, affected individuals. This strategy may be extendable to diseases with more complex genetics through larger sample sizes and appropriate weighting of non-synonymous variants by predicted functional impact.	[Ng, Sarah B.; Turner, Emily H.; Robertson, Peggy D.; Flygare, Steven D.; Lee, Choli; Shaffer, Tristan; Wong, Michelle; Eichler, Evan E.; Nickerson, Deborah A.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bigham, Abigail W.; Bamshad, Michael] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Bhattacharjee, Arindam] Agilent Technol, Santa Clara, CA 95051 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Agilent Technologies	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	sarahng@u.washington.edu; shendure@u.washington.edu	Shendure, Jay/AAU-3684-2021	Turner, Emily/0000-0001-9040-9229; Shendure, Jay/0000-0002-1516-1865	National Institutes of Health/National Heart Lung and Blood Institute; National Institutes of Health/National Human Genome Research Institute; National Institutes of Health/National Institute of Child Health and Human Development; Washington Research Foundation; Agency for Science, Technology and Research, Singapore; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094976] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004749] Funding Source: NIH RePORTER	National Institutes of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Washington Research Foundation; Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	For discussions or assistance with genotyping data, we thank P. Green, J. Akey, R. Patwardhan, G. Cooper, J. Kidd, D. Gordon, J. Smith, I. Stanaway and M. Rieder. For assistance with project management, computation, data management and submission, we thank E. Torskey, S. Thompson, T. Amburg, B. McNally, S. Hearsey, M. Shumway and L. Hillier. For Human1M-Duo genotype data on HapMap samples, we thank Illumina. Our work was supported in part by grants from the National Institutes of Health/National Heart Lung and Blood Institute, the National Institutes of Health/National Human Genome Research Institute, National Institutes of Health/National Institute of Child Health and Human Development, and the Washington Research Foundation. S. B. N. is supported by the Agency for Science, Technology and Research, Singapore. E. H. T. and A. W. B. are supported by a training fellowship from the National Institutes of Health/National Human Genome Research Institute. E. E. E. is an investigator of the Howard Hughes Medical Institute.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2008, GENOME RES, V18, P2016, DOI 10.1101/gr.081786.108; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; *NAT CTR BIOT INF, 2009, CONS CDS PROT SET; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Olson M, 2007, NAT METHODS, V4, P891, DOI 10.1038/nmeth1107-891; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008	30	1414	1560	4	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					272	U153		10.1038/nature08250	http://dx.doi.org/10.1038/nature08250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19684571	Green Accepted			2022-12-28	WOS:000269654600046
J	Li, H; Collado, M; Villasante, A; Strati, K; Ortega, S; Canamero, M; Blasco, MA; Serrano, M				Li, Han; Collado, Manuel; Villasante, Aranzazu; Strati, Katerina; Ortega, Sagrario; Canamero, Marta; Blasco, Maria A.; Serrano, Manuel			The Ink4/Arf locus is a barrier for iPS cell reprogramming	NATURE			English	Article							EMBRYONIC STEM-CELLS; HUMAN FIBROBLASTS; DEFINED FACTORS; SOMATIC-CELLS; ONCOGENIC RAS; SENESCENCE; EXPRESSION; PLURIPOTENT; CANCER; INK4A/ARF	The mechanisms involved in the reprogramming of differentiated cells into induced pluripotent stem (iPS) cells by the three transcription factors Oct4 (also known as Pou5f1), Klf4 and Sox2 remain poorly understood1. The Ink4/Arf locus comprises the Cdkn2a Cdkn2b genes encoding three potent tumour suppressors, namely p16 Ink4a, p19 Arf and p15 Ink4b, which are basally expressed in differentiated cells and upregulated by aberrant mitogenic signals(2-4). Here we show that the locus is completely silenced in iPS cells, as well as in embryonic stem (ES) cells, acquiring the epigenetic marks of a bivalent chromatin domain, and retaining the ability to be reactivated after differentiation. Cell culture conditions during reprogramming enhance the expression of the Ink4/Arf locus, further highlighting the importance of silencing the locus to allow proliferation and reprogramming. Indeed, the three factors together repress the Ink4/Arf locus soon after their expression and concomitant with the appearance of the first molecular markers of 'stemness'. This downregulation also occurs in cells carrying the oncoprotein large-T, which functionally inactivates the pathways regulated by the Ink4/Arf locus, thus indicating that the silencing of the locus is intrinsic to reprogramming and not the result of a selective process. Genetic inhibition of the Ink4/Arf locus has a profound positive effect on the efficiency of iPS cell generation, increasing both the kinetics of reprogramming and the number of emerging iPS cell colonies. In murine cells, Arf, rather than Ink4a, is the main barrier to reprogramming by activation of p53 (encoded by Trp53) and p21 (encoded by Cdkn1a); whereas, in human fibroblasts, INK4a is more important than ARF. Furthermore, organismal ageing upregulates the Ink4/Arf locus(2,5) and, accordingly, reprogramming is less efficient in cells from old organisms, but this defect can be rescued by inhibiting the locus with a short hairpin RNA. All together, we conclude that the silencing of Ink4/Arf locus is rate-limiting for reprogramming, and its transient inhibition may significantly improve the generation of iPS cells.	[Li, Han; Collado, Manuel; Villasante, Aranzazu; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain; [Strati, Katerina; Blasco, Maria A.] Spanish Natl Canc Res Ctr CNIO, Telomeres & Telomerase Grp, E-28029 Madrid, Spain; [Ortega, Sagrario] Spanish Natl Canc Res Ctr CNIO, Transgen Mice Unit, E-28029 Madrid, Spain; [Canamero, Marta] Spanish Natl Canc Res Ctr CNIO, Comparat Pathol Unit, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, 3 Melchor Fernandez Almagro St, E-28029 Madrid, Spain.	mserrano@cnio.es	/AAI-3238-2021; Serrano, Manuel/H-2634-2015; Strati, Katerina/GSN-2131-2022; Collado, Manuel/K-8140-2014; Blasco, Maria A./M-1694-2014; Villasante, Aranzazu/A-9100-2017	Serrano, Manuel/0000-0001-7177-9312; Strati, Katerina/0000-0002-2332-787X; Collado, Manuel/0000-0002-0330-0880; Blasco, Maria A./0000-0002-4211-233X; Villasante, Aranzazu/0000-0001-7919-9670	Spanish Ministry of Science (MICINN).; 'Ramon y Cajal' contract (MICINN).; Regional Government of Madrid; European Union; European Research Council (ERC),; 'Marcelino Botin' Foundation	Spanish Ministry of Science (MICINN).(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 'Ramon y Cajal' contract (MICINN).(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Union(European Commission); European Research Council (ERC),(European Research Council (ERC)European Commission); 'Marcelino Botin' Foundation	We thank S. Lowe and R. Agami for reagents. We are grateful to M. Munoz, O. Dominguez, D. Megias and H. Schonthaler. H. L. is the recipient of a 'Juan de la Cierva' contract from the Spanish Ministry of Science (MICINN). M. Co. is the recipient of a 'Ramon y Cajal' contract (MICINN). Work in the laboratory of M. S. is funded by the CNIO and by grants from the MICINN (SAF and CONSOLIDER), the Regional Government of Madrid, the European Union, the European Research Council (ERC), and the 'Marcelino Botin' Foundation.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Hara E, 1996, MOL CELL BIOL, V16, P859; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Savatier P, 1996, ONCOGENE, V12, P309; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	31	739	768	0	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1136	U101		10.1038/nature08290	http://dx.doi.org/10.1038/nature08290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19668188	Green Accepted			2022-12-28	WOS:000269314000040
J	Zhang, W; Dunkle, JA; Cate, JHD				Zhang, Wen; Dunkle, Jack A.; Cate, Jamie H. D.			Structures of the Ribosome in Intermediate States of Ratcheting	SCIENCE			English	Article							TRANSFER-RNA TRANSLOCATION; MESSENGER-RNA; 70S RIBOSOME; TRANSLATION TERMINATION; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; HYBRID STATE; COMPLEX; MOVEMENT; BINDING	Protein biosynthesis on the ribosome requires repeated cycles of ratcheting, which couples rotation of the two ribosomal subunits with respect to each other, and swiveling of the head domain of the small subunit. However, the molecular basis for how the two ribosomal subunits rearrange contacts with each other during ratcheting while remaining stably associated is not known. Here, we describe x-ray crystal structures of the intact Escherichia coli ribosome, either in the apo-form (3.5 angstrom resolution) or with one (4.0 angstrom resolution) or two (4.0 angstrom resolution) anticodon stem-loop tRNA mimics bound, that reveal intermediate states of intersubunit rotation. In the structures, the interface between the small and large ribosomal subunits rearranges in discrete steps along the ratcheting pathway. Positioning of the head domain of the small subunit is controlled by interactions with the large subunit and with the tRNA bound in the peptidyl-tRNA site. The intermediates observed here provide insight into how tRNAs move into the hybrid state of binding that precedes the final steps of mRNA and tRNA translocation.	[Zhang, Wen; Dunkle, Jack A.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Zhang, Wen; Dunkle, Jack A.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, W (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jcate@lbl.gov	Classen, Scott/AAY-8176-2020; Dunkle, Jack/ABB-9713-2020; ZHANG, WEN/HHS-1997-2022	Dunkle, Jack/0000-0001-6252-0587; ZHANG, WEN/0000-0002-4973-1168	NIH [GM65050]; National Cancer Institute [CA92584]; National Center for Research Resources [RR-15301]; Department of Energy [DE-AC03 76SF00098, DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065050] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH (grant GM65050 to J.H.D.C., National Cancer Institute grant CA92584 for the SIBYLS and 8.3.1 beamlines at the ALS, and National Center for Research Resources grant RR-15301 for the Northeastern Collaborative Access Team beamlines at 24-ID at the APS) and by the Department of Energy (grants DE-AC03 76SF00098 for the 12.3.1 and 8.3.1 beamlines at the ALS and DE-AC02-06CH11357 for the APS).	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cukras AR, 2005, J MOL BIOL, V349, P47, DOI 10.1016/j.jmb.2005.03.075; Ermolenko DN, 2007, NAT STRUCT MOL BIOL, V14, P493, DOI 10.1038/nsmb1243; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Hoang L, 2004, P NATL ACAD SCI USA, V101, P12439, DOI 10.1073/pnas.0405227101; Horan LH, 2007, P NATL ACAD SCI USA, V104, P4881, DOI 10.1073/pnas.0700762104; Johansen SK, 2006, MOL CELL, V23, P173, DOI 10.1016/j.molcel.2006.05.044; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840	28	191	196	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					1014	1017		10.1126/science.1175275	http://dx.doi.org/10.1126/science.1175275			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696352	Green Accepted			2022-12-28	WOS:000269242800051
J	Barton, GR; Sach, TH; Jenkinson, C; Doherty, M; Avery, AJ; Muir, KR				Barton, Garry R.; Sach, Tracey H.; Jenkinson, Claire; Doherty, Michael; Avery, Anthony J.; Muir, Kenneth R.			Lifestyle interventions for knee pain in overweight and obese adults aged >= 45: economic evaluation of randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COST-EFFECTIVENESS ANALYSIS; EXERCISE PROGRAM; HOME EXERCISE; OLDER-ADULTS; PRIMARY-CARE; OSTEOARTHRITIS; ARTHRITIS; EUROQOL; WEIGHT; HIP	Objective To estimate the cost effectiveness of four different lifestyle interventions for knee pain. Design Cost utility analysis of randomised controlled trial. Setting Five general practices in the United Kingdom. Participants 389 adults aged >= 45 with self reported knee pain and body mass index (BMI) >= 28. Interventions Dietary intervention plus quadriceps strengthening exercises, dietary intervention, quadriceps strengthening exercises, and leaflet provision. Participants received home visits over a two year period. Main outcome measure Incremental cost per quality adjusted life year (QALY) gained over two years from a health service perspective. Results Advice leaflet was associated with a mean change in cost of -31 pound, and a mean QALY gain of 0.085. Both strengthening exercises and dietary intervention were more effective (0.090 and 0.133 mean QALY gain, respectively) but were not cost effective. Dietary intervention plus strengthening exercises had a mean cost of 647 pound and a mean QALY gain of 0.147 and was estimated to have an incremental cost of 10 pound 469 per QALY gain (relative to leaflet provision), and a 23.1% probability of being cost effective at a 20 pound 000/QALY threshold. Conclusion Dietary intervention plus strengthening exercises was estimated to be cost effective for individuals with knee pain, but with a large level of uncertainty.	[Sach, Tracey H.] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Sach, Tracey H.; Jenkinson, Claire; Avery, Anthony J.; Muir, Kenneth R.] Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England; [Barton, Garry R.; Sach, Tracey H.] Univ E Anglia, Hlth Econ Grp, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Doherty, Michael] Univ Nottingham, Acad Rheumatol, Nottingham NG7 2RD, England	University of East Anglia; University of Nottingham; University of East Anglia; University of Nottingham	Sach, TH (corresponding author), Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England.	T.Sach@uea.ac.uk		Doherty, Michael/0000-0002-5763-8326; Sach, Tracey/0000-0002-8098-9220; Avery, Anthony/0000-0001-7591-4438	UK Arthritis Research Campaign (ARC) [13550]	UK Arthritis Research Campaign (ARC)(Versus Arthritis)	The study was funded by the UK Arthritis Research Campaign (ARC) (grant No 13550). ARC had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	[Anonymous], 2008, GUID METH TECHN APPR; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; CANTOR SB, 1994, MED DECIS MAKING, V14, P259, DOI 10.1177/0272989X9401400308; Curtis L, 2007, UNIT COSTS HLTH SOCI; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Hay EM, 2006, BRIT MED J, V333, P995, DOI 10.1136/BMJ.38977.590752.0B; HM Treasury, 2003, GREEN BOOK APPR EV C; Hurley MV, 2007, ARTHRIT RHEUM-ARTHR, V57, P1220, DOI 10.1002/art.23011; Jenkinson CM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3170; Jinks C, 2004, RHEUMATOLOGY, V43, P55, DOI 10.1093/rheumatology/keg438; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Nevitt MC, 1999, AM J MED, V107, P632, DOI 10.1016/S0002-9343(99)00297-1; O'Reilly SC, 1998, ANN RHEUM DIS, V57, P588, DOI 10.1136/ard.57.10.588; O'Reilly SC, 1999, ANN RHEUM DIS, V58, P15, DOI 10.1136/ard.58.1.15; Porcheret M, 2007, RHEUMATOLOGY, V46, P1694, DOI 10.1093/rheumatology/kem232; Porcheret M, 2007, RHEUMATOLOGY, V46, P638, DOI 10.1093/rheumatology/kel340; *PRESCR SUPP UN, 2007, PRESCR COST AN ENGL; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Slemenda C, 1997, ANN INTERN MED, V127, P97, DOI 10.7326/0003-4819-127-2-199707150-00001; Thomas KS, 2005, ARTHRIT RHEUM-ARTHR, V53, P388, DOI 10.1002/art.21173; Thomas KS, 2002, BMJ-BRIT MED J, V325, P752, DOI 10.1136/bmj.325.7367.752	28	15	15	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2009	339								b2273	10.1136/bmj.b2273	http://dx.doi.org/10.1136/bmj.b2273			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486RZ	19690341	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000269216700003
J	Juurlink, DN; Gomes, T; Lipscombe, LL; Austin, PC; Hux, JE; Mamdani, MM				Juurlink, David N.; Gomes, Tara; Lipscombe, Lorraine L.; Austin, Peter C.; Hux, Janet E.; Mamdani, Muhammad M.			Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONGESTIVE-HEART-FAILURE; ACUTE MYOCARDIAL-INFARCTION; TYPE-2 DIABETES-MELLITUS; ACTIVATED-RECEPTOR-GAMMA; ADMINISTRATIVE DATA; GLYCEMIC CONTROL; PULMONARY-EDEMA; TERM RISK; THIAZOLIDINEDIONES; METAANALYSIS	Objective To compare the risk of acute myocardial infarction, heart failure, and death in patients with type 2 diabetes treated with rosiglitazone and pioglitazone. Design Retrospective cohort study. Setting Ontario, Canada. Participants Outpatients aged 66 years and older who were started on rosiglitazone or pioglitazone between 1 April 2002 and 31 March 2008. Main outcome measure Composite of death or hospital admission for either acute myocardial infarction or heart failure. In a secondary analysis, each outcome was also examined individually. Results 39 736 patients who started on either pioglitazone or rosiglitazone were identified. During the six year study period, the composite outcome was reached in 895 (5.3%) of patients taking pioglitazone and 1563 (6.9%) of patients taking rosiglitazone. After extensive adjustment for demographic and clinical factors and drug doses, pioglitazone treated patients had a lower risk of developing the primary outcome than did patients treated with rosiglitazone (adjusted hazard ratio 0.83, 95% confidence interval 0.76 to 0.90). Secondary analyses revealed a lower risk of death (adjusted hazard ratio 0.86, 0.75 to 0.98) and heart failure (0.77, 0.69 to 0.87) with pioglitazone but no significant difference in the risk of acute myocardial infarction (0.95, 0.81 to 1.11). One additional composite outcome would be predicted to occur annually for every 93 patients treated with rosiglitazone rather than pioglitazone. Conclusions Among older patients with diabetes, pioglitazone is associated with a significantly lower risk of heart failure and death than is rosiglitazone. Given that rosiglitazone lacks a distinct clinical advantage over pioglitazone, continued use of rosiglitazone may not be justified.	[Juurlink, David N.; Hux, Janet E.] Sunnybrook Hlth Sci Ctr, Dept Med, Div Clin Pharmacol & Toxicol, Toronto, ON M4N 3M5, Canada; [Juurlink, David N.; Hux, Janet E.; Mamdani, Muhammad M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Juurlink, David N.] Univ Toronto, Dept Pediat, Toronto, ON M5S 1A1, Canada; [Juurlink, David N.; Austin, Peter C.; Hux, Janet E.; Mamdani, Muhammad M.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada; [Juurlink, David N.; Gomes, Tara; Lipscombe, Lorraine L.; Austin, Peter C.; Hux, Janet E.; Mamdani, Muhammad M.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Lipscombe, Lorraine L.] Womens Coll Hosp, Toronto, ON M5S 1B2, Canada; [Austin, Peter C.] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5S 1A1, Canada; [Mamdani, Muhammad M.] St Michaels Hosp, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Juurlink, DN (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Med, Div Clin Pharmacol & Toxicol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dnj@ices.on.ca		Gomes, Tara/0000-0002-1468-1965; Austin, Peter/0000-0003-3337-233X; Lipscombe, Lorraine/0000-0001-7412-7993	Ontario Ministry of Health and Long Term Care; Canadian Institutes for Health Research; Heart and Stroke Foundation of Ontario; Canadian Diabetes Association	Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Diabetes Association	This project was supported by a grant from the Ontario Ministry of Health and Long Term Care, which had no role in the design, analysis, writing, or interpretation of the study. DNJ is supported by a new investigator award from the Canadian Institutes for Health Research. PCA is supported by a career investigator award from the Heart and Stroke Foundation of Ontario. LLL is supported by a clinician scientist award from the Canadian Diabetes Association and Canadian Institutes for Health Research.	Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; AUSTIN PC, 2009, J CLIN EPIDEMIO 0218; Boyle PJ, 2002, CLIN THER, V24, P378, DOI 10.1016/S0149-2918(02)85040-8; Diamond GA, 2007, NEW ENGL J MED, V357, P938; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gerrits CM, 2007, PHARMACOEPIDEM DR S, V16, P1065, DOI 10.1002/pds.1470; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Haffner SM, 1999, DIABETES CARE, V22, P562, DOI 10.2337/diacare.22.4.562; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jamieson A, 2004, MAYO CLIN PROC, V79, P571, DOI 10.4065/79.4.571; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Karter AJ, 2005, DIABETIC MED, V22, P986, DOI 10.1111/j.1464-5491.2005.01704.x; Kermani A, 2003, MAYO CLIN PROC, V78, P1088, DOI 10.4065/78.9.1088; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; Margolis DJ, 2008, PHARMACOEPIDEM DR S, V17, P753, DOI 10.1002/pds.1630; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Pfutzner A, 2005, J AM COLL CARDIOL, V45, P1925, DOI 10.1016/j.jacc.2005.03.041; Psaty BM, 2007, NEW ENGL J MED, V357, P67, DOI 10.1056/NEJMe078116; Rosen CJ, 2007, NEW ENGL J MED, V357, P844, DOI 10.1056/NEJMp078167; Shah BR, 2008, DIABETIC MED, V25, P871, DOI 10.1111/j.1464-5491.2008.02462.x; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Solomon DH, 2007, JAMA-J AM MED ASSOC, V298, P1216, DOI 10.1001/jama.298.10.1216; Stafylas PC, 2009, INT J CARDIOL, V131, P298, DOI 10.1016/j.ijcard.2008.06.005; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Young PW, 1998, J PHARMACOL EXP THER, V284, P751; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102; Zinn A, 2008, CLIN CARDIOL, V31, P397, DOI 10.1002/clc.20312	35	116	117	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2009	339								b2942	10.1136/bmj.b2942	http://dx.doi.org/10.1136/bmj.b2942			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486RZ	19690342	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000269216700004
J	Lackner, LL; Horner, JS; Nunnari, J				Lackner, Laura L.; Horner, Jennifer S.; Nunnari, Jodi			Mechanistic Analysis of a Dynamin Effector	SCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; WD REPEAT PROTEIN; MITOCHONDRIAL FISSION; MEMBRANE FISSION; MAMMALIAN-CELLS; DIVISION; DNM1P; AMPHIPHYSIN; MORPHOLOGY; CURVATURE	Dynamin-related proteins (DRPs) can generate forces to remodel membranes. In cells, DRPs require additional proteins [DRP-associated proteins (DAPs)] to conduct their functions. To dissect the mechanistic role of a DAP, we used the yeast mitochondrial division machine as a model, which requires the DRP Dnm1, and two other proteins, Mdv1 and Fis1. Mdv1 played a postmitochondrial targeting role in division by specifically interacting and coassembling with the guanosine triphosphate-bound form of Dnm1. This regulated interaction nucleated and promoted the self-assembly of Dnm1 into helical structures, which drive membrane scission. The nucleation of DRP assembly probably represents a general regulatory strategy for this family of filament-forming proteins, similar to F-actin regulation.	[Lackner, Laura L.; Horner, Jennifer S.; Nunnari, Jodi] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Nunnari, J (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	jmnunnari@ucdavis.edu			NIH [R01GM062942, 1F32GM078749]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097432, F32GM078749, R01GM062942] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.N. is supported by NIH grant R01GM062942. L.L.L. is supported by NIH postdoctoral fellowship 1F32GM078749	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cerveny KL, 2007, DEV CELL, V12, P363, DOI 10.1016/j.devcel.2007.01.017; Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Jensen RE, 2000, MICROSC RES TECHNIQ, V51, P573, DOI 10.1002/1097-0029(20001215)51:6<573::AID-JEMT7>3.0.CO;2-2; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; Lackner LL, 2009, BBA-MOL BASIS DIS, V1792, P1138, DOI 10.1016/j.bbadis.2008.11.011; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Youle RJ, 2005, DEV CELL, V8, P298, DOI 10.1016/j.devcel.2005.02.003	31	102	104	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					874	877		10.1126/science.1176921	http://dx.doi.org/10.1126/science.1176921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679814	Green Accepted			2022-12-28	WOS:000269242400046
J	Califf, RM; Harrington, RA; Blazing, MA				Califf, Robert M.; Harrington, Robert A.; Blazing, Michael A.			Premature Release of Data from Clinical Trials of Ezetimibe	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SIMVASTATIN		[Califf, Robert M.] Duke Translat Med Inst, Durham, NC USA; [Harrington, Robert A.; Blazing, Michael A.] Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University	Califf, RM (corresponding author), Duke Translat Med Inst, Durham, NC USA.							Baigent C, 2003, KIDNEY INT, V63, pS207, DOI 10.1046/j.1523-1755.63.s84.4.x; Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x; Clader JW, 2004, J MED CHEM, V47, P1, DOI 10.1021/jm030283g; *CLINICALTRIALS GO, NCT00202878 CLINICAL; DeMets David L, 2004, Clin Trials, V1, P525, DOI 10.1191/1740774504cn54oa; *DIV MET END DRUG, 1990, GUID CLIN EV LIP ALT; Fleming TR, 2008, NEW ENGL J MED, V359, P1400, DOI 10.1056/NEJMe0807372; Meng C Q, 2001, Curr Opin Investig Drugs, V2, P389; Peto R, 2008, NEW ENGL J MED, V359, P1357, DOI 10.1056/NEJMsa0806603; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Rossebo AB, 2007, AM J CARDIOL, V99, P970, DOI 10.1016/j.amjcard.2006.10.064; Sager PT, 2003, AM J CARDIOL, V92, P1414, DOI 10.1016/j.amjcard.2003.08.048; Taylor AJ, 2008, CIRC-CARDIOVASC QUAL, V1, P54, DOI 10.1161/CIRCOUTCOMES.108.811901; Wood AJJ, 2009, NEW ENGL J MED, V360, P824, DOI 10.1056/NEJMsr0806582	15	23	26	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					712	717		10.1056/NEJMsr0900910	http://dx.doi.org/10.1056/NEJMsr0900910			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19675335	Bronze			2022-12-28	WOS:000268884100015
J	Lu, Y; Yeung, N; Sieracki, N; Marshall, NM				Lu, Yi; Yeung, Natasha; Sieracki, Nathan; Marshall, Nicholas M.			Design of functional metalloproteins	NATURE			English	Review							DE-NOVO DESIGN; 3-STRANDED COILED COILS; UNNATURAL AMINO-ACIDS; HEME-COPPER OXIDASES; GREEN FLUORESCENT PROTEIN; METAL-ION COORDINATION; BINDING-PROTEIN; ARTIFICIAL METALLOENZYMES; ELECTRON-TRANSFER; 4-HELIX BUNDLE	Metalloproteins catalyse some of the most complex and important processes in nature, such as photosynthesis and water oxidation. An ultimate test of our knowledge of how metalloproteins work is to design new metalloproteins. Doing so not only can reveal hidden structural features that may be missing from studies of native metalloproteins and their variants, but also can result in new metalloenzymes for biotechnological and pharmaceutical applications. Although it is much more challenging to design metalloproteins than non-metalloproteins, much progress has been made in this area, particularly in functional design, owing to recent advances in areas such as computational and structural biology.	[Lu, Yi; Yeung, Natasha; Sieracki, Nathan; Marshall, Nicholas M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Lu, Y (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	yi-lu@illinois.edu	Lu, Yi/B-5461-2010; Lu, Yi/GQQ-1069-2022; liu, yi/GXE-9662-2022	Lu, Yi/0000-0003-1221-6709; Lu, Yi/0000-0003-1221-6709; 	US National Science Foundation [CHE 05-52008]; National Institutes of Health [GM062211]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062211] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. F. DeGrado, B. R. Gibney and P. L. Dutton for providing images used in Figure 1, N. Nagraj for help with editing the manuscript, and the US National Science Foundation (CHE 05-52008) and National Institutes of Health (GM062211) for financial support.	Abe S, 2009, TOP ORGANOMETAL CHEM, V25, P25, DOI 10.1007/3418_2008_4; Barker PD, 2003, CURR OPIN STRUC BIOL, V13, P490, DOI 10.1016/S0959-440X(03)00108-8; BARRICK D, 1995, CURR OPIN BIOTECH, V6, P411, DOI 10.1016/0958-1669(95)80070-0; Bender GM, 2007, J AM CHEM SOC, V129, P10732, DOI 10.1021/ja071199j; Benson DE, 1998, BIOCHEMISTRY-US, V37, P7070, DOI 10.1021/bi980583d; Berry SM, 2003, J AM CHEM SOC, V125, P8760, DOI 10.1021/ja029699u; Berry SM, 2002, J AM CHEM SOC, V124, P2084, DOI 10.1021/ja0169163; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Calhoun JR, 2008, J AM CHEM SOC, V130, P9188, DOI 10.1021/ja801657y; Carey JR, 2004, J AM CHEM SOC, V126, P10812, DOI 10.1021/ja046908x; Case MA, 2004, ACCOUNTS CHEM RES, V37, P754, DOI 10.1021/ar960245+; Chen CHB, 2001, CHEMBIOCHEM, V2, P735, DOI 10.1002/1439-7633(20011001)2:10<735::AID-CBIC735>3.0.CO;2-#; CHOMA CT, 1994, J AM CHEM SOC, V116, P856, DOI 10.1021/ja00082a005; Cochran FV, 2005, J AM CHEM SOC, V127, P1346, DOI 10.1021/ja044129a; Collot J, 2003, J AM CHEM SOC, V125, P9030, DOI 10.1021/ja035545i; Creus M, 2008, ANGEW CHEM INT EDIT, V47, P1400, DOI 10.1002/anie.200704865; Das A, 2007, J INORG BIOCHEM, V101, P1820, DOI 10.1016/j.jinorgbio.2007.07.024; Davies RR, 1997, J AM CHEM SOC, V119, P11643, DOI 10.1021/ja970820k; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DeGrado WF, 1999, ANNU REV BIOCHEM, V68, P779, DOI 10.1146/annurev.biochem.68.1.779; DENNISON C, 1995, FEBS LETT, V365, P92, DOI 10.1016/0014-5793(95)00429-D; Desjarlais JR, 1998, CURR OPIN STRUC BIOL, V8, P471, DOI 10.1016/S0959-440X(98)80125-5; Dieckmann GR, 1997, J AM CHEM SOC, V119, P6195, DOI 10.1021/ja964351i; Evers TH, 2007, J MOL BIOL, V374, P411, DOI 10.1016/j.jmb.2007.09.021; Farrer BT, 2003, P NATL ACAD SCI USA, V100, P3760, DOI 10.1073/pnas.0336055100; Farver O, 1999, P NATL ACAD SCI USA, V96, P899, DOI 10.1073/pnas.96.3.899; Fasan R, 2007, ANGEW CHEM INT EDIT, V46, P8414, DOI 10.1002/anie.200702616; Franklin SJ, 2005, COMMENT INORG CHEM, V26, P127, DOI 10.1080/02603590500201188; Ghosh D, 2005, BIOCHEMISTRY-US, V44, P10732, DOI 10.1021/bi0506674; Ghosh D, 2005, CURR OPIN CHEM BIOL, V9, P97, DOI 10.1016/j.cbpa.2005.02.005; HANDEL T, 1990, J AM CHEM SOC, V112, P6710, DOI 10.1021/ja00174a039; Hay M, 1996, P NATL ACAD SCI USA, V93, P461, DOI 10.1073/pnas.93.1.461; Hayashi T, 2002, ACCOUNTS CHEM RES, V35, P35, DOI 10.1021/ar000087t; Hayashi T, 2006, INORG CHEM, V45, P10530, DOI 10.1021/ic061130x; Huang SS, 2004, P NATL ACAD SCI USA, V101, P5536, DOI 10.1073/pnas.0306676101; Ikeda Y, 2003, PROTEIN ENG, V16, P699, DOI 10.1093/protein/gzg084; Iranzo O, 2009, CHEM-EUR J, V15, P3761, DOI 10.1002/chem.200802105; Jensen KK, 2001, BIOCHEMISTRY-US, V40, P938, DOI 10.1021/bi001765m; Jones LH, 2003, J BIOL CHEM, V278, P47269, DOI 10.1074/jbc.M308863200; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Kharenko OA, 2004, J INORG BIOCHEM, V98, P1971, DOI 10.1016/j.jinorgbio.2004.07.015; KLEMBA M, 1995, BIOCHEMISTRY-US, V34, P10094, DOI 10.1021/bi00031a034; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; Kono H, 2001, J MOL BIOL, V306, P607, DOI 10.1006/jmbi.2000.4422; Lee HS, 2008, J AM CHEM SOC, V130, P13194, DOI 10.1021/ja804653f; Lee KH, 2006, ANGEW CHEM INT EDIT, V45, P2864, DOI 10.1002/anie.200504548; Letondor C, 2006, J AM CHEM SOC, V128, P8320, DOI 10.1021/ja061580o; Lombardi A, 2000, P NATL ACAD SCI USA, V97, P6298, DOI 10.1073/pnas.97.12.6298; Low DW, 1998, J AM CHEM SOC, V120, P11536, DOI 10.1021/ja982920b; Low DW, 2000, J AM CHEM SOC, V122, P11039, DOI 10.1021/ja001218o; Lu Y, 2001, CHEM REV, V101, P3047, DOI 10.1021/cr0000574; Lu Y, 2005, CURR OPIN CHEM BIOL, V9, P118, DOI 10.1016/j.cbpa.2005.02.017; Lu Y, 2006, INORG CHEM, V45, P9930, DOI 10.1021/ic052007t; Matsuo T, 2002, J AM CHEM SOC, V124, P11234, DOI 10.1021/ja027291r; Matthews JM, 2008, CURR OPIN STRUC BIOL, V18, P484, DOI 10.1016/j.sbi.2008.04.009; Matzapetakis M, 2002, J AM CHEM SOC, V124, P8042, DOI 10.1021/ja017520u; Merrifield B, 1997, METHOD ENZYMOL, V289, P3; Mizuno T, 2007, J AM CHEM SOC, V129, P11378, DOI 10.1021/ja0685102; Monien BH, 2007, J MOL BIOL, V371, P739, DOI 10.1016/j.jmb.2007.05.047; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; MULLER HN, 1994, BIOCHEMISTRY-US, V33, P14126; Nanda V, 2005, J AM CHEM SOC, V127, P5804, DOI 10.1021/ja050553f; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Ohashi M, 2003, ANGEW CHEM INT EDIT, V42, P1005, DOI 10.1002/anie.200390256; Ory JJ, 1998, PROTEIN ENG, V11, P253, DOI 10.1093/protein/11.4.253; Ozaki S, 1996, J AM CHEM SOC, V118, P9784, DOI 10.1021/ja961223l; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Peacock AFA, 2008, P NATL ACAD SCI USA, V105, P16566, DOI 10.1073/pnas.0806792105; Peacock AFA, 2009, DALTON T, P2271, DOI 10.1039/b818306f; Petros AK, 2004, INORG CHEM, V43, P4793, DOI 10.1021/ic0497679; Petros AK, 2006, INORG CHEM, V45, P9941, DOI 10.1021/ic052190q; Privett HK, 2002, J AM CHEM SOC, V124, P6828, DOI 10.1021/ja025534+; Qi DF, 2001, CHEM REV, V101, P3081, DOI 10.1021/cr000059o; Rasmussen BS, 2007, CHEMBIOCHEM, V8, P1974, DOI 10.1002/cbic.200700295; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Robinson H, 1999, BIOCHEMISTRY-US, V38, P5677, DOI 10.1021/bi9901634; Salgado EN, 2007, J AM CHEM SOC, V129, P13374, DOI 10.1021/ja075261o; SASAKI T, 1989, J AM CHEM SOC, V111, P380, DOI 10.1021/ja00183a065; Shete VS, 2009, BIOCHEMISTRY-US, V48, P462, DOI 10.1021/bi801777h; Sigman JA, 2003, P NATL ACAD SCI USA, V100, P3629, DOI 10.1073/pnas.0737308100; Sigman JA, 2000, J AM CHEM SOC, V122, P8192, DOI 10.1021/ja0015343; Steinreiber J, 2008, COORDIN CHEM REV, V252, P751, DOI 10.1016/j.ccr.2007.09.016; Summa CM, 2002, J MOL BIOL, V321, P923, DOI 10.1016/S0022-2836(02)00589-2; Touw DS, 2007, P NATL ACAD SCI USA, V104, P11969, DOI 10.1073/pnas.0701979104; Ueno T, 2004, INORG CHEM, V43, P2852, DOI 10.1021/ic0498539; Ueno T, 2004, J PORPHYR PHTHALOCYA, V8, P279, DOI 10.1142/S108842460400026X; Ueno T, 2004, ANGEW CHEM INT EDIT, V43, P2527, DOI 10.1002/anie.200353436; Varpness Z, 2005, NANO LETT, V5, P2306, DOI 10.1021/nl0517619; VITA C, 1995, P NATL ACAD SCI USA, V92, P6404, DOI 10.1073/pnas.92.14.6404; Wang NY, 2005, J AM CHEM SOC, V127, P16541, DOI 10.1021/ja052659g; Wegner SV, 2009, ANGEW CHEM INT EDIT, V48, P2339, DOI 10.1002/anie.200805262; WILLIAMS RJP, 1995, EUR J BIOCHEM, V234, P363, DOI 10.1111/j.1432-1033.1995.363_b.x; WILSON ME, 1978, J AM CHEM SOC, V100, P306, DOI 10.1021/ja00469a064; Yang W, 2003, J AM CHEM SOC, V125, P6165, DOI 10.1021/ja034724x; Yeung BKS, 1997, CHEM BIOL, V4, P215, DOI 10.1016/S1074-5521(97)90291-X; Yeung N, 2008, CHEM BIODIVERS, V5, P1437, DOI 10.1002/cbdv.200890134; Yin J, 2004, J AM CHEM SOC, V126, P3006, DOI 10.1021/ja039198o; Zhang JL, 2008, CHEM COMMUN, P1665, DOI 10.1039/b718915j; Zhao X, 2006, J AM CHEM SOC, V128, P6766, DOI 10.1021/ja058822p	100	539	545	9	380	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					855	862		10.1038/nature08304	http://dx.doi.org/10.1038/nature08304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675646	Green Accepted			2022-12-28	WOS:000268938300030
J	Scarmeas, N; Luchsinger, JA; Schupf, N; Brickman, AM; Cosentino, S; Tang, MX; Stern, Y				Scarmeas, Nikolaos; Luchsinger, Jose A.; Schupf, Nicole; Brickman, Adam M.; Cosentino, Stephanie; Tang, Ming X.; Stern, Yaakov			Physical Activity, Diet, and Risk of Alzheimer Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDITERRANEAN DIET; GROWTH-FACTOR; COGNITIVE IMPAIRMENT; LEISURE ACTIVITIES; OLDER-ADULTS; LATE-LIFE; DEMENTIA; EXERCISE; BRAIN; POPULATION	Context Both higher adherence to a Mediterranean-type diet and more physical activity have been independently associated with lower Alzheimer disease ( AD) risk but their combined association has not been investigated. Objective To investigate the combined association of diet and physical activity with AD risk. Design, Setting, and Patients Prospective cohort study of 2 cohorts comprising 1880 community-dwelling elders without dementia living in New York, New York, with both diet and physical activity information available. Standardized neurological and neuropsychological measures were administered approximately every 1.5 years from 1992 through 2006. Adherence to a Mediterranean-type diet (scale of 0-9; trichotomized into low, middle, or high; and dichotomized into low or high) and physical activity (sum of weekly participation in various physical activities, weighted by the type of physical activity [light, moderate, vigorous]; trichotomized into no physical activity, some, or much; and dichotomized into low or high), separately and combined, were the main predictors in Cox models. Models were adjusted for cohort, age, sex, ethnicity, education, apolipoprotein E genotype, caloric intake, body mass index, smoking status, depression, leisure activities, a comorbidity index, and baseline Clinical Dementia Rating score. Main Outcome Measure Time to incident AD. Results A total of 282 incident AD cases occurred during a mean (SD) of 5.4 (3.3) years of follow-up. When considered simultaneously, both Mediterranean-type diet adherence (compared with low diet score, hazard ratio [HR] for middle diet score was 0.98 [95% confidence interval {CI}, 0.72-1.33]; the HR for high diet score was 0.60 [95% CI, 0.42-0.87]; P=.008 for trend) and physical activity (compared with no physical activity, the HR for some physical activity was 0.75 [95% CI, 0.54-1.04]; the HR for much physical activity was 0.67 [95% CI, 0.47-0.95]; P=.03 for trend) were associated with lower AD risk. Compared with individuals neither adhering to the diet nor participating in physical activity (low diet score and no physical activity; absolute AD risk of 19%), those both adhering to the diet and participating in physical activity (high diet score and high physical activity) had a lower risk of AD (absolute risk, 12%; HR, 0.65 [95% CI, 0.44-0.96]; P=.03 for trend). Conclusion In this study, both higher Mediterranean-type diet adherence and higher physical activity were independently associated with reduced risk for AD. JAMA. 2009; 302(6):627-637 www.jama.com	[Scarmeas, Nikolaos; Luchsinger, Jose A.; Schupf, Nicole; Brickman, Adam M.; Cosentino, Stephanie; Stern, Yaakov] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Scarmeas, Nikolaos; Schupf, Nicole; Brickman, Adam M.; Cosentino, Stephanie; Tang, Ming X.; Stern, Yaakov] Columbia Univ, Med Ctr, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Scarmeas, Nikolaos; Brickman, Adam M.; Cosentino, Stephanie; Stern, Yaakov] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Luchsinger, Jose A.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Scarmeas, N (corresponding author), Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, 622 W 168th St,19th Floor, New York, NY 10032 USA.	ns257@columbia.edu	Scarmeas, Nikolaos/AAD-2512-2020; Scarmeas, Nikolaos/AAD-2517-2020	Scarmeas, Nikolaos/0000-0001-6453-8908; Scarmeas, Nikolaos/0000-0001-6453-8908; Stern, Yaakov/0000-0001-7542-3241; Luchsinger, Jose/0000-0002-5886-3648	National Institute on Aging [AG028506, P01AG07232]; NATIONAL INSTITUTE ON AGING [P50AG008702, R01AG037212, R01AG028506, P01AG007232] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by National Institute on Aging grants AG028506 and P01AG07232.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; BLOMSTRAND E, 1989, ACTA PHYSIOL SCAND, V136, P473, DOI 10.1111/j.1748-1716.1989.tb08689.x; Borst SE, 2002, J AM GERIATR SOC, V50, P884, DOI 10.1046/j.1532-5415.2002.50215.x; Botto LD, 2001, AM J EPIDEMIOL, V153, P1016, DOI 10.1093/aje/153.10.1016; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; Forbes D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub2; FORDYCE DE, 1991, BEHAV BRAIN RES, V43, P115, DOI 10.1016/S0166-4328(05)80061-0; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; Luchsinger JA, 2003, ARCH NEUROL-CHICAGO, V60, P203, DOI 10.1001/archneur.60.2.203; Luchsinger JA, 2007, CURR NEUROL NEUROSCI, V7, P366, DOI 10.1007/s11910-007-0057-8; Middleton LE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003124; MILLER DJ, 1994, MED SCI SPORT EXER, V26, P376; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; Reuben DB, 2003, J AM GERIATR SOC, V51, P1125, DOI 10.1046/j.1532-5415.2003.51380.x; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; SALLIS JF, 1993, MED SCI SPORT EXER, V25, P99, DOI 10.1249/00005768-199301000-00014; Scarmeas N, 2006, J NEUROL NEUROSUR PS, V77, P308, DOI 10.1136/jnnp.2005.072306; Scarmeas N, 2005, NEUROLOGY, V64, P1696, DOI 10.1212/01.WNL.0000162054.15428.E9; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Scarmeas N, 2005, ARCH NEUROL-CHICAGO, V62, P1601, DOI 10.1001/archneur.62.10.1601; Scarmeas N, 2007, NEUROLOGY, V69, P1084, DOI 10.1212/01.wnl.0000277320.50685.7c; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P216, DOI 10.1001/archneurol.2008.536; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Scarmeas N, 2006, ARCH NEUROL-CHICAGO, V63, P1709, DOI 10.1001/archneur.63.12.noc60109; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wang L, 2006, ARCH INTERN MED, V166, P1115, DOI 10.1001/archinte.166.10.1115; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742	50	587	609	2	118	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					627	637		10.1001/jama.2009.1144	http://dx.doi.org/10.1001/jama.2009.1144			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481ZI	19671904	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000268852300021
J	Barge-Caballero, E; Estevez-Cid, F; Bouzos-Mosquera, A; Juffe-Stein, A; Castro-Beiras, A				Barge-Caballero, Eduardo; Estevez-Cid, Francisco; Bouzos-Mosquera, Alberto; Juffe-Stein, Alberto; Castro-Beiras, Alfonso			Chest radiography of life-supporting medical interventions	LANCET			English	Editorial Material									[Barge-Caballero, Eduardo; Bouzos-Mosquera, Alberto; Castro-Beiras, Alfonso] A Coruna Univ Hosp, Dept Cardiol, La Coruna 15006, Spain; [Estevez-Cid, Francisco; Juffe-Stein, Alberto] A Coruna Univ Hosp, Dept Cardiovasc Surg, La Coruna 15006, Spain	Complejo Hospitalario Universitario A Coruna; Complejo Hospitalario Universitario A Coruna	Barge-Caballero, E (corresponding author), A Coruna Univ Hosp, Dept Cardiol, Xubias 84, La Coruna 15006, Spain.	blargesbueno@hotmail.com	Bouzas-Mosquera, Alberto/S-3919-2018	Bouzas-Mosquera, Alberto/0000-0002-2741-732X; Estevez-Cid, Francisco/0000-0002-3258-4712					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2009	374	9688					476	476		10.1016/S0140-6736(09)60312-3	http://dx.doi.org/10.1016/S0140-6736(09)60312-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482OK	19665646				2022-12-28	WOS:000268898400029
J	van Vollenhoven, RF; Ernestam, S; Geborek, P; Petersson, IF; Coster, L; Waltbrand, E; Zickert, A; Theander, J; Thorner, A; Hellstrom, H; Teleman, A; Dackhammar, C; Akre, F; Forslind, K; Ljung, L; Oding, R; Chatzidionysiou, A; Wornert, M; Bratt, J				van Vollenhoven, R. F.; Ernestam, S.; Geborek, P.; Petersson, I. F.; Coster, L.; Waltbrand, E.; Zickert, A.; Theander, J.; Thorner, A.; Hellstrom, H.; Teleman, A.; Dackhammar, C.; Akre, F.; Forslind, K.; Ljung, L.; Oding, R.; Chatzidionysiou, A.; Wornert, M.; Bratt, J.			Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial	LANCET			English	Article							PLACEBO-CONTROLLED TRIAL; COLLEGE-OF-RHEUMATOLOGY; DOUBLE-BLIND; COMBINATION THERAPY; NECROSIS-FACTOR; 3 MEDICATIONS; EFFICACY; MONOTHERAPY; ETANERCEPT; VALIDATION	Background New treatment strategies for early rheumatoid arthritis are evolving rapidly. We aimed to compare addition of conventional disease-modifying antirheumatic drugs (sulfasalazine and hydroxychloroquine) with addition of a tumour necrosis factor antagonist (infliximab) to methotrexate in patients with early rheumatoid arthritis. Methods We undertook a randomised trial in 15 rheumatology units in Sweden. We enrolled patients with early rheumatoid arthritis (symptom duration <1 year) and administered methotrexate (up to 20 mg per week). After 3-4 months, those who had not achieved low disease activity but who could tolerate methotrexate were randomly allocated by computer addition of either sulfasalazine and hydroxychloroquine or infliximab. Primary outcome was achievement of a good response according to European League Against Rheumatism (EULAR) criteria at 12 months. Patients were followed up to 24 months; here, we present findings at 12 months. Analysis was by intention to treat and we used non-responder imputation. The Swefot (Swedish Pharmacotherapy) study is registered in the WHO database at the Karolinska University Hospital, number CT20080004. Findings 487 patients were initially enrolled. Of 258 who had not achieved low disease activity with methotrexate, 130 were allocated sulfasalazine and hydroxychloroquine and 128 were assigned infliximab. 32 of 130 (25%) patients allocated sulfasalazine and hydroxychloroquine achieved the primary outcome compared with 50 of 128 (39%) assigned infliximab (risk ratio 1.59 [95% CI 1.10-2.30], p=0.0160). Adverse events were balanced fairly well between the two groups and accorded with known adverse events of the drugs used. No deaths occurred in either group. Interpretation In patients with early rheumatoid arthritis in whom methotrexate treatment failed, addition of a tumour necrosis factor antagonist to methotrexate monotherapy is clinically superior to addition of conventional disease-modifying antirheumatic drugs. Funding Swedish Rheumatism Association, Schering-Plough.	[van Vollenhoven, R. F.] Karolinska Inst, Rheumatol Unit, S-17176 Stockholm, Sweden; [van Vollenhoven, R. F.; Ernestam, S.; Chatzidionysiou, A.; Wornert, M.; Bratt, J.] Karolinska Univ Hosp, Rheumatol Clin, Stockholm, Sweden; [Zickert, A.] Danderyd Hosp, Dept Rheumatol, Stockholm, Sweden; [Geborek, P.; Petersson, I. F.; Forslind, K.] Univ Lund Hosp, Rheumatol Clin, S-22185 Lund, Sweden; [Petersson, I. F.] Univ Lund Hosp, Orthopaed Clin, S-22185 Lund, Sweden; [Coster, L.] Linkoping Univ Hosp, Dept Rheumatol, S-58185 Linkoping, Sweden; [Waltbrand, E.] Lasarettet, Dept Rheumatol, Boras, Sweden; [Theander, J.] Cent Sjukhuset, Dept Rheumatol, Kristianstad, Sweden; [Thorner, A.] Malarsjukhuset, Dept Rheumatol, Eskilstuna, Sweden; [Hellstrom, H.] Lasarettet, Dept Rheumatol, Falun, Sweden; [Teleman, A.] Spenshult Hosp, Dept Rheumatol, Halmstad, Sweden; [Dackhammar, C.] Univ Hosp, Dept Rheumatol, Molndal, Sweden; [Akre, F.] Univ Hosp, Dept Rheumatol, Orebro, Sweden; [Forslind, K.] Lasarettet, Dept Rheumatol, Helsingborg, Sweden; [Ljung, L.] Umea Univ Hosp, Dept Rheumatol, S-90185 Umea, Sweden; [Oding, R.] Cent Lasarettet, Dept Rheumatol, Vasteras, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Linkoping University; Orebro University; Helsingborgs Hospital; Umea University; Vasteras Central Hospital	van Vollenhoven, RF (corresponding author), Karolinska Inst, Rheumatol Unit, S-17176 Stockholm, Sweden.	ronald.van.vollenhoven@ki.se	Ljung, Lotta/H-8919-2019; van Vollenhoven, Ronald/ABE-1244-2021; Ljung, Lennart/B-3822-2014	Ljung, Lotta/0000-0001-8999-0925; Ljung, Lennart/0000-0003-4881-8955; Chatzidionysiou, Katerina/0000-0002-2669-1247; Petersson, Ingemar/0000-0001-9139-1892; Chatzidionysiou, Katerina/0000-0002-2163-0525	Stockholm county	Stockholm county(Stockholm County Council)	We thank all patients, study nurses, coinvestigators, and colleagues who made this trial possible; and Bjorn Svensson and Ingiald Hafstrom who founded and led the BARFOT (Battre AntiReumatisk FarmakOTerapie; better antirheumatic pharmacotherapy) study group. We dedicate this report to Thomas Lerndal, who was actively engaged in this trial until he was lost in the tsunami of December, 2004. The Swefot study was supported in part by a grant from the Swedish Rheumatism Association. RvV and SE were supported by clinical research funds from Stockholm county. An annual unrestricted grant was provided by Schering-Plough Sweden, which was used to support M W. Schering-Plough also provided support for a medical monitor during a limited period, for several investigator meetings, and is currently providing support for radiographic analyses.	Alonso-Ruiz A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-52; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Clair EWS, 2002, ARTHRITIS RHEUM, V46, P1451, DOI 10.1002/art.10302; Emery P, 2008, RHEUMATOLOGY, V47, P392, DOI 10.1093/rheumatology/kem257; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P1164, DOI 10.1002/art.10228; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; Pavelka K, 2009, ANN RHEUM DIS, V68, P1285, DOI 10.1136/ard.2008.090860; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Quinn MA, 2005, ARTHRITIS RHEUM-US, V52, P27, DOI 10.1002/art.20712; Svensson B, 2005, ARTHRITIS RHEUM-US, V52, P3360, DOI 10.1002/art.21298; TUGWELL P, 1995, NEW ENGL J MED, V333, P137, DOI 10.1056/NEJM199507203330301; van der Bijl AE, 2007, ARTHRITIS RHEUM-US, V56, P2129, DOI 10.1002/art.22718; van Vollenhoven RF, 2004, ANN RHEUM DIS, V63, P426, DOI 10.1136/ard.2003.010967; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wessels JAM, 2007, ARTHRITIS RHEUM-US, V56, P1765, DOI 10.1002/art.22640	22	236	251	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2009	374	9688					459	466		10.1016/S0140-6736(09)60944-2	http://dx.doi.org/10.1016/S0140-6736(09)60944-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482OK	19665644				2022-12-28	WOS:000268898400027
J	Whitby, E				Whitby, Elspeth			Minimally invasive autopsy	LANCET			English	Editorial Material							POSTMORTEM; ADJUNCT		Univ Sheffield, Royal Hallamshire Hosp, Unit Acad Radiol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Whitby, E (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Unit Acad Radiol, Sheffield S10 2JF, S Yorkshire, England.	e.whitby@sheffield.ac.uk	Whitby, Elspeth/G-5517-2010	Whitby, Elspeth/0000-0002-8912-8013				[Anonymous], 2009, BBC NEWS        0421; Breeze ACG, 2006, ULTRASOUND OBST GYN, V28, P918, DOI 10.1002/uog.3886; Brookes JAS, 1996, LANCET, V348, P1139, DOI 10.1016/S0140-6736(96)02287-8; Brookes JS, 1997, ULTRASOUND OBST GYN, V9, P145, DOI 10.1046/j.1469-0705.1997.09030145.x; Hagmann CF, 2007, ARCH DIS CHILD-FETAL, V92, pF215, DOI 10.1136/fnn.2005.092387; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; ROS PR, 1990, MAGN RESON IMAGING, V8, P303, DOI 10.1016/0730-725X(90)90103-9; Thayyil S, 2009, LANCET, V374, P467, DOI 10.1016/S0140-6736(09)60913-2; Whitby EH, 2005, SEMIN FETAL NEONAT M, V10, P475, DOI 10.1016/j.siny.2005.05.006; Woodward PJ, 1997, AM J ROENTGENOL, V168, P41, DOI 10.2214/ajr.168.1.8976917	10	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2009	374	9688					432	433		10.1016/S0140-6736(09)61433-1	http://dx.doi.org/10.1016/S0140-6736(09)61433-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482OK	19665631				2022-12-28	WOS:000268898400006
J	Dudukovic, MP				Dudukovic, Milorad P.			Frontiers in Reactor Engineering	SCIENCE			English	Editorial Material							METHANOL SYNTHESIS; FLOW REACTOR; SOLID RISER; LIQUID	The key challenge for reactor engineering is to establish the scientifically based sustainable technologies necessary for meeting the future energy, environmental, and materials needs of the world. This goal requires advancing our scientific understanding of multiscale kinetic transport interactions to enable better reactor choice and to ensure higher reactor and process efficiencies.	Washington Univ, Chem React Engn Lab, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA	Washington University (WUSTL)	Dudukovic, MP (corresponding author), Washington Univ, Chem React Engn Lab, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA.	dudu@wustl.edu						Agreda V.H., 1984, U. S. Patent, Patent No. 4435595; Allen D.T., 2002, GREEN ENG ENV CONSCI; Annaland MV, 2002, CHEM ENG SCI, V57, P855; BAUMAN H, 2004, H HIKERS GUIDE LCA; Bhusarapu S, 2006, POWDER TECHNOL, V163, P98, DOI 10.1016/j.powtec.2006.01.013; Chaouki J, 1997, IND ENG CHEM RES, V36, P4476, DOI 10.1021/ie970210t; Charpentier JC, 2009, COMPUT CHEM ENG, V33, P936, DOI 10.1016/j.compchemeng.2008.11.007; Dudukovic MP, 2007, IND ENG CHEM RES, V46, P8674, DOI 10.1021/ie070371p; Dudukovic MP, 2002, CATAL REV, V44, P123, DOI 10.1081/CR-120001460; Fox R. O., 2003, COMPUTATIONAL METHOD; Hessel V, 2005, IND ENG CHEM RES, V44, P9750, DOI 10.1021/ie0503139; Jensen KF, 2001, CHEM ENG SCI, V56, P293, DOI 10.1016/S0009-2509(00)00230-X; KRAMERS H, 1964, ELEMENTS CHEM REACTO; Kuipers JAM., 1998, ADV CHEM ENG, V24, P227, DOI [DOI 10.1016/50065-2377(08)60094-0, 10.1016/S0065-2377(08)60094-0]; Kulkarni MS, 1997, CHEM ENG SCI, V52, P1777, DOI 10.1016/S0009-2509(97)00023-7; Lerou JJ, 1996, CHEM ENG SCI, V51, P1595, DOI 10.1016/0009-2509(96)00022-X; Levenspiel O., 1962, CHEM REACTION ENG; Matros YuSh, 1989, CATALYTIC PROCESSES; MAURER RT, 1992, Patent No. 5171333; Ranade VV, 2002, COMPUTATIONAL FLOW M, V5; Roy S, 2005, AICHE J, V51, P802, DOI 10.1002/aic.10447; SCHOUTEN JP, 2008, 20 INT S CHEM REACT, P6; SMITH LA, 1994, Patent No. 5345006; Stankiewicz AI, 2000, CHEM ENG PROG, V96, P22; Struis RPWJ, 1996, J MEMBRANE SCI, V113, P93, DOI 10.1016/0376-7388(95)00222-7; Sundmacher K, 2003, REACTIVE DISTILLATIO; Van den Akker HEA, 2006, ADV CHEM ENG, V31, P151; WESTERTERP KR, 1987, CHEM ENG SCI, V42, P1871, DOI 10.1016/0009-2509(87)80134-3; [No title captured]	29	110	113	6	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					698	701		10.1126/science.1174274	http://dx.doi.org/10.1126/science.1174274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661416				2022-12-28	WOS:000268723700034
J	Rinehart, J; Maksimova, YD; Tanis, JE; Stone, KL; Hodson, CA; Zhang, JH; Risinger, M; Pan, WJ; Wu, DQ; Colangelo, CM; Forbush, B; Joiner, CH; Gulcicek, EE; Gallagher, PG; Lifton, RP				Rinehart, Jesse; Maksimova, Yelena D.; Tanis, Jessica E.; Stone, Kathryn L.; Hodson, Caleb A.; Zhang, Junhui; Risinger, Mary; Pan, Weijun; Wu, Dianqing; Colangelo, Christopher M.; Forbush, Biff; Joiner, Clinton H.; Gulcicek, Erol E.; Gallagher, Patrick G.; Lifton, Richard P.			Sites of Regulated Phosphorylation that Control K-Cl Cotransporter Activity	CELL			English	Article							CELL-VOLUME; NA-K-2CL COTRANSPORTER; SIGNALING NETWORKS; HUMAN-ERYTHROCYTES; KCL COTRANSPORT; ION-TRANSPORT; PROTEIN; KCC2; KINASE; NKCC1	Modulation of intracellular chloride concentration ([Cl-](i)) plays a fundamental role in cell volume regulation and neuronal response to GABA. Cl- exit via K-Cl cotransporters (KCCs) is a major determinant of [Cl-](I); however, mechanisms governing KCC activities are poorly understood. We identified two sites in KCC3 that are rapidly dephosphorylated in hypotonic conditions in cultured cells and human red blood cells in parallel with increased transport activity. Alanine substitutions at these sites result in constitutively active cotransport. These sites are highly phosphorylated in plasma membrane KCC3 in isotonic conditions, suggesting that dephosphorylation increases KCC3's intrinsic transport activity. Reduction of WNK1 expression via RNA interference reduces phosphorylation at these sites. Homologous sites are phosphorylated in all human KCCs. KCC2 is partially phosphorylated in neonatal mouse brain and dephosphorylated in parallel with KCC2 activation. These findings provide insight into regulation of [Cl-](i) and have implications for control of cell volume and neuronal function.	[Rinehart, Jesse; Hodson, Caleb A.; Zhang, Junhui; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Maksimova, Yelena D.; Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Tanis, Jessica E.; Forbush, Biff] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Pan, Weijun; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Rinehart, Jesse; Stone, Kathryn L.; Colangelo, Christopher M.; Gulcicek, Erol E.; Lifton, Richard P.] Yale Univ, Yale Natl Heart Lung & Blood Inst, Prote Ctr, New Haven, CT 06511 USA; [Stone, Kathryn L.; Colangelo, Christopher M.; Gulcicek, Erol E.] Yale Univ, Keck Biotechnol Resource Lab, New Haven, CT 06511 USA; [Risinger, Mary; Joiner, Clinton H.] Univ Cincinnati, Coll Med, Div Hematol Oncol, Cincinnati Comprehens Sickle Cell Ctr, Cincinnati, OH 45229 USA; [Risinger, Mary; Joiner, Clinton H.] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA.	richard.lifton@yale.edu		Colangelo, Christopher/0000-0002-0438-1395	National Heart, Lung, and Blood Institute (NHLBI) [N01HV-28186]; National Institute on Drug Abuse [1P30DA018343]; National Center for Research Resources (NCRR) [UL1 RR024139, 1S10RR024617-01, HL65448, DK62039]; Cincinnati Comprehensive Sickle Cell Center [U54HL07087, GM083340]; Leducq Transatlantic Network in Hypertension; Howard Hughes Medical Institute; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028186] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA132317, R01CA139395] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026707, S10RR024617, UL1RR024139] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065448, R01HL080706, U54HL070871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597, R01GM083340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cincinnati Comprehensive Sickle Cell Center; Leducq Transatlantic Network in Hypertension; Howard Hughes Medical Institute(Howard Hughes Medical Institute); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Terence Wu, Janet Crawford, Mary LoPresti, and Tom Abbott for their help and Christian Collin-Hansen and Angus Nairn for contributions to development of phosphoproteomics methods. This work was supported by National Heart, Lung, and Blood Institute (NHLBI) Proteomics Center N01HV-28186 and National Institute on Drug Abuse ( NIDA) 1P30DA018343, with instrumentation support from National Center for Research Resources (NCRR) UL1 RR024139 and 1S10RR024617-01 and HL65448 and DK62039 ( P. G. G.); Cincinnati Comprehensive Sickle Cell Center U54HL07087 ( C.H.J.) and GM083340 ( B. F.); and the Leducq Transatlantic Network in Hypertension ( R. P. L.). R. P. L. is an investigator of the Howard Hughes Medical Institute.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; ALTAMIRANO AA, 1988, AM J PHYSIOL, V254, pC582, DOI 10.1152/ajpcell.1988.254.4.C582; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; BRUGNARA C, 1987, AM J PHYSIOL, V252, pC269, DOI 10.1152/ajpcell.1987.252.3.C269; BRUGNARA C, 1986, SCIENCE, V232, P388, DOI 10.1126/science.3961486; BRUGNARA C, 1993, BRIT J HAEMATOL, V84, P118, DOI 10.1111/j.1365-2141.1993.tb03034.x; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; DUNHAM PB, 1980, P NATL ACAD SCI-BIOL, V77, P1711, DOI 10.1073/pnas.77.3.1711; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; JENNINGS ML, 1991, J GEN PHYSIOL, V97, P799, DOI 10.1085/jgp.97.4.799; Joiner CH, 2007, BLOOD, V109, P1728, DOI 10.1182/blood-2006-04-018630; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lew VL, 2005, PHYSIOL REV, V85, P179, DOI 10.1152/physrev.00052.2003; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Rinehart J, 2005, P NATL ACAD SCI USA, V102, P16777, DOI 10.1073/pnas.0508303102; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Shifman MA, 2007, J PROTEOME RES, V6, P4019, DOI 10.1021/pr070325f; Strange K, 2006, PHYSIOLOGY, V21, P61, DOI 10.1152/physiol.00139.2005; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471	43	211	213	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					525	536		10.1016/j.cell.2009.05.031	http://dx.doi.org/10.1016/j.cell.2009.05.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665974	Bronze, Green Accepted			2022-12-28	WOS:000268771900017
J	Hayward, G; Thompson, M; Heneghan, C; Perera, R; Del Mar, C; Glasziou, P				Hayward, Gail; Thompson, Matthew; Heneghan, Carl; Perera, Rafael; Del Mar, Chris; Glasziou, Paul			Corticosteroids for pain relief in sore throat: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTIONS; PRIMARY-CARE; COMPLICATIONS; ANTIBIOTICS; TRIAL	Objective To evaluate whether systemic corticosteroids improve symptoms of sore throat in adults and children. Design Systematic review and meta-analysis. Data sources Cochrane Central, Medline, Embase, Database of Reviews of Effectiveness (DARE), NHS Health Economics Database, and bibliographies. Outcome measures Percentage of patients with complete resolution at 24 and 48 hours, mean time to onset of pain relief, mean time to complete resolution of symptoms, days missed from work or school, recurrence, and adverse events. Results We included eight trials, consisting of 743 patients in total (369 children, 374 adults). 348 (47%) had exudative sore throat, and 330 (44%) were positive for group A beta-haemolytic streptococcus. In addition to antibiotics and analgesia, corticosteroids significantly increased the likelihood of complete resolution of pain at 24 hours (four trials) by more than three times (relative risk 3.2, 95% confidence interval 2.0 to 5.1), and at 48 hours (three trials) to a lesser extent (1.7, 1.3 to 2.1). Corticosteroids (six trials) reduced mean time to onset of pain relief by more than 6 hours (95% confidence interval 3.4 to 9.3, P<0.001), although significant heterogeneity was present. The mean time to complete resolution was inconsistent across trials and a pooled analysis was not undertaken. Reporting of other outcomes was limited. Conclusions Corticosteroids provide symptomatic relief of pain in sore throat, in addition to antibiotic therapy, mainly in participants with severe or exudative sore throat.	[Hayward, Gail; Thompson, Matthew; Heneghan, Carl; Perera, Rafael; Glasziou, Paul] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Del Mar, Chris] Bond Univ, Fac Med & Hlth Sci, Gold Coast, Qld 4229, Australia	University of Oxford; Bond University	Thompson, M (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	matthew.thompson@dphpc.ox.ac.uk	Glasziou, Paul/A-7832-2008; Del Mar, Chris/B-1136-2008	Glasziou, Paul/0000-0001-7564-073X; Hayward, Gail/0000-0003-0852-627X; Del Mar, Chris/0000-0003-3821-8163; Perera, Rafael/0000-0003-2418-2091	British Society for Antimicrobial Chemotherapy Systematic Review [GA722SRG]	British Society for Antimicrobial Chemotherapy Systematic Review	Funding for this work was provided in part by a grant from the British Society for Antimicrobial Chemotherapy Systematic Review Grant (GA722SRG). The Department of Primary Health care is part of the NIHR School of Primary Care Research. The study sponsors had no role in the study design; in the collection, analysis, or interpretation of data; in the writing of the report; nor in the decision to submit the article for publication.	AHN J, 2003, SO KOREAN J OTOLARYN, V46, P971; Bisno AL, 2001, NEW ENGL J MED, V344, P205, DOI 10.1056/NEJM200101183440308; Candy B, 2006, COCHRANE DB SYST REV, V3; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; DEL MC, 1992, MED J AUSTRALIA, V156, P572; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; Fuller H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004883; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOWIE JGR, 1985, J ROY COLL GEN PRACT, V35, P223; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; Little P, 2002, BRIT J GEN PRACT, V52, P187; Little P, 1997, BRIT MED J, V315, P350; Marvez-Valls EG, 2002, ACAD EMERG MED, V9, P9, DOI 10.1111/j.1553-2712.2002.tb01160.x; Mygind N, 2001, J ALLERGY CLIN IMMUN, V108, pS16, DOI 10.1067/mai.2001.115561; *NIH CLINC EXC, 2008, NICE GUID RESP TRACT; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; RUSSELL K, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001955.PUB2; *SCOTT INT GUID NE, 1999, SIGN GUID 34 MAN SOR; Standing Medical Advisory Committee: Sub-group on Antimicrobial Resistance, 1998, PATH LEAST RES; Thomas M, 2000, BRIT J GEN PRACT, V50, P817; Vincent MT, 2004, AM FAM PHYSICIAN, V69, P1465; WOODWELL DA, 2000, ADV DATA, V295, P1; Zalmanovici A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005149.pub2	23	39	41	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2009	339								b2976	10.1136/bmj.b2976	http://dx.doi.org/10.1136/bmj.b2976			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KE	19661138	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000268808100001
J	Arifeen, SE; Hoque, DME; Akter, T; Rahman, M; Hoque, ME; Begum, K; Chowdhury, EK; Khan, R; Blum, LS; Ahmed, S; Hossain, MA; Siddik, A; Begum, N; Rahman, QSU; Haque, TM; Billah, SM; Islam, M; Rumi, RA; Law, E; Al-Helal, ZAM; Baqui, AH; Schellenberg, J; Adam, T; Moulton, LH; Habicht, JP; Scherpbier, RW; Victora, CG; Bryce, J; Black, RE				Arifeen, Shams E.; Hoque, D. M. Emdadul; Akter, Tasnima; Rahman, Muntasirur; Hoque, Mohammad Enamul; Begum, Khadija; Chowdhury, Enayet K.; Khan, Rasheda; Blum, Lauren S.; Ahmed, Shakil; Hossain, M. Altaf; Siddik, Ashraf; Begum, Nazma; Rahman, Qazi Sadeq-ur; Haque, Twaha M.; Billah, Sk Masum; Islam, Mainul; Rumi, Reza Ali; Law, Erin; Al-Helal, Z. A. Motin; Baqui, Abdullah H.; Schellenberg, Joanna; Adam, Taghreed; Moulton, Lawrence H.; Habicht, Jean-Pierre; Scherpbier, Robert W.; Victora, Cesar G.; Bryce, Jennifer; Black, Robert E.			Effect of the Integrated Management of Childhood Illness strategy on childhood mortality and nutrition in a rural area in Bangladesh: a cluster randomised trial	LANCET			English	Article							MULTICOUNTRY EVALUATION; PUBLIC-HEALTH; CHILDREN; UNDERNUTRITION; INTERVENTIONS; FACILITIES; PNEUMONIA; POLICY; CARE; IMCI	Background WHO and UNICEF launched the Integrated Management of Childhood Illness (IMCI) strategy in the mid-1990s to reduce deaths from diarrhoea, pneumonia, malaria, measles, and malnutrition in children younger than 5 years. We assessed the effect of IMCI on health and nutrition of children younger than 5 years in Bangladesh. Methods In this cluster randomised trial, 20 first-level government health facilities in the Matlab subdistrict of Bangladesh and their catchment areas (total population about 3 50 000) were paired and randomly assigned to either IMCI (intervention; ten clusters) or usual services (comparison; ten clusters). All three components of IMCI-health-worker training, health-systems improvements, and family and community activities-were implemented beginning in February, 2002. Assessment included household and health facility surveys tracking intermediate outputs and outcomes, and nutrition and mortality changes in intervention and comparison areas. Primary endpoint was mortality in children aged between 7 days and 59 months. Analysis was by intention to treat. This study is registered, number ISRCTN52793850. Findings The yearly rate of mortality reduction in children younger than 5 years (excluding deaths in first week of life) was similar in IMCI and comparison areas (8.6% vs 7.8%). In the last 2 years of the study, the mortality rate was 13.4% lower in IMCI than in comparison areas (95% Cl -14.2 to 34.3), corresponding to 4.2 fewer deaths per 1000 livebirths (95% CI -4.1 to 12.4; p=0.30). Implementation of IMCI led to improved health-worker skills, health-system support, and family and community practices, translating into increased care-seeking for illnesses. In IMCI areas, more children younger than 6 months were exclusively breastfed (76% vs 65%, difference of differences 10.1%, 95% Cl 2.65-17.62), and prevalence of stunting in children aged 24-59 months decreased more rapidly (difference of differences -7.33, 95% Cl -13.83 to -0.83) than in comparison areas. Interpretation IMCI was associated with positive changes in all input, output, and outcome indicators, including increased exclusive breastfeeding and decreased stunting. However, IMCI implementation had no effect on mortality within the timeframe of the assessment.	[Arifeen, Shams E.; Hoque, D. M. Emdadul; Akter, Tasnima; Rahman, Muntasirur; Hoque, Mohammad Enamul; Begum, Khadija; Chowdhury, Enayet K.; Khan, Rasheda; Blum, Lauren S.; Ahmed, Shakil; Siddik, Ashraf; Begum, Nazma; Rahman, Qazi Sadeq-ur; Haque, Twaha M.; Billah, Sk Masum; Islam, Mainul; Rumi, Reza Ali; Law, Erin] ICDDR B, Dhaka 1212, Bangladesh; [Hossain, M. Altaf; Al-Helal, Z. A. Motin] Govt Bangladesh, Directorate Gen Hlth Serv, Dhaka, Bangladesh; [Baqui, Abdullah H.; Moulton, Lawrence H.; Bryce, Jennifer; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Schellenberg, Joanna] London Sch Hyg & Trop Med, London WC1, England; [Scherpbier, Robert W.] WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland; [Adam, Taghreed] WHO, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland; [Habicht, Jean-Pierre] Cornell Univ, Ithaca, NY USA; [Victora, Cesar G.] Univ Fed Pelotas, Pelotas, Brazil	International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of Geneva; World Health Organization; World Health Organization; Cornell University; Universidade Federal de Pelotas	Arifeen, SE (corresponding author), ICDDR B, 68 Shahid Tajuddin Ahmed Sharani, Dhaka 1212, Bangladesh.	shams@icddrb.org	Victora, Cesar G/D-4476-2013; Begum, Khadija/AAX-9372-2021; Victora, Cesar Gomes/Y-2455-2019; Hoque, Dewan Md. Emdadul/J-1999-2019; Hoque, Dewan/O-3606-2015; Sandall, Jane/D-4146-2009; Akter, Tasnima/AAX-6255-2020; Chowdhury, Enayet/I-1267-2019; Rahman, Muntasirur/U-8829-2017	Victora, Cesar G/0000-0002-2465-2180; Begum, Khadija/0000-0001-7333-8596; Victora, Cesar Gomes/0000-0002-2465-2180; Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; Hoque, Dewan/0000-0001-8219-9196; Sandall, Jane/0000-0003-2000-743X; Chowdhury, Enayet/0000-0002-9709-794X; Schellenberg, Joanna/0000-0002-0708-3676; Moulton, Lawrence/0000-0001-7041-7387; Arifeen, Shams/0000-0002-5372-5932; Black, Robert/0000-0001-9926-7984; Rahman, Muntasirur/0000-0003-3800-7489	Bill & Melinda Gates Foundation; WHO Department of Child and Adolescent Health and Development [388-A-00-97-00032-00]; United States Agency for International Development	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); WHO Department of Child and Adolescent Health and Development; United States Agency for International Development(United States Agency for International Development (USAID))	We thank the Bangladesh Government for the continuing support for the implementation of the study; the mothers and children who participated in the study; and the MCE Technical Advisors of WHO/CAH for providing important suggestions and guidance throughout the study. This study was undertaken at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) with support from the Bill & Melinda Gates Foundation through a grant to the WHO Department of Child and Adolescent Health and Development and of Cooperative Agreement (number 388-A-00-97-00032-00) from the United States Agency for International Development. ICDDR,B acknowledges with gratitude their commitment to the Centre's research effort.	Amaral J, 2005, HEALTH POLICY PLANN, V20, pI42, DOI 10.1093/heapol/czi058; Arifeen SE, 2005, B WORLD HEALTH ORGAN, V83, P260; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Chowdhury EK, 2008, LANCET, V372, P822, DOI 10.1016/S0140-6736(08)61166-6; DIEHR P, 1995, STAT MED, V14, P1491, DOI 10.1002/sim.4780141309; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; Graham N. M. H., 2007, Infectious disease epidemiology: theory and practice, P699; HUICHO L, 2005, HLTH POLICY PLANN S1, V20, P32, DOI DOI 10.1093/HEAPOL/CZI052; *ICDDR B, 2008, HLTH DEM SURV SYST M, P9; National Institute of Population Research and Training (NIPORT) Mitra and Associates Macro International, 2009, BANGL DEM HLTH SURV; *NIPORT 2004, 2004, BANGL DEM HLTH SURV, P126; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Rutstein SO, 1984, WFS COMP STUDIES, V43; Saha SK, 2003, J CLIN MICROBIOL, V41, P5582, DOI 10.1128/JCM.41.12.5582-5587.2003; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; STREATFIELD PK, 2004, POLICY IMPLICATION O, P215; Tulloch J., 1999, Lancet (British edition), V354, P16, DOI 10.1016/S0140-6736(99)90252-0; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; *WHO, 2007, WHO STAT INF SYST VE; WHO Department of Nutrition for Health and Development, 2006, WHO CHILD GROWTH STA; *WORLD BANK, 2007, ICROO00242 WORLD BAN	26	173	175	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2009	374	9687					393	403		10.1016/S0140-6736(09)60828-X	http://dx.doi.org/10.1016/S0140-6736(09)60828-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481MJ	19647607				2022-12-28	WOS:000268815200023
J	Polsky, D; Grande, D				Polsky, Daniel; Grande, David			Health Care 2009: The Burden of Health Care Costs for Working Families -- Implications for Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Polsky, Daniel; Grande, David] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Polsky, D (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.		Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735				Executive Office of the President Council of Economic Advisors, 2009, EC CAS HLTH CAR REF; Pauly M, 1997, HLTH BENEFITS WORK E; Sisko A, 2009, HEALTH AFFAIR, V28, pW346, DOI 10.1377/hlthaff.28.2.w346; *TECHN REV PAN MED, 2000, REV ASS METH MED TRU	4	21	21	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					437	439		10.1056/NEJMp0905297	http://dx.doi.org/10.1056/NEJMp0905297			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	476LW	19641198				2022-12-28	WOS:000268443900001
J	Malfertheiner, P; Chan, FKL; McColl, KEL				Malfertheiner, Peter; Chan, Francis K. L.; McColl, Kenneth E. L.			Peptic ulcer disease	LANCET			English	Review							HELICOBACTER-PYLORI INFECTION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROTON-PUMP INHIBITOR; LOW-DOSE ASPIRIN; UPPER GASTROINTESTINAL HEMORRHAGE; HUMAN GASTRIC EPITHELIUM; SELECTIVE CYCLO-OXYGENASE-2 INHIBITORS; UNIDENTIFIED CURVED BACILLI; DOUBLE-BLIND TRIAL; DUODENAL-ULCER	Peptic ulcer disease had a tremendous effect on morbidity and mortality until the last decades of the 20th century, when epidemiological trends started to point to an impressive fall in its incidence. Two important developments are associated with the decrease in rates of peptic ulcer disease: the discovery of effective and potent acid suppressants, and of Helicobacter pylori. With the discovery of H pylori infection, the causes, pathogenesis, and treatment of peptic ulcer disease have been rewritten. We focus on this revolution of understanding and management of peptic ulcer disease over the past 25 years. Despite substantial advances, this disease remains an important clinical problem, largely because of the increasingly widespread use of non-steroidal anti-inflammatory drugs (NSAIDs) and low-dose aspirin. We discuss the role of these agents in the causes of ulcer disease and therapeutic and preventive strategies for drug-induced ulcers. The rare but increasingly problematic H pylori-negative NSAID-negative ulcer is also examined.	[Malfertheiner, Peter] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, D-39120 Magdeburg, Germany; [Chan, Francis K. L.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [McColl, Kenneth E. L.] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland	Otto von Guericke University; Chinese University of Hong Kong; University of Glasgow	Malfertheiner, P (corresponding author), Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, D-39120 Magdeburg, Germany.	peter.malfertheiner@med.ovgu.de	Chan, Francis K. L./F-4851-2010	Chan, Francis K. L./0000-0001-7388-2436	AstraZeneca; Nycomed; Chief Scientist Office [CZB/4/709] Funding Source: researchfish	AstraZeneca(AstraZeneca); Nycomed; Chief Scientist Office	PM has received lecture fees from AstraZeneca, Bayer Schering, Novartis Vaccine, and Nycomed, consultancy fees from AstraZeneca, Axcan, and Novartis, a research grant from AstraZeneca, and lecture fees from Abbott and Falk. FKLC has received consulting fees from Pfizer, lecture fees from Pfizer, Takeda, Eisai, and AstraZeneca, and consulting fees from Otsuka. KELM has received consultancy fees from Sacoor Medical and WG Consultant, lecture fees from Janssen Cilag, AstraZeneca, Reckitt Benckiser, and Nycomed, lecture fees from Wyeth and Abbot, and a research grant from Nycomed.	Alain BBN, 2008, CHIN J TRAUMATOL, V11, P114; Aoyama N, 1998, AM J GASTROENTEROL, V93, P311, DOI 10.1111/j.1572-0241.1998.00311.x; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Atherton JC, 1997, GUT, V40, P701, DOI 10.1136/gut.40.6.701; AZUMA T, 1994, LANCET, V343, P542, DOI 10.1016/S0140-6736(94)91496-6; Bago J, 2009, WIEN KLIN WOCHENSCHR, V121, P47, DOI 10.1007/s00508-008-1122-2; Banerjee S, 1996, GASTROENTEROLOGY, V110, P717, DOI 10.1053/gast.1996.v110.pm8608880; Bhattacharyya NK, 2008, INDIAN J PATHOL MICR, V51, P17, DOI 10.4103/0377-4929.40384; BIANCHIPORRO G, 1992, STOMACH, P246; Blatchford O, 1997, BMJ-BRIT MED J, V315, P510, DOI 10.1136/bmj.315.7107.510; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chakravorty M, 2006, HUM MUTAT, V27, P411, DOI 10.1002/humu.20299; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Chan FKL, 2002, NEW ENGL J MED, V347, P2104, DOI 10.1056/NEJMoa021907; Chan FKL, 2002, LANCET, V359, P9, DOI 10.1016/S0140-6736(02)07272-0; Chan FKL, 1998, ALIMENT PHARM THER, V12, P1201; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Chan FKL, 1997, LANCET, V350, P975, DOI 10.1016/S0140-6736(97)04523-6; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; COLLEN MJ, 1991, PHARM PEPTIC ULCER D; COWAN WK, 1973, CLIN GASTROENTEROLOG, V2, P539; CRABTREE JE, 1993, SCAND J IMMUNOL, V37, P65, DOI 10.1111/j.1365-3083.1993.tb01666.x; CROWE SE, 1995, GASTROENTEROLOGY, V108, P65, DOI 10.1016/0016-5085(95)90009-8; DAVENPOR.HW, 1969, GASTROENTEROLOGY, V56, P439; DAVENPORT HW, 1967, NEW ENGL J MED, V276, P1307, DOI 10.1056/NEJM196706082762308; DEW MJ, 1987, BMJ-BRIT MED J, V15, P401; Dixon MF, 2000, BEST PRACT RES CL GA, V14, P27, DOI 10.1053/bega.1999.0057; El-Nujumi A, 1998, EUR J GASTROEN HEPAT, V10, P759; ELOMAR E, 1993, GUT, V34, P1060, DOI 10.1136/gut.34.8.1060; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; FELLENIUS E, 1981, NATURE, V290, P159, DOI 10.1038/290159a0; FIGURA N, 1989, J CLIN MICROBIOL, V27, P225, DOI 10.1128/JCM.27.1.225-226.1989; Fiorucci S, 2007, DIGEST LIVER DIS, V39, P1043, DOI 10.1016/j.dld.2007.09.001; Fischbach L, 2007, ALIMENT PHARM THER, V26, P343, DOI 10.1111/j.1365-2036.2007.03386.x; FLEMSTROM G, 1984, CLIN GASTROENTEROL, V13, P327; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; Rodriguez LAG, 2007, GASTROENTEROLOGY, V132, P498, DOI 10.1053/j.gastro.2006.12.007; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Gillen D, 1998, GASTROENTEROLOGY, V114, P50, DOI 10.1016/S0016-5085(98)70632-8; Gillen D, 1999, GASTROENTEROLOGY, V116, P239, DOI 10.1016/S0016-5085(99)70118-6; Gisbert JP, 1999, DIGEST DIS SCI, V44, P2295, DOI 10.1023/A:1026669123593; Gisbert JP, 2006, ALIMENT PHARM THER, V23, P35, DOI 10.1111/j.1365-2036.2006.02737.x; Gisbert JP, 2002, ALIMENT PHARM THER, V16, P1047, DOI 10.1046/j.1365-2036.2002.01276.x; Gisbert JR, 2003, HELICOBACTER, V8, P159, DOI 10.1046/j.1523-5378.2003.00139.x; Goddard AF, 1997, LANCET, V349, P1815, DOI 10.1016/S0140-6736(05)61696-0; GOGGIN PM, 1992, GASTROENTEROLOGY, V103, P1486, DOI 10.1016/0016-5085(92)91168-4; Goldstein JL, 2007, ALIMENT PHARM THER, V26, P1101, DOI 10.1111/j.1365-2036.2007.03460.x; GRAHAM DY, 1993, SCAND J GASTROENTERO, V28, P690, DOI 10.3109/00365529309098274; GRAHAM DY, 1993, SCAND J GASTROENTERO, V28, P939, DOI 10.3109/00365529309098288; Gratrix AP, 2007, ANAESTHESIA, V62, P421, DOI 10.1111/j.1365-2044.2007.05050.x; GREEN FW, 1978, GASTROENTEROLOGY, V74, P38; GROSSMAN MI, 1978, GASTROENTEROLOGY, V75, P524; GUSTAVSSON S, 1992, STOMACH, P266; Hallas J, 2006, BMJ-BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Harris AW, 1996, GUT, V39, P513, DOI 10.1136/gut.39.4.513; Heidelbaugh JJ, 2006, AM J GASTROENTEROL, V101, P2200, DOI 10.1111/j.1572-0241.2006.00839.x; HILLS BA, 1993, GUT, V34, P588, DOI 10.1136/gut.34.5.588; Hirshcowitz BI, 1997, GASTROENTEROLOGY, V112, pA150; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Hofner P, 2007, HELICOBACTER, V12, P124, DOI 10.1111/j.1523-5378.2007.00481.x; HOSKING SW, 1994, LANCET, V343, P508, DOI 10.1016/S0140-6736(94)91460-5; Huang JQ, 2002, LANCET, V359, P14, DOI 10.1016/S0140-6736(02)07273-2; Jafri NS, 2008, ANN INTERN MED, V148, P923, DOI 10.7326/0003-4819-148-12-200806170-00226; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Kahn JM, 2006, INTENS CARE MED, V32, P1151, DOI 10.1007/s00134-006-0244-0; KARTTUNEN R, 1991, CLIN EXP IMMUNOL, V83, P396; KATO I, 1992, AM J EPIDEMIOL, V135, P521, DOI 10.1093/oxfordjournals.aje.a116319; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kelly JP, 1996, LANCET, V348, P1413, DOI 10.1016/S0140-6736(96)01254-8; Khulusi S, 1996, GASTROENTEROLOGY, V110, P452, DOI 10.1053/gast.1996.v110.pm8566592; KUIPERS EJ, 1995, AM J GASTROENTEROL, V90, P1401; KURATA JH, 1984, CLIN GASTROENTEROL, V13, P289; Labenz J, 2002, GUT, V51, P329, DOI 10.1136/gut.51.3.329; Lai KC, 2006, CLIN GASTROENTEROL H, V4, P860, DOI 10.1016/j.cgh.2006.04.019; Laine L, 2004, GASTROENTEROLOGY, V127, P395, DOI 10.1053/j.gastro.2004.05.001; Laine L, 2002, GASTROENTEROLOGY, V123, P1006, DOI 10.1053/gast.2002.36013; Lamouliatte H, 2003, ALIMENT PHARM THERAP, V18, P791, DOI 10.1046/j.1365-2036.2003.01759.x; Lanas A, 2006, GUT, V55, P1731, DOI 10.1136/gut.2005.080754; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Lanas A, 2007, GASTROENTEROLOGY, V132, P490, DOI 10.1053/j.gastro.2006.11.012; Lanas A, 2007, CURR MED RES OPIN, V23, P162, DOI 10.1185/030079907X162656; LANCASTERSMITH MJ, 1991, GUT, V32, P252, DOI 10.1136/gut.32.3.252; LANGMAN MJS, 1994, LANCET, V343, P1075, DOI 10.1016/S0140-6736(94)90185-6; Lanza FL, 2009, AM J GASTROENTEROL, V104, P728, DOI 10.1038/ajg.2009.115; Leodolter A, 2001, ALIMENT PHARM THER, V15, P1949, DOI 10.1046/j.1365-2036.2001.01109.x; Leontiadis GI, 2007, HEALTH TECHNOL ASSES, V11, P1; Levenstein S, 2002, PSYCHOSOM MED, V64, P767, DOI 10.1097/01.PSY.0000024230.11538.C6; LICHTENBERGER LM, 1995, NAT MED, V1, P154, DOI 10.1038/nm0295-154; Lind T, 1999, GASTROENTEROLOGY, V116, P248, DOI 10.1016/S0016-5085(99)70119-8; LONGSTRETH GF, 1995, AM J GASTROENTEROL, V90, P206; MALATY HM, 1994, ANN INTERN MED, V120, P982, DOI 10.7326/0003-4819-120-12-199406150-00002; Malfertheiner P, 1999, ALIMENT PHARM THERAP, V13, P703, DOI 10.1046/j.1365-2036.1999.00535.x; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P1431, DOI 10.1046/j.1365-2036.2002.01285.x; Malfertheiner P, 2000, BEST PRACT RES CL GA, V14, P119, DOI 10.1053/bega.1999.0063; MALFERTHEINER P, 2005, CLIN GASTROENTEROLOG, P193; MARSHALL BJ, 1984, LANCET, V1, P1311; MAUCH F, 1993, GASTROENTEROLOGY, V105, P1698, DOI 10.1016/0016-5085(93)91065-P; McColl K, 2000, HELICOBACTER, V5, pS11; McColl K. E. L., 2002, BMJ, V324, P999, DOI 10.1136/bmj.324.7344.999; MCCOLL KEL, 1991, SCAND J GASTROENTERO, V26, P339, DOI 10.3109/00365529109025052; McColl KEL, 2000, BEST PRACT RES CL GA, V14, P13, DOI 10.1053/bega.1999.0056; McColl Kenneth E.L., 2000, Journal of Gastroenterology, V35, P47; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; MEDALIE JH, 1992, AM J EPIDEMIOL, V136, P1280, DOI 10.1093/oxfordjournals.aje.a116436; MOSS SF, 1992, LANCET, V340, P930, DOI 10.1016/0140-6736(92)92816-X; ODUM L, 1994, GUT, V35, P615, DOI 10.1136/gut.35.5.615; Ohyauchi M, 2005, GUT, V54, P330, DOI 10.1136/gut.2003.033050; Olbe L, 1996, GASTROENTEROLOGY, V110, P1386, DOI 10.1053/gast.1996.v110.pm8613042; Papatheodoridis GV, 2006, CLIN GASTROENTEROL H, V4, P130, DOI 10.1016/j.cgh.2005.10.006; Peek RM, 1995, LAB INVEST, V73, P760; PETERS MN, 1983, GASTROENTEROLOGY, V84, P114; PIPER JM, 1991, ANN INTERN MED, V114, P735, DOI 10.7326/0003-4819-114-9-735; Qasim A, 2005, ALIMENT PHARM THER, V21, P91, DOI 10.1111/j.1365-2036.2004.02210.x; Quan C, 2002, AM J GASTROENTEROL, V97, P2950; RAUWS EAJ, 1990, LANCET, V335, P1233, DOI 10.1016/0140-6736(90)91301-P; Ray WA, 2007, GASTROENTEROLOGY, V133, P790, DOI 10.1053/j.gastro.2007.06.058; Realdi G, 1999, HELICOBACTER, V4, P106, DOI 10.1046/j.1523-5378.1999.99002.x; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Robinson K, 2008, GUT, V57, P1375, DOI 10.1136/gut.2007.137539; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; ROKKAS T, 1995, GASTROINTEST ENDOSC, V41, P1, DOI 10.1016/S0016-5107(95)70266-0; ROSAM AC, 1986, NATURE, V319, P54, DOI 10.1038/319054a0; Rosenstock S, 2003, GUT, V52, P186, DOI 10.1136/gut.52.2.186; Rostom A, 2007, CLIN GASTROENTEROL H, V5, P818, DOI 10.1016/j.cgh.2007.03.011; Saad RJ, 2006, AM J GASTROENTEROL, V101, P488, DOI 10.1111/j.1572-0241.2006.00637.x; Sanchez-Delgado J, 2008, AM J GASTROENTEROL, V103, P2220, DOI 10.1111/j.1572-0241.2008.01924.x; Santander C, 1996, AM J GASTROENTEROL, V91, P1549; SCHMASSMANN A, 1995, AM J PHYSIOL-GASTR L, V268, pG276, DOI 10.1152/ajpgi.1995.268.2.G276; Schultze V, 1998, SCAND J GASTROENTERO, V33, P137, DOI 10.1080/00365529850166851; SCHWARTZ K, 1910, BEITRAGE KLINISCHEN, V67, P96; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; SIPPONEN P, 1992, DIGESTION, V51, P70, DOI 10.1159/000200919; SMOOT DT, 1990, INFECT IMMUN, V58, P1992, DOI 10.1128/IAI.58.6.1992-1994.1990; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530; Sonnenberg A, 2006, INT J EPIDEMIOL, V35, P1090, DOI 10.1093/ije/dyl093; Strand V, 2007, LANCET, V370, P2138, DOI 10.1016/S0140-6736(07)61909-6; Streitparth F, 2006, INT J RADIAT ONCOL, V65, P1479, DOI 10.1016/j.ijrobp.2006.02.052; SUSSER M, 1962, LANCET, V1, P115; Targownik LE, 2008, GASTROENTEROLOGY, V134, P937, DOI 10.1053/j.gastro.2008.01.010; Tulassay Z, 2008, EUR J GASTROEN HEPAT, V20, P526, DOI 10.1097/MEG.0b013e3282f427ac; van Doorn LJ, 1998, GASTROENTEROLOGY, V115, P58, DOI 10.1016/S0016-5085(98)70365-8; VERDU EF, 1995, GUT, V36, P539, DOI 10.1136/gut.36.4.539; Vergara M, 2005, ALIMENT PHARM THER, V21, P1411, DOI 10.1111/j.1365-2036.2005.02444.x; WALLACE JL, 1990, AM J PHYSIOL, V259, pG462, DOI 10.1152/ajpgi.1990.259.3.G462; WALLACE JL, 1990, GASTROENTEROLOGY, V99, P295, DOI 10.1016/0016-5085(90)91009-U; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; WARREN JR, 1983, LANCET, V1, P1273; Xia HHX, 2001, ALIMENT PHARM THERAP, V15, P1875, DOI 10.1046/j.1365-2036.2001.01115.x; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781; Yeomans ND, 2006, INT J CLIN PRACT, V60, P1401, DOI 10.1111/j.1742-1241.2006.01147.x	160	507	534	2	98	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2009	374	9699					1449	1461		10.1016/S0140-6736(09)60938-7	http://dx.doi.org/10.1016/S0140-6736(09)60938-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MZ	19683340				2022-12-28	WOS:000271255000034
J	Ding, EL; Song, YQ; Manson, JE; Hunter, DJ; Lee, CC; Rifai, N; Buring, JE; Gaziano, JM; Liu, SM				Ding, Eric L.; Song, Yiqing; Manson, JoAnn E.; Hunter, David J.; Lee, Cathy C.; Rifai, Nader; Buring, Julie E.; Gaziano, J. Michael; Liu, Simin			Sex Hormone-Binding Globulin and Risk of Type 2 Diabetes in Women and Men.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER; SHBG GENE; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; ESTROGEN; HEALTH; POLYMORPHISM; ESTRADIOL; ANDROGEN; PROGESTIN	Background: Circulating sex hormone-binding globulin levels are inversely associated with insulin resistance, but whether these levels can predict the risk of developing type 2 diabetes is uncertain. Methods: We performed a nested case-control study of postmenopausal women in the Women's Health Study who were not using hormone therapy (359 with newly diagnosed type 2 diabetes and 359 controls). Plasma levels of sex hormone-binding globulin were measured; two polymorphisms of the gene encoding sex hormone-binding globulin, SHBG, that were robustly associated with the protein levels were genotyped and applied in mendelian randomization analyses. We then conducted a replication study in an independent cohort of men from the Physicians' Health Study II (170 with newly diagnosed type 2 diabetes and 170 controls). Results: Among women, higher plasma levels of sex hormone-binding globulin were prospectively associated with a lower risk of type 2 diabetes: multivariable odds ratios were 1.00 for the first (lowest) quartile of plasma levels, 0.16 (95% confidence interval [CI], 0.08 to 0.33) for the second quartile, 0.04 (95% CI, 0.01 to 0.12) for the third quartile, and 0.09 (95% CI, 0.03 to 0.21) for the fourth (highest) quartile (P<0.001 for trend). These prospective associations were replicated among men (odds ratio for the highest quartile of plasma levels vs. the lowest quartile, 0.10; 95% CI, 0.03 to 0.36; P<0.001 for trend). As compared with homozygotes of the respective wild-type allele, carriers of a variant allele of the SHBG single-nucleotide polymorphism (SNP) rs6259 had 10% higher sex hormone-binding globulin levels (P=0.005), and carriers of an rs6257 variant had 10% lower plasma levels (P=0.004); variants of both SNPs were also associated with a risk of type 2 diabetes in directions corresponding to their associated sex hormone-binding globulin levels. In mendelian randomization analyses, the predicted odds ratio of type 2 diabetes per standard-deviation increase in the plasma level of sex hormone-binding globulin was 0.28 (95% CI, 0.13 to 0.58) among women and 0.29 (95% CI, 0.15 to 0.58) among men, a finding that suggests that sex hormone-binding globulin may have a causal role in the risk of type 2 diabetes. Conclusions: Low circulating levels of sex hormone-binding globulin are a strong predictor of the risk of type 2 diabetes in women and men. The clinical usefulness of both SHBG genotypes and plasma levels in stratification and intervention for the risk of type 2 diabetes warrants further examination. N Engl J Med 2009;361:1152-63.	[Lee, Cathy C.; Liu, Simin] Univ Calif Los Angeles, Sch Publ Hlth, Ctr Metab Dis Prevent, Los Angeles, CA 90095 USA; [Lee, Cathy C.; Liu, Simin] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Program Genom & Nutr, Los Angeles, CA 90095 USA; [Lee, Cathy C.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Lee, Cathy C.; Liu, Simin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Liu, Simin] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Ding, Eric L.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ding, Eric L.; Manson, JoAnn E.; Hunter, David J.; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ding, Eric L.; Song, Yiqing; Manson, JoAnn E.; Buring, Julie E.; Gaziano, J. Michael] Brigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02115 USA; [Ding, Eric L.; Manson, JoAnn E.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Div Aging, Dept Med, Boston, MA 02115 USA; [Rifai, Nader] Harvard Univ, Sch Med, Boston, MA USA; [Rifai, Nader] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Liu, SM (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Ctr Metab Dis Prevent, CHS 73-265,Box 951772,650 Charles E Young Dr, Los Angeles, CA 90095 USA.	siminliu@ucla.edu	Ding, Eric L./K-1118-2019; Liu, Simin/I-3689-2014; Liu, Simin/GSN-4159-2022	Ding, Eric L./0000-0002-5881-8097; Liu, Simin/0000-0003-2098-3844; 	National Institutes of Health [DK066401, HL043851, HL080467, CA047988]; Burroughs Wellcome Fund; National Cancer Institute [CA34944, CA40360, CA097193]; National Heart, Lung, and Blood Institute [HL26490, HL34595]; American Diabetes Association fellowship; Paul and Daisy Soros fellowship; National Institute of Diabetes and Digestive and Kidney Diseases [K01-DK078846]; NATIONAL CANCER INSTITUTE [R01CA097193, R01CA040360, R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, R01HL080467, R01HL034595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066401, K01DK078846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association fellowship(American Diabetes Association); Paul and Daisy Soros fellowship; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (DK066401, to Dr. Liu; HL043851, HL080467, and CA047988, to the Women's Health Study); the Burroughs Wellcome Fund (to Dr. Liu, for development of a metabolic disease research and training program at UCLA); the National Cancer Institute CA34944, CA40360, and CA097193, to the Physicians' Health Study II); the National Heart, Lung, and Blood Institute (HL26490 and HL34595); the American Diabetes Association fellowship (to Dr. Ding); the Paul and Daisy Soros fellowship (to Dr. Ding); and the National Institute of Diabetes and Digestive and Kidney Diseases (K01-DK078846, to Dr. Song).	An P, 2000, METABOLISM, V49, P1014, DOI 10.1053/meta.2000.7737; Berndt SI, 2007, CANCER EPIDEM BIOMAR, V16, P165, DOI 10.1158/1055-9965.EPI-06-0689; Bonds DE, 2006, DIABETOLOGIA, V49, P459, DOI 10.1007/s00125-005-0096-0; Catalano MG, 2005, MOL CELL ENDOCRINOL, V230, P31, DOI 10.1016/j.mce.2004.11.005; Cousin P, 2004, J CLIN ENDOCR METAB, V89, P917, DOI 10.1210/jc.2002-021553; Cui Y, 2005, CANCER EPIDEM BIOMAR, V14, P1096, DOI 10.1158/1055-9965.EPI-04-0721; Ding EL, 2007, DIABETOLOGIA, V50, P2076, DOI 10.1007/s00125-007-0785-y; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Ding EL, 2006, JAMA-J AM MED ASSOC, V296, P169, DOI 10.1001/jama.296.2.169-b; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Eriksson AL, 2006, J CLIN ENDOCR METAB, V91, P5029, DOI 10.1210/jc.2006-0679; Fortunati N, 1999, J STEROID BIOCHEM, V69, P473, DOI 10.1016/S0960-0760(99)00068-0; Golden SH, 2007, J CLIN ENDOCR METAB, V92, P1289, DOI 10.1210/jc.2006-1895; Haffner SM, 1996, HORM RES, V45, P233, DOI 10.1159/000184794; Haiman CA, 2005, J CLIN ENDOCR METAB, V90, P2198, DOI 10.1210/jc.2004-1417; Hammes A, 2005, CELL, V122, P751, DOI 10.1016/j.cell.2005.06.032; Hardin JW, 2003, STATA J, V3, P351, DOI 10.1177/1536867X0300300405; Jaquish CE, 1997, METABOLISM, V46, P988, DOI 10.1016/S0026-0495(97)90266-3; Kahn SM, 2002, J ENDOCRINOL, V175, P113, DOI 10.1677/joe.0.1750113; Kalme T, 2003, J STEROID BIOCHEM, V86, P197, DOI 10.1016/S0960-0760(03)00268-1; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; LINDSTEDT G, 1991, DIABETES, V40, P123, DOI 10.2337/diabetes.40.1.123; Liu SM, 2006, DIABETES, V55, P2856, DOI 10.2337/db06-0456; Low YL, 2006, CANCER RES, V66, P8980, DOI 10.1158/0008-5472.CAN-06-2432; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Meikle AW, 1997, PROSTATE, V33, P105; PORTO CS, 1995, J STEROID BIOCHEM, V53, P561, DOI 10.1016/0960-0760(95)00111-C; Reynders M, 2005, CLIN CHEM LAB MED, V43, P86, DOI 10.1515/CCLM.2005.013; Ring HJZ, 2005, J CLIN ENDOCR METAB, V90, P3653, DOI 10.1210/jc.2004-1025; Rosner W, 1999, J STEROID BIOCHEM, V69, P481, DOI 10.1016/S0960-0760(99)00070-9; SELBY PL, 1989, CLIN ENDOCRINOL, V30, P241, DOI 10.1111/j.1365-2265.1989.tb02232.x; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P1242, DOI 10.1161/01.CIR.0000157697.54255.CE; Taskinen MR, 1996, ARTERIOSCL THROM VAS, V16, P1215, DOI 10.1161/01.ATV.16.10.1215; Thomas DC, 2004, INT J EPIDEMIOL, V33, P21, DOI 10.1093/ije/dyh048; Vehkavaara S, 2000, CIRCULATION, V102, P2687, DOI 10.1161/01.CIR.102.22.2687; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; Zhao Jun-li, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P644	40	499	523	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1152	1163		10.1056/NEJMoa0804381	http://dx.doi.org/10.1056/NEJMoa0804381			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494QA	19657112	Green Accepted			2022-12-28	WOS:000269828000006
J	Kroger, N				Kroeger, Nils			The Molecular Basis of Nacre Formation	SCIENCE			English	Editorial Material							MATRIX PROTEIN; BIOMINERALIZATION		[Kroeger, Nils] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kroeger, Nils] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Kroeger, Nils] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Kroger, N (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	nils.kroger@chemistry.gatech.edu						Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Amos FF, 2009, BIOCHEMISTRY-US, V48, P1332, DOI 10.1021/bi802148r; Belcher AM, 1998, ACTA MATER, V46, P733, DOI 10.1016/S1359-6454(97)00253-X; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; Marinichev AN, 2007, RUSS J APPL CHEM+, V80, P209, DOI 10.1134/S1070427207020085; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Wenzl S, 2008, ANGEW CHEM INT EDIT, V47, P1729, DOI 10.1002/anie.200704994	10	33	37	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1351	1352		10.1126/science.1177055	http://dx.doi.org/10.1126/science.1177055			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19679772				2022-12-28	WOS:000269699100024
J	Wang, ZB; Zang, CZ; Cui, KR; Schones, DE; Barski, A; Peng, WQ; Zhao, KJ				Wang, Zhibin; Zang, Chongzhi; Cui, Kairong; Schones, Dustin E.; Barski, Artem; Peng, Weiqun; Zhao, Keji			Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes	CELL			English	Article							HISTONE DEACETYLASE; CHROMATIN SIGNATURES; CODING REGIONS; COMPLEX; YEAST; ACETYLATION; METHYLATION; ACETYLTRANSFERASE; TRANSCRIPTION; NUCLEOSOMES	Histone acetyltransferases (HATs) and deacetylases (HDACs) function antagonistically to control histone acetylation. As acetylation is a histone mark for active transcription, HATs have been associated with active and HDACs with inactive genes. We describe here genome-wide mapping of HATs and HDACs binding on chromatin and find that both are found at active genes with acetylated histones. Our data provide evidence that HATs and HDACs are both targeted to transcribed regions of active genes by phosphorylated RNA Pol II. Furthermore, the majority of HDACs in the human genome function to reset chromatin by removing acetylation at active genes. Inactive genes that are primed by MLL-mediated histone H3K4 methylation are subject to a dynamic cycle of acetylation and deacetylation by transient HAT/HDAC binding, preventing Pol II from binding to these genes but poising them for future activation. Silent genes without any H3K4 methylation signal show no evidence of being bound by HDACs.	[Wang, Zhibin; Cui, Kairong; Schones, Dustin E.; Barski, Artem; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Zang, Chongzhi; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	Zang, Chongzhi/D-1445-2011; /AAI-2516-2019	Zang, Chongzhi/0000-0003-4812-3627; Peng, Weiqun/0000-0001-5521-9091; Barski, Artem/0000-0002-1861-5316	George Washington University; Division of Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006018, ZIAHL005801, ZIAHL006030] Funding Source: NIH RePORTER	George Washington University; Division of Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The mRNA profiles were analyzed on Affymetrix gene chips by the National Heart, Lung, and Blood Institute (NHLBI) Genomics Core Facility. D. E. S. was supported by the Lenfant Biomedical Fellowship of the NHLBI. C.Z. and W. P. were partially supported by the University Facilitating Fund of the George Washington University. The research was supported by the Division of Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	54	964	993	0	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					1019	1031		10.1016/j.cell.2009.06.049	http://dx.doi.org/10.1016/j.cell.2009.06.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19698979	Green Accepted, Bronze			2022-12-28	WOS:000269564600025
J	Simon, GE; Ludman, EJ				Simon, Gregory E.; Ludman, Evette J.			It's time for disruptive innovation in psychotherapy	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; TELEPHONE-ADMINISTERED PSYCHOTHERAPY; DEPRESSION; INTERNET; CARE; SYMPTOMS		[Simon, Gregory E.; Ludman, Evette J.] Grp Hlth Res Inst, Seattle, WA 98101 USA		Simon, GE (corresponding author), Grp Hlth Res Inst, Seattle, WA 98101 USA.	Simon.g@ghc.org						Bee PE, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-60; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16; Clarke Greg, 2009, Cognitive Behaviour Therapy, V38, P222, DOI 10.1080/16506070802675353; Horvitz-Lennon M, 2003, AM J PSYCHIAT, V160, P720, DOI 10.1176/appi.ajp.160.4.720; Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5; Mohr DC, 2008, CLIN PSYCHOL-SCI PR, V15, P243, DOI 10.1111/j.1468-2850.2008.00134.x; Mohr DC, 2005, ARCH GEN PSYCHIAT, V62, P1007, DOI 10.1001/archpsyc.62.9.1007; Olfson M, 2002, JAMA-J AM MED ASSOC, V287, P203, DOI 10.1001/jama.287.2.203; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Smith MD, 2007, HEALTH AFFAIR, V26, pW288, DOI 10.1377/hlthaff.26.3.w288; Warmerdam L, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.954; Zivin K, 2009, AM J MANAG CARE, V15, P105	13	44	44	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 22	2009	374	9690					594	595		10.1016/S0140-6736(09)61415-X	http://dx.doi.org/10.1016/S0140-6736(09)61415-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19699995				2022-12-28	WOS:000269222600007
J	Osborn, KJ; Haddock, SHD; Pleijel, F; Madin, LP; Rouse, GW				Osborn, Karen J.; Haddock, Steven H. D.; Pleijel, Fredrik; Madin, Laurence P.; Rouse, Greg W.			Deep-Sea, Swimming Worms with Luminescent "Bombs"	SCIENCE			English	Article									[Osborn, Karen J.; Rouse, Greg W.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Haddock, Steven H. D.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Pleijel, Fredrik] Univ Gothenburg, Dept Marine Ecol Tjarno, SE-45296 Stromstad, Sweden; [Madin, Laurence P.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Monterey Bay Aquarium Research Institute; University of Gothenburg; Woods Hole Oceanographic Institution	Osborn, KJ (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	kjosborn@ucsd.edu	Rouse, Gregory/AAW-1494-2021; Rouse, Greg W/F-2611-2010; Osborn, Karen/E-9222-2011	Rouse, Gregory/0000-0001-9036-9263; Rouse, Greg W/0000-0001-9036-9263; Osborn, Karen/0000-0002-4226-9257	Scripps Institution of Oceanography; University of California; David and Lucile Packard Foundation; National Oceanic and Atmospheric Administration; WHOI; National Geographic Society	Scripps Institution of Oceanography(University of California System); University of California(University of California System); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); WHOI; National Geographic Society(National Geographic Society)	Research supported by Scripps Institution of Oceanography, University of California Presidents Postdoctoral Fellowship, David and Lucile Packard Foundation, National Oceanic and Atmospheric Administration, WHOI, and the National Geographic Society	Bush SL, 2009, BIOL BULL-US, V216, P7, DOI 10.1086/BBLv216n1p7; Deheyn D, 2000, J MAR BIOL ASSOC UK, V80, P179, DOI 10.1017/S0025315499001733; Osborn KJ, 2008, MOL PHYLOGENET EVOL, V49, P386, DOI 10.1016/j.ympev.2008.05.042	3	44	47	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					964	964		10.1126/science.1172488	http://dx.doi.org/10.1126/science.1172488			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696343				2022-12-28	WOS:000269242800036
J	Kinney, HC; Thach, BT				Kinney, Hannah C.; Thach, Bradley T.			MEDICAL PROGRESS The Sudden Infant Death Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BRAIN-STEM ABNORMALITIES; SLEEPING POSITION; SEROTONERGIC NEURONS; UNEXPECTED DEATH; RISK-FACTORS; MEDULLA-OBLONGATA; SYNDROME GENE; SIDS; PRONE; POPULATION		[Kinney, Hannah C.] Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA; [Kinney, Hannah C.] Harvard Univ, Sch Med, Boston, MA USA; [Thach, Bradley T.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL)	Kinney, HC (corresponding author), Childrens Hosp Boston, Dept Pathol, Enders Bldg 1112,300 Longwood Ave, Boston, MA 02115 USA.	hannah.kinney@childrens.harvard.edu			National Institute of Child Health and Human Development [R37-HD20991, PO1-HD036379, RO1-HD10993]; First Candle/SIDS Alliance; CJ Foundation for SIDS; C. J. Murphy Foundation; Deborah Evelyn Barrett Fellowship; Children's Hospital Developmental Disabilities Research Center [P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, P01HD036379] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD010993, R37HD020991] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); First Candle/SIDS Alliance; CJ Foundation for SIDS; C. J. Murphy Foundation; Deborah Evelyn Barrett Fellowship; Children's Hospital Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grants from the National Institute of Child Health and Human Development (R37-HD20991 and PO1-HD036379, to Dr. Kinney; and RO1-HD10993, to Dr. Thach), by the First Candle/SIDS Alliance, the CJ Foundation for SIDS, the C. J. Murphy Foundation, the Deborah Evelyn Barrett Fellowship, and the Scottish Cot Death Trust and by a grant from the Children's Hospital Developmental Disabilities Research Center (P30-HD18655).	Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; Ariagno RL, 2006, J PERINATOL, V26, P306, DOI 10.1038/sj.jp.7211490; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Audero E, 2008, SCIENCE, V321, P130, DOI 10.1126/science.1157871; Beal SM, 2000, J PAEDIATR CHILD H, V36, P540, DOI 10.1046/j.1440-1754.2000.00563.x; Beckwith J., 1970, DISCUSSION TERMINOLO; BENNETT MJ, 1994, HUM PATHOL, V25, P742, DOI 10.1016/0046-8177(94)90241-0; Blackmon LR, 2003, PEDIATRICS, V111, P914; Blair PS, 2006, LANCET, V367, P314, DOI 10.1016/S0140-6736(06)67968-3; Blair PS, 2006, ARCH DIS CHILD, V91, P101, DOI 10.1136/adc.2004.070391; Blair PS, 1996, BRIT MED J, V313, P195, DOI 10.1136/bmj.313.7051.195; Bradley SR, 2002, NAT NEUROSCI, V5, P401, DOI 10.1038/nn848; Byard R W, 1996, J Clin Forensic Med, V3, P115, DOI 10.1016/S1353-1131(96)90000-0; Byard Roger W, 2007, J Forensic Leg Med, V14, P453, DOI 10.1016/j.jflm.2006.11.003; Chong A, 2000, ARCH DIS CHILD, V82, P253, DOI 10.1136/adc.82.3.253; Colson ER, 2006, PEDIATRICS, V118, pE243, DOI 10.1542/peds.2005-2517; Corwin MJ, 2003, PEDIATRICS, V111, P52, DOI 10.1542/peds.111.1.52; Cutz E, 2007, PEDIATR DEVEL PATHOL, V10, P106, DOI 10.2350/06-06-0113.1; Darnall RA, 2005, J NEUROSCI, V25, P8322, DOI 10.1523/JNEUROSCI.1770-05.2005; DOWNING SE, 1975, PEDIATRICS, V55, P640; Duncan JR, 2008, BRAIN PATHOL, V18, P21, DOI 10.1111/j.1750-3639.2007.00093.x; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Fifer WP, 2005, DEV PSYCHOBIOL, V47, P288, DOI 10.1002/dev.20096; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; FLEMING PJ, 1992, J CLIN PATHOL, V45, P17; FLEMING PJ, 1990, BRIT MED J, V301, P85, DOI 10.1136/bmj.301.6743.85; FORD RPK, 1995, J PAEDIATR CHILD H, V31, P408, DOI 10.1111/j.1440-1754.1995.tb00848.x; Galland BC, 2002, J PAEDIATR CHILD H, V38, P332, DOI 10.1046/j.1440-1754.2002.00002.x; Guntheroth WG, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e64; Harper RM, 2001, ARCH ITAL BIOL, V139, P185; Hauck FR, 2008, PEDIATRICS, V122, P660, DOI 10.1542/peds.2007-0135; Hauck FR, 2003, PEDIATRICS, V111, P1207; Horne Rosemary S C, 2006, Expert Rev Cardiovasc Ther, V4, P335, DOI 10.1586/14779072.4.3.335; Horne RSC, 2002, ARCH DIS CHILD-FETAL, V87, pF100, DOI 10.1136/fn.87.2.F100; Horne RSC, 2001, J PEDIATR-US, V138, P811, DOI 10.1067/mpd.2001.114475; Hoyert DL, 2003, BIRTH DEFECTS RES A, V67, P651, DOI 10.1002/bdra.10117; Hunt CE, 2005, ARCH DIS CHILD, V90, P48, DOI 10.1136/adc.2004.051458; HUNT CE, 1987, J PEDIATR-US, V110, P669, DOI 10.1016/S0022-3476(87)80001-X; Hunt CE, 2001, AM J RESP CRIT CARE, V164, P346, DOI 10.1164/ajrccm.164.3.9910045; Hymel KP, 2006, PEDIATRICS, V118, P421, DOI 10.1542/peds.2006-1245; Iyasu S, 2002, JAMA-J AM MED ASSOC, V288, P2717, DOI 10.1001/jama.288.21.2717; IYASU S, 2003, JAMA-J AM MED ASSOC, V289, P303; JARDINE DS, 1992, J APPL PHYSIOL, V73, P340, DOI 10.1152/jappl.1992.73.1.340; John WMS, 2008, J APPL PHYSIOL, V104, P665, DOI 10.1152/japplphysiol.00599.2007; Jones KL, 2003, PEDIATRICS, V111, P358, DOI 10.1542/peds.111.2.358; KAHN A, 1992, SLEEP, V15, P287, DOI 10.1093/sleep/15.4.287; Kato I, 2003, AM J RESP CRIT CARE, V168, P1298, DOI 10.1164/rccm.200301-134OC; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; KEMP JS, 1991, NEW ENGL J MED, V324, P1858, DOI 10.1056/NEJM199106273242605; Kemp JS, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e41; KINNEY HC, 1983, PEDIATRICS, V72, P181; Kinney HC, 2005, J NEUROPATH EXP NEUR, V64, P689, DOI 10.1097/01.jnen.0000174334.27708.43; Kinney HC, 2003, J NEUROPATH EXP NEUR, V62, P1178, DOI 10.1093/jnen/62.11.1178; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; KINNEY HC, 2004, PATHOLOGY GENETICS A, P194; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; Leiter JC, 2007, RESP PHYSIOL NEUROBI, V159, P127, DOI 10.1016/j.resp.2007.05.014; Lijowska AS, 1997, J APPL PHYSIOL, V83, P219, DOI 10.1152/jappl.1997.83.1.219; Lovick TA, 1997, EXP PHYSIOL, V82, P31, DOI 10.1113/expphysiol.1997.sp004013; Machaalani R, 2008, BRAIN, V131, P218, DOI 10.1093/brain/awm290; Malloy MH, 2005, PEDIATRICS, V115, P1247, DOI 10.1542/peds.2004-2188; MALLOY MH, 1995, PEDIATRICS, V96, P464; MANDELL F, 1988, Pediatrician, V15, P179; McKenna JJ, 2007, YEARB PHYS ANTHROPOL, V50, P133, DOI 10.1002/ajpa.20736; Mitchell EA, 2008, ACTA PAEDIATR, V97, P584, DOI 10.1111/j.1651-2227.2008.00717.x; MITCHELL EA, 1992, J PAEDIATR CHILD H, V28, pS13, DOI 10.1111/j.1440-1754.1992.tb02724.x; MITCHELL EA, 1994, ARCH DIS CHILD, V70, P291, DOI 10.1136/adc.70.4.291; MOLTENO CD, 1989, S AFR MED J, V75, P570; MONTEAU R, 1993, J PHYSL, V466, P367; Moon RY, 2007, LANCET, V370, P1578, DOI 10.1016/S0140-6736(07)61662-6; Moore BM, 2008, CLIN PEDIATR, V47, P770, DOI 10.1177/0009922808316991; NAEYE RL, 1976, AM J CLIN PATHOL, V66, P526, DOI 10.1093/ajcp/66.3.526; Opdal SH, 2004, PEDIATRICS, V114, pE506, DOI 10.1542/peds.2004-0683; Oyen N, 1996, AM J EPIDEMIOL, V144, P300, DOI 10.1093/oxfordjournals.aje.a008925; Ozawa Y, 2002, NEUROPEDIATRICS, V33, P142, DOI 10.1055/s-2002-33678; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; Pasquale-Styles MA, 2007, J FORENSIC SCI, V52, P924, DOI 10.1111/j.1556-4029.2007.00477.x; Patel AL, 2001, J APPL PHYSIOL, V91, P2537, DOI 10.1152/jappl.2001.91.6.2537; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Paton JFR, 2006, NAT NEUROSCI, V9, P311, DOI 10.1038/nn1650; Penatti EM, 2006, J APPL PHYSIOL, V101, P1177, DOI 10.1152/japplphysiol.00376.2006; Platt MW, 2000, ARCH DIS CHILD, V82, P98, DOI 10.1136/adc.82.2.98; Poets CF, 1999, PEDIATR RES, V45, P350, DOI 10.1203/00006450-199903000-00010; Poets Christian F, 2004, Paediatr Respir Rev, V5 Suppl A, pS383, DOI 10.1016/S1526-0542(04)90068-1; PONSONBY AL, 1993, NEW ENGL J MED, V329, P377, DOI 10.1056/NEJM199308053290601; Ramanathan R, 2001, JAMA-J AM MED ASSOC, V285, P2199, DOI 10.1001/jama.285.17.2199; Raza MW, 1999, FEMS IMMUNOL MED MIC, V25, P85, DOI 10.1111/j.1574-695X.1999.tb01330.x; Sahni R, 2007, CURR OPIN PEDIATR, V19, P145, DOI 10.1097/MOP.0b013e32808373b6; SCHECHTMAN VL, 1992, PEDIATRICS, V89, P865; Schechtman VL, 1996, PEDIATR RES, V40, P571, DOI 10.1203/00006450-199610000-00010; SCHER MS, 1994, PEDIATR RES, V36, P738, DOI 10.1203/00006450-199412000-00010; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; SHANNON DC, 1982, NEW ENGL J MED, V306, P1022, DOI 10.1056/NEJM198204293061704; SHANNON DC, 1982, NEW ENGL J MED, V306, P959, DOI 10.1056/NEJM198204223061604; Shapiro-Mendoza CK, 2006, AM J EPIDEMIOL, V163, P762, DOI 10.1093/aje/kwj117; Sinton CM, 2004, SEMIN NEUROL, V24, P211, DOI 10.1055/s-2004-835067; Skadberg BT, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.2.e6; SOUTHALL DP, 1988, EUR J PEDIATR, V147, P74, DOI 10.1007/BF00442617; Sridhar R, 2003, PEDIATR PULM, V36, P113, DOI 10.1002/ppul.10287; Thach B, 2008, EMBO REP, V9, P114, DOI 10.1038/sj.embor.7401163; Thach BT, 1996, SLEEP, V19, pS271, DOI 10.1093/sleep/19.suppl_10.S271; THACH BT, 2000, AM J MED S4A, V408, pS144; Thach WT, 1998, NOVART FDN SYMP, V218, P219; Tryba AK, 2006, J NEUROSCI, V26, P2623, DOI 10.1523/JNEUROSCI.4186-05.2006; Vege A, 2004, FEMS IMMUNOL MED MIC, V42, P3, DOI 10.1016/j.femsim.2004.06.015; VEGE A, 1994, ACTA PAEDIATR, V83, P634; Vennemann M, 2007, ARCH DIS CHILD, V92, P133, DOI 10.1136/adc.2006.101337; Weber MA, 2008, LANCET, V371, P1848, DOI 10.1016/S0140-6736(08)60798-9; Weese-Mayer DE, 2007, AM J MED GENET A, V143A, P771, DOI 10.1002/ajmg.a.31722; WILLINGER M, 1994, PEDIATRICS, V93, P814; WILLINGER M, 1991, Pediatric Pathology, V11, P677	111	305	315	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					795	805		10.1056/NEJMra0803836	http://dx.doi.org/10.1056/NEJMra0803836			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484WX	19692691	Green Accepted			2022-12-28	WOS:000269081200008
J	Reich, ES				Reich, Eugenie Samuel			Whistleblowers at risk as science fails to correct itself	NATURE			English	Letter												eugenie.reich@gmail.com							0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					949	949		10.1038/460949c	http://dx.doi.org/10.1038/460949c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693062	Bronze			2022-12-28	WOS:000269085500013
J	Smith, MR; Egerdie, B; Toriz, NH; Feldman, R; Tammela, TLJ; Saad, F; Heracek, J; Szwedowski, M; Ke, CL; Kupic, A; Leder, BZ; Goessl, C				Smith, Matthew R.; Egerdie, Blair; Hernndez Toriz, Narciso; Feldman, Robert; Tammela, Teuvo L. J.; Saad, Fred; Heracek, Jiri; Szwedowski, Maciej; Ke, Chunlei; Kupic, Amy; Leder, Benjamin Z.; Goessl, Carsten		Denosumab HALT Prostate Canc Study	Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BONE-MINERAL DENSITY; ZOLEDRONIC ACID; POSTMENOPAUSAL WOMEN; OSTEOPOROSIS; FRACTURE; RISK; COMPLICATIONS; ALENDRONATE; PLACEBO	BACKGROUND Androgen-deprivation therapy is well-established for treating prostate cancer but is associated with bone loss and an increased risk of fracture. We investigated the effects of denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor-kappa B ligand, on bone mineral density and fractures in men receiving androgen-deprivation therapy for nonmetastatic prostate cancer. METHODS In this double-blind, multicenter study, we randomly assigned patients to receive denosumab at a dose of 60 mg subcutaneously every 6 months or placebo (734 patients in each group). The primary end point was percent change in bone mineral density at the lumbar spine at 24 months. Key secondary end points included percent change in bone mineral densities at the femoral neck and total hip at 24 months and at all three sites at 36 months, as well as incidence of new vertebral fractures. RESULTS At 24 months, bone mineral density of the lumbar spine had increased by 5.6% in the denosumab group as compared with a loss of 1.0% in the placebo group (P<0.001); significant differences between the two groups were seen at as early as 1 month and sustained through 36 months. Denosumab therapy was also associated with significant increases in bone mineral density at the total hip, femoral neck, and distal third of the radius at all time points. Patients who received denosumab had a decreased incidence of new vertebral fractures at 36 months (1.5%, vs. 3.9% with placebo) (relative risk, 0.38; 95% confidence interval, 0.19 to 0.78; P=0.006). Rates of adverse events were similar between the two groups. CONCLUSIONS Denosumab was associated with increased bone mineral density at all sites and a reduction in the incidence of new vertebral fractures among men receiving androgen-deprivation therapy for nonmetastatic prostate cancer. (ClinicalTrials.gov number, NCT00089674.)	[Smith, Matthew R.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Leder, Benjamin Z.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Egerdie, Blair] Urol Associates Urol Med Res, Kitchener, ON, Canada; [Hernndez Toriz, Narciso] Ctr Med Nacl Siglo XXI, Mexico City, DF, Mexico; [Feldman, Robert] Connecticut Clin Res Ctr Urol Specialists, Middlebury, VT USA; [Tammela, Teuvo L. J.] Tampere Univ Hosp, Tampere, Finland; [Heracek, Jiri] Androgeos, Prague, Czech Republic; [Saad, Fred] CHU Montreal, Montreal, PQ, Canada; [Szwedowski, Maciej] Wojewodzkie Ctr Med, Opole, Poland; [Ke, Chunlei; Kupic, Amy; Goessl, Carsten] Amgen Inc, Thousand Oaks, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Instituto Mexicano del Seguro Social; Tampere University; Tampere University Hospital; Universite de Montreal; Amgen	Smith, MR (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Yawkey 7038,55 Fruit St, Boston, MA 02114 USA.	smith.matthew@mgh.harvard.edu	Lamy, Olivier/E-5512-2013; Heracek, Jiri/K-4312-2012	Heracek, Jiri/0000-0002-7466-7532; Lippuner, Kurt/0000-0002-7195-3779; Jarzemski, Piotr/0000-0002-9451-7320; Koranyi, Laszlo/0000-0002-5733-9350; Aronoff, David/0000-0003-4587-6121; Lacombe, Louis/0000-0003-4811-0308	Amgen; National Institutes of Health [5K24CA121990-02]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [K24CA121990] Funding Source: NIH RePORTER	Amgen(Amgen); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from Amgen, the National Institutes of Health (K24 Midcareer Investigator Award 5K24CA121990-02, to Dr. Smith), and the Prostate Cancer Foundation (to Dr. Smith).	Bolla M, 1999, EUR UROL, V35, P23, DOI 10.1159/000052303; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Calis KA, 2007, NEW ENGL J MED, V357, P1861, DOI 10.1056/NEJMe078192; Dempster DW., 2006, PRIMER METABOLIC BON, P7; Ellis GK, 2008, J CLIN ONCOL, V26, P4875, DOI 10.1200/JCO.2008.16.3832; Greenspan SL, 2007, ANN INTERN MED, V146, P416, DOI 10.7326/0003-4819-146-6-200703200-00006; Heidenreich A, 2008, EUR UROL, V53, P68, DOI 10.1016/j.eururo.2007.09.002; Higano CS, 2008, NAT CLIN PRACT UROL, V5, P24, DOI 10.1038/ncpuro0995; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaufman JM, 2005, OSTEOPOROSIS INT, V16, P510, DOI 10.1007/s00198-004-1713-3; Krupski TL, 2004, CANCER, V101, P2370, DOI 10.1002/cncr.20663; Krupski TL, 2004, CANCER-AM CANCER SOC, V101, P541, DOI 10.1002/cncr.20388; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Loblaw DA, 2007, J CLIN ONCOL, V25, P1596, DOI 10.1200/JCO.2006.10.1949; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; MCLTON LJ, 2003, J UROLOGY, V169, P1747; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; Michaelson MD, 2007, J CLIN ONCOL, V25, P1038, DOI 10.1200/JCO.2006.07.3361; Michaelson MD, 2004, CLIN CANCER RES, V10, P2705, DOI 10.1158/1078-0432.CCR-03-0735; Miller PD, 2008, BONE, V43, P222, DOI 10.1016/j.bone.2008.04.007; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Orwoll E, 2000, NEW ENGL J MED, V343, P604, DOI 10.1056/NEJM200008313430902; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ragi-Eis S, 2006, J CLIN DENSITOM, V9, P274, DOI 10.1016/j.jocd.2006.04.001; Ringe JD, 2006, RHEUMATOL INT, V26, P427, DOI 10.1007/s00296-005-0004-4; Rosenblatt M, 2003, J BONE MINER RES, V18, P1142, DOI 10.1359/jbmr.2003.18.6.1142; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; SMITH M, 2008, AM ASS CANC RES 100; Smith MR, 2008, J UROLOGY, V179, P152, DOI 10.1016/j.juro.2007.08.137; Smith MR, 2005, J CLIN ONCOL, V23, P7897, DOI 10.1200/JCO.2004.00.6908; Smith MR, 2003, J UROLOGY, V169, P2008, DOI 10.1097/01.ju.0000063820.94994.95; Smith MR, 2004, J CLIN ENDOCR METAB, V89, P3841, DOI 10.1210/jc.2003-032058; Smith MR, 2001, NEW ENGL J MED, V345, P948, DOI 10.1056/NEJMoa010845; Steiner MS, 2004, J CLIN ONCOL, V22, p406S; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Temple RJ, 2003, J BONE MINER RES, V18, P1129, DOI 10.1359/jbmr.2003.18.6.1129	37	751	777	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					745	755		10.1056/NEJMoa0809003	http://dx.doi.org/10.1056/NEJMoa0809003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484WX	19671656	Green Accepted			2022-12-28	WOS:000269081200003
J	Ellis, MJ; Gao, F; Dehdashti, F; Jeffe, DB; Marcom, PK; Carey, LA; Dickler, MN; Silverman, P; Fleming, GF; Kommareddy, A; Jamalabadi-Majidi, S; Crowder, R; Siegel, BA				Ellis, Matthew J.; Gao, Feng; Dehdashti, Farrokh; Jeffe, Donna B.; Marcom, P. Kelly; Carey, Lisa A.; Dickler, Maura N.; Silverman, Paula; Fleming, Gini F.; Kommareddy, Aruna; Jamalabadi-Majidi, S.; Crowder, Robert; Siegel, Barry A.			Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor-Positive, Aromatase Inhibitor-Resistant Advanced Breast Cancer A Phase 2 Randomized Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	31st Annual San Antonio Breast Cancer Symposium	DEC 10-14, 2008	San Antonio, TX				POSTMENOPAUSAL WOMEN; CONTROLLED-TRIAL; ESTROGEN; DIETHYLSTILBESTROL	Context Estrogen deprivation therapy with aromatase inhibitors has been hypothesized to paradoxically sensitize hormone-receptor-positive breast cancer tumor cells to low-dose estradiol therapy. Objective To determine whether 6 mg of estradiol (daily) is a viable therapy for postmenopausal women with advanced aromatase inhibitor-resistant hormone receptor-positive breast cancer. Design, Setting, and Patients A phase 2 randomized trial of 6 mg vs 30 mg of oral estradiol used daily (April 2004-February 2008 [enrollment closed]). Eligible patients (66 randomized) had metastatic breast cancer treated with an aromatase inhibitor with progression-free survival (>= 24 wk) or relapse (after >= 2 y) of adjuvant aromatase inhibitor use. Patients at high risk of estradiol-related adverse events were excluded. Patients were examined after 1 and 2 weeks for clinical and laboratory toxicities and flare reactions and thereafter every 4 weeks. Tumor radiological assessment occurred every 12 weeks. At least 1 measurable lesion or 4 measurable lesions (bone-only disease) were evaluated for tumor response. Intervention Randomization to receive 1 oral 2-mg generic estradiol tablet 3 times daily or five 2-mg tablets 3 times daily. Main Outcome Measures Primary end point: clinical benefit rate (response plus stable disease at 24 weeks). Secondary outcomes: toxicity, progression-free survival, time to treatment failure, quality of life, and the predictive properties of the metabolic flare reaction detected by positron emission tomography/computed tomography with fluorodeoxyglucose F 18. Results The adverse event rate (> grade 3) in the 30-mg group (11/32 [34%]; 95% confidence interval [CI], 23%-47%) was higher than in the 6-mg group (4/34 [18%]; 95% CI, 5%-22%; P=.03). Clinical benefit rates were 9 of 32 (28%; 95% CI, 18%-41%) in the 30-mg group and 10 of 34 (29%; 95% CI, 19%-42%) in the 6-mg group. An estradiol-stimulated increase in fluorodeoxyglucose F 18 uptake (>= 12% prospectively defined) was predictive of response ( positive predictive value, 80%; 95% CI, 61%-92%). Seven patients with estradiol-sensitive disease were re-treated with aromatase inhibitors at estradiol progression, among which 2 had partial response and 1 had stable disease, suggesting resensitization to estrogen deprivation. Conclusions In women with advanced breast cancer and acquired resistance to aromatase inhibitors, a daily dose of 6 mg of estradiol provided a similar clinical benefit rate as 30 mg, with fewer serious adverse events. The efficacy of treatment with the lower dose should be further examined in phase 3 clinical trials. Trial Registration clinicaltrials.gov Identifier: NCT00324259 JAMA. 2009; 302(7):774-780 www.jama.com	[Ellis, Matthew J.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Ellis, Matthew J.; Gao, Feng; Dehdashti, Farrokh; Jeffe, Donna B.; Siegel, Barry A.] Washington Univ, Siteman Comprehens Can Ctr, St Louis, MO 63110 USA; [Gao, Feng] Washington Univ, Div Biostat, St Louis, MO 63110 USA; [Dehdashti, Farrokh; Siegel, Barry A.] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Jeffe, Donna B.] Washington Univ, Div Hlth Behav Res, St Louis, MO 63110 USA; [Marcom, P. Kelly] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA; [Carey, Lisa A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Dickler, Maura N.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Silverman, Paula] Case Comprehens Canc Ctr, Cleveland, OH USA; [Fleming, Gini F.] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Duke University; University of North Carolina; University of North Carolina Chapel Hill; Memorial Sloan Kettering Cancer Center; Case Western Reserve University; University of Chicago	Ellis, MJ (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, Campus Box 8056,660 S Euclid Ave, St Louis, MO 63110 USA.	mellis@dom.wustl.edu	Marcom, Paul/AAE-4761-2020; Jeffe, Donna B./AAI-3732-2020; Marcom, Paul/M-4516-2019	Marcom, Paul/0000-0001-5302-6368; Jeffe, Donna B./0000-0002-7642-3777; Gao, Feng/0000-0002-1425-1623	NCI NIH HHS [P30 CA008748, P30 CA091842, P30 CA016086, P30 CA91842, P30 CA043703, P30 CA014236, P30 CA14599, P30 CA014599] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA091842, P30CA014599, P30CA016086, P30CA008748, P30CA043703, P30CA014236] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Brady MJ, 1997, J CLIN ONCOL, V15, P974, DOI 10.1200/JCO.1997.15.3.974; CARTER AC, 1977, JAMA-J AM MED ASSOC, V237, P2079, DOI 10.1001/jama.237.19.2079; Chia S, 2008, J CLIN ONCOL, V26, P1664, DOI 10.1200/JCO.2007.13.5822; Dehdashti F, 2009, BREAST CANCER RES TR, V113, P509, DOI 10.1007/s10549-008-9953-0; Dodds EC, 1938, NATURE, V141, P247, DOI 10.1038/141247b0; Eton DT, 2004, J CLIN EPIDEMIOL, V57, P898, DOI 10.1016/j.jclinepi.2004.01.012; Haddow A, 1944, Br Med J, V2, P393; Hamaoka T, 2004, J CLIN ONCOL, V22, P2942, DOI 10.1200/jco.2004.08.181; INGLE JN, 1981, NEW ENGL J MED, V304, P16, DOI 10.1056/NEJM198101013040104; Lonning PE, 2001, BREAST CANCER RES TR, V67, P111, DOI 10.1023/A:1010619225209; Mortimer JE, 2001, J CLIN ONCOL, V19, P2797, DOI 10.1200/JCO.2001.19.11.2797; Song RXD, 2001, J NATL CANCER I, V93, P1714, DOI 10.1093/jnci/93.22.1714; STOLL BA, 1973, BMJ-BRIT MED J, V3, P446, DOI 10.1136/bmj.3.5877.446	14	215	223	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					774	780		10.1001/jama.2009.1204	http://dx.doi.org/10.1001/jama.2009.1204			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	484UT	19690310	Bronze, Green Accepted			2022-12-28	WOS:000269073800026
J	Hu, JJ; Shibata, Y; Zhu, PP; Voss, C; Rismanchi, N; Prinz, WA; Rapoport, TA; Blackstone, C				Hu, Junjie; Shibata, Yoko; Zhu, Peng-Peng; Voss, Christiane; Rismanchi, Neggy; Prinz, William A.; Rapoport, Tom A.; Blackstone, Craig			A Class of Dynamin-like GTPases Involved in the Generation of the Tubular ER Network	CELL			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM; MITOCHONDRIAL FUSION; MEMBRANE-PROTEINS; BINDING PARTNERS; GOLGI-APPARATUS; LIVING CELLS; ATLASTIN; GENE; YEAST	The endoplasmic reticulum ( ER) consists of tubules that are shaped by the reticulons and DP1/Yop1p, but how the tubules form an interconnected network is unknown. Here, we show that mammalian atlastins, which are dynamin-like, integral membrane GTPases, interact with the tubule-shaping proteins. The atlastins localize to the tubular ER and are required for proper network formation in vivo and in vitro. Depletion of the atlastins or overexpression of dominant-negative forms inhibits tubule interconnections. The Sey1p GTPase in S. cerevisiae is likely a functional ortholog of the atlastins; it shares the same signature motifs and membrane topology and interacts genetically and physically with the tubule-shaping proteins. Cells simultaneously lacking Sey1p and a tubule-shaping protein have ER morphology defects. These results indicate that formation of the tubular ER network depends on conserved dynamin-like GTPases. Since atlastin-1 mutations cause a common form of hereditary spastic paraplegia, we suggest ER-shaping defects as a neuropathogenic mechanism.	[Hu, Junjie; Shibata, Yoko; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Howard Hughes Med Inst, Boston, MA 02115 USA; [Zhu, Peng-Peng; Rismanchi, Neggy; Blackstone, Craig] NINDS, Cellular Neurol Unit, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Voss, Christiane; Prinz, William A.] NIDDKD, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu	Hu, Junjie/F-9713-2013		American Heart Association; Intramural Research Programs of the NINDS; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Howard Hughes Medical Institute investigator; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002992, Z01NS002992] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Intramural Research Programs of the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute investigator(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Jaffe ( National Institute of Neurological Disorders and Stroke; NINDS) for MALDI-TOF analysis, F. Yang ( National Institute of Child Health and Human Development) for providing Xenopus eggs, L. Dreier and G. Voeltz for advice, and P. Carvalho for generating some yeast deletion strains. We thank S. Schulman, A. Palazzo, and D. Pellman for critical reading of the manuscript. Y. S. was supported by the American Heart Association, and C. B. and W. A. P. by the Intramural Research Programs of the NINDS and National Institute of Diabetes and Digestive and Kidney Diseases, respectively, National Institutes of Health. T. A. R. is a Howard Hughes Medical Institute investigator.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Brands A, 2002, PLANT PHYSIOL, V130, P1121, DOI 10.1104/pp.007716; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Evans K, 2006, P NATL ACAD SCI USA, V103, P10666, DOI 10.1073/pnas.0510863103; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; Mannan AU, 2006, NEUROGENETICS, V7, P93, DOI 10.1007/s10048-006-0034-4; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Namekawa M, 2007, MOL CELL NEUROSCI, V35, P1, DOI 10.1016/j.mcn.2007.01.012; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447; SCHIEFELBEIN JW, 1990, PLANT CELL, V2, P235, DOI 10.1105/tpc.2.3.235; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang HY, 1997, GENE DEV, V11, P799, DOI 10.1101/gad.11.6.799; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	42	386	415	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					549	561		10.1016/j.cell.2009.05.025	http://dx.doi.org/10.1016/j.cell.2009.05.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665976	Green Accepted, Bronze			2022-12-28	WOS:000268771900019
J	Myrskyla, M; Kohler, HP; Billari, FC				Myrskylae, Mikko; Kohler, Hans-Peter; Billari, Francesco C.			Advances in development reverse fertility declines	NATURE			English	Article							LOWEST-LOW FERTILITY; POPULATION-GROWTH; EUROPE; CONSEQUENCES; CHILDBEARING; TRANSITION	During the twentieth century, the global population has gone through unprecedented increases in economic and social development that coincided with substantial declines in human fertility and population growth rates(1,2). The negative association of fertility with economic and social development has therefore become one of the most solidly established and generally accepted empirical regularities in the social sciences(1-3). As a result of this close connection between development and fertility decline, more than half of the global population now lives in regions with below-replacement fertility (less than 2.1 children per woman)(4). In many highly developed countries, the trend towards low fertility has also been deemed irreversible(5-9). Rapid population ageing, and in some cases the prospect of significant population decline, have therefore become a central socioeconomic concern and policy challenge(10). Here we show, using new cross-sectional and longitudinal analyses of the total fertility rate and the human development index (HDI), a fundamental change in the well-established negative relationship between fertility and development as the global population entered the twenty-first century. Although development continues to promote fertility decline at low and medium HDI levels, our analyses show that at advanced HDI levels, further development can reverse the declining trend in fertility. The previously negative development-fertility relationship has become J-shaped, with the HDI being positively associated with fertility among highly developed countries. This reversal of fertility decline as a result of continued economic and social development has the potential to slow the rates of population ageing, thereby ameliorating the social and economic problems that have been associated with the emergence and persistence of very low fertility.	[Myrskylae, Mikko; Kohler, Hans-Peter] Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA; [Billari, Francesco C.] Univ Bocconi, DONDENA Carlo F Dondena Ctr Res Social Dynam, Dept Decis Sci, I-20136 Milan, Italy; [Billari, Francesco C.] Univ Bocconi, IGIER, I-20136 Milan, Italy	University of Pennsylvania; Bocconi University; Bocconi University	Kohler, HP (corresponding author), Univ Penn, Ctr Populat Studies, 3718 Locust Walk, Philadelphia, PA 19104 USA.	hpkohler@pop.upenn.edu		Billari, Francesco C./0000-0003-4717-6129	University of Pennsylvania; Finnish Cultural Foundation; Ella and Georg Ehrnrooth foundation; Center for Advanced Studies at the Norwegian Academy of Science; Universita Bocconi; Italian Ministry for University and Research	University of Pennsylvania; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Ella and Georg Ehrnrooth foundation; Center for Advanced Studies at the Norwegian Academy of Science; Universita Bocconi; Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR))	M. M. acknowledges support from the University of Pennsylvania, the Finnish Cultural Foundation, and the Ella and Georg Ehrnrooth foundation. H.-P. K. acknowledges the support provided by the Center for Advanced Studies at the Norwegian Academy of Science and the University of Pennsylvania. F. C. B. acknowledges support from Universita Bocconi, the Italian Ministry for University and Research and the Distinguished International Scholars Program at the University of Pennsylvania. We are grateful to T. Sobotka for the provision of tempo-adjusted fertility data used in our analyses.	Balter M, 2006, SCIENCE, V312, P1894, DOI 10.1126/science.312.5782.1894; Billari FC, 2004, POP STUD-J DEMOG, V58, P161, DOI 10.1080/0032472042000213695; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Bongaarts J, 1998, POPUL DEV REV, V24, P271, DOI 10.2307/2807974; Bongaarts J, 1998, SCIENCE, V282, P419, DOI 10.1126/science.282.5388.419; Brewster KL, 2000, ANNU REV SOCIOL, V26, P271, DOI 10.1146/annurev.soc.26.1.271; Bryant J, 2007, POPUL DEV REV, V33, P101, DOI 10.1111/j.1728-4457.2007.00160.x; Butler D, 2004, NATURE, V432, P38, DOI 10.1038/432038a; Kohler HP, 2002, POPUL DEV REV, V28, P641, DOI 10.1111/j.1728-4457.2002.00641.x; Lee R, 2003, J ECON PERSPECT, V17, P167, DOI 10.1257/089533003772034943; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Lutz W, 2003, SCIENCE, V299, P1991, DOI 10.1126/science.1080316; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; McDonald P, 2000, POPUL DEV REV, V26, P427, DOI 10.1111/j.1728-4457.2000.00427.x; Neyer G, 2008, POPUL DEV REV, V34, P699, DOI 10.1111/j.1728-4457.2008.00246.x; Sobotka T, 2004, POPUL DEV REV, V30, P195, DOI 10.1111/j.1728-4457.2004.010_1.x; SUZUKI T, 2003, J POPULATION PROBLEM, V59, P1; United Nations, 2000, REPL MIGR IS IT SOL; United Nations Development Programme, 2008, STAT HUM DEV REP; Wilson C, 2004, SCIENCE, V304, P207; WOOLDRIDGE JM, 2002, ECONOMETRIC ANAL CRO, pCH10	21	300	312	4	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					741	743		10.1038/nature08230	http://dx.doi.org/10.1038/nature08230			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479OO	19661915				2022-12-28	WOS:000268670300039
J	Sorg, O; Zennegg, M; Schmid, P; Fedosyuk, R; Valikhnovskyi, R; Gaide, O; Kniazevych, V; Saurat, JH				Sorg, O.; Zennegg, M.; Schmid, P.; Fedosyuk, R.; Valikhnovskyi, R.; Gaide, O.; Kniazevych, V.; Saurat, J-H			2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites	LANCET			English	Article							DIBENZO-P-DIOXINS; TISSUE DISTRIBUTION; BILIARY-EXCRETION; ELIMINATION; RAT; SEVESO; TOXICITY; PRETREATMENT; KINETICS; RECEPTOR	Background 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has a long half-life of 5-10 years in human beings as a result of its high lipophilicity, and little or no metabolism. We monitored TCDD, its form, distribution, and elimination in Victor Yushchenko after he presented with severe poisoning. Methods In late December, 2004, a patient presented with TCDD poisoning; the levels in his blood serum (108000 pg/g lipid weight) were more than 50000-fold greater than those in the general population. We identified TCDD and its metabolites, and monitored their levels for 3 years using gas chromatography and high-resolution mass spectrometry in samples of blood serum, adipose tissue, faeces, skin, urine, and sweat, after they were extracted and cleaned with different organic solvents. Findings The amount of unmodified TCDD in the samples that were analysed accounted for about 60% of TCDD eliminated from the body during the same period. Two TCDD metabolites-2,3,7-trichloro-8-hydroxydibenzo-p-dioxin and 1,3,7,8-tetrachloro-2-hydroxydibenzo-p-dioxin-were identified in the faeces, blood serum, and urine. The faeces contained the highest concentration of TCDD metabolites, and were the main route of elimination. Altogether, the different routes of elimination of TCDD and its metabolites accounted for 98% of the loss of the toxin from the body. The half-life of TCDD in our patient was 15.4 months. Interpretation This case of poisoning with TCDD suggests that the design of methods for routine assessment of TCDD metabolites in human beings should be a main aim of TCDD research in the metabolomic era. Funding University of Geneva Dermatology Fund, and Swiss Centre for Applied Human Toxicology.	[Sorg, O.; Gaide, O.; Saurat, J-H] Univ Hosp Geneva, Swiss Ctr Appl Human Toxicol, CH-1211 Geneva 4, Switzerland; [Sorg, O.; Gaide, O.; Saurat, J-H] Univ Hosp Geneva, Dept Dermatol, CH-1211 Geneva 4, Switzerland; [Zennegg, M.; Schmid, P.] Swiss Fed Labs Mat Testing & Res, EMPA, Dubendorf, Switzerland; [Fedosyuk, R.; Valikhnovskyi, R.; Kniazevych, V.] Feofania Hosp, Kiev, Ukraine	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Saurat, JH (corresponding author), Univ Hosp Geneva, Swiss Ctr Appl Human Toxicol, 4 Rue Gabrielle Peret Gentil, CH-1211 Geneva 4, Switzerland.	Jean.Saurat@unige.ch			University of Geneva, Dermatology Foundation; Swiss Centre for Applied Human Toxicology, Geneva, Switzerland	University of Geneva, Dermatology Foundation; Swiss Centre for Applied Human Toxicology, Geneva, Switzerland	This study was supported by the University of Geneva, Dermatology Foundation, and Swiss Centre for Applied Human Toxicology, Geneva, Switzerland; the authors had the freedom to use the funds for their research on dioxin poisoning. We thank the patient for his ability to cope with this disease and his willingness to contribute to increasing scientific knowledge about TCDD toxicity; Norbert Heeb, Andreas C Gerecke, and Hans-Rudolf Buser for helpful discussions; Heldur Hakk and Janice K Huwe from the US Department of Agriculture, Fargo, ND, USA, for providing reference compounds of hydroxylated TCDD; and Richard W James for his careful reading of the report and helpful comments.	ABRAHAM K, 1989, ARCH TOXICOL, V63, P75, DOI 10.1007/BF00334639; Aylward LL, 2005, J EXPO ANAL ENV EPID, V15, P51, DOI 10.1038/sj.jea.7500370; Brouwer A., 2005, ORGANOHALOGEN COMPOU, V67, P1705; Chainuvati S, 2003, CLIN PHARMACOL THER, V74, P437, DOI 10.1016/S0009-9236(03)00229-7; DEJONGH J, 1993, XENOBIOTICA, V23, P19, DOI 10.3109/00498259309059358; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Geusau A, 1999, LANCET, V354, P1266, DOI 10.1016/S0140-6736(99)04271-3; Geusau A, 2002, ARCH TOXICOL, V76, P316, DOI 10.1007/s00204-002-0345-7; Holt E, 2005, LANCET, V365, P1375, DOI 10.1016/S0140-6736(05)66354-4; Jackson JA, 1998, DRUG METAB DISPOS, V26, P714; KEDDERIS LB, 1993, FUND APPL TOXICOL, V21, P405, DOI 10.1006/faat.1993.1115; Kerger BD, 2006, ENVIRON HEALTH PERSP, V114, P1596, DOI 10.1289/ehp.8884; Kohle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009; Landi MT, 2003, CARCINOGENESIS, V24, P673, DOI 10.1093/carcin/bgg002; MCKINLEY MK, 1993, FUND APPL TOXICOL, V21, P425, DOI 10.1006/faat.1993.1118; Michalek JE, 2002, J EXPO ANAL ENV EPID, V12, P44, DOI 10.1038/sj.jea.7500201; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Okino ST, 2007, MOL PHARMACOL, V72, P1457, DOI 10.1124/mol.107.039826; OLSON JR, 1994, FUND APPL TOXICOL, V22, P631, DOI 10.1006/faat.1994.1069; PATTERSON DG, 1988, ARCH ENVIRON CON TOX, V17, P139, DOI 10.1007/BF01056017; POHJANVIRTA R, 1990, PHARMACOL TOXICOL, V66, P93, DOI 10.1111/j.1600-0773.1990.tb00712.x; POIGER H, 1979, NATURE, V281, P706, DOI 10.1038/281706a0; POIGER H, 1982, EXPERIENTIA, V38, P484, DOI 10.1007/BF01952652; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Rifkind AB, 2006, DRUG METAB REV, V38, P291, DOI 10.1080/03602530600570107; ROSENTHAL E, 2004, NY TIMES        1212; STEELE EJ, 1990, TOXICOL LETT, V51, P261, DOI 10.1016/0378-4274(90)90068-W; Sulistyaningdyah WT, 2004, BIOTECHNOL LETT, V26, P1857, DOI 10.1007/s10529-004-5317-y; VANDENBERG M, 1994, CRIT REV TOXICOL, V24, P1; Walker NJ, 1998, CARCINOGENESIS, V19, P395, DOI 10.1093/carcin/19.3.395; WENDLING JM, 1990, ANAL CHEM, V62, P796, DOI 10.1021/ac00207a005; Wittsiepe J, 2007, CHEMOSPHERE, V67, pS286, DOI 10.1016/j.chemosphere.2006.05.118; Yoshimura T, 2003, IND HEALTH, V41, P139, DOI 10.2486/indhealth.41.139; 2006, BBC NEWS        0602	36	125	128	0	59	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1179	1185		10.1016/S0140-6736(09)60912-0	http://dx.doi.org/10.1016/S0140-6736(09)60912-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505IZ	19660807				2022-12-28	WOS:000270688200034
J	Ahel, D; Horejsi, Z; Wiechens, N; Polo, SE; Garcia-Wilson, E; Ahel, I; Flynn, H; Skehel, M; West, SC; Jackson, SP; Owen-Hughes, T; Boulton, SJ				Ahel, Dragana; Horejsi, Zuzana; Wiechens, Nicola; Polo, Sophie E.; Garcia-Wilson, Elisa; Ahel, Ivan; Flynn, Helen; Skehel, Mark; West, Stephen C.; Jackson, Stephen P.; Owen-Hughes, Tom; Boulton, Simon J.			Poly(ADP-ribose)-Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1	SCIENCE			English	Article							DAMAGE; POLY(ADP-RIBOSYL)ATION; BINDING; POLYNUCLEOSOMES; IDENTIFICATION; RELAXATION; PROTEINS; MOTIFS	Posttranslational modifications play key roles in regulating chromatin plasticity. Although various chromatin-remodeling enzymes have been described that respond to specific histone modifications, little is known about the role of poly[adenosine 5'-diphosphate (ADP)-ribose] in chromatin remodeling. Here, we identify a chromatin-remodeling enzyme, ALC1 (Amplified in Liver Cancer 1, also known as CHD1L), that interacts with poly(ADP-ribose) and catalyzes PARP1-stimulated nucleosome sliding. Our results define ALC1 as a DNA damage-response protein whose role in this process is sustained by its association with known DNA repair factors and its rapid poly(ADP-ribose)-dependent recruitment to DNA damage sites. Furthermore, we show that depletion or overexpression of ALC1 results in sensitivity to DNA-damaging agents. Collectively, these results provide new insights into the mechanisms by which poly(ADP-ribose) regulates DNA repair.	[Ahel, Dragana; Horejsi, Zuzana; Boulton, Simon J.] London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Wiechens, Nicola; Garcia-Wilson, Elisa; Owen-Hughes, Tom] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Polo, Sophie E.; Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Polo, Sophie E.; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Ahel, Ivan] Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Manchester M20 4BX, Lancs, England; [Ahel, Ivan] London Res Inst, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [Flynn, Helen; Skehel, Mark] London Res Inst, Prot Anal & Prote Lab, S Mimms EN6 3LD, Herts, England	University of Dundee; University of Cambridge; University of Cambridge; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester	Boulton, SJ (corresponding author), London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	Simon.boulton@cancer.org.uk	Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Owen-Hughes, Tom/0000-0002-0618-8185; Ahel, Ivan/0000-0002-9446-3756; Licenikova Horejsi, Zuzana/0000-0002-9943-1649; Flynn, Helen/0000-0001-7002-9130; Polo, Sophie/0000-0003-4821-9354; West, Stephen/0000-0001-8848-9418	Wellcome Trust Senior Fellowship [064414]; UK Biotechnology and Biological Sciences Research Council; Medical Research Council (UK); European Union; European Molecular Biology Organization; Human Frontier Science Program Organization; Louis-Jeantet Foundation	Wellcome Trust Senior Fellowship(Wellcome Trust); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program Organization(Human Frontier Science Program); Louis-Jeantet Foundation	Research in the labs of S. J. B., S. P. J., S. C. W., I. A., and M. S. is supported by Cancer Research UK. The lab of T. O.-H. is funded by a Wellcome Trust Senior Fellowship 064414. S. P. J. is also funded by the UK Biotechnology and Biological Sciences Research Council, Medical Research Council (UK), the Wellcome Trust, and the European Union (EU Projects GENICA and DNA Repair). D. A. is supported by the European Molecular Biology Organization. S. E. P. is supported by the Human Frontier Science Program Organization. S. C. W. and I. A. are also funded by the Louis-Jeantet Foundation. The authors declare no conflict of interest.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DEMURCIA G, 1986, J BIOL CHEM, V261, P7011; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; FRECHETTE A, 1985, CAN J BIOCHEM CELL B, V63, P764, DOI 10.1139/o85-096; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; KUO MT, 1981, CANCER RES, V41, P2439; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; LEDUC Y, 1986, BIOCHIM BIOPHYS ACTA, V885, P248, DOI 10.1016/0167-4889(86)90239-9; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LINDAHL T, 1995, PHILOS T ROY SOC B, V347, P57, DOI 10.1098/rstb.1995.0009; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; REALINI CA, 1992, J BIOL CHEM, V267, P18858; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0	23	428	445	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1240	1243		10.1126/science.1177321	http://dx.doi.org/10.1126/science.1177321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19661379	Green Accepted			2022-12-28	WOS:000269523200036
J	Schulte, DM; Burke, RP; Lipcius, RN				Schulte, David M.; Burke, Russell P.; Lipcius, Romuald N.			Unprecedented Restoration of a Native Oyster Metapopulation	SCIENCE			English	Article							CHESAPEAKE BAY; CRASSOSTREA-VIRGINICA; HABITAT; REEF; SURVIVAL; PERFORMANCE; ECOSYSTEMS; COLLAPSE; GROWTH	Native oyster species were once vital ecosystem engineers, but their populations have collapsed worldwide because of overfishing and habitat destruction. In 2004, we initiated a vast (35-hectare) field experiment by constructing native oyster reefs of three types (high-relief, low-relief, and unrestored) in nine protected sanctuaries throughout the Great Wicomico River in Virginia, United States. Upon sampling in 2007 and 2009, we found a thriving metapopulation comprising 185 million oysters of various age classes. Oyster density was fourfold greater on high-relief than on low-relief reefs, explaining the failure of past attempts. Juvenile recruitment and reef accretion correlated with oyster density, facilitating reef development and population persistence. This reestablished metapopulation is the largest of any native oyster worldwide and validates ecological restoration of native oyster species.	[Schulte, David M.; Burke, Russell P.; Lipcius, Romuald N.] Coll William & Mary, Dept Fisheries Sci, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA	William & Mary; Virginia Institute of Marine Science	Lipcius, RN (corresponding author), Coll William & Mary, Dept Fisheries Sci, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA.	rom@vims.edu			U.S. Army Corps of Engineers, Norfolk District; National Oceanic and Atmospheric Administration, Chesapeake Bay Office	U.S. Army Corps of Engineers, Norfolk District; National Oceanic and Atmospheric Administration, Chesapeake Bay Office(National Oceanic Atmospheric Admin (NOAA) - USA)	We thank Col. D. Hansen, Col. D. Anninos, S. Tosi, M. Hudgins, K. Groth, M. Hamor, M. Mansfield, B. Rheinhart, and C. Seltzer of the U.S. Army Corps of Engineers, Norfolk District, for support; D. Bushey of Commonwealth Pro-Dive, the Bristow brothers, S. Hardaway, J. Dowdy, D. McCulloch, R. Gill, M. Seebo, W. C. Long, J. van Montfrans, A. Smith, and C. Bovery for field assistance; G. Saluta for photo production; and J. Hoenig, C. Peterson, and R. Seitz for constructive comments on the manuscript. Funding was provided by the U.S. Army Corps of Engineers, Norfolk District, and the Blue Crab Advanced Research Consortium through the National Oceanic and Atmospheric Administration, Chesapeake Bay Office.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; BERMAN MS, 2002, VIRGINIA OYSTER REEF; DEALTERIS JT, 1988, ESTUARIES, V11, P240, DOI 10.2307/1352010; Encomio VG, 2005, J SHELLFISH RES, V24, P143; Grabowski JH, 2007, THEOR ECOL SER, P281; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Lenihan HS, 1999, ECOL MONOGR, V69, P251, DOI 10.1890/0012-9615(1999)069[0251:PBCOOR]2.0.CO;2; Lenihan HS, 1999, LIMNOL OCEANOGR, V44, P910, DOI 10.4319/lo.1999.44.3_part_2.0910; Lenihan HS, 2004, FISH B-NOAA, V102, P298; LIPCIUS RN, 2005, 390 COLL WILL MAR VI; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MANN R, 1991, Journal of Shellfish Research, V10, P379; Mitchell IM, 2000, AQUACULTURE, V191, P309, DOI 10.1016/S0044-8486(00)00441-5; Nestlerode JA, 2007, RESTOR ECOL, V15, P273, DOI 10.1111/j.1526-100X.2007.00210.x; Powell EN, 2006, ESTUAR COAST SHELF S, V69, P531, DOI 10.1016/j.ecss.2006.05.014; Powers SP, 2009, MAR ECOL PROG SER, V389, P159, DOI 10.3354/meps08164; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Ruesink JL, 2005, ANNU REV ECOL EVOL S, V36, P643, DOI 10.1146/annurev.ecolsys.36.102003.152638; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SCHULTE DM, 2009, USE ALTERNATIVE MAT; Smith GF, 2005, N AM J FISH MANAGE, V25, P1569, DOI 10.1577/M04-058.1; Tarnowski M, 2007, MARYLAND OYSTER POPU; Taylor J, 2008, MAR ECOL PROG SER, V361, P301, DOI 10.3354/meps07429; *USA CORPS ENG, 2003, CHES BAY OYST REC PH; *USA CORPS ENG, 2008, 11216 USA CORPS ENG; WINSLOW F, 1881, POP SCI MONTHLY, V12, P29	28	232	236	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1124	1128		10.1126/science.1176516	http://dx.doi.org/10.1126/science.1176516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19644073	Green Submitted			2022-12-28	WOS:000269382300040
J	Boswell, R				Boswell, Ray			Is Gas Hydrate Energy Within Reach?	SCIENCE			English	Editorial Material							METHANE HYDRATE; CARBON		Natl Energy Technol Lab, Morgantown, WV 26507 USA	United States Department of Energy (DOE); National Energy Technology Laboratory - USA	Boswell, R (corresponding author), Natl Energy Technol Lab, 3610 Collins Ferry Rd, Morgantown, WV 26507 USA.	ray.boswell@netl.doe.gov		Boswell, Ray/0000-0002-3824-2967				Archer D, 2007, BIOGEOSCIENCES, V4, P521, DOI 10.5194/bg-4-521-2007; Boswell R., 2006, METHANE HYDRATE NEWS, V6, P5; Collett T. S., 2008, P 6 INT C GAS HYDR V; Collett T.S., 2009, AAPG MEMOIR, V89, P1; COLLETT TS, 1993, AAPG BULL, V77, P793; COLLETT TS, 20083073 US GEOL SUR; Dickens GR, 2003, EARTH PLANET SC LETT, V213, P169, DOI 10.1016/S0012-821X(03)00325-X; Fisher CR, 2000, NATURWISSENSCHAFTEN, V87, P184, DOI 10.1007/s001140050700; FRYE M, 2008004 MIN MAN SERV; KVENVOLDEN KA, 1988, CHEM GEOL, V71, P41, DOI 10.1016/0009-2541(88)90104-0; PARK KP, 2008, METHANE HYDRATE SPR, P6; PAULL C, 1996, P OCEAN DRILLING PRO, V4; Stevens J.C., 2008, P 6 INT C GAS HYDR V; Tsuji Y, 2004, RESOUR GEOL, V54, P3, DOI 10.1111/j.1751-3928.2004.tb00182.x; White M.D., 2008, OFFSH TECHN C HOUST; YAMAMOTO K, 2008, METHANE HYDRATE  SUM, P1	16	295	308	5	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					957	958		10.1126/science.1175074	http://dx.doi.org/10.1126/science.1175074			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AN	19696340				2022-12-28	WOS:000269242800033
J	Kaessmann, H				Kaessmann, Henrik			More Than Just a Copy	SCIENCE			English	Editorial Material							MOUSE OOCYTES; GENE; EVOLUTION; PART		Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	University of Lausanne	Kaessmann, H (corresponding author), Univ Lausanne, Ctr Integrat Genom, Genopode Bldg, CH-1015 Lausanne, Switzerland.	henrik.kaessmann@unil.ch	Kaessmann, Henrik/B-4989-2013	Kaessmann, Henrik/0000-0001-7563-839X				Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Haldane JBS, 1933, AM NAT, V67, P5, DOI 10.1086/280465; Horton William A, 2002, Rev Endocr Metab Disord, V3, P381, DOI 10.1023/A:1020914026829; Johnson WE, 2009, IMMUNOGENETICS, V61, P163, DOI 10.1007/s00251-009-0358-y; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; MULLER H. J., 1935, GENETICA, V17, P237, DOI 10.1007/BF01985012; Ohno S., 1970, EVOLUTION GENE DUPLI; PARKER HG, SCIENCE, V325, P995; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Zaiss DMW, 1999, J MOL BIOL, V287, P829, DOI 10.1006/jmbi.1999.2656	17	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					958	959		10.1126/science.1178487	http://dx.doi.org/10.1126/science.1178487			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AN	19696341				2022-12-28	WOS:000269242800034
J	Villeneuve, J; Chaussidon, M; Libourel, G				Villeneuve, Johan; Chaussidon, Marc; Libourel, Guy			Homogeneous Distribution of Al-26 in the Solar System from the Mg Isotopic Composition of Chondrules	SCIENCE			English	Article							FERROMAGNESIAN CHONDRULES; REFRACTORY INCLUSIONS; MAGNESIAN CHONDRULES; INITIAL AL-26/AL-27; NEBULA; CHONDRITES; CONSTRAINTS; ORIGIN; CONDENSATION; AL-26-MG-26	The timing of the formation of the first solids in the solar system remains poorly constrained. Micrometer-scale, high-precision magnesium (Mg) isotopic analyses demonstrate that Earth, refractory inclusions, and chondrules from primitive meteorites formed from a reservoir in which short-lived aluminum-26 (Al-26) and Mg isotopes were homogeneously distributed at +/- 10%. This level of homogeneity validates the use of Al-26 as a precise chronometer for early solar system events. High-precision chondrule Al-26 isochrons show that several distinct chondrule melting events took place from similar to 1.2 million years (My) to similar to 4 My after the first solids condensed from the solar nebula, with peaks between similar to 1.5 and similar to 3 My, and that chondrule precursors formed as early as 0.87(-0.16)(+0.19) My after.	[Villeneuve, Johan; Chaussidon, Marc; Libourel, Guy] Nancy Univ, CNRS, CRPG, UPR 2300, F-54501 Vandoeuvre Les Nancy, France; [Libourel, Guy] Nancy Univ, ENSG, F-54501 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lorraine	Villeneuve, J (corresponding author), Nancy Univ, CNRS, CRPG, UPR 2300, 15 Rue Notre Dame des Pauvres,Boite Postale 20, F-54501 Vandoeuvre Les Nancy, France.	johanv@crpg.cnrs-nancy.fr	Chaussidon, Marc/E-7067-2017; Villeneuve, Johan/P-2378-2015	Villeneuve, Johan/0000-0002-9892-8530	L Agence Nationale de la Recherche [ANR-08-BLAN-0260-02]; T-Tauri, Chem, and European Research Council [ERC 226846]	L Agence Nationale de la Recherche(French National Research Agency (ANR)); T-Tauri, Chem, and European Research Council	This work was funded by L Agence Nationale de la Recherche grant ANR-08-BLAN-0260-02 T-Tauri, Chem, and European Research Council grant ERC 226846 Cosmochemical Exploration of the first two Million Years of the Solar System (CEMYSS). This is CRPG publication number 2001.	Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Amelin Y, 2007, METEORIT PLANET SCI, V42, P1321, DOI 10.1111/j.1945-5100.2007.tb00577.x; Bizzarro M, 2004, NATURE, V431, P275, DOI 10.1038/nature02882; Bizzarro M, 2005, NATURE, V435, P1280, DOI 10.1038/nature03919; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Boss AP, 2007, ASTROPHYS J, V660, P1707, DOI 10.1086/513184; Bouvier A, 2007, GEOCHIM COSMOCHIM AC, V71, P1583, DOI 10.1016/j.gca.2006.12.005; Chaussidon M, 2008, GEOCHIM COSMOCHIM AC, V72, P1924, DOI 10.1016/j.gca.2008.01.015; Chaussidon M, 2007, CR GEOSCI, V339, P872, DOI 10.1016/j.crte.2007.09.005; Galy A, 2000, SCIENCE, V290, P1751, DOI 10.1126/science.290.5497.1751; HUTCHEON ID, 1989, NATURE, V337, P238, DOI 10.1038/337238a0; Jacobsen B, 2008, EARTH PLANET SC LETT, V272, P353, DOI 10.1016/j.epsl.2008.05.003; Kita NT, 2000, GEOCHIM COSMOCHIM AC, V64, P3913, DOI 10.1016/S0016-7037(00)00488-9; Krot AN, 2005, NATURE, V436, P989, DOI 10.1038/nature03830; Kunihiro T, 2004, GEOCHIM COSMOCHIM AC, V68, P2947, DOI 10.1016/j.gca.2004.02.006; Kurahashi E, 2008, GEOCHIM COSMOCHIM AC, V72, P3865, DOI 10.1016/j.gca.2008.05.038; Libourel G, 2007, EARTH PLANET SC LETT, V254, P1, DOI 10.1016/j.epsl.2006.11.013; LIU MC, 2006, LUNAR PLANET SCI, V37, P2428; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; Mostefaoui S, 2002, METEORIT PLANET SCI, V37, P421, DOI 10.1111/j.1945-5100.2002.tb00825.x; Nagahara H, 2008, GEOCHIM COSMOCHIM AC, V72, P1442, DOI 10.1016/j.gca.2007.12.020; Nagashima K, 2007, METEORIT PLANET SCI, V42, pA115; Rudraswami NG, 2008, EARTH PLANET SC LETT, V274, P93, DOI 10.1016/j.epsl.2008.07.004; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; Sugiura N, 2007, METEORIT PLANET SCI, V42, P1183, DOI 10.1111/j.1945-5100.2007.tb00568.x; Thrane K, 2006, ASTROPHYS J, V646, pL159, DOI 10.1086/506910; Young ED, 2005, SCIENCE, V308, P223, DOI 10.1126/science.1108140; ZINNER E, 1995, METEORITICS, V27, P311	29	251	252	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					985	988		10.1126/science.1173907	http://dx.doi.org/10.1126/science.1173907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696348				2022-12-28	WOS:000269242800043
J	Caughey, AB; Sundaram, V; Kaimal, AJ; Gienger, A; Cheng, YW; McDonald, KM; Shaffer, BL; Owens, DK; Bravata, DM				Caughey, Aaron B.; Sundaram, Vandana; Kaimal, Anjali J.; Gienger, Allison; Cheng, Yvonne W.; McDonald, Kathryn M.; Shaffer, Brian L.; Owens, Douglas K.; Bravata, Dena M.			Systematic Review: Elective Induction of Labor Versus Expectant Management of Pregnancy	ANNALS OF INTERNAL MEDICINE			English	Review							CESAREAN DELIVERY; PROLONGED PREGNANCY; POSTTERM PREGNANCY; NULLIPAROUS WOMEN; RISK; TERM; FETAL; RATES; COMPLICATIONS; PROGRESSION	Background: The rates of induction of labor and elective induction of labor are increasing. Whether elective induction of labor improves outcomes or simply leads to greater complications and health care costs is commonly debated in the literature. Purpose: To compare the benefits and harms of elective induction of labor and expectant management of pregnancy. Data Sources: MEDLINE (through February 2009), Web of Science, CINAHL, Cochrane Central Register of Controlled Trials (through March 2009), bibliographies of included studies, and previous systematic reviews. Study Selection: Experimental and observational studies of elective induction of labor reported in English. Data Extraction: Two authors abstracted study design; patient characteristics; quality criteria; and outcomes, including cesarean delivery and maternal and neonatal morbidity. Data Synthesis: Of 6117 potentially relevant articles, 36 met inclusion criteria: 11 randomized, controlled trials (RCTs) and 25 observational studies. Overall, expectant management of pregnancy was associated with a higher odds ratio (OR) of cesarean delivery than was elective induction of labor (OR, 1.22 [95% CI, 1.07 to 1.39]; absolute risk difference, 1.9 percentage points [CI, 0.2 to 3.7 percentage points]) in 9 RCTs. Women at or beyond 41 completed weeks of gestation who were managed expectantly had a higher risk for cesarean delivery (OR, 1.21 [CI, 1.01 to 1.46]), but this difference was not statistically significant in women at less than 41 completed weeks of gestation (OR, 1.73 [CI, 0.67 to 4.5]). Women who were expectantly managed were more likely to have meconium-stained amniotic fluid than those who were electively induced (OR, 2.04 [CI, 1.34 to 3.09]). Limitations: There were no recent RCTs of elective induction of labor at less than 41 weeks of gestation. The 2 studies conducted at less than 41 weeks of gestation were of poor quality and were not generalizable to current practice. Conclusion: RCTs suggest that elective induction of labor at 41 weeks of gestation and beyond is associated with a decreased risk for cesarean delivery and meconium-stained amniotic fluid. There are concerns about the translation of these findings into actual practice; thus, future studies should examine elective induction of labor in settings where most obstetric care is provided.	Stanford Univ, Stanford, CA 94305 USA; [Caughey, Aaron B.] Univ Calif San Francisco, Div Maternal Fetal Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA	Stanford University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Caughey, AB (corresponding author), Univ Calif San Francisco, Div Maternal Fetal Med, Dept Obstet Gynecol & Reprod Sci, 505 Parnassus Ave,M-1495,Box 0132, San Francisco, CA 94143 USA.	abcmd@berkeley.edu			AHRQ [290-020017]; Health Services Research and Development Service, Department of Veterans Affairs	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Health Services Research and Development Service, Department of Veterans Affairs(US Department of Veterans Affairs)	This report is based on research conducted by the Stanford-UCSF Evidence-based Practice Center under contract 290-020017 from AHRQ. Dr. Owens and Ms. Sundaram were supported in part by the Health Services Research and Development Service, Department of Veterans Affairs.	Abotalib ZM, 1999, SAUDI MED J, V20, P185; AMANO K, 1999, J OBSTET GYNECOL RES, V39, P25; BELSKY DH, 1982, J AM OSTEOPATH ASSOC, V81, P524; BOOTH JH, 1970, CAN MED ASSOC J, V103, P245; Boulvain M, 2001, PAEDIATR PERINAT EP, V15, P131; BRAVATA DM, 2007, AHRQ PUBLICATION; BREART G, 1982, J GYNECOL OBST BIO R, V11, P107; Cammu H, 2002, AM J OBSTET GYNECOL, V186, P240, DOI 10.1067/mob.2002.119643; Caughey AB, 2006, AM J OBSTET GYNECOL, V195, P700, DOI 10.1016/j.ajog.2006.07.003; Caughey AB, 2005, AM J OBSTET GYNECOL, V192, P185, DOI 10.1016/j.ajog.2004.06.068; *COCH COLL, 2003, REV MAN REVMAN VERS; COLE RA, 1975, LANCET, V1, P767; Dublin S, 2000, AM J OBSTET GYNECOL, V183, P986, DOI 10.1067/mob.2000.106748; DYSON DC, 1987, AM J OBSTET GYNECOL, V156, P928, DOI 10.1016/0002-9378(87)90359-0; EGARTER C, 1989, GYNECOL OBSTET INVES, V27, P6, DOI 10.1159/000293605; Gelisen O, 2005, EUR J OBSTET GYN R B, V120, P164, DOI 10.1016/j.ejogrb.2004.08.013; Glantz JC, 2005, J REPROD MED, V50, P235; Grobman WA, 2007, CLIN OBSTET GYNECOL, V50, P537, DOI 10.1097/GRF.0b013e31804bdec4; Gulmezoglu AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945; Hannah ME, 1996, BIRTH-ISS PERINAT C, V23, P13, DOI 10.1111/j.1523-536X.1996.tb00455.x; HANNAH ME, 1992, NEW ENGL J MED, V326, P1587, DOI 10.1056/NEJM199206113262402; HEDGES LV, 1985, STAT METHODS META AN; Heimstad R, 2007, OBSTET GYNECOL, V109, P609, DOI 10.1097/01.AOG.0000255665.77009.94; Heinberg EM, 2002, J REPROD MED, V47, P399; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hilder L, 1998, BRIT J OBSTET GYNAEC, V105, P169, DOI 10.1111/j.1471-0528.1998.tb10047.x; Hoffman MK, 2006, OBSTET GYNECOL, V107, P1029, DOI 10.1097/01.AOG.0000210528.32940.c6; LAMPE L G, 1980, Acta Chirurgica Academiae Scientiarum Hungaricae, V21, P43; Lampe L G, 1986, Acta Chir Hung, V27, P143; Le Ray C, 2007, ACTA OBSTET GYN SCAN, V86, P657, DOI 10.1080/00016340701245427; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; LEIJON I, 1980, ACTA OBSTET GYN SCAN, V59, P103, DOI 10.3109/00016348009154623; LEIJON I, 1979, ACTA PAEDIATR SCAND, V68, P553, DOI 10.1111/j.1651-2227.1979.tb05054.x; Luthy DA, 2004, AM J OBSTET GYNECOL, V191, P1511, DOI 10.1016/j.ajog.2004.07.001; Lydon-Rochelle MT, 2007, MED CARE, V45, P505, DOI 10.1097/MLR.0b013e3180330e26; MACER JA, 1992, AM J OBSTET GYNECOL, V166, P1690, DOI 10.1016/0002-9378(92)91558-R; Martin Joyce A, 2006, Natl Vital Stat Rep, V55, P1; Maslow AS, 2000, OBSTET GYNECOL, V95, P917, DOI 10.1016/S0029-7844(00)00794-8; MCBRIDE WG, 1977, MED J AUSTRALIA, V2, P456, DOI 10.5694/j.1326-5377.1977.tb117730.x; MCNELLIS D, 1994, AM J OBSTET GYNECOL, V170, P716; MELTON LJ, 1979, MAYO CLIN PROC, V54, P646; Mukherjee S, 1995, J Indian Med Assoc, V93, P98; MUKHERJEE S, 1995, J INDIAN MED ASSOC, V93, P89; Nielsen PE, 2005, J MATERN-FETAL NEO M, V18, P59, DOI 10.1080/14767050500139604; OUT JJ, 1985, J PERINAT MED, V13, P163, DOI 10.1515/jpme.1985.13.4.163; OUT JJ, 1988, EUR J OBSTET GYN R B, V29, P275, DOI 10.1016/0028-2243(88)90067-6; OWENS DK, 1992, MED DECIS MAKING, V12, P346; OWENS DK, 2009, J CLIN EPID IN PRESS; Prysak M, 1998, OBSTET GYNECOL, V92, P47; Rayburn WF, 2002, OBSTET GYNECOL, V100, P164, DOI 10.1016/S0029-7844(02)02047-1; Robson S, 1997, AUST NZ J OBSTET GYN, V37, P16, DOI 10.1111/j.1479-828X.1997.tb02211.x; Sanchez-Ramos L, 2003, OBSTET GYNECOL, V101, P1312, DOI 10.1016/S0029-7844(03)00342-9; Seyb ST, 1999, OBSTET GYNECOL, V94, P600, DOI 10.1016/S0029-7844(99)00377-4; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; TYLLESKAR J, 1979, ACTA OBSTET GYN SCAN, V58, P513, DOI 10.3109/00016347909154610; Vahratian A, 2005, OBSTET GYNECOL, V105, P698, DOI 10.1097/01.AOG.0000157436.68847.3b; van Gemund N, 2003, GYNECOL OBSTET INVES, V56, P133, DOI 10.1159/000073771; VIERHOUT ME, 1985, J PERINAT MED, V13, P155, DOI 10.1515/jpme.1985.13.4.155; Vrouenraets FPJM, 2005, OBSTET GYNECOL, V105, P690, DOI 10.1097/01.AOG.0000152338.76759.38; Wilailak S, 1993, J Med Assoc Thai, V76 Suppl 1, P44; Yeast JD, 1999, AM J OBSTET GYNECOL, V180, P628, DOI 10.1016/S0002-9378(99)70265-6; Zhang J, 2002, J REPROD MED, V47, P120	63	159	162	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2009	151	4					252	W63		10.7326/0003-4819-151-4-200908180-00007	http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00007			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484IW	19687492				2022-12-28	WOS:000269038900005
J	Buckler, ES; Holland, JB; Bradbury, PJ; Acharya, CB; Brown, PJ; Browne, C; Ersoz, E; Flint-Garcia, S; Garcia, A; Glaubitz, JC; Goodman, MM; Harjes, C; Guill, K; Kroon, DE; Larsson, S; Lepak, NK; Li, HH; Mitchell, SE; Pressoir, G; Peiffer, JA; Rosas, MO; Rocheford, TR; Romay, MC; Romero, S; Salvo, S; Villeda, HS; da Silva, HS; Sun, Q; Tian, F; Upadyayula, N; Ware, D; Yates, H; Yu, JM; Zhang, ZW; Kresovich, S; McMullen, MD				Buckler, Edward S.; Holland, James B.; Bradbury, Peter J.; Acharya, Charlotte B.; Brown, Patrick J.; Browne, Chris; Ersoz, Elhan; Flint-Garcia, Sherry; Garcia, Arturo; Glaubitz, Jeffrey C.; Goodman, Major M.; Harjes, Carlos; Guill, Kate; Kroon, Dallas E.; Larsson, Sara; Lepak, Nicholas K.; Li, Huihui; Mitchell, Sharon E.; Pressoir, Gael; Peiffer, Jason A.; Rosas, Marco Oropeza; Rocheford, Torbert R.; Cinta Romay, M.; Romero, Susan; Salvo, Stella; Sanchez Villeda, Hector; da Silva, H. Sofia; Sun, Qi; Tian, Feng; Upadyayula, Narasimham; Ware, Doreen; Yates, Heather; Yu, Jianming; Zhang, Zhiwu; Kresovich, Stephen; McMullen, Michael D.			The Genetic Architecture of Maize Flowering Time	SCIENCE			English	Article							NATURAL VARIATION; ARTIFICIAL SELECTION; HEADING DATE; CO-ORTHOLOG; RICE; LOCUS; POLYMORPHISM; PHOTOPERIOD; REGULATOR; DIVERSITY	Flowering time is a complex trait that controls adaptation of plants to their local environment in the outcrossing species Zea mays (maize). We dissected variation for flowering time with a set of 5000 recombinant inbred lines (maize Nested Association Mapping population, NAM). Nearly a million plants were assayed in eight environments but showed no evidence for any single large-effect quantitative trait loci (QTLs). Instead, we identified evidence for numerous small-effect QTLs shared among families; however, allelic effects differ across founder lines. We identified no individual QTLs at which allelic effects are determined by geographic origin or large effects for epistasis or environmental interactions. Thus, a simple additive model accurately predicts flowering time for maize, in contrast to the genetic architecture observed in the selfing plant species rice and Arabidopsis.	[Buckler, Edward S.; Holland, James B.; Bradbury, Peter J.; Browne, Chris; Flint-Garcia, Sherry; Garcia, Arturo; Guill, Kate; Lepak, Nicholas K.; Salvo, Stella; Ware, Doreen; McMullen, Michael D.] Cornell Univ, USDA ARS, Ithaca, NY 14853 USA; [Buckler, Edward S.; Bradbury, Peter J.; Acharya, Charlotte B.; Brown, Patrick J.; Ersoz, Elhan; Kroon, Dallas E.; Li, Huihui; Mitchell, Sharon E.; Pressoir, Gael; Cinta Romay, M.; Romero, Susan; Tian, Feng; Yates, Heather; Zhang, Zhiwu; Kresovich, Stephen] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Buckler, Edward S.; Larsson, Sara; Lepak, Nicholas K.; Peiffer, Jason A.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Holland, James B.; Goodman, Major M.; Rosas, Marco Oropeza; Salvo, Stella] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Browne, Chris; Flint-Garcia, Sherry; Garcia, Arturo; Guill, Kate; Sanchez Villeda, Hector; McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Glaubitz, Jeffrey C.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Harjes, Carlos] Monsanto Co, Leesburg, GA 31763 USA; [Li, Huihui] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Li, Huihui] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Rocheford, Torbert R.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Rocheford, Torbert R.] Purdue Univ, Dept Agron, Urbana, IL 61801 USA; [Cinta Romay, M.] CSIC, Mision Biol Galicia, Pontevedra 36080, Spain; [Sanchez Villeda, Hector] CIMMYT, INT, Crop Res Lab, Carretera Mex Veracruz 56130, Mexico; [Sun, Qi] Cornell Univ, Computat Biol Serv Unit, Ithaca, NY 14853 USA; [Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Yu, Jianming] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA	Cornell University; United States Department of Agriculture (USDA); Cornell University; Cornell University; University of North Carolina; North Carolina State University; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; Monsanto; Beijing Normal University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Purdue University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Mision Biologica de Galicia (MBG); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Cornell University; Cold Spring Harbor Laboratory; Kansas State University	Buckler, ES (corresponding author), Cornell Univ, USDA ARS, Ithaca, NY 14853 USA.	esb33@cornell.edu; james_holland@ncsu.edu; sk20@cornell.edu; mcmullenm@missouri.edu	Zhang, zs/GXN-3521-2022; Zhang, Zhiwu/P-6156-2016; Romay, Cinta/ABE-8340-2020; Yu, Jianming/Q-6722-2019; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Zhang, Zhiwu/0000-0002-5784-9684; Romay, Cinta/0000-0001-9309-1586; Yu, Jianming/0000-0001-5326-3099; Buckler, Edward/0000-0002-3100-371X; Holland, James/0000-0002-4341-9675; Flint-Garcia, Sherry/0000-0003-4156-5318	U.S. NSF Plant Genome Program; U.S. Department of Agriculture; Spanish Ministry for Education and Science [AP-2004-6033];  [DBI-9872631];  [DBI-0321467];  [DBI-0820619];  [DBI-0604923]	U.S. NSF Plant Genome Program; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Spanish Ministry for Education and Science(Spanish Government); ; ; ; 	This work was supported by U.S. NSF Plant Genome Program DBI 9872631, DBI 0321467, DBI 0820619 to E.S.B., M.M.G. 98,03, J.B.H. 03,08, M.D.M. 03,08, S.K. 03,08, D.W. 03, DBI-0604923 to T.R.R., U.S. Department of Agriculture Agricultural Research Service to E.S.B., J.B.H., M.D.M., and Spanish Ministry for Education and Science AP-2004-6033, fellowship to M.C.R..	Alonso-Blanco C, 1998, GENETICS, V149, P749; Bolanos J, 1996, FIELD CROP RES, V48, P65, DOI 10.1016/0378-4290(96)00036-6; Bomblies K, 2006, GENETICS, V172, P519, DOI 10.1534/genetics.105.048595; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Henry AM, 1997, MOL GEN GENET, V256, P147, DOI 10.1007/s004380050556; Izawa T, 2003, CURR OPIN PLANT BIOL, V6, P113, DOI 10.1016/S1369-5266(03)00014-1; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; KULESHOV N. N., 1933, JOUR AMER SOC AGRON, V25, P688; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; LIN YR, 1995, GENETICS, V141, P391; Liu KJ, 2003, GENETICS, V165, P2117; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; McSteen P, 2007, PLANT PHYSIOL, V144, P1000, DOI 10.1104/pp.107.098558; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Pressoir G, 2009, PLANT J, V58, P618, DOI 10.1111/j.1365-313X.2009.03802.x; Salvi S, 2002, PLANT MOL BIOL, V48, P601, DOI 10.1023/A:1014838024509; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Uwatoko N, 2008, EUPHYTICA, V163, P167, DOI 10.1007/s10681-007-9584-2; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 1997, THEOR APPL GENET, V95, P1025, DOI 10.1007/s001220050658; YANO M, 2005, P 5 INT RIC GEN S 19, P177	31	940	998	10	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					714	718		10.1126/science.1174276	http://dx.doi.org/10.1126/science.1174276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661422				2022-12-28	WOS:000268723700040
J	Hustad, PD				Hustad, Phillip D.			Frontiers in Olefin Polymerization: Reinventing the World's Most Common Synthetic Polymers	SCIENCE			English	Editorial Material							BLOCK-COPOLYMERS; ETHYLENE; POLYETHYLENE	Synthetic polymers are vital to our society, affecting practically every aspect of modern life. The ubiquitous nature of these materials is a result of years of collaboration between basic and applied researchers across many disciplines, resulting in economic routes to materials that meet customer needs. These considerations are exemplified by recent developments in the synthesis of block copolymers from simple olefins. The practical application of creative chemistry has produced materials with a favorable balance of desirable polymer properties and process economics.	Dow Chem Co USA, Freeport, TX 77541 USA	Dow Chemical Company	Hustad, PD (corresponding author), Dow Chem Co USA, 2301 N Brazosport Blvd,B-3827, Freeport, TX 77541 USA.	pdhustad@dow.com						Arriola DJ, 2006, SCIENCE, V312, P714, DOI 10.1126/science.1125268; BATES FS, 1984, MACROMOLECULES, V17, P1987, DOI 10.1021/ma00140a019; Britovsek GJP, 2002, ANGEW CHEM INT EDIT, V41, P489, DOI 10.1002/1521-3773(20020201)41:3<489::AID-ANIE489>3.0.CO;2-C; Coates GW, 2002, ANGEW CHEM INT EDIT, V41, P2236, DOI 10.1002/1521-3773(20020703)41:13<2236::AID-ANIE2236>3.0.CO;2-3; COATES GW, 1995, SCIENCE, V267, P217, DOI 10.1126/science.267.5195.217; Domski GJ, 2007, PROG POLYM SCI, V32, P30, DOI 10.1016/j.progpolymsci.2006.11.001; FAWCETT EW, 1937, Patent No. 471590; HOLDEN G, 1987, ENCY POLYM SCI ENG, V5, P416; Hustad PD, 2007, MACROMOLECULES, V40, P7061, DOI 10.1021/ma0717791; Hustad PD, 2009, MACROMOLECULES, V42, P3788, DOI 10.1021/ma9002819; Libster D, 2007, POLYM ADVAN TECHNOL, V18, P685, DOI 10.1002/pat.970; Lynd NA, 2008, PROG POLYM SCI, V33, P875, DOI 10.1016/j.progpolymsci.2008.07.003; Markel EJ, 2000, MACROMOLECULES, V33, P8541, DOI 10.1021/ma001087b; Murphy V, 2002, CHEM REC, V2, P278, DOI 10.1002/tcr.10025; NATTA G, 1955, J AM CHEM SOC, V77, P1708, DOI 10.1021/ja01611a109; Ober CK, 2009, MACROMOLECULES, V42, P465, DOI 10.1021/ma802463z; Pelletier JF, 1996, ANGEW CHEM INT EDIT, V35, P1854, DOI 10.1002/anie.199618541; Saito J, 2001, CHEM LETT, P576, DOI 10.1246/cl.2001.576; Sinn H., 1980, ADV ORGANOMET CHEM, V18, P99; Szwarc M, 1998, J POLYM SCI POL CHEM, V36, pIX, DOI 10.1002/(SICI)1099-0518(19980115)36:1<IX::AID-POLA2>3.0.CO;2-9; Tian J, 2001, J AM CHEM SOC, V123, P5134, DOI 10.1021/ja0157189; Zhang W, 2008, J AM CHEM SOC, V130, P442, DOI 10.1021/ja078120v; ZIEGLER K, 1955, ANGEW CHEM INT EDIT, V67, P426, DOI 10.1002/ange.19550671610	23	134	138	6	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					704	707		10.1126/science.1174927	http://dx.doi.org/10.1126/science.1174927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661418				2022-12-28	WOS:000268723700036
J	Paulot, F; Crounse, JD; Kjaergaard, HG; Kurten, A; St Clair, JM; Seinfeld, JH; Wennberg, PO				Paulot, Fabien; Crounse, John D.; Kjaergaard, Henrik G.; Kuerten, Adreas; St Clair, Jason M.; Seinfeld, John H.; Wennberg, Paul O.			Unexpected Epoxide Formation in the Gas-Phase Photooxidation of Isoprene	SCIENCE			English	Article							AEROSOLS; OXIDATION; EMISSION; ACIDITY	Emissions of nonmethane hydrocarbon compounds to the atmosphere from the biosphere exceed those from anthropogenic activity. Isoprene, a five-carbon diene, contributes more than 40% of these emissions. Once emitted to the atmosphere, isoprene is rapidly oxidized by the hydroxyl radical OH. We report here that under pristine conditions isoprene is oxidized primarily to hydroxyhydroperoxides. Further oxidation of these hydroxyhydroperoxides by OH leads efficiently to the formation of dihydroxyepoxides and OH reformation. Global simulations show an enormous flux-nearly 100 teragrams of carbon per year-of these epoxides to the atmosphere. The discovery of these highly soluble epoxides provides a missing link tying the gas-phase degradation of isoprene to the observed formation of organic aerosols.	[Paulot, Fabien; Kuerten, Adreas; St Clair, Jason M.; Seinfeld, John H.; Wennberg, Paul O.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Crounse, John D.; Seinfeld, John H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Kjaergaard, Henrik G.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Kjaergaard, Henrik G.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Wennberg, Paul O.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; University of Otago; University of Copenhagen; California Institute of Technology	Paulot, F (corresponding author), CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	paulot@caltech.edu	Crounse, John/E-4622-2011; Paulot, Fabien/C-1002-2011; Kjaergaard, Henrik G/H-4333-2014; Crounse, John D/C-3700-2014; Kürten, Andreas/O-3851-2019; Wennberg, Paul O/A-5460-2012	Kjaergaard, Henrik G/0000-0002-7275-8297; Crounse, John D/0000-0001-5443-729X; Kürten, Andreas/0000-0002-8955-4450; Wennberg, Paul O/0000-0002-6126-3854; St. Clair, Jason/0000-0002-9367-5749	Office of Science, U.S. Department of Energy; U.S. Environmental Protection Agency [RD-833749]; Royal Society of New Zealand; NASA [NNX07AL33G, NNX08AD29G];  [DE-FG02-05ER63983]	Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); Royal Society of New Zealand(Royal Society of New Zealand); NASA(National Aeronautics & Space Administration (NASA)); 	This work was supported by the Office of Science (Biological and Environmental Research), U.S. Department of Energy grant DE-FG02-05ER63983, U.S. Environmental Protection Agency STAR agreement RD-833749, and the Marsden Fund administrated by the Royal Society of New Zealand. The TC4 and ARCTAS campaigns were supported by NASA grants NNX07AL33G and NNX08AD29G. This work has not been formally reviewed by the EPA. The views expressed in this document are solely those of the authors, and the EPA does not endorse any products or commercial services mentioned in this publication.	Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; BELL ER, 1950, J AM CHEM SOC, V72, P337, DOI 10.1021/ja01157a088; Bey I, 2001, J GEOPHYS RES-ATMOS, V106, P23073, DOI 10.1029/2001JD000807; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; Crounse JD, 2006, ANAL CHEM, V78, P6726, DOI 10.1021/ac0604235; Crutzen PJ, 2000, ATMOS ENVIRON, V34, P1161, DOI 10.1016/S1352-2310(99)00482-3; de Gouw JA, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005623; Dillon TJ, 2008, ATMOS CHEM PHYS, V8, P4877, DOI 10.5194/acp-8-4877-2008; Fuentes JD, 2000, B AM METEOROL SOC, V81, P1537, DOI 10.1175/1520-0477(2000)081<1537:BHITAB>2.3.CO;2; Gao S, 2004, ENVIRON SCI TECHNOL, V38, P6582, DOI 10.1021/es049125k; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Harley PC, 1999, OECOLOGIA, V118, P109, DOI 10.1007/s004420050709; Kerminen VM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023130; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; MCLAFFERTY FW, 1981, SCIENCE, V214, P280, DOI 10.1126/science.7280693; Minerath EC, 2009, ENVIRON SCI TECHNOL, V43, P1386, DOI 10.1021/es8029076; Paulot F, 2009, ATMOS CHEM PHYS, V9, P1479, DOI 10.5194/acp-9-1479-2009; Peeters J, 2009, PHYS CHEM CHEM PHYS, V11, P5935, DOI 10.1039/b908511d; Reeves CE, 2003, CHEM REV, V103, P5199, DOI 10.1021/cr0205053; Ren XR, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009166; Rosenstiel TN, 2003, NATURE, V421, P256, DOI 10.1038/nature01312; Ruppert L, 2000, ATMOS ENVIRON, V34, P1529, DOI 10.1016/S1352-2310(99)00408-2; Surratt JD, 2008, J PHYS CHEM A, V112, P8345, DOI 10.1021/jp802310p; Surratt JD, 2007, ENVIRON SCI TECHNOL, V41, P5363, DOI 10.1021/es0704176; Surratt JD, 2006, J PHYS CHEM A, V110, P9665, DOI 10.1021/jp061734m; Thornton JA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000932; Tunved P, 2006, SCIENCE, V312, P261, DOI 10.1126/science.1123052; von Kuhlmann R, 2004, ATMOS CHEM PHYS, V4, P1, DOI 10.5194/acp-4-1-2004; Wang W, 2005, RAPID COMMUN MASS SP, V19, P1343, DOI 10.1002/rcm.1940; WENT FW, 1960, NATURE, V187, P641, DOI 10.1038/187641a0; Wiedinmyer C, 2006, EARTH INTERACT, V10, DOI 10.1175/EI174.1	32	616	623	15	537	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					730	733		10.1126/science.1172910	http://dx.doi.org/10.1126/science.1172910			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661425				2022-12-28	WOS:000268723700044
J	Moynihan, R				Moynihan, Ray			Drug Safety Battle over popular bone drug Fosamax bursts into court	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; JAW					Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					*AM DENT ASS, 2008, DENT MAN PAT REC OR; *DEP HLTH HUM SERV, 2004, ODS POST MARK SAF RE; Khan AA, 2008, J RHEUMATOL, V35, P1391; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Landis BN, 2006, BMJ-BRIT MED J, V333, P982, DOI 10.1136/bmj.39024.647558.BE; LO JC, J ORAL MAXILLOFAC SU; Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; 2009, MERCK PRODUCT NEWS	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2009	339								b3155	10.1136/bmj.40024.494213.4D	http://dx.doi.org/10.1136/bmj.40024.494213.4D			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KE	19661142				2022-12-28	WOS:000268808100003
J	Thompson, JF; Scolyer, RA; Kefford, RF				Thompson, John F.; Scolyer, Richard A.; Kefford, Richard F.			Cutaneous melanoma in the era of molecular profiling	LANCET			English	Editorial Material							THERAPY		[Thompson, John F.] Melanoma Inst Australia, Sydney, NSW 2060, Australia; Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	Melanoma Institute Australia; University of Sydney	Thompson, JF (corresponding author), Melanoma Inst Australia, Sydney, NSW 2060, Australia.	john.thompson@smu.org.au	Thompson, John/F-9075-2013; Scolyer, Richard/AAE-8511-2019	Thompson, John/0000-0002-2816-2496; Scolyer, Richard/0000-0002-8991-0013; Kefford, Richard/0000-0001-9251-9229				*AUSTR NZ MEL TRIA, ANZMTG 1 07 WHOL BRA; BALCH CM, 2009, CUTANEOUS MELANOMA, P65; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Eggermont AMM, 2009, NAT REV CLIN ONCOL, V6, P256, DOI 10.1038/nrclinonc.2009.42; Flaherty K, 2009, J CLIN ONCOL, V27; Gershenwald JE, 2008, J CLIN ONCOL, V26, P4296, DOI 10.1200/JCO.2007.15.4179; Henderson MA, 2009, J CLIN ONCOL, V27; LEACHMAN SA, J AM ACAD D IN PRESS; *MEL MOL MAPP PROJ, 2009, FAM MEL; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; North JP, 2008, J INVEST DERMATOL, V128, P2024, DOI 10.1038/jid.2008.41; O'Day S, 2009, J CLIN ONCOL S, V27, P9033; Ribas A, 2008, ONCOLOGIST, V13, P10, DOI 10.1634/theoncologist.13-S4-10; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Wheatley K, 2007, J CLIN ONCOL, V25, P4693, DOI 10.1200/JCO.2007.13.3389	18	80	81	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2009	374	9687					362	365		10.1016/S0140-6736(09)61397-0	http://dx.doi.org/10.1016/S0140-6736(09)61397-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481MJ	19647595				2022-12-28	WOS:000268815200006
J	Kelley, KA; Cottrell, E				Kelley, Katherine A.; Cottrell, Elizabeth			Water and the Oxidation State of Subduction Zone Magmas	SCIENCE			English	Article							OXYGEN FUGACITIES; MANTLE; CONSTRAINTS; WASHINGTON; INCLUSIONS; VOLATILES; PRESSURE; LIQUIDS; EXAMPLE; FLUXES	Mantle oxygen fugacity exerts a primary control on mass exchange between Earth's surface and interior at subduction zones, but the major factors controlling mantle oxygen fugacity (such as volatiles and phase assemblages) and how tectonic cycles drive its secular evolution are still debated. We present integrated measurements of redox-sensitive ratios of oxidized iron to total iron (Fe3+/SFe), determined with Fe K-edge micro-x-ray absorption near-edge structure spectroscopy, and pre-eruptive magmatic H2O contents of a global sampling of primitive undegassed basaltic glasses and melt inclusions covering a range of plate tectonic settings. Magmatic Fe3+/SFe ratios increase toward subduction zones (at ridges, 0.13 to 0.17; at back arcs, 0.15 to 0.19; and at arcs, 0.18 to 0.32) and correlate linearly with H2O content and element tracers of slab-derived fluids. These observations indicate a direct link between mass transfer from the subducted plate and oxidation of the mantle wedge.	[Kelley, Katherine A.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Cottrell, Elizabeth] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	University of Rhode Island; Smithsonian Institution; Smithsonian National Museum of Natural History	Kelley, KA (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.	kelley@gso.uri.edu	Kelley, Katherine A/J-3728-2013	Kelley, Katherine A/0000-0002-7516-2683; Cottrell, Elizabeth/0000-0002-9402-9394	Smithsonian; NSF [EAR-0841108, EAR-0841006, OCE-0644625]; U.S. Department of Energy Geosciences Division [DE-FG02-92ER14244]; University of Chicago Consortium for Advanced Radiation Sources; DOE [DE-AC02-98CH10886]; Division Of Earth Sciences [0841108] Funding Source: National Science Foundation	Smithsonian(Smithsonian Institution); NSF(National Science Foundation (NSF)); U.S. Department of Energy Geosciences Division(United States Department of Energy (DOE)); University of Chicago Consortium for Advanced Radiation Sources(University of Chicago); DOE(United States Department of Energy (DOE)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by a Smithsonian Scholarly Studies Grant to E.C., a NSF ADVANCE fellowship to K.K., and NSF awards EAR-0841108 (K.K.) and EAR-0841006 (E.C.). NSF award OCE-0644625 provided curatorial support for marine geological samples at the University of Rhode Island. Beamline X26A is supported by the U.S. Department of Energy (DOE) Geosciences Division (grant DE-FG02-92ER14244 to the University of Chicago, Consortium for Advanced Radiation Sources). Use of the National Synchrotron Light Source was supported by DOE under contract no.DE-AC02-98CH10886.	Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; Botcharnikov RE, 2005, GEOCHIM COSMOCHIM AC, V69, P5071, DOI 10.1016/j.gca.2005.04.023; Brandon AD, 1998, GEOCHIM COSMOCHIM AC, V62, P333; CARROLL MR, 1987, J PETROL, V28, P781, DOI 10.1093/petrology/28.5.781; CHRISTIE DM, 1986, EARTH PLANET SC LETT, V79, P397, DOI 10.1016/0012-821X(86)90195-0; COTTRELL E, CHEM GEOL IN PRESS; Frost BR, 1998, GEOCHIM COSMOCHIM AC, V62, P329; Gaetani GA, 1998, CONTRIB MINERAL PETR, V131, P323, DOI 10.1007/s004100050396; Hauri E, 2002, CHEM GEOL, V183, P99, DOI 10.1016/S0009-2541(01)00375-8; HIROSE K, 1995, EARTH PLANET SC LETT, V133, P463, DOI 10.1016/0012-821X(95)00096-U; Johnson MC, 1999, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000014; Kelley KA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003732; Kessel R, 2005, NATURE, V437, P724, DOI 10.1038/nature03971; KRESS VC, 1991, CONTRIB MINERAL PETR, V108, P82, DOI 10.1007/BF00307328; KUSHIRO I, 1972, J PETROL, V13, P311, DOI 10.1093/petrology/13.2.311; Lee CTA, 2005, J PETROL, V46, P2313, DOI 10.1093/petrology/egi056; Luhr JF, 2001, CONTRIB MINERAL PETR, V142, P261, DOI 10.1007/s004100100293; Manning CE, 2004, EARTH PLANET SC LETT, V223, P1, DOI 10.1016/j.epsl.2004.04.030; Parkinson IJ, 1999, CHEM GEOL, V160, P409, DOI 10.1016/S0009-2541(99)00110-2; SATO M, 1966, SCIENCE, V153, P1103, DOI 10.1126/science.153.3740.1103; SCHNEIDER ME, 1986, GEOCHIM COSMOCHIM AC, V50, P711, DOI 10.1016/0016-7037(86)90347-9; Sisson TW, 1998, NATURE, V391, P883, DOI 10.1038/36087; STOLPER E, 1994, EARTH PLANET SC LETT, V121, P293, DOI 10.1016/0012-821X(94)90074-4; Wallace PJ, 2005, J VOLCANOL GEOTH RES, V140, P217, DOI 10.1016/j.jvolgeores.2004.07.023; Wilke M, 2005, CHEM GEOL, V220, P143, DOI 10.1016/j.chemgeo.2005.03.003; WOOD BJ, 1990, SCIENCE, V248, P337, DOI 10.1126/science.248.4953.337	28	571	605	9	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					605	607		10.1126/science.1174156	http://dx.doi.org/10.1126/science.1174156			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644118				2022-12-28	WOS:000268493000048
J	Ninfo, A; Fontana, A; Mozzi, P; Ferrarese, F				Ninfo, Andrea; Fontana, Alessandro; Mozzi, Paolo; Ferrarese, Francesco			The Map of Altinum, Ancestor of Venice	SCIENCE			English	Article									[Ninfo, Andrea; Fontana, Alessandro; Mozzi, Paolo; Ferrarese, Francesco] Univ Padua, Dept Geog, I-35123 Padua, Italy	University of Padua	Ninfo, A (corresponding author), Univ Padua, Dept Geog, I-35123 Padua, Italy.	andrea.ninfo@unipd.it	Mozzi, Paolo/AAH-9043-2020; Fontana, Alessandro/C-1674-2016	Fontana, Alessandro/0000-0003-1556-2770; Ninfo, Andrea/0000-0001-7405-4114; ferrarese, francesco/0000-0003-1411-4191	ARCUS S.p.A.; Municipality of Padua	ARCUS S.p.A.; Municipality of Padua	Research supported by ARCUS S.p.A., Veneto Region, and Municipality of Padua, within "Via Annia" project.	Ammerman AJ, 1999, ANTIQUITY, V73, P303, DOI 10.1017/S0003598X00088268; Ammerman Albert J., 2003, MEMOIRS AM ACAD ROME, V48, P141, DOI DOI 10.2307/4238806; Antonioli F, 2009, QUATERN INT, V206, P102, DOI 10.1016/j.quaint.2008.11.008; Cessi Roberto, 1933, ORIGO CIVITATUM ITAL; Christie N., 2006, CONSTANTINE CHARLEMA; Marrone G. Cresci, 1999, VIGILIA ROMANIZZAZIO	6	20	20	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					577	577		10.1126/science.1174206	http://dx.doi.org/10.1126/science.1174206			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644113				2022-12-28	WOS:000268493000041
J	Yamada, T				Yamada, Tadataka			Poverty, Wealth, and Access to Pandemic Influenza Vaccines.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA	Bill & Melinda Gates Foundation	Yamada, T (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA.								0	30	32	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1129	1131		10.1056/NEJMp0906972	http://dx.doi.org/10.1056/NEJMp0906972			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	494QA	19675324	Bronze			2022-12-28	WOS:000269828000001
J	Minas, H				Minas, Harry			Mentally ill patients dying in social shelters in Indonesia	LANCET			English	Editorial Material							HUMAN-RIGHTS; ILLNESS		Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Int Mental Hlth, Parkville, Vic 3010, Australia	University of Melbourne	Minas, H (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Int Mental Hlth, Parkville, Vic 3010, Australia.	h.minas@unimelb.edu.au	Minas, Harry/O-8276-2019; Minas, Harry/F-7718-2010	Minas, Harry/0000-0003-1719-7367; 				*AS HUM RIGHTS COM, 2006, IND RAT KEY HUM RIGH; BEECH H, 2003, TIME ASIA       1103; Gostin LO, 2008, PUBLIC HEALTH, V122, P906, DOI 10.1016/j.puhe.2007.11.003; IRMANSYAH PY, 2009, INT J MENT HLTH SYST, V3, P14; *MENT HLTH COUNC A, 2005, NOT SERV EXP INJ DES; Minas Harry, 2007, Int J Ment Health Syst, V1, P1, DOI 10.1186/1752-4458-1-1; Minas Harry, 2008, Int J Ment Health Syst, V2, P8, DOI 10.1186/1752-4458-2-8; NADIRSYAH H, 2007, MUSLIM WORLD, V97, P200; PRIMANITA A, 2009, JAKARTA GLOBE   0523; Silove D, 2001, LANCET, V357, P1436, DOI 10.1016/S0140-6736(00)04575-X; STANMEYER J, 2006, TIME ASIA; Tobin John, 2007, Irish Journal of Psychological Medicine, V24, P31, DOI 10.1017/S0790966700010144	12	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 22	2009	374	9690					592	593		10.1016/S0140-6736(09)61206-X	http://dx.doi.org/10.1016/S0140-6736(09)61206-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19699994				2022-12-28	WOS:000269222600006
J	Vrakking, M				Vrakking, Marc			CHEMICAL PHYSICS Electronic movies	NATURE			English	Editorial Material							HARMONIC-GENERATION; ALIGNED MOLECULES		FOM Inst Atom & Mol Phys AMOLF, NL-1098 XG Amsterdam, Netherlands	AMOLF	Vrakking, M (corresponding author), FOM Inst Atom & Mol Phys AMOLF, Sci Pk 113, NL-1098 XG Amsterdam, Netherlands.	m.vrakking@amolf.nl	Vrakking, Marc JJ/F-6770-2014	Vrakking, Marc JJ/0000-0002-3249-1663				Boutu W, 2008, NAT PHYS, V4, P545, DOI 10.1038/nphys964; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kanai T, 2005, NATURE, V435, P470, DOI 10.1038/nature03577; Lein M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.183903; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Rosca-Pruna F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.153902; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Vozzi C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.153902; Zhou XB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073902	11	13	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					960	961		10.1038/460960a	http://dx.doi.org/10.1038/460960a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693074				2022-12-28	WOS:000269085500021
J	Egholm, DL; Nielsen, SB; Pedersen, VK; Lesemann, JE				Egholm, D. L.; Nielsen, S. B.; Pedersen, V. K.; Lesemann, J. -E.			Glacial effects limiting mountain height	NATURE			English	Article							RELIEF PRODUCTION; EROSION; CLIMATE; LANDSCAPES; MORPHOLOGY; EVOLUTION; BELTS; RANGE; MODEL; USA	The height of mountain ranges reflects the balance between tectonic rock uplift, crustal strength and surface denudation. Tectonic deformation and surface denudation are interdependent, however, and feedback mechanisms-in particular, the potential link to climate-are subjects of intense debate(1,2). Spatial variations in fluvial denudation rate caused by precipitation gradients are known to provide first-order controls on mountain range width, crustal deformation rates and rock uplift(3,4). Moreover, limits to crustal strength(5) are thought to constrain the maximum elevation of large continental plateaus, such as those in Tibet and the central Andes. There are indications that the general height of mountain ranges is also directly influenced by the extent of glaciation through an efficient denudation mechanism known as the glacial buzzsaw(6-9). Here we use a global analysis of topography and show that variations in maximum mountain height correlate closely with climate-controlled gradients in snowline altitude for many high mountain ranges across orogenic ages and tectonic styles. With the aid of a numerical model, we further demonstrate how a combination of erosional destruction of topography above the snowline by glacier-sliding and commensurate isostatic landscape uplift caused by erosional unloading can explain observations of maximum mountain height by driving elevations towards an altitude window just below the snowline. The model thereby self-consistently produces the hypsometric signature of the glacial buzzsaw, and suggests that differences in the height of mountain ranges mainly reflect variations in local climate rather than tectonic forces.	[Egholm, D. L.; Nielsen, S. B.; Pedersen, V. K.; Lesemann, J. -E.] Aarhus Univ, Dept Earth Sci, DK-8000 Aarhus, Denmark	Aarhus University	Egholm, DL (corresponding author), Aarhus Univ, Dept Earth Sci, DK-8000 Aarhus, Denmark.	david@geo.au.dk	Egholm, David/G-8227-2011; Pedersen, Vivi Kathrine/H-7865-2016; Nielsen, Søren/A-5288-2012; Pedersen, Vivi Kathrine/AAX-3985-2020	Pedersen, Vivi Kathrine/0000-0002-5004-8438; Pedersen, Vivi Kathrine/0000-0002-5004-8438; Egholm, David Lundbek/0000-0003-4045-240X				Anderson RS, 2002, GEOMORPHOLOGY, V46, P35, DOI 10.1016/S0169-555X(02)00053-3; Baral DR., 2001, APPL MECH REV, V54, P215, DOI [10.1115/1.3097296, DOI 10.1115/1.3097296]; Beaumont C, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002809; BEAUMONT C, 1992, THRUST TECTONICS, P1; Berger AL, 2008, GEOLOGY, V36, P523, DOI 10.1130/G24883A.1; BINDSCHADLER R, 1983, J GLACIOL, V29, P3, DOI 10.3189/S0022143000005104; Braun J, 1999, ANN GLACIOL-SER, V28, P282, DOI 10.3189/172756499781821797; Brocklehurst SH, 2004, EARTH SURF PROC LAND, V29, P907, DOI 10.1002/esp.1083; Brocklehurst SH, 2002, GEOMORPHOLOGY, V42, P1, DOI 10.1016/S0169-555X(01)00069-1; Brocklehurst SH, 2006, GEOMORPHOLOGY, V75, P283, DOI 10.1016/j.geomorph.2005.07.028; Brocklehurst SH, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000667; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; Brozovic N, 1997, SCIENCE, V276, P571, DOI 10.1126/science.276.5312.571; Budd W., 1979, J GLACIOL, V23, P157, DOI [DOI 10.3198/1979JOG23-89-157-170, 10.3189/S0022143000029804]; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Foster D, 2008, GEOMORPHOLOGY, V102, P624, DOI 10.1016/j.geomorph.2008.06.009; Hallet B, 1996, ANN GLACIOL, V22, P1; HARBOR JM, 1988, NATURE, V333, P347, DOI 10.1038/333347a0; HARBOR JM, 1992, J GLACIOL, V38, P182, DOI 10.3189/S0022143000009710; HOOKE RL, 1981, REV GEOPHYS, V19, P664; HUMPHREY NF, 1994, J GLACIOL, V40, P539, DOI 10.1017/S0022143000012429; Jamieson SSR, 2008, GEOMORPHOLOGY, V97, P91, DOI 10.1016/j.geomorph.2007.02.047; MacGregor KR, 2000, GEOLOGY, V28, P1031, DOI 10.1130/0091-7613(2000)28<1031:NSOGLP>2.0.CO;2; Mitchell SG, 2006, QUATERNARY RES, V65, P96, DOI 10.1016/j.yqres.2005.08.018; MOLNAR P, 1990, NATURE, V346, P29, DOI 10.1038/346029a0; Montgomery DR, 2001, GEOLOGY, V29, P579, DOI 10.1130/0091-7613(2001)029<0579:CTATMO>2.0.CO;2; MONTGOMERY DR, 1994, J GEOPHYS RES-SOL EA, V99, P13913, DOI 10.1029/94JB00122; Munroe JS, 2006, GEOMORPHOLOGY, V75, P437, DOI 10.1016/j.geomorph.2005.07.030; *NAT SNOW IC DAT C, 2009, WORLD GLAC INV; Paterson W.S.B., 1994, PHYS GLACIERS, Vthird; Pelletier J. D, 2008, QUANTITATIVE MODELIN; Roering JJ, 1999, WATER RESOUR RES, V35, P853, DOI 10.1029/1998WR900090; Shuster DL, 2005, SCIENCE, V310, P1668, DOI 10.1126/science.1118519; Small EE, 1998, GEOLOGY, V26, P123, DOI 10.1130/0091-7613(1998)026<0123:PRPILM>2.3.CO;2; Stern TA, 2005, GEOLOGY, V33, P221, DOI 10.1130/G21068.1; Tomkin JH, 2002, AM J SCI, V302, P169, DOI 10.2475/ajs.302.3.169; Tomkin JH, 2009, GEOMORPHOLOGY, V103, P180, DOI 10.1016/j.geomorph.2008.04.021; Whipple KX, 2009, NAT GEOSCI, V2, P97, DOI 10.1038/ngeo413; Whipple KX, 1999, NATURE, V401, P39, DOI 10.1038/43375; Willett SD, 1999, J GEOPHYS RES-SOL EA, V104, P28957, DOI 10.1029/1999JB900248	40	220	229	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					884	U120		10.1038/nature08263	http://dx.doi.org/10.1038/nature08263			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675651				2022-12-28	WOS:000268938300036
J	Amy, JJ; Tripathi, V				Amy, Jean-Jacques; Tripathi, Vrijesh			Contraception for women: an evidence based overview	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VENOUS THROMBOEMBOLISM; INTRAUTERINE-DEVICES; RISK; LEVONORGESTREL		[Amy, Jean-Jacques] European Journal Contracept & Reprod Hlth Care, B-1740 Ternat, Belgium; [Tripathi, Vrijesh] Univ W Indies, Fac Sci & Agr, St Augustine, Trinidad Tobago	University West Indies Mona Jamaica; University West Indies Saint Augustine	Amy, JJ (corresponding author), Florencestr 62, B-1050 Brussels, Belgium.	jeanjacques.amy@skynet.be						[Anonymous], 2003, ADDING IT BENEFITS I; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; CHENG L, 2007, COCHRANE DB SYST REV; Cole JA, 2007, OBSTET GYNECOL, V109, P339, DOI 10.1097/01.AOG.0000250968.82370.04; El-Ibiary SY, 2008, EUR J CONTRACEP REPR, V13, P123, DOI 10.1080/13625180701829952; Grimes DA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006034.pub2; GRIMES DA, 2007, COCHRANE DB SYST REV; Grimes DA, 2007, CONTRACEPTION, V75, pS55, DOI 10.1016/j.contraception.2006.12.004; Hillis SD, 1999, OBSTET GYNECOL, V93, P889, DOI 10.1016/S0029-7844(98)00539-0; Hubacher D, 2002, OBSTET GYNECOL SURV, V57, P120, DOI 10.1097/00006254-200202000-00024; Hubacher D, 2001, NEW ENGL J MED, V345, P561, DOI 10.1056/NEJMoa010438; Lopez LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006260.pub2; Lopez LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006964.pub2; Lopez LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003552.pub2; Martinez F, 2007, EUR J CONTRACEP REPR, V12, P97, DOI 10.1080/13625180701300194; Piaggio G, 1999, LANCET, V353, P697; Polis CB, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005497.pub2; Raymond EG, 2007, OBSTET GYNECOL, V109, P181, DOI 10.1097/01.AOG.0000250904.06923.4a; Rosenberg MJ, 1998, AM J OBSTET GYNECOL, V179, P577, DOI 10.1016/S0002-9378(98)70047-X; TRUSSELL J, 2004, CONTRACEPTIVE TECHNO, P355; United Nations Department of Economic and Social Affairs, 2007, WORLD CONTR US; VANDERWIJDEN C, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001329; Varma R, 2006, EUR J OBSTET GYN R B, V125, P9, DOI 10.1016/j.ejogrb.2005.10.029; von Hertzen H, 2002, LANCET, V360, P1803, DOI 10.1016/S0140-6736(02)11767-3; WHO, 2004, MED EL CRIT CONTR US, V3; World Health Organization, 2008, SEL PRACT REC CONTR; Wu O, 2005, THROMB HAEMOSTASIS, V94, P17, DOI 10.1160/TH04-11-0759; XIONG X, 1995, CONTRACEPTION, V52, P23, DOI 10.1016/0010-7824(95)00120-Y	28	34	33	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2009	339								b2895	10.1136/bmj.b2895	http://dx.doi.org/10.1136/bmj.b2895			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KF	19666684				2022-12-28	WOS:000268808200004
J	Borucki, WJ; Koch, D; Jenkins, J; Sasselov, D; Gilliland, R; Batalha, N; Latham, DW; Caldwell, D; Basri, G; Brown, T; Christensen-Dalsgaard, J; Cochran, WD; DeVore, E; Dunham, E; Dupree, AK; Gautier, T; Geary, J; Gould, A; Howell, S; Kjeldsen, H; Lissauer, J; Marcy, G; Meibom, S; Morrison, D; Tarter, J				Borucki, W. J.; Koch, D.; Jenkins, J.; Sasselov, D.; Gilliland, R.; Batalha, N.; Latham, D. W.; Caldwell, D.; Basri, G.; Brown, T.; Christensen-Dalsgaard, J.; Cochran, W. D.; DeVore, E.; Dunham, E.; Dupree, A. K.; Gautier, T.; Geary, J.; Gould, A.; Howell, S.; Kjeldsen, H.; Lissauer, J.; Marcy, G.; Meibom, S.; Morrison, D.; Tarter, J.			Kepler's Optical Phase Curve of the Exoplanet HAT-P-7b	SCIENCE			English	Article							HOT JUPITERS		[Borucki, W. J.; Koch, D.; Lissauer, J.; Morrison, D.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Jenkins, J.; Caldwell, D.; DeVore, E.; Tarter, J.] SETI Inst, Mountain View, CA 94043 USA; [Sasselov, D.; Latham, D. W.; Dupree, A. K.; Geary, J.; Meibom, S.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Gilliland, R.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Batalha, N.] San Jose State Univ, San Jose, CA 95192 USA; [Basri, G.; Marcy, G.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Brown, T.] Las Cumbres Observ Global Telescope, Goleta, CA 93117 USA; [Christensen-Dalsgaard, J.; Kjeldsen, H.] Aarhus Univ, DK-8000 Aarhus, Denmark; [Cochran, W. D.] Univ Texas Austin, Austin, TX 78712 USA; [Dunham, E.] Lowell Observ, Flagstaff, AZ 86001 USA; [Gautier, T.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Gould, A.] Lawrence Hall Sci, Berkeley, CA 94720 USA; [Howell, S.] Natl Opt Astron Observ, Tucson, AZ 85719 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Space Telescope Science Institute; California State University System; San Jose State University; University of California System; University of California Berkeley; Aarhus University; University of Texas System; University of Texas Austin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Optical Astronomy Observatory	Borucki, WJ (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	william.j.borucki@nasa.gov	Marcy, Geoff/AAC-6050-2019; Cochran, William D/M-4421-2014; Basri, Gibor B/Y-4048-2018; Caldwell, Douglas A/L-7911-2014	Cochran, William D/0000-0001-9662-3496; Caldwell, Douglas A/0000-0003-1963-9616; Christensen-Dalsgaard, Jorgen/0000-0001-5137-0966; Batalha, Natalie/0000-0002-7030-9519	NASA; Ball Aerospace; NASA Discovery program	NASA(National Aeronautics & Space Administration (NASA)); Ball Aerospace; NASA Discovery program(National Aeronautics & Space Administration (NASA))	We acknowledge the contributions of hundreds of individuals across NASA, Ball Aerospace, and the scientific community who made this mission possible. Funding was provided by the NASA Discovery program.	BORUCKI WJ, 1984, ICARUS, V58, P121, DOI 10.1016/0019-1035(84)90102-7; Fortney JJ, 2008, ASTROPHYS J, V678, P1419, DOI 10.1086/528370; Lopez-Morales M, 2007, ASTROPHYS J, V667, pL191, DOI 10.1086/522118; Pal A, 2008, ASTROPHYS J, V680, P1450, DOI 10.1086/588010; Snellen IAG, 2009, NATURE, V459, P543, DOI 10.1038/nature08045	5	167	167	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					709	709		10.1126/science.1178312	http://dx.doi.org/10.1126/science.1178312			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661420	Green Submitted			2022-12-28	WOS:000268723700038
J	Breukink, E				Breukink, Eefjan			Lethal Traffic Jam	SCIENCE			English	Editorial Material							PROTEIN-TRANSLOCATION; ANTIBIOTICS; MEMBRANE; CHANNEL; COMPLEX		Univ Utrecht, Dept Chem Biol & Organ Chem, NL-3584 CJ Utrecht, Netherlands	Utrecht University	Breukink, E (corresponding author), Univ Utrecht, Dept Chem Biol & Organ Chem, Padualaan 8, NL-3584 CJ Utrecht, Netherlands.	e.j.breukink@uu.nl	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660				Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Economou A, 2001, Expert Opin Ther Targets, V5, P141, DOI 10.1517/14728222.5.2.141; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; MISRA R, 1992, EMERGING TARGETS ANT, P163; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Stephens C, 1997, CHEM BIOL, V4, P637, DOI 10.1016/S1074-5521(97)90217-9; van Stelten J, 2009, SCIENCE, V325, P753, DOI 10.1126/science.1172221; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	14	3	3	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					684	685		10.1126/science.1178424	http://dx.doi.org/10.1126/science.1178424			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661407				2022-12-28	WOS:000268723700025
J	Gross, T; Rudolf, L; Levin, SA; Dieckmann, U				Gross, Thilo; Rudolf, Lars; Levin, Simon A.; Dieckmann, Ulf			Generalized Models Reveal Stabilizing Factors in Food Webs	SCIENCE			English	Article							LARGE COMPLEX SYSTEM; INTERACTION STRENGTHS; DIVERSITY; WILL	Insights into what stabilizes natural food webs have always been limited by a fundamental dilemma: Studies either need to make unwarranted simplifying assumptions, which undermines their relevance, or only examine few replicates of small food webs, which hampers the robustness of findings. We used generalized modeling to study several billion replicates of food webs with nonlinear interactions and up to 50 species. In this way, first we show that higher variability in link strengths stabilizes food webs only when webs are relatively small, whereas larger webs are instead destabilized. Second, we reveal a new power law describing how food-web stability scales with the number of species and their connectance. Third, we report two universal rules: Food-web stability is enhanced when (i) species at a high trophic level feed on multiple prey species and (ii) species at an intermediate trophic level are fed upon by multiple predator species.	[Gross, Thilo; Rudolf, Lars] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Levin, Simon A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Levin, Simon A.] Princeton Univ, Ctr BioComplex, Princeton, NJ 08540 USA; [Dieckmann, Ulf] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria	Max Planck Society; Princeton University; Princeton University; International Institute for Applied Systems Analysis (IIASA)	Gross, T (corresponding author), Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany.	thilo.gross@physics.org	Levin, Simon A/J-1218-2014; Dieckmann, Ulf/E-1424-2011; Gross, Thilo/B-4444-2010	Levin, Simon A/0000-0002-8216-5639; Dieckmann, Ulf/0000-0001-7089-0393; Gross, Thilo/0000-0002-1356-6690	NSF [DEB-0083566]; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; European Commission; European Science Foundation; Austrian Science Fund; Vienna Science and Technology Fund	NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation(European Science Foundation (ESF)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); Vienna Science and Technology Fund	T.G. and L.R. thank B. Blasius for extensive discussions and insightful comments. S.L. acknowledges the support of NSF (grant DEB-0083566) and the Defense Advanced Research Projects Agency (grant HR0011-05-1-0057). U.D. acknowledges support by the European Commission, the European Science Foundation, the Austrian Science Fund, and the Vienna Science and Technology Fund.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; COHEN JE, 1985, J THEOR BIOL, V113, P153, DOI 10.1016/S0022-5193(85)80081-3; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Gross T, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016205; Jansen VAA, 2003, ECOL LETT, V6, P498, DOI 10.1046/j.1461-0248.2003.00464.x; KING AW, 1983, AM NAT, V122, P229, DOI 10.1086/284132; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Navarrete SA, 2006, ECOL LETT, V9, P526, DOI 10.1111/j.1461-0248.2006.00899.x; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Sinha S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.020902; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	22	197	198	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					747	750		10.1126/science.1173536	http://dx.doi.org/10.1126/science.1173536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661430	Green Submitted			2022-12-28	WOS:000268723700049
J	O'Neill, LAJ				O'Neill, Luke A. J.			DNA Makes RNA Makes Innate Immunity	CELL			English	Editorial Material							DOUBLE-STRANDED-RNA; EPSTEIN-BARR-VIRUS	Microbial DNA in the cytosol induces production of interferon-beta (IFN-beta) and an innate immune response. Chiu et al. (2009) now implicate cytosolic DNA-dependent RNA polymerase III as the DNA sensor linking DNA release by pathogenic bacteria and viruses in the host cell cytosol to IFN-beta production and innate immunity.	Univ Dublin Trinity Coll, Sch Biochem & Immunol, Coll Green, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Coll Green, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; JAEHNING JA, 1977, J BIOL CHEM, V252, P8753; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; ROSA MD, 1981, MOL CELL BIOL, V1, P785, DOI 10.1128/MCB.1.9.785; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008	8	24	26	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					428	430		10.1016/j.cell.2009.07.021	http://dx.doi.org/10.1016/j.cell.2009.07.021			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665965	Bronze			2022-12-28	WOS:000268771900007
J	Sanchez, PA; Ahamed, S; Carre, F; Hartemink, AE; Hempel, J; Huising, J; Lagacherie, P; McBratney, AB; McKenzie, NJ; Mendonca-Santos, MD; Minasny, B; Montanarella, L; Okoth, P; Palm, CA; Sachs, JD; Shepherd, KD; Vagen, TG; Vanlauwe, B; Walsh, MG; Winowiecki, LA; Zhang, GL				Sanchez, Pedro A.; Ahamed, Sonya; Carre, Florence; Hartemink, Alfred E.; Hempel, Jonathan; Huising, Jeroen; Lagacherie, Philippe; McBratney, Alex B.; McKenzie, Neil J.; Mendonca-Santos, Maria de Lourdes; Minasny, Budiman; Montanarella, Luca; Okoth, Peter; Palm, Cheryl A.; Sachs, Jeffrey D.; Shepherd, Keith D.; Vagen, Tor-Gunnar; Vanlauwe, Bernard; Walsh, Markus G.; Winowiecki, Leigh A.; Zhang, Gan-Lin			Digital Soil Map of the World	SCIENCE			English	Editorial Material							CLASSIFICATION		[Sanchez, Pedro A.; Ahamed, Sonya; Palm, Cheryl A.; Sachs, Jeffrey D.; Walsh, Markus G.; Winowiecki, Leigh A.] Columbia Univ, Earth Inst, Palisades, NY 10964 USA; [Carre, Florence; Montanarella, Luca] European Commiss, Joint Res Ctr, I-21020 Ispra, VA, Italy; [Hartemink, Alfred E.] ISRIC World Soil Informat, NL-6700 AJ Wageningen, Netherlands; [Hempel, Jonathan] Nat Resources Conservat Serv, Natl Soil Survey Ctr, USDA, Lincoln, NE 68508 USA; [Huising, Jeroen; Okoth, Peter; Vanlauwe, Bernard] Ctr Int Agr Trop, Trop Soil Biol & Fertil Inst, Nairobi, Kenya; [Lagacherie, Philippe] INRA, Inst Rech Dev, Lab Etud Interact Sols Agrosyst Hydrosyst, F-34060 Montpellier 1, France; [McBratney, Alex B.; Minasny, Budiman] Univ Sydney, Fac Agr Food & Nat Resources, Sydney, NSW 2006, Australia; [McKenzie, Neil J.] CSIRO Land & Water, Canberra, ACT 2601, Australia; [Mendonca-Santos, Maria de Lourdes] EMBRAPA, Brazilian Agr Res Corp, Natl Ctr Soil Res, BR-22460000 Rio De Janeiro, Brazil; [Shepherd, Keith D.; Vagen, Tor-Gunnar] World Agroforestry Ctr, Nairobi 00100, Kenya; [Zhang, Gan-Lin] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Peoples R China	Columbia University; European Commission Joint Research Centre; EC JRC ISPRA Site; United States Department of Agriculture (USDA); Alliance; International Center for Tropical Agriculture - CIAT; INRAE; Institut de Recherche pour le Developpement (IRD); University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CGIAR; World Agroforestry (ICRAF); Chinese Academy of Sciences; Institute of Soil Science, CAS	Sanchez, PA (corresponding author), Columbia Univ, Earth Inst, 61 Route 9W, Palisades, NY 10964 USA.	psanchez@ei.columbia.edu	Ahamed, Sonya/AAN-1997-2020; Lagacherie, Philippe/F-9019-2010; Montanarella, Luca/AAE-7112-2019; Minasny, Budiman/B-4744-2011; Carre, Florence/GQZ-4297-2022; de Lourdes Mendonca Santos Brefin, Maria/I-6078-2016; Zhang, Gan-Lin/V-9261-2017; Hartemink, Alfred/G-1149-2011; McKenzie, Neil J/A-9921-2011; McBratney, Alex B/C-2199-2011	Lagacherie, Philippe/0000-0002-2948-1966; Minasny, Budiman/0000-0002-1182-2371; de Lourdes Mendonca Santos Brefin, Maria/0000-0001-5424-5028; Zhang, Gan-Lin/0000-0002-6189-5018; Hartemink, Alfred/0000-0002-5797-6798; McKenzie, Neil J/0000-0003-3803-3492; Carre, Florence/0000-0002-3594-8139; McBratney, Alex/0000-0003-0913-2643; Ahamed, Sonya/0000-0002-8734-6041; Vagen, Tor-Gunnar/0000-0002-8699-731X				[Anonymous], 2008, GUIDELINES SURVEYING; Carre F, 2007, GEODERMA, V142, P69, DOI 10.1016/j.geoderma.2007.08.015; FAO/UNESCO, 1988, 60 FAOUNESCO; Hartemink AE, 2008, DIGITAL SOIL MAPPING WITH LIMITED DATA, P53, DOI 10.1007/978-1-4020-8592-5_5; Jenny H., 1941, FACTORS SOIL FORMATI; JENNY HANS, 1961, SOIL SCI SOC AMER PROC, V25, P385; Lagacherie P, 2007, DEV SOIL SCI, V31, P1; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING; Minasny B., 2008, ENCY SOIL SCI; Minasny B, 2008, DIGITAL SOIL MAPPING WITH LIMITED DATA, P15, DOI 10.1007/978-1-4020-8592-5_2; Nachtergaele F, 2003, EVOLUTION TROPICAL S, P107; Oldeman LR, 1991, GLOBAL ASSESSMENT SO; Palm C, 2007, ANNU REV ENV RESOUR, V32, P99, DOI 10.1146/annurev.energy.31.020105.100307; Sanchez PA, 2003, GEODERMA, V114, P157, DOI 10.1016/S0016-7061(03)00040-5; SANCHEZ PA, 1982, GEODERMA, V27, P283, DOI 10.1016/0016-7061(82)90019-2; WEBSTER R, 1972, J SOIL SCI, V23, P210, DOI 10.1111/j.1365-2389.1972.tb01654.x; 2008, 3 GLOB WORKSH DIG SO	18	355	372	4	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					680	681		10.1126/science.1175084	http://dx.doi.org/10.1126/science.1175084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480HF	19661405				2022-12-28	WOS:000268723700022
J	Astin, C				Astin, Christina			Helping young scientists to speak for themselves	NATURE			English	Letter									Kings Sch, Dept Phys, Canterbury CT1 2ES, Kent, England		Astin, C (corresponding author), Kings Sch, Dept Phys, Canterbury CT1 2ES, Kent, England.	cma@kings-school.co.uk						[Anonymous], 2009, NATURE, V459, P1033, DOI 10.1038/4591033b	1	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					683	683		10.1038/460683a	http://dx.doi.org/10.1038/460683a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661890	Bronze			2022-12-28	WOS:000268670300014
J	Shelton, JD				Shelton, James D.			Why multiple sexual partners?	LANCET			English	Editorial Material							AIDS		US Agcy Int Dev, Bur Global Heath, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Heath, Washington, DC 20523 USA.	JShelton@usaid.gov						GOURVENEC D, 2007, PSI BOTSWANA MULTIPL; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Leclerc-Madlala S, 2004, SOCIAL DYNAMICS, V29, P1; Moore Ann M, 2007, Afr J Reprod Health, V11, P44, DOI 10.2307/25549731; *NAT AIDS COORD AG, 2009, NAT CAMP PLAN MULT C; *ONE LOV, 2008, MULT CONC SEX PARTN; Parker W, 2007, CONCURRENT SEXUAL PA; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Swidler A, 2007, STUD FAMILY PLANN, V38, P147, DOI 10.1111/j.1728-4465.2007.00127.x; Tawfik L, 2007, SOC SCI MED, V64, P1090, DOI 10.1016/j.socscimed.2006.10.002; *UNAID SUPP TEAM E, STRAT CONS COMM MULT; Watkins SC, 2004, POPUL DEV REV, V30, P673, DOI 10.1111/j.1728-4457.2004.00037.x; ZULU EM, 2003, DEMOGRAPHIC RES S, V0001; 2008, RES REPORT CONCURREN	14	37	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2009	374	9687					367	369		10.1016/S0140-6736(09)61399-4	http://dx.doi.org/10.1016/S0140-6736(09)61399-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481MJ	19647597				2022-12-28	WOS:000268815200008
J	Rowan-Robinson, M				Rowan-Robinson, Michael			Probing the Cold Universe	SCIENCE			English	Editorial Material							INSTRUMENT		Univ London Imperial Coll Sci Technol & Med, Astrophys Grp, London SW7 2BZ, England	Imperial College London	Rowan-Robinson, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Astrophys Grp, Prince Consort Rd, London SW7 2BZ, England.	mrr@imperial.ac.uk						de Graauw T, 2009, EAS PUBLICATIONS, V34, P3, DOI 10.1051/eas:0934001; Griffin M, 2009, EAS PUBLICATIONS, V34, P33, DOI 10.1051/eas:0934003; PILBRATT A, 2008, P SOC PHOTO-OPT INS, V7010, P1; Pilbratt GL, 2009, EAS PUBLICATIONS, V35, P15, DOI 10.1051/eas/0935002; Poglitsch A, 2009, EAS PUBLICATIONS, V34, P43, DOI 10.1051/eas:0934004	5	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					546	547		10.1126/science.1177305	http://dx.doi.org/10.1126/science.1177305			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644098				2022-12-28	WOS:000268493000026
J	Swirski, FK; Nahrendorf, M; Etzrodt, M; Wildgruber, M; Cortez-Retamozo, V; Panizzi, P; Figueiredo, JL; Kohler, RH; Chudnovskiy, A; Waterman, P; Aikawa, E; Mempel, TR; Libby, P; Weissleder, R; Pittet, MJ				Swirski, Filip K.; Nahrendorf, Matthias; Etzrodt, Martin; Wildgruber, Moritz; Cortez-Retamozo, Virna; Panizzi, Peter; Figueiredo, Jose-Luiz; Kohler, Rainer H.; Chudnovskiy, Aleksey; Waterman, Peter; Aikawa, Elena; Mempel, Thorsten R.; Libby, Peter; Weissleder, Ralph; Pittet, Mikael J.			Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites	SCIENCE			English	Article							BLOOD-VESSELS; BONE-MARROW; RECEPTOR; SUBSETS; CCR2; HETEROGENEITY; RECRUITMENT; MACROPHAGES; MIGRATION; ORIGIN	A current paradigm states that monocytes circulate freely and patrol blood vessels but differentiate irreversibly into dendritic cells (DCs) or macrophages upon tissue entry. Here we show that bona fide undifferentiated monocytes reside in the spleen and outnumber their equivalents in circulation. The reservoir monocytes assemble in clusters in the cords of the subcapsular red pulp and are distinct from macrophages and DCs. In response to ischemic myocardial injury, splenic monocytes increase their motility, exit the spleen en masse, accumulate in injured tissue, and participate in wound healing. These observations uncover a role for the spleen as a site for storage and rapid deployment of monocytes and identify splenic monocytes as a resource that the body exploits to regulate inflammation.	[Swirski, Filip K.; Nahrendorf, Matthias; Etzrodt, Martin; Wildgruber, Moritz; Cortez-Retamozo, Virna; Panizzi, Peter; Figueiredo, Jose-Luiz; Kohler, Rainer H.; Chudnovskiy, Aleksey; Waterman, Peter; Aikawa, Elena; Mempel, Thorsten R.; Weissleder, Ralph; Pittet, Mikael J.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Swirski, Filip K.; Nahrendorf, Matthias; Etzrodt, Martin; Wildgruber, Moritz; Cortez-Retamozo, Virna; Panizzi, Peter; Figueiredo, Jose-Luiz; Kohler, Rainer H.; Chudnovskiy, Aleksey; Waterman, Peter; Aikawa, Elena; Mempel, Thorsten R.; Weissleder, Ralph; Pittet, Mikael J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Etzrodt, Martin] Univ Lausanne, Fac Biol & Med, CH-1015 Lausanne, Switzerland; [Mempel, Thorsten R.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Mempel, Thorsten R.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Libby, Peter] Brigham & Womens Hosp, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Lausanne; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Swirski, FK (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	fswirski@mgh.harvard.edu; rweissleder@mgh.harvard.edu; mpittet@mgh.harvard.edu	Panizzi, Peter/A-6072-2019; Pittet, Mikael/ABD-6300-2021; Aikawa, Elena/L-6173-2019; Etzrodt, Martin/P-3325-2015; Swirski, Filip/AAF-1340-2019; Libby, Peter/AAY-6404-2021	Panizzi, Peter/0000-0003-0141-8807; Etzrodt, Martin/0000-0003-1928-3904; Libby, Peter/0000-0002-1502-502X; Swirski, Filip/0000-0002-3163-9152; kohler, rainer/0000-0001-6269-6590; /0000-0003-0828-4143; Aikawa, Elena/0000-0001-7835-2135	NIH [U01 HL080731, P50 CA86355, R24 CA69246, U54 CA126515, P01 A154904, 1R01HL095612]; MGH-Center for Systems Biology; AHA [SDG 0835623D]; NATIONAL CANCER INSTITUTE [P50CA086355, U54CA126515, P01CA069246] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL094533, U01HL080731, R01HL095629, R01HL096576, R01HL095612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH-Center for Systems Biology; AHA(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grants U01 HL080731, P50 CA86355, R24 CA69246, U54 CA126515, and P01 A154904 to RW, MGH Center for Systems Biology to MJP, AHA SDG 0835623D to MN, and NIH grant 1R01HL095612 to FKS. The authors thank U. von Andrian for critical assessment of the manuscript, A. Luster for providing Ccr2 mice, D. Erle, A. Barcak, and C. Eisley for microarray hybridization and data analysis, M. Waring for sorting cells, A. Moseman for helpful discussion and feedback with parabiosis experiments, and A. Newton, C. Siegel, N. Sergeyev, and Y. Iwamoto for technical assistance. MIAME minimum information about a microarray experiment compliant expression data have been deposited under accession no. GSE14850. This work is dedicated to the memory of Marc Henri Pittet.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; DAVIES BN, 1973, PHARMACOL REV, V25, P373; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Kintscher U, 2001, HYPERTENSION, V37, P587, DOI 10.1161/01.HYP.37.2.587; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McAlpine H M, 1988, Am J Med, V84, P61, DOI 10.1016/0002-9343(88)90206-9; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2007, CIRC RES, V100, P1218, DOI 10.1161/01.RES.0000265064.46075.31; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917	27	1490	1547	5	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					612	616		10.1126/science.1175202	http://dx.doi.org/10.1126/science.1175202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644120	Green Accepted			2022-12-28	WOS:000268493000051
J	Finkel, T; Deng, CX; Mostoslavsky, R				Finkel, Toren; Deng, Chu-Xia; Mostoslavsky, Raul			Recent progress in the biology and physiology of sirtuins	NATURE			English	Review							PANCREATIC BETA-CELLS; SIRT1 REGULATES APOPTOSIS; CALORIE RESTRICTION; DEACETYLASE SIRT1; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; INSULIN-SECRETION; LIFE-SPAN; TRANSCRIPTION FACTORS; LYSINE ACETYLATION	The sirtuins are a highly conserved family of NAD(+)-dependent enzymes that regulate lifespan in lower organisms. Recently, the mammalian sirtuins have been connected to an ever widening circle of activities that encompass cellular stress resistance, genomic stability, tumorigenesis and energy metabolism. Here we review the recent progress in sirtuin biology, the role these proteins have in various age-related diseases and the tantalizing notion that the activity of this family of enzymes somehow regulates how long we live.	[Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Finkel, Toren] NHLBI, Translat Med Branch, Bethesda, MD 20892 USA; [Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; Massachusetts General Hospital	Deng, CX (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016		NIH; Ellison Medical Foundation; Sidney Kimmel Cancer Research Foundation; V Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006038, ZIAHL005012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056009, R01DK088190, ZIADK056011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Sidney Kimmel Cancer Research Foundation; V Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to our colleagues for being unable to cite all appropriate references owing to space limitations. Highlighted references are a subjective appraisal of some of the most interesting manuscripts published in the last year. We are grateful to I. Rovira for help with figures. This work was supported by NIH Intramural funds (T. F, C.-X. D.), The Ellison Medical Foundation (T. F.), The Sidney Kimmel Cancer Research Foundation (R. M.) and the V Foundation (R. M.).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Crujeiras AB, 2008, EUR J CLIN INVEST, V38, P672, DOI 10.1111/j.1365-2362.2008.01998.x; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1; Elliott PJ, 2008, CURR OPIN INVEST DR, V9, P371; Fainzilber M, 2006, NEURON, V50, P819, DOI 10.1016/j.neuron.2006.05.023; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Peeters AV, 2008, HUM GENET, V124, P431, DOI 10.1007/s00439-008-0567-8; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; RINE J, 1979, GENETICS, V93, P877; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; [王福 WANG Fu], 2008, [扬州大学学报. 自然科学版, Journal of Yangzhou University], V11, P20; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Weyrich P, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-100; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	84	1119	1167	8	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					587	591		10.1038/nature08197	http://dx.doi.org/10.1038/nature08197			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19641587	Green Accepted			2022-12-28	WOS:000268454300041
J	Guydosh, NR; Block, SM				Guydosh, Nicholas R.; Block, Steven M.			Direct observation of the binding state of the kinesin head to the microtubule	NATURE			English	Article							OPTICAL FORCE CLAMP; HAND-OVER-HAND; SINGLE-MOLECULE; ATP; RESOLUTION; MECHANISM; STRAIN; STEPS; CYCLE	The dimeric motor protein kinesin-1 converts chemical energy from ATP hydrolysis into mechanical work used to transport cargo along microtubules(1,2). Cargo attached to the kinesin stalk moves processively in 8-nm increments(3) as its twin motor domains (heads) carry out an asymmetric, 'hand-over-hand' walk(4-7). The extent of individual head interactions with the microtubule during stepping, however, remains controversial(4,8-14). A major experimental limitation has been the lack of a means to monitor the attachment of an individual head to the microtubule during movement, necessitating indirect approaches. Here we report the development of a single-molecule assay that can directly report head binding in a walking kinesin molecule, and show that only a single head is bound to the microtubule between steps at low ATP concentrations. A bead was linked to one of the two kinesin heads by means of a short DNA tether and used to apply rapidly alternating hindering and assisting loads with an optical trap. The time-dependent difference between forwards and backwards displacements of the bead alternated between two discrete values during stepping, corresponding to those intervals when the linked head adopted a bound or an unbound state. The linked head could only rebind the microtubule once ATP had become bound to its partner head.	[Block, Steven M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Guydosh, Nicholas R.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	sblock@stanford.edu	Guydosh, Nicholas/AFQ-5807-2022	Guydosh, Nicholas/0000-0001-7116-326X	US National Institutes of Health [GM51453]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051453] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Dunn, B. Choi and W. Hwang for advice on labelling kinesin; S. Gilbert for advice on expressing kinesin; and B. Gutierrez-Medina, C. Sindelar, C. Perez and K. Frieda for comments on the manuscript. This work was supported by grant GM51453 from the US National Institutes of Health.	Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Asenjo AB, 2009, P NATL ACAD SCI USA, V106, P5657, DOI 10.1073/pnas.0808355106; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Crevel I, 1999, EMBO J, V18, P5863, DOI 10.1093/emboj/18.21.5863; DELANO WL, 2002, PYMOL MOL VIEWER VER; FEHR AN, BIOPHYS J IN PRESS; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kawaguchi K, 2003, BIOPHYS J, V84, P1103, DOI 10.1016/S0006-3495(03)74926-1; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Mandelkow E, 1999, CURR OPIN CELL BIOL, V11, P34, DOI 10.1016/S0955-0674(99)80005-2; Mori T, 2007, NATURE, V450, P750, DOI 10.1038/nature06346; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Sablin EP, 2004, J BIOL CHEM, V279, P15707, DOI 10.1074/jbc.R300036200; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Taniguchi Y, 2005, NAT CHEM BIOL, V1, P342, DOI 10.1038/nchembio741; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	31	80	80	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					125	U137		10.1038/nature08259	http://dx.doi.org/10.1038/nature08259			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19693012	Green Accepted			2022-12-28	WOS:000269478800043
J	Mateen, FJ; Dorji, C				Mateen, Farrah J.; Dorji, Chencho			Health-care worker burnout and the mental health imperative	LANCET			English	Editorial Material							MEDICAL-STUDENTS; PSYCHIATRY; ATTITUDES		[Mateen, Farrah J.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Dorji, Chencho] Jigme Dorji Wamgchuk Natl Referral Hosp, Dept Psychiat, Thimphu, Bhutan	Mayo Clinic	Mateen, FJ (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	Farrah_Mateen@hotmail.com						Boulet J, 2007, MED TEACH, V29, P20, DOI 10.1080/01421590601131823; Carpenter LM, 1997, OCCUP ENVIRON MED, V54, P388, DOI 10.1136/oem.54.6.388; Chopra SS, 2004, JAMA-J AM MED ASSOC, V291, P633, DOI 10.1001/jama.291.5.633; Hawton K, 2001, J EPIDEMIOL COMMUN H, V55, P296, DOI 10.1136/jech.55.5.296; Korkeila JA, 2003, SCAND J PUBLIC HEALT, V31, P85, DOI 10.1080/14034940210133880; Kumar S, 2007, WORLD PSYCHIATRY, V6, P186; Laugharne R, 2009, ACAD PSYCHIATR, V33, P71, DOI 10.1176/appi.ap.33.1.71; Maric NP, 2009, PSYCHIAT DANUB, V21, P206; Ndetei DM, 2008, ACAD PSYCHIATR, V32, P154, DOI 10.1176/appi.ap.32.2.154; Pan YJ, 2009, J FORMOS MED ASSOC, V108, P328, DOI 10.1016/S0929-6646(09)60073-5; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Silva Andrea Tenorio Correia da, 2008, Rev Saude Publica, V42, P921, DOI 10.1590/S0034-89102008000500019; Syed EU, 2008, ACAD PSYCHIATR, V32, P160, DOI 10.1176/appi.ap.32.2.160	13	26	26	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2009	374	9690					595	597		10.1016/S0140-6736(09)61483-5	http://dx.doi.org/10.1016/S0140-6736(09)61483-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19699996				2022-12-28	WOS:000269222600008
J	McLachlan, G				McLachlan, Greta			Taking the spice out of legal smoking mixtures	LANCET			English	Editorial Material									Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	McLachlan, G (corresponding author), Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England.	ugm3gmcm@leeds.ac.uk						[Anonymous], 2009, CONS MAJ CANN AG; Burley B., 2008, BBC NEWSBEAT    1007; European Monitoring Centre for Drugs and Drug Addiction, 2009, ACT NEW DRUGS BRIEF; MANN N, 2009, GUERNSEY PRESS  0407; ROSS K, 2009, LONDON PAPER    0812	5	20	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2009	374	9690					600	600		10.1016/S0140-6736(09)61507-5	http://dx.doi.org/10.1016/S0140-6736(09)61507-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19699999				2022-12-28	WOS:000269222600011
J	Davis, AM				Davis, Andrew M.			Early Solar System Chronology	SCIENCE			English	Editorial Material									[Davis, Andrew M.] Univ Chicago, Enrico Fermi Inst, Dept Geophys Sci, Chicago, IL 60637 USA; [Davis, Andrew M.] Univ Chicago, Chicago Ctr Cosmochem, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Davis, AM (corresponding author), Univ Chicago, Enrico Fermi Inst, Dept Geophys Sci, 5640 S Ellis Ave, Chicago, IL 60637 USA.	a-davis@uchicago.edu		Davis, Andrew/0000-0001-7955-6236				Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Dauphas N, 2008, ASTROPHYS J, V686, P560, DOI 10.1086/589959; LEE T, 1976, GEOPHYS RES LETT, V3, P109, DOI 10.1029/GL003i002p00109; Libourel G, 2006, EARTH PLANET SC LETT, V251, P232, DOI 10.1016/j.epsl.2006.09.011; SCOTT ERD, 2007, METEORITES PLANETS C, V1, P1; Villeneuve J, 2009, SCIENCE, V325, P985, DOI 10.1126/science.1173907	7	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					951	952		10.1126/science.1176730	http://dx.doi.org/10.1126/science.1176730			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AN	19696337				2022-12-28	WOS:000269242800029
J	Brown, KS; Marean, CW; Herries, AIR; Jacobs, Z; Tribolo, C; Braun, D; Roberts, DL; Meyer, MC; Bernatchez, J				Brown, Kyle S.; Marean, Curtis W.; Herries, Andy I. R.; Jacobs, Zenobia; Tribolo, Chantal; Braun, David; Roberts, David L.; Meyer, Michael C.; Bernatchez, Jocelyn			Fire As an Engineering Tool of Early Modern Humans	SCIENCE			English	Article							MIDDLE STONE-AGE; MODERN HUMAN-BEHAVIOR; SOUTH-AFRICA; TECHNOLOGICAL-CHANGE; SYMBOLIC BEHAVIOR; BLOMBOS CAVE; ORIGINS	The controlled use of fire was a breakthrough adaptation in human evolution. It first provided heat and light and later allowed the physical properties of materials to be manipulated for the production of ceramics and metals. The analysis of tools at multiple sites shows that the source stone materials were systematically manipulated with fire to improve their flaking properties. Heat treatment predominates among silcrete tools at similar to 72 thousand years ago (ka) and appears as early as 164 ka at Pinnacle Point, on the south coast of South Africa. Heat treatment demands a sophisticated knowledge of fire and an elevated cognitive ability and appears at roughly the same time as widespread evidence for symbolic behavior.	[Brown, Kyle S.; Braun, David] Univ Cape Town, Dept Archaeol, ZA-7701 Cape Town, South Africa; [Brown, Kyle S.; Marean, Curtis W.; Bernatchez, Jocelyn] Arizona State Univ, Inst Human Origins, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Herries, Andy I. R.] Univ New S Wales, Archaeomagnet Lab, Kensington, NSW 2052, Australia; [Herries, Andy I. R.] Univ New S Wales, Palaeosci Lab, Sch Med Sci, Kensington, NSW 2052, Australia; [Herries, Andy I. R.] Univ Liverpool, Geomagnetism Lab, Dept Earth & Ocean Sci, Liverpool L69 3BX, Merseyside, England; [Jacobs, Zenobia; Meyer, Michael C.] Univ Wollongong, GeoQuEST Res Ctr, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; [Tribolo, Chantal] Univ Bordeaux, CNRS, Inst Rech Archeomat, Ctr Rech Phys Appl Archeol, F-33607 Pessac, France; [Roberts, David L.] Council Geosci, ZA-7535 Bellville, South Africa	University of Cape Town; Arizona State University; Arizona State University-Tempe; University of New South Wales Sydney; University of New South Wales Sydney; University of Liverpool; University of Wollongong; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Universite de Orleans; Universite de Technologie de Belfort-Montbeliard (UTBM); UDICE-French Research Universities; Universite de Bordeaux	Brown, KS (corresponding author), Univ Cape Town, Dept Archaeol, ZA-7701 Cape Town, South Africa.		Jacobs, Zenobia/B-2721-2012; Meyer, Michael C/S-8214-2016; Braun, David/C-9680-2009	Jacobs, Zenobia/0000-0001-5424-5837; Meyer, Michael C/0000-0001-6677-7419; Herries, Andy/0000-0002-2905-2002; TRIBOLO, Chantal/0000-0003-0506-2430	NSF (USA) [BCS-9912465, BCS-0130713, BCS-0524087]; Hyde Family Trust; Institute for Human Origins, ASU; University of Liverpool Geomagnetism Laboratory; Faculty of Medicine at UNSW; Australian Research Council [DP0877603]; Marie Curie International;  [PIOF-GA-2008-21994]	NSF (USA)(National Science Foundation (NSF)); Hyde Family Trust; Institute for Human Origins, ASU; University of Liverpool Geomagnetism Laboratory; Faculty of Medicine at UNSW; Australian Research Council(Australian Research Council); Marie Curie International(European Commission); 	This research was funded by NSF (USA) (grants BCS-9912465, BCS-0130713, and BCS-0524087 to C.W.M.); the Hyde Family Trust; and the Institute for Human Origins, ASU. Additional support to A.I.R.H. was provided by M. Hill at the University of Liverpool Geomagnetism Laboratory, and funds were provided by the Faculty of Medicine at UNSW and Australian Research Council grant DP0877603. M.C.M. was funded via a Marie Curie International Outgoing fellowship (PIOF-GA-2008-21994).	Aitken MJ, 1985, THERMOLUMINESCENCE D; Ambrose SH., 2022, SOCIAL ECOLOGICAL MO, P3, DOI [DOI 10.1515/9781474470957-003, 10.1515/9781474470957-003]; [Anonymous], 1985, ARCHAEOL OCEAN, DOI DOI 10.1002/j.1834-4453.1985.tb00116.x; Callahan E., 1979, ARCHAEOLOGY E N AM, V7, P1; CLARK JD, 1988, J WORLD PREHIST, V2, P235, DOI 10.1007/BF00975618; Clark JD, 1985, AFR ARCHAEOL REV, V3, P3, DOI DOI 10.1007/BF01117453; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; DEACON HJ, 1989, HUMAN REVOLUTION, P547; Fener M, 2005, ROCK MECH ROCK ENG, V38, P329, DOI 10.1007/s00603-005-0061-8; Flenniken J. Jeffrey, 1983, AUST ABORIG STUD, V1, P43; Goren-Inbar N, 2004, SCIENCE, V304, P725, DOI 10.1126/science.1095443; Goudie AS, 2006, PROG PHYS GEOG, V30, P703, DOI 10.1177/0309133306071954; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; HERRIES AIR, 2009, AUSTR ARCHAEOMETRY, P235; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Mackay A, 2008, J ARCHAEOL SCI, V35, P614, DOI 10.1016/j.jas.2007.05.013; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McCall GS, 2007, J ARCHAEOL SCI, V34, P1738, DOI 10.1016/j.jas.2006.12.015; Merrick H.V., 1994, SOC CULTURE TECHNOLO, P29; Pelcin AW, 1997, J ARCHAEOL SCI, V24, P749, DOI 10.1006/jasc.1996.0156; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; Tribolo C, 2009, J ARCHAEOL SCI, V36, P730, DOI 10.1016/j.jas.2008.10.018; Tryon CA, 2002, J HUM EVOL, V42, P211, DOI 10.1006/jhev.2001.0513; Volman T.P., 1984, P169; Webb JA, 2008, ARCHAEOMETRY, V50, P555, DOI 10.1111/j.1475-4754.2007.00381.x; Wurz S, 1999, S AFR ARCHAEOL BULL, V54, P38, DOI 10.2307/3889138	29	397	407	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					859	862		10.1126/science.1175028	http://dx.doi.org/10.1126/science.1175028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679810				2022-12-28	WOS:000269242400042
J	Li, QW; Zhang, WY; Miljanic, OS; Sue, CH; Zhao, YL; Liu, LH; Knobler, CB; Stoddart, JF; Yaghi, OM				Li, Qiaowei; Zhang, Wenyu; Miljanic, Ognjen S.; Sue, Chi-Hau; Zhao, Yan-Li; Liu, Lihua; Knobler, Carolyn B.; Stoddart, J. Fraser; Yaghi, Omar M.			Docking in Metal-Organic Frameworks	SCIENCE			English	Article							SUPRAMOLECULAR CHEMISTRY; SURFACE-AREA; DESIGN; MOLECULES	The use of metal-organic frameworks (MOFs) so far has largely relied on nonspecific binding interactions to host small molecular guests. We used long organic struts (similar to 2 nanometers) incorporating 34- and 36-membered macrocyclic polyethers as recognition modules in the construction of several crystalline primitive cubic frameworks that engage in specific binding in a way not observed in passive, open reticulated geometries. MOF-1001 is capable of docking paraquat dication (PQT(2+)) guests within the macrocycles in a stereoelectronically controlled fashion. This act of specific complexation yields quantitatively the corresponding MOF-1001 pseudorotaxanes, as confirmed by x-ray diffraction and by solid-and solution-state nuclear magnetic resonance spectroscopic studies performed on MOF-1001, its pseudorotaxanes, and their molecular strut precursors. A control experiment involving the attempted inclusion of PQT(2+) inside a framework (MOF-177) devoid of polyether struts showed negligible uptake of PQT(2+), indicating the importance of the macrocyclic polyether in PQT(2+) docking.	[Li, Qiaowei; Zhang, Wenyu; Miljanic, Ognjen S.; Knobler, Carolyn B.; Yaghi, Omar M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sue, Chi-Hau; Zhao, Yan-Li; Liu, Lihua; Stoddart, J. Fraser] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	University of California System; University of California Los Angeles; Northwestern University	Li, QW (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	qwli@chem.ucla.edu; wyzhang@chem.ucla.edu	Li, Qiaowei/G-2115-2010; Sue, Andrew/G-2517-2012; Yaghi, Omar M/C-6749-2013; Sue, Andrew C.-H./K-1641-2015; Stoddart, James Fraser/H-1518-2011; Zhao, Yanli/B-7028-2011	Li, Qiaowei/0000-0002-5987-9465; Sue, Andrew C.-H./0000-0001-9557-2658; Stoddart, James Fraser/0000-0003-3161-3697; Zhao, Yanli/0000-0002-9231-8360; Yaghi, Omar/0000-0002-5611-3325	U.S. Department of Defense [HDTRA1-08-10023]; Northwestern University	U.S. Department of Defense(United States Department of Defense); Northwestern University	This work was supported by the U.S. Department of Defense (Defense Threat Reduction Agency grant HDTRA1-08-10023) and Northwestern University.	Amabilino DB, 1995, CHEM REV, V95, P2725, DOI 10.1021/cr00040a005; AMABILINO DB, 1995, J AM CHEM SOC, V117, P11142; ASHTON PR, 1991, J CHEM SOC CHEM COMM, P1677, DOI 10.1039/c39910001677; Balzani V, 2000, ANGEW CHEM INT EDIT, V39, P3348, DOI 10.1002/1521-3773(20001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Kim K, 2002, CHEM SOC REV, V31, P96, DOI 10.1039/a900939f; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Lee CF, 2009, NATURE, V458, P314, DOI 10.1038/nature07847; Lee J, 2009, CHEM SOC REV, V38, P1450, DOI 10.1039/b807080f; LEHN JM, 1985, SCIENCE, V227, P849, DOI 10.1126/science.227.4689.849; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Loeb SJ, 2005, CHEM COMMUN, P1511, DOI 10.1039/b416609d; PRELOG V, 1982, ANGEW CHEM INT EDIT, V21, P567, DOI 10.1002/anie.198205671; Rowsell JLC, 2005, SCIENCE, V309, P1350, DOI 10.1126/science.1113247; Sonogashira K., 1975, TETRAHEDRON LETT, V16, P4467, DOI DOI 10.1016/S0040-4039(00)91094-3; Stoddart JF, 2009, NAT CHEM, V1, P14, DOI 10.1038/nchem.142; Wang ZQ, 2009, CHEM SOC REV, V38, P1315, DOI 10.1039/b802258p; Wong-Foy AG, 2006, J AM CHEM SOC, V128, P3494, DOI 10.1021/ja058213h; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650	21	316	337	20	523	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					855	859		10.1126/science.1175441	http://dx.doi.org/10.1126/science.1175441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679809	Green Accepted			2022-12-28	WOS:000269242400041
J	Dekel, N				Dekel, Nava			Master Regulators of Female Fertility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELLS		Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dekel, N (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.		DEKEL, NAVA/R-8817-2019					Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Sela-Abramovich S, 2005, ENDOCRINOLOGY, V146, P1236, DOI 10.1210/en.2004-1006; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221	3	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					718	719		10.1056/NEJMcibr0904558	http://dx.doi.org/10.1056/NEJMcibr0904558			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19675336				2022-12-28	WOS:000268884100016
J	Schwarz, G; Mendel, RR; Ribbe, MW				Schwarz, Guenter; Mendel, Ralf R.; Ribbe, Markus W.			Molybdenum cofactors, enzymes and pathways	NATURE			English	Review							NITROGENASE FEMO-COFACTOR; PROTEIN ALPHA-SUBUNIT; AFFINITY MOLYBDATE TRANSPORTER; SULFITE-OXIDIZING ENZYMES; THALIANA PROVIDES INSIGHT; NITRATE REDUCTASE-A; IN-VITRO SYNTHESIS; ESCHERICHIA-COLI; MOFE-PROTEIN; MOLYBDOPTERIN SYNTHASE	The trace element molybdenum is essential for nearly all organisms and forms the catalytic centre of a large variety of enzymes such as nitrogenase, nitrate reductases, sulphite oxidase and xanthine oxidoreductases. Nature has developed two scaffolds holding molybdenum in place, the iron-molybdenum cofactor and pterin-based molybdenum cofactors. Despite the different structures and functions of molybdenum-dependent enzymes, there are important similarities, which we highlight here. The biosynthetic pathways leading to both types of cofactor have common mechanistic aspects relating to scaffold formation, metal activation and cofactor insertion into apoenzymes, and have served as an evolutionary 'toolbox' to mediate additional cellular functions in eukaryotic metabolism.	[Schwarz, Guenter] Univ Cologne, Dept Chem, Inst Biochem, D-50674 Cologne, Germany; [Schwarz, Guenter] Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany; [Mendel, Ralf R.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Plant Biol, D-38106 Braunschweig, Germany; [Ribbe, Markus W.] Univ Calif Irvine, Sch Biol Sci, Dept Biochem & Mol Biol, Irvine, CA 92697 USA	University of Cologne; University of Cologne; Braunschweig University of Technology; University of California System; University of California Irvine	Schwarz, G (corresponding author), Univ Cologne, Dept Chem, Inst Biochem, 47 Zuelpicher St, D-50674 Cologne, Germany.	gschwarz@uni-koeln.de	Schwarz, Guenter/ABE-9643-2021; Schwarz, Guenter/F-2217-2013	Schwarz, Guenter/0000-0002-2118-9338; 	Deutsche Forschungsgemeinschaft; Bundeministerium fur Bildung und Forschung; Fonds der Chemischen Industrie; European Union; US National Institutes of Health [GM-67626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundeministerium fur Bildung und Forschung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Union(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support from the Deutsche Forschungsgemeinschaft (G. S., R. R. M.), the Bundeministerium fur Bildung und Forschung (G. S.), the Fonds der Chemischen Industrie (G. S.), the European Union (R. R. M.) and the US National Institutes of Health (grant GM-67626; M. W. R.) is gratefully acknowledged, as is the contribution of all co-workers, especially graduate students and post-docs, during the past ten years.	ALLEN RM, 1995, J BIOL CHEM, V270, P26890, DOI 10.1074/jbc.270.45.26890; Ataya FS, 2003, J BIOL CHEM, V278, P10885, DOI 10.1074/jbc.M211320200; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Bevers LE, 2008, BIOCHEMISTRY-US, V47, P949, DOI 10.1021/bi7020487; Bevers LE, 2006, J BACTERIOL, V188, P6498, DOI 10.1128/JB.00548-06; Bevers LE, 2009, COORDIN CHEM REV, V253, P269, DOI 10.1016/j.ccr.2008.01.017; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; Brewer GJ, 2005, DRUG DISCOV TODAY, V10, P1103, DOI 10.1016/S1359-6446(05)03541-5; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; Chen S, 2007, J BIOL CHEM, V282, P21561, DOI 10.1074/jbc.M702383200; Corbett MC, 2006, P NATL ACAD SCI USA, V103, P1238, DOI 10.1073/pnas.0507853103; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Daniels JN, 2008, BIOCHEMISTRY-US, V47, P615, DOI 10.1021/bi701734g; Dobbek H, 2002, P NATL ACAD SCI USA, V99, P15971, DOI 10.1073/pnas.212640899; Dos Santos PC, 2004, CHEM REV, V104, P1159, DOI 10.1021/cr020608l; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Fay AW, 2007, J INORG BIOCHEM, V101, P1630, DOI 10.1016/j.jinorgbio.2007.03.013; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; Fischer K, 2005, PLANT CELL, V17, P1167, DOI 10.1105/tpc.104.029694; Fischer K, 2006, J BIOL CHEM, V281, P30186, DOI 10.1074/jbc.M603919200; Forlani F, 2005, FEBS LETT, V579, P6786, DOI 10.1016/j.febslet.2005.11.013; Garattini E, 2003, BIOCHEM J, V372, P15, DOI 10.1042/BJ20030121; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Groysman S, 2009, BIOCHEMISTRY-US, V48, P2310, DOI 10.1021/bi900044e; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hansch R, 2006, J BIOL CHEM, V281, P6884, DOI 10.1074/jbc.M513054200; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2002, J BIOL CHEM, V277, P18303, DOI 10.1074/jbc.M200947200; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; Hernandez JA, 2008, P NATL ACAD SCI USA, V105, P11679, DOI 10.1073/pnas.0803576105; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hollenstein K, 2009, J BIOL INORG CHEM, V14, P663, DOI 10.1007/s00775-009-0479-7; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; Hu Y, 2007, J BIOL INORG CHEM, V12, P449, DOI 10.1007/s00775-006-0199-1; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17119, DOI 10.1073/pnas.0602647103; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Hu YL, 2006, J BIOL CHEM, V281, P30534, DOI 10.1074/jbc.M605527200; Hu YL, 2005, P NATL ACAD SCI USA, V102, P3236, DOI 10.1073/pnas.0409201102; IMPERIAL J, 1984, J BACTERIOL, V158, P187, DOI 10.1128/JB.158.1.187-194.1984; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnson JL., 2001, METABOLIC MOL BASES, P3163; Kappler U, 2005, J BIOL CHEM, V280, P24999, DOI 10.1074/jbc.M503237200; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Kuper J, 2004, NATURE, V430, P803, DOI 10.1038/nature02681; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lee HJ, 2002, HUM MOL GENET, V11, P3309, DOI 10.1093/hmg/11.26.3309; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Llamas A, 2004, J BIOL CHEM, V279, P55241, DOI 10.1074/jbc.M409862200; Llamas A, 2006, J BIOL CHEM, V281, P18343, DOI 10.1074/jbc.M601415200; MASON J, 1986, TOXICOLOGY, V42, P99, DOI 10.1016/0300-483X(86)90001-6; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Mercer JFB, 2001, TRENDS MOL MED, V7, P64, DOI 10.1016/S1471-4914(01)01920-7; Moura JJG, 2004, J BIOL INORG CHEM, V9, P791, DOI 10.1007/s00775-004-0573-9; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Neumann M, 2009, FEBS J, V276, P2762, DOI 10.1111/j.1742-4658.2009.07000.x; Pau RN, 2002, MET IONS BIOL SYST, V39, P31; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Reiss J, 2003, HUM MUTAT, V21, P569, DOI 10.1002/humu.10223; Reiss J, 2001, AM J HUM GENET, V68, P208, DOI 10.1086/316941; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Rubio LM, 2002, J BIOL CHEM, V277, P14299, DOI 10.1074/jbc.M107289200; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Santamaria-Araujo JA, 2004, J BIOL CHEM, V279, P15994, DOI 10.1074/jbc.M311815200; Sargent F, 2007, MICROBIOL-SGM, V153, P633, DOI 10.1099/mic.0.2006/004762-0; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Schwarz G, 2004, HUM MOL GENET, V13, P1249, DOI 10.1093/hmg/ddh136; Schwarz G., 2007, MOL MICROBIOLOGY HEA, P421, DOI DOI 10.1007/7171_2006_088; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Stallmeyer B, 1999, AM J HUM GENET, V64, P698, DOI 10.1086/302295; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; Stevenson CEM, 2000, STRUCTURE, V8, P1115, DOI 10.1016/S0969-2126(00)00518-9; SUTTLE NF, 1991, ANNU REV NUTR, V11, P121, DOI 10.1146/annurev.nu.11.070191.001005; Tan WH, 2005, PEDIATRICS, V116, P757, DOI 10.1542/peds.2004-1897; Tejada-Jimenez M, 2007, P NATL ACAD SCI USA, V104, P20126, DOI 10.1073/pnas.0704646104; Tomatsu H, 2007, P NATL ACAD SCI USA, V104, P18807, DOI 10.1073/pnas.0706373104; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Vergnes A, 2004, J BIOL CHEM, V279, P41398, DOI 10.1074/jbc.M407087200; Wollers S, 2008, J BIOL CHEM, V283, P9642, DOI 10.1074/jbc.M708549200; WUEBBENS MM, 1993, J BIOL CHEM, V268, P13493; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Zhang X, 2004, J BIOL CHEM, V279, P43035, DOI 10.1074/jbc.M402759200; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051; Zheng LM, 1997, J BACTERIOL, V179, P5963, DOI 10.1128/jb.179.18.5963-5966.1997	100	534	558	13	263	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					839	847		10.1038/nature08302	http://dx.doi.org/10.1038/nature08302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675644				2022-12-28	WOS:000268938300028
J	Thayyil, S; Cleary, JO; Sebire, NJ; Scott, RJ; Chong, K; Gunny, R; Owens, CM; Olsen, OE; Offiah, AC; Parks, HG; Chitty, LS; Price, AN; Yousry, TA; Robertson, NJ; Lythgoe, MF; Taylor, AM				Thayyil, Sudhin; Cleary, Jon O.; Sebire, Neil J.; Scott, Rosemary J.; Chong, Kling; Gunny, Roxanna; Owens, Catherine M.; Olsen, Oystein E.; Offiah, Amaka C.; Parks, Harold G.; Chitty, Lyn S.; Price, Anthony N.; Yousry, Tarek A.; Robertson, Nicola J.; Lythgoe, Mark F.; Taylor, Andrew M.			Post-mortem examination of human fetuses: a comparison of whole-body high-field MRI at 9.4 T with conventional MRI and invasive autopsy	LANCET			English	Article							PARENTAL CONSENT; NEONATAL AUTOPSY; FETAL; ULTRASOUND; ADJUNCT; MOUSE; DEATH	Background Conventional whole-body MRI at 1.5 T does not provide adequate image quality of small fetuses, thus reducing its potential for use as an alternative to invasive autopsy. High-field whole-body MRI at 9.4 T provides good images of small animals. We therefore compared the diagnostic usefulness of high-field MRI with conventional MRI for post-mortem examination of human fetuses. Methods We did whole-body MRI at 9.4 T and 1.5 T on 18 fetuses of less than 22 weeks' gestation, using three-dimensional T(2)-weighted fast-spin echo sequences, before doing invasive autopsy. Images obtained with MRI for each system were compared with the findings of invasive autopsy in a blinded manner. Tissue contrast of 14 different regions was compared on 1.5 T and 9.4 T images that were provided by paediatric radiologists separately and in a random order, and image quality was scored on a four-point scale. The primary endpoint was diagnostic accuracy. Findings Spatial resolution, tissue contrast, and image quality of all organ systems were much better with high-field MRI than with conventional MRI. All structural abnormalities that were detected with invasive autopsy and internal examination of visceral organs were also detected with high-field MRI, whereas conventional MRI was not diagnostically useful in 14 (78%) cases. Interpretation Whole-body high-field MRI is a feasible option for post-mortem examination of human fetuses, and can provide good tissue characterisation even in small fetuses (5 g). The use of MRI at 9.4 T might be helpful in the development of a minimally invasive perinatal autopsy system. Funding Department of Health Policy Research Programme, British Heart Foundation, National Institute of Health Research, Higher Education Funding Council for England, Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council, Great Ormond Street Hospital, University College London (UCL) Institute of Child Health, UCL Hospital, and UCL.	[Thayyil, Sudhin; Taylor, Andrew M.] UCL, Inst Child Hlth, Ctr Cardiovasc Imaging, London WC1N 1EH, England; [Chong, Kling; Gunny, Roxanna; Owens, Catherine M.; Olsen, Oystein E.; Offiah, Amaka C.] Great Ormond St Hosp Sick Children, Dept Radiol, London WC1N 3JH, England; [Cleary, Jon O.; Price, Anthony N.; Lythgoe, Mark F.] Ctr Adv Biomed Imaging, Dept Med, London, England; [Sebire, Neil J.] UCL, Inst Child Hlth, Dept Histopathol, London WC1N 1EH, England; [Scott, Rosemary J.] Univ Coll London Hosp, Dept Histopathol, London, England; [Parks, Harold G.; Yousry, Tarek A.] UCL, Inst Neurol, London WC1N 1EH, England; [Chitty, Lyn S.] UCL, Inst Child Hlth, Clin Mol Genet Unit, London WC1N 1EH, England; [Thayyil, Sudhin; Chitty, Lyn S.; Robertson, Nicola J.] UCL, Inst Womens Hlth, London WC1N 1EH, England; [Cleary, Jon O.] UCL, Dept Med Phys & Bioengn, London WC1N 1EH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Thayyil, S (corresponding author), UCL, Inst Child Hlth, Ctr Cardiovasc Imaging, 30 Guilford St, London WC1N 1EH, England.	s.thayyil@ich.ucl.ac.uk	Taylor, Andrew M/C-4311-2008; Offiah, Amaka/G-2911-2010; Parkes, Harold G/I-7412-2012; Robertson, Nicola/GWR-2021-2022	Offiah, Amaka/0000-0001-8991-5036; Price, Anthony/0000-0002-6907-7554; chitty, lyn/0000-0002-4857-7138; Thayyil, Sudhin/0000-0001-8795-5165; Taylor, Andrew/0000-0003-4194-7113; Lythgoe, Mark/0000-0002-4945-0171; Cleary, Jon/0000-0001-8836-9934; Sebire, Neil/0000-0001-5348-9063	UK Department of Health [0550004]; British Heart Foundation, London [C1/05/010]; National Institute of Health Research, London [SRF/08/01/018]; UK Department of Health; Higher Education Funding Council for England, Bristol, UK; British Heart Foundation; Biotechnology and Biological Sciences Research Council, Swindon, UK; Engineering and Physical Sciences Research Council, Swindon; Great Ormond Street Hospital, Institute of Child Health, University College London Hospital; University College London; UK Department of Health's National Institute of Health Research Biomedical Research Centres; Great Ormond Street Hospital Childrens Charity [V0907] Funding Source: researchfish	UK Department of Health; British Heart Foundation, London(British Heart Foundation); National Institute of Health Research, London(National Institute for Health Research (NIHR)); UK Department of Health; Higher Education Funding Council for England, Bristol, UK(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council, Swindon, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council, Swindon(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Great Ormond Street Hospital, Institute of Child Health, University College London Hospital; University College London(General Electric); UK Department of Health's National Institute of Health Research Biomedical Research Centres; Great Ormond Street Hospital Childrens Charity	We are indebted to Alistair Parker (UK Department of Health, London, UK), who has guided us through the process of this project. The work for this project was funded by the UK Department of Health (0550004) and the British Heart Foundation, London (C1/05/010). AMT is funded by the National Institute of Health Research, London (SRF/08/01/018). ST is funded by the UK Department of Health. NJR and NIS are funded by Higher Education Funding Council for England, Bristol, UK. MFL is funded by the British Heart Foundation, ANP is funded by Biotechnology and Biological Sciences Research Council, Swindon, UK, and JOC by the Engineering and Physical Sciences Research Council, Swindon. This work was undertaken at Great Ormond Street Hospital, Institute of Child Health, University College London Hospital, and University College London. University College London Hospital and University College London received a proportion of the funding from the UK Department of Health's National Institute of Health Research Biomedical Research Centres funding scheme.	Aghayev Emin, 2008, J Forensic Leg Med, V15, P382, DOI 10.1016/j.jflm.2008.02.007; Alderliesten ME, 2003, BJOG-INT J OBSTET GY, V110, P378, DOI 10.1016/S1470-0328(02)02076-1; Beuls EAM, 2003, J NEUROSURG, V98, P210, DOI 10.3171/spi.2003.98.2.0210; Breeze ACG, 2006, ULTRASOUND OBST GYN, V28, P918, DOI 10.1002/uog.3886; Brookes JAS, 1996, LANCET, V348, P1139, DOI 10.1016/S0140-6736(96)02287-8; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Cohen MC, 2008, PEDIATR DEVEL PATHOL, V11, P1, DOI 10.2350/07-01-0213.1; Corabian P, 2007, J OBSTET GYNAECOL CA, V29, P560, DOI 10.1016/S1701-2163(16)32500-2; CURRY CJR, 1992, PEDIATR CLIN N AM, V39, P157; Dickinson JE, 2007, AUST NZ J OBSTET GYN, V47, P445, DOI 10.1111/j.1479-828X.2007.00777.x; Driehuys B, 2008, ILAR J, V49, P35, DOI 10.1093/ilar.49.1.35; Griffiths PD, 2005, LANCET, V365, P1271, DOI 10.1016/S0140-6736(05)74816-9; Griffiths PD, 2003, AM J NEURORADIOL, V24, P22; Khong TY, 2006, J PAEDIATR CHILD H, V42, P366, DOI 10.1111/j.1440-1754.2006.00874.x; Lavanya T, 2008, Br J Radiol, V81, pe242, DOI 10.1259/bjr/77399621; Maroun LL, 2005, PEDIATR DEVEL PATHOL, V8, P204, DOI 10.1007/s10024-004-7084-0; MCROBBIE DW, 2007, MRI PICTURE PROTON, P66; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; Petiet AE, 2008, P NATL ACAD SCI USA, V105, P12331, DOI 10.1073/pnas.0805747105; Picone O, 2008, PRENATAL DIAG, V28, P191, DOI 10.1002/pd.1952; Sankar VH, 2006, J PERINATOL, V26, P224, DOI 10.1038/sj.jp.7211482; Schneider JE, 2003, J MOL CELL CARDIOL, V35, P217, DOI 10.1016/S0022-2828(02)00291-2; Scholtes F, 2006, NEUROSURGERY, V59, P671, DOI 10.1227/01.NEU.0000228929.15492.A9; Thayyil S, 2009, ARCH DIS CHILD, V94, P354, DOI 10.1136/adc.2008.150904; THAYYIL S, 2009, EUR J RADIOL, DOI DOI 10.1016/J.EJRAD.2008.07013; Thayyil S, 2008, LANCET, V372, P715, DOI 10.1016/S0140-6736(08)61298-2; Whitby EH, 2005, SEMIN FETAL NEONAT M, V10, P475, DOI 10.1016/j.siny.2005.05.006; WYNENBACH R, 2003, RADIOLOGY, V227, P261; 2006, LANCET, V367, P1460; 2007, LANCET, V369, P1404	30	96	98	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 8	2009	374	9688					467	475		10.1016/S0140-6736(09)60913-2	http://dx.doi.org/10.1016/S0140-6736(09)60913-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482OK	19665645	Bronze			2022-12-28	WOS:000268898400028
J	Wu, P; de Lange, T				Wu, Peng; de Lange, Titia			Human Telomerase caught in the Act	CELL			English	Editorial Material							LENGTH	Based on prior work, it was expected that telomerase would preferentially elongate the shortest telomeres in a cell, extending the telomeric G-rich strand through a process that is coupled to the synthesis of the complementary strand. Contrary to this view, Zhao et al. (2009) now show that telomerase in human cancer cells extends most telomeres during every S phase and that complementary strand synthesis does not immediately follow telomerase action.	[Wu, Peng; de Lange, Titia] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Wu, P (corresponding author), Rockefeller Univ, New York, NY 10065 USA.	pwu01@mail.rockefeller.edu; delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; Wu, Peng/0000-0001-6565-0002	NIGMS NIH HHS [T32 GM007739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Fan XQ, 1997, MOL BIOL CELL, V8, P2145, DOI 10.1091/mbc.8.11.2145; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357	8	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					432	434		10.1016/j.cell.2009.07.018	http://dx.doi.org/10.1016/j.cell.2009.07.018			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665967	Bronze			2022-12-28	WOS:000268771900009
J	Farmer, JD; Foley, D				Farmer, J. Doyne; Foley, Duncan			The economy needs agent-based modelling	NATURE			English	Editorial Material									[Farmer, J. Doyne; Foley, Duncan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Farmer, J. Doyne] LUISS Guido Carli Rome, Rome, Italy; [Foley, Duncan] New Sch Social Res, New York, NY 10003 USA	The Santa Fe Institute; Luiss Guido Carli University; The New School	Farmer, JD (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	jdf@santafe.edu; foleyd@newschool.edu						Bouchaud JP, 2008, NATURE, V455, P1181, DOI 10.1038/4551181a; 2009, NATURE, V457, P957	2	633	657	5	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					685	686		10.1038/460685a	http://dx.doi.org/10.1038/460685a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479OO	19661896	Green Submitted			2022-12-28	WOS:000268670300020
J	Glazebrook, K				Glazebrook, Karl			GALAXY FORMATION Too small to ignore	NATURE			English	Editorial Material							ELLIPTIC GALAXIES; MASSIVE GALAXIES; COMPACT; EVOLUTION; UNIVERSE		Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia	Swinburne University of Technology	Glazebrook, K (corresponding author), Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia.	karl@astro.swin.edu.au	Glazebrook, Karl/N-3488-2015	Glazebrook, Karl/0000-0002-3254-9044				Abraham RG, 2007, ASTROPHYS J, V669, P184, DOI 10.1086/521138; Bezanson R, 2009, ASTROPHYS J, V697, P1290, DOI 10.1088/0004-637X/697/2/1290; Boylan-Kolchin M, 2006, MON NOT R ASTRON SOC, V369, P1081, DOI 10.1111/j.1365-2966.2006.10379.x; Cimatti A, 2004, NATURE, V430, P184, DOI 10.1038/nature02668; Damjanov I, 2009, ASTROPHYS J, V695, P101, DOI 10.1088/0004-637X/695/1/101; De Lucia G, 2006, MON NOT R ASTRON SOC, V366, P499, DOI 10.1111/j.1365-2966.2005.09879.x; Fan L, 2008, ASTROPHYS J LETT, V689, pL101, DOI 10.1086/595784; Cenarro AJ, 2009, ASTROPHYS J LETT, V696, pL43, DOI 10.1088/0004-637X/696/1/L43; Kriek M, 2009, ASTROPHYS J, V700, P221, DOI 10.1088/0004-637X/700/1/221; Trujillo I, 2009, ASTROPHYS J LETT, V692, pL118, DOI 10.1088/0004-637X/692/2/L118; van Dokkum PG, 2006, ASTROPHYS J, V638, pL59, DOI 10.1086/501045; van Dokkum PG, 2009, NATURE, V460, P717, DOI 10.1038/nature08220	12	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					694	695		10.1038/460694a	http://dx.doi.org/10.1038/460694a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661904				2022-12-28	WOS:000268670300026
J	Watts, JM; Dang, KK; Gorelick, RJ; Leonard, CW; Bess, JW; Swanstrom, R; Burch, CL; Weeks, KM				Watts, Joseph M.; Dang, Kristen K.; Gorelick, Robert J.; Leonard, Christopher W.; Bess, Julian W., Jr.; Swanstrom, Ronald; Burch, Christina L.; Weeks, Kevin M.			Architecture and secondary structure of an entire HIV-1 RNA genome	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; CONTEXT-FREE GRAMMARS; REVERSE TRANSCRIPTION; THERMODYNAMIC PARAMETERS; STRUCTURE PREDICTION; PROTEIN EXPRESSION; CODING REGIONS	Single-stranded RNA viruses encompass broad classes of infectious agents and cause the common cold, cancer, AIDS and other serious health threats. Viral replication is regulated at many levels, including the use of conserved genomic RNA structures. Most potential regulatory elements in viral RNA genomes are uncharacterized. Here we report the structure of an entire HIV-1 genome at single nucleotide resolution using SHAPE, a high-throughput RNA analysis technology. The genome encodes protein structure at two levels. In addition to the correspondence between RNA and protein primary sequences, a correlation exists between high levels of RNA structure and sequences that encode inter-domain loops in HIV proteins. This correlation suggests that RNA structure modulates ribosome elongation to promote native protein folding. Some simple genome elements previously shown to be important, including the ribosomal gag-pol frameshift stem-loop, are components of larger RNA motifs. We also identify organizational principles for unstructured RNA regions, including splice site acceptors and hypervariable regions. These results emphasize that the HIV-1 genome and, potentially, many coding RNAs are punctuated by previously unrecognized regulatory motifs and that extensive RNA structure constitutes an important component of the genetic code.	[Watts, Joseph M.; Leonard, Christopher W.; Weeks, Kevin M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Dang, Kristen K.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Swanstrom, Ronald] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA; [Burch, Christina L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Gorelick, Robert J.; Bess, Julian W., Jr.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21702 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Weeks, KM (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	weeks@unc.edu		Dang, Kristen/0000-0002-7512-4476; Burch, Christina/0000-0001-7830-0124	US National Institutes of Health [AI068462]; National Cancer Institute [N01-CO-12400, HHSN261200800001E]; National Institutes of Health (NIH) [AI44667, T32 AI07419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044667, R01AI044667, R56AI044667, R01AI068462, T32AI007419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064803] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the US National Institutes of Health (AI068462 to K. M. W.) and by the National Cancer Institute, under contracts N01-CO-12400 and HHSN261200800001E (to R. J. G. and J. W. B.). J. M. W. was supported as a Fellow of the UNC Lineberger Cancer Center and a National Institutes of Health (NIH) Kirschstein Postdoctoral Fellowship. R. S. and K. K. D. were supported by NIH grants AI44667 and T32 AI07419, respectively. We are indebted to D. Mathews and J. Low for assistance with the RNA structure program and genome secondary structure analysis, respectively. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations indicate endorsement by the US Government.	Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Badorrek CS, 2006, BIOCHEMISTRY-US, V45, P12664, DOI 10.1021/bi060521k; Badorrek CS, 2005, NAT CHEM BIOL, V1, P104, DOI 10.1038/nchembio712; Biswas P, 2004, J VIROL, V78, P2082, DOI 10.1128/JVI.78.4.2082-2087.2004; Buckman JS, 2003, J VIROL, V77, P1469, DOI 10.1128/JVI.77.2.1469-1480.2003; CANN AJ, 2005, PRINCIPLES MOL VIROL, pCH2; Chang TH, 2008, NUCLEIC ACIDS RES, V36, pW91, DOI 10.1093/nar/gkn258; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Cline AN, 2005, J MED PRIMATOL, V34, P303; Coffin J, 1997, RETROVIRUSES; Damgaard CK, 2004, J MOL BIOL, V336, P369, DOI 10.1016/j.jmb.2003.12.010; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Dowell RD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-71; Durbin R., 1998, BIOL SEQUENCE ANAL, DOI [10.1017/cbo9780511790492, DOI 10.1017/CBO9780511790492]; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Gherghe CM, 2008, J AM CHEM SOC, V130, P12244, DOI 10.1021/ja804541s; Giedroc DP, 2000, J MOL BIOL, V298, P167, DOI 10.1006/jmbi.2000.3668; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEITNER T, 2005, HIV SEQUENCE COMPEND; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Means RE, 2001, J VIROL, V75, P3903, DOI 10.1128/JVI.75.8.3903-3915.2001; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; OLSEN HS, 1990, SCIENCE, V247, P845, DOI 10.1126/science.2406903; OTT DE, 1995, AIDS RES HUM RETROV, V11, P1003, DOI 10.1089/aid.1995.11.1003; Paillart JC, 2002, J BIOL CHEM, V277, P5995, DOI 10.1074/jbc.M108972200; Pedersen JS, 2004, NUCLEIC ACIDS RES, V32, P4925, DOI 10.1093/nar/gkh839; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; *R DEV CORE TEAM, 2008, R FDN STAT COMPUTING; STEIN BS, 1990, J BIOL CHEM, V265, P2640; Thomas JA, 2006, VIROLOGY, V353, P41, DOI 10.1016/j.virol.2006.05.014; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilkinson KA, 2009, RNA, V15, P1314, DOI 10.1261/rna.1536209; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425	52	581	601	0	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					711	U87		10.1038/nature08237	http://dx.doi.org/10.1038/nature08237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661910	Green Accepted, Green Submitted			2022-12-28	WOS:000268670300032
J	Peleg, K; Kellermann, AL				Peleg, Kobi; Kellermann, Arthur L.			Enhancing Hospital Surge Capacity for Mass Casualty Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kellermann, Arthur L.] Emory Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Peleg, Kobi] Tel Aviv Univ, Sch Publ Hlth, Disaster Med Dept, IL-69978 Tel Aviv, Israel; [Peleg, Kobi] Gertner Inst Hlth Policy & Epidemiol, Natl Ctr Trauma & Emergency Med Res, Tel Hashomer, Israel	Emory University; Tel Aviv University	Kellermann, AL (corresponding author), Emory Sch Med, Dept Emergency Med, 1648 Pierce Dr NE,Ste 445, Atlanta, GA 30322 USA.	akell01@emory.edu						Bloch YH, 2007, PREHOSP DISASTER MED, V22, P186, DOI 10.1017/S1049023X00004635; *GOV ACC OFF, 2009 C PRES TRANS; GROSSMAN JM, 2008, 2 CTR STUD HLTH SYST; Hogan DE, 1999, ANN EMERG MED, V34, P160, DOI 10.1016/S0196-0644(99)70224-6; Institute of Medicine Committee on the Future of Emergency Care in the U. S. Health System, 2006, PED EM CAR GROW PAIN; Institute of Medicine Committee on the Future of Emergency Care in the United States Health System, 2006, EM MED SERV CROSSR; Institute of Medicine Committee on the Future of Emergency Care in the United States Health System, 2006, HOSP BAS EM CAR BREA; *ISR MIN HLTH, 1976, SAH COMM HOSP PREP; Kaji AH, 2007, JAMA-J AM MED ASSOC, V298, P2188, DOI 10.1001/jama.298.18.2188; Kluger Y, 2004, EUR J EMERG MED, V11, P329, DOI 10.1097/00063110-200412000-00006; MARCUS L, ANAL IS OBAMA READY; *MIN HLTH, 2006, 00535006 MIN HLTH; National Center for Injury Prevention and Control, 2007, MOM NOT SURG CAP TER; SALINSKY E, 65 NAT HLTH POL FOR; US House of Representatives, 2008, HOSP EM SURG CAP NOT	15	37	39	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					565	567		10.1001/jama.2009.1119	http://dx.doi.org/10.1001/jama.2009.1119			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479DS	19654391				2022-12-28	WOS:000268640500021
J	Sonis, J; Gibson, JL; de Jong, JTVM; Field, NP; Hean, S; Komproe, I				Sonis, Jeffrey; Gibson, James L.; de Jong, Joop T. V. M.; Field, Nigel P.; Hean, Sokhom; Komproe, Ivan			Probable Posttraumatic Stress Disorder and Disability in Cambodia Associations With Perceived Justice, Desire for Revenge, and Attitudes Toward the Khmer Rouge Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MENTAL-HEALTH; TRAUMA; REFUGEES; FEELINGS; WAR	Context Millions of Cambodians suffered profound trauma during the Khmer Rouge era (1975 to 1979). A joint United Nations-Cambodian tribunal (the "Khmer Rouge trials") was empanelled in 2006 to prosecute top Khmer Rouge leaders and began substantive hearings in March 2009. Objectives To establish the prevalence of probable posttraumatic stress disorder (PTSD) among adult Cambodians and to assess correlates of PTSD symptoms and disability with perceived justice, desire for revenge, and knowledge of and attitudes toward the trials. Design, Setting, and Participants A national probability sample of 1017 Cambodians was assembled using a multistage, stratified cluster design, including 813 adults older than 35 years who had been at least 3 years old during the Khmer Rouge era and 204 adults aged 18 to 35 years who had not been exposed to the Khmer Rouge era. Face-to-face interviews were conducted between December 2006 and August 2007. Main Outcome Measures Prevalence of probable PTSD using the PTSD Checklist, Civilian version (cutoff score of 44), and mental and physical disability using the Medical Outcomes Study 12-item Short Form Health Survey. Results The prevalence of current probable PTSD was 11.2% (95% confidence interval [CI], 8.6%-13.9%) overall and 7.9% ( 95% CI, 3.8%-12.0%) among the younger group and 14.2% ( 95% CI, 11.0%-17.3%) in the older group. Probable PTSD was significantly associated with mental disability (40.2% vs 7.9%; adjusted odds ratio [AOR], 7.80; 95% CI, 3.90-15.60) and physical disability (39.6% vs 20.1%; AOR, 2.60; 95% CI, 1.26-5.39). Although Cambodians were hopeful that the trials would promote justice, 87.2% (n=681) of those older than 35 years believed that the trials would create painful memories for them. In multivariate analysis, respondents with high levels of perceived justice for violations during the Khmer Rouge era were less likely to have probable PTSD than those with low levels (7.4% vs 12.7%; AOR, 0.54; 95% CI, 0.34-0.86). Respondents with high levels of desire for revenge were more likely to have probable PTSD than those with low levels (12.0% vs 7.2%), but the difference was not statistically significant in the multivariate analysis (AOR, 1.76; 95% CI, 0.99-3.11). Conclusions Probable PTSD is common and associated with disability in Cambodia. Although Cambodians had positive attitudes toward the trials, most were concerned that the trials would bring back painful memories. Now that the trials have begun, longitudinal research is needed to determine the impact of the trials on Cambodians' mental health. JAMA. 2009;302(5):527-536 www.jama.com	[Sonis, Jeffrey] Univ N Carolina, Dept Social Med, Sch Med, Chapel Hill, NC 27599 USA; [Gibson, James L.] Washington Univ, St Louis, MO USA; [de Jong, Joop T. V. M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Field, Nigel P.] Pacific Grad Sch Psychol, Palo Alto, CA USA; [Hean, Sokhom] Ctr Adv Study, Phnom Penh, Cambodia; [Komproe, Ivan] HealthNet TPO, Amsterdam, Netherlands; [Gibson, James L.] Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa; [de Jong, Joop T. V. M.] Boston Univ, Sch Med, Boston, MA 02118 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Washington University (WUSTL); Vrije Universiteit Amsterdam; Stellenbosch University; Boston University	Sonis, J (corresponding author), Univ N Carolina, Dept Social Med, Sch Med, CB 7240, Chapel Hill, NC 27599 USA.	jsonis@med.unc.edu	Gibson, James/AAF-6703-2020; Komproe, Ivan/AAJ-8699-2021		United States Institute of Peace [USIP-094-06S]	United States Institute of Peace	This study was supported by grant USIP-094-06S from the United States Institute of Peace.	Adams RE, 2006, SOC SCI MED, V62, P176, DOI 10.1016/j.socscimed.2005.05.008; Basoglu M, 2005, JAMA-J AM MED ASSOC, V294, P580, DOI 10.1001/jama.294.5.580; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Cardozo BL, 2003, J TRAUMA STRESS, V16, P351, DOI 10.1023/A:1024413918346; *CDCP, 2004, EP VERS 3 3 2 COMP P; Chandler David, 2000, HIST CAMBODIA; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Fawthrop T., 2004, GETTING AWAY GENOCID; Field NP, 2008, J LOSS TRAUMA, V13, P352, DOI 10.1080/15325020701742086; Friedman Merle, 2000, PL S STRESS, P399; Gibson James., 2004, OVERCOMING APARTHEID; GROVES RM, 2004, SURV METHODOL, P182; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kiernan B., 2002, POL POT REGIME RACE; Kish L, 1965, SURVEY SAMPLING; Korn EL., 1999, ANAL HLTH SURVEYS; LOHR S, 1999, SAMPLING DESIGN ANAL, P42; LOHR S, 1999, SAMPLING DESIGN ANAL, P221; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; McCullough ME, 2003, J PERS SOC PSYCHOL, V84, P540, DOI 10.1037/0022-3514.84.3.540; McCullough ME, 1998, J PERS SOC PSYCHOL, V75, P1586, DOI 10.1037/0022-3514.75.6.1586; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; MYDANS S, 2006, NY TIMES        0216, pA4; MYDANS S, 2006, NY TIMES        0123, pA6; *NAT I STAT KINGD, 2002, GEN POP CENS 1998 FI; Norris F. H., 2004, ASSESSING PSYCHOL TR, P63; Orth U, 2006, J INTERPERS VIOLENCE, V21, P229, DOI 10.1177/0886260505282286; Orth U, 2004, J INTERPERS VIOLENCE, V19, P212, DOI 10.1177/0886260503260326; Ouimette P, 2004, J NERV MENT DIS, V192, P563, DOI 10.1097/01.nmd.0000135650.71761.0b; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; RAO JNK, 1981, J AM STAT ASSOC, V76, P221, DOI 10.2307/2287815; Steel Z, 2005, ACTA PSYCHIAT SCAND, V111, P300, DOI 10.1111/j.1600-0447.2004.00458.x; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; CAMBODIAN INTERCENSA	38	76	76	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					527	536		10.1001/jama.2009.1085	http://dx.doi.org/10.1001/jama.2009.1085			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479DS	19654387	Bronze			2022-12-28	WOS:000268640500017
J	Peterson, LR; Robicsek, A				Peterson, Lance R.; Robicsek, Ari			Does My Patient Have Clostridium difficile Infection?	ANNALS OF INTERNAL MEDICINE			English	Article							REAL-TIME PCR; ENZYME-IMMUNOASSAY; TOXIN-A; MULTICENTER EVALUATION; HOSPITALIZED-PATIENTS; LABORATORY DETECTION; LATEX AGGLUTINATION; FECAL SPECIMENS; CYTOTOXIN ASSAY; DIARRHEA	Clostridium difficile infection (CDI) seems to be changing-with increasing virulence and incidence, more resistance to metronidazole, and worse outcomes. Accurate diagnosis is critical, but 3 common misconceptions lead to misdiagnosis: Clostridium difficile infection is a possibility when the patient has fewer than 3 loose stools per day; the glutamate dehydrogenase test for CDI is sensitive and thus is a good initial test; and repeating an insensitive laboratory test for CDI is useful. These misconceptions can lead to missed diagnoses (for example, when tests with low sensitivity are used) and to false diagnoses (for example, when tests are done in patients who are unlikely to have CDI because they have minimal diarrhea or negative results on recent tests). Diagnoses of CDI will be more accurate if clinicians use tests with a higher sensitivity, reduce the frequency of testing for a single episode of diarrhea, and give more attention to key elements of the patient's history.	[Peterson, Lance R.] NorthShore Univ HealthSyst, Dept Pathol & Lab Med, Evanston, IL 60201 USA; Northwestern Univ, Evanston, IL USA	NorthShore University Health System; Northwestern University	Peterson, LR (corresponding author), NorthShore Univ HealthSyst, Dept Pathol & Lab Med, Walgreen SB525,2650 Ridge Ave, Evanston, IL 60201 USA.	lancer@northwestern.edu						Aichinger E, 2008, J CLIN MICROBIOL, V46, P3795, DOI 10.1128/JCM.00684-08; Al-Nassir WN, 2008, CLIN INFECT DIS, V47, P56, DOI 10.1086/588293; Alcala L, 2008, J CLIN MICROBIOL, V46, P3833, DOI 10.1128/JCM.01060-08; *COLL AM PATH, 2008, D B BACT SAMPL D 13, P9; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; Gilligan PH, 2008, J CLIN MICROBIOL, V46, P1523, DOI 10.1128/JCM.02100-07; Johnson S, 2001, ANN INTERN MED, V135, P434, DOI 10.7326/0003-4819-135-6-200109180-00012; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Kato H, 1998, J CLIN MICROBIOL, V36, P2178, DOI 10.1128/JCM.36.8.2178-2182.1998; Katz DA, 1996, AM J MED, V100, P487, DOI 10.1016/S0002-9343(95)00016-X; Katz DA, 1997, J GEN INTERN MED, V12, P57; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; MANABE YC, 1995, ANN INTERN MED, V123, P835, DOI 10.7326/0003-4819-123-11-199512010-00004; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; MUNDY LS, 1995, AM J CLIN PATHOL, V103, P52, DOI 10.1093/ajcp/103.1.52; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Peterson LR, 2007, CLIN INFECT DIS, V45, P1152, DOI 10.1086/522185; PETERSON LR, 1986, AM J CLIN PATHOL, V86, P208, DOI 10.1093/ajcp/86.2.208; Peterson LR, 1996, EUR J CLIN MICROBIOL, V15, P330, DOI 10.1007/BF01695667; PETERSON LR, 1987, AM J CLIN PATHOL, V87, P298, DOI 10.1093/ajcp/87.2.298; PETERSON LR, 2001, SEMINARS INFECT CONT, V1, P172; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Reller ME, 2007, J CLIN MICROBIOL, V45, P3601, DOI 10.1128/JCM.01305-07; Sloan LM, 2008, J CLIN MICROBIOL, V46, P1996, DOI 10.1128/JCM.00032-08; Snell H, 2004, J CLIN MICROBIOL, V42, P4863, DOI 10.1128/JCM.42.10.4863-4865.2004; Stamper PD, 2009, J CLIN MICROBIOL, V47, P373, DOI 10.1128/JCM.01613-08; Staneck JL, 1996, J CLIN MICROBIOL, V34, P2718, DOI 10.1128/JCM.34.11.2718-2721.1996; Stoddart B, 2002, CURR OPIN INFECT DIS, V15, P513, DOI 10.1097/00001432-200210000-00010; Zheng L, 2004, J CLIN MICROBIOL, V42, P3837, DOI 10.1128/JCM.42.8.3837-3840.2004	29	86	89	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					176	W41		10.7326/0003-4819-151-3-200908040-00005	http://dx.doi.org/10.7326/0003-4819-151-3-200908040-00005			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19652187				2022-12-28	WOS:000268947800004
J	Duke, T				Duke, Trevor			Child survival and IMCI: in need of sustained global support	LANCET			English	Editorial Material							COUNTRIES; MORTALITY		[Duke, Trevor] Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, MCRI, Parkville, Vic 3052, Australia; [Duke, Trevor] Univ Papua New Guinea, Sch Med, Port Moresby, Papua N Guinea	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Papua New Guinea	Duke, T (corresponding author), Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, MCRI, Flemington Rd, Parkville, Vic 3052, Australia.	trevor.duke@rch.org.au						Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Johns B, 2007, B WORLD HEALTH ORGAN, V85, P256, DOI 10.2471/BLT.06.032037; Rutherford ME, 2009, B WORLD HEALTH ORGAN, V87, P216, DOI 10.2471/BLT.08.052175; Schell CO, 2007, SCAND J PUBLIC HEALT, V35, P288, DOI 10.1080/14034940600979171; Stenberg K, 2007, B WORLD HEALTH ORGAN, V85, P305, DOI 10.2471/BLT.06.032052	6	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 1	2009	374	9687					361	362		10.1016/S0140-6736(09)61396-9	http://dx.doi.org/10.1016/S0140-6736(09)61396-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481MJ	19647594				2022-12-28	WOS:000268815200005
J	Stafford, RS; Wagner, TH; Lavori, PW				Stafford, Randall S.; Wagner, Todd H.; Lavori, Philip W.			New, but Not Improved? Incorporating Comparative-Effectiveness Information into FDA Labeling	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Stafford, Randall S.] Stanford Univ, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA; [Wagner, Todd H.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Wagner, Todd H.; Lavori, Philip W.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Stafford, RS (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA.		; Stafford, Randall/F-3974-2017	Wagner, Todd/0000-0001-7625-3504; Stafford, Randall/0000-0003-1805-1271	NHLBI NIH HHS [K24 HL086703] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL086703] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2001, GUID IND E 10 CHOIC; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Hamburg MA, 2009, NEW ENGL J MED, V360, P2493, DOI 10.1056/NEJMp0903764; Schuber S, 2006, ANN INTERN MED, V145, P448, DOI 10.7326/0003-4819-145-6-200609190-00008; Sisko A, 2009, HEALTH AFFAIR, V28, pW346, DOI 10.1377/hlthaff.28.2.w346	5	57	58	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1230	1233		10.1056/NEJMp0906490	http://dx.doi.org/10.1056/NEJMp0906490			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497RN	19675326				2022-12-28	WOS:000270078700003
J	Yun, JY; Rago, C; Cheong, I; Pagliarini, R; Angenendt, P; Rajagopalan, H; Schmidt, K; Willson, JKV; Markowitz, S; Zhou, SB; Diaz, LA; Velculescu, VE; Lengauer, C; Kinzler, KW; Vogelstein, B; Papadopoulos, N				Yun, Jihye; Rago, Carlo; Cheong, Ian; Pagliarini, Ray; Angenendt, Philipp; Rajagopalan, Harith; Schmidt, Kerstin; Willson, James K. V.; Markowitz, Sandy; Zhou, Shibin; Diaz, Luis A., Jr.; Velculescu, Victor E.; Lengauer, Christoph; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas			Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells	SCIENCE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; POSITRON-EMISSION-TOMOGRAPHY; MESSENGER-RNA; CANCER-CELLS; COLON-CANCER; COLORECTAL CARCINOMAS; MISMATCH-REPAIR; RAS; METABOLISM; TRANSPORT	Tumor progression is driven by genetic mutations, but little is known about the environmental conditions that select for these mutations. Studying the transcriptomes of paired colorectal cancer cell lines that differed only in the mutational status of their KRAS or BRAF genes, we found that GLUT1, encoding glucose transporter-1, was one of three genes consistently up-regulated in cells with KRAS or BRAF mutations. The mutant cells exhibited enhanced glucose uptake and glycolysis and survived in low-glucose conditions, phenotypes that all required GLUT1 expression. In contrast, when cells with wild-type KRAS alleles were subjected to a low-glucose environment, very few cells survived. Most surviving cells expressed high levels of GLUT1, and 4% of these survivors had acquired KRAS mutations not present in their parents. The glycolysis inhibitor 3-bromopyruvate preferentially suppressed the growth of cells with KRAS or BRAF mutations. Together, these data suggest that glucose deprivation can drive the acquisition of KRAS pathway mutations in human tumors.	[Yun, Jihye; Rago, Carlo; Cheong, Ian; Pagliarini, Ray; Angenendt, Philipp; Rajagopalan, Harith; Schmidt, Kerstin; Zhou, Shibin; Diaz, Luis A., Jr.; Velculescu, Victor E.; Lengauer, Christoph; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Yun, Jihye; Rago, Carlo; Cheong, Ian; Pagliarini, Ray; Angenendt, Philipp; Rajagopalan, Harith; Schmidt, Kerstin; Zhou, Shibin; Diaz, Luis A., Jr.; Velculescu, Victor E.; Lengauer, Christoph; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Willson, James K. V.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Markowitz, Sandy] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Markowitz, Sandy] Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA; [Markowitz, Sandy] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Markowitz, Sandy] Howard Hughes Med Inst, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Howard Hughes Medical Institute	Vogelstein, B (corresponding author), Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	vogelbe@jhmi.edu	Papadopoulos, Nickolas/K-7272-2012; Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X; Cheong, Ian/0000-0002-3062-6878; Diaz, Luis/0000-0002-7079-8914	NIH [CA43460, CA62924]; the Johns Hopkins University; Genzyme Molecular Oncology; Novartis; Wyeth; Amgen; Glaxo-Smith-Kline; Horizon; NATIONAL CANCER INSTITUTE [R37CA043460, P50CA062924, R01CA043460] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); the Johns Hopkins University; Genzyme Molecular Oncology(Sanofi-AventisGenzyme Corporation); Novartis(Novartis); Wyeth(Wyeth); Amgen(Amgen); Glaxo-Smith-Kline(GlaxoSmithKline); Horizon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Y. He for helpful discussions, W. Yu for help with the microarray experiments, and E. Watson for expert technical assistance. This work was supported by the Virginia and D. K. Ludwig Fund for Cancer Research and NIH grants CA43460 and CA62924. Under agreements between the Johns Hopkins University, Genzyme Molecular Oncology, Novartis, Wyeth, Amgen, Glaxo-Smith-Kline, and Horizon, J. Y., V. E. V., H. R., R. P., C. L., K. W. K., B. V., and N. P. are entitled to a share of the royalties and licensing fees received by the university on cell lines described in this paper, some of which are the subject of patent applications. The Johns Hopkins University and V. E. V., K. W. K., and B. V. also own stock in Genzyme, which is subject to certain restrictions under university policy. The terms of these arrangements are being managed by the university in accordance with its conflict of interest policies.	Abdel-Nabi H, 1998, RADIOLOGY, V206, P755, DOI 10.1148/radiology.206.3.9494497; Airley R, 2001, CLIN CANCER RES, V7, P928; Airley RE, 2007, CHEMOTHERAPY, V53, P233, DOI 10.1159/000104457; Blum R, 2005, CANCER RES, V65, P999; BOS JL, 1989, CANCER RES, V49, P4682; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Dang DT, 2006, CANCER RES, V66, P1684, DOI 10.1158/0008-5472.CAN-05-2887; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delbeke D, 1997, J NUCL MED, V38, P1196; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Gu J, 2006, DIGEST DIS SCI, V51, P2198, DOI 10.1007/s10620-006-9428-2; HAUSDORFF SF, 1994, J BIOL CHEM, V269, P21391; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kim JW, 2007, CANCER METAST REV, V26, P291, DOI 10.1007/s10555-007-9060-4; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Lin J, 2007, GENOME RES, V17, P1304, DOI 10.1101/gr.6431107; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Noguchi Y, 2000, CANCER LETT, V154, P137, DOI 10.1016/S0304-3835(00)00354-2; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Sakashita M, 2001, EUR J CANCER, V37, P204, DOI 10.1016/S0959-8049(00)00371-3; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; van Kouwen MCA, 2005, J CLIN ONCOL, V23, P3713, DOI 10.1200/JCO.2005.02.401; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yasuda S, 2001, J NUCL MED, V42, P989; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang JZ, 1999, AM J KIDNEY DIS, V34, P189, DOI 10.1016/S0272-6386(99)70131-9	40	649	672	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1555	1559		10.1126/science.1174229	http://dx.doi.org/10.1126/science.1174229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19661383	Green Accepted			2022-12-28	WOS:000269887900044
J	Abbott, BP; Abbott, R; Acernese, F; Adhikari, R; Ajith, P; Allen, B; Allen, G; Alshourbagy, M; Amin, RS; Anderson, SB; Anderson, WG; Antonucci, F; Aoudia, S; Arain, MA; Araya, M; Armandula, H; Armor, P; Arun, KG; Aso, Y; Aston, S; Astone, P; Aufmuth, P; Aulbert, C; Babak, S; Baker, P; Ballardin, G; Ballmer, S; Barker, C; Barker, D; Barone, F; Barr, B; Barriga, P; Barsotti, L; Barsuglia, M; Barton, MA; Bartos, I; Bassiri, R; Bastarrika, M; Bauer, TS; Behnke, B; Beker, M; Benacquista, M; Betzwieser, J; Beyersdorf, PT; Bigotta, S; Bilenko, IA; Billingsley, G; Birindelli, S; Biswas, R; Bizouard, MA; Black, E; Blackburn, JK; Blackburn, L; Blair, D; Bland, B; Boccara, C; Bodiya, TP; Bogue, L; Bondu, F; Bonelli, L; Bork, R; Boschi, V; Bose, S; Bosi, L; Braccini, S; Bradaschia, C; Brady, PR; Braginsky, VB; van den Brand, JFJ; Brau, JE; Bridges, DO; Brillet, A; Brinkmann, M; Brisson, V; Van Den Broeck, C; Brooks, AF; Brown, DA; Brummit, A; Brunet, G; Bullington, A; Bulten, HJ; Buonanno, A; Burmeister, O; Buskulic, D; Byer, RL; Cadonati, L; Cagnoli, G; Calloni, E; Camp, JB; Campagna, E; Cannizzo, J; Cannon, KC; Canuel, B; Cao, J; Carbognani, F; Cardenas, L; Caride, S; Castaldi, G; Caudill, S; Cavaglia, M; Cavalier, F; Cavalieri, R; Cella, G; Cepeda, C; Cesarini, E; Chalermsongsak, T; Chalkley, E; Charlton, P; Chassande-Mottin, E; Chatterji, S; Chelkowski, S; Chen, Y; Christensen, N; Chung, CTY; Clark, D; Clark, J; Clayton, JH; Cleva, F; Coccia, E; Cokelaer, T; Colacino, CN; Colas, J; Colla, A; Colombini, M; Conte, R; Cook, D; Corbitt, TRC; Corda, C; Cornish, N; Corsi, A; Coulon, JP; Coward, D; Coyne, DC; Creighton, JDE; Creighton, TD; Cruise, AM; Culter, RM; Cumming, A; Cunningham, L; Cuoco, E; Danilishin, SL; D'Antonio, S; Danzmann, K; Dari, A; Dattilo, V; Daudert, B; Davier, M; Davies, G; Daw, EJ; Day, R; De Rosa, R; Debra, D; Degallaix, J; del Prete, M; Dergachev, V; Desai, S; DeSalvo, R; Dhurandhar, S; Di Fiore, L; Di Lieto, A; Emilio, MD; Di Virgilio, A; Diaz, M; Dietz, A; Donovan, F; Dooley, KL; Doomes, EE; Drago, M; Drever, RWP; Dueck, J; Duke, I; Dumas, JC; Dwyer, JG; Echols, C; Edgar, M; Effler, A; Ehrens, P; Ely, G; Espinoza, E; Etzel, T; Evans, T; Fafone, V; Fairhurst, S; Faltas, Y; Fan, Y; Fazi, D; Fehrmann, H; Ferrante, I; Fidecaro, F; Finn, LS; Fiori, I; Flaminio, R; Flasch, K; Foley, S; Forrest, C; Fotopoulos, N; Fournier, JD; Franc, J; Franzen, A; Frasca, S; Frasconi, F; Frede, M; Frei, M; Frei, Z; Freise, A; Frey, R; Fricke, T; Fritschel, P; Frolov, VV; Fyffe, M; Galdi, V; Gammaitoni, L; Garofoli, JA; Garufi, F; Genin, E; Gennai, A; Gholami, I; Giaime, JA; Giampanis, S; Giardina, KD; Giazotto, A; Goda, K; Goetz, E; Goggin, LM; Gonzalez, G; Gorodetsky, ML; Gosser, S; Gouaty, R; Granata, M; Granata, V; Grant, A; Gras, S; Gray, C; Gray, M; Greenhalgh, RJS; Gretarsson, AM; Greverie, C; Grimaldi, F; Grosso, R; Grote, H; Grunewald, S; Guenther, M; Guidi, G; Gustafson, EK; Gustafson, R; Hage, B; Hallam, JM; Hammer, D; Hammond, GD; Hanna, C; Hanson, J; Harms, J; Harry, GM; Harry, IW; Harstad, ED; Haughian, K; Hayama, K; Heefner, J; Heitmann, H; Hello, P; Heng, IS; Heptonstall, A; Hewitson, M; Hild, S; Hirose, E; Hoak, D; Hodge, KA; Holt, K; Hosken, DJ; Hough, J; Hoyland, D; Huet, D; Hughey, B; Huttner, SH; Ingram, DR; Isogai, T; Ito, M; Ivanov, A; Johnson, B; Johnson, WW; Jones, DI; Jones, G; Jones, R; de la Jordana, LS; Ju, L; Kalmus, P; Kalogera, V; Kandhasamy, S; Kanner, J; Kasprzyk, D; Katsavounidis, E; Kawabe, K; Kawamura, S; Kawazoe, F; Kells, W; Keppel, DG; Khalaidovski, A; Khalili, FY; Khan, R; Khazanov, E; King, P; Kissel, JS; Klimenko, S; Kokeyama, K; Kondrashov, V; Kopparapu, R; Koranda, S; Kozak, D; Krishnan, B; Kumar, R; Kwee, P; La Penna, P; Lam, PK; Landry, M; Lantz, B; Laval, M; Lazzarini, A; Lei, H; Lei, M; Leindecker, N; Leonor, I; Leroy, N; Letendre, N; Li, C; Lin, H; Lindquist, PE; Littenberg, B; Lockerbie, NA; Lodhia, D; Longo, M; Lorenzini, M; Loriette, V; Lormand, M; Losurdo, G; Lu, P; Lubinski, M; Lucianetti, A; Luck, H; Machenschalk, B; MacInnis, M; Mackowski, JM; Mageswaran, M; Mailand, K; Majorana, E; Man, N; Mandel, I; Mandic, V; Mantovani, M; Marchesoni, F; Marion, F; Marka, S; Marka, Z; Markosyan, A; Markowitz, J; Maros, E; Marque, J; Martelli, F; Martin, IW; Martin, RM; Marx, JN; Mason, K; Masserot, A; Matichard, F; Matone, L; Matzner, RA; Mavalvala, N; McCarthy, R; McClelland, DE; McGuire, SC; McHugh, M; McIntyre, G; McKechan, DJA; McKenzie, K; Mehmet, M; Melatos, A; Melissinos, AC; Mendell, G; Menendez, DF; Menzinger, F; Mercer, RA; Meshkov, S; Messenger, C; Meyer, MS; Michel, C; Milano, L; Miller, J; Minelli, J; Minenkov, Y; Mino, Y; Mitrofanov, VP; Mitselmakher, G; Mittleman, R; Miyakawa, O; Moe, B; Mohan, M; Mohanty, SD; Mohapatra, SRP; Moreau, J; Moreno, G; Morgado, N; Morgia, A; Morioka, T; Mors, K; Mosca, S; Mossavi, K; Mours, B; MowLowry, C; Mueller, G; Muhammad, D; zur Muhlen, H; Mukherjee, S; Mukhopadhyay, H; Mullavey, A; Muller-Ebhardt, H; Munch, J; Murray, PG; Myers, E; Myers, J; Nash, T; Nelson, J; Neri, I; Newton, G; Nishizawa, A; Nocera, F; Numata, K; Ochsner, E; O'Dell, J; Ogin, GH; O'Reilly, B; O'Shaughnessy, R; Ottaway, DJ; Ottens, RS; Overmier, H; Owen, BJ; Pagliaroli, G; Palomba, C; Pan, Y; Pankow, C; Paoletti, F; Papa, MA; Parameshwaraiah, V; Pardi, S; Pasqualetti, A; Passaquieti, R; Passuello, D; Patel, P; Pedraza, M; Penn, S; Perreca, A; Persichetti, G; Pichot, M; Piergiovanni, F; Pierro, V; Pinard, L; Pinto, IM; Pitkin, M; Pletsch, HJ; Plissi, MV; Poggiani, R; Postiglione, F; Principe, M; Prix, R; Prodi, GA; Prokhorov, L; Punken, O; Punturo, M; Puppo, P; Van der Putten, S; Quetschke, V; Raab, FJ; Rabaste, O; Rabeling, DS; Radkins, H; Raffai, P; Raics, Z; Rainer, N; Rakhmanov, M; Rapagnani, P; Raymond, V; Re, V; Reed, CM; Reed, T; Regimbau, T; Rehbein, H; Reid, S; Reitze, DH; Ricci, F; Riesen, R; Riles, K; Rivera, B; Roberts, P; Robertson, NA; Robinet, F; Robinson, C; Robinson, EL; Rocchi, A; Roddy, S; Rolland, L; Rollins, J; Romano, JD; Romano, R; Romie, JH; Rover, C; Rowan, S; Rudiger, A; Ruggi, P; Russell, P; Ryan, K; Sakata, S; Salemi, F; Sandberg, V; Sannibale, V; Santamaria, L; Saraf, S; Sarin, P; Sassolas, B; Sathyaprakash, BS; Sato, S; Satterthwaite, M; Saulson, PR; Savage, R; Savov, P; Scanlan, M; Schilling, R; Schnabel, R; Schofield, R; Schulz, B; Schutz, BF; Schwinberg, P; Scott, J; Scott, SM; Searle, AC; Sears, B; Seifert, F; Sellers, D; Sengupta, AS; Sentenac, D; Sergeev, A; Shapiro, B; Shawhan, P; Shoemaker, DH; Sibley, A; Siemens, X; Sigg, D; Sinha, S; Sintes, AM; Slagmolen, BJJ; Slutsky, J; van der Sluys, MV; Smith, JR; Smith, MR; Smith, ND; Somiya, K; Sorazu, B; Stein, A; Stein, LC; Steplewski, S; Stochino, A; Stone, R; Strain, KA; Strigin, S; Stroeer, A; Sturani, R; Stuver, AL; Summerscales, TZ; Sun, KX; Sung, M; Sutton, PJ; Swinkels, BL; Szokoly, GP; Talukder, D; Tang, L; Tanner, DB; Tarabrin, SP; Taylor, JR; Taylor, R; Terenzi, R; Thacker, J; Thorne, KA; Thorne, KS; Thuring, A; Tokmakov, KV; Toncelli, A; Tonelli, M; Torres, C; Torrie, C; Tournefier, E; Travasso, F; Traylor, G; Trias, M; Trummer, J; Ugolini, D; Ulmen, J; Urbanek, K; Vahlbruch, H; Vajente, G; Vallisneri, M; Vass, S; Vaulin, R; Vavoulidis, M; Vecchio, A; Vedovato, G; van Veggel, AA; Veitch, J; Veitch, P; Veltkamp, C; Verkindt, D; Vetrano, F; Vicere, A; Villar, A; Vinet, JY; Vocca, H; Vorvick, C; Vyachanin, SP; Waldman, SJ; Wallace, L; Ward, H; Ward, RL; Was, M; Weidner, A; Weinert, M; Weinstein, AJ; Weiss, R; Wen, L; Wen, S; Wette, K; Whelan, JT; Whitcomb, SE; Whiting, BF; Wilkinson, C; Willems, PA; Williams, HR; Williams, L; Willke, B; Wilmut, I; Winkelmann, L; Winkler, W; Wipf, CC; Wiseman, AG; Woan, G; Wooley, R; Worden, J; Wu, W; Yakushin, I; Yamamoto, H; Yan, Z; Yoshida, S; Yvert, M; Zanolin, M; Zhang, J; Zhang, L; Zhao, C; Zotov, N; Zucker, ME; Zweizig, J				Abbott, B. P.; Abbott, R.; Acernese, F.; Adhikari, R.; Ajith, P.; Allen, B.; Allen, G.; Alshourbagy, M.; Amin, R. S.; Anderson, S. B.; Anderson, W. G.; Antonucci, F.; Aoudia, S.; Arain, M. A.; Araya, M.; Armandula, H.; Armor, P.; Arun, K. G.; Aso, Y.; Aston, S.; Astone, P.; Aufmuth, P.; Aulbert, C.; Babak, S.; Baker, P.; Ballardin, G.; Ballmer, S.; Barker, C.; Barker, D.; Barone, F.; Barr, B.; Barriga, P.; Barsotti, L.; Barsuglia, M.; Barton, M. A.; Bartos, I.; Bassiri, R.; Bastarrika, M.; Bauer, Th. S.; Behnke, B.; Beker, M.; Benacquista, M.; Betzwieser, J.; Beyersdorf, P. T.; Bigotta, S.; Bilenko, I. A.; Billingsley, G.; Birindelli, S.; Biswas, R.; Bizouard, M. A.; Black, E.; Blackburn, J. K.; Blackburn, L.; Blair, D.; Bland, B.; Boccara, C.; Bodiya, T. P.; Bogue, L.; Bondu, F.; Bonelli, L.; Bork, R.; Boschi, V.; Bose, S.; Bosi, L.; Braccini, S.; Bradaschia, C.; Brady, P. R.; Braginsky, V. B.; van den Brand, J. F. J.; Brau, J. E.; Bridges, D. O.; Brillet, A.; Brinkmann, M.; Brisson, V.; Van Den Broeck, C.; Brooks, A. F.; Brown, D. A.; Brummit, A.; Brunet, G.; Bullington, A.; Bulten, H. J.; Buonanno, A.; Burmeister, O.; Buskulic, D.; Byer, R. L.; Cadonati, L.; Cagnoli, G.; Calloni, E.; Camp, J. B.; Campagna, E.; Cannizzo, J.; Cannon, K. C.; Canuel, B.; Cao, J.; Carbognani, F.; Cardenas, L.; Caride, S.; Castaldi, G.; Caudill, S.; Cavaglia, M.; Cavalier, F.; Cavalieri, R.; Cella, G.; Cepeda, C.; Cesarini, E.; Chalermsongsak, T.; Chalkley, E.; Charlton, P.; Chassande-Mottin, E.; Chatterji, S.; Chelkowski, S.; Chen, Y.; Christensen, N.; Chung, C. T. Y.; Clark, D.; Clark, J.; Clayton, J. H.; Cleva, F.; Coccia, E.; Cokelaer, T.; Colacino, C. N.; Colas, J.; Colla, A.; Colombini, M.; Conte, R.; Cook, D.; Corbitt, T. R. C.; Corda, C.; Cornish, N.; Corsi, A.; Coulon, J. -P.; Coward, D.; Coyne, D. C.; Creighton, J. D. E.; Creighton, T. D.; Cruise, A. M.; Culter, R. M.; Cumming, A.; Cunningham, L.; Cuoco, E.; Danilishin, S. L.; D'Antonio, S.; Danzmann, K.; Dari, A.; Dattilo, V.; Daudert, B.; Davier, M.; Davies, G.; Daw, E. J.; Day, R.; De Rosa, R.; Debra, D.; Degallaix, J.; del Prete, M.; Dergachev, V.; Desai, S.; DeSalvo, R.; Dhurandhar, S.; Di Fiore, L.; Di Lieto, A.; Emilio, M. Di Paolo; Di Virgilio, A.; Diaz, M.; Dietz, A.; Donovan, F.; Dooley, K. L.; Doomes, E. E.; Drago, M.; Drever, R. W. P.; Dueck, J.; Duke, I.; Dumas, J. -C.; Dwyer, J. G.; Echols, C.; Edgar, M.; Effler, A.; Ehrens, P.; Ely, G.; Espinoza, E.; Etzel, T.; Evans, T.; Fafone, V.; Fairhurst, S.; Faltas, Y.; Fan, Y.; Fazi, D.; Fehrmann, H.; Ferrante, I.; Fidecaro, F.; Finn, L. S.; Fiori, I.; Flaminio, R.; Flasch, K.; Foley, S.; Forrest, C.; Fotopoulos, N.; Fournier, J. -D.; Franc, J.; Franzen, A.; Frasca, S.; Frasconi, F.; Frede, M.; Frei, M.; Frei, Z.; Freise, A.; Frey, R.; Fricke, T.; Fritschel, P.; Frolov, V. V.; Fyffe, M.; Galdi, V.; Gammaitoni, L.; Garofoli, J. A.; Garufi, F.; Genin, E.; Gennai, A.; Gholami, I.; Giaime, J. A.; Giampanis, S.; Giardina, K. D.; Giazotto, A.; Goda, K.; Goetz, E.; Goggin, L. M.; Gonzalez, G.; Gorodetsky, M. L.; Gosser, S.; Gouaty, R.; Granata, M.; Granata, V.; Grant, A.; Gras, S.; Gray, C.; Gray, M.; Greenhalgh, R. J. S.; Gretarsson, A. M.; Greverie, C.; Grimaldi, F.; Grosso, R.; Grote, H.; Grunewald, S.; Guenther, M.; Guidi, G.; Gustafson, E. K.; Gustafson, R.; Hage, B.; Hallam, J. M.; Hammer, D.; Hammond, G. D.; Hanna, C.; Hanson, J.; Harms, J.; Harry, G. M.; Harry, I. W.; Harstad, E. D.; Haughian, K.; Hayama, K.; Heefner, J.; Heitmann, H.; Hello, P.; Heng, I. S.; Heptonstall, A.; Hewitson, M.; Hild, S.; Hirose, E.; Hoak, D.; Hodge, K. A.; Holt, K.; Hosken, D. J.; Hough, J.; Hoyland, D.; Huet, D.; Hughey, B.; Huttner, S. H.; Ingram, D. R.; Isogai, T.; Ito, M.; Ivanov, A.; Johnson, B.; Johnson, W. W.; Jones, D. I.; Jones, G.; Jones, R.; Sancho de la Jordana, L.; Ju, L.; Kalmus, P.; Kalogera, V.; Kandhasamy, S.; Kanner, J.; Kasprzyk, D.; Katsavounidis, E.; Kawabe, K.; Kawamura, S.; Kawazoe, F.; Kells, W.; Keppel, D. G.; Khalaidovski, A.; Khalili, F. Y.; Khan, R.; Khazanov, E.; King, P.; Kissel, J. S.; Klimenko, S.; Kokeyama, K.; Kondrashov, V.; Kopparapu, R.; Koranda, S.; Kozak, D.; Krishnan, B.; Kumar, R.; Kwee, P.; La Penna, P.; Lam, P. K.; Landry, M.; Lantz, B.; Laval, M.; Lazzarini, A.; Lei, H.; Lei, M.; Leindecker, N.; Leonor, I.; Leroy, N.; Letendre, N.; Li, C.; Lin, H.; Lindquist, P. E.; Littenberg, B.; Lockerbie, N. A.; Lodhia, D.; Longo, M.; Lorenzini, M.; Loriette, V.; Lormand, M.; Losurdo, G.; Lu, P.; Lubinski, M.; Lucianetti, A.; Lueck, H.; Machenschalk, B.; MacInnis, M.; Mackowski, J. -M.; Mageswaran, M.; Mailand, K.; Majorana, E.; Man, N.; Mandel, I.; Mandic, V.; Mantovani, M.; Marchesoni, F.; Marion, F.; Marka, S.; Marka, Z.; Markosyan, A.; Markowitz, J.; Maros, E.; Marque, J.; Martelli, F.; Martin, I. W.; Martin, R. M.; Marx, J. N.; Mason, K.; Masserot, A.; Matichard, F.; Matone, L.; Matzner, R. A.; Mavalvala, N.; McCarthy, R.; McClelland, D. E.; McGuire, S. C.; McHugh, M.; McIntyre, G.; McKechan, D. J. A.; McKenzie, K.; Mehmet, M.; Melatos, A.; Melissinos, A. C.; Mendell, G.; Menendez, D. F.; Menzinger, F.; Mercer, R. A.; Meshkov, S.; Messenger, C.; Meyer, M. S.; Michel, C.; Milano, L.; Miller, J.; Minelli, J.; Minenkov, Y.; Mino, Y.; Mitrofanov, V. P.; Mitselmakher, G.; Mittleman, R.; Miyakawa, O.; Moe, B.; Mohan, M.; Mohanty, S. D.; Mohapatra, S. R. P.; Moreau, J.; Moreno, G.; Morgado, N.; Morgia, A.; Morioka, T.; Mors, K.; Mosca, S.; Mossavi, K.; Mours, B.; MowLowry, C.; Mueller, G.; Muhammad, D.; zur Muehlen, H.; Mukherjee, S.; Mukhopadhyay, H.; Mullavey, A.; Mueller-Ebhardt, H.; Munch, J.; Murray, P. G.; Myers, E.; Myers, J.; Nash, T.; Nelson, J.; Neri, I.; Newton, G.; Nishizawa, A.; Nocera, F.; Numata, K.; Ochsner, E.; O'Dell, J.; Ogin, G. H.; O'Reilly, B.; O'Shaughnessy, R.; Ottaway, D. J.; Ottens, R. S.; Overmier, H.; Owen, B. J.; Pagliaroli, G.; Palomba, C.; Pan, Y.; Pankow, C.; Paoletti, F.; Papa, M. A.; Parameshwaraiah, V.; Pardi, S.; Pasqualetti, A.; Passaquieti, R.; Passuello, D.; Patel, P.; Pedraza, M.; Penn, S.; Perreca, A.; Persichetti, G.; Pichot, M.; Piergiovanni, F.; Pierro, V.; Pinard, L.; Pinto, I. M.; Pitkin, M.; Pletsch, H. J.; Plissi, M. V.; Poggiani, R.; Postiglione, F.; Principe, M.; Prix, R.; Prodi, G. A.; Prokhorov, L.; Punken, O.; Punturo, M.; Puppo, P.; van der Putten, S.; Quetschke, V.; Raab, F. J.; Rabaste, O.; Rabeling, D. S.; Radkins, H.; Raffai, P.; Raics, Z.; Rainer, N.; Rakhmanov, M.; Rapagnani, P.; Raymond, V.; Re, V.; Reed, C. M.; Reed, T.; Regimbau, T.; Rehbein, H.; Reid, S.; Reitze, D. H.; Ricci, F.; Riesen, R.; Riles, K.; Rivera, B.; Roberts, P.; Robertson, N. A.; Robinet, F.; Robinson, C.; Robinson, E. L.; Rocchi, A.; Roddy, S.; Rolland, L.; Rollins, J.; Romano, J. D.; Romano, R.; Romie, J. H.; Roever, C.; Rowan, S.; Ruediger, A.; Ruggi, P.; Russell, P.; Ryan, K.; Sakata, S.; Salemi, F.; Sandberg, V.; Sannibale, V.; Santamaria, L.; Saraf, S.; Sarin, P.; Sassolas, B.; Sathyaprakash, B. S.; Sato, S.; Satterthwaite, M.; Saulson, P. R.; Savage, R.; Savov, P.; Scanlan, M.; Schilling, R.; Schnabel, R.; Schofield, R.; Schulz, B.; Schutz, B. F.; Schwinberg, P.; Scott, J.; Scott, S. M.; Searle, A. C.; Sears, B.; Seifert, F.; Sellers, D.; Sengupta, A. S.; Sentenac, D.; Sergeev, A.; Shapiro, B.; Shawhan, P.; Shoemaker, D. H.; Sibley, A.; Siemens, X.; Sigg, D.; Sinha, S.; Sintes, A. M.; Slagmolen, B. J. J.; Slutsky, J.; van der Sluys, M. V.; Smith, J. R.; Smith, M. R.; Smith, N. D.; Somiya, K.; Sorazu, B.; Stein, A.; Stein, L. C.; Steplewski, S.; Stochino, A.; Stone, R.; Strain, K. A.; Strigin, S.; Stroeer, A.; Sturani, R.; Stuver, A. L.; Summerscales, T. Z.; Sun, K. -X.; Sung, M.; Sutton, P. J.; Swinkels, B. L.; Szokoly, G. P.; Talukder, D.; Tang, L.; Tanner, D. B.; Tarabrin, S. P.; Taylor, J. R.; Taylor, R.; Terenzi, R.; Thacker, J.; Thorne, K. A.; Thorne, K. S.; Thuering, A.; Tokmakov, K. V.; Toncelli, A.; Tonelli, M.; Torres, C.; Torrie, C.; Tournefier, E.; Travasso, F.; Traylor, G.; Trias, M.; Trummer, J.; Ugolini, D.; Ulmen, J.; Urbanek, K.; Vahlbruch, H.; Vajente, G.; Vallisneri, M.; Vass, S.; Vaulin, R.; Vavoulidis, M.; Vecchio, A.; Vedovato, G.; van Veggel, A. A.; Veitch, J.; Veitch, P.; Veltkamp, C.; Verkindt, D.; Vetrano, F.; Vicere, A.; Villar, A.; Vinet, J. -Y.; Vocca, H.; Vorvick, C.; Vyachanin, S. P.; Waldman, S. J.; Wallace, L.; Ward, H.; Ward, R. L.; Was, M.; Weidner, A.; Weinert, M.; Weinstein, A. J.; Weiss, R.; Wen, L.; Wen, S.; Wette, K.; Whelan, J. T.; Whitcomb, S. E.; Whiting, B. F.; Wilkinson, C.; Willems, P. A.; Williams, H. R.; Williams, L.; Willke, B.; Wilmut, I.; Winkelmann, L.; Winkler, W.; Wipf, C. C.; Wiseman, A. G.; Woan, G.; Wooley, R.; Worden, J.; Wu, W.; Yakushin, I.; Yamamoto, H.; Yan, Z.; Yoshida, S.; Yvert, M.; Zanolin, M.; Zhang, J.; Zhang, L.; Zhao, C.; Zotov, N.; Zucker, M. E.; Zweizig, J.		LIGO Sci Collaboration; Virgo Collaboration	An upper limit on the stochastic gravitational-wave background of cosmological origin	NATURE			English	Article							SPECTRUM	A stochastic background of gravitational waves is expected to arise from a superposition of a large number of unresolved gravitational-wave sources of astrophysical and cosmological origin. It should carry unique signatures from the earliest epochs in the evolution of the Universe, inaccessible to standard astrophysical observations(1). Direct measurements of the amplitude of this background are therefore of fundamental importance for understanding the evolution of the Universe when it was younger than one minute. Here we report limits on the amplitude of the stochastic gravitational-wave background using the data from a two-year science run of the Laser Interferometer Gravitational-wave Observatory(2) (LIGO). Our result constrains the energy density of the stochastic gravitational-wave background normalized by the critical energy density of the Universe, in the frequency band around 100 Hz, to be <6.9 X 10(-6) at 95% confidence. The data rule out models of early Universe evolution with relatively large equation-of-state parameter(3), as well as cosmic (super) string models with relatively small string tension(4) that are favoured in some string theory models(5). This search for the stochastic background improves on the indirect limits from Big Bang nucleosynthesis(1,6) and cosmic microwave background(7) at 100Hz.	[Harms, J.; Kandhasamy, S.; Mandic, V.] Univ Minnesota, Minneapolis, MN 55455 USA; [Abbott, B. P.; Abbott, R.; Adhikari, R.; Anderson, S. B.; Araya, M.; Armandula, H.; Aso, Y.; Ballmer, S.; Barton, M. A.; Betzwieser, J.; Billingsley, G.; Black, E.; Blackburn, J. K.; Bork, R.; Boschi, V.; Brooks, A. F.; Cannon, K. C.; Cardenas, L.; Cepeda, C.; Chalermsongsak, T.; Coyne, D. C.; Daudert, B.; DeSalvo, R.; Echols, C.; Ehrens, P.; Espinoza, E.; Etzel, T.; Fazi, D.; Gustafson, E. K.; Hanna, C.; Heefner, J.; Heptonstall, A.; Hodge, K. A.; Ivanov, A.; Kalmus, P.; Kells, W.; Keppel, D. G.; King, P.; Kondrashov, V.; Kozak, D.; Lazzarini, A.; Lei, M.; Lindquist, P. E.; Mageswaran, M.; Mailand, K.; Maros, E.; Marx, J. N.; McIntyre, G.; Meshkov, S.; Miyakawa, O.; Nash, T.; Ogin, G. H.; Patel, P.; Pedraza, M.; Robertson, N. A.; Russell, P.; Sannibale, V.; Searle, A. C.; Sears, B.; Sengupta, A. S.; Smith, M. R.; Stochino, A.; Taylor, R.; Torrie, C.; Vass, S.; Villar, A.; Wallace, L.; Ward, R. L.; Weinstein, A. J.; Whitcomb, S. E.; Willems, P. A.; Yamamoto, H.; Zhang, L.; Zweizig, J.] CALTECH, LIGO, Pasadena, CA 91125 USA; [Calloni, E.; De Rosa, R.; Di Fiore, L.; Garufi, F.; Milano, L.; Mosca, S.; Pardi, S.; Persichetti, G.; Romano, R.] Ist Nazl Fis Nucl, Sez Napoli, I-80126 Naples, Italy; [Barone, F.; Calloni, E.; De Rosa, R.; Garufi, F.; Milano, L.; Mosca, S.; Pardi, S.; Persichetti, G.] Univ Napoli Federico II Complesso Univ Monte S An, I-80126 Naples, Italy; [Barone, F.; Romano, R.] Univ Salerno, I-84084 Salerno, Italy; [Acernese, F.; Ajith, P.; Allen, B.; Aulbert, C.; Brinkmann, M.; Burmeister, O.; Danzmann, K.; Degallaix, J.; Dueck, J.; Fehrmann, H.; Frede, M.; Giampanis, S.; Grote, H.; Hewitson, M.; Kawazoe, F.; Khalaidovski, A.; Lueck, H.; Mehmet, M.; Messenger, C.; Mors, K.; Mossavi, K.; Mueller-Ebhardt, H.; Pletsch, H. J.; Prix, R.; Punken, O.; Rainer, N.; Rehbein, H.; Roever, C.; Ruediger, A.; Schilling, R.; Schnabel, R.; Schulz, B.; Seifert, F.] Max Planck Inst Gravitat Phys, Albert Einstein Inst, D-30167 Hannover, Germany; [Allen, B.; Anderson, W. G.; Armor, P.; Biswas, R.; Brady, P. R.; Clayton, J. H.; Creighton, J. D. E.; Fotopoulos, N.; Goggin, L. M.; Hammer, D.; Koranda, S.; Mercer, R. A.; Moe, B.; Papa, M. A.; Siemens, X.] Univ Wisconsin, Milwaukee, WI 53201 USA; [Allen, G.; Bullington, A.; Byer, R. L.; Clark, D.; Debra, D.; Lantz, B.; Leindecker, N.; Lu, P.; Markosyan, A.; Sinha, S.; Sun, K. -X.; Ulmen, J.; Urbanek, K.] Stanford Univ, Stanford, CA 94305 USA; [Amin, R. S.; Caudill, S.; Giaime, J. A.; Gonzalez, G.; Gouaty, R.; Johnson, W. W.; Kissel, J. S.; Matichard, F.; Slutsky, J.; Sung, M.; Wen, S.] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Arain, M. A.; Dooley, K. L.; Faltas, Y.; Klimenko, S.; Lin, H.; Lucianetti, A.; Martin, R. M.; Mitselmakher, G.; Mueller, G.; Ottens, R. S.; Pankow, C.; Quetschke, V.; Reitze, D. H.; Tanner, D. B.; Whiting, B. F.; Williams, L.; Wu, W.] Univ Florida, Gainesville, FL 32611 USA; [Aoudia, S.; Birindelli, S.; Bondu, F.; Brillet, A.; Cleva, F.; Coulon, J. -P.; Fournier, J. -D.; Greverie, C.; Heitmann, H.; Laval, M.; Man, N.; Pichot, M.; Regimbau, T.; Vinet, J. -Y.] Observ Cote Azur, CNRS, Dept Artemis, F-06304 Nice, France; [Arun, K. G.; Bizouard, M. A.; Brisson, V.; Cavalier, F.; Davier, M.; Hello, P.; Leroy, N.; Robinet, F.; Vavoulidis, M.; Was, M.] Univ Paris 11, CNRS, IN2P3, LAL, F-91899 Orsay, France; [Aston, S.; Cruise, A. M.; Culter, R. M.; Freise, A.; Hallam, J. M.; Hild, S.; Kasprzyk, D.; Lodhia, D.; Perreca, A.; Vecchio, A.; Veitch, J.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Aufmuth, P.; Danzmann, K.; Franzen, A.; Hage, B.; Kwee, P.; Lueck, H.; zur Muehlen, H.; Thuering, A.; Vahlbruch, H.; Willke, B.] Leibniz Univ Hannover, D-30167 Hannover, Germany; [Babak, S.; Behnke, B.; Chelkowski, S.; Chen, Y.; Gholami, I.; Grunewald, S.; Krishnan, B.; Machenschalk, B.; Papa, M. A.; Robinson, E. L.; Santamaria, L.; Schutz, B. F.; Whelan, J. T.] Max Planck Inst Gravitat Phys, Albert Einstein Inst, D-14476 Golm, Germany; [Baker, P.; Cornish, N.; Littenberg, B.] Montana State Univ, Bozeman, MT 59717 USA; [Ballardin, G.; Canuel, B.; Carbognani, F.; Cavalieri, R.; Colas, J.; Cuoco, E.; Dattilo, V.; Day, R.; Fiori, I.; Genin, E.; Huet, D.; La Penna, P.; Marque, J.; Menzinger, F.; Mohan, M.; Nocera, F.; Paoletti, F.; Pasqualetti, A.; Ruggi, P.; Sentenac, D.; Swinkels, B. L.] European Gravitat Observ, I-56021 Cascina, Pi, Italy; [Barker, C.; Barker, D.; Bland, B.; Cook, D.; Effler, A.; Gray, C.; Guenther, M.; Ingram, D. R.; Johnson, B.; Kawabe, K.; Landry, M.; Lubinski, M.; McCarthy, R.; Mendell, G.; Moreno, G.; Myers, E.; Myers, J.; Parameshwaraiah, V.; Raab, F. J.; Radkins, H.; Reed, C. M.; Rivera, B.; Ryan, K.; Sandberg, V.; Savage, R.; Schwinberg, P.; Sigg, D.; Vorvick, C.; Wilkinson, C.; Worden, J.] LIGO Hanford Observ, Richland, WA 99352 USA; [Barr, B.; Bassiri, R.; Bastarrika, M.; Chalkley, E.; Chatterji, S.; Cumming, A.; Cunningham, L.; Edgar, M.; Grant, A.; Hammond, G. D.; Haughian, K.; Heng, I. S.; Hough, J.; Huttner, S. H.; Jones, R.; Kumar, R.; Martin, I. W.; Miller, J.; Murray, P. G.; Nelson, J.; Newton, G.; Pitkin, M.; Plissi, M. V.; Reid, S.; Robertson, N. A.; Rowan, S.; Scott, J.; Sorazu, B.; Strain, K. A.; Tokmakov, K. V.; van Veggel, A. A.; Ward, H.; Woan, G.] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [Barriga, P.; Blair, D.; Coward, D.; Dumas, J. -C.; Fan, Y.; Gras, S.; Hoyland, D.; Ju, L.; Wen, L.; Yan, Z.; Zhao, C.] Univ Western Australia, Crawley, WA 6009, Australia; [Barsotti, L.; Blackburn, L.; Bodiya, T. P.; Brunet, G.; Cao, J.; Corbitt, T. R. C.; Donovan, F.; Duke, I.; Evans, T.; Foley, S.; Fritschel, P.; Goda, K.; Grimaldi, F.; Harry, G. M.; Hughey, B.; Katsavounidis, E.; MacInnis, M.; Markowitz, J.; Mason, K.; Mavalvala, N.; Mittleman, R.; Sarin, P.; Shapiro, B.; Shoemaker, D. H.; Smith, N. D.; Stein, A.; Stein, L. C.; Waldman, S. J.; Weiss, R.; Wipf, C. C.; Zucker, M. E.] MIT, LIGO, Cambridge, MA 02139 USA; [Barsuglia, M.; Chassande-Mottin, E.; Granata, M.; Rabaste, O.] Univ Paris 07, CNRS, IN2P3, Observ Paris,APC,UMR 7164, F-75205 Paris, France; [Alshourbagy, M.; Bigotta, S.; Bonelli, L.; Braccini, S.; Bradaschia, C.; Cella, G.; Corda, C.; del Prete, M.; Di Lieto, A.; Di Virgilio, A.; Ferrante, I.; Fidecaro, F.; Frasconi, F.; Gennai, A.; Giazotto, A.; Mantovani, M.; Paoletti, F.; Passaquieti, R.; Passuello, D.; Poggiani, R.; Toncelli, A.; Tonelli, M.; Vajente, G.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Alshourbagy, M.; Bigotta, S.; Bonelli, L.; Corda, C.; Di Lieto, A.; Ferrante, I.; Fidecaro, F.; Passaquieti, R.; Poggiani, R.; Toncelli, A.; Tonelli, M.; Vajente, G.] Univ Pisa, I-56127 Pisa, Italy; [del Prete, M.; Mantovani, M.] Univ Siena, I-53100 Siena, Italy; [Antonucci, F.; Astone, P.; Colla, A.; Colombini, M.; Corsi, A.; Frasca, S.; Majorana, E.; Palomba, C.; Puppo, P.; Rapagnani, P.; Ricci, F.] Ist Nazl Fis Nucl, Sez Roma, I-00185 Rome, Italy; [Colla, A.; Colombini, M.; Frasca, S.; Rapagnani, P.; Ricci, F.] Univ Roma La Sapienza, I-00185 Rome, Italy; [Barsuglia, M.; Chassande-Mottin, E.; Granata, M.; Rabaste, O.] DSM IRSU, F-91191 Gif Sur Yvette, France; [Bartos, I.; Dwyer, J. G.; Khan, R.; Marka, S.; Marka, Z.; Matone, L.; Raics, Z.; Rollins, J.] Columbia Univ, New York, NY 10027 USA; [Bauer, Th. S.; Beker, M.; van den Brand, J. F. J.; Bulten, H. J.; van der Putten, S.; Rabeling, D. S.] NIKHEF H, Natl Inst Subatom Phys, NL-1009 DB Amsterdam, Netherlands; [Beker, M.; van den Brand, J. F. J.; Bulten, H. J.; Rabeling, D. S.] Netherlands VU Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Benacquista, M.; Creighton, T. D.; Diaz, M.; Grosso, R.; Hayama, K.; Lei, H.; Mohanty, S. D.; Mukherjee, S.; Rakhmanov, M.; Romano, J. D.; Stone, R.; Tang, L.] Univ Texas Brownsville & Texas Southmost Coll, Brownsville, TX 78520 USA; [Beyersdorf, P. T.] San Jose State Univ, San Jose, CA 95192 USA; [Bilenko, I. A.; Braginsky, V. B.; Danilishin, S. L.; Gorodetsky, M. L.; Khalili, F. Y.; Mitrofanov, V. P.; Prokhorov, L.; Strigin, S.; Tarabrin, S. P.; Vyachanin, S. P.] Moscow MV Lomonosov State Univ, Moscow 119992, Russia; [Boccara, C.; Loriette, V.; Moreau, J.] CNRS, ESPCI, F-75005 Paris, France; [Bogue, L.; Bridges, D. O.; Fafone, V.; Fricke, T.; Frolov, V. V.; Fyffe, M.; Giaime, J. A.; Giardina, K. D.; Hanson, J.; Hoak, D.; Holt, K.; Lormand, M.; Meyer, M. S.; Muhammad, D.; O'Reilly, B.; Overmier, H.; Riesen, R.; Roddy, S.; Romie, J. H.; Sellers, D.; Sibley, A.; Stuver, A. L.; Thacker, J.; Thorne, K. A.; Torres, C.; Traylor, G.; Wooley, R.; Yakushin, I.] Livingston Observ, LIGO, Livingston, LA 70754 USA; [Bose, S.; Steplewski, S.; Talukder, D.] Washington State Univ, Pullman, WA 99164 USA; [Bosi, L.; Dari, A.; Marchesoni, F.; Neri, I.; Punturo, M.; Travasso, F.; Vocca, H.] Ist Nazl Fis Nucl, Sez Perugia, I-6123 Perugia, Italy; [Dari, A.; Gammaitoni, L.; Neri, I.; Travasso, F.] Univ Perugia, I-6123 Perugia, Italy; [Marchesoni, F.] Univ Camerino, I-62032 Camerino, Italy; [Brau, J. E.; Frey, R.; Harstad, E. D.; Ito, M.; Leonor, I.; Schofield, R.] Univ Oregon, Eugene, OR 97403 USA; [Van Den Broeck, C.; Clark, J.; Cokelaer, T.; Davies, G.; Dietz, A.; Fairhurst, S.; Harry, I. W.; Jones, G.; McKechan, D. J. A.; Robinson, C.; Sathyaprakash, B. S.; Schutz, B. F.; Sutton, P. J.] Cardiff Univ, Cardiff CF24 3AA, S Glam, Wales; [Brown, D. A.; Garofoli, J. A.; Gosser, S.; Hirose, E.; Saulson, P. R.; Smith, J. R.] Syracuse Univ, Syracuse, NY 13244 USA; [Brummit, A.; Greenhalgh, R. J. S.; O'Dell, J.; Wilmut, I.] HSIC, Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; [Buonanno, A.; Kanner, J.; Ochsner, E.; Pan, Y.; Shawhan, P.] Univ Maryland, College Pk, MD 20742 USA; [Buskulic, D.; Granata, V.; Letendre, N.; Marion, F.; Masserot, A.; Mours, B.; Rolland, L.; Tournefier, E.; Trummer, J.; Verkindt, D.; Yvert, M.] Univ Savoie, CNRS, IN2P3, LAPP, F-74941 Annecy Le Vieux, France; [Cadonati, L.; Mohapatra, S. R. P.] Univ Massachusetts, Amherst, MA 01003 USA; [Cagnoli, G.; Campagna, E.; Cesarini, E.; Guidi, G.; Lorenzini, M.; Losurdo, G.; Martelli, F.; Piergiovanni, F.; Sturani, R.; Terenzi, R.; Vetrano, F.; Vicere, A.] Ist Nazl Fis Nucl, Sez Firenze, I-50019 Sesto Fiorentino, Italy; Univ Florence, I-50121 Florence, Italy; [Campagna, E.; Cesarini, E.; Guidi, G.; Martelli, F.; Piergiovanni, F.; Sturani, R.; Terenzi, R.; Vetrano, F.; Vicere, A.] Univ Urbino Carlo Bo, I-61029 Urbino, Italy; [Camp, J. B.; Cannizzo, J.; Numata, K.; Stroeer, A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Caride, S.; Dergachev, V.; Goetz, E.; Gustafson, R.; Riles, K.; Zhang, J.] Univ Michigan, Ann Arbor, MI 48109 USA; [Castaldi, G.; Galdi, V.; Longo, M.; Pierro, V.; Pinto, I. M.; Principe, M.] Univ Sannio Benevento, I-82100 Benevento, Italy; [Cavaglia, M.] Univ Mississippi, University, MS 38677 USA; [Charlton, P.] Charles Sturt Univ, Wagga Wagga, NSW 2678, Australia; [Chen, Y.; Li, C.; Mino, Y.; Savov, P.; Somiya, K.; Thorne, K. S.; Vallisneri, M.; Wen, L.] CALTECH CaRT, Pasadena, CA 91125 USA; [Christensen, N.; Ely, G.; Isogai, T.] Carleton Coll, Northfield, MN 55057 USA; [Chung, C. T. Y.; Melatos, A.] Univ Melbourne, Parkville, Vic 3010, Australia; [Coccia, E.; D'Antonio, S.; Emilio, M. Di Paolo; Minenkov, Y.; Morgia, A.; Pagliaroli, G.; Rocchi, A.; Terenzi, R.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Coccia, E.; Morgia, A.; Pagliaroli, G.] Univ Roma Tor Vergata, I-00133 Rome, Italy; [Terenzi, R.] IFSI, I-00133 Rome, Italy; [Emilio, M. Di Paolo] Univ Aquila, I-67100 Laquila, Italy; [Colacino, C. N.; Frei, Z.; Raffai, P.; Szokoly, G. P.] Eotvos Lorand Univ, ELTE, H-1053 Budapest, Hungary; [Conte, R.; Postiglione, F.] Univ Salerno, I-84084 Salerno, Italy; [Daw, E. J.] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; [Desai, S.; Finn, L. S.; Kopparapu, R.; Menendez, D. F.; Minelli, J.; O'Shaughnessy, R.; Owen, B. J.; Williams, H. R.] Penn State Univ, University Pk, PA 16802 USA; [Dhurandhar, S.; Mukhopadhyay, H.] Inter Univ Ctr Astron & Astrophys, Pune 411007, Maharashtra, India; [Doomes, E. E.; McGuire, S. C.] Southern Univ, Baton Rouge, LA 70813 USA; [Doomes, E. E.; McGuire, S. C.] A&M Coll, Baton Rouge, LA 70813 USA; [Prodi, G. A.; Re, V.; Salemi, F.] Ist Nazl Fis Nucl, Grp Coll Trento, I-38050 Trento, Italy; [Prodi, G. A.; Re, V.; Salemi, F.] Univ Trent, I-38050 Trento, Italy; [Drago, M.; Vedovato, G.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Drago, M.] Univ Padua, I-35131 Padua, Italy; [Flaminio, R.; Franc, J.; Mackowski, J. -M.; Michel, C.; Morgado, N.; Pinard, L.; Sassolas, B.] CNRS, IN2P3, LMA, F-69622 Villeurbanne, France; [Forrest, C.; Melissinos, A. C.] Univ Rochester, Rochester, NY 14627 USA; [Frei, M.; Matzner, R. A.] Univ Texas Austin, Austin, TX 78712 USA; [Gray, M.; Lam, P. K.; McClelland, D. E.; McKenzie, K.; MowLowry, C.; Mullavey, A.; Satterthwaite, M.; Scott, S. M.; Slagmolen, B. J. J.; Wette, K.] Australian Natl Univ, Canberra, ACT 0200, Australia; [Gretarsson, A. M.; Zanolin, M.] Embry Riddle Aeronaut Univ, Prescott, AZ 86301 USA; [Hosken, D. J.; Munch, J.; Ottaway, D. J.; Veitch, P.] Univ Adelaide, Adelaide, SA 5005, Australia; [Jones, D. I.] Univ Southampton, Southampton SO17 1BJ, Hants, England; [Sancho de la Jordana, L.; Sintes, A. M.; Trias, M.] Univ Illes Balears, Dept Fis, E-07122 Palma de Mallorca, Spain; [Kalogera, V.; Mandel, I.; Raymond, V.; van der Sluys, M. V.] Northwestern Univ, Evanston, IL 60208 USA; [Kawamura, S.; Kokeyama, K.; Morioka, T.; Nishizawa, A.; Sakata, S.; Sato, S.] Natl Astron Observ Japan, Tokyo 1818588, Japan; [Khazanov, E.; Sergeev, A.] Inst Appl Phys, Nizhnii Novgorod 603950, Russia; [Lockerbie, N. A.] Univ Strathclyde, Glasgow G1 1XQ, Lanark, Scotland; [McHugh, M.] Tulane Univ, New Orleans, LA 70118 USA; [Penn, S.] Hobart & William Smith Coll, Geneva, NY 14456 USA; [Reed, T.; Scanlan, M.; Zotov, N.] Louisiana Tech Univ, Ruston, LA 71272 USA; [Roberts, P.; Summerscales, T. Z.] Andrews Univ, Berrien Springs, MI 49104 USA; [Saraf, S.] Sonoma State Univ, Rohnert Pk, CA 94928 USA; [Ugolini, D.] Trinity Univ, San Antonio, TX 78712 USA; [Whelan, J. T.] Rochester Inst Technol, Rochester, NY 14623 USA; [Yoshida, S.] SE Louisiana Univ, Hammond, LA 70402 USA	University of Minnesota System; University of Minnesota Twin Cities; California Institute of Technology; Istituto Nazionale di Fisica Nucleare (INFN); University of Naples Federico II; University of Salerno; Max Planck Society; University of Wisconsin System; University of Wisconsin Milwaukee; Stanford University; Louisiana State University System; Louisiana State University; State University System of Florida; University of Florida; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; University of Birmingham; Leibniz University Hannover; Max Planck Society; Montana State University System; Montana State University Bozeman; University of Glasgow; University of Western Australia; Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Istituto Nazionale di Fisica Nucleare (INFN); University of Pisa; University of Siena; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Columbia University; FOM National Institute for Subatomic Physics; Vrije Universiteit Amsterdam; University of Texas System; University of Texas Rio Grande Valley; California State University System; San Jose State University; Lomonosov Moscow State University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Washington State University; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; University of Camerino; University of Oregon; Cardiff University; Syracuse University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Savoie; University of Massachusetts System; University of Massachusetts Amherst; Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; University of Urbino; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Michigan System; University of Michigan; University of Sannio; University of Mississippi; Charles Sturt University; California Institute of Technology; Carleton College; University of Melbourne; Istituto Nazionale di Fisica Nucleare (INFN); University of Rome Tor Vergata; Istituto Nazionale Astrofisica (INAF); University of L'Aquila; Eotvos Lorand University; University of Salerno; University of Sheffield; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Inter-University Centre for Astronomy & Astrophysics; Southern University System; Southern University & A&M College; Louisiana State University System; Louisiana State University; Istituto Nazionale di Fisica Nucleare (INFN); University of Trento; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); University of Rochester; University of Texas System; University of Texas Austin; Australian National University; Embry-Riddle Aeronautical University; University of Adelaide; University of Southampton; Universitat de les Illes Balears; Northwestern University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences; University of Strathclyde; Tulane University; University of Louisiana System; Louisiana Technical University; Andrews University; California State University System; Sonoma State University; Trinity University; Rochester Institute of Technology; University of Louisiana System; Southeastern Louisiana University	Mandic, V (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	mandic@physics.umn.edu	Harms, Jan/O-7967-2019; Hallam, Jonathan Mark/AAI-9469-2020; Pierro, Vincenzo/AHD-9078-2022; Freise, Andreas/F-8892-2011; Frey, Raymond E/E-2830-2016; Stein, Leo/K-3857-2019; Martin, Iain/A-2445-2010; di virgilio, angela/E-9078-2015; Mitrofanov, Valery/D-8501-2012; Aso, Yoichi/R-9361-2019; dattilo, vincenzino/N-9732-2015; Puppo, Paola/J-4250-2012; CHASSANDE-MOTTIN, Eric/ABC-2478-2020; Martelli, Filippo/P-4041-2015; Prokhorov, Leonid/AAE-4810-2019; Postiglione, Fabio/O-4744-2015; Frei, Zsolt/O-9538-2019; Rowan, Sheila/E-3032-2010; Lam, Ping Koy/A-5276-2008; Bilenko, Igor A/D-5172-2012; DRAGO, Marco/K-6895-2019; Pagliaroli, Giulia/AAA-7637-2020; Re, Virginia/F-6403-2013; Willke, Benno/U-8992-2017; Hammond, Giles/B-7861-2009; di virgilio, angela/AAA-4814-2019; Cuoco, Elena/O-4680-2019; Lucianetti, Antonio/G-7383-2014; Schutz, Bernard F/B-1504-2010; Barker, David JP/A-5671-2013; Sigg, Daniel/I-4308-2015; Christensen, Nelson/AAH-9184-2019; Lorenzini, Matteo/AAC-6035-2021; Goetz, Evan/HHS-2153-2022; Vicere', Andrea/J-1742-2012; Roberts, Peter/J-8535-2016; O'Shaughnessy, Richard/AAA-3625-2021; Gammaitoni, Luca/B-5375-2009; Babak, Stanislav/H-9689-2017; Khan, Rubab/F-9455-2015; Frasconi, Franco/K-1068-2016; McClelland, David E/E-6765-2010; Marchesoni, Fabio/A-1920-2008; Prodi, Giovanni Andrea/B-4398-2010; Acernese, Fausto/AAX-5705-2020; Hild, Stefan/A-3864-2010; Canuel, Benjamin/C-7459-2014; Galdi, Vincenzo/B-1670-2008; Rocchi, Alessio/O-9499-2015; Cesarini, Elisabetta/C-4507-2017; Cokelaer, Thomas/AAN-8240-2020; Khazanov, Efim/B-6643-2014; Cella, Giancarlo/A-9946-2012; Chen, Yanbei/A-2604-2013; Allen, Bruce/K-2327-2012; Sergeev, Alexander M/F-3027-2017; Sturani, Riccardo/B-3899-2014; Fidecaro, Francesco/H-9581-2017; Vocca, Helios/J-9579-2016; Pinto, Innocenzo M/L-3520-2016; Bigotta, Stefano/F-8652-2011; Kawazoe, Fumiko/F-7700-2011; Boschi, Valerio/AAP-2034-2020; Schnabel, Roman/V-7759-2019; calloni, enrico/K-5852-2019; Brooks, Aidan/U-5988-2017; Van Den Broeck, Chris/R-7871-2018; Losurdo, Giovanni/K-1241-2014; Marka, Szabolcs/ABE-7493-2021; Acernese, Fausto/E-4989-2010; Garufi, Fabio/K-3263-2015; Khalili, Farit Ya/D-8113-2012; Ju, Li/C-2623-2013; Prokhorov, Leonid/I-2953-2012; Ferrante, Isidoro/F-1017-2012; Bartos, Imre/A-2592-2017; Hammond, Giles/A-8168-2012; Barr, Bryan/G-3348-2019; Harms, Jan/J-4359-2012; Kalmus, Peter/K-2871-2018; Corda, Christian/C-1169-2013; Taylor, John Robert/G-5523-2019; Zhao, Chunnong/AAE-7836-2021; Strigin, Sergey E/I-8337-2012; Zhao, Chunnong/C-2403-2013; Salemi, Francesco/F-6988-2014; Santamaria, Lucia/G-1297-2017; Mow-Lowry, Conor M/F-8843-2015; Toncelli, Alessandra/A-5352-2012; Lueck, Harald/F-7100-2011; Cuoco, Elena Dr./I-8789-2012; Somiya, Kentaro/ABE-2215-2020; Travasso, Flavio/J-9595-2016; Danilishin, Stefan/K-7262-2012; Martin, Iain/V-1198-2018; Punturo, Michele/I-3995-2012; mosca, simona/I-7116-2012; Rapagnani, Piero/T-2050-2019; Finn, Lee Samuel Samuel/A-3452-2009; Sintes, Alicia M/AAF-4791-2019; Tuluc, Petronel/C-2527-2011; Poggiani, Rosa/P-8801-2018; Neri, Igor/F-1482-2010; Bartos, Imre/AAD-6024-2019; Slagmolen, Bram/AAY-1638-2020; Biswas, Rahul/H-7474-2016; Colla, Alberto/J-4694-2012; Raab, Frederick J/E-2222-2011; Pitkin, Matthew/I-3802-2013; Rapagnani, Piero/J-4783-2012; Drago, Marco/E-7134-2013; Ottaway, David J/J-5908-2015; Santamaria, Lucia/A-7269-2012; Brown, Duncan/U-2343-2019; Vyatchanin, Sergey P/J-2238-2012; Wette, Karl/H-9897-2019; Bondu, Francois/A-2071-2012; Gorodetsky, Michael L./C-5938-2008; Vecchio, Alberto/F-8310-2015; GODA, KEISUKE/G-4997-2014; Vocca, Helios/F-1444-2010; Ward, Robert/I-8032-2014; Stuver, Amber/L-9985-2018; Sorazu, Borja/H-6966-2018; Sathyaprakash, Bangalore/M-1235-2014; Passaquieti, Roberto/U-3083-2017; Strain, Kenneth/D-5236-2011	Harms, Jan/0000-0002-7332-9806; Hallam, Jonathan Mark/0000-0002-7087-0461; Frey, Raymond E/0000-0003-0341-2636; Stein, Leo/0000-0001-7559-9597; di virgilio, angela/0000-0002-2237-7533; Aso, Yoichi/0000-0002-1902-6695; Puppo, Paola/0000-0003-4677-5015; CHASSANDE-MOTTIN, Eric/0000-0003-3768-9908; Martelli, Filippo/0000-0003-3761-8616; Postiglione, Fabio/0000-0003-0628-3796; Lam, Ping Koy/0000-0002-4421-601X; DRAGO, Marco/0000-0002-3738-2431; Willke, Benno/0000-0003-0524-2925; Cuoco, Elena/0000-0002-6528-3449; Sigg, Daniel/0000-0003-4606-6526; Christensen, Nelson/0000-0002-6870-4202; Lorenzini, Matteo/0000-0002-2765-7905; Goetz, Evan/0000-0003-2666-721X; Vicere', Andrea/0000-0003-0624-6231; O'Shaughnessy, Richard/0000-0001-5832-8517; Gammaitoni, Luca/0000-0002-4972-7062; Babak, Stanislav/0000-0001-7469-4250; Khan, Rubab/0000-0001-5100-5168; Frasconi, Franco/0000-0003-4204-6587; McClelland, David E/0000-0001-6210-5842; Marchesoni, Fabio/0000-0001-9240-6793; Prodi, Giovanni Andrea/0000-0001-5256-915X; Acernese, Fausto/0000-0003-3103-3473; Hild, Stefan/0000-0001-9221-6009; Galdi, Vincenzo/0000-0002-4796-3600; Rocchi, Alessio/0000-0002-1382-9016; Cesarini, Elisabetta/0000-0001-9127-3167; Cokelaer, Thomas/0000-0001-6286-1138; Cella, Giancarlo/0000-0002-0752-0338; Allen, Bruce/0000-0003-4285-6256; Fidecaro, Francesco/0000-0002-6189-3311; Vocca, Helios/0000-0002-1200-3917; Pinto, Innocenzo M/0000-0002-2679-4457; Boschi, Valerio/0000-0001-8665-2293; Brooks, Aidan/0000-0003-4295-792X; Van Den Broeck, Chris/0000-0001-6800-4006; Losurdo, Giovanni/0000-0003-0452-746X; Acernese, Fausto/0000-0003-3103-3473; Garufi, Fabio/0000-0003-1391-6168; Ferrante, Isidoro/0000-0002-0083-7228; Barr, Bryan/0000-0002-5232-2736; Harms, Jan/0000-0002-7332-9806; Kalmus, Peter/0000-0001-7557-8614; Taylor, John Robert/0000-0003-4314-2685; Zhao, Chunnong/0000-0001-5825-2401; Zhao, Chunnong/0000-0001-5825-2401; Salemi, Francesco/0000-0002-9511-3846; Santamaria, Lucia/0000-0002-5986-0449; Mow-Lowry, Conor M/0000-0002-0351-4555; Toncelli, Alessandra/0000-0003-4400-8808; Lueck, Harald/0000-0001-9350-4846; Cuoco, Elena Dr./0000-0002-6528-3449; Somiya, Kentaro/0000-0003-2601-2264; Travasso, Flavio/0000-0002-4653-6156; Danilishin, Stefan/0000-0001-7758-7493; Martin, Iain/0000-0001-7300-9151; Punturo, Michele/0000-0001-8722-4485; mosca, simona/0000-0001-7869-8275; Rapagnani, Piero/0000-0002-1865-6126; Finn, Lee Samuel Samuel/0000-0002-3937-0688; Poggiani, Rosa/0000-0002-9968-2464; Neri, Igor/0000-0002-9047-9822; Slagmolen, Bram/0000-0002-2471-3828; Biswas, Rahul/0000-0002-0774-8906; Pitkin, Matthew/0000-0003-4548-526X; Rapagnani, Piero/0000-0002-1865-6126; Brown, Duncan/0000-0002-9180-5765; Vyatchanin, Sergey P/0000-0002-6823-911X; Wette, Karl/0000-0002-4394-7179; Bondu, Francois/0000-0001-6487-5197; Vecchio, Alberto/0000-0002-6254-1617; Vocca, Helios/0000-0002-1200-3917; Majorana, Ettore/0000-0002-2383-3692; Bridges, Derek/0000-0002-8099-3924; Guidi, Gianluca/0000-0002-3061-9870; , dattilo/0000-0002-8816-8566; Charlton, Philip/0000-0002-4263-2706; calloni, enrico/0000-0003-4819-3297; O'Reilly, Brian/0000-0002-3874-8335; Ottaway, David/0000-0001-6794-1591; Hanna, Chad/0000-0002-0965-7493; Mitselmakher, Guenakh/0000-0001-5745-3658; Granata, Massimo/0000-0003-3275-1186; Cavaglia, Marco/0000-0002-3835-6729; Matichard, Fabrice/0000-0001-8982-8418; mantovani, maddalena/0000-0002-4424-5726; Barone, Fabrizio/0000-0002-8069-8490; Swinkels, Bas/0000-0002-3066-3601; Whiting, Bernard F/0000-0002-8501-8669; Ward, Robert/0000-0001-5503-5241; De Rosa, Rosario/0000-0002-4004-947X; Stuver, Amber/0000-0003-0324-5735; Whelan, John/0000-0001-5710-6576; Blair, David/0000-0002-1501-2405; Papa, M.Alessandra/0000-0002-1007-5298; Sorazu, Borja/0000-0002-6178-3198; Heng, Ik Siong/0000-0002-1977-0019; Harry, Ian/0000-0002-5304-9372; Ricci, Fulvio/0000-0001-5475-4447; Clark, James/0000-0003-3243-1393; Schutz, Bernard/0000-0001-9487-6983; van den Brand, Johannes/0000-0003-4434-5353; Sathyaprakash, Bangalore/0000-0003-3845-7586; Di Paolo Emilio, Maurizio/0000-0002-9558-3610; McKenzie, Kirk/0000-0002-1463-4595; Owen, Benjamin/0000-0003-3919-0780; Milano, Leopoldo/0000-0001-9487-5876; Riles, Keith/0000-0002-6418-5812; Prokhorov, Leonid/0000-0002-0869-185X; Palomba, Cristiano/0000-0002-4450-9883; Gennai, Alberto/0000-0003-0149-2089; LONGO, Maurizio/0000-0001-8325-4003; Passaquieti, Roberto/0000-0003-4753-9428; Melatos, Andrew/0000-0003-4642-141X; Zweizig, John/0000-0002-1521-3397; CASTALDI, Giuseppe/0000-0003-4400-9990; Vedovato, Gabriele/0000-0001-7226-1320; Vajente, Gabriele/0000-0002-7656-6882; Vetrano, Flavio/0000-0002-7523-4296; Strain, Kenneth/0000-0002-2066-5355; Tokmakov, Kirill/0000-0002-2808-6593; Kanner, Jonah/0000-0001-8115-0577; DI LIETO, ALBERTO/0000-0002-4787-0754; Minelli, Jeff/0000-0002-5330-912X; Mandel, Ilya/0000-0002-6134-8946; Coccia, Eugenio/0000-0002-6669-5787; Romano, Rocco/0000-0002-0485-6936; Raymond, Vivien/0000-0003-0066-0095; Creighton, Jolien/0000-0003-3600-2406; Wen, Linqing/0000-0001-7987-295X; Krishnan, Badri/0000-0003-3015-234X; Ju, Li/0000-0002-7951-4295; Messenger, Chris/0000-0001-7488-5022; Aulbert, Carsten/0000-0002-1481-8319; Goda, Keisuke/0000-0001-6302-6038; Hammond, Giles/0000-0002-1414-3622; Bassiri, Riccardo/0000-0001-8171-6833; Anderson, Warren/0000-0003-0482-5942; Coward, David/0000-0002-7795-9354; Freise, Andreas/0000-0001-6586-9901; Principe, Maria/0000-0002-6327-0628; Piergiovanni, Francesco/0000-0001-8063-828X; Talukder, Dipongkar/0000-0002-9178-8870; /0000-0001-8459-4499; Lucianetti, Antonio/0000-0002-2228-8397; WU, WAN/0000-0003-0417-3905; Boccara, Claude/0000-0002-9603-0700; Fairhurst, Stephen/0000-0001-8480-1961; Di Fiore, Luciano/0000-0001-6296-1526; Woan, Graham/0000-0003-0381-0394; Sintes, Alicia M/0000-0001-9050-7515; Arun, K G/0000-0002-6960-8538; Scott, Susan M./0000-0002-9875-7700; PERSICHETTI, GIANLUCA/0000-0001-8424-9791; Veitch, John/0000-0002-6508-0713; Tanner, David/0000-0003-1940-4710; Cannon, Kipp/0000-0003-4068-6572; Brady, Patrick/0000-0002-4611-9387; Nishizawa, Atsushi/0000-0003-3562-0990; Khalaidovski, Alexander/0000-0002-5163-4228; Pierro, Vincenzo/0000-0002-6020-5521	United States National Science Foundation; Science and Technology Facilities Council of the United Kingdom; Max Planck Society; State of Niedersachsen/Germany [GEO600]; Italian Istituto Nazionale di Fisica Nucleare; French Centre National de la Recherche Scientifique; Australian Research Council; Council of Scientific and Industrial Research of India; Istituto Nazionale di Fisica Nucleare of Italy; Spanish Ministerio de Educacion y Ciencia; Conselleria d'Economia Hisenda i Innovacio of the Govern de les Illes Balears; Royal Society; Scottish Funding Council; Scottish Universities Physics Alliance; The National Aeronautics and Space Administration; Carnegie Trust; Leverhulme Trust; David and Lucile Packard Foundation; Research Corporation; Alfred P. Sloan Foundation; STFC [PP/E001203/1, ST/F01032X/1, ST/G504284/1, PP/F001118/1, PP/F00110X/1, PP/F001096/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F01032X/1, PP/F001096/1, PP/E001203/1, ST/G504284/1, PP/F001118/1, PP/F00110X/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [0855679, 0757058] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Science and Technology Facilities Council of the United Kingdom(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); State of Niedersachsen/Germany; Italian Istituto Nazionale di Fisica Nucleare(Istituto Nazionale di Fisica Nucleare (INFN)); French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Australian Research Council(Australian Research Council); Council of Scientific and Industrial Research of India(Council of Scientific & Industrial Research (CSIR) - India); Istituto Nazionale di Fisica Nucleare of Italy(Istituto Nazionale di Fisica Nucleare (INFN)); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Conselleria d'Economia Hisenda i Innovacio of the Govern de les Illes Balears; Royal Society(Royal Society of London); Scottish Funding Council; Scottish Universities Physics Alliance; The National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Carnegie Trust(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Leverhulme Trust(Leverhulme Trust); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Research Corporation(Research Corporation for Science Advancement); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge the support of the United States National Science Foundation for the construction and operation of the LIGO Laboratory, the Science and Technology Facilities Council of the United Kingdom, the Max Planck Society, and the State of Niedersachsen/Germany for support of the construction and operation of the GEO600 detector, and the Italian Istituto Nazionale di Fisica Nucleare and the French Centre National de la Recherche Scientifique for the construction and operation of the Virgo detector. We also acknowledge the support of the research by these agencies and by the Australian Research Council, the Council of Scientific and Industrial Research of India, the Istituto Nazionale di Fisica Nucleare of Italy, the Spanish Ministerio de Educacion y Ciencia, the Conselleria d'Economia Hisenda i Innovacio of the Govern de les Illes Balears, the Royal Society, the Scottish Funding Council, the Scottish Universities Physics Alliance, The National Aeronautics and Space Administration, the Carnegie Trust, the Leverhulme Trust, the David and Lucile Packard Foundation, the Research Corporation, and the Alfred P. Sloan Foundation.	Abbott B, 2004, NUCL INSTRUM METH A, V517, P154, DOI 10.1016/j.nima.2003.11.124; Abbott B, 2007, ASTROPHYS J, V659, P918, DOI 10.1086/511329; Acernese F, 2008, CLASSICAL QUANT GRAV, V25, DOI 10.1088/0264-9381/25/11/114045; *ADV LIGO TEAM, 2007, ADV LIGO REF DES; Allen B, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.102001; ALLEN B, 1996, STOCHASTIC GRAVITY W; Apreda R, 2002, NUCL PHYS B, V631, P342, DOI 10.1016/S0550-3213(02)00264-X; BARKANA R, 1994, PHYS REV D, V50, P1157, DOI 10.1103/PhysRevD.50.1157; BENDER PL, 1998, MPQ233 M PLANK I QUA; Bennett CL, 2003, ASTROPHYS J SUPPL S, V148, P1, DOI 10.1086/377253; Boyle LA, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.043531; BRUSTEIN R, 1995, PHYS LETT B, V361, P45, DOI 10.1016/0370-2693(95)01128-D; Buonanno A, 1997, PHYS REV D, V55, P3330, DOI 10.1103/PhysRevD.55.3330; Cyburt RH, 2005, ASTROPART PHYS, V23, P313, DOI 10.1016/j.astropartphys.2005.01.005; Damour T, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.063510; GRISHCHUK LP, 1990, PHYS REV D, V42, P3413, DOI 10.1103/PhysRevD.42.3413; Jenet FA, 2006, ASTROPHYS J, V653, P1571, DOI 10.1086/508702; KIBBLE TWB, 1976, J PHYS A-MATH GEN, V9, P1387, DOI 10.1088/0305-4470/9/8/029; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Maggiore M, 2000, PHYS REP, V331, P284; Mandic V, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.063008; Regimbau T, 2006, ASTRON ASTROPHYS, V447, P1, DOI 10.1051/0004-6361:20053702; Regimbau T, 2001, ASTRON ASTROPHYS, V376, P381, DOI 10.1051/0004-6361:20011005; Siemens X, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.043501; Siemens X, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.105001; Smith TL, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.021301; STAROBINSKII AA, 1979, JETP LETT+, V30, P682; Willke B, 2006, CLASSICAL QUANT GRAV, V23, pS207, DOI 10.1088/0264-9381/23/8/S26	30	278	281	2	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					990	994		10.1038/nature08278	http://dx.doi.org/10.1038/nature08278			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693079	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000269085500029
J	Del Pozo, JL; Patel, R				Del Pozo, Jose L.; Patel, Robin			Infection Associated with Prosthetic Joints	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAOPERATIVE FROZEN-SECTION; C-REACTIVE PROTEIN; BROAD-RANGE PCR; RISK-FACTORS; TOTAL HIP; KNEE ARTHROPLASTY; REVISION HIP; DIAGNOSIS; CULTURE; PROPHYLAXIS	A 62-year-old woman with osteoarthritis presents with a 7-month history of progressively worsening left hip pain radiating to the groin, 8 months after undergoing total left-hip arthroplasty. The pain has not responded to nonsteroidal antiinflammatory drugs. Physical examination reveals a sinus tract overlying her left hip. Her leukocyte count is 8000 per cubic millimeter, and the C-reactive protein (CRP) level is 15.5 mg per liter. A radiograph shows loosening of the prosthesis at the bone-cement interface. Synovial-fluid aspirate shows 15x10(3) cells per cubic millimeter (89% neutrophils); cultures of an aspirate from the hip grow Staphylococcus epidermidis. How should her case be managed?	[Patel, Robin] Mayo Clin, Div Clin Microbiol, Dept Lab Med & Pathol, Coll Med, Rochester, MN 55905 USA; [Del Pozo, Jose L.; Patel, Robin] Mayo Clin, Dept Med, Div Infect Dis, Coll Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Patel, R (corresponding author), Mayo Clin, Div Clin Microbiol, Dept Lab Med & Pathol, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	patel.robin@mayo.edu	Del Pozo, Jose L/Q-4442-2016	Del Pozo, Jose L/0000-0002-5402-3334	National Center for Research Resources of the National Institutes of Health (NIH); NIH Roadmap for Medical Research [1 UL1 RR024150]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR056647]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056647] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by grants from the National Center for Research Resources of the National Institutes of Health (NIH) and the NIH Roadmap for Medical Research (1 UL1 RR024150), and by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR056647).	Atkins BL, 1998, J CLIN MICROBIOL, V36, P2932, DOI 10.1128/JCM.36.10.2932-2939.1998; Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991; Berbari EF, 2006, CLIN INFECT DIS, V42, P216, DOI 10.1086/498507; Berbari EF, 2007, CLIN INFECT DIS, V45, P1113, DOI 10.1086/522184; Betsch BY, 2008, CLIN INFECT DIS, V46, P1221, DOI 10.1086/529436; Bilgen OF, 2001, J INT MED RES, V29, P7, DOI 10.1177/147323000102900102; Bongartz T, 2008, ARTHRIT RHEUM-ARTHR, V59, P1713, DOI 10.1002/art.24060; Borrego AF, 2007, INT ORTHOP, V31, P33, DOI 10.1007/s00264-005-0069-4; Bratzler DW, 2005, AM J SURG, V189, P395, DOI 10.1016/j.amjsurg.2005.01.015; Cabrita HB, 2007, CLINICS, V62, P99, DOI 10.1590/S1807-59322007000200002; Centers for Disease Control and Prevention, 2009, NAT HOSP DISCH SURV; Choong PFM, 2007, ACTA ORTHOP, V78, P755, DOI 10.1080/17453670710014527; De Man FHR, 2009, INFECTION, V37, P292, DOI 10.1007/s15010-008-8246-1; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Dora C, 2008, J CLIN MICROBIOL, V46, P824, DOI 10.1128/JCM.01227-07; Dowsey MM, 2008, CLIN ORTHOP RELAT R, V466, P153, DOI 10.1007/s11999-007-0016-3; Esteban J, 2008, J CLIN MICROBIOL, V46, P488, DOI 10.1128/JCM.01762-07; Fihman V, 2007, J INFECTION, V55, P510, DOI 10.1016/j.jinf.2007.09.001; Fink B, 2008, J BONE JOINT SURG BR, V90B, P874, DOI 10.1302/0301-620X.90B7.20417; Gallo J, 2008, NEW MICROBIOL, V31, P97; Greidanus NV, 2007, J BONE JOINT SURG AM, V89A, P1409, DOI 10.2106/JBJS.D.02602; Hughes JG, 2001, J CLIN MICROBIOL, V39, P4468, DOI 10.1128/JCM.39.12.4468-4471.2001; Jamsen E, 2009, J BONE JOINT SURG AM, V91A, P38, DOI 10.2106/JBJS.G.01686; Jiranek WA, 2006, J BONE JOINT SURG AM, V88A, P2487, DOI 10.2106/JBJS.E.01126; Ko PS, 2005, J ARTHROPLASTY, V20, P189, DOI 10.1016/j.arth.2004.06.034; Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017; Kwee TC, 2008, EUR J NUCL MED MOL I, V35, P2122, DOI 10.1007/s00259-008-0887-x; Love C, 2009, SEMIN NUCL MED, V39, P66, DOI 10.1053/j.semnuclmed.2008.08.007; Marculescu CE, 2008, CLIN ORTHOP RELAT R, V466, P1397, DOI 10.1007/s11999-008-0230-7; Marculescu CE, 2006, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.blo.0000229337.21653.f2; Marculescu CE, 2006, CLIN ORTHOP RELAT R, P55, DOI 10.1097/01.blo.0000229317.43631.81; Marculescu CE, 2006, CLIN INFECT DIS, V42, P471, DOI 10.1086/499234; Marculescu CE, 2005, CLIN ORTHOP RELAT R, P38, DOI 10.1097/01.blo.0000183091.83509.d8; Morawietz L, 2006, J CLIN PATHOL, V59, P591, DOI 10.1136/jcp.2005.027458; Muller Michael, 2008, J Orthop Surg Res, V3, P31, DOI 10.1186/1749-799X-3-31; Murdoch DR, 2001, CLIN INFECT DIS, V32, P647, DOI 10.1086/318704; Nunez LV, 2007, ACTA ORTHOP, V78, P226, DOI 10.1080/17453670710013726; Panousis K, 2005, ACTA ORTHOP, V76, P341, DOI 10.1080/00016470510030805; Peersman G, 2001, CLIN ORTHOP RELAT R, P15, DOI 10.1097/00003086-200111000-00003; Phillips JE, 2006, J BONE JOINT SURG BR, V88B, P943, DOI 10.1302/0301-620X.88B7.17150; Piper KE, 2009, J CLIN MICROBIOL, V47, P1878, DOI 10.1128/JCM.01686-08; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Schinsky MF, 2008, J BONE JOINT SURG AM, V90A, P1869, DOI 10.2106/JBJS.G.01255; Sendi P, 2006, CLIN INFECT DIS, V43, P961, DOI 10.1086/507633; Stockley I, 2008, J BONE JOINT SURG BR, V90B, P145, DOI 10.1302/0301-620X.90B2.19855; Trampuz A, 2006, J CLIN MICROBIOL, V44, P628, DOI 10.1128/JCM.44.2.628-631.2006; Trampuz A, 2004, AM J MED, V117, P556, DOI 10.1016/j.amjmed.2004.06.022; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Vandercam B, 2008, J MOL DIAGN, V10, P537, DOI 10.2353/jmoldx.2008.070137; Virolainen P, 2002, Scand J Surg, V91, P178; Whittaker JP, 2009, J BONE JOINT SURG BR, V91B, P700; Whittaker JP, 2009, J BONE JOINT SURG BR, V91B, P44, DOI 10.1302/0301-620X.91B1.20930; Wong YC, 2005, J ARTHROPLASTY, V20, P1015, DOI 10.1016/j.arth.2004.08.003; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537	55	543	548	1	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					787	794		10.1056/NEJMcp0905029	http://dx.doi.org/10.1056/NEJMcp0905029			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484WX	19692690	Green Accepted			2022-12-28	WOS:000269081200007
J	Putnam, CD; Hayes, TK; Kolodner, RD				Putnam, Christopher D.; Hayes, Tikvah K.; Kolodner, Richard D.			Specific pathways prevent duplication-mediated genome rearrangements	NATURE			English	Article							GROSS CHROMOSOMAL REARRANGEMENTS; SACCHAROMYCES-CEREVISIAE HOMOLOG; BREAK-INDUCED REPLICATION; S-PHASE CHECKPOINT; DNA HELICASE; ALU REPEATS; MITOTIC RECOMBINATION; GENETIC INSTABILITY; REPAIR PROTEINS; CROSSING-OVER	We have investigated the ability of different regions of the left arm of Saccharomyces cerevisiae chromosome V to participate in the formation of gross chromosomal rearrangements (GCRs). We found that the 4.2-kilobase HXT13-DSF1 region sharing divergent homology with chromosomes IV, X and XIV, similar to mammalian segmental duplications, was 'at risk' for participating in duplication-mediated GCRs generated by homologous recombination. Numerous genes and pathways, including SGS1, TOP3, RMI1, SRS2, RAD6, SLX1, SLX4, SLX5, MSH2, MSH6, RAD10 and the DNA replication stress checkpoint requiring MRC1 and TOF1, were highly specific for suppressing these GCRs compared to GCRs mediated by single-copy sequences. These results indicate that the mechanisms for formation and suppression of rearrangements occurring in regions containing at-risk sequences differ from those occurring in regions of single-copy sequence. This explains how extensive genome instability is prevented in eukaryotic cells whose genomes contain numerous divergent repeated sequences.	[Putnam, Christopher D.; Hayes, Tikvah K.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Putnam, Christopher D.; Hayes, Tikvah K.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Putnam, Christopher D.; Hayes, Tikvah K.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu		Putnam, Christopher/0000-0002-6145-1265	NIH [GM26017]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026017, R01GM026017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Acknowledgements We thank the UCSD Microarray Core Facility for assistance in the aCGH experiments and C. Smith, S. Shell and J. Petrini for comments on the manuscript. This work was supported by NIH grant GM26017.	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bosco G, 1998, GENETICS, V150, P1037; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Deem A, 2008, GENETICS, V179, P1845, DOI 10.1534/genetics.108.087940; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; Gorringe KL, 2005, CARCINOGENESIS, V26, P923, DOI 10.1093/carcin/bgi032; HARRIS S, 1993, GENETICS, V135, P5; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hwang JY, 2005, GENETICS, V169, P1927, DOI 10.1534/genetics.104.039768; *J HOPK U NAT CTR, 1999, ONL MEND INH MAN OMI; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mertens F., 1991, CATALOG CHROMOSOME A; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Mullen JR, 2001, GENETICS, V157, P103; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Putnam CD, 2005, MOL CELL BIOL, V25, P7226, DOI 10.1128/MCB.25.16.7226-7238.2005; Ribas M, 2002, FASEB J, V16, P289, DOI 10.1096/fj.02-0425fje; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Schmidt KH, 2004, MOL CELL BIOL, V24, P3213, DOI 10.1128/MCB.24.8.3213-3226.2004; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Spell RM, 2004, GENETICS, V168, P1855, DOI 10.1534/genetics.104.032771; Stankiewicz P, 2006, GENOME DYN, V1, P1, DOI 10.1159/000092496; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; Umezu K, 2002, GENETICS, V160, P97; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	52	100	100	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					984	U65		10.1038/nature08217	http://dx.doi.org/10.1038/nature08217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19641493	Green Accepted			2022-12-28	WOS:000269085500028
J	Verheugt, FWA				Verheugt, Freek W. A.			Who is ineligible for warfarin in atrial fibrillation?	LANCET			English	Editorial Material							ST-SEGMENT ELEVATION; MYOCARDIAL-INFARCTION; CONTROLLED-TRIAL; CLOPIDOGREL; ASPIRIN; THERAPY; STROKE		Onze Lieve Vrouw Hosp, Dept Cardiol, NL-1091 AC Amsterdam, Netherlands	Onze Lieve Vrouwe Gasthuis Hospital	Verheugt, FWA (corresponding author), Onze Lieve Vrouw Hosp, Dept Cardiol, NL-1091 AC Amsterdam, Netherlands.	f.w.a.verheugt@olvg.nl	Verheugt, F.W.A./H-8105-2014					Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Lip GYH, 2002, BRIT MED J, V325, P1022, DOI 10.1136/bmj.325.7371.1022; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Verheugt FWA, 2003, LANCET, V362, P1686, DOI 10.1016/S0140-6736(03)14880-5; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; Yusuf S, 2001, NEW ENGL J MED, V345, P494	9	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					510	511		10.1016/S0140-6736(09)61471-9	http://dx.doi.org/10.1016/S0140-6736(09)61471-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683630				2022-12-28	WOS:000269019400008
J	Gilbert, N				Gilbert, Natasha			Who speaks for science in Europe?	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					672	673		10.1038/460672a	http://dx.doi.org/10.1038/460672a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661878	Bronze			2022-12-28	WOS:000268670300006
J	Paras, ML; Murad, MH; Chen, LP; Goranson, EN; Sattler, AL; Colbenson, KM; Elamin, MB; Seime, RJ; Prokop, LJ; Zirakzadeh, A				Paras, Molly L.; Murad, Mohammad Hassan; Chen, Laura P.; Goranson, Erin N.; Sattler, Amelia L.; Colbenson, Kristina M.; Elamin, Mohamed B.; Seime, Richard J.; Prokop, Larry J.; Zirakzadeh, Ali			Sexual Abuse and Lifetime Diagnosis of Somatic Disorders A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CHRONIC PELVIC PAIN; POSTTRAUMATIC-STRESS-DISORDER; IRRITABLE-BOWEL-SYNDROME; CORTICOTROPIN-RELEASING-FACTOR; HEALTH-CARE UTILIZATION; PITUITARY-ADRENAL AXIS; CHILDHOOD ABUSE; PHYSICAL ABUSE; PSYCHIATRIC DIAGNOSES; FIBROMYALGIA SYNDROME	Context Many patients presenting for general medical care have a history of sexual abuse. The literature suggests an association between a history of sexual abuse and somatic sequelae. Objective To systematically assess the association between sexual abuse and a lifetime diagnosis of somatic disorders. Data Sources and Extraction A systematic literature search of electronic databases from January 1980 to December 2008. Pairs of reviewers extracted descriptive, quality, and outcome data from included studies. Odds ratios (ORs) and 95% confidence intervals (CIs) were pooled across studies by using the random-effects model. The I-2 statistic was used to assess heterogeneity. Study Selection Eligible studies were longitudinal (case-control and cohort) and reported somatic outcomes in persons with and without history of sexual abuse. Results The search identified 23 eligible studies describing 4640 subjects. There was a significant association between a history of sexual abuse and lifetime diagnosis of functional gastrointestinal disorders (OR, 2.43; 95% CI, 1.36-4.31; I-2=82%; 5 studies), nonspecific chronic pain ( OR, 2.20; 95% CI, 1.54-3.15; 1 study), psychogenic seizures (OR, 2.96; 95% CI, 1.12-4.69, I-2=0%; 3 studies), and chronic pelvic pain (OR, 2.73; 95% CI, 1.73-4.30, I-2=40%; 10 studies). There was no statistically significant association between sexual abuse and a lifetime diagnosis of fibromyalgia (OR, 1.61; 95% CI, 0.85-3.07, I-2=0%; 4 studies), obesity ( OR, 1.47; 95% CI, 0.88-2.46; I-2=71%; 2 studies), or headache (OR, 1.49; 95% CI, 0.96-2.31; 1 study). We found no studies that assessed syncope. When analysis was restricted to studies in which sexual abuse was defined as rape, significant associations were observed between rape and a lifetime diagnosis of fibromyalgia (OR, 3.35; 95% CI, 1.51-7.46), chronic pelvic pain (OR, 3.27; 95% CI, 1.02-10.53), and functional gastrointestinal disorders (OR, 4.01; 95% CI, 1.88-8.57). Conclusion Evidence suggests a history of sexual abuse is associated with lifetime diagnosis of multiple somatic disorders. JAMA. 2009; 302(5):550-561 www.jama.com	[Zirakzadeh, Ali] Mayo Clin, Dept Gen Internal Med, Rochester, MN 55906 USA; [Paras, Molly L.; Chen, Laura P.; Goranson, Erin N.; Sattler, Amelia L.; Colbenson, Kristina M.] Mayo Clin, Coll Med, Rochester, MN 55906 USA; [Murad, Mohammad Hassan] Mayo Clin, Div Prevent Med, Rochester, MN 55906 USA; [Murad, Mohammad Hassan; Elamin, Mohamed B.] Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN 55906 USA; [Prokop, Larry J.] Mayo Clin, Mayo Clin Lib, Rochester, MN 55906 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Zirakzadeh, A (corresponding author), Mayo Clin, Dept Gen Internal Med, 200 1st St SW, Rochester, MN 55906 USA.	zirakzadeh.ali@mayo.edu	Murad, M. Hassan/AAW-4367-2020	Murad, Mohammad Hassan/0000-0001-5502-5975; Paras, Molly/0000-0001-6658-8634				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Basile Kathleen C, 2007, Violence Vict, V22, P437, DOI 10.1891/088667007781553955; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; *BIOST INC, 2005, COMPR MET COMP PROGR; BOISSETPIORO MH, 1995, ARTHRITIS RHEUM, V38, P235, DOI 10.1002/art.1780380212; Bonomi AE, 2008, J GEN INTERN MED, V23, P294, DOI 10.1007/s11606-008-0516-1; Bradley RG, 2001, CLIN PSYCHOL REV, V21, P1, DOI 10.1016/S0272-7358(00)00077-5; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; Chelminski PR, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-3; Ciccone DS, 2005, CLIN J PAIN, V21, P378, DOI 10.1097/01.ajp.0000149796.08746.ea; CLARK M, 1999, FORMULATING PROBLEM; Coid J, 2003, BRIT J GEN PRACT, V53, P858; Collett BJ, 1998, BRIT J OBSTET GYNAEC, V105, P87, DOI 10.1111/j.1471-0528.1998.tb09356.x; CROFT P, 1993, J RHEUMATOL, V20, P710; Delvaux M, 1997, EUR J GASTROEN HEPAT, V9, P345, DOI 10.1097/00042737-199704000-00006; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dikel TN, 2003, EPILEPSY BEHAV, V4, P644, DOI 10.1016/j.yebeh.2003.08.006; DROSSMAN DA, 1990, ANN INTERN MED, V113, P828, DOI 10.7326/0003-4819-113-11-828; Dube SR, 2005, AM J PREV MED, V28, P430, DOI 10.1016/j.amepre.2005.01.015; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Ehlert U, 1999, PSYCHOTHER PSYCHOSOM, V68, P87, DOI 10.1159/000012318; FELITTI VJ, 1993, SOUTHERN MED J, V86, P732, DOI 10.1097/00007611-199307000-00002; FELITTI VJ, 1991, SOUTHERN MED J, V84, P328, DOI 10.1097/00007611-199103000-00008; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Goodman GS, 2003, PSYCHOL SCI, V14, P113, DOI 10.1111/1467-9280.01428; GOODWIN J, 1979, AM J ORTHOPSYCHIAT, V49, P698, DOI 10.1111/j.1939-0025.1979.tb02655.x; Griep EN, 1998, J RHEUMATOL, V25, P1374; HARROPGRIFFITHS J, 1988, OBSTET GYNECOL, V71, P589; Hasler WL, 2003, ALIMENT PHARM THER, V17, P997, DOI 10.1046/j.1365-2036.2003.01499.x; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Heim C, 1998, PSYCHOSOM MED, V60, P309, DOI 10.1097/00006842-199805000-00017; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HUDSON JI, 1995, ARTHRITIS RHEUM, V38, P161, DOI 10.1002/art.1780380203; Hulme PA, 2000, CHILD ABUSE NEGLECT, V24, P1471, DOI 10.1016/S0145-2134(00)00200-3; JUMPER SA, 1995, CHILD ABUSE NEGLECT, V19, P715, DOI 10.1016/0145-2134(95)00029-8; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kellogg ND, 2003, CHILD ABUSE NEGLECT, V27, P1367, DOI 10.1016/j.chiabu.2003.10.008; Kogan SM, 2004, CHILD ABUSE NEGLECT, V28, P147, DOI 10.1016/j.chiabu.2003.09.014; Koloski NA, 2005, DIGESTION, V72, P86, DOI 10.1159/000087722; Lampe A, 2000, OBSTET GYNECOL, V96, P929, DOI 10.1016/S0029-7844(00)01072-3; Lampe A, 2003, J PSYCHOSOM RES, V54, P361, DOI 10.1016/S0022-3999(02)00399-9; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Longstreth GF, 2004, GASTROENTEROLOGY, V126, P1665, DOI 10.1053/j.gastro.2004.02.020; Lowry CA, 2006, GEN COMP ENDOCR, V146, P19, DOI 10.1016/j.ygcen.2005.12.006; Maillot C, 2000, GASTROENTEROLOGY, V119, P1569, DOI 10.1053/gast.2000.20251; Martinez V, 2004, J PHYSIOL-LONDON, V556, P221, DOI 10.1113/jphysiol.2003.059659; McEuen JG, 2008, J NEUROSCI, V28, P8169, DOI 10.1523/JNEUROSCI.0004-08.2008; Million M, 2007, AM J PHYSIOL-REG I, V292, pR1429, DOI 10.1152/ajpregu.00626.2006; Murad MH, 2008, J VASC SURG, V48, p26S, DOI 10.1016/j.jvs.2008.08.045; Nemeroff CB, 1999, MOL PSYCHIATR, V4, P106, DOI 10.1038/sj.mp.4000512; Noll JG, 2007, PEDIATRICS, V120, pE61, DOI 10.1542/peds.2006-3058; Paolucci EO, 2001, J PSYCHOL, V135, P17, DOI 10.1080/00223980109603677; Parris W C, 1985, J Tenn Med Assoc, V78, P493; PENNEBAKER JW, 1985, CAN PSYCHOL, V26, P82, DOI 10.1037/h0080025; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Priebe G, 2008, CHILD ABUSE NEGLECT, V32, P1095, DOI 10.1016/j.chiabu.2008.04.001; Raghavan R, 2004, PERSPECT SEX REPRO H, V36, P225, DOI 10.1111/j.1931-2393.2004.tb00026.x; Raphael KG, 2001, PAIN, V92, P283, DOI 10.1016/S0304-3959(01)00270-6; RAPKIN AJ, 1990, OBSTET GYNECOL, V76, P92; REINHARD MJ, 2004, LONG TERM NEUROPSYCH; REITER RC, 1990, OBSTET GYNECOL, V75, P428; Rengaraj R, 2005, NEUROL INDIA, V53, P308; Resick PA, 2003, CNS SPECTR, V8, P340, DOI 10.1017/S1092852900018605; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; RIMSZA ME, 1988, CHILD ABUSE NEGLECT, V12, P201, DOI 10.1016/0145-2134(88)90028-2; Romans S, 2002, PSYCHOTHER PSYCHOSOM, V71, P141, DOI 10.1159/000056281; ROTHBAUM BO, 1992, J TRAUMA STRESS, V5, P455, DOI 10.1007/BF00977239; Sachs-Ericsson N, 2007, CHILD ABUSE NEGLECT, V31, P531, DOI 10.1016/j.chiabu.2006.12.007; Sachs-Ericsson N, 2009, J TRAUMA DISSOCIATIO, V10, P170, DOI 10.1080/15299730802624585; Salmon P, 2003, PSYCHOSOM MED, V65, P695, DOI 10.1097/01.PSY.0000075976.20244.D8; SALTO YA, 2002, AM J GASTROENTEROL, V97, P1910; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suris A, 2004, PSYCHOSOM MED, V66, P749, DOI 10.1097/01.psy.0000138117.58559.7b; TALLEY NJ, 1991, GASTROENTEROLOGY, V101, P927, DOI 10.1016/0016-5085(91)90717-Y; Tang B, 2006, SOC SCI MED, V63, P1711, DOI 10.1016/j.socscimed.2006.04.015; TAYLOR ML, 1995, ARTHRITIS RHEUM, V38, P229, DOI 10.1002/art.1780380211; Thompson CA, 2007, AM J HEALTH-SYST PH, V64, P1020, DOI 10.2146/news070044; WALKER E, 1988, AM J PSYCHIAT, V145, P75; WALKER EA, 1995, PSYCHOSOMATICS, V36, P531, DOI 10.1016/S0033-3182(95)71608-5; WALKER EA, 1993, AM J PSYCHIAT, V150, P1502; Walker EA, 1999, ARCH GEN PSYCHIAT, V56, P609, DOI 10.1001/archpsyc.56.7.609; Walker EA, 1997, PSYCHOSOM MED, V59, P572, DOI 10.1097/00006842-199711000-00003; Wells G., NEWCASTLE OTTAWA SCA; Widom CS, 1997, PSYCHOL ASSESSMENT, V9, P34, DOI 10.1037/1040-3590.9.1.34; WILLIAMS LM, 1994, J CONSULT CLIN PSYCH, V62, P1167, DOI 10.1037//0022-006X.63.3.343; Wingenfeld K, 2008, PSYCHOSOM MED, V70, P65, DOI 10.1097/PSY.0b013e31815ff3ce; Wingenfeld K, 2007, J PSYCHOSOM RES, V62, P85, DOI 10.1016/j.jpsychores.2006.06.006; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; World Health Organization, 2002, WORLD REPORT VIOLENC; Wyatt GE, 1999, CHILD ABUSE NEGLECT, V23, P45, DOI 10.1016/S0145-2134(98)00110-0; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	92	300	302	1	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					550	561		10.1001/jama.2009.1091	http://dx.doi.org/10.1001/jama.2009.1091			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479DS	19654389				2022-12-28	WOS:000268640500019
J	Steel, Z; Chey, T; Silove, D; Marnane, C; Bryant, RA; van Ommeren, M				Steel, Zachary; Chey, Tien; Silove, Derrick; Marnane, Claire; Bryant, Richard A.; van Ommeren, Mark			Association of Torture and Other Potentially Traumatic Events With Mental Health Outcomes Among Populations Exposed to Mass Conflict and Displacement A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSTTRAUMATIC-STRESS-DISORDER; DOSE-EFFECT RELATIONSHIPS; VIETNAMESE REFUGEES; PSYCHIATRIC-DISORDERS; PSYCHOLOGICAL TRAUMA; LIFETIME PREVALENCE; BHUTANESE REFUGEES; WAR; DEPRESSION; SURVIVORS	Context Uncertainties continue about the roles that methodological factors and key risk factors, particularly torture and other potentially traumatic events (PTEs), play in the variation of reported prevalence rates of posttraumatic stress disorder (PTSD) and depression across epidemiologic surveys among postconflict populations worldwide. Objective To undertake a systematic review and meta-regression of the prevalence rates of PTSD and depression in the refugee and postconflict mental health field. Data Sources An initial pool of 5904 articles, identified through MEDLINE, PsycINFO and PILOTS, of surveys involving refugee, conflict-affected populations, or both, published in English-language journals between 1980 and May 2009. Study Selection Surveys were limited to those of adult populations (n >= 50) reporting PTSD prevalence, depression prevalence, or both. Excluded surveys comprised patients, war veterans, and civilian populations (nonrefugees/asylum seekers) from high-income countries exposed to terrorist attacks or involved in distal conflicts (>= 25 years). Data Extraction Methodological factors ( response rate, sample size and design, diagnostic method) and substantive factors (sociodemographics, place of survey, torture and other PTEs, Political Terror Scale score, residency status, time since conflict). Data Synthesis A total of 161 articles reporting results of 181 surveys comprising 81 866 refugees and other conflict-affected persons from 40 countries were identified. Rates of reported PTSD and depression showed large intersurvey variability (0%-99% and 3%-85.5%, respectively). The unadjusted weighted prevalence rate reported across all surveys for PTSD was 30.6% (95% CI, 26.3%-35.2%) and for depression was 30.8% (95% CI, 26.3%-35.6%). Methodological factors accounted for 12.9% and 27.7% PTSD and depression, respectively. Nonrandom sampling, small sample sizes, and self-report questionnaires were associated with higher rates of mental disorder. Adjusting for methodological factors, reported torture (Delta total R-2 between base methodological model and base model + substantive factor [Delta R-2]=23.6%; OR, 2.01; 95% CI, 1.52-2.65) emerged as the strongest factor associated with PTSD, followed by cumulative exposure to PTEs (Delta R-2=10.8%; OR, 1.52; 95% CI, 1.21-1.91), time since conflict (Delta R-2=10%; OR, 0.77; 95% CI, 0.66-0.91), and assessed level of political terror (Delta R-2=3.5%; OR, 1.60; 95% CI, 1.03-2.50). For depression, significant factors were number of PTEs (Delta R-2=22.0%; OR, 1.64; 95% CI, 1.39-1.93), time since conflict (Delta R-2=21.9%; OR, 0.80; 95% CI, 0.69-0.93), reported torture (Delta R-2= 11.4%; OR, 1.48; 95% CI, 1.07-2.04), and residency status (Delta R-2= 5.0%; OR, 1.30; 95% CI, 1.07-1.57). Conclusion Methodological factors and substantive population risk factors, such as exposure to torture and other PTEs, after adjusting for methodological factors account for higher rates of reported prevalence of PTSD and depression. JAMA. 2009;302(5):537-549 www.jama.com	[Steel, Zachary; Chey, Tien; Silove, Derrick; Marnane, Claire] Univ New S Wales, Psychiat Res & Teaching Unit, Liverpool, NSW, Australia; [Bryant, Richard A.] Univ New S Wales, Sch Psychol, Liverpool, NSW, Australia; [van Ommeren, Mark] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland	University of New South Wales Sydney; University of New South Wales Sydney; World Health Organization	Steel, Z (corresponding author), Liverpool Hosp, Mental Hlth Ctr, Ctr Populat Mental Hlth Res, Level 1,Corner Forbes & Campbell St, Liverpool, NSW 2710, Australia.	z.steel@unsw.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X; Steel, Zachary/0000-0002-5048-2920	National Health and Medical Research Council Program [300403]	National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grant 300403 from the National Health and Medical Research Council Program.	Alhasnawi S, 2009, WORLD PSYCHIATRY, V8, P97; *AMN INT, AMN INT REP 2008; BASOGLU M, 1994, AM J PSYCHIAT, V151, P76; Beusenberg M, 1994, USERS GUIDE SELF REP; Bleich A, 2003, JAMA-J AM MED ASSOC, V290, P612, DOI 10.1001/jama.290.5.612; BRACKEN PJ, 1995, SOC SCI MED, V40, P1073, DOI 10.1016/0277-9536(94)00181-R; de Jong K, 2000, LANCET, V355, P2067, DOI 10.1016/S0140-6736(00)02364-3; DERSHOWITZ A, 2004, NEW YORK LAW SCH REV, V48, P275; Egger M, 1998, BRIT MED J, V316, P140; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; First M. B., 1997, STRUCTURED CLIN INTE; Fox SH, 2000, J NERV MENT DIS, V188, P490, DOI 10.1097/00005053-200008000-00003; Gibney, 1996, POLICY STUDIES DEV N, V4, P73; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; Hashemian F, 2006, JAMA-J AM MED ASSOC, V296, P560, DOI 10.1001/jama.296.5.560; HAUFF E, 1995, BRIT J PSYCHIAT, V166, P360, DOI 10.1192/bjp.166.3.360; Hollifield M, 2002, JAMA-J AM MED ASSOC, V288, P611, DOI 10.1001/jama.288.5.611; Hollifield M, 2005, COMPR PSYCHIAT, V46, P67, DOI 10.1016/j.comppsych.2004.07.003; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Inter-Agency Standing Committee (IASC), 2007, IASC GUID MENT HLTH; Johnson H, 2008, CLIN PSYCHOL REV, V28, P36, DOI 10.1016/j.cpr.2007.01.017; Karam E, 2003, CURR OPIN PSYCHIATR, V16, P413, DOI 10.1097/01.yco.0000079211.36371.1b; Karam EG, 2008, PLOS MED, V5, P579, DOI 10.1371/journal.pmed.0050061; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Khoshdel A, 2006, INT J CLIN PRACT, V60, P1287, DOI 10.1111/j.1742-1241.2006.01078.x; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; Miller KE, 2006, AM J ORTHOPSYCHIAT, V76, P409, DOI 10.1037/0002-9432.76.4.409; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Mollica RF, 1998, J NERV MENT DIS, V186, P543, DOI 10.1097/00005053-199809000-00005; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; Momartin S, 2006, MED J AUSTRALIA, V185, P357, DOI 10.5694/j.1326-5377.2006.tb00610.x; Murthy RS, 2006, WORLD PSYCHIATRY, V5, P25; Obermeyer Z, 2008, BMJ-BRIT MED J, V336, p1482A, DOI 10.1136/bmj.a137; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Porter Matthew, 2007, Transcult Psychiatry, V44, P418, DOI 10.1177/1363461507081639; Quiroga JJ, 2005, TORTURE, V16, P3; RODIN D, 2009, INT J EPIDEMIOL; *SAS I INC, 2002, SAS SOFTW COMP PROGR; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; Silove D, 1999, J NERV MENT DIS, V187, P200, DOI 10.1097/00005053-199904000-00002; Silove D, 2000, JAMA-J AM MED ASSOC, V284, P604, DOI 10.1001/jama.284.5.604; Steel Z, 2006, BRIT J PSYCHIAT, V188, P58, DOI 10.1192/bjp.bp.104.007864; Steel Z, 2005, ACTA PSYCHIAT SCAND, V111, P300, DOI 10.1111/j.1600-0447.2004.00458.x; Steel Z, 2002, LANCET, V360, P1056, DOI 10.1016/S0140-6736(02)11142-1; Stein DJ, 2008, BRIT J PSYCHIAT, V192, P112, DOI 10.1192/bjp.bp.106.029280; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Summerfield D, 1999, SOC SCI MED, V48, P1449, DOI 10.1016/S0277-9536(98)00450-X; Tennant C, 2002, AUST NZ J PSYCHIAT, V36, P173, DOI 10.1046/j.1440-1614.2002.01007.x; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; *UN HIGH COMM REF, 2008, STAT YB 2007 TRENDS; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; van Ommeren M, 2005, B WORLD HEALTH ORGAN, V83, P71; van Ommeren M, 2005, BRIT MED J, V330, P1160, DOI 10.1136/bmj.330.7501.1160; Van Ommeren M, 2001, ARCH GEN PSYCHIAT, V58, P475, DOI 10.1001/archpsyc.58.5.475; Wakefield, 2007, LOSS SADNESS PSYCHIA; Weathers FW, 2007, J TRAUMA STRESS, V20, P107, DOI 10.1002/jts.20210; Weathers FW, 1993, 9 ANN M INT SOC TRAU; Wenzel T, 2007, CURR OPIN PSYCHIATR, V20, P491, DOI 10.1097/YCO.0b013e3282c3a5c1; Wilczynski Nancy L, 2006, Ann Gen Psychiatry, V5, P4, DOI 10.1186/1744-859X-5-4; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Zlotnick C, 2006, PSYCHOL MED, V36, P1523, DOI 10.1017/S0033291706008282; PILOTS DATABASE ELEC	65	1184	1197	4	184	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					537	549		10.1001/jama.2009.1132	http://dx.doi.org/10.1001/jama.2009.1132			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479DS	19654388				2022-12-28	WOS:000268640500018
J	Freemantle, N; Wood, J; Griffin, C; Gill, P; Calvert, MJ; Shankar, A; Chambers, J; MacArthur, C				Freemantle, Nick; Wood, J.; Griffin, C.; Gill, P.; Calvert, M. J.; Shankar, A.; Chambers, J.; MacArthur, C.			What factors predict differences in infant and perinatal mortality in primary care trusts in England? A prognostic model	BRITISH MEDICAL JOURNAL			English	Article							HEALTH; BIRTH; RISK	Objective To identify predictors of perinatal and infant mortality variations between primary care trusts (PCTs) and identify outlier trusts where outcomes were worse than expected. Design Prognostic multivariable mixed models attempting to explain observed variability between PCTs in perinatal and infant mortality. We used these predictive models to identify PCTs with higher than expected rates of either outcome. Setting All primary care trusts in England. Population For each PCT, data on the number of infant and perinatal deaths, ethnicity, deprivation, maternal age, PCT spending on maternal services, and "Spearhead" status. Main outcome measures Rates of perinatal and infant mortality across PCTs. Results The final models for infant mortality and perinatal mortality included measures of deprivation, ethnicity, and maternal age. The final model for infant mortality explained 70% of the observed heterogeneity in outcome between PCTs. The final model for perinatal mortality explained 80.5% of the between-PCT heterogeneity. PCT spending on maternal services did not explain differences in observed events. Two PCTs had higher than expected rates of perinatal mortality. Conclusions Social deprivation, ethnicity, and maternal age are important predictors of infant and perinatal mortality. Spearhead PCTs are performing in line with expectations given their levels of deprivation, ethnicity, and maternal age. Higher spending on maternity services using the current configuration of services may not reduce rates of infant and perinatal mortality.	[Freemantle, Nick; Gill, P.; Calvert, M. J.; MacArthur, C.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Wood, J.] Univ E Anglia, Dept Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England; [Griffin, C.] Sandwell Primary Care Trust, W Bromwich B70 9LD, England; [Shankar, A.] UCL, Hlth & Social Surveys Res Grp, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Chambers, J.] Heart Birmingham PCT, Birmingham B16 9NX, W Midlands, England	University of Birmingham; University of East Anglia; University of London; University College London	Freemantle, N (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	N.Freemantle@bham.ac.uk	MacArthur, Christine/ABA-8601-2021; Shankar, Aparna/S-9592-2019; Calvert, Melanie/F-7055-2011	MacArthur, Christine/0000-0003-0434-2158; Calvert, Melanie/0000-0002-1856-837X; Freemantle, Nick/0000-0001-5807-5740; Shankar, Aparna/0000-0002-7948-8189	Birmingham Health and Wellbeing partnership	Birmingham Health and Wellbeing partnership	Funded by the Birmingham Health and Wellbeing partnership.	Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; AHMAD WIU, 1994, J PUBLIC HEALTH MED, V16, P423, DOI 10.1093/oxfordjournals.pubmed.a043023; [Anonymous], 2008, PER MORT 2006 ENGL W; Bakeo AC, 2006, PAEDIATR PERINAT EP, V20, P127, DOI 10.1111/j.1365-3016.2006.00708.x; BRAMBLEY P, 2007, BETTER ALLOCATION BE; Bundey S, 1991, Paediatr Perinat Epidemiol, V5, P101, DOI 10.1111/j.1365-3016.1991.tb00689.x; Collett D, 2002, MODELLING BINARY DAT; *DEP HLTH, HLTH IN REV LIST SPR; *DEP HLTH, 2003, TACKL HLTH IN PROGR; *DEP HLTH, PROGR BUDG CAT 18 MA; Department of Health, 2006, TACKL HLTH IN 2003 0; Gill P. S., 2007, HLTH CARE NEEDS ASSE; Glinianaia SV, 2005, J CLIN EPIDEMIOL, V58, P1299, DOI 10.1016/j.jclinepi.2005.03.015; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; KELSEY JL, 1986, METHODS OBSERVATIONA; MacArthur C, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b131; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Modell, 1997, COMMUNITY CONTROL GE; Nixon John, 2006, Eur J Health Econ, V7, P7, DOI 10.1007/s10198-005-0336-8; Noble M, 2004, INDICES DEPRIVATION; Reddy UM, 2006, AM J OBSTET GYNECOL, V195, P764, DOI 10.1016/j.ajog.2006.06.019	21	18	18	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 4	2009	339								b2892	10.1136/bmj.b2892	http://dx.doi.org/10.1136/bmj.b2892			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KB	19654185	hybrid, Green Published			2022-12-28	WOS:000268807800003
J	Jia, T; Pamer, EG				Jia, Ting; Pamer, Eric G.			Dispensable But Not Irrelevant	SCIENCE			English	Editorial Material							MONOCYTE SUBSETS; DENDRITIC CELLS; BONE-MARROW; CCR2; ATHEROSCLEROSIS; INFECTION; BLOOD; RISE; MICE		[Jia, Ting; Pamer, Eric G.] Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA; [Pamer, Eric G.] Mem Hosp, Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jia, T (corresponding author), Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA.	pamere@mskcc.org			NCI NIH HHS [P01 CA023766-320044, P01 CA023766] Funding Source: Medline; NIAID NIH HHS [R37 AI039031-16, R37 AI039031, R01 AI080619] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA023766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080619, R37AI039031] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Sabin FR, 1927, J EXP MED, V46, P627, DOI 10.1084/jem.46.4.627; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; ZIEGLERHEITBROCK HWL, 1988, HYBRIDOMA, V7, P521, DOI 10.1089/hyb.1988.7.521	13	21	22	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					549	550		10.1126/science.1178329	http://dx.doi.org/10.1126/science.1178329			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644100	Green Accepted			2022-12-28	WOS:000268493000028
J	Palmer, MA; Filoso, S				Palmer, Margaret A.; Filoso, Solange			Restoration of Ecosystem Services for Environmental Markets	SCIENCE			English	Editorial Material							STREAM RESTORATION; WETLANDS; GOALS; NEED	Ecological restoration is an activity that ideally results in the return of an ecosystem to an undisturbed state. Ecosystem services are the benefits humans derive from ecosystems. The two have been joined to support growing environmental markets with the goal of creating restoration-based credits that can be bought and sold. However, the allure of these markets may be overshadowing shortcomings in the science and practice of ecological restoration. Before making risky investments, we must understand why and when restoration efforts fall short of recovering the full suite of ecosystem services, what can be done to improve restoration success, and why direct measurement of the biophysical processes that support ecosystem services is the only way to guarantee the future success of these markets. Without new science and an oversight framework to protect the ecosystem service assets on which people depend, markets could actually accelerate environmental degradation.	[Palmer, Margaret A.; Filoso, Solange] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Palmer, Margaret A.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Center for Environmental Science; University System of Maryland; University of Maryland College Park	Palmer, MA (corresponding author), Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA.	mpalmer@umd.edu	Filoso, Solange/G-4461-2015; Palmer, Margaret A/F-9648-2013	Palmer, Margaret A/0000-0003-1468-7993				AMBROSE RF, 2007, EVALUATION COMPENSAT; BenDor T, 2007, J AM PLANN ASSOC, V73, P263, DOI 10.1080/01944360708977977; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Ehrenfeld JG, 2000, RESTOR ECOL, V8, P2, DOI 10.1046/j.1526-100x.2000.80002.x; Euliss NH, 2008, WETLANDS, V28, P553, DOI 10.1672/07-154.1; Helfield JM, 1997, ENVIRON MANAGE, V21, P329, DOI 10.1007/s002679900033; Hepburn C, 2007, ANNU REV ENV RESOUR, V32, P375, DOI 10.1146/annurev.energy.32.053006.141203; Hoeltje SM, 2009, ENVIRON MANAGE, V43, P597, DOI 10.1007/s00267-008-9180-9; King D, 2002, ENV LAW REV, V32, P11317; Lave R., 2008, ECOLOGICAL RESTORATI, V26, P287, DOI [10.3368/er.26.4.287, DOI 10.3368/ER.26.4.287]; Leopold Aldo, 1949, S COUNTY ALMANAC; Palmer MA, 2009, ESTUAR COAST, V32, P1, DOI 10.1007/s12237-008-9129-5; Rumps JM, 2007, RESTOR ECOL, V15, P506, DOI 10.1111/j.1526-100X.2007.00246.x; Tischew S, 2010, RESTOR ECOL, V18, P467, DOI 10.1111/j.1526-100X.2008.00462.x; WAINGER LA, 2009, ECOSYSTEM BASED MANA, pCH6; ZINN JA, 2008, PUBL C RES SERVICE; 2008, FED REG, V73, P9594	19	193	206	11	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					575	576		10.1126/science.1172976	http://dx.doi.org/10.1126/science.1172976			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644112				2022-12-28	WOS:000268493000040
J	Lipsitch, M; Hayden, FG; Cowling, BJ; Leung, GM				Lipsitch, Marc; Hayden, Frederick G.; Cowling, Benjamin J.; Leung, Gabriel M.			How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count	LANCET			English	Editorial Material									[Lipsitch, Marc] Harvard Univ, Ctr Communicable Dis Dynam, Dept Epidemiol, Dept Immunol & Infect Dis,Sch Publ Hlth, Boston, MA 02115 USA; [Hayden, Frederick G.] Univ Virginia, Sch Med, Div Infect Dis & Int Hlth, Dept Med, Charlottesville, VA 22908 USA; [Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Leung, Gabriel M.] Govt Hong Kong Special Adm Reg, Food & Hlth Bur, Hong Kong, Hong Kong, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; University of Virginia; University of Hong Kong	Lipsitch, M (corresponding author), Harvard Univ, Ctr Communicable Dis Dynam, Dept Epidemiol, Dept Immunol & Infect Dis,Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	mlipsitc@hsph.harvard.edu	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154; Leung, Gabriel/0000-0002-2503-6283; Lipsitch, Marc/0000-0003-1504-9213	NIGMS NIH HHS [U01 GM076497] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM076497] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; *CDC, 2009, FLU ACT SURV REP SUR; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; *ECDC, 2009, 1 IS SEC OLS A H1N1; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Fleming DM, 2008, EPIDEMIOL INFECT, V136, P866, DOI 10.1017/S0950268807009910; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; van Noort S P, 2007, Euro Surveill, V12, pE5; *WHO, 2009, SEAS INFL ACT WORLD; World Health Organization, 2009, HUM INF PAND H1N1 20	14	71	75	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1209	1211		10.1016/S0140-6736(09)61377-5	http://dx.doi.org/10.1016/S0140-6736(09)61377-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505IZ	19679345				2022-12-28	WOS:000270688200037
J	Ferrer, M; Sellares, J; Valencia, M; Carrillo, A; Gonzalez, G; Badia, JR; Nicolas, JM; Torres, A				Ferrer, Miquel; Sellares, Jacobo; Valencia, Mauricio; Carrillo, Andres; Gonzalez, Gumersindo; Ramon Badia, Joan; Maria Nicolas, Josep; Torres, Antoni			Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial	LANCET			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; POSITIVE-PRESSURE VENTILATION; MECHANICAL VENTILATION; ACUTE EXACERBATIONS; COPD PATIENTS; FAILURE; RISK; PNEUMONIA; ETIOLOGY; SUPPORT	Background Non-invasive ventilation can prevent respiratory failure after extubation in individuals at increased risk of this complication, and enhanced survival in patients with hypercapnia has been recorded. We aimed to assess prospectively the effectiveness of non-invasive ventilation after extubation in patients with hypercapnia and as rescue therapy when respiratory failure develops. Methods We undertook a randomised controlled trial in three intensive-care units in Spain. We enrolled 106 mechanically ventilated patients with chronic respiratory disorders and hypercapnia after a successful spontaneous breathing trial. We randomly allocated participants by computer to receive after extubation either non-invasive ventilation for 24 h (n=54) or conventional oxygen treatment (n=52). The primary endpoint was avoidance of respiratory failure within 72 h after extubation. Analysis was by intention to treat. This trial is registered with clinicaltrials.gov, identifier NCT00539708. Findings Respiratory failure after extubation was less frequent in patients assigned non-invasive ventilation than in those allocated conventional oxygen therapy (8 [15%] vs 25 [48%]; odds ratio 5.32 [95% CI 2.11-13.46]; p<0.0001). In patients with respiratory failure, non-invasive ventilation as rescue therapy avoided reintubation in 17 of 27 patients. Non-invasive ventilation was independently associated with a lower risk of respiratory failure after extubation (adjusted odds ratio 0.17 [95% CI 0.06-0.44]; p<0.0001). 90-day mortality was lower in patients assigned non-invasive ventilation than in those allocated conventional oxygen (p=0.0146). Interpretation Early non-invasive ventilation after extubation diminished risk of respiratory failure and lowered 90-day mortality in patients with hypercapnia during a spontaneous breathing trial. Routine implementation of this strategy for management of mechanically ventilated patients with chronic respiratory disorders is advisable. Funding IDIBAPS, CibeRes, Fondo de Investigaciones Sanitarias, European Respiratory Society.	[Ferrer, Miquel; Sellares, Jacobo; Valencia, Mauricio; Ramon Badia, Joan; Torres, Antoni] Univ Barcelona, IDIBAPS, Hosp Clin, Serv Pneumol,Inst Clin Torax, E-08036 Barcelona, Spain; [Maria Nicolas, Josep] Univ Barcelona, IDIBAPS, Hosp Clin, Med Interna Serv, E-08036 Barcelona, Spain; [Carrillo, Andres; Gonzalez, Gumersindo] Hosp Morales Meseguer, Serv Cuidados Intens, Murcia, Spain; [Ferrer, Miquel; Sellares, Jacobo; Ramon Badia, Joan; Torres, Antoni] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Ferrer, M (corresponding author), Univ Barcelona, IDIBAPS, Hosp Clin, Serv Pneumol,Inst Clin Torax, Villarroel 170, E-08036 Barcelona, Spain.	miferrer@clinic.ub.es	Sellares, Jacobo/AAN-3250-2020; Torres, Antoni/H-6128-2017	Torres, Antoni/0000-0002-8643-2167; Sellares, Jacobo/0000-0001-6047-1670; Ferrer, Miguel/0000-0001-8171-6673	FIS [04/1130]; CibeRes [CB06/06/0028]; IDIBAPS; European Respiratory Society; Fondo de Investigaciones Sanitarias;  [2009 SGR 911]	FIS(Instituto de Salud Carlos III); CibeRes; IDIBAPS; European Respiratory Society; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); 	We thank the nursing staff of the three intensive-care units for their cooperation in this trial. This study was funded by grant FIS 04/1130, CibeRes (CB06/06/0028), 2009 SGR 911, and IDIBAPS (Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain). MV is supported by fellowships from the European Respiratory Society and Fondo de Investigaciones Sanitarias.	*AM THOR SOC, 2001, AM J RESP CRIT CARE, V163, P283; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; APPENDINI L, 1994, AM J RESP CRIT CARE, V149, P1069, DOI 10.1164/ajrccm.149.5.8173743; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; Carlucci A, 2003, INTENS CARE MED, V29, P419, DOI 10.1007/s00134-002-1574-1; Confalonieri M, 1999, AM J RESP CRIT CARE, V160, P1585, DOI 10.1164/ajrccm.160.5.9903015; Confalonieri M, 1996, EUR RESPIR J, V9, P422, DOI 10.1183/09031936.96.09030422; Epstein SK, 2002, INTENS CARE MED, V28, P535, DOI 10.1007/s00134-002-1268-8; Epstein SK, 1998, AM J RESP CRIT CARE, V158, P489, DOI 10.1164/ajrccm.158.2.9711045; Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186; Esteban A, 1999, AM J RESP CRIT CARE, V159, P512, DOI 10.1164/ajrccm.159.2.9803106; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Ferrer M, 2006, AM J RESP CRIT CARE, V173, P164, DOI 10.1164/rccm.200505-718OC; Ferrer M, 2003, AM J RESP CRIT CARE, V168, P1438, DOI 10.1164/rccm.200301-072OC; Ferrer M, 2003, AM J RESP CRIT CARE, V168, P70, DOI 10.1164/rccm.200209-1074OC; Girault C, 1999, AM J RESP CRIT CARE, V160, P86, DOI 10.1164/ajrccm.160.1.9802120; Hilbert G, 1998, EUR RESPIR J, V11, P1349, DOI 10.1183/09031936.98.11061349; Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238; KNAUS WA, 1985, ANN SURG, V202, P685, DOI 10.1097/00000658-198512000-00004; Lightowler JV, 2003, BMJ-BRIT MED J, V326, P185, DOI 10.1136/bmj.326.7382.185; Nava S, 2005, CRIT CARE MED, V33, P2465, DOI 10.1097/01.CCM.0000186416.44752.72; Nava S, 2003, AM J RESP CRIT CARE, V168, P1432, DOI 10.1164/rccm.200211-1270OC; Nava S, 1998, ANN INTERN MED, V128, P721, DOI 10.7326/0003-4819-128-9-199805010-00004; Nseir S, 2002, EUR RESPIR J, V20, P1483, DOI 10.1183/09031936.02.00012902; Plant PK, 2001, THORAX, V56, P708, DOI 10.1136/thorax.56.9.708; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Schettino G, 2008, CRIT CARE MED, V36, P441, DOI 10.1097/01.CCM.0000300084.67277.90; Stell IM, 2001, AM J RESP CRIT CARE, V164, P2092, DOI 10.1164/ajrccm.164.11.2011147; TORRES A, 1995, AM J RESP CRIT CARE, V152, P137, DOI 10.1164/ajrccm.152.1.7599812; Woodhead MA, 1997, PNEUMONIA, P1	30	217	232	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2009	374	9695					1082	1088		10.1016/S0140-6736(09)61038-2	http://dx.doi.org/10.1016/S0140-6736(09)61038-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19682735				2022-12-28	WOS:000270370900030
J	Wilson, JF				Wilson, Jennifer Fisher			Making Electronic Health Records Meaningful	ANNALS OF INTERNAL MEDICINE			English	News Item							AMBULATORY-CARE; QUALITY; ADOPTION; SYSTEM					jenwilson@acponline.org	Goldbach-Mansky, Raphaela/N-5917-2017	Wilson, Jennifer/0000-0003-4025-3136				Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Baron RJ, 2007, ANN INTERN MED, V147, P549, DOI 10.7326/0003-4819-147-8-200710160-00007; Baron RJ, 2005, ANN INTERN MED, V143, P222, DOI 10.7326/0003-4819-143-3-200508020-00008; Blumenthal D, 2009, NEW ENGL J MED, V360, P1477, DOI 10.1056/NEJMp0901592; Brown Steven H, 2007, Am J Public Health, V97 Suppl 1, pS136, DOI 10.2105/AJPH.2006.104943; Chen C, 2009, HEALTH AFFAIR, V28, P323, DOI 10.1377/hlthaff.28.2.323; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Grossman Joy M, 2006, Issue Brief Cent Stud Health Syst Change, P1; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; Kralewski JE, 2008, HEALTH CARE MANAGE R, V33, P361, DOI 10.1097/01.HCM.0000318773.67395.ce; Ross JS, 2008, ARCH INTERN MED, V168, P950, DOI 10.1001/archinte.168.9.950; Silvestre AL, 2009, HEALTH AFFAIR, V28, P334, DOI 10.1377/hlthaff.28.2.334	14	15	17	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2009	151	4								10.7326/0003-4819-151-4-200908180-00026	http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484IW	19687504				2022-12-28	WOS:000269038900023
J	Guenther, M; Wunderlich, C; Madisch, A; Altmann, O; Bergert, H; Gastmeier, J; Simonis, G; Strasser, RH				Guenther, Michael; Wunderlich, Carsten; Madisch, Ahmed; Altmann, Olaf; Bergert, Hendrik; Gastmeier, Joerg; Simonis, Gregor; Strasser, Ruth H.			Beans in the pericardium	LANCET			English	Editorial Material									[Guenther, Michael; Wunderlich, Carsten; Simonis, Gregor; Strasser, Ruth H.] Tech Univ Dresden, Univ Hosp, Dept Internal Med 2, Heart Ctr Dresden, D-01307 Dresden, Germany; [Madisch, Ahmed] Tech Univ Dresden, Univ Hosp, Heart Ctr Dresden, Dept Internal Med 1, D-01307 Dresden, Germany; [Altmann, Olaf] Tech Univ Dresden, Univ Hosp, Heart Ctr Dresden, Diakonissenkrankenhaus Dresden,Dept Internal Med, D-01307 Dresden, Germany; [Bergert, Hendrik; Gastmeier, Joerg] Tech Univ Dresden, Univ Hosp, Heart Ctr Dresden, Dept Surg, D-01307 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Guenther, M (corresponding author), Tech Univ Dresden, Univ Hosp, Dept Internal Med 2, Heart Ctr Dresden, Fetscherstr 76, D-01307 Dresden, Germany.	michael.guenther2@mailbox.tu-dresden.de						Karoui M, 2008, NEW ENGL J MED, V359, pE16, DOI 10.1056/NEJMicm074422; LETOQUART JP, 1990, J CHIR-PARIS, V127, P6; Shaheen NJ, 2009, LANCET, V373, P850, DOI 10.1016/S0140-6736(09)60487-6	3	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 15	2009	374	9689					586	586		10.1016/S0140-6736(09)60910-7	http://dx.doi.org/10.1016/S0140-6736(09)60910-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683644				2022-12-28	WOS:000269019400026
J	Goodson, JL; Schrock, SE; Klatt, JD; Kabelik, D; Kingsbury, MA				Goodson, James L.; Schrock, Sara E.; Klatt, James D.; Kabelik, David; Kingsbury, Marcy A.			Mesotocin and Nonapeptide Receptors Promote Estrildid Flocking Behavior	SCIENCE			English	Article							SOCIAL RECOGNITION; OXYTOCIN RELEASE; NEURAL CIRCUITRY; MEDIAL AMYGDALA; VASOPRESSIN; FEMALE; BRAIN; VASOTOCIN	Proximate neural mechanisms that influence preferences for groups of a given size are almost wholly unknown. In the highly gregarious zebra finch (Estrildidae: Taeniopygia guttata), blockade of nonapeptide receptors by an oxytocin (OT) antagonist significantly reduced time spent with large groups and familiar social partners independent of time spent in social contact. Opposing effects were produced by central infusions of mesotocin (MT, avian homolog of OT). Most drug effects appeared to be female-specific. Across five estrildid finch species, species-typical group size correlates with nonapeptide receptor distributions in the lateral septum, and sociality in female zebra finches was reduced by OT antagonist infusions into the septum but not a control area. We propose that titration of sociality by MT represents a phylogenetically deep framework for the evolution of OT's female-specific roles in pair bonding and maternal functions.	[Goodson, James L.; Schrock, Sara E.; Klatt, James D.; Kabelik, David; Kingsbury, Marcy A.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Goodson, JL (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jlgoodso@indiana.edu	Kabelik, David/O-9932-2019		NIH [MH062656]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by NIH MH062656 (study section on Biobehavioral Regulation, Learning, and Ethology) to J.L.G.	Acher R, 1995, ADV EXP MED BIOL, V395, P615; Baeyens DA, 2006, COMP BIOCHEM PHYS B, V143, P12, DOI 10.1016/j.cbpb.2005.09.012; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Carter CS, 2008, PROG BRAIN RES, V170, P331, DOI 10.1016/S0079-6123(08)00427-5; Choleris E, 2007, P NATL ACAD SCI USA, V104, P4670, DOI 10.1073/pnas.0700670104; Cushing BS, 2000, HORM BEHAV, V37, P49, DOI 10.1006/hbeh.1999.1558; DEVRIES GJ, 1983, BRAIN RES, V273, P307, DOI 10.1016/0006-8993(83)90855-7; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Goodson JL, 2006, P NATL ACAD SCI USA, V103, P17013, DOI 10.1073/pnas.0606278103; Goodson JL, 2006, HORM BEHAV, V50, P223, DOI 10.1016/j.yhbeh.2006.03.005; Goodson JL, 2008, PROG BRAIN RES, V170, P3, DOI 10.1016/S0079-6123(08)00401-9; Goodson JL, 2004, HORM BEHAV, V45, P136, DOI 10.1016/j.yhbeh.2003.08.006; Goodson JL, 2000, NATURE, V403, P769, DOI 10.1038/35001581; Goodwin, 1982, ESTRILDID FINCHES WO; INSEL TR, 1995, BEHAV NEUROSCI, V109, P782, DOI 10.1037/0735-7044.109.4.782; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Krause J, 2002, LIVING GROUPS; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Leng G, 2008, CURR OPIN PHARMACOL, V8, P731, DOI 10.1016/j.coph.2008.07.001; Leung CH, 2009, J COMP NEUROL, V513, P197, DOI 10.1002/cne.21947; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Ross HE, 2009, J NEUROSCI, V29, P1312, DOI 10.1523/JNEUROSCI.5039-08.2009; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Skead D.M., 1975, Ostrich (), VNo. 11, P1; Thompson RR, 2004, BEHAV NEUROSCI, V118, P620, DOI 10.1037/0735-7044.118.3.620; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Zann RA., 1996, ZEBRA FINCH SYNTHESI	29	172	173	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					862	866		10.1126/science.1174929	http://dx.doi.org/10.1126/science.1174929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679811	Green Accepted			2022-12-28	WOS:000269242400043
J	Alby, K; Schaefer, D; Bennett, RJ				Alby, Kevin; Schaefer, Dana; Bennett, Richard J.			Homothallic and heterothallic mating in the opportunistic pathogen Candida albicans	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; SEXUAL REPRODUCTION; GENE-EXPRESSION; BAR1 GENE; PHEROMONE; PROTEIN; YEAST; IDENTIFICATION; INFECTIONS	Candida albicans is the most common fungal pathogen in humans, causing both debilitating mucosal infections and potentially life-threatening systemic infections(1,2). Until recently, C. albicans was thought to be strictly asexual, existing only as an obligate diploid. A cryptic mating cycle has since been uncovered in which diploid a and alpha cells undergo efficient cell and nuclear fusion, resulting in tetraploid a/alpha mating products(3-6). Whereas mating between a and alpha cells has been established (heterothallism), we report here two pathways for same-sex mating (homothallism) in C. albicans. First, unisexual populations of a cells were found to undergo autocrine pheromone signalling and same-sex mating in the absence of the Bar1 protease. In both C. albicans and Saccharomyces cerevisiae, Bar1 is produced by a cells and inactivates mating pheromone alpha, typically secreted by alpha cells(7-10). C. albicans Delta bar1 a cells were shown to secrete both a and alpha mating pheromones; alpha-pheromone activated self-mating in these cells in a process dependent on Ste2, the receptor for alpha-pheromone. In addition, pheromone production by alpha cells was found to promote same-sex mating between wild-type a cells. These results establish that homothallic mating can occur in C. albicans, revealing the potential for genetic exchange even within unisexual populations of the organism. Furthermore, Bar1 protease has an unexpected but pivotal role in determining whether sexual reproduction can potentially be homothallic or is exclusively heterothallic. These findings also have implications for the mode of sexual reproduction in related species that propagate unisexually, and indicate a role for specialized sexual cycles in the survival and adaptation of pathogenic fungi.	[Alby, Kevin; Schaefer, Dana; Bennett, Richard J.] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA	Brown University	Bennett, RJ (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Richard_Bennett@brown.edu		Bennett, Richard/0000-0001-7563-484X	Burroughs Wellcome Fund; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE019752] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors would like to thank D. MacCallum and the Aberdeen Fungal Group for strains, and J. Laney, T. Serio, R. Sherwood and M. Tessmer for discussions and critical reading of the manuscript. We also thank D. Koveal and S. Gilman for assistance during the preliminary stages of this work. R. J. B. holds an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. K. A. was supported by a training grant for Graduate Assistance in Areas of National Need.	Alby K, 2009, MOL BIOL CELL, V20, P3178, DOI 10.1091/mbc.E09-01-0040; Bennett RJ, 2006, MOL MICROBIOL, V62, P100, DOI 10.1111/j.1365-2958.2006.05367.x; Bennett RJ, 2005, MOL MICROBIOL, V55, P1046, DOI 10.1111/j.1365-2958.2005.04466.x; Bennett RJ, 2003, MOL CELL BIOL, V23, P8189, DOI 10.1128/MCB.23.22.8189-8201.2003; Bui T, 2008, EUKARYOT CELL, V7, P1771, DOI 10.1128/EC.00097-08; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Guthrie C, 1991, GUIDE YEAST GENETICS; HALL M, 1993, EARLY DAYS YEAST GEN; HICKS JB, 1976, NATURE, V260, P246, DOI 10.1038/260246a0; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; JACKSON CL, 1990, MOL CELL BIOL, V10, P2202, DOI 10.1128/MCB.10.5.2202; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Lin XR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000283; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Lockhart SR, 2003, EUKARYOT CELL, V2, P49, DOI 10.1128/EC.2.1.49-61.2003; Lockhart SR, 2002, GENETICS, V162, P737; MACKAY VL, 1988, P NATL ACAD SCI USA, V85, P55, DOI 10.1073/pnas.85.1.55; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; MANNEY TR, 1983, J BACTERIOL, V155, P291, DOI 10.1128/JB.155.1.291-301.1983; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Panwar SL, 2003, EUKARYOT CELL, V2, P1350, DOI 10.1128/EC.2.6.1350-1360.2003; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Samaranayake LP, 2002, ORAL DIS, V8, P151, DOI 10.1034/j.1601-0825.8.s2.6.x; Schaefer D, 2007, EUKARYOT CELL, V6, P907, DOI 10.1128/EC.00090-07; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Sherwood RK, 2008, EUKARYOT CELL, V7, P1460, DOI 10.1128/EC.00138-08; Smulian AG, 2001, GENETICS, V157, P991; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	34	148	155	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					890	U127		10.1038/nature08252	http://dx.doi.org/10.1038/nature08252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675652	Green Accepted			2022-12-28	WOS:000268938300038
J	Butler, A; Sandy, M				Butler, Alison; Sandy, Moriah			Mechanistic considerations of halogenating enzymes	NATURE			English	Review							METHYL-CHLORIDE TRANSFERASE; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; VANADIUM BROMOPEROXIDASE; NATURAL-PRODUCT; HETEROLOGOUS EXPRESSION; CURVULARIA-INAEQUALIS; STREPTOMYCES-CATTLEYA; ASCOPHYLLUM-NODOSUM; GENE-CLUSTER	In nature, halogenation is a strategy used to increase the biological activity of secondary metabolites, compounds that are often effective as drugs. However, halides are not particularly reactive unless they are activated, typically by oxidation. The pace of discovery of new enzymes for halogenation is increasing, revealing new metalloenzymes, flavoenzymes, S-adenosyl-l-methionine (SAM)-dependent enzymes and others that catalyse halide oxidation using dioxygen, hydrogen peroxide and hydroperoxides, or that promote nucleophilic halide addition reactions.	[Butler, Alison; Sandy, Moriah] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Butler, A (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	butler@chem.ucsb.edu	Butler, Alison/D-5094-2015	Butler, Alison/0000-0002-3525-7864	US National Science Foundation Division of Chemistry [0719553]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038130] Funding Source: NIH RePORTER	US National Science Foundation Division of Chemistry(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A. B. greatly acknowledges US National Science Foundation Division of Chemistry award number 0719553 for support of her research.	Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Blasiak LC, 2009, ACCOUNTS CHEM RES, V42, P147, DOI 10.1021/ar800088r; Brochardt SA, 2001, APPL ENVIRON MICROB, V67, P3174, DOI 10.1128/AEM.67.7.3174-3179.2001; Butler A, 2004, NAT PROD REP, V21, P180, DOI 10.1039/b302337k; Cadicamo CD, 2004, CHEMBIOCHEM, V5, P685, DOI 10.1002/cbic.200300839; Carpenter LJ, 2000, J GEOPHYS RES-ATMOS, V105, P20539, DOI 10.1029/2000JD900242; Carter-Franklin JN, 2004, J AM CHEM SOC, V126, P15060, DOI 10.1021/ja047925p; Carter-Franklin JN, 2003, J AM CHEM SOC, V125, P3688, DOI 10.1021/ja029271v; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Chen XP, 2008, ACTA BIOCH BIOPH SIN, V40, P183, DOI 10.1111/j.1745-7270.2008.00390.x; Colpas GJ, 1996, J AM CHEM SOC, V118, P3469, DOI 10.1021/ja953791r; Deng H, 2006, ANGEW CHEM INT EDIT, V45, P759, DOI 10.1002/anie.200503582; Deng H, 2008, CURR OPIN CHEM BIOL, V12, P582, DOI 10.1016/j.cbpa.2008.06.036; Dong CJ, 2004, NATURE, V427, P561, DOI 10.1038/nature02280; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Eustaquio AS, 2008, NAT CHEM BIOL, V4, P69, DOI 10.1038/nchembio.2007.56; EVERETT RR, 1990, J BIOL CHEM, V265, P15671; Faulkner DJ, 2002, NAT PROD REP, V19, P1, DOI 10.1039/b009029h; FENICAL W, 1975, J PHYCOL, V11, P245, DOI 10.1111/j.0022-3646.1975.00245.x; Fujimori DG, 2007, CURR OPIN CHEM BIOL, V11, P553, DOI 10.1016/j.cbpa.2007.08.002; Galonic DP, 2006, J AM CHEM SOC, V128, P3900, DOI 10.1021/ja060151n; Gribble GW, 1998, ACCOUNTS CHEM RES, V31, P141, DOI 10.1021/ar9701777; Gu LC, 2009, NATURE, V459, P731, DOI 10.1038/nature07870; HAGER LP, 1966, J BIOL CHEM, V241, P1769; Hanauske-Abel HM, 2003, CURR MED CHEM, V10, P1005, DOI 10.2174/0929867033457601; Hemrika W, 1999, J BIOL CHEM, V274, P23820, DOI 10.1074/jbc.274.34.23820; Isupov MN, 2000, J MOL BIOL, V299, P1035, DOI 10.1006/jmbi.2000.3806; Kuhnel K, 2006, J BIOL CHEM, V281, P23990, DOI 10.1074/jbc.M603166200; Kupper FC, 2008, P NATL ACAD SCI USA, V105, P6954, DOI 10.1073/pnas.0709959105; Libby RD, 1996, J BIOL CHEM, V271, P21820, DOI 10.1074/jbc.271.36.21820; Littlechild J, 2009, J INORG BIOCHEM, V103, P617, DOI 10.1016/j.jinorgbio.2009.01.011; MANTHEY JA, 1989, BIOCHEMISTRY-US, V28, P3052, DOI 10.1021/bi00433a047; MANTHEY JA, 1985, J BIOL CHEM, V260, P9654; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; Messerschmidt A, 1996, P NATL ACAD SCI USA, V93, P392, DOI 10.1073/pnas.93.1.392; Michels JJ, 2000, J CHROMATOGR A, V898, P153, DOI 10.1016/S0021-9673(00)00849-9; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; Ni XH, 1998, P NATL ACAD SCI USA, V95, P12866, DOI 10.1073/pnas.95.22.12866; Ortiz-Bermudez P, 2007, P NATL ACAD SCI USA, V104, P3895, DOI 10.1073/pnas.0610074104; Reddy CM, 2002, J AM CHEM SOC, V124, P14526, DOI 10.1021/ja0284097; Roach MP, 1997, BIOCHEMISTRY-US, V36, P2197, DOI 10.1021/bi9621371; Steinberg PD, 2001, CRC MAR SCI, P355; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; TSCHIRRETGUTH RA, 1994, J AM CHEM SOC, V116, P411, DOI 10.1021/ja00080a063; Ueki M, 2006, CHEM BIOL, V13, P1183, DOI 10.1016/j.chembiol.2006.09.012; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; VANSCHIJNDEL JWPM, 1993, BIOCHIM BIOPHYS ACTA, V1161, P249, DOI 10.1016/0167-4838(93)90221-C; VILTER H, 1983, BOT MAR, V26, P429, DOI 10.1515/botm.1983.26.9.429; VILTER H, 1984, PHYTOCHEMISTRY, V23, P1387, DOI 10.1016/S0031-9422(00)80471-9; Wagenknecht HA, 1997, CHEM BIOL, V4, P367, DOI 10.1016/S1074-5521(97)90127-7; Wagner C, 2009, J NAT PROD, V72, P540, DOI 10.1021/np800651m; Wang YJ, 2007, ADV APPL MICROBIOL, V61, P27, DOI 10.1016/S0065-2164(06)61002-2; WEVER R, 1985, BIOCHIM BIOPHYS ACTA, V830, P181, DOI 10.1016/0167-4838(85)90026-3; Weyand M, 1999, J MOL BIOL, V293, P595, DOI 10.1006/jmbi.1999.3179; Winter JM, 2007, J BIOL CHEM, V282, P16362, DOI 10.1074/jbc.M611046200; WOLINSKY LE, 1976, J ORG CHEM, V41, P597, DOI 10.1021/jo00866a003; WUOSMAA AM, 1990, SCIENCE, V249, P160, DOI 10.1126/science.2371563	60	232	234	7	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					848	854		10.1038/nature08303	http://dx.doi.org/10.1038/nature08303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675645				2022-12-28	WOS:000268938300029
J	Brown, AEX; Litvinov, RI; Discher, DE; Purohit, PK; Weisel, JW				Brown, Andre E. X.; Litvinov, Rustem I.; Discher, Dennis E.; Purohit, Prashant K.; Weisel, John W.			Multiscale Mechanics of Fibrin Polymer: Gel Stretching with Protein Unfolding and Loss of Water	SCIENCE			English	Article							NONLINEAR ELASTICITY; X-RAY; FIBERS; MICROSCOPY; NETWORKS; KERATIN; STRESS; CELLS; CLOTS; FINE	Blood clots and thrombi consist primarily of a mesh of branched fibers made of the protein fibrin. We propose a molecular basis for the marked extensibility and negative compressibility of fibrin gels based on the structural and mechanical properties of clots at the network, fiber, and molecular levels. The force required to stretch a clot initially rises linearly and is accompanied by a dramatic decrease in clot volume and a peak in compressibility. These macroscopic transitions are accompanied by fiber alignment and bundling after forced protein unfolding. Constitutive models are developed to integrate observations at spatial scales that span six orders of magnitude and indicate that gel extensibility and expulsion of water are both manifestations of protein unfolding, which is not apparent in other matrix proteins such as collagen.	[Litvinov, Rustem I.; Weisel, John W.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Brown, Andre E. X.; Discher, Dennis E.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Brown, Andre E. X.; Discher, Dennis E.] Univ Penn, Nano Bio Interface Ctr, Philadelphia, PA 19104 USA; [Discher, Dennis E.] Univ Penn, Grad Grp Phys, Philadelphia, PA 19104 USA; [Discher, Dennis E.] Univ Penn, Grad Grp Cell Biol & Physiol, Philadelphia, PA 19104 USA; [Purohit, Prashant K.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Weisel, JW (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	weisel@mail.med.upenn.edu	Brown, Andre/D-6516-2012; Litvinov, Rustem/E-5291-2011	Litvinov, Rustem/0000-0003-0643-1496; Brown, Andre/0000-0002-1324-8764; discher, dennis/0000-0001-6163-2229	NIH [HL090774, HL30954, HL62352]; Nano/Bio Interface Center NSF Nanoscale Science and Engineering Center; Natural Sciences and Engineering Research Council of Canada;  [DMR-0425780]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090774, R56HL090774, R01HL030954, R01HL062352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nano/Bio Interface Center NSF Nanoscale Science and Engineering Center; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH (grants HL090774 and HL30954 to J.W.W. and grant HL62352 to D.E.D.) and by the Nano/Bio Interface Center through NSF Nanoscale Science and Engineering Center (grant DMR-0425780). A.E.X.B. was supported by a scholarship from the Natural Sciences and Engineering Research Council of Canada.	Albala DM, 2003, CARDIOVASC SURG, V11, P5, DOI 10.1016/S0967-2109(03)00065-6; Alexander L.E., 1979, XRAY DIFFRACTION MET; Astbury WT, 1934, P R SOC LOND B-CONTA, V114, P314, DOI 10.1098/rspb.1934.0009; Bailey K, 1943, NATURE, V151, P716, DOI 10.1038/151716a0; Brown AEX, 2007, BIOPHYS J, V92, pL39, DOI 10.1529/biophysj.106.101261; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; COLMAN RW, 2005, HEMOSTASIS THROMBOSI; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; GABRIEL DA, 1992, J BIOL CHEM, V267, P24259; Hearle JWS, 2000, INT J BIOL MACROMOL, V27, P123, DOI 10.1016/S0141-8130(00)00116-1; JANMEY PA, 1983, J RHEOL, V27, P135, DOI 10.1122/1.549722; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kang H, 2009, J PHYS CHEM B, V113, P3799, DOI 10.1021/jp807749f; Kharakoz DP, 2000, BIOPHYS J, V79, P511, DOI 10.1016/S0006-3495(00)76313-2; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; Lim BBC, 2008, STRUCTURE, V16, P449, DOI 10.1016/j.str.2007.12.019; Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317; MULLER MF, 1984, J MOL BIOL, V174, P369, DOI 10.1016/0022-2836(84)90343-7; Qi HJ, 2006, J ENG MATER-T ASME, V128, P509, DOI 10.1115/1.2345442; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; ROSKA FJ, 1982, BIOPOLYMERS, V21, P1833, DOI 10.1002/bip.360210911; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; STRYER L, 1963, NATURE, V197, P793, DOI 10.1038/197793a0; Treloar L. R. G., 1975, PHYS TODAY, DOI DOI 10.1063/1.3060678; VOTER WA, 1986, BIOPOLYMERS, V25, P2375, DOI 10.1002/bip.360251214; WEISEL JW, 1987, P NATL ACAD SCI USA, V84, P8991, DOI 10.1073/pnas.84.24.8991; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X	29	268	273	7	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					741	744		10.1126/science.1172484	http://dx.doi.org/10.1126/science.1172484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661428	Green Accepted			2022-12-28	WOS:000268723700047
J	Chase, MW; Fay, MF				Chase, Mark W.; Fay, Michael F.			Barcoding of Plants and Fungi	SCIENCE			English	Editorial Material							DNA BARCODES		[Chase, Mark W.; Fay, Michael F.] Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England	Royal Botanic Gardens, Kew	Chase, MW (corresponding author), Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England.	m.fay@rbgkew.org.uk	Chase, Mark W/A-6642-2011; 赵, 鹏/B-8401-2009; Fay, Michael F/G-4741-2010; Fay, Michael/AAU-5861-2021	Fay, Michael F/0000-0003-3491-9093; 				Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Thomas C, 2009, SCIENCE, V324, P1632, DOI 10.1126/science.324_1632; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8	15	135	157	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					682	683		10.1126/science.1176906	http://dx.doi.org/10.1126/science.1176906			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480HF	19644072				2022-12-28	WOS:000268723700023
J	Dietz, H; Douglas, SM; Shih, WM				Dietz, Hendrik; Douglas, Shawn M.; Shih, William M.			Folding DNA into Twisted and Curved Nanoscale Shapes	SCIENCE			English	Article							DOUBLE-CROSSOVER MOLECULES; CONDUCTIVE NANOWIRES; NANOTUBES; NANOSTRUCTURES; OCTAHEDRON; DESIGN	We demonstrate the ability to engineer complex shapes that twist and curve at the nanoscale from DNA. Through programmable self-assembly, strands of DNA are directed to form a custom-shaped bundle of tightly cross-linked double helices, arrayed in parallel to their helical axes. Targeted insertions and deletions of base pairs cause the DNA bundles to develop twist of either handedness or to curve. The degree of curvature could be quantitatively controlled, and a radius of curvature as tight as 6 nanometers was achieved. We also combined multiple curved elements to build several different types of intricate nanostructures, such as a wireframe beach ball or square-toothed gears.	[Dietz, Hendrik; Douglas, Shawn M.; Shih, William M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Dietz, Hendrik; Douglas, Shawn M.; Shih, William M.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Douglas, Shawn M.; Shih, William M.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University	Shih, WM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	william_shih@dfci.harvard.edu	Douglas, Shawn/GVU-2004-2022	Douglas, Shawn/0000-0001-5398-9041; Dietz, Hendrik/0000-0003-1270-3662	Claudia Adams Barr Program; Wyss Institute for Biologically Inspired Engineering; NIH [1DP2OD004641-01]; Feodor-Lynen Humboldt; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004641] Funding Source: NIH RePORTER	Claudia Adams Barr Program; Wyss Institute for Biologically Inspired Engineering; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feodor-Lynen Humboldt; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Claudia Adams Barr Program Investigator, Wyss Institute for Biologically Inspired Engineering, and NIH New Innovator (1DP2OD004641-01) grants to W.M.S. and a Feodor-Lynen Humboldt Fellowship to H.D. H.D., S.M.D., and W.M.S. designed the research for this paper. H.D. developed rules for twisting and bending; H.D. and S.M.D. designed all shapes; H.D. and S.M.D. collected data; H.D. analyzed data; S.M.D. provided caDNAno software support; and H.D., W.M.S., and S.M.D. wrote the manuscript.	BOROWIEC JA, 1987, J MOL BIOL, V196, P101, DOI 10.1016/0022-2836(87)90513-4; Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Li XJ, 1996, J AM CHEM SOC, V118, P6131, DOI 10.1021/ja960162o; Lin CX, 2009, NANO LETT, V9, P433, DOI 10.1021/nl803328v; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Mitchell JC, 2004, J AM CHEM SOC, V126, P16342, DOI 10.1021/ja043890h; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006	27	911	969	19	398	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					725	730		10.1126/science.1174251	http://dx.doi.org/10.1126/science.1174251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661424	Green Accepted			2022-12-28	WOS:000268723700043
J	Mayer, D				Mayer, Dan			Diagnosis in General Practice The injured ankle and foot	BRITISH MEDICAL JOURNAL			English	Article							CLINICAL DECISION RULES; RANDOMIZED CONTROLLED-TRIAL; RADIOGRAPHY; MULTICENTER; FRACTURES; SPRAINS; BRACE		Albany Med Coll, Albany, NY 12208 USA	Albany Medical College	Mayer, D (corresponding author), Albany Med Coll, Albany, NY 12208 USA.	mayerd@mail.amc.edu						Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Beynnon BD, 2006, AM J SPORT MED, V34, P1401, DOI 10.1177/0363546506288676; Boutis K, 2007, PEDIATRICS, V119, pE1256, DOI 10.1542/peds.2006-2958; Boyce SH, 2005, BRIT J SPORT MED, V39, P91, DOI 10.1136/bjsm.2003.009233; Kerkhoffs GMMJ, 2003, ACTA ORTHOP SCAND, V74, P69, DOI 10.1080/00016470310013699; Lamb SE, 2009, LANCET, V373, P575, DOI 10.1016/S0140-6736(09)60206-3; Perry JJ, 2006, INJURY, V37, P1157, DOI 10.1016/j.injury.2006.07.028; PIGMAN EC, 1994, ANN EMERG MED, V24, P41, DOI 10.1016/S0196-0644(94)70160-1; STIELL I, 1995, BRIT MED J, V311, P594, DOI 10.1136/bmj.311.7005.594; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827	11	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 7	2009	339								b2901	10.1136/bmj.b2901	http://dx.doi.org/10.1136/bmj.b2901			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KF	19666680				2022-12-28	WOS:000268808200015
J	Butt, Y				Butt, Yousaf			Beyond the myth of the supernova-remnant origin of cosmic rays	NATURE			English	Article							MOLECULAR CLOUDS; OB ASSOCIATIONS; ACCELERATION; EMISSION; DISCOVERY; SHOCK; REACCELERATION; CONSTRAINTS; PROPAGATION; SUPERBUBBLE	The origin of Galactic cosmic-ray ions has remained an enigma for almost a century. Although it has generally been thought that they are accelerated in the shock waves associated with powerful supernova explosions-for which there have been recent claims of evidence-the mystery is far from resolved. In fact, we may be on the wrong track altogether in looking for isolated regions of cosmic-ray acceleration.	Harvard Smithsonian Ctr Astrophys, Div High Energy Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Butt, Y (corresponding author), Harvard Smithsonian Ctr Astrophys, Div High Energy Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	ybutt@cfa.harvard.edu			NASA Long Term Space Astrophysics	NASA Long Term Space Astrophysics	Part of this work was carried out while the author was a fellow at the National Academy of Sciences. The support of a NASA Long Term Space Astrophysics grant is gratefully acknowledged.	Abdo AA, 2007, ASTROPHYS J, V664, pL91, DOI 10.1086/520717; Abdo AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.221101; ACCIARI VA, ASTROPHYS J IN PRESS; Aharonian F, 2008, ASTRON ASTROPHYS, V481, P401, DOI 10.1051/0004-6361:20077765; Albert J, 2007, ASTROPHYS J, V664, pL87, DOI 10.1086/520957; Bartko H, 2008, MON NOT R ASTRON SOC, V385, P1105, DOI 10.1111/j.1365-2966.2008.12870.x; Berezhko EG, 2006, ASTRON ASTROPHYS, V451, P981, DOI 10.1051/0004-6361:20054595; Binns WR, 2007, SPACE SCI REV, V130, P439, DOI 10.1007/s11214-007-9195-1; Busching I, 2005, ASTROPHYS J, V619, P314, DOI 10.1086/426537; Butt YM, 2008, ASTROPHYS J LETT, V677, pL21, DOI 10.1086/587875; Butt YM, 2008, MON NOT R ASTRON SOC, V386, pL20, DOI 10.1111/j.1745-3933.2008.00452.x; COLGATE S, 2001, ROLE NEUTRINOS STRIN, P149; Drury LO, 2008, ASTROPART PHYS, V29, P420, DOI 10.1016/j.astropartphys.2008.04.007; DURIC N, 1988, SPACE SCI REV, V48, P73, DOI 10.1007/BF00183130; Ellison DC, 2000, ASTROPHYS J, V540, P292, DOI 10.1086/309324; Erlykin AD, 2005, J PHYS G NUCL PARTIC, V31, P1475, DOI 10.1088/0954-3899/31/12/009; Fisk LA, 2007, P NATL ACAD SCI USA, V104, P5749, DOI 10.1073/pnas.0700881104; Gaisser TK, 1998, ASTROPHYS J, V492, P219, DOI 10.1086/305011; Grenier IA, 2005, SCIENCE, V307, P1292, DOI 10.1126/science.1106924; HELDER EA, 2009, SCIENCE         0625, DOI DOI 10.1126/SCIENCE.1173383; Higdon JC, 2005, ASTROPHYS J, V628, P738, DOI 10.1086/430814; HILLAS MJ, 2005, J PHYS G, V95, pR131; Hughes JP, 2000, ASTROPHYS J, V543, pL61, DOI 10.1086/317102; Katz B, 2008, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2008/01/018; KRIMIGIS SM, 1992, SPACE SCI REV, V59, P167, DOI 10.1007/BF01262539; Liu SM, 2008, ASTROPHYS J LETT, V683, pL163, DOI 10.1086/591793; Medina Tanco G. A., 1993, Astrophysical Journal, V411, P690, DOI 10.1086/172872; PARIZOT E, 2001, P 27 INT COSM RAY C, P2070; Pidopryhora Y, 2007, ASTROPHYS J, V656, P928, DOI 10.1086/510521; SEO ES, 1994, ASTROPHYS J, V431, P705, DOI 10.1086/174520; SHKLOVSKII IS, 1953, DOKL AKAD NAUK SSSR+, V91, P475; Strong AW, 2007, ANNU REV NUCL PART S, V57, P285, DOI 10.1146/annurev.nucl.57.090506.123011; Tang SK, 2005, ASTROPHYS J, V628, P205, DOI 10.1086/430875; Tian WW, 2008, ASTROPHYS J LETT, V679, pL85, DOI 10.1086/589506; Tian WW, 2007, ASTROPHYS J, V657, pL25, DOI 10.1086/512544; Torres DF, 2008, MON NOT R ASTRON SOC, V387, pL59, DOI 10.1111/j.1745-3933.2008.00485.x; Voelk HJ, 2008, ASTRON ASTROPHYS, V483, P529, DOI 10.1051/0004-6361:20079337; Volk HJ, 2004, ASTRON ASTROPHYS, V417, P807, DOI 10.1051/0004-6361:20040018; Warren JS, 2005, ASTROPHYS J, V634, P376, DOI 10.1086/496941; WIEDENBECK M, 2003, P 28 INT COSM RAY C, P1899; Wiedenbeck ME, 1999, ASTROPHYS J, V523, pL61, DOI 10.1086/312242; Woermann B, 2001, MON NOT R ASTRON SOC, V325, P1213, DOI 10.1046/j.1365-8711.2001.04558.x; Yamaguchi N, 1999, PUBL ASTRON SOC JPN, V51, P765, DOI 10.1093/pasj/51.6.765; Yamazaki R, 2006, MON NOT R ASTRON SOC, V371, P1975, DOI 10.1111/j.1365-2966.2006.10832.x; Zhang L, 2008, ASTROPHYS J LETT, V675, pL21, DOI 10.1086/529404; Zirakashvili VN, 2006, ADV SPACE RES-SERIES, V37, P1923, DOI 10.1016/j.asr.2005.06.013	46	72	72	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					701	704		10.1038/nature08127	http://dx.doi.org/10.1038/nature08127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661909	Green Submitted			2022-12-28	WOS:000268670300030
J	Zhang, CL; Katoh, M; Shibasaki, T; Minami, K; Sunaga, Y; Takahashi, H; Yokoi, N; Iwasaki, M; Miki, T; Seino, S				Zhang, Chang-Liang; Katoh, Megumi; Shibasaki, Tadao; Minami, Kohtaro; Sunaga, Yasuhiro; Takahashi, Harumi; Yokoi, Norihide; Iwasaki, Masahiro; Miki, Takashi; Seino, Susumu			The cAMP Sensor Epac2 Is a Direct Target of Antidiabetic Sulfonylurea Drugs	SCIENCE			English	Article							PANCREATIC BETA-CELLS; K-ATP CHANNELS; INSULIN-SECRETION; B-CELLS; RECEPTOR; STIMULATION; EXOCYTOSIS; GRANULE; MICE; ACTIVATION	Epac2, a guanine nucleotide exchange factor for the small guanosine triphosphatase Rap1, is activated by adenosine 3',5'-monophosphate. Fluorescence resonance energy transfer and binding experiments revealed that sulfonylureas, widely used antidiabetic drugs, interact directly with Epac2. Sulfonylureas activated Rap1 specifically through Epac2. Sulfonylurea-stimulated insulin secretion was reduced both in vitro and in vivo in mice lacking Epac2, and the glucose-lowering effect of the sulfonylurea tolbutamide was decreased in these mice. Epac2 thus contributes to the effect of sulfonylureas to promote insulin secretion. Because Epac2 is also required for the action of incretins, gut hormones crucial for potentiating insulin secretion, it may be a promising target for antidiabetic drug development.	[Zhang, Chang-Liang; Katoh, Megumi; Shibasaki, Tadao; Minami, Kohtaro; Sunaga, Yasuhiro; Takahashi, Harumi; Yokoi, Norihide; Iwasaki, Masahiro; Miki, Takashi; Seino, Susumu] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cellular & Mol Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Seino, Susumu] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Seino, Susumu] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Kobe University; Kobe University; Japan Science & Technology Agency (JST)	Seino, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cellular & Mol Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	seino@med.kobe-u.ac.jp	MIKI, Takashi/ABD-3995-2020	MIKI, Takashi/0000-0001-5741-1626; Minami, Kohtaro/0000-0003-4698-6250	Japan Science and Technology Agency; Global Centers of Excellence; Ministry of Education, Culture, Sports, Science and Technology	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Global Centers of Excellence; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a CREST grant from the Japan Science and Technology Agency and Grant-in-Aid for Scientific Research and by a grant for the Global Centers of Excellence Program "Global Center of Excellence for Education and research on Signal Transduction Medicine in the Coming Generation" from the Ministry of Education, Culture, Sports, Science and Technology.	Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Eliasson L, 1996, SCIENCE, V271, P813, DOI 10.1126/science.271.5250.813; FLATT PR, 1994, DIABETES METAB, V20, P157; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; Geng XH, 2007, AM J PHYSIOL-ENDOC M, V293, pE293, DOI 10.1152/ajpendo.00016.2007; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Kang GX, 2006, J PHYSIOL-LONDON, V573, P595, DOI 10.1113/jphysiol.2006.107391; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; OZANNE SE, 1995, DIABETOLOGIA, V38, P277; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Sunaga Y, 2001, EUR J PHARMACOL, V431, P119, DOI 10.1016/S0014-2999(01)01412-1	28	167	172	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					607	610		10.1126/science.1172256	http://dx.doi.org/10.1126/science.1172256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644119				2022-12-28	WOS:000268493000049
J	Andrade, J; Aymong, E				Andrade, Jason; Aymong, Eve			Pneumopericardium and Pneumothorax.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Andrade, Jason; Aymong, Eve] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada	St. Paul's Hospital; University of Saskatchewan	Andrade, J (corresponding author), St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada.		Andrade, Jason/AAK-5889-2020	Andrade, Jason/0000-0002-8493-5123					0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					510	510		10.1056/NEJMicm075654	http://dx.doi.org/10.1056/NEJMicm075654			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	476LW	19641207				2022-12-28	WOS:000268443900011
J	Greenbaum, DC; FitzGerald, GA				Greenbaum, Doron C.; FitzGerald, Garret A.			Platelets, Pyrexia, and Plasmodia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Greenbaum, Doron C.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Greenbaum, DC (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.		FitzGerald, Garret A/A-4222-2010					Clark I, 2001, LANCET, V357, P625, DOI 10.1016/S0140-6736(00)04061-7; Looney MR, 2009, NAT MED, V15, P364, DOI 10.1038/nm0409-364; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Rocca B, 1997, CIRCULATION, V95, P11, DOI 10.1161/01.CIR.95.1.11; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003	5	18	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					526	528		10.1056/NEJMcibr0903050	http://dx.doi.org/10.1056/NEJMcibr0903050			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	476LW	19641212				2022-12-28	WOS:000268443900017
J	Richette, P; Bardin, T				Richette, Pascal; Bardin, Thomas			Gout	LANCET			English	Article							SERUM URIC-ACID; 3RD NATIONAL-HEALTH; EVIDENCE BASED RECOMMENDATIONS; LIVER-TRANSPLANT PATIENTS; TOPHACEOUS GOUT; RISK-FACTORS; SYNOVIAL-FLUID; MYCOPHENOLATE-MOFETIL; INFLAMMATORY PROCESS; METABOLIC SYNDROME	Gout is a common arthritis caused by deposition of monosodium. urate crystals within joints after chronic hyperuricaemia. It affects 1-2% of adults in developed countries, where it is the most common inflammatory arthritis in men. Epidemiological data are consistent with a rise in prevalence of gout. Diet and genetic polymorphisms of renal transporters of urate seem to be the main causal factors of primary gout. Gout and hyperuricaemia are associated with hypertension, diabetes mellitus, metabolic syndrome, and renal and cardiovascular diseases. Non-steroidal anti-inflammatory drugs and colchicine remain the most widely recommended drugs to treat acute attacks. Oral corticosteroids could be an alternative to these drugs. Interleukin 1 beta is a pivotal mediator of acute gout and could become a therapeutic target. When serum uric acid concentrations are lowered below monosodium urate saturation point, the crystals dissolve and gout can be cured. Patient education, appropriate lifestyle advice, and treatment of comorbidities are an important part of management of patients with gout.	[Richette, Pascal; Bardin, Thomas] Univ Paris 07, Hop Lariboisiere, APHP, UFR Med, F-75475 Paris 10, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Richette, P (corresponding author), Univ Paris 07, Hop Lariboisiere, APHP, UFR Med, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pascal.richette@lrb.aphp.fr			Association Rhumatisme et Travail (Centre Viggo Petersen, Hopital Lariboisiere, Paris, France)	Association Rhumatisme et Travail (Centre Viggo Petersen, Hopital Lariboisiere, Paris, France)	We thank the Association Rhumatisme et Travail (Centre Viggo Petersen, Hopital Lariboisiere, Paris, France), which funded copyediting (Laura Heraty) of this manuscript, and Pr Eliseo Pascual and Dr Hang-Korng. Ea for providing photos Of figure 313, and figure 4, respectively.	Abbott KC, 2005, TRANSPLANTATION, V80, P1383, DOI 10.1097/01.tp.0000188722.84775.af; Alvarez-Hernandez E, 2008, ARTHRIT RHEUM-ARTHR, V59, P665, DOI 10.1002/art.23575; Alvarez-Nemegyei J, 2005, J RHEUMATOL, V32, P2189; Annemans L, 2008, ANN RHEUM DIS, V67, P960, DOI 10.1136/ard.2007.076232; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Avram Z, 2008, RHEUMATOLOGY, V47, P960, DOI 10.1093/rheumatology/ken070; AXELROD D, 1988, ARTHRITIS RHEUM-US, V31, P803, DOI 10.1002/art.1780310618; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Baker JF, 2007, ANGIOLOGY, V58, P450, DOI 10.1177/0003319707303444; Bardin T, 2004, JOINT BONE SPINE, V71, P481, DOI 10.1016/j.jbspin.2004.07.006; Bardin T, 2003, ANN RHEUM DIS, V62, P497, DOI 10.1136/ard.62.6.497; Barrett K, 2001, NEUROSURGERY, V48, P1170, DOI 10.1097/00006123-200105000-00046; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; BENEDEK TG, 1982, B RHEUM DIS, V32, P59; Bieber JD, 2004, ARTHRITIS RHEUM-US, V50, P2400, DOI 10.1002/art.20438; Borstad GC, 2004, J RHEUMATOL, V31, P2429; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chen CKH, 2000, AM J ROENTGENOL, V175, P655, DOI 10.2214/ajr.175.3.1750655; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; CHOI HK, 2008, BMJ-BRIT MED J, V36, P309; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P816, DOI 10.1002/art.22762; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P109, DOI 10.1002/art.22466; Chopra KF, 2002, NEW ENGL J MED, V346, P1714, DOI 10.1056/NEJMicm990355; Cronstein BN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1908; Dalbeth N, 2007, RHEUMATOLOGY, V46, P1804, DOI 10.1093/rheumatology/kem246; Dalbeth N, 2009, ANN RHEUM DIS, V68, P1290, DOI 10.1136/ard.2008.094201; Dalbeth N, 2007, ARTHRIT RHEUM-ARTHR, V57, P461, DOI 10.1002/art.22612; Darmawan J, 2003, J RHEUMATOL, V30, P2437; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dessein PH, 2000, ANN RHEUM DIS, V59, P539, DOI 10.1136/ard.59.7.539; Diaz A, 2003, NEUROCHIRURGIE, V49, P600; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Enomoto Atsushi, 2005, Clin Exp Nephrol, V9, P195, DOI 10.1007/s10157-005-0368-5; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2003, HYPERTENSION, V42, P247, DOI 10.1161/01.HYP.0000085858.66548.59; Friedman JE, 2008, SURG OBES RELAT DIS, V4, P11, DOI 10.1016/j.soard.2007.09.012; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; Galvez J, 2002, ANN RHEUM DIS, V61, P444, DOI 10.1136/ard.61.5.444; Gao X, 2008, J RHEUMATOL, V35, P1853; Garcia-Pavia P, 2003, ARTHRITIS RHEUM, V48, P2036, DOI 10.1002/art.11058; Gentili Amilcare, 2006, Curr Rheumatol Rep, V8, P231, DOI 10.1007/s11926-996-0030-6; Gerster JC, 2004, ANN RHEUM DIS, V63, P894, DOI 10.1136/ard.2003.006478; Gerster JC, 2002, ANN RHEUM DIS, V61, P52, DOI 10.1136/ard.61.1.52; GIBSON T, 2003, RHEUMATOLOGY, P1919; Grassi W, 2006, SEMIN ARTHRITIS RHEU, V36, P197, DOI 10.1016/j.semarthrit.2006.08.001; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; GUAN M, 2009, SCAND J RHEUMATOL, V20, P1; GUTTENPLAN MD, 1991, ANN OTO RHINOL LARYN, V100, P899, DOI 10.1177/000348949110001108; Hak AE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2519; Hamada T, 2008, AM J HYPERTENS, V21, P1157, DOI 10.1038/ajh.2008.245; HANDE KR, 1984, AM J MED, V76, P47, DOI 10.1016/0002-9343(84)90743-5; Harle P, 2006, LANCET, V367, P2032, DOI 10.1016/S0140-6736(06)68894-6; HARRIS CM, 1995, J CLIN EPIDEMIOL, V48, P1153, DOI 10.1016/0895-4356(94)00244-K; Holland NW, 1996, J RHEUMATOL, V23, P690; Hunter DJ, 2006, J RHEUMATOL, V33, P1341; Iacobellis G, 2004, J ENDOCRINOL INVEST, V27, P965, DOI 10.1007/BF03347542; Jacobs F, 1997, TRANSPLANTATION, V64, P1087, DOI 10.1097/00007890-199710150-00027; Janssens HJEM, 2006, ANN RHEUM DIS, V65, P1080, DOI 10.1136/ard.2005.040360; Janssens HJEM, 2008, LANCET, V371, P1854, DOI 10.1016/S0140-6736(08)60799-0; Janssens HJ, 2008, COCHRANE DB SYST REV, V2; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Kang EH, 2008, ANN RHEUM DIS, V67, P1271, DOI 10.1136/ard.2007.078683; Klemp P, 1997, ANN RHEUM DIS, V56, P22, DOI 10.1136/ard.56.1.22; Kramer HJ, 2003, KIDNEY INT, V64, P1022, DOI 10.1046/j.1523-1755.2003.t01-2-00171.x; Krishnan E, 2008, ARCH INTERN MED, V168, P1104, DOI 10.1001/archinte.168.10.1104; Krishnan E, 2007, HYPERTENSION, V49, P298, DOI 10.1161/01.HYP.0000254480.64564.b6; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Liebman Scott E, 2007, Curr Rheumatol Rep, V9, P251, DOI 10.1007/s11926-007-0040-z; Liote Frederic, 2007, Curr Rheumatol Rep, V9, P243, DOI 10.1007/s11926-007-0039-5; Liote F, 2006, RHEUM DIS CLIN N AM, V32, P295, DOI 10.1016/j.rdc.2006.03.001; Lo WR, 2005, AM J OPHTHALMOL, V140, P1152, DOI 10.1016/j.ajo.2005.07.023; Maalouf NM, 2004, CURR OPIN NEPHROL HY, V13, P181, DOI 10.1097/00041552-200403000-00006; Man CY, 2007, ANN EMERG MED, V49, P670, DOI 10.1016/j.annemergmed.2006.11.014; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; MCCARTY DJ, 1994, JAMA-J AM MED ASSOC, V271, P302, DOI 10.1001/jama.271.4.302; MCLEAN L, 2003, RHEUMATOLOGY, P1903; Miao ZM, 2008, J RHEUMATOL, V35, P1859; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Monu JUV, 2004, RADIOL CLIN N AM, V42, P169, DOI 10.1016/S0033-8389(03)00158-1; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Neogi T, 2006, J RHEUMATOL, V33, P104; Nuki G, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1906; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Pascual E, 2006, ANN RHEUM DIS, V65, P981, DOI 10.1136/ard.2005.049023; PASCUAL E, 1991, ARTHRITIS RHEUM, V34, P141, DOI 10.1002/art.1780340203; Pascual E, 2009, ANN RHEUM DIS, V68, P3, DOI 10.1136/ard.2008.088328; Pascual E, 2007, ANN RHEUM DIS, V66, P1056, DOI 10.1136/ard.2006.060368; Perez-Ruiz F, 2002, ARTHRIT RHEUM-ARTHR, V47, P356, DOI 10.1002/art.10511; Perez-Ruiz F, 1998, ANN RHEUM DIS, V57, P545, DOI 10.1136/ard.57.9.545; Perez-Ruiz F, 2007, ARTHRIT RHEUM-ARTHR, V57, P1324, DOI 10.1002/art.23007; Perez-Ruiz F, 2007, J RHEUMATOL, V34, P1888; Perez-Ruiz F, 2007, JOINT BONE SPINE, V74, P313, DOI 10.1016/j.jbspin.2006.11.011; Perez-Ruiz F, 2007, CURR OPIN RHEUMATOL, V19, P128, DOI 10.1097/BOR.0b013e32801450b7; Petrilli V, 2007, JOINT BONE SPINE, V74, P571, DOI 10.1016/j.jbspin.2007.04.004; Puig JG, 2008, CURR OPIN RHEUMATOL, V20, P187, DOI 10.1097/BOR.0b013e3282f4b1ed; Resnick D, 1988, DIAGNOSIS BONE JOINT, P1619; Richette P, 2007, J RHEUMATOL, V34, P2093; Roddy E, 2007, RHEUMATOLOGY, V46, P1441, DOI 10.1093/rheumatology/kem150; Roddy E, 2007, ANN RHEUM DIS, V66, P1374, DOI 10.1136/ard.2006.063768; Rott KT, 2003, JAMA-J AM MED ASSOC, V289, P2857, DOI 10.1001/jama.289.21.2857; Rousseau I, 2001, SKELETAL RADIOL, V30, P565, DOI 10.1007/s002560100392; Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238; Saag KG, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1907; Schlesinger N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006190; Schlesinger N, 2002, J RHEUMATOL, V29, P331; Schlitt HJ, 2001, LANCET, V357, P587, DOI 10.1016/S0140-6736(00)04055-1; Schumacher HR, 2007, J RHEUMATOL, V34, P1381; Schumacher HR, 2005, J RHEUMATOL, V32, P2368; Scott P, 2006, J IMMUNOL, V177, P6370, DOI 10.4049/jimmunol.177.9.6370; Simkin P A, 1977, Adv Exp Med Biol, V76B, P41; Simkin PA, 2001, J RHEUMATOL, V28, P1207; Sivera F, 2008, ANN RHEUM DIS, V67, P273, DOI 10.1136/ard.2007.073460; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; So A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2509; Stamp L, 2005, DRUGS, V65, P2593, DOI 10.2165/00003495-200565180-00004; Stark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001948; Stein RA, 2008, CLIN GENET, V74, P410, DOI 10.1111/j.1399-0004.2008.01080_2.x; Sundy JS, 2008, ARTHRITIS RHEUM, V58, P2882, DOI 10.1002/art.23810; Tan G, 2003, Hand Surg, V8, P121, DOI 10.1142/S0218810403001467; Ter-Keltaub R, 2008, ARTHRITIS RHEUM, V58, pS879; Terkeltaub RA, 2003, NEW ENGL J MED, V349, P1647, DOI 10.1056/NEJMcp030733; Terkeltaub R, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1909; Thiele RG, 2007, RHEUMATOLOGY, V46, P1116, DOI 10.1093/rheumatology/kem058; Torres RJ, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-48; UNGER S, 2007, Z RHEUMATOL, V66, P58; Urano W, 2002, J RHEUMATOL, V29, P1950; VANLIESHOUTZUIDEMA MF, 1993, J RHEUMATOL, V20, P1383; Vazquez-Mellado J, 2001, ANN RHEUM DIS, V60, P981, DOI 10.1136/ard.60.10.981; Vazquez-Mellado J, 1999, J RHEUMATOL, V26, P136; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace KL, 2004, J RHEUMATOL, V31, P1582; WALLACE SL, 1991, J RHEUMATOL, V18, P264; WORTMANN RL, 2008, TXB RHEUMATOLOGY, P1481; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007; Yu KH, 2004, RHEUMATOLOGY, V43, P1541, DOI 10.1093/rheumatology/keh379; Yu KH, 2003, RHEUMATOLOGY, V42, P1062, DOI 10.1093/rheumatology/keg297; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251; ZHANG Y, 2006, AM J MED, V119, P800	150	633	711	14	291	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2010	375	9711					318	328		10.1016/S0140-6736(09)60883-7	http://dx.doi.org/10.1016/S0140-6736(09)60883-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549QS	19692116				2022-12-28	WOS:000274069300034
J	Schafer, ZT; Grassian, AR; Song, LL; Jiang, ZY; Gerhart-Hines, Z; Irie, HY; Gao, SZ; Puigserver, P; Brugge, JS				Schafer, Zachary T.; Grassian, Alexandra R.; Song, Loling; Jiang, Zhenyang; Gerhart-Hines, Zachary; Irie, Hanna Y.; Gao, Sizhen; Puigserver, Pere; Brugge, Joan S.			Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment	NATURE			English	Article							BREAST-CANCER; DUCTAL MORPHOGENESIS; EXTRACELLULAR-MATRIX; EPITHELIAL ACINI; CELL-GROWTH; APOPTOSIS; ANOIKIS; MECHANISMS; AUTOPHAGY; CULTURES	Normal epithelial cells require matrix attachment for survival, and the ability of tumour cells to survive outside their natural extracellular matrix (ECM) niches is dependent on acquisition of anchorage independence(1). Although apoptosis is the most rapid mechanism for eliminating cells lacking appropriate ECM attachment(2), recent reports suggest that non-apoptotic death processes prevent survival when apoptosis is inhibited in matrix-deprived cells(3,4). Here we demonstrate that detachment of mammary epithelial cells from ECM causes an ATP deficiency owing to the loss of glucose transport. Overexpression of ERBB2 rescues the ATP deficiency by restoring glucose uptake through stabilization of EGFR and phosphatidylinositol-3-OH kinase (PI(3) K) activation, and this rescue is dependent on glucose-stimulated flux through the antioxidant-generating pentose phosphate pathway. Notably, we found that the ATP deficiency could be rescued by antioxidant treatment without rescue of glucose uptake. This rescue was found to be dependent on stimulation of fatty acid oxidation, which is inhibited by detachment-induced reactive oxygen species (ROS). The significance of these findings was supported by evidence of an increase in ROS in matrix-deprived cells in the luminal space of mammary acini, and the discovery that antioxidants facilitate the survival of these cells and enhance anchorage-independent colony formation. These results show both the importance of matrix attachment in regulating metabolic activity and an unanticipated mechanism for cell survival in altered matrix environments by antioxidant restoration of ATP generation.	[Schafer, Zachary T.; Grassian, Alexandra R.; Song, Loling; Jiang, Zhenyang; Irie, Hanna Y.; Gao, Sizhen; Puigserver, Pere; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Gerhart-Hines, Zachary; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gerhart-Hines, Zachary] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Johns Hopkins University	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu			National Cancer Institute; National Institutes of Health (NIH); NCI; National Science Graduate Research Fellowship; NATIONAL CANCER INSTITUTE [K25CA100290, R01CA105134] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Graduate Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Overholtzer, G. Mouneimne, M. Mazzone and C. Leung for critical reading of the manuscript and/or experimental assistance. We thank A. Mailleux, A. Kaanta, V. Schafer, A. Zhou, K. Simpson, and the members of the Brugge laboratory for experimental assistance, comments, and/or discussion. This work was supported by a grant from the National Cancer Institute (J. S. B.) and a grant from the National Institutes of Health (NIH) (P. P.). Z. T. S. is the recipient of a Ruth L. Kirschstein National Research Service Award (NRSA) for Postdoctoral Fellows from the National Cancer Institute; L. S. an NCI Mentored Quantitative Research Development Award (K25); A. R. G. a National Science Graduate Research Fellowship; and H. Y. I. an NCI K08 Award.	Bennett BD, 1996, J BIOL CHEM, V271, P3647; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Lawenda BD, 2008, JNCI-J NATL CANCER I, V100, P773, DOI 10.1093/jnci/djn148; Li AE, 1999, CIRC RES, V85, P304, DOI 10.1161/01.RES.85.4.304; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Narayanan BA, 2006, CURR CANCER DRUG TAR, V6, P711, DOI 10.2174/156800906779010218; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Schafer ZT, 2006, CANCER RES, V66, P2210, DOI 10.1158/0008-5472.CAN-05-3923; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200	34	731	743	9	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					109	U118		10.1038/nature08268	http://dx.doi.org/10.1038/nature08268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19693011	Green Accepted			2022-12-28	WOS:000269478800040
J	Pan, F; Yu, H; Dang, EV; Barbi, J; Pan, XY; Grosso, JF; Jinasena, D; Sharma, SM; McCadden, EM; Getnet, D; Drake, CG; Liu, JO; Ostrowski, MC; Pardoll, DM				Pan, Fan; Yu, Hong; Dang, Eric V.; Barbi, Joseph; Pan, Xiaoyu; Grosso, Joseph F.; Jinasena, Dinili; Sharma, Sudarshana M.; McCadden, Erin M.; Getnet, Derese; Drake, Charles G.; Liu, Jun O.; Ostrowski, Michael C.; Pardoll, Drew M.			Eos Mediates Foxp3-Dependent Gene Silencing in CD4(+) Regulatory T Cells	SCIENCE			English	Article							INTESTINAL INFLAMMATION; IN-VIVO; FOXP3; DEMETHYLATION; TRANSCRIPTION; COREPRESSORS; IKAROS	CD4(+) regulatory T cells (T-regs) maintain immunological self-tolerance and immune homeostasis by suppressing aberrant or excessive immune responses. The core genetic program of T-regs and their ability to suppress pathologic immune responses depends on the transcription factor Foxp3. Despite progress in understanding mechanisms of Foxp3-dependent gene activation, the molecular mechanism of Foxp3-dependent gene repression remains largely unknown. We identified Eos, a zinc-finger transcription factor of the Ikaros family, as a critical mediator of Foxp3-dependent gene silencing in T-regs. Eos interacts directly with Foxp3 and induces chromatin modifications that result in gene silencing in T-regs. Silencing of Eos in T-regs abrogates their ability to suppress immune responses and endows them with partial effector function, thus demonstrating the critical role that Eos plays in T-reg programming.	[Pan, Fan; Yu, Hong; Dang, Eric V.; Barbi, Joseph; Pan, Xiaoyu; Grosso, Joseph F.; Jinasena, Dinili; McCadden, Erin M.; Getnet, Derese; Drake, Charles G.; Pardoll, Drew M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Immunol & Hematopoiesis Div, Baltimore, MD 21231 USA; [Sharma, Sudarshana M.; Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Sharma, Sudarshana M.; Ostrowski, Michael C.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Johns Hopkins University	Pardoll, DM (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Immunol & Hematopoiesis Div, Baltimore, MD 21231 USA.	dpardol1@jhmi.edu	Getnet, Derese/C-5421-2012; Sharma, Sudarshana Mangalore/AAI-2475-2019; Ostrowski, Michael/H-3108-2011	Ostrowski, Michael/0000-0003-2948-6297; Dang, Eric/0000-0002-2389-6167; Sharma, Sudarshana/0000-0002-9745-0061	NIH; Melanoma Research Alliance; Janey Fund; Seraph Foundation; NATIONAL CANCER INSTITUTE [P01CA097189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089830, R01AI058156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044719] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Janey Fund; Seraph Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Rudensky, Y. Shi, M. Crossley, S. Smale, A. Friedman, H. Levisky, C. V. Dang, J. D. Powell, and S. L. Topalian for reagents and helpful suggestions. We are grateful to G. Zhou, K. J. Rhee, and members of the Pardoll laboratory for helpful discussions. The array data sets are deposited at Gene Expression Omnibus (accession number GSE17166). This work was supported by grants from NIH and the Melanoma Research Alliance, the Janey Fund and Seraph Foundation, and gifts from Bill and Betty Topecer and Dorothy Needle.	Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Heo K, 2007, J BIOL CHEM, V282, P15476, DOI 10.1074/jbc.M610270200; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Koipally J, 2002, J BIOL CHEM, V277, P27697, DOI 10.1074/jbc.M201694200; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pan F, 2007, NATURE, V445, P433, DOI 10.1038/nature05476; Perdomo J, 2002, EUR J BIOCHEM, V269, P5885, DOI 10.1046/j.1432-1033.2002.03313.x; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	24	234	244	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1142	1146		10.1126/science.1176077	http://dx.doi.org/10.1126/science.1176077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19696312	Green Accepted			2022-12-28	WOS:000269382300045
J	Yazdanpanah, B; Wiegmann, K; Tchikov, V; Krut, O; Pongratz, C; Schramm, M; Kleinridders, A; Wunderlich, T; Kashkar, H; Utermohlen, O; Bruning, JC; Schutze, S; Kronke, M				Yazdanpanah, Benjamin; Wiegmann, Katja; Tchikov, Vladimir; Krut, Oleg; Pongratz, Carola; Schramm, Michael; Kleinridders, Andre; Wunderlich, Thomas; Kashkar, Hamid; Utermoehlen, Olaf; Bruening, Jens C.; Schuetze, Stefan; Kroenke, Martin			Riboflavin kinase couples TNF receptor 1 to NADPH oxidase	NATURE			English	Article							REACTIVE OXYGEN; CELL-DEATH; SUPEROXIDE-PRODUCTION; INDUCED ACTIVATION; PROTEIN; NECROSIS; TRADD; SPHINGOMYELINASE; PHOSPHORYLATION; INDUCTION	Reactive oxygen species (ROS) produced by NADPH oxidase function as defence and signalling molecules related to innate immunity and various cellular responses(1,2). The activation of NADPH oxidase in response to plasma membrane receptor activation depends on the phosphorylation of cytoplasmic oxidase subunits, their translocation to membranes and the assembly of all NADPH oxidase components(3). Tumour necrosis factor (TNF) is a prominent stimulus of ROS production, but the molecular mechanisms by which TNF activates NADPH oxidase are poorly understood. Here we identify riboflavin kinase (RFK, formerly known as flavokinase(4)) as a previously unrecognized TNF-receptor-1 (TNFR1)-binding protein that physically and functionally couples TNFR1 to NADPH oxidase. In mouse and human cells, RFK binds to both the TNFR1-death domain and to p22(phox), the common subunit of NADPH oxidase isoforms. RFK-mediated bridging of TNFR1 and p22(phox) is a pre-requisite for TNF-induced but not for Toll-like-receptor-induced ROS production. Exogenous flavin mononucleotide or FAD was able to substitute fully for TNF stimulation of NADPH oxidase in RFK-deficient cells. RFK is rate-limiting in the synthesis of FAD, an essential prosthetic group of NADPH oxidase. The results suggest that TNF, through the activation of RFK, enhances the incorporation of FAD in NADPH oxidase enzymes, a critical step for the assembly and activation of NADPH oxidase.	[Yazdanpanah, Benjamin; Wiegmann, Katja; Krut, Oleg; Pongratz, Carola; Schramm, Michael; Kashkar, Hamid; Utermoehlen, Olaf; Kroenke, Martin] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany; [Yazdanpanah, Benjamin; Krut, Oleg; Kashkar, Hamid; Utermoehlen, Olaf; Bruening, Jens C.; Kroenke, Martin] Univ Cologne, Ctr Mol Med Cologne, D-50935 Cologne, Germany; [Kleinridders, Andre; Wunderlich, Thomas; Bruening, Jens C.] Univ Cologne, Inst Genet, D-50935 Cologne, Germany; [Tchikov, Vladimir; Schuetze, Stefan] Univ Kiel, Inst Immunol, D-24105 Kiel, Germany; [Kashkar, Hamid; Bruening, Jens C.; Kroenke, Martin] Cologne Cluster Excellence Cellular Stress Respon, D-50674 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Kiel; University of Cologne	Kronke, M (corresponding author), Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany.	m.kroenke@uni-koeln.de	Schütze, Stefan/C-8596-2011	Kleinridders, Andre/0000-0002-4248-6366	Deutsche Forschungsgemeinschaft [SFB670, SFB415, 733/7-1]; DFG Leibniz programme	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Leibniz programme(German Research Foundation (DFG))	We thank M. Pasparakis for TRADD-deficient and TNFR1-deficient MEFs, R. Brandes for gp91-deficient mice and helpful discussions, and D. Mannel for TNFR1 and TNFR2 doubly deficient MEFs and for recombinant TNF. This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG; SFB670 to O. K., J. C. B., O. U. and M. K., and SFB415 to S. S.), DFG grant 733/7-1 to S. S., and a grant from the DFG Leibniz programme to J. C. B. and M. K.	AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Hashida S, 2004, J BIOL CHEM, V279, P26378, DOI 10.1074/jbc.M309724200; Ho A, 2001, CANCER RES, V61, P474; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karthikeyan S, 2003, STRUCTURE, V11, P265, DOI 10.1016/S0969-2126(03)00024-8; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; KRUISBEEK AM, 1999, CURRENT PROTOCOLS IM, V3; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Merrill A H Jr, 1980, Methods Enzymol, V66, P287; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROSS NS, 1992, BIOFACTORS, V3, P185; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Tsao DHH, 2007, J BIOMOL NMR, V39, P337, DOI 10.1007/s10858-007-9198-y; TSUNAWAKI S, 1984, J BIOL CHEM, V259, P4305; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; White DJ, 2001, MOL MICROBIOL, V42, P503, DOI 10.1046/j.1365-2958.2001.02659.x; Wiegmann K, 1999, J BIOL CHEM, V274, P5267, DOI 10.1074/jbc.274.9.5267; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	30	154	156	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1159	U132		10.1038/nature08206	http://dx.doi.org/10.1038/nature08206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19641494				2022-12-28	WOS:000269314000045
J	Kueh, HY; Mitchison, TJ				Kueh, Hao Yuan; Mitchison, Timothy J.			Structural Plasticity in Actin and Tubulin Polymer Dynamics	SCIENCE			English	Review							SLOWLY HYDROLYZABLE ANALOG; F-ACTIN; MICROTUBULE DYNAMICS; GTP HYDROLYSIS; FILAMENT TURNOVER; MECHANISM; ADF/COFILIN; ENDS; COOPERATIVITY; INFORMATION	Actin filaments and microtubules polymerize and depolymerize by adding and removing subunits at polymer ends, and these dynamics drive cytoplasmic organization, cell division, and cell motility. Since Wegner proposed the treadmilling theory for actin in 1976, it has largely been assumed that the chemical state of the bound nucleotide determines the rates of subunit addition and removal. This chemical kinetics view is difficult to reconcile with observations revealing multiple structural states of the polymer that influence polymerization dynamics but that are not strictly coupled to the bound nucleotide state. We refer to these phenomena as "structural plasticity" and discuss emerging evidence that they play a central role in polymer dynamics and function.	[Kueh, Hao Yuan; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA; [Kueh, Hao Yuan] Harvard Univ, Grad Program Biophys, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University	Mitchison, TJ (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02215 USA.	timothy_mitchison@hms.harvard.edu			NIH [GM 23928]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM 23928. H.Y.K. is a Howard Hughes Medical Institute predoctoral fellow.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bindschadler M, 2004, BIOPHYS J, V86, P2720, DOI 10.1016/S0006-3495(04)74326-X; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dye NA, 2007, TRENDS CELL BIOL, V17, P239, DOI 10.1016/j.tcb.2007.03.005; Egelman EH, 2003, NAT REV MOL CELL BIO, V4, P621, DOI 10.1038/nrm1176; Egelman EH, 2003, CURR OPIN STRUC BIOL, V13, P244, DOI 10.1016/S0959-440X(03)00027-7; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P6918, DOI 10.1073/pnas.0801811105; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; INOUE S, 1967, J GEN PHYSIOL, V50, P259, DOI 10.1085/jgp.50.6.259; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KIRSCHNER MW, 1974, P NATL ACAD SCI USA, V71, P1159, DOI 10.1073/pnas.71.4.1159; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Maciver SK, 2002, GENOME BIOL, V3; MANDELKOW EM, 1985, J MOL BIOL, V181, P123, DOI 10.1016/0022-2836(85)90330-4; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MARGOLIS RL, 1981, P NATL ACAD SCI-BIOL, V78, P1586, DOI 10.1073/pnas.78.3.1586; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102; ORLOVA A, 1995, J MOL BIOL, V245, P598, DOI 10.1006/jmbi.1994.0049; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Papp G, 2006, BIOPHYS J, V91, P2564, DOI 10.1529/biophysj.106.087775; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Prochniewicz E, 1996, J MOL BIOL, V260, P756, DOI 10.1006/jmbi.1996.0435; Reisler E, 2007, J BIOL CHEM, V282, P36133, DOI 10.1074/jbc.R700030200; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Schoenenberger CA, 2005, J STRUCT BIOL, V152, P157, DOI 10.1016/j.jsb.2005.09.003; Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559; Vavylonis D, 2005, P NATL ACAD SCI USA, V102, P8543, DOI 10.1073/pnas.0501435102; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Vorobjev IA, 1999, J CELL SCI, V112, P2277; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409	54	188	191	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					960	963		10.1126/science.1168823	http://dx.doi.org/10.1126/science.1168823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696342	Green Accepted			2022-12-28	WOS:000269242800035
J	Picotti, P; Bodenmiller, B; Mueller, LN; Domon, B; Aebersold, R				Picotti, Paola; Bodenmiller, Bernd; Mueller, Lukas N.; Domon, Bruno; Aebersold, Ruedi			Full Dynamic Range Proteome Analysis of S. cerevisiae by Targeted Proteomics	CELL			English	Article							MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; GLYCOLYTIC-ENZYMES; YEAST; QUANTIFICATION; EXPRESSION; PEPTIDES; IDENTIFICATION; PROTEINS; RESOURCE	The rise of systems biology implied a growing demand for highly sensitive techniques for the fast and consistent detection and quantification of target sets of proteins across multiple samples. This is only partly achieved by classical mass spectrometry or affinity-based methods. We applied a targeted proteomics approach based on selected reaction monitoring (SRM) to detect and quantify proteins expressed to a concentration below 50 copies/cell in total S. cerevisiae digests. The detection range can be extended to single-digit copies/cell and to proteins undetected by classical methods. We illustrate the power of the technique by the consistent and fast measurement of a network of proteins spanning the entire abundance range over a growth time course of S. cerevisiae transiting through a series of metabolic phases. We therefore demonstrate the potential of SRM-based proteomics to provide assays for the measurement of any set of proteins of interest in yeast at high-throughput and quantitative accuracy.	[Picotti, Paola; Bodenmiller, Bernd; Mueller, Lukas N.; Domon, Bruno; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Inst Syst Biol, Seattle, WA 98103 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Institute for Systems Biology (ISB); University of Zurich	Aebersold, R (corresponding author), ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch			ETH Zurich; Swiss National Science Foundation; National Heart, Lung, and Blood Institute; National Institutes of Health [HV-28179]; SystemsX.ch; Swiss initiative; Boehringer Ingelheim Fonds; Marie Curie Intra-European fellowship; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SystemsX.ch; Swiss initiative; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Marie Curie Intra-European fellowship(European Commission); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge Holger Wenschuh (JPT Peptide Technologies), Marko Jovanovic, Vinzenz Lange, Sarah Maria Fendt, Nichole King, and Matthias Heinemann for insightful discussions. We are also grateful to Roeland Costenoble and Uwe Sauer for providing <SUP>15</SUP>N- labeled S. cerevisiae cells. This project has been funded in part by ETH Zurich; the Swiss National Science Foundation, with Federal funds from the National Heart, Lung, and Blood Institute; the National Institutes of Health, under contract No. N01-HV-28179; and SystemsX.ch, the Swiss initiative for systems biology. B.B. is the recipient of a fellowship from the Boehringer Ingelheim Fonds. P.P. is the recipient of a Marie Curie Intra-European fellowship.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Chen EI, 2006, MOL CELL PROTEOMICS, V5, P53, DOI 10.1074/mcp.T500013-MCP200; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DESIDERIO DM, 1983, BIOMED MASS SPECTROM, V10, P471, DOI 10.1002/bms.1200100806; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Domon B, 2004, J PROTEOME RES, V3, P253, DOI 10.1021/pr034082c; ENTIAN KD, 1980, MOL GEN GENET, V177, P345, DOI 10.1007/BF00267449; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Haurie V, 2004, PROTEOMICS, V4, P364, DOI 10.1002/pmic.200300564; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; MacQueen J., 1967, P 5 BERK S MATH STAT, V1, P281, DOI DOI 10.1007/S11665-016-2173-6; MACQUEEN J, 1967, U CALIFORNIA PRESS, P5; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Malmstrom J, 2006, J PROTEOME RES, V5, P2241, DOI 10.1021/pr0600632; Pawlak M, 2002, PROTEOMICS, V2, P383, DOI 10.1002/1615-9861(200204)2:4<383::AID-PROT383>3.0.CO;2-E; Picotti P, 2008, NAT METHODS, V5, P913, DOI 10.1038/nmeth1108-913; Picotti P, 2007, MOL CELL PROTEOMICS, V6, P1589, DOI 10.1074/mcp.M700029-MCP200; POLAKIS ES, 1965, BIOCHEM J, V97, P284, DOI 10.1042/bj0970284; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Stahl-Zeng J, 2007, MOL CELL PROTEOMICS, V6, P1809, DOI 10.1074/mcp.M700132-MCP200; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; Uhlen M, 2008, BIOTECHNIQUES, V44, P649, DOI 10.2144/000112803; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104	36	604	620	1	136	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					795	806		10.1016/j.cell.2009.05.051	http://dx.doi.org/10.1016/j.cell.2009.05.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19664813	Green Accepted, Bronze			2022-12-28	WOS:000269156100020
J	Abdo, AA; Ackermann, M; Ajello, M; Atwood, WB; Axelsson, M; Baldini, L; Ballet, J; Barbiellini, G; Bastieri, D; Baughman, BM; Bechtol, K; Bellazzini, R; Berenji, B; Blandford, RD; Bloom, ED; Bonamente, E; Borgland, AW; Bregeon, J; Brez, A; Brigida, M; Bruel, P; Burnett, TH; Caliandro, GA; Cameron, RA; Caraveo, PA; Casandjian, JM; Cecchi, C; Celik, O; Charles, E; Chaty, S; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Conrad, J; Cutini, S; Dermer, CD; de Palma, F; Digel, SW; Dormody, M; Silva, EDE; Drell, PS; Dubois, R; Dumora, D; Farnier, C; Favuzzi, C; Fegan, SJ; Focke, WB; Frailis, M; Fukazawa, Y; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Giebels, B; Giglietto, N; Giordano, F; Glanzman, T; Godfrey, G; Grenier, IA; Grove, JE; Guillemot, L; Guiriec, S; Hanabata, Y; Harding, AK; Hayashida, M; Hays, E; Horan, D; Hughes, RE; Johannesson, G; Johnson, AS; Johnson, RP; Johnson, TJ; Johnson, WN; Kamae, T; Katagiri, H; Kawai, N; Kerr, M; Knodlseder, J; Kuehn, F; Kuss, M; Lande, J; Latronico, L; Lemoine-Goumard, M; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Makeev, A; Mazziotta, MN; McConville, W; McEnery, JE; Meurer, C; Michelson, PF; Mitthumsiri, W; Mizuno, T; Moiseev, AA; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nolan, PL; Norris, JP; Nuss, E; Ohsugi, T; Omodei, N; Orlando, E; Ormes, JF; Paneque, D; Panetta, JH; Parent, D; Pelassa, V; Pepe, M; Pierbattista, M; Piron, F; Porter, TA; Raino, S; Rando, R; Razzano, M; Rea, N; Reimer, A; Reimer, O; Reposeur, T; Ritz, S; Rochester, LS; Rodriguez, AY; Romani, RW; Roth, M; Ryde, F; Sadrozinski, HFW; Sanchez, D; Sander, A; Parkinson, PMS; Sgro, C; Smith, DA; Smith, PD; Spandre, G; Spinelli, P; Starck, JL; Strickman, MS; Suson, DJ; Tajima, H; Takahashi, H; Tanaka, T; Thayer, JB; Thayer, JG; Thompson, DJ; Tibaldo, L; Torres, DF; Tosti, G; Tramacere, A; Uchiyama, Y; Usher, TL; Vasileiou, V; Vilchez, N; Vitale, V; Wang, P; Webb, N; Winer, BL; Wood, KS; Ylinen, T; Ziegler, M				Abdo, A. A.; Ackermann, M.; Ajello, M.; Atwood, W. B.; Axelsson, M.; Baldini, L.; Ballet, J.; Barbiellini, G.; Bastieri, D.; Baughman, B. M.; Bechtol, K.; Bellazzini, R.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bonamente, E.; Borgland, A. W.; Bregeon, J.; Brez, A.; Brigida, M.; Bruel, P.; Burnett, T. H.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Casandjian, J. M.; Cecchi, C.; Celik, Oe; Charles, E.; Chaty, S.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Conrad, J.; Cutini, S.; Dermer, C. D.; de Palma, F.; Digel, S. W.; Dormody, M.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Dumora, D.; Farnier, C.; Favuzzi, C.; Fegan, S. J.; Focke, W. B.; Frailis, M.; Fukazawa, Y.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Giebels, B.; Giglietto, N.; Giordano, F.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grove, J. E.; Guillemot, L.; Guiriec, S.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hays, E.; Horan, D.; Hughes, R. E.; Johannesson, G.; Johnson, A. S.; Johnson, R. P.; Johnson, T. J.; Johnson, W. N.; Kamae, T.; Katagiri, H.; Kawai, N.; Kerr, M.; Knoedlseder, J.; Kuehn, F.; Kuss, M.; Lande, J.; Latronico, L.; Lemoine-Goumard, M.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Makeev, A.; Mazziotta, M. N.; McConville, W.; McEnery, J. E.; Meurer, C.; Michelson, P. F.; Mitthumsiri, W.; Mizuno, T.; Moiseev, A. A.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Norris, J. P.; Nuss, E.; Ohsugi, T.; Omodei, N.; Orlando, E.; Ormes, J. F.; Paneque, D.; Panetta, J. H.; Parent, D.; Pelassa, V.; Pepe, M.; Pierbattista, M.; Piron, F.; Porter, T. A.; Raino, S.; Rando, R.; Razzano, M.; Rea, N.; Reimer, A.; Reimer, O.; Reposeur, T.; Ritz, S.; Rochester, L. S.; Rodriguez, A. Y.; Romani, R. W.; Roth, M.; Ryde, F.; Sadrozinski, H. F. -W.; Sanchez, D.; Sander, A.; Parkinson, P. M. Saz; Sgro, C.; Smith, D. A.; Smith, P. D.; Spandre, G.; Spinelli, P.; Starck, J. -L.; Strickman, M. S.; Suson, D. J.; Tajima, H.; Takahashi, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Thompson, D. J.; Tibaldo, L.; Torres, D. F.; Tosti, G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Vasileiou, V.; Vilchez, N.; Vitale, V.; Wang, P.; Webb, N.; Winer, B. L.; Wood, K. S.; Ylinen, T.; Ziegler, M.			Detection of High-Energy Gamma-Ray Emission from the Globular Cluster 47 Tucanae with Fermi	SCIENCE			English	Article							MILLISECOND PULSARS; X-RAY; BINARIES; POPULATION; CORE	We report the detection of gamma-ray emissions above 200 megaelectron volts at a significance level of 17 sigma from the globular cluster 47 Tucanae, using data obtained with the Large Area Telescope onboard the Fermi Gamma-ray Space Telescope. Globular clusters are expected to emit gamma rays because of the large populations of millisecond pulsars that they contain. The spectral shape of 47 Tucanae is consistent with gamma-ray emission from a population of millisecond pulsars. The observed gamma-ray luminosity implies an upper limit of 60 millisecond pulsars present in 47 Tucanae.	[Knoedlseder, J.] UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; [Abdo, A. A.; Chekhtman, A.; Dermer, C. D.; Grove, J. E.; Johnson, W. N.; Lovellette, M. N.; Makeev, A.; Strickman, M. S.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Lande, J.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Wang, P.] Stanford Univ, WW Hansen Expt Phys Lab, Kavli Inst Particle Astrophys & Cosmol, Dept Phys, Stanford, CA 94305 USA; [Atwood, W. B.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Axelsson, M.; Conrad, J.; Monzani, M. E.; Ryde, F.; Ylinen, T.] Oskar Klein Ctr Cosmo Particle Phys, SE-10691 Stockholm, Sweden; [Axelsson, M.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Baldini, L.; Bellazzini, R.; Bregeon, J.; Brez, A.; Kuss, M.; Latronico, L.; Omodei, N.; Razzano, M.; Sgro, C.; Spandre, G.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Chaty, S.; Grenier, I. A.; Pierbattista, M.; Starck, J. -L.; Thayer, J. B.] Univ Paris Diderot, Lab AIM, CEA Saclay, CEA IRFU CNRS,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Bastieri, D.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Baughman, B. M.; Hughes, R. E.; Kuehn, F.; Sander, A.; Smith, P. D.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lemoine-Goumard, M.; Pepe, M.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Farnier, C.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Giebels, B.; Horan, D.; Sanchez, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Burnett, T. H.; Kerr, M.; Roth, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Caraveo, P. A.] INAF Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Celik, Oe; Cheung, C. C.; Gehrels, N.; Harding, A. K.; Johnson, T. J.; McConville, W.; McEnery, J. E.; Ritz, S.; Thompson, D. J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Chekhtman, A.; Makeev, A.] George Mason Univ, Fairfax, VA 22030 USA; [Cohen-Tanugi, J.; Farnier, C.; Nuss, E.; Pelassa, V.; Piron, F.] Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, Montpellier, France; [Conrad, J.; Ryde, F.; Ylinen, T.] Royal Inst Technol KTH, Dept Phys, SE-10691 Stockholm, Sweden; [Conrad, J.; Monzani, M. E.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Cutini, S.; Gasparrini, D.] ASI, Sci Data Ctr, I-00044 Frascati, Roma, Italy; [Dumora, D.; Guillemot, L.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] Ctr Etud Nucl Bordeaux Gradignan, CNRS, IN2P3, UMR 5797, F-33175 Gradignan, France; [Dumora, D.; Guillemot, L.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] Univ Bordeaux, UMR 5797, Ctr Etud Nucl Bordeaux Gradignan, F-33175 Gradignan, France; [Frailis, M.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [Fukazawa, Y.; Hanabata, Y.; Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Gehrels, N.; Johnson, T. J.; McConville, W.; Moiseev, A. A.] Univ Maryland, College Pk, MD 20742 USA; [Guiriec, S.] Univ Alabama, Huntsville, AL 35899 USA; [Kawai, N.] RIKEN, Inst Phys & Chem Res, Cosm Radiat Lab, Wako, Saitama 3510198, Japan; [Kawai, N.] Tokyo Inst Technol, Dept Phys, Meguro, Tokyo 1528551, Japan; [Atwood, W. B.; Dormody, M.; Johnson, R. P.; Porter, T. A.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Vilchez, N.; Webb, N.; Ziegler, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Moiseev, A. A.; Vasileiou, V.] NASA, Goddard Space Flight Ctr, Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Orlando, E.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Rea, N.] Sterrenkundig Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; [Rea, N.; Rodriguez, A. Y.; Torres, D. F.] Inst Ciencies Espai IEEC CSIC, Barcelona 08193, Spain; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchen Phys, A-6020 Innsbruck, Austria; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Torres, D. F.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Tramacere, A.] Consorzio Interuniv Fis Spaziale, I-10133 Turin, Italy; [Vasileiou, V.] Univ Maryland, Baltimore, MD 21250 USA; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Ylinen, T.] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Lande, J.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Panetta, J. H.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Wang, P.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Frailis, M.] Ist Nazl Fis Nucl, Sez Trieste, Grp Coll Udine, I-33100 Udine, Italy	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; United States Department of Defense; United States Navy; Naval Research Laboratory; Stanford University; University of California System; University of California Santa Cruz; Oskar Klein Centre; Stockholm University; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University System of Ohio; Ohio State University; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; University of Washington; University of Washington Seattle; Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; George Mason University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Royal Institute of Technology; Stockholm University; Agenzia Spaziale Italiana (ASI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; University of Udine; Hiroshima University; University System of Maryland; University of Maryland College Park; University of Alabama System; University of Alabama Huntsville; RIKEN; Tokyo Institute of Technology; University of California System; University of California Santa Cruz; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Istituto Nazionale di Fisica Nucleare (INFN); University of Denver; Max Planck Society; University of Amsterdam; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Innsbruck; Purdue University System; Purdue University; ICREA; University System of Maryland; University of Maryland Baltimore; University of Rome Tor Vergata; Linnaeus University; University of Kalmar; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN)	Knodlseder, J (corresponding author), UPS, CNRS, Ctr Etud Spatiale Rayonnements, BP 44346, F-31028 Toulouse 4, France.	jurgen.knodlseder@cesr.fr; natalie.webb@cesr.fr	Starck, Jean-Luc/D-9467-2011; Moskalenko, Igor V/A-1301-2007; Kuss, Michael W/H-8959-2012; Cutini, Sara/ABB-1787-2020; Gehrels, Neil/D-2971-2012; Harding, Alice K/D-3160-2012; Parkinson, Pablo Miguel Saz/I-7980-2013; Baldini, Luca/E-5396-2012; Morselli, Aldo/G-6769-2011; tramacere, andrea/B-9424-2012; Fukazawa, Yasushi/G-2081-2017; Giglietto, Nicola/Y-2425-2019; giglietto, nicola/I-8951-2012; Torres, Diego F./O-9422-2016; cohen-tanugi, Johann/ABB-1481-2021; Reimer, Anita/K-5822-2015; Mazziotta, Mario N/O-8867-2015; McEnery, Julie E/D-6612-2012; Gasparrini, Dario/X-6699-2019; lubrano, pasquale/F-7269-2012; Torres, Diego F./AAF-7931-2019; Bastieri, Denis/AAC-5917-2020; Johnson, Neil/G-3309-2014; Reimer, Olaf/A-3117-2013; Torres, Diego F/ABD-7940-2020; Nolan, Patrick L/A-5582-2009; Rando, Riccardo/O-1302-2019; Takahashi, Hiromitsu H/T-2713-2017; Caraveo, Patrizia/AAL-5708-2020; Jóhannesson, Guðlaugur/O-8741-2015; Hays, Elizabeth/D-3257-2012; Thompson, David J/D-2939-2012; Tosti, Gino/E-9976-2013; Jóhannesson, Guðlaugur/ABC-7216-2020; Gargano, Fabio/AAD-5121-2021; Loparco, Francesco/O-8847-2015; Tajima, Hiroyasu/I-6228-2014; Gargano, Fabio/O-8934-2015; Rando, Riccardo/M-7179-2013; Sgrò, Carmelo/K-3395-2016; Rea, Nanda/I-2853-2015; Chaty, Sylvain/B-8671-2016; Orlando, Elena/R-5594-2016	Starck, Jean-Luc/0000-0003-2177-7794; Moskalenko, Igor V/0000-0001-6141-458X; Cutini, Sara/0000-0002-1271-2924; Morselli, Aldo/0000-0002-7704-9553; tramacere, andrea/0000-0002-8186-3793; Fukazawa, Yasushi/0000-0002-0921-8837; Giglietto, Nicola/0000-0002-9021-2888; giglietto, nicola/0000-0002-9021-2888; Torres, Diego F./0000-0002-1522-9065; cohen-tanugi, Johann/0000-0001-9022-4232; Reimer, Anita/0000-0001-8604-7077; Mazziotta, Mario N/0000-0001-9325-4672; Gasparrini, Dario/0000-0002-5064-9495; lubrano, pasquale/0000-0003-0221-4806; Torres, Diego F./0000-0002-1522-9065; Bastieri, Denis/0000-0002-6954-8862; Reimer, Olaf/0000-0001-6953-1385; Rando, Riccardo/0000-0001-6992-818X; Takahashi, Hiromitsu H/0000-0001-6314-5897; Caraveo, Patrizia/0000-0003-2478-8018; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Thompson, David J/0000-0001-5217-9135; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Gargano, Fabio/0000-0002-5055-6395; Loparco, Francesco/0000-0002-1173-5673; Tajima, Hiroyasu/0000-0002-1721-7252; Gargano, Fabio/0000-0002-5055-6395; Rea, Nanda/0000-0003-2177-6388; de Palma, Francesco/0000-0001-5898-2834; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Spandre, Gloria/0000-0003-0802-3453; Johnson, Tyrel/0000-0002-2771-472X; Berenji, Bijan/0000-0002-4551-772X; Sgro', Carmelo/0000-0001-5676-6214; Frailis, Marco/0000-0002-7400-2135; Chaty, Sylvain/0000-0002-5769-8601; Omodei, Nicola/0000-0002-5448-7577; Cecchi, Claudia/0000-0002-2192-8233; Orlando, Elena/0000-0001-6406-9910; Porter, Troy/0000-0002-2621-4440; Tanaka, Takaaki/0000-0002-4383-0368; Murgia, Simona/0000-0003-0516-9422; Cheung, Chi (Teddy)/0000-0002-4377-0174; Charles, Eric/0000-0002-3925-7802; Cameron, Robert/0000-0003-0942-2747; Ackermann, Markus/0000-0001-8952-588X; Grenier, Isabelle/0000-0003-3274-674X; Kerr, Matthew/0000-0002-0893-4073; SANCHEZ, David/0000-0002-7210-4496; Casandjian, Jean-Marc/0000-0003-1404-0524; Baldini, Luca/0000-0002-9785-7726; Tibaldo, Luigi/0000-0001-7523-570X; Ciprini, Stefano/0000-0002-0712-2479; Fusco, Piergiorgio/0000-0002-9383-2425; Sadrozinski, Hartmut/0000-0003-0019-5410; Pepe, Monica/0000-0001-5624-4010; Katagiri, Hideaki/0000-0003-2347-8819	NASA; U.S. Department of Energy; Commissariat a l Energie Atomique; CNRS; Institut National de Physique Nuclaire et de Physique des Particules; Agenzia Spaziale Italiana and Istituto Nazionale di Fisica Nucleare; Ministry of Education, Culture, Sports, Science and Technology; High Energy Accelerator Research Organization (KEK); Japan Aerospace Exploration Agency; K. A. Wallenberg Foundation; Swedish Research Council; National Space Board (Sweden); Istituto Nazionale di Astrofisica (Italy); Centre National d Etudes Spatiales (France); ICREA Funding Source: Custom	NASA(National Aeronautics & Space Administration (NASA)); U.S. Department of Energy(United States Department of Energy (DOE)); Commissariat a l Energie Atomique(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National de Physique Nuclaire et de Physique des Particules; Agenzia Spaziale Italiana and Istituto Nazionale di Fisica Nucleare; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High Energy Accelerator Research Organization (KEK)(High Energy Accelerator Research Organization (KEK)); Japan Aerospace Exploration Agency; K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Space Board (Sweden); Istituto Nazionale di Astrofisica (Italy)(Istituto Nazionale Astrofisica (INAF)); Centre National d Etudes Spatiales (France)(Centre National D'etudes Spatiales); ICREA(ICREA)	The Fermi LAT Collaboration is supported by NASA and the U.S. Department of Energy; the Commissariat a l Energie Atomique and CNRS/Institut National de Physique Nuclaire et de Physique des Particules (France); the Agenzia Spaziale Italiana and Istituto Nazionale di Fisica Nucleare (Italy); the Ministry of Education, Culture, Sports, Science and Technology, High Energy Accelerator Research Organization (KEK), and Japan Aerospace Exploration Agency (Japan); and the K. A. Wallenberg Foundation, Swedish Research Council, and National Space Board (Sweden). Additional support was provided by the Istituto Nazionale di Astrofisica (Italy) and the Centre National d Etudes Spatiales (France).	Abdo AA, 2009, ASTROPHYS J, V699, P1171, DOI 10.1088/0004-637X/699/2/1171; Abdo AA, 2009, SCIENCE, V325, P848, DOI 10.1126/science.1176113; Abdo AA, 2009, ASTROPHYS J SUPPL S, V183, P46, DOI 10.1088/0067-0049/183/1/46; Aharonian F, 2009, ASTRON ASTROPHYS, V499, P273, DOI 10.1051/0004-6361/200811564; ALPAR MA, 1982, NATURE, V300, P728, DOI 10.1038/300728a0; Bednarek W, 2007, MON NOT R ASTRON SOC, V377, P920, DOI 10.1111/j.1365-2966.2007.11664.x; Camilo F, 2000, ASTROPHYS J, V535, P975, DOI 10.1086/308859; CAMILO F, 2005, ASP C SER, V328, P147; FIERRO JM, 1995, ASTROPHYS J, V447, P807, DOI 10.1086/175919; Freire PC, 2003, MON NOT R ASTRON SOC, V340, P1359, DOI 10.1046/j.1365-8711.2003.06392.x; Gendre B, 2003, ASTRON ASTROPHYS, V403, pL11, DOI 10.1051/0004-6361:20030423; Grindlay JE, 2001, SCIENCE, V292, P2290, DOI 10.1126/science.1061135; Harding AK, 2005, ASTROPHYS J, V622, P531, DOI 10.1086/427840; Harding AK, 2002, ASTROPHYS J, V576, P366, DOI 10.1086/341633; HUT P, 1992, PUBL ASTRON SOC PAC, V104, P981, DOI 10.1086/133085; Manandhar RP, 1996, ASTRON ASTROPHYS SUP, V120, pC255; McConnell D, 2004, MON NOT R ASTRON SOC, V348, P1409, DOI 10.1111/j.1365-2966.2004.07447.x; McLaughlin DE, 2006, ASTROPHYS J SUPPL S, V166, P249, DOI 10.1086/505692; McLean BJ, 2000, ASTR SOC P, V216, P145; MICHELSON PF, 1994, ASTROPHYS J, V435, P218, DOI 10.1086/174808; Pooley D, 2003, ASTROPHYS J, V591, pL131, DOI 10.1086/377074; Venter C, 2009, ASTROPHYS J LETT, V696, pL52, DOI 10.1088/0004-637X/696/1/L52; VERBUNT F, 1987, IAU SYMP, P187; Watters KP, 2009, ASTROPHYS J, V695, P1289, DOI 10.1088/0004-637X/695/2/1289; Wei DM, 1996, ASTROPHYS J, V468, P207, DOI 10.1086/177683; Zhang L, 2003, ASTRON ASTROPHYS, V398, P639, DOI 10.1051/0004-6361:20021570	28	78	78	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					845	848		10.1126/science.1177023	http://dx.doi.org/10.1126/science.1177023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679807				2022-12-28	WOS:000269242400038
J	Vecchi, C; Montosi, G; Zhang, KZ; Lamberti, I; Duncan, SA; Kaufman, RJ; Pietrangelo, A				Vecchi, Chiara; Montosi, Giuliana; Zhang, Kezhong; Lamberti, Igor; Duncan, Stephen A.; Kaufman, Randal J.; Pietrangelo, Antonello			ER Stress Controls Iron Metabolism Through Induction of Hepcidin	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; ANTIMICROBIAL PEPTIDE; IN-VIVO; EXPRESSION; HEMOCHROMATOSIS; TRANSCRIPTION; INFLAMMATION; STAT3; LIVER	Hepcidin is a peptide hormone that is secreted by the liver and controls body iron homeostasis. Hepcidin overproduction causes anemia of inflammation, whereas its deficiency leads to hemochromatosis. Inflammation and iron are known extracellular stimuli for hepcidin expression. We found that endoplasmic reticulum (ER) stress also induces hepcidin expression and causes hypoferremia and spleen iron sequestration in mice. CREBH (cyclic AMP response element-binding protein H), an ER stress-activated transcription factor, binds to and transactivates the hepcidin promoter. Hepcidin induction in response to exogenously administered toxins or accumulation of unfolded protein in the ER is defective in CREBH knockout mice, indicating a role for CREBH in ER stress-regulated hepcidin expression. The regulation of hepcidin by ER stress links the intracellular response involved in protein quality control to innate immunity and iron homeostasis.	[Vecchi, Chiara; Montosi, Giuliana; Lamberti, Igor; Pietrangelo, Antonello] Univ Hosp Policlin Modena, Dept Internal Med, Ctr Hemochromatosis, Modena, Italy; [Zhang, Kezhong] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Kaufman, Randal J.] Univ Michigan, Howard Hughes Med Inst, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Med Ctr, Ann Arbor, MI 48109 USA	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Wayne State University; Medical College of Wisconsin; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Pietrangelo, A (corresponding author), Univ Hosp Policlin Modena, Dept Internal Med, Ctr Hemochromatosis, Modena, Italy.	antonello.pietrangelo@unimore.it	Vecchi, Chiara/C-1552-2014; Pietrangelo, Antonello/K-1517-2016	Pietrangelo, Antonello/0000-0002-7411-935X; Zhang, Kezhong/0000-0002-6062-235X; Duncan, Stephen/0000-0002-2507-7827; VECCHI, Chiara/0000-0001-7761-4922	European Union [EUROIRON Ct.2006-037296]; NIH [DK42394, HL52173, PO1 HL057346]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, R37DK042394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH089782] Funding Source: NIH RePORTER	European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by European Union grant EUROIRON Ct.2006-037296 (A.P.) and NIH grants DK42394, HL52173, and PO1 HL057346 R.J.K.). R.J.K. is an Investigator of the Howard Hughes Medical Institute.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; CARTWRIGHT G. E., 1966, SEMINARS HEMATOL, V3, P351; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Flanagan JM, 2007, BLOOD CELL MOL DIS, V38, P253, DOI 10.1016/j.bcmd.2007.01.004; Ganz T, 2006, CURR TOP MICROBIOL, V306, P183; HURST HC, 1995, PROTEIN PROFILE, V2, P105; Miao HZ, 2004, BLOOD, V103, P3412, DOI 10.1182/blood-2003-10-3591; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	21	231	239	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					877	880		10.1126/science.1176639	http://dx.doi.org/10.1126/science.1176639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679815	Green Accepted			2022-12-28	WOS:000269242400047
J	Jones, R; Charlton, J; Latinovic, R; Gulliford, MC				Jones, Roger; Charlton, Judith; Latinovic, Radoslav; Gulliford, Martin C.			Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study	BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; PROTON PUMP INHIBITOR; GENERAL-PRACTICE; HELICOBACTER-PYLORI; COLORECTAL-CANCER; COMMON SYMPTOMS; INFORMATION; VALIDATION; HEMATURIA; DYSPEPSIA	Objective To evaluate the predictive value of alarm symptoms for specified non-cancer diagnoses and cancer diagnoses in primary care. Design Cohort study using the general practice research database. Setting 128 general practices in the UK contributing data, 1994-2000. Participants 762 325 patients aged 15 or older. Main outcome measures Up to 15 pre-specified, non-cancer diagnoses associated with four alarm symptoms ( haematuria, haemoptysis, dysphagia, rectal bleeding) at 90 days and three years after the first recorded alarm symptom. For each outcome analyses were implemented separately in a time to event framework. Data were censored if patients died, left the practice, or reached the end of the study period. Results We analysed data on first episodes of haematuria ( 11 108), haemoptysis (4812), dysphagia (5999), or rectal bleeding ( 15 289). Non-cancer diagnoses were commonin patients who presented with alarm symptoms. The proportion diagnosed with either cancer or non-cancer diagnoses generally increased with age. In patients presenting with haematuria, the proportions diagnosed with either cancer or non-cancer diagnoses within 90 days were 17.5% (95% confidence interval 16.4% to 18.6%) in women and 18.3% (17.4% to 19.3%) in men. For the other symptoms the proportions were 25.7% (23.8% to 27.8%) and 24% (22.5% to 25.6%) for haemoptysis, 17.2% (16% to 18.5%) and 22.6% (21% to 24.3%) for dysphagia, and 14.5% (13.7% to 15.3%) and 16.7% (15.8% to 17.5%) for rectal bleeding. Conclusion Clinically relevant diagnoses are made in a high proportion of patients presenting with alarm symptoms. For every four to seven patients evaluated for haematuria, haemoptysis, dysphagia, or rectal bleeding, relevant diagnoses will be identified in one patient within 90 days.	[Jones, Roger; Gulliford, Martin C.] Kings Coll London, Sch Med Guys, Dept Gen Practice & Primary Care, Div Hlth & Social Care Res, London SE11 6SP, England; [Jones, Roger; Gulliford, Martin C.] St Thomas Hosp, London SE11 6SP, England; [Charlton, Judith; Latinovic, Radoslav] St Thomas Hosp, London SE1 3QD, England; [Charlton, Judith; Latinovic, Radoslav] Kings Coll London, Sch Med Guys, Dept Publ Hlth Sci, Div Hlth & Social Care Res, London SE1 3QD, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Jones, R (corresponding author), Kings Coll London, Sch Med Guys, Dept Gen Practice & Primary Care, Div Hlth & Social Care Res, London SE11 6SP, England.	roger.jones@kcl.ac.uk	Gulliford, Martin C/I-8606-2018	Gulliford, Martin C/0000-0003-1898-9075				Bindman AB, 2007, BMJ-BRIT MED J, V334, P1261, DOI 10.1136/bmj.39203.658970.55; Bruyninckx R, 2003, BRIT J GEN PRACT, V53, P31; Delaney B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001961.pub2; Delaney BC, 2008, BMJ-BRIT MED J, V336, P651, DOI 10.1136/bmj.39479.640486.AE; ELSTEIN AS, 1981, J MED EDUC, V56, P75; Hansell A, 1999, THORAX, V54, P413, DOI 10.1136/thx.54.5.413; Hollowell J, 1997, Popul Trends, P36; Jarbol DE, 2006, AM J GASTROENTEROL, V101, P1200, DOI 10.1038/ajg2006227; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; JOHNSTON H, 1989, ARCH INTERN MED, V149, P1666, DOI 10.1001/archinte.149.7.1666; Jones R, 2001, BRIT MED J, V322, P1555, DOI 10.1136/bmj.322.7302.1555; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; Kroenke K, 1998, FAM PRACT, V15, P398, DOI 10.1093/fampra/15.5.398; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lawrenson R, 2006, EUR J CANCER CARE, V15, P267, DOI 10.1111/j.1365-2354.2005.00637.x; MARINKER M, 1998, CLIN FUTURES; Murtagh J, 1990, Aust Fam Physician, V19, P733; *NAT STAT ONL, MORB STAT GEN PRACT; Norman G, 2006, NEW ENGL J MED, V355, P2251, DOI 10.1056/NEJMe068134; Polmear A., 2008, EVIDENCE BASED DIAGN; Robertson R, 2006, BRIT J GEN PRACT, V56, P763; SANTIAGO S, 1991, ARCH INTERN MED, V151, P1461; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Summerton N, 2002, BRIT J GEN PRACT, V52, P284; THOMAS KB, 1974, BRIT MED J, V1, P625, DOI 10.1136/bmj.1.5908.625; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029	29	44	44	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 13	2009	339								b3094	10.1136/bmj.b3094	http://dx.doi.org/10.1136/bmj.b3094			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YK	19679615	Green Published, hybrid			2022-12-28	WOS:000269162100004
J	Tendal, B; Higgins, JPT; Juni, P; Hrobjartsson, A; Trelle, S; Nuesch, E; Wandel, S; Jorgensen, AW; Gesser, K; Ilsoe-Kristensen, S; Gotzsche, PC				Tendal, Britta; Higgins, Julian P. T.; Juni, Peter; Hrobjartsson, Asbjorn; Trelle, Sven; Nuesch, Eveline; Wandel, Simon; Jorgensen, Anders W.; Gesser, Katarina; Ilsoe-Kristensen, Soren; Gotzsche, Peter C.			Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMPLIANCE THERAPY; DATA EXTRACTION; RANDOMIZED-TRIALS; ERRORS	Objective To study the inter-observer variation related to extraction of continuous and numerical rating scale data from trial reports for use in meta-analyses. Design Observer agreement study. Data sources A random sample of 10 Cochrane reviews that presented a result as a standardised mean difference (SMD), the protocols for the reviews and the trial reports (n=45) were retrieved. Data extraction Five experienced methodologists and five PhD students independently extracted data from the trial reports for calculation of the first SMD result in each review. The observers did not have access to the reviews but to the protocols, where the relevant outcome was highlighted. The agreement was analysed at both trial and meta-analysis level, pairing the observers in all possible ways ( 45 pairs, yielding 2025 pairs of trials and 450 pairs of meta-analyses). Agreement was defined as SMDs that differed less than 0.1 in their point estimates or confidence intervals. Results The agreement was 53% at trial level and 31% at meta- analysis level. Including all pairs, the median disagreement was SMD=0.22 ( interquartile range 0.07-0.61). The experts agreed somewhat more than the PhD students at trial level (61% v 46%), but not at meta-analysis level. Important reasons for disagreement were differences in selection of time points, scales, control groups, and type of calculations; whether to include a trial in the meta-analysis; and data extraction errors made by the observers. In 14 out of the 100 SMDs calculated at the meta- analysis level, individual observers reached different conclusions than the originally published review. Conclusions Disagreements were common and often larger than the effect of commonly used treatments. Meta-analyses using SMDs are prone to observer variation and should be interpreted with caution. The reliability of meta-analyses might be improved by having more detailed review protocols, more than one observer, and statistical expertise.	[Tendal, Britta; Hrobjartsson, Asbjorn; Jorgensen, Anders W.; Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, Dept 3343, DK-2100 Copenhagen, Denmark; [Juni, Peter; Trelle, Sven; Nuesch, Eveline; Wandel, Simon] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Juni, Peter; Trelle, Sven; Nuesch, Eveline; Wandel, Simon] Univ Hosp Bern, CTU Bern, Bern, Switzerland; [Higgins, Julian P. T.] Univ Cambridge, Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 1TN, England; [Gesser, Katarina; Ilsoe-Kristensen, Soren] Univ Copenhagen, Fac Pharmaceut Sci, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Bern; University of Bern; University Hospital of Bern; MRC Biostatistics Unit; University of Cambridge; University of Copenhagen	Tendal, B (corresponding author), Rigshosp, Nord Cochrane Ctr, Dept 3343, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	bt@cochrane.dk	Trelle, Sven/D-3760-2009; Juni, Peter/Q-8700-2016; Higgins, Julian PT/H-4008-2011	Trelle, Sven/0000-0002-8162-8910; Juni, Peter/0000-0002-5985-0670; Higgins, Julian PT/0000-0002-8323-2514; , Simon/0000-0002-1442-597X	MRC [MC_U105285807] Funding Source: UKRI; Medical Research Council [MC_U105285807] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adams NP, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003135.pub3; Afolabi BB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004350.pub2; BUCKLEY LA, 2007, COCHRANE DATABASE SY; Buscemi N, 2006, J CLIN EPIDEMIOL, V59, P697, DOI 10.1016/j.jclinepi.2005.11.010; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Durham RC, 2003, BRIT J PSYCHIAT, V182, P303, DOI 10.1192/bjp.182.4.303; Gava I, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005333.pub2; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Healey A, 1998, BRIT J PSYCHIAT, V172, P420, DOI 10.1192/bjp.172.5.420; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Ipser JC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005473.pub2; Jones AP, 2005, J CLIN EPIDEMIOL, V58, P741, DOI 10.1016/j.jclinepi.2004.11.024; Jones MK, 1998, BEHAV RES THER, V36, P959, DOI 10.1016/S0005-7967(98)00057-6; Kemp R, 1996, BRIT MED J, V312, P345; Kemp R, 1998, BRIT J PSYCHIAT, V172, P413, DOI 10.1192/bjp.172.5.413; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Martinez DP, 2007, COCHRANE DB SYST REV; Mistiaen P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004510.pub3; Moher D, 2005, EXPLORE-NY, V1, P40, DOI 10.1016/j.explore.2004.11.001; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moore M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002870.pub2; Orlando R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005160.pub2; Uman LS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005179; Woodford H, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004585.pub2	24	46	46	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2009	339								b3128	10.1136/bmj.b3128	http://dx.doi.org/10.1136/bmj.b3128			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YK	19679616	hybrid, Green Published			2022-12-28	WOS:000269162100005
J	Kallmes, DF; Comstock, BA; Heagerty, PJ; Turner, JA; Wilson, DJ; Diamond, TH; Edwards, R; Gray, LA; Stout, L; Owen, S; Hollingworth, W; Ghdoke, B; Annesley-Williams, DJ; Ralston, SH; Jarvik, JG				Kallmes, David F.; Comstock, Bryan A.; Heagerty, Patrick J.; Turner, Judith A.; Wilson, David J.; Diamond, Terry H.; Edwards, Richard; Gray, Leigh A.; Stout, Lydia; Owen, Sara; Hollingworth, William; Ghdoke, Basavaraj; Annesley-Williams, Deborah J.; Ralston, Stuart H.; Jarvik, Jeffrey G.			A Randomized Trial of Vertebroplasty for Osteoporotic Spinal Fractures	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERTEBRAL COMPRESSION FRACTURES; COMPARING PERCUTANEOUS VERTEBROPLASTY; SICKNESS IMPACT PROFILE; PAIN CLINICAL-TRIALS; LOW-BACK-PAIN; PLACEBO POWERLESS; FUNCTIONAL STATUS; OUTCOMES; DISABILITY; QUESTIONNAIRE	BACKGROUND Vertebroplasty is commonly used to treat painful, osteoporotic vertebral compression fractures. METHODS In this multicenter trial, we randomly assigned 131 patients who had one to three painful osteoporotic vertebral compression fractures to undergo either vertebroplasty or a simulated procedure without cement (control group). The primary outcomes were scores on the modified Roland-Morris Disability Questionnaire (RDQ) (on a scale of 0 to 23, with higher scores indicating greater disability) and patients' ratings of average pain intensity during the preceding 24 hours at 1 month (on a scale of 0 to 10, with higher scores indicating more severe pain). Patients were allowed to cross over to the other study group after 1 month. RESULTS All patients underwent the assigned intervention (68 vertebroplasties and 63 simulated procedures). The baseline characteristics were similar in the two groups. At 1 month, there was no significant difference between the vertebroplasty group and the control group in either the RDQ score (difference, 0.7; 95% confidence interval [CI], -1.3 to 2.8; P = 0.49) or the pain rating (difference, 0.7; 95% CI, -0.3 to 1.7; P = 0.19). Both groups had immediate improvement in disability and pain scores after the intervention. Although the two groups did not differ significantly on any secondary outcome measure at 1 month, there was a trend toward a higher rate of clinically meaningful improvement in pain (a 30% decrease from baseline) in the vertebroplasty group (64% vs. 48%, P = 0.06). At 3 months, there was a higher crossover rate in the control group than in the vertebroplasty group (43% vs. 12%, P<0.001). There was one serious adverse event in each group. CONCLUSIONS Improvements in pain and pain-related disability associated with osteoporotic compression fractures in patients treated with vertebroplasty were similar to the improvements in a control group. (ClinicalTrials.gov number, NCT00068822.)	[Kallmes, David F.] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA; [Comstock, Bryan A.; Heagerty, Patrick J.; Turner, Judith A.; Stout, Lydia; Ghdoke, Basavaraj; Jarvik, Jeffrey G.] Univ Washington, Seattle, WA 98195 USA; [Wilson, David J.; Owen, Sara] Nuffield Orthopaed Ctr NHS Trust, Oxford, England; [Edwards, Richard] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland; [Hollingworth, William] Univ Bristol, Bristol, Avon, England; [Annesley-Williams, Deborah J.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Ralston, Stuart H.] Univ Edinburgh, Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Diamond, Terry H.] Univ New S Wales, St George Hosp, Sydney, NSW, Australia	Mayo Clinic; University of Washington; University of Washington Seattle; Nuffield Orthopaedic Centre; Gartnavel Royal Hospital; University of Bristol; Nottingham University Hospital NHS Trust; University of Edinburgh; St George Hospital; University of New South Wales Sydney	Kallmes, DF (corresponding author), Mayo Clin, Dept Radiol, 200 1st St SW, Rochester, MN 55905 USA.	kallmes.david@mayo.edu	Jarvik, Jeffrey/AAL-4292-2021; Wilson, David/I-2368-2019	Wilson, David/0000-0002-7034-5421; Wilson, David/0000-0002-3155-5143; Hollingworth, William/0000-0002-0840-6254	National Institute of Arthritis [R01-AR49373]; Musculoskeletal and Skin Diseases; GlaxoSmithKline; Novartis; Procter Gamble; Wyeth; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0800800] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0800800] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049373] Funding Source: NIH RePORTER	National Institute of Arthritis(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Procter Gamble(Procter & Gamble); Wyeth(Wyeth); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by a grant (R01-AR49373) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.; Dr. Kallmes reports receiving consulting fees from Zelos Therapeutics and grant support from ArthroCare, Stryker, Cardinal, and Cook and serving as an unpaid consultant to Bone Support; Dr. Heagerty, receiving grant support from GlaxoSmithKline; Dr. Annesley-Williams, receiving lecture fees from Stryker; Dr. Ralston, receiving consulting fees from Procter & Gamble, Novartis, and Merck, lecture fees from Novartis and Procter & Gamble, and grant support from Novartis and Wyeth; and Dr. Jarvik, receiving consulting fees from HealthHelp and having an equity interest in PhysioSonics and Nevro. No other potential conflict of interest relevant to this article was reported.	Alvarez L, 2006, SPINE, V31, P1113; Beurskens AJHM, 1996, PAIN, V65, P71, DOI 10.1016/0304-3959(95)00149-2; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; DEYO RA, 1986, SPINE, V11, P951, DOI 10.1097/00007632-198611000-00017; Diamond TH, 2006, MED J AUSTRALIA, V184, P113, DOI 10.5694/j.1326-5377.2006.tb00148.x; Diamond TH, 2003, AM J MED, V114, P257, DOI 10.1016/S0002-9343(02)01524-3; Do HM, 2005, AM J NEURORADIOL, V26, P1623; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; ETTINGER B, 1992, J BONE MINER RES, V7, P449; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Gray LA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-126; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Hrobjartsson A, 2004, J INTERN MED, V256, P91, DOI 10.1111/j.1365-2796.2004.01355.x; Jensen ME, 1997, AM J NEURORADIOL, V18, P1897; JENSEN MP, 1992, PAIN, V50, P157, DOI 10.1016/0304-3959(92)90156-6; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kaufmann TJ, 2001, AM J NEURORADIOL, V22, P1860; Kobayashi K, 2005, EUR RADIOL, V15, P360, DOI 10.1007/s00330-004-2549-0; Layton KF, 2007, AM J NEURORADIOL, V28, P683; McGraw JK, 2002, J VASC INTERV RADIOL, V13, P883, DOI 10.1016/S1051-0443(07)61770-9; McGraw K, 2003, J VASC INTERV RADIOL, V14, P827, DOI 10.1097/01.RVI.0000082822.75926.4c; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Peh WCG, 2002, RADIOLOGY, V223, P121, DOI 10.1148/radiol.2231010234; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Taylor RS, 2007, EUR SPINE J, V16, P1085, DOI 10.1007/s00586-007-0308-z; Team RC., 2022, LANG ENV STAT COMP; Trout AT, 2005, AM J NEURORADIOL, V26, P2652; Underwood MR, 1999, SPINE, V24, P1104, DOI 10.1097/00007632-199906010-00010; Vase L, 2002, PAIN, V99, P443, DOI 10.1016/S0304-3959(02)00205-1; Voormolen MHJ, 2007, AM J NEURORADIOL, V28, P555; Voormolen MHJ, 2006, J VASC INTERV RADIOL, V17, P1313, DOI 10.1097/01.RVI.0000231952.75209.4A; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Ware J.E., 2002, SCORE VERSION 2 SF 3; Zoarski GH, 2002, J VASC INTERV RADIOL, V13, P139, DOI 10.1016/S1051-0443(07)61930-7	38	928	996	3	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					569	579		10.1056/NEJMoa0900563	http://dx.doi.org/10.1056/NEJMoa0900563			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479NR	19657122	Green Accepted			2022-12-28	WOS:000268667300007
J	Benayas, JMR; Newton, AC; Diaz, A; Bullock, JM				Rey Benayas, Jose M.; Newton, Adrian C.; Diaz, Anita; Bullock, James M.			Enhancement of Biodiversity and Ecosystem Services by Ecological Restoration: A Meta-Analysis	SCIENCE			English	Article							CONSERVATION	Ecological restoration is widely used to reverse the environmental degradation caused by human activities. However, the effectiveness of restoration actions in increasing provision of both biodiversity and ecosystem services has not been evaluated systematically. A meta-analysis of 89 restoration assessments in a wide range of ecosystem types across the globe indicates that ecological restoration increased provision of biodiversity and ecosystem services by 44 and 25%, respectively. However, values of both remained lower in restored versus intact reference ecosystems. Increases in biodiversity and ecosystem service measures after restoration were positively correlated. Results indicate that restoration actions focused on enhancing biodiversity should support increased provision of ecosystem services, particularly in tropical terrestrial biomes.	[Rey Benayas, Jose M.] Univ Alcala de Henares, Dept Ecol, E-28871 Alcala De Henares, Spain; [Rey Benayas, Jose M.] Univ Alcala de Henares, Fdn Int Restaurac Ecosistemas, E-28871 Alcala De Henares, Spain; [Newton, Adrian C.; Diaz, Anita] Bournemouth Univ, Sch Conservat Sci, Poole BH12 5BB, Dorset, England; [Bullock, James M.] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England	Universidad de Alcala; Universidad de Alcala; Bournemouth University; UK Centre for Ecology & Hydrology (UKCEH)	Benayas, JMR (corresponding author), Univ Alcala de Henares, Dept Ecol, E-28871 Alcala De Henares, Spain.	josem.rey@uah.es	Bullock, James M/F-9997-2011; Newton, Adrian C/B-3855-2009	Newton, Adrian C/0000-0003-3591-6089	European Communitys Sixth Framework Programme [032132]; Spanish Ministry of Science and Education [CGL2007-60533-BOS]; Madrid Government [S-0505/AMB/0355]; U.K. Centre for Ecology and Hydrology [C03513]; Natural Environment Research Council [CEH010021] Funding Source: researchfish	European Communitys Sixth Framework Programme(European Commission); Spanish Ministry of Science and Education(Spanish Government); Madrid Government; U.K. Centre for Ecology and Hydrology; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the European Communitys Sixth Framework Programme (project ReForLan, contract 032132), the Spanish Ministry of Science and Education (project CGL2007-60533-BOS), the Madrid Government (project S-0505/AMB/0355, REMEDINAL), and the U.K. Centre for Ecology and Hydrology (project C03513). The views presented here do not necessarily represent the opinion of the European Community, and the Community is not liable for any use that may be made of the information contained therein. We thank N. Tejedor for assistance.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Aronson James, 2007, RESTORING NATURAL CA; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Benayas JMR, 2008, FRONT ECOL ENVIRON, V6, P329, DOI 10.1890/070057; Bullock JM, 2007, J APPL ECOL, V44, P6, DOI 10.1111/j.1365-2664.2006.01252.x; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Clewell A. F., 2007, ECOLOGICAL RESTORATI; *CONV BIOL DIV, 2000, UNEPCBDCOP523; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Dodds WK, 2008, BIOSCIENCE, V58, P837, DOI 10.1641/B580909; Fagan KC, 2008, J APPL ECOL, V45, P1293, DOI 10.1111/j.1365-2664.2008.01492.x; Gilpin M.E., 1987, RESTORATION ECOLOGY; Goldstein JH, 2008, CONSERV LETT, V1, P236, DOI 10.1111/j.1755-263X.2008.00031.x; Gurevitch J., 2001, DESIGNS ANAL ECOLOGI, P347; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Jack BK, 2008, P NATL ACAD SCI USA, V105, P9465, DOI 10.1073/pnas.0705503104; Kaimowitz D, 2007, BIOTROPICA, V39, P567, DOI 10.1111/j.1744-7429.2007.00332.x; Millennium, 2005, EC HUM WELL BEING SY; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	23	1004	1057	53	1094	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1121	1124		10.1126/science.1172460	http://dx.doi.org/10.1126/science.1172460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19644076				2022-12-28	WOS:000269382300039
J	Kawamura, T; Suzuki, J; Wang, YV; Menendez, S; Morera, LB; Raya, A; Wahl, GM; Belmonte, JCI				Kawamura, Teruhisa; Suzuki, Jotaro; Wang, Yunyuan V.; Menendez, Sergio; Batlle Morera, Laura; Raya, Angel; Wahl, Geoffrey M.; Izpisua Belmonte, Juan Carlos			Linking the p53 tumour suppressor pathway to somatic cell reprogramming	NATURE			English	Article							PLURIPOTENT STEM-CELLS; EXPRESSION CLONING; HUMAN FIBROBLASTS; C-MYC; GENERATION; MOUSE; INDUCTION; DIFFERENTIATION; EFFICIENCY; OCT4	Reprogramming somatic cells to induced pluripotent stem (iPS) cells has been accomplished by expressing pluripotency factors and oncogenes(1-8), but the low frequency and tendency to induce malignant transformation(9) compromise the clinical utility of this powerful approach. We address both issues by investigating the mechanisms limiting reprogramming efficiency in somatic cells. Here we show that reprogramming factors can activate the p53 (also known as Trp53 in mice, TP53 in humans) pathway. Reducing signalling to p53 by expressing a mutated version of one of its negative regulators, by deleting or knocking down p53 or its target gene, p21 (also known as Cdkn1a), or by antagonizing reprogramming-induced apoptosis in mouse fibroblasts increases reprogramming efficiency. Notably, decreasing p53 protein levels enabled fibroblasts to give rise to iPS cells capable of generating germline-transmitting chimaeric mice using only Oct4 ( also known as Pou5f1) and Sox2. Furthermore, silencing of p53 significantly increased the reprogramming efficiency of human somatic cells. These results provide insights into reprogramming mechanisms and suggest new routes to more efficient reprogramming while minimizing the use of oncogenes.	[Kawamura, Teruhisa; Suzuki, Jotaro; Wang, Yunyuan V.; Wahl, Geoffrey M.; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Kawamura, Teruhisa] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan; [Wang, Yunyuan V.] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; [Menendez, Sergio; Batlle Morera, Laura; Raya, Angel; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Raya, Angel] ICREA, Barcelona 08010, Spain; [Raya, Angel] Networking Ctr Biomed Res Bioengn Biomat & Nanome, Barcelona 08003, Spain	Salk Institute; Kyoto University; Astellas Pharmaceuticals; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; ICREA	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wahl@salk.edu; belmonte@salk.edu	Raya, Angel/E-6205-2010	Raya, Angel/0000-0003-2189-9775; BATLLE MORERA, LAURA/0000-0002-6924-9002; Menendez, Sergio/0000-0002-7929-8641	Astellas Pharma Inc; Japan Society for the Promotion of Science; NIH [5 R01 CA061449, CA100845]; Leila Y. Mathers Charitable Foundation and Fundacion Cellex; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA061449, R01CA100845] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL088293] Funding Source: NIH RePORTER	Astellas Pharma Inc(Astellas Pharmaceuticals); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leila Y. Mathers Charitable Foundation and Fundacion Cellex; ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to the CMRB Histology & Bioimaging and Cell culture Platforms for assistance, S. Boue for microarray analysis, S. Kim for help with maintenance of mouse colonies, Y. Richaud for technical assistance, M. Nagao for preparation of mouse neural stem cells, K. Brennand and F. Gage for preparation of human neural stem cells, I. Verma and A. Consiglio for advice and help with lentiviral transduction, Y. Dayn for chimaeric mouse production, and all members of the Gene Expression Laboratory and CMRB for discussions and M. Serrano for sharing unpublished results. J. S. was partially supported by Astellas Pharma Inc. T. K. was partially supported by Japan Society for the Promotion of Science. Work in the laboratory of G. M. W. was supported by NIH grants ( 5 R01 CA061449 and CA100845). Work in the laboratory of J. C. I. B. was supported by grants from the NIH, Tercel, Marato, G. Harold and Leila Y. Mathers Charitable Foundation and Fundacion Cellex.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Cleveland JL, 2004, CANCER CELL, V6, P309, DOI 10.1016/j.ccr.2004.09.020; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; HUPPI K, 1994, ONCOGENE, V9, P3017; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; MIYASHITA T, 1995, CELL, V80, P293; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; SHERLEY JL, 1991, J BIOL CHEM, V266, P24815; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	38	836	905	0	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1140	U107		10.1038/nature08311	http://dx.doi.org/10.1038/nature08311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19668186	Green Accepted			2022-12-28	WOS:000269314000041
J	Rossato, JI; Bevilaqua, LRM; Izquierdo, I; Medina, JH; Cammarota, M				Rossato, Janine I.; Bevilaqua, Lia R. M.; Izquierdo, Ivan; Medina, Jorge H.; Cammarota, Martin			Dopamine Controls Persistence of Long-Term Memory Storage	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; HIPPOCAMPAL SLICES; CA1 REGION; NEURONS; RECEPTORS; RAT; LTP; POTENTIATION; INFORMATION; ACTIVATION	The paradigmatic feature of long-term memory (LTM) is its persistence. However, little is known about the mechanisms that make some LTMs last longer than others. In rats, a long-lasting fear LTM vanished rapidly when the D1 dopamine receptor antagonist SCH23390 was injected into the dorsal hippocampus 12 hours, but not immediately or 9 hours, after the fearful experience. Conversely, intrahippocampal application of the D1 agonist SK38393 at the same critical post-training time converted a rapidly decaying fear LTM into a persistent one. This effect was mediated by brain-derived neurotrophic factor and regulated by the ventral tegmental area (VTA). Thus, the persistence of LTM depends on activation of VTA/hippocampus dopaminergic connections and can be specifically modulated by manipulating this system at definite post-learning time points.	[Rossato, Janine I.; Bevilaqua, Lia R. M.; Izquierdo, Ivan; Medina, Jorge H.; Cammarota, Martin] Pontificia Univ Catolica Rio Grande do Sul, Inst Cerebro, Ctr Memoria, Porto Alegre, RS, Brazil; [Medina, Jorge H.; Cammarota, Martin] Univ Buenos Aires, Inst Biol Celular & Neurociencias Prof Dr Eduardo, Buenos Aires, DF, Argentina; [Medina, Jorge H.] Univ Buenos Aires, Dept Fisiol, Buenos Aires, DF, Argentina	Pontificia Universidade Catolica Do Rio Grande Do Sul; University of Buenos Aires; University of Buenos Aires	Cammarota, M (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Inst Cerebro, Ctr Memoria, Porto Alegre, RS, Brazil.	mcammaro@terra.com.br	Cammarota, Martin/AAC-7478-2021; Rossato, Janine/E-9543-2014; Rossato, Janine Inez/AHD-3513-2022	Cammarota, Martin/0000-0001-9741-5074; Rossato, Janine Inez/0000-0002-7980-5842; Izquierdo, Ivan/0000-0002-7208-0869; Bevilaqua, Lia/0000-0001-8537-1289	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil); Consejo Nacional de Investigaciones Cientificas y Tecnicas; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT)	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil) and the Consejo Nacional de Investigaciones Cientificas y Tecnicas and Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina).	Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Carr DB, 2008, NEURON, V59, P353, DOI 10.1016/j.neuron.2008.07.025; CARTER DA, 1977, NEUROSCIENCE, V2, P569, DOI 10.1016/0306-4522(77)90052-5; CHERGUI K, 1993, EUR J NEUROSCI, V5, P137, DOI 10.1111/j.1460-9568.1993.tb00479.x; Dahan L, 2007, NEUROPSYCHOPHARMACOL, V32, P1232, DOI 10.1038/sj.npp.1301251; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Gifkins A, 2002, BEHAV NEUROSCI, V116, P785, DOI 10.1037//0735-7044.116.5.785; Huang YY, 2006, LEARN MEMORY, V13, P298, DOI 10.1101/lm.166906; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; IZQUIERDO I, 2006, TRENDS NEUROSCI, V69, P356; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; JOH TH, 1978, P NATL ACAD SCI USA, V75, P4744, DOI 10.1073/pnas.75.10.4744; Kuppers E, 2001, NEUROREPORT, V12, P1175; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Mereu G, 1997, NEUROSCIENCE, V77, P1029, DOI 10.1016/S0306-4522(96)00474-5; Navakkode S, 2007, NEUROPHARMACOLOGY, V52, P1547, DOI 10.1016/j.neuropharm.2007.02.010; O'Carroll CM, 2006, LEARN MEMORY, V13, P760, DOI 10.1101/lm.321006; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	24	309	317	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					1017	1020		10.1126/science.1172545	http://dx.doi.org/10.1126/science.1172545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696353				2022-12-28	WOS:000269242800052
J	Rogers, E; Mohseni, M				Rogers, Ethan; Mohseni, Michael			Rectovesical Fistula	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rogers, Ethan] Univ Florida, Jacksonville, FL 32209 USA; [Mohseni, Michael] Mayo Clin, Jacksonville, FL 32224 USA	State University System of Florida; University of Florida; Mayo Clinic	Rogers, E (corresponding author), Univ Florida, Jacksonville, FL 32209 USA.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					806	806		10.1056/NEJMicm0806133	http://dx.doi.org/10.1056/NEJMicm0806133			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484WX	19692692				2022-12-28	WOS:000269081200009
J	Sloat, DL				Sloat, Deborah L.			South Dakota school replies to sexual harassment claims	NATURE			English	Letter									S Dakota Sch Mines & Technol, Rapid City, SD 57701 USA	South Dakota School Mines & Technology	Sloat, DL (corresponding author), S Dakota Sch Mines & Technol, 501 E St Joseph St, Rapid City, SD 57701 USA.	deborah.sloat@sdsmt.edu							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					949	949		10.1038/460949d	http://dx.doi.org/10.1038/460949d			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693061	Bronze			2022-12-28	WOS:000269085500014
J	Silvestri, GA; Alberg, AJ; Ravenel, J				Silvestri, Gerard A.; Alberg, Anthony J.; Ravenel, James			The changing epidemiology of lung cancer with a focus on screening	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HELICAL COMPUTED-TOMOGRAPHY; SUSCEPTIBILITY LOCUS; BASE-LINE; STAGE-I; CT; MORTALITY; RISK; POPULATION; CRITERIA; SMOKING		[Silvestri, Gerard A.] Med Univ S Carolina, Div Pulm & Crit Care Med, Charleston, SC 29425 USA; [Alberg, Anthony J.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Alberg, Anthony J.] Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC 29425 USA; [Ravenel, James] Med Univ S Carolina, Dept Radiol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Silvestri, GA (corresponding author), Med Univ S Carolina, Div Pulm & Crit Care Med, Charleston, SC 29425 USA.	silvestri@musc.edu						Alberg AJ, 2008, SEMIN RESP CRIT CARE, V29, P223, DOI 10.1055/s-2008-1076742; Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; *AM CANC SOC, 2007, CANC FACTS FIG 2007; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; [Anonymous], 1993, HIST PUBLIC HLTH; Bach PB, 2003, CHEST, V123, p83S, DOI 10.1378/chest.123.1_suppl.83S; Bach PB, 2007, CHEST, V132, p69S, DOI 10.1378/chest.07-1349; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; FERLAY J, 2004, IARC CANC BASE, V5; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Lam WK, 2004, INT J TUBERC LUNG D, V8, P1045; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Mahadevia PJ, 2003, JAMA-J AM MED ASSOC, V289, P313, DOI 10.1001/jama.289.3.313; Manser RL, 2004, COCHRANE DB SYST REV, P1, DOI [10.1002/14651858.CD001991.pub2, DOI 10.1002/14651858.CD001991.PUB2]; Marcus PM, 2000, J NATL CANCER I, V92, P1308, DOI 10.1093/jnci/92.16.1308; Menvielle G, 2009, JNCI-J NATL CANCER I, V101, P321, DOI 10.1093/jnci/djn513; Molina JR, 2006, CHEST, V130, P1211, DOI 10.1378/chest.130.4.1211; Nawa T, 2002, CHEST, V122, P15, DOI 10.1378/chest.122.1.15; Obuchowski NA, 2001, AM J ROENTGENOL, V176, P1357, DOI 10.2214/ajr.176.6.1761357; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Scott WJ, 2007, CHEST, V132, p234S, DOI 10.1378/chest.07-1378; Sobue T, 2002, J CLIN ONCOL, V20, P911, DOI 10.1200/JCO.2002.20.4.911; Sone S, 2001, BRIT J CANCER, V84, P25, DOI 10.1054/bjoc.2000.1531; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; Welch HG, 2007, ARCH INTERN MED, V167, P2289, DOI 10.1001/archinte.167.21.2289; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243	31	11	11	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2009	339								b3053	10.1136/bmj.b3053	http://dx.doi.org/10.1136/bmj.b3053			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486RX	19687094				2022-12-28	WOS:000269216500007
J	Barron, DJ; Kilby, MD; Davies, B; Wright, JGC; Jones, TJ; Brawn, WJ				Barron, David J.; Kilby, Mark D.; Davies, Ben; Wright, John G. C.; Jones, Timothy J.; Brawn, William J.			Hypoplastic left heart syndrome	LANCET			English	Review							SINGLE-VENTRICLE PALLIATION; MODIFIED NORWOOD-PROCEDURE; PULMONARY ARTERY SHUNT; AORTIC ATRESIA; RISK-FACTORS; CARDIAC TRANSPLANTATION; BIVENTRICULAR REPAIR; NUCHAL TRANSLUCENCY; CEREBRAL PERFUSION; PRENATAL-DIAGNOSIS	Hypoplastic left heart syndrome is a rare congenital heart defect in which the left side of the heart is underdeveloped. Surgical management of hypoplastic left heart syndrome has changed the prognosis of the condition that was previously regarded as fatal. We discuss surgical strategies based on staged procedures, with the right ventricle supporting both systemic and pulmonary circulation. We also discuss other management options, such as neonatal transplantation and the recent innovation of hybrid techniques. Surgical techniques and the understanding of the pathophysiology of this condition have been at the forefront of neonatal cardiac surgery and intensive care. The management of the syndrome remains a challenge because affected children grow into adolescence and adulthood posing various new problems and demands.	[Barron, David J.; Davies, Ben; Jones, Timothy J.; Brawn, William J.] Birmingham Childrens Hosp, Dept Cardiac Surg, Birmingham B4 6NH, W Midlands, England; [Kilby, Mark D.] Univ Birmingham, Dept Fetal Med, Birmingham Womens Fdn Trsut, Sch Clin & Expt Med,Coll Med & Dent, Birmingham, W Midlands, England; [Wright, John G. C.] Birmingham Childrens Hosp, Dept Paediat Cardiol, Birmingham B4 6NH, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham	Barron, DJ (corresponding author), Birmingham Childrens Hosp, Dept Cardiac Surg, Steelhouse Lane, Birmingham B4 6NH, W Midlands, England.	david.barron@bch.nhs.uk	Davies, Ben/GYD-9163-2022; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020	Davies, Ben/0000-0003-3405-507X; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; Davies, Ben/0000-0002-9720-5410				ABUHARB M, 1994, ARCH DIS CHILD-FETAL, V71, pF179, DOI 10.1136/fn.71.3.F179; ABUHARB M, 1994, ARCH DIS CHILD, V71, P3, DOI 10.1136/adc.71.1.3; Akinturk H, 2007, PEDIATR CARDIOL, V28, P79, DOI 10.1007/s00246-006-1444-7; ALLAN LD, 1994, J AM COLL CARDIOL, V23, P1452, DOI 10.1016/0735-1097(94)90391-3; Atzei A, 2005, ULTRASOUND OBST GYN, V26, P154, DOI 10.1002/uog.1936; Azakie A, 2001, ANN THORAC SURG, V72, P1349, DOI 10.1016/S0003-4975(01)02795-3; Bacha EA, 2006, J THORAC CARDIOV SUR, V131, P163, DOI 10.1016/j.jtcvs.2005.07.053; BAILEY L, 1986, J THORAC CARDIOV SUR, V92, P1; BARNEA O, 1994, J AM COLL CARDIOL, V24, P1376, DOI 10.1016/0735-1097(94)90123-6; Bartram U, 1997, ANN THORAC SURG, V64, P1795, DOI 10.1016/S0003-4975(97)01041-2; Bove EL, 1998, PEDIATR CARDIOL, V19, P308, DOI 10.1007/s002469900314; Brackley KJ, 2000, LANCET, V356, P1143, DOI 10.1016/S0140-6736(00)02756-2; BRIDGES ND, 1990, CIRCULATION, V82, P170; Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8; Checchia PA, 2005, J THORAC CARDIOV SUR, V129, P754, DOI 10.1016/j.jtcvs.2004.07.056; Chrisant MRK, 2005, J HEART LUNG TRANSPL, V24, P576, DOI 10.1016/j.healun.2004.01.019; Cox H., 2007, Fetal and Maternal Medicine Review, V18, P103, DOI 10.1017/S0965539507001970; Daebritz SH, 2000, J THORAC CARDIOV SUR, V119, P358, DOI 10.1016/S0022-5223(00)70192-9; FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240; Forbess JM, 2001, CIRCULATION, V104, pI127; FORBESS JM, 1995, CIRCULATION, V92, P262, DOI 10.1161/01.CIR.92.9.262; Galantowicz M, 2008, ANN THORAC SURG, V85, P2063, DOI 10.1016/j.athoracsur.2008.02.009; Gaynor JW, 2002, EUR J CARDIO-THORAC, V22, P82, DOI 10.1016/S1010-7940(02)00198-7; Gaynor JW, 2002, J THORAC CARDIOV SUR, V123, P237, DOI 10.1067/mtc.2002.119337; Ghanayem NS, 2003, J THORAC CARDIOV SUR, V126, P1367, DOI 10.1016/S0022-5223(03)00071-0; Glatz JA, 2008, ANN THORAC SURG, V85, P2057, DOI 10.1016/j.athoracsur.2008.02.026; Goldberg CS, 2007, J THORAC CARDIOV SUR, V133, P880, DOI 10.1016/j.jtcvs.2006.11.029; Graham EM, 2007, CARDIOL YOUNG, V17, P145, DOI 10.1017/S1047951107000133; Grossfeld PD, 2004, AM J MED GENET A, V129A, P51, DOI 10.1002/ajmg.a.30090; GUENTHARD J, 1994, ANN GENET-PARIS, V37, P143; Hannan RL, 2006, ANN THORAC SURG, V82, P1278, DOI 10.1016/j.athoracsur.2006.05.017; HAWKINS JA, 1984, J THORAC CARDIOV SUR, V88, P620; Hehir DA, 2008, J THORAC CARDIOV SUR, V136, P94, DOI 10.1016/j.jtcvs.2007.12.012; Hickey EJ, 2007, J THORAC CARDIOV SUR, V134, P1429, DOI 10.1016/j.jtcvs.2007.07.052; Hirsch JC, 2008, ANN SURG, V248, P402, DOI 10.1097/SLA.0b013e3181858286; Hirsch JC, 2008, PEDIATR CARDIOL, V29, P713, DOI 10.1007/s00246-007-9171-2; Hoffman GM, 2004, J THORAC CARDIOV SUR, V127, P738, DOI 10.1016/S0022-5223(03)01315-1; Hyett J, 1999, BRIT MED J, V318, P81, DOI 10.1136/bmj.318.7176.81; Jacobs JP, 2004, ANN THORAC SURG, V78, P1703, DOI 10.1016/j.athoracsur.2004.03.031; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; KITCHINER D, 2004, CURR PAEDIAT, V14, P39; Kohl T, 2000, AM J CARDIOL, V85, P1230, DOI 10.1016/S0002-9149(00)00733-5; Kostolny M, 2007, CARDIOL YOUNG, V17, P517, DOI 10.1017/S104795110700100X; Li J, 2007, J THORAC CARDIOV SUR, V133, P441, DOI 10.1016/j.jtcvs.2006.09.033; Maher KO, 2003, CIRCULATION, V108, P782, DOI 10.1161/01.CIR.0000087338.09589.21; Mahle WT, 2000, PEDIATRICS, V105, P1082, DOI 10.1542/peds.105.5.1082; Mahle WT, 2001, PEDIATRICS, V107, P1277, DOI 10.1542/peds.107.6.1277; Mahle WT, 2000, CIRCULATION, V102, P136; Malec E, 2003, EUR J CARDIO-THORAC, V23, P728, DOI 10.1016/S1010-7940(03)00072-1; Malec E, 2000, EUR J CARDIO-THORAC, V18, P202, DOI 10.1016/S1010-7940(00)00495-4; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; McGuirk SP, 2006, EUR J CARDIO-THORAC, V29, P675, DOI 10.1016/j.ejcts.2006.01.061; McGuirk SP, 2006, HEART, V92, P364, DOI 10.1136/hrt.2005.068684; McGuirk SP, 2003, EUR J CARDIO-THORAC, V24, P37, DOI 10.1016/S1010-7940(03)00186-6; Mellander M, 2007, ACTA PAEDIATR, V96, P53, DOI 10.1111/j.1651-2227.2007.00039.x; Migliavacca F, 2001, AM J PHYSIOL-HEART C, V280, pH2076, DOI 10.1152/ajpheart.2001.280.5.H2076; MORRIS CD, 1990, PEDIATRICS, V85, P977; MURDISON KA, 1990, CIRCULATION, V82, P199; *NHLBI, COMP 2 TYP SHUNTS IN; NORWOOD WI, 1983, NEW ENGL J MED, V308, P23, DOI 10.1056/NEJM198301063080106; Ohye RG, 2006, CARDIOL YOUNG, V16, P21, DOI 10.1017/S1047951106000722; Oppido G, 2006, ANN THORAC SURG, V82, P2233, DOI 10.1016/j.athoracsur.2006.06.042; Osiovich H, 2000, J Perinatol, V20, P363, DOI 10.1038/sj.jp.7200406; Pizarro C, 2004, ANN THORAC SURG, V78, P1959, DOI 10.1016/j.athoracsur.2004.06.020; Pizarro C, 2003, CIRCULATION, V108, P155, DOI 10.1161/01.cir.0000087390.94142.1d; Pizarro C, 2008, EUR J CARDIO-THORAC, V33, P613, DOI 10.1016/j.ejcts.2007.12.042; Pizarro C, 2008, ANN THORAC SURG, V85, P1382, DOI 10.1016/j.athoracsur.2007.12.042; Rasiah SV, 2008, ARCH DIS CHILD-FETAL, V93, pF192, DOI 10.1136/adc.2006.112482; Rasiah SV, 2006, ULTRASOUND OBST GYN, V28, P110, DOI 10.1002/uog.2803; Raymond FL, 1997, LANCET, V350, P930, DOI 10.1016/S0140-6736(05)63265-5; Razzouk AJ, 1996, ANN THORAC SURG, V62, P1, DOI 10.1016/0003-4975(96)00295-0; Richmond S, 2002, ARCH DIS CHILD-FETAL, V87, pF83, DOI 10.1136/fn.87.2.F83; RIZZO G, 2006, HIGH RISK PREGNANCY, P341; *ROYAL COLL OBST G, 2000, WORK PART ULTR OBST; Rumball EM, 2005, EUR J CARDIO-THORAC, V27, P801, DOI 10.1016/j.ejcts.2005.01.061; Sano S, 2003, J THORAC CARDIOV SUR, V126, P504, DOI 10.1016/S0022-5223(02)73575-7; Schelonka RL, 1998, SEMIN PERINATOL, V22, P2, DOI 10.1016/S0146-0005(98)80003-7; SHARLAND GK, 1992, BRIT J OBSTET GYNAEC, V99, P220, DOI 10.1111/j.1471-0528.1992.tb14503.x; Simpson JM, 2000, ULTRASOUND OBST GYN, V15, P271, DOI 10.1046/j.1469-0705.2000.00086.x; Stasik CN, 2006, J THORAC CARDIOV SUR, V131, P412, DOI 10.1016/j.jtcvs.2005.09.030; Tabbutt S, 2001, CIRCULATION, V104, pI159; Tanoue Y, 2004, ANN THORAC SURG, V78, P1965, DOI 10.1016/j.athoracsur.2004.06.014; Tchervenkov C I, 2000, Ann Thorac Surg, V69, pS170; Tweddell JS, 2002, CIRCULATION, V106, pI82, DOI 10.1161/01.cir.0000032878.55215.bd; Tweddell JS, 1999, ANN THORAC SURG, V67, P161, DOI 10.1016/S0003-4975(98)01266-1; Tworetzky W, 2004, CIRCULATION, V110, P2125, DOI 10.1161/01.CIR.0000144357.29279.54; Tworetzky W, 2001, CIRCULATION, V103, P1269, DOI 10.1161/01.cir.103.9.1269; Ungerleider RM, 2004, ANN THORAC SURG, V77, P18, DOI 10.1016/S0003-4975(03)01365-1; Vida VL, 2007, ANN THORAC SURG, V84, P581, DOI 10.1016/j.athoracsur.2007.04.017; Weinstein S, 1999, CIRCULATION, V100, P167; Wernovsky G, 2007, CARDIOL YOUNG, V17, P75, DOI 10.1017/S1047951107001187; West LJ, 2001, NEW ENGL J MED, V344, P793, DOI 10.1056/NEJM200103153441102; Yagel S, 1997, CIRCULATION, V96, P550	93	135	135	2	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					551	564		10.1016/S0140-6736(09)60563-8	http://dx.doi.org/10.1016/S0140-6736(09)60563-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683641				2022-12-28	WOS:000269019400023
J	Holmes, DR; Reddy, VY; Turi, ZG; Doshi, SK; Sievert, H; Buchbinder, M; Mullin, CM; Sick, P				Holmes, David R.; Reddy, Vivek Y.; Turi, Zoltan G.; Doshi, Shephal K.; Sievert, Horst; Buchbinder, Maurice; Mullin, Christopher M.; Sick, Peter		PROTECT AF Investigators	Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial	LANCET			English	Article							TRANSCATHETER OCCLUSION PLAATO; HIGH-RISK PATIENTS; ANTITHROMBOTIC THERAPY; RHYTHM CONTROL; ANTICOAGULATION; OUTCOMES; SYSTEM; PREDICTORS; EVENTS	Background In patients with non-valvular atrial fibrillation, embolic stroke is thought to be associated with left atrial appendage (LAA) thrombi. We assessed the efficacy and safety of percutaneous closure of the LAA for prevention of stroke compared with warfarin treatment in patients with atrial fibrillation. Methods Adult patients with non-valvular atrial fibrillation were eligible for inclusion in this multicentre, randomised non-inferiority trial if they had at least one of the following: previous stroke or transient ischaemic attack, congestive heart failure, diabetes, hypertension, or were 75 years or older. 707 eligible patients were randomly assigned in a 2:1 ratio by computer-generated randomisation sequence to percutaneous closure of the LAA and subsequent discontinuation of warfarin (intervention; n=463) or to warfarin treatment with a target international normalised ratio between 2.0 and 3.0 (control; n=244). Efficacy was assessed by a primary composite endpoint of stroke, cardiovascular death, and systemic embolism. We selected a one-sided probability criterion of non-inferiority for the intervention of at least 97.5%, by use of a two-fold non-inferiority margin. Serious adverse events that constituted the primary endpoint for safety included major bleeding, pericardial effusion, and device embolisation. Analysis was by intention to treat. This study is registered with Clinicaltrials.gov, number NCT00129545. Findings At 1065 patient-years of follow-up, the primary efficacy event rate was 3.0 per 100 patient-years (95% credible interval [CrI] 1.9-4.5) in the intervention group and 4.9 per 100 patient-years (2.8-7.1) in the control group (rate ratio [RRI 0.62, 95% CrI 0.35-1.25). The probability of non-inferiority of the intervention was more than 99.9%. Primary safety events were more frequent in the intervention group than in the control group (7.4 per 100 patient-years, 95% CrI 5.5-9.7, vs 4.4 per 100 patient-years, 95% CrI 2.5-6.7; RR 1.69, 1.01-3.19). Interpretation The efficacy of percutaneous closure of the LAA with this device was non-inferior to that of warfarin therapy. Although there was a higher rate of adverse safety events in the intervention group than in the control group, events in the intervention group were mainly a result of periprocedural complications. Closure of the LAA might provide an alternative strategy to chronic warfarin therapy for stroke prophylaxis in patients with non-valvular atrial fibrillation. Funding Atritech.	[Holmes, David R.] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Reddy, Vivek Y.] Mt Sinai Sch Med, New York, NY USA; [Turi, Zoltan G.] Cooper Univ Hosp, Camden, NJ 08103 USA; [Doshi, Shephal K.] St Johns Hosp, Pacific Heart Inst, Santa Monica, CA USA; [Sievert, Horst] CardioVasc Ctr Frankfurt, Frankfurt, Germany; [Buchbinder, Maurice] Fdn Cardiovasc Med, La Jolla, CA USA; [Mullin, Christopher M.] Integra Grp, Brooklyn Pk, MN USA; [Sick, Peter] Krankenhaus Barmherzigen Bruder, Regensburg, Germany	Mayo Clinic; Icahn School of Medicine at Mount Sinai; Cooper University Hospital; Cardiovascular Center (CVC) Frankfurt	Holmes, DR (corresponding author), Mayo Clin, Coll Med, 200 1st St SW,SMH MB 4-523, Rochester, MN 55905 USA.	holmes.david@mayo.edu		Reddy, Vivek/0000-0002-5638-4993; Pickett, Robert/0000-0002-7764-3800	Atritech	Atritech	This study was sponsored by Atritech.	Alberg H, 1969, ACTA MED SCAND, V185, P373; Albers GW, 2004, AM J MANAG CARE, V10, pS462; Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; Connolly SJ, 2007, CIRCULATION, V116, P449, DOI 10.1161/CIRCULATIONAHA.107.695163; Ei-Chami MF, 2007, CATHETER CARDIO INTE, V69, P704, DOI 10.1002/ccd.21026; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Fountain RB, 2006, AM HEART J, V151, P956, DOI 10.1016/j.ahj.2006.02.005; Franzen OW, 2008, CATHETER CARDIO INTE, V71, P553, DOI 10.1002/ccd.21445; Gage BF, 2000, STROKE, V31, P822, DOI 10.1161/01.STR.31.4.822; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Garcia DA, 2008, CARDIOL CLIN, V26, P267, DOI 10.1016/j.ccl.2007.12.011; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Haas S, 2009, VASA-J VASCULAR DIS, V38, P13, DOI 10.1024/0301-1526.38.1.13; Hanna IR, 2004, J AM COLL CARDIOL, V43, P1868, DOI 10.1016/j.jacc.2003.12.050; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Jorgensen J, 2007, ECHOCARDIOGR-J CARD, V24, P159, DOI 10.1111/j.1540-8175.2007.00369.x; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; KOUDSTAAL PJ, 1995, NEW ENGL J MED, V333, P5; Lerakis S, 2008, Minerva Cardioangiol, V56, P667; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; MCBRIDE R, 1994, LANCET, V343, P687; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Ostermayer SH, 2005, J AM COLL CARDIOL, V46, P9, DOI 10.1016/j.jacc.2005.03.042; PETERSEN P, 1989, LANCET, V1, P175; Psaty BM, 1997, CIRCULATION, V96, P2455; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruigomez A, 2002, J CLIN EPIDEMIOL, V55, P358, DOI 10.1016/S0895-4356(01)00478-4; Sherman DG, 2007, STROKE, V38, P615, DOI 10.1161/01.STR.0000254719.26536.a9; Sherman DG, 2005, ARCH INTERN MED, V165, P1185, DOI 10.1001/archinte.165.10.1185; Sick PB, 2007, J AM COLL CARDIOL, V49, P1490, DOI 10.1016/j.jacc.2007.02.035; Sievert H, 2002, CIRCULATION, V105, P1887, DOI 10.1161/01.CIR.0000015698.54752.6D; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; STODDARD MF, 1995, J AM COLL CARDIOL, V25, P452, DOI 10.1016/0735-1097(94)00396-8; Stroke Prevention in Atrial Fibrillation Investigators, 1997, J STROKE CEREBROVASC, V5, P341; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Walker AM, 2008, HEART RHYTHM, V5, P1365, DOI 10.1016/j.hrthm.2008.07.014; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	50	1359	1442	3	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					534	542		10.1016/S0140-6736(09)61343-X	http://dx.doi.org/10.1016/S0140-6736(09)61343-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683639				2022-12-28	WOS:000269019400021
J	Goodwin, SC; Spies, JB				Goodwin, Scott C.; Spies, James B.			Uterine Fibroid Embolization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTICENTER RETROSPECTIVE COHORT; RANDOMIZED CONTROLLED-TRIAL; ARTERY EMBOLIZATION; PATHOLOGICAL FEATURES; TERM OUTCOMES; EMMY TRIAL; LEIOMYOMATA; HYSTERECTOMY; REGISTRY; SYMPTOM	A 45-year-old, premenopausal black woman (gravida 3, para 2, with a history of one spontaneous abortion) presents with menorrhagia and dysmenorrhea that has worsened progressively over a period of 10 years. She does not wish to have any more children. On physical examination, she has a firm, nontender, enlarged uterus. The ovaries are not palpable. Laboratory tests in the past had revealed intermittent mild anemia that was correctable with iron supplementation, but more severe anemia has been noted recently, and she has had increasing difficulty managing her menstrual bleeding. In-office ultrasound examinations have shown several intramural uterine masses consistent with uterine fibroids that have been slowly increasing in size; the largest measures 6.5 cm at the point of its greatest dimension. The adnexa are normal. The patient's gynecologist has recommended a hysterectomy. However, the patient does not want to undergo a hysterectomy, and her gynecologist suggests uterine fibroid embolization as an alternative. She is referred to an interventional radiologist who orders a magnetic resonance imaging (MRI) scan. The results of the MRI confirm the ultrasound findings and rule out adenomyosis. The interventional radiologist discusses with the patient uterine fibroid embolization as an alternative to hysterectomy. What treatment should be recommended for this patient?	[Goodwin, Scott C.] Univ Calif Irvine, Dept Radiol Sci, Orange, CA 92868 USA; [Spies, James B.] Georgetown Univ, Med Ctr, Dept Radiol, Washington, DC 20007 USA	University of California System; University of California Irvine; Georgetown University	Goodwin, SC (corresponding author), Univ Calif Irvine, Dept Radiol Sci, 101 City Dr S,Rte 140, Orange, CA 92868 USA.	sgoodwin@uci.edu						*AM COLL OBST GYN, 2008, OBSTET GYNECOL, V112, P387, DOI DOI 10.1097/AOG.0B013E318183FBAB; Bruno J, 2004, J VASC INTERV RADIOL, V15, P801, DOI 10.1097/01.RVI.0000136983.45640.E4; Chen CR, 2001, AM J EPIDEMIOL, V153, P20, DOI 10.1093/aje/153.1.20; Colgan TJ, 2003, AM J SURG PATHOL, V27, P167, DOI 10.1097/00000478-200302000-00004; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Czeyda-Pommersheim F, 2006, CARDIOVASC INTER RAD, V29, P1136, DOI 10.1007/s00270-005-0245-3; DAYBAIRD D, 2003, AM J OBSTET GYNECOL, V188, P100; de Blok S, 2003, J VASC INTERV RADIOL, V14, P779, DOI 10.1097/01.RVI.0000079988.80153.61; Dembek CJ, 2007, J VASC INTERV RADIOL, V18, P1207, DOI 10.1016/j.jvir.2007.07.007; Dietz DM, 2004, OBSTET GYNECOL, V104, P1159, DOI 10.1097/01.AOG.0000141567.25541.26; Dutton S, 2007, BJOG-INT J OBSTET GY, V114, P1340, DOI 10.1111/j.1471-0528.2007.01526.x; Edwards RD, 2007, NEW ENGL J MED, V356, P360; El-Shalakany AH, 2003, BJOG-INT J OBSTET GY, V110, P215, DOI 10.1046/j.1471-0528.2003.01151.x; Flynn M, 2006, AM J OBSTET GYNECOL, V195, P955, DOI 10.1016/j.ajog.2006.02.020; Goodwin SC, 1997, J VASC INTERV RADIOL, V8, P517, DOI 10.1016/S1051-0443(97)70603-1; Goodwin SC, 1999, J VASC INTERV RADIOL, V10, P991, DOI 10.1016/S1051-0443(99)70177-6; Goodwin SC, 2008, OBSTET GYNECOL, V111, P22, DOI 10.1097/01.AOG.0000296526.71749.c9; Hehenkamp WJK, 2005, AM J OBSTET GYNECOL, V193, P1618, DOI 10.1016/j.ajog.2005.05.017; Hehenkamp WJK, 2008, RADIOLOGY, V246, P823, DOI 10.1148/radiol.2463070260; Hirst A, 2008, HEALTH TECHNOL ASSES, V12, P1; Hovsepian DM, 2004, CARDIOVASC INTER RAD, V27, P307, DOI 10.1007/s00270-004-0087-4; Khaund A, 2004, BJOG-INT J OBSTET GY, V111, P700, DOI 10.1111/j.1471-0528.2004.00158.x; Lanocita R, 1999, SMIT CIMIT 11 ANN SC; Lefebvre GG, 2004, J OBSTET GYNAECOL CA, V26, P913; Lefebvre Guylaine G, 2004, J Obstet Gynaecol Can, V26, P899; Mara M, 2008, CARDIOVASC INTER RAD, V31, P73, DOI 10.1007/s00270-007-9195-2; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; McCluggage WG, 2000, INT J GYNECOL PATHOL, V19, P342, DOI 10.1097/00004347-200010000-00008; Nikolic B, 2003, J VASC INTERV RADIOL, V14, P1147, DOI 10.1097/01.RVI.0000086540.44800.FE; Parker WH, 2007, FERTIL STERIL, V88, P255, DOI 10.1016/j.fertnstert.2007.06.044; Parker WH, 2007, FERTIL STERIL, V87, P725, DOI 10.1016/j.fertnstert.2007.01.093; Pelage JP, 2005, RADIOGRAPHICS, V25, pS99, DOI 10.1148/rg.25si055510; Pelage JP, 2005, RADIOLOGY, V234, P948, DOI 10.1148/radiol.2343031697; Pelage JP, 2004, RADIOLOGY, V230, P803, DOI 10.1148/radiol.2303030111; Pron G, 2005, OBSTET GYNECOL, V105, P67, DOI 10.1097/01.AOG.0000149156.07061.1f; Pron G, 2003, FERTIL STERIL, V79, P120, DOI 10.1016/S0015-0282(02)04538-7; Spies J, 2001, J VASC INTERV RADIOL, V12, P19, DOI 10.1016/S1051-0443(07)61396-7; Spies JB, 2005, OBSTET GYNECOL, V106, P1309, DOI 10.1097/01.AOG.0000188386.53878.49; Spies JB, 2005, OBSTET GYNECOL, V106, P933, DOI 10.1097/01.AOG.0000182582.64088.84; Spies JB, 2002, OBSTET GYNECOL, V100, P873, DOI 10.1016/S0029-7844(02)02341-4; Spies JB, 2002, RADIOLOGY, V222, P45, DOI 10.1148/radiol.2221010661; Spies JB, 2001, OBSTET GYNECOL, V98, P29, DOI 10.1016/S0029-7844(01)01382-5; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Sultana CJ, 2002, AM J OBSTET GYNECOL, V187, P1726, DOI 10.1067/mob.2002.128989; Vashisht A, 1999, LANCET, V354, P307, DOI 10.1016/S0140-6736(99)02987-6; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Walker WJ, 2006, AM J OBSTET GYNECOL, V195, P1266, DOI 10.1016/j.ajog.2006.04.011; Weichert W, 2005, AM J SURG PATHOL, V29, P955, DOI 10.1097/01.pas.0000159776.77912.ce; Wise LA, 2005, OBSTET GYNECOL, V105, P563, DOI 10.1097/01.AOG.0000154161.03418.e3; Wise LA, 2004, AM J EPIDEMIOL, V159, P113, DOI 10.1093/aje/kwh016; Worthington-Kirsch R, 2005, OBSTET GYNECOL, V106, P52, DOI 10.1097/01.AOG.0000165828.68787.a9; WORTHINGTONKIRS.R, 2005, OBSTET GYNECOL, V106, P869; Yousefi S, 2006, J VASC INTERV RADIOL, V17, P1923, DOI 10.1097/01.RVI.0000244851.04692.B5; 2009, J VASC INTERV RADIOL, V20, P419	54	48	52	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					690	697		10.1056/NEJMct0806942	http://dx.doi.org/10.1056/NEJMct0806942			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19675331				2022-12-28	WOS:000268884100009
J	Shun-Shin, M; Thompson, M; Heneghan, C; Perera, R; Harnden, A; Mant, D				Shun-Shin, Matthew; Thompson, Matthew; Heneghan, Carl; Perera, Rafael; Harnden, Anthony; Mant, David			Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OSELTAMIVIR; INFANTS; YOUNGER; BURDEN	Objective To assess the effects of the neuraminidase inhibitors oseltamivir and zanamivir in treatment of children with seasonal influenza and prevention of transmission to children in households. Design Systematic review and meta-analysis of data from published and unpublished randomised controlled trials. Data sources Medline and Embase to June 2009, trial registries, and manufacturers and authors of relevant studies. Review methods Eligible studies were randomised controlled trials of neuraminidase inhibitors in children aged <= 12 in the community (that is, not admitted to hospital) with confirmed or clinically suspected influenza. Primary outcome measures were time to resolution of illness and incidence of influenza in children living in households with index cases of influenza. Results We identified four randomised trials of treatment of influenza (two with oseltamivir, two with zanamivir) involving 1766 children (1243 with confirmed influenza, of whom 55-69% had influenza A), and three randomised trials for postexposure prophylaxis ( one with oseltamivir, two with zanamivir) involving 863 children; none of these trials tested efficacy with the current pandemic strain. Treatment trials showed reductions in median time to resolution of symptoms or return to normal activities, or both, of 0.5-1.5 days, which were significant in only two trials. A 10 day course of postexposure prophylaxis with zanamivir or oseltamivir resulted in an 8% (95% confidence interval 5% to 12%) decrease in the incidence of symptomatic influenza. Based on only one trial, oseltamivir did not reduce asthma exacerbations or improve peak flow in children with asthma. Treatment was not associated with reduction in overall use of antibiotics (risk difference -0.30, -0.13 to 0.01). Zanamivir was well tolerated, but oseltamivir was associated with an increased risk of vomiting (0.05, 0.02 to 0.09, number needed to harm=20). Conclusions Neuraminidase inhibitors provide a small benefit by shortening the duration of illness in children with seasonal influenza and reducing household transmission. They have little effect on asthma exacerbations or the use of antibiotics. Their effects on the incidence of serious complications, and on the current A/H1N1 influenza strain remain to be determined.	[Thompson, Matthew; Heneghan, Carl; Perera, Rafael; Harnden, Anthony; Mant, David] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Shun-Shin, Matthew] John Radcliffe Hosp, Kadoorie Ctr, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Thompson, M (corresponding author), Univ Oxford, Dept Primary Hlth Care, Rosemary Rue Bldg, Oxford OX3 7LF, England.	matthew.thompson@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009	Perera, Rafael/0000-0003-2418-2091; Shun-Shin, Matthew/0000-0002-1179-0867	The Department of Primary Health care is part of the NIHR School of Primary Care Research	The Department of Primary Health care is part of the NIHR School of Primary Care Research	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The Department of Primary Health care is part of the NIHR School of Primary Care Research.	Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; *FDA, 2003, DEAR DOCT; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Harnden A, 2007, ARCH DIS CHILD, V92, P594, DOI 10.1136/adc.2007.116665; Hayden FG, 2001, INT CONGR SER, V1219, P797, DOI 10.1016/S0531-5131(01)00358-2; Health Protection Agency, 2009, HPA WEEKL NAT INFL R; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Jacobs B, 2000, J CLIN EPIDEMIOL, V53, P793, DOI 10.1016/S0895-4356(99)00238-3; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub3; Matheson NJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002744.pub2; *NAT I HLTH CLIN E, 2009, OS AM ZAN PROPH INFL; National Institute for Health and Clinical Excellence, 2009, AM OS ZAN TREATM INF; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Okamoto S, 2005, PEDIATR INFECT DIS J, V24, P575, DOI 10.1097/01.inf.0000164799.33635.fe; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Rodriguez WJ, 2002, PEDIATR INFECT DIS J, V21, P193, DOI 10.1097/00006454-200203000-00006; Tamura D, 2005, PEDIATR INT, V47, P484, DOI 10.1111/j.1442-200x.2005.02088.x; Tappenden P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13110; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116	22	104	111	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2009	339								b3172	10.1136/bmj.b3172	http://dx.doi.org/10.1136/bmj.b3172			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YG	19666987	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000269161700003
J	Kanzaria, HK; Fischette, S; Jain, S				Kanzaria, Hemal K.; Fischette, Scott; Jain, Sharad			Remedy at UCSF: a sustainable student-run initiative	LANCET			English	Editorial Material							OPERATING-ROOM; SUPPLIES; DONATION		[Kanzaria, Hemal K.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Fischette, Scott] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Jain, Sharad] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kanzaria, HK (corresponding author), Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA.	Hemal.Kanzaria@ucsf.edu						CRONE RK, 1992, JAMA-J AM MED ASSOC, V268, P1462, DOI 10.1001/jama.268.11.1462; Czajkowski-Beckwith H, 1996, AORN J, V63, P236, DOI 10.1016/S0001-2092(06)63459-5; Goldberg ME, 1996, J CLIN ANESTH, V8, P475, DOI 10.1016/0952-8180(96)00127-4; Miller, 2002, EINSTEIN Q J BIOL ME, V19, P121; PENNINO R, 1994, PLAST RECONSTR SURG, V94, P397, DOI 10.1097/00006534-199408000-00031; ROSENBLATT WH, 1992, JAMA-J AM MED ASSOC, V268, P1441, DOI 10.1001/jama.268.11.1441; ROSENBLATT WH, 1993, JAMA-J AM MED ASSOC, V269, P2647, DOI 10.1001/jama.269.20.2647; Rosenblatt WH, 1997, J CLIN ANESTH, V9, P478, DOI 10.1016/S0952-8180(97)00104-9; ROSENBLATT WH, 1994, J CLIN ANESTH, V6, P400, DOI 10.1016/S0952-8180(05)80010-8; *UCSF, REM UCSF	10	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 8	2009	374	9688					438	440		10.1016/S0140-6736(09)61436-7	http://dx.doi.org/10.1016/S0140-6736(09)61436-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482OK	19665634				2022-12-28	WOS:000268898400010
J	Cahoon, LA; Seifert, HS				Cahoon, Laty A.; Seifert, H. Steven			An Alternative DNA Structure Is Necessary for Pilin Antigenic Variation in Neisseria gonorrhoeae	SCIENCE			English	Article							HOMOLOGOUS RECOMBINATION; G-QUADRUPLEX; NUCLEOTIDE-SEQUENCES; G4 DNA; GENE; REPAIR; PATHWAYS; PROTEIN; PATHOGENS; BACTERIAL	Pathogens can use DNA recombination to promote antigenic variation (Av) of surface structures to avoid immune detection. We identified a cis-acting DNA sequence near the antigenically variable pilin locus of the human pathogen, Neisseria gonorrhoeae. This 16-base pair guanine (G)-rich sequence was required for pilin Av and formed a guanine quartet (G4) structure in vitro. Individual mutations that disrupted the structure also blocked pilin Av and prevented nicks required for recombination from occurring within the G4 region. A compound that binds and stabilizes G4 structures also inhibited pilin Av and prevented nicks from occurring on the G-rich strand. This site constitutes a recombination initiation sequence/structure that directs gene conversion to a specific chromosomal locus.	[Cahoon, Laty A.; Seifert, H. Steven] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Seifert, HS (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	h-seifert@northwestern.edu		Cahoon, Laty/0000-0003-2061-319X	NIH [R37AI033493, R01AI055977, R01AI044239, T32GM08061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044239, R37AI033493, R01AI055977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R37AI033493, R01AI055977, and R01AI044239 to H.S.S. L.A.C. was partially supported by NIH grant T32GM08061.	Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Criss AK, 2005, MOL MICROBIOL, V58, P510, DOI 10.1111/j.1365-2958.2005.04838.x; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Fry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4336, DOI 10.2741/2391; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kline KA, 2005, J BACTERIOL, V187, P2903, DOI 10.1128/JB.187.8.2903-2907.2005; Kline KA, 2003, MOL MICROBIOL, V50, P3, DOI 10.1046/j.1365-2958.2003.03679.x; Kline KA, 2007, J BACTERIOL, V189, P3462, DOI 10.1128/JB.01911-06; Kong QZ, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e33; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; Muniyappa K, 2000, MOL CELL BIOL, V20, P1361, DOI 10.1128/MCB.20.4.1361-1369.2000; Paeschke K, 2008, NAT STRUCT MOL BIOL, V15, P598, DOI 10.1038/nsmb.1422; Rachwal PA, 2007, BIOCHEMISTRY-US, V46, P3036, DOI 10.1021/bi062118j; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Scaria V, 2006, NUCLEIC ACIDS RES, V34, pW683, DOI 10.1093/nar/gkl299; SCHIERER T, 1994, BIOCHEMISTRY-US, V33, P2240, DOI 10.1021/bi00174a034; Sechman EV, 2006, MOL MICROBIOL, V61, P185, DOI 10.1111/j.1365-2958.2006.05213.x; Sechman EV, 2005, MOL MICROBIOL, V57, P468, DOI 10.1111/j.1365-2958.2005.04657.x; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Skaar EP, 2002, J BACTERIOL, V184, P919, DOI 10.1128/jb.184.4.919-927.2002; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; SWANSON J, 1987, A VAN LEEUW J MICROB, V53, P441, DOI 10.1007/BF00415500; Tang J, 2008, NUCLEIC ACIDS RES, V36, P1200, DOI 10.1093/nar/gkm1137; Wu X, 2001, NUCLEIC ACIDS RES, V29, P1765, DOI 10.1093/nar/29.8.1765	28	232	234	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					764	767		10.1126/science.1175653	http://dx.doi.org/10.1126/science.1175653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661435	Green Accepted			2022-12-28	WOS:000268723700054
J	Luft, HS				Luft, Harold S.			Health Care Reform - Toward More Freedom, and Responsibility, for Physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICARE; COSTS		[Luft, Harold S.] Palo Alto Med Fdn, Res Inst, Palo Alto, CA 94301 USA; [Luft, Harold S.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	Palo Alto Medical Foundation Research Institute; University of California System; University of California San Francisco	Luft, HS (corresponding author), Palo Alto Med Fdn, Res Inst, 795 El Camino Real, Palo Alto, CA 94301 USA.	lufth@pamfri.org						American College of Physicians, 2007, JOINT PRINC PAT CTR; ARROW KJ, 1963, AM ECON REV, V53, P941; Cohen JJ, 1997, NEW ENGL J MED, V336, P1317, DOI 10.1056/NEJM199705013361811; Dudley RA, 2003, MED CARE, V41, P56; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Hauer KE, 2008, JAMA-J AM MED ASSOC, V300, P1154, DOI 10.1001/jama.300.10.1154; Iglehart JK, 2005, NEW ENGL J MED, V352, P78, DOI 10.1056/NEJMhpr043631; Luft H.S., 2008, TOTAL CURE ANTIDOTE; Orszag PR, 2007, NEW ENGL J MED, V357, P1793, DOI 10.1056/NEJMp078190; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979	10	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					623	628		10.1056/NEJMsb0900424	http://dx.doi.org/10.1056/NEJMsb0900424			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479NR	19657129				2022-12-28	WOS:000268667300015
J	Bell, KM; Orcutt, HK				Bell, Kathryn M.; Orcutt, Holly K.			Posttraumatic Stress Disorder and Male-Perpetrated Intimate Partner Violence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIETNAM VETERANS; SYMPTOMS; ABUSE; ANGER; HYPERAROUSAL; AGGRESSION; DEFICITS; PTSD		[Bell, Kathryn M.; Orcutt, Holly K.] No Illinois Univ, Dept Psychol, De Kalb, IL 60115 USA	Northern Illinois University	Bell, KM (corresponding author), No Illinois Univ, Dept Psychol, Psychol Comp Sci Bldg, De Kalb, IL 60115 USA.	kbell9@niu.edu		Orcutt, Holly/0000-0002-0197-0784; Bell, Kathryn/0000-0002-3321-6989				Chemtob CM, 1997, J TRAUMA STRESS, V10, P17, DOI 10.1002/jts.2490100104; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Jakupcak Matthew, 2005, Violence Vict, V20, P589, DOI 10.1891/088667005780927494; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; King L. A., 2004, DEV RES PRACTICE POL; McFall M, 1999, J TRAUMA STRESS, V12, P501, DOI 10.1023/A:1024771121189; Orcutt HK, 2003, J TRAUMA STRESS, V16, P381, DOI 10.1023/A:1024470103325; Rosenbaum A, 2003, J COMP FAM STUD, V34, P7, DOI 10.3138/jcfs.34.1.7; Savarese VW, 2001, J TRAUMA STRESS, V14, P717, DOI 10.1023/A:1013038021175; Schell TL, 2004, J ABNORM PSYCHOL, V113, P189, DOI 10.1037/0021-843X.113.2.189; Taft CT, 2008, J ABNORM PSYCHOL, V117, P637, DOI 10.1037/0021-843X.117.3.637; Taft CT, 2007, J ABNORM PSYCHOL, V116, P498, DOI 10.1037/0021-843X.116.3.498; Taft CT, 2007, J FAM PSYCHOL, V21, P270, DOI 10.1037/0893-3200.21.2.270	13	60	63	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					562	564		10.1001/jama.2009.1126	http://dx.doi.org/10.1001/jama.2009.1126			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479DS	19654390				2022-12-28	WOS:000268640500020
J	Comondore, VR; Devereaux, PJ; Zhou, Q; Stone, SB; Busse, JW; Ravindran, NC; Burns, KE; Haines, T; Stringer, B; Cook, DJ; Walter, SD; Sullivan, T; Berwanger, O; Bhandari, M; Banglawala, S; Lavis, JN; Petrisor, B; Schunemann, H; Walsh, K; Bhatnagar, N; Guyatt, GH				Comondore, Vikram R.; Devereaux, P. J.; Zhou, Qi; Stone, Samuel B.; Busse, Jason W.; Ravindran, Nikila C.; Burns, Karen E.; Haines, Ted; Stringer, Bernadette; Cook, Deborah J.; Walter, Stephen D.; Sullivan, Terrence; Berwanger, Otavio; Bhandari, Mohit; Banglawala, Sarfaraz; Lavis, John N.; Petrisor, Brad; Schuenemann, Holger; Walsh, Katie; Bhatnagar, Neera; Guyatt, Gordon H.			Quality of care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOSPITALS; MORTALITY; OUTCOMES	Objective To compare quality of care in for-profit and not-for-profit nursing homes. Design Systematic review and meta-analysis of observational studies and randomised controlled trials investigating quality of care in for-profit versus not-for-profit nursing homes. Results A comprehensive search yielded 8827 citations, of which 956 were judged appropriate for full text review. Study characteristics and results of 82 articles that met inclusion criteria were summarised, and results for the four most frequently reported quality measures were pooled. Included studies reported results dating from 1965 to 2003. In 40 studies, all statistically significant comparisons (P<0.05) favoured not-for-profit facilities; in three studies, all statistically significant comparisons favoured for-profit facilities, and the remaining studies had less consistent findings. Meta-analyses suggested that not-for-profit facilities delivered higher quality care than did for-profit facilities for two of the four most frequently reported quality measures: more or higher quality staffing (ratio of effect 1.11, 95% confidence interval 1.07 to 1.14, P<0.001) and lower pressure ulcer prevalence (odds ratio 0.91, 95% confidence interval 0.83 to 0.98, P=0.02). Non-significant results favouring not-for-profit homes were found for the two other most frequently used measures: physical restraint use (odds ratio 0.93, 0.82 to 1.05, P=0.25) and fewer deficiencies in governmental regulatory assessments (ratio of effect 0.90, 0.78 to 1.04, P=0.17). Conclusions This systematic review and meta-analysis of the evidence suggests that, on average, not-for-profit nursing homes deliver higher quality care than do for-profit nursing homes. Many factors may, however, influence this relation in the case of individual institutions.	[Devereaux, P. J.; Zhou, Qi; Busse, Jason W.; Haines, Ted; Stringer, Bernadette; Cook, Deborah J.; Walter, Stephen D.; Bhandari, Mohit; Lavis, John N.; Schuenemann, Holger; Walsh, Katie; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Comondore, Vikram R.] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Stone, Samuel B.; Banglawala, Sarfaraz; Petrisor, Brad] McMaster Univ, Dept Surg, Hamilton, ON L8N 3Z5, Canada; [Busse, Jason W.] Inst Work & Hlth, Toronto, ON M5G 2E9, Canada; [Ravindran, Nikila C.] Univ Toronto, Dept Med, Div Gastroenterol, Toronto, ON M5T 2S8, Canada; [Burns, Karen E.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Burns, Karen E.] Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Burns, Karen E.] Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Sullivan, Terrence] Canc Care Ontario, Toronto, ON M5G 2L7, Canada; [Berwanger, Otavio] Univ Fed Rio Grande do Sul, Dept Clin Epidemiol, Porto Alegre, RS, Brazil; [Schuenemann, Holger] Italian Natl Canc Inst Regina Elena, I-00144 Rome, Italy; [Bhatnagar, Neera] McMaster Univ, Hlth Sci Lib, Hamilton, ON L8N 3Z5, Canada	McMaster University; University of British Columbia; McMaster University; Institute for Work & Health; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; Cancer Care Ontario; Universidade Federal do Rio Grande do Sul; McMaster University	Devereaux, PJ (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada.	philipj@mcmaster.ca	Devereaux, PJ/AAY-1757-2021; Walter, Stephen/AAB-5548-2022; Petrisor, Brad/AAQ-2278-2021; Devereaux, PJ/AAF-2862-2019; Zhou, Qi/GSM-9583-2022; Bhatnagar, Neera/B-8004-2013; Bhandari, Mohit/AAQ-1675-2021; Iats, Inct/K-2300-2013; Busse, Jason/CAH-3696-2022; Lavis, John N/I-7555-2013	Walter, Stephen/0000-0003-4157-8928; Bhatnagar, Neera/0000-0002-5060-5257; Busse, Jason/0000-0002-0178-8712; Lavis, John N/0000-0001-7917-3657; Schunemann, Holger/0000-0003-3211-8479	Atkinson Foundation Grant; Canadian Institutes of Health; European Commission; Human Factor, Mobility and Marie Curie Actions [IGR 42192]	Atkinson Foundation Grant; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Factor, Mobility and Marie Curie Actions	Atkinson Foundation Grant; the study sponsor did not contribute to the study design. JWB is funded by a Canadian Institutes of Health research fellowship award. DJC, MB, and JNL are supported, in part, by their respective Canada Research chairs. PJD is supported by a Canadian Institutes of Health Research new investigator award. HS is funded by a European Commission: The Human Factor, Mobility and Marie Curie Actions scientist reintegration grant (IGR 42192).	Abt Associates, 2001, APPR MIN NURS STAFF, VI; [Anonymous], 2007, CBC NEWS; [Anonymous], 2007, BBC NEWS; Castle NG, 2007, HEALTH SERV RES, V42, P1822, DOI 10.1111/j.1475-6773.2007.00704.x; Castle Nicholas G, 2008, J Healthc Qual, V30, P4; COVELLO L, 2008, NURSING HOME QUALITY; Davis M A, 1991, Med Care Rev, V48, P129, DOI 10.1177/002570879104800202; Devereaux PJ, 2002, CAN MED ASSOC J, V166, P1399; Devereaux PJ, 2004, CAN MED ASSOC J, V170, P1817, DOI 10.1503/cmaj.1040722; Devereaux PJ, 2002, JAMA-J AM MED ASSOC, V288, P2449, DOI 10.1001/jama.288.19.2449; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DUHIGG C, 2007, MANY HOMES MORE PROF; European Commission, 2008, LONG TERM CAR EUR UN; Friedman B S, 1990, Adv Health Econ Health Serv Res, V11, P131; Georgiades S, 2008, J GERONTOL SOC WORK, V50, P3, DOI 10.1300/J083v50n3_02; Goodson J, 2008, GERONTOLOGIST, V48, P338, DOI 10.1093/geront/48.3.338; GRIFFIN N, 1986, JAMA-J AM MED ASSOC, V256, P1032; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hillmer MP, 2005, MED CARE RES REV, V62, P139, DOI 10.1177/1077558704273769; Hutt E, 2008, J GERONTOL A-BIOL, V63, P1105, DOI 10.1093/gerona/63.10.1105; Institute of Medicine, 1986, IMPR QUAL CAR NURS H; Kerrison SH, 2001, BMJ-BRIT MED J, V323, P566, DOI 10.1136/bmj.323.7312.566; Konetzka RT, 2008, HEALTH SERV RES, V43, P1025, DOI 10.1111/j.1475-6773.2007.00803.x; Mukamel DB, 2008, MED CARE, V46, P532, DOI 10.1097/MLR.0b013e31816099c5; Mukamel DB, 1997, MED CARE, V35, P367, DOI 10.1097/00005650-199704000-00007; National Cancer Institute, DICT CANC TERMS; Nudelman PM, 1996, NEW ENGL J MED, V334, P1057, DOI 10.1056/NEJM199604183341611; Shapiro E, 1995, CAN J AGING, V14, P755, DOI 10.1017/S0714980800016445; *STAT CAN, 2006, RES CAR FAC 2003 200; Statistics Canada, 2008, RES CAR FAC 2006 200; *TOR STAR, 2008, TROUBL REP NURS HOM; Tyszko P, 2007, CENT EUR J MED, V2, P528, DOI 10.2478/s11536-007-0045-z; *US BUR CENS, 2003, CENS 2000 PHC T 26 P; US Department of Health and Human Services, NURS HOM COMP; WELSH M, 2008, NO MINIMUM STANDARD	35	211	211	3	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2009	339								b2732	10.1136/bmj.b2732	http://dx.doi.org/10.1136/bmj.b2732			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481KB	19654184	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000268807800002
J	Lee, G; Papapetrou, EP; Kim, H; Chambers, SM; Tomishima, MJ; Fasano, CA; Ganat, YM; Menon, J; Shimizu, F; Viale, A; Tabar, V; Sadelain, M; Studer, L				Lee, Gabsang; Papapetrou, Eirini P.; Kim, Hyesoo; Chambers, Stuart M.; Tomishima, Mark J.; Fasano, Christopher A.; Ganat, Yosif M.; Menon, Jayanthi; Shimizu, Fumiko; Viale, Agnes; Tabar, Viviane; Sadelain, Michel; Studer, Lorenz			Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs	NATURE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN ES; MESSENGER-RNA; DIFFERENTIATION; EXPRESSION; DISEASE; INHIBITION; INDUCTION; DEFECTS	The isolation of human induced pluripotent stem cells (iPSCs)(1-3) offers a new strategy for modelling human disease. Recent studies have reported the derivation and differentiation of disease-specific human iPSCs(4-7). However, a key challenge in the field is the demonstration of disease-related phenotypes and the ability to model pathogenesis and treatment of disease in iPSCs. Familial dysautonomia (FD) is a rare but fatal peripheral neuropathy, caused by a point mutation in the IKBKAP(8) gene involved in transcriptional elongation(9). The disease is characterized by the depletion of autonomic and sensory neurons. The specificity to the peripheral nervous system and the mechanism of neuron loss in FD are poorly understood owing to the lack of an appropriate model system. Here we report the derivation of patient-specific FD-iPSCs and the directed differentiation into cells of all three germ layers including peripheral neurons. Gene expression analysis in purified FD-iPSC-derived lineages demonstrates tissue-specific mis-splicing of IKBKAP in vitro. Patient-specific neural crest precursors express particularly low levels of normal IKBKAP transcript, suggesting a mechanism for disease specificity. FD pathogenesis is further characterized by transcriptome analysis and cell-based assays revealing marked defects in neurogenic differentiation and migration behaviour. Furthermore, we use FD-iPSCs for validating the potency of candidate drugs in reversing aberrant splicing and ameliorating neuronal differentiation and migration. Our study illustrates the promise of iPSC technology for gaining new insights into human disease pathogenesis and treatment.	[Papapetrou, Eirini P.; Tomishima, Mark J.; Tabar, Viviane; Sadelain, Michel; Studer, Lorenz] Sloan Kettering Inst, Ctr Cell Engn, New York, NY 10065 USA; [Lee, Gabsang; Kim, Hyesoo; Chambers, Stuart M.; Tomishima, Mark J.; Fasano, Christopher A.; Ganat, Yosif M.; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Tomishima, Mark J.] Sloan Kettering Inst, SKI Stem Cell Res Facil, New York, NY 10065 USA; [Menon, Jayanthi; Shimizu, Fumiko; Tabar, Viviane; Studer, Lorenz] Sloan Kettering Inst, Dept Neurosurg, New York, NY 10065 USA; [Viale, Agnes] Sloan Kettering Inst, Genom Core Facil, New York, NY 10065 USA; [Ganat, Yosif M.] Weill Cornell Grad Sch, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Studer, L (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	studerl@mskcc.org	Pillay, Nischalan/F-9536-2012; Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Lee, Gabsang/0000-0002-5052-5927	Starr Foundation; NYSTEM; New York Stem Cell Foundation (NYCSF); Druckenmiller fellowships; Starr Scholar fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052671] Funding Source: NIH RePORTER	Starr Foundation; NYSTEM; New York Stem Cell Foundation (NYCSF); Druckenmiller fellowships; Starr Scholar fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Hendrikx, M. Leversha and C. Zhao for technical help. The work was supported by grants from the Starr Foundation and NYSTEM, by the New York Stem Cell Foundation (NYCSF, Druckenmiller fellowships to G. L. and C. A. F.) and by the Starr Scholar fellowship to S. M. C.	Anderson SL, 2003, BIOCHEM BIOPH RES CO, V310, P627, DOI 10.1016/j.bbrc.2003.09.019; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V306, P303, DOI 10.1016/S0006-291X(03)00971-9; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2005, EXPERT OPIN PHARMACO, V6, P561, DOI 10.1517/14656566.6.4.561; Axelrod FB, 2002, J PEDIATR-US, V141, P518, DOI 10.1067/mpd.2002.127088; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Lee GS, 2008, MOL CELLS, V25, P487; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Rodriguez Luis G., 2004, V294, P23; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	30	641	712	2	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					402	U100		10.1038/nature08320	http://dx.doi.org/10.1038/nature08320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19693009	Green Accepted			2022-12-28	WOS:000269828100041
J	de Brantes, F; Rosenthal, MB; Painter, M				de Brantes, Francois; Rosenthal, Meredith B.; Painter, Michael			Building a Bridge from Fragmentation to Accountability - The Prometheus Payment Model	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[de Brantes, Francois] Bridges Excellence, Newtown, CT USA; [Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Painter, Michael] Robert Wood Johnson Fdn, Princeton, NJ 08540 USA	Harvard University; Harvard T.H. Chan School of Public Health; Robert Wood Johnson Foundation (RWJF)	de Brantes, F (corresponding author), Bridges Excellence, Newtown, CT USA.			Rosenthal, Meredith/0000-0003-3410-0184				Camillus JA, 2007, EVIDENCE INFORM CASE; de Brantes F, 2009, HEALTH AFFAIR, V28, pW678, DOI 10.1377/hlthaff.28.4.w678; GOSFIELD A, 2008, MAKING PROMETHEUS PA; RASTOGI A, 2009, CLIN ORTHOP REL 0623; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127	5	67	67	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1033	1036		10.1056/NEJMp0906121	http://dx.doi.org/10.1056/NEJMp0906121			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492LP	19692682				2022-12-28	WOS:000269659400001
J	Cook, AG; Fukuhara, N; Jinek, M; Conti, E				Cook, Atlanta G.; Fukuhara, Noemi; Jinek, Martin; Conti, Elena			Structures of the tRNA export factor in the nuclear and cytosolic states	NATURE			English	Article							PHENYLALANINE TRANSFER-RNA; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; TRANSPORT; COMPLEX; PROTEIN; RECEPTOR; IDENTIFICATION; TRANSLOCATION; CRM1	Transfer RNAs are among the most ubiquitous molecules in cells, central to decoding information from messenger RNAs on translating ribosomes. In eukaryotic cells, tRNAs are actively transported from their site of synthesis in the nucleus to their site of function in the cytosol. This is mediated by a dedicated nucleo-cytoplasmic transport factor of the karyopherin-beta family (Xpot, also known as Los1 in Saccharomyces cerevisiae). Here we report the 3.2 angstrom resolution structure of Schizosaccharomyces pombe Xpot in complex with tRNA and RanGTP, and the 3.1 angstrom structure of unbound Xpot, revealing both nuclear and cytosolic snapshots of this transport factor. Xpot undergoes a large conformational change on binding cargo, wrapping around the tRNA and, in particular, binding to the tRNA 59 and 39 ends. The binding mode explains how Xpot can recognize all mature tRNAs in the cell and yet distinguish them from those that have not been properly processed, thus coupling tRNA export to quality control.	[Cook, Atlanta G.; Conti, Elena] MPI Biochem, D-82152 Martinsried, Germany; [Fukuhara, Noemi; Jinek, Martin; Conti, Elena] EMBL, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Conti, E (corresponding author), MPI Biochem, Am Klopferspitz 18, D-82152 Martinsried, Germany.	conti@biochem.mpg.de	Cook, Atlanta/A-8641-2015; Jinek, Martin/E-6621-2011	Cook, Atlanta/0000-0003-2087-9772; Jinek, Martin/0000-0002-7601-210X; Conti, Elena/0000-0003-1254-5588	Max Planck Gesellschaft; European Molecular Biology Laboratory (EMBL); Sonderforschungsbereich SFB646; Deutsche Forschungsgemeinschaft (DFG); EU [LSHG-CT-2005-512028]	Max Planck Gesellschaft(Max Planck Society); European Molecular Biology Laboratory (EMBL); Sonderforschungsbereich SFB646(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU(European Commission)	We would like to thank P. Brick for comments and critical reading of the manuscript. We also thank P. Reichelt and J. Ebert for technical assistance, S. Kuersten and I. Mattaj at the initial phase of the project, K. Valer-Saldana, S. Pleyer and J. Basquin of the MPI-Martinsried crystallization facility and the staff at the Swiss Light Source (Villigen, Switzerland) for assistance during data collection. We would like to thank C. Vonrhein (Global Phasing) for optimising the phase calculations of unbound Xpot with SHARP. This study was supported by the Max Planck Gesellschaft, the European Molecular Biology Laboratory (EMBL), the Sonderforschungsbereich SFB646 and the Gottfried Wilhelm Leibniz Program of the Deutsche Forschungsgemeinschaft (DFG), the EU grant 3D Repertoire contract number LSHG-CT-2005-512028.	Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; BLOOMFIELD VA, 1999, NUCL ACIDS STRUCTURE, P298; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2005, MOL CELL, V18, P355, DOI 10.1016/j.molcel.2005.03.021; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dong XH, 2009, NAT STRUCT MOL BIOL, V16, P558, DOI 10.1038/nsmb.1586; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Elad N, 2009, CURR OPIN STRUC BIOL, V19, P226, DOI 10.1016/j.sbi.2009.02.009; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Iwata-Reuyl D, 2008, CURR OPIN CHEM BIOL, V12, P126, DOI 10.1016/j.cbpa.2008.01.041; JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kuersten S, 2002, MOL CELL BIOL, V22, P5708, DOI 10.1128/MCB.22.16.5708-5720.2002; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x; Lipowsky G, 1999, RNA, V5, P539, DOI 10.1017/S1355838299982134; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Marvin MC, 2009, RNA BIOL, V6, P40, DOI 10.4161/rna.6.1.7566; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Spath B, 2007, CELL MOL LIFE SCI, V64, P2404, DOI 10.1007/s00018-007-7160-5; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; WALKER PA, 1994, BIO-TECHNOL, V12, P601, DOI 10.1038/nbt0694-601; Xiong Y, 2006, CURR OPIN STRUC BIOL, V16, P12, DOI 10.1016/j.sbi.2005.12.001; ZASLOFF M, 1983, P NATL ACAD SCI-BIOL, V80, P6436, DOI 10.1073/pnas.80.21.6436	53	91	93	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					60	U60		10.1038/nature08394	http://dx.doi.org/10.1038/nature08394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19680239				2022-12-28	WOS:000269478800029
J	Marion, RM; Strati, K; Li, H; Murga, M; Blanco, R; Ortega, S; Fernandez-Capetillo, O; Serrano, M; Blasco, MA				Marion, Rosa M.; Strati, Katerina; Li, Han; Murga, Matilde; Blanco, Raquel; Ortega, Sagrario; Fernandez-Capetillo, Oscar; Serrano, Manuel; Blasco, Maria A.			A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity	NATURE			English	Article							PLURIPOTENT STEM-CELLS; MOUSE; FIBROBLASTS; ATM; P53; SENESCENCE; GENERATION; TELOMERES; ABSENCE; MICE	The reprogramming of differentiated cells to pluripotent cells (induced pluripotent stem (iPS) cells) is known to be an inefficient process. We recently reported that cells with short telomeres cannot be reprogrammed to iPS cells despite their normal proliferation rates(1,2), probably reflecting the existence of 'reprogramming barriers' that abort the reprogramming of cells with uncapped telomeres. Here we show that p53 (also known as Trp53 in mice and TP53 in humans) is critically involved in preventing the reprogramming of cells carrying various types of DNA damage, including short telomeres, DNA repair deficiencies, or exogenously inflicted DNA damage. Reprogramming in the presence of pre-existing, but tolerated, DNA damage is aborted by the activation of a DNA damage response and p53-dependent apoptosis. Abrogation of p53 allows efficient reprogramming in the face of DNA damage and the generation of iPS cells carrying persistent DNA damage and chromosomal aberrations. These observations indicate that during reprogramming cells increase their intolerance to different types of DNA damage and that p53 is critical in preventing the generation of human and mouse pluripotent cells from suboptimal parental cells.	[Marion, Rosa M.; Strati, Katerina; Blanco, Raquel; Blasco, Maria A.] Spanish Natl Canc Res Ctr CNIO, Telomeres & Telomerase Grp, E-28029 Madrid, Spain; [Li, Han; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain; [Murga, Matilde; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Genet Instabil Grp, Mol Oncol Program, E-28029 Madrid, Spain; [Ortega, Sagrario] Spanish Natl Canc Res Ctr CNIO, Biotechnol Program, Transgen Mice Unit, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Res Ctr CNIO, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mblasco@cnio.es	Strati, Katerina/GSN-2131-2022; Marión, Rosa/AAE-8657-2020; Marión, Rosa/L-1488-2015; Blasco, Maria A./M-1694-2014; Serrano, Manuel/H-2634-2015; Fernandez-Capetillo, Oscar/H-3508-2015; Murga, Matilde/B-3499-2018	Strati, Katerina/0000-0002-2332-787X; Marión, Rosa/0000-0002-0374-3884; Marión, Rosa/0000-0002-0374-3884; Blasco, Maria A./0000-0002-4211-233X; Serrano, Manuel/0000-0001-7177-9312; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; 	Spanish Association Against Cancer (AECC); MICINN (CONSOLIDER); Regional Government of Madrid; European Union; European Research Council (ERC); AECC; Korber European Research Award	Spanish Association Against Cancer (AECC); MICINN (CONSOLIDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); AECC; Korber European Research Award	We thank R. Serrano for mouse colony management, and M. Canamero and the Comparative Pathology Unit at the CNIO for teratoma analysis. K. S. is recipient of a contract from the Spanish Association Against Cancer (AECC). Work in the laboratory of M. A. B. is funded by grants from the MICINN (CONSOLIDER), the Regional Government of Madrid, the European Union, the European Research Council (ERC), the AECC, and the Korber European Research Award.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Davy P, 2009, CELL STEM CELL, V4, P95, DOI 10.1016/j.stem.2009.01.004; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	29	785	824	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1149	U119		10.1038/nature08287	http://dx.doi.org/10.1038/nature08287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19668189	Green Accepted			2022-12-28	WOS:000269314000043
J	Tape, C; Liu, QY; Maggi, A; Tromp, J				Tape, Carl; Liu, Qinya; Maggi, Alessia; Tromp, Jeroen			Adjoint Tomography of the Southern California Crust	SCIENCE			English	Article							SPECTRAL-ELEMENT METHOD; LOS-ANGELES BASIN; SEISMIC TOMOGRAPHY; REFLECTION DATA; INVERSION; MANTLE; KERNELS; REGION	Using an inversion strategy based on adjoint methods, we developed a three-dimensional seismological model of the southern California crust. The resulting model involved 16 tomographic iterations, which required 6800 wavefield simulations and a total of 0.8 million central processing unit hours. The new crustal model reveals strong heterogeneity, including local changes of +/- 30% with respect to the initial three-dimensional model provided by the Southern California Earthquake Center. The model illuminates shallow features such as sedimentary basins and compositional contrasts across faults. It also reveals crustal features at depth that aid in the tectonic reconstruction of southern California, such as subduction-captured oceanic crustal fragments. The new model enables more realistic and accurate assessments of seismic hazard.	[Tape, Carl] CALTECH, Seismol Lab, Pasadena, CA 91125 USA; [Liu, Qinya] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Maggi, Alessia] Univ Strasbourg, Inst Phys Globe, F-67084 Strasbourg, France; [Tromp, Jeroen] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Tromp, Jeroen] Princeton Univ, Program Appl & Computat Math, Princeton, NJ 08544 USA	California Institute of Technology; University of Toronto; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Princeton University; Princeton University	Tape, C (corresponding author), CALTECH, Seismol Lab, Pasadena, CA 91125 USA.	carltape@gps.caltech.edu	Maggi, Alessia/P-5041-2016; Tromp, Jeroen/B-6185-2015	Maggi, Alessia/0000-0001-8859-8948; Tromp, Jeroen/0000-0002-2742-8299	National Science Foundation [EAR-0711177]; Southern California Earthquake Center [EAR-0106924, 02HQAG0008]	National Science Foundation(National Science Foundation (NSF)); Southern California Earthquake Center	We acknowledge support by the National Science Foundation under grant EAR-0711177. This research was supported by the Southern California Earthquake Center. SCEC is funded by NSF Cooperative Agreement EAR-0106924 and U.S. Geological Service Cooperative Agreement 02HQAG0008. The SCEC contribution number for this paper is 1261	AKCELIK V, 2003, P ACM IEEE SUP SC200; Bleibinhaus F, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004611; Bonner JL, 2003, B SEISMOL SOC AM, V93, P2333, DOI 10.1785/0120030041; Brocher TA, 2005, B SEISMOL SOC AM, V95, P2081, DOI 10.1785/0120050077; Chen P, 2007, B SEISMOL SOC AM, V97, P1094, DOI 10.1785/0120060222; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Fichtner A, 2008, GEOPHYS J INT, V175, P665, DOI 10.1111/j.1365-246X.2008.03923.x; FUIS GS, 1984, J GEOPHYS RES, V89, P1165, DOI 10.1029/JB089iB02p01165; GOODMAN ED, 1992, TECTONICS, V11, P478, DOI 10.1029/91TC02871; Grand SP., 1997, GSA TODAY, V7, P1; Hauksson E, 2000, J GEOPHYS RES-SOL EA, V105, P13875, DOI 10.1029/2000JB900016; Humphreys E. D., 1990, J GEOPHYS RES, V95, P19; Komatitsch D, 2004, B SEISMOL SOC AM, V94, P187, DOI 10.1785/0120030077; Komatitsch D, 2002, SCIENCE, V298, P1737, DOI 10.1126/science.1076024; Lin G, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004977; Liu QY, 2006, B SEISMOL SOC AM, V96, P2383, DOI 10.1785/0120060041; Luffi P, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005906; Maggi A, 2009, GEOPHYS J INT, V178, P257, DOI [10.1111/j.1365-246X.2009.04099.x, 10.1111/J.1365-246X.2009.04099.X]; Montelli R, 2004, SCIENCE, V303, P338, DOI 10.1126/science.1092485; NICHOLSON C, 1994, GEOLOGY, V22, P491, DOI 10.1130/0091-7613(1994)022<0491:MCROTW>2.3.CO;2; Olsen KB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025472; Romanowicz B, 2003, ANNU REV EARTH PL SC, V31, P303, DOI 10.1146/annurev.earth.31.091602.113555; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Suss MP, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001628; TALAGRAND O, 1987, Q J ROY METEOR SOC, V113, P1311, DOI 10.1256/smsqj.47811; Tape C, 2007, GEOPHYS J INT, V168, P1105, DOI 10.1111/j.1365-246X.2006.03191.x; TARANTOLA A, 1984, GEOPHYSICS, V49, P1259, DOI 10.1190/1.1441754; Tromp J, 2005, GEOPHYS J INT, V160, P195, DOI [10.1111/j.1365-246X.2004.02453.x, 10.1111/J.1365-246X.2004.02453.X]; WOODHOUSE JH, 1984, J GEOPHYS RES, V89, P5953, DOI 10.1029/JB089iB07p05953	29	333	346	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					988	992		10.1126/science.1175298	http://dx.doi.org/10.1126/science.1175298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696349				2022-12-28	WOS:000269242800044
J	Collins, D				Collins, Desmond			Misadventures in the Burgess Shale	NATURE			English	Editorial Material									Royal Ontario Museum, Toronto, ON, Canada	Royal Ontario Museum	Collins, D (corresponding author), Royal Ontario Museum, Toronto, ON, Canada.	Suzanne.collins029@sympatico.ca							0	7	9	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					952	953		10.1038/460952a	http://dx.doi.org/10.1038/460952a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693066				2022-12-28	WOS:000269085500016
J	Kerschensteiner, D; Morgan, JL; Parker, ED; Lewis, RM; Wong, ROL				Kerschensteiner, Daniel; Morgan, Josh L.; Parker, Edward D.; Lewis, Renate M.; Wong, Rachel O. L.			Neurotransmission selectively regulates synapse formation in parallel circuits in vivo	NATURE			English	Article							RETINAL GANGLION-CELLS; BIPOLAR CELLS; MOUSE RETINA; MAMMALIAN RETINA; RIBBON SYNAPSES; COMPETITION; EXPRESSION	Activity is thought to guide the patterning of synaptic connections in the developing nervous system. Specifically, differences in the activity of converging inputs are thought to cause the elimination of synapses from less active inputs and increase connectivity with more active inputs(1,2). Here we present findings that challenge the generality of this notion and offer a new view of the role of activity in synapse development. To imbalance neurotransmission from different sets of inputs in vivo, we generated transgenic mice in which ON but not OFF types of bipolar cells in the retina express tetanus toxin ( TeNT). During development, retinal ganglion cells (RGCs) select between ON and OFF bipolar cell inputs ( ON or OFF RGCs) or establish a similar number of synapses with both on separate dendritic arborizations (ON-OFF RGCs). In TeNT retinas, ON RGCs correctly selected the silenced ON bipolar cell inputs over the transmitting OFF bipolar cells, but were connected with them through fewer synapses at maturity. Time-lapse imaging revealed that this was caused by a reduced rate of synapse formation rather than an increase in synapse elimination. Similarly, TeNT-expressing ON bipolar cell axons generated fewer presynaptic active zones. The remaining active zones often recruited multiple, instead of single, synaptic ribbons. ON-OFF RGCs in TeNT mice maintained convergence of ON and OFF bipolar cells inputs and had fewer synapses on their ON arbor without changes to OFF arbor synapses. Our results reveal an unexpected and remarkably selective role for activity in circuit development in vivo, regulating synapse formation but not elimination, affecting synapse number but not dendritic or axonal patterning, and mediating independently the refinement of connections from parallel (ON and OFF) processing streams even where they converge onto the same postsynaptic cell.	[Kerschensteiner, Daniel; Morgan, Josh L.; Lewis, Renate M.; Wong, Rachel O. L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Kerschensteiner, Daniel; Morgan, Josh L.; Wong, Rachel O. L.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Parker, Edward D.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kerschensteiner, D (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	KerschensteinerD@vision.wustl.edu; wongr2@u.washington.edu			National Institutes of Health [EY10699, T32 EY07031]; McDonnell Foundation at Washington University; National Eye Institute [EY01730]; Deutsche Forschungsgemeinschaft [1466/1-1]; NATIONAL EYE INSTITUTE [P30EY001730, T32EY007031, R01EY010699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation at Washington University; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to J. Sanes and R. W. Burgess for TeNT-CFP, S. Naganishi for the mGluR6 promoter fragment, A. M. Craig for PSD95-CFP and R. Y. Tsien for tdTomato. We thank F. Soto, L. Godinho, A. Lewis, F. Dunn and T. Misgeld for comments on the manuscript. This work was supported by the National Institutes of Health ( R. O. L. W., EY10699, J. L. M. T32 EY07031), the McDonnell Foundation at Washington University ( R. O. L. W.), National Eye Institute core grant ( E. D. P., EY01730) and the Deutsche Forschungsgemeinschaft ( D. K., KE 1466/1-1).	Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Kerschensteiner D, 2008, J NEUROSCI, V28, P2342, DOI 10.1523/JNEUROSCI.4784-07.2008; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASLIM J, 1986, J COMP NEUROL, V254, P382, DOI 10.1002/cne.902540310; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Regus-Leidig H, 2009, J COMP NEUROL, V512, P814, DOI 10.1002/cne.21915; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Ueda Y, 1997, J NEUROSCI, V17, P3014; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong R. O. L., 2002, FUNDAMENTAL NEUROSCI, P533; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4	28	134	134	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					1016	U103		10.1038/nature08236	http://dx.doi.org/10.1038/nature08236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693082	Green Accepted			2022-12-28	WOS:000269085500035
J	Geersing, GJ; Janssen, KJM; Oudega, R; Bax, L; Hoes, AW; Reitsma, JB; Moons, KGM				Geersing, G. J.; Janssen, K. J. M.; Oudega, R.; Bax, L.; Hoes, A. W.; Reitsma, J. B.; Moons, K. G. M.			Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; SUSPECTED PULMONARY-EMBOLISM; CLINICAL PROBABILITY; PATIENT; SENSITIVITY; REVIEWS; ASSAY; BIAS	Objective To review the evidence on the diagnostic accuracy of the currently available point of care D-dimer tests for excluding venous thromboembolism. Design Systematic review of research on the accuracy of point of care D-dimer tests, using bivariate regression to examine sources of variation and to estimate sensitivity and specificity. Data sources Studies on the diagnostic accuracy of point of care D-dimer tests published between January 1995 and September 2008 and available in either Medline or Embase. Review methods The analysis included studies that compared point of care D-dimer tests with predefined reference criteria for venous thromboembolism, enrolled consecutive outpatients, and allowed for construction of a 2 x 2 table. Results 23 studies (total number of patients 13 959, range in mean age 38-65 years, range of venous thromboembolism prevalence 4-51%) were included in the meta-analysis. The studies reported two qualitative point of care D-dimer tests (SimpliRED D-dimer (n=12) and Clearview Simplify D-dimer (n=7)) and two quantitative point of care D-dimer tests (Cardiac D-dimer (n=4) and Triage D-dimer (n=2)). Overall sensitivity ranged from 0.85 (95% confidence interval 0.78 to 0.90) to 0.96 (0.91 to 0.98) and overall specificity from 0.48 (0.33 to 0.62) to 0.74 (0.69 to 0.78). The two quantitative tests Cardiac D-dimer and Triage D-dimer scored most favourably. Conclusions In outpatients suspected of venous thromboembolism, point of care D-dimer tests can contribute important information and guide patient management, notably in low risk patients (that is, those patients with a low score on a clinical decision rule).	[Geersing, G. J.; Janssen, K. J. M.; Oudega, R.; Bax, L.; Hoes, A. W.; Moons, K. G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bax, L.] Kitasato Univ, Kitasato Clin Res Ctr, Tokyo, Japan; [Reitsma, J. B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Kitasato University; University of Amsterdam; Academic Medical Center Amsterdam	Geersing, GJ (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	g.j.geersing@umcutrecht.nl	Geersing, Geert-Jan/AAY-1119-2021		Netherlands Heart Foundation [2006B237]; Zilveren Kruis Achmea [Z195]	Netherlands Heart Foundation(Netherlands Heart Foundation); Zilveren Kruis Achmea	Financial support was provided by the Netherlands Heart Foundation (project number 2006B237) and "Zilveren Kruis Achmea" ( project number Z195). These organisations had no influence on any aspect of this study.	Chunilal SD, 2003, JAMA-J AM MED ASSOC, V290, P2849, DOI 10.1001/jama.290.21.2849; De Monye W, 2002, AM J RESP CRIT CARE, V165, P345, DOI 10.1164/ajrccm.165.3.2104099; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Dwamena B., 2007, MIDAS COMPUTATIONAL; Fancher TL, 2004, BMJ-BRIT MED J, V329, P821, DOI 10.1136/bmj.38226.719803.EB; Goodacre S, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-6; Harbord R., 2008, METANDI STATA MODULE; Heim SW, 2004, CLIN CHEM, V50, P1136, DOI 10.1373/clinchem.2004.031765; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Kraaijenhagen RA, 2003, THROMB RES, V111, P155, DOI 10.1016/j.thromres.2003.08.028; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Le Gal G, 2004, J THROMB HAEMOST, V2, P1244, DOI 10.1111/j.1538-7836.2004.00795.x; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Meijer P, 2005, Semin Vasc Med, V5, P321, DOI 10.1055/s-2005-922477; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Oudega R, 2005, FAM PRACT, V22, P86, DOI 10.1093/fampra/cmh718; Perzanowski C, 2003, J THROMB HAEMOST, V1, P849, DOI 10.1046/j.1538-7836.2003.00115.x; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Sanson BJ, 2000, THROMB HAEMOSTASIS, V83, P199; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Ten Cate-Hoek AJ, 2005, J THROMB HAEMOST, V3, P2465, DOI 10.1111/j.1538-7836.2005.01556.x; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Wells PS, 2006, JAMA-J AM MED ASSOC, V295, P199, DOI 10.1001/jama.295.2.199; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	26	94	97	5	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2009	339								b2990	10.1136/bmj.b2990	http://dx.doi.org/10.1136/bmj.b2990			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YL	19684102	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000269162200005
J	Regalbuto, JR				Regalbuto, John R.			Cellulosic Biofuels-Got Gasoline?	SCIENCE			English	Editorial Material							SOLID BIOMASS; HYDROCARBONS		Natl Sci Fdn, Arlington, VA 22230 USA	National Science Foundation (NSF)	Regalbuto, JR (corresponding author), Natl Sci Fdn, 4201 Wilson Blvd, Arlington, VA 22230 USA.	jregalbu@nsf.gov						Carlson TR, 2008, CHEMSUSCHEM, V1, P397, DOI 10.1002/cssc.200800018; Chheda JN, 2007, ANGEW CHEM INT EDIT, V46, P7164, DOI 10.1002/anie.200604274; CONNOR PO, COMMUNICATION; CORTRIGHT R, 2009, COMMUNICATION   0408; Dauenhauer PJ, 2007, ANGEW CHEM INT EDIT, V46, P5864, DOI 10.1002/anie.200701238; GOODFELLOW R, 2009, COMMUNICATION   0414; Huber GW, 2009, SCI AM, V301, P52, DOI 10.1038/scientificamerican0709-52; JENSEN A, COMMUNICATION; JONIETZ E, 2007, TECHNOL REV     1109; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; National Renewable Energy Laboratory, 1998, LOOK BACK US DEP EN; U.S. National Science Foundation, 2008, BREAK CHEM ENG BARR; United States Department of Energy (US DOE), 2005, BIOM FEEDST BIOEN BI; US-DOE, 2006, BREAK BIOL BARR CELL; *VIR EN SYST WHIT, 2008, PROD CONV LIQ FUELS; [No title captured]	17	224	234	1	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					822	824		10.1126/science.1174581	http://dx.doi.org/10.1126/science.1174581			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679801				2022-12-28	WOS:000269242400030
J	Schaller, EL; Roe, HG; Schneider, T; Brown, ME				Schaller, E. L.; Roe, H. G.; Schneider, T.; Brown, M. E.			Storms in the tropics of Titan	NATURE			English	Article							CLOUDS	Methane clouds, lakes and most fluvial features on Saturn's moon Titan have been observed in the moist high latitudes(1-6), while the tropics have been nearly devoid of convective clouds and have shown an abundance of wind-carved surface features like dunes(7,8). The presence of small-scale channels and dry riverbeds near the equator observed by the Huygens probe(9) at latitudes thought incapable of supporting convection(10-12) (and thus strong rain) has been suggested to be due to geological seepage or other mechanisms not related to precipitation(13). Here we report the presence of bright, transient, tropospheric clouds in tropical latitudes. We find that the initial pulse of cloud activity generated planetary waves that instigated cloud activity at other latitudes across Titan that had been cloud-free for at least several years. These observations show that convective pulses at one latitude can trigger short-term convection at other latitudes, even those not generally considered capable of supporting convection, and may also explain the presence of methane-carved rivers and channels near the Huygens landing site.	[Schaller, E. L.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Roe, H. G.] Lowell Observ, Flagstaff, AZ 86001 USA; [Schneider, T.; Brown, M. E.] CALTECH, Pasadena, CA 91125 USA	University of Hawaii System; California Institute of Technology	Schaller, EL (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	schaller@ifa.hawaii.edu	Schneider, Tapio/A-7038-2014	Schneider, Tapio/0000-0001-5687-2287; Schaller, Emily/0000-0001-8967-5423; Brown, Michael E./0000-0002-8255-0545	Hubble Postdoctoral Fellowship; NASA Planetary Astronomy Program; NSF Planetary Astronomy grant	Hubble Postdoctoral Fellowship; NASA Planetary Astronomy Program(National Aeronautics & Space Administration (NASA)); NSF Planetary Astronomy grant	E. L. S. is supported by a Hubble Postdoctoral Fellowship. H. G. R is supported by the NASA Planetary Astronomy Program. M. E. B. is supported by an NSF Planetary Astronomy grant. We thank IRTF telescope operators, D. Griep, W. Golisch, P. Sears and E. Volquardsen. The IRTF is operated by the University of Hawaii under a cooperative agreement with the Planetary Astronomy Program of the NASA Science Mission Directorate. Gemini Observatory is operated by the Association of Universities for Research in Astronomy, Inc., under a cooperative agreement with the NSF on behalf of the International Gemini partnership.	Barnes JW, 2008, ICARUS, V195, P400, DOI 10.1016/j.icarus.2007.12.006; Barnes JW, 2005, SCIENCE, V310, P92, DOI 10.1126/science.1117075; Bouchez AH, 2005, ASTROPHYS J, V618, pL53, DOI 10.1086/427693; Brown ME, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035964; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; BROWN ME, ICARUS UNPUB; Brown RH, 2008, NATURE, V454, P607, DOI 10.1038/nature07100; Griffith CA, 2000, SCIENCE, V290, P509, DOI 10.1126/science.290.5491.509; Griffith CA, 2005, SCIENCE, V310, P474, DOI 10.1126/science.1117702; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; Griffith CA, 2008, ASTROPHYS J LETT, V687, pL41, DOI 10.1086/593117; Hueso R, 2006, NATURE, V442, P428, DOI 10.1038/nature04933; Lebreton JP, 2005, NATURE, V438, P758, DOI 10.1038/nature04347; Lorenz RD, 2008, PLANET SPACE SCI, V56, P1132, DOI 10.1016/j.pss.2008.02.009; Mitchell JL, 2006, P NATL ACAD SCI USA, V103, P18421, DOI 10.1073/pnas.0605074103; Mitchell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003017; Perron JT, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002602; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Roe HG, 2005, SCIENCE, V310, P477, DOI 10.1126/science.1116760; Roe HG, 2002, ASTROPHYS J, V581, P1399, DOI 10.1086/344403; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; Schaller EL, 2006, ICARUS, V182, P224, DOI 10.1016/j.icarus.2005.12.021; SCHALLER EL, ASTRON J UNPUB; Schaller EL, 2006, ICARUS, V184, P517, DOI 10.1016/j.icarus.2006.05.025; Soderblom LA, 2007, PLANET SPACE SCI, V55, P2015, DOI 10.1016/j.pss.2007.04.015; Stofan ER, 2007, NATURE, V445, P61, DOI 10.1038/nature05438; Tokano T, 2005, ICARUS, V173, P222, DOI 10.1016/j.icarus.2004.08.019; Tokano T, 2006, NATURE, V442, P432, DOI 10.1038/nature04948; Turtle EP, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036186	29	66	68	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					873	875		10.1038/nature08193	http://dx.doi.org/10.1038/nature08193			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675648				2022-12-28	WOS:000268938300033
J	Stone, M; Laughren, T; Jones, ML; Levenson, M; Holland, PC; Hughes, A; Hammad, TA; Temple, R; Rochester, G				Stone, Marc; Laughren, Thomas; Jones, M. Lisa; Levenson, Mark; Holland, P. Chris; Hughes, Alice; Hammad, Tarek A.; Temple, Robert; Rochester, George			Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; PLACEBO; METAANALYSIS; DEPRESSION; RATES	Objective To examine the risk of suicidal behaviour within clinical trials of antidepressants in adults. Design Meta-analysis of 372 double blind randomised placebo controlled trials. Setting Drug development programmes for any indication in adults. Participants 99 231 adults assigned to antidepressants or placebo. Median age was 42 and 63.1% were women. Indications for treatment were major depression (45.6%), other depression (4.6%), other psychiatric disorders (27.6%), and non-psychiatric disorders (22.2%). Main outcome measures Suicidal behaviour (completed suicide, attempted suicide, or preparatory acts) and ideation. Results For participants with non-psychiatric indications, suicidal behaviour and ideation were extremely rare. For those with psychiatric indications, risk was associated with age. For suicidal behaviour or ideation and for suicidal behaviour only, the respective odds ratios were 1.62 (95% confidence interval 0.97 to 2.71) and 2.30 (1.04 to 5.09) for participants aged <25, 0.79 (0.64 to 0.98) and 0.87 (0.58 to 1.29) for those aged 25-64, and 0.37 (0.18 to 0.76) and 0.06 (0.01 to 0.58) for those aged >= 65. When age was modelled as a continuous variable, the odds ratio for suicidal behaviour or ideation declined at a rate of 2.6% per year of age (-3.9% to -1.3%, P=0.0001) and the odds ratio for suicidal behaviour declined at a rate of 4.6% per year of age (-7.4% to -1.8%, P=0.001). Conclusions Risk of suicidality associated with use of antidepressants is strongly age dependent. Compared with placebo, the increased risk for suicidality and suicidal behaviour among adults under 25 approaches that seen in children and adolescents. The net effect seems to be neutral on suicidal behaviour but possibly protective for suicidal ideation in adults aged 25-64 and to reduce the risk of both suicidality and suicidal behaviour in those aged >= 65.	[Stone, Marc; Laughren, Thomas] US FDA, Ctr Drug Evaluat & Res, Div Psychiat Prod, Silver Spring, MD 20993 USA; [Hughes, Alice] US FDA, Ctr Drug Evaluat & Res, Div Neurol Prod, Silver Spring, MD 20993 USA; [Hammad, Tarek A.] US FDA, Ctr Drug Evaluat & Res, Div Epidemiol, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Stone, M (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Psychiat Prod, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	marc.stone@fda.hhs.gov	Stone, Marc/H-3223-2019					Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Grunebaum MF, 2004, J CLIN PSYCHIAT, V65, P1456, DOI 10.4088/JCP.v65n1103; Gunnell D, 2003, SOC SCI MED, V57, P595, DOI 10.1016/S0277-9536(02)00408-2; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hall WD, 2006, AUST NZ J PSYCHIAT, V40, P941, DOI 10.1111/j.1440-1614.2006.01917.x; Hammad TA, 2006, J CLIN PSYCHOPHARM, V26, P203, DOI 10.1097/01.jcp.0000203198.11453.95; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Juurlink DN, 2006, AM J PSYCHIAT, V163, P813, DOI 10.1176/appi.ajp.163.5.813; Kelly CB, 2003, EUR PSYCHIAT, V18, P325, DOI 10.1016/j.eurpsy.2003.03.005; Khan A, 2000, ARCH GEN PSYCHIAT, V57, P311, DOI 10.1001/archpsyc.57.4.311; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Milanovic N, 2006, INT J WEB SERV RES, V3, P1, DOI 10.4018/jwsr.2006040101; Olfson M, 2006, ARCH GEN PSYCHIAT, V63, P865, DOI 10.1001/archpsyc.63.8.865; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Storosum JG, 2001, AM J PSYCHIAT, V158, P1271, DOI 10.1176/appi.ajp.158.8.1271; Sutton AJAK, 2000, METHODS METAANALYSIS	18	344	351	3	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2009	339								b2880	10.1136/bmj.b2880	http://dx.doi.org/10.1136/bmj.b2880			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YH	19671933	Green Published, hybrid			2022-12-28	WOS:000269161800002
J	Ford, E; Thanos, D				Ford, Ethan; Thanos, Dimitris			Time's up: Bursting out of Transcription	CELL			English	Editorial Material							GENE	Many inducible genes are transcribed in bursts. In this issue, Degenhardt et al. (2009) report computational models that predict and validate patterns of stochastic gene expression.	[Ford, Ethan; Thanos, Dimitris] Acad Athens, Biomed Res Fdn, Inst Mol Biol Genet & Biotechnol, Athens 11527, Greece	Academy of Athens	Thanos, D (corresponding author), Acad Athens, Biomed Res Fdn, Inst Mol Biol Genet & Biotechnol, 4 Soranou Efesiou St, Athens 11527, Greece.	thanos@bioacademy.gr	Thanos, Dimitris/AAE-5720-2019					Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050	5	4	4	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					430	432		10.1016/j.cell.2009.07.023	http://dx.doi.org/10.1016/j.cell.2009.07.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665966	Bronze			2022-12-28	WOS:000268771900008
J	Jhunjhunwala, S; van Zelm, MC; Peak, MM; Murre, C				Jhunjhunwala, Suchit; van Zelm, Menno C.; Peak, Mandy M.; Murre, Cornelis			Chromatin Architecture and the Generation of Antigen Receptor Diversity	CELL			English	Review							ANTISENSE INTERGENIC TRANSCRIPTION; HEAVY-CHAIN LOCUS; ALLELIC EXCLUSION; IMMUNOGLOBULIN LOCI; GERMLINE TRANSCRIPTION; CHROMOSOMAL POSITION; GENE REARRANGEMENTS; PLANT HOMEODOMAIN; BETA-GENE; RECOMBINATION	The adaptive immune system generates a specific response to a vast spectrum of antigens. This remarkable property is achieved by lymphocytes that each express single and unique antigen receptors. During lymphocyte development, antigen receptor coding elements are assembled from widely dispersed gene segments. The assembly of antigen receptors is controlled at multiple levels, including epigenetic marking, nuclear location, and chromatin topology. Here, we review recently uncovered mechanisms that underpin long-range genomic interactions and the generation of antigen receptor diversity.	[Jhunjhunwala, Suchit; van Zelm, Menno C.; Peak, Mandy M.; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA; [van Zelm, Menno C.] Erasmus MC, Dept Immunol, NL-3015 GE Rotterdam, Netherlands	University of California System; University of California San Diego; Erasmus University Rotterdam; Erasmus MC	Murre, C (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	murre@biomail.ucsd.edu	Jhunjhunwala, Suchit/GNH-2256-2022; van Zelm, Menno C/O-4404-2015	Jhunjhunwala, Suchit/0000-0003-3484-0588; van Zelm, Menno C/0000-0003-4161-1919	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA054198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to D. Forbes, A. Goldrath, M. Levine, G. Arya, B. McGinnis, R. Riblet, anonymous reviewers, and members of the Murre laboratory for comments on the manuscript. We especially thank T. Knoch for many stimulating discussions, T. Hwa for suggesting that we perform triple-point measurements and define chromatin compartments as physical units, and S. Cutchin for lessons in geometry. We thank D. Heermann for making us aware of the "random loop" model. We thank the National Institutes of Health for support.	Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Agata Y, 2007, IMMUNITY, V27, P871, DOI 10.1016/j.immuni.2007.11.015; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Bassing CH, 2008, EUR J IMMUNOL, V38, P2564, DOI 10.1002/eji.200838347; Bates JG, 2007, J EXP MED, V204, P3247, DOI 10.1084/jem.20071787; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Bohn M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051805; Bolland DJ, 2007, MOL CELL BIOL, V27, P5523, DOI 10.1128/MCB.02407-06; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; BRACK C, 1978, CELL, V15, P1, DOI 10.1016/0092-8674(78)90078-8; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cedar H, 2008, CURR OPIN IMMUNOL, V20, P308, DOI 10.1016/j.coi.2008.02.002; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chowdhury D, 2004, IMMUNOL REV, V200, P182, DOI 10.1111/j.0105-2896.2004.00177.x; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; COSTA TEF, 1992, P NATL ACAD SCI USA, V89, P2205, DOI 10.1073/pnas.89.6.2205; de Almeida CR, 2009, J IMMUNOL, V182, P999, DOI 10.4049/jimmunol.182.2.999; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; DREYER WJ, 1965, P NATL ACAD SCI USA, V54, P864, DOI 10.1073/pnas.54.3.864; Feeney AJ, 1997, J IMMUNOL, V158, P3761; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; HADJUR S, 2009, NATURE, DOI DOI 10.1038/NATURE09079; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Hewitt SL, 2008, NAT IMMUNOL, V9, P396, DOI 10.1038/ni1567; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jia JQ, 2007, EMBO J, V26, P2387, DOI 10.1038/sj.emboj.7601671; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Knoch TA, 2000, HIGH PERFORMANCE COMPUTING IN SCIENCE AND ENGINEERING '99, P229; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Krangel MS, 2007, NAT IMMUNOL, V8, P686, DOI 10.1038/ni1484; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Langowski J, 2007, SEMIN CELL DEV BIOL, V18, P659, DOI 10.1016/j.semcdb.2007.08.011; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Liu Z, 2006, IMMUNITY, V24, P405, DOI 10.1016/j.immuni.2006.02.001; Love VA, 2000, MOL IMMUNOL, V37, P29, DOI 10.1016/S0161-5890(00)00023-7; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Morawetz H., 1985, POLYM ORIGINS GROWTH; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; OKADA TA, 1979, CHROMOSOMA, V72, P1, DOI 10.1007/BF00286426; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; PIENTA KJ, 1984, J CELL SCI, P123; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; RATTNER JB, 1985, CELL, V42, P291, DOI 10.1016/S0092-8674(85)80124-0; Rauch J, 2008, DIFFERENTIATION, V76, P66, DOI 10.1111/j.1432-0436.2007.00237.x; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schatz DG, 2005, CURR TOP MICROBIOL, V290, P49; Schlimgen RJ, 2008, NAT IMMUNOL, V9, P802, DOI 10.1038/ni.1624; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; SEDAT J, 1977, COLD SPRING HARB SYM, V42, P331, DOI 10.1101/SQB.1978.042.01.035; SEIDMAN JG, 1978, P NATL ACAD SCI USA, V75, P3881, DOI 10.1073/pnas.75.8.3881; Shimazaki N, 2009, MOL CELL, V34, P535, DOI 10.1016/j.molcel.2009.05.011; Singh N, 2003, J EXP MED, V197, P743, DOI 10.1084/jem.20021392; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; WARRINGTON JA, 1994, GENOMICS, V24, P395, DOI 10.1006/geno.1994.1636; WEIGERT M, 1978, NATURE, V276, P785, DOI 10.1038/276785a0; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239	89	99	100	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					435	448		10.1016/j.cell.2009.07.016	http://dx.doi.org/10.1016/j.cell.2009.07.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665968	Bronze, Green Accepted			2022-12-28	WOS:000268771900010
J	Buchbinder, R; Osborne, RH; Ebeling, PR; Wark, JD; Mitchell, P; Wriedt, C; Graves, S; Staples, MP; Murphy, B				Buchbinder, Rachelle; Osborne, Richard H.; Ebeling, Peter R.; Wark, John D.; Mitchell, Peter; Wriedt, Chris; Graves, Stephen; Staples, Margaret P.; Murphy, Bridie			A Randomized Trial of Vertebroplasty for Painful Osteoporotic Vertebral Fractures	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; PERCUTANEOUS VERTEBROPLASTY; COMPRESSION FRACTURES; AUGMENTATION; EFFICACY; SAFETY; RISK; MEN	BACKGROUND Vertebroplasty has become a common treatment for painful osteoporotic vertebral fractures, but there is limited evidence to support its use. METHODS We performed a multicenter, randomized, double-blind, placebo-controlled trial in which participants with one or two painful osteoporotic vertebral fractures that were of less than 12 months' duration and unhealed, as confirmed by magnetic resonance imaging, were randomly assigned to undergo vertebroplasty or a sham procedure. Participants were stratified according to treatment center, sex, and duration of symptoms (<6 weeks or >= 6 weeks). Outcomes were assessed at 1 week and at 1, 3, and 6 months. The primary outcome was overall pain (on a scale of 0 to 10, with 10 being the maximum imaginable pain) at 3 months. RESULTS A total of 78 participants were enrolled, and 71 (35 of 38 in the vertebroplasty group and 36 of 40 in the placebo group) completed the 6-month follow-up (91%). Vertebroplasty did not result in a significant advantage in any measured outcome at any time point. There were significant reductions in overall pain in both study groups at each follow-up assessment. At 3 months, the mean (+/- SD) reductions in the score for pain in the vertebroplasty and control groups were 2.6 +/- 2.9 and 1.9 +/- 3.3, respectively (adjusted between-group difference, 0.6; 95% confidence interval, -0.7 to 1.8). Similar improvements were seen in both groups with respect to pain at night and at rest, physical functioning, quality of life, and perceived improvement. Seven incident vertebral fractures (three in the vertebroplasty group and four in the placebo group) occurred during the 6-month follow-up period. CONCLUSIONS We found no beneficial effect of vertebroplasty as compared with a sham procedure in patients with painful osteoporotic vertebral fractures, at 1 week or at 1, 3, or 6 months after treatment. (Australian New Zealand Clinical Trials Registry number, ACTRN012605000079640.)	[Buchbinder, Rachelle; Staples, Margaret P.; Murphy, Bridie] Monash Univ, Cabrini Hosp, Monash Dept Clin Epidemiol, Malvern, Vic, Australia; [Buchbinder, Rachelle; Staples, Margaret P.; Murphy, Bridie] Monash Univ, Dept Epidemiol & Prevent Med, Malvern, Vic, Australia; [Osborne, Richard H.] Deakin Univ, Melbourne, Vic, Australia; [Ebeling, Peter R.] Univ Melbourne, Western Hosp, Royal Melbourne Hosp, Dept Med, Footscray, Vic, Australia; [Wark, John D.; Mitchell, Peter] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Western Hosp, Parkville, Vic 3052, Australia; [Wark, John D.; Mitchell, Peter] Univ Melbourne, Dept Radiol, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Wriedt, Chris] Cabrini Hlth, Cabrini Med Imaging, Malvern, Vic, Australia; [Graves, Stephen] Univ Adelaide, Data Management & Anal Ctr, Australian Orthopaed Assoc, Natl Joint Replacement Register, Adelaide, SA, Australia	Cabrini Health; Monash University; Monash University; Deakin University; Royal Melbourne Hospital; University of Melbourne; Western Hospital; Royal Melbourne Hospital; University of Melbourne; Western Hospital; Royal Melbourne Hospital; University of Melbourne; Cabrini Health; University of Adelaide	Buchbinder, R (corresponding author), Cabrini Med Ctr, Dept Clin Epidemiol, Suite 41,183 Wattletree Rd, Malvern, Vic 3144, Australia.	rachelle.buchbinder@med.monash.edu.au	Osborne, Richard H/A-9447-2010; Graves, Stephen E/A-9463-2016; Buchbinder, Rachelle/G-2952-2011; Ebeling, Peter R/A-9129-2012	Osborne, Richard H/0000-0002-9081-2699; Graves, Stephen E/0000-0002-1629-319X; Buchbinder, Rachelle/0000-0002-0597-0933; Ebeling, Peter/0000-0002-2921-3742	National Health and Medical Research Council of Australia [284354]; Arthritis Australia; Cabrini Education and Research Institute; Cook Australia; National Health and Medical Research Council Population Health Career Development Award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Australia; Cabrini Education and Research Institute; Cook Australia; National Health and Medical Research Council Population Health Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the National Health and Medical Research Council of Australia (284354), Arthritis Australia, the Cabrini Education and Research Institute, and Cook Australia. Dr. Buchbinder is the recipient of a National Health and Medical Research Council Practitioner Fellowship, and Dr. Osborne is the recipient of a National Health and Medical Research Council Population Health Career Development Award.; Dr. Buchbinder reports receiving grant support from Cook Australia to perform this trial. No other potential conflict of interest relevant to this article was reported.	Alvarez L, 2006, SPINE, V31, P1113; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Buchbinder R, 2006, MED J AUSTRALIA, V185, P351, DOI 10.5694/j.1326-5377.2006.tb00607.x; Buchbinder R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-156; Diamond TH, 2003, AM J MED, V114, P257, DOI 10.1016/S0002-9343(02)01524-3; Flum DR, 2006, JAMA-J AM MED ASSOC, V296, P2483, DOI 10.1001/jama.296.20.2483; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gray DT, 2007, JAMA-J AM MED ASSOC, V298, P2370; Gray LA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-126; Grotle M, 2004, SPINE, V29, pE492, DOI 10.1097/01.brs.0000143664.02702.0b; Hawthorne G, 2005, AUST NZ J PUBL HEAL, V29, P136, DOI 10.1111/j.1467-842X.2005.tb00063.x; He SC, 2008, SPINE, V33, P640, DOI 10.1097/BRS.0b013e318166955f; Hollingworth W, 2006, ACAD RADIOL, V13, P550, DOI 10.1016/j.acra.2006.01.003; HUSKISSON EC, 1982, J RHEUMATOL, V9, P768; Jarvik JG, 2000, AM J NEURORADIOL, V21, P1373; Jensen ME, 2007, J VASC INTERV RADIOL, V18, P325, DOI 10.1016/j.jvir.2007.01.014; Jones G, 1996, OSTEOPOROSIS INT, V6, P233, DOI 10.1007/BF01622740; Kanis J. A., 1999, Journal of Endocrinological Investigation, V22, P583; Lad SP, 2009, SURG NEUROL, V71, P580, DOI 10.1016/j.surneu.2008.02.043; Lips P, 1999, OSTEOPOROSIS INT, V10, P150, DOI 10.1007/s001980050210; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; *MED SERV ADV COMM, 2005, 31 M 24 AUG 2005 BRI; Melton LJ, 1997, J BONE MINER RES, V12, P16, DOI 10.1359/jbmr.1997.12.1.16; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Pham T, 2005, SPINE, V30, P2430, DOI 10.1097/01.brs.0000184303.86932.77; Ploeg WT, 2006, EUR SPINE J, V15, P1749, DOI 10.1007/s00586-006-0159-z; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Trout AT, 2006, AM J NEURORADIOL, V27, P1397; Trout AT, 2005, AM J NEURORADIOL, V26, P2652; Uebelhart B, 2008, JOINT BONE SPINE, V75, P322, DOI 10.1016/j.jbspin.2007.05.008; Voormolen MHJ, 2007, AM J NEURORADIOL, V28, P555; Wagner AL, 2005, AM J NEURORADIOL, V26, P1610; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Watts NB, 2003, AM J MED, V114, P326, DOI 10.1016/S0002-9343(03)00050-0	36	923	989	3	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					557	568		10.1056/NEJMoa0900429	http://dx.doi.org/10.1056/NEJMoa0900429			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479NR	19657121				2022-12-28	WOS:000268667300006
J	Pearce, SM				Pearce, Solomon M.			Answering the Call of the Wounded Warrior	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												docpearce@yahoo.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					471	472		10.1001/jama.2009.999	http://dx.doi.org/10.1001/jama.2009.999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479DS	19654376				2022-12-28	WOS:000268640500001
J	Marinkovic, SP; Moldwin, R; Gillen, LM; Stanton, SL				Marinkovic, Serge P.; Moldwin, Robert; Gillen, Lisa M.; Stanton, Stuart L.			The management of interstitial cystitis or painful bladder syndrome in women	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ORAL PENTOSAN POLYSULFATE; HYDROXYZINE; DIAGNOSIS; SYMPTOMS; EFFICACY		[Marinkovic, Serge P.] St Francis Hosp, Indianapolis, IN 46259 USA; [Moldwin, Robert] Long Isl Jewish Med Ctr, Arthur Smith Inst Urol, New Hyde Pk, NY 11040 USA; [Gillen, Lisa M.] So Illinois Univ, Sch Med, Div Urol, Springfield, IL 62794 USA; [Stanton, Stuart L.] St George Hosp, London SW17 0QT, England	Northwell Health; Southern Illinois University System; Southern Illinois University; St Georges University London	Marinkovic, SP (corresponding author), St Francis Hosp, 5255 Stop 11 Rd, Indianapolis, IN 46259 USA.	urourogyn@yahoo.com						Alagiri M, 1997, UROLOGY, V49, P52, DOI 10.1016/S0090-4295(99)80332-X; Bogart LM, 2007, J UROLOGY, V177, P450, DOI 10.1016/j.juro.2006.09.032; Chancellor MB, 2004, UROLOGY, V63, P85, DOI 10.1016/j.urology.2003.10.034; CLEMENS JQ, 2005, J UROLOGY, V173, P6; Hanno PM, 1999, J UROLOGY, V161, P553, DOI 10.1016/S0022-5347(01)61948-7; Hunner GL, 1915, BOSTON MED SURG J, V172, P660, DOI 10.1056/NEJM191505061721802; Kumar V, 2007, J UROLOGY, V178, P1533, DOI 10.1016/j.juro.2007.05.116; Kushner L, 2006, J UROLOGY, V176, P587, DOI 10.1016/j.juro.2006.03.035; Lukban JC, 2002, UROL CLIN N AM, V29, P649, DOI 10.1016/S0094-0143(02)00055-1; MESSING E M, 1978, Urology, V12, P381, DOI 10.1016/0090-4295(78)90286-8; MOLDWIN RM, 2000, IC SURVIVAL GUIDE; Nickel JC, 2005, UROLOGY, V65, P654, DOI 10.1016/j.urology.2004.10.071; Ottem DP, 2005, UROLOGY, V66, P494, DOI 10.1016/j.urology.2005.04.011; Parsons CL, 2002, UROLOGY, V60, P573, DOI 10.1016/S0090-4295(02)01829-0; Peters KM, 2007, J UROLOGY, V178, P891, DOI 10.1016/j.juro.2007.05.047; Sairanen J, 2004, J UROLOGY, V171, P2138, DOI 10.1097/01.ju.0000125139.91203.7a; Sant G R, 1999, Curr Opin Urol, V9, P297, DOI 10.1097/00042307-199907000-00004; Sant GR, 2003, J UROLOGY, V170, P810, DOI 10.1097/01.ju.0000083020.06212.3d; Sant GR, 2001, UROLOGY, V57, P82, DOI 10.1016/S0090-4295(01)01131-1; Shorter B, 2007, J UROLOGY, V178, P145, DOI 10.1016/j.juro.2007.03.020; Soucy F, 2005, J UROLOGY, V173, P841, DOI 10.1097/01.ju.0000153612.14639.19; Theoharides TC, 1997, UROLOGY, V49, P108, DOI 10.1016/S0090-4295(97)00182-9; van Ophoven A, 2005, UROLOGY, V66, P707, DOI 10.1016/j.urology.2005.04.056; van Ophoven A, 2004, J UROLOGY, V172, P533, DOI 10.1097/01.ju.0000132388.54703.4d; Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99	25	14	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2009	339								b2707	10.1136/bmj.b2707	http://dx.doi.org/10.1136/bmj.b2707			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479PJ	19648180				2022-12-28	WOS:000268673100001
J	Apitz, C; Webb, GD; Redington, AN				Apitz, Christian; Webb, Gary D.; Redington, Andrew N.			Tetralogy of Fallot	LANCET			English	Review							PULMONARY VALVE-REPLACEMENT; VENTRICULAR DIASTOLIC FUNCTION; CONGENITAL HEART-DISEASE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; AORTIC ROOT DILATATION; SUDDEN CARDIAC DEATH; REPAIRED TETRALOGY; RESTRICTIVE PHYSIOLOGY; ADULTS LATE; OUTFLOW TRACT	Tetralogy of Fallot is the most common form of cyanotic congenital heart disease, and one of the first to be successfully repaired by congenital heart surgeons. Since the first procedures in the 1950s, advances in the diagnosis, perioperative and surgical treatment, and postoperative care have been such that almost all those born with tetralogy of Fallot can now expect to survive to adulthood. The startling improvement in outcomes for babies born with congenital heart disease in general-and for those with tetralogy of Fallot in particular-is one of the success stories of modem medicine. Indeed, in many countries adults with tetralogy of Fallot outnumber children. Consequently, new issues have emerged, ranging from hitherto unpredicted medical complications to issues with training for caregivers and resource allocation for this population of survivors. Therefore, evolution of treatment, recognition of late complications, research on disease mechanisms and therapies-with feedback to changes in care of affected children born nowadays-are templates on which the timely discussion of Organisation of care of those affected by congenital heart diseases from the fetus to the elderly can be based. Here, we focus on new developments in the understanding of the causes, diagnosis, early treatment, and late outcomes of tetralogy of Fallot, emphasising the continuum of multidisciplinary care that is necessary for best possible lifelong treatment of the 1% of the population born with congenital heart diseases.	[Apitz, Christian; Redington, Andrew N.] Hosp Sick Children, Div Cardiol, Labatt Family Heart Ctr, Toronto, ON M5G 1X8, Canada; [Webb, Gary D.] Univ Penn, Hosp Univ Penn, Philadelphia Adult Congenital Heart Ctr, Philadelphia, PA 19104 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Pennsylvania; Pennsylvania Medicine	Redington, AN (corresponding author), Hosp Sick Children, Div Cardiol, Labatt Family Heart Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	andrew.redington@sickkids.ca			Deutsche Herzstiftung eV, Frankfurt, Germany	Deutsche Herzstiftung eV, Frankfurt, Germany	CA is supported by a research scholarship of Deutsche Herzstiftung eV, Frankfurt, Germany.	ANDERSEN HR, 1992, EUR HEART J, V13, P704, DOI 10.1093/oxfordjournals.eurheartj.a060238; Balaji S, 1997, AM J CARDIOL, V80, P160, DOI 10.1016/S0002-9149(97)00311-1; Bassett Anne S, 2008, Curr Psychiatry Rep, V10, P148; Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; BERTRANOU EG, 1978, AM J CARDIOL, V42, P458, DOI 10.1016/0002-9149(78)90941-4; Berul CI, 1997, J CARDIOVASC ELECTR, V8, P1349, DOI 10.1111/j.1540-8167.1997.tb01031.x; Bleeker GB, 2006, HEART, V92, pI19, DOI 10.1136/hrt.2005.082503; Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0; Bonhoeffer P, 2000, CIRCULATION, V102, P813, DOI 10.1161/01.CIR.102.7.813; Bonhoeffer P, 2002, J AM COLL CARDIOL, V39, P1664, DOI 10.1016/S0735-1097(02)01822-3; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Brookes C, 1999, CIRCULATION, V100, P761, DOI 10.1161/01.CIR.100.7.761; Buechel ERV, 2005, EUR HEART J, V26, P2721, DOI 10.1093/eurheartj/ehi581; CARVALHO JS, 1992, BRIT HEART J, V67, P470; Cava JR, 2004, PEDIATR CLIN N AM, V51, P1401, DOI 10.1016/j.pcl.2004.04.004; Chaturvedi RR, 1997, CIRCULATION, V95, P643, DOI 10.1161/01.CIR.95.3.643; Chaturvedi RR, 1999, CIRCULATION, V100, P1540, DOI 10.1161/01.CIR.100.14.1540; Choi JY, 2008, INT J CARDIOL, V125, P28, DOI 10.1016/j.ijcard.2007.02.020; Chong WY, 2006, AM J CARDIOL, V97, P905, DOI 10.1016/j.amjcard.2005.09.141; Chowdhury UK, 2006, J THORAC CARDIOV SUR, V132, P270, DOI 10.1016/j.jtcvs.2006.04.001; Coutu M, 2004, ANN THORAC SURG, V77, P1454, DOI 10.1016/S0003-4975(03)01001-4; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; CULLEN S, 1995, CIRCULATION, V91, P1782, DOI 10.1161/01.CIR.91.6.1782; Cusimano RJ, 1996, CAN J CARDIOL, V12, P172; D'Andrea A, 2004, Eur J Echocardiogr, V5, P123, DOI 10.1016/S1525-2167(03)00053-2; DAMIANO RJ, 1991, AM J PHYSIOL, V261, pH1514, DOI 10.1152/ajpheart.1991.261.5.H1514; Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4; Deanfield J, 2003, EUR HEART J, V24, P1035, DOI 10.1016/S0195-668X(03)00131-3; Dohlen G, 2009, HEART, V95, P142, DOI 10.1136/hrt.2007.135723; Dubin AM, 2003, CIRCULATION, V107, P2287, DOI 10.1161/01.CIR.0000070930.33499.9F; Eroglu AG, 1999, CARDIOL YOUNG, V9, P384; Eyskens B, 2000, AM J CARDIOL, V85, P221, DOI 10.1016/S0002-9149(99)00640-2; FALLINER A, 1981, Z KARDIOL, V70, P754; Fitzgerald DA, 2007, PAEDIATR RESPIR REV, V8, P313, DOI 10.1016/j.prrv.2007.08.006; Frigiola A, 2008, CIRCULATION, V118, pS182, DOI 10.1161/CIRCULATIONAHA.107.756825; Garay F, 2006, CATHETER CARDIO INTE, V67, P659, DOI 10.1002/ccd.20753; Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8; GATZOULIS MA, 1995, CIRCULATION, V92, P231, DOI 10.1161/01.CIR.92.2.231; GATZOULIS MA, 1995, CIRCULATION, V91, P1775, DOI 10.1161/01.CIR.91.6.1775; Gatzoulis MA, 1997, CIRCULATION, V95, P401; Ghai A, 2002, J AM COLL CARDIOL, V40, P1675, DOI 10.1016/S0735-1097(02)02344-6; Gioli-Pereira L, 2008, INT J CARDIOL, V126, P374, DOI 10.1016/j.ijcard.2007.04.043; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; GRAHAM TP, 1982, AM J CARDIOL, V50, P612, DOI 10.1016/0002-9149(82)90330-7; Harrild DM, 2009, CIRCULATION, V119, P445, DOI 10.1161/CIRCULATIONAHA.108.775221; Harrison DA, 1997, J AM COLL CARDIOL, V30, P1368, DOI 10.1016/S0735-1097(97)00316-1; Harrison DA, 2001, AM J CARDIOL, V87, P584, DOI 10.1016/S0002-9149(00)01435-1; Helbing WA, 1996, J AM COLL CARDIOL, V28, P1827, DOI 10.1016/S0735-1097(96)00387-7; HOFFMAN D, 1994, J THORAC CARDIOV SUR, V107, P1496, DOI 10.1016/S0022-5223(12)70150-2; HUNTER W, 1784, MED OBSERVATIONS INQ, P417; Karamlou T, 2006, ANN THORAC SURG, V81, P1786, DOI 10.1016/j.athoracsur.2005.12.039; Karamlou T, 2008, CIRCULATION, V118, P2345, DOI 10.1161/CIRCULATIONAHA.108.776963; KARL TR, 1992, ANN THORAC SURG, V54, P903, DOI 10.1016/0003-4975(92)90646-L; Khairy P, 2006, CIRCULATION, V113, P517, DOI 10.1161/CIRCULATIONAHA.105.589655; Khairy P, 2008, CIRCULATION, V117, P363, DOI 10.1161/CIRCULATIONAHA.107.726372; Khambadkone S, 2005, CIRCULATION, V112, P1189, DOI 10.1161/CIRCULATIONAHA.104.523266; Khambadkone Sachin, 2006, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P23; KIRKLIN JW, 1984, THORAC CARDIOV SURG, V32, P208, DOI 10.1055/s-2007-1023386; Kirsh JA, 2006, CIRCULATION, V113, pE691, DOI 10.1161/CIRCULATIONAHA.105.580126; LILLEHEI CW, 1955, ANN SURG, V142, P418, DOI 10.1097/00000658-195509000-00010; Lurz P, 2008, CIRCULATION, V117, P1964, DOI 10.1161/CIRCULATIONAHA.107.735779; Michielon G, 2006, ANN THORAC SURG, V81, P968, DOI 10.1016/j.athoracsur.2005.09.033; Munkhammar P, 1998, J AM COLL CARDIOL, V32, P1083, DOI 10.1016/S0735-1097(98)00351-9; Niwa K, 2005, INT J CARDIOL, V103, P117, DOI 10.1016/j.ijcard.2004.07.002; Niwa K, 2002, CIRCULATION, V106, P1374, DOI 10.1161/01.CIR.0000028462.88597.AD; Nordmeyer J, 2008, EUR HEART J, V29, P810, DOI 10.1093/eurheartj/ehn073; Nordmeyer J, 2007, CIRCULATION, V115, P1392, DOI 10.1161/CIRCULATIONAHA.106.674259; Norgard G, 1996, CIRCULATION, V94, P3276, DOI 10.1161/01.CIR.94.12.3276; Norgard G, 1998, HEART, V79, P481, DOI 10.1136/hrt.79.5.481; Oosterhof T, 2007, CIRCULATION, V116, P545, DOI 10.1161/CIRCULATIONAHA.106.659664; REDINGTON AN, 1988, BRIT HEART J, V60, P57; ROOSHESSELINK J, 1995, CIRCULATION, V91, P2214, DOI 10.1161/01.CIR.91.8.2214; Sachdev MS, 2006, PEDIATR CARDIOL, V27, P250, DOI 10.1007/s00246-005-1186-y; SHIMAZAKI Y, 1984, THORAC CARDIOV SURG, V32, P257, DOI 10.1055/s-2007-1023399; Shinebourne EA., 2002, PAEDIAT CARDIOLOGY, P1213; Skorton DJ, 2001, J AM COLL CARDIOL, V37, P1193, DOI 10.1016/S0735-1097(01)01274-8; Sommer RJ, 2008, CIRCULATION, V117, P1340, DOI 10.1161/CIRCULATIONAHA.107.714428; STENSEN N, 1671, ACTA MED PHILOS HAFN, V1, P202; Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X; Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037; Therrien J, 2001, CIRCULATION, V103, P2489; Uebing A, 2006, BMJ-BRIT MED J, V332, P401, DOI 10.1136/bmj.332.7538.401; Uebing A, 2010, INT J CARDIOL, V139, P50, DOI 10.1016/j.ijcard.2008.09.001; Van Arsdell Glen, 2005, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P128; Van Arsdell GS, 2000, CIRCULATION, V102, P123; van den Berg J, 2007, RADIOLOGY, V243, P212, DOI 10.1148/radiol.2431060213; Veldtman GR, 2004, J AM COLL CARDIOL, V44, P174, DOI 10.1016/j.jacc.2003.11.067; Warner KG, 2003, ANN THORAC SURG, V76, P1066, DOI 10.1016/S0003-4975(03)00748-3; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]; Webb CL, 2002, CIRCULATION, V105, P2318, DOI 10.1161/01.CIR.0000017557.24261.A7; Webber SA, 1996, J PEDIATR-US, V129, P26, DOI 10.1016/S0022-3476(96)70186-5; WESSEL HU, 1980, J THORAC CARDIOV SUR, V80, P582; Yap SC, 2007, EUR HEART J, V28, P1854, DOI 10.1093/eurheartj/ehl306; Zeltser I, 2008, J THORAC CARDIOV SUR, V135, P91, DOI 10.1016/j.jtcvs.2007.04.074	94	307	326	5	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2009	374	9699					1462	1471		10.1016/S0140-6736(09)60657-7	http://dx.doi.org/10.1016/S0140-6736(09)60657-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MZ	19683809				2022-12-28	WOS:000271255000035
J	Cowling, BJ; Chan, KH; Fang, VJ; Cheng, CKY; Fung, ROP; Wai, W; Sin, J; Seto, WH; Yung, R; Chu, DWS; Chiu, BCF; Lee, PWY; Chiu, MC; Lee, HC; Uyeki, TM; Houck, PM; Peiris, JSM; Leung, GM				Cowling, Benjamin J.; Chan, Kwok-Hung; Fang, Vicky J.; Cheng, Calvin K. Y.; Fung, Rita O. P.; Wai, Winnie; Sin, Joey; Seto, Wing Hong; Yung, Raymond; Chu, Daniel W. S.; Chiu, Billy C. F.; Lee, Paco W. Y.; Chiu, Ming Chi; Lee, Hoi Che; Uyeki, Timothy M.; Houck, Peter M.; Peiris, J. S. Malik; Leung, Gabriel M.			Facemasks and Hand Hygiene to Prevent Influenza Transmission in Households A Cluster Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PUBLIC-HEALTH INTERVENTIONS; NONPHARMACEUTICAL INTERVENTIONS; PANDEMIC INFLUENZA; RESPIRATORY VIRUSES; DISEASE; CHILDREN; PROPHYLAXIS; REDUCE; IMPACT; SWABS	Background: Few data are available about the effectiveness of nonpharmaceutical interventions for preventing influenza virus transmission. Objective: To investigate whether hand hygiene and use of facemasks prevents household transmission of influenza. Design: Cluster randomized, controlled trial. Randomization was computer generated; allocation was concealed from treating physicians and clinics and implemented by study nurses at the time of the initial household visit. Participants and personnel administering the interventions were not blinded to group assignment. (Clinical-Trials.gov registration number: NCT00425893) Setting: Households in Hong Kong. Patients: 407 people presenting to outpatient clinics with influenza-like illness who were positive for influenza A or B virus by rapid testing (index patients) and 794 household members (contacts) in 259 households. Intervention: Lifestyle education (control) (134 households), hand hygiene (136 households), or surgical facemasks plus hand hygiene (137 households) for all household members. Measurements: Influenza virus infection in contacts, as confirmed by reverse-transcription polymerase chain reaction (RT-PCR) or diagnosed clinically after 7 days. Results: Sixty (8%) contacts in the 259 households had RT-PCR-confirmed influenza virus infection in the 7 days after intervention. Hand hygiene with or without facemasks seemed to reduce influenza transmission, but the differences compared with the control group were not significant. In 154 households in which interventions were implemented within 36 hours of symptom onset in the index patient, transmission of RT-PCR-confirmed infection seemed reduced, an effect attributable to fewer infections among participants using facemasks plus hand hygiene (adjusted odds ratio, 0.33 [95% CI, 0.13 to 0.87]). Adherence to interventions varied. Limitation: The delay from index patient symptom onset to intervention and variable adherence may have mitigated intervention effectiveness. Conclusion: Hand hygiene and facemasks seemed to prevent household transmission of influenza virus when implemented within 36 hours of index patient symptom onset. These findings suggest that nonpharmaceutical interventions are important for mitigation of pandemic and interpandemic influenza.	[Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Cowling, BJ (corresponding author), Univ Hong Kong, Sch Publ Hlth, Units 624-7,Core F,Cyberport 3, Pokfulam, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009; Chan, Kwok Hung/ABD-5399-2021; Peiris, Joseph Sriyal Malik/C-4380-2009	Cowling, Benjamin John/0000-0002-6297-7154; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Leung, Gabriel/0000-0002-2503-6283; Seto, Wing Hong/0000-0002-1139-9200	Centers for Disease Control and Prevention, Atlanta, Georgia [1 U01 CI000439-02]; The Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong [08070632]; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000439] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention, Atlanta, Georgia(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); The Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong; Area of Excellence Scheme of the Hong Kong University Grants Committee; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	By the Centers for Disease Control and Prevention, Atlanta, Georgia (grant 1 U01 CI000439-02). The Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR (grant 08070632); and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant AoE/M-12/06).	Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208; Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; DONNER A, 2000, DESIGN ANAL CLUSTER, P90; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Luby SP, 2006, TROP MED INT HEALTH, V11, P479, DOI 10.1111/j.1365-3156.2006.01592.x; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Monto AS, 1999, PHARMACOECONOMICS, V16, P1, DOI 10.2165/00019053-199916001-00001; Oshitani H, 2008, EMERG INFECT DIS, V14, P875, DOI 10.3201/eid1406.070839; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Sandora TJ, 2005, PEDIATRICS, V116, P587, DOI 10.1542/peds.2005-0199; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Viboud C, 2004, BRIT J GEN PRACT, V54, P684	33	374	382	0	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2009	151	7					437	W144		10.7326/0003-4819-151-7-200910060-00142	http://dx.doi.org/10.7326/0003-4819-151-7-200910060-00142			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502OT	19652172				2022-12-28	WOS:000270470500001
J	Home, JP; Hanneke, D; Jost, JD; Amini, JM; Leibfried, D; Wineland, DJ				Home, Jonathan P.; Hanneke, David; Jost, John D.; Amini, Jason M.; Leibfried, Dietrich; Wineland, David J.			Complete Methods Set for Scalable Ion Trap Quantum Information Processing	SCIENCE			English	Article							ATOMIC IONS; TELEPORTATION; MANIPULATION; COMPUTATION; COMPUTER; GATES	Large-scale quantum information processors must be able to transport and maintain quantum information and repeatedly perform logical operations. Here, we show a combination of all of the fundamental elements required to perform scalable quantum computing through the use of qubits stored in the internal states of trapped atomic ions. We quantified the repeatability of a multiple-qubit operation and observed no loss of performance despite qubit transport over macroscopic distances. Key to these results is the use of different pairs of Be-9(+) hyperfine states for robust qubit storage, readout, and gates, and simultaneous trapping of Mg-24(+) "re-cooling" ions along with the qubit ions.	[Home, Jonathan P.; Hanneke, David; Jost, John D.; Amini, Jason M.; Leibfried, Dietrich; Wineland, David J.] Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Home, JP (corresponding author), Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA.	jonathan.home@gmail.com	Hanneke, David/E-6941-2011; Jost, John D/F-4701-2010	Hanneke, David/0000-0001-9278-7231; jost, john/0000-0002-1698-8602; Home, Jonathan/0000-0002-4093-1550	Intelligence Advanced Research Projects Activity; NIST Quantum Information Program; Lindemann Trust Fellowship	Intelligence Advanced Research Projects Activity; NIST Quantum Information Program; Lindemann Trust Fellowship	This work was supported by Intelligence Advanced Research Projects Activity and the NIST Quantum Information Program. J. P. H. acknowledges support from a Lindemann Trust Fellowship. We thank E. Knill for helpful discussions, J. J. Bollinger for technical assistance, and Y. Colombe for comments on the manuscript. This paper is a contribution by NIST and not subject to U. S. copyright.	BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; Blakestad RB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.153002; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Blinov BB, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.040304; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Hradil Z, 2004, LECT NOTES PHYS, V649, P59; Jost JD, 2009, NATURE, V459, P683, DOI 10.1038/nature08006; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Kirchmair G, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.020304; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; LUNDBLAD N, 2009, ARXIV09023213; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Ozeri R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042329; Riebe M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220407; Rohde H, 2001, J OPT B-QUANTUM S O, V3, pS34, DOI 10.1088/1464-4266/3/1/357; Steane AM, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.042322; Steane AM, 2007, QUANTUM INF COMPUT, V7, P171	28	200	204	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1227	1230		10.1126/science.1177077	http://dx.doi.org/10.1126/science.1177077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19661380	Green Submitted			2022-12-28	WOS:000269523200032
J	Kessler, D; Lewis, G; Kaur, S; Wiles, N; King, M; Weich, S; Sharp, DJ; Araya, R; Hollinghurst, S; Peters, TJ				Kessler, David; Lewis, Glyn; Kaur, Surinder; Wiles, Nicola; King, Michael; Weich, Scott; Sharp, Debbie J.; Araya, Ricardo; Hollinghurst, Sandra; Peters, Tim J.			Therapist-delivered internet psychotherapy for depression in primary care: a randomised controlled trial	LANCET			English	Article							COGNITIVE-BEHAVIORAL THERAPY; CLINICAL-TRIALS; BENEFITS; DISORDER	Background Despite strong evidence for its effectiveness, cognitive-behavioural therapy (CBT) remains difficult to access. Computerised programs have been developed to improve accessibility, but whether these interventions are responsive to individual needs is unknown. We investigated the effectiveness of CBT delivered online in real time by a therapist for patients with depression in primary care. Methods in this multicentre, randomised controlled trial, 297 individuals with a score of 14 or more on the Beck depression inventory (BDI) and a confirmed diagnosis of depression were recruited from 55 general practices in Bristol, London, and Warwickshire, UK. Participants were randomly assigned, by a computer-generated code, to online CRT in addition to usual care (intervention; n=149) or to usual care from their general practitioner while on an 8-month waiting list for online CBT (control; n=148). Participants, researchers involved in recruitment, and therapists were masked in advance to allocation. The primary outcome was recovery from depression (BDI score <10) at 4 months. Analysis was by intention to treat. This trial is registered, number ISRCTN 45444578. Findings 113 participants in the intervention group and 97 in the control group completed 4-month follow-up. 43 (38%) patients recovered from depression (BDI score <10) in the intervention group versus 23 (24%) in the control group at 4 months (odds ratio 2.39, 95% CI 1.23-4.67; p=0.011), and 46 (42%) versus 26 (26%) at 8 months (2.07,1.11-3.87; p=0.023). Interpretation CBT seems to be effective when delivered online in real time by a therapist, with benefits maintained over 8 months. This method of delivery could broaden access to CBT.	[Kessler, David; Kaur, Surinder; Sharp, Debbie J.; Hollinghurst, Sandra; Peters, Tim J.] Univ Bristol, Acad Unit Primary Hlth Care, NIHR Natl Sch Primary Care Res, Dept Community Based Med, Bristol BS8 2AA, Avon, England; [Lewis, Glyn; Wiles, Nicola; Araya, Ricardo] Univ Bristol, Dept Community Based Med, Acad Unit Psychiat, Bristol BS8 2AA, Avon, England; [King, Michael] Dept Mental Hlth Sci, London, England; [Weich, Scott] Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England	University of Bristol; University of Bristol; University of London; University College London; University of Warwick	Kessler, D (corresponding author), Univ Bristol, Acad Unit Primary Hlth Care, NIHR Natl Sch Primary Care Res, Dept Community Based Med, 25 Belgrave Rd, Bristol BS8 2AA, Avon, England.	david.kessler@bristol.ac.uk	Kessler, david/ABB-6489-2021; Burls, Amanda J.E./D-7641-2011; King, Michael B/D-7477-2011; Lewis, Glyn/E-9944-2012; Araya, Ricardo/S-3144-2019	King, Michael B/0000-0003-4715-7171; Lewis, Glyn/0000-0001-5205-8245; Araya, Ricardo/0000-0002-0420-5148; Weich, Scott/0000-0002-7552-7697; Peters, Tim/0000-0003-2881-4180; sharp, deborah/0000-0003-3071-9860; Wiles, Nicola/0000-0002-5250-3553	BUPA Foundation; MRC [G0800800] Funding Source: UKRI; Medical Research Council [G0800800] Funding Source: researchfish	BUPA Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the BUPA Foundation. We thank all the practices and study participants; Harbinder Sandhu and Nick Green for assistance with data collection; and Nadine Field and Sue Wright from PsychologyOnline for facilitating the involvement of this organisation in the trial.	Beattie A, 2009, HEALTH EXPECT, V12, P45, DOI 10.1111/j.1369-7625.2008.00531.x; Beck A.T., 1987, MANUAL BECK DEPRESSI; Blackburn IM, 2001, BEHAV COGN PSYCHOTH, V29, P431, DOI 10.1017/S1352465801004040; Christensen H, 2006, PSYCHOL MED, V36, P1737, DOI 10.1017/S0033291706008695; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Churchill R, 2001, Health Technol Assess, V5, P1; Department of Health, IMPR ACC PSYCH THER; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Dunn G, 2005, STAT METHODS MED RES, V14, P369, DOI 10.1191/0962280205sm403oa; Hollinghurst S, 2005, BRIT MED J, V330, P999, DOI 10.1136/bmj.38377.715799.F7; Jenkinson C, 1997, J Health Serv Res Policy, V2, P14; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; *MED HEALTHC PROD, SEL SER REUPT INH SS; Pennebaker JW, 1999, J CLIN PSYCHOL, V55, P1243, DOI 10.1002/(SICI)1097-4679(199910)55:10<1243::AID-JCLP6>3.0.CO;2-N; Proudfoot J, 2004, BRIT J PSYCHIAT, V185, P46, DOI 10.1192/bjp.185.1.46; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; TAYLOR EB, 1989, COGNITIVE THER RES, V13, P1, DOI 10.1007/BF01178485; Teasdale JD, 2002, J CONSULT CLIN PSYCH, V70, P275, DOI 10.1037//0022-006X.70.2.275; VANSCHAIK DJF, 2002, TIJDSCHR PSYCHIAT, V44, P609; Ward E, 2000, BRIT MED J, V321, P1383, DOI 10.1136/bmj.321.7273.1383; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn	26	244	250	0	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2009	374	9690					628	634		10.1016/S0140-6736(09)61257-5	http://dx.doi.org/10.1016/S0140-6736(09)61257-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19700005				2022-12-28	WOS:000269222600023
J	Cyranoski, D				Cyranoski, David			Japan election sparks science pledges	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					938	938		10.1038/460938a	http://dx.doi.org/10.1038/460938a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693049	Bronze			2022-12-28	WOS:000269085500005
J	Suzuki, T; Hasan, Z; Funahashi, Y; Yamaguchi, T; Fujishiro, Y; Awano, M				Suzuki, Toshio; Hasan, Zahir; Funahashi, Yoshihiro; Yamaguchi, Toshiaki; Fujishiro, Yoshinobu; Awano, Masanobu			Impact of Anode Microstructure on Solid Oxide Fuel Cells	SCIENCE			English	Article							ELECTROLYTES; PERFORMANCE; FABRICATION; DESIGN; SOFCS; STACK; FILM	We report a correlation between the microstructure of the anode electrode of a solid oxide fuel cell (SOFC) and its electrochemical performance for a tubular design. It was shown that the electrochemical performance of the cell was extensively improved when the size of constituent particles was reduced so as to yield a highly porous microstructure. The SOFC had a power density of greater than 1 watt per square centimeter at an operating temperature as low as 600 degrees C with a conventional zirconia-based electrolyte, a nickel cermet anode, and a lanthanum ferrite perovskite cathode material. The effect of the hydrogen fuel flow rate (linear velocity) was also examined for the optimization of operating conditions. Higher linear fuel velocity led to better cell performance for the cell with higher anode porosity. A zirconia-based cell could be used for a low-temperature SOFC system under 600 degrees C just by optimizing the microstructure of the anode electrode and operating conditions.	[Suzuki, Toshio; Hasan, Zahir; Yamaguchi, Toshiaki; Fujishiro, Yoshinobu; Awano, Masanobu] Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Nagoya, Aichi 4638560, Japan; [Funahashi, Yoshihiro] Fine Ceram Res Assoc, Nagoya, Aichi 4638560, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Fine Ceramics Center	Suzuki, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Nagoya, Aichi 4638560, Japan.	toshio.suzuki@aist.go.jp	Yamaguchi, Toshiaki/H-1796-2018; Fujishiro, Yoshinobu/K-2224-2016; Zahir, Hasan/C-6167-2013	Yamaguchi, Toshiaki/0000-0002-0022-9214; Fujishiro, Yoshinobu/0000-0002-8570-6517; Zahir, Hasan/0000-0002-6752-9318	New Energy and Industrial Technology Development Organization	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the New Energy and Industrial Technology Development Organization as part of the Advanced Ceramic Reactor Project. The authors have submitted a patent related to low-temperature-operable microtubular SOFCs.	Chan SH, 2001, J POWER SOURCES, V93, P130, DOI 10.1016/S0378-7753(00)00556-5; deSouza S, 1997, J ELECTROCHEM SOC, V144, pL35, DOI 10.1149/1.1837484; EGUCHI K, 1992, SOLID STATE IONICS, V52, P165, DOI 10.1016/0167-2738(92)90102-U; Gunji A, 2004, J POWER SOURCES, V131, P285, DOI 10.1016/j.jpowsour.2003.11.086; Hibino T, 2002, ELECTROCHEM SOLID ST, V5, pA242, DOI 10.1149/1.1508551; Huang H, 2007, J ELECTROCHEM SOC, V154, pB20, DOI 10.1149/1.2372592; Kendall K, 1998, J POWER SOURCES, V71, P268, DOI 10.1016/S0378-7753(97)02761-4; Leah RT, 2005, J POWER SOURCES, V145, P336, DOI 10.1016/j.jpowsour.2004.12.067; Lehnert W, 2000, J POWER SOURCES, V87, P57, DOI 10.1016/S0378-7753(99)00356-0; MINH NQ, 1993, J AM CERAM SOC, V76, P563, DOI 10.1111/j.1151-2916.1993.tb03645.x; Sammes NM, 2005, J POWER SOURCES, V145, P428, DOI 10.1016/j.jpowsour.2005.01.079; Shao ZP, 2004, NATURE, V431, P170, DOI 10.1038/nature02863; Simner SP, 2002, ELECTROCHEM SOLID ST, V5, pA173, DOI 10.1149/1.1483156; Singhal SC, 2002, SOLID STATE IONICS, V152, P405, DOI 10.1016/S0167-2738(02)00349-1; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Suzuki T, 2007, J POWER SOURCES, V171, P92, DOI 10.1016/j.jpowsour.2007.01.003; Suzuki T, 2007, ELECTROCHEM SOLID ST, V10, pA177, DOI 10.1149/1.2739211; Tao SW, 2003, NAT MATER, V2, P320, DOI 10.1038/nmat871; Wachsman ED, 2002, SOLID STATE IONICS, V152, P657, DOI 10.1016/S0167-2738(02)00405-8; Wang ZW, 2005, MATER LETT, V59, P2579, DOI 10.1016/j.matlet.2004.07.065; Yamamoto O, 2000, ELECTROCHIM ACTA, V45, P2423, DOI 10.1016/S0013-4686(00)00330-3; Yan JW, 2005, ELECTROCHEM SOLID ST, V8, pA389, DOI 10.1149/1.1943568; Yashiro K, 2002, ELECTROCHEMISTRY, V70, P958, DOI 10.5796/electrochemistry.70.958; Yokokawa H, 2005, MRS BULL, V30, P591, DOI 10.1557/mrs2005.166	24	397	406	10	462	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					852	855		10.1126/science.1176404	http://dx.doi.org/10.1126/science.1176404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679808				2022-12-28	WOS:000269242400040
J	Pool, E; Preston, H; van der Loeff, IV				Pool, Erica; Preston, Helen; van der Loeff, Ina van Schim			Health care for refused asylum seekers: evidence over ideology	LANCET			English	Editorial Material									[Pool, Erica] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [Preston, Helen] Univ Manchester, Sch Med, Manchester, Lancs, England; [van der Loeff, Ina van Schim] UCL, Sch Med, London W1N 8AA, England	University of Leeds; University of Manchester; University of London; University College London; UCL Medical School	Pool, E (corresponding author), Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England.	erica.r.m.pool@googlemail.com		Pool, Erica/0000-0001-8086-7285; Schim van der Loeff, Ina/0000-0003-1196-6196				Bevan A, 1952, PLACE FEAR FREE HLTH; *DEP HLTH, 2007, PROP EXCL OV VIS EL; FAY S, 2007, COMMUNICATION   1002; *GLOB HLTH ADV PRO, 2009, 4 YEARS LAT CHARG VU; *GLOB HLTH ADV PRO, 2008, PROP EXCL OV VIS EL; JOHNSON M, 2005, EVIDENCE 3 REPORT HL; *REF ACT, DEP HLTH CONS PROP E	7	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 8	2009	374	9688					437	438		10.1016/S0140-6736(09)61435-5	http://dx.doi.org/10.1016/S0140-6736(09)61435-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482OK	19665633				2022-12-28	WOS:000268898400009
J	Dinarina, A; Pugieux, C; Corral, MM; Loose, M; Spatz, J; Karsenti, E; Nedelec, F				Dinarina, Ana; Pugieux, Celine; Corral, Maria Mora; Loose, Martin; Spatz, Joachim; Karsenti, Eric; Nedelec, Francois			Chromatin Shapes the Mitotic Spindle	CELL			English	Article							XENOPUS EGG EXTRACTS; POLYMERIZATION DYNAMICS; CHROMOSOME ALIGNMENT; SELF-ORGANIZATION; MICROTUBULE FLUX; IN-VITRO; CENTROSOME; METAPHASE; PROTEIN; CYCLIN	In animal and plant cells, mitotic chromatin locally generates microtubules that self-organize into a mitotic spindle, and its dimensions and bipolar symmetry are essential for accurate chromosome segregation. By immobilizing microscopic chromatin-coated beads on slide surfaces using a microprinting technique, we have examined the effect of chromatin on the dimensions and symmetry of spindles in Xenopus laevis cytoplasmic extracts. While circular spots with diameters around 14-18 mu m trigger bipolar spindle formation, larger spots generate an incorrect number of poles. We also examined lines of chromatin with various dimensions. Their length determined the number of poles that formed, with a 6 x 18 mu m rectangular patch generating normal spindle morphology. Around longer lines, multiple poles formed and the structures were disorganized. While lines thinner than 10 mu m generated symmetric structures, thicker lines induced the formation of asymmetric structures where all microtubules are on the same side of the line. Our results show that chromatin defines spindle shape and orientation. For a video summary of this article, see the Paper-Flick file available with the online Supplemental Data.	[Dinarina, Ana; Pugieux, Celine; Corral, Maria Mora; Loose, Martin; Karsenti, Eric; Nedelec, Francois] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Spatz, Joachim] Univ Heidelberg, Dept Biophys Chem, D-69120 Heidelberg, Germany; [Spatz, Joachim] MPI Met Res, D-70569 Stuttgart, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Nedelec, F (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	nedelec@embl.de	Nedelec, Francois/AAC-1673-2019; Spatz, Joachim P/A-1107-2017; Nedelec, Francois J/H-3317-2011	Nedelec, Francois/0000-0002-8141-5288; Spatz, Joachim P/0000-0003-3419-9807; Nedelec, Francois J/0000-0002-8141-5288; Loose, Martin/0000-0001-7309-9724	EU [LSHG-CT-2004-503568]; Spanish ministry of education; EU-STREP active BioMics; Center for Modeling and Simulation in the Biosciences; Volkswagenstiftung, and Human Frontier Science Program [RGY84]	EU(European Commission); Spanish ministry of education(Spanish Government); EU-STREP active BioMics; Center for Modeling and Simulation in the Biosciences; Volkswagenstiftung, and Human Frontier Science Program(Volkswagen)	A. D. and C. P. performed the experiments. M. M. C. established the chromatin patterning technique. M. L. developed the microfluidic chambers. M. M. C. obtained the initial results with M. L. J. S. and colleagues advised with microfabrication and offered access to the necessary facilities. E. K. contributed expertise with X. laevis egg extracts and bead assays and helped supervise the project. F. N. wrote the Matlab functions and analyzed the results with A. D. and C. P. He conceived and directed the research. F. N., A. D., and C. P. wrote the article with help from E. K. and M. L.; We thank C. Roduit, M. Kaksonen, R. Loughlin, T. Surrey, and J. Ward for critically reading the manuscript and Z. Gueroui for discussions. We used the Advanced Light Microscopy Facility and the animal facility at the European Molecular Biology Laboratory. We thank K. Crnokic, M. Caudron, S. Kandels-Lewis, S. Ruf ( egg extracts), J. Ulmer and A. Lindner (microcontact printing), A. Wunsche ( image acquisition), S. Laffont, M. Etzrodt, and N. Charuttini for help with the assay development. This work was supported by EU contract LSHG-CT-2004-503568 ComBio, the Spanish ministry of education ( M. M. C.), and EU-STREP active BioMics ( A. D.). Research in the Nedelec lab is funded by the Center for Modeling and Simulation in the Biosciences (http://www.bioms.de), the Volkswagenstiftung, and Human Frontier Science Program grant RGY84.	Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Athale CA, 2008, SCIENCE, V322, P1243, DOI 10.1126/science.1161820; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Bornens M, 2007, ADV EXP MED BIOL, V607, P119; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Burbank KS, 2007, CURR BIOL, V17, P1373, DOI 10.1016/j.cub.2007.07.058; Clausen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000244; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Gaetz J, 2006, NAT CELL BIOL, V8, P924, DOI 10.1038/ncb1455; Gatlin JC, 2009, CURR BIOL, V19, P287, DOI 10.1016/j.cub.2009.01.055; Gehmlich K, 2004, EMBO REP, V5, P97, DOI 10.1038/sj.embor.7400046; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; KARSENTI E, 1984, J CELL BIOL, V99, pS47, DOI 10.1083/jcb.99.1.47s; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Lloyd C, 2006, NAT REV MOL CELL BIO, V7, P147, DOI 10.1038/nrm1831; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Maresca Thomas J., 2006, V322, P459; Matthies HJG, 1996, J CELL BIOL, V134, P455, DOI 10.1083/jcb.134.2.455; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; THIEBAUD CH, 1977, CHROMOSOMA, V59, P253, DOI 10.1007/BF00292781; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092	41	69	69	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					502	513		10.1016/j.cell.2009.05.027	http://dx.doi.org/10.1016/j.cell.2009.05.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665972	Bronze			2022-12-28	WOS:000268771900015
J	Coutsoudis, A; Coovadia, HM; King, J				Coutsoudis, Anna; Coovadia, Hoosen M.; King, Judith			The breastmilk brand: promotion of child survival in the face of formula-milk marketing	LANCET			English	Editorial Material									[Coutsoudis, Anna] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Nelson R Mandela Sch Med, ZA-4013 Congella, South Africa; [Coovadia, Hoosen M.] Univ KwaZulu Natal, Victor Daitz Unit HIV AIDS Res, ZA-4013 Congella, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Coutsoudis, A (corresponding author), Univ KwaZulu Natal, Dept Paediat & Child Hlth, Nelson R Mandela Sch Med, DDMRI Bldg,Private Bag 7, ZA-4013 Congella, South Africa.	coutsoud@ukzn.ac.za						ALLAIN A, 2006, STATE CODE COUNTRY; BRANCO HC, 1990, DEV COMMUN REP, V71, P7; Gottschang SK, 2000, FEEDING CHINA'S LITTLE EMPERORS, P160; Hoddinott P, 2008, BMJ-BRIT MED J, V336, P881, DOI 10.1136/bmj.39521.566296.BE; *IBFAN, REP; Ingelfinger JR, 2008, NEW ENGL J MED, V359, P2745, DOI 10.1056/NEJMp0808410; *INT LAB ORG IC183, 2000, MAT PROT CONV; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KAUFMANN M, 2007, WASHINGTON POST 0831; Loewenberg S, 2008, LANCET, V372, P1209, DOI 10.1016/S0140-6736(08)61502-0; Xu FL, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-22; 2007, LOOK WHAT THEY RE DO; 2004, CHINA DAILY     0521	13	18	18	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 1	2009	374	9687					423	425		10.1016/S0140-6736(09)60661-9	http://dx.doi.org/10.1016/S0140-6736(09)60661-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481MJ	19647609				2022-12-28	WOS:000268815200027
J	Otterstrom, JJ; van Oijen, AM				Otterstrom, Jason J.; van Oijen, Antoine M.			Nudging Through a Nucleosome	SCIENCE			English	Editorial Material							RNA-POLYMERASE-II; TRANSCRIPTION		[Otterstrom, Jason J.; van Oijen, Antoine M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Otterstrom, JJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	antoine_van_oijen@hms.harvard.edu	van Oijen, Antoine/I-3167-2014; Otterstrom, Jason J/H-3356-2015	van Oijen, Antoine/0000-0002-1794-5161; Otterstrom, Jason J/0000-0002-0176-9976	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077248] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077248, R01 GM077248-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Depken M, 2009, BIOPHYS J, V96, P2189, DOI 10.1016/j.bpj.2008.12.3918; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	9	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					547	548		10.1126/science.1177311	http://dx.doi.org/10.1126/science.1177311			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644099	Green Submitted			2022-12-28	WOS:000268493000027
J	Gonzales, EB; Kawate, T; Gouaux, E				Gonzales, Eric B.; Kawate, Toshimitsu; Gouaux, Eric			Pore architecture and ion sites in acid-sensing ion channels and P2X receptors	NATURE			English	Article							STRUCTURAL MOTIF; SODIUM; SELECTIVITY; NEURODEGENERATION; MUTATION; DESENSITIZATION; IDENTIFICATION; SENSITIVITY; PERMEATION; PROTEINS	Acid-sensing ion channels are proton-activated, sodium-selective channels composed of three subunits, and are members of the superfamily of epithelial sodium channels, mechanosensitive and FMRF-amide peptide-gated ion channels. These ubiquitous eukaryotic ion channels have essential roles in biological activities as diverse as sodium homeostasis, taste and pain. Despite their crucial roles in biology and their unusual trimeric subunit stoichiometry, there is little knowledge of the structural and chemical principles underlying their ion channel architecture and ion-binding sites. Here we present the structure of a functional acid-sensing ion channel in a desensitized state at 3 angstrom resolution, the location and composition of the similar to 8 angstrom 'thick' desensitization gate, and the trigonal antiprism coordination of caesium ions bound in the extracellular vestibule. Comparison of the acid-sensing ion channel structure with the ATP-gated P2X(4) receptor reveals similarity in pore architecture and aqueous vestibules, suggesting that there are unanticipated yet common structural and mechanistic principles.	[Gonzales, Eric B.; Kawate, Toshimitsu; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Gonzales, Eric B./0000-0001-8596-9053	National Institute of General Medical Sciences (NIGMS)-National Research Service Award (NRSA); National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083615] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)-National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel at beamlines 5.0.2 of the Advanced Light Source. We also thank C. Canessa for chicken ASIC1 DNA, L. Vaskalis for assistance with illustrations, and Gouaux laboratory members for discussion. This work was supported by a National Institute of General Medical Sciences (NIGMS)-National Research Service Award (NRSA) to E. B. G. and the National Institutes of Health (NIH) (E. G.). E. G. is an investigator with the Howard Hughes Medical Institute.	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; BENOS DJ, 1980, J GEN PHYSIOL, V76, P233, DOI 10.1085/jgp.76.2.233; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Brown AL, 2007, J GEN PHYSIOL, V129, P161, DOI 10.1085/jgp.200609672; Carnally SM, 2008, BIOCHEM BIOPH RES CO, V372, P752, DOI 10.1016/j.bbrc.2008.05.100; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2008, FASEB J, V22, P1914, DOI 10.1096/fj.07-100313; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; DANI JA, 1986, BIOPHYS J, V49, P607, DOI 10.1016/S0006-3495(86)83688-8; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; HILLE B, 2001, ION CHANNELS EXCITAB, pCH10; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang LH, 2003, J NEUROSCI, V23, P8903; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEUPERTLAVES K, 1975, HELV CHIM ACTA, V58, P432, DOI 10.1002/hlca.19750580212; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER LG, 1982, J MEMBRANE BIOL, V67, P91, DOI 10.1007/BF01868651; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	48	330	339	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					599	U62		10.1038/nature08218	http://dx.doi.org/10.1038/nature08218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19641589	Green Accepted			2022-12-28	WOS:000268454300043
J	Suzuki, M; Saruwatari, K; Kogure, T; Yamamoto, Y; Nishimura, T; Kato, T; Nagasawa, H				Suzuki, Michio; Saruwatari, Kazuko; Kogure, Toshihiro; Yamamoto, Yuya; Nishimura, Tatsuya; Kato, Takashi; Nagasawa, Hiromichi			An Acidic Matrix Protein, Pif, Is a Key Macromolecule for Nacre Formation	SCIENCE			English	Article							CHITIN-BINDING PROTEINS; ORGANIC MATRIX; SHELL FORMATION; MOLLUSK SHELLS; EVOLUTION; INVERTEBRATES; CARBONATE; DOMAINS	The mollusk shell is a hard tissue consisting of calcium carbonate crystals and an organic matrix. The nacre of the shell is characterized by a stacked compartment structure with a uniformly oriented c axis of aragonite crystals in each compartment. Using a calcium carbonate-binding assay, we identified an acidic matrix protein, Pif, in the pearl oyster Pinctada fucata that specifically binds to aragonite crystals. The Pif complementary DNA (cDNA) encoded a precursor protein, which was posttranslationally cleaved to produce Pif 97 and Pif 80. The results from immunolocalization, a knockdown experiment that used RNA interference, and in vitro calcium carbonate crystallization studies strongly indicate that Pif regulates nacre formation.	[Suzuki, Michio; Nagasawa, Hiromichi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Saruwatari, Kazuko; Kogure, Toshihiro] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yamamoto, Yuya; Nishimura, Tatsuya; Kato, Takashi] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Nagasawa, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	anagahi@mail.ecc.u-tokyo.ac.jp	Kato, Takashi/Q-8050-2016; Kogure, Toshihiro/K-7857-2015; Nishimura, Tatsuya/A-3013-2013	Kato, Takashi/0000-0002-0571-0883; Kogure, Toshihiro/0000-0002-3494-8989; Nishimura, Tatsuya/0000-0002-8416-4007	Japan Society for the Promotion of Science (JSPS) [17GS0311]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to M. Hayashi and H. Aoki of the Fisheries Research Institute, Mie Prefecture, Japan, for a kind gift of live pearl oysters and to S. Akera and E. Okamoto of Tasaki Shinju Co. for providing us Japanese pearl oyster shells. We are also grateful to H. Kagi of the Geochemical Laboratory, Graduate School of Science, the University of Tokyo, Japan, for measuring Raman spectra and to H. Tanaka of Okutama Kogyo Co. for a kind gift of aragonite crystals. We also thank V. Jayasankar of the Japan International Research Center for Agricultural Sciences for critical reading of this manuscript. This work was supported by a Grant-in-Aid for Scientific Research (17GS0311) from the Japan Society for the Promotion of Science (JSPS). M. S. was supported by a Research Fellowship of JSPS for young scientists.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; BROOKS R, 1950, PHILOS T R SOC S-A, V243, P145, DOI 10.1098/rsta.1950.0016; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Dauphin Y, 2008, ANAL BIOANAL CHEM, V390, P1659, DOI 10.1007/s00216-008-1860-z; Elvin CM, 1996, J BIOL CHEM, V271, P8925, DOI 10.1074/jbc.271.15.8925; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Kato T, 2000, CHEM LETT, P186, DOI 10.1246/cl.2000.186; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Mann S., 2002, BIOMINERALIZATION; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Saruwatari K, 2009, BIOMATERIALS, V30, P3028, DOI 10.1016/j.biomaterials.2009.03.011; Shen ZC, 1999, J MOL EVOL, V48, P341, DOI 10.1007/PL00006478; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Sugawara A, 2006, J POLYM SCI POL CHEM, V44, P5153, DOI 10.1002/pola.21604; Tuckwell D, 1999, BIOCHEM SOC T, V27, P835, DOI 10.1042/bst0270835; WATABE N, 1960, NATURE, V188, P334, DOI 10.1038/188334a0; WATABE N, 1965, J ULTRA MOL STRUCT R, V12, P351, DOI 10.1016/S0022-5320(65)80104-6; WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259	25	503	527	10	300	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1388	1390		10.1126/science.1173793	http://dx.doi.org/10.1126/science.1173793			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19679771				2022-12-28	WOS:000269699100037
J	Wee, CC				Wee, Christina C.			A 52-Year-Old Woman With Obesity Review of Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREOPERATIVE WEIGHT-LOSS; BODY-MASS INDEX; QUALITY-OF-LIFE; CARDIOVASCULAR RISK-FACTORS; Y GASTRIC BYPASS; LONGITUDINAL ASSESSMENT; AFRICAN-AMERICAN; BREAST-CANCER; MORTALITY; SAFETY	Ms J is a 52-year-old woman with severe obesity and depression, anxiety, and osteoarthritis who has not been able to sustain weight loss through dieting and is now considering having weight loss surgery. She would like to know the long-term effects of surgery, including its psychological consequences. The article discusses the consequences of the 2 most commonly performed bariatric procedures, Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding, and their effects on weight loss, comorbidities, psychological function, and overall quality of life. Evidence suggests average weight loss at 10 years after surgery of 25% and 13%, respectively. The risk of perioperative mortality varies with patient factors and surgeon experience but is typically less than 1% with experienced surgeons. Roux-en-Y gastric bypass has a higher complication rate than laparoscopic adjustable gastric banding. Many obesity-related comorbidities such as diabetes and hypertension resolve or improve with weight loss, and quality of life generally improves in parallel with weight loss. However, depression and anxiety, as Ms J experiences, do not necessarily improve as a result of surgery. JAMA. 2009;302(10):1097-1104 www.jama.com	[Wee, Christina C.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Wee, Christina C.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Wee, CC (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,CO 222, Boston, MA 02215 USA.	cwee@bidmc.harvard.edu			National Institutes of Health [R01 DK073302, R01 DK071083]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr Wee reports that she is the recipient of National Institutes of Health grants R01 DK073302 ("Understanding How Patients Value Bariatric Surgery") and R01 DK071083 ("Race and Health Outcomes Associated With Obesity").	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Alger-Mayer S, 2009, OBES SURG, V19, P139, DOI 10.1007/s11695-008-9540-9; Alvarado R, 2005, OBES SURG, V15, P1282, DOI 10.1381/096089205774512429; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Angrisani L, 2007, SURG OBES RELAT DIS, V3, P127, DOI 10.1016/j.soard.2006.12.005; Apovian CM, 2009, OBESITY, V17, P871, DOI 10.1038/oby.2008.580; Arterburn DE, 2004, ARCH INTERN MED, V164, P994, DOI 10.1001/archinte.164.9.994; Averbukh Y, 2003, OBES SURG, V13, P833, DOI 10.1381/096089203322618605; Ballantyne GH, 2005, OBES SURG, V15, P172, DOI 10.1381/0960892053268507; Ballantyne GH, 2003, OBES SURG, V13, P954, DOI 10.1381/096089203322618867; Belle SH, 2007, SURG OBES RELAT DIS, V3, P116, DOI 10.1016/j.soard.2007.01.006; Berg AO, 2003, ANN INTERN MED, V139, P930, DOI 10.7326/0003-4819-139-11-200312020-00012; Branson R, 2005, OBES SURG, V15, P834, DOI 10.1381/0960892054222605; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235; DeMaria EJ, 2007, SURG OBES RELAT DIS, V3, P134, DOI 10.1016/j.soard.2007.01.005; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; Elder KA, 2007, GASTROENTEROLOGY, V132, P2253, DOI 10.1053/j.gastro.2007.03.057; Encinosa WE, 2006, MED CARE, V44, P706, DOI 10.1097/01.mlr.0000220833.89050.ed; Evans RK, 2007, SURG OBES RELAT DIS, V3, P526, DOI 10.1016/j.soard.2007.06.002; Favretti F, 2007, OBES SURG, V17, P168, DOI 10.1007/s11695-007-9043-0; Finkelstein EA, 2008, OBESITY, V16, P1843, DOI 10.1038/oby.2008.290; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Greenberg I, 2009, OBESITY, V17, P880, DOI 10.1038/oby.2008.571; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Gusenoff JA, 2008, PLAST RECONSTR SURG, V121, P2120, DOI 10.1097/PRS.0b013e31817081a3; Herpertz S, 2003, INT J OBESITY, V27, P1300, DOI 10.1038/sj.ijo.0802410; Jamal Mohammad Khalid, 2005, Surg Obes Relat Dis, V1, P511, DOI 10.1016/j.soard.2005.08.010; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; Kelly JJ, 2009, OBESITY, V17, P863, DOI 10.1038/oby.2008.570; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li ZP, 2005, SURG CLIN N AM, V85, P681, DOI 10.1016/j.suc.2005.04.006; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; McMahon FG, 2000, ARCH INTERN MED, V160, P2185, DOI 10.1001/archinte.160.14.2185; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Mrad BA, 2008, AM J SURG, V195, P570, DOI 10.1016/j.amjsurg.2007.12.043; Mummadi RR, 2008, CLIN GASTROENTEROL H, V6, P1396, DOI 10.1016/j.cgh.2008.08.012; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PEACE K, 1989, NEW ZEAL MED J, V102, P76; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Ramani GV, 2008, CLIN CARDIOL, V31, P516, DOI [10.1002/clc.20315, 10.1002/ClC.20315]; Rosen AB, 2004, J GEN INTERN MED, V19, P332, DOI 10.1111/j.1525-1497.2004.30339.x; Rossner S, 2000, OBES RES, V8, P49, DOI 10.1038/oby.2000.8; Saber AA, 2008, OBES SURG, V18, P652, DOI 10.1007/s11695-008-9505-z; Sallet PC, 2007, OBES SURG, V17, P445, DOI 10.1007/s11695-007-9077-3; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Tarnoff M, 2008, OBES SURG, V18, P1059, DOI 10.1007/s11695-008-9603-y; Tucker ON, 2007, MED CLIN N AM, V91, P499, DOI 10.1016/j.mcna.2007.01.006; van Hout GCM, 2006, OBES SURG, V16, P787, DOI 10.1381/096089206777346808; Wagner AJ, 2007, ARCH SURG-CHICAGO, V142, P935, DOI 10.1001/archsurg.142.10.935; Weber M, 2004, ANN SURG, V240, P975, DOI 10.1097/01.sla.0000145924.64932.8f; Wee CC, 2005, OBES RES, V13, P1275, DOI 10.1038/oby.2005.152; Wee CC, 2004, J GEN INTERN MED, V19, P324, DOI 10.1111/j.1525-1497.2004.30354.x; Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003; Wee CC, 2009, OBESITY, V17, P885, DOI 10.1038/oby.2008.567; White MA, 2004, OBES RES, V12, P949, DOI 10.1038/oby.2004.116; Zingmond DS, 2005, JAMA-J AM MED ASSOC, V294, P1918, DOI 10.1001/jama.294.15.1918	68	12	12	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1097	1104		10.1001/jama.2009.1197	http://dx.doi.org/10.1001/jama.2009.1197			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491XH	19671886				2022-12-28	WOS:000269616200028
J	Aaron, HJ				Aaron, Henry J.			Why Paying for Health Care Reform Is Difficult and Essential -- Numbers and Rules.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Aaron, HJ (corresponding author), Brookings Inst, Washington, DC 20036 USA.							AARON HJ, 1991, SERIOUS UNSTABLE CON, P140; BURMAN LE, 2009, COMMUNICATION   0512; *C BUDG OFF, 2009, LONG TERM BUDG OUTL; Clemans-Cope L., 2009, CHANGES TAX EXCLUSIO; Emanuel EJ, 2005, NEW ENGL J MED, V352, P1255, DOI 10.1056/NEJMsb041704	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					937	939		10.1056/NEJMp0905967	http://dx.doi.org/10.1056/NEJMp0905967			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	490EI	19657109				2022-12-28	WOS:000269480400001
J	Gupta, PB; Onder, TT; Jiang, GZ; Tao, K; Kuperwasser, C; Weinberg, RA; Lander, ES				Gupta, Piyush B.; Onder, Tamer T.; Jiang, Guozhi; Tao, Kai; Kuperwasser, Charlotte; Weinberg, Robert A.; Lander, Eric S.			Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening	CELL			English	Article							BREAST-CANCER; MESENCHYMAL TRANSITION; RESISTANCE; METASTASIS; LINES; RADIORESISTANCE; TRANSFORMATION; HETEROGENEITY; CHEMOTHERAPY; SENSITIVITY	Screens for agents that specifically kill epithelial cancer stem cells (CSCs) have not been possible due to the rarity of these cells within tumor cell populations and their relative instability in culture. We describe here an approach to screening for agents with epithelial CSC-specific toxicity. We implemented this method in a chemical screen and discovered compounds showing selective toxicity for breast CSCs. One compound, salinomycin, reduces the proportion of CSCs by > 100-fold relative to paclitaxel, a commonly used breast cancer chemotherapeutic drug. Treatment of mice with salinomycin inhibits mammary tumor growth in vivo and induces increased epithelial differentiation of tumor cells. In addition, global gene expression analyses show that salinomycin treatment results in the loss of expression of breast CSC genes previously identified by analyses of breast tissues isolated directly from patients. This study demonstrates the ability to identify agents with specific toxicity for epithelial CSCs.	[Gupta, Piyush B.; Onder, Tamer T.; Jiang, Guozhi; Weinberg, Robert A.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Onder, Tamer T.; Weinberg, Robert A.; Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gupta, Piyush B.; Jiang, Guozhi; Lander, Eric S.] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Tao, Kai; Kuperwasser, Charlotte] Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA; [Tao, Kai; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts University; Tufts Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Gupta, PB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	piyush@broadinstitute.org; weinberg@wi.mit.edu; lander@broadinstitute.org	Onder, Tamer T/H-3330-2013; Onder, Tamer/O-3669-2019	Onder, Tamer T/0000-0002-2372-9158; Onder, Tamer/0000-0002-2372-9158	National Cancer Institute; Initiative for Chemical Genetics; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH089663] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Initiative for Chemical Genetics; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the National Cancer Institute and the Initiative for Chemical Genetics, who provided support for this publication, and the Chemical Biology Platform of the Broad Institute of Harvard and the Massachusetts Institute of Technology (MIT) for their assistance in this work. We also wish to thank David Root and the RNAi Platform of the Broad Institute as well as the Breast Cancer Research Foundation for their support. We are grateful to Stephanie Norton, Nicola Tolliday, and Paul Clemons for assistance with chemical screening experiments and analysis. We thank Ina Klebba for assistance with animal experiments, Annette Shepard-Barry in the Histology-Special Procedures Lab at Tufts Medical Center for histological and immunohistochemical staining, Tugba Bagci Onder for help with initial drug resistance characterization, and Supriya Gupta in the Genetic Analysis Platform at the Broad Institute for assistance with gene expression microarray data collection. We thank Li Li in the Department of Chemistry Instrumentation Facility at MIT for fourier-transform mass spectrometry analysis and Dr. Sagi Shapira for helpful criticism of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; R Development Core Team, 2007, R LANG ENV STAT COMP; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2003, CANCER RES, V63, P5821; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	33	1820	1964	5	370	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 21	2009	138	4					645	659		10.1016/j.cell.2009.06.034	http://dx.doi.org/10.1016/j.cell.2009.06.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19682730	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000269156100008
J	Hegerl, GC; Solomon, S				Hegerl, Gabriele C.; Solomon, Susan			Risks of Climate Engineering	SCIENCE			English	Editorial Material									[Hegerl, Gabriele C.] Grant Inst, Edinburgh EH9 3JW, Midlothian, Scotland; [Solomon, Susan] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA	University of Edinburgh; National Oceanic Atmospheric Admin (NOAA) - USA	Hegerl, GC (corresponding author), Grant Inst, Kings Buildings,W Mains Rd, Edinburgh EH9 3JW, Midlothian, Scotland.	gabi.hegerl@ed.ac.uk; susan.solomon@noaa.gov		Hegerl, Gabriele/0000-0002-4159-1295				Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; ALLEN MR, 2002, NATURE, V419, P223; Blackstock J. J., 2009, CLIMATE ENG RESPONSE; Caldeira K, 2008, PHILOS T R SOC A, V366, P4039, DOI 10.1098/rsta.2008.0132; Crutzen PJ, 2006, CLIMATIC CHANGE, V77, P211, DOI 10.1007/s10584-006-9101-y; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020876; Hegerl GC, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Hegerl GC, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016635; Lambert FH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023654; Lambert FH., 2008, EOS T AM GEOPHYS UN, V89, P193, DOI [10.1029/2008EO210001, DOI 10.1029/2008EO210001]; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; MITCHELL JFB, 1987, Q J ROY METEOR SOC, V113, P293, DOI 10.1256/smsqj.47516; Narisma GT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028628; ROBOCK A, 1994, J CLIMATE, V7, P44, DOI 10.1175/1520-0442(1994)007<0044:TVSIGI>2.0.CO;2; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; Robock A, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1175/2779.1; Robock A, 2008, B ATOM SCI, V64, P14, DOI 10.1080/00963402.2008.11461140; Trenberth KE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030524; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025	20	50	51	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					955	956		10.1126/science.1178530	http://dx.doi.org/10.1126/science.1178530			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AN	19661378				2022-12-28	WOS:000269242800032
J	Hattori, Y; Nagai, K; Furukawa, S; Song, XJ; Kawano, R; Sakakibara, H; Wu, JZ; Matsumoto, T; Yoshimura, A; Kitano, H; Matsuoka, M; Mori, H; Ashikari, M				Hattori, Yoko; Nagai, Keisuke; Furukawa, Shizuka; Song, Xian-Jun; Kawano, Ritsuko; Sakakibara, Hitoshi; Wu, Jianzhong; Matsumoto, Takashi; Yoshimura, Atsushi; Kitano, Hidemi; Matsuoka, Makoto; Mori, Hitoshi; Ashikari, Motoyuki			The ethylene response factors SNORKEL1 and SNORKEL2 allow rice to adapt to deep water	NATURE			English	Article							SUBMERGENCE TOLERANCE; INTERNODE ELONGATION; GROWTH-RESPONSE; FLOATING RICE; ABSCISIC-ACID; GRAIN WIDTH; MAJOR QTL; GIBBERELLIN; GENE; AGROBACTERIUM	Living organisms must acquire new biological functions to adapt to changing and hostile environments. Deepwater rice has evolved and adapted to flooding by acquiring the ability to significantly elongate its internodes, which have hollow structures and function as snorkels to allow gas exchange with the atmosphere, and thus prevent drowning(1-3). Many physiological studies have shown that the phytohormones ethylene, gibberellin and abscisic acid are involved in this response(4-8), but the gene(s) responsible for this trait has not been identified. Here we show the molecular mechanism of deepwater response through the identification of the genes SNORKEL1 and SNORKEL2, which trigger deepwater response by encoding ethylene response factors involved in ethylene signalling. Under deepwater conditions, ethylene accumulates in the plant and induces expression of these two genes. The products of SNORKEL1 and SNORKEL2 then trigger remarkable internode elongation via gibberellin. We also demonstrate that the introduction of three quantitative trait loci from deepwater rice into non-deepwater rice enabled the latter to become deepwater rice. This discovery will contribute to rice breeding in lowland areas that are frequently flooded during the rainy season.	[Hattori, Yoko; Nagai, Keisuke; Furukawa, Shizuka; Song, Xian-Jun; Kitano, Hidemi; Matsuoka, Makoto; Ashikari, Motoyuki] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Mori, Hitoshi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kawano, Ritsuko; Yoshimura, Atsushi] Kyushu Univ, Sch Agr, Fukuoka 8128581, Japan; [Sakakibara, Hitoshi] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Wu, Jianzhong; Matsumoto, Takashi] Natl Inst Agrobiol Resources, Tsukuba, Ibaraki 3058602, Japan	Nagoya University; Nagoya University; Kyushu University; RIKEN; National Institute of Agrobiological Sciences - Japan	Ashikari, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	ashi@agr.nagoya-u.ac.jp	Wu, Jian/AAU-5221-2020; Matsumura, Ritsuko/AAS-7122-2020; Hattori, Yoko/AAG-7622-2020; Sakakibara, Hitoshi/A-6040-2010; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Sakakibara, Hitoshi/0000-0001-5449-6492; Nagai, Keisuke/0000-0001-9273-5562; Wu, Jian/0000-0002-3394-1507	Ministry of Agriculture, Forestry, and Fisheries of Japan [QT-2003, QT-4002]; Japan Society for the Promotion of Science (Y. H.); National Bioresource Project, MEXT, Japan; International Rice Research Institute, Philippines	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for the Promotion of Science (Y. H.)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Bioresource Project, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Rice Research Institute, Philippines	We thank I. Aichi for helping to produce the transgenic lines and M. Ito for helping to map the genes. We also thank P. Chaiyawat for the opportunity to photograph the deepwater rice specimen and M. Kojima for technical assistance with the hormone analysis. This work was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan ( Integrated Research Project for Plants, Insects, and Animals using Genome Technology, QT-2003 and QT-4002) and a research fellowship from the Japan Society for the Promotion of Science (Y. H.). The wild rice lines used in this study were obtained from the National Institute of Genetics supported by the National Bioresource Project, MEXT, Japan and the International Rice Research Institute, Philippines.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashikari M, 2006, TRENDS PLANT SCI, V11, P344, DOI 10.1016/j.tplants.2006.05.008; AZUMA T, 1995, J PLANT PHYSIOL, V146, P323, DOI 10.1016/S0176-1617(11)82062-6; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Catling D., 1992, RICE DEEPWATER, V1st edition; Cheng CY, 2002, GENES GENET SYST, V77, P323, DOI 10.1266/ggs.77.323; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fukao T, 2008, P NATL ACAD SCI USA, V105, P16814, DOI 10.1073/pnas.0807821105; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; Hattori Y, 2008, BREEDING SCI, V58, P39, DOI 10.1270/jsbbs.58.39; Hattori Y, 2007, BREEDING SCI, V57, P305, DOI 10.1270/jsbbs.57.305; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirano K, 2008, PLANT CELL PHYSIOL, V49, P1429, DOI 10.1093/pcp/pcn123; HOFFMANNBENNING S, 1992, PLANT PHYSIOL, V99, P1156, DOI 10.1104/pp.99.3.1156; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; JACKSON MB, 1985, ANNU REV PLANT PHYS, V36, P145, DOI 10.1146/annurev.pp.36.060185.001045; Kaneko M, 2003, PLANT J, V35, P104, DOI 10.1046/j.1365-313X.2003.01780.x; Kawano R, 2008, BREEDING SCI, V58, P47, DOI 10.1270/jsbbs.58.47; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; Mao CZ, 2006, PLANT MOL BIOL, V61, P141, DOI 10.1007/s11103-005-6184-1; METRAUX JP, 1983, PLANT PHYSIOL, V72, P441, DOI 10.1104/pp.72.2.441; MORISHIMA H., 1962, Indian Journal of Genetics, V22, P1; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nemoto K, 2004, THEOR APPL GENET, V109, P42, DOI 10.1007/s00122-004-1600-5; RASKIN I, 1984, PLANT PHYSIOL, V76, P947, DOI 10.1104/pp.76.4.947; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; VERGARA B S, 1976, P301; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920	34	587	640	15	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1026	U116		10.1038/nature08258	http://dx.doi.org/10.1038/nature08258			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693083				2022-12-28	WOS:000269085500037
J	Damman, K; Hillege, HL; van Veldhuisen, DJ				Damman, Kevin; Hillege, Hans L.; van Veldhuisen, Dirk J.			Albuminuria in heart failure: a CHARMing new risk factor?	LANCET			English	Editorial Material							RENAL-FUNCTION; CARDIOVASCULAR-DISEASE; BROAD-SPECTRUM; KIDNEY; MICROALBUMINURIA; PREVALENCE; GUIDELINES; MORTALITY		[Damman, Kevin; Hillege, Hans L.; van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Hillege, Hans L.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands	University of Groningen; University of Groningen	Damman, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands.	k.damman@thorax.umcg.nl	van Veldhuisen, Dirk Jan/E-8967-2014					Comper WD, 2008, AM J PHYSIOL-RENAL, V295, pF1589, DOI 10.1152/ajprenal.00142.2008; Damman K, 2008, EUR J HEART FAIL, V10, P997, DOI 10.1016/j.ejheart.2008.07.001; Damman K, 2009, J AM COLL CARDIOL, V53, P582, DOI 10.1016/j.jacc.2008.08.080; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506; Jackson CE, 2009, LANCET, V374, P543, DOI 10.1016/S0140-6736(09)61378-7; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Smilde TDJ, 2009, CLIN RES CARDIOL, V98, P121, DOI 10.1007/s00392-008-0732-z; Van De Wal RMA, 2005, J CARD FAIL, V11, P602, DOI 10.1016/j.cardfail.2005.05.007; WEGRIA R, 1955, J CLIN INVEST, V34, P737, DOI 10.1172/JCI103127; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906	13	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 15	2009	374	9689					506	508		10.1016/S0140-6736(09)61469-0	http://dx.doi.org/10.1016/S0140-6736(09)61469-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683628				2022-12-28	WOS:000269019400006
J	Verdecchia, P; Staessen, JA; Angeli, F; de Simone, G; Achilli, A; Ganau, A; Mureddu, G; Pede, S; Maggioni, AP; Lucci, D; Reboldi, G				Verdecchia, Paolo; Staessen, Jan A.; Angeli, Fabio; de Simone, Giovanni; Achilli, Augusto; Ganau, Antonello; Mureddu, Gianfrancesco; Pede, Sergio; Maggioni, Aldo P.; Lucci, Donato; Reboldi, Gianpaolo		Cardio Sis Investigators	Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial	LANCET			English	Article							LEFT-VENTRICULAR HYPERTROPHY; PROGNOSTIC VALUE; REDUCTION; DIAGNOSIS; RISK; MANAGEMENT; DISEASE	Background The level to which systolic blood pressure should be controlled in hypertensive patients without diabetes remains unknown. We tested the hypothesis that tight control compared with usual control of systolic blood pressure would be beneficial in such patients. Methods In this randomised open-label trial undertaken in 44 centres in Italy, 1111 non-diabetic patients with systolic blood pressure 150 mm Hg or greater were randomly assigned to a target systolic blood pressure of less than 140 mm Hg (usual control; n=553) or less than 130 mm Hg (tight control; n=558). After stratification by Centre, we used a computerised random function to allocate patients to either group. Observers who were unaware of randomisation read electrocardiograms and adjudicated events. Open-label agents were used to reach the randomised targets. The primary endpoint was the rate of electrocardiographic left ventricular hypertrophy 2 years after randomisation. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00421863. Results Over a median follow-up of 2.0 years (IQR 1.93-2.03), systolic and diastolic blood pressure were reduced by a mean of 23.5/8.9 mm Hg (S D 10.6/7.0) in the usual-control group and by 27.3/10.4 mm Hg (11.0/7.5) in the tight-control group (between-group difference 3.8 mm Hg systolic [95% CI 2.4-5.21, p<0.0001; and 1.5 mm Hg diastolic [0.6-2.4]; p=0.041). The primary endpoint occurred in 82 of 483 patients (17.0%) in the usual-control group and in 55 of 484 patients (11.4%) of the tight-control group (odds ratio 0.63; 95% CI 0.43-0.91; p=0.013). A composite cardiovascular endpoint occurred in 52 (9.4%) patients in the usual-control group and in 27 (4.8%) in the tight-control group (hazard ratio 0.50, 95% CI 0.31-0.79; p=0.003). Side-effects were rare and did not differ significantly between the two groups. Interpretation Our findings lend support to a lower blood pressure goal than is recommended at present in non-diabetic patients with hypertension. Funding Boehringer-Ingelheim, Sanofi-Aventis, Pfizer.	[Verdecchia, Paolo; Angeli, Fabio] Hosp S Maria della Misericordia, Div Cardiol, Perugia, Italy; [Staessen, Jan A.] Univ Leuven, Dept Cardiovasc Dis, Div Hypertens & Cardiac Rehabil, Louvain, Belgium; [Staessen, Jan A.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [de Simone, Giovanni] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Achilli, Augusto] Belcolle Hosp, Div Cardiol, Viterbo, Italy; [Ganau, Antonello] Univ Sassari, Dept Internal Med, Cardiol Unit, I-07100 Sassari, Italy; [Mureddu, Gianfrancesco] Hosp S Giovanni Addolorata, Dept Cardiovasc Dis, Rome, Italy; [Pede, Sergio] Hosp S Pietro Vernotico, Div Cardiol, San Pietro Vernotico, Italy; [Verdecchia, Paolo] ANMCO Res Ctr, Cardiosis Coordinating Ctr, I-50121 Florence, Italy; [Reboldi, Gianpaolo] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy	Hospital Santa Maria della Misericordia; KU Leuven; Maastricht University; University of Naples Federico II; University of Sassari; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); University of Perugia	Verdecchia, P (corresponding author), ANMCO Res Ctr, Cardiosis Coordinating Ctr, Via Marmora 34, I-50121 Florence, Italy.	verdec@tin.it	Lembo, Giuseppe/AAE-8096-2020; Muscella, Antonella/B-2630-2013; de Simone, Giovanni/D-1767-2011; Maggioni, Aldo Pietro/AAL-5334-2020; Reboldi, Gianpaolo/A-3444-2009; Staessen, Jan A/A-1065-2011; Angeli, Fabio/K-8775-2019; Ganau, Antonello/D-6899-2012	Lembo, Giuseppe/0000-0002-3510-223X; de Simone, Giovanni/0000-0001-8567-9881; Maggioni, Aldo Pietro/0000-0003-2764-6779; Reboldi, Gianpaolo/0000-0002-9877-0702; Staessen, Jan A/0000-0002-3026-1637; Angeli, Fabio/0000-0003-4925-7985; GANAU, Antonello/0000-0002-7053-293X; MALATINO, Lorenzo Salvatore/0000-0003-2944-2729; Colivicchi, Furio/0000-0001-7187-2234; Galletti, Ferruccio/0000-0001-7556-0254; Gulizia, Michele Massimo/0000-0003-1513-7125; Seghieri, Giuseppe/0000-0002-7599-4455; Barbato, Antonio/0000-0002-4660-821X	Boehringer-Ingelheim; Sanofi-Aventis; Pfizer; AstraZeneca; Daiichi-Sankyo; Mitsubishi Tanabe Pharma; Novartis; Sigma-Tau	Boehringer-Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Novartis(Novartis); Sigma-Tau	PV, FA, and G R received consulting and lecturing fees from Boehringer-Ingelheim and Sanofi-Aventis. AM and DL received research support from Boehringer-Ingelheim, Sanofi-Aventis, and Pfizer. JAS received consulting and lecturing fees and research support from AstraZeneca, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, Novartis, Pfizer, and Sigma-Tau. GM, AA, GdS, AG, and SP declare that they have no conflicts ofinterest.	CASALE PN, 1985, J AM COLL CARDIOL, V6, P572, DOI 10.1016/S0735-1097(85)80115-7; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Estacio RO, 2000, DIABETES CARE, V23, pB54; Franklin SS, 2001, CIRCULATION, V103, P1245; Fujiwara T, 2002, BLOOD PRESS MONIT, V7, P77, DOI 10.1097/00126097-200202000-00016; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; LEVY D, 1994, CIRCULATION, V90, P1786, DOI 10.1161/01.CIR.90.4.1786; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mathew J, 2001, CIRCULATION, V104, P1615, DOI 10.1161/hc3901.096700; Mindlen F, 1996, CAN J CARDIOL, V12, P127; Okin PM, 2000, HYPERTENSION, V35, P13, DOI 10.1161/01.HYP.35.1.13; ROMHILT DW, 1968, AM HEART J, V75, P752, DOI 10.1016/0002-8703(68)90035-5; SCHILLACI G, 1994, AM J CARDIOL, V74, P714, DOI 10.1016/0002-9149(94)90316-6; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Thomas MC, 2008, AM J HYPERTENS, V21, P1111, DOI 10.1038/ajh.2008.248; Verdecchia P, 1998, J AM COLL CARDIOL, V31, P383, DOI 10.1016/S0735-1097(97)00493-2; Verdecchia P, 2008, J HUM HYPERTENS, V22, P243, DOI 10.1038/sj.jhh.1002313; Verdecchia P, 2007, AM J HYPERTENS, V20, P997, DOI 10.1016/j.amjhyper.2007.04.003; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zanchetti A, 2009, J HYPERTENS, V27, P673, DOI 10.1097/HJH.0b013e3283298ea2	29	317	331	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					525	533		10.1016/S0140-6736(09)61340-4	http://dx.doi.org/10.1016/S0140-6736(09)61340-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683638	Green Accepted			2022-12-28	WOS:000269019400020
J	[Anonymous]				[Anonymous]			Heart disease: breaking down barriers	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					501	501						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484BX	19683623				2022-12-28	WOS:000269019400001
J	McMullen, MD; Kresovich, S; Villeda, HS; Bradbury, P; Li, HH; Sun, Q; Flint-Garcia, S; Thornsberry, J; Acharya, C; Bottoms, C; Brown, P; Browne, C; Eller, M; Guill, K; Harjes, C; Kroon, D; Lepak, N; Mitchell, SE; Peterson, B; Pressoir, G; Romero, S; Rosas, MO; Salvo, S; Yates, H; Hanson, M; Jones, E; Smith, S; Glaubitz, JC; Goodman, M; Ware, D; Holland, JB; Buckler, ES				McMullen, Michael D.; Kresovich, Stephen; Villeda, Hector Sanchez; Bradbury, Peter; Li, Huihui; Sun, Qi; Flint-Garcia, Sherry; Thornsberry, Jeffry; Acharya, Charlotte; Bottoms, Christopher; Brown, Patrick; Browne, Chris; Eller, Magen; Guill, Kate; Harjes, Carlos; Kroon, Dallas; Lepak, Nick; Mitchell, Sharon E.; Peterson, Brooke; Pressoir, Gael; Romero, Susan; Rosas, Marco Oropeza; Salvo, Stella; Yates, Heather; Hanson, Mark; Jones, Elizabeth; Smith, Stephen; Glaubitz, Jeffrey C.; Goodman, Major; Ware, Doreen; Holland, James B.; Buckler, Edward S.			Genetic Properties of the Maize Nested Association Mapping Population	SCIENCE			English	Article							QUANTITATIVE TRAIT LOCI; INBRED LINES; LINKAGE; RECOMBINATION; ARCHITECTURE; PATTERNS; MARKERS	Maize genetic diversity has been used to understand the molecular basis of phenotypic variation and to improve agricultural efficiency and sustainability. We crossed 25 diverse inbred maize lines to the B73 reference line, capturing a total of 136,000 recombination events. Variation for recombination frequencies was observed among families, influenced by local (cis) genetic variation. We identified evidence for numerous minor single-locus effects but little two-locus linkage disequilibrium or segregation distortion, which indicated a limited role for genes with large effects and epistatic interactions on fitness. We observed excess residual heterozygosity in pericentromeric regions, which suggested that selection in inbred lines has been less efficient in these regions because of reduced recombination frequency. This implies that pericentromeric regions may contribute disproportionally to heterosis.	[McMullen, Michael D.; Bradbury, Peter; Flint-Garcia, Sherry; Browne, Chris; Eller, Magen; Guill, Kate; Lepak, Nick; Peterson, Brooke; Romero, Susan; Salvo, Stella; Ware, Doreen; Holland, James B.; Buckler, Edward S.] Univ Missouri, USDA ARS, Columbia, MO 65211 USA; [McMullen, Michael D.; Villeda, Hector Sanchez; Flint-Garcia, Sherry; Bottoms, Christopher] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Kresovich, Stephen; Bradbury, Peter; Li, Huihui; Acharya, Charlotte; Brown, Patrick; Harjes, Carlos; Kroon, Dallas; Mitchell, Sharon E.; Pressoir, Gael; Yates, Heather; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Li, Huihui] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Li, Huihui] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Sun, Qi] Cornell Univ, Computat Biol Serv Unit, Ithaca, NY 14853 USA; [Thornsberry, Jeffry] NW Missouri State Univ, Maryville, MO 64468 USA; [Rosas, Marco Oropeza; Goodman, Major; Holland, James B.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Hanson, Mark] Illumina Inc, San Diego, CA 92121 USA; [Jones, Elizabeth; Smith, Stephen] Pioneer HiBred Int Inc, Johnston, IA 50131 USA; [Glaubitz, Jeffrey C.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA	United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Cornell University; Beijing Normal University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Cornell University; University of North Carolina; North Carolina State University; Illumina; DuPont; University of Wisconsin System; University of Wisconsin Madison; Cold Spring Harbor Laboratory; Cornell University	McMullen, MD (corresponding author), Univ Missouri, USDA ARS, Columbia, MO 65211 USA.	mcmullenm@missouri.edu; sk20@cornell.edu; james_holland@ncsu.edu; esb33@cornell.edu	Brown, Patrick/E-4085-2012; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Brown, Patrick/0000-0001-6857-8608; Buckler, Edward/0000-0002-3100-371X; Flint-Garcia, Sherry/0000-0003-4156-5318; Holland, James/0000-0002-4341-9675	National Science Foundation [DBI0321467]; USDA-ARS	National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Supported by National Science Foundation Award DBI0321467 and by research funds provided by USDA-ARS to M.D.M., E.S.B., and J.B.H.	BEAVIS WD, 1991, THEOR APPL GENET, V82, P636, DOI 10.1007/BF00226803; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Casa AM, 2000, P NATL ACAD SCI USA, V97, P10083, DOI 10.1073/pnas.97.18.10083; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; Emerson RA, 1934, GENETICS, V19, P0137; Esch E, 2007, GENETICS, V177, P1851, DOI 10.1534/genetics.107.080622; Falque M, 2005, GENETICS, V170, P1957, DOI 10.1534/genetics.104.040204; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Graham GI, 1997, CROP SCI, V37, P1601, DOI 10.2135/cropsci1997.0011183X003700050033x; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; LANDER ES, 1989, GENETICS, V121, P185; Liu KJ, 2003, GENETICS, V165, P2117; LONGLEY AE, 1961, GENETICS, V46, P641; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; NASS HG, 1970, CROP SCI, V10, P139, DOI 10.2135/cropsci1970.0011183X001000020004x; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; STUBER CW, 1992, GENETICS, V132, P823; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; WILLIAMS CG, 1995, GENETICS, V141, P1573; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yao H, 2005, GENETICS, V170, P1929, DOI 10.1534/genetics.104.034454; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhang M, 2005, GENETICS, V169, P2305, DOI 10.1534/genetics.104.034181	27	690	717	1	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					737	740		10.1126/science.1174320	http://dx.doi.org/10.1126/science.1174320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661427				2022-12-28	WOS:000268723700046
J	Neeley, M; Ansmann, M; Bialczak, RC; Hofheinz, M; Lucero, E; O'Connell, AD; Sank, D; Wang, HH; Wenner, J; Cleland, AN; Geller, MR; Martinis, JM				Neeley, Matthew; Ansmann, Markus; Bialczak, Radoslaw C.; Hofheinz, Max; Lucero, Erik; O'Connell, Aaron D.; Sank, Daniel; Wang, Haohua; Wenner, James; Cleland, Andrew N.; Geller, Michael R.; Martinis, John M.			Emulation of a Quantum Spin with a Superconducting Phase Qudit	SCIENCE			English	Article							STATISTICS; QUBITS; SHIFT	In quantum information processing, qudits (d-level systems) are an extension of qubits that could speed up certain computing tasks. We demonstrate the operation of a superconducting phase qudit with a number of levels d up to d = 5 and show how to manipulate and measure the qudit state, including simultaneous control of multiple transitions. We used the qudit to emulate the dynamics of single spins with principal quantum number s = 1/2, 1, and 3/2, allowing a measurement of Berry's phase and the even parity of integer spins (and odd parity of half-integer spins) under 2 pi-rotation. This extension of the two-level qubit to a multilevel qudit holds promise for more-complex quantum computational architectures and for richer simulations of quantum mechanical systems.	[Neeley, Matthew; Ansmann, Markus; Bialczak, Radoslaw C.; Hofheinz, Max; Lucero, Erik; O'Connell, Aaron D.; Sank, Daniel; Wang, Haohua; Wenner, James; Cleland, Andrew N.; Martinis, John M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Geller, Michael R.] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA	University of California System; University of California Santa Barbara; University System of Georgia; University of Georgia	Martinis, JM (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	martinis@physics.ucsb.edu	Wang, Haohua/G-8875-2011; Hofheinz, Max/F-3288-2010; Wenner, James/G-3777-2014; Cleland, Andrew/AAG-7581-2019	Wang, Haohua/0000-0001-5380-4297; Wenner, James/0000-0001-7107-4734; 	Intelligence Advanced Research Projects Activity [W911NF-04-1-0204]; NSF [CCF-0507227]	Intelligence Advanced Research Projects Activity; NSF(National Science Foundation (NSF))	This work was supported by the Intelligence Advanced Research Projects Activity (grant W911NF-04-1-0204) and NSF (grant CCF-0507227).	BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Bregman I, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.050301; Brennen GK, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.052318; Brune M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.240402; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Duck I, 1998, AM J PHYS, V66, P284, DOI 10.1119/1.18860; Fragner A, 2008, SCIENCE, V322, P1357, DOI 10.1126/science.1164482; KAISER R, 1978, CAN J PHYS, V56, P1321, DOI 10.1139/p78-173; Lanyon BP, 2009, NAT PHYS, V5, P134, DOI 10.1038/NPHYS1150; Lucero E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247001; Martinis JM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.210503; Muthukrishnan A, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.052309; Neeley M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180508; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Niskanen AO, 2007, SCIENCE, V316, P723, DOI 10.1126/science.1141324; O'Leary DP, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.032334; Pauli W, 1940, PHYS REV, V58, P716, DOI 10.1103/PhysRev.58.716; RAUCH H, 1975, PHYS LETT A, V54, P425, DOI 10.1016/0375-9601(75)90798-7; Steffen M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.224518; Steffen M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050502; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; Wang H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.240401; WERNER SA, 1975, PHYS REV LETT, V35, P1053, DOI 10.1103/PhysRevLett.35.1053	25	200	204	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					722	725		10.1126/science.1173440	http://dx.doi.org/10.1126/science.1173440			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661423				2022-12-28	WOS:000268723700042
J	van Stelten, J; Silva, F; Belin, D; Silhavy, TJ				van Stelten, Johna; Silva, Filo; Belin, Dominique; Silhavy, Thomas J.			Effects of Antibiotics and a Proto-Oncogene Homolog on Destruction of Protein Translocator SecY	SCIENCE			English	Article							BAX INHIBITOR-1; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; CHLORAMPHENICOL; DEGRADATION; SUPPRESSES; ACTIVATION; SECRETION; TOXICITY; ANIMALS	Protein secretion occurs via translocation by the evolutionarily conserved Sec complex. LacZ hybrid proteins have long been used to study translocation in Escherichia coli. Some LacZ hybrids were thought to block secretion by physically jamming the Sec complex, leading to cell death. We found that jammed Sec complexes caused the degradation of essential translocator components by the protease FtsH. Increasing the amounts or the stability of the membrane protein YccA, a known inhibitor of FtsH, counteracted this destruction. Antibiotics that inhibit translation elongation also jammed the translocator and caused the degradation of translocator components, which may contribute to their effectiveness. Intriguingly, YccA is a functional homolog of the proto-oncogene product Bax Inhibitor-1, which may share a similar mechanism of action in regulating apoptosis upon prolonged secretion stress.	[van Stelten, Johna; Silhavy, Thomas J.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Silva, Filo; Belin, Dominique] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland	Princeton University; University of Geneva	Silhavy, TJ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	tsilhavy@princeton.edu		Silhavy, Thomas/0000-0001-7672-5153	National Institute of General Medical Sciences; New Jersey Commission on Cancer Research; Canton de Geneve; Swiss National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034821] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); New Jersey Commission on Cancer Research; Canton de Geneve; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (T.J.S.), the New Jersey Commission on Cancer Research (J.v.S.), and the Canton de Geneve and the Swiss National Science Foundation (F.S. and D.B.).	AKIYAMA Y, 1989, J BIOL CHEM, V264, P437; BASSFORD PJ, 1979, J BACTERIOL, V139, P19, DOI 10.1128/JB.139.1.19-31.1979; Bowers CW, 2003, J BACTERIOL, V185, P5697, DOI 10.1128/JB.185.19.5697-5705.2003; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; COSMA CL, 1995, MOL MICROBIOL, V18, P491, DOI 10.1111/j.1365-2958.1995.mmi_18030491.x; FELDMAN WE, 1983, ANTIMICROB AGENTS CH, V23, P551, DOI 10.1128/AAC.23.4.551; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Huckelhoven R, 2004, APOPTOSIS, V9, P299, DOI 10.1023/B:APPT.0000025806.71000.1c; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Kihara A, 1998, J MOL BIOL, V279, P175, DOI 10.1006/jmbi.1998.1781; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; RAHAL JJ, 1979, ANTIMICROB AGENTS CH, V16, P13, DOI 10.1128/AAC.16.1.13; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; SILHAVY TJ, 1977, P NATL ACAD SCI USA, V74, P5411, DOI 10.1073/pnas.74.12.5411; Smith MI, 2007, CELL DEATH DIFFER, V14, P1011, DOI 10.1038/sj.cdd.4402089; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Walsh C., 2003, ANTIBIOTICS ACTIONS; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yamamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1688, DOI 10.1271/bbb.60024	22	84	88	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					753	756		10.1126/science.1172221	http://dx.doi.org/10.1126/science.1172221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661432	Green Accepted			2022-12-28	WOS:000268723700051
J	Li, WX				Li, Wanxin			Small but effective moves towards a greener China	NATURE			English	Letter									[Li, Wanxin] City Univ Hong Kong, Kowloon, Hong Kong, Peoples R China; [Li, Wanxin] Tsinghua Grad Sch Shenzhen, Shenzhen, Peoples R China	City University of Hong Kong	Li, WX (corresponding author), City Univ Hong Kong, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.	wanxili@cityu.edu.hk	Li, Wanxin/K-7982-2015	Li, Wanxin/0000-0003-4501-701X				2009, NATURE, V459, P1033	1	0	0	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					683	684		10.1038/460683c	http://dx.doi.org/10.1038/460683c			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661891	Bronze			2022-12-28	WOS:000268670300016
J	Margaretten, ME; Tierney, LM; Dhaliwal, G				Margaretten, Mary E.; Tierney, Lawrence M., Jr.; Dhaliwal, Gurpreet			A Hard Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SCLERODERMA RENAL CRISIS; SCLEROSIS SINE SCLERODERMA; SYSTEMIC-SCLEROSIS		[Margaretten, Mary E.] Univ Calif San Francisco, Div Rheumatol, San Francisco, CA 94118 USA; [Tierney, Lawrence M., Jr.; Dhaliwal, Gurpreet] Univ Calif San Francisco, Dept Med, San Francisco, CA 94118 USA; [Tierney, Lawrence M., Jr.; Dhaliwal, Gurpreet] San Francisco VA Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Margaretten, ME (corresponding author), Univ Calif San Francisco, Div Rheumatol, 3333 Calif St,Suite 270, San Francisco, CA 94118 USA.	mary.margaretten@ucsf.edu						DeMarco PJ, 2002, ARTHRITIS RHEUM-US, V46, P2983, DOI 10.1002/art.10589; DONOHOE JF, 1992, KIDNEY INT, V41, P462, DOI 10.1038/ki.1992.65; MOLINA JF, 1995, J RHEUMATOL, V22, P557; Poormoghim H, 2000, ARTHRITIS RHEUM, V43, P444, DOI 10.1002/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G; Rosvold EA, 2005, LANCET, V365, P1372, DOI 10.1016/S0140-6736(05)66353-2; Steen VD, 1998, ARTHRITIS RHEUM, V41, P1613, DOI 10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O; STEEN VD, 1990, ANN INTERN MED, V113, P352, DOI 10.7326/0003-4819-113-5-352; Teixeira L, 2008, ANN RHEUM DIS, V67, P110, DOI 10.1136/ard.2006.066985; WACHTEL TJ, 1995, J GEN INTERN MED, V10, P261, DOI 10.1007/BF02599883; WIGLEY RM, 2001, PRIMER RHEUMATIC DIS, P353	10	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					613	617		10.1056/NEJMcps0804137	http://dx.doi.org/10.1056/NEJMcps0804137			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479NR	19657126				2022-12-28	WOS:000268667300013
J	Dickerson, EH; Raghunath, AS; Atkin, SL				Dickerson, E. H.; Raghunath, A. S.; Atkin, S. L.			Rational Testing Initial investigation of amenorrhoea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREMATURE OVARIAN FAILURE		[Raghunath, A. S.; Atkin, S. L.] Hull York Med Sch, Kingston Upon Hull HU3 2RW, N Humberside, England	University of Hull; University of York - UK	Atkin, SL (corresponding author), Hull York Med Sch, Kingston Upon Hull HU3 2RW, N Humberside, England.	Stephen.Atkin@hyms.ac.uk	atkin, stephen/D-7400-2014; Atkin, stephen/ABE-7047-2020	atkin, stephen/0000-0002-5887-7257; 				Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS219, DOI 10.1016/j.fertnstert.2008.08.038; Bidet M, 2008, CURR OPIN OBSTET GYN, V20, P416, DOI 10.1097/GCO.0b013e328306a06b; Conway GS, 1996, FERTIL STERIL, V65, P337, DOI 10.1016/S0015-0282(16)58095-9; CRITCHLEY H, 2004, CONSENSUS VIEWS ARIS, P345; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; FRANKS S, 1987, BRIT MED J, V294, P815, DOI 10.1136/bmj.294.6575.815; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Hull M G, 1987, Gynecol Endocrinol, V1, P235, DOI 10.3109/09513598709023610; LAUFER MR, 1995, GYNECOL OBSTET INVES, V40, P200, DOI 10.1159/000292335; Ledger W. L., 2004, CURRENT OBSTET GYNAE, V14, P254; LOUCKS AB, 1985, MED SCI SPORT EXER, V17, P56, DOI 10.1249/00005768-198502000-00010; REINDOLLAR RH, 1986, AM J OBSTET GYNECOL, V155, P531, DOI 10.1016/0002-9378(86)90274-7; SCHACHTER M, 1994, FERTIL STERIL, V62, P1; SINGH KB, 1981, AM J OBSTET GYNECOL, V140, P299, DOI 10.1016/0002-9378(81)90277-5	14	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2009	339								b2184	10.1136/bmj.b2184	http://dx.doi.org/10.1136/bmj.b2184			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KB	19654161				2022-12-28	WOS:000268807800009
J	Vago, L; Perna, SK; Zanussi, M; Mazzi, B; Barlassina, C; Stanghellini, MTL; Perrelli, NF; Cosentino, C; Torri, F; Angius, A; Forno, B; Casucci, M; Bernardi, M; Peccatori, J; Corti, C; Bondanza, A; Ferrari, M; Rossini, S; Roncarolo, MG; Bordignon, C; Bonini, C; Ciceri, F; Fleischhauer, K				Vago, Luca; Perna, Serena Kimi; Zanussi, Monica; Mazzi, Benedetta; Barlassina, Cristina; Stanghellini, Maria Teresa Lupo; Perrelli, Nicola Flavio; Cosentino, Cristian; Torri, Federica; Angius, Andrea; Forno, Barbara; Casucci, Monica; Bernardi, Massimo; Peccatori, Jacopo; Corti, Consuelo; Bondanza, Attilio; Ferrari, Maurizio; Rossini, Silvano; Roncarolo, Maria Grazia; Bordignon, Claudio; Bonini, Chiara; Ciceri, Fabio; Fleischhauer, Katharina			Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC TUMOR VARIANTS; RISK ACUTE-LEUKEMIA; HEMATOPOIETIC TRANSPLANTS; UNIPARENTAL DISOMY; DONOR LYMPHOCYTES; DOWN-REGULATION; ANTIGENS; RELAPSE; RECONSTITUTION; ALLOREACTIVITY	Background: Transplantation of hematopoietic stem cells from partially matched family donors is a promising therapy for patients who have a hematologic cancer and are at high risk for relapse. The donor T-cell infusions associated with such transplantation can promote post-transplantation immune reconstitution and control residual disease. Methods: We identified 43 patients who underwent haploidentical transplantation and infusion of donor T cells for acute myeloid leukemia or myelodysplastic syndrome and conducted post-transplantation studies that included morphologic examination of bone marrow, assessment of hematopoietic chimerism with the use of short-tandem-repeat amplification, and HLA typing. The genomic rearrangements in mutant variants of leukemia were studied with the use of genomic HLA typing, microsatellite mapping, and single-nucleotide-polymorphism arrays. The post-transplantation immune responses against the original cells and the mutated leukemic cells were analyzed with the use of mixed lymphocyte cultures. Results: In 5 of 17 patients with leukemia relapse after haploidentical transplantation and infusion of donor T cells, we identified mutant variants of the original leukemic cells. In the mutant leukemic cells, the HLA haplotype that differed from the donor's haplotype had been lost because of acquired uniparental disomy of chromosome 6p. T cells from the donor and the patient after transplantation did not recognize the mutant leukemic cells, whereas the original leukemic cells taken at the time of diagnosis were efficiently recognized and killed. Conclusions: After transplantation of haploidentical hematopoietic stem cells and infusion of donor T cells, leukemic cells can escape from the donor's antileukemic T cells through the loss of the mismatched HLA haplotype. This event leads to relapse. N Engl J Med 2009;361:478-88.	[Vago, Luca; Perna, Serena Kimi; Stanghellini, Maria Teresa Lupo; Forno, Barbara; Bernardi, Massimo; Peccatori, Jacopo; Corti, Consuelo; Ciceri, Fabio] IRCCS H San Raffaele, Hematol & Bone Marrow Transplantat Unit, Dept Oncol, I-20132 Milan, Italy; [Vago, Luca; Roncarolo, Maria Grazia; Fleischhauer, Katharina] IRCCS H San Raffaele, HSR TIGET, I-20132 Milan, Italy; [Perna, Serena Kimi; Casucci, Monica; Bondanza, Attilio; Bonini, Chiara] IRCCS H San Raffaele, Canc Immunotherapy & Gene Therapy Program, I-20132 Milan, Italy; [Mazzi, Benedetta; Rossini, Silvano; Fleischhauer, Katharina] IRCCS H San Raffaele, HLA Tissue Typing Lab, I-20132 Milan, Italy; [Mazzi, Benedetta; Rossini, Silvano; Fleischhauer, Katharina] IRCCS H San Raffaele, Immunohematol & Transfus Med Serv, I-20132 Milan, Italy; [Ferrari, Maurizio; Roncarolo, Maria Grazia; Bordignon, Claudio] Univ Vita Salute San Raffaele, Milan, Italy; [Barlassina, Cristina; Cosentino, Cristian; Torri, Federica] Univ Milan, Dipartimento Sci & Tecnol Biomed, Milan, Italy; [Barlassina, Cristina; Cosentino, Cristian; Torri, Federica] Fdn Filarete, Milan, Italy; [Bordignon, Claudio] MolMed, Milan, Italy; [Angius, Andrea] Shardna Life Sci, Cagliari, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan	Ciceri, F (corresponding author), IRCCS H San Raffaele, Hematol & Bone Marrow Transplantat Unit, Dept Oncol, Via Olgettina 60, I-20132 Milan, Italy.	ciceri.fabio@hsr.it	Angius, Andrea/P-9549-2015; Ferrari, Maurizio/D-9107-2013; Casucci, Monica/AAN-4115-2020; Cosentino, Cristian/F-2604-2010; bonini, chiara/I-9202-2012; bernardi, massimo/ABG-4445-2020; Angius, Andrea/B-8966-2015; Peccatori, Iacopo/AAB-7506-2019	Angius, Andrea/0000-0003-2596-6461; Cosentino, Cristian/0000-0002-2784-0048; bernardi, massimo/0000-0002-1334-0851; Peccatori, Iacopo/0000-0003-4639-1716; BONINI, Maria Chiara/0000-0002-0772-1674; Lupo-Stanghellini, Maria Teresa/0000-0003-1382-6939; Angius, Andrea/0000-0001-9372-1162; RONCAROLO, Maria Grazia/0000-0002-2193-9186; Vago, Luca/0000-0003-4247-3175; Barlassina, Cristina/0000-0001-7407-2697; Casucci, Monica/0000-0003-4500-9060	Associazione Italiana per la Ricerca sul Cancro [AIRC 44/2007]; Cariplo Foundation [2007.5486]; Telethon Foundation [GGP08201]; European Commission [FP7-ICT-2007-216088]; Italian Ministry of Health; Italian Ministry of Research and University	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Cariplo Foundation(Fondazione Cariplo); Telethon Foundation(Fondazione Telethon); European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Research and University(Ministry of Education, Universities and Research (MIUR))	Supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC 44/2007), the Cariplo Foundation (2007.5486), the Telethon Foundation (GGP08201), the European Commission (FP7-ICT-2007-216088), the Italian Ministry of Health, and the Italian Ministry of Research and University.	Amrolia PJ, 2006, BLOOD, V108, P1797, DOI 10.1182/blood-2006-02-001909; Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Aversa F, 2005, J CLIN ONCOL, V23, P3447, DOI 10.1200/JCO.2005.09.117; Burroughs LM, 2008, BIOL BLOOD MARROW TR, V14, P1279, DOI 10.1016/j.bbmt.2008.08.014; Ciceri F, 2008, BLOOD, V112, P3574, DOI 10.1182/blood-2008-02-140095; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200; Garcia-Lora A, 2001, INT J CANCER, V91, P109, DOI 10.1002/1097-0215(20010101)91:1<109::AID-IJC1017>3.0.CO;2-E; Garcia-Lora A, 2003, INT J CANCER, V106, P521, DOI 10.1002/ijc.11241; Garrido F, 2001, ADV CANCER RES, V83, P117, DOI 10.1016/S0065-230X(01)83005-0; Gorletta TA, 2005, GENE CHROMOSOME CANC, V44, P334, DOI 10.1002/gcc.20234; Goulmy E, 2006, HUM IMMUNOL, V67, P433, DOI 10.1016/j.humimm.2006.03.012; Huang XJ, 2008, J CLIN IMMUNOL, V28, P276, DOI 10.1007/s10875-007-9166-z; Kennedy-Nasser AA, 2007, CURR OPIN HEMATOL, V14, P616, DOI 10.1097/MOH.0b013e3282ef615a; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Koh LP, 2007, BIOL BLOOD MARROW TR, V13, P1249, DOI 10.1016/j.bbmt.2007.08.003; Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974; Lewalle P, 2004, BLOOD CELL MOL DIS, V33, P256, DOI 10.1016/j.bcmd.2004.08.012; Masuda K, 2007, CANCER SCI, V98, P102, DOI 10.1111/j.1349-7006.2006.00356.x; Mazzi B, 2008, LEUKEMIA, V22, P2119, DOI 10.1038/leu.2008.98; Parham P, 2003, NAT REV IMMUNOL, V3, P108, DOI 10.1038/nri999; Raghavan M, 2005, CANCER RES, V65, P375; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Vago L, 2008, BLOOD, V112, P3488, DOI 10.1182/blood-2007-07-103325; van Rood JJ, 2005, SEMIN HEMATOL, V42, P104, DOI 10.1053/j.seminhematol.2005.01.008; Velardi A, 2008, SEMIN IMMUNOPATHOL, V30, P489, DOI 10.1007/s00281-008-0136-1; Zheng P, 1999, CANCER RES, V59, P3461	31	341	350	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					478	488		10.1056/NEJMoa0811036	http://dx.doi.org/10.1056/NEJMoa0811036			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LW	19641204				2022-12-28	WOS:000268443900008
J	Lennox, JL; Dejesus, E; Lazzarin, A; Pollard, RB; Madruga, JVR; Berger, DS; Zhao, J; Xu, X; Williams-Diaz, A; Rodgers, AJ; Barnard, RJO; Miller, MD; DiNubile, MJ; Nguyen, BY; Leavitt, R; Sklar, P				Lennox, Jeffrey L.; Dejesus, Edwin; Lazzarin, Adriano; Pollard, Richard B.; Ramalho Madruga, Jose Valdez; Berger, Daniel S.; Zhao, Jing; Xu, Xio; Williams-Diaz, Angela; Rodgers, Anthony J.; Barnard, Richard J. O.; Miller, Michael D.; DiNubile, Mark J.; Nguyen, Bach-Yen; Leavitt, Randi; Sklar, Peter		STARTMRK Investigators	Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial	LANCET			English	Article							INTEGRASE INHIBITOR RALTEGRAVIR; ANTIRETROVIRAL DRUG-RESISTANCE; NEUROPSYCHIATRIC ADVERSE EVENTS; SOCIETY-USA PANEL; 2008 RECOMMENDATIONS; PHASE-II; PREVALENCE; TRANSMISSION; REPLICATION; NEVIRAPINE	Background Use of raltegravir with optimum background therapy is effective and well tolerated in treatment-experienced patients with multidrug-resistant HIV-1 infection. We compared the safety and efficacy of raltegravir with efavirenz as part of combination antiretroviral therapy for treatment-naive patients. Methods Patients from 67 study centres on five continents were enrolled between Sept 14, 2006, and June 5, 2008. Eligible patients were infected with HIV-1, had viral RNA (vRNA) concentration of more than 5000 copies per mL, and no baseline resistance to efavirenz, tenofovir, or emtricitabine. Patients were randomly allocated by interactive voice response system in a 1:1 ratio (double-blind) to receive 400 mg oral raltegravir twice daily or 600 mg oral efavirenz once daily, in combination with tenofovir and emtricitabine. The primary efficacy endpoint was achievement of a vRNA concentration of less than 50 copies per mL at week 48. The primary analysis was per protocol. The margin of non-inferiority was 12%. This study is registered with ClinicalTrials.gov, number NCT00369941. Findings 566 patients were enrolled and randomly allocated to treatment, of whom 281 received raltegravir, 282 received efavirenz, and three were never treated. At baseline, 297 (53%) patients had more than 100 000 vRNA copies per mL and 267 (47%) had CD4 counts of 200 cells per mu L or less. The main analysis (with non-completion counted as failure) showed that 86.1% (n=241 patients) of the raltegravir group and 81.9% (n=230) of the efavirenz group achieved the primary endpoint (difference 4.2%, 95% CI -1.9 to 10.3). The time to achieve such viral suppression was shorter for patients on raltegravir than on efavirenz (log-rank test p<0.0001). Significantly fewer drug-related clinical adverse events occurred in patients on raltegravir (n=124 [44.1%]) than those on efavirenz (n=217 [77.0%]; difference -32.8%, 95% CI -40.2 to -25.0, p<0.0001). Serious drug-related clinical adverse events occurred in less than 2% of patients in each drug group. Interpretation Raltegravir-based combination treatment had rapid and potent antiretroviral activity, which was non-inferior to that of efavirenz at week 48. Raltegravir is a well tolerated alternative to efavirenz as part of a combination regimen against HIV-1 in treatment-naive patients.	[Zhao, Jing; Xu, Xio; Williams-Diaz, Angela; Rodgers, Anthony J.; Barnard, Richard J. O.; Miller, Michael D.; DiNubile, Mark J.; Nguyen, Bach-Yen; Leavitt, Randi; Sklar, Peter] Merck Res Labs, N Wales, PA 19454 USA; [Lennox, Jeffrey L.] Emory Univ, Sch Med, Atlanta, GA USA; [Dejesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Lazzarin, Adriano] Univ Vita Salute San Raffaele, Milan, Italy; [Pollard, Richard B.] Univ Calif Davis, Sacramento, CA 95817 USA; [Ramalho Madruga, Jose Valdez] Ctr Referencia & Treinamento DST AIDS, Sao Paulo, Brazil; [Berger, Daniel S.] Univ Illinois, Northstar Med Ctr, Chicago, IL USA	Merck & Company; Emory University; Orlando Immunology Center; Vita-Salute San Raffaele University; University of California System; University of California Davis; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sklar, P (corresponding author), Merck Res Labs, POB 1000,UG3D-56, N Wales, PA 19454 USA.	peter_sklar@merck.com	Portilla, Joaquín/O-7609-2018; Netto, Eduardo/D-1432-2013; Lennox, Jeffrey/D-1654-2014; LAZZARIN, Adriano/K-3607-2018	Portilla, Joaquín/0000-0002-3676-9511; Netto, Eduardo/0000-0003-1691-6761; Lennox, Jeffrey/0000-0002-2064-5565; Tamara, Jose Roberto/0000-0003-3036-5484; LAZZARIN, Adriano/0000-0003-2551-7754; Kozal, Michael/0000-0002-3100-8254	Merck [NIK-0518]	Merck(Merck & Company)	We thank the patients and their caregivers who participated in this study, Robin Isaacs and Keith Gottesdiener for their thoughtful advice, and Joann DiLullo and Karyn Davis for expert technical assistance. This study (NIK-0518 Protocol 021) was sponsored and funded by Merck, which manufactures raltegravir under the name Isentress.	Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Best BM, 2008, EXPERT OPIN DRUG MET, V4, P965, DOI 10.1517/17425255.4.7.965 ; Bezemer D, 2006, ANTIVIR THER, V11, P173; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P304, DOI 10.1097/QAI.0b013e31815e7453; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Fumaz CR, 2005, JAIDS-J ACQ IMM DEF, V38, P560, DOI 10.1097/01.qai.0000147523.41993.47; Gentz M, 2006, AIDS PATIENT CARE ST, V20, P741, DOI 10.1089/apc.2006.20.741; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Gutierrez F, 2005, CLIN INFECT DIS, V41, P1648, DOI 10.1086/497835; Haas DW, 2004, AIDS, V18, P2391; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hare CB, 2008, CLIN INFECT DIS, V47, P421, DOI 10.1086/589867; Hawkins T, 2005, HIV CLIN TRIALS, V6, P187, DOI 10.1310/92VR-FP24-J8GA-B49Q; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Hirschel B, 2008, NEW ENGL J MED, V358, P2170, DOI 10.1056/NEJMe0803013; Kijak GH, 2001, ANTIVIR THER, V6, P71; Kotler DP, 2008, JAIDS-J ACQ IMM DEF, V49, pS79, DOI 10.1097/QAI.0b013e318186519c; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Kuritzkes DR, 2007, J INFECT DIS, V195, P1169, DOI 10.1086/512619; Landovitz RJ, 2008, J INFECT DIS, V198, P1113, DOI 10.1086/592052; Lochet P, 2003, HIV Med, V4, P62, DOI 10.1046/j.1468-1293.2003.00136.x; MARKOWITZ M, 2008, 17 INT AIDS C MEX CI; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Markowitz M, 2006, JAIDS-J ACQ IMM DEF, V43, P509, DOI 10.1097/QAI.0b013e31802b4956; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Raffi F, 2006, CLIN INFECT DIS, V42, P870, DOI 10.1086/500206; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Riddler SA, 2008, JAIDS-J ACQ IMM DEF, V48, P281, DOI 10.1097/QAI.0b013e31817bbbf0; Rihs TA, 2006, HIV MED, V7, P544, DOI 10.1111/j.1468-1293.2006.00419.x; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Tozzi V, 2006, ANTIVIR THER, V11, P553; Truong HHA, 2006, AIDS, V20, P2193, DOI 10.1097/01.aids.0000252059.85236.af; Turner D, 2006, AIDS REV, V8, P17; *US DEP HHS, GUID US ANT AG HIV 1; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Viani RM, 2006, J INFECT DIS, V194, P1505, DOI 10.1086/508749; Ward DJ, 2006, AIDS PATIENT CARE ST, V20, P542, DOI 10.1089/apc.2006.20.542; Welles SL, 2007, JAIDS-J ACQ IMM DEF, V44, P329, DOI 10.1097/QAI.0b013e31802f1296; Wenning LA, 2008, ANTIMICROB AGENTS CH, V52, P3253, DOI 10.1128/AAC.00005-08	44	500	514	1	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2009	374	9692					796	806		10.1016/S0140-6736(09)60918-1	http://dx.doi.org/10.1016/S0140-6736(09)60918-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492QU	19647866				2022-12-28	WOS:000269675000028
J	Panter-Brick, C; Eggerman, M; Gonzalez, V; Safdar, S				Panter-Brick, Catherine; Eggerman, Mark; Gonzalez, Viani; Safdar, Sarah			Violence, suffering, and mental health in Afghanistan: a school-based survey	LANCET			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DIFFICULTIES QUESTIONNAIRE SDQ; ADOLESCENT PSYCHOPATHOLOGY; RANDOMIZED-TRIAL; COMMUNITY SAMPLE; CHILDREN; WAR; STRENGTHS; TRAUMA; DEPRESSION	Background Studies in Afghanistan have shown substantial mental health problems in adults. We did a survey of young people (11-16 years old) in the country to assess mental health, traumatic experiences, and social functioning. Methods In 2006, we interviewed 1011 children, 1011 caregivers, and 358 teachers, who were randomly sampled in 25 government-operated schools within three purposively chosen areas (Kabul, Bamyan, and Mazar-e-Sharif municipalities). We assessed probable psychiatric disorder and social functioning in students with the Strength and Difficulties Questionnaire multi-informant (child, parent, teacher) ratings. We also used the Depression Self-Rating Scale and an Impact of Events Scale. We assessed caregiver mental health with both international and culturally-specific screening instruments (Self-Reported Questionnaire and Afghan Symptom Checklist). We implemented a checklist of traumatic events to examine the exposure to, and nature of, traumatic experiences. We analysed risk factors for mental health and reports of traumatic experiences. Findings Trauma exposure and caregiver mental health were predictive across all child outcomes. Probable psychiatric ratings were associated with female gender (odds ratio [OR] 2.47, 95% CI 1.65-3.68), five or more traumatic events (2.58, 1.36-4.90), caregiver mental health (1.11, 1.08-1.14), and residence areas (0.29, 0.17-0.51 for Bamyan and 0.37, 0.23-0.57 for Mazar-e-Sharif vs Kabul). The same variables predicted symptoms of depression. Two thirds of children reported traumatic experiences. Symptoms of post-traumatic stress were associated with five or more traumatic events (3.07, 1.78-5.30), caregiver mental health (1.06, 1.02-1.09), and child age (1.19, 1.04-1.36). Children's most distressing traumatic experiences included accidents, medical treatment, domestic and community violence, and war-related events. Interpretation Young Afghans experience violence that is persistent and not confined to acts of war. Our study emphasises the value of school-based initiatives to address child mental health, and the importance of understanding trauma in the context of everyday forms of suffering, violence, and adversity.	[Panter-Brick, Catherine] Univ Durham, Dept Anthropol, Durham DH1 3LE, England; [Gonzalez, Viani] ALTAI Consulting, Kabul, Afghanistan; [Safdar, Sarah] Univ Peshawar, Peshawar, Pakistan	Durham University; University of Peshawar	Panter-Brick, C (corresponding author), Univ Durham, Dept Anthropol, Dawson Bldg,South Rd, Durham DH1 3LE, England.	catherine.panter-brick@durham.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; Alyahri A., 2006, Eastern Mediterranean Health Journal, V12, pS138; Bakhshi P, 2006, INCLUSION EQUALITY E; Barenbaum J, 2004, J CHILD PSYCHOL PSYC, V45, P41, DOI 10.1046/j.0021-9630.2003.00304.x; Bernard H.R., 1995, RES METHODS ANTHR QU; Betancourt TS, 2008, INTERVENTION, V6, P39, DOI 10.1097/WTF.0b013e3282f761ff; Betancourt TS, 2008, INT REV PSYCHIATR, V20, P317, DOI 10.1080/09540260802090363; BIRD HR, 1990, J AM ACAD CHILD PSY, V29, P796, DOI 10.1097/00004583-199009000-00020; BIRLESON P, 1987, J CHILD PSYCHOL PSYC, V28, P43, DOI 10.1111/j.1469-7610.1987.tb00651.x; Boyden J., 2004, CHILDREN YOUTH FRONT; Cardozo BL, 2004, JAMA-J AM MED ASSOC, V292, P575, DOI 10.1001/jama.292.5.575; De Berry J., 2004, INTERVENTION, V2, P143; De Berry J., 2003, CHILDREN KABUL DISCU; de Berry Joanna., 2008, YEARS CONFLICT ADOLE, P209; EYBER C, 2003, POVERTY DISPLACEMENT; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Hackett R, 1999, INT REV PSYCHIATR, V11, P225, DOI 10.1080/09540269974410; Harpham T, 2003, HEALTH POLICY PLANN, V18, P344, DOI 10.1093/heapol/czg041; Heptinstall E, 2004, EUR CHILD ADOLES PSY, V13, P373, DOI 10.1007/s00787-004-0422-y; Husain N, 2007, BRIT J PSYCHIAT, V190, P36, DOI 10.1192/bjp.bp.106.022913; Inter-Agency Standing Committee (IASC), 2007, IASC GUID MENT HLTH; Jones L, 2002, CHILD ABUSE NEGLECT, V26, P1059, DOI 10.1016/S0145-2134(02)00381-2; Jordans MJD, 2009, CHILD ADOL MENT H-UK, V14, P2, DOI 10.1111/j.1475-3588.2008.00515.x; Khamis V., 2004, IMPACT CLASSROOM COM; Kleinman A, 1997, SOCIAL SUFFERING; Kostelny K., 2006, WORLD TURNED UPSIDE, P19; Miller KE, 2006, AM J ORTHOPSYCHIAT, V76, P409, DOI 10.1037/0002-9432.76.4.409; Miller KE, 2006, AM J ORTHOPSYCHIAT, V76, P423, DOI 10.1037/0002-9432.76.4.423; Miller KE, 2008, TRANSCULT PSYCHIATRY, V45, P611, DOI 10.1177/1363461508100785; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Morris J, 2007, DISASTERS, V31, P71, DOI 10.1111/j.1467-7717.2007.00341.x; Mullick MSI, 2001, SOC PSYCH PSYCH EPID, V36, P94, DOI 10.1007/s001270050295; Palmer N, 2006, BMJ-BRIT MED J, V332, P718, DOI 10.1136/bmj.332.7543.718; Panter-Brick C, 2008, AM J HUM BIOL, V20, P627, DOI 10.1002/ajhb.20797; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Rahman A, 1998, LANCET, V352, P1022, DOI 10.1016/S0140-6736(98)02381-2; Rasekh Z, 1998, JAMA-J AM MED ASSOC, V280, P449, DOI 10.1001/jama.280.5.449; Samad L, 2005, INT J METH PSYCH RES, V14, P158, DOI 10.1002/mpr.3; Scholte WF, 2004, JAMA-J AM MED ASSOC, V292, P585, DOI 10.1001/jama.292.5.585; Smith, 2008, LOVE FEAR DISCIPLINE; Smith P, 2002, J TRAUMA STRESS, V15, P147, DOI 10.1023/A:1014812209051; Stallard P, 1999, J CHILD PSYCHOL PSYC, V40, P1075, DOI 10.1111/1469-7610.00525; Stein DJ, 2007, LANCET, V369, P139, DOI 10.1016/S0140-6736(07)60075-0; Summerfield DA, 1998, LANCET, V351, P1580, DOI 10.1016/S0140-6736(98)02001-7; Syed EU, 2007, SOC PSYCH PSYCH EPID, V42, P421, DOI 10.1007/s00127-007-0188-x; Thabet AA, 2000, INT J SOC PSYCHIATR, V46, P266, DOI 10.1177/002076400004600404; Thabet AAM, 1999, J CHILD PSYCHOL PSYC, V40, P385, DOI 10.1111/1469-7610.00456; Thabet AAM, 2002, LANCET, V359, P1801, DOI 10.1016/S0140-6736(02)08709-3; Tol WA, 2008, JAMA-J AM MED ASSOC, V300, P655, DOI 10.1001/jama.300.6.655; van de Put W, 2002, LANCET, V360, pS41, DOI 10.1016/S0140-6736(02)11816-2; Van Ommeren M, 2003, BRIT J PSYCHIAT, V182, P376, DOI 10.1192/bjp.182.5.376; van Ommeren M., 1999, TRANSCULT PSYCHIATRY, V36, P285, DOI [10.1177/136346159903600304, DOI 10.1177/136346159903600304]; Ventevogel P, 2007, SOC PSYCH PSYCH EPID, V42, P328, DOI 10.1007/s00127-007-0161-8; Waldman R, 2006, AFGHANISTANS HLTH SY; *WHO, 2008, SOC DET HLTH COUNTR	57	137	139	1	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 5	2009	374	9692					807	816		10.1016/S0140-6736(09)61080-1	http://dx.doi.org/10.1016/S0140-6736(09)61080-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492QU	19699514	Green Accepted, Green Published			2022-12-28	WOS:000269675000029
J	Mok, TS; Wu, YL; Thongprasert, S; Yang, CH; Chu, DT; Saijo, N; Sunpaweravong, P; Han, BH; Margono, B; Ichinose, Y; Nishiwaki, Y; Ohe, Y; Yang, JJ; Chewaskulyong, B; Jiang, HY; Duffield, EL; Watkins, CL; Armour, AA; Fukuoka, M				Mok, Tony S.; Wu, Yi-Long; Thongprasert, Sumitra; Yang, Chih-Hsin; Chu, Da-Tong; Saijo, Nagahiro; Sunpaweravong, Patrapim; Han, Baohui; Margono, Benjamin; Ichinose, Yukito; Nishiwaki, Yutaka; Ohe, Yuichiro; Yang, Jin-Ji; Chewaskulyong, Busyamas; Jiang, Haiyi; Duffield, Emma L.; Watkins, Claire L.; Armour, Alison A.; Fukuoka, Masahiro			Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL LUNG-CANCER; FACTOR-RECEPTOR GENE; PROSPECTIVE PHASE-II; FUNCTIONAL ASSESSMENT; 1ST-LINE GEFITINIB; TREATED PATIENTS; EGFR MUTATIONS; THERAPY; MULTICENTER; ERLOTINIB	Background: Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in selected patients with non-small-cell lung cancer. Methods: In this phase 3, open-label study, we randomly assigned previously untreated patients in East Asia who had advanced pulmonary adenocarcinoma and who were nonsmokers or former light smokers to receive gefitinib (250 mg per day) (609 patients) or carboplatin (at a dose calculated to produce an area under the curve of 5 or 6 mg per milliliter per minute) plus paclitaxel (200 mg per square meter of body-surface area) (608 patients). The primary end point was progression-free survival. Results: The 12-month rates of progression-free survival were 24.9% with gefitinib and 6.7% with carboplatin-paclitaxel. The study met its primary objective of showing the noninferiority of gefitinib and also showed its superiority, as compared with carboplatin-paclitaxel, with respect to progression-free survival in the intention-to-treat population (hazard ratio for progression or death, 0.74; 95% confidence interval [CI], 0.65 to 0.85; P<0.001). In the subgroup of 261 patients who were positive for the epidermal growth factor receptor gene (EGFR) mutation, progression-free survival was significantly longer among those who received gefitinib than among those who received carboplatin-paclitaxel (hazard ratio for progression or death, 0.48; 95% CI, 0.36 to 0.64; P<0.001), whereas in the subgroup of 176 patients who were negative for the mutation, progression-free survival was significantly longer among those who received carboplatin-paclitaxel (hazard ratio for progression or death with gefitinib, 2.85; 95% CI, 2.05 to 3.98; P<0.001). The most common adverse events were rash or acne (in 66.2% of patients) and diarrhea (46.6%) in the gefitinib group and neurotoxic effects (69.9%), neutropenia (67.1%), and alopecia (58.4%) in the carboplatin-paclitaxel group. Conclusions: Gefitinib is superior to carboplatin-paclitaxel as an initial treatment for pulmonary adenocarcinoma among nonsmokers or former light smokers in East Asia. The presence in the tumor of a mutation of the EGFR gene is a strong predictor of a better outcome with gefitinib. (ClinicalTrials.gov number, NCT00322452.) N Engl J Med 2009;361:947-57.	[Mok, Tony S.] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China; [Wu, Yi-Long; Yang, Jin-Ji] Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Chu, Da-Tong] Chinese Acad Med Sci, Canc Hosp, Beijing 100037, Peoples R China; [Han, Baohui] Shanghai Chest Hosp, Shanghai, Peoples R China; [Thongprasert, Sumitra; Chewaskulyong, Busyamas] Chiang Mai Univ, Maharaj Nakorn Chiang Mai Hosp, Chiang Mai 50000, Thailand; [Sunpaweravong, Patrapim] Prince Songkla Univ, Hat Yai, Thailand; [Yang, Chih-Hsin] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Saijo, Nagahiro; Nishiwaki, Yutaka] Natl Canc Ctr Hosp E, Chiba, Japan; [Ichinose, Yukito] Kyushu Natl Canc Ctr, Fukuoka, Japan; [Ohe, Yuichiro] Natl Canc Ctr, Tokyo, Japan; [Jiang, Haiyi] AstraZeneca, Osaka, Japan; [Fukuoka, Masahiro] Kinki Univ, Sch Med, Osaka 589, Japan; [Margono, Benjamin] Dr Soetomo Hosp, Surabaya, Indonesia; [Duffield, Emma L.; Watkins, Claire L.; Armour, Alison A.] AstraZeneca, Macclesfield, Cheshire, England	Chinese University of Hong Kong; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Shanghai Jiao Tong University; Chiang Mai University; Prince of Songkla University; National Taiwan University; National Taiwan University Hospital; National Cancer Center - Japan; National Cancer Center - Japan; AstraZeneca; Kindai University (Kinki University); Dr Soetomo General Hospital Surabaya; AstraZeneca	Mok, TS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China.	tony@clo.cuhk.edu.hk	Mok, Tony Shu Kam/B-2310-2019; Wu, Yi-Long/AAB-9137-2022; Wu, Yi-Long/C-3396-2008; Yang, James Chih-Hsin/W-1587-2019; Wu, Yi-Long/GRJ-9238-2022; Wu, Yi-Long/AAW-9832-2020	Mok, Tony Shu Kam/0000-0002-8251-0551; Wu, Yi-Long/0000-0002-3611-0258; Wu, Yi-Long/0000-0002-3611-0258; Yang, James Chih-Hsin/0000-0002-5586-5138	AstraZeneca	AstraZeneca(AstraZeneca)	We thank the patients and investigators for their participation in this study and Annette Smith, Ph. D., from Complete Medical Communications, who provided editing support funded by AstraZeneca.	Cella D, 2002, J CLIN EPIDEMIOL, V55, P285, DOI 10.1016/S0895-4356(01)00477-2; CELLA DF, 1995, LUNG CANCER-J IASLC, V12, P199, DOI 10.1016/0169-5002(95)00450-F; Chang GC, 2005, INVEST NEW DRUG, V23, P73, DOI 10.1023/B:DRUG.0000047108.39129.7c; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kimura H, 2006, J THORAC ONCOL, V1, P260, DOI 10.1016/S1556-0864(15)31577-X; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lee DH, 2005, CLIN CANCER RES, V11, P3032, DOI 10.1158/1078-0432.CCR-04-2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Morikawa T, 1995, J Biopharm Stat, V5, P297, DOI 10.1080/10543409508835115; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park K, 2006, CURR MED RES OPIN, V22, P561, DOI 10.1185/030079906X89847; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist, 2008, J CLIN ONCOL, V26, P3472, DOI 10.1200/JCO.2008.18.4747; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Tamura K, 2008, BRIT J CANCER, V98, P907, DOI 10.1038/sj.bjc.6604249; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Westfall P.H., 1993, RESAMPLING BASED MUL; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Yang CH, 2008, J CLIN ONCOL, V26, P2745, DOI 10.1200/JCO.2007.15.6695; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	32	6229	6661	13	637	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					947	957		10.1056/NEJMoa0810699	http://dx.doi.org/10.1056/NEJMoa0810699			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490EI	19692680	Bronze			2022-12-28	WOS:000269480400004
J	Baqui, AH; Ahmed, S; El Arifeen, S; Darmstadt, GL; Rosecrans, AM; Mannan, I; Rahman, SM; Begum, N; Mahmud, ABA; Seraji, HR; Williams, EK; Winch, PJ; Santosham, M; Black, RE				Baqui, Abdullah H.; Ahmed, Saifuddin; El Arifeen, Shams; Darmstadt, Gary L.; Rosecrans, Amanda M.; Mannan, Ishtiaq; Rahman, Syed M.; Begum, Nazma; Mahmud, Arif B. A.; Seraji, Habibur R.; Williams, Emma K.; Winch, Peter J.; Santosham, Mathuram; Black, Robert E.		Projahnmo 1 Study Grp	Effect of timing of first postnatal care home visit on neonatal mortality in Bangladesh: a observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MATERNAL MORTALITY; HEALTH; COMMUNITY; INTERVENTIONS; MANAGEMENT; STRATEGIES; CHILDREN; IMPACT; TRIAL	Objective To assess the effect of the timing of first postnatal home visit by community health workers on neonatal mortality. Design Analysis of prospectively collected data using time varying discrete hazard models to estimate hazard ratios for neonatal mortality according to day of first postnatal home visit. Data source Data from a community based trial of neonatal care interventions conducted in Bangladesh during 2004-5. Main outcome measure Neonatal mortality. Results 9211 live births were included. Among infants who survived the first day of life, neonatal mortality was 67% lower in those who received a visit on day one than in those who received no visit ( adjusted hazard ratio 0.33, 95% confidence interval 0.23 to 0.46; P<0.001). For those infants who survived the first two days of life, receiving the first visit on the second day was associated with a 64% lower neonatal mortality than in those who did not receive a visit ( adjusted hazard ratio 0.36, 0.23 to 0.55; P<0.001). First visits on any day after the second day of life were not associated with reduced mortality. Conclusions In developing countries, especially where home delivery with unskilled attendants is common, postnatal home visits within the first two days of life by trained community health workers can significantly reduce neonatal mortality.	[Baqui, Abdullah H.; Darmstadt, Gary L.; Rosecrans, Amanda M.; Williams, Emma K.; Winch, Peter J.; Santosham, Mathuram; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Ahmed, Saifuddin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat & Family Hlth, Baltimore, MD 21205 USA; [Baqui, Abdullah H.; El Arifeen, Shams; Rahman, Syed M.; Begum, Nazma; Mahmud, Arif B. A.; Seraji, Habibur R.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Darmstadt, Gary L.] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Bill & Melinda Gates Foundation	Baqui, AH (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	abaqui@jhsph.edu	LeFevre, Amnesty E/A-3162-2019; Rahman, Syed Moshfiqur/AAH-9000-2019; Darmstadt, Gary/AAU-7488-2020	LeFevre, Amnesty E/0000-0001-8437-7240; Rahman, Syed Moshfiqur/0000-0002-9441-0590; Williams, Emma/0000-0003-0547-0194; Arifeen, Shams/0000-0002-5372-5932; Darmstadt, Gary/0000-0002-7522-5824; Black, Robert/0000-0001-9926-7984	United States Agency for International Development; Johns Hopkins University Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research, Bangladesh; Bill and Melinda Gates Foundation; FOGARTY INTERNATIONAL CENTER [D43TW007587] Funding Source: NIH RePORTER	United States Agency for International Development(United States Agency for International Development (USAID)); Johns Hopkins University Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research, Bangladesh; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was funded by the United States Agency for International Development, through cooperative agreements with the Johns Hopkins University Bloomberg School of Public Health and the International Centre for Diarrhoeal Disease Research, Bangladesh, and by the Saving Newborn Lives programme of Save the Children through a grant from the Bill and Melinda Gates Foundation. The study sponsors had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The researchers were independent of the funders.	Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS62, DOI 10.1038/sj.jp.7211273; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS92, DOI 10.1038/sj.jp.7211277; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS29, DOI 10.1038/sj.jp.7211269; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS82, DOI 10.1038/sj.jp.7211275; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS72, DOI 10.1038/sj.jp.7211276; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS108, DOI 10.1038/sj.jp.7211278; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2006, Bull World Health Organ, V84, P706, DOI 10.2471/BLT.05.026443; Baqui A. H., 2008, Global Public Health, V3, P366, DOI 10.1080/17441690701592866; Baqui AH, 2008, B WORLD HEALTH ORGAN, V86, P796, DOI 10.2471/BLT.07.042226; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2009, PEDIATR INFECT DIS J, V28, P304, DOI 10.1097/INF.0b013e31819069e8; BARTLETT AV, 1991, PEDIATR INFECT DIS J, V10, P752, DOI 10.1097/00006454-199110000-00007; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Daga S. R., 1993, Indian Journal of Pediatrics, V60, P627, DOI 10.1007/BF02821721; DAGA S R, 1992, Indian Pediatrics, V29, P189; Darmstadt GL, 2007, PEDIATR INFECT DIS J, V26, P501, DOI 10.1097/INF.0b013e318059c25b; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Freeman JV, 2005, PAEDIATR PERINAT EP, V19, P323, DOI 10.1111/j.1365-3016.2005.00652.x; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Haws RA, 2007, HEALTH POLICY PLANN, V22, P193, DOI 10.1093/heapol/czm009; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Levy PS., 2014, WILEY STATSREF STAT; McKenzie D.J., 2003, 042 BREAD HARV U CTR; Morris SS, 2007, CONTEMP CLIN TRIALS, V28, P382, DOI 10.1016/j.cct.2006.10.008; PRATINIDHI A, 1986, B WORLD HEALTH ORGAN, V64, P291; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Wagstaff A, 2003, HEALTH ECON, V12, P885, DOI 10.1002/hec.805; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307	32	84	84	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2009	339								b2826	10.1136/bmj.b2826	http://dx.doi.org/10.1136/bmj.b2826			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YL	19684100	Green Published, hybrid			2022-12-28	WOS:000269162200003
J	Hobsley, M; Tovey, FI; Bardhan, KD; Holton, J				Hobsley, Michael; Tovey, Frank I.; Bardhan, Karna Dev; Holton, John			Does Helicobacter pylori really cause duodenal ulcers? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							GASTRIC-SECRETION; AFRICAN ENIGMA; INFECTION; ULCERATION; SOUTH; UREA		[Hobsley, Michael; Tovey, Frank I.] UCL, Sch Med, London N20 8AS, England; [Bardhan, Karna Dev] Rotherham Gen Hosp, Rotherham, S Yorkshire, England; [Holton, John] UCL, Windeyer Inst Med Sci, London N20 8AS, England	University of London; University College London; UCL Medical School; University of London; University College London	Hobsley, M (corresponding author), UCL, Sch Med, London N20 8AS, England.	m.hobsley@ucl.ac.uk	Holton, John/AAX-1521-2021					Agha A, 2005, SCAND J GASTROENTERO, V40, P523, DOI 10.1080/00365520510012280; Boulos PB, 2002, QJM-INT J MED, V95, P749, DOI 10.1093/qjmed/95.11.749; Bytzer P, 2001, AM J GASTROENTEROL, V96, P1409; CHANDRAKUMARAN K, 1994, GUT, V35, P1033, DOI 10.1136/gut.35.8.1033; Gunawan E, 2002, J GASTROEN HEPATOL, V17, P960, DOI 10.1046/j.1440-1746.2002.02782.x; Hobsley M, 1987, THEORETICAL SURGERY, V2, P106; Hobsley M, 2008, T ROY SOC TROP MED H, V102, P1171, DOI 10.1016/j.trstmh.2008.04.035; HOLCOMBE C, 1992, GUT, V33, P429, DOI 10.1136/gut.33.4.429; MARSHALL BJ, 1990, GASTROENTEROLOGY, V99, P697, DOI 10.1016/0016-5085(90)90957-3; Miwa H, 2004, HELICOBACTER, V9, P9, DOI 10.1111/j.1083-4389.2004.00194.x; Pearce HR, 2004, DIGESTION, V69, P201, DOI 10.1159/000079149; Pest P., 1996, Acta Gastroenterologica Latinoamericana, V26, P273; REINBACH DH, 1993, GUT, V34, P1344, DOI 10.1136/gut.34.10.1344; Sjostrom JE, 1996, J MED MICROBIOL, V44, P425; Tabel G, 2003, J LAB CLIN MED, V142, P421, DOI 10.1016/j.lab.2003.06.001; TOVEY F, 1979, GUT, V20, P329, DOI 10.1136/gut.20.4.329; TOVEY FI, 1975, GUT, V16, P564, DOI 10.1136/gut.16.7.564; TOVEY FI, 1992, J GASTROEN HEPATOL, V4, P427; Tovey FI, 2006, WORLD J GASTROENTERO, V12, P6, DOI 10.3748/wjg.v12.i1.6; WHITFIELD PF, 1979, AGENTS ACTIONS, V9, P327, DOI 10.1007/BF01970656; Wong BCY, 1998, J GASTROEN HEPATOL, V13, P1050, DOI 10.1111/j.1440-1746.1998.tb00569.x	21	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 14	2009	339								b2788	10.1136/bmj.b2788	http://dx.doi.org/10.1136/bmj.b2788			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YL	19684099				2022-12-28	WOS:000269162200002
J	Fontecilla-Camps, JC; Amara, P; Cavazza, C; Nicolet, Y; Volbeda, A				Fontecilla-Camps, Juan C.; Amara, Patricia; Cavazza, Christine; Nicolet, Yvain; Volbeda, Anne			Structure-function relationships of anaerobic gas-processing metalloenzymes	NATURE			English	Review							COENZYME-M-REDUCTASE; CARBON-MONOXIDE DEHYDROGENASE; IRON-MOLYBDENUM COFACTOR; HYDROGENASE H-CLUSTER; BIOLOGICAL METHANE FORMATION; A SYNTHASE/CO DEHYDROGENASE; ACTIVE-SITE REGION; ACETYL-COENZYME; CRYSTAL-STRUCTURE; NIFE-HYDROGENASE	Reactions involving H(2), N(2), CO, CO(2) and CH(4) are likely to have been central to the origin of life. This is indicated by the active-site structures of the enzymes involved, which are often reminiscent of minerals. Through the combined efforts of protein crystallography, various types of spectroscopy, theoretical calculations and model chemistry, it has been possible to put forward plausible mechanisms for gas-based metabolism by extant microorganisms. Although the reactions are based on metal centres, the protein matrix regulates reactivity and substrate and product trafficking through internal pathways, specific ligation and dielectricity.	[Fontecilla-Camps, Juan C.; Amara, Patricia; Cavazza, Christine; Nicolet, Yvain; Volbeda, Anne] Univ Grenoble 1, CEA, CNRS, Lab Cristallog & Cristallogenese Prot,Inst Biol S, F-38027 Grenoble 1, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fontecilla-Camps, JC (corresponding author), Univ Grenoble 1, CEA, CNRS, Lab Cristallog & Cristallogenese Prot,Inst Biol S, 41 Rue J Horowitz, F-38027 Grenoble 1, France.	juan-carlos.fontecilla@ibs.fr	Cavazza, Christine/AAL-5795-2020; Yvain, Nicolet/AAP-9763-2020	Yvain, Nicolet/0000-0002-4189-7067; Amara, Patricia/0000-0001-9634-7305; Volbeda, Anne/0000-0002-6038-0979	Agence Nationale de la Recherche; BIOTEC programme of the European Union	Agence Nationale de la Recherche(French National Research Agency (ANR)); BIOTEC programme of the European Union	We thank D. M. Lawson and S. M. Mayer for providing data concerning the xenon sites in nitrogenase. We also thank the Commissariat a l'Energie Atomique and the Centre National de la Recherche Scientifique for institutional support, and the Agence Nationale de la Recherche and the BIOTEC programme of the European Union for funding.	Amara P, 2005, J AM CHEM SOC, V127, P2776, DOI 10.1021/ja0439221; ANDRADE SLA, 2008, HDB METALLOPROTEINS, DOI DOI 10.1002/0470028637.MET224; Barton BE, 2008, J AM CHEM SOC, V130, P16834, DOI 10.1021/ja8057666; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Brecht M, 2003, J AM CHEM SOC, V125, P13075, DOI 10.1021/ja036624x; Bruschi M, 2008, INORG CHEM, V47, P6056, DOI 10.1021/ic8006298; BULEN WA, 1966, P NATL ACAD SCI USA, V56, P979, DOI 10.1073/pnas.56.3.979; CAMMACK R, 1982, FEBS LETT, V142, P289, DOI 10.1016/0014-5793(82)80154-3; Chen YH, 2008, J AM CHEM SOC, V130, P15250, DOI 10.1021/ja805025w; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Cohen J, 2005, STRUCTURE, V13, P1321, DOI 10.1016/j.str.2005.05.013; COREMANS JMCC, 1992, BIOCHIM BIOPHYS ACTA, V1119, P148, DOI 10.1016/0167-4838(92)90385-Q; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Dance I, 2008, DALTON T, P5977, DOI 10.1039/b806100a; Darnault C, 2003, NAT STRUCT BIOL, V10, P271, DOI 10.1038/nsb912; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; Doukov TI, 2008, BIOCHEMISTRY-US, V47, P3474, DOI 10.1021/bi702386t; DuBois MR, 2009, CHEM SOC REV, V38, P62, DOI 10.1039/b801197b; Durrant MC, 2001, BIOCHEM J, V355, P569, DOI 10.1042/bj3550569; Eckert NA, 2007, J AM CHEM SOC, V129, P9286, DOI 10.1021/ja072063o; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; FONTECILLACAMPS.JC, 2008, HDB METALLOPROTEINS, DOI DOI 10.1002/0470028637.MET212; Garcin E, 1999, STRUCT FOLD DES, V7, P557, DOI 10.1016/S0969-2126(99)80072-0; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Goenrich M, 2005, J BIOL INORG CHEM, V10, P333, DOI 10.1007/s00775-005-0636-6; Gong W, 2008, P NATL ACAD SCI USA, V105, P9558, DOI 10.1073/pnas.0800415105; Grabarse W, 2001, J MOL BIOL, V309, P315, DOI 10.1006/jmbi.2001.4647; Grahame DA, 2005, ARCH MICROBIOL, V184, P32, DOI 10.1007/s00203-005-0006-3; Harmer J, 2008, J AM CHEM SOC, V130, P10907, DOI 10.1021/ja710949e; Harrop TC, 2006, INORG CHEM, V45, P3424, DOI 10.1021/ic0520465; Harrop TC, 2004, CHEM COMMUN, P1744, DOI 10.1039/b405572c; Hernandez JA, 2008, P NATL ACAD SCI USA, V105, P11679, DOI 10.1073/pnas.0803576105; Hiromoto T, 2009, ANGEW CHEM INT EDIT, V48, P6457, DOI 10.1002/anie.200902695; Hiromoto T, 2009, FEBS LETT, V583, P585, DOI 10.1016/j.febslet.2009.01.017; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Jeon WB, 2005, J BIOL INORG CHEM, V10, P903, DOI 10.1007/s00775-005-0043-z; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Jeoung JH, 2007, SCIENCE, V318, P1461, DOI 10.1126/science.1148481; Jones AK, 2002, CHEM COMMUN, P866, DOI 10.1039/b201337a; Kahnt J, 2007, FEBS J, V274, P4913, DOI 10.1111/j.1742-4658.2007.06016.x; Kerby RL, 1997, J BACTERIOL, V179, P2259, DOI 10.1128/jb.179.7.2259-2266.1997; KIRN J, 1992, NATURE, V360, P553, DOI DOI 10.1038/360553A0; Konhauser KO, 2009, NATURE, V458, P750, DOI 10.1038/nature07858; Lai CH, 1996, ANGEW CHEM INT EDIT, V35, P2390, DOI 10.1002/anie.199623901; Leach MR, 2007, J BIOL CHEM, V282, P16177, DOI 10.1074/jbc.M610834200; Lemon BJ, 1999, BIOCHEMISTRY-US, V38, P12969, DOI 10.1021/bi9913193; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Lill SON, 2009, BIOCHEMISTRY-US, V48, P1056, DOI 10.1021/bi801218n; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Nicolet Y, 2000, TRENDS BIOCHEM SCI, V25, P138, DOI 10.1016/S0968-0004(99)01536-4; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Obrist BV, 2009, INORG CHEM, V48, P3514, DOI 10.1021/ic900281g; Ogata H, 2002, J AM CHEM SOC, V124, P11628, DOI 10.1021/ja012645k; Ohki Y, 2007, J AM CHEM SOC, V129, P10457, DOI 10.1021/ja072256b; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Pelmenschikov V, 2008, INORG CHEM, V47, P6162, DOI 10.1021/ic7022743; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Rao PV, 2005, J AM CHEM SOC, V127, P1933, DOI 10.1021/ja040222n; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; ROSENFIELD RE, 1977, J AM CHEM SOC, V99, P4860, DOI 10.1021/ja00456a072; ROSSMANN R, 1995, EUR J BIOCHEM, V227, P545, DOI 10.1111/j.1432-1033.1995.tb20422.x; Royer AM, 2008, INORG CHEM, V47, P395, DOI 10.1021/ic7018692; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Sarangi R, 2009, BIOCHEMISTRY-US, V48, P3146, DOI 10.1021/bi900087w; Schenker RP, 2003, J AM CHEM SOC, V125, P13962, DOI 10.1021/ja037893q; Schrock RR, 2008, ANGEW CHEM INT EDIT, V47, P5512, DOI 10.1002/anie.200705246; Seefeldt LC, 2004, BIOCHEMISTRY-US, V43, P1401, DOI 10.1021/bi036038g; Selmer T, 2000, J BIOL CHEM, V275, P3755, DOI 10.1074/jbc.275.6.3755; Seravalli J, 2008, J BIOL CHEM, V283, P8384, DOI 10.1074/jbc.M709470200; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; Shima S, 2005, J AM CHEM SOC, V127, P10430, DOI 10.1021/ja051895o; Siegbahn PEM, 2007, CHEM REV, V107, P4414, DOI 10.1021/cr050185y; Signor L, 2000, CHEM-EUR J, V6, P3508, DOI 10.1002/1521-3765(20001002)6:19<3508::AID-CHEM3508>3.3.CO;2-N; SILVER WS, 1973, J THEOR BIOL, V40, P1, DOI 10.1016/0022-5193(73)90160-4; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Sun JB, 2007, INORG CHEM, V46, P2691, DOI 10.1021/ic062362z; Tada M, 1997, CHEM COMMUN, P2161, DOI 10.1039/a705187e; Tan X, 2008, J AM CHEM SOC, V130, P6712, DOI 10.1021/ja801981h; Tan XS, 2006, J AM CHEM SOC, V128, P12331, DOI 10.1021/ja0627702; Tanino S, 2009, INORG CHEM, V48, P2358, DOI 10.1021/ic900017s; Teixeira VH, 2006, BIOPHYS J, V91, P2035, DOI 10.1529/biophysj.106.084376; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Volbeda A, 2005, DALTON T, P3443, DOI 10.1039/b508403b; Volbeda A, 2005, COORDIN CHEM REV, V249, P1609, DOI 10.1016/j.ccr.2004.12.009; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Wachtershauser G, 2006, PHILOS T R SOC B, V361, P1787, DOI 10.1098/rstb.2006.1904; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Yang N, 2007, J AM CHEM SOC, V129, P11028, DOI 10.1021/ja0734501; Zheng LM, 1997, J BACTERIOL, V179, P5963, DOI 10.1128/jb.179.18.5963-5966.1997	101	186	186	0	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 13	2009	460	7257					814	822		10.1038/nature08299	http://dx.doi.org/10.1038/nature08299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675641				2022-12-28	WOS:000268938300025
J	Abramowitz, JS; Taylor, S; Mckay, D				Abramowitz, Jonathan S.; Taylor, Steven; McKay, Dean			Obsessive-compulsive disorder	LANCET			English	Review							D-CYCLOSERINE; SPECTRUM DISORDERS; EXPOSURE THERAPY; BEHAVIOR-THERAPY; CONTROLLED-TRIAL; RESPONSE PREVENTION; TRANSPORTER GENE; COGNITIVE THEORY; BASAL GANGLIA; METAANALYSIS	Obsessive-compulsive disorder is a severe and disabling clinical condition that usually arises in late adolescence or early adulthood and, if left untreated, has a chronic course. Whether this disorder should be classified as an anxiety disorder or in a group of putative obsessive-compulsive-related disorders is still a matter of debate. Biological models of obsessive-compulsive disorder propose anomalies in the serotonin pathway and dysfunctional circuits in the orbito-striatal area and dorsolateral prefrontal cortex. Support for these models is mixed and they do not account for the symptomatic heterogeneity of the disorder. The cognitive-behavioural model of obsessive-compulsive disorder, which has some empirical support but does not fully explain the disorder, emphasises the importance of dysfunctional beliefs in individuals affected. Both biological and cognitive models have led to empirical treatments for the disorder-ie, serotonin-reuptake inhibitors and various forms of cognitive-behavioural therapy. New developments in the treatment of obsessive-compulsive disorder involve medications that work in conjuction with cognitive-behavioural therapy, the most promising of which is D-cycloserine.	[Abramowitz, Jonathan S.] Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA; [Taylor, Steven] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [McKay, Dean] Fordham Univ, Bronx, NY 10458 USA	University of North Carolina; University of North Carolina Chapel Hill; University of British Columbia; Fordham University	Abramowitz, JS (corresponding author), Univ N Carolina, Dept Psychol, CB 3270, Chapel Hill, NC 27599 USA.	jabramowitz@unc.edu		McKay, Dean/0000-0003-1158-5043				ABRAMOWITZ J, EXPOSURE BA IN PRESS; Abramowitz J., 2010, ROM J COGN BEHAV PSY, V2002, P89, DOI [DOI 10.1016/J.CPR.2005.07.003, 10.1016/j.cpr.2005.07.003]; Abramowitz J.S., 2006, UNDERSTANDING TREATI; Abramowitz JS, 2008, BEHAV RES THER, V46, P1026, DOI 10.1016/j.brat.2008.05.006; Abramowitz JS, 2007, J ANXIETY DISORD, V21, P91, DOI 10.1016/j.janxdis.2006.05.003; Abramowitz JS, 2006, BEHAV RES THER, V44, P1361, DOI 10.1016/j.brat.2005.09.011; Abramowitz JS, 2006, CAN J PSYCHIAT, V51, P407, DOI 10.1177/070674370605100702; Abramowitz JS, 2005, BEHAV THER, V36, P55, DOI 10.1016/S0005-7894(05)80054-1; Abramowitz JS, 1997, J CONSULT CLIN PSYCH, V65, P44, DOI 10.1037/0022-006X.65.1.44; Alvarenga P, 2007, HDB CHILD ADOLESCENT, P1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aouizcrate B, 2006, CLIN NEUROPSYCHIATR, V3, P391; Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769; Bienvenu OJ, 2000, BIOL PSYCHIAT, V48, P287, DOI 10.1016/S0006-3223(00)00831-3; Bloch MH, 2006, MOL PSYCHIATR, V11, P622, DOI 10.1038/sj.mp.4001823; BOJE KM, 1993, BRAIN RES, V603, P207, DOI 10.1016/0006-8993(93)91239-O; Camarena B, 2007, EUR NEUROPSYCHOPHARM, V17, P406, DOI 10.1016/j.euroneuro.2006.08.001; Chakrabarty K, 2005, NEUROPSYCHOPHARMACOL, V30, P1735, DOI 10.1038/sj.npp.1300733; CHRISTENSON GA, 1991, AM J PSYCHIAT, V148, P1566; Coric V, 2005, BIOL PSYCHIAT, V58, P424, DOI 10.1016/j.biopsych.2005.04.043; da Rocha FF, 2008, PROG NEURO-PSYCHOPH, V32, P1139, DOI 10.1016/j.pnpbp.2007.12.026; Dickel DE, 2006, ARCH GEN PSYCHIAT, V63, P778, DOI 10.1001/archpsyc.63.7.778; do Rosario-Campos MC, 2005, AM J MED GENET B, V136B, P92, DOI 10.1002/ajmg.b.30149; Eddy KT, 2004, CLIN PSYCHOL REV, V24, P1011, DOI 10.1016/j.cpr.2004.08.004; FALSSTEWART W, 1993, J NERV MENT DIS, V181, P189, DOI 10.1097/00005053-199303000-00007; Foa EB, 2005, AM J PSYCHIAT, V162, P151, DOI 10.1176/appi.ajp.162.1.151; Foa EB, 2002, BIOL PSYCHIAT, V52, P987, DOI 10.1016/S0006-3223(02)01552-4; FOTNENELLE LF, 2006, PROG NEUROPSYCHOPHAR, V30, P327; Franklin ME, 2000, J CONSULT CLIN PSYCH, V68, P594, DOI 10.1037//0022-006X.68.4.594; Geller DA, 2006, PSYCHIAT CLIN N AM, V29, P353, DOI 10.1016/j.psc.2006.02.012; Geller DA, 2003, AM J PSYCHIAT, V160, P1919, DOI 10.1176/appi.ajp.160.11.1919; Gibbs NA, 1996, CLIN PSYCHOL REV, V16, P729, DOI 10.1016/S0272-7358(96)00043-8; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; Grant Jon E, 2004, Ann Clin Psychiatry, V16, P27, DOI 10.1080/10401230490281366; Grant P, 2007, J CHILD ADOL PSYCHOP, V17, P761, DOI 10.1089/cap.2007.0021; GREENBERG B, 2000, PSYCHOPHARMACOLOGY, V140, P434; GREIST JH, 1995, ARCH GEN PSYCHIAT, V52, P53; Gross R, 1998, OBSESSIVE-COMPULSIVE DISORDER, P141; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Heyman I, 2003, INT REV PSYCHIATR, V15, P178, DOI 10.1080/0954026021000046146; Hofmann SG, 2006, ARCH GEN PSYCHIAT, V63, P298, DOI 10.1001/archpsyc.63.3.298; Hollander E, 2008, DEPRESS ANXIETY, V25, P317, DOI 10.1002/da.20500; Jaisoorya TS, 2003, COMPR PSYCHIAT, V44, P317, DOI 10.1016/S0010-440X(03)00084-1; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kopell BH, 2008, NEUROSCI BIOBEHAV R, V32, P408, DOI 10.1016/j.neubiorev.2007.07.004; Koran LM, 2007, AM J PSYCHIAT, V164, P5; Kushner MG, 2007, BIOL PSYCHIAT, V62, P835, DOI 10.1016/j.biopsych.2006.12.020; Lindsay M, 1997, BRIT J PSYCHIAT, V171, P135, DOI 10.1192/bjp.171.2.135; Lopez-Ibor JJ, 2003, CURR OPIN PSYCHIATR, V16, pS85, DOI 10.1097/00001504-200304002-00013; MacMaster FP, 2008, J AM ACAD CHILD PSY, V47, P1262, DOI 10.1097/CHI.0b013e318185d2be; Mataix-Cols D, 2005, AM J PSYCHIAT, V162, P228, DOI 10.1176/appi.ajp.162.2.228; Mataix-Cols D, 2002, AM J PSYCHIAT, V159, P263, DOI 10.1176/appi.ajp.159.2.263; McKay D, 2004, CLIN PSYCHOL REV, V24, P283, DOI 10.1016/j.cpr.2004.04.003; MCKAY D, COGNITIVE B IN PRESS; Menzies L, 2008, AM J PSYCHIAT, V165, P1308, DOI 10.1176/appi.ajp.2008.07101677; Nakamae T, 2008, PROG NEURO-PSYCHOPH, V32, P1221, DOI 10.1016/j.pnpbp.2008.03.010; Nakatani E, 2005, PSYCHOTHER PSYCHOSOM, V74, P269, DOI 10.1159/000086317; Nestadt G, 2000, ARCH GEN PSYCHIAT, V57, P358, DOI 10.1001/archpsyc.57.4.358; Nestadt G, 2001, PSYCHOL MED, V31, P481, DOI 10.1017/S0033291701003579; Ninan PT, 2000, J CLIN PSYCHIAT, V61, P47, DOI 10.4088/JCP.v61n0111; OSullivan RL, 1997, BIOL PSYCHIAT, V42, P39, DOI 10.1016/S0006-3223(96)00297-1; Pallanti S, 2008, AM J PSYCHIAT, V165, P169, DOI 10.1176/appi.ajp.2007.07111815; PATO MT, 1988, AM J PSYCHIAT, V145, P1521; Rachman S, 1998, BEHAV RES THER, V36, P385, DOI 10.1016/S0005-7967(97)10041-9; Rachman S, 1997, BEHAV RES THER, V35, P793, DOI 10.1016/S0005-7967(97)00040-5; Rauch S. L., 1998, OBSESSIVE COMPULSIVE, P222; Ravizza L, 1996, PSYCHOPHARMACOL BULL, V32, P167; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Sachdev PS, 2007, PSYCHOL MED, V37, P1645, DOI 10.1017/S0033291707001092; Saiz PA, 2008, PROG NEURO-PSYCHOPH, V32, P765, DOI 10.1016/j.pnpbp.2007.12.005; SALKOVSKIS PM, 1985, BEHAV RES THER, V23, P571, DOI 10.1016/0005-7967(85)90105-6; Simpson HB, 2004, DEPRESS ANXIETY, V19, P225, DOI 10.1002/da.20003; Spitzer M, 1997, INT REV PSYCHIATR, V9, P7; Stein DJ, 1997, PSYCHIAT RES-NEUROIM, V74, P177, DOI 10.1016/S0925-4927(97)00010-3; Steketee G., 2002, ANXIETY ITS DISORDER, P516; Stewart SE, 2008, J AM ACAD CHILD PSY, V47, P763, DOI 10.1097/CHI.0b013e318172ef1e; Stewart SE, 2007, AM J MED GENET B, V144B, P1027, DOI 10.1002/ajmg.b.30533; Stewart SE, 2004, ACTA PSYCHIAT SCAND, V110, P4, DOI 10.1111/j.1600-0447.2004.00302.x; Storch EA, 2008, DEPRESS ANXIETY, V25, P336, DOI 10.1002/da.20488; Storch EA, 2007, INT CLIN PSYCHOPHARM, V22, P230, DOI 10.1097/YIC.0b013e32819f8480; Swedo SE, 2001, J AM ACAD CHILD PSY, V40, P1479, DOI 10.1097/00004583-200112000-00021; Taylor S, 2006, J ANXIETY DISORD, V20, P85, DOI 10.1016/j.janxdis.2004.11.005; Torres AR, 2006, AM J PSYCHIAT, V163, P1978, DOI 10.1176/appi.ajp.163.11.1978; Trifiletti RR, 1999, CHILD ADOL PSYCH CL, V8, P767; van Balkom AJLM, 1998, J NERV MENT DIS, V186, P492, DOI 10.1097/00005053-199808000-00007; Van Grootheest DS, 2007, PSYCHOL MED, V37, P1635, DOI 10.1017/S0033291707000980; van Grootheest DS, 2005, TWIN RES HUM GENET, V8, P450, DOI 10.1375/183242705774310060; van Minnen A, 2003, ARCH GEN PSYCHIAT, V60, P517, DOI 10.1001/archpsyc.60.5.517; VANBALKOM AJLM, 1994, CLIN PSYCHOL REV, V14, P359, DOI 10.1016/0272-7358(94)90033-7; Vishne T, 2008, INT J SOC PSYCHIATR, V54, P219, DOI 10.1177/0020764008083872; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Watson HJ, 2008, J CHILD PSYCHOL PSYC, V49, P489, DOI 10.1111/j.1469-7610.2007.01875.x; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001; Wilhelm S, 2008, AM J PSYCHIAT, V165, P335, DOI 10.1176/appi.ajp.2007.07050776	95	309	319	2	88	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2009	374	9688					491	499		10.1016/S0140-6736(09)60240-3	http://dx.doi.org/10.1016/S0140-6736(09)60240-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482OK	19665647				2022-12-28	WOS:000268898400031
J	Tsao, YT; Chen, WL; Tsai, WC				Tsao, Yu-Tzu; Chen, Wei-Liang; Tsai, Wei-Chi			Steroids for acute spinal cord injury: revealing silent pathology	LANCET			English	Editorial Material							TUMOR LYSIS SYNDROME; MANAGEMENT; LYMPHOMA		[Tsao, Yu-Tzu; Chen, Wei-Liang; Tsai, Wei-Chi] Tri Serv Gen Hosp, Dept Med, Natl Def Med Ctr, Taipei 114, Taiwan	National Defense Medical Center; Tri-Service General Hospital	Tsao, YT (corresponding author), Tri Serv Gen Hosp, Dept Med, Natl Def Med Ctr, 325,Sect 2,Cheng Kung Rd, Taipei 114, Taiwan.	tsaoyutzu@gmail.com		Tsao, Yu-Tzu/0000-0002-2413-1684				Coiffier B, 2008, J CLIN ONCOL, V26, P2767, DOI 10.1200/JCO.2007.15.0177; Davidson MB, 2004, AM J MED, V116, P546, DOI 10.1016/j.amjmed.2003.09.045; Greenstein S, 2002, CLIN CANCER RES, V8, P1681; Ponzoni M, 2007, J CLIN ONCOL, V25, P3168, DOI 10.1200/JCO.2006.08.2313; SPARANO J, 1990, CANCER, V65, P1072, DOI 10.1002/1097-0142(19900301)65:5<1072::AID-CNCR2820650504>3.0.CO;2-A	5	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 8	2009	374	9688					500	500		10.1016/S0140-6736(09)60939-9	http://dx.doi.org/10.1016/S0140-6736(09)60939-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482OK	19665648				2022-12-28	WOS:000268898400032
J	Liu, Y; Ye, XC; Jiang, F; Liang, CY; Chen, DM; Peng, JM; Kinch, LN; Grishin, NV; Liu, QH				Liu, Ying; Ye, Xuecheng; Jiang, Feng; Liang, Chunyang; Chen, Dongmei; Peng, Junmin; Kinch, Lisa N.; Grishin, Nick V.; Liu, Qinghua			C3PO, an Endoribonuclease That Promotes RNAi by Facilitating RISC Activation	SCIENCE			English	Article							DROSOPHILA TRANSLIN; SIRNA; MECHANISMS; ARGONAUTE2; COMPLEXES; PROTEIN; CLEAVES; MUTANT; STRAND; R2D2	The catalytic engine of RNA interference (RNAi) is the RNA-induced silencing complex (RISC), wherein the endoribonuclease Argonaute and single-stranded small interfering RNA (siRNA) direct target mRNA cleavage. We reconstituted long double-stranded RNA-and duplex siRNA-initiated RISC activities with the use of recombinant Drosophila Dicer-2, R2D2, and Ago2 proteins. We used this core reconstitution system to purify an RNAi regulator that we term C3PO (component 3 promoter of RISC), a complex of Translin and Trax. C3PO is a Mg2+-dependent endoribonuclease that promotes RISC activation by removing siRNA passenger strand cleavage products. These studies establish an in vitro RNAi reconstitution system and identify C3PO as a key activator of the core RNAi machinery.	[Liu, Ying; Ye, Xuecheng; Jiang, Feng; Liang, Chunyang; Kinch, Lisa N.; Grishin, Nick V.; Liu, Qinghua] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Dongmei; Peng, Junmin] Emory Univ, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, QH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	qinghua.liu@utsouthwestern.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Kinch, Lisa/0000-0003-3041-2615	Sara and Frank McKnight fellowship; Welch [I-1608, AG025688, GM078163, GM084010]; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078163, R01GM084010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	Sara and Frank McKnight fellowship; Welch(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a Sara and Frank McKnight fellowship (Y.L.), Welch grant I-1608 and NIH grant AG025688 (J.P.), and NIH grants GM078163 and GM084010 (Q.L.).	Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Claussen M, 2006, GENETICS, V174, P1337, DOI 10.1534/genetics.106.063016; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Paroo Z, 2007, CELL RES, V17, P187, DOI 10.1038/sj.cr.7310148; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Sugiura I, 2004, ACTA CRYSTALLOGR D, V60, P674, DOI 10.1107/S0907444904002549; Suseendranathan K, 2007, EUR J CELL BIOL, V86, P173, DOI 10.1016/j.ejcb.2006.11.005; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Wang J, 2004, BIOCHEMISTRY-US, V43, P13424, DOI 10.1021/bi048847l	19	180	187	5	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					750	753		10.1126/science.1176325	http://dx.doi.org/10.1126/science.1176325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661431	Green Accepted			2022-12-28	WOS:000268723700050
J	Carlile, A				Carlile, Alex			Assisted Suicide The law as it stands on assisted suicide could not be clearer	BRITISH MEDICAL JOURNAL			English	Editorial Material												carlileqc@aol.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 5	2009	339								b3169	10.1136/bmj.b3169	http://dx.doi.org/10.1136/bmj.b3169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481KD	19656830				2022-12-28	WOS:000268808000009
J	Jompol, Y; Ford, CJB; Griffiths, JP; Farrer, I; Jones, GAC; Anderson, D; Ritchie, DA; Silk, TW; Schofield, AJ				Jompol, Y.; Ford, C. J. B.; Griffiths, J. P.; Farrer, I.; Jones, G. A. C.; Anderson, D.; Ritchie, D. A.; Silk, T. W.; Schofield, A. J.			Probing Spin-Charge Separation in a Tomonaga-Luttinger Liquid	SCIENCE			English	Article							ONE-DIMENSIONAL SRCUO2; QUANTUM WIRES; ELECTRON-GAS; BEHAVIOR	In a one-dimensional (1D) system of interacting electrons, excitations of spin and charge travel at different speeds, according to the theory of a Tomonaga-Luttinger liquid (TLL) at low energies. However, the clear observation of this spin-charge separation is an ongoing challenge experimentally. We have fabricated an electrostatically gated 1D system in which we observe spin-charge separation and also the predicted power-law suppression of tunneling into the 1D system. The spin-charge separation persists even beyond the low-energy regime where the TLL approximation should hold. TLL effects should therefore also be important in similar, but shorter, electrostatically gated wires, where interaction effects are being studied extensively worldwide.	[Jompol, Y.; Ford, C. J. B.; Griffiths, J. P.; Farrer, I.; Jones, G. A. C.; Anderson, D.; Ritchie, D. A.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Silk, T. W.; Schofield, A. J.] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England	University of Cambridge; University of Birmingham	Jompol, Y (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	yodchay.jompol@cantab.net	Schofield, Andy J/C-5004-2009; Schofield, Andy/AAL-7382-2020; Farrer, Ian/A-7671-2009; Ford, Christopher JB/G-5690-2017; Ritchie, David/K-2206-2014	Schofield, Andy J/0000-0002-1218-8560; Schofield, Andy/0000-0002-1218-8560; Farrer, Ian/0000-0002-3033-4306; Ford, Christopher JB/0000-0002-4557-3721; Ritchie, David/0000-0002-9844-8350	UK Engineering and Physical Sciences Research Council; Thai Ministry of Science	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Thai Ministry of Science	We acknowledge the UK Engineering and Physical Sciences Research Council for funding. Y.J. was supported by a scholarship from the Thai Ministry of Science.	Altland A, 1999, PHYS REV LETT, V83, P1203, DOI 10.1103/PhysRevLett.83.1203; Auslaender OM, 2005, SCIENCE, V308, P88, DOI 10.1126/science.1107821; Auslaender OM, 2002, SCIENCE, V295, P825, DOI 10.1126/science.1066266; Benthien H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.256401; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; Carpentier D, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.153304; Chang AM, 2001, PHYS REV LETT, V86, P143, DOI 10.1103/PhysRevLett.86.143; Creffield CE, 2001, EUROPHYS LETT, V53, P221, DOI 10.1209/epl/i2001-00140-7; Grigera SA, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.245109; HALDANE FDM, 1981, J PHYS C SOLID STATE, V14, P2585, DOI 10.1088/0022-3719/14/19/010; Imambekov A, 2009, SCIENCE, V323, P228, DOI 10.1126/science.1165403; Jompol Y, 2008, PHYSICA E, V40, P1220, DOI 10.1016/j.physe.2007.08.102; KANE CL, 1992, PHYS REV B, V46, P15233, DOI 10.1103/PhysRevB.46.15233; Kardynal B, 1996, PHYS REV LETT, V76, P3802, DOI 10.1103/PhysRevLett.76.3802; Kim BJ, 2006, NAT PHYS, V2, P397, DOI 10.1038/nphys316; Kim C, 1996, PHYS REV LETT, V77, P4054, DOI 10.1103/PhysRevLett.77.4054; Nield SA, 2000, J APPL PHYS, V87, P4036, DOI 10.1063/1.372451; Tserkovnyak Y, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.125312; Turner N, 1996, PHYS REV B, V54, P10614, DOI 10.1103/PhysRevB.54.10614; VOIT J, 1993, PHYS REV B, V47, P6740, DOI 10.1103/PhysRevB.47.6740; Zacher MG, 1998, PHYS REV B, V57, P6370, DOI 10.1103/PhysRevB.57.6370	23	171	172	5	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					597	601		10.1126/science.1171769	http://dx.doi.org/10.1126/science.1171769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644117	Green Submitted, Green Accepted			2022-12-28	WOS:000268493000046
J	Brett, AS				Brett, Allan S.			Health Care 2009: ``American Values'' -- A Smoke Screen in the Debate on Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ S Carolina, Sch Med, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Brett, AS (corresponding author), Univ S Carolina, Sch Med, Columbia, SC 29208 USA.							DANIELS N, 1996, BENCHMARKS FAIRNESS, P15; DASCHLE T, 2008, CRITICAL WHAT WE CAN, P144; EMANUEL EJ, 2008, HEALTHCARE GUARANTEE, P12; GARSON A, 2007, HLTH CARE HALF TRUTH, P131; 2009, MED NEWS TODAY  0305	5	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					440	441		10.1056/NEJMp0905144	http://dx.doi.org/10.1056/NEJMp0905144			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	476LW	19641199				2022-12-28	WOS:000268443900002
J	Wibom, R; Lasorsa, FM; Tohonen, V; Barbaro, M; Sterky, FH; Kucinski, T; Naess, K; Jonsson, M; Pierri, CL; Palmieri, F; Wedell, A				Wibom, Rolf; Lasorsa, Francesco M.; Tohonen, Virpi; Barbaro, Michela; Sterky, Fredrik H.; Kucinski, Thomas; Naess, Karin; Jonsson, Monica; Pierri, Ciro L.; Palmieri, Ferdinando; Wedell, Anna			AGC1 Deficiency Associated with Global Cerebral Hypomyelination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACETYL-L-ASPARTATE; N-ACETYLASPARTATE; MITOCHONDRIAL CARRIERS; LIPID-SYNTHESIS; BRAIN; EXPRESSION; CITRIN; CITRULLINEMIA; TRANSPORT; ARALAR1	The mitochondrial aspartate-glutamate carrier isoform 1 (AGC1), specific to neurons and muscle, supplies aspartate to the cytosol and, as a component of the malate-aspartate shuttle, enables mitochondrial oxidation of cytosolic NADH, thought to be important in providing energy for neurons in the central nervous system. We describe AGC1 deficiency, a novel syndrome characterized by arrested psychomotor development, hypotonia, and seizures in a child with a homozygous missense mutation in the solute carrier family 25, member 12, gene SLC25A12, which encodes the AGC1 protein. Functional analysis of the mutant AGC1 protein showed abolished activity. The child had global hypomyelination in the cerebral hemispheres, suggesting that impaired efflux of aspartate from neuronal mitochondria prevents normal myelin formation.	[Wibom, Rolf; Barbaro, Michela; Naess, Karin; Wedell, Anna] Karolinska Univ Hosp, Ctr Inherited Metab Dis, SE-17176 Stockholm, Sweden; [Kucinski, Thomas] Karolinska Univ Hosp, Dept Neuroradiol, SE-17176 Stockholm, Sweden; [Tohonen, Virpi; Barbaro, Michela; Wedell, Anna] Karolinska Inst, Dept Mol Med & Surg, Ctr Mol Med, Stockholm, Sweden; [Sterky, Fredrik H.] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Kucinski, Thomas] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lasorsa, Francesco M.; Pierri, Ciro L.; Palmieri, Ferdinando] Univ Bari, Dept Pharmacobiol, Bari, Italy; [Jonsson, Monica] Ostersund Hosp, Ctr Child Neurol & Habilitat, Ostersund, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Universita degli Studi di Bari Aldo Moro	Wedell, A (corresponding author), Karolinska Univ Hosp, Dept Mol Med & Surg, Ctr Mol Med 02, Karolinska Inst, SE-17176 Stockholm, Sweden.	anna.wedell@ki.se	Pierri, Ciro Leonardo L/G-4753-2013; Sterky, Fredrik/ABZ-7879-2022; lasorsa, francesco massimo m/B-7931-2008; Kucinski, Thomas/H-3385-2019	Pierri, Ciro Leonardo L/0000-0003-1816-548X; lasorsa, francesco massimo m/0000-0001-8418-5222; Naess, Karin/0000-0003-4310-7927; Barbaro, Michela/0000-0002-7598-9330	Swedish Research Council [12198]; Karolinska Institutet; Stockholm County Council; Ministero dell'Universita e della Ricerca; Italian Human ProteomeNet [RBRN07BMCT_009]; Apulia Region Neurobiotech [124]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Italian Human ProteomeNet; Apulia Region Neurobiotech	Supported by grants from the Swedish Research Council (12198), the Karolinska Institutet, and the Stockholm County Council (to Dr. Wedell) and from Ministero dell'Universita e della Ricerca, the Italian Human ProteomeNet (project RBRN07BMCT_009), and Apulia Region Neurobiotech (Progetto Strategico 124) (to Dr. Palmieri).	Begum L, 2002, BBA-GENE STRUCT EXPR, V1574, P283, DOI 10.1016/S0167-4781(01)00376-1; Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z; BURRI R, 1991, DEV NEUROSCI-BASEL, V13, P403, DOI 10.1159/000112191; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; del Arco A, 2002, EUR J BIOCHEM, V269, P3313, DOI 10.1046/j.1432-1033.2002.03018.x; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Lu ZH, 2004, MOL BRAIN RES, V122, P71, DOI 10.1016/j.molbrainres.2003.12.002; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; Ramos M, 2003, DEV BRAIN RES, V143, P33, DOI 10.1016/S0165-3806(03)00097-X; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; SAHEKI T, 1981, CLIN CHIM ACTA, V109, P325, DOI 10.1016/0009-8981(81)90318-1; Weitzel JM, 2000, BIOL CHEM, V381, P611, DOI 10.1515/BC.2000.078; Wibom R, 2003, ANAL BIOCHEM, V317, P288, DOI 10.1016/S0003-2697(03)00247-1; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4	20	110	112	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					489	495		10.1056/NEJMoa0900591	http://dx.doi.org/10.1056/NEJMoa0900591			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LW	19641205				2022-12-28	WOS:000268443900009
J	Medlock, J; Galvani, AP				Medlock, Jan; Galvani, Alison P.			Optimizing Influenza Vaccine Distribution	SCIENCE			English	Article							PANDEMIC INFLUENZA; UNITED-STATES; DISEASE; TIME; AGE; INFECTIONS; COMMUNITY; HOUSEHOLD; MORTALITY; FAMILIES	The criteria to assess public health policies are fundamental to policy optimization. Using a model parametrized with survey-based contact data and mortality data from influenza pandemics, we determined optimal vaccine allocation for five outcome measures: deaths, infections, years of life lost, contingent valuation, and economic costs. We find that optimal vaccination is achieved by prioritization of schoolchildren and adults aged 30 to 39 years. Schoolchildren are most responsible for transmission, and their parents serve as bridges to the rest of the population. Our results indicate that consideration of age-specific transmission dynamics is paramount to the optimal allocation of influenza vaccines. We also found that previous and new recommendations from the U. S. Centers for Disease Control and Prevention both for the novel swine-origin influenza and, particularly, for seasonal influenza, are suboptimal for all outcome measures.	[Medlock, Jan; Galvani, Alison P.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Medlock, Jan] Clemson Univ, Dept Math Sci, Clemson, SC 29634 USA	Yale University; Clemson University	Medlock, J (corresponding author), Yale Univ, Sch Med, 60 Coll St, New Haven, CT 06520 USA.	medlock@clemson.edu			NSF [SBE-0624117]; Notsew Orm Sands Foundation	NSF(National Science Foundation (NSF)); Notsew Orm Sands Foundation	A. G. and J. M. were funded by NSF grant SBE-0624117 and the Notsew Orm Sands Foundation. We thank two anonymous reviewers for their helpful comments and A. Hofmann for editorial support.	ANDERSON R M, 1991; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Centers for Disease Control and Prevention, PREV CONTR INFL REC; Centers for Disease Control and Prevention, 2007, 2007 NAT HLTH INT SU; Couzin J, 2004, SCIENCE, V306, P960; CROPPER ML, 1994, J RISK UNCERTAINTY, V8, P243, DOI 10.1007/BF01064044; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Emanuel EJ, 2006, SCIENCE, V312, P854, DOI 10.1126/science.1125347; Enserink M, 2004, SCIENCE, V306, P385, DOI 10.1126/science.306.5695.385; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Galvani AP, 2006, SCIENCE, V313, P758; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Haddix A, 1996, PREVENTION EFFECTIVE; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; JENNINGS LC, 1978, J HYG-CAMBRIDGE, V81, P67, DOI 10.1017/S0022172400053778; Lipsitch M, 2005, SCIENCE, V307, P41; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1978, MATH BIOSCI, V38, P141, DOI 10.1016/0025-5564(78)90023-8; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; REINBERG S, HEALTHDAY; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; TABER LH, 1981, J HYG-CAMBRIDGE, V86, P303, DOI 10.1017/S0022172400069059; *US CDCP, NOV H1N1 VACC REC	37	269	271	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1705	1708		10.1126/science.1175570	http://dx.doi.org/10.1126/science.1175570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19696313				2022-12-28	WOS:000270131800050
J	Rost, AW; Perry, RS; Mercure, JF; Mackenzie, AP; Grigera, SA				Rost, A. W.; Perry, R. S.; Mercure, J. -F.; Mackenzie, A. P.; Grigera, S. A.			Entropy Landscape of Phase Formation Associated with Quantum Criticality in Sr3Ru2O7	SCIENCE			English	Article							SUPERCONDUCTIVITY; INSTABILITY; STATE	Low-temperature phase transitions and the associated quantum critical points are a major field of research, but one in which experimental information about thermodynamics is sparse. Thermodynamic information is vital for the understanding of quantum many-body problems. We show that combining measurements of the magnetocaloric effect and specific heat allows a comprehensive study of the entropy of a system. We present a quantitative measurement of the entropic landscape of Sr3Ru2O7, a quantum critical system in which magnetic field is used as a tuning parameter. This allows us to track the development of the entropy as the quantum critical point is approached and to study the thermodynamic consequences of the formation of a novel electronic liquid crystalline phase in its vicinity.	[Rost, A. W.; Mercure, J. -F.; Mackenzie, A. P.; Grigera, S. A.] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland; [Perry, R. S.] Univ Edinburgh, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland; [Grigera, S. A.] Univ Nacl La Plata, Consejo Nacl Invest Cient & Tecn, Inst Fis Liquidos & Sistemas Biol, RA-1900 La Plata, Argentina	University of St Andrews; University of Edinburgh; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Mackenzie, AP (corresponding author), Univ St Andrews, Sch Phys & Astron, SUPA, North Haugh, St Andrews KY16 9SS, Fife, Scotland.	apm9@st-and.ac.uk; sag2@st-and.ac.uk	Mackenzie, Andrew P/K-6742-2015; Rost, Andreas/B-8379-2008; Rost, Andreas/F-3004-2011; Mercure, Jean-Francois A/G-2386-2017; grigera, santiago a/A-4932-2010	Mackenzie, Andrew P/0000-0001-8000-4949; Rost, Andreas/0000-0002-1688-4109; Rost, Andreas/0000-0002-1688-4109; Mercure, Jean-Francois A/0000-0003-2620-9200; Grigera, Santiago/0000-0002-1343-5885	SUPA Graduate School; UK Engineering and Physical Sciences Research Council; Royal Society; EPSRC [EP/F044704/1, EP/G007357/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G007357/1, EP/C511778/1, EP/F044704/1] Funding Source: researchfish	SUPA Graduate School; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank R. A. Borzi, J. C. Davis, Z. Fisk, E. Fradkin, A. G. Green, C. A. Hooley, E.-U. Kim, S. A. Kivelson, and Q. Si for insightful discussions; A. S. Gibbs for providing Sr<INF>2</INF>RuO<INF>4</INF> samples used for characterizing the experimental setup; and the SUPA Graduate School, the UK Engineering and Physical Sciences Research Council, and the Royal Society for financial support.	Aoki Y, 1998, J MAGN MAGN MATER, V177, P271, DOI 10.1016/S0304-8853(97)00484-8; Berridge AM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.136404; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Green AG, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.267001; Grigera SA, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.214427; Grigera SA, 2004, SCIENCE, V306, P1154, DOI 10.1126/science.1104306; Grigera SA, 2001, SCIENCE, V294, P329, DOI 10.1126/science.1063539; Halboth CJ, 2000, PHYS REV LETT, V85, P5162, DOI 10.1103/PhysRevLett.85.5162; Ikeda S, 2000, PHYS REV B, V62, pR6089, DOI 10.1103/PhysRevB.62.R6089; Jaime M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.287201; Kee HY, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.184402; Kim KH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.206402; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Levy F, 2005, SCIENCE, V309, P1343, DOI 10.1126/science.1115498; Lilly MP, 1999, PHYS REV LETT, V82, P394, DOI 10.1103/PhysRevLett.82.394; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; Mitra A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236808; Ohmichi E, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.024432; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; Pan W, 1999, PHYS REV LETT, V83, P820, DOI 10.1103/PhysRevLett.83.820; Perry RS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.166602; Perry RS, 2001, PHYS REV LETT, V86, P2661, DOI 10.1103/PhysRevLett.86.2661; Raghu S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.214402; Sachdev S., 2001, QUANTUM PHASE TRANSI; SAKAKIBARA T, 1994, JPN J APPL PHYS 1, V33, P5067, DOI 10.1143/JJAP.33.5067; Saxena SS, 2000, NATURE, V406, P587, DOI 10.1038/35020500; Tokiwa Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.066401; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Yamase H, 2000, J PHYS SOC JPN, V69, P2151, DOI 10.1143/JPSJ.69.2151; Yamase H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.116404; Zhu LJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.066404	32	113	114	5	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1360	1363		10.1126/science.1176627	http://dx.doi.org/10.1126/science.1176627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19661381				2022-12-28	WOS:000269699100029
J	Resulaj, A; Kiani, R; Wolpert, DM; Shadlen, MN				Resulaj, Arbora; Kiani, Roozbeh; Wolpert, Daniel M.; Shadlen, Michael N.			Changes of mind in decision-making	NATURE			English	Article							PERCEPTUAL DECISION; ACCUMULATOR MODEL; NEURAL BASIS; TIME; PERFORMANCE; CHOICE; DISCRIMINATION; INTEGRATION; VALUATION; NEURONS	A decision is a commitment to a proposition or plan of action based on evidence and the expected costs and benefits associated with the outcome. Progress in a variety of fields has led to a quantitative understanding of the mechanisms that evaluate evidence and reach a decision(1-3). Several formalisms propose that a representation of noisy evidence is evaluated against a criterion to produce a decision(4-8). Without additional evidence, however, these formalisms fail to explain why a decision-maker would change their mind. Here we extend a model, developed to account for both the timing and the accuracy of the initial decision(9), to explain subsequent changes of mind. Subjects made decisions about a noisy visual stimulus, which they indicated by moving a handle. Although they received no additional information after initiating their movement, their hand trajectories betrayed a change of mind in some trials. We propose that noisy evidence is accumulated over time until it reaches a criterion level, or bound, which determines the initial decision, and that the brain exploits information that is in the processing pipeline when the initial decision is made to subsequently either reverse or reaffirm the initial decision. The model explains both the frequency of changes of mind as well as their dependence on both task difficulty and whether the initial decision was accurate or erroneous. The theoretical and experimental findings advance the understanding of decision-making to the highly flexible and cognitive acts of vacillation and self-correction.	[Kiani, Roozbeh; Shadlen, Michael N.] Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA; [Kiani, Roozbeh; Shadlen, Michael N.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Resulaj, Arbora; Wolpert, Daniel M.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Resulaj, Arbora] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Cambridge; Howard Hughes Medical Institute	Shadlen, MN (corresponding author), Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA.	shadlen@uw.edu	Shadlen, Michael Neil/AAL-1870-2020	Wolpert, Daniel/0000-0003-2011-2790; Shadlen, Michael/0000-0002-2002-2210	Wellcome Trust; European grant SENSOPAC [IST-2005-028056]; Howard Hughes Medical Institute; US National Eye Institute [EY11378]; Trinity College, Cambridge; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); European grant SENSOPAC; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Trinity College, Cambridge; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Wellcome Trust, the European grant SENSOPAC IST-2005-028056, Howard Hughes Medical Institute and US National Eye Institute grant EY11378. We thank A. Faisal, H. Vincent, I. Howard and J. Ingram for their assistance. M. N. S. thanks Trinity College, Cambridge, for support.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; [Anonymous], 1982, JACKKNIFE BOOTSTRAP; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; GHEZ C, 1989, BRAIN BEHAV EVOLUT, V33, P69, DOI 10.1159/000115902; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Green DM, 1966, SIGNAL DETECTION THE; Hanks TD, 2006, BAYESIAN BRAIN PROBA, P209, DOI [10.7551/mitpress/9780262042383.003.0010, DOI 10.7551/MITPRESS/9780262042383.003.0010]; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; KASS RE, 1995, J AM STAT ASSOC, V90, P928, DOI 10.2307/2291327; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Laming DR, 1968, INFORM THEORY CHOICE; LINK SW, 1975, J MATH PSYCHOL, V12, P114, DOI 10.1016/0022-2496(75)90053-X; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; RABBITT P, 1981, Q J EXP PSYCHOL-A, V33, P223, DOI 10.1080/14640748108400790; RABBITT PMA, 1966, NATURE, V212, P438, DOI 10.1038/212438a0; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; RISKEN H, 1989, FOKKERPLANCK EQUATIO; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; SMITH PL, 1988, J MATH PSYCHOL, V32, P135, DOI 10.1016/0022-2496(88)90043-0; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wang YH, 2000, AM STAT, V54, P105, DOI 10.2307/2686026; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	36	373	375	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					263	U141		10.1038/nature08275	http://dx.doi.org/10.1038/nature08275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	492KN	19693010	Green Accepted			2022-12-28	WOS:000269654600044
J	Kaib, NA; Quinn, T				Kaib, Nathan A.; Quinn, Thomas			Reassessing the Source of Long-Period Comets	SCIENCE			English	Article							EMBEDDED STAR-CLUSTERS; OORT CLOUD; FUNDAMENTAL ROLE; SHOWERS; EVOLUTION	We present numerical simulations to model the production of observable long-period comets (LPCs) from the Oort Cloud, a vast reservoir of icy bodies surrounding the Sun. We show that inner Oort Cloud objects can penetrate Jupiter's orbit via a largely unexplored dynamical pathway, and they are an important, if not the dominant, source of known LPCs. We use this LPC production to place observationally motivated constraints on the population and mass of the inner Oort Cloud, which are consistent with giant planet formation theory. These constraints indicate that only one comet shower producing late Eocene bombardment levels has likely occurred since the Cambrian Explosion, making these phenomena an improbable cause of additional extinction events.	[Kaib, Nathan A.; Quinn, Thomas] Univ Washington, Dept Astron, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kaib, NA (corresponding author), Univ Washington, Dept Astron, Box 351580, Seattle, WA 98195 USA.	kaib@astro.washington.edu		Quinn, Thomas/0000-0001-5510-2803	NASA Earth and Space Science Fellowship; NSF [AST-0709191]	NASA Earth and Space Science Fellowship; NSF(National Science Foundation (NSF))	This research was funded by a NASA Earth and Space Science Fellowship and an NSF grant (AST-0709191). Our computing was performed by using Purdue Teragrid computing facilities managed with Condor scheduling software (www.cs.wisc.edu/condor). A. Morbidelli and two anonymous reviewers provided helpful comments that greatly improved our work.	Brasser R, 2008, ICARUS, V196, P274, DOI 10.1016/j.icarus.2008.02.016; Brasser R, 2006, ICARUS, V184, P59, DOI 10.1016/j.icarus.2006.04.010; Brown ME, 2004, ASTROPHYS J, V617, P645, DOI 10.1086/422095; Dones L, 2004, SPACE SCI S, P153; DUNCAN MJ, 2008, ROLE GALAXY DYNAMICA, P315; Emel'yanenko VV, 2007, MON NOT R ASTRON SOC, V381, P779, DOI 10.1111/j.1365-2966.2007.12269.x; EVERHART E, 1967, ASTRON J, V72, P716, DOI 10.1086/110299; Farley KA, 1998, SCIENCE, V280, P1250, DOI 10.1126/science.280.5367.1250; FERNANDEZ JA, 1981, ASTRON ASTROPHYS, V96, P26; Francis PJ, 2005, ASTROPHYS J, V635, P1348, DOI 10.1086/497684; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; HEISLER J, 1986, ICARUS, V65, P13, DOI 10.1016/0019-1035(86)90060-6; HEISLER J, 1987, ICARUS, V70, P269, DOI 10.1016/0019-1035(87)90135-7; HUT P, 1987, NATURE, V329, P118, DOI 10.1038/329118a0; Kaib NA, 2009, ASTROPHYS J, V695, P268, DOI 10.1088/0004-637X/695/1/268; Levison HF, 2006, ICARUS, V184, P619, DOI 10.1016/j.icarus.2006.05.008; Neslusan L, 2007, ASTRON ASTROPHYS, V461, P741, DOI 10.1051/0004-6361:20065200; Oort J. H., 1950, B ASTRON I NETH, V11, P91; Rickman H, 2008, CELEST MECH DYN ASTR, V102, P111, DOI 10.1007/s10569-008-9140-y; Thommes EW, 2003, ICARUS, V161, P431, DOI 10.1016/S0019-1035(02)00043-X; Weissman P. R., 2007, IAU S, P441; Weissman PR, 1996, ASTR SOC P, V107, P265; Wiegert P, 1999, ICARUS, V137, P84, DOI 10.1006/icar.1998.6040	24	76	76	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1234	1236		10.1126/science.1172676	http://dx.doi.org/10.1126/science.1172676			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19644075	Green Submitted			2022-12-28	WOS:000269523200034
J	Sankaran, VG; Xu, J; Ragoczy, T; Ippolito, GC; Walkley, CR; Maika, SD; Fujiwara, Y; Ito, M; Groudine, M; Bender, MA; Tucker, PW; Orkin, SH				Sankaran, Vijay G.; Xu, Jian; Ragoczy, Tobias; Ippolito, Gregory C.; Walkley, Carl R.; Maika, Shanna D.; Fujiwara, Yuko; Ito, Masafumi; Groudine, Mark; Bender, M. A.; Tucker, Philip W.; Orkin, Stuart H.			Developmental and species-divergent globin switching are driven by BCL11A	NATURE			English	Article							YEAST ARTIFICIAL CHROMOSOME; LOCUS-CONTROL REGION; TRANSGENIC MICE; FETAL-HEMOGLOBIN; GENE-EXPRESSION; FUNCTIONAL-ANALYSIS; EVO-DEVO; TRANSCRIPTION; CELLS; MOUSE	The contribution of changes in cis-regulatory elements or trans-acting factors to interspecies differences in gene expression is not well understood. The mammalian beta-globin loci have served as a model for gene regulation during development. Transgenic mice containing the human beta-globin locus, consisting of the linked embryonic (epsilon), fetal (gamma) and adult (beta) genes, have been used as a system to investigate the temporal switch from fetal to adult haemoglobin, as occurs in humans. Here we show that the human gamma-globin (HBG) genes in these mice behave as murine embryonic globin genes, revealing a limitation of the model and demonstrating that critical differences in the trans-acting milieu have arisen during mammalian evolution. We show that the expression of BCL11A, a repressor of human gamma-globin expression identified by genome-wide association studies, differs between mouse and human. Developmental silencing of the mouse embryonic globin and human gamma-globin genes fails to occur in mice in the absence of BCL11A. Thus, BCL11A is a critical mediator of species-divergent globin switching. By comparing the ontogeny of beta-globin gene regulation in mice and humans, we have shown that alterations in the expression of a trans-acting factor constitute a critical driver of gene expression changes during evolution.	[Sankaran, Vijay G.; Xu, Jian; Walkley, Carl R.; Fujiwara, Yuko; Orkin, Stuart H.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA; [Sankaran, Vijay G.; Xu, Jian; Walkley, Carl R.; Fujiwara, Yuko; Orkin, Stuart H.] Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Xu, Jian; Fujiwara, Yuko; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Ragoczy, Tobias; Groudine, Mark; Bender, M. A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Ippolito, Gregory C.; Maika, Shanna D.; Tucker, Philip W.] Univ Texas Austin, Inst Mol & Cellular Biol, Austin, TX 78712 USA; [Ito, Masafumi] Nagoya First Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Groudine, Mark] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Austin; Red Cross Nagoya Daiichi Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Walkley, Carl/AAO-6021-2020; Ippolito, Gregory C./AAR-2930-2021	Walkley, Carl/0000-0002-4784-9031; Ippolito, Gregory C./0000-0002-7565-7002	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH); National Cancer Institute; Howard Hughes Medical Institute (HHMI); Leukemia & Lymphoma Society; American Society of Hematology; Helen Hay Whitney Foundation; NCI postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); American Society of Hematology; Helen Hay Whitney Foundation; NCI postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to K. Peterson and H. Fedosyuk for providing beta-locus mice, K. Gaensler for the A20 and A85 strains of b- locus mice, and T. Jacks for providing the K- RasG12D mice. We thank J. Palis and P. Kingsley for providing mouse embryonic globin antibodies, H. Mikkola and B. Van Handel for providing sorted human samples, and R. Byron and A. Telling for technical support. Wethank L. Zon, K. McGrath, P. Kingsley, J. Palis, M. Kowalczyk and T. Menne for advice and discussions. This work was supported by funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) (S.H.O. and M. G.) and the National Cancer Institute ( P. W. T.). S. H. O. is an Investigator of the Howard Hughes Medical Institute (HHMI). C. R. W. is a special fellow of the Leukemia & Lymphoma Society. T. R. is supported by a fellowship from the American Society of Hematology. J. X. is an HHMI fellow of the Helen Hay Whitney Foundation. V. G. S. is supported by a Medical Scientist Training Program Award from the NIH and G. C. I. is supported by a NCI postdoctoral fellowship.	Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CHADA K, 1986, NATURE, V319, P685, DOI 10.1038/319685a0; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Choi JW, 2001, INT J HEMATOL, V74, P277, DOI 10.1007/BF02982061; Fraser ST, 2007, BLOOD, V109, P343, DOI 10.1182/blood-2006-03-006569; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Harju S, 2005, MOL CELL BIOL, V25, P8765, DOI 10.1128/MCB.25.20.8765-8778.2005; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Jasinski M, 2001, BLOOD, V98, P2248, DOI 10.1182/blood.V98.7.2248; Johnson RM, 2006, P NATL ACAD SCI USA, V103, P3186, DOI 10.1073/pnas.0511347103; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; McGrath K, 2008, CURR TOP DEV BIOL, V82, P1, DOI 10.1016/S0070-2153(07)00001-4; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; PACE B, 1994, BLOOD, V84, P4344, DOI 10.1182/blood.V84.12.4344.bloodjournal84124344; PAPAYANNOPOULOU T, 1984, SCIENCE, V224, P617, DOI 10.1126/science.6200940; PESCHLE C, 1985, NATURE, V313, P235, DOI 10.1038/313235a0; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Peterson KR, 1998, HUM MOL GENET, V7, P2079, DOI 10.1093/hmg/7.13.2079; Porcu S, 1997, BLOOD, V90, P4602, DOI 10.1182/blood.V90.11.4602.4602_4602_4609; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Sloane-Stanley J, 2006, BRIT J HAEMATOL, V135, P735, DOI 10.1111/j.1365-2141.2006.06354.x; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; WEATHERALL DJ, 1975, NATURE, V257, P710, DOI 10.1038/257710a0; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	38	286	311	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1093	U50		10.1038/nature08243	http://dx.doi.org/10.1038/nature08243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19657335	Green Accepted			2022-12-28	WOS:000269314000030
J	Park, SI; Xiong, YJ; Kim, RH; Elvikis, P; Meitl, M; Kim, DH; Wu, J; Yoon, J; Yu, CJ; Liu, ZJ; Huang, YG; Hwang, K; Ferreira, P; Li, XL; Choquette, K; Rogers, JA				Park, Sang-Il; Xiong, Yujie; Kim, Rak-Hwan; Elvikis, Paulius; Meitl, Matthew; Kim, Dae-Hyeong; Wu, Jian; Yoon, Jongseung; Yu, Chang-Jae; Liu, Zhuangjian; Huang, Yonggang; Hwang, Keh-chih; Ferreira, Placid; Li, Xiuling; Choquette, Kent; Rogers, John A.			Printed Assemblies of Inorganic Light-Emitting Diodes for Deformable and Semitransparent Displays	SCIENCE			English	Article							EPITAXIAL LIFTOFF; UNIAXIAL-STRESS; OHMIC CONTACTS; SOLAR-CELLS; GAAS; FILMS; ELECTRONICS; DEVICES; SILICON; DESIGNS	We have developed methods for creating microscale inorganic light-emitting diodes (LEDs) and for assembling and interconnecting them into unusual display and lighting systems. The LEDs use specialized epitaxial semiconductor layers that allow delineation and release of large collections of ultrathin devices. Diverse shapes are possible, with dimensions from micrometers to millimeters, in either flat or "wavy" configurations. Printing-based assembly methods can deposit these devices on substrates of glass, plastic, or rubber, in arbitrary spatial layouts and over areas that can be much larger than those of the growth wafer. The thin geometries of these LEDs enable them to be interconnected by conventional planar processing techniques. Displays, lighting elements, and related systems formed in this manner can offer interesting mechanical and optical properties.	[Park, Sang-Il; Xiong, Yujie; Kim, Rak-Hwan; Kim, Dae-Hyeong; Yoon, Jongseung; Yu, Chang-Jae; Rogers, John A.] Univ Illinois, Dept Mat Sci, Urbana, IL 61801 USA; [Park, Sang-Il; Xiong, Yujie; Kim, Rak-Hwan; Kim, Dae-Hyeong; Yoon, Jongseung; Yu, Chang-Jae; Rogers, John A.] Univ Illinois, Dept Engn, Beckman Inst, Urbana, IL 61801 USA; [Park, Sang-Il; Xiong, Yujie; Kim, Rak-Hwan; Kim, Dae-Hyeong; Yoon, Jongseung; Yu, Chang-Jae; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Elvikis, Paulius; Ferreira, Placid; Rogers, John A.] Univ Illinois, Dept Engn Sci & Mech, Urbana, IL 61801 USA; [Meitl, Matthew] Semprius, Durham, NC 27713 USA; [Wu, Jian; Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Liu, Zhuangjian] Inst High Performance Comp, Singapore 138632, Singapore; [Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Hwang, Keh-chih] Tsinghua Univ, Dept Engn Mech, Beijing 100084, Peoples R China; [Li, Xiuling; Choquette, Kent] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Northwestern University; Tsinghua University; University of Illinois System; University of Illinois Urbana-Champaign	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci, 1304 W Green St, Urbana, IL 61801 USA.	jrogers@uiuc.edu	Xiong, Yujie/G-3203-2010; Li, Xiuling/A-2240-2010; Kim, Rak-Hwan/A-6155-2012; HWANG, Keh-Chih/A-9989-2014; Wu, Jian/I-3466-2012; Rogers, John/L-2798-2016; ferreira, placid m/D-5308-2012; Huang, Yonggang/B-6998-2009; huang, yonggang/O-6236-2019	Xiong, Yujie/0000-0002-1995-8257; Wu, Jian/0000-0003-2295-6815; ferreira, placid m/0000-0002-5517-6586; Kim, Dae-Hyeong/0000-0002-4722-1893	Ford Motor Company; NSF [DMI-0328162]; U.S. Department of Energy, Division of Materials Sciences [DE-FG02-07ER46471]; Materials Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign [DE-FG02-07ER46453]	Ford Motor Company; NSF(National Science Foundation (NSF)); U.S. Department of Energy, Division of Materials Sciences(United States Department of Energy (DOE)); Materials Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign	This material is based on work supported by Ford Motor Company, the NSF (grant DMI-0328162), and the U.S. Department of Energy, Division of Materials Sciences (Award No. DE-FG02-07ER46471), through the Materials Research Laboratory and Center for Microanalysis of Materials (DE-FG02-07ER46453) at the University of Illinois at Urbana-Champaign. S.-I. Park and R.-H. Kim thank Samsung for doctoral fellowships.	Axisa F, 2008, ESTC 2008: 2ND ELECTRONICS SYSTEM-INTEGRATION TECHNOLOGY CONFERENCE, VOLS 1 AND 2, PROCEEDINGS, P1387, DOI 10.1109/ESTC.2008.4684558; BOUR DP, 1994, IEEE J QUANTUM ELECT, V30, P593, DOI 10.1109/3.283808; CAMPERIGINESTET C, 1991, IEEE PHOTONIC TECH L, V3, P1123, DOI 10.1109/68.118028; CarterComan C, 1997, APPL PHYS LETT, V70, P1754, DOI 10.1063/1.118647; CHANDRASEKHAR M, 1977, PHYS REV B, V15, P2127, DOI 10.1103/PhysRevB.15.2127; CHEN CL, 1986, APPL PHYS LETT, V48, P535, DOI 10.1063/1.96498; Gaul DA, 2000, ADV MATER, V12, P935, DOI 10.1002/1521-4095(200006)12:13<935::AID-ADMA935>3.0.CO;2-J; Gray DS, 2004, ADV MATER, V16, P393, DOI 10.1002/adma.200306107; Jiang HQ, 2007, P NATL ACAD SCI USA, V104, P15607, DOI 10.1073/pnas.0702927104; Jiang HX, 2001, APPL PHYS LETT, V78, P1303, DOI 10.1063/1.1351521; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Kim DH, 2008, P NATL ACAD SCI USA, V105, P18675, DOI 10.1073/pnas.0807476105; KONAGAI M, 1978, J CRYST GROWTH, V45, P277, DOI 10.1016/0022-0248(78)90449-9; Lo SC, 2007, CHEM REV, V107, P1097, DOI 10.1021/cr050136l; Meitl MA, 2006, NAT MATER, V5, P33, DOI 10.1038/nmat1532; Nakamura S., 1997, BLUE LASER DIODE GAN; PAN SH, 1988, PHYS REV B, V38, P3375, DOI 10.1103/PhysRevB.38.3375; POLLAK FH, 1973, SURF SCI, V37, P863, DOI 10.1016/0039-6028(73)90375-0; SCHUBERT EF, 2003, LIGHT EMITTING DIODE, P43; So F, 2008, MRS BULL, V33, P663, DOI 10.1557/mrs2008.137; STAREEV G, 1993, APPL PHYS LETT, V62, P2801, DOI 10.1063/1.109214; Tamura M, 1998, JPN J APPL PHYS 1, V37, P3576, DOI 10.1143/JJAP.37.3576; YABLONOVITCH E, 1987, APPL PHYS LETT, V51, P2222, DOI 10.1063/1.98946; YABLONOVITCH E, 1990, APPL PHYS LETT, V56, P2419, DOI 10.1063/1.102896; Yoon J, 2008, NAT MATER, V7, P907, DOI 10.1038/nmat2287	25	615	696	20	489	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					977	981		10.1126/science.1175690	http://dx.doi.org/10.1126/science.1175690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696346	Green Submitted			2022-12-28	WOS:000269242800041
J	Dreyer, NA; Garner, S				Dreyer, Nancy A.; Garner, Sarah			Registries for Robust Evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dreyer, Nancy A.] Outcome Sci Inc, Cambridge, MA 02139 USA; [Garner, Sarah] Natl Inst Hlth & Clin Excellence, Res & Dev, London, England	National Institute for Health & Care Excellence	Dreyer, NA (corresponding author), Outcome Sci Inc, 201 Broadway, Cambridge, MA 02139 USA.	ndreyer@outcome.com						*AM AC OPHTH, NAT REG DRUG IND OC; Bravata DM, 2007, COMP EFFECTIVENESS R; Gliklich R, AHRQ PUBLICATION; Hillner BE, 2008, J CLIN ONCOL, V26, P2155, DOI 10.1200/JCO.2007.14.5631; Lyratzopoulos G, 2008, LANCET, V371, P1734, DOI 10.1016/S0140-6736(08)60742-4; *NIH, AM REC REINV ACT 200; Sturmer T, 2007, AM J EPIDEMIOL, V165, P1110, DOI 10.1093/aje/kwm074; Tilson HH, 2007, OBSTET GYNECOL SURV, V62, P137, DOI 10.1097/01.ogx.0000253377.14647.80; Walker AM, 1997, EPIDEMIOLOGY, V8, P671, DOI 10.1097/00001648-199710000-00010	9	150	155	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					790	791		10.1001/jama.2009.1092	http://dx.doi.org/10.1001/jama.2009.1092			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690313				2022-12-28	WOS:000269073800029
J	Zegers, RHC; Weigl, A; Steptoe, A				Zegers, Richard H. C.; Weigl, Andreas; Steptoe, Andrew			The Death of Wolfgang Amadeus Mozart: An Epidemiologic Perspective	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								The early death of the composer Wolfgang Amadeus Mozart on 5 December 1791 has fascinated the world for more than 2 centuries. It has been suggested that his final illness was caused by poisoning, renal failure, Henoch-Schonlein purpura, trichinosis, and many other conditions. The official daily register of deaths in Mozart's Vienna was evaluated to provide an epidemiologic framework into which the observations of contemporary witnesses of his death can be integrated. All recorded deaths in Vienna during November and December 1791 and January 1792 were analyzed, together with the corresponding periods in 1790 to 1791 and 1792 to 1793. The deaths of 5011 adults (3442 men, 1569 women) were recorded over these periods. The mean ages of death were 45.5 years (SD, 18.5) for men and 54.5 years (SD, 19.9) for women. Tuberculosis and related conditions accounted for the highest number of deaths; cachexia and malnutrition ranked second, and edema was the third most common cause. According to eyewitness accounts, the hallmark of Mozart's final disease was severe edema. Deaths from edema were markedly increased among younger men in the weeks surrounding Mozart's death compared with the previous and following years. This minor epidemic may have originated in the military hospital. Our analysis is consistent with Mozart's last illness and death being due to a streptococcal infection leading to an acute nephritic syndrome caused by poststreptococcal glomerulonephritis. Scarlet fever, which represents the same underlying disease from an etiologic perspective, is a less likely possibility.	[Zegers, Richard H. C.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; Univ Vienna, Municipal & Prov Arch Vienna, Vienna, Austria; UCL, London, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Vienna; University of London; University College London	Zegers, RHC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.h.zegers@amc.uva.nl	Steptoe, Andrew/Y-2440-2019	Steptoe, Andrew/0000-0001-7808-4943				BAR C, 1966, MOZART KRANKHEIT TOD; BAUER WA, 1965H OE MOZART BRIE, V4, P1787; DAVIES PJ, 1989, MOZART PERSON HIS CH; Deutsch Otto Erich, 1961, MOZART DOKUMENTE SEI; EIBL JH, 1977, WOLFGANG AMADE  MOZA; GREITHER A, 1975, DEUT MED WOCHENSCHR, V82, P928; GULDENER V, 1891, MOZARTS ILLNESS MUSI, V32, P20; HIRSCHMANN JV, 2001, ARCH INTERN MED, V1381, P9; KASPER DL, 2005, HARRISONS PRINCIPLES, P16; KERNER D, 1957, FORTBILD, V5, P1; METZKE H, 2005, VERLAG DEGENER; NACHRICHTEN A, 1793, MUSIKALISCHES WOCHEN, V12, P189; NIEMTSCHEK F, 1941, LEBEN KK KAPELLMEIST; ROCHLITZ F, 1826, ALLGEMEINE MUSIKALIS, V21, P337; Rodriguez-Iturbe B, 2007, KIDNEY INT, V71, P1094, DOI 10.1038/sj.ki.5002169; STAFFORD W, 1991, MOZARTS DEATH CORREC; UHL R, 1938, DIE SIPPE, V53, P6; von Nissen Georg Nikolaus, 1828, BIOGRAPHIE WA MOZART; WEIGL A, 1997, N F, V2, P23	19	15	18	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2009	151	4					274	W97		10.7326/0003-4819-151-4-200908180-00010	http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484IW	19687494				2022-12-28	WOS:000269038900008
J	Hor, H; Tafti, M				Hor, Hyun; Tafti, Mehdi			How Much Sleep Do We Need?	SCIENCE			English	Editorial Material							CIRCADIAN PACEMAKER; LONG SLEEPERS; GENETICS; CLOCK		[Hor, Hyun; Tafti, Mehdi] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Tafti, Mehdi] Vaud Univ, Ctr Hosp, Ctr Invest & Res Sleep, CH-1011 Lausanne, Switzerland	University of Lausanne	Hor, H (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	mehdi.tafti@unil.ch	Tafti, Mehdi/A-8887-2017	Tafti, Mehdi/0000-0002-6997-3914				Aeschbach D, 2003, J CLIN ENDOCR METAB, V88, P26, DOI 10.1210/jc.2002-020827; Aeschbach D, 1996, AM J PHYSIOL-REG I, V270, pR41, DOI 10.1152/ajpregu.1996.270.1.R41; Andretic R, 2008, ANNU REV GENET, V42, P361, DOI 10.1146/annurev.genet.42.110807.091541; Borbely A A, 1982, Hum Neurobiol, V1, P195; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Tafti M, 2007, CURR OPIN GENET DEV, V17, P222, DOI 10.1016/j.gde.2007.04.007	13	6	6	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					825	826		10.1126/science.1178713	http://dx.doi.org/10.1126/science.1178713			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679803				2022-12-28	WOS:000269242400032
J	Sweeney, K; Toy, L; Cornwell, J				Sweeney, Kieran; Toy, Liz; Cornwell, Jocelyn			Practice A patient's journey Mesothelioma	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sweeney, Kieran] Peninsula Med Sch, Exeter EX2 1PU, Devon, England; [Toy, Liz] Royal Devon & Exeter NHS Fdn Trust, Exeter EX2 5DW, Devon, England; [Cornwell, Jocelyn] Kings Fund, Point Care Programme, London, England	University of Exeter; University of Exeter	Sweeney, K (corresponding author), Peninsula Med Sch, Exeter EX2 1PU, Devon, England.	kieran.sweeney@pms.ac.uk							0	17	17	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 14	2009	339								b2862	10.1136/bmj.b2862	http://dx.doi.org/10.1136/bmj.b2862			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YL	19684101				2022-12-28	WOS:000269162200004
J	Ramadan, MM; El-Desouky, MES				Ramadan, Mahmoud Mohammed; El-Desouky, Mohamed El-Sayed			Esophageal Foreign Body	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ramadan, Mahmoud Mohammed; El-Desouky, Mohamed El-Sayed] Mansoura Univ, Mansoura 35516, Dakahleya, Egypt	Egyptian Knowledge Bank (EKB); Mansoura University	Ramadan, MM (corresponding author), Mansoura Univ, Mansoura 35516, Dakahleya, Egypt.			Ramadan, Mahmoud/0000-0001-8843-0141					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					E11	E11		10.1056/NEJMicm0803473	http://dx.doi.org/10.1056/NEJMicm0803473			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19675327				2022-12-28	WOS:000268884100011
J	Freynhagen, R; Bennett, MI				Freynhagen, R.; Bennett, M. I.			Diagnosis and management of neuropathic pain	BMJ-BRITISH MEDICAL JOURNAL			English	Review							QUALITY-OF-LIFE; EFNS GUIDELINES; PHARMACOLOGICAL MANAGEMENT; PREVALENCE; ORIGIN; HEALTH; IMPACT; TOOLS		[Freynhagen, R.] Benedictus Krankenhaus Tutzing, Pain Ctr Lake Starnberg, Dept Anaesthesiol Crit Care Med Pain Therapy & Pa, D-82327 Tutzing, Germany; [Bennett, M. I.] Univ Lancaster, Sch Hlth & Med, Int Observ End Life Care, Lancaster LA1 4YT, England	Lancaster University	Freynhagen, R (corresponding author), Benedictus Krankenhaus Tutzing, Pain Ctr Lake Starnberg, Dept Anaesthesiol Crit Care Med Pain Therapy & Pa, D-82327 Tutzing, Germany.	r.freynhagen@krankenhaus-tutzing.de	Bennett, Michael I/A-1620-2009	Bennett, Michael I/0000-0002-8369-8349; Freynhagen, Rainer/0000-0002-3759-1508				Attal N, 2006, EUR J NEUROL, V13, P1153, DOI 10.1111/j.1468-1331.2006.01511.x; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Bennett MI, 2006, PAIN, V122, P289, DOI 10.1016/j.pain.2006.02.002; Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034; Boswell Mark V, 2007, Pain Physician, V10, P7; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Cruccu G, 2008, EUR J NEUROL, V15, P1013, DOI 10.1111/j.1468-1331.2008.02185.x; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; Cruccu G, 2004, EUR J NEUROL, V11, P153, DOI 10.1111/j.1468-1331.2004.00791.x; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Finnerup NB, 2008, CURR OPIN ANESTHESIO, V21, P586, DOI 10.1097/ACO.0b013e32830a4c11; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Gilron Ian, 2005, Expert Rev Neurother, V5, P823, DOI 10.1586/14737175.5.6.823; Gustorff B, 2008, ACTA ANAESTH SCAND, V52, P132, DOI 10.1111/j.1399-6576.2007.01486.x; Hall GC, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-26; Iskedjian M, 2007, CURR MED RES OPIN, V23, P17, DOI 10.1185/030079906X158066; Jensen MP, 2007, NEUROLOGY, V68, P1178, DOI 10.1212/01.wnl.0000259085.61898.9e; Mailis A., 2003, COCHRANE DB SYST REV, V2, pCd002918, DOI [DOI 10.1002/14651858.CD002918, 10.1002/14651858.CD002918]; McDermott AM, 2006, EUR J PAIN, V10, P127, DOI 10.1016/j.ejpain.2005.01.014; Moulin DE, 2007, PAIN RES MANAG, V12, P13; Pittler MH, 2008, CLIN J PAIN, V24, P731, DOI 10.1097/AJP.0b013e3181759231; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; SCHMIDT CO, 2009, EUR J PAIN      0205; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Smith BH, 2007, CLIN J PAIN, V23, P143, DOI 10.1097/01.ajp.0000210956.31997.89; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Tzellos TG, 2008, EUR J CLIN PHARMACOL, V64, P851, DOI 10.1007/s00228-008-0523-5	30	112	116	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2009	339								b3002	10.1136/bmj.b3002	http://dx.doi.org/10.1136/bmj.b3002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YI	19675082				2022-12-28	WOS:000269161900002
J	Morens, DM; Taubenberger, JK				Morens, David M.; Taubenberger, Jeffery K.			Understanding Influenza Backward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS		[Taubenberger, Jeffery K.] NIAID, Viral Pathogenesis & Evolut Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Morens, David M.] NIAID, Off Director, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Taubenberger, JK (corresponding author), NIAID, Viral Pathogenesis & Evolut Sect, Infect Dis Lab, NIH, 33 North Dr, Bethesda, MD 20892 USA.	taubenbergerj@niaid.nih.gov	Taubenberger, Jeffery/AAQ-1407-2021		Intramural NIH HHS [ZIA AI000995-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001114, ZIAAI000986, ZIAAI000995] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Burnet F. M., 1942, INFLUENZA SURVEY LAS; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P635, DOI 10.4269/ajtmh.1980.29.635; Jordan EO., 1927, EPIDEMIC INFLUENZA S; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Oxford JS, 2002, LANCET INFECT DIS, V2, P111, DOI 10.1016/S1473-3099(02)00185-8; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187, DOI 10.20506/rst.28.1.1879; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979	10	30	30	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					679	680		10.1001/jama.2009.1127	http://dx.doi.org/10.1001/jama.2009.1127			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481ZI	19671909	Green Accepted			2022-12-28	WOS:000268852300027
J	Pasupathy, D; Wood, AM; Pell, JP; Fleming, M; Smith, GCS				Pasupathy, Dharmintra; Wood, Angela M.; Pell, Jill P.; Fleming, Michael; Smith, Gordon C. S.			Rates of and Factors Associated With Delivery-Related Perinatal Death Among Term Infants in Scotland	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	28th Annual Meeting of the Society-for-Maternal-Fetal-Medicine	JAN 28-FEB 02, 2008	Dallas, TX	Soc Maternal Fetal Med (SMFM)			CESAREAN-SECTION; FETAL-DEATH; RISK; MORTALITY; STILLBIRTH; BIRTH; AGE	Context Rates of obstetric intervention in labor, including cesarean delivery, have increased significantly in most developed countries. It is, however, unclear if this has been paralleled by decreased rates of perinatal and neonatal death associated with complications of labor at term. Objectives To determine whether rates of perinatal death at term, either during labor or in the neonatal period, have changed in Scotland during the last 20 years and whether this was associated with a reduction in deaths ascribed to intrapartum anoxia. Design, Setting, and Participants A population-based, retrospective cohort study of linked data from a registry of births ( Scottish Morbidity Record 02) and a registry of perinatal deaths ( Scottish Stillbirth and Infant Death Survey) between 1988 and 2007. Participants included all births of a singleton infant in a cephalic presentation at term (N = 1 012 266), excluding those with perinatal death due to congenital anomaly or antepartum stillbirth. Main Outcome Measure Delivery-related perinatal death, defined as intrapartum stillbirth or neonatal death unrelated to congenital abnormality. These events were also subdivided into those events ascribed to intrapartum anoxia and all other causes. The risk of death was modeled using logistic regression and analyses were adjusted for maternal age, height, parity, socioeconomic deprivation status, gestational age, birth weight percentile, fetal sex, onset of labor, and the annual number of births per hospital. Results During the study period, the risk of delivery-related perinatal death decreased from 8.8 to 5.5 per 10 000 births (unadjusted change, -38%; 95% confidence interval [CI], -51% to -21%). When analyzed by the cause of death, there was a significant decrease in the risk of death ascribed to intrapartum anoxia (5.7 to 3.0 per 10 000 births; unadjusted change, -48%; 95% CI, -62% to -29%), but no significant change in the risk of death ascribed to other causes. When deaths ascribed to intrapartum anoxia were analyzed by the time of death in relation to delivery, the reduction was similar comparing intrapartum stillbirths (2.6 to 1.1 per 10 000 births; unadjusted change, -60%; 95% CI, -75% to -34%) and neonatal deaths (3.1 to 1.9 per 10 000 births; unadjusted change, -38%; 95% CI, -59% to -7%). Adjustment for maternal, fetal, and obstetric factors was without material effect. Conclusion Rates of intrapartum stillbirth and neonatal death at term decreased in Scotland between 1988 and 2007. This decrease was only significant for deaths ascribed to intrapartum anoxia. JAMA. 2009; 302(6):660-668 www.jama.com	[Pasupathy, Dharmintra; Smith, Gordon C. S.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2SW, England; [Wood, Angela M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 2SW, England; [Pell, Jill P.] Univ Glasgow, Publ Hlth Sect, Glasgow, Lanark, Scotland; [Fleming, Michael] Natl Serv Scotland, Natl Hlth Serv, Informat & Stat Div, Paisley, Renfrew, Scotland; [Smith, Gordon C. S.] Cambridge Comprehens Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England	University of Cambridge; University of Cambridge; University of Glasgow; NHS Blood & Transplant (NHSBT); NHS National Services Scotland; University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2SW, England.	gcss2@cam.ac.uk	Pasupathy, Dharmintra/N-9586-2019; Smith, Gordon/A-8070-2008; Wood, Angela/GZA-5762-2022	Pasupathy, Dharmintra/0000-0002-6722-1006; Smith, Gordon/0000-0003-2124-0997; Wood, Angela/0000-0002-7937-304X; fleming, michael/0000-0002-2185-4502; Pell, Jill/0000-0002-8898-7035	MRC [G0600469] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: Medline; Medical Research Council [G0600469] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 1985, LANCET, V2, P436; Bell R, 2004, BJOG-INT J OBSTET GY, V111, P1400, DOI 10.1111/j.1471-0528.2004.00296.x; Bell R, 2004, ARCH DIS CHILD-FETAL, V89, pF531, DOI 10.1136/adc.2003.038414; Cahill AG, 2006, AM J OBSTET GYNECOL, V194, P909, DOI 10.1016/j.ajog.2006.02.031; COLE SK, 1980, PERINATAL AUDIT SURV, P39; Eichenwald EC, 2008, NEW ENGL J MED, V358, P1700, DOI 10.1056/NEJMra0707601; FORBES JF, 1982, J EPIDEMIOL COMMUN H, V36, P282, DOI 10.1136/jech.36.4.282; FRETTS RC, 1992, OBSTET GYNECOL, V79, P35; Glinianaia SV, 2005, J CLIN EPIDEMIOL, V58, P1299, DOI 10.1016/j.jclinepi.2005.03.015; HEY EN, 1986, BRIT J OBSTET GYNAEC, V93, P1213, DOI 10.1111/j.1471-0528.1986.tb07854.x; Little R. J. A., 1987, STAT ANAL MISSING DA; MacDorman Marian F, 2007, Natl Vital Stat Rep, V56, P1; MACFARLANE A, 2000, BIRTH COUNTS STAT PR, V1; MCILWAINE GM, 1985, BRIT J OBSTET GYNAEC, V92, P9, DOI 10.1111/j.1471-0528.1985.tb01041.x; *NAT HLTH SERV SCO, 2001, SCOTT PER INF MORT M; O'Leary CM, 2007, PAEDIATR PERINAT EP, V21, P541, DOI 10.1111/j.1365-3016.2007.00849.x; Pasupathy D, 2009, INT J EPIDEMIOL, V38, P490, DOI 10.1093/ije/dyn225; Rankin J, 2005, PAEDIATR PERINAT EP, V19, P56, DOI 10.1111/j.1365-3016.2004.00625.x; Rietberg CCT, 2005, BJOG-INT J OBSTET GY, V112, P205, DOI 10.1111/j.1471-0528.2004.00317.x; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Smith GCS, 2005, AM J OBSTET GYNECOL, V192, P17, DOI 10.1016/j.ajog.2004.08.014; Smith GCS, 2004, BRIT MED J, V329, P375, DOI 10.1136/bmj.38160.634352.55; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2002, BRIT MED J, V324, P483; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Stoelhorst GMSJ, 2005, PEDIATRICS, V115, P396, DOI 10.1542/peds.2004-1497; Thornton CM, 1998, BRIT J OBSTET GYNAEC, V105, P18, DOI 10.1111/j.1471-0528.1998.tb09344.x; Walsh CA, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.018; WHITFIELD CR, 1986, BRIT J OBSTET GYNAEC, V93, P694, DOI 10.1111/j.1471-0528.1986.tb08054.x	30	34	34	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					660	668		10.1001/jama.2009.1111	http://dx.doi.org/10.1001/jama.2009.1111			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	481ZI	19671907	Bronze			2022-12-28	WOS:000268852300024
J	Guo, M; Chong, YE; Beebe, K; Shapiro, R; Yang, XL; Schimmel, P				Guo, Min; Chong, Yeeting E.; Beebe, Kirk; Shapiro, Ryan; Yang, Xiang-Lei; Schimmel, Paul			The C-Ala Domain Brings Together Editing and Aminoacylation Functions on One tRNA	SCIENCE			English	Article							AMINO-ACID; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; BINDING DOMAIN; SYNTHETASE; DISCRIMINATION; RECOGNITION; COMPLEX; MISTRANSLATION; DETERMINANTS	Protein synthesis involves the accurate attachment of amino acids to their matching transfer RNA (tRNA) molecules. Mistranslating the amino acids serine or glycine for alanine is prevented by the function of independent but collaborative aminoacylation and editing domains of alanyl-tRNA synthetases (AlaRSs). We show that the C-Ala domain plays a key role in AlaRS function. The C-Ala domain is universally tethered to the editing domain both in AlaRS and in many homologous free-standing editing proteins. Crystal structure and functional analyses showed that C-Ala forms an ancient single-stranded nucleic acid binding motif that promotes cooperative binding of both aminoacylation and editing domains to tRNA(Ala). In addition, C-Ala may have played an essential role in the evolution of AlaRSs by coupling aminoacylation to editing to prevent mistranslation.	[Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, BCC-379,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Chong, Yeeting/AAE-3792-2020; Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X	NIH [GM 15539]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant GM 15539 and by a fellowship from the National Foundation for Cancer Research. The atomic coordinates have been deposited in the Protein Data Bank (PDB ID:3G98).	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Beebe K, 2003, J BIOL CHEM, V278, P45056, DOI 10.1074/jbc.M307080200; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; BUECHTER DD, 1993, BIOCHEMISTRY-US, V32, P5267, DOI 10.1021/bi00070a039; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2007, BIOCHEMISTRY-US, V46, P4985, DOI 10.1021/bi6024935; Fukunaga R, 2007, ACTA CRYSTALLOGR D, V63, P390, DOI 10.1107/S090744490605640X; Gale AJ, 1996, BIOCHEMISTRY-US, V35, P608, DOI 10.1021/bi9520904; HOU YM, 1989, BIOCHEMISTRY-US, V28, P4942, DOI 10.1021/bi00438a005; Hsu JL, 2008, J MOL BIOL, V376, P482, DOI 10.1016/j.jmb.2007.11.065; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Nomanbhoy T, 2001, NAT STRUCT BIOL, V8, P344, DOI 10.1038/86228; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Ribas De Pouplana L, 2005, AMINOACYL TRNA SYNTH, P241; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wong FC, 2003, J BIOL CHEM, V278, P52857, DOI 10.1074/jbc.M309627200; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099	32	57	62	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					744	747		10.1126/science.1174343	http://dx.doi.org/10.1126/science.1174343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661429	Green Accepted			2022-12-28	WOS:000268723700048
J	Dong, XQ; Simon, M; de Leon, CM; Fulmer, T; Beck, T; Hebert, L; Dyer, C; Paveza, G; Evans, D				Dong, XinQi; Simon, Melissa; de Leon, Carlos Mendes; Fulmer, Terry; Beck, Todd; Hebert, Liesi; Dyer, Carmel; Paveza, Gregory; Evans, Denis			Elder Self-neglect and Abuse and Mortality Risk in a Community-Dwelling Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL PERFORMANCE; UNITED-STATES; MISTREATMENT; DISABILITY; DISEASE; ADULTS	Context Both elder self-neglect and abuse have become increasingly prominent public health issues. The association of either elder self-neglect or abuse with mortality remains unclear. Objective To examine the relationship of elder self-neglect or abuse reported to social services agencies with all-cause mortality among a community-dwelling elderly population. Design, Setting, and Participants Prospective, population-based cohort study (conducted from 1993 to 2005) of residents living in a geographically defined community of 3 adjacent neighborhoods in Chicago, Illinois, who were participating in the Chicago Health and Aging Project (CHAP; a longitudinal, population-based, epidemiological study of residents aged >= 65 years). A subset of these participants had suspected elder self-neglect or abuse reported to social services agencies. Main Outcome Measures Mortality ascertained during follow-up and by use of the National Death Index. Cox proportional hazard models were used to assess independent associations of self-neglect or elder abuse reporting with the risk of all-cause mortality using time-varying covariate analyses. Results Of 9318 CHAP participants, 1544 participants were reported for elder self-neglect and 113 participants were reported for elder abuse from 1993 to 2005. All CHAP participants were followed up for a median of 6.9 years (interquartile range, 7.4 years), during which 4306 deaths occurred. In multivariable analyses, reported elder self-neglect was associated with a significantly increased risk of 1-year mortality (hazard ratio [HR], 5.82; 95% confidence interval [CI], 5.20-6.51). Mortality risk was lower but still elevated after 1 year ( HR, 1.88; 95% CI, 1.67-2.14). Reported elder abuse also was associated with significantly increased risk of overall mortality (HR, 1.39; 95% CI, 1.07-1.84). Confirmed elder self-neglect or abuse also was associated with mortality. Increased mortality risks associated with either elder self-neglect or abuse were not restricted to those with the lowest levels of cognitive or physical function. Conclusion Both elder self-neglect and abuse reported to social services agencies were associated with increased risk of mortality. JAMA. 2009; 302(5):517-526 www.jama.com	[Dong, XinQi; de Leon, Carlos Mendes; Beck, Todd; Hebert, Liesi; Evans, Denis] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Simon, Melissa] Northwestern Univ, Med Ctr, Chicago, IL 60611 USA; [Fulmer, Terry] NYU, Coll Nursing, New York, NY USA; [Dyer, Carmel] Univ Texas Houston, Dept Med, Houston, TX USA; [Paveza, Gregory] So Connecticut State Univ, Sch Hlth & Human Serv, New Haven, CT 06515 USA	Rush University; Northwestern University; New York University; University of Texas System; University of Texas Health Science Center Houston; Connecticut State University System; Southern Connecticut State University	Dong, XQ (corresponding author), Rush Inst Healthy Aging, 1645 Jackson,Ste 675, Chicago, IL 60612 USA.	xinqidong@gmail.com			National Institute on Aging [R01 AG11101]; Paul B. Beeson Career Development Award in Aging [K23 AG030944]; American Federation for Aging Research; Starr Foundation; John A. Hartford Foundation; Atlantic Philanthropies; National Institute of Child Health and Human Development [K12 HD 050121]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD050121] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG033927, R21AG030664, R01AG011101, K23AG030944] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Paul B. Beeson Career Development Award in Aging; American Federation for Aging Research; Starr Foundation; John A. Hartford Foundation; Atlantic Philanthropies; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging grant R01 AG11101 and by the Paul B. Beeson Career Development Award in Aging (K23 AG030944), and funding from the American Federation for Aging Research, the Starr Foundation, the John A. Hartford Foundation, and the Atlantic Philanthropies. Dr Simon was supported by grant K12 HD 050121 from the National Institute of Child Health and Human Development.	ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Bienias JL, 2003, J ALZHEIMERS DIS, V5, P349, DOI 10.3233/JAD-2003-5501; BURSTON GR, 1975, BRIT MED J, V3, P592, DOI 10.1136/bmj.3.5983.592-a; CLARK ANG, 1975, LANCET, V1, P366; CORNONIHUNTLEY J, 1986, NIH PUBLICATION; Cornwall J V, 1981, Nurs Mirror, V153, P48; COX DR, 1972, J R STAT SOC B, V187, P220; Dong XQ, 2005, J ELDER ABUSE NEGL, V17, P19, DOI 10.1300/J084v17n03_02; Dong XQ, 2009, J AGING HEALTH, V21, P596, DOI 10.1177/0898264309333323; Dong XQ, 2005, CLIN GERIATR MED, V21, P293, DOI 10.1016/j.cger.2004.10.006; Dyer CB, 2007, JAMA-J AM MED ASSOC, V298, P1448, DOI 10.1001/jama.298.12.1448; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GILL TM, 1995, J AM GERIATR SOC, V43, P603, DOI 10.1111/j.1532-5415.1995.tb07192.x; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; *IL DEP AG, 1989, DET NEED REV FIN REP, V1; *IL DEP AG, ELD AB NEGL PROGR ST; KATZ S, 1976, INT J HEALTH SERV, V6, P493, DOI 10.2190/UURL-2RYU-WRYD-EY3K; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Lachs MS, 1998, JAMA-J AM MED ASSOC, V280, P428, DOI 10.1001/jama.280.5.428; LACHS MS, 1994, J AM GERIATR SOC, V42, P169, DOI 10.1111/j.1532-5415.1994.tb04947.x; Laumann EO, 2008, J GERONTOL B-PSYCHOL, V63, pS248, DOI 10.1093/geronb/63.4.S248; MACMILLAN D, 1966, BMJ-BRIT MED J, V2, P1032, DOI 10.1136/bmj.2.5521.1032; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; *NAT CTR ELD AB, ELD AB MISTR DEF; *NAT CTR ELD AB, 1998, NAT EL AB INC STUD; National Center on Elder Abuse, 2006, 2004 SURV STAT AD PR; National Research Council, 2003, ELD MISTR AB NEGL EX; Ortiz N, 2009, PSYCHOSOMATICS, V50, P166, DOI 10.1176/appi.psy.50.2.166; Ortmann C, 2001, INT J LEGAL MED, V114, P191, DOI 10.1007/s004140000173; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROE P F, 1977, Age and Ageing, V6, P192, DOI 10.1093/ageing/6.3.192; *SAS I INC, 2004, SAS ONLINEDOC VERS 9; Shields LBE, 2004, J FORENSIC SCI, V49, P122, DOI 10.1520/JFS2003161; Smith A., 1984, SYMBOL DIGIT MODALIT; TEASTER PB, RESPONSE ABUSE VULNE; World Health Organization, 2002, WORLD REP VIOL HLTH, P360	38	257	262	7	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					517	526		10.1001/jama.2009.1109	http://dx.doi.org/10.1001/jama.2009.1109			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479DS	19654386	Green Accepted, Bronze			2022-12-28	WOS:000268640500016
J	Dias-Ferreira, E; Sousa, JC; Melo, I; Morgado, P; Mesquita, AR; Cerqueira, JJ; Costa, RM; Sousa, N				Dias-Ferreira, Eduardo; Sousa, Joao C.; Melo, Irene; Morgado, Pedro; Mesquita, Ana R.; Cerqueira, Joao J.; Costa, Rui M.; Sousa, Nuno			Chronic Stress Causes Frontostriatal Reorganization and Affects Decision-Making	SCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; BASAL GANGLIA; CONTINGENCY; STRIATUM; HIPPOCAMPAL; SENSITIVITY; MORPHOLOGY; HABITS; REWARD	The ability to shift between different behavioral strategies is necessary for appropriate decision-making. Here, we show that chronic stress biases decision-making strategies, affecting the ability of stressed animals to perform actions on the basis of their consequences. Using two different operant tasks, we revealed that, in making choices, rats subjected to chronic stress became insensitive to changes in outcome value and resistant to changes in action-outcome contingency. Furthermore, chronic stress caused opposing structural changes in the associative and sensorimotor corticostriatal circuits underlying these different behavioral strategies, with atrophy of medial prefrontal cortex and the associative striatum and hypertrophy of the sensorimotor striatum. These data suggest that the relative advantage of circuits coursing through sensorimotor striatum observed after chronic stress leads to a bias in behavioral strategies toward habit.	[Dias-Ferreira, Eduardo; Costa, Rui M.] NIAAA, Sect Vivo Neural Funct, Lab Integrat Neurosci, NIH, Bethesda, MD 20852 USA; [Dias-Ferreira, Eduardo; Sousa, Joao C.; Melo, Irene; Morgado, Pedro; Mesquita, Ana R.; Cerqueira, Joao J.; Sousa, Nuno] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal; [Dias-Ferreira, Eduardo] Univ Coimbra, PhD Programme Expt Biol & Biomed PDBEB, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Costa, Rui M.] Gulbenkian Inst Sci, Champalimaud Neurosci Programme, P-2780901 Oeiras, Portugal	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Universidade do Minho; Universidade de Coimbra; Fundacao Champalimaud	Costa, RM (corresponding author), NIAAA, Sect Vivo Neural Funct, Lab Integrat Neurosci, NIH, Bethesda, MD 20852 USA.	costarui@mail.nih.gov; njcsousa@ecsaude.uminho.pt	Sousa, Nuno JC/N-9137-2017; Morgado, Pedro/Q-1769-2015; Sousa, João/T-6628-2019; Sousa, Nuno/C-2782-2009; Sousa, João C/C-1048-2009; Cerqueira, Joao J/B-4579-2008	Sousa, Nuno JC/0000-0002-8755-5126; Morgado, Pedro/0000-0003-3880-3258; Sousa, João/0000-0003-3249-0035; Sousa, João C/0000-0003-3249-0035; Cerqueira, Joao J/0000-0003-3155-2775; Mesquita, Ana/0000-0002-9635-2355; Costa, Rui M./0000-0003-0495-8374	Bial Foundation [134/06]; ICV; Division of Intramural Clinical and Basic Research, NIAAA, NIH; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416, Z01AA000416] Funding Source: NIH RePORTER	Bial Foundation(Bial Foundation); ICV; Division of Intramural Clinical and Basic Research, NIAAA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Bial Foundation (134/06), the ICV, and the Division of Intramural Clinical and Basic Research, NIAAA, NIH.	ADAMS CD, 1981, Q J EXP PSYCHOL-B, V33, P109, DOI 10.1080/14640748108400816; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Cleck JN, 2008, J CLIN INVEST, V118, P454, DOI 10.1172/JCI33946; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; HAMMOND LJ, 1980, J EXP ANAL BEHAV, V34, P297, DOI 10.1901/jeab.1980.34-297; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Jedynak JP, 2007, EUR J NEUROSCI, V25, P847, DOI 10.1111/j.1460-9568.2007.05316.x; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Schilman EA, 2008, NEUROSCI LETT, V432, P40, DOI 10.1016/j.neulet.2007.12.024; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Vyas A, 2002, J NEUROSCI, V22, P6810; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	30	573	588	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					621	625		10.1126/science.1171203	http://dx.doi.org/10.1126/science.1171203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644122				2022-12-28	WOS:000268493000053
J	Harris, J				Harris, Jim			Soil Microbial Communities and Restoration Ecology: Facilitators or Followers?	SCIENCE			English	Editorial Material							ABANDONED AGRICULTURAL FIELDS; LAND ABANDONMENT; ECOSYSTEMS; DIVERSITY; PRODUCTIVITY; MANAGEMENT; FORESTS	Microorganisms have critical roles in the functioning of soil in nutrient cycling, structural formation, and plant interactions, both positive and negative. These roles are important in reestablishing function and biodiversity in ecosystem restoration. Measurement of the community indicates the status of the system in relation to restoration targets and the effectiveness of management interventions, and manipulation of the community shows promise in the enhancement of the rate of recovery of degraded systems.	Cranfield Univ, Dept Nat Resources, Cranfield MK43 0AL, Beds, England	Cranfield University	Harris, J (corresponding author), Cranfield Univ, Dept Nat Resources, Cranfield MK43 0AL, Beds, England.		Harris, Jim A/B-2816-2011	Harris, Jim A/0000-0001-9266-4979				Bending GD, 2007, NEW PHYTOL, V174, P707, DOI 10.1111/j.1469-8137.2007.02076.x; Feeney DS, 2006, MICROB ECOL, V52, P151, DOI 10.1007/s00248-006-9062-8; Gros R, 2006, ENVIRON MICROBIOL, V8, P1889, DOI 10.1111/j.1462-2920.2006.01106.x; Harris JA, 2003, EUR J SOIL SCI, V54, P801, DOI 10.1046/j.1351-0754.2003.0559.x; Harris JA, 2006, RESTOR ECOL, V14, P170, DOI 10.1111/j.1526-100X.2006.00136.x; Heneghan L, 2008, RESTOR ECOL, V16, P608, DOI 10.1111/j.1526-100X.2008.00477.x; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; Hodkinson ID, 2002, J ECOL, V90, P569, DOI 10.1046/j.1365-2745.2002.00696.x; Holtkamp R, 2008, APPL SOIL ECOL, V39, P23, DOI 10.1016/j.apsoil.2007.11.002; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Jasper DA, 2007, RESTOR ECOL, V15, pS74, DOI 10.1111/j.1526-100X.2007.00295.x; Kardol P, 2009, RESTOR ECOL, V17, P258, DOI 10.1111/j.1526-100X.2007.00351.x; Kulmatiski A, 2006, RESTOR ECOL, V14, P251, DOI 10.1111/j.1526-100X.2006.00127.x; Mummey DL, 2009, SOIL BIOL BIOCHEM, V41, P1173, DOI 10.1016/j.soilbio.2009.02.027; Requena N, 2001, APPL ENVIRON MICROB, V67, P495, DOI 10.1128/AEM.67.2.495-498.2001; Richter BS, 2002, RESTOR ECOL, V10, P607, DOI 10.1046/j.1526-100X.2002.01041.x; Teste FP, 2008, OECOLOGIA, V158, P193, DOI 10.1007/s00442-008-1136-5; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Wal A, 2006, SOIL BIOL BIOCHEM, V38, P51, DOI 10.1016/j.soilbio.2005.04.017; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875	21	360	398	34	417	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					573	574		10.1126/science.1172975	http://dx.doi.org/10.1126/science.1172975			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19644111				2022-12-28	WOS:000268493000039
J	Roestenberg, M; McCall, M; Hopman, J; Wiersma, J; Luty, AJF; van Gemert, GJ; van de Vegte-Bolmer, M; van Schaijk, B; Teelen, K; Arens, T; Spaarman, L; de Mast, Q; Roeffen, W; Snounou, G; Renia, L; van der Ven, A; Hermsen, CC; Sauerwein, R				Roestenberg, Meta; McCall, Matthew; Hopman, Joost; Wiersma, Jorien; Luty, Adrian J. F.; van Gemert, Geert Jan; van de Vegte-Bolmer, Marga; van Schaijk, Ben; Teelen, Karina; Arens, Theo; Spaarman, Lopke; de Mast, Quirijn; Roeffen, Will; Snounou, Georges; Renia, Laurent; van der Ven, Andre; Hermsen, Cornelus C.; Sauerwein, Robert			Protection against a Malaria Challenge by Sporozoite Inoculation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM SPOROZOITES; APICAL MEMBRANE ANTIGEN-1; IRRADIATED SPOROZOITES; LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; VACCINE; IMMUNIZATION; CHLOROQUINE; RESPONSES; IMMUNITY	Background: An effective vaccine for malaria is urgently needed. Naturally acquired immunity to malaria develops slowly, and induction of protection in humans can be achieved artificially by the inoculation of radiation-attenuated sporozoites by means of more than 1000 infective mosquito bites. Methods: We exposed 15 healthy volunteers -- with 10 assigned to a vaccine group and 5 assigned to a control group -- to bites of mosquitoes once a month for 3 months while they were receiving a prophylactic regimen of chloroquine. The vaccine group was exposed to mosquitoes that were infected with Plasmodium falciparum, and the control group was exposed to mosquitoes that were not infected with the malaria parasite. One month after the discontinuation of chloroquine, protection was assessed by homologous challenge with five mosquitoes infected with P. falciparum. We assessed humoral and cellular responses before vaccination and before the challenge to investigate correlates of protection. Results: All 10 subjects in the vaccine group were protected against a malaria challenge with the infected mosquitoes. In contrast, patent parasitemia (i.e., parasites found in the blood on microscopical examination) developed in all five control subjects. Adverse events were mainly reported by vaccinees after the first immunization and by control subjects after the challenge; no serious adverse events occurred. In this model, we identified the induction of parasite-specific pluripotent effector memory T cells producing interferon-(gamma), tumor necrosis factor (alpha), and interleukin-2 as a promising immunologic marker of protection. Conclusions: Protection against a homologous malaria challenge can be induced by the inoculation of intact sporozoites. (ClinicalTrials.gov number, NCT00442377.) N Engl J Med 2009;361:468-77.	[Roestenberg, Meta; McCall, Matthew; Hopman, Joost; Wiersma, Jorien; Luty, Adrian J. F.; van Gemert, Geert Jan; van de Vegte-Bolmer, Marga; van Schaijk, Ben; Teelen, Karina; Arens, Theo; Spaarman, Lopke; Roeffen, Will; Hermsen, Cornelus C.; Sauerwein, Robert] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [de Mast, Quirijn; van der Ven, Andre] Radboud Univ Nijmegen, Dept Gen Internal Med, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Snounou, Georges] Hop La Pitie Salpetriere, INSERM, U511, Dept Parasitol, Paris, France; [Snounou, Georges] Univ Paris 06, Paris, France; [Renia, Laurent] Agcy Technol & Res, Singapore Immunol Network, Lab Malaria Immunobiol, Singapore, Singapore	Radboud University Nijmegen; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Sauerwein, R (corresponding author), Radboud Univ Nijmegen, Dept Med Microbiol 268, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	r.sauerwein@mmb.umcn.nl	van der Ven, A.J.A.M./H-8102-2014; Roestenberg, Meta/AAP-9413-2021; Luty, Adrian/CAH-2547-2022; Snounou, Georges/F-3352-2011; de Mast, Quirijn/H-3427-2015; Sauerwein, Robert/C-8519-2013; Roeffen, W.F.G./L-4607-2015; Hermsen, C.C./L-4368-2015; Renia, Laurent/E-2117-2011	van der Ven, A.J.A.M./0000-0003-1833-3391; Roestenberg, Meta/0000-0002-5052-2830; Snounou, Georges/0000-0002-6133-6398; Renia, Laurent/0000-0003-0349-1557; de Mast, Quirijn/0000-0001-6056-157X; Luty, Adrian John Frederick/0000-0001-8830-3425; McCall, Matthew/0000-0002-5738-1401	Dioraphte Foundation; European Union FP6 Network of Excellence; NutsOhra Foundation; Agence Nationale de la Recherche in France	Dioraphte Foundation; European Union FP6 Network of Excellence(European Commission); NutsOhra Foundation; Agence Nationale de la Recherche in France(French National Research Agency (ANR))	Supported by the Dioraphte Foundation, by a fellowship from the European Union FP6 Network of Excellence (to Dr. McCall), and by grants from the NutsOhra Foundation (to Dr. van der Ven) and Agence Nationale de la Recherche in France (to Dr. Snounou).	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; BEAUDOIN RL, 1977, EXP PARASITOL, V42, P1, DOI 10.1016/0014-4894(77)90054-6; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bejon P, 2006, INFECT IMMUN, V74, P6331, DOI 10.1128/IAI.00774-06; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Bousema JT, 2006, AM J TROP MED HYG, V74, P425; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; DAVIS JR, 1992, EXP PARASITOL, V74, P159, DOI 10.1016/0014-4894(92)90043-A; Edstein MD, 2005, ANTIMICROB AGENTS CH, V49, P4421, DOI 10.1128/AAC.49.10.4421-4422.2005; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Grobusch MP, 2007, CURR OPIN INFECT DIS, V20, P613, DOI 10.1097/QCO.0b013e3282f1ae3b; Hermsen CC, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.2.0700196; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Hermsen CC, 2007, VACCINE, V25, P2930, DOI 10.1016/j.vaccine.2006.06.081; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hogh B., 1993, Parassitologia (Rome), V35, P47; HOUZE P, 1992, J CHROMATOGR-BIOMED, V574, P305, DOI 10.1016/0378-4347(92)80044-Q; KRZYCH U, 1995, J IMMUNOL, V155, P4072; Lejeune D, 2007, J PHARMACEUT BIOMED, V43, P1106, DOI 10.1016/j.jpba.2006.09.036; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; MELLOUK S, 1990, LANCET, V335, P721, DOI 10.1016/0140-6736(90)90832-P; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; ORJIH AU, 1985, CLIN EXP IMMUNOL, V61, P67; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; ROMBO L, 1987, B WORLD HEALTH ORGAN, V65, P879; Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Sutherland CJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-161; Verhage DF, 2005, NETH J MED, V63, P52; YAYON A, 1983, J PROTOZOOL, V30, P642, DOI 10.1111/j.1550-7408.1983.tb05336.x	37	443	459	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					468	477		10.1056/NEJMoa0805832	http://dx.doi.org/10.1056/NEJMoa0805832			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LW	19641203	Green Published			2022-12-28	WOS:000268443900007
J	Sun, YG; Zhao, ZQ; Meng, XL; Yin, J; Liu, XY; Chen, ZF				Sun, Yan-Gang; Zhao, Zhong-Qiu; Meng, Xiu-Li; Yin, Jun; Liu, Xian-Yu; Chen, Zhou-Feng			Cellular Basis of Itch Sensation	SCIENCE			English	Article							SPINOTHALAMIC TRACT NEURONS; SUBSTANCE-P RECEPTOR; NEURAL PATHWAY; SPINAL-CORD; LAMINAE-I; PRURITUS; MICE; INHIBITION; HISTAMINE; AGENTS	Itch and pain are two distinct sensations. Although our previous study suggested that gastrin-releasing peptide receptor (GRPR) is an itch-specific gene in the spinal cord, a long-standing question of whether there are separate neuronal pathways for itch and pain remains unsettled. We selectively ablated lamina I neurons expressing GRPR in the spinal cord of mice. These mice showed profound scratching deficits in response to all of the itching (pruritogenic) stimuli tested, irrespective of their histamine dependence. In contrast, pain behaviors were unaffected. Our data also suggest that GRPR(+) neurons are different from the spinothalamic tract neurons that have been the focus of the debate. Together, the present study suggests that GRPR(+) neurons constitute a long-sought labeled line for itch sensation in the spinal cord.	[Sun, Yan-Gang; Zhao, Zhong-Qiu; Meng, Xiu-Li; Yin, Jun; Liu, Xian-Yu; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Anesthesiol, Pain Ctr, St Louis, MO 63110 USA; [Sun, Yan-Gang; Zhao, Zhong-Qiu; Meng, Xiu-Li; Yin, Jun; Liu, Xian-Yu; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Psychiat, Pain Ctr, St Louis, MO 63110 USA; [Sun, Yan-Gang; Zhao, Zhong-Qiu; Meng, Xiu-Li; Yin, Jun; Liu, Xian-Yu; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Dev Biol, Pain Ctr, St Louis, MO 63110 USA; [Meng, Xiu-Li] Peking Univ, Hosp 3, Dept Anesthesiol, Beijing 100191, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Peking University	Chen, ZF (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Pain Ctr, St Louis, MO 63110 USA.	chenz@wustl.edu	LIU, XIANYU/B-8111-2014	Liu, Xianyu/0000-0001-6089-8826	NIH [P30 NS057105]; Washington University Pain Center Animal Behavior Core; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105, R01NS046036, P01NS049048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Pain Center Animal Behavior Core; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Y. Kim and S. Y. Kim for technical help, J. Battey for GRPR mutant mice, and R. LaMotte for comments. The work was supported by a NIH grant to Z. F. C and by the Washington University Pain Center Animal Behavior Core and NIH Neuroscience Blueprint Interdisciplinary Center Core Grant P30 NS057105 to Washington University. The work presented in this report is the subject of a pending patent filed by Washington University in St. Louis.	Al-Khater KM, 2008, J COMP NEUROL, V511, P1, DOI 10.1002/cne.21811; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; Bickford RG, 1938, CLIN SCI, V3, P337; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; GRAHAM DT, 1951, J CLIN INVEST, V30, P37, DOI 10.1172/JCI102414; Hyndman OR, 1943, ARCH NEURO PSYCHIATR, V50, P129, DOI 10.1001/archneurpsyc.1943.02290200029002; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Rothman S, 1941, PHYSIOL REV, V21, P357, DOI 10.1152/physrev.1941.21.2.357; Schmelz M, 2001, NAT NEUROSCI, V4, P9, DOI 10.1038/82956; Seike M, 2005, EXP DERMATOL, V14, P169, DOI 10.1111/j.0906-6705.2005.00247.x; SHELLEY WB, 1957, ARCH DERMATOL, V76, P296, DOI 10.1001/archderm.1957.01550210020004; Simone DA, 2004, J NEUROPHYSIOL, V91, P213, DOI 10.1152/jn.00527.2003; SOWUNMI A, 1989, LANCET, V2, P213; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Trentin PG, 2006, EXP BIOL MED, V231, P1146; Tuckett R. P, 1994, ITCH MECH MANAGEMENT, P1; VANDERSTEEN PHM, 1991, J AM ACAD DERMATOL, V24, P253, DOI 10.1016/0190-9622(91)70037-3; von Frey M., 1922, ARCH NEERLAND PHYSL, V7, P142; Wahlgren Carl-Fredrik, 1999, Journal of Dermatology (Tokyo), V26, P770	28	408	424	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1531	1534		10.1126/science.1174868	http://dx.doi.org/10.1126/science.1174868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19661382	Green Accepted			2022-12-28	WOS:000269887900036
J	Coufal, NG; Garcia-Perez, JL; Peng, GE; Yeo, GW; Mu, YL; Lovci, MT; Morell, M; O'Shea, KS; Moran, JV; Gage, FH				Coufal, Nicole G.; Garcia-Perez, Jose L.; Peng, Grace E.; Yeo, Gene W.; Mu, Yangling; Lovci, Michael T.; Morell, Maria; O'Shea, K. Sue; Moran, John V.; Gage, Fred H.			L1 retrotransposition in human neural progenitor cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; LINE-1 RETROTRANSPOSITION; ELEMENTS	Long interspersed element 1 (LINE-1 or L1) retrotransposons have markedly affected the human genome. L1s must retrotranspose in the germ line or during early development to ensure their evolutionary success, yet the extent to which this process affects somatic cells is poorly understood. We previously demonstrated that engineered human L1s can retrotranspose in adult rat hippocampus progenitor cells in vitro and in the mouse brain in vivo(1). Here we demonstrate that neural progenitor cells isolated from human fetal brain and derived from human embryonic stem cells support the retrotransposition of engineered human L1s in vitro. Furthermore, we developed a quantitative multiplex polymerase chain reaction that detected an increase in the copy number of endogenous L1s in the hippocampus, and in several regions of adult human brains, when compared to the copy number of endogenous L1s in heart or liver genomic DNAs from the same donor. These data suggest that de novo L1 retrotransposition events may occur in the human brain and, in principle, have the potential to contribute to individual somatic mosaicism.	[Coufal, Nicole G.; Peng, Grace E.; Yeo, Gene W.; Mu, Yangling; Lovci, Michael T.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Garcia-Perez, Jose L.; Moran, John V.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Garcia-Perez, Jose L.; Moran, John V.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Garcia-Perez, Jose L.] Univ Granada, Ctr Biomed Res, Andalusian Stem Cell Bank, Granada 18100, Spain; [Morell, Maria; O'Shea, K. Sue] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Moran, John V.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Salk Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Granada; University of Michigan System; University of Michigan; Howard Hughes Medical Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Coufal, Nicole/ABA-9471-2021; Morell, Maria/C-4606-2017; Morell, Maria/ABF-8213-2020; Lovci, Michael/C-8685-2014; Yeo, Gene/AAE-7676-2019	Morell, Maria/0000-0002-3692-1333; Morell, Maria/0000-0001-9613-9741; Lovci, Michael/0000-0002-0077-7608; Yeo, Gene/0000-0002-0799-6037; Peng, Grace/0000-0002-8901-725X; Garcia-Perez, Jose Luis/0000-0002-8132-9849; Coufal, Nicole/0000-0001-6547-1733	Picower Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Lookout Fund [MH082070]; California Institute for Regenerative Medicine (CIRM).; Plan Estabilizacion Grupos SNS ENCYT 2015 [EMER07/56]; Marie Curie program [IRG-FP7-PEOPLE-2007]; National Institutes of Health (NIH) [GM069985, NS048187, GM082970]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082970, R01GM060518, P20GM069985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH082070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048187] Funding Source: NIH RePORTER	Picower Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Lookout Fund; California Institute for Regenerative Medicine (CIRM).(California Institute for Regenerative Medicine); Plan Estabilizacion Grupos SNS ENCYT 2015; Marie Curie program(European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Simon for excellent schematic drawings, M. L. Gage, J. Kim and H. Kopera for editorial comments, B. Miller and R. Keithley for cell culture assistance, C. T. Carson for hESC advice, D. Chambers and J. Barrie for flow cytometry assistance, L. Randolph-Moore for molecular advice, B. Aimone for statistics advice, T. Liang for microarray assistance, and Y. Lineu and J. Mosher for helpful comments. We also thank T. Fanning and M. Klymkowsky for the ORF1 protein and SOX3 antibodies, respectively. F. H. G. and N. G. C. are supported by the Picower Foundation, G. Harold and Leila Y. Mathers Charitable Foundation, Lookout Fund (MH082070), and the California Institute for Regenerative Medicine (CIRM). J. L. G.-P. is supported by Plan Estabilizacion Grupos SNS ENCYT 2015 (EMER07/56, Instituto de Salud Carlos III, Spain) and through the IRG-FP7-PEOPLE-2007 Marie Curie program. K. S. O. was supported by grants GM069985 and NS048187 from the National Institutes of Health (NIH). J. V. M. was supported by grants GM082970 and GM069985 from the NIH and by the Howard Hughes Medical Institute. Work in the laboratories of K. S. O. and J. V. M. only used NIH-approved stem cell lines.	Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Forslund O, 2003, VIROLOGY, V312, P255, DOI 10.1016/S0042-6822(03)00391-X; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; GRIMALDI G, 1984, EMBO J, V3, P1753, DOI 10.1002/j.1460-2075.1984.tb02042.x; Kulpa DA, 2005, HUM MOL GENET, V14, P3237, DOI 10.1093/hmg/ddi354; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; MORAN J, 2002, MAMMALIAN LINE 1 RET; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Pavlicek A, 2002, GENE, V300, P189, DOI 10.1016/S0378-1119(02)01047-8; Prak ETL, 2003, P NATL ACAD SCI USA, V100, P1832, DOI 10.1073/pnas.0337627100; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Takai Daiya, 2003, In Silico Biology, V3, P235; Tang Y, 2001, SYNAPSE, V41, P258, DOI 10.1002/syn.1083; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yu F, 2001, NUCLEIC ACIDS RES, V29, P4493, DOI 10.1093/nar/29.21.4493; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	28	564	617	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 27	2009	460	7259					1127	1131		10.1038/nature08248	http://dx.doi.org/10.1038/nature08248			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19657334	Green Accepted			2022-12-28	WOS:000269314000038
J	Oliver, KM; Degnan, PH; Hunter, MS; Moran, NA				Oliver, Kerry M.; Degnan, Patrick H.; Hunter, Martha S.; Moran, Nancy A.			Bacteriophages Encode Factors Required for Protection in a Symbiotic Mutualism	SCIENCE			English	Article							DEFENSIVE SYMBIONTS; ENDOSYMBIONT; APHIDS; RESISTANCE; EVOLUTION; BACTERIA; GENOME	Bacteriophages are known to carry key virulence factors for pathogenic bacteria, but their roles in symbiotic bacteria are less well understood. The heritable symbiont Hamiltonella defensa protects the aphid Acyrthosiphon pisum from attack by the parasitoid Aphidius ervi by killing developing wasp larvae. In a controlled genetic background, we show that a toxin-encoding bacteriophage is required to produce the protective phenotype. Phage loss occurs repeatedly in laboratory-held H. defensa-infected aphid clonal lines, resulting in increased susceptibility to parasitism in each instance. Our results show that these mobile genetic elements can endow a bacterial symbiont with benefits that extend to the animal host. Thus, phages vector ecologically important traits, such as defense against parasitoids, within and among symbiont and animal host lineages.	[Oliver, Kerry M.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Degnan, Patrick H.; Moran, Nancy A.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Hunter, Martha S.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University System of Georgia; University of Georgia; University of Arizona; University of Arizona	Oliver, KM (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	kmoliver@uga.edu	oliver, kerry/H-4498-2017; Hunter, Martha/B-7307-2012; Hunter, Martha/AAF-5288-2020; Moran, Nancy A/G-1591-2010	oliver, kerry/0000-0002-2835-4017; Hunter, Martha/0000-0002-6342-675X; Hunter, Martha/0000-0002-6342-675X; 	National Research Initiative of the U.S. Department of Agriculture Cooperative Research, Education, and Extension Service [2006-35302-17307]; NSF [0313737]; NIH [1K 12 GM00708];  [NSF 0654435]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Research Initiative of the U.S. Department of Agriculture Cooperative Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the National Research Initiative of the U.S. Department of Agriculture Cooperative Research, Education, and Extension Service, grant 2006-35302-17307 to K.M.O. and M.S.H., and NSF grant 0313737 to N.A.M. K.M.O. also received support from NIH training grant 1K 12 GM00708, and P.H.D. was supported by an NSF Integrative Graduate Education and Research Traineeship fellowship in comparative genomics (NSF 0654435).	Bordenstein SR, 2005, NAT REV MICROBIOL, V3, P688, DOI 10.1038/nrmicro1233; Clark AJ, 2007, J BACTERIOL, V189, P2949, DOI 10.1128/JB.00913-06; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Haynes S, 2003, APPL ENVIRON MICROB, V69, P7216, DOI 10.1128/AEM.69.12.7216-7223.2003; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2006, P ROY SOC B-BIOL SCI, V273, P1273, DOI 10.1098/rspb.2005.3436; Oliver KM, 2009, MYCOL SER, V27, P129; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; van der Wilk F, 1999, VIROLOGY, V262, P104, DOI 10.1006/viro.1999.9902; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	21	325	342	0	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					992	994		10.1126/science.1174463	http://dx.doi.org/10.1126/science.1174463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696350	Green Accepted			2022-12-28	WOS:000269242800045
J	Chambers, J				Chambers, John			PLANETARY SCIENCE Archaeology of the asteroid belt	NATURE			English	Editorial Material							PROTOPLANETARY DISKS; BODIES; NEBULA		Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Chambers, J (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	chambers@dtm.ciw.edu		Chambers, John/0000-0001-9046-2265				Blum J, 2008, ANNU REV ASTRON ASTR, V46, P21, DOI 10.1146/annurev.astro.46.060407.145152; Bottke WF, 2005, ICARUS, V175, P111, DOI 10.1016/j.icarus.2004.10.026; Brauer F, 2008, ASTRON ASTROPHYS, V480, P859, DOI 10.1051/0004-6361:20077759; Cuzzi JN, 2008, ASTROPHYS J, V687, P1432, DOI 10.1086/591239; Johansen A, 2007, NATURE, V448, P1022, DOI 10.1038/nature06086	8	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					963	964		10.1038/460963a	http://dx.doi.org/10.1038/460963a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693076				2022-12-28	WOS:000269085500023
J	Freedman, SD; Uppot, RN; Mino-Kenudson, M				Freedman, Steven D.; Uppot, Raul N.; Mino-Kenudson, Mari			A Man with Cystic Fibrosis with Abdominal Pain and Distention Pseudomembranous colitis and enteritis, features consistent with Clostridium difficile enterocolitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONOPATHY		[Freedman, Steven D.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Uppot, Raul N.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mino-Kenudson, Mari] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Freedman, Steven D.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Uppot, Raul N.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mino-Kenudson, Mari] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Freedman, SD (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.		Uppot, Raul/AAF-1859-2019					Accurso FJ, 2008, AM J RESP CRIT CARE, V177, P1058, DOI 10.1164/rccm.200801-069UP; Binkovitz LA, 1999, AM J ROENTGENOL, V172, P517, DOI 10.2214/ajr.172.2.9930816; Blossom DB, 2007, CLIN INFECT DIS, V45, P222, DOI 10.1086/518874; Dray X, 2004, CLIN GASTROENTEROL H, V2, P498, DOI 10.1016/S1542-3565(04)00169-7; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Kawamoto S, 1999, RADIOGRAPHICS, V19, P887, DOI 10.1148/radiographics.19.4.g99jl07887; LLOYDSTILL JD, 1994, DIGEST DIS SCI, V39, P880, DOI 10.1007/BF02087437; Macari M, 1999, RADIOLOGY, V211, P743, DOI 10.1148/radiology.211.3.r99jn32743; Maisonneuve P, 2003, JNCI-J NATL CANCER I, V95, P381, DOI 10.1093/jnci/95.5.381; PEACH SL, 1986, J CLIN PATHOL, V39, P1013, DOI 10.1136/jcp.39.9.1013; Rivlin J, 1998, J PEDIATR-US, V132, P177, DOI 10.1016/S0022-3476(98)70511-6; Robertson MB, 2006, RADIOGRAPHICS, V26, P679, DOI 10.1148/rg.263055101; SCHWARZENBERG SJ, 1995, J PEDIATR-US, V127, P565, DOI 10.1016/S0022-3476(95)70113-3; SMYTH RL, 1995, LANCET, V346, P1247, DOI 10.1016/S0140-6736(95)91860-4; WELKON CJ, 1985, AM J DIS CHILD, V139, P805, DOI 10.1001/archpedi.1985.02140100067032; Yates B, 2007, THORAX, V62, P554, DOI 10.1136/thx.2005.048652	16	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					807	816		10.1056/NEJMcpc0902225	http://dx.doi.org/10.1056/NEJMcpc0902225			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484WX	19692693				2022-12-28	WOS:000269081200011
J	Rodell, M; Velicogna, I; Famiglietti, JS				Rodell, Matthew; Velicogna, Isabella; Famiglietti, James S.			Satellite-based estimates of groundwater depletion in India	NATURE			English	Article							WATER-RESOURCES; GRACE; PRECIPITATION; SYSTEM	Groundwater is a primary source of fresh water in many parts of the world. Some regions are becoming overly dependent on it, consuming groundwater faster than it is naturally replenished and causing water tables to decline unremittingly(1). Indirect evidence suggests that this is the case in northwest India(2), but there has been no regional assessment of the rate of groundwater depletion. Here we use terrestrial water storage-change observations from the NASA Gravity Recovery and Climate Experiment satellites(3) and simulated soil-water variations from a data-integrating hydrological modelling system(4) to show that groundwater is being depleted at a mean rate of 4.0 +/- 1.0 cm yr(-1) equivalent height of water (17.7 +/- 4.5 km(3) yr(-1)) over the Indian states of Rajasthan, Punjab and Haryana (including Delhi). During our study period of August 2002 to October 2008, groundwater depletion was equivalent to a net loss of 109 km(3) of water, which is double the capacity of India's largest surface-water reservoir. Annual rainfall was close to normal throughout the period and we demonstrate that the other terrestrial water storage components (soil moisture, surface waters, snow, glaciers and biomass) did not contribute significantly to the observed decline in total water levels. Although our observational record is brief, the available evidence suggests that unsustainable consumption of groundwater for irrigation and other anthropogenic uses is likely to be the cause. If measures are not taken soon to ensure sustainable groundwater usage, the consequences for the 114,000,000 residents of the region may include a reduction of agricultural output and shortages of potable water, leading to extensive socioeconomic stresses.	[Rodell, Matthew] NASA, Goddard Space Flight Ctr, Hydrol Sci Branch, Greenbelt, MD 20771 USA; [Velicogna, Isabella; Famiglietti, James S.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Velicogna, Isabella] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Velicogna, Isabella] Univ Udine, Dept Phys, I-33100 Udine, Italy	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Irvine; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Udine	Rodell, M (corresponding author), NASA, Goddard Space Flight Ctr, Hydrol Sci Branch, Code 614-3, Greenbelt, MD 20771 USA.	matthew.rodell@nasa.gov	Rodell, Matthew/E-4946-2012; Velicogna, Isabella/R-5561-2018; Famiglietti, James S/G-7383-2017	Rodell, Matthew/0000-0003-0106-7437; Velicogna, Isabella/0000-0002-9020-1898; Famiglietti, James S/0000-0002-6053-5379	NASA's Solid Earth; Natural Hazards Program; Terrestrial Hydrology Program; Cryospheric Science Program	NASA's Solid Earth; Natural Hazards Program; Terrestrial Hydrology Program(National Aeronautics & Space Administration (NASA)); Cryospheric Science Program	We thank H. K. Beaudoing for assistance in preparing the GLDAS time series. This research was funded by grants from NASA's Solid Earth and Natural Hazards Program, Terrestrial Hydrology Program and Cryospheric Science Program.	Briscoe J, 2005, 34750IN WORLD BANK, pviii; Central Ground Water Board, 2006, DYN GROUND WAT RES I; Changnon SA, 1988, J CLIMATE, V1, P1239, DOI 10.1175/1520-0442(1988)001<1239:RBPASG>2.0.CO;2; Cheng MK, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003028; Dyurgerov M., 2005, GLACIERS CHANGING EA; Frolking S, 2006, FIELD CROP RES, V98, P164, DOI 10.1016/j.fcr.2006.01.004; *GOV IND CENTR WAT, 2002, NAT REG LARG DAMS 20; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Kato H, 2007, J METEOROL SOC JPN, V85A, P187, DOI 10.2151/jmsj.85A.187; Kumar R, 2005, CURR SCI INDIA, V89, P794; Livingston ML, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002737; Mall RK, 2006, CURR SCI INDIA, V90, P1610; *MIN WAT RES GOV I, 2009, CENTR GROUND WAT AUT; Paulson A, 2007, GEOPHYS J INT, V171, P497, DOI 10.1111/J.1365-246X.2007.03556.X; PERSSON A, 2001, METEOROLOGICAL B EUR; Postel Sandra, 1993, P56; Rodell M, 2005, EARTH INTERACT, V9, DOI 10.1175/EI126.1; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Rodell M, 2001, WATER RESOUR RES, V37, P1327, DOI 10.1029/2000WR900306; Rodell M, 2007, HYDROGEOL J, V15, P159, DOI 10.1007/s10040-006-0103-7; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Sturchio NC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019234; Swenson S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025285; Swenson S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030733; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Velicogna I, 2006, NATURE, V443, P329, DOI 10.1038/nature05168; Wahr J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025305; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Yeh PJF, 2006, WATER RESOUR RES, V42, DOI 10.1029/2006WR005374; ZAISHENG H, 2006, TRANSBOUNDARY AQUIFE, P10	30	1601	1653	34	734	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					999	U80		10.1038/nature08238	http://dx.doi.org/10.1038/nature08238			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19675570	Green Published			2022-12-28	WOS:000269085500031
J	Powell, J				Powell, James			Endgames Case report Fever in the vaccinated returning traveller	BRITISH MEDICAL JOURNAL			English	Editorial Material							TYPHOID-FEVER				Powell, J (corresponding author), Flat 6,233 Acton Lane, London W4 5DD, England.	jbpowell@doctors.org.uk						[Anonymous], 2004, COMMUN DIS PUBLIC HL, V7, P362; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; *DEP HLTH, 2009, IMM INF DIS; Health Protection Agency, 2008, PIL ENH SURV ENT FEV; *HLTH PROT AG, 2009, SALM TYPH SALM PAR L; Kanungo S, 2008, J INFECT DEV COUNTR, V2, P454; Parry CM, 2006, BRIT MED J, V333, P260, DOI 10.1136/bmj.333.7561.260-b; Thaver D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004530.pub3; WHO, 2003, BACKGR DOC DIAGN PRE	10	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 19	2009	339								b2985	10.1136/bmj.b2985	http://dx.doi.org/10.1136/bmj.b2985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486SB	19692440				2022-12-28	WOS:000269216900005
J	Call, J; Carpenter, M				Call, Josep; Carpenter, Malinda			Monkeys Like Mimics	SCIENCE			English	Editorial Material							IMITATION RECOGNITION		[Call, Josep; Carpenter, Malinda] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Call, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	call@eva.mpg.de; carpenter@eva.mpg.de		Carpenter, Malinda/0000-0003-3983-2034; Call Balaguer, Josep/0000-0002-8597-8336				Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; CALL J, 2003, INFANC APRENDIZ, V26, P325, DOI DOI 10.1174/021037003322299070; Carpenter M., 2006, IMITATION SOCIAL MIN, P48; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; Haun DBM, 2008, CURR BIOL, V18, pR288, DOI 10.1016/j.cub.2008.02.031; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Lyons DE, 2007, P NATL ACAD SCI USA, V104, P19751, DOI 10.1073/pnas.0704452104; Nielsen M, 2005, ANIM COGN, V8, P31, DOI 10.1007/s10071-004-0232-0; Over H, 2009, DEVELOPMENTAL SCI, V12, pF1, DOI 10.1111/j.1467-7687.2008.00820.x; Paukner A, 2005, BIOL LETTERS, V1, P219, DOI 10.1098/rsbl.2004.0291; Paukner A, 2009, SCIENCE, V325, P880, DOI 10.1126/science.1176269; Rakoczy H, 2008, DEV PSYCHOL, V44, P875, DOI 10.1037/0012-1649.44.3.875; Ross MD, 2008, BIOL LETTERS, V4, P27, DOI 10.1098/rsbl.2007.0535; UZGIRIS IC, 1981, INT J BEHAV DEV, V4, P1, DOI 10.1177/016502548100400101; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x	15	13	13	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					824	825		10.1126/science.1178714	http://dx.doi.org/10.1126/science.1178714			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679802				2022-12-28	WOS:000269242400031
J	Bae, JH; Lew, ED; Yuzawa, S; Tome, F; Lax, I; Schlessinger, J				Bae, Jae Hyun; Lew, Erin Denise; Yuzawa, Satoru; Tome, Francisco; Lax, Irit; Schlessinger, Joseph			The Selectivity of Receptor Tyrosine Kinase Signaling Is Controlled by a Secondary SH2 Domain Binding Site	CELL			English	Article							PHOSPHOLIPASE C-GAMMA-1; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; REQUIREMENT; SPECIFICITY; SUBSTRATE; RESIDUES; PEPTIDE; COMPLEX	SH2 domain-mediated interactions represent a crucial step in transmembrane signaling by receptor tyrosine kinases. SH2 domains recognize phosphotyrosine (pY) in the context of particular sequence motifs in receptor phosphorylation sites. However, the modest binding affinity of SH2 domains to pY containing peptides may not account for and likely represents an oversimplified mechanism for regulation of selectivity of signaling pathways in living cells. Here we describe the crystal structure of the activated tyrosine kinase domain of FGFR1 in complex with a phospholipase C gamma fragment. The structural and biochemical data and experiments with cultured cells show that the selectivity of phospholipase C gamma binding and signaling via activated FGFR1 are determined by interactions between a secondary binding site on an SH2 domain and a region in FGFR1 kinase domain in a phosphorylation independent manner. These experiments reveal a mechanism for how SH2 domain selectivity is regulated in vivo to mediate a specific cellular process.	[Bae, Jae Hyun; Lew, Erin Denise; Yuzawa, Satoru; Tome, Francisco; Lax, Irit; Schlessinger, Joseph] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Schlessinger, J (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	joseph.schlessinger@yale.edu		Yuzawa, Satoru/0000-0002-1031-5781	NIH [R01-AR051448, R01-AR051886, P50-AR054086]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051886, P50AR054086, R01AR051448] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grants R01-AR051448, R01-AR051886, and P50-AR054086 to J. S. We thank Titus Boggon, Mark Lemmon, Kate Ferguson, Benjamin Turk, David Calderwood, Valsan Mandiyan, Ewa Folta-Stogniew, Cristina Furdui, and Steve Hubbard for their advice and support; and members of Brookhaven National Laboratory Beamlines X6, X25, and X29 for their support.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chattopadhyay A, 1999, J BIOL CHEM, V274, P26091, DOI 10.1074/jbc.274.37.26091; Donaldson LW, 2002, P NATL ACAD SCI USA, V99, P14053, DOI 10.1073/pnas.212518799; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Groesch TD, 2006, J MOL BIOL, V356, P1222, DOI 10.1016/j.jmb.2005.11.095; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Ji QS, 1999, MOL CELL BIOL, V19, P4961; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; LAROSE L, 1995, J BIOL CHEM, V270, P3858, DOI 10.1074/jbc.270.8.3858; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Liu HH, 2006, ACTA PHYS-CHIM SIN, V22, P868, DOI 10.3866/PKU.WHXB20060720; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Poulin B, 2000, J BIOL CHEM, V275, P6411, DOI 10.1074/jbc.275.9.6411; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	34	109	112	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					514	524		10.1016/j.cell.2009.05.028	http://dx.doi.org/10.1016/j.cell.2009.05.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665973	Green Accepted, Bronze			2022-12-28	WOS:000268771900016
J	Raymond, JC				Raymond, John C.			Cosmic-Ray Acceleration in Supernova Remnants	SCIENCE			English	Editorial Material							EMISSION; SHOCK; WAVE		Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Raymond, JC (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	raymond@cfa.harvard.edu						Aharonian F, 2009, ASTROPHYS J, V692, P1500, DOI 10.1088/0004-637X/692/2/1500; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; Cassam-Chenai G, 2008, ASTROPHYS J, V680, P1180, DOI 10.1086/588015; CHEVALIER RA, 1978, ASTROPHYS J, V225, pL27, DOI 10.1086/182785; Ghavamian P, 2007, ASTROPHYS J, V654, pL69, DOI 10.1086/510740; Helder EA, 2009, SCIENCE, V325, P719, DOI 10.1126/science.1173383; Hughes JP, 2000, ASTROPHYS J, V543, pL61, DOI 10.1086/317102; Katz B, 2008, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2008/01/018; van Adelsberg M, 2008, ASTROPHYS J, V689, P1089, DOI 10.1086/592680; Vink J, 2006, ASTROPHYS J, V648, pL33, DOI 10.1086/507628; Warren JS, 2005, ASTROPHYS J, V634, P376, DOI 10.1086/496941	11	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					683	684		10.1126/science.1177743	http://dx.doi.org/10.1126/science.1177743			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480HF	19661406				2022-12-28	WOS:000268723700024
J	Roy, K; Hunt, G; Jablonski, D				Roy, Kaustuv; Hunt, Gene; Jablonski, David			Phylogenetic Conservatism of Extinctions in Marine Bivalves	SCIENCE			English	Article							FOSSIL RECORD; TAXONOMIC SELECTIVITY; MOLECULAR PHYLOGENIES; GEOGRAPHIC RANGE; MASS EXTINCTIONS; DIVERSITY; HISTORY; PATTERNS; RATES; MACROEVOLUTION	Evolutionary histories of species and lineages can influence their vulnerabilities to extinction, but the importance of this effect remains poorly explored for extinctions in the geologic past. When analyzed using a standardized taxonomy within a phylogenetic framework, extinction rates of marine bivalves estimated from the fossil record for the last similar to 200 million years show conservatism at multiple levels of evolutionary divergence, both within individual families and among related families. The strength of such phylogenetic clustering varies over time and is influenced by earlier extinction history, especially by the demise of volatile taxa in the end-Cretaceous mass extinction. Analyses of the evolutionary roles of ancient extinctions and predictive models of vulnerability of taxa to future natural and anthropogenic stressors should take phylogenetic relationships and extinction history into account.	[Roy, Kaustuv] Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; [Hunt, Gene] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Jablonski, David] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of California System; University of California San Diego; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Chicago	Roy, K (corresponding author), Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA.	kroy@ucsd.edu	Hunt, Gene/B-3783-2010	Hunt, Gene/0000-0001-6430-5020	NASA	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by a grant from NASA.	[Anonymous], 1991, EXTINCTION BAD GENES; Bennett PM, 2005, CONSERV BIOL SER, V8, P317; Bielby J, 2006, ANIM CONSERV, V9, P135, DOI 10.1111/j.1469-1795.2005.00013.x; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; JABLONSKI D, 1994, PHILOS T R SOC B, V344, P11, DOI 10.1098/rstb.1994.0045; Jablonski D, 2008, P NATL ACAD SCI USA, V105, P11528, DOI 10.1073/pnas.0801919105; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jablonski D, 2009, P NATL ACAD SCI USA, V106, P8262, DOI 10.1073/pnas.0902973106; Jackson J. B. C., 1995, P45; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; Lockwood JL, 2002, CONSERV BIOL, V16, P1137, DOI 10.1046/j.1523-1739.2002.01152.x; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; MCKINNEY ML, 1995, PALEOBIOLOGY, V21, P300, DOI 10.1017/S0094837300013312; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Pancost RD, 2004, J GEOL SOC LONDON, V161, P353, DOI 10.1144/0016764903-059; Payne JL, 2007, P NATL ACAD SCI USA, V104, P10506, DOI 10.1073/pnas.0701257104; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Powell MG, 2007, PALEOBIOLOGY, V33, P530, DOI 10.1666/07011.1; Purvis A, 2005, CONSERV BIOL SER, V8, P295; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; Smith AB, 2007, PALAEONTOLOGY, V50, P765, DOI 10.1111/j.1475-4983.2007.00693.x; Smith JT, 2006, PALEOBIOLOGY, V32, P408, DOI 10.1666/05078.1; STANLEY SM, 1990, PALEOBIOLOGY, V16, P401, DOI 10.1017/S0094837300010150; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Valentine J.W., 1990, P128; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Wang SC, 2008, PALEOBIOLOGY, V34, P434, DOI 10.1666/07060.1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	40	58	58	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					733	737		10.1126/science.1173073	http://dx.doi.org/10.1126/science.1173073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661426				2022-12-28	WOS:000268723700045
J	Murad, SD; Plessier, A; Hernandez-Guerra, M; Fabris, F; Eapen, CE; Bahr, MJ; Trebicka, J; Morard, I; Lasser, L; Heller, J; Hadengue, A; Langlet, P; Miranda, H; Primignani, M; Elias, E; Leebeek, FW; Rosendaal, FR; Garcia-Pagan, JC; Valla, DC; Janssen, HLA				Murad, Sarwa Darwish; Plessier, Aurelie; Hernandez-Guerra, Manuel; Fabris, Federica; Eapen, Chundamannil E.; Bahr, Matthias J.; Trebicka, Jonel; Morard, Isabelle; Lasser, Luc; Heller, Joerg; Hadengue, Antoine; Langlet, Philippe; Miranda, Helena; Primignani, Massimo; Elias, Elwyn; Leebeek, Frank W.; Rosendaal, Frits R.; Garcia-Pagan, Juan-Carlos; Valla, Dominique C.; Janssen, Harry L. A.		En-Vie	Etiology, Management, and Outcome of the Budd-Chiari Syndrome	ANNALS OF INTERNAL MEDICINE			English	Article							HEPATIC VEIN-THROMBOSIS; FACTOR-V; VENOUS THROMBOSIS; MYELOPROLIFERATIVE DISORDER; PROTHROMBIN GENE; MUTATION; DIAGNOSIS; SURVIVAL; PATENCY	Background: The Budd-Chiari syndrome (BCS) is hepatic venous outflow obstruction. What is known about the syndrome is based on small studies of prevalent cases. Objective: To characterize the causes and treatment of incident BCS. Design: Consecutive case series of patients with incident BCS, enrolled from October 2003 to October 2005 and followed until May 2006. Setting: Academic and nonacademic hospitals in France, Spain, Italy, Great Britain, Germany, Belgium, the Netherlands, Portugal, and Switzerland. Patients: Persons older than 16 years with definite hepatic outflow obstruction diagnosed by imaging. Persons with hepatic outflow obstruction due to heart failure, sinusoidal obstruction syndrome, cancer, or liver transplantation were excluded. Measurements: Signs and symptoms; laboratory and imaging findings; diagnosis; treatment; and overall, transplantation-free, and intervention-free survival. Results: 163 incident cases of BCS were identified. Median follow-up was 17 months (range, 0.1 to 31 months). Most patients (84%) had at least 1 thrombotic risk factor, and many (46%) had more than 1; the most common was myeloproliferative disorders (49% of 103 tested patients). Patients were mainly treated with anticoagulation (140 patients [86%]), transjugular intrahepatic porto-systemic shunting (56 patients [34%]), or liver transplantation (20 patients [12%]), and 80 patients (49%) were managed noninvasively. Only 3 patients underwent surgical shunting. The survival rate was 87% (95% CI, 82% to 93%) at 1 year and 82% (CI, 75% to 88%) at 2 years. Limitation: Treatment was not standardized across all centers, and data on important clinical variables were missing for some patients. Conclusion: Most patients with BCS have at least 1 thrombotic risk factor, and many have more than 1; myeloproliferative disorders are most common. One- and 2-year survival rates are good with contemporary management, which includes noninvasive therapies (anticoagulation and diuretics) and invasive techniques. Transjugular intrahepatic portosystemic shunting seems to have replaced surgical shunting as the most common invasive therapeutic procedure. Primary Funding Source: Fifth Framework Programme of the European Commission.	[Janssen, Harry L. A.] Erasmus MC Univ Hosp Rotterdam, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands; Leiden Univ, Med Ctr, Leiden, Netherlands; Hop Beaujon, AP HP, INSERM, U773, Clichy, France; Univ Paris 07, Clichy, France; Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain; Ciberehd, Barcelona, Spain; IRCCS Maggiore Hosp, Mangiagalli & Regina Elena Fdn, Milan, Italy; Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; Hannover Med Sch, D-3000 Hannover, Germany; Univ Bonn, Univ Hosp Bonn, D-5300 Bonn, Germany; Univ Hosp Geneva, Geneva, Switzerland; CHU Brugmann, Brussels, Belgium; Hosp Gen Santo Antonio, Oporto, Portugal	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Birmingham; Hannover Medical School; University of Bonn; University of Geneva	Janssen, HLA (corresponding author), Erasmus MC Univ Hosp Rotterdam, Dept Gastroenterol & Hepatol, S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	h.janssen@erasmusmc.nl	De Santis, Adriano/M-9712-2013; Mathurin, Philippe/A-9121-2018; Nicolini, Antonio Federico/J-1852-2015; Burroughs, Andrew K/C-5645-2009; Garcia-Pagan, Juan-Carlos/P-6291-2015; Tjwa, E.T./L-4694-2015; Murad, Sarwa Darwish/AAO-5493-2020; Rosendaal, Frits/Q-3842-2017	De Santis, Adriano/0000-0001-7338-9203; Mathurin, Philippe/0000-0003-3447-2025; Nicolini, Antonio Federico/0000-0002-3465-6601; Burroughs, Andrew K/0000-0001-6527-457X; Garcia-Pagan, Juan-Carlos/0000-0001-9032-4954; Murad, Sarwa Darwish/0000-0003-2804-1165; Rosendaal, Frits/0000-0003-2558-7496; Hernandez-Guerra, Manuel/0000-0002-3478-9981; Monescillo, Alberto/0000-0002-9490-4427; Fernandez Bermejo, Miguel/0000-0002-0052-1215; Bahr, Matthias J./0000-0001-6242-5299; Valla, Dominique/0000-0002-4460-7643; Reverter, Joan Carles/0000-0002-1274-4782; Trebicka, Jonel/0000-0002-7028-3881; Garcia-Criado, Angeles/0000-0003-3536-4288; Pessegueiro Miranda, Helena/0000-0003-2072-8763	European Commission [QLG1-CT-2002-01686]; GIS Maladies Rares; Netherlands Organization for Scientific Research; Instituto de Salud Carlos III	European Commission(European CommissionEuropean Commission Joint Research Centre); GIS Maladies Rares; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Grant Support: The EN-Vie project was financially supported by the Fifth Framework Programme of the European Commission (contract QLG1-CT-2002-01686) and public funding from GIS Maladies Rares (France 2001). Dr. Darwish Murad is a Mosaic Laureate of the Netherlands Organization for Scientific Research. Dr. Janssen is a Clinical Fellow and VIDI laureate of the Netherlands Organization for Scientific Research. Ciberehd is funded by Instituto de Salud Carlos III.	Chait Y, 2005, BRIT J HAEMATOL, V129, P553, DOI 10.1111/j.1365-2141.2005.05490.x; Deltenre P, 2001, GUT, V48, P264, DOI 10.1136/gut.48.2.264; Denninger MH, 2000, HEPATOLOGY, V31, P587, DOI 10.1002/hep.510310307; Gandini R, 2006, RADIOLOGY, V241, P298, DOI 10.1148/radiol.2411050347; HADENGUE A, 1994, GASTROENTEROLOGY, V106, P1042, DOI 10.1016/0016-5085(94)90765-X; Hernandez-Guerra M, 2004, HEPATOLOGY, V40, P1197, DOI 10.1002/hep.20436; Janssen HLA, 2003, J HEPATOL, V38, P364, DOI 10.1016/S0168-8278(02)00434-8; Janssen HLA, 2000, BLOOD, V96, P2364; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Langlet P, 2003, J HEPATOL, V39, P496, DOI 10.1016/S0168-8278(03)00323-4; LUDWIG J, 1990, MAYO CLIN PROC, V65, P51, DOI 10.1016/S0025-6196(12)62109-0; MAHMOUD AEA, 1995, LANCET, V345, P526; Murad SD, 2004, HEPATOLOGY, V39, P500, DOI 10.1002/hep.20064; Patel RK, 2006, GASTROENTEROLOGY, V130, P2031, DOI 10.1053/j.gastro.2006.04.008; Plessier A, 2006, HEPATOLOGY, V44, P1308, DOI 10.1002/hep.21354; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Primignani M, 2006, HEPATOLOGY, V44, P1528, DOI 10.1002/hep.21435; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Smalberg JH, 2006, HAEMATOLOGICA, V91, P1712; Tang TJ, 2001, J HEPATOL, V35, P338, DOI 10.1016/S0168-8278(01)00131-3; VALLA D, 1985, ANN INTERN MED, V103, P329, DOI 10.7326/0003-4819-103-3-329; Valla DC, 2003, HEPATOLOGY, V38, P793, DOI 10.1053/jhep.2003.50415; Valla DC, 2004, J GASTROEN HEPATOL, V19, pS204, DOI [10.1111/j.1440-1746.2004.03642.x, DOI 10.1111/J.1440-1746.2004.03642.X]; Zeitoun G, 1999, HEPATOLOGY, V30, P84, DOI 10.1002/hep.510300125	25	307	318	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					167	W40		10.7326/0003-4819-151-3-200908040-00004	http://dx.doi.org/10.7326/0003-4819-151-3-200908040-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19652186	Green Published			2022-12-28	WOS:000268947800003
J	Thomas, C				Thomas, Claire			BOTANY Plant Bar Code Soon to Become Reality	SCIENCE			English	News Item																			0	18	26	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					526	526		10.1126/science.325_526	http://dx.doi.org/10.1126/science.325_526			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644082				2022-12-28	WOS:000268493000005
J	Zhao, XY; Li, W; Lv, Z; Liu, L; Tong, M; Hai, T; Hao, J; Guo, CL; Ma, QW; Wang, L; Zeng, FY; Zhou, Q				Zhao, Xiao-yang; Li, Wei; Lv, Zhuo; Liu, Lei; Tong, Man; Hai, Tang; Hao, Jie; Guo, Chang-long; Ma, Qing-wen; Wang, Liu; Zeng, Fanyi; Zhou, Qi			iPS cells produce viable mice through tetraploid complementation	NATURE			English	Article							PLURIPOTENT STEM-CELLS; FIBROBLASTS; GENERATION; INDUCTION; ABSENCE	Since the initial description of induced pluripotent stem (iPS) cells created by forced expression of four transcription factors in mouse fibroblasts, the technique has been used to generate embryonic stem (ES)-cell-like pluripotent cells from a variety of cell types in other species, including primates and rat(1-6). It has become a popular means to reprogram somatic genomes into an embryonic-like pluripotent state, and a preferred alternative to somatic-cell nuclear transfer and somatic-cell fusion with ES cells(7,8). However, iPS cell reprogramming remains slow and inefficient. Notably, no live animals have been produced by the most stringent tetraploid complementation assay, indicative of a failure to create fully pluripotent cells. Here we report the generation of several iPS cell lines that are capable of generating viable, fertile live-born progeny by tetraploid complementation. These iPS cells maintain a pluripotent potential that is very close to ES cells generated from in vivo or nuclear transfer embryos. We demonstrate the practicality of using iPS cells as useful tools for the characterization of cellular reprogramming and developmental potency, and confirm that iPS cells can attain true pluripotency that is similar to that of ES cells.	[Zhao, Xiao-yang; Li, Wei; Lv, Zhuo; Liu, Lei; Tong, Man; Hai, Tang; Hao, Jie; Guo, Chang-long; Ma, Qing-wen; Wang, Liu; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Zhao, Xiao-yang; Li, Wei; Lv, Zhuo; Tong, Man; Hao, Jie; Guo, Chang-long] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China; [Ma, Qing-wen; Zeng, Fanyi] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai Inst Med Genet, Shanghai 200040, Peoples R China; [Zeng, Fanyi] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, Q (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	fzeng@sjtu.edu.cn; qzhou@ioz.ac.cn	Lu, Zhuo/D-4517-2014	ZHAO, Xiao-Yang/0000-0003-2544-8293; , Haitang/0000-0002-3192-0753	China National Basic Research Program [2006CB701500, 2007CB947800, 2007CB947700]; National Science Foundation of China [30525040];  [30871379/C0607]	China National Basic Research Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This study was supported in part by grants from the China National Basic Research Program 2006CB701500 (to Q. Z.), 2007CB947800 (to F. Z.), 2007CB947700 (to L. W.) and grants from the National Science Foundation of China 30525040 (to Q. Z.) and 30871379/C0607 (to F. Z.).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY T, 2003, MANIPULATING MOUSE E; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhou Q, 2001, BIOL REPROD, V65, P412, DOI 10.1093/biolreprod/65.2.412	35	574	686	11	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					86	U88		10.1038/nature08267	http://dx.doi.org/10.1038/nature08267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19672241				2022-12-28	WOS:000269478800035
J	Blendon, RJ; Benson, JM				Blendon, Robert J.; Benson, John M.			Understanding How Americans View Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blendon, Robert J.; Benson, John M.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							BLENDON R, 2007, CHALLENGE, V50, P5; Blendon RJ, 2001, HEALTH AFFAIR, V20, P33, DOI 10.1377/hlthaff.20.2.33	2	10	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					E13	U18		10.1056/NEJMp0906392	http://dx.doi.org/10.1056/NEJMp0906392			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	487XV	19675325				2022-12-28	WOS:000269312700004
J	Noginov, MA; Zhu, G; Belgrave, AM; Bakker, R; Shalaev, VM; Narimanov, EE; Stout, S; Herz, E; Suteewong, T; Wiesner, U				Noginov, M. A.; Zhu, G.; Belgrave, A. M.; Bakker, R.; Shalaev, V. M.; Narimanov, E. E.; Stout, S.; Herz, E.; Suteewong, T.; Wiesner, U.			Demonstration of a spaser-based nanolaser	NATURE			English	Article							SURFACE-PLASMONS; GAIN; LASERS	One of the most rapidly growing areas of physics and nanotechnology focuses on plasmonic effects on the nanometre scale, with possible applications ranging from sensing and biomedicine to imaging and information technology(1,2). However, the full development of nanoplasmonics is hindered by the lack of devices that can generate coherent plasmonic fields. It has been proposed(3) that in the same way as a laser generates stimulated emission of coherent photons, a 'spaser' could generate stimulated emission of surface plasmons (oscillations of free electrons in metallic nanostructures) in resonating metallic nanostructures adjacent to a gain medium. But attempts to realize a spaser face the challenge of absorption loss in metal, which is particularly strong at optical frequencies. The suggestion(4-6) to compensate loss by optical gain in localized and propagating surface plasmons has been implemented recently(7-10) and even allowed the amplification of propagating surface plasmons in open paths(11). Still, these experiments and the reported enhancement of the stimulated emission of dye molecules in the presence of metallic nanoparticles(12-14) lack the feedback mechanism present in a spaser. Here we show that 44-nm-diameter nanoparticles with a gold core and dye-doped silica shell allow us to completely overcome the loss of localized surface plasmons by gain and realize a spaser. And in accord with the notion that only surface plasmon resonances are capable of squeezing optical frequency oscillations into a nanoscopic cavity to enable a true nanolaser(15-18), we show that outcoupling of surface plasmon oscillations to photonic modes at a wavelength of 531 nm makes our system the smallest nanolaser reported to date-and to our knowledge the first operating at visible wavelengths. We anticipate that now it has been realized experimentally, the spaser will advance our fundamental understanding of nanoplasmonics and the development of practical applications.	[Noginov, M. A.; Zhu, G.; Belgrave, A. M.; Stout, S.] Norfolk State Univ, Ctr Mat Res, Norfolk, VA 23504 USA; [Bakker, R.; Shalaev, V. M.; Narimanov, E. E.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Bakker, R.; Shalaev, V. M.; Narimanov, E. E.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Stout, S.; Herz, E.; Suteewong, T.; Wiesner, U.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14850 USA	Norfolk State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cornell University	Noginov, MA (corresponding author), Norfolk State Univ, Ctr Mat Res, Norfolk, VA 23504 USA.	mnoginov@nsu.edu	Shalaev, Vladimir M./B-9331-2019	Shalaev, Vladimir M./0000-0001-8976-1102; Stout, Samantha/0000-0003-4674-0525; Belgrave, Akeisha/0000-0002-4666-2734	NSF PREM [0611430]; NSF NCN [EEC-0228390]; NASA URC [NCC3-1035]; ARO-MURI [50342-PH-MUR]; United States Army award [W911NF-06-C-0124]	NSF PREM(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NSF NCN(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NASA URC(National Aeronautics & Space Administration (NASA)); ARO-MURI(MURI); United States Army award	The work was supported by NSF PREM grant DMR 0611430, NSF NCN (EEC-0228390), NASA URC (NCC3-1035), an ARO-MURI award (50342-PH-MUR) and a United States Army award (W911NF-06-C-0124). We thank M. I. Stockman for discussions, and J. Chen and J. Irudayaraj for the assistance with the kinetics measurements. S. S. was a member of the Summer Research Program at the Center for Materials Research, Norfolk State University.	Bergman DJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.027402; Born M., 1998, PRINCIPLES OPTICS; BRONGERSMA ML, 2007, SERIES OPTICAL SCI, V131; Dice GD, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1894590; ENUSTUN BV, 1963, J AM CHEM SOC, V85, P3317, DOI 10.1021/ja00904a001; Gordon JA, 2007, OPT EXPRESS, V15, P2622, DOI 10.1364/OE.15.002622; Hill MT, 2007, NAT PHOTONICS, V1, P589, DOI 10.1038/nphoton.2007.171; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Kawasaki M, 2006, J PHYS CHEM B, V110, P15052, DOI 10.1021/jp062518g; Landau L. D., 1977, QUANTUM MECH NONRELA; Lawandy NM, 2004, APPL PHYS LETT, V85, P5040, DOI 10.1063/1.1825058; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; Muhlschlegel P, 2005, SCIENCE, V308, P1607, DOI 10.1126/science.1111886; Mulvaney P, 2000, J MATER CHEM, V10, P1259, DOI 10.1039/b000136h; Nezhad MP, 2004, OPT EXPRESS, V12, P4072, DOI 10.1364/OPEX.12.004072; Noda S, 2006, SCIENCE, V314, P260, DOI 10.1126/science.1131322; Noginov MA, 2008, OPT EXPRESS, V16, P1385, DOI 10.1364/OE.16.001385; Noginov MA, 2007, APPL PHYS B-LASERS O, V86, P455, DOI 10.1007/s00340-006-2401-0; Noginov MA, 2006, OPT LETT, V31, P3022, DOI 10.1364/OL.31.003022; Noginov MA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.226806; Noginov MA, 2000, J OPT SOC AM B, V17, P1329, DOI 10.1364/JOSAB.17.001329; Noginov MA, 2004, J MOD OPTIC, V51, P2543, DOI [10.1080/09500340408231813, 10.1080/09500340412331284966]; Ow H, 2005, NANO LETT, V5, P113, DOI [10.1021/nl0482478, 10.1012/nl0482478]; Popov O, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364857; PURCELL EM, 1946, PHYS REV, V69, P681; Seidel J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.177401; Sirtori C, 1998, OPT LETT, V23, P1366, DOI 10.1364/OL.23.001366; Sudarkin A. N., 1989, Soviet Physics - Technical Physics, V34, P764; Svelto O., 1998, PRINCIPLES LASERS, Vvol 4; Zheludev NI, 2008, NAT PHOTONICS, V2, P351, DOI 10.1038/nphoton.2008.82	30	1718	1778	16	943	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1110	U68		10.1038/nature08318	http://dx.doi.org/10.1038/nature08318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19684572				2022-12-28	WOS:000269314000034
J	Beaulac, R; Schneider, L; Archer, PI; Bacher, G; Gamelin, DR				Beaulac, Remi; Schneider, Lars; Archer, Paul I.; Bacher, Gerd; Gamelin, Daniel R.			Light-Induced Spontaneous Magnetization in Doped Colloidal Quantum Dots	SCIENCE			English	Article							SEMICONDUCTOR NANOCRYSTALS; SEMIMAGNETIC SEMICONDUCTOR; POLARONS; SPECTROSCOPY; DYNAMICS; ALLOYS	An attractive approach to controlling spin effects in semiconductor nanostructures for applications in electronics is the use of light to generate, manipulate, or read out spins. Here, we demonstrate spontaneous photoinduced polarization of manganese(II) spins in doped colloidal cadmium selenide quantum dots. Photoexcitation generates large dopant-carrier exchange fields, enhanced by strong spatial confinement, that lead to giant Zeeman splittings of the semiconductor band structure in the absence of applied magnetic fields. These internal exchange fields allow spontaneous magnetic saturation of the manganese(II) spins to be achieved at zero external magnetic field up to similar to 50 kelvin. Photomagnetic effects are observed all the way up to room temperature.	[Beaulac, Remi; Archer, Paul I.; Gamelin, Daniel R.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Schneider, Lars; Bacher, Gerd] Univ Duisburg Essen, Werkstoffe Elektrotech, D-47057 Duisburg, Germany; [Schneider, Lars; Bacher, Gerd] Univ Duisburg Essen, Ctr Nanointegrat Duisburg Essen, D-47057 Duisburg, Germany	University of Washington; University of Washington Seattle; University of Duisburg Essen; University of Duisburg Essen	Gamelin, DR (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	gamelin@chem.washington.edu	Bacher, Gerd/U-1858-2017	Bacher, Gerd/0000-0001-8419-2158	US NSF [DMR-0239325]; Dreyfus Foundation; Sloan Foundation; Natural Sciences and Engineering Research Council of Canada; Deutsche Forschungsgemeinschaft [SFB 445]	US NSF(National Science Foundation (NSF)); Dreyfus Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the U.S. NSF (Presidential Early Career Award for Scientists and Engineers, DMR-0239325), the Dreyfus Foundation, the Sloan Foundation, the Natural Sciences and Engineering Research Council of Canada postdoctoral fellowship program (to R.B.), and the Deutsche Forschungsgemeinschaft (project SFB 445) for financial support.	AWSCHALOM DD, 1987, PHYS REV LETT, V58, P812, DOI 10.1103/PhysRevLett.58.812; Bacher G, 2001, APPL PHYS LETT, V79, P524, DOI 10.1063/1.1387256; Beaulac R, 2008, NANO LETT, V8, P2949, DOI 10.1021/nl801847e; Beaulac R, 2008, NANO LETT, V8, P1197, DOI 10.1021/nl080195p; Beaulac R, 2008, ADV FUNCT MATER, V18, P3873, DOI 10.1002/adfm.200801016; Bhattacharjee AK, 1997, PHYS REV B, V55, P10613, DOI 10.1103/PhysRevB.55.10613; Bryan JD, 2005, PROG INORG CHEM, V54, P47, DOI 10.1002/0471725560.ch2; Coey JMD, 2005, NAT MATER, V4, P173, DOI 10.1038/nmat1310; Debnath MC, 2000, J APPL PHYS, V87, P6457, DOI 10.1063/1.372737; DIETL T, 1995, PHYS REV LETT, V74, P474, DOI 10.1103/PhysRevLett.74.474; Dietl T, 2008, SEMICONDUCT SEMIMET, V82, P371, DOI 10.1016/S0080-8784(08)00009-4; Efros AL, 2000, ANNU REV MATER SCI, V30, P475, DOI 10.1146/annurev.matsci.30.1.475; Fernandez-Rossier J, 2006, PHYS STATUS SOLIDI C, V3, P3734, DOI 10.1002/pssc.200671504; Fiederling R, 1998, PHYS REV B, V58, P4785, DOI 10.1103/PhysRevB.58.4785; Furdyna J. K., 1988, DILUTED MAGNETIC SEM, V25; Gurung T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2993331; HARRIS JH, 1983, PHYS REV LETT, V51, P1472, DOI 10.1103/PhysRevLett.51.1472; Hoffman DM, 2000, SOLID STATE COMMUN, V114, P547, DOI 10.1016/S0038-1098(00)00089-2; KASUYA T, 1968, REV MOD PHYS, V40, P684, DOI 10.1103/RevModPhys.40.684; Kavokin KV, 1999, PHYS REV B, V60, P16499, DOI 10.1103/PhysRevB.60.16499; Leger Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.107401; Linnik TL, 1996, JETP LETT+, V63, P222, DOI 10.1134/1.566994; Liptay TJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.155314; Liptay TJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2400107; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Maksimov AA, 2000, PHYS REV B, V62, pR7767, DOI 10.1103/PhysRevB.62.R7767; MERKULOV IA, 1995, JETP LETT+, V62, P335; Myers RC, 2008, NAT MATER, V7, P203, DOI 10.1038/nmat2123; Norris DJ, 2008, SCIENCE, V319, P1776, DOI 10.1126/science.1143802; Oka Y, 1999, J LUMIN, V83-4, P83, DOI 10.1016/S0022-2313(99)00078-2; Seufert J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.027402	31	270	274	5	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					973	976		10.1126/science.1174419	http://dx.doi.org/10.1126/science.1174419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696345				2022-12-28	WOS:000269242800040
J	Connor, A; Tomson, C				Connor, Andrew; Tomson, Charlie			Uncertainties Page Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OUTCOMES; EVENTS; METAANALYSIS; TRIALS		[Connor, Andrew] Dorset Cty Hosp, Dept Renal Med, Dorchester DT1 2JY, England; [Tomson, Charlie] Southmead Hosp, Richard Bright Renal Unit, Bristol BS10 5NB, Avon, England	Southmead Hospital	Connor, A (corresponding author), 3 Hope Terrace, Martinstown DT2 9JN, North Ireland.	andrewconnor1974@hotmail.co.uk		Tomson, Charles/0000-0002-0224-8726				Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Baigent C, 2003, KIDNEY INT, V63, pS207, DOI 10.1046/j.1523-1755.63.s84.4.x; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fellstrom B, 2007, KIDNEY BLOOD PRESS R, V30, P314, DOI 10.1159/000106803; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Keough-Ryan TM, 2005, AM J KIDNEY DIS, V46, P845, DOI 10.1053/j.ajkd.2005.07.043; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V73; Navaneethan SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007784; *REN ASS, GUID COMPL CKD; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	16	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2009	339								b2949	10.1136/bmj.b2949	http://dx.doi.org/10.1136/bmj.b2949			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486SC	19696089				2022-12-28	WOS:000269217000005
J	Patel, RB; Burke, TF				Patel, Ronak B.; Burke, Thomas F.			GLOBAL HEALTH Urbanization - An Emerging Humanitarian Disaster	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Patel, Ronak B.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Burke, Thomas F.] Massachusetts Gen Hosp, Dept Emergency Med, Div Global Hlth & Human Rights, Boston, MA 02114 USA; [Burke, Thomas F.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Burke, Thomas F.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Patel, RB (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							*AFR POP HLTH RES, 2002, POP HLTH DYN NAIR IN; GARNER P, 1993, BRIT MED J, V306, P667, DOI 10.1136/bmj.306.6879.667; Kapil U, 1989, Indian J Public Health, V33, P79; UNFPA, 2007, STAT WORLD POP 2007; United Nations Human Settlement Program, 2003, GLOBAL REPORT HUMAN	5	93	95	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					741	743		10.1056/NEJMp0810878	http://dx.doi.org/10.1056/NEJMp0810878			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484WX	19692687				2022-12-28	WOS:000269081200002
J	Bakitas, M; Lyons, KD; Hegel, MT; Balan, S; Brokaw, FC; Seville, J; Hull, JG; Li, ZZ; Tosteson, TD; Byock, IR; Ahles, TA				Bakitas, Marie; Lyons, Kathleen Doyle; Hegel, Mark T.; Balan, Stefan; Brokaw, Frances C.; Seville, Janette; Hull, Jay G.; Li, Zhongze; Tosteson, Tor D.; Byock, Ira R.; Ahles, Tim A.			Effects of a Palliative Care Intervention on Clinical Outcomes in Patients With Advanced Cancer The Project ENABLE II Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; CHRONIC ILLNESS CARE; END; MANAGEMENT; HEALTH; CONSULTATION; MEANINGFUL; DEPRESSION; PROVIDERS; FAMILIES	Context There are few randomized controlled trials on the effectiveness of palliative care interventions to improve the care of patients with advanced cancer. Objective To determine the effect of a nursing-led intervention on quality of life, symptom intensity, mood, and resource use in patients with advanced cancer. Design, Setting, and Participants Randomized controlled trial conducted from November 2003 through May 2008 of 322 patients with advanced cancer in a rural, National Cancer Institute-designated comprehensive cancer center in New Hampshire and affiliated outreach clinics and a VA medical center in Vermont. Interventions A multicomponent, psychoeducational intervention (Project ENABLE [Educate, Nurture, Advise, Before Life Ends]) conducted by advanced practice nurses consisting of 4 weekly educational sessions and monthly follow-up sessions until death or study completion (n = 161) vs usual care (n = 161). Main Outcome Measures Quality of life was measured by the Functional Assessment of Chronic Illness Therapy for Palliative Care (score range, 0-184). Symptom intensity was measured by the Edmonton Symptom Assessment Scale (score range, 0-900). Mood was measured by the Center for Epidemiological Studies Depression Scale (range, 0-60). These measures were assessed at baseline, 1 month, and every 3 months until death or study completion. Intensity of service was measured as the number of days in the hospital and in the intensive care unit (ICU) and the number of emergency department visits recorded in the electronic medical record. Results A total of 322 participants with cancer of the gastrointestinal tract (41%; 67 in the usual care group vs 66 in the intervention group), lung (36%; 58 vs 59), genitourinary tract (12%; 20 vs 19), and breast (10%; 16 vs 17) were randomized. The estimated treatment effects (intervention minus usual care) for all participants were a mean (SE) of 4.6 (2) for quality of life (P = .02), -27.8 (15) for symptom intensity (P = .06), and -1.8 (0.81) for depressed mood (P = .02). The estimated treatment effects in participants who died during the study were a mean (SE) of 8.6 (3.6) for quality of life (P = .02), -24.2 (20.5) for symptom intensity (P = .24), and -2.7 (1.2) for depressed mood (P = .03). Intensity of service did not differ between the 2 groups. Conclusion Compared with participants receiving usual oncology care, those receiving a nurse-led, palliative care-focused intervention addressing physical, psychosocial, and care coordination provided concurrently with oncology care had higher scores for quality of life and mood, but did not have improvements in symptom intensity scores or reduced days in the hospital or ICU or emergency department visits. Trial Registration clinicaltrials.gov Identifier: NCT00253383 JAMA. 2009;302(7):741-749	[Bakitas, Marie; Brokaw, Frances C.; Byock, Ira R.] Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Dept Anesthesiol, Sect Palliat Med, Lebanon, NH 03756 USA; [Lyons, Kathleen Doyle; Hegel, Mark T.; Seville, Janette; Ahles, Tim A.] Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Dept Psychiat, Lebanon, NH 03756 USA; [Balan, Stefan; Brokaw, Frances C.] Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Lebanon, NH 03756 USA; [Hull, Jay G.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Bakitas, Marie] Yale Univ, Sch Nursing, New Haven, CT 06536 USA; [Balan, Stefan] White River Junct VA Med Ctr, White River Jct, VT USA; [Li, Zhongze; Tosteson, Tor D.] Norris Cotton Canc Ctr, Lebanon, NH USA; [Ahles, Tim A.] Mem Sloan Kettering Canc Ctr, Dept Psychiat, New York, NY 10021 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Yale University; Norris Cotton Cancer Center; Memorial Sloan Kettering Cancer Center	Bakitas, M (corresponding author), Dartmouth Hitchcock Med Ctr, Dartmouth Med Sch, Dept Anesthesiol, Sect Palliat Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	marie.bakitas@dartmouth.edu	Lyons, Kathleen/ABA-2433-2020	Lyons, Kathleen/0000-0002-8895-4612; Bakitas, Marie/0000-0002-2913-2053	Department of Defense Clinical Nurse Researcher award; American Cancer Society Doctoral Scholarship; National Institutes of Health/National Institute of Nursing Research [T32NR008346]; National Cancer Institute [R01 CA101704]; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA101704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR011871, T32NR008346] Funding Source: NIH RePORTER	Department of Defense Clinical Nurse Researcher award(United States Department of Defense); American Cancer Society Doctoral Scholarship(American Cancer Society); National Institutes of Health/National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Dr Bakitas is a recipient of a Department of Defense Clinical Nurse Researcher award, an American Cancer Society Doctoral Scholarship, and a postdoctoral fellowship at Yale University's School of Nursing (National Institutes of Health/National Institute of Nursing Research grant T32NR008346). This study was supported by National Cancer Institute grant R01 CA101704.	Ahles TA, 2001, J PAIN SYMPTOM MANAG, V22, P584, DOI 10.1016/S0885-3924(01)00301-3; *AM CANC SOC, 2007, CANC FACTS FIG 2007; [Anonymous], 2002, STAT ANAL MISSING DA; Bakitas MA, 2006, J PAIN SYMPTOM MANAG, V31, P270, DOI 10.1016/j.jpainsymman.2005.07.011; Bakitas M, 2008, CANCER-AM CANCER SOC, V112, P1854, DOI 10.1002/cncr.23381; Bakitas Marie, 2004, J Palliat Med, V7, P363, DOI 10.1089/109662104773709530; Bakitas Marie, 2009, Palliat Support Care, V7, P75, DOI 10.1017/S1478951509000108; Bee PE, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-60; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Brady M J, 1999, Cancer Treat Res, V100, P203; Bruera E, 1991, J Palliat Care, V7, P6; Byock I, 2006, J PALLIAT MED, V9, P137, DOI 10.1089/jpm.2006.9.137; Cella D, 2002, QUAL LIFE RES, V11, P207, DOI 10.1023/A:1015276414526; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Epstein RM, 2007, NIH PUBLICATION; FERGUSON R, 2003, GROUP SHARED MED APP, V2; Ferris FD, 2002, MODEL GUIDE HOSPICE; Field MJ, 1997, APPROACHING DEATH IM; Foley KM, 2001, IMPROVING PALLIATIVE; Follwell M, 2009, J CLIN ONCOL, V27, P206, DOI 10.1200/JCO.2008.17.7568; Glasgow RE, 2006, HEALTH PROMOT INT, V21, P245, DOI 10.1093/heapro/dal017; Greisinger AJ, 1997, CANCER PRACT, V5, P147; Hays RD, 2000, PHARMACOECONOMICS, V18, P419, DOI 10.2165/00019053-200018050-00001; Hegel M. T., 2000, FAMILIES SYSTEMS HLT, V18, P423, DOI DOI 10.1037/H0091866; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Holland J C, 2001, Cancer Control, V8, P88; Holland JC, 1999, ONCOLOGY-NY, V13, P459; Jakobsson U, 2007, J CLIN NURS, V16, P95, DOI 10.1111/j.1365-2702.2006.01584.x; Lyons KD, 2009, J PAIN SYMPTOM MANAG, V37, P23, DOI 10.1016/j.jpainsymman.2007.12.015; McNiff KK, 2008, J CLIN ONCOL, V26, P3832, DOI 10.1200/JCO.2008.16.8674; Meier Diane E, 2004, J Palliat Med, V7, P119, DOI 10.1089/109662104322737395; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Mularski RA, 2007, J PAIN SYMPTOM MANAG, V34, pS7, DOI 10.1016/j.jpainsymman.2007.04.004; *NAT COMPR CANC NE, 2006, PALL CAR V 1 2006 NC; National Consensus Project, 2009, CLIN PRACT GUID QUAL; Nelson EL, 2008, CLIN CANCER RES, V14, P2111, DOI 10.1158/1078-0432.CCR-07-1632; Noffsinger EB, 2000, GROUP PRACT J, V48, P46; Okun A, 1996, PSYCHOL REP, V79, P1059, DOI 10.2466/pr0.1996.79.3.1059; Rabow MW, 2004, ARCH INTERN MED, V164, P83, DOI 10.1001/archinte.164.1.83; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ringash J, 2007, CANCER-AM CANCER SOC, V110, P196, DOI 10.1002/cncr.22799; ROCCAFORTE WH, 1992, J AM GERIATR SOC, V40, P697, DOI 10.1111/j.1532-5415.1992.tb01962.x; Schild SE, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.8076; Schnipper L, 1998, J CLIN ONCOL, V16, P1986; Skalla KA, 2004, ONCOL NURS FORUM, V31, P313, DOI 10.1188/04.ONF.313-319; Smith Thomas J, 2003, J Palliat Med, V6, P699, DOI 10.1089/109662103322515202; Sohl SJ, 2007, PREV MED, V45, P252, DOI 10.1016/j.ypmed.2007.06.009; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Steinhauser KE, 2001, J PAIN SYMPTOM MANAG, V22, P727, DOI 10.1016/S0885-3924(01)00334-7; Sweeney L, 2007, AM J MANAG CARE, V13, P84; Tan AD, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.9515; Temel JS, 2007, J CLIN ONCOL, V25, P2377, DOI 10.1200/JCO.2006.09.2627; Wagner E H, 1998, Eff Clin Pract, V1, P2; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wagner EH, 2005, J ALTERN COMPLEM MED, V11, pS7, DOI 10.1089/acm.2005.11.s-7; Wasson J H, 1998, Jt Comm J Qual Improv, V24, P513; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; Wennberg JE, 2006, CARE PATIENTS SEVERE; World Health Organization, WHO DEF PALL CAR; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Zimmermann C, 2008, JAMA-J AM MED ASSOC, V299, P1698, DOI 10.1001/jama.299.14.1698	64	1114	1117	5	171	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					741	749		10.1001/jama.2009.1198	http://dx.doi.org/10.1001/jama.2009.1198			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484UT	19690306	Green Accepted, Bronze			2022-12-28	WOS:000269073800022
J	Fonarow, GC; Peterson, ED				Fonarow, Gregg C.; Peterson, Eric D.			Heart Failure Performance Measures and Outcomes Real or Illusory Gains	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY-OF-CARE; US HOSPITALS; MORTALITY		[Fonarow, Gregg C.] Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA; [Peterson, Eric D.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Peterson, Eric D.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center; Duke University; Duke University	Fonarow, GC (corresponding author), Ahmanson UCLA Cardiomyopathy Ctr, 10833 LeConte Ave,Room 47-123 CHS, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Fonarow, Gregg C/D-5988-2014; Peterson, Eric David/ABF-5033-2021	Fonarow, Gregg C/0000-0002-3192-8093; 				Curtis LH, 2008, ARCH INTERN MED, V168, P2481, DOI 10.1001/archinte.168.22.2481; Fonarow GC, 2005, ARCH INTERN MED, V165, P1469, DOI 10.1001/archinte.165.13.1469; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; *JOINT COMM ACCR H, COMPR REV DEV TEST N; *JOINT COMM ACCR H, JOINT COMM ANN REP Q; Krumholz HM, 2008, CIRCULATION, V118, P1394, DOI 10.1161/CIRCULATIONAHA.108.804880; *US DEP HHS, FIND COMP HOSP; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	10	75	76	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					792	794		10.1001/jama.2009.1180	http://dx.doi.org/10.1001/jama.2009.1180			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690314				2022-12-28	WOS:000269073800030
J	McCabe, DJH; Kinsella, JA; Tobin, WO				McCabe, Dominick J. H.; Kinsella, Justin A.; Tobin, W. Oliver			Left atrial appendage occlusion in non-valvular atrial fibrillation	LANCET			English	Editorial Material							TRANSIENT ISCHEMIC ATTACK; STROKE; PREVENTION		[McCabe, Dominick J. H.; Kinsella, Justin A.; Tobin, W. Oliver] Trinity Coll Dublin, Natl Childrens Hosp, Adelaide & Meath Hosp, Dept Neurol, Dublin 24, Ireland; [McCabe, Dominick J. H.] UCL Inst Neurol, Dept Clin Neurosci, London, England	Trinity College Dublin; University of London; University College London	McCabe, DJH (corresponding author), Trinity Coll Dublin, Natl Childrens Hosp, Adelaide & Meath Hosp, Dept Neurol, Dublin 24, Ireland.	dominick.mccabe@amnch.ie	Tobin, William Oliver/HII-8589-2022; Tobin, William Oliver/W-7553-2019	Tobin, William Oliver/0000-0002-8141-2394; Tobin, William Oliver/0000-0002-8141-2394; McCabe, Dominick J.H./0000-0003-0493-4516				Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Maisel WH, 2009, NEW ENGL J MED, V360, P2601, DOI 10.1056/NEJMp0903763; McCabe DJH, 2007, J NEUROL NEUROSUR PS, V78, P14, DOI 10.1136/jnnp.2006.092031; Onalan O, 2007, STROKE, V38, P624, DOI 10.1161/01.STR.0000250166.06949.95; Stollberger C, 2003, CHEST, V124, P2356, DOI 10.1378/chest.124.6.2356	7	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 15	2009	374	9689					504	506		10.1016/S0140-6736(09)61468-9	http://dx.doi.org/10.1016/S0140-6736(09)61468-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683627				2022-12-28	WOS:000269019400005
J	Waldron, KJ; Rutherford, JC; Ford, D; Robinson, NJ				Waldron, Kevin J.; Rutherford, Julian C.; Ford, Dianne; Robinson, Nigel J.			Metalloproteins and metal sensing	NATURE			English	Review							TRANSCRIPTION FACTOR-I; HUMAN ZINC TRANSPORTER; SACCHAROMYCES-CEREVISIAE; COPPER HOMEOSTASIS; IRON-DEFICIENCY; DNA-BINDING; SCHIZOSACCHAROMYCES-POMBE; SUPEROXIDE-DISMUTASE; CARBONIC-ANHYDRASE; PLASMA-MEMBRANE	Almost half of all enzymes must associate with a particular metal to function. An ambition is to understand why each metal-protein partnership arose and how it is maintained. Metal availability provides part of the explanation, and has changed over geological time and varies between habitats but is held within vital limits in cells. Such homeostasis needs metal sensors, and there is an ongoing search to discover the metal-sensing mechanisms. For metalloproteins to acquire the right metals, metal sensors must correctly distinguish between the inorganic elements.	[Waldron, Kevin J.; Rutherford, Julian C.; Ford, Dianne; Robinson, Nigel J.] Newcastle Univ, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Robinson, NJ (corresponding author), Newcastle Univ, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	n.j.robinson@ncl.ac.uk	Waldron, Kevin/J-2368-2016; Waldron, Kevin John/HHM-8983-2022; Robinson, Nigel J/J-6363-2012	Waldron, Kevin/0000-0002-5577-7357; Waldron, Kevin John/0000-0002-5577-7357; Robinson, Nigel J/0000-0001-5586-1092	Biotechnology and Biological Sciences Research Council [BB/E001688/1, BB/F019637/1]; BBSRC [BB/F019637/1, BB/E001688/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This article describes a selection of the insights of many friends and colleagues. The authors are supported by grants BB/E001688/1 and BB/F019637/1 from the Biotechnology and Biological Sciences Research Council.	Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bird AJ, 2003, EMBO J, V22, P5137, DOI 10.1093/emboj/cdg484; Braiterman L, 2009, AM J PHYSIOL-GASTR L, V296, pG433, DOI 10.1152/ajpgi.90489.2008; Brown KR, 2002, BIOCHEMISTRY-US, V41, P6469, DOI 10.1021/bi0160664; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Chen XH, 2008, NUCLEIC ACIDS RES, V36, P3128, DOI 10.1093/nar/gkn103; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Dudev T, 2008, ANNU REV BIOPHYS, V37, P97, DOI 10.1146/annurev.biophys.37.032807.125811; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Giedroc DP, 2007, DALTON T, P3107, DOI 10.1039/b706769k; Giedroc DP, 2001, J BIOL CHEM, V276, P42322, DOI 10.1074/jbc.M106517200; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Guedon E, 2003, MOL MICROBIOL, V48, P495, DOI 10.1046/j.1365-2958.2003.03445.x; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Haurie V, 2003, J BIOL CHEM, V278, P45391, DOI 10.1074/jbc.M307447200; Heredia J, 2001, J BIOL CHEM, V276, P8793, DOI 10.1074/jbc.M008179200; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; JOHNSON DA, 1995, INORG CHEM, V34, P5666, DOI 10.1021/ic00126a041; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kim BE, 2004, J BIOL CHEM, V279, P4523, DOI 10.1074/jbc.M310799200; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Konhauser KO, 2009, NATURE, V458, P750, DOI 10.1038/nature07858; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Labbe RF, 2004, CLIN BIOCHEM, V37, P165, DOI 10.1016/j.clinbiochem.2003.10.006; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Laity JH, 2007, ARCH BIOCHEM BIOPHYS, V463, P201, DOI 10.1016/j.abb.2007.03.019; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lane TW, 2005, NATURE, V435, P42, DOI 10.1038/435042a; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li Y, 2008, MOL CELL BIOL, V28, P4275, DOI 10.1128/MCB.00369-08; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Ma JK, 2008, J INORG BIOCHEM, V102, P342, DOI 10.1016/j.jinorgbio.2007.09.007; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Park H, 2007, ENVIRON MICROBIOL, V9, P403, DOI 10.1111/j.1462-2920.2006.01151.x; Peers G, 2006, NATURE, V441, P341, DOI 10.1038/nature04630; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Pena MMO, 1998, MOL CELL BIOL, V18, P2514, DOI 10.1128/MCB.18.5.2514; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Phillips CM, 2008, BIOCHEMISTRY-US, V47, P1938, DOI 10.1021/bi702006h; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Qiao W, 2006, P NATL ACAD SCI USA, V103, P8674, DOI 10.1073/pnas.0600928103; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; Saito MA, 2009, NATURE, V458, P714, DOI 10.1038/458714a; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Song IS, 2008, MOL PHARMACOL, V74, P705, DOI 10.1124/mol.108.046771; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Turner RB, 1998, NAT STRUCT BIOL, V5, P551, DOI 10.1038/805; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang ZH, 2006, J MOL BIOL, V357, P1167, DOI 10.1016/j.jmb.2006.01.010; Wimmer U, 2005, NUCLEIC ACIDS RES, V33, P5715, DOI 10.1093/nar/gki881; Wood LK, 2009, J BIOL CHEM, V284, P404, DOI 10.1074/jbc.M807027200; Xiao ZG, 2002, CHEM COMMUN, P588, DOI 10.1039/b111180a; Xu Y, 2008, NATURE, V452, P56, DOI 10.1038/nature06636; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yonkovich J, 2002, J BIOL CHEM, V277, P23981, DOI 10.1074/jbc.C200203200; Zhang B, 2003, MOL CELL BIOL, V23, P8471, DOI 10.1128/MCB.23.23.8471-8485.2003; Zheng DL, 2008, PHYSIOL GENOMICS, V34, P205, DOI 10.1152/physiolgenomics.90206.2008	100	818	830	12	321	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					823	830		10.1038/nature08300	http://dx.doi.org/10.1038/nature08300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675642				2022-12-28	WOS:000268938300026
J	Jamieson, DJ; Honein, MA; Rasmussen, SA; Williams, JL; Swerdlow, DL; Biggerstaff, MS; Lindstrom, S; Louie, JK; Christ, CM; Bohm, SR; Fonseca, VP; Ritger, KA; Kuhles, DJ; Eggers, P; Bruce, H; Davidson, HA; Lutterloh, E; Harris, ML; Burke, C; Cocoros, N; Finelli, L; MacFarlane, KF; Shu, B; Olsen, SJ				Jamieson, Denise J.; Honein, Margaret A.; Rasmussen, Sonja A.; Williams, Jennifer L.; Swerdlow, David L.; Biggerstaff, Matthew S.; Lindstrom, Stephen; Louie, Janice K.; Christ, Cara M.; Bohm, Susan R.; Fonseca, Vincent P.; Ritger, Kathleen A.; Kuhles, Danel J.; Eggers, Paula; Bruce, Hollianne; Davidson, Heidi A.; Lutterloh, Emily; Harris, Meghan L.; Burke, Colleen; Cocoros, Noelle; Finelli, Lyn; MacFarlane, Kitty F.; Shu, Bo; Olsen, Sonja J.		Novel Influenza A H1N1 Pregnancy W	H1N1 2009 influenza virus infection during pregnancy in the USA	LANCET			English	Article							ASIAN INFLUENZA; PANDEMIC INFLUENZA; MATERNAL INFLUENZA; H5N1 INFECTION; SAFETY; IMPACT; WOMEN; RISK; IMMUNIZATION; VACCINATION	Background Pandemic HlN1 2009 influenza virus has been identified as the cause of a widespread outbreak of febrile respiratory infection in the USA and worldwide. We summarised cases of infection with pandemic H1N1 virus in pregnant women identified in the USA during the first month of the present outbreak, and deaths associated with this virus during the first 2 months of the outbreak. Methods After initial reports of infection in pregnant women, the US Centers for Disease Control and Prevention (CDC) began systematically collecting additional information about cases and deaths in pregnant women in the USA with pandemic H1N1 virus infection as part of enhanced surveillance. A confirmed case was defined as an acute respiratory illness with laboratory-confirmed pandemic H1N1 virus infection by real-time reverse-transcriptase PCR or viral culture; a probable case was defined as a person with an acute febrile respiratory illness who was positive for influenza A, but negative for H1 and H3. We used population estimates derived from the 2007 census data to calculate rates of admission to hospital and illness. Findings From April 15 to May 18, 2009, 34 confirmed or probable cases of pandemic H1N1 in pregnant women were reported to CDC from 13 states. 11 (32%) women were admitted to hospital. The estimated rate of admission for pandemic H1N1 influenza virus infection in pregnant women during the first month of the outbreak was higher than it was in the general population (0.32 per 100000 pregnant women, 95% CI 0.13-0.52 vs 0.076 per 100 000 population at risk, 95% CI 0.07-0.09). Between April 15 and June 16, 2009, six deaths in pregnant women were reported to the CDC; all were in women who had developed pneumonia and subsequent acute respiratory distress syndrome requiring mechanical ventilation. Interpretation Pregnant women might be at increased risk for complications from pandemic H1N1 virus infection. These data lend support to the present recommendation to promptly treat pregnant women with H1N1 influenza virus infection with anti-influenza drugs. Funding US CDC.	[Jamieson, Denise J.] CDC, Div Reprod Hlth, NCCDPHP, Atlanta, GA 30341 USA; [Honein, Margaret A.; Rasmussen, Sonja A.; Williams, Jennifer L.] CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; [Swerdlow, David L.; Biggerstaff, Matthew S.; Lindstrom, Stephen; Finelli, Lyn; Shu, Bo; Olsen, Sonja J.] CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30341 USA; [Lutterloh, Emily] CDC, EIS Program, Off Workforce & Career Dev, Atlanta, GA 30341 USA; [Louie, Janice K.] Calif Dept Publ Hlth, Richmond, CA USA; [Christ, Cara M.] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Bohm, Susan R.] Michigan Dept Community Hlth, Lansing, MI USA; [Fonseca, Vincent P.] Texas Dept State Hlth Serv, Austin, TX USA; [Ritger, Kathleen A.] Chicago Dept Publ Hlth, Chicago, IL USA; [Kuhles, Danel J.] Nassau Cty Dept Hlth, Uniondale, NY USA; [Eggers, Paula] Delaware Div Publ Hlth, Dover, DE USA; [Bruce, Hollianne] Snohomish Hlth Dist, Everett, WA USA; [Davidson, Heidi A.] DeKalb Cty Board Hlth, Atlanta, GA USA; [Lutterloh, Emily] Kentucky Dept Publ Hlth, Frankfort, KY USA; [Harris, Meghan L.] Iowa Dept Publ Hlth, Des Moines, IA 50319 USA; [Burke, Colleen] Philadelphia Dept Publ Hlth, Philadelphia, PA USA; [Cocoros, Noelle] Massachusetts Dept Publ Hlth, Jamaica Plain, MA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; California Department of Public Health; Arizona Department of Health Services; MDHHS - Michigan Department of Health & Human Services; Texas Department of State Health Services; Chicago Department of Public Health; Massachusetts Department of Public Health	Jamieson, DJ (corresponding author), CDC, Div Reprod Hlth, NCCDPHP, Mail Stop K-34,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	DJamieson@cdc.gov	fonseca, vincent/AAD-5865-2019; Finelli, Lyn/AAK-2360-2020	Cocoros, Noelle/0000-0001-7090-2761; Jamieson, Denise/0000-0003-2597-1201; Biggerstaff, Matthew/0000-0001-5108-8311; Patel, Minal/0000-0002-8707-7531; Dharan, Nila/0000-0003-1175-5962	US CDC	US CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The US CDC provided funding for this study. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	ACOG Committee on Obstetric Practice, 2004, Obstet Gynecol, V104, P1125; Acs N, 2005, BIRTH DEFECTS RES A, V73, P989, DOI 10.1002/bdra.20195; Callaghan WM, 2007, MATERN CHILD HLTH J, V11, P307, DOI 10.1007/s10995-007-0177-4; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1050; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P661; COFFEY VP, 1963, LANCET, V1, P748; Cono J, 2006, EMERG INFECT DIS, V12, P1631, DOI 10.3201/eid1211.060618; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Fonseca V., 2009, Morbidity and Mortality Weekly Report, V58, P497; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Freund B, 1999, DRUG SAFETY, V21, P267, DOI 10.2165/00002018-199921040-00003; Glass HC, 2009, J PEDIATR-US, V154, P24, DOI 10.1016/j.jpeds.2008.07.008; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Irving WL, 2000, BRIT J OBSTET GYNAEC, V107, P1282, DOI 10.1111/j.1471-0528.2000.tb11621.x; Lo WY, 2002, OBSTET GYNECOL, V100, P465, DOI 10.1016/S0029-7844(02)02122-1; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; MCKINNEY WP, 1990, ARCH INTERN MED, V150, P213, DOI 10.1001/archinte.150.1.213; Mello MM, 2009, NEW ENGL J MED, V361, P1, DOI 10.1056/NEJMp0903765; Moretti ME, 2005, EPIDEMIOLOGY, V16, P216, DOI 10.1097/01.ede.0000152903.55579.15; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nuzum J W, 1976, IMJ Ill Med J, V150, P612; Petrova A, 2001, OBSTET GYNECOL, V98, P20, DOI 10.1016/S0029-7844(01)01361-8; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900; SAXEN LAURI, 1960, ACTA PATHOL ET MICROBIOL SCAND, V49, P114; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Tanaka T, 2009, CAN MED ASSOC J, V181, P55, DOI 10.1503/cmaj.090866; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; WILSON MG, 1969, J AMER MED ASSOC, V210, P336, DOI 10.1001/jama.210.2.336; Yudin MH, 2009, J OBSTET GYNAECOL CA, V31, P120, DOI 10.1016/S1701-2163(16)34095-6; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2425; Zou SM, 2006, TRANSFUS MED REV, V20, P181, DOI 10.1016/j.tmrv.2006.03.001	40	974	1055	0	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2009	374	9688					451	458		10.1016/S0140-6736(09)61304-0	http://dx.doi.org/10.1016/S0140-6736(09)61304-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482OK	19643469				2022-12-28	WOS:000268898400026
J	[Anonymous]				[Anonymous]			A model approach	NATURE			English	Editorial Material																			0	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					667	667		10.1038/460667a	http://dx.doi.org/10.1038/460667a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479OO	19661863	Bronze			2022-12-28	WOS:000268670300001
J	Gao, CQ				Gao, Chang-Qing			Taking Responsibility for Lung Cancer	ANNALS OF INTERNAL MEDICINE			English	Article									Cent S Univ, Third Hosp Xiangya Sch Med, Changsha, Hunan 410013, Peoples R China	Central South University	Gao, CQ (corresponding author), Cent S Univ, Third Hosp Xiangya Sch Med, Tongzipo Rd 138, Changsha, Hunan 410013, Peoples R China.	cgao9@yahoo.com							0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					214	215		10.7326/0003-4819-151-3-200907210-00012	http://dx.doi.org/10.7326/0003-4819-151-3-200907210-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19652189				2022-12-28	WOS:000268947800016
J	Miyamichi, K; Luo, LQ				Miyamichi, Kazunari; Luo, Liqun			Brain Wiring by Presorting Axons	SCIENCE			English	Editorial Material							ODORANT RECEPTORS; OLFACTORY-BULB; CONVERGENCE; GLOMERULI; DOMAINS; NEURONS		[Miyamichi, Kazunari; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Miyamichi, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	lluo@stanford.edu	Miyamichi, Kazunari/AAO-3705-2021	Luo, Liqun/0000-0001-5467-9264	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS050835] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Lattemann M, 2007, NEURON, V53, P169, DOI 10.1016/j.neuron.2006.12.024; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554	15	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 31	2009	325	5940					544	545		10.1126/science.1178117	http://dx.doi.org/10.1126/science.1178117			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644096				2022-12-28	WOS:000268493000024
J	Nagpal, P; Lindquist, NC; Oh, SH; Norris, DJ				Nagpal, Prashant; Lindquist, Nathan C.; Oh, Sang-Hyun; Norris, David J.			Ultrasmooth Patterned Metals for Plasmonics and Metamaterials	SCIENCE			English	Article							SURFACE-PLASMONS; NANOSTRUCTURES; SPECTROSCOPY; POLARITONS; INDEX; LIGHT	Surface plasmons are electromagnetic waves that can exist at metal interfaces because of coupling between light and free electrons. Restricted to travel along the interface, these waves can be channeled, concentrated, or otherwise manipulated by surface patterning. However, because surface roughness and other inhomogeneities have so far limited surface-plasmon propagation in real plasmonic devices, simple high-throughput methods are needed to fabricate high-quality patterned metals. We combined template stripping with precisely patterned silicon substrates to obtain ultrasmooth pure metal films with grooves, bumps, pyramids, ridges, and holes. Measured surface-plasmon-propagation lengths on the resulting surfaces approach theoretical values for perfectly flat films. With the use of our method, we demonstrated structures that exhibit Raman scattering enhancements above 10(7) for sensing applications and multilayer films for optical metamaterials.	[Nagpal, Prashant; Norris, David J.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Lindquist, Nathan C.; Oh, Sang-Hyun] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Norris, DJ (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	dnorris@umn.edu	Nagpal, Prashant/G-7802-2012; Norris, David J/F-4022-2010	Norris, David J/0000-0002-3765-0678; NAGPAL, PRASHANT/0000-0002-7966-2554; Oh, Sang-Hyun/0000-0002-6992-5007	U.S. Department of Energy [DE-FG02- 06ER46438]; Institute of Technology at the University of Minnesota; Minnesota Partnership for Biotechnology; 3M; University of Minnesota; NIH	U.S. Department of Energy(United States Department of Energy (DOE)); Institute of Technology at the University of Minnesota(University of Minnesota System); Minnesota Partnership for Biotechnology; 3M(3M); University of Minnesota(University of Minnesota System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the U.S. Department of Energy (grant DE-FG02- 06ER46438) and used resources in the Institute of Technology at the University of Minnesota, including the Nanofabrication Center, which receives partial support from NSF through the National Nanotechnology Infrastructure Network program, and the Characterization Facility, which has received capital equipment funding from NSF through the Materials Research Science and Engineering Center, Major Research Instrumentation, and Engineering Research Center programs. S.-H.O. acknowledges support from a Minnesota Partnership for Biotechnology Award and a 3M Non-Tenured Faculty Award. P.N. and N.C.L. acknowledge support from a University of Minnesota doctoral dissertation fellowship and an NIH Biotechnology training grant, respectively. The authors have applied for a patent on the fabricationmethods described.	Atwater HA, 2007, SCI AM, V296, P56, DOI 10.1038/scientificamerican0407-56; Bantz KC, 2008, LANGMUIR, V24, P5862, DOI 10.1021/la800103b; Dolling G, 2007, OPT LETT, V32, P551, DOI 10.1364/OL.32.000551; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Frey W, 2000, ADV MATER, V12, P1515, DOI 10.1002/1521-4095(200010)12:20<1515::AID-ADMA1515>3.0.CO;2-J; Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o; Genet C, 2007, NATURE, V445, P39, DOI 10.1038/nature05350; Graca M, 2007, J APPL PHYS, V102, DOI 10.1063/1.2777125; Haes AJ, 2005, MRS BULL, V30, P368, DOI 10.1557/mrs2005.100; Haynes CL, 2003, J PHYS CHEM B, V107, P7426, DOI 10.1021/jp027749b; HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4; Henzie J, 2005, NANO LETT, V5, P1199, DOI 10.1021/nl0506148; Jung B, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/14/145303; Kumar G, 2009, NATURE, V457, P868, DOI 10.1038/nature07718; Kuttge M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2987458; Loo YL, 2002, J AM CHEM SOC, V124, P7654, DOI 10.1021/ja026355v; MILLS DL, 1975, PHYS REV B, V12, P4036, DOI 10.1103/PhysRevB.12.4036; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Polman A, 2008, SCIENCE, V322, P868, DOI 10.1126/science.1163959; Raether H., 1988, SURFACE PLASMONS; Samori P, 1999, LANGMUIR, V15, P2592, DOI 10.1021/Ia981414x; SARID D, 1981, PHYS REV LETT, V47, P1927, DOI 10.1103/PhysRevLett.47.1927; SHIBA H, 1994, J PHYS SOC JPN, V63, P1400, DOI 10.1143/JPSJ.63.1400; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Temnov VV, 2007, OPT LETT, V32, P1235, DOI 10.1364/OL.32.001235; van Wijngaarden JT, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208556; Vesseur EJR, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2885344; Xu QB, 2004, NANO LETT, V4, P2509, DOI 10.1021/nl0484797; Yin LL, 2005, NANO LETT, V5, P1399, DOI 10.1021/nl050723m	29	702	723	17	490	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					594	597		10.1126/science.1174655	http://dx.doi.org/10.1126/science.1174655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644116				2022-12-28	WOS:000268493000045
J	Kawate, T; Michel, JC; Birdsong, WT; Gouaux, E				Kawate, Toshimitsu; Michel, Jennifer Carlisle; Birdsong, William T.; Gouaux, Eric			Crystal structure of the ATP-gated P2X(4) ion channel in the closed state	NATURE			English	Article							CYSTEINE RESIDUES; BINDING-SITE; AMINO-ACIDS; RECEPTOR; IDENTIFICATION; CLONING; RELEASE; PAIN; EXPRESSION; ECTODOMAIN	P2X receptors are cation-selective ion channels gated by extracellular ATP, and are implicated in diverse physiological processes, from synaptic transmission to inflammation to the sensing of taste and pain. Because P2X receptors are not related to other ion channel proteins of known structure, there is at present no molecular foundation for mechanisms of ligand-gating, allosteric modulation and ion permeation. Here we present crystal structures of the zebrafish P2X(4) receptor in its closed, resting state. The chalice-shaped, trimeric receptor is knit together by subunit-subunit contacts implicated in ion channel gating and receptor assembly. Extracellular domains, rich in beta-strands, have large acidic patches that may attract cations, through fenestrations, to vestibules near the ion channel. In the transmembrane pore, the 'gate' is defined by an similar to 8 angstrom slab of protein. We define the location of three non-canonical, intersubunit ATP-binding sites, and suggest that ATP binding promotes subunit rearrangement and ion channel opening.	[Kawate, Toshimitsu; Michel, Jennifer Carlisle; Birdsong, William T.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Birdsong, William/AAS-5655-2021	Gouaux, Eric/0000-0002-8549-2360; Birdsong, William/0000-0003-3514-9158	National Institutes of Health (NIH); American Asthma Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the personnel at beamlines 5.0.2, 8.2.1 and 8.2.2 of the Advanced Light Source and at beamline 24-ID-E of the Advanced Photon Source. We also thank M. Voigt for zebrafish P2X receptor DNA, T. Homrichhausen for help with cloning and FSEC screening, J. Berriman for help with electron microscopy, L. Vaskalis for assistance with illustrations, and Gouaux laboratory members for discussions. This work was supported by the National Institutes of Health (NIH) and the American Asthma Foundation. E. G. is an investigator with the Howard Hughes Medical Institute.	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Diaz-Hernandez M, 2002, BIOCHEM BIOPH RES CO, V295, P849, DOI 10.1016/S0006-291X(02)00760-X; Donato R, 2008, CELL CALCIUM, V44, P521, DOI 10.1016/j.ceca.2008.03.006; Duckwitz W, 2006, J BIOL CHEM, V281, P39561, DOI 10.1074/jbc.M606113200; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Fabbretti E, 2004, J BIOL CHEM, V279, P53109, DOI 10.1074/jbc.M409772200; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; HOLTON FA, 1954, J PHYSIOL-LONDON, V126, P124, DOI 10.1113/jphysiol.1954.sp005198; Hugel S, 2000, J NEUROSCI, V20, P2121; Inscho EW, 2004, ACTA PHYSIOL SCAND, V181, P445, DOI 10.1111/j.1365-201X.2004.01317.x; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Khakh BS, 1998, MOL PHARMACOL, V54, P372, DOI 10.1124/mol.54.2.372; Kucenas S, 2003, NEUROSCIENCE, V121, P935, DOI 10.1016/S0306-4522(03)00566-9; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; LUSTIG KD, 1993, P NATL ACAD SCI USA, V90, P5113, DOI 10.1073/pnas.90.11.5113; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Michel AD, 2008, BRIT J PHARMACOL, V155, P738, DOI 10.1038/bjp.2008.306; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Roberts JA, 2006, J NEUROCHEM, V96, P843, DOI 10.1111/j.1471-4159.2005.03593.x; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sim JA, 2008, J BIOL CHEM, V283, P29841, DOI 10.1074/jbc.M802523200; Sim JA, 2006, J NEUROSCI, V26, P9006, DOI 10.1523/JNEUROSCI.2370-06.2006; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338	50	556	574	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					592	U55		10.1038/nature08198	http://dx.doi.org/10.1038/nature08198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19641588	Green Accepted			2022-12-28	WOS:000268454300042
J	Mateja, A; Szlachcic, A; Downing, ME; Dobosz, M; Mariappan, M; Hegde, RS; Keenan, RJ				Mateja, Agnieszka; Szlachcic, Anna; Downing, Maureen E.; Dobosz, Malgorzata; Mariappan, Malaiyalam; Hegde, Ramanujan S.; Keenan, Robert J.			The structural basis of tail-anchored membrane protein recognition by Get3	NATURE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; ARSA-ATPASE; CRYSTALLOGRAPHIC STRUCTURE; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SIGNAL; PARTICLE; INSERTION; BINDING	Targeting of newly synthesized membrane proteins to the endoplasmic reticulum is an essential cellular process. Most membrane proteins are recognized and targeted co-translationally by the signal recognition particle. However, nearly 5% of membrane proteins are 'tail-anchored' by a single carboxy-terminal transmembrane domain that cannot access the co-translational pathway. Instead, tail-anchored proteins are targeted post-translationally by a conserved ATPase termed Get3. The mechanistic basis for tail-anchored protein recognition or targeting by Get3 is not known. Here we present crystal structures of yeast Get3 in 'open' (nucleotide-free) and 'closed' (ADP center dot AlF4--bound) dimer states. In the closed state, the dimer interface of Get3 contains an enormous hydrophobic groove implicated by mutational analyses in tail-anchored protein binding. In the open state, Get3 undergoes a striking rearrangement that disrupts the groove and shields its hydrophobic surfaces. These data provide a molecular mechanism for nucleotide-regulated binding and release of tail-anchored proteins during their membrane targeting by Get3.	[Mateja, Agnieszka; Szlachcic, Anna; Downing, Maureen E.; Dobosz, Malgorzata; Keenan, Robert J.] Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci, Chicago, IL 60637 USA; [Mariappan, Malaiyalam; Hegde, Ramanujan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Szlachcic, Anna] Univ Wroclaw, Fac Biotechnol, Dept Prot Engn, PL-50137 Wroclaw, Poland; [Dobosz, Malgorzata] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland	University of Chicago; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Wroclaw; Jagiellonian University	Keenan, RJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci, Room W238,920 E 57th St, Chicago, IL 60637 USA.	bkeenan@uchicago.edu	mariappan, malaiyalam/K-9024-2012	Keenan, Robert/0000-0003-1466-0889; Hegde, Ramanujan/0000-0001-8338-852X; Dobosz-Bartoszek, Malgorzata/0000-0001-7773-596X; Szlachcic, Anna/0000-0003-0574-1476	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Edward Mallinckrodt, Jr. Foundation; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086487] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Edward Mallinckrodt, Jr. Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data were collected at beamlines 21-IDG and 23-IDD at the Advanced Photon Source (APS), Argonne National Laboratory, and we thank the beamline staff for support. Use of the APS was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. We thank B. Glick and R. Strack for reagents and advice, X. Li for assay characterization, and A. Shiau and T. Steck for comments on the manuscript. This work was supported by a grant from the Edward Mallinckrodt, Jr. Foundation (to R. J. K.) and by the Intramural Research Program of the National Institutes of Health (to R. S. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; DeLano W.L, PYMOL MOL GRAPHICS S; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Hayashi I, 2001, EMBO J, V20, P1819, DOI 10.1093/emboj/20.8.1819; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Jiang Y, 2005, J BIOL CHEM, V280, P9921, DOI 10.1074/jbc.M413391200; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Kurdi-Haidar B, 1998, J BIOL CHEM, V273, P22173, DOI 10.1074/jbc.273.35.22173; KurdiHaidar B, 1996, GENOMICS, V36, P486, DOI 10.1006/geno.1996.0494; Kuroda R, 1998, J BIOL CHEM, V273, P31097, DOI 10.1074/jbc.273.47.31097; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metz J, 2006, J BIOL CHEM, V281, P410, DOI 10.1074/jbc.M507481200; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rosen BP, 1999, BBA-BIOMEMBRANES, V1461, P207, DOI 10.1016/S0005-2736(99)00159-5; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838; Zhou TQ, 2001, J BIOL CHEM, V276, P30414, DOI 10.1074/jbc.M103671200	40	131	133	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					361	U58		10.1038/nature08319	http://dx.doi.org/10.1038/nature08319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19675567	Green Accepted			2022-12-28	WOS:000269828100032
J	Machacek, M; Hodgson, L; Welch, C; Elliott, H; Pertz, O; Nalbant, P; Abell, A; Johnson, GL; Hahn, KM; Danuser, G				Machacek, Matthias; Hodgson, Louis; Welch, Christopher; Elliott, Hunter; Pertz, Olivier; Nalbant, Perihan; Abell, Amy; Johnson, Gary L.; Hahn, Klaus M.; Danuser, Gaudenz			Coordination of Rho GTPase activities during cell protrusion	NATURE			English	Article							MIGRATING CELLS; LIVING CELLS; RAC; ACTIVATION; DYNAMICS; ACTIN; MEMBRANE; ADHESION; POLARITY	The GTPases Rac1, RhoA and Cdc42 act together to control cytoskeleton dynamics(1-3). Recent biosensor studies have shown that all three GTPases are activated at the front of migrating cells(4-7), and biochemical evidence suggests that they may regulate one another: Cdc42 can activate Rac1 (ref. 8), and Rac1 and RhoA are mutually inhibitory(9-12). However, their spatiotemporal coordination, at the seconds and single-micrometre dimensions typical of individual protrusion events, remains unknown. Here we examine GTPase coordination in mouse embryonic fibroblasts both through simultaneous visualization of two GTPase biosensors and using a 'computational multiplexing' approach capable of defining the relationships between multiple protein activities visualized in separate experiments. We found that RhoA is activated at the cell edge synchronous with edge advancement, whereas Cdc42 and Rac1 are activated 2 mm behind the edge with a delay of 40s. This indicates that Rac1 and RhoA operate antagonistically through spatial separation and precise timing, and that RhoA has a role in the initial events of protrusion, whereas Rac1 and Cdc42 activate pathways implicated in reinforcement and stabilization of newly expanded protrusions.	[Hodgson, Louis; Welch, Christopher; Abell, Amy; Johnson, Gary L.; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Hodgson, Louis; Welch, Christopher; Abell, Amy; Johnson, Gary L.; Hahn, Klaus M.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA; [Hodgson, Louis; Welch, Christopher; Abell, Amy; Johnson, Gary L.; Hahn, Klaus M.] Univ N Carolina, Dept Med Chem, Chapel Hill, NC 27599 USA; [Machacek, Matthias; Elliott, Hunter; Pertz, Olivier; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Nalbant, Perihan] Univ Duisburg Essen, Ctr Med Biotechnol, Dept Mol Cell Biol, D-45117 Essen, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Scripps Research Institute; University of Duisburg Essen	Hahn, KM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	khahn@med.unc.edu; gdanuser@scripps.edu		pertz, olivier/0000-0001-8579-4919; Hodgson, Louis/0000-0001-9188-7580; Danuser, Gaudenz/0000-0001-8583-2014; Hahn, Klaus/0000-0002-1970-7562	Swiss National Science Foundation; Novartis Foundation; Ciba-Geigy Jubilee Foundation; NIGMS [U54 GM064346];  [NIH T32 GM008719];  [NIH F30 HL094020];  [NIH R01 GM57464];  [NIH R01 GM71868]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL094020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030324, R01GM057464, T32GM008719, U54GM064346, R01GM071868] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); Ciba-Geigy Jubilee Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge funding from the Swiss National Science Foundation and the Novartis Foundation, formerly the Ciba-Geigy Jubilee Foundation (M. M.), NIH T32 GM008719 and NIH F30 HL094020 (C. W.), NIH R01 GM57464 (K. M. H.), NIH R01 GM71868 (G. D.), and the Cell Migration Consortium, grant U54 GM064346 from NIGMS (G. D. and K. M. H.).	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; HODGSON L, CURR PROTOC IN PRESS; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792	28	653	663	4	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					99	103		10.1038/nature08242	http://dx.doi.org/10.1038/nature08242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19693013	Green Accepted, Green Submitted			2022-12-28	WOS:000269478800038
J	[Anonymous]				[Anonymous]			Movement for global mental health gains momentum	LANCET			English	Editorial Material																			0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2009	374	9690					587	587						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19699991	Bronze			2022-12-28	WOS:000269222600001
J	Itoh, Y; Shinya, K; Kiso, M; Watanabe, T; Sakoda, Y; Hatta, M; Muramoto, Y; Tamura, D; Sakai-Tagawa, Y; Noda, T; Sakabe, S; Imai, M; Hatta, Y; Watanabe, S; Li, CJ; Yamada, S; Fujii, K; Murakami, S; Imai, H; Kakugawa, S; Ito, M; Takano, R; Iwatsuki-Horimoto, K; Shimojima, M; Horimoto, T; Goto, H; Takahashi, K; Makino, A; Ishigaki, H; Nakayama, M; Okamatsu, M; Takahashi, K; Warshauer, D; Shult, PA; Saito, R; Suzuki, H; Furuta, Y; Yamashita, M; Mitamura, K; Nakano, K; Nakamura, M; Brockman-Schneider, R; Mitamura, H; Yamazaki, M; Sugaya, N; Suresh, M; Ozawa, M; Neumann, G; Gern, J; Kida, H; Ogasawara, K; Kawaoka, Y				Itoh, Yasushi; Shinya, Kyoko; Kiso, Maki; Watanabe, Tokiko; Sakoda, Yoshihiro; Hatta, Masato; Muramoto, Yukiko; Tamura, Daisuke; Sakai-Tagawa, Yuko; Noda, Takeshi; Sakabe, Saori; Imai, Masaki; Hatta, Yasuko; Watanabe, Shinji; Li, Chengjun; Yamada, Shinya; Fujii, Ken; Murakami, Shin; Imai, Hirotaka; Kakugawa, Satoshi; Ito, Mutsumi; Takano, Ryo; Iwatsuki-Horimoto, Kiyoko; Shimojima, Masayuki; Horimoto, Taisuke; Goto, Hideo; Takahashi, Kei; Makino, Akiko; Ishigaki, Hirohito; Nakayama, Misako; Okamatsu, Masatoshi; Takahashi, Kazuo; Warshauer, David; Shult, Peter A.; Saito, Reiko; Suzuki, Hiroshi; Furuta, Yousuke; Yamashita, Makoto; Mitamura, Keiko; Nakano, Kunio; Nakamura, Morio; Brockman-Schneider, Rebecca; Mitamura, Hiroshi; Yamazaki, Masahiko; Sugaya, Norio; Suresh, M.; Ozawa, Makoto; Neumann, Gabriele; Gern, James; Kida, Hiroshi; Ogasawara, Kazumasa; Kawaoka, Yoshihiro			In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses	NATURE			English	Article							RESISTANT INFLUENZA; A VIRUSES; CELLS; INFECTION; TRANSMISSION; MODEL	Influenza A viruses cause recurrent outbreaks at local or global scale with potentially severe consequences for human health and the global economy. Recently, a new strain of influenza A virus was detected that causes disease in and transmits among humans, probably owing to little or no pre-existing immunity to the new strain. On 11 June 2009 the World Health Organization declared that the infections caused by the new strain had reached pandemic proportion. Characterized as an influenza A virus of the H1N1 subtype, the genomic segments of the new strain were most closely related to swine viruses(1). Most human infections with swine-origin H1N1 influenza viruses (S-OIVs) seem to be mild; however, a substantial number of hospitalized individuals do not have underlying health issues, attesting to the pathogenic potential of S-OIVs. To achieve a better assessment of the risk posed by the new virus, we characterized one of the first US S-OIV isolates, A/California/04/09 ( H1N1; hereafter referred to as CA04), as well as several other S-OIV isolates, in vitro and in vivo. In mice and ferrets, CA04 and other S- OIV isolates tested replicate more efficiently than a currently circulating human H1N1 virus. In addition, CA04 replicates efficiently in non-human primates, causes more severe pathological lesions in the lungs of infected mice, ferrets and non-human primates than a currently circulating human H1N1 virus, and transmits among ferrets. In specific-pathogen-free miniature pigs, CA04 replicates without clinical symptoms. The assessment of human sera from different age groups suggests that infection with human H1N1 viruses antigenically closely related to viruses circulating in 1918 confers neutralizing antibody activity to CA04. Finally, we show that CA04 is sensitive to approved and experimental antiviral drugs, suggesting that these compounds could function as a first line of defence against the recently declared S- OIV pandemic.	[Itoh, Yasushi; Makino, Akiko; Kawaoka, Yoshihiro] Kobe Univ, Dept Microbiol & Infect Dis, Kobe, Hyogo 6500017, Japan; [Itoh, Yasushi; Ishigaki, Hirohito; Nakayama, Misako; Ogasawara, Kazumasa] Shiga Univ Med Sci, Dept Pathol, Shiga 5202192, Japan; [Kiso, Maki; Tamura, Daisuke; Sakai-Tagawa, Yuko; Sakabe, Saori; Yamada, Shinya; Murakami, Shin; Imai, Hirotaka; Kakugawa, Satoshi; Ito, Mutsumi; Takano, Ryo; Iwatsuki-Horimoto, Kiyoko; Shimojima, Masayuki; Horimoto, Taisuke; Goto, Hideo; Takahashi, Kei; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; [Watanabe, Tokiko; Hatta, Masato; Imai, Masaki; Hatta, Yasuko; Watanabe, Shinji; Li, Chengjun; Suresh, M.; Ozawa, Makoto; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53711 USA; [Sakoda, Yoshihiro; Okamatsu, Masatoshi; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido 0600818, Japan; [Muramoto, Yukiko; Fujii, Ken; Kawaoka, Yoshihiro] ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan; [Noda, Takeshi; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens, Tokyo 1088639, Japan; [Takahashi, Kazuo] Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Osaka 5370025, Japan; [Warshauer, David; Shult, Peter A.] Wisconsin State Lab Hyg, Madison, WI 53706 USA; [Saito, Reiko; Suzuki, Hiroshi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Publ Hlth, Niigata 9518510, Japan; [Furuta, Yousuke] Toyama Chem Co Ltd, Toyama 9308508, Japan; [Yamashita, Makoto] Daiichi Sankyo Co Ltd, Tokyo 1408710, Japan; [Mitamura, Keiko; Nakano, Kunio; Nakamura, Morio] Eiju Gen Hosp, Tokyo 1108654, Japan; [Brockman-Schneider, Rebecca; Gern, James] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53792 USA; [Mitamura, Hiroshi] Mitamura Clin, Dept Internal Med, Shizuoka 4130103, Japan; [Yamazaki, Masahiko] Childrens Clin, Dept Pediat, Kanagawa 2280023, Japan; [Sugaya, Norio] Keiyu Hosp, Kanagawa 2200012, Japan; [Kawaoka, Yoshihiro] Hokkaido Univ, Creat Res Initiat, Sapporo, Hokkaido 0600818, Japan	Kobe University; Shiga University of Medical Science; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Hokkaido University; Japan Science & Technology Agency (JST); University of Tokyo; Osaka Prefectural Institute of Public Health; Niigata University; Daiichi Sankyo Company Limited; University of Wisconsin System; University of Wisconsin Madison; Hokkaido University	Kawaoka, Y (corresponding author), Kobe Univ, Dept Microbiol & Infect Dis, Kobe, Hyogo 6500017, Japan.	kawaokay@svm.vetmed.wisc.edu	Ishigaki, Hirohito/AAO-7458-2020; Kida, Hiroshi/F-7244-2012; Okamatsu, Masatoshi/F-9124-2012; Ozawa, Makoto/AFM-4137-2022; Sakoda, Yoshihiro/A-5183-2012; Li, Chengjun/GWM-7661-2022	Ishigaki, Hirohito/0000-0002-5249-8598; Ozawa, Makoto/0000-0002-7731-5321; Nakayama, Misako/0000-0001-8611-0662; Suresh, Marulasiddappa/0000-0003-1794-3358; Itoh, Yasushi/0000-0001-7462-2193	Centers for Disease Control (CDC) [A/California/04/09, A/Netherlands/603/09]; National Institute of Allergy and Infectious Diseases Public Health Service; NIAID [HHSN266200700010C]; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health and by ERATO ( Japan Science and Technology Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503, R01AI069274] Funding Source: NIH RePORTER	Centers for Disease Control (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)United States Public Health Service); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and by ERATO ( Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Centers for Disease Control (CDC) for A/California/04/09 virus and R. Fouchier for A/Netherlands/603/09 virus. We thank K. Wells for editing the manuscript, and M. McGregor, R. Moritz, A. Hanson, H. Ishida, H. Tsuchiya, R. Torii, N. Yamamoto, K. Soda, N. Nomura and H. Yoshida for technical assistance. We also thank T. Umemura, Y. Sunden and T. Tanaka for pathological analyses of virus-infected pigs. This work was supported by National Institute of Allergy and Infectious Diseases Public Health Service research grants, by an NIAID-funded Center for Research on Influenza Pathogenesis ( CRIP, HHSN266200700010C), by Grant- in-Aid for Specially Promoted Research, by a contract research fund for the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, and by grants-in-aid from the Ministry of Health and by ERATO ( Japan Science and Technology Agency).	Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Neumann G, 2005, J VIROL, V79, P10300, DOI 10.1128/JVI.79.16.10300-10307.2005; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Yamashita M, 2009, ANTIMICROB AGENTS CH, V53, P186, DOI 10.1128/AAC.00333-08	21	856	902	1	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1021	U110		10.1038/nature08260	http://dx.doi.org/10.1038/nature08260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19672242	Green Accepted, Bronze			2022-12-28	WOS:000269085500036
J	Okie, S				Okie, Susan			Multinational Medicines - Ensuring Drug Quality in an Era of Global Manufacturing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												susan.okie@verizon.net						Government Accountability Office, 2008, GOV ACC OFF PUBL; *I SAF MED PRACT, 2009, QUARTERWATCH 2008 QU	2	13	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					737	740		10.1056/NEJMp0903870	http://dx.doi.org/10.1056/NEJMp0903870			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484WX	19692686				2022-12-28	WOS:000269081200001
J	Oviedo-Joekes, E; Brissette, S; Marsh, DC; Lauzon, P; Guh, D; Anis, A; Schechter, MT				Oviedo-Joekes, Eugenia; Brissette, Suzanne; Marsh, David C.; Lauzon, Pierre; Guh, Daphne; Anis, Aslam; Schechter, Martin T.			Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MAINTENANCE TREATMENT; HEROIN DEPENDENCE; PRESCRIBED HEROIN; CONTROLLED-TRIAL; DRUG-USERS; PRESCRIPTION; SAFETY	BACKGROUND Studies in Europe have suggested that injectable diacetylmorphine, the active ingredient in heroin, can be an effective adjunctive treatment for chronic, relapsing opioid dependence. METHODS In an open-label, phase 3, randomized, controlled trial in Canada, we compared injectable diacetylmorphine with oral methadone maintenance therapy in patients with opioid dependence that was refractory to treatment. Long-term users of injectable heroin who had not benefited from at least two previous attempts at treatment for addiction (including at least one methadone treatment) were randomly assigned to receive methadone (111 patients) or diacetylmorphine (115 patients). The primary outcomes, assessed at 12 months, were retention in addiction treatment or drug-free status and a reduction in illicit-drug use or other illegal activity according to the European Addiction Severity Index. RESULTS The primary outcomes were determined in 95.2% of the participants. On the basis of an intention-to-treat analysis, the rate of retention in addiction treatment in the diacetylmorphine group was 87.8%, as compared with 54.1% in the methadone group (rate ratio for retention, 1.62; 95% confidence interval [CI], 1.35 to 1.95; P<0.001). The reduction in rates of illicit-drug use or other illegal activity was 67.0% in the diacetylmorphine group and 47.7% in the methadone group (rate ratio, 1.40; 95% CI, 1.11 to 1.77; P=0.004). The most common serious adverse events associated with diacetylmorphine injections were overdoses (in 10 patients) and seizures (in 6 patients). CONCLUSIONS Injectable diacetylmorphine was more effective than oral methadone. Because of a risk of overdoses and seizures, diacetylmorphine maintenance therapy should be delivered in settings where prompt medical intervention is available. (ClinicalTrials.gov number, NCT00175357.)	[Oviedo-Joekes, Eugenia; Marsh, David C.; Anis, Aslam; Schechter, Martin T.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada; [Oviedo-Joekes, Eugenia; Marsh, David C.; Guh, Daphne; Anis, Aslam; Schechter, Martin T.] Providence Hlth Care, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Brissette, Suzanne; Lauzon, Pierre] Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Lauzon, Pierre] Ctr Rech & Aide Narcomanes, Montreal, PQ, Canada	University of British Columbia; Universite de Montreal	Schechter, MT (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, 5804 Fairview Ave, Vancouver, BC V6T 1Z3, Canada.	martin.schechter@ubc.ca	Marsh, David C./AAU-7184-2020	Marsh, David C./0000-0002-8769-1785; Schechter, Martin/0000-0001-6063-2155	Canadian Institutes of Health Research; Canada Foundation for Innovation; Canada Research Chairs Program; University of British Columbia, Providence Health Care; University of Montreal, Centre de Recherche et Aide aux Narcomanes; Government of Quebec, Vancouver Coastal Health; BC Centre for Disease Control	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); University of British Columbia, Providence Health Care; University of Montreal, Centre de Recherche et Aide aux Narcomanes; Government of Quebec, Vancouver Coastal Health; BC Centre for Disease Control	Supported by grants from the Canadian Institutes of Health Research, the Canada Foundation for Innovation, the Canada Research Chairs Program, the University of British Columbia, Providence Health Care, the University of Montreal, Centre de Recherche et Aide aux Narcomanes, the Government of Quebec, Vancouver Coastal Health, and the BC Centre for Disease Control.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Blattler R, 2002, SOZ PRAVENTIV MED, V47, P24, DOI 10.1007/BF01318402; Brust JCM, 2006, NEUROLOGY, V67, pS45, DOI 10.1212/WNL.67.12_suppl_4.S45; Cami J, 2003, NEW ENGL J MED, V349, P975, DOI 10.1056/NEJMra023160; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; *EUR MED AG, 2002, ICH HARM TRIP GUID G; FARRELL M, 1994, BMJ-BRIT MED J, V309, P997, DOI 10.1136/bmj.309.6960.997; Goldstein MF, 2002, DRUG ALCOHOL DEPEN, V66, P181, DOI 10.1016/S0376-8716(01)00199-5; GOWING L, 2004, COCHRANE DB SYST REV, V4; Haasen C, 2007, BRIT J PSYCHIAT, V191, P55, DOI 10.1192/bjp.bp.106.026112; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Kokkevi A., 1995, EUR ADDICT RES, V1, P208, DOI [10.1159/000259089, DOI 10.1159/000259089]; Ladewig D, 2002, EUR PSYCHIAT, V17, P163, DOI 10.1016/S0924-9338(02)00644-2; March JC, 2006, J SUBST ABUSE TREAT, V31, P203, DOI 10.1016/j.jsat.2006.04.007; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2003, COCHRANE DB SYST REV, V2; McLellan AT, 2006, AM J ADDICTION, V15, P113, DOI 10.1080/10550490500528316; *MIN PUBL WORKD GO, 2002, BEST PRACT METH MAIN; Office Federal de la Sante Publique, 2004, MAN TRAIT AV PRESCR; Popova S, 2006, PUBLIC HEALTH, V120, P320, DOI 10.1016/j.puhe.2005.09.010; Rehm J, 2001, LANCET, V358, P1417, DOI 10.1016/S0140-6736(01)06529-1; Stoermer R, 2003, BIOL PSYCHIAT, V54, P854, DOI 10.1016/S0006-3223(03)00290-7; Termorshuizen F, 2005, DRUG ALCOHOL DEPEN, V79, P231, DOI 10.1016/j.drugalcdep.2005.01.013; United Nations Office on Drugs and Crime, 2008, WORLD DRUG REP 2008; van den Brink W, 2003, BRIT MED J, V327, P310, DOI 10.1136/bmj.327.7410.310	25	222	227	2	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					777	786		10.1056/NEJMoa0810635	http://dx.doi.org/10.1056/NEJMoa0810635			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484WX	19692689	Green Accepted			2022-12-28	WOS:000269081200006
J	Torres-Reveron, A				Torres-Reveron, Annelyn			Hispanic people start leaping over barriers to better jobs	NATURE			English	Letter									Nova SE Univ, Coll Pharm, Ponce, PR 00717 USA	Nova Southeastern University	Torres-Reveron, A (corresponding author), Nova SE Univ, Coll Pharm, 2250 Ave Amer, Ponce, PR 00717 USA.	at583@nova.edu	Torres, Annelyn/AAS-1981-2021						0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					949	949		10.1038/460949b	http://dx.doi.org/10.1038/460949b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693063	Bronze			2022-12-28	WOS:000269085500012
J	Grijalva, CG; Nuorti, JP; Griffin, MR				Grijalva, Carlos G.; Nuorti, J. Pekka; Griffin, Marie R.			Antibiotic Prescription Rates for Acute Respiratory Tract Infections in US Ambulatory Settings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; ACUTE OTITIS-MEDIA; COMMUNITY-ACQUIRED PNEUMONIA; HEALTH-CARE UTILIZATION; UNITED-STATES; STREPTOCOCCUS-PNEUMONIAE; CHILDHOOD IMMUNIZATION; CHANGING EPIDEMIOLOGY; DISEASES-SOCIETY; YOUNG-CHILDREN	Context During the 1990s, antibiotic prescriptions for acute respiratory tract infection (ARTI) decreased in the United States. The sustainability of those changes is unknown. Objective To assess trends in antibiotic prescriptions for ARTI. Design, Setting, and Participants The National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey data (1995-2006) were used to examine trends in antibiotic prescription rates by antibiotic indication and class. Annual survey data and census denominators were combined in 2-year intervals for rate calculations. Main Outcome Measures National annual visit rates and antibiotic prescription rates for ARTI, including otitis media (OM) and non-ARTI. Results Among children younger than 5 years, annual ARTI visit rates decreased by 17% (95% confidence interval [CI], 9%-24%), from 1883 per 1000 population in 1995-1996 to 1560 per 1000 population in 2005-2006, primarily due to a 33% (95% CI, 22%-43%) decrease in OM visit rates (950 to 634 per 1000 population, respectively). This decrease was accompanied by a 36% (95% CI, 26%-45%) decrease in ARTI-associated antibiotic prescriptions (1216 to 779 per 1000 population). Among persons aged 5 years or older, ARTI visit rates remained stable but associated antibiotic prescription rates decreased by 18% (95% CI, 6%-29%), from 178 to 146 per 1000 population. Antibiotic prescription rates for non-OM ARTI for which antibiotics are rarely indicated decreased by 41% (95% CI, 22%-55%) and 24% (95% CI, 10%-37%) among persons younger than 5 years and 5 years or older, respectively. Overall, ARTI-associated prescription rates for penicillin, cephalosporin, and sulfonamide/tetracycline decreased. Prescription rates for azithromycin increased and it became the most commonly prescribed macrolide for ARTI and OM (10% of OM visits). Among adults, quinolone prescriptions increased. Conclusions Overall antibiotic prescription rates for ARTI decreased, associated with fewer OM visits in children younger than 5 years and with fewer prescriptions for ARTI for which antibiotics are rarely indicated. However, prescription rates for broad-spectrum antibiotics increased significantly. JAMA. 2009;302(7):758-766	[Grijalva, Carlos G.; Griffin, Marie R.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA; [Griffin, Marie R.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Nuorti, J. Pekka] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Centers for Disease Control & Prevention - USA	Grijalva, CG (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, 1500 21st Ave,Ste 2600, Nashville, TN 37232 USA.	carlos.grijalva@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	MedImmune; Pfizer; Centers for Disease Control and Prevention (CDC) [TS-1392, TS-1454, K01 CI000163]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [K01IP000163] Funding Source: NIH RePORTER	MedImmune(AstraZenecaMedimmune); Pfizer(Pfizer); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Drs Grijalva and Griffin reported receiving lecture fees and negotiating potential research support from Wyeth. Dr Griffin reported receiving grant support from MedImmune and Pfizer. Dr Nuorti reported no disclosures.; This study was funded by the Centers for Disease Control and Prevention (CDC) through Cooperative Agreements with the Association for Prevention Teaching and Research (TS-1392 and TS-1454). Dr Grijalva is supported by a CDC career development award (K01 CI000163).	Besser RE, 2003, ANN INTERN MED, V138, P605, DOI 10.7326/0003-4819-138-7-200304010-00020; Black S, 2008, CLIN INFECT DIS, V47, P485, DOI 10.1086/590002; Centers for Disease Control and Prevention, ACT BACT COR SURV AB; Centers for Disease Control and Prevention, GET SMART KNOW ANT W; CHANCEY S, 2008, 6 INT S PNEUM PNEUM; Cosby JL, 2007, LANCET INFECT DIS, V7, P749, DOI 10.1016/S1473-3099(07)70263-3; Dagan R, 2009, J INFECT DIS, V199, P776, DOI 10.1086/597044; Doern GV, 2006, MED CLIN N AM, V90, P1109, DOI 10.1016/j.mcna.2006.07.010; Dowell SF, 1998, AM FAM PHYSICIAN, V58, P1335; Dowell SF, 1998, AM FAM PHYSICIAN, V58, P1113; Dowell SF, 1998, PEDIATRICS, V101, P163; Dowell SF, 1998, AM FAM PHYSICIAN, V58, P1345; Felmingham D, 2002, J ANTIMICROB CHEMOTH, V50, P25, DOI 10.1093/jac/dkf808; Finkelstein JA, 2005, PEDIATRICS, V115, P1466, DOI 10.1542/peds.2004-1473; Finkelstein JA, 2003, PEDIATRICS, V112, P620, DOI 10.1542/peds.112.3.620; Finkelstein JA, 2008, PEDIATRICS, V121, pE15, DOI 10.1542/peds.2007-0819; Gonzales R, 2008, MED CARE, V46, P597, DOI 10.1097/MLR.0b013e3181653d2e; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Halasa NB, 2002, PEDIATR INFECT DIS J, V21, P1023, DOI 10.1097/00006454-200211000-00009; Healthy People 2010, 2010, HLTH PEOPLE 2010; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Jacobs RF, 2000, PEDIATR INFECT DIS J, V19, P938, DOI 10.1097/00006454-200009000-00038; Karchmer AW, 2004, CLIN INFECT DIS, V39, pS142, DOI 10.1086/421352; Klugman KP, 2005, EMERG INFECT DIS, V11, P802, DOI 10.3201/eid1106.050147; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lacapa R, 2008, CLIN INFECT DIS, V47, P476, DOI 10.1086/590001; Lieberman JM, 2003, PEDIATR INFECT DIS J, V22, P1143, DOI 10.1097/01.inf.0000101851.57263.63; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Linder JA, 2005, PHARMACOEPIDEM DR S, V14, P531, DOI 10.1002/pds.1067; Linder JA, 2005, AM J MED, V118, P259, DOI 10.1016/j.amjmed.2004.09.015; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; McCaig LF, 2003, EMERG INFECT DIS, V9, P432; McKenna S, 2001, Can J Infect Dis, V12, P218; McWilliams DB, 2008, ARCH PEDIAT ADOL MED, V162, P151, DOI 10.1001/archpediatrics.2007.30; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; *NAT CTR HLTH STAT, AMB HLTH CAR DAT NHA; National Center for Health Statistics, 2011, AMB HLTH CAR DAT NAM; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; Panpanich R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001954.pub3; Poehling KA, 2007, PEDIATRICS, V119, P707, DOI 10.1542/peds.2006-2138; Roumie CL, 2005, J GEN INTERN MED, V20, P697, DOI 10.1111/j.1525-1497.2005.0148.x; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; Steinman MA, 2003, ANN INTERN MED, V138, P525, DOI 10.7326/0003-4819-138-7-200304010-00008; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; *US BUR CENS, POP EST DAT SETS; Vernacchio L, 2007, PEDIATRICS, V120, P281, DOI 10.1542/peds.2006-3601; von Gottberg A, 2008, LANCET, V371, P1108, DOI 10.1016/S0140-6736(08)60350-5; Weissman Jennifer, 2004, Semin Pediatr Infect Dis, V15, P41, DOI 10.1053/j.spid.2004.01.004; Zhou FJ, 2008, PEDIATRICS, V121, P253, DOI 10.1542/peds.2007-0619; Zhou FJ, 2007, ARCH PEDIAT ADOL MED, V161, P1162, DOI 10.1001/archpedi.161.12.1162	53	369	379	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					758	766		10.1001/jama.2009.1163	http://dx.doi.org/10.1001/jama.2009.1163			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690308	Green Accepted, Bronze			2022-12-28	WOS:000269073800024
J	Burstein, HJ; Souter, I; D'Alessandro, HA; Sgroi, DC				Burstein, Harold J.; Souter, Irene; D'Alessandro, Helen Anne; Sgroi, Dennis C.			A Woman with Hormone-Receptor-Positive Breast Cancer Invasive ductal carcinoma, grade 2 of 3, ER-positive, PR-positive, HER2-negative, T1c pN1mi (stage II). Ductal carcinoma in situ, solid and cribriform types.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Postgraduate Course Breast Cancer - Current Controversies and New Horizons	JUL 10-12, 2008	Boston, MA				GENE-EXPRESSION SIGNATURES; ADJUVANT ENDOCRINE THERAPY; AMERICAN-JOINT-COMMITTEE; PREMENOPAUSAL WOMEN; OVARIAN STIMULATION; LYMPH-NODES; ESTROGEN; CHEMOTHERAPY; METASTASES; LETROZOLE		[Burstein, Harold J.] Massachusetts Gen Hosp, Div Med Oncol, Dana Farber Canc Inst, Boston, MA 02114 USA; [Burstein, Harold J.] Massachusetts Gen Hosp, Brigham & Womens Hosp, Dept Med, Boston, MA 02114 USA; [Souter, Irene] Massachusetts Gen Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02114 USA; [D'Alessandro, Helen Anne] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Burstein, Harold J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Souter, Irene] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [D'Alessandro, Helen Anne] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sgroi, Dennis C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Burstein, HJ (corresponding author), Massachusetts Gen Hosp, Div Med Oncol, Dana Farber Canc Inst, Boston, MA 02114 USA.		Sgroi, Dennis/AAV-2487-2021					ALBAIN K, 2007, BREAST CANC RES T S1, V106, P10; Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS241, DOI 10.1016/j.fertnstert.2008.08.039; Azim AA, 2008, J CLIN ONCOL, V26, P2630, DOI 10.1200/JCO.2007.14.8700; Barroso G, 2006, FERTIL STERIL, V86, P1428, DOI 10.1016/j.fertnstert.2006.03.044; Bedaiwy MA, 2008, FERTIL STERIL, V90, P2031, DOI 10.1016/j.fertnstert.2008.08.009; Calderon-Margalit R, 2009, AM J EPIDEMIOL, V169, P365, DOI 10.1093/aje/kwn318; Chen SL, 2007, ANN SURG ONCOL, V14, P3378, DOI 10.1245/s10434-007-9513-6; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Colleoni M, 2006, J CLIN ONCOL, V24, P1332, DOI 10.1200/JCO.2005.03.0783; Colleoni M, 2006, ANN ONCOL, V17, P1497, DOI 10.1093/annonc/mdl145; Colleoni M, 2005, J CLIN ONCOL, V23, P1379, DOI 10.1200/JCO.2005.07.094; Davidson NE, 2005, J CLIN ONCOL, V23, P5973, DOI 10.1200/JCO.2005.05.551; Dellapasqua S, 2005, J CLIN ONCOL, V23, P1736, DOI 10.1200/JCO.2005.11.050; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fisher B, 2004, LANCET, V364, P858, DOI 10.1016/S0140-6736(04)16981-X; GIULIANO AE, Z0010 PROGNOSTIC STU; Gnant M, 2009, NEW ENGL J MED, V360, P2379; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Gobardhan PD, 2009, ANN ONCOL, V20, P41, DOI 10.1093/annonc/mdn535; Goldhirsch A, 2006, ANN ONCOL, V17, P1772, DOI 10.1093/annonc/mdl398; GOLDHIRSCH A, 2009, ANN ONCOL       0617; Goodwin PJ, 1999, J CLIN ONCOL, V17, P2365, DOI 10.1200/JCO.1999.17.8.2365; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Ives A, 2007, BMJ-BRIT MED J, V334, P194, DOI 10.1136/bmj.39035.667176.55; Jain JK, 2006, FERTIL STERIL, V86, P1037, DOI 10.1016/j.fertnstert.2006.07.1478; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Mancini J, 2008, FERTIL STERIL, V90, P1616, DOI 10.1016/j.fertnstert.2007.08.064; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Mueller BA, 2003, CANCER, V98, P1131, DOI 10.1002/cncr.11634; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; NIXON AJ, 1994, J CLIN ONCOL, V12, P888, DOI 10.1200/JCO.1994.12.5.888; OKTAY K, 2008, FERTIL STERIL   1113; Oktay K, 2006, J CLIN ENDOCR METAB, V91, P3885, DOI 10.1210/jc.2006-0962; Oktay K, 2006, FERTIL STERIL, V86, P70, DOI 10.1016/j.fertnstert.2006.03.017; Pacheco BP, 2001, GYNECOL ONCOL, V81, P391, DOI 10.1006/gyno.2001.6181; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; PANEL N. I. O. H. C. D, 2001, J NATL CANCER INST M, P5; Parton M, 2008, J CLIN ONCOL, V26, P745, DOI 10.1200/JCO.2007.14.3016; Partridge A, 2007, EUR J CANCER, V43, P1646, DOI 10.1016/j.ejca.2007.04.006; Singletary SE, 2003, CANCER, V98, P2740, DOI 10.1002/cncr.11865; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Tan LK, 2008, J CLIN ONCOL, V26, P1803, DOI 10.1200/JCO.2007.12.6425; Thurlimann B, 2009, BREAST CANCER RES TR, V113, P137, DOI 10.1007/s10549-008-9912-9; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Viale G, 2005, ANN SURG, V241, P319, DOI 10.1097/01.sla.0000150255.30665.52; Walshe JM, 2006, J CLIN ONCOL, V24, P5769, DOI 10.1200/JCO.2006.07.2793	51	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					699	707		10.1056/NEJMcpc0902224	http://dx.doi.org/10.1056/NEJMcpc0902224			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	482JX	19675333				2022-12-28	WOS:000268884100012
J	Gatlin, JC; Salmon, ED				Gatlin, Jesse C.; Salmon, E. D.			Data Harvesting from fields of spindles	CELL			English	Editorial Material							ORGANIZATION; MICROTUBULES	The mitotic spindle is essential for chromosome segregation and must be large enough to accommodate all of the chromatin in the dividing cell. In this issue, Dinarina et al. (2009) grow "fields" of spindles on coverslips to investigate the relationship between chromatin and spindle size as well as intrinsic mechanisms of spindle assembly.	[Gatlin, Jesse C.; Salmon, E. D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Gatlin, JC (corresponding author), Univ N Carolina, Dept Biol, 607 Fordham Hall,CB 3280, Chapel Hill, NC 27599 USA.	jgatlin@email.unc.edu		Gatlin, Jesse/0000-0002-5417-225X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024364] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM024364] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Desai A, 2002, DEV CELL, V3, P465, DOI 10.1016/S1534-5807(02)00294-0; Gaetz J, 2006, NAT CELL BIOL, V8, P924, DOI 10.1038/ncb1455; Gatlin JC, 2009, CURR BIOL, V19, P287, DOI 10.1016/j.cub.2009.01.055; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Mogilner M, 2006, TRENDS CELL BIOL, V16, P88, DOI 10.1016/j.tcb.2005.12.007; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925	9	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					426	428		10.1016/j.cell.2009.07.019	http://dx.doi.org/10.1016/j.cell.2009.07.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665964	Green Accepted, Bronze			2022-12-28	WOS:000268771900006
J	Corral-Gudino, L; Jorge-Sanchez, RJ; Borao-Cengotita-Bengoa, M; Garcia-Aparicio, J; Cascon-Bueno, M				Corral-Gudino, Luis; Jorge-Sanchez, Ramon J.; Borao-Cengotita-Bengoa, Maria; Garcia-Aparicio, Judit; Cascon-Bueno, Manuel			Picture quiz Exertional dyspnoea and abnormal chest radiography	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY ARTERIAL-HYPERTENSION; DIAGNOSIS		[Corral-Gudino, Luis; Jorge-Sanchez, Ramon J.; Borao-Cengotita-Bengoa, Maria; Garcia-Aparicio, Judit] Hosp Univ Salamanca, Hosp Montalvos, Dept Internal Med, Salamanca 37192, Spain; [Cascon-Bueno, Manuel] Hosp Univ Salamanca, Dept Cardiol, Salamanca 37007, Spain	University of Salamanca; University of Salamanca	Corral-Gudino, L (corresponding author), Hosp Univ Salamanca, Hosp Montalvos, Dept Internal Med, Salamanca 37192, Spain.	lcorral@husa.sacyl.es	Corral-Gudino, Luis/K-4863-2019	Corral-Gudino, Luis/0000-0003-0151-5420				Ahearn GS, 2002, CHEST, V122, P524, DOI 10.1378/chest.122.2.524; Engelfriet P, 2005, EUR HEART J, V26, P2325, DOI 10.1093/eurheartj/ehi396; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; McArdle JR, 2007, CLIN CHEST MED, V28, P717, DOI 10.1016/j.ccm.2007.08.006; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Schannwell CM, 2007, J PHYSIOL PHARMACOL, V58, P591; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; WEBB WR, 2004, THORACIC IMAGING PUL, P148	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2009	339								b2920	10.1136/bmj.b2920	http://dx.doi.org/10.1136/bmj.b2920			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KD	19656833				2022-12-28	WOS:000268808000002
J	Kahn, MW				Kahn, Michael W.			Becoming a Physician: What Would Osler Do? Learning from ``Difficult'' Patients.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kahn, Michael W.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kahn, Michael W.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kahn, MW (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.								0	17	17	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 30	2009	361	5					442	443		10.1056/NEJMp0902021	http://dx.doi.org/10.1056/NEJMp0902021			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	476LW	19641200				2022-12-28	WOS:000268443900003
J	Ge, DL; Fellay, J; Thompson, AJ; Simon, JS; Shianna, KV; Urban, TJ; Heinzen, EL; Qiu, P; Bertelsen, AH; Muir, AJ; Sulkowski, M; McHutchison, JG; Goldstein, DB				Ge, Dongliang; Fellay, Jacques; Thompson, Alexander J.; Simon, Jason S.; Shianna, Kevin V.; Urban, Thomas J.; Heinzen, Erin L.; Qiu, Ping; Bertelsen, Arthur H.; Muir, Andrew J.; Sulkowski, Mark; McHutchison, John G.; Goldstein, David B.			Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance	NATURE			English	Article							PEGINTERFERON ALPHA-2B; RIBAVIRIN	Chronic infection with hepatitis C virus (HCV) affects 170 million people worldwide and is the leading cause of cirrhosis in North America(1). Although the recommended treatment for chronic infection involves a 48-week course of peginterferon-alpha-2b (PegIFN-alpha-2b) or-alpha-2a (PegIFN-alpha-2a) combined with ribavirin (RBV), it is well known that many patients will not be cured by treatment, and that patients of European ancestry have a significantly higher probability of being cured than patients of African ancestry. In addition to limited efficacy, treatment is often poorly tolerated because of side effects that prevent some patients from completing therapy. For these reasons, identification of the determinants of response to treatment is a high priority. Here we report that a genetic polymorphism near the IL28B gene, encoding interferon-lambda-3 (IFN-lambda-3), is associated with an approximately twofold change in response to treatment, both among patients of European ancestry (P = 1.06 x 10(-25)) and African-Americans (P = 2.06 x 10(-3)). Because the genotype leading to better response is in substantially greater frequency in European than African populations, this genetic polymorphism also explains approximately half of the difference in response rates between African-Americans and patients of European ancestry.	[Ge, Dongliang; Fellay, Jacques; Shianna, Kevin V.; Urban, Thomas J.; Heinzen, Erin L.; Goldstein, David B.] Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Thompson, Alexander J.; Muir, Andrew J.; McHutchison, John G.] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; [Thompson, Alexander J.; Muir, Andrew J.; McHutchison, John G.] Duke Univ, Div Gastroenterol, Sch Med, Durham, NC 27705 USA; [Simon, Jason S.; Qiu, Ping; Bertelsen, Arthur H.] Schering Plough Res Inst, Kenilworth, NJ 07033 USA; [Sulkowski, Mark] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Duke University; Duke University; Duke University; Merck & Company; Schering-Plough Research Institute; Johns Hopkins University	Goldstein, DB (corresponding author), Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC 27708 USA.	d.goldstein@duke.edu	Goldstein, David/AAY-8125-2020; Ge, Dongliang/A-2073-2010; Fellay, Jacques/A-6681-2009	Fellay, Jacques/0000-0002-8240-939X; Ge, David/0000-0002-9732-8170	National Health and Medical Research Council of Australia; Gastroenterological Society of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Gastroenterological Society of Australia	We are indebted to the IDEAL principal investigators, the study coordinators, nurses and patients involved in the study. We also recognize E. Gustafson, P. Savino, D. Devlin, S. Noviello, M. Geffner, J. Albrecht and A. C. Need for their contributions to the study. This study was funded by Schering-Plough Research Institute, Kenilworth, New Jersey. A. J. T. received funding support from the National Health and Medical Research Council of Australia and the Gastroenterological Society of Australia.	BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; SHIFFMAN ML, 2009, J HEPATOL S1, V50; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; *WHO, 2009, HEP; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Yan KK, 2008, WORLD J GASTROENTERO, V14, P3416, DOI 10.3748/wjg.14.3416	19	2822	3005	0	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					399	401		10.1038/nature08309	http://dx.doi.org/10.1038/nature08309			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19684573				2022-12-28	WOS:000269828100040
J	Dando, M				Dando, Malcolm			Biologists napping while work militarized	NATURE			English	Editorial Material									Univ Bradford, Wellcome Trust Project Bldg Sustainable Capac Dua, Dept Peace Studies, Bradford BD7 1DP, W Yorkshire, England	University of Bradford	Dando, M (corresponding author), Univ Bradford, Wellcome Trust Project Bldg Sustainable Capac Dua, Dept Peace Studies, Richmond Rd, Bradford BD7 1DP, W Yorkshire, England.	mrdando@bradford.ac.uk						*CHEM COMM, 1959, 32 M 5 MARCH 1959; HESS L, 2007, P 4 EUR S NONL WEAP; Lakoski J. M., 2000, ADVANTAGES LIMITATIO; Petro James B, 2003, Biosecur Bioterror, V1, P161, DOI 10.1089/153871303769201815; WHITBRED G, 2006, OFFENSIVE USE CHEM T	5	11	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					950	951		10.1038/460950a	http://dx.doi.org/10.1038/460950a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693065	Bronze			2022-12-28	WOS:000269085500015
J	Kelbert, A; Schultz, A; Egbert, G				Kelbert, Anna; Schultz, Adam; Egbert, Gary			Global electromagnetic induction constraints on transition-zone water content variations	NATURE			English	Article							UPPER-MANTLE BENEATH; ELECTRICAL-CONDUCTIVITY; C-RESPONSES; MID-MANTLE; CARBONATED ECLOGITE; REGION; WADSLEYITE; HYDROGEN; TRANSPORTATION; MODEL	Small amounts of water can significantly affect the physical properties of mantle materials, including lowering of the solidus(1), and reducing effective viscosity(2) and seismic velocity(3). The amount and distribution of water within the mantle thus has profound implications for the dynamics and geochemical evolution of the Earth(4,5). Electrical conductivity is also highly sensitive to the presence of hydrogen in mantle minerals(6). The mantle transition zone minerals wadsleyite and ringwoodite in particular have high water solubility(4), and recent high pressure experiments show that the electrical conductivity of these minerals is very sensitive to water content(7-9). Thus estimates of the electrical conductivity of the mantle transition zone derived from electromagnetic induction studies have the potential to constrain the water content of this region. Here we invert long period geomagnetic response functions to derive a global-scale three-dimensional model of electrical conductivity variations in the Earth's mantle, revealing variations in the electrical conductivity of the transition zone of approximately one order of magnitude. Conductivities are high in cold, seismically fast, areas where slabs have subducted into or through the transition zone. Significant variations in water content throughout the transition zone provide a plausible explanation for the observed patterns. Our results support the view(10,11) that at least some of the water in the transition zone has been carried into that region by cold subducting slabs.	[Kelbert, Anna; Schultz, Adam; Egbert, Gary] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Kelbert, A (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	anya@coas.oregonstate.edu	Schultz, Adam/K-7394-2012; Kelbert, Anna/AAF-2467-2020	Kelbert, Anna/0000-0003-4395-398X; Egbert, Gary/0000-0003-1276-8538; Schultz, Adam/0000-0003-1663-1547	US National Science Foundation [EAR-0739111]; US National Aeronautics and Space Administration [NNX08AG04G]	US National Science Foundation(National Science Foundation (NSF)); US National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	We acknowledge support from the US National Science Foundation ( grant number EAR-0739111) and from the US National Aeronautics and Space Administration ( grant number NNX08AG04G). A. Kuvshinov is thanked for help with the near-surface data correction.	Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; Booker JR, 2004, NATURE, V429, P399, DOI 10.1038/naturt02565; Dasgupta R, 2004, EARTH PLANET SC LETT, V227, P73, DOI 10.1016/j.epsl.2004.08.004; Dixon JE, 2004, EARTH PLANET SC LETT, V222, P451, DOI 10.1016/j.epsl.2004.03.022; EGBERT GD, 1992, J GEOPHYS RES-SOL EA, V97, P15099, DOI 10.1029/92JB01251; Evans RL, 2005, NATURE, V437, P249, DOI 10.1038/nature04014; Fujii I, 2002, GEOPHYS J INT, V151, P689, DOI 10.1046/j.1365-246X.2002.01775.x; Fukao Y, 2004, EARTH PLANET SC LETT, V217, P425, DOI 10.1016/S0012-821X(03)00610-1; Fukao Y, 2001, REV GEOPHYS, V39, P291, DOI 10.1029/1999RG000068; Gaillard F, 2008, SCIENCE, V322, P1363, DOI 10.1126/science.1164446; Goes S, 1999, SCIENCE, V286, P1928, DOI 10.1126/science.286.5446.1928; Hae R, 2006, EARTH PLANET SC LETT, V243, P141, DOI 10.1016/j.epsl.2005.12.035; Hammouda T, 2003, EARTH PLANET SC LETT, V214, P357, DOI 10.1016/S0012-821X(03)00361-3; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Huang XG, 2005, NATURE, V434, P746, DOI 10.1038/nature03426; Ichiki M, 2001, GEOPHYS RES LETT, V28, P3773, DOI 10.1029/2001GL012983; *INTERMAGNET, PART OBS MAP; Karato S, 1998, EARTH PLANET SC LETT, V157, P193, DOI 10.1016/S0012-821X(98)00034-X; KARATO S, 1990, NATURE, V347, P272, DOI 10.1038/347272a0; KARATO S, PHYS EARTH IN PRESS; Kawakatsu H, 2007, SCIENCE, V316, P1468, DOI 10.1126/science.1140855; Kelbert A, 2008, GEOPHYS J INT, V173, P365, DOI 10.1111/j.1365-246X.2008.03717.x; Koyama T, 2006, GEOPHYS MONOGR SER, V168, P171, DOI 10.1029/168GM13; Kuvshinov A, 2005, GEOPHYS J INT, V160, P505, DOI 10.1111/j.1365-246X.2005.02477.x; Kuvshinov A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027083; Kuvshinov AV, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014409; Lawrence JF, 2008, GEOPHYS J INT, V174, P143, DOI 10.1111/J.1365-246X.2007.03673.X; LIZARRALDE D, 1995, J GEOPHYS RES-SOL EA, V100, P17837, DOI 10.1029/95JB01244; Maruyama S, 2007, GONDWANA RES, V11, P148, DOI 10.1016/j.gr.2006.06.001; Neal SL, 2000, J GEOPHYS RES-SOL EA, V105, P8229, DOI 10.1029/1999JB900447; Ohtani E, 2004, PHYS EARTH PLANET IN, V143, P255, DOI 10.1016/j.pepi.2003.09.015; Olsen N, 1998, GEOPHYS J INT, V133, P298, DOI 10.1046/j.1365-246X.1998.00503.x; Olsen N, 2006, GEOPHYS J INT, V166, P67, DOI 10.1111/j.1365-246X.2006.02959.x; SCHULTZ A, 1993, GEOPHYS RES LETT, V20, P2941, DOI 10.1029/93GL02833; SCHULTZ A, 1987, GEOPHYS J ROY ASTR S, V88, P733, DOI 10.1111/j.1365-246X.1987.tb01654.x; SCHULTZ A, 1999, 3 DIMENSIONAL ELECTR, P451; Semenov VY, 2006, TECTONOPHYSICS, V416, P279, DOI 10.1016/j.tecto.2005.11.017; Tarits P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019277; Toffelmier DA, 2007, NATURE, V447, P991, DOI 10.1038/nature05922; Utada H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016092; Uyeshima M, 2000, GEOPHYS J INT, V140, P636, DOI 10.1046/j.1365-246X.2000.00051.x; Williams Q, 2001, ANNU REV EARTH PL SC, V29, P365, DOI 10.1146/annurev.earth.29.1.365; YOSHINO T, PHYS EARTH IN PRESS; Yoshino T, 2008, NATURE, V451, P326, DOI 10.1038/nature06427	44	189	209	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1003	U85		10.1038/nature08257	http://dx.doi.org/10.1038/nature08257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693081				2022-12-28	WOS:000269085500032
J	Vassiliou, MC; Adrales, GL				Vassiliou, Melina C.; Adrales, Gina L.			Pneumatosis Cystoides Coli	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vassiliou, Melina C.; Adrales, Gina L.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA	Dartmouth College	Vassiliou, MC (corresponding author), Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					E12	E12		10.1056/NEJMicm0805985	http://dx.doi.org/10.1056/NEJMicm0805985			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484WX	19692685				2022-12-28	WOS:000269081200010
J	Ballard, JO				Ballard, J. O., III			More Things in Heaven and Earth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jballard@psu.edu						HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					723	724		10.1001/jama.2009.1114	http://dx.doi.org/10.1001/jama.2009.1114			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690294				2022-12-28	WOS:000269073800001
J	Jenkinson, CM; Doherty, M; Avery, AJ; Read, A; Taylor, MA; Sach, TH; Silcocks, P; Muir, KR				Jenkinson, Claire M.; Doherty, Michael; Avery, Anthony J.; Read, Anna; Taylor, Moira A.; Sach, Tracey H.; Silcocks, Paul; Muir, Kenneth R.			Effects of dietary intervention and quadriceps strengthening exercises on pain and function in overweight people with knee pain: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; OLDER-ADULTS; WEIGHT-LOSS; EULAR RECOMMENDATIONS; STANDING COMMITTEE; OSTEO-ARTHRITIS; TASK-FORCE; OSTEOARTHRITIS; HIP	Objective To determine whether dietary intervention or knee strengthening exercise, or both, can reduce knee pain and improve knee function in overweight and obese adults in the community. Design Pragmatic factorial randomised controlled trial. Setting Five general practices in Nottingham. Participants 389 men and women aged 45 and over with a body mass index (BMI) of >= 28.0 and self reported knee pain. Interventions Participants were randomised to dietary intervention plus quadriceps strengthening exercises; dietary intervention alone; quadriceps strengthening exercises alone; advice leaflet only (control group). Dietary intervention consisted of individualised healthy eating advice that would reduce normal intake by 2.5 MJ (600 kcal) a day. Interventions were delivered at home visits over a two year period. Main outcome measures The primary outcome was severity of knee pain scored with the Western Ontario McMaster (WOMAC) osteoarthritis index at 6, 12, and 24 months. Secondary outcomes (all at 24 months) included WOMAC knee physical function and stiffness scores and selected domains on the SF-36 and the hospital anxiety and depression index. Results 289 (74%) participants completed the trial. There was a significant reduction in knee pain in the knee exercise groups compared with those in the non-exercise groups at 24 months (percentage risk difference 11.61, 95% confidence interval 1.81% to 21.41%). The absolute effect size (0.25) was moderate. The number needed to treat to benefit from a >= 30% improvement in knee pain at 24 months was 9 (5 to 55). In those randomised to knee exercise improvement in function was evident at 24 months (mean difference -3.64, -6.01 to -1.27). The mean difference in weight loss at 24 months in the dietary intervention group compared with no dietary intervention was 2.95 kg (1.44 to 4.46); for exercise versus no exercise the difference was 0.43 kg (-0.82 to 1.68). This difference in weight loss was not associated with improvement in knee pain or function but was associated with a reduction in depression (absolute effect size 0.19). Conclusions A home based, self managed programme of simple knee strengthening exercises over a two year period can significantly reduce knee pain and improve knee function in overweight and obese people with knee pain. A moderate sustained weight loss is achievable with dietary intervention and is associated with reduced depression but is without apparent influence on pain or function.	[Jenkinson, Claire M.; Muir, Kenneth R.] Univ Nottingham, Div Epidemiol & Publ Hlth, Sch Community Hlth Sci, Queens Med Ctr, Nottingham NG7 2UH, England; [Doherty, Michael] Univ Nottingham, City Hosp, Acad Rheumatol, Nottingham NG5 1PB, England; [Avery, Anthony J.] Univ Nottingham, Div Primary Care, Sch Community Hlth Sci, Queens Med Ctr, Nottingham NG7 2UH, England; [Read, Anna] Nottingham Univ NHS Trust, Dept Nutr & Dietet, Queens Med Ctr, Nottingham NG7 2UH, England; [Taylor, Moira A.] Univ Nottingham, Sch Biomed Sci, Queenss Med Ctr, Nottingham NG7 2UH, England; [Sach, Tracey H.] Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England; [Silcocks, Paul] Univ Nottingham, Nottingham Clin Trials Unit, Sch Community Hlth Sci, Queens Med Ctr, Nottingham NG7 2UH, England	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; University of East Anglia; University of Nottingham	Jenkinson, CM (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Sch Community Hlth Sci, Queens Med Ctr, Nottingham NG7 2UH, England.	claire.jenkinson@nottingham.ac.uk		Avery, Anthony/0000-0001-7591-4438; Doherty, Michael/0000-0002-5763-8326; Taylor, Moira/0000-0003-4100-8343; Sach, Tracey/0000-0002-8098-9220	Arthritis Research Campaign [13550, 17375]	Arthritis Research Campaign(Versus Arthritis)	The study was funded by the Arthritis Research Campaign (grant Nos 13550 and 17375). The funder monitored the trial progress through a trial steering committee chaired by Richard Keen. Trial data were monitored by a data monitoring committee subgroup chaired by Ian Harvey. The study sponsor was the University of Nottingham.	Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Anandacoomarasamy A, 2008, INT J OBESITY, V32, P211, DOI 10.1038/sj.ijo.0803715; [Anonymous], 2001, MISSING DATA; BELLAMY N, 1995, J RHEUMATOL, V22, P49; Carpenter J, MISSING DATA RANDOMI; Christensen R, 2007, ANN RHEUM DIS, V66, P433, DOI 10.1136/ard.2006.065904; Contopoulos-Ioannidis DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3006; Day N, 1999, BRIT J CANCER, V80, P95; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420; FELSON DT, 1992, ANN INTERN MED, V116, P535, DOI 10.7326/0003-4819-116-7-535; FELSON DT, 1988, EPIDEMIOL REV, V10, P1; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; FRANSEN M, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004376; Gupta S, 2005, RHEUMATOLOGY, V44, P1531, DOI 10.1093/rheumatology/kei049; Jamtvedt G, 2008, PHYS THER, V88, P123, DOI 10.2522/ptj.20070043; Jinks C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-258; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Lin EHB, 2003, JAMA-J AM MED ASSOC, V290, P2428, DOI 10.1001/jama.290.18.2428; MEDEIROS R, PRED EQ PROGRAM CREA; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Miller GD, 2006, OBESITY, V14, P1219, DOI 10.1038/oby.2006.139; Nagaosa Y, 2000, ANN RHEUM DIS, V59, P587, DOI 10.1136/ard.59.8.587; *NAT I HLTH CLIN E, 2008, CLIN GUID NICE, V59; O'Reilly SC, 1999, ANN RHEUM DIS, V58, P15, DOI 10.1136/ard.58.1.15; ono t, 2005, WHO GLOBAL COMPARABL; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Pendleton A, 2000, ANN RHEUM DIS, V59, P936, DOI 10.1136/ard.59.12.936; Peterfy C, 2003, SKELETAL RADIOL, V32, P128, DOI 10.1007/s00256-002-0603-z; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Reijman M, 2007, ANN RHEUM DIS, V66, P158, DOI 10.1136/ard.2006.053538; Roddy E, 2005, ANN RHEUM DIS, V64, P544, DOI 10.1136/ard.2004.028746; Roddy E, 2005, RHEUMATOLOGY, V44, P67, DOI 10.1093/rheumatology/keh399; Rosemann T, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-4; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sach TH, 2007, INT J OBESITY, V31, P189, DOI 10.1038/sj.ijo.0803365; SPECTOR TD, 1994, ANN RHEUM DIS, V53, P565, DOI 10.1136/ard.53.9.565; Thomas KS, 2002, BMJ-BRIT MED J, V325, P752, DOI 10.1136/bmj.325.7367.752; Underwood MR, 2004, RHEUMATOLOGY, V43, P2, DOI 10.1093/rheumatology/keg439; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WOOLF A, 2004, EUROPEAN BONE JOINT; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	44	72	72	2	20	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 18	2009	339								b3170	10.1136/bmj.b3170	http://dx.doi.org/10.1136/bmj.b3170			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486RZ	19690345	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000269216700006
J	Ford, AC; Talley, NJ				Ford, Alexander C.; Talley, Nicholas J.			Does Helicobacter pylori really cause duodenal ulcers? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PEPTIC-ULCER; GASTRIC-CANCER; DISEASE; ERADICATION; INFECTION; COHORT; ACID		[Ford, Alexander C.] St James Univ Hosp, Acad Dept Med, Leeds LS9 7TF, W Yorkshire, England; [Talley, Nicholas J.] Mayo Clin Florida, Dept Med, Jacksonville, FL 32224 USA; [Talley, Nicholas J.] Univ Sydney, Dept Med, Nepean Hosp, Sydney, NSW 2006, Australia	Saint James's University Hospital; Mayo Clinic; Nepean Hospital; University of Sydney	Ford, AC (corresponding author), St James Univ Hosp, Acad Dept Med, Leeds LS9 7TF, W Yorkshire, England.	alexf12399@yahoo.com	Talley, Nicholas J/D-5399-2013; Ford, Alexander/K-5491-2012	Talley, Nicholas J/0000-0003-2537-3092; Ford, Alexander/0000-0001-6371-4359				Agha A, 2005, SCAND J GASTROENTERO, V40, P523, DOI 10.1080/00365520510012280; BANATVALA N, 1993, J INFECT DIS, V168, P219, DOI 10.1093/infdis/168.1.219; BARON JH, 1969, GUT, V10, P637, DOI 10.1136/gut.10.8.637; El-Serag HB, 1998, GUT, V43, P327, DOI 10.1136/gut.43.3.327; Ford AC, 2005, GASTROENTEROLOGY, V129, P1910, DOI 10.1053/j.gastro.2005.09.016; Ford AC, 2004, AM J GASTROENTEROL, V99, P1833, DOI 10.1111/j.1572-0241.2004.40014.x; Harvey RF, 2002, QJM-INT J MED, V95, P519, DOI 10.1093/qjmed/95.8.519; Iijima K, 2000, GUT, V46, P20, DOI 10.1136/gut.46.1.20; Leung WK, 1999, AM J GASTROENTEROL, V94, P2881, DOI 10.1111/j.1572-0241.1999.01431.x; MARSHALL BJ, 1985, MED J AUSTRALIA, V142, P436, DOI 10.5694/j.1326-5377.1985.tb113443.x; Moayyedi P, 2008, GASTROENTEROLOGY, V134, pA631; Ohkusa T, 2003, GUT, V52, P797, DOI 10.1136/gut.52.6.797; Rosenstock S, 2003, GUT, V52, P186, DOI 10.1136/gut.52.2.186; Schultze V, 1998, SCAND J GASTROENTERO, V33, P137, DOI 10.1080/00365529850166851; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347	15	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2009	339								b2784	10.1136/bmj.b2784	http://dx.doi.org/10.1136/bmj.b2784			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YL	19684098				2022-12-28	WOS:000269162200001
J	Jain, SH				Jain, Sachin H.			BECOMING A PHYSICIAN Practicing Medicine in the Age of Facebook	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jain, Sachin H.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Jain, Sachin H.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard University; Brigham & Women's Hospital	Jain, SH (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.		Roundtree, Aimee/B-8838-2012						0	119	124	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					649	651		10.1056/NEJMp0901277	http://dx.doi.org/10.1056/NEJMp0901277			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19675328				2022-12-28	WOS:000268884100003
J	Samet, JM; Wipfli, H				Samet, Jonathan M.; Wipfli, Heather			Unfinished Business in Tobacco Control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Samet, Jonathan M.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; Univ So Calif, Inst Global Hlth, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Samet, JM (corresponding author), Univ So Calif, Dept Prevent Med, 1441 Eastlake Ave,Room 4436,MC 9175, Los Angeles, CA 90089 USA.	jsamet@usc.edu						Blecher EH, 2009, TOB CONTROL, V18, P167, DOI 10.1136/tc.2008.026682; Centers for Disease Control and Prevention, 2007, BEST PRACT COMPR TOB; *I MED, 2007, END TOB PROBL BLUEPR; International Agency for Research on Cancer, 2004, IARC MON, V83; Roosaar A, 2008, INT J CANCER, V123, P168, DOI 10.1002/ijc.23469; World Health Organization, 2008, SCI BAS TOB PROD REG; World Health Organization, 2003, WHO FRAM CONV TOB CO; COUNSELING INTERVENT	8	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					681	682		10.1001/jama.2009.1155	http://dx.doi.org/10.1001/jama.2009.1155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481ZI	19671910				2022-12-28	WOS:000268852300028
J	Sokka, T; Pincus, T				Sokka, Tuulikki; Pincus, Theodore			Rheumatoid arthritis: strategy more important than agent	LANCET			English	Editorial Material							COMBINATION THERAPY; RANDOMIZED-TRIAL; METHOTREXATE; CARE		[Sokka, Tuulikki] Jyvaskyla Cent Hosp, Jyvaskyla 40620, Finland; [Pincus, Theodore] NYU, Hosp Joint Dis, New York, NY USA	Central Finland Central Hospital; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC	Sokka, T (corresponding author), Jyvaskyla Cent Hosp, Jyvaskyla 40620, Finland.	tuulikki.sokka@ksshp.fi						Goekoop-Ruiterman YPM, 2007, ANN INTERN MED, V146, P406, DOI 10.7326/0003-4819-146-6-200703200-00005; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Hetland ML, 2008, ANN RHEUM DIS, V67, P815, DOI 10.1136/ard.2007.076307; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Pincus T, 2005, ARTHRITIS RHEUM-US, V52, P1009, DOI 10.1002/art.20941; Silman AJ, 2002, ARTHRITIS RHEUM-US, V46, P579, DOI 10.1002/art.508; Sokka T, 2008, RHEUMATOLOGY, V47, P1543, DOI 10.1093/rheumatology/ken316; Sokka T, 2009, ANN RHEUM DIS, V68, P1666, DOI 10.1136/ard.2009.109983; van Vollenhoven RF, 2009, LANCET, V374, P459, DOI 10.1016/S0140-6736(09)60944-2; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P1443, DOI 10.1136/ard.2007.071092	10	33	39	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 8	2009	374	9688					430	432		10.1016/S0140-6736(09)61432-X	http://dx.doi.org/10.1016/S0140-6736(09)61432-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482OK	19665630				2022-12-28	WOS:000268898400005
J	Kleindienst, TE				Kleindienst, Tadeusz E.			Epoxying Isoprene Chemistry	SCIENCE			English	Editorial Material							SECONDARY ORGANIC AEROSOL; PHOTOOXIDATION; OZONE		US EPA, Natl Exposure Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency	Kleindienst, TE (corresponding author), US EPA, Natl Exposure Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	kleindienst.tad@epa.gov						Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; Dillon TJ, 2008, ATMOS CHEM PHYS, V8, P4877, DOI 10.5194/acp-8-4877-2008; Edney EO, 2005, ATMOS ENVIRON, V39, P5281, DOI 10.1016/j.atmosenv.2005.05.031; FinlaysonPitts BJ, 1997, SCIENCE, V276, P1045, DOI 10.1126/science.276.5315.1045; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Henze DK, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025976; Hofzumahaus A, 2009, SCIENCE, V324, P1702, DOI 10.1126/science.1164566; Jenkin ME, 2008, PHYS CHEM CHEM PHYS, V10, P4274, DOI 10.1039/b802898b; Kalberer M, 2004, SCIENCE, V303, P1659, DOI 10.1126/science.1092185; Kroll JH, 2006, ENVIRON SCI TECHNOL, V40, P1869, DOI 10.1021/es0524301; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Paulot F, 2009, SCIENCE, V325, P730, DOI 10.1126/science.1172910; PEETERS J, 2009, PHYS CHEM CHEM PHYS, V11; Reeves CE, 2003, CHEM REV, V103, P5199, DOI 10.1021/cr0205053; Ren XR, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009166; Thornton JA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000932	16	5	5	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					687	688		10.1126/science.1178324	http://dx.doi.org/10.1126/science.1178324			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661409				2022-12-28	WOS:000268723700027
J	Lefevre, F; Forget, F				Lefevre, Franck; Forget, Francois			Observed variations of methane on Mars unexplained by known atmospheric chemistry and physics	NATURE			English	Article							MARTIAN DUST DEVILS; INTERANNUAL VARIABILITY; OXIDANT ENHANCEMENT; STORMS; ORIGIN; LIFE	The detection of methane on Mars(1-3) has revived the possibility of past or extant life on this planet, despite the fact that an abiogenic origin is thought to be equally plausible(4). An intriguing aspect of the recent observations of methane on Mars is that methane concentrations appear to be locally enhanced and change with the seasons(3). However, methane has a photochemical lifetime of several centuries, and is therefore expected to have a spatially uniform distribution on the planet(5). Here we use a global climate model of Mars with coupled chemistry(6-8) to examine the implications of the recently observed variations of Martian methane for our understanding of the chemistry of methane. We find that photochemistry as currently understood does not produce measurable variations in methane concentrations, even in the case of a current, local and episodic methane release. In contrast, we find that the condensation-sublimation cycle of Mars' carbon dioxide atmosphere can generate large-scale methane variations differing from those observed. In order to reproduce local methane enhancements similar to those recently reported(3), we show that an atmospheric lifetime of less than 200 days is necessary, even if a local source of methane is only active around the time of the observation itself. This implies an unidentified methane loss process that is 600 times faster than predicted by standard photochemistry. The existence of such a fast loss in the Martian atmosphere is difficult to reconcile with the observed distribution of other trace gas species. In the case of a destruction mechanism only active at the surface of Mars, destruction of methane must occur with an even shorter timescale of the order of similar to 1 hour to explain the observations. If recent observations of spatial and temporal variations of methane are confirmed, this would suggest an extraordinarily harsh environment for the survival of organics on the planet.	[Lefevre, Franck] Univ Paris 06, CNRS, LATMOS, F-75005 Paris, France; [Forget, Francois] Univ Paris 06, CNRS, Meteorol Dynam Lab, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Lefevre, F (corresponding author), Univ Paris 06, CNRS, LATMOS, F-75005 Paris, France.	franck.lefevre@upmc.fr			CNRS; ESA; CNES	CNRS(Centre National de la Recherche Scientifique (CNRS)); ESA(European Space Agency); CNES(Centre National D'etudes Spatiales)	The LMD Martian global climate model has been developed with the support of CNRS, ESA and CNES. We thank R. M. Haberle and F. Montmessin for their contributions to an early phase of this work, as well as P.- Y. Meslin and R. Wordsworth for discussions.	Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Atreya SK, 2006, ASTROBIOLOGY, V6, P439, DOI 10.1089/ast.2006.6.439; Clancy RT, 2004, ICARUS, V168, P116, DOI 10.1016/j.icarus.2003.12.003; Davila AF, 2008, EARTH PLANET SC LETT, V272, P456, DOI 10.1016/j.epsl.2008.05.015; Delory GT, 2006, ASTROBIOLOGY, V6, P451, DOI 10.1089/ast.2006.6.451; Farrell WM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027210; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; FORGET F, 2008, 3 WORKSH MARS MOD OB; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Geminale A, 2008, PLANET SPACE SCI, V56, P1194, DOI 10.1016/j.pss.2008.03.004; GOUGH RV, 2009, 40 LUN PLAN SCI C; Hurowitz JA, 2007, EARTH PLANET SC LETT, V255, P41, DOI 10.1016/j.epsl.2006.12.004; Keir RS, 2005, DEEP-SEA RES PT I, V52, P1043, DOI 10.1016/j.dsr.2004.12.006; Kok JF, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036691; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Krasnopolsky VA, 2006, ICARUS, V180, P359, DOI 10.1016/j.icarus.2005.10.015; Lefevre F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002268; Lefevre F, 2008, NATURE, V454, P971, DOI 10.1038/nature07116; Melnik O, 1998, J GEOPHYS RES-SPACE, V103, P29107, DOI 10.1029/98JA01954; Montabone L, 2005, ADV SPACE RES-SERIES, V36, P2146, DOI 10.1016/j.asr.2005.07.047; MUMMA M, 2008, 3 WORKSH MARS MOD OB; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Sander S. P., 2006, JPL PUBLICATION; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Smith MD, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003288; Solomon S., 2007, PHYS SCI BASIS WORKI; Sprague AL, 2004, SCIENCE, V306, P1364, DOI 10.1126/science.1098496; SPRAGUE AL, 2007, J GEOPHYS RES-PLANET, V112; Summers ME, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015377; Wong AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002003	30	172	172	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					720	723		10.1038/nature08228	http://dx.doi.org/10.1038/nature08228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661912				2022-12-28	WOS:000268670300034
J	Wannamaker, PE; Caldwell, TG; Jiracek, GR; Maris, V; Hill, GJ; Ogawa, Y; Bibby, HM; Bennie, SL; Heise, W				Wannamaker, Philip E.; Caldwell, T. Grant; Jiracek, George R.; Maris, Virginie; Hill, Graham J.; Ogawa, Yasuo; Bibby, Hugh M.; Bennie, Stewart L.; Heise, Wiebke			Fluid and deformation regime of an advancing subduction system at Marlborough, New Zealand	NATURE			English	Article							SOUTH ISLAND; FAULT SYSTEM; SEISMICITY; BENEATH; ALPS	Newly forming subduction zones on Earth can provide insights into the evolution of major fault zone geometries from shallow levels to deep in the lithosphere and into the role of fluids in element transport and in promoting rock failure by several modes(1,2). The transpressional subduction regime of New Zealand, which is advancing laterally to the southwest below the Marlborough strike-slip fault system of the northern South Island(3,4), is an ideal setting in which to investigate these processes. Here we acquired a dense, high-quality transect of magnetotelluric soundings across the system, yielding an electrical resistivity cross-section to depths beyond 100 km. Our data imply three distinct processes connecting fluid generation along the upper mantle plate interface to rock deformation in the crust as the subduction zone develops. Massive fluid release just inland of the trench induces fault-fracture meshes through the crust above that undoubtedly weaken it as regional shear initiates. Narrow strike-slip faults in the shallow brittle regime of interior Marlborough diffuse in width upon entering the deeper ductile domain aided by fluids and do not project as narrow deformation zones. Deep subduction-generated fluids rise from 100 km or more and invade upper crustal seismogenic zones that have exhibited historic great earthquakes on high-angle thrusts that are poorly oriented for failure under dry conditions. The fluid-deformation connections described in our work emphasize the need to include metamorphic and fluid transport processes in geodynamic models.	[Wannamaker, Philip E.] Univ Utah, Energy & Geosci Inst, Salt Lake City, UT 84108 USA; [Caldwell, T. Grant; Hill, Graham J.; Bibby, Hugh M.; Bennie, Stewart L.; Heise, Wiebke] GNS Sci, Wellington 6315, New Zealand; [Jiracek, George R.] San Diego State Univ, Dept Geol Sci, San Diego, CA 92182 USA; [Maris, Virginie] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Ogawa, Yasuo] Tokyo Inst Technol, Volcan Fluid Res Ctr, Meguro Ku, Tokyo 1528551, Japan	Utah System of Higher Education; University of Utah; GNS Science - New Zealand; California State University System; San Diego State University; Utah System of Higher Education; University of Utah; Tokyo Institute of Technology	Wannamaker, PE (corresponding author), Univ Utah, Energy & Geosci Inst, 423 Wakara Way,Suite 300, Salt Lake City, UT 84108 USA.	pewanna@egi.utah.edu	Ogawa, Yasuo/B-4094-2009	Ogawa, Yasuo/0000-0002-6663-401X; Wannamaker, Phil/0000-0001-5744-6474	US National Science Foundation [EAR0440050]; New Zealand Foundation for Research, Science and Technology	US National Science Foundation(National Science Foundation (NSF)); New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	This research was supported by the Geophysics program of the US National Science Foundation (grant EAR0440050), and the Plate Boundary program of the New Zealand Foundation for Research, Science and Technology. W. Hales of Alpine Springs Helicopters provided an airborne transport service to remote locations of the Marlborough and Westland regions. We thank B. Freer, C. Davis and P. Thorton of the New Zealand Department of Conservation, and numerous private landholders, for permission to access site locations. Additional field assistance was given by students M. Burgess and P. Winther. Many discussions were held with D. Eberhart-Phillips, R. Sibson and P. Upton. Illustrations were finalized by D. Jensen.	Beavan J, 2007, GEOPHYS MONOGR SER, V175, P75, DOI 10.1029/175GM05; Becken M, 2008, GEOPHYS J INT, V173, P718, DOI 10.1111/j.1365-246X.2008.03754.x; Booker JR, 2004, NATURE, V429, P399, DOI 10.1038/naturt02565; Bourne SJ, 1998, NATURE, V391, P655, DOI 10.1038/35556; Brasse H, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005142.2008; Caldwell TG, 2004, GEOPHYS J INT, V158, P457, DOI 10.1111/j.1365-246X.2004.02281.x; Cox SF, 1999, GEOL SOC SPEC PUBL, V155, P123, DOI 10.1144/GSL.SP.1999.155.01.10; COX SF, 2005, SOC EC GEOL 100 ANNI, P39; Davey FJ, 2007, GEOPHYS MONOGR SER, V175, P47, DOI 10.1029/175GM04; Eberhart-Phillips D, 2004, GEOPHYS J INT, V156, P237, DOI 10.1046/j.1365-246X.2003.02044.x; Eberhart-Phillips D, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005359; Furlong KP, 2007, GEOL SOC AM SPEC PAP, V434, P1, DOI 10.1130/2007.2434(01); GHISETTI FC, 1994, J STRUCT GEOL, V28, P2007; Heise W, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029629; Jiracek G.R., 2007, GEOPHYS MONOGR SER A, V175, P75; JONES AG, 1989, J GEOPHYS RES-SOLID, V94, P14201, DOI 10.1029/JB094iB10p14201; Jones AG, 1999, LITHOS, V48, P57, DOI 10.1016/S0024-4937(99)00022-5; Jongens R, 2006, NEW ZEAL J GEOL GEOP, V49, P443, DOI 10.1080/00288306.2006.9515180; Mason DPM, 2006, GEOL SOC AM BULL, V118, P1431, DOI 10.1130/B25961.1; Mortimer N, 2004, GONDWANA RES, V7, P261, DOI 10.1016/S1342-937X(05)70324-5; Nicol A, 2002, J STRUCT GEOL, V24, P1521, DOI 10.1016/S0191-8141(01)00141-9; Ogawa Y, 2004, EARTH PLANETS SPACE, V56, P1285, DOI 10.1186/BF03353352; Patro PK, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035326; PEACOCK SM, 2003, AM GEOPHYS UNION GEO, V138, P7; PETIAU G, 1980, GEOPHYS PROSPECT, V28, P792, DOI 10.1111/j.1365-2478.1980.tb01261.x; Reyners M, 2007, NATURE, V446, P1075, DOI 10.1038/nature05743; Schellart WP, 2007, NATURE, V446, P308, DOI 10.1038/nature05615; Sibson RH, 2007, GEOL SOC SPEC PUBL, V272, P519, DOI 10.1144/GSL.SP.2007.272.01.26; Stern RJ, 2004, EARTH PLANET SC LETT, V226, P275, DOI 10.1016/j.epsl.2004.08.007; Upton P, 2007, GEOPHYS MONOGR SER, V175, P253, DOI 10.1029/175GM13; Vozoff K., 1991, ELECTROMAGNETIC METH, P641, DOI [10.1190/1.1444178, DOI 10.1190/1.1444178]; Walcott RI, 1998, REV GEOPHYS, V36, P1, DOI 10.1029/97RG03084; Wannamaker PE, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000186; Wannamaker PE, 1999, GEOPHYS DEV SER, V7, P349; WANNAMAKER PE, 2004, P WORKSH GEOTH RES E, P1; Wannamaker PE, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001886; WESNOUSKY SG, 1990, B SEISMOL SOC AM, V80, P1374; Wilson CK, 2004, GEOLOGY, V32, P837, DOI 10.1130/G20657.1	38	174	176	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					733	U90		10.1038/nature08204	http://dx.doi.org/10.1038/nature08204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661914				2022-12-28	WOS:000268670300037
J	Young, GB				Young, G. Bryan			Neurologic Prognosis after Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEURON-SPECIFIC ENOLASE; COMATOSE SURVIVORS; CARDIOPULMONARY-RESUSCITATION; MISMATCH NEGATIVITY; STATUS EPILEPTICUS; COST-EFFECTIVENESS; PREDICTION; BRAIN; DEFIBRILLATORS; SPECTROSCOPY	A 55-year-old man collapses while jogging through the park. A bystander finds him unconscious and without a pulse and initiates cardiopulmonary resuscitation (CPR) while an ambulance is summoned. On arrival in the emergency room, the patient is in ventricular fibrillation; the partial pressure of oxygen in arterial blood is 200 mm Hg, the pH is 7.25, and the bicarbonate level is 18 mmol per liter. Spontaneous circulation is reestablished, but he remains comatose with absent pupillary reflexes. He is then treated with hypothermia, achieving a core temperature of 34 degrees C in 4 hours, which is maintained for 24 hours, after which he remains unconscious. What would you advise regarding his neurologic prognosis?	[Young, G. Bryan] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Young, G. Bryan] Univ Western Ontario, Dept Med, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Young, GB (corresponding author), Univ Western Ontario Hosp, Rm B10-106,339 Windermere Rd, London, ON N6A 5A5, Canada.	bryan.young@lhsc.on.ca						Al Thenayan E, 2008, NEUROLOGY, V71, P1535, DOI 10.1212/01.wnl.0000334205.81148.31; Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; Arbelaez A, 1999, AM J NEURORADIOL, V20, P999; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BEREK K, 1995, STROKE, V26, P543, DOI 10.1161/01.STR.26.4.543; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bleck TP, 2006, NEUROLOGY, V67, P556, DOI 10.1212/01.wnl.0000237019.78248.27; Callans DJ, 2004, NEW ENGL J MED, V351, P632, DOI 10.1056/NEJMp048174; Chausson N, 2008, REV NEUROL-FRANCE, V164, pF34; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; Chen R, 1996, CRIT CARE MED, V24, P1277; EARNEST MP, 1979, NEUROLOGY, V29, P56, DOI 10.1212/WNL.29.1.56; EDGREN E, 1987, CRIT CARE MED, V15, P820, DOI 10.1097/00003246-198709000-00004; Els T, 2004, ACTA NEUROL SCAND, V110, P361, DOI 10.1111/j.1600-0404.2004.00342.x; Gendo A, 2001, INTENS CARE MED, V27, P1305, DOI 10.1007/s001340101008; Gofton TE, 2009, EXP NEUROL, V217, P320, DOI 10.1016/j.expneurol.2009.03.011; Groeneveld PW, 2001, JAMA-J AM MED ASSOC, V286, P1482, DOI 10.1001/jama.286.12.1482; Herlitz J, 2000, EUR HEART J, V21, P1251, DOI 10.1053/euhj.2000.2150; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hovland A, 2006, RESUSCITATION, V68, P143, DOI 10.1016/j.resuscitation.2005.05.019; KANO T, 1992, RESUSCITATION, V23, P235, DOI 10.1016/0300-9572(92)90007-Y; KRUMHOLZ A, 1988, NEUROLOGY, V38, P401, DOI 10.1212/WNL.38.3.401; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; MARTIN GB, 1991, STROKE, V22, P462, DOI 10.1161/01.STR.22.4.462; Mell HK, 2008, PROG CARDIOVASC DIS, V51, P204, DOI 10.1016/j.pcad.2008.05.003; Morrow SA, 2007, NEUROCRIT CARE, V6, P45, DOI 10.1385/NCC:6:1:45; *MULT TASK FORC PV, 1995, NEW ENGL J MED, V333, P130; Niskanen M, 2007, ACTA ANAESTH SCAND, V51, P151, DOI 10.1111/j.1399-6576.2006.01182.x; Pusswald G, 2000, RESUSCITATION, V47, P241, DOI 10.1016/S0300-9572(00)00240-9; Rech TH, 2006, CRIT CARE, V10, DOI 10.1186/cc5046; ROGOVE HJ, 1995, CRIT CARE MED, V23, P18, DOI 10.1097/00003246-199501000-00007; Rossetti AO, 2009, NEUROLOGY, V72, P744, DOI 10.1212/01.wnl.0000343006.60851.62; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Schaafsma A, 2003, J NEUROL SCI, V210, P23, DOI 10.1016/S0022-510X(03)00063-7; Schoerkhuber W, 1999, STROKE, V30, P1598, DOI 10.1161/01.STR.30.8.1598; Sukhija R, 2007, CLIN CARDIOL, V30, P3, DOI 10.1002/clc.20001; Torbey MT, 2000, STROKE, V31, P2163, DOI 10.1161/01.STR.31.9.2163; Wartenberg KE, 2004, J NEUROIMAGING, V14, P180, DOI 10.1177/1051228403259514; WASTERLAIN CG, 1993, EPILEPSIA, V34, pS37, DOI 10.1111/j.1528-1157.1993.tb05905.x; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; WIJDICKS EFM, 1994, ANN NEUROL, V35, P239, DOI 10.1002/ana.410350219; Wijdicks EFM, 2001, AM J NEURORADIOL, V22, P1561; Wijman CAC, 2009, ANN NEUROL, V65, P394, DOI 10.1002/ana.21632; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; WU O, RADIOLOGY IN PRESS; Young GB, 2005, NEUROCRIT CARE, V2, P159, DOI 10.1385/NCC:2:2:159; YOUNG GB, 1990, NEUROLOGY, V40, P1843, DOI 10.1212/WNL.40.12.1843; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88; ZANDBERGEN EGJ, 2006, THESIS U AMSTERDAM A; Zingler VC, 2003, EUR NEUROL, V49, P79, DOI 10.1159/000068503	52	192	214	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					605	611		10.1056/NEJMcp0903466	http://dx.doi.org/10.1056/NEJMcp0903466			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479NR	19657124				2022-12-28	WOS:000268667300010
J	Brackbill, RM; Hadler, JL; DiGrande, L; Ekenga, CC; Farfel, MR; Friedman, S; Perlman, SE; Stellman, SD; Walker, DJ; Wu, D; Yu, SC; Thorpe, LE				Brackbill, Robert M.; Hadler, James L.; DiGrande, Laura; Ekenga, Christine C.; Farfel, Mark R.; Friedman, Stephen; Perlman, Sharon E.; Stellman, Steven D.; Walker, Deborah J.; Wu, David; Yu, Shengchao; Thorpe, Lorna E.			Asthma and Posttraumatic Stress Symptoms 5 to 6 Years Following Exposure to the World Trade Center Terrorist Attack	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK-CITY; CENTER HEALTH REGISTRY; DISASTER VICTIMS SPEAK; 11 SEPTEMBER 2001; PSYCHOMETRIC PROPERTIES; RESPIRATORY SYMPTOMS; RECOVERY WORKERS; PTSD CHECKLIST; RISK-FACTORS; CENTER SITE	Context The World Trade Center Health Registry provides a unique opportunity to examine long-term health effects of a large-scale disaster. Objective To examine risk factors for new asthma diagnoses and event-related post-traumatic stress (PTS) symptoms among exposed adults 5 to 6 years following exposure to the September 11, 2001, World Trade Center (WTC) terrorist attack. Design, Setting, and Participants Longitudinal cohort study with wave 1 (W1) enrollment of 71 437 adults in 2003-2004, including rescue/recovery worker, lower Manhattan resident, lower Manhattan office worker, and passersby eligibility groups; 46 322 adults (68%) completed the wave 2 (W2) survey in 2006-2007. Main Outcome Measures Self-reported diagnosed asthma following September 11; event-related current PTS symptoms indicative of probable posttraumatic stress disorder (PTSD), assessed using the PTSD Checklist (cutoff score >= 44). Results Of W2 participants with no stated asthma history, 10.2% (95% confidence interval [CI], 9.9%-10.5%) reported new asthma diagnoses postevent. Intense dust cloud exposure on September 11 was a major contributor to new asthma diagnoses for all eligibility groups: for example, 19.1% vs 9.6% in those without exposure among rescue/recovery workers (adjusted odds ratio, 1.5 [ 95% CI, 1.4-1.7]). Asthma risk was highest among rescue/recovery workers on the WTC pile on September 11 (20.5% [ 95% CI, 19.0%-22.0%]). Persistent risks included working longer at the WTC site, not evacuating homes, and experiencing a heavy layer of dust in home or office. Of participants with no PTSD history, 23.8% ( 95% CI, 23.4%-24.2%) reported PTS symptoms at either W1(14.3%) or W2 (19.1%). Nearly 10% ( 9.6% [ 95% CI, 9.3%-9.8%]) had PTS symptoms at both surveys, 4.7% ( 95% CI, 4.5%-4.9%) had PTS symptoms at W1 only, and 9.5% ( 95% CI, 9.3%-9.8%) had PTS symptoms at W2 only. At W2, passersby had the highest rate of PTS symptoms (23.2% [ 95% CI, 21.4%-25.0%]). Event-related loss of spouse or job was associated with PTS symptoms at W2. Conclusion Acute and prolonged exposures were both associated with a large burden of asthma and PTS symptoms 5 to 6 years after the September 11 WTC attack. JAMA. 2009;302(5):502-516 www.jama.com	[Hadler, James L.; DiGrande, Laura; Ekenga, Christine C.; Farfel, Mark R.; Friedman, Stephen; Perlman, Sharon E.; Stellman, Steven D.; Walker, Deborah J.; Wu, David; Yu, Shengchao; Thorpe, Lorna E.] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA; [Brackbill, Robert M.] Ctr Dis Control & Prevent, Agcy Tox Subst & Dis Registry, Atlanta, GA USA; [Stellman, Steven D.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA; Columbia University	Thorpe, LE (corresponding author), New York City Dept Hlth & Mental Hyg, 125 Worth St,Room 315, New York, NY 10013 USA.	lthorpe@health.nyc.gov	Walker, Deborah/GSE-2426-2022	DiGrande, Laura/0000-0002-7742-0164	Agency for Toxic Substances and Disease Registry (ATSDR) of the Centers for Disease Control and Prevention (CDC) [U50/ATU272750]; National Center for Environmental Health (NCEH); New York City Department of Health and Mental Hygiene (NYCDOHMH)	Agency for Toxic Substances and Disease Registry (ATSDR) of the Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Environmental Health (NCEH); New York City Department of Health and Mental Hygiene (NYCDOHMH)	This study was supported by Cooperative Agreement U50/ATU272750 from the Agency for Toxic Substances and Disease Registry (ATSDR) of the Centers for Disease Control and Prevention (CDC), which included support from the National Center for Environmental Health (NCEH), and by the New York City Department of Health and Mental Hygiene (NYCDOHMH).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Banauch GI, 2006, AM J RESP CRIT CARE, V174, P312, DOI 10.1164/rccm.200511-1736OC; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brackbill Robert M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brewin CR, 2008, J TRAUMA STRESS, V21, P3, DOI 10.1002/jts.20310; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; Buyantseva LV, 2007, J OCCUP ENVIRON MED, V49, P310, DOI 10.1097/JOM.0b013e318032256e; Daly ES, 2008, J TRAUMA STRESS, V21, P227, DOI 10.1002/jts.20311; de la Hoz RE, 2008, INT ARCH OCC ENV HEA, V81, P479, DOI 10.1007/s00420-007-0240-x; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Fagan J, 2003, PSYCHOSOM MED, V65, P993, DOI 10.1097/01.PSY.0000097334.48556.5F; Farfel M, 2008, J URBAN HEALTH, V85, P880, DOI 10.1007/s11524-008-9317-4; Friedman S, 2008, CITY HLTH INFORM, V27, P41; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Galea S, 2008, EPIDEMIOLOGY, V19, P47, DOI 10.1097/EDE.0b013e31815c1dbf; GAUTRIN D, 2006, ASTHMA WORKPLACE REL; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Herbstman JB, 2005, ENVIRON RES, V99, P85, DOI 10.1016/j.envres.2004.08.010; Hobfoll SE, 2006, J TRAUMA STRESS, V19, P867, DOI 10.1002/jts.20166; Izbicki G, 2007, CHEST, V131, P1414, DOI 10.1378/chest.06-2114; King LA, 1998, J PERS SOC PSYCHOL, V74, P420, DOI 10.1037/0022-3514.74.2.420; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Lin S, 2007, J ASTHMA, V44, P325, DOI 10.1080/02770900701344181; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Lioy PJ, 2006, ENVIRON SCI TECHNOL, V40, P6876, DOI 10.1021/es062980e; Lioy PJ, 2006, ANN NY ACAD SCI, V1076, P54, DOI 10.1196/annals.1371.002; Litz B.T, 1993, PTSD CHECKL PCL REL; Lombardo LJ, 2000, ENVIRON HEALTH PERSP, V108, P697, DOI 10.2307/3454406; Murphy J, 2007, STAT MED, V26, P1688, DOI 10.1002/sim.2806; Nandi A, 2004, J OCCUP ENVIRON MED, V46, P1057, DOI 10.1097/01.jom.0000141663.22902.0a; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 2002, PSYCHIATRY, V65, P240, DOI 10.1521/psyc.65.3.240.20169; North Carol S, 2004, Ann Clin Psychiatry, V16, P209, DOI 10.1080/10401230490522034; North CS, 2002, J URBAN HEALTH, V79, P383, DOI 10.1093/jurban/79.3.383; Perrin MA, 2007, AM J PSYCHIAT, V164, P1385, DOI 10.1176/appi.ajp.2007.06101645; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Reibman J, 2009, J OCCUP ENVIRON MED, V51, P534, DOI 10.1097/JOM.0b013e3181a0365b; Rodriguez JJ, 2008, CURR OPIN PSYCHIATR, V21, P370, DOI 10.1097/YCO.0b013e328304d984; Rudd RA, 2007, J ASTHMA, V44, P65, DOI 10.1080/02770900601125896; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Skloot GS, 2009, CHEST, V135, P492, DOI 10.1378/chest.08-1391; Thomas PA, 2008, ENVIRON HEALTH PERSP, V116, P1383, DOI 10.1289/ehp.11205; Ventureyra VAG, 2002, PSYCHOTHER PSYCHOSOM, V71, P47, DOI 10.1159/000049343; Verger P, 2004, AM J PSYCHIAT, V161, P1384, DOI 10.1176/appi.ajp.161.8.1384; Wagner VL, 2005, J URBAN HEALTH, V82, P76, DOI 10.1093/jurban/jti010; Webber MP, 2009, ENVIRON HEALTH PERSP, V117, P975, DOI 10.1289/ehp.0800291; Wheeler K, 2007, ENVIRON HEALTH PERSP, V115, P1584, DOI 10.1289/ehp.10248; *WORLD TRAD CTR HL, 2006, SAMPL BUILD DEN EST	52	260	260	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					502	516		10.1001/jama.2009.1121	http://dx.doi.org/10.1001/jama.2009.1121			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479DS	19654385	Green Published			2022-12-28	WOS:000268640500015
J	Heath, I				Heath, Iona			Life and Death Dirty work	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												aque22@dsl.pipex.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2009	339								b3149	10.1136/bmj.b3149	http://dx.doi.org/10.1136/bmj.b3149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KA	19651698				2022-12-28	WOS:000268807700004
J	Jackson, ST; Hobbs, RJ				Jackson, Stephen T.; Hobbs, Richard J.			Ecological Restoration in the Light of Ecological History	SCIENCE			English	Editorial Material							MANAGEMENT; VEGETATION; PALEOECOLOGY; ECOSYSTEMS; FLORIDA; FACE	Ecological history plays many roles in ecological restoration, most notably as a tool to identify and characterize appropriate targets for restoration efforts. However, ecological history also reveals deep human imprints on many ecological systems and indicates that secular climate change has kept many targets moving at centennial to millennial time scales. Past and ongoing environmental changes ensure that many historical restoration targets will be unsustainable in the coming decades. Ecological restoration efforts should aim to conserve and restore historical ecosystems where viable, while simultaneously preparing to design or steer emerging novel ecosystems to ensure maintenance of ecological goods and services.	[Jackson, Stephen T.] Univ Wyoming, Dept Bot & Program Ecol, Laramie, WY 82071 USA; [Hobbs, Richard J.] Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia	University of Wyoming; University of Western Australia	Jackson, ST (corresponding author), Univ Wyoming, Dept Bot & Program Ecol, Laramie, WY 82071 USA.	Jackson@uwyo.edu; rhobbs@cyllene.uwa.edu.au	Hobbs, Richard J/F-5883-2010	Hobbs, Richard J/0000-0003-4047-3147; Jackson, Stephen/0000-0002-1487-4652				Black BA, 2006, CAN J FOREST RES, V36, P1266, DOI 10.1139/X06-027; Bowman DMJS, 1998, NEW PHYTOL, V140, P385, DOI [10.1046/j.1469-8137.1998.00289.x, 10.1111/j.1469-8137.1998.00289.x]; Burney DA, 2007, FRONT ECOL ENVIRON, V5, P483, DOI 10.1890/070051; Bush MB, 2007, FRONT ECOL ENVIRON, V5, P457, DOI 10.1890/070018; Chambers FM, 2007, BIODIVERS CONSERV, V16, P2821, DOI 10.1007/s10531-007-9169-3; Dambrine E, 2007, ECOLOGY, V88, P1430, DOI 10.1890/05-1314; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Gorham E, 2003, WETL ECOL MANAG, V11, P109, DOI 10.1023/A:1022065723511; Hobbs RJ, 2008, ANNU REV ENV RESOUR, V33, P39, DOI 10.1146/annurev.environ.33.020107.113631; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Huxley Thomas, 1869, NATURE, V1, P9, DOI [10.1038/001009a0, DOI 10.1038/001009A0]; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson ST, 2006, J VEG SCI, V17, P549, DOI 10.1111/j.1654-1103.2006.tb02478.x; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; MOTZKIN G, 2004, FORESTS TIME; Naveh Z, 2005, RESTOR ECOL, V13, P228, DOI 10.1111/j.1526-100X.2005.00028.x; *NOAA NAT CLIM DAT, PAL; Peterken GF, 1999, GLOBAL ECOL BIOGEOGR, V8, P321, DOI 10.1046/j.1365-2699.1999.00140.x; Schelske CL, 2005, AMBIO, V34, P192, DOI 10.1639/0044-7447(2005)034[0192:ABRTHA]2.0.CO;2; Schindler DE, 2001, ECOSYSTEMS, V4, P308, DOI 10.1007/s10021-001-0013-4; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Shuman B, 2009, ECOLOGY, V90, P2792, DOI 10.1890/08-0985.1; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; Vale T.R., 2002, FIRE NATIVE PEOPLES; Willard DA, 2007, FRONT ECOL ENVIRON, V5, P491, DOI 10.1890/070015; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045	29	370	403	15	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					567	569		10.1126/science.1172977	http://dx.doi.org/10.1126/science.1172977			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	477BY	19644108				2022-12-28	WOS:000268493000036
J	Van den Block, L; Deschepper, R; Bilsen, J; Bossuyt, N; Van Casteren, V; Deliens, L				Van den Block, Lieve; Deschepper, Reginald; Bilsen, Johan; Bossuyt, Nathalie; Van Casteren, Viviane; Deliens, Luc			Euthanasia and other end of life decisions and care provided in final three months of life: nationwide retrospective study in Belgium	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICIAN-ASSISTED SUICIDE; 6 EUROPEAN COUNTRIES; PALLIATIVE CARE; MEDICAL-PRACTICE; NETWORK; PRACTITIONERS; FLANDERS; DEATH	Objective To explore the relation between the care provided in the final three months of life and the prevalence and types of end of life decisions in Belgium. Design Two year nationwide retrospective study, 2005-6 (SENTI-MELC study). Setting Data collection via the sentinel network of general practitioners, an epidemiological surveillance system representative of all general practitioners in Belgium. Subjects 1690 non-sudden deaths in practices of the sentinel general practitioners. Main outcome measures Non-sudden deaths of patients (aged >1 year) reported each week. Reported care provided in the final three months of life and the end of life decisions made. Multivariable regression analysis controlled for age, sex, cause, and place of death. Results Use of specialist multidisciplinary palliative care services was associated with intensified alleviation of symptoms (odds ratio 2.1, 95% confidence interval 1.6 to 2.6), continuous deep sedation forgoing food/fluid (2.9, 1.7 to 4.9), and the total of decisions explicitly intended to shorten life (1.5, 1.1 to 2.1) but not with euthanasia or physician assisted suicide in particular. To a large extent receiving spiritual care was associated with higher frequencies of euthanasia or physician assisted suicide than receiving little spiritual care (18.5, 2.0 to 172.7). Conclusions End of life decisions that shorten life, including euthanasia or physician assisted suicide, are not related to a lower use of palliative care in Belgium and often occur within the context of multidisciplinary care.	[Van den Block, Lieve; Deschepper, Reginald; Bilsen, Johan; Deliens, Luc] Vrije Univ Brussel, End Life Care Res Grp, B-1090 Brussels, Belgium; [Van den Block, Lieve] Vrije Univ Brussel, Dept Gen Practice, B-1090 Brussels, Belgium; [Bossuyt, Nathalie; Van Casteren, Viviane] Sci Inst Publ Hlth, Dept Epidemiol, B-1040 Brussels, Belgium; [Bilsen, Johan] Vrije Univ Brussel, Dept Publ Hlth, B-1090 Brussels, Belgium; [Deliens, Luc] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, NL-1007 MB Amsterdam, Netherlands; [Deschepper, Reginald] Vrije Univ Brussel, Dept Crit Care, B-1090 Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Amsterdam; Vrije Universiteit Brussel	Van den Block, L (corresponding author), Vrije Univ Brussel, End Life Care Res Grp, Laarbeeklaan 103, B-1090 Brussels, Belgium.	lvdblock@vub.ac.be	Van den Block, Lieve/D-1247-2011; Deschepper, Reginald/B-8103-2013	Van den Block, Lieve/0000-0002-7770-348X; Deschepper, Reginald/0000-0002-4222-3945; Deliens, Luc/0000-0002-8158-2422; Bossuyt, Nathalie/0000-0002-4213-9209	Fund for Scientific Research in Flanders, Belgium; Research Council of the Vrije Universiteit Brussel in Belgium [GOA27 20032007]; Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project (SBO) [050158]; Flemish and Walloon Ministry of Welfare, Public Health and Family	Fund for Scientific Research in Flanders, Belgium; Research Council of the Vrije Universiteit Brussel in Belgium; Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project (SBO); Flemish and Walloon Ministry of Welfare, Public Health and Family	LVdB is a postdoctoral researcher of the Fund for Scientific Research in Flanders, Belgium. This study was funded by the Research Council of the Vrije Universiteit Brussel in Belgium ( project GOA27 20032007) and the Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project (SBO) ( contract SBO IWT 050158) (2006- 2010), as part of the Monitoring Quality of End-of-Life Care ( MELC) Study. The Belgian Sentinel Network of GPs is supported by the Flemish and Walloon Ministry of Welfare, Public Health and Family. The sponsors had no role in design and conduct of the study, in the collection, analysis, and interpretation of the data, in the writing of the report or in the decision to submit the article for publication. The researchers are independent from the funders. Competing interest: None declared.	BAYINGANA K, 2006, D200625054 SCI I PUB; Bernheim JL, 2008, BRIT MED J, V336, P864, DOI 10.1136/bmj.39497.397257.AD; BOFFIN N, 2007, 2007013 IPHEPI SCI I; Clark D, 2000, PALLIATIVE MED, V14, P479, DOI 10.1191/026921600701536408; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; Emanuel EJ, 2000, ANN INTERN MED, V133, P527, DOI 10.7326/0003-4819-133-7-200010030-00011; *FED EV PALL ZORG, 2005, EV PALL ZORG OV UITB; Hermsen MA, 2002, J PAIN SYMPTOM MANAG, V23, P517, DOI 10.1016/S0885-3924(02)00401-3; Hinkka H, 2002, J MED ETHICS, V28, P109, DOI 10.1136/jme.28.2.109; Kuhse H, 1997, MED J AUSTRALIA, V166, P191, DOI 10.5694/j.1326-5377.1997.tb140074.x; LOBET MP, 1987, INT J EPIDEMIOL, V16, P612, DOI 10.1093/ije/16.4.612; Materstvedt LJ, 2003, PALLIATIVE MED, V17, P97, DOI 10.1191/0269216303pm673oa; Meier DE, 2003, ARCH INTERN MED, V163, P1537, DOI 10.1001/archinte.163.13.1537; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Miccinesi G, 2006, J PAIN SYMPTOM MANAG, V31, P122, DOI 10.1016/j.jpainsymman.2005.07.004; Onwuteaka-Philipsen BD, 2006, ARCH INTERN MED, V166, P921, DOI 10.1001/archinte.166.8.921; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; Quill TE, 2007, NEW ENGL J MED, V356, P1911, DOI 10.1056/NEJMp078061; SEALE C, 1995, SOC SCI MED, V40, P581, DOI 10.1016/0277-9536(94)00171-O; Seale C, 2006, PALLIATIVE MED, V20, P3, DOI 10.1191/0269216306pm1094oa; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Van den Block L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-69; Van den Block L, 2008, ARCH INTERN MED, V168, P1747, DOI 10.1001/archinte.168.16.1747; Van den Block L, 2007, JAMA-J AM MED ASSOC, V298, P1638, DOI 10.1001/jama.298.14.1638; Van den Block L, 2006, J CLIN ONCOL, V24, P2842, DOI 10.1200/JCO.2005.03.7531; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; VANDENBLOCK L, 2007, BMC PALLIAT CARE, V8, P6; Weide MCJV, 2005, ARCH INTERN MED, V165, P1698, DOI 10.1001/archinte.165.15.1698; World Health Organization, 2002, NAT CANC CONTR PROGR	29	42	42	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2009	339								b2772	10.1136/bmj.b2772	http://dx.doi.org/10.1136/bmj.b2772			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479PI	19643825	hybrid, Green Published			2022-12-28	WOS:000268673000002
J	McKee, M				McKee, Martin			The poisoning of Victor Yushchenko	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	martin.mckee@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683				CHIVERS CJ, 2005, NY TIMES        0117; MAKSYMIUK J, ANAL UKRAINIAN MEDIA; *OSCE, 2005, UKR PRES EL 31 OCT 2; Sorg O, 2009, LANCET, V374, P1179, DOI 10.1016/S0140-6736(09)60912-0; Watts G, 2007, LANCET, V370, P214, DOI 10.1016/S0140-6736(07)61111-8; Wilson A., 2000, UKRAINIANS UNEXPECTE; 2005, BBC NEWS        0309; 2004, BBC NEWS        1211	8	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 3	2009	374	9696					1131	1132		10.1016/S0140-6736(09)61027-8	http://dx.doi.org/10.1016/S0140-6736(09)61027-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505IZ	19660808				2022-12-28	WOS:000270688200010
J	Chan, JKK; Lovegrove, R; Dunckley, M; Woo, EK; Farouk, M				Chan, James K. K.; Lovegrove, Richard; Dunckley, Matt; Woo, Eric K.; Farouk, Marwan			Endgames Picture quiz Unusual computed tomography findings in a patient presenting with acute abdominal pain	BRITISH MEDICAL JOURNAL			English	Editorial Material							SHORT-BOWEL SYNDROME; MESENTERIC ISCHEMIA; VENOUS GAS; ADULTS; CT		[Chan, James K. K.; Lovegrove, Richard; Dunckley, Matt; Woo, Eric K.; Farouk, Marwan] Stoke Mandeville Hosp, Buckinghamshire NHS Trust, Aylesbury HP21 8AL, Bucks, England		Chan, JKK (corresponding author), Stoke Mandeville Hosp, Buckinghamshire NHS Trust, Aylesbury HP21 8AL, Bucks, England.	jackichan17@hotmail.com	Lovegrove, Richard/B-7421-2008	Lovegrove, Richard/0000-0003-4347-5607				Berland Todd, 2008, Curr Gastroenterol Rep, V10, P341, DOI 10.1007/s11894-008-0065-0; Hagspiel KD, 2002, RADIOL CLIN N AM, V40, P867, DOI 10.1016/S0033-8389(02)00027-1; KLEIN HM, 1995, RADIOLOGY, V197, P79, DOI 10.1148/radiology.197.1.7568858; Oldenburg WA, 2004, ARCH INTERN MED, V164, P1054, DOI 10.1001/archinte.164.10.1054; Peloponissios N, 2003, ARCH SURG-CHICAGO, V138, P1367, DOI 10.1001/archsurg.138.12.1367; Sreenarasimhaiah J, 2003, BRIT MED J, V326, P1372, DOI 10.1136/bmj.326.7403.1372; Sudan D, 2007, ANN SURG, V246, P593, DOI 10.1097/SLA.0b013e318155aa0c; Vanderhoof JA, 1997, GASTROENTEROLOGY, V113, P1767, DOI 10.1053/gast.1997.v113.pm9352883; Wiesner W, 2003, RADIOLOGY, V226, P635, DOI 10.1148/radiol.2263011540; Wiesner W, 2002, EUR RADIOL, V12, P1432, DOI 10.1007/s00330-001-1159-3; Wiesner W, 2001, AM J ROENTGENOL, V177, P1319, DOI 10.2214/ajr.177.6.1771319	11	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 19	2009	339								b3192	10.1136/bmj.b3192	http://dx.doi.org/10.1136/bmj.b3192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486SB	19692441				2022-12-28	WOS:000269216900009
J	Jackson, CE; Solomon, SD; Gerstein, HC; Zetterstrand, S; Olofsson, B; Michelson, EL; Granger, CB; Swedberg, K; Pfeffer, MA; Yusuf, S; McMurray, JJV				Jackson, Colette E.; Solomon, Scott D.; Gerstein, Hertzel C.; Zetterstrand, Sofia; Olofsson, Bertil; Michelson, Eric L.; Granger, Christopher B.; Swedberg, Karl; Pfeffer, Marc A.; Yusuf, Salim; McMurray, John J. V.		CHARM Investigators Comm	Albuminuria in chronic heart failure: prevalence and prognostic importance	LANCET			English	Article							CARDIOVASCULAR RISK; RENAL-FUNCTION; CLINICAL PROTEINURIA; BROAD-SPECTRUM; MORTALITY; MICROALBUMINURIA; MORBIDITY; DISEASE; CANDESARTAN; EVENTS	Background Increased excretion of albumin in urine might be a marker of the various pathophysiological changes that arise in patients with heart failure. Therefore our aim was to assess the prevalence and prognostic value of a spot urinary albumin to creatinine ratio (UACR) in patients with heart failure. Methods UACR was measured at baseline and during follow-up of 2310 patients in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme. The prevalence of microalbuminuria and macroalbuminuria, and the predictive value of UACR for the primary composite outcome of each CHARM study-ie, death from cardiovascular causes or admission to hospital with worsening heart failure-and death from any cause were assessed. Findings 1349 (58%) patients had a normal UACR 704 (30%) had microalbuminuria, and 257 (11%) had macroalbuminuria. The prevalence of increased UACR was similar in patients with reduced and preserved left ventricular ejection fractions. Patients with an increased UACR were older, had more cardiovascular comorbidity, worse renal function, and a higher prevalence of diabetes mellitus than did those with normoalbuminuria. However, a high prevalence of increased UACR was still noted among patients without diabetes, hypertension, or renal dysfunction. Elevated UACR was associated with increased risk of the composite outcome and death even after adjustment for other prognostic variables including renal function, diabetes, and haemoglobin A(1c). The adjusted hazard ratio (HR) for the composite outcome in patients with microalbuminuria versus normoalbuminuria was 1.43 (95% CI 1.21-1.69; p<0.0001) and for macroalbuminuria versus normoalbuminuria was 1.75 (1.39-2.20; p<0.0001). The adjusted values for death were 1.62 (1.32-1.99; p<0.0001) for microalbuminuria versus normoalbuminuria, and 1.76 (1.32-2.35; p=0.0001) for macroalbuminuria versus normoalbuminuria. Treatment with candesartan did not reduce or prevent the development of excessive excretion of urinary albumin. Interpretation Increased UACR is a powerful and independent predictor of prognosis in heart failure. Funding AstraZeneca.	[Jackson, Colette E.; McMurray, John J. V.] Univ Glasgow, Cardiovasc Res Ctr, British Heart Fdn, Glasgow G12 8TA, Lanark, Scotland; [Solomon, Scott D.; Pfeffer, Marc A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gerstein, Hertzel C.; Yusuf, Salim] McMaster Univ & Hamilton Hlth Sci, Dept Med, Hamilton, ON, Canada; [Gerstein, Hertzel C.; Yusuf, Salim] McMaster Univ & Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Zetterstrand, Sofia; Olofsson, Bertil] AstraZeneca Res & Dev, Molndal, Sweden; [Michelson, Eric L.] AstraZeneca, Wilmington, DE USA; [Granger, Christopher B.] Duke Univ, Med Ctr, Durham, NC USA; [Swedberg, Karl] Univ Gothenburg, Sahlgrenska Acad, Dept Emergency & Cardiovasc Med, Gothenburg, Sweden	University of Glasgow; Harvard University; Brigham & Women's Hospital; McMaster University; McMaster University; Population Health Research Institute; AstraZeneca; AstraZeneca; Duke University; University of Gothenburg	McMurray, JJV (corresponding author), Univ Glasgow, Cardiovasc Res Ctr, British Heart Fdn, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	j.mcmurray@bio.gla.ac.uk	Solomon, Scott/I-5789-2013; Granger, Christopher B/D-3458-2014; Gerstein, Hertzel/ABB-8781-2020; mcmurray, John/B-2467-2013; Gerstein, Hertzel C/B-1235-2013; Swedberg, Karl/B-2475-2008	Granger, Christopher B/0000-0002-0045-3291; Gerstein, Hertzel/0000-0001-8072-2836; mcmurray, John/0000-0002-6317-3975; Gerstein, Hertzel C/0000-0001-8072-2836; Yusuf, Salim/0000-0003-4776-5601	AstraZeneca	AstraZeneca(AstraZeneca)	The CHARM Programme was funded by AstraZeneca.	Agewall S, 1997, AM J CARDIOL, V80, P164, DOI 10.1016/S0002-9149(97)00312-3; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Brantsma AH, 2008, NEPHROL DIAL TRANSPL, V23, P3851, DOI 10.1093/ndt/gfn356; Capes SE, 2000, DIABETES CARE, V23, P377, DOI 10.2337/diacare.23.3.377; Chugh Atul, 2007, J Clin Hypertens (Greenwich), V9, P196, DOI 10.1111/j.1524-6175.2007.06445.x; Damman K, 2009, J AM COLL CARDIOL, V53, P582, DOI 10.1016/j.jacc.2008.08.080; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Deckert T, 1996, BRIT MED J, V312, P871; Diercks GFH, 2000, EUR HEART J, V21, P1922, DOI 10.1053/euhj.2000.2248; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2008, ARCH INTERN MED, V168, P1699, DOI 10.1001/archinte.168.15.1699; Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506; Home P, 2006, DIABETIC MED, V23, P579; Jensen JS, 1997, NEPHROL DIAL TRANSPL, V12, P6; Jose P, 2006, J AM COLL CARDIOL, V47, P1725, DOI 10.1016/j.jacc.2006.01.047; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Silverberg D, 2004, CURR OPIN NEPHROL HY, V13, P163, DOI 10.1097/00041552-200403000-00004; Smilde TDJ, 2009, CLIN RES CARDIOL, V98, P121, DOI 10.1007/s00392-008-0732-z; Solomon SD, 2007, CIRCULATION, V116, P2687, DOI 10.1161/CIRCULATIONAHA.107.723270; Swedberg K, 1999, J Card Fail, V5, P276, DOI 10.1016/S1071-9164(99)90013-1; Van De Wal RMA, 2005, J CARD FAIL, V11, P602, DOI 10.1016/j.cardfail.2005.05.007; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008; WEGRIA R, 1955, J CLIN INVEST, V34, P737, DOI 10.1172/JCI103127; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906	30	202	220	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					543	550		10.1016/S0140-6736(09)61378-7	http://dx.doi.org/10.1016/S0140-6736(09)61378-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683640				2022-12-28	WOS:000269019400022
J	Paukner, A; Suomi, SJ; Visalberghi, E; Ferrari, PF				Paukner, Annika; Suomi, Stephen J.; Visalberghi, Elisabetta; Ferrari, Pier F.			Capuchin Monkeys Display Affiliation Toward Humans Who Imitate Them	SCIENCE			English	Article							MIMICRY; RECOGNITION; SYNCHRONY	During social interactions, humans often unconsciously and unintentionally imitate the behaviors of others, which increases rapport, liking, and empathy between interaction partners. This effect is thought to be an evolutionary adaptation that facilitates group living and may be shared with other primate species. Here, we show that capuchin monkeys, a highly social primate species, prefer human imitators over non-imitators in a variety of ways: The monkeys look longer at imitators, spend more time in proximity to imitators, and choose to interact more frequently with imitators in a token exchange task. These results demonstrate that imitation can promote affiliation in nonhuman primates. Behavior matching that leads to prosocial behaviors toward others may have been one of the mechanisms at the basis of altruistic behavioral tendencies in capuchins and in other primates, including humans.	[Paukner, Annika; Suomi, Stephen J.; Ferrari, Pier F.] Eunice Kennedy Shriver NICHHD, Comparat Ethol Lab, NIH, Anim Ctr, Poolesville, MD 20837 USA; [Visalberghi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, I-00197 Rome, Italy; [Ferrari, Pier F.] Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Parma	Paukner, A (corresponding author), Eunice Kennedy Shriver NICHHD, Comparat Ethol Lab, NIH, Anim Ctr, POB 529, Poolesville, MD 20837 USA.	pauknera@mail.nih.gov	Ferrari, Pier Francesco/G-5547-2017; Paukner, Annika/ABA-3275-2020	Paukner, Annika/0000-0002-3421-1864; Visalberghi, Elisabetta/0000-0001-7407-5468	Division of Intramural Research; National Institute of Child Health and Human Development; ECT ESF The Evolution of Cooperation and Trading European Science Foundation project SOCCOP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001107] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ECT ESF The Evolution of Cooperation and Trading European Science Foundation project SOCCOP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Division of Intramural Research, National Institute of Child Health and Human Development, and the TECT ESF The Evolution of Cooperation and Trading European Science Foundation project SOCCOP The Social and Mental Dynamics of Cooperation.	Addessi E, 2007, P ROY SOC B-BIOL SCI, V274, P2579, DOI 10.1098/rspb.2007.0726; Agnetta B, 2004, INFANCY, V6, P1, DOI 10.1207/s15327078in0601_1; Agostini I, 2005, AM J PRIMATOL, V65, P335, DOI 10.1002/ajp.20120; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; de Waal F., 2001, APE SUSHI MASTER CUL; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; FRAGASZY DM, 2005, COMPLETE CAPUCHIN; Hattori Y, 2007, ANIM COGN, V10, P141, DOI 10.1007/s10071-006-0049-0; Haun DBM, 2008, CURR BIOL, V18, pR288, DOI 10.1016/j.cub.2008.02.031; HERVE N, 1993, PRIMATES, V34, P227, DOI 10.1007/BF02381395; LAFRANCE M, 1979, US SOC PSYCHOL, V42, P66, DOI 10.2307/3033875; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Meltzoff AN., 1998, INTERSUBJECTIVE COMM, P47; Nielsen M, 2005, ANIM COGN, V8, P31, DOI 10.1007/s10071-004-0232-0; Paukner A, 2005, BIOL LETTERS, V1, P219, DOI 10.1098/rsbl.2004.0291; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van Baaren RB, 2003, J EXP SOC PSYCHOL, V39, P393, DOI 10.1016/S0022-1031(03)00014-3; Visalberghi E, 2002, FROM ANIM ANIMAT, P471; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	21	127	130	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					880	883		10.1126/science.1176269	http://dx.doi.org/10.1126/science.1176269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679816	Green Accepted			2022-12-28	WOS:000269242400048
J	de Boer, M; van Deurzen, CHM; van Dijck, JAAM; Borm, GF; van Diest, PJ; Adang, EMM; Nortier, JWR; Rutgers, EJT; Seynaeve, C; Menke-Pluymers, MBE; Bult, P; Tjan-Heijnen, VCG				de Boer, Maaike; van Deurzen, Carolien H. M.; van Dijck, Jos A. A. M.; Borm, George F.; van Diest, Paul J.; Adang, Eddy M. M.; Nortier, Johan W. R.; Rutgers, Emiel J. T.; Seynaeve, Caroline; Menke-Pluymers, Marian B. E.; Bult, Peter; Tjan-Heijnen, Vivianne C. G.			Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	31st San Antonio Breast Cancer Symposium	DEC 10-14, 2008	San Antonio, TX				LYMPH-NODE MICROMETASTASES; PROGNOSTIC-SIGNIFICANCE; GUIDELINE TREATMENT; METASTASES; SURVIVAL; BIOPSY; NUMBER; WOMEN	Background The association of isolated tumor cells and micrometastases in regional lymph nodes with the clinical outcome of breast cancer is unclear. Methods We identified all patients in the Netherlands who underwent a sentinel-node biopsy for breast cancer before 2006 and had breast cancer with favorable primary-tumor characteristics and isolated tumor cells or micrometastases in the regional lymph nodes. Patients with node-negative disease were randomly selected from the years 2000 and 2001. The primary end point was disease-free survival. Results We identified 856 patients with node-negative disease who had not received systemic adjuvant therapy ( the node-negative, no-adjuvant-therapy cohort), 856 patients with isolated tumor cells or micrometastases who had not received systemic adjuvant therapy ( the node-positive, no-adjuvant-therapy cohort), and 995 patients with isolated tumor cells or micrometastases who had received such treatment ( the node-positive, adjuvant-therapy cohort). The median follow-up was 5.1 years. The adjusted hazard ratio for disease events among patients with isolated tumor cells who did not receive systemic therapy, as compared with women with node-negative disease, was 1.50 (95% confidence interval [CI], 1.15 to 1.94); among patients with micrometastases, the adjusted hazard ratio was 1.56 ( 95% CI, 1.15 to 2.13). Among patients with isolated tumor cells or micrometastases, the adjusted hazard ratio was 0.57 ( 95% CI, 0.45 to 0.73) in the node-positive, adjuvant-therapy cohort, as compared with the node-positive, no-adjuvant-therapy cohort. Conclusions Isolated tumor cells or micrometastases in regional lymph nodes were associated with a reduced 5-year rate of disease-free survival among women with favorable early-stage breast cancer who did not receive adjuvant therapy. In patients with isolated tumor cells or micrometastases who received adjuvant therapy, disease-free survival was improved.	[Tjan-Heijnen, Vivianne C. G.] Maastricht Univ, Med Ctr, Dept Internal Med, Div Med Oncol, NL-6202 AZ Maastricht, Netherlands; [de Boer, Maaike; van Dijck, Jos A. A. M.] Radboud Univ Nijmegen, Med Ctr, Comprehens Canc Ctr E, NL-6525 ED Nijmegen, Netherlands; [van Dijck, Jos A. A. M.; Borm, George F.; Adang, Eddy M. M.] Radboud Univ Nijmegen, Med Ctr, Div Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Bult, Peter] Radboud Univ Nijmegen, Med Ctr, Div Pathol, NL-6525 ED Nijmegen, Netherlands; [van Deurzen, Carolien H. M.; van Diest, Paul J.] Univ Med Ctr Utrecht, Div Pathol, Utrecht, Netherlands; [Nortier, Johan W. R.] Leiden Univ, Med Ctr, Div Med Oncol, Leiden, Netherlands; [Rutgers, Emiel J. T.] Netherlands Canc Inst, Div Surg, Amsterdam, Netherlands; [Seynaeve, Caroline] Dr Daniel Den Hoed Canc Ctr, Erasmus Med Ctr, Div Med Oncol, NL-3008 AE Rotterdam, Netherlands; [Menke-Pluymers, Marian B. E.] Dr Daniel Den Hoed Canc Ctr, Erasmus Med Ctr, Div Surg, NL-3008 AE Rotterdam, Netherlands	Maastricht University; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Tjan-Heijnen, VCG (corresponding author), Maastricht Univ, Med Ctr, Dept Internal Med, Div Med Oncol, POB 5800, NL-6202 AZ Maastricht, Netherlands.	vcg.tjan.heijnen@mumc.nl	Bult, Peter/L-4236-2015; Rutgers, Emiel J T/C-5934-2015; Adang, E.M.M./L-4169-2015; van Dijck, Jos/A-1676-2016	Bult, Peter/0000-0001-6427-9889; 				Bleiweiss IJ, 2006, J CLIN ONCOL, V24, P2013, DOI 10.1200/JCO.2005.04.7076; Bolster MJ, 2006, ANN SURG ONCOL, V13, P1466, DOI 10.1245/s10434-006-9084-y; Chen SL, 2007, ANN SURG ONCOL, V14, P3378, DOI 10.1245/s10434-007-9513-6; Colleoni M, 2005, J CLIN ONCOL, V23, P1379, DOI 10.1200/JCO.2005.07.094; Cote RJ, 1999, LANCET, V354, P896, DOI 10.1016/S0140-6736(98)11104-2; Cox CE, 2008, J AM COLL SURGEONS, V206, P261, DOI 10.1016/j.jamcollsurg.2007.08.024; Cserni G, 2003, EUR J CANCER, V39, P1654, DOI 10.1016/S0959-8049(03)00203-X; Cummings MC, 2002, AM J SURG PATHOL, V26, P1286, DOI 10.1097/00000478-200210000-00005; DEMASCAREL I, 1992, BRIT J CANCER, V66, P523, DOI 10.1038/bjc.1992.306; *DUTCH I HEALTHC I, 2002, TREATM BREAST CANC G; Ernst-Kruis M R, 2003, Ned Tijdschr Geneeskd, V147, P1126; Fan YG, 2005, ANN SURG ONCOL, V12, P705, DOI 10.1245/ASO.2005.08.020; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Gobardhan PD, 2009, ANN ONCOL, V20, P41, DOI 10.1093/annonc/mdn535; Grabau D, 2007, APMIS, V115, P828, DOI 10.1111/j.1600-0463.2007.apm_442.x; GREEN EL, 2002, AJCC CANC STAGING MA; Kuijt GP, 2005, EJSO, V31, P500, DOI 10.1016/j.ejso.2005.01.001; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Maibenco DC, 2006, CANCER, V107, P1234, DOI 10.1002/cncr.22112; Millis RR, 2002, BRIT J CANCER, V86, P396, DOI 10.1038/sj.bjc.6600070; Rutgers E J Th, 2002, Ned Tijdschr Geneeskd, V146, P2144; SAS Institute, 1999, SAS STAT US GUID VER; Sobin, 2009, UICC TNM CLASSIFICAT; Struikmans H, 2008, Ned Tijdschr Geneeskd, V152, P2507; Tan LK, 2008, J CLIN ONCOL, V26, P1803, DOI 10.1200/JCO.2007.12.6425; Truong PT, 2008, EUR J CANCER, V44, P1670, DOI 10.1016/j.ejca.2008.05.011; van der Heiden-vander Loo M, 2006, EJSO-EUR J SURG ONC, V32, P710, DOI 10.1016/j.ejso.2006.04.001; van Deurzen CHM, 2009, AM J SURG PATHOL, V33, P106, DOI 10.1097/PAS.0b013e31817eec40	28	372	375	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					653	663		10.1056/NEJMoa0904832	http://dx.doi.org/10.1056/NEJMoa0904832			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	482JX	19675329	Green Published			2022-12-28	WOS:000268884100005
J	Mann, ME; Woodruff, JD; Donnelly, JP; Zhang, ZH				Mann, Michael E.; Woodruff, Jonathan D.; Donnelly, Jeffrey P.; Zhang, Zhihua			Atlantic hurricanes and climate over the past 1,500 years	NATURE			English	Article							PREHISTORIC LANDFALL FREQUENCIES; TROPICAL PACIFIC; SEDIMENTOLOGICAL EVIDENCE; COAST RECORDS; NEW-JERSEY; SEA; RECONSTRUCTION; OSCILLATION	Atlantic tropical cyclone activity, as measured by annual storm counts, reached anomalous levels over the past decade(1). The short nature of the historical record and potential issues with its reliability in earlier decades, however, has prompted an ongoing debate regarding the reality and significance of the recent rise(2-5). Here we place recent activity in a longer-term context by comparing two independent estimates of tropical cyclone activity over the past 1,500 years. The first estimate is based on a composite of regional sedimentary evidence of landfalling hurricanes, while the second estimate uses a previously published statistical model of Atlantic tropical cyclone activity driven by proxy reconstructions of past climate changes. Both approaches yield consistent evidence of a peak in Atlantic tropical cyclone activity during medieval times (around AD 1000) followed by a subsequent lull in activity. The statistical model indicates that the medieval peak, which rivals or even exceeds (within uncertainties) recent levels of activity, results from the reinforcing effects of La-Nina-like climate conditions and relative tropical Atlantic warmth.	[Mann, Michael E.; Zhang, Zhihua] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; [Mann, Michael E.; Zhang, Zhihua] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Woodruff, Jonathan D.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Donnelly, Jeffrey P.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Massachusetts System; University of Massachusetts Amherst; Woods Hole Oceanographic Institution	Mann, ME (corresponding author), Penn State Univ, Dept Meteorol, 503 Walker Bldg, University Pk, PA 16802 USA.	mann@psu.edu	Mann, Michael E/B-8472-2017; zhang, zh/GWV-4677-2022	Mann, Michael E/0000-0003-3067-296X; 	National Science Foundation [ATM-0542356, EAR-0519118, OCE-0402746]; Division Of Ocean Sciences [0902889] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank C. Landsea for comments on the manuscript. M. E. M. and Z. Z. acknowledge support from the ATM programme of the National Science Foundation (grant ATM-0542356). J. P. D. acknowledges support from the EAR and OCE programmes of the National Science Foundation (grants EAR-0519118 and OCE-0402746), the Risk Prediction Initiative at the Bermuda Institute for Ocean Sciences, and the Inter-American Institute for Global Change Research. This is a contribution of IGCP 495-'Holocene land -ocean interactions: driving mechanisms and coastal responses'.	BOLDT K, MAR GEOL UNPUB; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Donnelly JP, 2007, NATURE, V447, P465, DOI 10.1038/nature05834; Donnelly JP, 2004, MAR GEOL, V210, P107, DOI 10.1016/j.margeo.2004.05.005; Donnelly JP, 2001, GEOLOGY, V29, P615, DOI 10.1130/0091-7613(2001)029<0615:SEOIHS>2.0.CO;2; Donnelly JP, 2001, GEOL SOC AM BULL, V113, P714, DOI 10.1130/0016-7606(2001)113<0714:YSROIH>2.0.CO;2; Elsner JB, 2008, J APPL METEOROL CLIM, V47, P368, DOI 10.1175/2007JAMC1692.1; Garcia-Herrera R, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005272; Graham NE, 2007, CLIMATIC CHANGE, V83, P241, DOI [10.1007/s10584-007-9239-2, 10.1007/s 10584-007-9239-2]; Hippensteel SP, 2005, GEOL SOC AM BULL, V117, P250, DOI 10.1130/B25535.1; Holland GJ, 2007, PHILOS T R SOC A, V365, P2695, DOI 10.1098/rsta.2007.2083; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Keigwin LD, 1996, SCIENCE, V274, P1504, DOI 10.1126/science.274.5292.1504; Knutson TR, 2008, NAT GEOSCI, V1, P359, DOI 10.1038/ngeo202; LAMBERT WJ, 2003, T GULF COAST ASS GEO, V53, P443; Landsea C, 2007, EOS T AGU, V88, P197, DOI [10.1029/2007EO180001, DOI 10.1029/2007EO180001]; Liu KB, 2000, QUATERNARY RES, V54, P238, DOI 10.1006/qres.2000.2166; Luterbacher J, 2001, ATMOS SCI LETT, V2, P114, DOI 10.1006/asle.2001.0044; Mann ME, 2005, J CLIMATE, V18, P447, DOI 10.1175/JCLI-3276.1; MANN ME, SCIENCE UNPUB; Mann ME, 2007, EOS, V88, P349, DOI DOI 10.1029/2007EO360002; Mann ME, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031781; Mann ME, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034716; Neu U, 2008, NATURE, V451, pE5, DOI 10.1038/nature06576; Nyberg J, 2007, NATURE, V447, P698, DOI 10.1038/nature05895; Otvos EG, 2002, QUATERNARY RES, V57, P425, DOI 10.1006/qres.2002.2333; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Richey JN, 2007, GEOLOGY, V35, P423, DOI 10.1130/G23507A.1; SABBATELLI TA, J GEOPHYS RES UNPUB; Sabbatelli TA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008385; Scileppi E, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001463; Scott DB, 2003, GEOL SOC AM BULL, V115, P1027, DOI 10.1130/B25011.1; Smith TM, 2003, J CLIMATE, V16, P1495, DOI 10.1175/1520-0442-16.10.1495; Vecchi GA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028905; Woodruff JD, 2008, GEOLOGY, V36, P391, DOI 10.1130/G24731A.1; Woodruff JD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002043	37	156	166	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					880	U115		10.1038/nature08219	http://dx.doi.org/10.1038/nature08219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675650	Green Submitted			2022-12-28	WOS:000268938300035
J	Barrett, N; Sheehan, SR; Murphy, DJ				Barrett, Niamh; Sheehan, Sharon R.; Murphy, Deirdre J.			Endgames Case report A complication after a previous caesarean section	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UTERINE RUPTURE; PERINATAL DEATH; VAGINAL BIRTH; LABOR; DELIVERY; TRIAL; TERM; MORBIDITY; RISK; PREGNANCIES		[Barrett, Niamh; Murphy, Deirdre J.] Coombe Women & Infants Univ Hosp, Dublin 8, Ireland; [Murphy, Deirdre J.] Univ Dublin Trinity Coll, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin		sharon.sheehan@tcd.ie						FEDORKOW DM, 1987, CAN MED ASSOC J, V137, P27; Guise JM, 2004, BMJ-BRIT MED J, V329, P19, DOI 10.1136/bmj.329.7456.19; Gyamfi C, 2004, OBSTET GYNECOL, V104, P715, DOI 10.1097/01.AOG.0000139516.43748.1b; Landon MB, 2005, AM J OBSTET GYNECOL, V193, P1016, DOI 10.1016/j.ajog.2005.05.066; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Levine EM, 2001, OBSTET GYNECOL, V97, P439, DOI 10.1016/S0029-7844(00)01150-9; Lewis G., 2004, WHY MOTHERS DIE 2000; Montgomery AA, 2007, BMJ-BRIT MED J, V334, P1307, DOI 10.1136/bmj.39217.671019.55; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; Murphy DJ, 2006, CURR OPIN OBSTET GYN, V18, P135, DOI 10.1097/01.gco.0000192989.45589.57; PRADHAN P, 2007, MANAGING OBSTET EMER, P257; Richardson BS, 2005, AM J OBSTET GYNECOL, V192, P219, DOI 10.1016/j.ajog.2004.06.034; *ROYAL COLL OBST G, 2007, GREEN TOP GUID, V45; Royal College of Obstetricians and Gynaecologists, 2008, BIRTH PREV CAES INF; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Smith GCS, 2005, PLOS MED, V2, P871, DOI 10.1371/journal.pmed.0020252; Smith GCS, 2004, BRIT MED J, V329, P375, DOI 10.1136/bmj.38160.634352.55; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; SWEETEN KM, 1995, AM J OBSTET GYNECOL, V172, P1851, DOI 10.1016/0002-9378(95)91422-6; Turner MJ, 2002, BEST PRACT RES CL OB, V16, P69, DOI 10.1053/beog.2001.0256; Turner MJA, 2006, BJOG-INT J OBSTET GY, V113, P729, DOI 10.1111/j.1471-0528.2006.00940.x; Wen SW, 2004, AM J OBSTET GYNECOL, V191, P1263, DOI 10.1016/j.ajog.2004.03.022	23	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2009	339								b2979	10.1136/bmj.b2979	http://dx.doi.org/10.1136/bmj.b2979			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YI	19675077				2022-12-28	WOS:000269161900001
J	Dudley, S				Dudley, Steve			A Paucity of Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												doctordudley@comcast.net							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					609	610		10.1001/jama.2009.1090	http://dx.doi.org/10.1001/jama.2009.1090			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481ZI	19671893				2022-12-28	WOS:000268852300001
J	Feart, C; Samieri, C; Rondeau, V; Amieva, H; Portet, F; Dartigues, JF; Scarmeas, N; Barberger-Gateau, P				Feart, Catherine; Samieri, Cecilia; Rondeau, Virginie; Amieva, Helene; Portet, Florence; Dartigues, Jean-Francois; Scarmeas, Nikolaos; Barberger-Gateau, Pascale			Adherence to a Mediterranean Diet, Cognitive Decline, and Risk of Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; PATTERNS; HEALTH; ASSOCIATION; POPULATION; 3-CITY; CONSUMPTION; IMPAIRMENT; SYMPTOMS	Context Higher adherence to a Mediterranean-type diet is linked to lower risk for mortality and chronic diseases, but its association with cognitive decline is unclear. Objective To investigate the association of a Mediterranean diet with change in cognitive performance and risk for dementia in elderly French persons. Design, Setting, and Participants Prospective cohort study of 1410 adults (>= 65 years) from Bordeaux, France, included in the Three-City cohort in 20012002 and reexamined at least once over 5 years. Adherence to a Mediterranean diet ( scored as 0 to 9) was computed from a food frequency questionnaire and 24-hour recall. Main Outcome Measures Cognitive performance was assessed on 4 neuropsychological tests: the Mini-Mental State Examination (MMSE), Isaacs Set Test (IST), Benton Visual Retention Test (BVRT), and Free and Cued Selective Reminding Test (FCSRT). Incident cases of dementia (n=99) were validated by an independent expert committee of neurologists. Results Adjusting for age, sex, education, marital status, energy intake, physical activity, depressive symptomatology, taking 5 medications/d or more, apolipoprotein E genotype, cardiovascular risk factors, and stroke, higher Mediterranean diet score was associated with fewer MMSE errors (beta=-0.006; 95% confidence interval [CI], -0.01 to -0.0003; P=.04 for 1 point of the Mediterranean diet score). Performance on the IST, BVRT, or FCSRT over time was not significantly associated with Mediterranean diet adherence. Greater adherence as a categorical variable (score 6-9) was not significantly associated with fewer MMSE errors and better FCSRT scores in the entire cohort, but among individuals who remained free from dementia over 5 years, the association for the highest compared with the lowest group was significant (adjusted for all factors, for MMSE: beta=-0.03; 95% CI, -0.05 to -0.001; P=.04; for FCSRT: beta=0.21; 95% CI, 0.008 to 0.41; P=. 04). Mediterranean diet adherence was not associated with the risk for incident dementia (fully adjusted model: hazard ratio, 1.12; 95% CI, 0.60 to 2.10; P=.72), although power to detect a difference was limited. Conclusions Higher adherence to a Mediterranean diet was associated with slower MMSE cognitive decline but not consistently with other cognitive tests. Higher adherence was not associated with risk for incident dementia. JAMA. 2009; 302(6):638-648 www.jama.com	[Feart, Catherine] Univ Bordeaux 2, INSERM, Equipe Epidemiol Nutr & Comportements Alimentaire, Res Ctr,ISPED Case 11,U897, F-33076 Bordeaux, France; [Portet, Florence] Univ Montpellier I, INSERM, U888, Montpellier, France; [Scarmeas, Nikolaos] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Columbia University	Feart, C (corresponding author), Univ Bordeaux 2, INSERM, Equipe Epidemiol Nutr & Comportements Alimentaire, Res Ctr,ISPED Case 11,U897, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	catherine.feart@isped.u-bordeaux2.fr	Amieva, Helene/T-4170-2019; Scarmeas, Nikolaos/AAD-2517-2020; Samieri, Cécilia/E-3334-2014; rondeau, virginie/E-4192-2014; Samieri, Cecilia/T-3267-2019; Scarmeas, Nikolaos/AAD-2512-2020; rondeau, virginie/T-9763-2019; Amieva, Helene/E-4850-2014; DARTIGUES, Jean François/T-4513-2019; FEART, Catherine/A-3339-2016	Amieva, Helene/0000-0002-0119-7242; Scarmeas, Nikolaos/0000-0001-6453-8908; Samieri, Cécilia/0000-0001-9809-7506; rondeau, virginie/0000-0001-7109-4831; Samieri, Cecilia/0000-0001-9809-7506; Scarmeas, Nikolaos/0000-0001-6453-8908; rondeau, virginie/0000-0001-7109-4831; FEART, Catherine/0000-0002-7959-1610	Institut National de la Sante et de la Recherche Medicale (INSERM); Institut de Sante Publique et Developpement of the Victor Segalen Bordeaux 2 University; Sanofi-Aventis; The Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Regional Governments of Aquitaine and Bourgogne; Fondation de France; Ministry of Research-INSERM Programme; French National Research Agency [ANR-06PNRA-005]; Association France Alzheimer; Aquitaine Regional Government	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut de Sante Publique et Developpement of the Victor Segalen Bordeaux 2 University; Sanofi-Aventis(Sanofi-Aventis); The Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Regional Governments of Aquitaine and Bourgogne(Region Nouvelle-Aquitaine); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Research Agency(French National Research Agency (ANR)); Association France Alzheimer; Aquitaine Regional Government(Region Nouvelle-Aquitaine)	The Three-City (3C) Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Institut de Sante Publique et Developpement of the Victor Segalen Bordeaux 2 University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale, Institut de la Longevite, Regional Governments of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques." Financial support for the 3C-COGINUT project was provided by the French National Research Agency (ANR-06PNRA-005). Dr Feart was funded by Association France Alzheimer; Dr Samieri was funded by Aquitaine Regional Government.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Bach A, 2006, PUBLIC HEALTH NUTR, V9, P132, DOI 10.1079/PHN2005936; Bach-Faig A, 2006, PUBLIC HEALTH NUTR, V9, P1110, DOI 10.1017/S1368980007668499; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Benton A, 1965, MANUEL APPL TEST RET; BERKMAN LF, 1986, AM J EPIDEMIOL, V124, P372, DOI 10.1093/oxfordjournals.aje.a114408; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Dai J, 2008, AM J CLIN NUTR, V88, P1364, DOI 10.3945/ajcn.2008.26528; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Feart C, 2007, BRIT J NUTR, V98, P1046, DOI 10.1017/S0007114507756520; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giugliano D, 2008, CURR OPIN LIPIDOL, V19, P63, DOI 10.1097/MOL.0b013e3282f2fa4d; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Jacques PF, 2001, AM J CLIN NUTR, V73, P1, DOI 10.1093/ajcn/73.1.1; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Lamarca R, 1998, J GERONTOL A-BIOL, V53, pM337, DOI 10.1093/gerona/53A.5.M337; Letenneur L, 2007, AM J EPIDEMIOL, V165, P1364, DOI 10.1093/aje/kwm036; Luchsinger JA, 2004, LANCET NEUROL, V3, P579, DOI 10.1016/S1474-4422(04)00878-6; Panza F, 2007, EXP GERONTOL, V42, P6, DOI 10.1016/j.exger.2006.09.011; Reynolds E, 2006, LANCET NEUROL, V5, P949, DOI 10.1016/S1474-4422(06)70598-1; Rock CL, 2007, AM J CLIN NUTR, V85, p277S, DOI 10.1093/ajcn/85.1.277S; Samieri C, 2008, J AM DIET ASSOC, V108, P1461, DOI 10.1016/j.jada.2008.06.437; Sanchez-Villegas A, 2006, PUBLIC HEALTH NUTR, V9, P1104, DOI 10.1017/S1368980007668578; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P216, DOI 10.1001/archneurol.2008.536; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; SIMERMANN J, 2007, 25 ANN C SOC FRANC N; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Solfrizzi V, 2006, NEUROBIOL AGING, V27, P1694, DOI 10.1016/j.neurobiolaging.2005.09.026; Stampfer MJ, 2005, NEW ENGL J MED, V352, P245, DOI 10.1056/NEJMoa041152; Steele M, 2007, EXP GERONTOL, V42, P28, DOI 10.1016/j.exger.2006.06.002; Tamers SL, 2009, EUR J CLIN NUTR, V63, P11, DOI 10.1038/ejcn.2008.2; Touvier M, 2009, EUR J CLIN NUTR, V63, P39, DOI 10.1038/sj.ejcn.1602907; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S	39	465	473	1	98	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					638	648		10.1001/jama.2009.1146	http://dx.doi.org/10.1001/jama.2009.1146			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481ZI	19671905	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000268852300022
J	Dirks, PB				Dirks, Peter B.			MicroRNAs and Parallel Stem Cell Lives	CELL			English	Editorial Material								A new study by Shimono et al. ( 2009) demonstrates that certain microRNAs that regulate the self-renewal factor BMI1 are downregulated in purified populations of normal mammary epithelial stem cells and breast tumor-initiating cells. These findings have important implications for the regulation of self-renewal and differentiation by microRNAs and suggest new ways of targeting cancer stem cells.	Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Dirks, PB (corresponding author), Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada.	peter.dirks@sickkids.ca						Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005	3	16	18	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 7	2009	138	3					423	424		10.1016/j.cell.2009.07.025	http://dx.doi.org/10.1016/j.cell.2009.07.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665962	Bronze			2022-12-28	WOS:000268771900004
J	Willems, PA				Willems, Paul A.			The Biofuels Landscape Through the Lens of Industrial Chemistry	SCIENCE			English	Editorial Material								Replacing petroleum feedstock with biomass in the production of fuels and value-added chemicals carries considerable appeal. As in industrial chemistry more broadly, high-throughput experimentation has greatly facilitated innovation in small-scale exploration of biomass production and processing. Yet biomass is hard to transport, potentially hindering the integration of manufacturing-scale processes. Moreover, the path from laboratory breakthrough to commercial production remains as tortuous as ever.	Univ Calif Berkeley, Energy Biosci Inst, Calvin Lab 326, BP Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Willems, PA (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Calvin Lab 326, BP Grp, MC 5230, Berkeley, CA 94720 USA.								0	31	31	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					707	708		10.1126/science.1175502	http://dx.doi.org/10.1126/science.1175502			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661419				2022-12-28	WOS:000268723700037
J	Yeston, J; Coontz, R				Yeston, Jake; Coontz, Robert			Chemistry Writ Large INTRODUCTION	SCIENCE			English	Editorial Material																			0	2	2	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					691	691		10.1126/science.325_691	http://dx.doi.org/10.1126/science.325_691			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661412				2022-12-28	WOS:000268723700030
J	Zhao, Y; Sfeir, AJ; Zou, Y; Buseman, CM; Chow, TT; Shay, JW; Wright, WE				Zhao, Yong; Sfeir, Agnel J.; Zou, Ying; Buseman, Christen M.; Chow, Tracy T.; Shay, Jerry W.; Wright, Woodring E.			Telomere Extension Occurs at Most Chromosome Ends and Is Uncoupled from Fill-In in Human Cancer Cells	CELL			English	Article							DNA-POLYMERASE-ALPHA; MAMMALIAN TELOMERES; LENGTH REGULATION; C-STRAND; G TAILS; REPLICATION; CYCLE; MECHANISM; FIBROBLASTS; MAINTENANCE	Telomeres are thought to be maintained by the preferential recruitment of telomerase to the shortest telomeres. The extension of the G-rich telomeric strand by telomerase is also believed to be coordinated with the complementary synthesis of the C strand by the conventional replication machinery. However, we show that under telomere length-maintenance conditions in cancer cells, human telomerase extends most chromosome ends during each S phase and is not preferentially recruited to the shortest telomeres. Telomerase rapidly extends the G-rich strand following telomere replication but fill-in of the C strand is delayed into late S phase. This late C-strand fill-in is not executed by conventional Okazaki fragment synthesis but by a mechanism using a series of small incremental steps. These findings highlight differences between telomerase actions during steady state versus nonequilibrium conditions and reveal steps in the human telomere maintenance pathway that may provide additional targets for the development of anti-telomerase therapeutics.	[Zhao, Yong; Sfeir, Agnel J.; Zou, Ying; Buseman, Christen M.; Chow, Tracy T.; Shay, Jerry W.; Wright, Woodring E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Wright, WE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	woodring.wright@utsouthwestern.edu	Shay, Jerry W/F-7878-2011	Zou, Ying/0000-0003-2787-1917; Zhao, Yong/0000-0001-5068-2212	National Institutes of Health [AG01228, P50 CA70907, CA12729701]; American Federation for Aging Research [NNJ05HD36G]; Department of Defense Breast Cancer Program; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG001228, R37AG001228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research; Department of Defense Breast Cancer Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants AG01228, P50 CA70907, and CA12729701 from the National Institutes of Health, NASA NNJ05HD36G, fellowship support from the American Federation for Aging Research ( AFAR) to Y.Z., and the Department of Defense Breast Cancer Program to C. B. and T. C. We thank Angela Diehl for help in preparing Figure 1.	Adams AK, 1996, MOL CELL BIOL, V16, P4614; Bailey SM, 2004, CYTOGENET GENOME RES, V107, P14, DOI 10.1159/000079565; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Chakhparonian M, 2003, TRENDS GENET, V19, P439, DOI 10.1016/S0168-9525(03)00135-5; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1998, NUCLEIC ACIDS RES, V26, P5365, DOI 10.1093/nar/26.23.5365; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbert BS, 2005, ONCOGENE, V24, P5262, DOI 10.1038/sj.onc.1208760; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; Nakamura M, 2005, MOL CELL BIOL, V25, P11073, DOI 10.1128/MCB.25.24.11073-11088.2005; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Price CM, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1216; PRICE CM, 1994, J EUKARYOT MICROBIOL, V41, P267, DOI 10.1111/j.1550-7408.1994.tb01507.x; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; TENHAGEN KG, 1990, MOL CELL BIOL, V10, P6348, DOI 10.1128/MCB.10.12.6348; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Zhao Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1063; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648; Zou Y, 2004, P NATL ACAD SCI USA, V101, P12928, DOI 10.1073/pnas.0404106101	45	165	174	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					463	475		10.1016/j.cell.2009.05.026	http://dx.doi.org/10.1016/j.cell.2009.05.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665970	Bronze, Green Accepted			2022-12-28	WOS:000268771900012
J	Cutler, DM				Cutler, David M.			The Next Wave of Corporate Medicine - How We All Might Benefit	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Cutler, DM (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.			Cutler, David/0000-0002-4949-8917				*AM HOSP ASS, 2008, CHARTB TRENDS AFF HO; *AM HOSP ASS, 2008, REP EC CRIS IN IMP H; *C BUDG OFF, 2008, KEY ISS AN MAJ HLTH	3	10	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					549	551		10.1056/NEJMp0904259	http://dx.doi.org/10.1056/NEJMp0904259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479NR	19657118	Green Submitted			2022-12-28	WOS:000268667300001
J	Epstein, JM				Epstein, Joshua M.			Modelling to contain pandemics	NATURE			English	Editorial Material									Brookings Inst, Ctr Social & Econ Dynam, Washington, DC 20036 USA	Brookings Institution	Epstein, JM (corresponding author), Brookings Inst, Ctr Social & Econ Dynam, 1775 Massachusetts Ave, Washington, DC 20036 USA.	jepstein@brookings.edu			NIGMS NIH HHS [U54 GM088491] Funding Source: Medline; NIH HHS [DP1 OD003874] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003874] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Epstein J.M., 1996, GROWING ARTIFICIAL S; PARKER JA, ACM T MODEL IN PRESS	2	176	184	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					687	687		10.1038/460687a	http://dx.doi.org/10.1038/460687a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	479OO	19661897	Green Accepted			2022-12-28	WOS:000268670300021
J	Hartzband, P; Groopman, J				Hartzband, Pamela; Groopman, Jerome			Keeping the Patient in the Equation - Humanism and Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hartzband, Pamela] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hartzband, P (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Aron D, 2009, JAMA-J AM MED ASSOC, V301, P210, DOI 10.1001/jama.2008.930; Institute of Medicine, 2009, CONFL INT MED RES ED; Marmor T, 2009, ANN INTERN MED, V150, P485, DOI 10.7326/0003-4819-150-7-200904070-00114; Resnic FS, 2009, J AM COLL CARDIOL, V53, P825, DOI 10.1016/j.jacc.2008.11.034; World Health Organization, 2000, WORLD HLTH REP 2000	5	48	53	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2009	361	6					554	555		10.1056/NEJMp0904813	http://dx.doi.org/10.1056/NEJMp0904813			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479NR	19657120				2022-12-28	WOS:000268667300003
J	Tauro, S; Hutcheon, S				Tauro, Sudhir; Hutcheon, Stuart			Chest pain and small red cells: size does matter	LANCET			English	Editorial Material							MUTATION		[Tauro, Sudhir] Univ Dundee, Ninewells Hosp & Med Sch, Dept Haematol, Dundee DD1 9SY, Scotland; [Hutcheon, Stuart] Univ Dundee, Ninewells Hosp & Med Sch, Dept Cardiol, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Tauro, S (corresponding author), Univ Dundee, Div Med Sci, Ctr Ontol & Mol Med, Dundee DD1 9SY, Scotland.	s.tauro@dundee.ac.uk						Austin SK, 2008, BRIT J HAEMATOL, V143, P307, DOI 10.1111/j.1365-2141.2008.07258.x; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501	3	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 1	2009	374	9687					426	426		10.1016/S0140-6736(09)60936-3	http://dx.doi.org/10.1016/S0140-6736(09)60936-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481MJ	19647610				2022-12-28	WOS:000268815200028
J	Driscoll, T; Kim, HT; Chae, BG; Kim, BJ; Lee, YW; Jokerst, NM; Palit, S; Smith, DR; Di Ventra, M; Basov, DN				Driscoll, T.; Kim, Hyun-Tak; Chae, Byung-Gyu; Kim, Bong-Jun; Lee, Yong-Wook; Jokerst, N. Marie; Palit, S.; Smith, D. R.; Di Ventra, M.; Basov, D. N.			Memory Metamaterials	SCIENCE			English	Article							METAL-INSULATOR-TRANSITION; MOTT TRANSITION; MECHANISM	The resonant elements that grant metamaterials their distinct properties have the fundamental limitation of restricting their useable frequency bandwidth. The development of frequency-agile metamaterials has helped to alleviate these bandwidth restrictions by allowing real-time tuning of the metamaterial frequency response. We demonstrate electrically controlled persistent frequency tuning of a metamaterial, which allows the lasting modification of its response by using a transient stimulus. This work demonstrates a form of memory capacitance that interfaces metamaterials with a class of devices known collectively as memory devices.	[Driscoll, T.; Di Ventra, M.; Basov, D. N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Kim, Hyun-Tak; Chae, Byung-Gyu; Kim, Bong-Jun; Lee, Yong-Wook] ETRI, Met Insulator Transit Lab, Taejon 305350, South Korea; [Lee, Yong-Wook] Pukyong Natl Univ, Sch Elect & Engn, Pusan 608739, South Korea; [Jokerst, N. Marie; Palit, S.; Smith, D. R.] Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA; [Jokerst, N. Marie; Palit, S.; Smith, D. R.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA	University of California System; University of California San Diego; Electronics & Telecommunications Research Institute - Korea (ETRI); Pukyong National University; Duke University; Duke University	Driscoll, T (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	tdriscol@physics.ucsd.edu	Di Ventra, Massimiliano/E-1667-2011; Smith, David R/E-4710-2012; Driscoll, Tom/E-2293-2012; Driscoll, Tom/GSN-8530-2022	Di Ventra, Massimiliano/0000-0001-9416-189X; Kim, Hyun Tak/0000-0002-4315-1701; Chae, Byung Gyu/0000-0001-5721-3064	U. S. Department of Energy (DOE),; Air Force Office of Scientific Research (AFOSR); ETRI; AFOSR; Ministry of Knowledge Economy in Korea	U. S. Department of Energy (DOE),(United States Department of Energy (DOE)); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ETRI; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Ministry of Knowledge Economy in Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work is supported by the U. S. Department of Energy (DOE), the Air Force Office of Scientific Research (AFOSR), and ETRI. Work at UCSD on VO<INF>2</INF> was supported by DOE-Basic Energy Sciences and the metamaterials work was supported by AFOSR and ETRI. M. D. acknowledges partial support from NSF. H. K. acknowledges research support from a project of the Ministry of Knowledge Economy in Korea.	Baena JD, 2005, IEEE T MICROW THEORY, V53, P1451, DOI 10.1109/TMTT.2005.845211; Chae BG, 2005, PHYSICA B, V369, P76, DOI 10.1016/j.physb.2005.07.032; Chen HT, 2008, NAT PHOTONICS, V2, P295, DOI 10.1038/nphoton.2008.52; Chen HT, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2978071; Degiron A, 2007, OPT EXPRESS, V15, P1115, DOI 10.1364/OE.15.001115; Di Ventra M, 2009, P IEEE, V97, P1371, DOI 10.1109/JPROC.2009.2022882; Driscoll T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768300; Driscoll T, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3187531; Driscoll T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2956675; Eleftheriades GV, 2003, IEEE MICROW WIREL CO, V13, P51, DOI 10.1109/LMWC.2003.808719; Gil I, 2004, ELECTRON LETT, V40, P1347, DOI 10.1049/el:20046389; Gollub JN, 2009, OPT EXPRESS, V17, P2122, DOI 10.1364/OE.17.002122; Kildishev AV, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/11/115029; Kim HT, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/052; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Lopez R, 2004, APPL PHYS LETT, V85, P1410, DOI 10.1063/1.1784546; Lysenko S, 2006, APPL SURF SCI, V252, P5512, DOI 10.1016/j.apsusc.2005.12.137; Muraoka Y, 2002, APPL PHYS LETT, V80, P583, DOI 10.1063/1.1446215; Padilla WJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107401; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Qazilbash MM, 2007, SCIENCE, V318, P1750, DOI 10.1126/science.1150124; Qazilbash MM, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2939434; Schurig D, 2007, OPT EXPRESS, V15, P14772, DOI 10.1364/OE.15.014772; SHADRIVOV I, SPIE NEWSROOM, DOI DOI 10.1117/2.1200811.1390; Shadrivov IV, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046615; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Yang JJ, 2008, NAT NANOTECHNOL, V3, P429, DOI 10.1038/nnano.2008.160; ZYLBERSZTEJN A, 1975, PHYS REV B, V11, P4383, DOI 10.1103/PhysRevB.11.4383	28	699	723	13	342	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1518	1521		10.1126/science.1176580	http://dx.doi.org/10.1126/science.1176580			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19696311	Green Submitted			2022-12-28	WOS:000269887900032
J	Emery, S; Winston, A				Emery, Sean; Winston, Alan			Raltegravir: a new choice in HIV and new chances for research	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; INTEGRASE INHIBITOR; INFECTION		[Emery, Sean] Univ New S Wales, Therapeut & Vaccine Res Program, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia; [Winston, Alan] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Div Med, London, England	University of New South Wales Sydney; Kirby Institute; Imperial College London	Emery, S (corresponding author), Univ New S Wales, Therapeut & Vaccine Res Program, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia.	semery@nchecr.unsw.edu.au	Emery, Sean/O-9122-2019; Winston, Alan/AGZ-3015-2022; Emery, Sean/J-3825-2017	Emery, Sean/0000-0001-6072-8309; Winston, Alan/0000-0002-5847-8416; Emery, Sean/0000-0001-6072-8309				*CLINICALTRIALS GO, STUD SAF EFF ELV EMT; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; ERON J, 2009, 15 C RETR OPP INF MO, pALB70; Evering TH, 2008, EXPERT OPIN INV DRUG, V17, P413, DOI 10.1517/13543784.17.3.413 ; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Pace P, 2008, CURR OPIN DRUG DISC, V11, P471; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Wenning LA, 2009, ANTIMICROB AGENTS CH, V53, P2852, DOI 10.1128/AAC.01468-08	10	12	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 5	2009	374	9692					764	766		10.1016/S0140-6736(09)61392-1	http://dx.doi.org/10.1016/S0140-6736(09)61392-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492QU	19647865				2022-12-28	WOS:000269675000007
J	Utikal, J; Polo, JM; Stadtfeld, M; Maherali, N; Kulalert, W; Walsh, RM; Khalil, A; Rheinwald, JG; Hochedlinger, K				Utikal, Jochen; Polo, Jose M.; Stadtfeld, Matthias; Maherali, Nimet; Kulalert, Warakorn; Walsh, Ryan M.; Khalil, Adam; Rheinwald, James G.; Hochedlinger, Konrad			Immortalization eliminates a roadblock during cellular reprogramming into iPS cells	NATURE			English	Article							PLURIPOTENT STEM-CELLS; TUMOR SUPPRESSION; INK4A LOCUS; LIFE-SPAN; FIBROBLASTS; EFFICIENCY; SYSTEM; GENERATION; PROMOTER; LIMITS	The overexpression of defined transcription factors in somatic cells results in their reprogramming into induced pluripotent stem (iPS) cells(1-3). The extremely low efficiency and slow kinetics of in vitro reprogramming suggest that further rare events are required to generate iPS cells. The nature and identity of these events, however, remain elusive. We noticed that the reprogramming potential of primary murine fibroblasts into iPS cells decreases after serial passaging and the concomitant onset of senescence. Consistent with the notion that loss of replicative potential provides a barrier for reprogramming, here we show that cells with low endogenous p19(Arf) (encoded by the Ink4a/Arf locus, also known as Cdkn2a locus) protein levels and immortal fibroblasts deficient in components of the Arf-Trp53 pathway yield iPS cell colonies with up to threefold faster kinetics and at a significantly higher efficiency than wild-type cells, endowing almost every somatic cell with the potential to form iPS cells. Notably, the acute genetic ablation of Trp53 (also known as p53) in cellular sub-populations that normally fail to reprogram rescues their ability to produce iPS cells. Our results show that the acquisition of immortality is a crucial and rate-limiting step towards the establishment of a pluripotent state in somatic cells and underscore the similarities between induced pluripotency and tumorigenesis.	[Utikal, Jochen; Polo, Jose M.; Stadtfeld, Matthias; Maherali, Nimet; Kulalert, Warakorn; Walsh, Ryan M.; Khalil, Adam; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Utikal, Jochen; Polo, Jose M.; Stadtfeld, Matthias; Maherali, Nimet; Kulalert, Warakorn; Walsh, Ryan M.; Khalil, Adam; Hochedlinger, Konrad] Harvard Stem Cell Inst, Ctr Regenerat Med, Boston, MA 02114 USA; [Utikal, Jochen; Polo, Jose M.; Stadtfeld, Matthias; Maherali, Nimet; Kulalert, Warakorn; Walsh, Ryan M.; Khalil, Adam; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Utikal, Jochen] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, D-68135 Mannheim, Germany; [Maherali, Nimet] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Rheinwald, James G.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Rheinwald, James G.] Harvard Skin Dis Res Ctr, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Ruprecht Karls University Heidelberg; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu		Stadtfeld, Matthias/0000-0002-5852-9906; Polo, Jose M/0000-0002-2531-778X; Utikal, Jochen/0000-0001-5316-0241	Mildred Scheel Foundation; ECOR fellowship; Schering Foundation; NIH Skin Disease Research Center Grant; Natural Sciences and Engineering Council of Canada; NIH Director's Innovator Award; Harvard Stem Cell Institute; Kimmel Foundation and the V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Mildred Scheel Foundation(Deutsche Krebshilfe); ECOR fellowship; Schering Foundation; NIH Skin Disease Research Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH Director's Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Kimmel Foundation and the V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Roussel and C. Sherr for providing us with Arf-GFP cells, D. C. Bennett and E. Sviderskaya for sharing Melan A cells, and A. Ventura and T. Jacks for tail biopsies of conditional Trp53-mutant mice. We also thank A. Tzatsos and N. Bardeesy for suggestions, for critical reading of the manuscript and for providing Ink4a/Arf2/2 MEFs. We are grateful to P. Follett for blastocyst injections and L. Prickett and K. Folz-Donahue for assistance with FACS. J. U. was supported by a postdoctoral fellowship from the Mildred Scheel Foundation, J. M. P. by an ECOR fellowship, and M. S. by a fellowship from the Schering Foundation. J. G. R. was supported by an NIH Skin Disease Research Center Grant. N. M. was supported by a graduated scholarship from the Natural Sciences and Engineering Council of Canada. Support to K. H. came from the NIH Director's Innovator Award, the Harvard Stem Cell Institute, the Kimmel Foundation and the V Foundation.	BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; EMINLI S, NATURE GENE IN PRESS; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100	29	651	703	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1145	U112		10.1038/nature08285	http://dx.doi.org/10.1038/nature08285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19668190	Green Accepted			2022-12-28	WOS:000269314000042
J	Cummings, SR; San Martin, J; McClung, MR; Siris, ES; Eastell, R; Reid, IR; Delmas, P; Zoog, HB; Austin, M; Wang, A; Kutilek, S; Adami, S; Zanchetta, J; Libanati, C; Siddhanti, S; Christiansen, C				Cummings, Steven R.; San Martin, Javier; McClung, Michael R.; Siris, Ethel S.; Eastell, Richard; Reid, Ian R.; Delmas, Pierre; Zoog, Holly B.; Austin, Matt; Wang, Andrea; Kutilek, Stepan; Adami, Silvano; Zanchetta, Jose; Libanati, Cesar; Siddhanti, Suresh; Christiansen, Claus		FREEDOM Trial	Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; NONVERTEBRAL FRACTURES; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL; RISK; RISEDRONATE; ALENDRONATE; THERAPY; TURNOVER; LONG	BACKGROUND Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear factor-kappa B ligand (RANKL) that blocks its binding to RANK, inhibiting the development and activity of osteoclasts, decreasing bone resorption, and increasing bone density. Given its unique actions, denosumab may be useful in the treatment of osteoporosis. METHODS We enrolled 7868 women between the ages of 60 and 90 years who had a bone mineral density T score of less than -2.5 but not less than -4.0 at the lumbar spine or total hip. Subjects were randomly assigned to receive either 60 mg of denosumab or placebo subcutaneously every 6 months for 36 months. The primary end point was new vertebral fracture. Secondary end points included nonvertebral and hip fractures. RESULTS As compared with placebo, denosumab reduced the risk of new radiographic vertebral fracture, with a cumulative incidence of 2.3% in the denosumab group, versus 7.2% in the placebo group (risk ratio, 0.32; 95% confidence interval [CI], 0.26 to 0.41; P<0.001)-a relative decrease of 68%. Denosumab reduced the risk of hip fracture, with a cumulative incidence of 0.7% in the denosumab group, versus 1.2% in the placebo group (hazard ratio, 0.60; 95% CI, 0.37 to 0.97; P=0.04)-a relative decrease of 40%. Denosumab also reduced the risk of nonvertebral fracture, with a cumulative incidence of 6.5% in the denosumab group, versus 8.0% in the placebo group (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01)-a relative decrease of 20%. There was no increase in the risk of cancer, infection, cardiovascular disease, delayed fracture healing, or hypocalcemia, and there were no cases of osteonecrosis of the jaw and no adverse reactions to the injection of denosumab. CONCLUSIONS Denosumab given subcutaneously twice yearly for 36 months was associated with a reduction in the risk of vertebral, nonvertebral, and hip fractures in women with osteoporosis. (ClinicalTrials.gov number, NCT00089791.)	[Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, San Francisco, CA USA; [Cummings, Steven R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [San Martin, Javier; Zoog, Holly B.; Austin, Matt; Wang, Andrea; Libanati, Cesar; Siddhanti, Suresh] Amgen Inc, Thousand Oaks, CA USA; [McClung, Michael R.] Oregon Osteoporosis Ctr, Portland, OR USA; [Siris, Ethel S.] Columbia Univ, Med Ctr, New York, NY USA; [Eastell, Richard] Univ Sheffield, Sheffield, S Yorkshire, England; [Reid, Ian R.] Univ Auckland, Auckland 1, New Zealand; [Delmas, Pierre] Univ Lyon, Lyon, France; [Delmas, Pierre] INSERM, Res Unit 831, F-69008 Lyon, France; [Kutilek, Stepan] Ctr Clin & Basic Res, Pardubice, Czech Republic; [Adami, Silvano] Univ Verona, I-37100 Verona, Italy; [Zanchetta, Jose] Inst Invest Metab, Buenos Aires, DF, Argentina; [Zanchetta, Jose] Univ Salvador, Buenos Aires, DF, Argentina; [Libanati, Cesar] Ctr Clin & Basic Res, Ballerup, Denmark	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; Amgen; Oregon Osteoporosis Center; Columbia University; University of Sheffield; University of Auckland; Institut National de la Sante et de la Recherche Medicale (Inserm); Center Clinical & Basic Research; University of Verona; Center Clinical & Basic Research	Cummings, SR (corresponding author), 185 Berry St Lobby 4,Suite 5700, San Francisco, CA 94107 USA.	hglicklandes@sfcc-cpmc.net	Del Pino-Montes, Javier/M-3544-2014; Eastell, Richard/G-5851-2011; McClung, Michael/ABA-4100-2021	Del Pino-Montes, Javier/0000-0002-3145-6137; Eastell, Richard/0000-0002-0323-3366; McClung, Michael/0000-0002-7827-0778; Jensen, Jens-Erik Beck/0000-0003-4290-0480; Reid, Ian/0000-0001-6021-5458; WERYHA, Georges/0000-0003-2062-3419; Lippuner, Kurt/0000-0002-7195-3779	Amgen	Amgen(Amgen)	Supported by Amgen.	Agresti A, 2003, CATEGORICAL DATA ANA; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bone HG, 2008, J CLIN ENDOCR METAB, V93, P2149, DOI 10.1210/jc.2007-2814; Bouxsein ML, 2008, J BONE MINER RES, V23, P1155, DOI 10.1359/JBMR.080301; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown JP, 2009, J BONE MINER RES, V24, P153, DOI [10.1359/JBMR.0809010, 10.1359/jbmr.080901]; Capron A, 2003, J BONE MINER RES, V18, P1160, DOI 10.1359/jbmr.2003.18.6.1160; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Delmas PD, 2008, J CLIN DENSITOM, V11, P325, DOI 10.1016/j.jocd.2008.02.002; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Harrington JT, 2004, CALCIFIED TISSUE INT, V74, P129, DOI 10.1007/s00223-003-0042-4; HARRIS ST, 1993, AM J MED, V95, P557, DOI 10.1016/0002-9343(93)90350-X; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Jorgensen EB, 2008, KAIS, V2021, P1, DOI [DOI 10.1002/14651858.CD001155.PUB2, 10.1002/mp.15257]; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Lewiecki EM, 2007, J BONE MINER RES, V22, P1832, DOI 10.1359/JBMR.070809; Maricic M, 2002, ARCH INTERN MED, V162, P1140, DOI 10.1001/archinte.162.10.1140; Martin T. J., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P243; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Miller PD, 2008, BONE, V43, P222, DOI 10.1016/j.bone.2008.04.007; Mueller PS, 2007, ANN INTERN MED, V146, P878, DOI 10.7326/0003-4819-146-12-200706190-00009; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Sebba AI, 2005, CURR MED RES OPIN, V21, P325; Sebba AI, 2004, CURR MED RES OPIN, V20, P2031, DOI 10.1185/030079904X16768; Silverman SL, 2008, J BONE MINER RES, V23, P159, DOI 10.1359/JBMR.070905; Siris ES, 2006, MAYO CLIN PROC, V81, P1013, DOI 10.4065/81.8.1013; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Whyte MP, 2006, NEW ENGL J MED, V355, P638; Whyte MP, 2006, NEW ENGL J MED, V354, P860, DOI 10.1056/NEJMe068003	37	2055	2160	5	217	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					756	765		10.1056/NEJMoa0809493	http://dx.doi.org/10.1056/NEJMoa0809493			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484WX	19671655	Bronze			2022-12-28	WOS:000269081200004
J	Manning, A				Manning, Adrian			Personal View Glad to be here	BRITISH MEDICAL JOURNAL			English	Editorial Material												amanning@blueyonder.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 19	2009	339								b3356	10.1136/bmj.b3356	http://dx.doi.org/10.1136/bmj.b3356			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486SB	19692445				2022-12-28	WOS:000269216900006
J	Bormuth, V; Varga, V; Howard, J; Schaffer, E				Bormuth, Volker; Varga, Vladimir; Howard, Jonathon; Schaeffer, Erik			Protein Friction Limits Diffusive and Directed Movements of Kinesin Motors on Microtubules	SCIENCE			English	Article							DEPENDENT MANNER; MOLECULAR MOTORS; FORCE; MICROSPHERES; SPINDLE; ENDS	Friction limits the operation of macroscopic engines and is critical to the performance of micromechanical devices. We report measurements of friction in a biological nanomachine. Using optical tweezers, we characterized the frictional drag force of individual kinesin-8 motor proteins interacting with their microtubule tracks. At low speeds and with no energy source, the frictional drag was related to the diffusion coefficient by the Einstein relation. At higher speeds, the frictional drag force increased nonlinearly, consistent with the motor jumping 8 nanometers between adjacent tubulin dimers along the microtubule, and was asymmetric, reflecting the structural polarity of the microtubule. We argue that these frictional forces arise from breaking bonds between the motor domains and the microtubule, and they limit the speed and efficiency of kinesin.	[Bormuth, Volker; Varga, Vladimir; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Schaeffer, Erik] Tech Univ Dresden, Nanomech Grp, Biotechnol Ctr, D-01307 Dresden, Germany	Max Planck Society; Technische Universitat Dresden	Howard, J (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	Howard@mpi-cbg.de; Erik.Schaeffer@biotec.tu-dresden.de	Schäffer, Erik/A-4664-2010; Howard, Jonathon/D-4229-2011	Schäffer, Erik/0000-0001-7876-085X; Howard, Jonathon/0000-0003-0086-1196; Varga, Vladimir/0000-0002-0384-1281	Deutsche Forschungsgemeinschaft (E. Noether Program); Max Planck Society; Technische Universitat Dresden; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft (E. Noether Program)(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Technische Universitat Dresden; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	The work was supported by the Deutsche Forschungsgemeinschaft (E. Noether Program), the Max Planck Society, and the Technische Universitat Dresden. V.B. had a fellowship from the Boehringer Ingelheim Fonds.	Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Bormuth V, 2008, OPT EXPRESS, V16, P13831, DOI 10.1364/OE.16.013831; BRENNER B, 1982, P NATL ACAD SCI-BIOL, V79, P7288, DOI 10.1073/pnas.79.23.7288; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Charvin G, 2002, SINGLE MOL, V3, P43, DOI 10.1002/1438-5171(200204)3:1<43::AID-SIMO43>3.3.CO;2-J; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Fisher ME, 1999, P NATL ACAD SCI USA, V96, P6597, DOI 10.1073/pnas.96.12.6597; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Howard J, 2001, MOTOR PROTEINS CYTOS; Howard J, 2009, ANNU REV BIOPHYS, V38, P217, DOI 10.1146/annurcv.biophys.050708.133732; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Parmeggiani A, 1999, PHYS REV E, V60, P2127, DOI 10.1103/PhysRevE.60.2127; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Schaffer E, 2007, LANGMUIR, V23, P3654, DOI 10.1021/la0622368; Suda H, 2001, LANGMUIR, V17, P6045, DOI 10.1021/la0106384; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; TAWADA K, 1991, J THEOR BIOL, V150, P193, DOI 10.1016/S0022-5193(05)80331-5; Thomas N, 2001, P ROY SOC B-BIOL SCI, V268, P2113, DOI 10.1098/rspb.2001.1764; Tolic-Norrelykke SF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2356852; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	34	161	162	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					870	873		10.1126/science.1174923	http://dx.doi.org/10.1126/science.1174923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679813				2022-12-28	WOS:000269242400045
J	Halpern, JP				Halpern, Jules P.			Gamma-Ray Pulsars Old and New	SCIENCE			English	Editorial Material									Columbia Univ, Dept Astron, New York, NY 10027 USA	Columbia University	Halpern, JP (corresponding author), Columbia Univ, Dept Astron, 550 W 120th St, New York, NY 10027 USA.	jules@astro.columbia.edu						Abdo AA, 2009, SCIENCE, V325, P840, DOI 10.1126/science.1175558; Abdo AA, 2009, SCIENCE, V325, P848, DOI 10.1126/science.1176113; Abdo AA, 2009, ASTROPHYS J LETT, V700, pL127, DOI 10.1088/0004-637X/700/2/L127	4	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					821	822		10.1126/science.1178573	http://dx.doi.org/10.1126/science.1178573			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679800				2022-12-28	WOS:000269242400029
J	He, Y; Jones, CR; Fujiki, N; Xu, Y; Guo, B; Holder, JL; Rossner, MJ; Nishino, S; Fu, YH				He, Ying; Jones, Christopher R.; Fujiki, Nobuhiro; Xu, Ying; Guo, Bin; Holder, Jimmy L., Jr.; Rossner, Moritz J.; Nishino, Seiji; Fu, Ying-Hui			The Transcriptional Repressor DEC2 Regulates Sleep Length in Mammals	SCIENCE			English	Article							PHASE SYNDROME; MOLECULAR CLOCK; MUSHROOM BODIES; MUTANT MICE; DROSOPHILA; EXPRESSION; MUTATION; CONSEQUENCES; NEUROBIOLOGY; DEPRIVATION	Sleep deprivation can impair human health and performance. Habitual total sleep time and homeostatic sleep response to sleep deprivation are quantitative traits in humans. Genetic loci for these traits have been identified in model organisms, but none of these potential animal models have a corresponding human genotype and phenotype. We have identified a mutation in a transcriptional repressor (hDEC2-P385R) that is associated with a human short sleep phenotype. Activity profiles and sleep recordings of transgenic mice carrying this mutation showed increased vigilance time and less sleep time than control mice in a zeitgeber time- and sleep deprivation-dependent manner. These mice represent a model of human sleep homeostasis that provides an opportunity to probe the effect of sleep on human physical and mental health.	[He, Ying; Xu, Ying; Holder, Jimmy L., Jr.; Fu, Ying-Hui] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Jones, Christopher R.] Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA; [Fujiki, Nobuhiro; Nishino, Seiji] Stanford Univ, Sleep & Circadian Neurobiol Lab, Palo Alto, CA 94304 USA; [Guo, Bin] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Rossner, Moritz J.] Max Planck Inst Expt Med, D-37075 Gottingen, Germany	University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Stanford University; University of California System; University of California Berkeley; Max Planck Society	Fu, YH (corresponding author), Univ Calif San Francisco, Dept Neurol, Mission Bay,1550 4th St, San Francisco, CA 94158 USA.	ying-hui.fu@ucsf.edu	Xu, Ying/A-3009-2013; He, Ying/B-3952-2010; Holder, J. Lloyd/AFT-0389-2022; Xu, Ying/AAF-3081-2019	Xu, Ying/0000-0002-6689-7768; He, Ying/0000-0002-2052-8350; Xu, Ying/0000-0002-6689-7768; Rossner, Moritz/0000-0002-0667-3420	NIH [HL059596]; Conte Center [MH074924]; Sandler Neurogenetics fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conte Center; Sandler Neurogenetics fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grant HL059596, Conte Center grant (MH074924), and by the Sandler Neurogenetics fund.	Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103; Fuller PM, 2006, J BIOL RHYTHM, V21, P482, DOI 10.1177/0748730406294627; Hamaguchi H, 2004, BIOCHEM J, V382, P43, DOI 10.1042/BJ20031760; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Kondo J, 2006, INT J MOL MED, V17, P1053; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Noshiro M, 2005, J BIOL RHYTHM, V20, P404, DOI 10.1177/0748730405280195; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; YANG MY, 1995, NEURON, V15, P45; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	23	200	208	4	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					866	870		10.1126/science.1174443	http://dx.doi.org/10.1126/science.1174443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679812	Green Accepted			2022-12-28	WOS:000269242400044
J	Webb, J; Domanski, M				Webb, John; Domanski, Marian			Fire and Stone	SCIENCE			English	Editorial Material							LITHIC TECHNOLOGY		[Webb, John; Domanski, Marian] La Trobe Univ, Bundoora, Vic 3086, Australia	La Trobe University	Webb, J (corresponding author), La Trobe Univ, Bundoora, Vic 3086, Australia.	John.Webb@latrobe.edu.au	Webb, John/B-2479-2012	Webb, John/0000-0002-6357-5966				Akerman K., 1979, ARCHAEOLOGY PHYS ANT, V14; [Anonymous], 1964, TEBIWA; BINFORD LR, 1979, J ANTHROPOL RES, V35, P255, DOI 10.1086/jar.35.3.3629902; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; DOMANSKI M, 1992, J ARCHAEOL SCI, V19, P601, DOI 10.1016/0305-4403(92)90031-W; Domanski M., 1994, ARCHAEOMETRY, V36, P177, DOI DOI 10.1111/J.1475-4754.1994.TB00963.X; Domanski M, 2007, LITHIC TECHNOL, V32, P153, DOI 10.1080/01977261.2007.11721052; FLENNIKEN JJ, 1978, AM ANTIQUITY, V43, P473, DOI 10.2307/279406; INIZAN ML, 1992, MATER RES SOC SYMP P, V267, P661, DOI 10.1557/PROC-267-661; Kenoyer JM, 1994, LIVING TRADITIONS ST, P281; Torrence Robin., 1983, HUNTER GATHERER EC P, P11, DOI DOI 10.1073/PNAS.0913047107	11	12	13	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					820	821		10.1126/science.1178014	http://dx.doi.org/10.1126/science.1178014			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679799				2022-12-28	WOS:000269242400028
J	Finkelstein, J				Finkelstein, Joshua			METALLOPROTEINS	NATURE			English	Editorial Material														Finkelstein, Joshua/0000-0003-2613-9345					0	36	37	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 13	2009	460	7257					813	813		10.1038/460813a	http://dx.doi.org/10.1038/460813a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675640	Bronze			2022-12-28	WOS:000268938300024
J	Lill, R				Lill, Roland			Function and biogenesis of iron-sulphur proteins	NATURE			English	Review							FE-S CLUSTER; CYSTEINE DESULFURASE ACTIVITY; ESCHERICHIA-COLI; SCAFFOLD PROTEIN; CRYSTAL-STRUCTURE; ASSEMBLY PROTEIN; 2FE-2S CLUSTER; MITOCHONDRIAL; ISCU; TRANSPORTER	Iron-sulphur (Fe-S) clusters have long been recognized as essential and versatile cofactors of proteins involved in catalysis, electron transport and sensing of ambient conditions. Despite the relative simplicity of Fe-S clusters in terms of structure and composition, their synthesis and assembly into apoproteins is a highly complex and coordinated process in living cells. Different biogenesis machineries in both bacteria and eukaryotes have been discovered that assist Fe-S-protein maturation according to uniform biosynthetic principles. The importance of Fe-S proteins for life is documented by an increasing number of diseases linked to these components and their biogenesis.	Univ Marburg, Inst Zytobiol, D-35033 Marburg, Germany	Philipps University Marburg	Lill, R (corresponding author), Univ Marburg, Inst Zytobiol, Robert Koch Str 6, D-35033 Marburg, Germany.	lill@staff.uni-marburg.de		Lill, Roland/0000-0002-8345-6518	Deutsche Forschungsgemeinschaft [SFB 593, TR1, GRK 1216]; Max-Planck Gesellschaft; von Behring-Rntgen-Stiftung; German-Israeli Foundation for Scientific Research and Development; Alexander von Humboldt-Stiftung; Rhn Klinikum AG; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Gesellschaft(Max Planck Society); von Behring-Rntgen-Stiftung; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation); Rhn Klinikum AG; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	I wish to thank all present and past members of my group for their excellent and dedicated work. Generous financial support from the Deutsche Forschungsgemeinschaft (SFB 593 and TR1, Gottfried-Wilhelm Leibniz programme and GRK 1216), the Max-Planck Gesellschaft, the von Behring-Rntgen-Stiftung, the German-Israeli Foundation for Scientific Research and Development, the Alexander von Humboldt-Stiftung, Rhn Klinikum AG and Fonds der Chemischen Industrie is gratefully acknowledged. I apologize to all colleagues whose original work could not be discussed or cited owing to length limitations.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bekri S, 2000, BLOOD, V96, P3256; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Bonomi F, 2008, BIOCHEMISTRY-US, V47, P12795, DOI 10.1021/bi801565j; Booker SJ, 2007, CURR OPIN CHEM BIOL, V11, P543, DOI 10.1016/j.cbpa.2007.08.028; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Dutkiewicz R, 2004, J BIOL CHEM, V279, P29167, DOI 10.1074/jbc.M402947200; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Karcher A, 2008, J BIOL CHEM, V283, P7962, DOI 10.1074/jbc.M707347200; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leach MR, 2007, CURR OPIN CHEM BIOL, V11, P159, DOI 10.1016/j.cbpa.2007.01.011; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Liu GH, 2005, PROTEIN SCI, V14, P1597, DOI 10.1110/ps.041322705; Liu JY, 2005, PROTEINS, V59, P875, DOI 10.1002/prot.20421; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; MALKIN R, 1966, BIOCHEM BIOPH RES CO, V23, P822, DOI 10.1016/0006-291X(66)90561-4; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Riboldi GP, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-3; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Sendra M, 2007, FEBS LETT, V581, P1362, DOI 10.1016/j.febslet.2007.02.058; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Stehling O, 2004, HUM MOL GENET, V13, P3007, DOI 10.1093/hmg/ddh324; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; Tokumoto U, 2004, J BIOCHEM, V136, P199, DOI 10.1093/jb/mvh104; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Volz K, 2008, CURR OPIN STRUC BIOL, V18, P106, DOI 10.1016/j.sbi.2007.12.010; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Xu XM, 2008, CHEMBIOCHEM, V9, P2355, DOI 10.1002/cbic.200800384; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Ye H, 2006, NEW PHYTOL, V171, P285, DOI 10.1111/j.1469-8137.2006.01751.x; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	100	792	812	6	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					831	838		10.1038/nature08301	http://dx.doi.org/10.1038/nature08301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675643				2022-12-28	WOS:000268938300027
J	Mattson-DiCecca, AA; Reynolds, E				Mattson-DiCecca, Anna A.; Reynolds, Eileen			Update: A 68-Year-Old Man With COPD Contemplating Colon Cancer Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Smetana GW, 2007, JAMA-J AM MED ASSOC, V297, P2121, DOI 10.1001/jama.297.19.2121	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					678	678		10.1001/jama.2009.1148	http://dx.doi.org/10.1001/jama.2009.1148			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481ZI	19671908				2022-12-28	WOS:000268852300026
J	Mackay, TFC				Mackay, Trudy F. C.			A-maize-ing Diversity	SCIENCE			English	Editorial Material							QUANTITATIVE TRAIT LOCI; ARABIDOPSIS-THALIANA; GENETIC ARCHITECTURE; PHOTOPERIOD; RICE; MAP		N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Mackay, TFC (corresponding author), N Carolina State Univ, Dept Genet, Campus Box 7614, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu			NIGMS NIH HHS [GM45146] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso-Blanco C, 1998, GENETICS, V149, P749; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; LIN YR, 1995, GENETICS, V141, P391; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Uwatoko N, 2008, EUPHYTICA, V163, P167, DOI 10.1007/s10681-007-9584-2; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yano M, 1997, THEOR APPL GENET, V95, P1025, DOI 10.1007/s001220050658; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245	15	6	6	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 7	2009	325	5941					688	689		10.1126/science.1178420	http://dx.doi.org/10.1126/science.1178420			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661410				2022-12-28	WOS:000268723700028
J	Pernia-Andrade, AJ; Kato, A; Witschi, R; Nyilas, R; Katona, I; Freund, TF; Watanabe, M; Filitz, J; Koppert, W; Schuttler, J; Ji, GC; Neugebauer, V; Marsicano, G; Lutz, B; Vanegas, H; Zeilhofer, HU				Pernia-Andrade, Alejandro J.; Kato, Ako; Witschi, Robert; Nyilas, Rita; Katona, Istvan; Freund, Tamas F.; Watanabe, Masahiko; Filitz, Joerg; Koppert, Wolfgang; Schuettler, Juergen; Ji, Guangchen; Neugebauer, Volker; Marsicano, Giovanni; Lutz, Beat; Vanegas, Horacio; Zeilhofer, Hanns Ulrich			Spinal Endocannabinoids and CB1 Receptors Mediate C-Fiber-Induced Heterosynaptic Pain Sensitization	SCIENCE			English	Article							EVOKED ALLODYNIA; NEURONS; SYSTEM; DISINHIBITION; TARGET	Diminished synaptic inhibition in the spinal dorsal horn is a major contributor to chronic pain. Pathways that reduce synaptic inhibition in inflammatory and neuropathic pain states have been identified, but central hyperalgesia and diminished dorsal horn synaptic inhibition also occur in the absence of inflammation or neuropathy, solely triggered by intense nociceptive (C-fiber) input to the spinal dorsal horn. We found that endocannabinoids, produced upon strong nociceptive stimulation, activated type 1 cannabinoid (CB1) receptors on inhibitory dorsal horn neurons to reduce the synaptic release of gamma-aminobutyric acid and glycine and thus rendered nociceptive neurons excitable by nonpainful stimuli. Our results suggest that spinal endocannabinoids and CB1 receptors on inhibitory dorsal horn interneurons act as mediators of heterosynaptic pain sensitization and play an unexpected role in dorsal horn pain-controlling circuits.	[Pernia-Andrade, Alejandro J.; Kato, Ako; Witschi, Robert; Zeilhofer, Hanns Ulrich] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Nyilas, Rita; Katona, Istvan; Freund, Tamas F.] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Filitz, Joerg; Koppert, Wolfgang; Schuettler, Juergen] Univ Erlangen Nurnberg, Dept Anesthesiol, D-91054 Erlangen, Germany; [Ji, Guangchen; Neugebauer, Volker] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Marsicano, Giovanni] Ctr Rech, INSERM Francois Magendie, U862, F-33077 Bordeaux, France; [Lutz, Beat] Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, D-55099 Mainz, Germany; [Vanegas, Horacio] Inst Venezolano Invest Cient, Caracas 1020A, Venezuela; [Kato, Ako; Witschi, Robert; Vanegas, Horacio; Zeilhofer, Hanns Ulrich] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	University of Zurich; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hokkaido University; University of Erlangen Nuremberg; University of Texas System; University of Texas Medical Branch Galveston; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Johannes Gutenberg University of Mainz; Venezuelan Institute Science Research; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zeilhofer, HU (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	zeilhofer@pharma.uzh.ch	Watanabe, Masahiko/S-3614-2019; Lutz, Beat/AAG-4538-2022; Marsicano, Giovanni/I-9603-2016; Lutz, Beat/AFK-6229-2022; WATANABE, Masahiko/A-4055-2012; Zeilhofer, Hanns Ulrich/A-4600-2008; Katona, Istvan/D-9729-2011	Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138; Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Katona, Istvan/0000-0003-2808-3330; Nyilas, Rita/0000-0002-9634-9535; Marsicano, Giovanni/0000-0003-3804-1951; Schuttler, Jurgen/0000-0001-5088-2169	Schweizerischer National Fonds [3100A0-116064/1]; Deutsche Forschungsgemeinschaft [KO 1878/2-2, ZE 377/8-2]; NIH [NS38261, NS11255]; European Union [LSHM-CT-2004-005166]; OTKA [F046407]; ETT [561/2006]; German DAAD; Venezuelan FONACIT; Janos Bolyai scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011255, R01NS038261] Funding Source: NIH RePORTER	Schweizerischer National Fonds(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ETT; German DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Venezuelan FONACIT; Janos Bolyai scholarship(Hungarian Academy of Sciences); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by grants from the Schweizerischer National Fonds to H.U.Z. (3100A0-116064/1), from the Deutsche Forschungsgemeinschaft to W.K. (KO 1878/2-2) and H.U.Z. (ZE 377/8-2), from NIH (NS38261 and NS11255) to V.N., from the European Union (LSHM-CT-2004-005166) to T.F.F., and from the OTKA (F046407) and ETT (561/2006) to I.K. A.J.P.A. was supported partly by scholarships from the German DAAD and the Venezuelan FONACIT for graduate study at IVIC. I.K. was supported by a Janos Bolyai scholarship. The authors thank R. Kuner and C. V. Wright for providing sns-cre and ptf1a-cre mice, respectively, J.-M. Fritschy, H. Handwerker, H. Mohler, and M. Schmelz for critical reading of the manuscript, T. Muller for very valuable suggestions, and I. Camenisch and L. Scheurer for genotyping of the mice.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Farquhar-Smith WP, 2000, MOL CELL NEUROSCI, V15, P510, DOI 10.1006/mcne.2000.0844; Fioravanti B, 2008, J NEUROSCI, V28, P11593, DOI 10.1523/JNEUROSCI.3322-08.2008; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Jennings EA, 2001, J PHYSIOL-LONDON, V534, P805, DOI 10.1111/j.1469-7793.2001.00805.x; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Neugebauer V, 1999, J NEUROPHYSIOL, V82, P272, DOI 10.1152/jn.1999.82.1.272; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; SIVILOTTI L, 1994, J NEUROPHYSIOL, V72, P169, DOI 10.1152/jn.1994.72.1.169; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; Treede R D, 2000, Prog Brain Res, V129, P331; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349	24	140	144	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					760	764		10.1126/science.1171870	http://dx.doi.org/10.1126/science.1171870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19661434	Green Accepted			2022-12-28	WOS:000268723700053
J	Pipkin, ME; Rao, A				Pipkin, Matthew E.; Rao, Anjana			SnapShot: Effector and Memory T Cell Differentiation	CELL			English	Editorial Material									[Pipkin, Matthew E.; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Pipkin, ME (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.			Pipkin, Matthew/0000-0002-9688-0190	NCI NIH HHS [F32 CA126247-02, F32 CA126247, R01 CA042471] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042471, F32CA126247] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Singh H, 2007, NAT IMMUNOL, V8, P119, DOI 10.1038/ni0207-119; Taniuchi I, 2009, CURR OPIN IMMUNOL, V21, P127, DOI 10.1016/j.coi.2009.03.012; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	9	8	8	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					606	U209	606.e1	10.1016/j.cell.2009.07.020	http://dx.doi.org/10.1016/j.cell.2009.07.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665979	Green Accepted, Bronze			2022-12-28	WOS:000268771900024
J	MacMillan, HL; Wathen, CN; Jamieson, E; Boyle, MH; Shannon, HS; Ford-Gilboe, M; Worster, A; Lent, B; Coben, JH; Campbell, JC; McNutt, LA				MacMillan, Harriet L.; Wathen, C. Nadine; Jamieson, Ellen; Boyle, Michael H.; Shannon, Harry S.; Ford-Gilboe, Marilyn; Worster, Andrew; Lent, Barbara; Coben, Jeffrey H.; Campbell, Jacquelyn C.; McNutt, Louise-Anne		McMaster Violence Women Res Grp	Screening for Intimate Partner Violence in Health Care Settings A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; DOMESTIC VIOLENCE; PROFESSIONALS SCREEN; TASK-FORCE; WOMEN; ABUSE; FAMILY; VALIDATION; SCALES	Context Whether intimate partner violence (IPV) screening reduces violence or improves health outcomes for women is unknown. Objective To determine the effectiveness of IPV screening and communication of positive results to clinicians. Design, Setting, and Participants Randomized controlled trial conducted in 11 emergency departments, 12 family practices, and 3 obstetrics/gynecology clinics in Ontario, Canada, among 6743 English-speaking female patients aged 18 to 64 years who presented between July 2005 and December 2006, could be seen individually, and were well enough to participate. Intervention Women in the screened group (n=3271) self-completed the Woman Abuse Screening Tool (WAST); if a woman screened positive, this information was given to her clinician before the health care visit. Subsequent discussions and/or referrals were at the discretion of the treating clinician. The nonscreened group (n=3472) self-completed the WAST and other measures after their visit. Main Outcome Measures Women disclosing past-year IPV were interviewed at baseline and every 6 months until 18 months regarding IPV reexposure and quality of life (primary outcomes), as well as several health outcomes and potential harms of screening. Results Participant loss to follow-up was high: 43% (148/347) of screened women and 41% (148/360) of nonscreened women. At 18 months (n=411), observed recurrence of IPV among screened vs nonscreened women was 46% vs 53% (modeled odds ratio, 0.82; 95% confidence interval, 0.32-2.12). Screened vs nonscreened women exhibited about a 0.2-SD greater improvement in quality-of-life scores ( modeled score difference at 18 months, 3.74; 95% confidence interval, 0.47-7.00). When multiple imputation was used to account for sample loss, differences between groups were reduced and quality-of-life differences were no longer significant. Screened women reported no harms of screening. Conclusions Although sample attrition urges cautious interpretation, the results of this trial do not provide sufficient evidence to support IPV screening in health care settings. Evaluation of services for women after identification of IPV remains a priority. Trial Registration clinicaltrials.gov Identifier: NCT00182468 JAMA. 2009;302(5):493-501 www.jama.com	[MacMillan, Harriet L.] McMaster Univ, Offord Ctr Child Studies, Dept Psychiat & Behav Neurosci, Hamilton, ON L8N 3Z5, Canada; [MacMillan, Harriet L.] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; [Boyle, Michael H.; Shannon, Harry S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Worster, Andrew] McMaster Univ, Dept Emergency Med, Hamilton, ON L8N 3Z5, Canada; [Wathen, C. Nadine] Univ Western Ontario, Fac Informat & Media Studies, London, ON, Canada; [Ford-Gilboe, Marilyn] Univ Western Ontario, Arthur Labatt Family Sch Nursing, London, ON, Canada; [Lent, Barbara] Univ Western Ontario, Dept Family Med, London, ON, Canada; [Coben, Jeffrey H.] W Virginia Univ, Sch Med, Dept Emergency Med & Community Med, Morgantown, WV 26506 USA; [Campbell, Jacquelyn C.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA; [McNutt, Louise-Anne] SUNY Albany, Sch Publ Hlth, Dept Epidemiol, Albany, NY 12222 USA	McMaster University; McMaster University; McMaster University; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); West Virginia University; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	MacMillan, HL (corresponding author), McMaster Univ, Offord Ctr Child Studies, Dept Psychiat & Behav Neurosci, Patterson Bldg,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	macmilnh@mcmaster.ca	MacMillan, Harriet/B-4530-2016	MacMillan, Harriet/0000-0002-1223-706X	Ontario Women's Health Council; Ontario Ministry of Health and Long-Term Care, (CIHR) New Emerging Team grant from the Institutes of Gender and Health; Human Development, Child and Youth Health; Neurosciences, Mental Health, and Addiction; Population and Public Health; CIHR-Ontario Women's Health Council New Investigator Award	Ontario Women's Health Council; Ontario Ministry of Health and Long-Term Care, (CIHR) New Emerging Team grant from the Institutes of Gender and Health(Ministry of Health and Long-Term Care, OntarioCanadian Institutes of Health Research (CIHR)); Human Development, Child and Youth Health; Neurosciences, Mental Health, and Addiction; Population and Public Health; CIHR-Ontario Women's Health Council New Investigator Award(Canadian Institutes of Health Research (CIHR))	This research was generously funded by a grant from the former Ontario Women's Health Council ( Ontario Ministry of Health and Long-Term Care), whose work was taken on by Echo: Improving Women's Health in Ontario, an agency of the Ontario Ministry of Health and Long-Term Care, in 2007. Dr MacMillan held a Canadian Institutes of Health Research (CIHR) New Emerging Team grant from the Institutes of Gender and Health; Aging; Human Development, Child and Youth Health; Neurosciences, Mental Health, and Addiction; and Population and Public Health and holds the David R. (Dan) Offord Chair in Child Studies. Dr Wathen holds a CIHR-Ontario Women's Health Council New Investigator Award. Dr Boyle holds a Canada Research Chair in the Social Determinants of Child Health.	Alpert EJ, 2007, ANN INTERN MED, V147, P666, DOI 10.7326/0003-4819-147-9-200711060-00011; *AM MED ASS, 2008, POL STAT FAM INT PAR; [Anonymous], NAT CONS GUID ID RES; Bonomi AE, 2000, J CLIN EPIDEMIOL, V53, P1, DOI 10.1016/S0895-4356(99)00123-7; Brown J B, 1996, Fam Med, V28, P422; Brown JB, 2000, J FAM PRACTICE, V49, P896; BROWNE GB, 1990, MED CARE, V28, P43, DOI 10.1097/00005650-199001000-00006; Chuang CH., 2002, JCOM WAYNE PA, V9, P565; Coker AL, 2007, AM J PUBLIC HEALTH, V97, P1319, DOI 10.2105/AJPH.2005.085357; Cole TB, 2000, JAMA-J AM MED ASSOC, V284, P551, DOI 10.1001/jama.284.5.551; ElBassel N, 1997, RES SOCIAL WORK PRAC, V7, P99, DOI 10.1177/104973159700700106; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hegarty K, 1999, J FAM VIOLENCE, V14, P399, DOI 10.1023/A:1022834215681; Hegarty Kelsey, 2005, Violence Vict, V20, P529, DOI 10.1891/088667005780927548; Houry D, 2008, ANN EMERG MED, V51, P433, DOI 10.1016/j.annemergmed.2007.11.019; Joint Commission on Accreditation of Healthcare Organizations, 1996, COMPR MAN HOSP; Lock J., 2008, THESIS MCMASTER U HA; MacMillan HL, 2006, JAMA-J AM MED ASSOC, V296, P530, DOI 10.1001/jama.296.5.530; Meltzer-Brody S, 1999, PSYCHIAT RES, V88, P63, DOI 10.1016/S0165-1781(99)00070-0; Nelson HD, 2004, ANN INTERN MED, V140, P387, DOI 10.7326/0003-4819-140-5-200403020-00015; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Phelan MB, 2007, TRAUMA VIOLENCE ABUS, V8, P199, DOI 10.1177/1524838007301221; RABIN R, 2009, AM J PREV MED, V36; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramsay J, 2002, BRIT MED J, V325, P314, DOI 10.1136/bmj.325.7359.314; RASBASH J, 2000, USERS GUIDE MLWIN VE; Rodriguez MA, 1999, JAMA-J AM MED ASSOC, V282, P468, DOI 10.1001/jama.282.5.468; RUSSELL M, 1994, ALCOHOL CLIN EXP RES, V18, P1156, DOI 10.1111/j.1530-0277.1994.tb00097.x; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Taket A, 2004, PLOS MED, V1, P7, DOI 10.1371/journal.pmed.0010004; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wathen CN, 2008, WOMEN HEALTH ISS, V18, P423, DOI 10.1016/j.whi.2008.08.003; Wathen C Nadine, 2007, Open Med, V1, pe113; Wathen CN, 2003, CAN MED ASSOC J, V169, P582; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589	35	308	313	0	36	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 5	2009	302	5					493	501		10.1001/jama.2009.1089	http://dx.doi.org/10.1001/jama.2009.1089			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479DS	19654384				2022-12-28	WOS:000268640500014
J	Mirsadraee, S; Kessel, D				Mirsadraee, Saeed; Kessel, David			Case report Abdominal pain and swelling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RECTUS SHEATH HEMATOMA		[Mirsadraee, Saeed; Kessel, David] Leeds Gen Infirm, Radiol Acad, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary; University of Leeds	Mirsadraee, S (corresponding author), Leeds Gen Infirm, Radiol Acad, Leeds LS1 3EX, W Yorkshire, England.	niloogan@yahoo.co.uk						Berna JD, 2000, ABDOM IMAGING, V25, P230, DOI 10.1007/s002610000007; Edlow JA, 1999, ANN EMERG MED, V34, P671, DOI 10.1016/S0196-0644(99)70172-1; Fukuda T, 1996, ABDOM IMAGING, V21, P58, DOI 10.1007/s002619900010; Klingler PJ, 1999, SURG ENDOSC-ULTRAS, V13, P1129, DOI 10.1007/s004649901188; Rimola J, 2007, AM J ROENTGENOL, V188, pW497, DOI 10.2214/AJR.06.0861; Tai CM, 2005, AM J EMERG MED, V23, P911, DOI 10.1016/j.ajem.2005.04.013; TESKE JM, 1946, AM J SURG, V71, P689, DOI 10.1016/0002-9610(46)90453-9	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2009	339								b2870	10.1136/bmj.b2870	http://dx.doi.org/10.1136/bmj.b2870			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481KD	19656832				2022-12-28	WOS:000268808000001
J	Worm, B; Hilborn, R; Baum, JK; Branch, TA; Collie, JS; Costello, C; Fogarty, MJ; Fulton, EA; Hutchings, JA; Jennings, S; Jensen, OP; Lotze, HK; Mace, PM; McClanahan, TR; Minto, C; Palumbi, SR; Parma, AM; Ricard, D; Rosenberg, AA; Watson, R; Zeller, D				Worm, Boris; Hilborn, Ray; Baum, Julia K.; Branch, Trevor A.; Collie, Jeremy S.; Costello, Christopher; Fogarty, Michael J.; Fulton, Elizabeth A.; Hutchings, Jeffrey A.; Jennings, Simon; Jensen, Olaf P.; Lotze, Heike K.; Mace, Pamela M.; McClanahan, Tim R.; Minto, Coilin; Palumbi, Stephen R.; Parma, Ana M.; Ricard, Daniel; Rosenberg, Andrew A.; Watson, Reg; Zeller, Dirk			Rebuilding Global Fisheries	SCIENCE			English	Article							BIODIVERSITY LOSS; FISH; MANAGEMENT; RECOVERY; ESTUARIES; OCEAN	After a long history of overexploitation, increasing efforts to restore marine ecosystems and rebuild fisheries are under way. Here, we analyze current trends from a fisheries and conservation perspective. In 5 of 10 well-studied ecosystems, the average exploitation rate has recently declined and is now at or below the rate predicted to achieve maximum sustainable yield for seven systems. Yet 63% of assessed fish stocks worldwide still require rebuilding, and even lower exploitation rates are needed to reverse the collapse of vulnerable species. Combined fisheries and conservation objectives can be achieved by merging diverse management actions, including catch restrictions, gear modification, and closed areas, depending on local context. Impacts of international fleets and the lack of alternatives to fishing complicate prospects for rebuilding fisheries in many poorer regions, highlighting the need for a global perspective on rebuilding marine resources.	[Worm, Boris; Hutchings, Jeffrey A.; Lotze, Heike K.; Minto, Coilin; Ricard, Daniel] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Hilborn, Ray; Branch, Trevor A.; Jensen, Olaf P.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Baum, Julia K.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Collie, Jeremy S.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Costello, Christopher] Univ Calif Santa Barbara, Donald Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Fogarty, Michael J.] NOAA, Natl Marine Fisheries Serv, Woods Hole, MA 02543 USA; [Fulton, Elizabeth A.] CSIRO Marine & Atmospher Res, Hobart, Tas 7001, Australia; [Jennings, Simon] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England; [Jennings, Simon] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Mace, Pamela M.] Minist Fisheries, Wellington, New Zealand; [McClanahan, Tim R.] Wildlife Conservat Soc Marine Programs, Mombasa, Kenya; [Palumbi, Stephen R.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Parma, Ana M.] Ctr Nacl Patagon, RA-9120 Puerto Madryn, Argentina; [Rosenberg, Andrew A.] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Watson, Reg; Zeller, Dirk] Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	Dalhousie University; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Rhode Island; University of California System; University of California Santa Barbara; National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre for Environment Fisheries & Aquaculture Science; University of East Anglia; Stanford University; Centro Nacional Patagonico (CENPAT); University System Of New Hampshire; University of New Hampshire; University of British Columbia	Worm, B (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.	bworm@dal.ca; rayh@u.washington.edu	Jensen, Olaf/E-4947-2011; Fulton, Beth/A-2871-2008; Hutchings, Jeffrey/ABA-1098-2020; Ricard, Daniel/G-1814-2014; McClanahan, Tim/K-4998-2019; Fulton, Beth/AAJ-1398-2021; Jennings, Simon/F-5085-2012; Watson, Reg A/F-4850-2012; Hilborn, Ray W/D-6332-2013; Branch, Trevor/A-5691-2009	Fulton, Beth/0000-0002-5904-7917; Fulton, Beth/0000-0002-5904-7917; Jennings, Simon/0000-0002-2390-7225; Watson, Reg A/0000-0001-7201-8865; Hutchings, Jeffrey/0000-0003-1572-5429; Zeller, Dirk/0000-0001-7304-4125; Worm, Boris/0000-0002-5742-8716; Minto, Coilin/0000-0003-0630-6775; McClanahan, Timothy/0000-0001-5821-3584; Lotze, Heike/0000-0001-6258-1304	National Center for Ecological Analysis and Synthesis; NSF; University of California, Santa Barbara; Natural Sciences and Engineering Research Council (NSERC); Canadian Foundation for Innovation; Sea Around Us Project; Pew Charitable Trusts	National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Sea Around Us Project; Pew Charitable Trusts	This work was conducted as part of the "Finding common ground in marine conservation and management" Working Group supported by the National Center for Ecological Analysis and Synthesis funded by NSF, the University of California, and the Santa Barbara campus. The authors acknowledge the Natural Sciences and Engineering Research Council (NSERC) and the Canadian Foundation for Innovation for funding database development, the Sea Around Us Project funded by Pew Charitable Trusts for compiling global catch data, and numerous colleagues and institutions around the world for sharing fisheries assessment, catch, access, and survey data, and ecosystem models.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Alder J., 2004, Journal of Environment & Development, V13, P156, DOI 10.1177/1070496504266092; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Branch TA, 2008, CAN J FISH AQUAT SCI, V65, P1435, DOI 10.1139/F08-065; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Caddy JF, 2004, REV FISH BIOL FISHER, V14, P43, DOI 10.1007/s11160-004-3770-2; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Dalton M. G., 2004, MAR RESOUR ECON, V18, P67; Defeo O, 2005, REV FISH BIOL FISHER, V15, P265, DOI 10.1007/s11160-005-4865-0; FAO, 2009, STAT WORLD FISH AQ 2; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Garcia SM, 2003, ECOSYSTEM APPROACH F; Grafton RQ, 2007, SCIENCE, V318, P1601, DOI 10.1126/science.1146017; Hall SJ, 2006, CAN J FISH AQUAT SCI, V63, P1344, DOI 10.1139/F06-039; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hilborn R, 2007, ECOSYSTEMS, V10, P1362, DOI 10.1007/s10021-007-9100-5; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; HUXLEY TH, 1883, IN M FISH C ADDR HUX; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 2007, ICES J MAR SCI, V64, P1525, DOI 10.1093/icesjms/fsm104; LARKIN PA, 1978, ANNU REV ECOL SYST, V9, P57, DOI 10.1146/annurev.es.09.110178.000421; Ley JA, 2002, MAR ECOL PROG SER, V245, P223, DOI 10.3354/meps245223; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Murawski SA, 2000, B MAR SCI, V66, P775; Murawski S, 2007, SCIENCE, V316, P1281; NRC (National Research Council), 2003, COOP RES NAT MAR FIS; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; SAINSBURY KJ, 1997, FISHERIES MANAGEMENT, P107; Sumaila UR, 2007, FISH RES, V88, P1, DOI 10.1016/j.fishres.2007.08.017; Swain DP, 2008, CAN J FISH AQUAT SCI, V65, P2315, DOI 10.1139/F08-175; Swain DP, 2000, CAN J FISH AQUAT SCI, V57, P1321, DOI 10.1139/cjfas-57-7-1321; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	41	1515	1537	23	1315	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2009	325	5940					578	585		10.1126/science.1173146	http://dx.doi.org/10.1126/science.1173146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	477BY	19644114	Green Submitted			2022-12-28	WOS:000268493000042
J	van Os, J; Kapur, S				van Os, Jim; Kapur, Shitij			Schizophrenia	LANCET			English	Review							GENE-ENVIRONMENT INTERACTIONS; RANDOMIZED CONTROLLED-TRIAL; CANNABIS-INDUCED PSYCHOSIS; SEVERE MENTAL-ILLNESS; FOLLOW-UP; 1ST-EPISODE SCHIZOPHRENIA; BIPOLAR DISORDER; LONG-TERM; SCHIZOAFFECTIVE DISORDER; NONAFFECTIVE PSYCHOSES	Schizophrenia is still one of the most mysterious and costliest mental disorders in terms of human suffering and societal expenditure. Here, we focus on the key developments in biology, epidemiology, and pharmacology of schizophrenia and provide a syndromal framework in which these aspects can be understood together. Symptoms typically emerge in adolescence and early adulthood. The incidence of the disorder varies greatly across places and migrant groups, as do symptoms, course, and treatment response across individuals. Genetic vulnerability is shared in part with bipolar disorder and recent molecular genetic findings also indicate an overlap with developmental disorders such as autism. The diagnosis of schizophrenia is associated with demonstrable alterations in brain structure and changes in dopamine neurotransmission, the latter being directly related to hallucinations and delusions. Pharmacological treatments, which block the dopamine system, are effective for delusions and hallucinations but less so for disabling cognitive and motivational impairments. Specific vocational and psychological interventions, in combination with antipsychotic medication in a context of community-case management, can improve functional outcome but are not widely available. 100 years after being so named, research is beginning to understand the biological mechanisms underlying the symptoms of schizophrenia and the psychosocial factors that moderate their expression. Although current treatments provide control rather than cure, long-term hospitalisation is not required and prognosis is better than traditionally assumed.	[van Os, Jim] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol,EURON, S Limburg Mental Hlth Res & Teaching Network, NL-6200 MD Maastricht, Netherlands; [van Os, Jim; Kapur, Shitij] Kings Coll London, Div Psychol Med, Inst Psychiat, London WC2R 2LS, England	Maastricht University; University of London; King's College London	van Os, J (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat & Psychol,EURON, S Limburg Mental Hlth Res & Teaching Network, POB 616, NL-6200 MD Maastricht, Netherlands.	j.vanos@sp.unimaas.nl	van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019; Zhang, Xiao/V-9027-2017; Mortensen, Preben Bo/D-2358-2015	van Os, Jim/0000-0002-7245-1586; Zhang, Xiao/0000-0002-2932-5875; Mortensen, Preben Bo/0000-0002-5230-9865; Kapur, Shitij/0000-0002-2231-2924	Medical Research Council [G0800509, MR/L010305/1] Funding Source: Medline; Medical Research Council [G0701748] Funding Source: Medline; NIDA NIH HHS [R21 DA040127, DA-040127] Funding Source: Medline; NIMH NIH HHS [MH-092443, MH-069853, MH-105660, MH-084018, MH-094268, MH-085226, R01 MH105660, R01 MH092443, P50 MH094268, MH-088753] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0701748] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agid O, 2008, EXPERT OPIN EMERG DR, V13, P479, DOI [10.1517/14728214.13.3.479, 10.1517/14728214.13.3.479 ]; ALLARDYCE J, 2008, DIMENSIONAL APPROACH, P53; Allen AJ, 2009, SCHIZOPHR RES, V109, P24, DOI 10.1016/j.schres.2009.01.016; An Der Heiden W., 1995, Nervenarzt, V66, P820; Arendt M, 2005, BRIT J PSYCHIAT, V187, P510, DOI 10.1192/bjp.187.6.510; Arendt M, 2008, ARCH GEN PSYCHIAT, V65, P1269, DOI 10.1001/archpsyc.65.11.1269; Artaloytia JF, 2006, AM J PSYCHIAT, V163, P488, DOI 10.1176/appi.ajp.163.3.488; Arts B, 2008, PSYCHOL MED, V38, P771, DOI 10.1017/S0033291707001675; Beauchamp G, 2004, SOC PSYCH PSYCH EPID, V39, P1017, DOI 10.1007/s00127-004-0844-3; Bentall R, 2006, MED HYPOTHESES, V66, P220, DOI 10.1016/j.mehy.2005.09.026; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Bertelsen M, 2008, ARCH GEN PSYCHIAT, V65, P762, DOI 10.1001/archpsyc.65.7.762; BLAND RC, 1978, ARCH GEN PSYCHIAT, V35, P72; Boevink WA, 2006, SCHIZOPHRENIA BULL, V32, P17, DOI 10.1093/schbul/sbi068; Boos HBM, 2007, ARCH GEN PSYCHIAT, V64, P297, DOI 10.1001/archpsyc.64.3.297; Boydell J, 2001, BMJ-BRIT MED J, V323, P1336, DOI 10.1136/bmj.323.7325.1336; Bramon E, 2005, NEUROIMAGE, V27, P960, DOI 10.1016/j.neuroimage.2005.05.022; Brockington I., 1992, European Psychiatry, V7, P203; Brown AS, 2008, SCHIZOPHRENIA BULL, V34, P1054, DOI 10.1093/schbul/sbn096; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Buchanan RW, 2007, SCHIZOPHRENIA BULL, V33, P1120, DOI 10.1093/schbul/sbm083; Buckley PF, 2007, ACTA PSYCHIAT SCAND, V115, P93, DOI 10.1111/j.1600-0447.2007.00992.x; Burns T, 2007, LANCET, V370, P1146, DOI 10.1016/S0140-6736(07)61516-5; Burns T, 2007, BRIT MED J, V335, P336, DOI 10.1136/bmj.39251.599259.55; Cannon M, 2002, ARCH GEN PSYCHIAT, V59, P449, DOI 10.1001/archpsyc.59.5.449; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Cannon TD, 2007, SCHIZOPHRENIA BULL, V33, P661, DOI 10.1093/schbul/sbm031; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; CASTLE DJ, 1993, BRIT J PSYCHIAT, V162, P658, DOI 10.1192/bjp.162.5.658; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; CIOMPI L, 1980, SCHIZOPHRENIA BULL, V6, P606, DOI 10.1093/schbul/6.4.606; Cleary M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001088.pub2; Cougnard A, 2005, SCHIZOPHR RES, V74, P27, DOI 10.1016/j.schres.2004.09.018; Craddock N, 2007, WORLD PSYCHIATRY, V6, P20; D'Souza DC, 2005, BIOL PSYCHIAT, V57, P594, DOI 10.1016/j.biopsych.2004.12.006; D'Souza DC, 2004, NEUROPSYCHOPHARMACOL, V29, P1558, DOI 10.1038/sj.npp.1300496; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Dominguez MD, 2009, PSYCHOL BULL, V135, P157, DOI 10.1037/a0014415; EATON WW, 1995, ARCH GEN PSYCHIAT, V52, P127; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fine Cordelia, 2007, Cogn Neuropsychiatry, V12, P46, DOI 10.1080/13546800600750597; Fioravanti M, 2005, NEUROPSYCHOL REV, V15, P73, DOI 10.1007/s11065-005-6254-9; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Freeman D, 2008, SCHIZOPHRENIA BULL, V34, P605, DOI 10.1093/schbul/sbn020; Frese FJ, 2009, SCHIZOPHRENIA BULL, V35, P370, DOI 10.1093/schbul/sbn175; Fusar-Poli P, 2007, NEUROSCI BIOBEHAV R, V31, P465, DOI 10.1016/j.neubiorev.2006.11.006; Ganev K, 1998, ACTA PSYCHIAT SCAND, V98, P200, DOI 10.1111/j.1600-0447.1998.tb10067.x; Garety PA, 2001, PSYCHOL MED, V31, P189, DOI 10.1017/S0033291701003312; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Goldberg TE, 2007, ARCH GEN PSYCHIAT, V64, P1115, DOI 10.1001/archpsyc.64.10.1115; Goldman AL, 2008, BIOL PSYCHIAT, V63, P475, DOI 10.1016/j.biopsych.2007.06.006; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Greenwood TA, 2007, ARCH GEN PSYCHIAT, V64, P1242, DOI 10.1001/archpsyc.64.11.1242; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; Hall FS, 1999, SYNAPSE, V32, P37; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Henquet C, 2006, NEUROPSYCHOPHARMACOL, V31, P2748, DOI 10.1038/sj.npp.1301197; Jacobs N, 2006, PSYCHOSOM MED, V68, P201, DOI 10.1097/01.psy.0000204919.15727.43; Jensen J, 2008, NEUROPSYCHOPHARMACOL, V33, P473, DOI 10.1038/sj.npp.1301437; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kapur S, 2004, TRENDS PHARMACOL SCI, V25, P402, DOI 10.1016/j.tips.2004.06.005; Kapur Shitij, 2006, NeuroRx, V3, P10, DOI 10.1016/j.nurx.2005.12.003; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P645; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; Kingdon D, 2008, SOC PSYCH PSYCH EPID, V43, P239, DOI 10.1007/s00127-007-0284-y; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Laruelle M, 1998, Q J NUCL MED, V42, P211; Leboyer M, 2008, SCHIZOPHR RES, V102, P21, DOI 10.1016/j.schres.2008.04.003; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Linscott RJ, 2010, SCHIZOPHRENIA BULL, V36, P811, DOI 10.1093/schbul/sbn181; March D, 2008, EPIDEMIOL REV, V30, P84, DOI 10.1093/epirev/mxn006; MARNEROS A, 1992, BRIT J PSYCHIAT, V161, P44, DOI 10.1192/S0007125000297043; Marshall M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004718.pub2; Marshall M, 2000, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001089, DOI 10.1002/14651858.CD001089]; Mason P, 1996, BRIT J PSYCHIAT, V169, P580, DOI 10.1192/bjp.169.5.580; MCCREADIE RG, 1989, ACTA PSYCHIAT SCAND, V80, P597; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; McGurk SR, 2007, AM J PSYCHIAT, V164, P1791, DOI 10.1176/appi.ajp.2007.07060906; Menezes NM, 2006, PSYCHOL MED, V36, P1349, DOI 10.1017/S0033291706007951; Mizrahi R, 2007, AM J PSYCHIAT, V164, P630, DOI 10.1176/appi.ajp.164.4.630; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Morgan C, 2008, PSYCHOL MED, V38, P1701, DOI 10.1017/S0033291708004534; Morrison AP, 2003, BRIT J CLIN PSYCHOL, V42, P331, DOI 10.1348/014466503322528892; Morrison PD, 2009, PSYCHOL MED, V39, P1607, DOI 10.1017/S0033291709005522; Mortensen PB, 2003, ARCH GEN PSYCHIAT, V60, P1209, DOI 10.1001/archpsyc.60.12.1209; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Muller V, 1951, MON PSYCHIATR NEUROL, V122, P257; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Murray RM, 2007, NAT REV NEUROSCI, V8, P885, DOI 10.1038/nrn2253; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Nose M, 2003, BRIT J PSYCHIAT, V183, P197, DOI 10.1192/bjp.183.3.197; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Donovan MC, 2008, NAT GENET, V40, P1392, DOI 10.1038/ng1208-1392; Patel JK, 2009, SCHIZOPHR RES, V111, P9, DOI 10.1016/j.schres.2009.03.025; Patterson JV, 2008, PSYCHIAT RES, V158, P226, DOI 10.1016/j.psychres.2007.02.009; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; RABINER CJ, 1986, AM J PSYCHIAT, V143, P1155; Reichenberg A, 2002, AM J PSYCHIAT, V159, P2027, DOI 10.1176/appi.ajp.159.12.2027; Robinson D, 1999, ARCH GEN PSYCHIAT, V56, P241, DOI 10.1001/archpsyc.56.3.241; Roiser JP, 2009, PSYCHOL MED, V39, P199, DOI 10.1017/S0033291708003863; Roy MA, 2001, SCHIZOPHR RES, V47, P141, DOI 10.1016/S0920-9964(99)00231-5; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; SALOKANGAS RKR, 1983, BRIT J PSYCHIAT, V142, P145, DOI 10.1192/bjp.142.2.145; SARTORIUS N, 1986, PSYCHOL MED, V16, P909, DOI 10.1017/S0033291700011910; Sato M, 2006, WORLD PSYCHIATRY, V5, P53; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SHEPHERD M, 1989, PSYCHOL MED S, V15, P46; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; STEPHENS JH, 1978, SCHIZOPHRENIA BULL, V4, P25, DOI 10.1093/schbul/4.1.25; Stirling J, 2003, SCHIZOPHR RES, V65, P75, DOI 10.1016/S0920-9964(03)00014-8; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szoke A, 2008, BRIT J PSYCHIAT, V192, P248, DOI 10.1192/bjp.bp.106.029009; Tarbox SI, 2008, PSYCHOL BULL, V134, P561, DOI 10.1037/0033-2909.34.4.561; THARA R, 1994, ACTA PSYCHIAT SCAND, V90, P329, DOI 10.1111/j.1600-0447.1994.tb01602.x; Thompson A, 2008, PSYCHOL MED, V38, P705, DOI 10.1017/S003329170700147X; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; Toulopoulou T, 2007, ARCH GEN PSYCHIAT, V64, P1348, DOI 10.1001/archpsyc.64.12.1348; Twamley EW, 2003, J NERV MENT DIS, V191, P515, DOI 10.1097/01.nmd.0000082213.42509.69; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117; van Os J, 2009, BRIT J PSYCHIAT, V194, P101, DOI 10.1192/bjp.bp.108.054254; van Veldhuizen JR, 2007, COMMUNITY MENT HLT J, V43, P421, DOI 10.1007/s10597-007-9089-4; van Zelst C, 2009, SCHIZOPHRENIA BULL, V35, P293, DOI 10.1093/schbul/sbn184; VANOS J, 2009, KAPLAN SADO IN PRESS; Vazquez-Barquero JL, 1999, BRIT J PSYCHIAT, V174, P141, DOI 10.1192/bjp.174.2.141; Veling W, 2008, AM J PSYCHIAT, V165, P66, DOI 10.1176/appi.ajp.2007.07030423; Vita A, 2006, SCHIZOPHR RES, V82, P75, DOI 10.1016/j.schres.2005.11.004; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiser M, 2009, SCHIZOPHRENIA BULL, V35, P74; WELHAM J, 2009, PSYCHOL MED, V166, P567; Welham J, 2009, SCHIZOPHRENIA BULL, V35, P603, DOI 10.1093/schbul/sbn084; Wiersma D, 1998, SCHIZOPHRENIA BULL, V24, P75, DOI 10.1093/oxfordjournals.schbul.a033315; Wieselgren IM, 1996, ACTA PSYCHIAT SCAND, V94, P311, DOI 10.1111/j.1600-0447.1996.tb09866.x; Wobrock T, 2008, PROG NEURO-PSYCHOPH, V32, P1375, DOI 10.1016/j.pnpbp.2008.02.008; Wohl M, 2007, EUR PSYCHIAT, V22, P22, DOI 10.1016/j.eurpsy.2006.08.007; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242; Wright C, 2004, SOC PSYCH PSYCH EPID, V39, P789, DOI 10.1007/s00127-004-0818-5; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P283, DOI 10.1093/schbul/22.2.283; Zammit S, 2004, ARCH GEN PSYCHIAT, V61, P354, DOI 10.1001/archpsyc.61.4.354; Zygmunt A, 2002, AM J PSYCHIAT, V159, P1653, DOI 10.1176/appi.ajp.159.10.1653	152	1626	1674	48	856	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2009	374	9690					635	645		10.1016/S0140-6736(09)60995-8	http://dx.doi.org/10.1016/S0140-6736(09)60995-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19700006				2022-12-28	WOS:000269222600024
